PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bendesky, A; Tsunozaki, M; Rockman, MV; Kruglyak, L; Bargmann, CI				Bendesky, Andres; Tsunozaki, Makoto; Rockman, Matthew V.; Kruglyak, Leonid; Bargmann, Cornelia I.			Catecholamine receptor polymorphisms affect decision-making in C. elegans	NATURE			English	Article							QUANTITATIVE TRAIT LOCUS; CARBON-DIOXIDE AVOIDANCE; DEPENDENT PROTEIN-KINASE; CAENORHABDITIS-ELEGANS; PHEROMONE ATTRACTION; NATURAL VARIATION; SOCIAL-BEHAVIOR; OCTOPAMINE; TYRAMINE; NEURONS	Innate behaviours are flexible: they change rapidly in response to transient environmental conditions, and are modified slowly by changes in the genome. A classical flexible behaviour is the exploration-exploitation decision, which describes the time at which foraging animals choose to abandon a depleting food supply. We have used quantitative genetic analysis to examine the decision to leave a food patch in Caenorhabditis elegans. Here we show that patch-leaving is a multigenic trait regulated in part by naturally occurring non-coding polymorphisms in tyra-3 (tyramine receptor 3), which encodes a G-protein-coupled catecholamine receptor related to vertebrate adrenergic receptors. tyra-3 acts in sensory neurons that detect environmental cues, suggesting that the internal catecholamines detected by tyra-3 regulate responses to external conditions. These results indicate that genetic variation and environmental cues converge on common circuits to regulate behaviour, and suggest that catecholamines have an ancient role in regulating behavioural decisions.	[Bendesky, Andres; Tsunozaki, Makoto; Bargmann, Cornelia I.] Rockefeller Univ, Howard Hughes Med Inst, Lab Neural Circuits & Behav, New York, NY 10065 USA; [Rockman, Matthew V.] New York Univ, Dept Biol, New York, NY 10003 USA; [Rockman, Matthew V.] New York Univ, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Kruglyak, Leonid] Princeton Univ, Howard Hughes Med Inst, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Kruglyak, Leonid] Princeton Univ, Dept Ecol & Evolutionary Biol, Carl Icahn Lab, Princeton, NJ 08544 USA	Howard Hughes Medical Institute; Rockefeller University; New York University; New York University; Howard Hughes Medical Institute; Princeton University; Princeton University	Bargmann, CI (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Neural Circuits & Behav, New York, NY 10065 USA.	cori@rockefeller.edu		Bendesky, Andres/0000-0002-4220-3653; Bargmann, Cornelia/0000-0002-8484-0618	Secretaria de Educacion Publica of Mexico; Rockefeller University; HHMI; NIH [GM089972]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089972] Funding Source: NIH RePORTER	Secretaria de Educacion Publica of Mexico; Rockefeller University; HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Shingai for strains, and P. McGrath and members of the C. I. B. laboratory for discussions. A. B. was supported by the Secretaria de Educacion Publica of Mexico and by The Rockefeller University. C. I. B. and L. K. are Investigators of the Howard Hughes Medical Institute. This work was supported by HHMI and by NIH grant GM089972.	Ahringer J., 2006, WORMBOOK, P1, DOI [DOI 10.1895/WORMBOOK.1.47.1, 10.1895/wormbook.1.47.1]; Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; Bargmann CI, 1995, METHOD CELL BIOL, V48, P225; Barrett HC, 2000, TRENDS COGN SCI, V4, P251, DOI 10.1016/S1364-6613(00)01495-9; Bretscher AJ, 2008, P NATL ACAD SCI USA, V105, P8044, DOI 10.1073/pnas.0707607105; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chelur DS, 2007, P NATL ACAD SCI USA, V104, P2283, DOI 10.1073/pnas.0610877104; Crocker A, 2008, J NEUROSCI, V28, P9377, DOI 10.1523/JNEUROSCI.3072-08a.2008; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Edwards AC, 2009, GENETICS, V182, P889, DOI 10.1534/genetics.109.101691; Flint J, 2009, GENOME RES, V19, P723, DOI 10.1101/gr.086660.108; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Gerke J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001144; Gloria-Soria A, 2008, CURR BIOL, V18, P1694, DOI 10.1016/j.cub.2008.09.043; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Greer ER, 2008, CELL METAB, V8, P118, DOI 10.1016/j.cmet.2008.06.005; Hallem EA, 2008, P NATL ACAD SCI USA, V105, P8038, DOI 10.1073/pnas.0707469105; Harvey SC, 2009, J EXP ZOOL PART B, V312B, P224, DOI 10.1002/jez.b.21287; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Hong RL, 2008, P NATL ACAD SCI USA, V105, P7779, DOI 10.1073/pnas.0708406105; Hoyer SC, 2008, CURR BIOL, V18, P159, DOI 10.1016/j.cub.2007.12.052; Kim K, 2009, SCIENCE, V326, P994, DOI 10.1126/science.1176331; Legare ME, 2000, GENOME RES, V10, P42; Lipton J, 2004, J NEUROSCI, V24, P7427, DOI 10.1523/JNEUROSCI.1746-04.2004; Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; March JG, 1991, ORGAN SCI, V2, P71, DOI 10.1287/orsc.2.1.71; McGrath PT, 2009, NEURON, V61, P692, DOI 10.1016/j.neuron.2009.02.012; Mello C, 1995, METHOD CELL BIOL, V48, P451; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Pirri JK, 2009, NEURON, V62, P526, DOI 10.1016/j.neuron.2009.04.013; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Reaume Christopher J., 2009, V191, P423, DOI 10.1007/978-3-540-68964-5_18; Reddy KC, 2009, SCIENCE, V323, P382, DOI 10.1126/science.1166527; Rockman MV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000419; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Rogers C, 2006, CURR BIOL, V16, P649, DOI 10.1016/j.cub.2006.03.023; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Stephens DW., 2007, FORAGING BEHAV ECOLO, DOI 10.7208/chicago/9780226772653.001.0001; Styer KL, 2008, SCIENCE, V322, P460, DOI 10.1126/science.1163673; Suo S, 2006, J NEUROSCI, V26, P10082, DOI 10.1523/JNEUROSCI.0819-06.2006; Thomson MJ, 2006, GENETICS, V172, P2501, DOI 10.1534/genetics.105.050500; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Wakabayashi T, 2004, NEUROSCI RES, V50, P103, DOI 10.1016/j.neures.2004.06.005; Wragg RT, 2007, J NEUROSCI, V27, P13402, DOI 10.1523/JNEUROSCI.3495-07.2007; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450; Young LJ, 1999, NATURE, V400, P766, DOI 10.1038/23475; Zimmer M, 2009, NEURON, V61, P865, DOI 10.1016/j.neuron.2009.02.013	56	131	132	3	54	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					313	U207		10.1038/nature09821	http://dx.doi.org/10.1038/nature09821			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21412235	Green Submitted, Green Accepted			2022-12-28	WOS:000289724600032
J	Brennan, DF; Dar, AC; Hertz, NT; Chao, WCH; Burlingame, AL; Shokat, KM; Barford, D				Brennan, Damian F.; Dar, Arvin C.; Hertz, Nicholas T.; Chao, William C. H.; Burlingame, Alma L.; Shokat, Kevan M.; Barford, David			A Raf-induced allosteric transition of KSR stimulates phosphorylation of MEK	NATURE			English	Article							KINASE SUPPRESSOR; GENE ENCODES; WEB SERVER; PROTEIN; ACTIVATION; INHIBITOR; MECHANISM; DOMAIN; SCAFFOLDS; PATHWAY	In metazoans, the Ras-Raf-MEK (mitogen-activated protein-kinase kinase)-ERK (extracellular signal-regulated kinase) signalling pathway relays extracellular stimuli to elicit changes in cellular function and gene expression. Aberrant activation of this pathway through oncogenic mutations is responsible for a large proportion of human cancer. Kinase suppressor of Ras (KSR)(1-3) functions as an essential scaffolding protein to coordinate the assembly of Raf-MEK-ERK complexes(4,5). Here we integrate structural and biochemical studies to understand how KSR promotes stimulatory Raf phosphorylation of MEK (refs 6, 7). We show, from the crystal structure of the kinase domain of human KSR2 (KSR2(KD)) in complex with rabbit MEK1, that interactions between KSR2(KD) and MEK1 are mediated by their respective activation segments and C-lobe alpha G helices. Analogous to BRAF (refs 8, 9), KSR2 self-associates through a side-to-side interface involving Arg 718, a residue identified in a genetic screen as a suppressor of Ras signalling(1-3). ATP is bound to the KSR2(KD) catalytic site, and we demonstrate KSR2 kinase activity towards MEK1 by in vitro assays and chemical genetics. In the KSR2(KD)-MEK1 complex, the activation segments of both kinases are mutually constrained, and KSR2 adopts an inactive conformation. BRAF allosterically stimulates the kinase activity of KSR2, which is dependent on formation of a side-to-side KSR2-BRAF heterodimer. Furthermore, KSR2-BRAF heterodimerization results in an increase of BRAF-induced MEK phosphorylation via the KSR2-mediated relay of a signal from BRAF to release the activation segment of MEK for phosphorylation. We propose that KSR interacts with a regulatory Raf molecule in cis to induce a conformational switch of MEK, facilitating MEK's phosphorylation by a separate catalytic Raf molecule in trans.	[Brennan, Damian F.; Chao, William C. H.; Barford, David] Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England; [Dar, Arvin C.; Hertz, Nicholas T.; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94107 USA; [Dar, Arvin C.; Hertz, Nicholas T.; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94107 USA; [Burlingame, Alma L.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94107 USA	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Barford, D (corresponding author), Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, 237 Fulham Rd, London SW3 6JB, England.	shokat@cmp.ucsf.edu; david.barford@ic.ac.uk		Hertz, Nicholas/0000-0002-6527-6898	Cancer Research UK; ICR; HHMI; NIH [NCRR RR015804, NCRR RR001614]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015804, P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); ICR; HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Cancer Research UK grant to D. B., ICR studentships to D. F. B. and W. C. H. C. and HHMI grant to K. M. S. We thank staff at the ESRF for help with data collection and K. Wood and V. Good for help with protein production and Z. Zhang for assistance with cloning. Mass spectrometry was made possible by NIH grants NCRR RR015804 and NCRR RR001614. The MEK1/p50<SUP>Cdc37</SUP> baculovirus was a gift from C. Vaughan. We thank Cell Signaling Technologies for help with phosphospecific MEK antibodies.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Allen JJ, 2007, NAT METHODS, V4, P511, DOI 10.1038/nmeth1048; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bankston D, 2002, ORG PROCESS RES DEV, V6, P777, DOI 10.1021/op020205n; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cai Z, 2009, MOL CELL, V35, P818, DOI 10.1016/j.molcel.2009.09.007; Claperon A, 2007, ONCOGENE, V26, P3143, DOI 10.1038/sj.onc.1210408; Claude JB, 2004, NUCLEIC ACIDS RES, V32, pW606, DOI 10.1093/nar/gkh400; Cronin CN, 2007, PROTEIN SCI, V16, P2023, DOI 10.1110/ps.072931407; Denouel-Galy A, 1998, CURR BIOL, V8, P46, DOI 10.1016/S0960-9822(98)70019-3; Douziech M, 2006, GENE DEV, V20, P807, DOI 10.1101/gad.1390406; Fischmann TO, 2009, BIOCHEMISTRY-US, V48, P2661, DOI 10.1021/bi801898e; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hertz Nicholas T, 2010, Curr Protoc Chem Biol, V2, P15, DOI 10.1002/9780470559277.ch090201; Iverson C, 2009, CANCER RES, V69, P6839, DOI 10.1158/0008-5472.CAN-09-0679; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; KORNFELD K, 1995, CELL, V83, P903, DOI 10.1016/0092-8674(95)90206-6; McGuffin LJ, 2003, BIOINFORMATICS, V19, P874, DOI 10.1093/bioinformatics/btg097; McKay MM, 2009, P NATL ACAD SCI USA, V106, P11022, DOI 10.1073/pnas.0901590106; Michaud NR, 1997, P NATL ACAD SCI USA, V94, P12792, DOI 10.1073/pnas.94.24.12792; Muller J, 2000, MOL CELL BIOL, V20, P5529, DOI 10.1128/MCB.20.15.5529-5539.2000; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Poirot O, 2004, NUCLEIC ACIDS RES, V32, pW37, DOI 10.1093/nar/gkh382; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Roy F, 2002, GENE DEV, V16, P427, DOI 10.1101/gad.962902; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Statsuk AV, 2008, J AM CHEM SOC, V130, P17568, DOI 10.1021/ja807066f; Stewart S, 1999, MOL CELL BIOL, V19, P5523; Sugimoto T, 1998, EMBO J, V17, P1717, DOI 10.1093/emboj/17.6.1717; SUNDARAM M, 1995, CELL, V83, P889, DOI 10.1016/0092-8674(95)90205-8; THERRIEN M, 1995, CELL, V83, P879, DOI 10.1016/0092-8674(95)90204-X; Therrien M, 1996, GENE DEV, V10, P2684, DOI 10.1101/gad.10.21.2684; Trinidad JC, 2008, MOL CELL PROTEOMICS, V7, P684, DOI 10.1074/mcp.M700170-MCP200; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yu W, 1998, CURR BIOL, V8, P56, DOI 10.1016/S0960-9822(98)70020-X; Zhang YH, 1997, CELL, V89, P63, DOI 10.1016/S0092-8674(00)80183-X	39	185	189	3	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					366	U134		10.1038/nature09860	http://dx.doi.org/10.1038/nature09860			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21441910				2022-12-28	WOS:000289724600043
J	Cooper, DJ; Rosenfeld, JV; Murray, L; Arabi, YM; Davies, AR; D'Urso, P; Kossmann, T; Ponsford, J; Seppelt, I; Reilly, P; Wolfe, R				Cooper, D. James; Rosenfeld, Jeffrey V.; Murray, Lynnette; Arabi, Yaseen M.; Davies, Andrew R.; D'Urso, Paul; Kossmann, Thomas; Ponsford, Jennie; Seppelt, Ian; Reilly, Peter; Wolfe, Rory		DECRA Trial Investigators; Australian New Zealand Intensive C	Decompressive Craniectomy in Diffuse Traumatic Brain Injury	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GLASGOW OUTCOME SCALE; SEVERE HEAD-INJURY; REFRACTORY INTRACRANIAL HYPERTENSION; AXONAL STRETCH INJURY; STRUCTURED INTERVIEWS; CLINICAL-TRIALS; CEREBRAL EDEMA; MANAGEMENT; SECONDARY; PRESSURE	BACKGROUND It is unclear whether decompressive craniectomy improves the functional outcome in patients with severe traumatic brain injury and refractory raised intracranial pressure. METHODS From December 2002 through April 2010, we randomly assigned 155 adults with severe diffuse traumatic brain injury and intracranial hypertension that was refractory to first-tier therapies to undergo either bifrontotemporoparietal decompressive craniectomy or standard care. The original primary outcome was an unfavorable outcome (a composite of death, vegetative state, or severe disability), as evaluated on the Extended Glasgow Outcome Scale 6 months after the injury. The final primary outcome was the score on the Extended Glasgow Outcome Scale at 6 months. RESULTS Patients in the craniectomy group, as compared with those in the standard-care group, had less time with intracranial pressures above the treatment threshold (P<0.001), fewer interventions for increased intracranial pressure (P<0.02 for all comparisons), and fewer days in the intensive care unit (ICU) (P<0.001). However, patients undergoing craniectomy had worse scores on the Extended Glasgow Outcome Scale than those receiving standard care (odds ratio for a worse score in the craniectomy group, 1.84; 95% confidence interval [CI], 1.05 to 3.24; P = 0.03) and a greater risk of an unfavorable outcome (odds ratio, 2.21; 95% CI, 1.14 to 4.26; P = 0.02). Rates of death at 6 months were similar in the craniectomy group (19%) and the standard-care group (18%). CONCLUSIONS In adults with severe diffuse traumatic brain injury and refractory intracranial hypertension, early bifrontotemporoparietal decompressive craniectomy decreased intracranial pressure and the length of stay in the ICU but was associated with more unfavorable outcomes.	[Cooper, D. James; Murray, Lynnette; Davies, Andrew R.] Alfred Hosp, Dept Intens Care, Melbourne, Vic 3004, Australia; [Rosenfeld, Jeffrey V.] Alfred Hosp, Dept Neurosurg, Melbourne, Vic 3004, Australia; [Cooper, D. James; Murray, Lynnette; Davies, Andrew R.; Ponsford, Jennie; Wolfe, Rory] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Rosenfeld, Jeffrey V.] Monash Univ, Dept Surg, Melbourne, Vic 3004, Australia; [D'Urso, Paul] Epworth Healthcare, Neurosci Clin Inst, Melbourne, Vic, Australia; [Ponsford, Jennie] Epworth Healthcare, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [Kossmann, Thomas] Epworth Med Fdn, Melbourne, Vic, Australia; [Seppelt, Ian] Univ Sydney, Dept Intens Care Med, Nepean Hosp, Sydney, NSW 2006, Australia; [Reilly, Peter] Royal Adelaide Hosp, Dept Neurosurg, Adelaide, SA 5000, Australia; [Arabi, Yaseen M.] King Saud Bin Abdulaziz Univ Hlth Sci, Dept Intens Care, Riyadh, Saudi Arabia	Florey Institute of Neuroscience & Mental Health; Florey Institute of Neuroscience & Mental Health; Monash University; Monash University; Monash University; Epworth Medical Foundation; Nepean Hospital; University of Sydney; Royal Adelaide Hospital; King Saud Bin Abdulaziz University for Health Sciences	Cooper, DJ (corresponding author), Alfred Hosp, Dept Intens Care, Commercial Rd, Melbourne, Vic 3004, Australia.	jamie.cooper@monash.edu	Wolfe, Rory/F-5185-2013; Venkatesh, Bala/F-4700-2010; Cooper, D. James/G-7961-2013; Joyce, Christopher/B-7437-2013; Arabi, Yaseen/ABF-3316-2020; Presneill, Jeffrey J/B-4894-2012; Rosenfeld, Jeffrey V/B-7249-2011	Cooper, D. James/0000-0002-5872-9051; Arabi, Yaseen/0000-0001-5735-6241; Presneill, Jeffrey J/0000-0001-7177-7667; Myles, Paul/0000-0002-3324-5456; Micallef, Sharon/0000-0002-8496-2324; Wolfe, Rory/0000-0002-2126-1045; Reilly, Peter/0000-0003-3173-0666; Venkatesh, Bala/0000-0002-3234-5244	National Health and Medical Research Council of Australia [NHMRC 314502]; Transport Accident Commission of Victoria (Victorian Trauma Foundation and Victorian Neurotrauma Initiative); Intensive Care Foundation (Australia); Western Australian Institute for Medical Research	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Transport Accident Commission of Victoria (Victorian Trauma Foundation and Victorian Neurotrauma Initiative); Intensive Care Foundation (Australia); Western Australian Institute for Medical Research	Supported by grants from the National Health and Medical Research Council of Australia (NHMRC 314502), the Transport Accident Commission of Victoria (Victorian Trauma Foundation and Victorian Neurotrauma Initiative), the Intensive Care Foundation (Australia), and the Western Australian Institute for Medical Research.	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Arikan R, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003983-PUB2; Australian Bureau of Statistics, 2011, POP CLOCK; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS14, DOI 10.1089/neu.2007.9994; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Bullock AR, 2006, NEUROSURGERY, V58, pVI; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chung RS, 2005, J NEUROTRAUM, V22, P1081, DOI 10.1089/neu.2005.22.1081; Cooper DJ, 2008, J CRIT CARE, V23, P387, DOI 10.1016/j.jcrc.2007.05.002; COOPER PR, 1979, NEUROSURGERY, V4, P296, DOI 10.1227/00006123-197904000-00004; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Menon DK, 1999, BRIT MED BULL, V55, P226, DOI 10.1258/0007142991902231; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Pettigrew LEL, 1998, J NEUROSURG, V89, P939, DOI 10.3171/jns.1998.89.6.0939; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Soustiel JF, 2010, NEUROSURGERY, V67, P65, DOI 10.1227/01.NEU.0000370604.30037.F5; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; The Victorian Neurotrauma Initiative, 2009, EC COST SPIN CORD IN; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Venkatesh B, 2004, INTENS CARE MED, V30, P510, DOI 10.1007/s00134-003-2102-7; Whitfield PC, 2001, BRIT J NEUROSURG, V15, P500, DOI 10.1080/02688690120105110; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	34	918	976	2	94	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2011	364	16					1493	1502		10.1056/NEJMoa1102077	http://dx.doi.org/10.1056/NEJMoa1102077			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752VH	21434843				2022-12-28	WOS:000289722700006
J	Garcia, NVD; Karayannis, T; Fishell, G				Garcia, Natalia V. De Marco; Karayannis, Theofanis; Fishell, Gord			Neuronal activity is required for the development of specific cortical interneuron subtypes	NATURE			English	Article							ELECTRICAL-ACTIVITY; IN-VIVO; GANGLIONIC EMINENCE; APOPTOTIC CELLS; CEREBRAL-CORTEX; MIGRATION; NETWORKS; MOUSE; PROJECTIONS; ENGULFMENT	Electrical activity has been shown to regulate development in a variety of species and in various structures(1), including the retina(2-4), spinal cord(5,6) and cortex(5). Within the mammalian cortex specifically, the development of dendrites and commissural axons in pyramidal cells is activity-dependent(7,8). However, little is known about the developmental role of activity in the other major cortical population of neurons, the GABA-producing interneurons. These neurons are morphologically and functionally heterogeneous and efforts over the past decade have focused on determining the mechanisms that contribute to this diversity(9-11). It was recently discovered that 30% of all cortical interneurons arise from a relatively novel source within the ventral telencephalon, the caudal ganglionic eminence (CGE)(11,12). Owing to their late birth date, these interneurons populate the cortex only after the majority of other interneurons and pyramidal cells are already in place and have started to functionally integrate. Here we demonstrate in mice that for CGE-derived reelin (Re)-positive and calretinin (Cr)-positive (but not vasoactive intestinal peptide (VIP)-positive) interneurons(12,13), activity is essential before postnatal day 3 for correct migration, and that after postnatal day 3, glutamate-mediated activity controls the development of their axons and dendrites. Furthermore, we show that the engulfment and cell motility 1 gene (Elmo1)(14), a target of the transcription factor distal-less homeobox 1 (Dlx1)(15), is selectively expressed in Re+ and Cr+ interneurons and is both necessary and sufficient for activity-dependent interneuron migration. Our findings reveal a selective requirement for activity in shaping the cortical integration of specific neuronal subtypes.	[Garcia, Natalia V. De Marco; Karayannis, Theofanis; Fishell, Gord] NYU, Langone Med Ctr, Smilow Neurosci Program, Dept Cell Biol, New York, NY 10016 USA; [Garcia, Natalia V. De Marco; Karayannis, Theofanis; Fishell, Gord] NYU, Langone Med Ctr, Dept Neural Sci, New York, NY 10016 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center	Fishell, G (corresponding author), NYU, Langone Med Ctr, Smilow Neurosci Program, Dept Cell Biol, 550 1St Ave, New York, NY 10016 USA.	fisheg01@nyumc.org	Karayannis, Theofanis/GRR-3982-2022; Karayannis, Theofanis/O-5194-2014	Karayannis, Theofanis/0000-0002-3267-6254; Fishell, Gordon/0000-0002-9640-9278	Patterson Trust; National Institutes of Health, National Institute of Mental Health [5RO1MH068469-08, 2R01MH071679-09]; National Institute of Neurological Disorders and Stroke [5R01NS039007-1]; New York Stem Cell Science State [NGSG-130]; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039007, R01NS032993] Funding Source: NIH RePORTER	Patterson Trust; National Institutes of Health, National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); New York Stem Cell Science State; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to R. Batista-Brito, E. Chiappe, R. Cossart, J. Dasen, J. Kaltschmidt, S. Lee, J. Hjerling Leffler, M. Long, D. Pisapia and B. Rudy for comments on the manuscript. We thank L. Yin for technical assistance. We are indebted to K. Ravichandran for providing the ELMO1 constructs. N.V.D.G. and T. K. are both supported by grants from The Patterson Trust. Research in the Fishell laboratory is supported by the National Institutes of Health, National Institute of Mental Health (5RO1MH068469-08 and 2R01MH071679-09), National Institute of Neurological Disorders and Stroke (5R01NS039007-1), New York Stem Cell Science State (NGSG-130) and the Simons Foundation.	Allene C, 2010, J PHYSIOL-LONDON, V588, P83, DOI 10.1113/jphysiol.2009.178798; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Batista-Brito R, 2009, CURR TOP DEV BIOL, V87, P81, DOI 10.1016/S0070-2153(09)01203-4; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; Bortone D, 2009, NEURON, V62, P53, DOI 10.1016/j.neuron.2009.01.034; Butt SJB, 2008, NEURON, V59, P722, DOI 10.1016/j.neuron.2008.07.031; Cancedda L, 2007, J NEUROSCI, V27, P5224, DOI 10.1523/JNEUROSCI.5169-06.2007; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; Cobos I, 2007, NEURON, V54, P873, DOI 10.1016/j.neuron.2007.05.024; Dupont E, 2006, NATURE, V439, P79, DOI 10.1038/nature04264; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Karube F, 2004, J NEUROSCI, V24, P2853, DOI 10.1523/JNEUROSCI.4814-03.2004; Khazipov R, 2006, TRENDS NEUROSCI, V29, P414, DOI 10.1016/j.tins.2006.05.007; Manent JB, 2006, J NEUROSCI, V26, P5901, DOI 10.1523/JNEUROSCI.1033-06.2006; McCabe AK, 2006, J PHYSIOL-LONDON, V577, P155, DOI 10.1113/jphysiol.2006.117523; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Root CM, 2008, J NEUROSCI, V28, P4777, DOI 10.1523/JNEUROSCI.4873-07.2008; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Stenman J, 2003, J NEUROSCI, V23, P167; STONE TW, 1993, PHARMACOL REV, V45, P309; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Wang CL, 2007, J NEUROSCI, V27, P11334, DOI 10.1523/JNEUROSCI.3380-07.2007; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; WONG ROL, 1995, NATURE, V374, P716, DOI 10.1038/374716a0; Yang JW, 2009, J NEUROSCI, V29, P9011, DOI 10.1523/JNEUROSCI.5646-08.2009; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7	34	171	172	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					351	U116		10.1038/nature09865	http://dx.doi.org/10.1038/nature09865			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21460837	Green Accepted			2022-12-28	WOS:000289724600040
J	Yu, XJ; Liang, MF; Zhang, SY; Liu, Y; Li, JD; Sun, YL; Zhang, LH; Zhang, QF; Popov, VL; Li, C; Qu, J; Li, Q; Zhang, YP; Hai, R; Wu, W; Wang, Q; Zhan, FX; Wang, XJ; Kan, B; Wang, SW; Wan, KL; Jing, HQ; Lu, JX; Yin, WW; Zhou, H; Guan, XH; Liu, JF; Bi, ZQ; Liu, GH; Ren, J; Wang, H; Zhao, Z; Song, JD; He, JR; Wan, T; Zhang, JS; Fu, XP; Sun, LN; Dong, XP; Feng, ZJ; Yang, WZ; Hong, T; Zhang, Y; Walker, DH; Wang, Y; Li, DX				Yu, Xue-Jie; Liang, Mi-Fang; Zhang, Shou-Yin; Liu, Yan; Li, Jian-Dong; Sun, Yu-Lan; Zhang, Lihong; Zhang, Quan-Fu; Popov, Vsevolod L.; Li, Chuan; Qu, Jing; Li, Qun; Zhang, Yan-Ping; Hai, Rong; Wu, Wei; Wang, Qin; Zhan, Fa-Xian; Wang, Xian-Jun; Kan, Biao; Wang, Shi-Wen; Wan, Kang-Lin; Jing, Huai-Qi; Lu, Jin-Xin; Yin, Wen-Wu; Zhou, Hang; Guan, Xu-Hua; Liu, Jia-Fa; Bi, Zhen-Qiang; Liu, Guo-Hua; Ren, Jun; Wang, Hua; Zhao, Zhuo; Song, Jing-Dong; He, Jin-Rong; Wan, Tao; Zhang, Jing-Shan; Fu, Xiu-Ping; Sun, Li-Na; Dong, Xiao-Ping; Feng, Zi-Jian; Yang, Wei-Zhong; Hong, Tao; Zhang, Yu; Walker, David H.; Wang, Yu; Li, De-Xin			Fever with Thrombocytopenia Associated with a Novel Bunyavirus in China	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN GRANULOCYTIC ANAPLASMOSIS	BACKGROUND Heightened surveillance of acute febrile illness in China since 2009 has led to the identification of a severe fever with thrombocytopenia syndrome (SFTS) with an unknown cause. Infection with Anaplasma phagocytophilum has been suggested as a cause, but the pathogen has not been detected in most patients on laboratory testing. METHODS We obtained blood samples from patients with the case definition of SFTS in six provinces in China. The blood samples were used to isolate the causal pathogen by inoculation of cell culture and for detection of viral RNA on polymerase-chain-reaction assay. The pathogen was characterized on electron microscopy and nucleic acid sequencing. We used enzyme-linked immunosorbent assay, indirect immunofluorescence assay, and neutralization testing to analyze the level of virus-specific antibody in patients' serum samples. RESULTS We isolated a novel virus, designated SFTS bunyavirus, from patients who presented with fever, thrombocytopenia, leukocytopenia, and multiorgan dysfunction. RNA sequence analysis revealed that the virus was a newly identified member of the genus phlebovirus in the Bunyaviridae family. Electron-microscopical examination revealed virions with the morphologic characteristics of a bunyavirus. The presence of the virus was confirmed in 171 patients with SFTS from six provinces by detection of viral RNA, specific antibodies to the virus in blood, or both. Serologic assays showed a virus-specific immune response in all 35 pairs of serum samples collected from patients during the acute and convalescent phases of the illness. CONCLUSIONS A novel phlebovirus was identified in patients with a life-threatening illness associated with fever and thrombocytopenia in China.	[Liang, Mi-Fang; Li, Jian-Dong; Sun, Yu-Lan; Zhang, Quan-Fu; Li, Chuan; Qu, Jing; Zhang, Yan-Ping; Wu, Wei; Wang, Qin; Wang, Shi-Wen; Song, Jing-Dong; Wan, Tao; Sun, Li-Na; Hong, Tao; Li, De-Xin] Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing 102206, Peoples R China; [Yu, Xue-Jie; Li, Qun; Yin, Wen-Wu; Zhou, Hang; Dong, Xiao-Ping; Feng, Zi-Jian; Yang, Wei-Zhong; Wang, Yu] Chinese Ctr Dis Control & Prevent, Chinese CDC, Beijing 102206, Peoples R China; [Zhang, Shou-Yin; Hai, Rong; Kan, Biao; Wan, Kang-Lin; Jing, Huai-Qi; Lu, Jin-Xin; He, Jin-Rong; Zhang, Jing-Shan; Fu, Xiu-Ping] Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Control & Prevent, Beijing, Peoples R China; [Wang, Xian-Jun; Bi, Zhen-Qiang] Shandong Prov CDC, Jinan, Shandong, Peoples R China; [Zhan, Fa-Xian; Guan, Xu-Hua; Liu, Jia-Fa] Hubei Prov CDC, Wuhan, Hubei, Peoples R China; [Liu, Guo-Hua] Henan Prov CDC, Zhengzhou, Henan, Peoples R China; [Liu, Yan; Ren, Jun] Anhui Prov CDC, Hefei, Anhui, Peoples R China; [Wang, Hua] Jiangshu Prov CDC, Nanjing, Jiangshu, Peoples R China; [Zhao, Zhuo] Liaoning Prov CDC, Shenyang, Liaoning, Peoples R China; [Zhang, Yu] Hubei Prov Dept Hlth, Wuhan, Hubei, Peoples R China; [Yu, Xue-Jie; Liu, Yan; Zhang, Lihong; Popov, Vsevolod L.; Walker, David H.] Univ Texas Galveston, Med Branch, Dept Pathol, Galveston, TX 77550 USA	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; University of Texas System; University of Texas Medical Branch Galveston	Li, DX (corresponding author), Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing 102206, Peoples R China.	wangyu@chinacdc.cn; lidx@chinacdc.cn	Yang, Wei/HIA-0360-2022; Wang, Tao/B-1331-2016; Yu, Xuejie/AAP-9246-2021		Ministry of Science and Technology [2008ZX10004-001, 2009ZX10004]; Ministry of Health; National Institute of Allergy and Infectious Diseases [U54 AI057156]; Chinese Center for Disease Control and Prevention; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057156] Funding Source: NIH RePORTER	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Chinese Center for Disease Control and Prevention; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by China Mega-Project for Infectious Diseases grants (2008ZX10004-001 and 2009ZX10004) from the Ministry of Science and Technology and the Ministry of Health, by a Western Regional Center of Excellence for Biodefense and Emerging Infectious Diseases grant (U54 AI057156) from the National Institute of Allergy and Infectious Diseases, and by a grant from the Chinese Recruitment Program of Global Experts in the Chinese Center for Disease Control and Prevention (to Dr. Yu).	Depaquit J, 2010, EUROSURVEILLANCE, V15, P40; Dumler JS, 2005, EMERG INFECT DIS, V11, P1828, DOI 10.3201/eid1112.050898; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Li CA, 2010, VACCINE, V28, P4294, DOI 10.1016/j.vaccine.2010.04.025; Nichol S. T., 2005, VIRUS TAXONOMY, P695; Peters CJ, 1999, ANNU REV MED, V50, P531, DOI 10.1146/annurev.med.50.1.531; POPOV VL, 1995, J MED MICROBIOL, V43, P411, DOI 10.1099/00222615-43-6-411; Pyrc Krzysztof, 2008, V454, P73, DOI 10.1007/978-1-59745-181-9_7; Schmaljohn C, 1997, EMERG INFECT DIS, V3, P95, DOI 10.3201/eid0302.970202; Tenquist JD, 2001, J ROY SOC NEW ZEAL, V31, P481, DOI 10.1080/03014223.2001.9517666; Victoria JG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000163; Zhang LJ, 2008, JAMA-J AM MED ASSOC, V300, P2263, DOI 10.1001/jama.2008.626; 2010, NATL GUIDELINE PREVE	14	970	1213	5	186	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2011	364	16					1523	1532		10.1056/NEJMoa1010095	http://dx.doi.org/10.1056/NEJMoa1010095			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752VH	21410387	Green Accepted			2022-12-28	WOS:000289722700009
J	Beck, PG; Bedding, TR; Mosser, B; Stello, D; Garcia, RA; Kallinger, T; Hekker, S; Elsworth, Y; Frandsen, S; Carrier, F; De Ridder, J; Aerts, C; White, TR; Huber, D; Dupret, MA; Montalban, J; Miglio, A; Noels, A; Chaplin, WJ; Kjeldsen, H; Christensen-Dalsgaard, J; Gilliland, RL; Brown, TM; Kawaler, SD; Mathur, S; Jenkins, JM				Beck, P. G.; Bedding, T. R.; Mosser, B.; Stello, D.; Garcia, R. A.; Kallinger, T.; Hekker, S.; Elsworth, Y.; Frandsen, S.; Carrier, F.; De Ridder, J.; Aerts, C.; White, T. R.; Huber, D.; Dupret, M-A; Montalban, J.; Miglio, A.; Noels, A.; Chaplin, W. J.; Kjeldsen, H.; Christensen-Dalsgaard, J.; Gilliland, R. L.; Brown, T. M.; Kawaler, S. D.; Mathur, S.; Jenkins, J. M.			Kepler Detected Gravity-Mode Period Spacings in a Red Giant Star	SCIENCE			English	Article									[Beck, P. G.; Carrier, F.; De Ridder, J.; Aerts, C.] Katholieke Univ Leuven, Inst Sterrenkunde, B-3001 Louvain, Belgium; [Bedding, T. R.; Stello, D.; White, T. R.; Huber, D.] Univ Sydney, Sch Phys, Sydney Inst Astron, Sydney, NSW 2006, Australia; [Mosser, B.] Univ Paris 07, Univ Paris 06, Lab Etud Spatiales & Instrumentat Astrophys, Observ Paris,CNRS, F-92195 Meudon, France; [Garcia, R. A.] Univ Paris Diderot, Lab Astrophys Instrumentat & Modelisat, Inst Rech Lois Fondamentales Univers, Serv Astrophys,Direct Sci Mat,CEA,CNRS,Ctr Saclay, F-91191 Gif Sur Yvette, France; [Kallinger, T.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Hekker, S.; Elsworth, Y.; Chaplin, W. J.] Univ Birmingham, Birmingham B15 2TT, W Midlands, England; [Hekker, S.; Frandsen, S.] Univ Amsterdam, Astron Inst, NL-1090 GE Amsterdam, Netherlands; [Kjeldsen, H.; Christensen-Dalsgaard, J.] Aarhus Univ, Dept Phys & Astron, DK-8000 Aarhus C, Denmark; [Aerts, C.] Radboud Univ Nijmegen, Dept Astrophys, Inst Math Astrophys & Particle Phys, NL-6500 GL Nijmegen, Netherlands; [Dupret, M-A; Montalban, J.; Miglio, A.; Noels, A.] Univ Liege, Inst Astrophys & Geophys, B-4000 Liege, Belgium; [Gilliland, R. L.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Brown, T. M.] Las Cumbres Observ Global Telescope, Goleta, CA 93117 USA; [Kawaler, S. D.] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA; [Mathur, S.] Natl Ctr Atmospher Res, High Altitude Observ, Boulder, CO 80307 USA; [Jenkins, J. M.] NASA, Ames Res Ctr, SETI Inst, Moffett Field, CA 94035 USA	KU Leuven; University of Sydney; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; University of British Columbia; University of Birmingham; University of Amsterdam; Aarhus University; Radboud University Nijmegen; University of Liege; Space Telescope Science Institute; Iowa State University; National Center Atmospheric Research (NCAR) - USA; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Beck, PG (corresponding author), Katholieke Univ Leuven, Inst Sterrenkunde, B-3001 Louvain, Belgium.	paul.beck@ster.kuleuven.be	Stello, Dennis/Q-9754-2019; Kallinger, Thomas/N-7501-2019; Bedding, Timothy/AAU-9400-2021; Mathur, Savita/AAA-3102-2019; Huber, Daniel/AAE-9440-2019; miglio, andrea/O-9594-2019; Miglio, Andrea/M-5789-2018; Chaplin, William/M-9160-2018	Stello, Dennis/0000-0002-4879-3519; Kallinger, Thomas/0000-0003-3627-2561; Bedding, Timothy/0000-0001-5222-4661; Huber, Daniel/0000-0001-8832-4488; miglio, andrea/0000-0001-5998-8533; Miglio, Andrea/0000-0001-5998-8533; Hekker, Saskia/0000-0002-1463-726X; White, Timothy/0000-0002-6980-3392; Chaplin, William/0000-0002-5714-8618; Aerts, Conny/0000-0003-1822-7126; Christensen-Dalsgaard, Jorgen/0000-0001-5137-0966; Mosser, Benoit/0000-0002-7547-1208; Garcia, Rafael A./0000-0002-8854-3776; Kawaler, Steven/0000-0002-6536-6367; Beck, Paul G./0000-0003-4745-2242; Mathur, Savita/0000-0002-0129-0316; Bedding, Timothy/0000-0001-5943-1460	NASA's Science Mission Directorate; European Community, European Research Council [227224]; STFC [ST/F002041/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/F002041/1] Funding Source: researchfish	NASA's Science Mission Directorate; European Community, European Research Council(European CommissionEuropean Research Council (ERC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We acknowledge the work of the team behind Kepler. Funding for the Kepler mission is provided by NASA's Science Mission Directorate. We received funding from the European Community's 7th Framework Programme, European Research Council grant no. 227224 (PROSPERITY). All authors thank their national funding agencies.	Borucki WJ, 2010, SCIENCE, V327, P977, DOI 10.1126/science.1185402; DERIDDER J, 2009, ASTROPHYS J, V459, pL176; Dupret MA, 2009, ASTRON ASTROPHYS, V506, P57, DOI 10.1051/0004-6361/200911713; Montalban J, 2010, ASTROPHYS J LETT, V721, pL182, DOI 10.1088/2041-8205/721/2/L182	4	184	184	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2011	332	6026					205	205		10.1126/science.1201939	http://dx.doi.org/10.1126/science.1201939			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21415318	Green Submitted, Green Accepted			2022-12-28	WOS:000289251100041
J	Chaplin, WJ; Kjeldsen, H; Christensen-Dalsgaard, J; Basu, S; Miglio, A; Appourchaux, T; Bedding, TR; Elsworth, Y; Garcia, RA; Gilliland, RL; Girardi, L; Houdek, G; Karoff, C; Kawaler, SD; Metcalfe, TS; Molenda-Zakowicz, J; Monteiro, MJPFG; Thompson, MJ; Verner, GA; Ballot, J; Bonanno, A; Brandao, IM; Broomhall, AM; Bruntt, H; Campante, TL; Corsaro, E; Creevey, OL; Dogan, G; Esch, L; Gai, N; Gaulme, P; Hale, SJ; Handberg, R; Hekker, S; Huber, D; Jimenez, A; Mathur, S; Mazumdar, A; Mosser, B; New, R; Pinsonneault, MH; Pricopi, D; Quirion, PO; Regulo, C; Salabert, D; Serenelli, AM; Aguirre, VS; Sousa, SG; Stello, D; Stevens, IR; Suran, MD; Uytterhoeven, K; White, TR; Borucki, WJ; Brown, TM; Jenkins, JM; Kinemuchi, K; Van Cleve, J; Klaus, TC				Chaplin, W. J.; Kjeldsen, H.; Christensen-Dalsgaard, J.; Basu, S.; Miglio, A.; Appourchaux, T.; Bedding, T. R.; Elsworth, Y.; Garcia, R. A.; Gilliland, R. L.; Girardi, L.; Houdek, G.; Karoff, C.; Kawaler, S. D.; Metcalfe, T. S.; Molenda-Zakowicz, J.; Monteiro, M. J. P. F. G.; Thompson, M. J.; Verner, G. A.; Ballot, J.; Bonanno, A.; Brandao, I. M.; Broomhall, A-M; Bruntt, H.; Campante, T. L.; Corsaro, E.; Creevey, O. L.; Dogan, G.; Esch, L.; Gai, N.; Gaulme, P.; Hale, S. J.; Handberg, R.; Hekker, S.; Huber, D.; Jimenez, A.; Mathur, S.; Mazumdar, A.; Mosser, B.; New, R.; Pinsonneault, M. H.; Pricopi, D.; Quirion, P-O; Regulo, C.; Salabert, D.; Serenelli, A. M.; Aguirre, V. Silva; Sousa, S. G.; Stello, D.; Stevens, I. R.; Suran, M. D.; Uytterhoeven, K.; White, T. R.; Borucki, W. J.; Brown, T. M.; Jenkins, J. M.; Kinemuchi, K.; Van Cleve, J.; Klaus, T. C.			Ensemble Asteroseismology of Solar-Type Stars with the NASA Kepler Mission	SCIENCE			English	Article							SUN-LIKE STAR; RED GIANTS; OSCILLATIONS; COROT; AMPLITUDES; ISOCHRONES; RADIUS; CYCLE; DEEP	In addition to its search for extrasolar planets, the NASA Kepler mission provides exquisite data on stellar oscillations. We report the detections of oscillations in 500 solar-type stars in the Kepler field of view, an ensemble that is large enough to allow statistical studies of intrinsic stellar properties (such as mass, radius, and age) and to test theories of stellar evolution. We find that the distribution of observed masses of these stars shows intriguing differences to predictions from models of synthetic stellar populations in the Galaxy.	[Chaplin, W. J.; Miglio, A.; Elsworth, Y.; Verner, G. A.; Broomhall, A-M; Hale, S. J.; Hekker, S.; Stevens, I. R.] Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England; [Kjeldsen, H.; Christensen-Dalsgaard, J.; Karoff, C.; Bruntt, H.; Campante, T. L.; Dogan, G.; Handberg, R.] Aarhus Univ, Dept Phys & Astron, DK-8000 Aarhus C, Denmark; [Basu, S.; Esch, L.; Gai, N.] Yale Univ, Dept Astron, New Haven, CT 06520 USA; [Miglio, A.] Univ Liege, Dept Astrophys Geophys & Oceanog, B-4000 Liege 1, Belgium; [Appourchaux, T.; Gaulme, P.] Univ Paris 11, CNRS, UMR8617, Inst Astrophys Spatiale, F-91405 Orsay, France; [Bedding, T. R.; Huber, D.; Stello, D.; White, T. R.] Univ Sydney, Sch Phys, Sydney Inst Astron, Sydney, NSW 2006, Australia; [Garcia, R. A.; Uytterhoeven, K.] Univ Paris Diderot, Inst Rech Lois Fondamentales Univers, Lab Astrophys Instrumentat & Modelisat, Direct Sci Mat,CEA,CNRS,Serv Astrophys,Ctr Saclay, F-91191 Gif Sur Yvette, France; [Gilliland, R. L.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Girardi, L.] Ist Nazl Astrofis INAF, Osservatorio Astron Padova, I-35122 Padua, Italy; [Houdek, G.] Univ Vienna, Inst Astron, A-1180 Vienna, Austria; [Kawaler, S. D.] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA; [Metcalfe, T. S.; Thompson, M. J.; Mathur, S.] Natl Ctr Atmospher Res, High Altitude Observ, Boulder, CO 80307 USA; [Molenda-Zakowicz, J.] Univ Wroclaw, Astron Inst, PL-51622 Wroclaw, Poland; [Monteiro, M. J. P. F. G.; Brandao, I. M.; Campante, T. L.; Sousa, S. G.] Univ Porto, Ctr Astrofis, P-4150762 Oporto, Portugal; [Monteiro, M. J. P. F. G.; Brandao, I. M.; Campante, T. L.; Sousa, S. G.] Univ Porto, Fac Ciencias, P-4150762 Oporto, Portugal; [Verner, G. A.] Univ London, Astron Unit, London E1 4NS, England; [Ballot, J.] Univ Toulouse, CNRS, Inst Rech Astrophys & Planetol, F-31400 Toulouse, France; [Bonanno, A.; Corsaro, E.] INAF Osservatorio Astrofis Catania, I-95123 Catania, Italy; [Creevey, O. L.; Jimenez, A.; Regulo, C.; Salabert, D.] Univ La Laguna, Dept Astrofis, E-38206 Tenerife, Spain; [Creevey, O. L.; Jimenez, A.; Regulo, C.; Salabert, D.] Inst Astrofis Canarias, E-38200 Tenerife, Spain; [Gai, N.] Dezhou Univ, Dept Phys, Dezhou 253023, Peoples R China; [Hekker, S.] Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1090 GE Amsterdam, Netherlands; [Mazumdar, A.] Homi Bhabha Ctr Sci Educ, Bombay 400088, Maharashtra, India; [Mosser, B.] Univ Paris 07, Univ Paris 06, Lab Etud Spatiales & Instrumentat Astrophys, Observ Paris,CNRS, F-92195 Meudon, France; [New, R.] Sheffield Hallam Univ, Fac Arts Comp Engn & Sci, Mat Engn Res Inst, Sheffield S1 1WB, S Yorkshire, England; [Pinsonneault, M. H.] Ohio State Univ, Dept Astron, McPherson Lab 4055, Columbus, OH 43210 USA; [Pricopi, D.; Suran, M. D.] Acad Romana, Astron Inst, RO-40557 Bucharest, Romania; [Quirion, P-O] Canadian Space Agcy, St Hubert, PQ J3Y 8Y9, Canada; [Serenelli, A. M.] Fac Ciencies, Inst Estudis Espacials Catalunya, Inst Ciencias Espacio, Bellaterra 08193, Spain; [Aguirre, V. Silva] Max Planck Inst Astrophys, D-85741 Garching, Germany; [Borucki, W. J.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Brown, T. M.] Las Cumbres Observ Global Telescope, Goleta, CA 93117 USA; [Jenkins, J. M.; Van Cleve, J.] NASA, Ames Res Ctr, SETI Inst, Moffett Field, CA 94035 USA; [Kinemuchi, K.] NASA, Ames Res Ctr, Bay Area Environm Res Inst, Moffett Field, CA 94035 USA; [Klaus, T. C.] NASA, Ames Res Ctr, Orbital Sci Corp, Moffett Field, CA 94035 USA	University of Birmingham; Aarhus University; Yale University; University of Liege; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; University of Sydney; UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; Space Telescope Science Institute; University of Padua; University of Vienna; Iowa State University; National Center Atmospheric Research (NCAR) - USA; University of Wroclaw; Universidade do Porto; Universidade do Porto; University of London; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Istituto Nazionale Astrofisica (INAF); Universidad de la Laguna; Instituto de Astrofisica de Canarias; Dezhou University; University of Amsterdam; Tata Institute of Fundamental Research (TIFR); Homi Bhabha Centre for Science Education (HBCSE), Mumbai; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; Sheffield Hallam University; University System of Ohio; Ohio State University; Romanian Academy of Sciences; Astronomical Institute of Romanian Academy; Canadian Space Agency; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); Max Planck Society; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Chaplin, WJ (corresponding author), Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England.	w.j.chaplin@bham.ac.uk	Basu, Sarbani/B-8015-2014; PRICOPI, Dumitru/C-4358-2011; miglio, andrea/O-9594-2019; Stello, Dennis/Q-9754-2019; Brandão, Isa/M-5172-2013; Bedding, Timothy/AAU-9400-2021; Ballot, Jérôme/G-1019-2010; Mazumdar, Anwesh/B-1588-2012; Hale, Steven J/HDM-7599-2022; Sousa, Sérgio G./I-7466-2013; Hale, Steven J/E-3472-2015; Serenelli, Aldo/F-2836-2017; Mathur, Savita/AAA-3102-2019; Monteiro, Mario J. P. F. G./B-4715-2008; Huber, Daniel/AAE-9440-2019; Bonanno, Alfio/J-1845-2012; Karoff, Christoffer/L-1007-2013; Miglio, Andrea/M-5789-2018; Girardi, Léo/AAC-1787-2022; Metcalfe, Travis/A-9388-2008; Chaplin, William/M-9160-2018	Basu, Sarbani/0000-0002-6163-3472; miglio, andrea/0000-0001-5998-8533; Stello, Dennis/0000-0002-4879-3519; Brandão, Isa/0000-0002-1153-0942; Bedding, Timothy/0000-0001-5222-4661; Mazumdar, Anwesh/0000-0003-2409-2942; Hale, Steven J/0000-0002-6402-8382; Sousa, Sérgio G./0000-0001-9047-2965; Hale, Steven J/0000-0002-6402-8382; Serenelli, Aldo/0000-0001-6359-2769; Monteiro, Mario J. P. F. G./0000-0003-0513-8116; Huber, Daniel/0000-0001-8832-4488; Karoff, Christoffer/0000-0003-2009-7965; Miglio, Andrea/0000-0001-5998-8533; Girardi, Léo/0000-0002-6301-3269; White, Timothy/0000-0002-6980-3392; Campante, Tiago/0000-0002-4588-5389; Appourchaux, Thierry/0000-0002-1790-1951; Aguirre Borsen-Koch, Victor/0000-0002-6137-903X; Corsaro, Enrico/0000-0001-8835-2075; Kawaler, Steven/0000-0002-6536-6367; Mosser, Benoit/0000-0002-7547-1208; Bedding, Timothy/0000-0001-5943-1460; Metcalfe, Travis/0000-0003-4034-0416; Mathur, Savita/0000-0002-0129-0316; Garcia, Rafael A./0000-0002-8854-3776; Bonanno, Alfio/0000-0003-3175-9776; Chaplin, William/0000-0002-5714-8618; Stevens, Ian/0000-0001-7673-4340; Ballot, Jerome/0000-0002-9649-1013; Christensen-Dalsgaard, Jorgen/0000-0001-5137-0966; Hekker, Saskia/0000-0002-1463-726X; Molenda-Zakowicz, Joanna/0000-0001-9466-3566; Houdek, Gunter/0000-0003-1819-810X; Handberg, Rasmus/0000-0001-8725-4502	NASA's Science Mission Directorate; STFC [ST/F002041/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/F002041/1] Funding Source: researchfish	NASA's Science Mission Directorate; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	Kepler is a NASA discovery class mission, which was launched in March 2009 and whose funding is provided by NASA's Science Mission Directorate. The authors thank the entire Kepler team, without whom these results would not be possible. The asteroseismology program of Kepler is being conducted by the Kepler Asteroseismic Science Consortium.	Aerts C, 2008, SOL PHYS, V251, P3, DOI 10.1007/s11207-008-9182-z; An D, 2009, ASTROPHYS J, V700, P523, DOI 10.1088/0004-637X/700/1/523; Appourchaux T, 2008, ASTRON ASTROPHYS, V488, P705, DOI 10.1051/0004-6361:200810297; Bedding TR, 2010, ASTROPHYS J LETT, V713, pL176, DOI 10.1088/2041-8205/713/2/L176; Bedding TR, 2008, ASTR SOC P, V384, P21; Bedding TR, 2010, ASTROPHYS J, V713, P935, DOI 10.1088/0004-637X/713/2/935; Borucki WJ, 2009, SCIENCE, V325, P709, DOI 10.1126/science.1178312; Borucki WJ, 2010, SCIENCE, V327, P977, DOI 10.1126/science.1185402; Broomhall AM, 2009, ASTROPHYS J LETT, V700, pL162, DOI 10.1088/0004-637X/700/2/L162; BROWN TM, 1994, ANNU REV ASTRON ASTR, V32, P37; BROWN TM, 1991, ASTROPHYS J, V368, P599, DOI 10.1086/169725; Chaplin WJ, 2010, ASTROPHYS J LETT, V713, pL169, DOI 10.1088/2041-8205/713/2/L169; Christensen-Dalsgaard J, 2002, REV MOD PHYS, V74, P1073, DOI 10.1103/RevModPhys.74.1073; Christensen-Dalsgaard J, 2004, SOL PHYS, V220, P137, DOI 10.1023/B:SOLA.0000031392.43227.7d; Christensen-Dalsgaard J, 2010, ASTROPHYS J LETT, V713, pL164, DOI 10.1088/2041-8205/713/2/L164; De Ridder J, 2009, NATURE, V459, P398, DOI 10.1038/nature08022; Garcia RA, 2010, SCIENCE, V329, P1032, DOI 10.1126/science.1191064; Gilliland RL, 2010, PUBL ASTRON SOC PAC, V122, P131, DOI 10.1086/650399; Girardi L, 2005, ASTRON ASTROPHYS, V436, P895, DOI 10.1051/0004-6361:20042352; Gough DO, 1996, SCIENCE, V272, P1296, DOI 10.1126/science.272.5266.1296; Hathaway DH, 2010, SCIENCE, V327, P1350, DOI 10.1126/science.1181990; Houdek G, 1999, ASTRON ASTROPHYS, V351, P582; KJELDSEN H, 1995, ASTRON ASTROPHYS, V293, P87; Marigo P, 2008, ASTRON ASTROPHYS, V482, P883, DOI 10.1051/0004-6361:20078467; Metcalfe TS, 2010, ASTROPHYS J, V723, P1583, DOI 10.1088/0004-637X/723/2/1583; Michel E, 2008, SCIENCE, V322, P558, DOI 10.1126/science.1163004; Miglio A, 2009, ASTRON ASTROPHYS, V503, pL21, DOI 10.1051/0004-6361/200912822; Samadi R, 2007, ASTRON ASTROPHYS, V463, P297, DOI 10.1051/0004-6361:20041953; Stello D, 2009, ASTROPHYS J, V700, P1589, DOI 10.1088/0004-637X/700/2/1589; Torres G, 2010, ASTRON ASTROPHYS REV, V18, P67, DOI 10.1007/s00159-009-0025-1; TURON C, 2008, 4 ESAESO WORK GROUP; VORONTSOV SV, 1991, NATURE, V349, P49, DOI 10.1038/349049a0	32	252	254	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					213	216		10.1126/science.1201827	http://dx.doi.org/10.1126/science.1201827			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474754	Green Submitted			2022-12-28	WOS:000289251100044
J	Reed, MC; Dhaliwal, G; Saint, S; Nallamothu, BK				Reed, Michael C.; Dhaliwal, Gurpreet; Saint, Sanjay; Nallamothu, Brahmajee K.			The Right Angle	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CENTRAL VENOUS-PRESSURE; CONSTRICTIVE PERICARDITIS; RESTRICTIVE CARDIOMYOPATHY; CRITICALLY ILL; MODERN-ERA; PATIENT; IMPACT		[Reed, Michael C.; Saint, Sanjay; Nallamothu, Brahmajee K.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Saint, Sanjay; Nallamothu, Brahmajee K.] Ann Arbor Vet Affairs Med Ctr, Hlth Serv Res & Dev Ctr Excellence, Ann Arbor, MI USA; [Dhaliwal, Gurpreet] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Dhaliwal, Gurpreet] San Francisco VA Med Ctr, Dept Internal Med, San Francisco, CA USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Reed, MC (corresponding author), Univ Michigan, Dept Internal Med, 1500 E Med Ctr Dr,SPC 5869, Ann Arbor, MI 48109 USA.	micreed@med.umich.edu	Saint, Sanjay/AAF-5126-2019					Bertog SC, 2004, J AM COLL CARDIOL, V43, P1445, DOI 10.1016/j.jacc.2003.11.048; CONNORS AF, 1983, NEW ENGL J MED, V308, P263, DOI 10.1056/NEJM198302033080508; Cook DJ, 1996, JAMA-J AM MED ASSOC, V275, P630, DOI 10.1001/jama.275.8.630; COOK DJ, 1990, AM J MED SCI, V299, P175, DOI 10.1097/00000441-199003000-00006; Ha JW, 2008, J THORAC CARDIOV SUR, V136, P1136, DOI 10.1016/j.jtcvs.2008.03.065; HANSEN AT, 1951, CIRCULATION, V3, P881, DOI 10.1161/01.CIR.3.6.881; Hurrell DG, 1996, CIRCULATION, V93, P2007, DOI 10.1161/01.CIR.93.11.2007; Leya FS, 2005, J AM COLL CARDIOL, V45, P1900, DOI 10.1016/j.jacc.2005.03.050; Ling LH, 1999, CIRCULATION, V100, P1380, DOI 10.1161/01.CIR.100.13.1380; MEANEY E, 1976, AM J CARDIOL, V38, P547, DOI 10.1016/S0002-9149(76)80001-X; OH JK, 1994, J AM COLL CARDIOL, V23, P154, DOI 10.1016/0735-1097(94)90514-2; RUNYON BA, 1994, NEW ENGL J MED, V330, P337, DOI 10.1056/NEJM199402033300508; Talreja DR, 2008, J AM COLL CARDIOL, V51, P315, DOI 10.1016/j.jacc.2007.09.039; Talreja DR, 2003, CIRCULATION, V108, P1852, DOI 10.1161/01.CIR.0000087606.18453.FD; Troughton RW, 2004, LANCET, V363, P717, DOI 10.1016/S0140-6736(04)15648-1	15	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 7	2011	364	14					1350	1356		10.1056/NEJMcps0910164	http://dx.doi.org/10.1056/NEJMcps0910164			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745WS	21470013				2022-12-28	WOS:000289202800012
J	Smith, J				Smith, Jim			A long shadow over Fukushima	NATURE			English	Editorial Material									Univ Portsmouth, Portsmouth PO1 2UP, Hants, England	University of Portsmouth	Smith, J (corresponding author), Univ Portsmouth, Portsmouth PO1 2UP, Hants, England.	jim.smith@port.ac.uk	Smith, Jim T/G-7716-2011	Smith, Jim T/0000-0002-0808-2739					0	11	11	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 7	2011	472	7341					7	7		10.1038/472007a	http://dx.doi.org/10.1038/472007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	745VV	21475152	Green Submitted			2022-12-28	WOS:000289199400006
J	Volkow, ND; McLellan, TA; Cotto, JH; Karithanom, M; Weiss, SRB				Volkow, Nora D.; McLellan, Thomas A.; Cotto, Jessica H.; Karithanom, Meena; Weiss, Susan R. B.			Characteristics of Opioid Prescriptions in 2009	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							ADOLESCENTS; DEPENDENCE; ADULTS; ABUSE		[Volkow, Nora D.; Cotto, Jessica H.; Karithanom, Meena; Weiss, Susan R. B.] NIDA, NIH, Bethesda, MD 20892 USA; [McLellan, Thomas A.] Univ Penn, Sch Med, Ctr Subst Abuse Solut, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of Pennsylvania	Volkow, ND (corresponding author), NIDA, NIH, Bethesda, MD 20892 USA.	nvolkow@nida.nih.gov			Intramural NIH HHS [Z99 DA999999] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		[Anonymous], CDCS ISS BRIEF UN DR; [Anonymous], VECT ON NAT VONA; Fortuna RJ, 2010, PEDIATRICS, V126, P1108, DOI 10.1542/peds.2010-0791; Grant BF, 1998, J SUBST ABUSE, V10, P163, DOI 10.1016/S0899-3289(99)80131-X; Schramm-Sapyta NL, 2009, PSYCHOPHARMACOLOGY, V206, P1, DOI 10.1007/s00213-009-1585-5; Zacny J, 2003, DRUG ALCOHOL DEPEN, V69, P215, DOI 10.1016/S0376-8716(03)00003-6	6	550	553	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2011	305	13					1299	1301		10.1001/jama.2011.401	http://dx.doi.org/10.1001/jama.2011.401			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745JT	21467282	Bronze, Green Accepted			2022-12-28	WOS:000289162400016
J	Volkow, ND; McLellan, TA				Volkow, Nora D.; McLellan, Thomas A.			Curtailing Diversion and Abuse of Opioid Analgesics Without Jeopardizing Pain Treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHRONIC NONCANCER PAIN		[Volkow, Nora D.] NIDA, NIH, Bethesda, MD 20892 USA; [McLellan, Thomas A.] Univ Penn, Sch Med, Ctr Subst Abuse Solut, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of Pennsylvania	Volkow, ND (corresponding author), NIDA, NIH, 6001 Execut Blvd,Room 5274,MSC 9581, Bethesda, MD 20892 USA.	nvolkow@nida.nih.gov			NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		*AM MED ASS, 2011, ASS TREAT PAIN PAT S; Centers for Disease Control and Prevention, 2010, UN DRUG POIS US; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Halperin EC, 2010, ACAD MED, V85, P203, DOI 10.1097/ACM.0b013e3181c88506; Inciardi JA, 2007, PAIN MED, V8, P171, DOI 10.1111/j.1526-4637.2006.00255.x; JOHNSTON LD, NIH PUBLICATION, V1; Manchikanti L, 2010, PAIN PHYSICIAN, V13, P401; Reid MC, 2002, J GEN INTERN MED, V17, P173, DOI 10.1046/j.1525-1497.2002.10435.x; *SAMHSA, TRENDS EM DEP VIS IN; *SAMHSA DRUG ALC S, 2008, SUBST AB TREATM ADM	10	160	162	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2011	305	13					1346	1347		10.1001/jama.2011.369	http://dx.doi.org/10.1001/jama.2011.369			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	745JT	21467287				2022-12-28	WOS:000289162400024
J	Eliason, EJ; Clark, TD; Hague, MJ; Hanson, LM; Gallagher, ZS; Jeffries, KM; Gale, MK; Patterson, DA; Hinch, SG; Farrell, AP				Eliason, Erika J.; Clark, Timothy D.; Hague, Merran J.; Hanson, Linda M.; Gallagher, Zoe S.; Jeffries, Ken M.; Gale, Marika K.; Patterson, David A.; Hinch, Scott G.; Farrell, Anthony P.			Differences in Thermal Tolerance Among Sockeye Salmon Populations	SCIENCE			English	Article							CLIMATE-CHANGE; FRASER-RIVER; TEMPERATURE; MIGRATION; PACIFIC; PERFORMANCE; PHYSIOLOGY; WATER	Climate change-induced increases in summer water temperature have been associated with elevated mortality of adult sockeye salmon ( Oncorhynchus nerka) during river migration. We show that cardiorespiratory physiology varies at the population level among Fraser River sockeye salmon and relates to historical environmental conditions encountered while migrating. Fish from populations with more challenging migratory environments have greater aerobic scope, larger hearts, and better coronary supply. Furthermore, thermal optima for aerobic, cardiac, and heart rate scopes are consistent with the historic river temperature ranges for each population. This study suggests that physiological adaptation occurs at a very local scale, with population-specific thermal limits being set by physiological limitations in aerobic performance, possibly due to cardiac collapse at high temperatures.	[Eliason, Erika J.; Clark, Timothy D.; Gallagher, Zoe S.; Farrell, Anthony P.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Clark, Timothy D.; Hanson, Linda M.; Farrell, Anthony P.] Univ British Columbia, Fac Land & Food Syst, Vancouver, BC V6T 1Z4, Canada; [Clark, Timothy D.; Jeffries, Ken M.; Gale, Marika K.; Hinch, Scott G.] Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1Z4, Canada; [Hague, Merran J.; Patterson, David A.] Simon Fraser Univ, Fisheries & Oceans Canada, Sci Branch, Sch Resource & Environm Management, Burnaby, BC V5A 1S6, Canada	University of British Columbia; University of British Columbia; University of British Columbia; Fisheries & Oceans Canada; Simon Fraser University	Eliason, EJ (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	eliason@zoology.ubc.ca	Clark, Timothy Darren/K-7129-2012	Clark, Timothy Darren/0000-0001-8738-3347; Eliason, Erika/0000-0002-0120-7498	Natural Sciences and Engineering Research Council of Canada (NSERC); Pacific Salmon Forum grants; Killam Postdoctoral Fellowship	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Pacific Salmon Forum grants; Killam Postdoctoral Fellowship	We thank C. Whitney for assistance with the beta-adrenoceptors experiment and field assistance; A. Lotto, G. Cox, E. Sandblom, A. Collins, M. Drenner, C. Wilson, D. Roscoe, M. Donaldson, J. Burt, E. Martins, S. Pieperhoff, L. Thompson, J. Hills, V. Ives, S. Tang, B. Smith, M. Hamer, D. Eliason, G. Eliason, and P. Parsons for field assistance; S. Ballesta and S. Lague for assistance with the b-adrenoceptors experiment; D. Guo for assistance with heart dissection; S. Cooke for valuable discussions; S. Latham for scale analysis; K. Miller, N. Ginther, C. Wallace, and J. Candy for DNA analysis; and the Department of Fisheries and Oceans (DFO) Environmental Watch Program and the DFO Cultus Lake Salmon Research Laboratory. This research was funded by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grants to A. P. F. and S. G. H.; an NSERC Strategic grant to S. G. H. and A. P. F.; Pacific Salmon Forum grants to E. J. E., A. P. F., and S. G. H.; NSERC postgraduate scholarships to E. J. E., K. M. J., and M. K. G.; and a Killam Postdoctoral Fellowship to T. D. C.	Beacham TD, 2005, T AM FISH SOC, V134, P1124, DOI 10.1577/T05-005.1; Brander K, 2003, ICES MARINE SCI S, V219, P261; Cooke SJ, 2004, FISHERIES, V29, P22, DOI 10.1577/1548-8446(2004)29[22:AMTAHE]2.0.CO;2; Crozier LG, 2008, EVOL APPL, V1, P252, DOI 10.1111/j.1752-4571.2008.00033.x; Endler J.A., 1986, Monographs in Population Biology, pviii; English KK, 2005, T AM FISH SOC, V134, P1342, DOI 10.1577/T04-119.1; Farrell AP, 2008, PHYSIOL BIOCHEM ZOOL, V81, P697, DOI 10.1086/592057; Farrell AP, 2009, J EXP BIOL, V212, P3771, DOI 10.1242/jeb.023671; Ferrari MR, 2007, J HYDROL, V342, P336, DOI 10.1016/j.jhydrol.2007.06.002; Grebmeier JM, 2006, SCIENCE, V311, P1461, DOI 10.1126/science.1121365; Hanson LM, 2007, J FISH BIOL, V71, P926, DOI 10.1111/j.1095-8649.2007.01533.x; Hinch SG, 2000, CAN J FISH AQUAT SCI, V57, P2470, DOI 10.1139/cjfas-57-12-2470; Hodgson S, 2002, CAN J ZOOL, V80, P542, DOI 10.1139/Z02-030; Hyatt K.D., 2003, CANADIAN WATER RESOU, V28, P689, DOI DOI 10.4296/CWRJ2804689; KEEN JE, 1993, J EXP BIOL, V181, P27; Lee CG, 2003, J EXP BIOL, V206, P3239, DOI 10.1242/jeb.00547; Mathes MT, 2010, CAN J FISH AQUAT SCI, V67, P70, DOI 10.1139/F09-158; Munday PL, 2008, CORAL REEFS, V27, P927, DOI 10.1007/s00338-008-0393-4; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Rodnick KJ, 2004, J FISH BIOL, V64, P310, DOI 10.1111/j.0022-1112.2004.00292.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Shiels HA, 1997, J EXP BIOL, V200, P1607; Steinhausen MF, 2008, J EXP BIOL, V211, P3915, DOI 10.1242/jeb.019281; TAYLOR EB, 1991, AQUACULTURE, V98, P185, DOI 10.1016/0044-8486(91)90383-I; Wang T, 2007, SCIENCE, V315, P49, DOI 10.1126/science.1137359	28	602	623	6	392	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2011	332	6025					109	112		10.1126/science.1199158	http://dx.doi.org/10.1126/science.1199158			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21454790				2022-12-28	WOS:000289000000049
J	Kaspi, Y; Schneider, T				Kaspi, Yohai; Schneider, Tapio			Winter cold of eastern continental boundaries induced by warm ocean waters	NATURE			English	Article							STATIONARY WAVES; OROGRAPHY; SCALE; CIRCULATION; DYNAMICS; HEAT; GCM	In winter, northeastern North America and northeastern Asia are both colder than other regions at similar latitudes. This has been attributed to the effects of stationary weather systems set by elevated terrain (orography)(1), and to a lack of maritime influences from the prevailing westerly winds(2). However, the differences in extent and orography between the two continents suggest that further mechanisms are involved. Here we show that this anomalous winter cold can result in part from westward radiation of large-scale atmospheric waves-nearly stationary Rossby waves-generated by heating of the atmosphere over warm ocean waters. We demonstrate this mechanism using simulations with an idealized general circulation model(3-5), with which we show that the extent of the cold region is controlled by properties of Rossby waves, such as their group velocity and its dependence on the planetary rotation rate. Our results show that warm ocean waters contribute to the contrast in mid-latitude winter temperatures between eastern and western continental boundaries not only by warming western boundaries, but also by cooling eastern boundaries.	[Kaspi, Yohai; Schneider, Tapio] CALTECH, Pasadena, CA 91125 USA	California Institute of Technology	Kaspi, Y (corresponding author), CALTECH, Pasadena, CA 91125 USA.	yohai@alum.mit.edu	Kim, Baek-Min/A-4634-2015; Schneider, Tapio/A-7038-2014	Schneider, Tapio/0000-0001-5687-2287; Kaspi, Yohai/0000-0003-4089-0020	National Oceanic and Atmospheric Administration Climate and Global Change; David and Lucile Packard Fellowship; National Science Foundation [AGS-1019211]; Directorate For Geosciences [1019211] Funding Source: National Science Foundation	National Oceanic and Atmospheric Administration Climate and Global Change(National Oceanic Atmospheric Admin (NOAA) - USA); David and Lucile Packard Fellowship(The David & Lucile Packard Foundation); National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank D. Abbot, I. Eisenman, X. Levine and T. Merlis for comments. This research was supported by the National Oceanic and Atmospheric Administration Climate and Global Change Postdoctoral Fellowship administered by the University Corporation for Atmospheric Research (Y.K.), by a David and Lucile Packard Fellowship (T.S.), and by a grant from the National Science Foundation (AGS-1019211). The simulations were performed on the California Institute of Technology's Division of Geological and Planetary Sciences Dell cluster.	COOK KH, 1992, J ATMOS SCI, V49, P525, DOI 10.1175/1520-0469(1992)049<0525:TSRTLS>2.0.CO;2; Frierson DMW, 2007, J ATMOS SCI, V64, P1959, DOI 10.1175/JAS3935.1; Frierson DMW, 2006, J ATMOS SCI, V63, P2548, DOI 10.1175/JAS3753.1; GROSE WL, 1979, J ATMOS SCI, V36, P223, DOI 10.1175/1520-0469(1979)036<0223:OTIOOO>2.0.CO;2; Hartmann D. L., 1994, GLOBAL PHYS CLIMATOL; Held I M, 1983, LARGE SCALE DYNAMICA, P127; HELD IM, 1990, J ATMOS SCI, V47, P495, DOI 10.1175/1520-0469(1990)047<0495:OVTFOS>2.0.CO;2; Held IM, 2002, J CLIMATE, V15, P2125, DOI 10.1175/1520-0442(2002)015<2125:NWSWTA>2.0.CO;2; HOSKINS BJ, 1981, J ATMOS SCI, V38, P1179, DOI 10.1175/1520-0469(1981)038<1179:TSLROA>2.0.CO;2; HSIUNG J, 1985, J PHYS OCEANOGR, V15, P1405, DOI 10.1175/1520-0485(1985)015<1405:EOGOMH>2.0.CO;2; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; KASPI Y, 2011, J ATMOS SCI IN PRESS; LAU NC, 1979, J ATMOS SCI, V36, P996; LIGHTHILL MJ, 1967, J FLUID MECH, V27, P725, DOI 10.1017/S0022112067002563; O'Gorman PA, 2008, J CLIMATE, V21, P3815, DOI 10.1175/2007JCLI2065.1; Pedlosky J., 1987, GEOPHYS FLUID DYN, VVolume 710; Rhines PB, 2007, J ATMOS SCI, V64, P3627, DOI 10.1175/JAS4008.1; RHINES PB, 2002, ROSSBY WAVES ENCY AT; RHINES PB, 1983, DYNAMICS ASTROPHYSIC, P3; Schneider T, 2006, J ATMOS SCI, V63, P1569, DOI 10.1175/JAS3699.1; Seager R, 2002, Q J ROY METEOR SOC, V128, P2563, DOI 10.1256/qj.01.128; SMAGORINSKY J, 1953, Q J ROY METEOR SOC, V79, P342, DOI 10.1002/qj.49707934103	22	48	54	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 31	2011	471	7340					621	+		10.1038/nature09924	http://dx.doi.org/10.1038/nature09924			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21455177				2022-12-28	WOS:000288951200039
J	McArthur, KS; Quinn, TJ; Dawson, J; Walters, MR				McArthur, K. S.; Quinn, T. J.; Dawson, J.; Walters, M. R.			Diagnosis and management of transient ischaemic attack and ischaemic stroke in the acute phase	BMJ-BRITISH MEDICAL JOURNAL			English	Review							POOLED ANALYSIS; CAROTID-ENDARTERECTOMY; THROMBOLYSIS; ALTEPLASE; HYPERGLYCEMIA; RECOGNITION; POPULATION; VALIDATION; ATLANTIS; SURGERY		[McArthur, K. S.; Quinn, T. J.; Dawson, J.; Walters, M. R.] Univ Glasgow, Western Infirm, Inst Cardiovasc & Med Sci, Glasgow G11 6NT, Lanark, Scotland	University of Glasgow	McArthur, KS (corresponding author), Univ Glasgow, Western Infirm, Inst Cardiovasc & Med Sci, Glasgow G11 6NT, Lanark, Scotland.	kate.mcarthur@glasgow.ac.uk	Quinn, Terence Joseph/H-7000-2019	Quinn, Terence Joseph/0000-0003-1401-0181	Bristol Myers Squibb; Pfizer	Bristol Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer)	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: KSMcA, TJQ, JD, MRW have no external support for the submitted work; KSMcA and MRW have no relationships with companies that might have an interest in the submitted work in the previous three years, JD and TQ have received speaker fees for educational meetings sponsored by Bristol Myers Squibb and Pfizer; KSMcA, TJQ, JD, MRW have no non-financial interests that may be relevant to the submitted work.	Albers GW, 2002, NEW ENGL J MED, V347, P1713, DOI 10.1056/NEJMsb020987; [Anonymous], 2008, MAN PAT STROK TIA AS; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; CORREIA M, 2009, COCHRANE DB SYST REV, V1; Dawson J, 2009, QJM-INT J MED, V102, P43, DOI 10.1093/qjmed/hcn139; Giles MF, 2007, LANCET NEUROL, V6, P1063, DOI 10.1016/S1474-4422(07)70274-0; Gray CS, 2007, LANCET NEUROL, V6, P397, DOI 10.1016/S1474-4422(07)70080-7; Hacke W, 2004, LANCET, V363, P768; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hajat C, 2000, STROKE, V31, P410, DOI 10.1161/01.STR.31.2.410; Hand PJ, 2006, STROKE, V37, P769, DOI 10.1161/01.STR.0000204041.13466.4c; Hart RG, 2002, STROKE, V33, P2722, DOI 10.1161/01.STR.0000035735.49388.4A; Johnston SC, 2007, LANCET, V369, P283, DOI 10.1016/S0140-6736(07)60150-0; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Leonardi-Bee J, 2002, STROKE, V33, P1315, DOI 10.1161/01.STR.0000014509.11540.66; Mishra NK, 2010, BRIT MED J, V341, pc6046; National Audit Office, 2010, PROGR IMPR STROK CAR; National Institute for Health and Clinical Excellence, 2008, STROK NAT CLIN GUID; Nor AM, 2005, LANCET NEUROL, V4, P727, DOI 10.1016/S1474-4422(05)70201-5; Quinn TJ, 2009, STROKE, V40, P749, DOI 10.1161/STROKEAHA.108.530444; Robinson TG, 2010, LANCET NEUROL, V9, P767, DOI 10.1016/S1474-4422(10)70163-0; Rothwell PM, 2007, LANCET, V370, P1432, DOI 10.1016/S0140-6736(07)61448-2; Rothwell PM, 2004, STROKE, V35, P2855, DOI 10.1161/01.STR.0000147040.20446.f6; Sandercock P, 2004, STROKE, V35, P1490, DOI 10.1161/01.STR.0000126871.98801.6E; Sandercock PAG, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000029.pub2; Sandset EC, 2011, LANCET, V377, P741, DOI 10.1016/S0140-6736(11)60104-9; Schrader J, 2003, STROKE, V34, P1699, DOI 10.1161/01.STR.0000075777.18006.89; Stroke Association, 2010, SUSP STROK ACT FAST; The Intercollegiate Stroke Working Party, 2010, NAT SENT STROK AUD O; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Whiteley W, 2010, INT J STROKE, V5, P3	34	8	8	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2011	342								d1938	10.1136/bmj.d1938	http://dx.doi.org/10.1136/bmj.d1938			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745WI	21454457	Green Accepted			2022-12-28	WOS:000289201600004
J	Liu, TB; Langston, MLK; Li, D; Pigga, JM; Pichon, C; Todea, AM; Muller, A				Liu, Tianbo; Langston, Melissa L. K.; Li, Dong; Pigga, Joseph M.; Pichon, Celine; Todea, Ana Maria; Mueller, Achim			Self-Recognition Among Different Polyprotic Macroions During Assembly Processes in Dilute Solution	SCIENCE			English	Article							AQUEOUS-SOLUTION; KEPLERATE-TYPE; CLUSTERS; WATER; EXCHANGE; IONS	We report a self-recognition phenomenon based on an assembly process in a homogeneous dilute aqueous solution of two nano-scaled, spherical polyprotic metal oxide-based macroions (neutral species in crystals), also called Keplerates of the type [(linker)(30)(pentagon)(12)]=[{M(H2O)}(30){(Mo)Mo-5}(12)] where M is Fe-III or Cr-III. Upon deprotonation of the neutral species, the resulting macroions assemble into hollow "blackberry"-type structures through very slow homogeneous dimer-oligomerization processes. Although the geometrical surface structures of the two macroions are practically identical, mixtures of these form homogeneous superstructures, rather than mixed species. The phase separation is based on the difference in macroionic charge densities present during the slow homogeneous dimer or oligomer formation. The surface water ligands' residence times of Cr-III and Fe-III differ markedly and lead to very different interfacial water mobilities between the Keplerates.	[Liu, Tianbo; Langston, Melissa L. K.; Li, Dong; Pigga, Joseph M.; Pichon, Celine] Lehigh Univ, Dept Chem, Bethlehem, PA 18015 USA; [Todea, Ana Maria; Mueller, Achim] Univ Bielefeld, Fak Chem, D-33501 Bielefeld, Germany	Lehigh University; University of Bielefeld	Liu, TB (corresponding author), Lehigh Univ, Dept Chem, Bethlehem, PA 18015 USA.	liu@lehigh.edu; a.mueller@uni-bielefeld.de	Pichon, Celine M/H-4804-2013; Li, Dong/D-9221-2015; Liu, Tianbo/D-8915-2017	Pichon, Celine M/0000-0002-5429-1224; Li, Dong/0000-0002-5282-6918; Liu, Tianbo/0000-0002-8181-1790; Muller, Achim/0000-0003-0117-4021	National Science Foundation; Lehigh University; Alfred P. Sloan Foundation	National Science Foundation(National Science Foundation (NSF)); Lehigh University; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	T. L. acknowledges support of this work by the National Science Foundation, Lehigh University, and the Alfred P. Sloan Foundation. A. M. acknowledges the continuous support of the Deutsche Forschungsgemeinschaft.	Balogh E, 2007, INORG CHEM, V46, P7087, DOI 10.1021/ic7009308; Fratini E, 2010, INORG CHIM ACTA, V363, P4234, DOI 10.1016/j.ica.2010.07.021; Hall N, 2003, CHEM COMMUN, P803, DOI 10.1039/b300207c; Holzmann J, 2009, Z PHYS CHEM, V223, P1001, DOI 10.1524/zpch.2009.6065; Jelinek R, 2009, CELLULAR BIOMOLECULA; Kistler ML, 2007, J AM CHEM SOC, V129, P6453, DOI 10.1021/ja0685809; Kistler ML, 2009, DALTON T, P5094, DOI 10.1039/b901505a; Lehn J., 1995, SUPRAMOLECULAR CHEM, V1st; Liu G, 2005, LANGMUIR, V21, P2713, DOI 10.1021/la047897o; Liu TB, 2004, J AM CHEM SOC, V126, P406, DOI 10.1021/ja039353z; Liu TB, 2003, NATURE, V426, P59, DOI 10.1038/nature02036; Liu TB, 2002, J AM CHEM SOC, V124, P10942, DOI 10.1021/ja027045f; Liu TB, 2010, LANGMUIR, V26, P9202, DOI 10.1021/la902917q; Long DL, 2007, CHEM SOC REV, V36, P105, DOI 10.1039/b502666k; Long DL, 2006, CHEM-EUR J, V12, P3699, DOI 10.1002/chem.200501002; Mishra PP, 2008, J AM CHEM SOC, V130, P1548, DOI 10.1021/ja077715n; Muller A, 2009, NAT CHEM, V1, P13, DOI 10.1038/nchem.140; Muller A, 2005, J MATER CHEM, V15, P4673, DOI 10.1039/b503285g; Muller A, 1999, ANGEW CHEM INT EDIT, V38, P3238; Muller A, 2001, CHEM COMMUN, P1928, DOI 10.1039/b103639b; Muller A., 2004, CHEM NANOMATERIALS S, P452; Proust A, 2008, CHEM COMMUN, P1837, DOI 10.1039/b715502f; PROVENCHER SW, 1976, BIOPHYS J, V16, P27, DOI 10.1016/S0006-3495(76)85660-3; Rousochatzakis I, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.094420; Todea AM, 2007, ANGEW CHEM INT EDIT, V46, P6106, DOI 10.1002/anie.200700795; XU FC, 1985, INORG CHEM, V24, P267, DOI 10.1021/ic00197a005; Zhang J, 2009, J AM CHEM SOC, V131, P15152, DOI 10.1021/ja903548m; Zlotnick A, 1999, BIOCHEMISTRY-US, V38, P14644, DOI 10.1021/bi991611a	28	93	94	3	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2011	331	6024					1590	1592		10.1126/science.1201121	http://dx.doi.org/10.1126/science.1201121			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21436449				2022-12-28	WOS:000288754500051
J	Hawkes, N				Hawkes, Nigel			General Practice Bigger is better for primary care	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						*DEP HLTH, 2010, GP PAT SURV 2009 10; King's Fund, 2011, IMPR QUAL CAR GEN PR	2	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 23	2011	342								d1754	10.1136/bmj.d1754	http://dx.doi.org/10.1136/bmj.d1754			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	742MJ	21430000				2022-12-28	WOS:000288948000005
J	Norton, C				Norton, Christine			Treating faecal incontinence with bulking-agent injections	LANCET			English	Editorial Material							ADULTS		[Norton, Christine] Bucks New Univ, London W2 1NY, England; [Norton, Christine] Imperial Coll Healthcare NHS Trust, St Marys Hosp, London W2 1NY, England	Buckinghamshire New University; Imperial College London	Norton, C (corresponding author), Bucks New Univ, London W2 1NY, England.	Christine.norton2@imperial.nhs.uk						Fayers PM, 2007, QUALITY LIFE ASSESSM; Graf W, 2011, LANCET, V377, P997, DOI 10.1016/S0140-6736(10)62297-0; Madoff RD, 2004, LANCET, V364, P621, DOI 10.1016/S0140-6736(04)16856-6; Madoff RD, 2009, INCONTINENCE, P1387; Maeda Y, 2007, COLORECTAL DIS, V9, P357, DOI 10.1111/j.1463-1318.2006.01164.x; Maeda Y, 2010, COCHRANE DB SYST REV, V12; National Collaborating Centre for Acute Care (UK), 2007, FAEC INC MAN FAEC IN; NORTON C, 2007, BRIT MED J, V334, P1371; Norton C, 2009, INCONTINENCE, P1323; Perry S, 2002, GUT, V50, P480, DOI 10.1136/gut.50.4.480; Siproudhis L, 2007, ALIMENT PHARM THER, V25, P1125, DOI 10.1111/j.1365-2036.2007.03293.x; Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3; Whitehead WE, 2009, GASTROENTEROLOGY, V137, P512, DOI 10.1053/j.gastro.2009.04.054	13	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 19	2011	377	9770					971	972		10.1016/S0140-6736(11)60173-6	http://dx.doi.org/10.1016/S0140-6736(11)60173-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	740FA	21420542				2022-12-28	WOS:000288775800005
J	Lishko, PV; Botchkina, IL; Kirichok, Y				Lishko, Polina V.; Botchkina, Inna L.; Kirichok, Yuriy			Progesterone activates the principal Ca2+ channel of human sperm	NATURE			English	Article							HUMAN SPERMATOZOA; STEROID-HORMONES; CALCIUM INFLUX; HYPERACTIVATED MOTILITY; MAMMALIAN SPERMATOZOA; NONGENOMIC ACTIONS; ACROSOME REACTION; CATSPER CHANNELS; MALE-FERTILITY; MOUSE SPERM	Steroid hormone progesterone released by cumulus cells surrounding the egg is a potent stimulator of human spermatozoa. It attracts spermatozoa towards the egg and helps them penetrate the egg's protective vestments(1). Progesterone induces Ca2+ influx into spermatozoa(1-3) and triggers multiple Ca2+-dependent physiological responses essential for successful fertilization, such as sperm hyperactivation, acrosome reaction and chemotaxis towards the egg(4-8). As an ovarian hormone, progesterone acts by regulating gene expression through a well-characterized progesterone nuclear receptor(9). However, the effect of progesterone upon transcriptionally silent spermatozoa remains unexplained and is believed to be mediated by a specialized, non-genomic membrane progesterone receptor(5,10). The identity of this non-genomic progesterone receptor and the mechanism by which it causes Ca2+ entry remain fundamental unresolved questions in human reproduction. Here we elucidate the mechanism of the non-genomic action of progesterone on human spermatozoa by identifying the Ca2+ channel activated by progesterone. By applying the patch-clamp technique to mature human spermatozoa, we found that nanomolar concentrations of progesterone dramatically potentiate CatSper, a pH-dependent Ca2+ channel of the sperm flagellum. We demonstrate that human CatSper is synergistically activated by elevation of intracellular pH and extracellular progesterone. Interestingly, human CatSper can be further potentiated by prostaglandins, but apparently through a binding site other than that of progesterone. Because our experimental conditions did not support second messenger signalling, CatSper or a directly associated protein serves as the elusive non-genomic progesterone receptor of sperm. Given that the CatSper-associated progesterone receptor is sperm specific and structurally different from the genomic progesterone receptor, it represents a promising target for the development of a new class of non-hormonal contraceptives.	[Lishko, Polina V.; Botchkina, Inna L.; Kirichok, Yuriy] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Kirichok, Y (corresponding author), Univ Calif San Francisco, Dept Physiol, UCSF Mail Code 2140,Genentech Hall Room N272F,600, San Francisco, CA 94158 USA.	yuriy.kirichok@ucsf.edu	Lishko, Polina/GQH-9569-2022; Lishko, Polina/L-1191-2017		UCSF	UCSF	This work was funded by the UCSF Program for Breakthrough Biomedical Research.	AITKEN RJ, 1986, J REPROD FERTIL, V77, P451; Baldi E, 2009, MOL CELL ENDOCRINOL, V308, P39, DOI 10.1016/j.mce.2009.02.006; BAULIEU EE, 1989, SCIENCE, V245, P1351, DOI 10.1126/science.2781282; BLACKMORE PF, 1990, J BIOL CHEM, V265, P1376; Carlson AE, 2005, J BIOL CHEM, V280, P32238, DOI 10.1074/jbc.M501430200; Carlson AE, 2003, P NATL ACAD SCI USA, V100, P14864, DOI 10.1073/pnas.2536658100; Eisenbach M, 2006, NAT REV MOL CELL BIO, V7, P276, DOI 10.1038/nrm1893; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Gellersen B, 2009, HUM REPROD UPDATE, V15, P119, DOI 10.1093/humupd/dmn044; Harper CV, 2004, J BIOL CHEM, V279, P46315, DOI 10.1074/jbc.M401194200; Huang LP, 2004, J PHARMACOL EXP THER, V309, P193, DOI 10.1124/jpet.103.060814; Kaupp UB, 2008, ANNU REV PHYSIOL, V70, P93, DOI 10.1146/annurev.physiol.70.113006.100654; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; Lishko PV, 2010, CELL, V140, P327, DOI 10.1016/j.cell.2009.12.053; Liu J, 2007, J BIOL CHEM, V282, P18945, DOI 10.1074/jbc.M701083200; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; Neri-Vidaurri PD, 2006, BIOCHEM BIOPH RES CO, V343, P105, DOI 10.1016/j.bbrc.2006.02.095; Olsona SD, 2010, B MATH BIOL, V72, P1925, DOI 10.1007/s11538-010-9516-5; Publicover S, 2007, NAT CELL BIOL, V9, P235, DOI 10.1038/ncb0307-235; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Ren DJ, 2010, PHYSIOLOGY, V25, P165, DOI 10.1152/physiol.00049.2009; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Revelli A, 1998, ENDOCR REV, V19, P3, DOI 10.1210/er.19.1.3; ROLDAN ERS, 1994, SCIENCE, V266, P1578, DOI 10.1126/science.7985030; Schaefer M, 1998, P NATL ACAD SCI USA, V95, P3008, DOI 10.1073/pnas.95.6.3008; Shimizu Y, 1998, MOL HUM REPROD, V4, P555, DOI 10.1093/molehr/4.6.555; Teves ME, 2006, FERTIL STERIL, V86, P745, DOI 10.1016/j.fertnstert.2006.02.080; UHLER ML, 1992, FERTIL STERIL, V58, P1191; Xia JS, 2007, BIOL REPROD, V77, P551, DOI 10.1095/biolreprod.107.061358; Xia JS, 2009, BIOL REPROD, V80, P1092, DOI 10.1095/biolreprod.108.074039	30	423	449	1	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2011	471	7338					387	+		10.1038/nature09767	http://dx.doi.org/10.1038/nature09767			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21412339				2022-12-28	WOS:000288444000047
J	Lowenberg, B; Pabst, T; Vellenga, E; van Putten, W; Schouten, HC; Graux, C; Ferrant, A; Sonneveld, P; Biemond, BJ; Gratwohl, A; de Greef, GE; Verdonck, LF; Schaafsma, MR; Gregor, M; Theobald, M; Schanz, U; Maertens, J; Ossenkoppele, GJ				Lowenberg, Bob; Pabst, Thomas; Vellenga, Edo; van Putten, Wim; Schouten, Harry C.; Graux, Carlos; Ferrant, Augustin; Sonneveld, Pieter; Biemond, Bart J.; Gratwohl, Alois; de Greef, Georgine E.; Verdonck, Leo F.; Schaafsma, Martijn R.; Gregor, Michael; Theobald, Matthias; Schanz, Urs; Maertens, Johan; Ossenkoppele, Gert J.		Dutch-Belgian Cooperative Trial; Swiss Grp Clinical Canc Res SAKK	Cytarabine Dose for Acute Myeloid Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLONY-STIMULATING FACTOR; CYTOSINE-ARABINOSIDE; POSTREMISSION CHEMOTHERAPY; INDUCTION THERAPY; REPETITIVE CYCLES; 1ST REMISSION; DAUNORUBICIN; ADULTS; INTENSIFICATION; PROGNOSIS	BACKGROUND Cytarabine (ara-C) is an important drug in the treatment of acute myeloid leukemia (AML). High-dose cytarabine (2000 to 3000 mg per square meter of body-surface area) is toxic but results in higher rates of relapse-free survival than does the conventional dose of 100 to 400 mg per square meter. Intermediate dose levels have not been thoroughly evaluated. METHODS We compared two induction regimens in patients 18 to 60 years of age (median, 49) who had newly diagnosed AML. The intermediate-dose group, totaling 431 patients, received cytarabine at a dose of 200 mg per square meter given by continuous intravenous infusion for 24 hours during cycle 1 of induction therapy and 1000 mg per square meter by infusion for 3 hours twice daily during cycle 2 of induction therapy. The high-dose group, totaling 429 patients, received a dose-escalated regimen of 1000 mg of cytarabine per square meter every 12 hours in cycle 1 and 2000 mg per square meter twice daily in cycle 2. Patients with a complete response did not receive additional cytarabine but received consolidation therapy in a third cycle of chemotherapy (mitoxantrone-etoposide) or underwent autologous or allogeneic stem-cell transplantation. Complete remission rates, survival rates, and toxic effects were assessed for each treatment group. RESULTS At a median follow-up of 5 years, no significant differences were noted between the intermediate-dose group and the high-dose group with respect to complete remission rates (80% and 82%, respectively), probability of relapse, event-free survival at 5 years (34% and 35%), or overall survival (40% and 42%). High-dose cytarabine provided no clear advantage in any prognostic subgroup. The high-dose treatment resulted in higher incidences of grade 3 and grade 4 toxic effects (in cycle 1), prolonged hospitalization, and delayed neutrophil recovery (in cycle 2) and platelet recovery (in cycles 2 and 3). CONCLUSIONS Induction therapy with cytarabine at the lower dose already produced maximal antileukemic effects for all response end points, suggesting a plateau in the dose-response relationship above this dose level. High-dose cytarabine results in excessive toxic effects without therapeutic benefit.	[Lowenberg, Bob] Erasmus Univ, Med Ctr, Dept Hematol L413, NL-3000 CA Rotterdam, Netherlands; [van Putten, Wim] Erasmus Univ, Med Ctr, HOVON Data Ctr, NL-3000 CA Rotterdam, Netherlands; [van Putten, Wim] Erasmus Univ, Med Ctr, Dept Trials & Stat, NL-3000 CA Rotterdam, Netherlands; [Vellenga, Edo] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Schouten, Harry C.] Univ Med Ctr, Maastricht, Netherlands; [Biemond, Bart J.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Verdonck, Leo F.] Univ Med Ctr, Utrecht, Netherlands; [Schaafsma, Martijn R.] Med Spectrum Twente, Enschede, Netherlands; [Ossenkoppele, Gert J.] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [Pabst, Thomas] Univ Bern, Inselspital, CH-3010 Bern, Switzerland; [Gratwohl, Alois] Univ Basel Hosp, CH-4031 Basel, Switzerland; [Gregor, Michael] Kantonsspital, Luzern, Switzerland; [Schanz, Urs] Univ Zurich Hosp, CH-8091 Zurich, Switzerland; [Schanz, Urs] Univ Hosp, Luzern, Switzerland; [Graux, Carlos] Hop Mt Godinne, Yvoir, Belgium; [Ferrant, Augustin] Hop St Luc, Brussels, Belgium; [Maertens, Johan] Univ Hosp Gasthuisberg, B-3000 Leuven, Belgium; [Theobald, Matthias] Univ Hosp, Dept Internal Med 3, Mainz, Germany	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Groningen; Maastricht University; Maastricht University Medical Centre (MUMC); University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; Medical Spectrum Twente; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Bern; University of Basel; Kantonsspital Aarau AG (KSA); Lucerne Cantonal Hospital; University of Zurich; University Zurich Hospital; Universite Catholique Louvain; Universite Catholique Louvain Hospital; KU Leuven; University Hospital Leuven; University Hospital Mainz	Lowenberg, B (corresponding author), Erasmus Univ, Med Ctr, Dept Hematol L413, POB 2040, NL-3000 CA Rotterdam, Netherlands.	b.lowenberg@erasmusmc.nl	Zachee, Pierre/B-5391-2018; Biesma, Douwe H./AAV-6343-2020	Zachee, Pierre/0000-0002-2275-5143; Biesma, Douwe H./0000-0001-8334-3057				Bishop JF, 1996, BLOOD, V87, P1710, DOI 10.1182/blood.V87.5.1710.bloodjournal8751710; Bloomfield CD, 1998, CANCER RES, V58, P4173; Bradstock KF, 2005, BLOOD, V105, P481, DOI 10.1182/blood-2004-01-0326; Breems DA, 2008, J CLIN ONCOL, V26, P4791, DOI 10.1200/JCO.2008.16.0259; Buchner T, 2006, J CLIN ONCOL, V24, P2480, DOI 10.1200/JCO.2005.04.5013; Byrd JC, 1999, J CLIN ONCOL, V17, P3767, DOI 10.1200/JCO.1999.17.12.3767; Byrd JC, 2004, J CLIN ONCOL, V22, P1087, DOI 10.1200/JCO.2004.07.012; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Farag SS, 2005, J CLIN ONCOL, V23, P482, DOI 10.1200/JCO.2005.06.090; Fernandez HF, 2009, NEW ENGL J MED, V361, P1249, DOI 10.1056/NEJMoa0904544; Greenberg, 1998, BLOOD, V91, P1100; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; HERZIG RH, 1985, J CLIN ONCOL, V3, P992, DOI 10.1200/JCO.1985.3.7.992; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Lowenberg B, 1997, J CLIN ONCOL, V15, P3496; Lowenberg B, 2003, NEW ENGL J MED, V349, P743, DOI 10.1056/NEJMoa025406; Lowenberg B, 2010, NEW ENGL J MED, V362, P1155; Lowenberg B, 2009, NEW ENGL J MED, V361, P1235, DOI 10.1056/NEJMoa0901409; MAYER RJ, 1994, NEW ENGL J MED, V331, P896, DOI 10.1056/NEJM199410063311402; Moore JO, 2005, BLOOD, V105, P3420, DOI 10.1182/blood-2004-08-2977; Ohtake S, 2010, BLOOD           0806; PHILLIPS GL, 1991, BLOOD, V77, P1429; PLUNKETT W, 1987, CANCER RES, V47, P3005; van der Holt B, 2005, BLOOD, V106, P2646, DOI 10.1182/blood-2005-04-1395; Weick JK, 1996, BLOOD, V88, P2841, DOI 10.1182/blood.V88.8.2841.bloodjournal8882841; WOLFF SN, 1985, BLOOD, V65, P1407, DOI 10.1182/blood.V65.6.1407.bloodjournal6561407	26	280	295	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2011	364	11					1027	1036						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735SX	21410371				2022-12-28	WOS:000288439000008
J	Lowry, AR; Perez-Gussinye, M				Lowry, Anthony R.; Perez-Gussinye, Marta			The role of crustal quartz in controlling Cordilleran deformation	NATURE			English	Article							THERMAL TRANSPORT-PROPERTIES; WESTERN UNITED-STATES; HEAT-FLOW DATA; CONTINENTAL-CRUST; FORE-ARC; MANTLE; CALIFORNIA; LITHOSPHERE; TEMPERATURE; EXPANSION	Large-scale deformation of continents remains poorly understood more than 40 years after the plate tectonic revolution(1). Rock flow strength and mass density variations both contribute to stress, so both are certain to be important, but these depend (somewhat nebulously) on rock type, temperature and whether or not unbound water is present(2). Hence, it is unclear precisely how Earth material properties translate to continental deformation zones ranging from tens to thousands of kilometres in width, why deforming zones are sometimes interspersed with non-deforming blocks and why large earthquakes occasionally rupture in otherwise stable continental interiors. An important clue comes from observations that mountain belts and rift zones cyclically form at the same locations despite separation across vast gulfs of time(3) (dubbed the Wilson tectonic cycle), accompanied by inversion of extensional basins(4) and reactivation of faults and other structures formed in previous deformation events(5). Here we show that the abundance of crustal quartz, the weakest mineral in continental rocks(2), may strongly condition continental temperature and deformation. We use EarthScope seismic receiver functions(6), gravity and surface heat flow measurements(7) to estimate thickness and seismic velocity ratio, v(P)/v(S), of continental crust in the western United States. The ratio v(P)/v(S) is relatively insensitive to temperature but very sensitive to quartz abundance(8,9). Our results demonstrate a surprising correlation of low crustal v(P)/v(S) with both higher lithospheric temperature and deformation of the Cordillera, the mountainous region of the western United States. The most plausible explanation for the relationship to temperature is a robust dynamical feedback, in which ductile strain first localizes in relatively weak, quartz-rich crust, and then initiatesprocesses that promote advective warming, hydration and further weakening. The feedback mechanism-proposed here would not only explain stationarity and spatial distributions of deformation, but also lend insight into the timing and distribution of thermal uplift(10) and observations of deep-derived fluids in springs(11).	[Lowry, Anthony R.] Utah State Univ, Dept Geol, Logan, UT 84322 USA; [Perez-Gussinye, Marta] Univ London, Dept Earth Sci, Egham TW20 0EX, Surrey, England	Utah System of Higher Education; Utah State University; University of London; Royal Holloway University London	Lowry, AR (corresponding author), Utah State Univ, Dept Geol, Logan, UT 84322 USA.	Tony.Lowry@usu.edu	Lowry, Anthony R/F-8158-2012; Perez-Gussinye, Marta/R-1704-2016	Lowry, Anthony R/0000-0001-6023-3090; Perez-Gussinye, Marta/0000-0003-4109-1810	National Science Foundation [EAR-0454541, EAR-0955909]; Utah State University; Directorate For Geosciences [0955909] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Utah State University; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank K. Dueker, G. Pavlis, T. Ravat, J. Shervais and D. Schutt for discussions, and A. Braathen and R. Burgmann for comments. We are grateful to P. Crotwell, T. Owens andmembers of IRIS for their efforts on the EARSdatabase, and to P. Crotwell and B. Kucks for help with data acquisition. The work of A. R. L. on this project was supported by National Science Foundation grants EAR-0454541 (EarthScope Science: Rio Grande Rift) and EAR-0955909 (Geophysics/EarthScope CAREER: Deformation Processes), and by a Utah State University New Faculty Research Grant.	Afonso JC, 2005, PHYS EARTH PLANET IN, V149, P279, DOI 10.1016/j.pepi.2004.10.003; Beck J.V, 1977, PARAMETER ESTIMATION; Bouhifd MA, 1996, GEOPHYS RES LETT, V23, P1143, DOI 10.1029/96GL01118; Burgmann R, 2008, ANNU REV EARTH PL SC, V36, P531, DOI 10.1146/annurev.earth.36.031207.124326; CHRISTENSEN NI, 1995, J GEOPHYS RES-SOL EA, V100, P9761, DOI 10.1029/95JB00259; Christensen NI, 1996, J GEOPHYS RES-SOL EA, V101, P3139, DOI 10.1029/95JB03446; Crossey LJ, 2009, GEOL SOC AM BULL, V121, P1034, DOI 10.1130/B26394.1; Crotwell HP, 2005, SEISMOL RES LETT, V76, P702, DOI 10.1785/gssrl.76.6.702; Davis J.C., 1986, STAT DATA ANAL GEOLO; DeNosaquo KR, 2009, J VOLCANOL GEOTH RES, V188, P108, DOI 10.1016/j.jvolgeores.2009.08.006; Duval J.S., 2005, US GEOL SURV OPEN FI, V1413, P2005; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Erkan K, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2007JB005498; Fleck R. J., 2004, 20041039 US GEOL SUR, P1; Godfrey NJ, 1998, TECTONICS, V17, P558, DOI 10.1029/98TC01536; Grieser J., 2006, DATA SOURCES FAO WOR; HEARD HC, 1982, J GEOPHYS RES, V87, P9340, DOI 10.1029/JB087iB11p09340; Kistler R. W., 1990, B US GEOL SURV, V1920, P1; Kono Y, 2008, AM MINERAL, V93, P558, DOI 10.2138/am.2008.2591; Korenaga J, 2007, EARTH PLANET SC LETT, V257, P343, DOI 10.1016/j.epsl.2007.03.010; Kucks R.P., 2005, TERRESTRIAL RADIOACT; Kukkonen IT, 1999, SURV GEOPHYS, V20, P33, DOI 10.1023/A:1006655023894; Lowry AR, 2000, J GEOPHYS RES-SOL EA, V105, P23371, DOI 10.1029/2000JB900182; MARESCHAL JC, 1985, GEOPHYSICS, V50, P846, DOI 10.1190/1.1441960; MCKENZIE D, 1978, EARTH PLANET SC LETT, V40, P25, DOI 10.1016/0012-821X(78)90071-7; MOLNAR P, 1993, REV GEOPHYS, V31, P357, DOI 10.1029/93RG02030; Moschetti MP, 2010, NATURE, V464, P885, DOI 10.1038/nature08951; Perez-Gussinye M, 2009, EARTH PLANET SC LETT, V287, P152, DOI 10.1016/j.epsl.2009.08.004; POLLACK HN, 1980, TECTONOPHYSICS, V64, pT45, DOI 10.1016/0040-1951(80)90095-5; Roy M, 2009, NATURE, V459, P978, DOI 10.1038/nature08052; SASS JH, 1994, J GEOPHYS RES-SOL EA, V99, P22093, DOI 10.1029/94JB01891; Seipold U, 1998, TECTONOPHYSICS, V291, P161, DOI 10.1016/S0040-1951(98)00037-7; SMITH RB, 1994, J VOLCANOL GEOTH RES, V61, P121, DOI 10.1016/0377-0273(94)90002-7; SYKES LR, 1978, REV GEOPHYS, V16, P621, DOI 10.1029/RG016i004p00621; TREHU AM, 1994, SCIENCE, V266, P237, DOI 10.1126/science.266.5183.237; Turcotte D.L., 2002, GEODYNAMICS, DOI DOI 10.1002/GJ.987; West JD, 2009, NAT GEOSCI, V2, P438, DOI 10.1038/NGEO526; Williams M.L., 2010, UNLOCKING SECRETS N, P178; WILSON JT, 1966, NATURE, V211, P676, DOI 10.1038/211676a0; Yardley BWD, 2009, J GEOL SOC LONDON, V166, P585, DOI 10.1144/0016-76492008-101; Yuan HY, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002787; Zandt G, 2004, NATURE, V431, P41, DOI 10.1038/nature02847; Zhu LP, 2000, J GEOPHYS RES-SOL EA, V105, P2969, DOI 10.1029/1999JB900322; Ziegler PA, 1995, TECTONOPHYSICS, V252, P7, DOI 10.1016/0040-1951(95)00102-6	44	124	125	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2011	471	7338					353	+		10.1038/nature09912	http://dx.doi.org/10.1038/nature09912			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21412337				2022-12-28	WOS:000288444000040
J	Prescott, H; Ellis, E; Soule, S				Prescott, Helen; Ellis, Elna; Soule, Steven			Lesson of the Week Pituitary infarction: a potentially fatal cause of postoperative hyponatraemia and ocular palsy	BRITISH MEDICAL JOURNAL			English	Article							PRECIPITATING FACTORS; APOPLEXY					mda05hap@sheffield.ac.uk						Biousse V, 2001, J NEUROL NEUROSUR PS, V71, P542, DOI 10.1136/jnnp.71.4.542; Diederich S, 2003, EUR J ENDOCRINOL, V148, P609, DOI 10.1530/eje.0.1480609; Ezzat S, 2004, CANCER-AM CANCER SOC, V101, P613, DOI 10.1002/cncr.20412; GOEL V, 2009, J ARTHROPLASTY, V24; Randeva HS, 1999, CLIN ENDOCRINOL, V51, P181, DOI 10.1046/j.1365-2265.1999.00754.x; Reynolds RM, 2005, CLIN ENDOCRINOL, V63, P366, DOI 10.1111/j.1365-2265.2005.02318.x; Semple PL, 2007, NEUROSURGERY, V61, P956, DOI 10.1227/01.neu.0000303191.57178.2a; Semple PL, 2005, NEUROSURGERY, V56, P65, DOI 10.1227/01.NEU.0000144840.55247.38; Sibal Latika, 2004, Pituitary, V7, P157, DOI 10.1007/s11102-005-1050-3; Tambe AA, 2003, INJURY, V34, P253, DOI 10.1016/S0020-1383(02)00256-5; THOMASON K, 2009, ANN R COLL SURG ENGL, V91, P3	11	2	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 17	2011	342								d1221	10.1136/bmj.d1221	http://dx.doi.org/10.1136/bmj.d1221			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739FQ	21415109				2022-12-28	WOS:000288700200009
J	Price, MJ; Berger, PB; Teirstein, PS; Tanguay, JF; Angiolillo, DJ; Spriggs, D; Puri, S; Robbins, M; Garratt, KN; Bertrand, OF; Stillablower, ME; Aragon, JR; Kandzari, DE; Stinis, CT; Lee, MS; Manoukian, SV; Cannon, CP; Schork, NJ; Topol, EJ				Price, Matthew J.; Berger, Peter B.; Teirstein, Paul S.; Tanguay, Jean-Francois; Angiolillo, Dominick J.; Spriggs, Douglas; Puri, Sanjeev; Robbins, Mark; Garratt, Kirk N.; Bertrand, Olivier F.; Stillablower, Michael E.; Aragon, Joseph R.; Kandzari, David E.; Stinis, Curtiss T.; Lee, Michael S.; Manoukian, Steven V.; Cannon, Christopher P.; Schork, Nicholas J.; Topol, Eric J.		GRAVITAS Investigators	Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention The GRAVITAS Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	American-Heart-Association Scientific Sessions	NOV 16-16, 2010	Chicago, IL	Amer Heart Assoc			OF-CARE ASSAY; ANTIPLATELET THERAPY; ARTERY-DISEASE; REACTIVITY; INHIBITION; ASPIRIN; RESPONSIVENESS; POLYMORPHISM; GENOTYPE; IMPACT	Context High platelet reactivity while receiving clopidogrel has been linked to cardiovascular events after percutaneous coronary intervention (PCI), but a treatment strategy for this issue is not well defined. Objective To evaluate the effect of high-dose compared with standard-dose clopidogrel in patients with high on-treatment platelet reactivity after PCI. Design, Setting, and Patients Randomized, double-blind, active-control trial (Gauging Responsiveness with A VerifyNow assay-Impact on Thrombosis And Safety [GRAVITAS]) of 2214 patients with high on-treatment reactivity 12 to 24 hours after PCI with drug-eluting stents at 83 centers in North America between July 2008 and April 2010. Interventions High-dose clopidogrel (600-mg initial dose, 150 mg daily thereafter) or standard-dose clopidogrel (no additional loading dose, 75 mg daily) for 6 months. Main Outcome Measures The primary end point was the 6-month incidence of death from cardiovascular causes, nonfatal myocardial infarction, or stent thrombosis. The key safety end point was severe or moderate bleeding according to the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) definition. A key pharmacodynamic endpoint was the rate of persistently high on-treatment reactivity at 30 days. Results At 6 months, the primary end point had occurred in 25 of 1109 patients (2.3%) receiving high-dose clopidogrel compared with 25 of 1105 patients (2.3%) receiving standard-dose clopidogrel (hazard ratio [HR], 1.01; 95% confidence interval [CI], 0.58-1.76; P=.97). Severe or moderate bleeding was not increased with the high-dose regimen (15 [1.4%] vs 25 [2.3%], HR, 0.59; 95% CI, 0.31-1.11; P=.10). Compared with standard-dose clopidogrel, high-dose clopidogrel provided a 22% (95% CI, 18%-26%) absolute reduction in the rate of high on-treatment reactivity at 30 days (62%; 95% CI, 59%-65% vs 40%; 95% CI, 37%-43%; P<.001). Conclusions Among patients with high on-treatment reactivity after PCI with drug-eluting stents, the use of high-dose clopidogrel compared with standard-dose clopidogrel did not reduce the incidence of death from cardiovascular causes, nonfatal myocardial infarction, or stent thrombosis.	[Price, Matthew J.; Teirstein, Paul S.; Stinis, Curtiss T.; Topol, Eric J.] Scripps Clin, La Jolla, CA 92037 USA; [Price, Matthew J.; Teirstein, Paul S.; Schork, Nicholas J.; Topol, Eric J.] Scripps Translat Sci Inst, La Jolla, CA USA; [Schork, Nicholas J.] Scripps Res Inst, La Jolla, CA 92037 USA; [Berger, Peter B.] Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA; [Tanguay, Jean-Francois] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Angiolillo, Dominick J.] Univ Florida Shands Jacksonville, Jacksonville, FL USA; [Spriggs, Douglas] Clearwater Cardiovasc Consultants, Clearwater, FL USA; [Puri, Sanjeev] Trinity Med Ctr, Moline, IL USA; [Robbins, Mark] Vanderbilt Univ, Nashville, TN USA; [Garratt, Kirk N.] Lenox Hill Hosp, New York, NY 10021 USA; [Bertrand, Olivier F.] Laval Hosp, Quebec City, PQ, Canada; [Stillablower, Michael E.] Christiana Hosp, Newark, DE USA; [Aragon, Joseph R.] Sansum Clin, Santa Barbara, CA USA; [Kandzari, David E.] Piedmt Heart Inst, Atlanta, GA USA; [Lee, Michael S.] Univ Calif Los Angeles, Los Angeles, CA USA; [Manoukian, Steven V.] Sarah Cannon Res Inst, Nashville, TN USA; [Manoukian, Steven V.] Hosp Corp Amer, Nashville, TN USA; [Cannon, Christopher P.] Brigham & Womens Hosp, Boston, MA 02115 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Universite de Montreal; State University System of Florida; University of Florida; Vanderbilt University; Northwell Health; Piedmont Heart Institute; University of California System; University of California Los Angeles; Sarah Cannon Research Institute; Hospital Corporation of America; Harvard University; Brigham & Women's Hospital	Price, MJ (corresponding author), 10666 N Torrey Pines Rd,Maildrop S1056, La Jolla, CA 92037 USA.	price.matthew@scrippshealth.org	Price, Matthew/AAJ-7679-2020; Cannon, Christopher P/AAY-7644-2020	Price, Matthew/0000-0002-7892-2430; Cannon, Christopher P/0000-0003-4596-2791; Topol, Eric/0000-0002-1478-4729; Schork, Nicholas/0000-0003-0920-5013				Angiolillo DJ, 2005, DIABETES, V54, P2430, DOI 10.2337/diabetes.54.8.2430; Angiolillo DJ, 2007, CIRCULATION, V115, P708, DOI 10.1161/CIRCULATIONAHA.106.667741; Angiolillo DJ, 2007, J AM COLL CARDIOL, V49, P1505, DOI 10.1016/j.jacc.2006.11.044; Barker CM, 2010, JACC-CARDIOVASC INTE, V3, P1001, DOI 10.1016/j.jcin.2010.07.012; Bertrand ME, 1998, CIRCULATION, V98, P1597, DOI 10.1161/01.CIR.98.16.1597; Bonello L, 2010, J AM COLL CARDIOL, V56, P919, DOI 10.1016/j.jacc.2010.04.047; Bonello-Palot N, 2009, AM J CARDIOL, V104, P1511, DOI 10.1016/j.amjcard.2009.07.015; Brandt JT, 2007, J THROMB HAEMOST, V5, P2429, DOI 10.1111/j.1538-7836.2007.02775.x; Breet NJ, 2010, JAMA-J AM MED ASSOC, V303, P754, DOI 10.1001/jama.2010.181; Buonamici P, 2007, J AM COLL CARDIOL, V49, P2312, DOI 10.1016/j.jacc.2007.01.094; Campo G, 2010, J AM COLL CARDIOL, V56, P1447, DOI 10.1016/j.jacc.2010.03.103; Cannon CP, 2001, J AM COLL CARDIOL, V38, P2114, DOI 10.1016/S0735-1097(01)01702-8; CONCATO J, 1993, ANN INTERN MED, V118, P201, DOI 10.7326/0003-4819-118-3-199302010-00009; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Fontana P, 2008, THROMB RES, V121, P463, DOI 10.1016/j.thromres.2007.06.012; Gurbel PA, 2003, AM J CARDIOL, V91, P1123, DOI 10.1016/S0002-9149(03)00163-2; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Hochholzer W, 2006, J AM COLL CARDIOL, V48, P1742, DOI 10.1016/j.jacc.2006.06.065; Hochholzer W, 2010, J AM COLL CARDIOL, V55, P2427, DOI 10.1016/j.jacc.2010.02.031; Jeong YH, 2010, JACC-CARDIOVASC INTE, V3, P731, DOI 10.1016/j.jcin.2010.05.007; Jeong YH, 2009, J AM COLL CARDIOL, V53, P2009, DOI 10.1016/j.jacc.2008.12.025; Jernberg T, 2006, EUR HEART J, V27, P1166, DOI 10.1093/eurheartj/ehi877; Kazui M, 2010, DRUG METAB DISPOS, V38, P92, DOI 10.1124/dmd.109.029132; Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663; Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303; Mangiacapra F, 2010, JACC-CARDIOVASC INTE, V3, P318, DOI 10.1016/j.jcin.2009.12.012; Marcucci R, 2009, CIRCULATION, V119, P237, DOI 10.1161/CIRCULATIONAHA.108.812636; Mehta SR, 2010, NEW ENGL J MED, V363, P930, DOI 10.1056/NEJMoa0909475; Migliorini A, 2009, CIRCULATION, V120, P2214, DOI 10.1161/CIRCULATIONAHA.109.883454; Patti G, 2008, J AM COLL CARDIOL, V52, P1128, DOI 10.1016/j.jacc.2008.06.038; Pena A, 2009, CIRCULATION, V119, P2854, DOI 10.1161/CIRCULATIONAHA.108.857722; Price MJ, 2008, EUR HEART J, V29, P992, DOI 10.1093/eurheartj/ehn046; Price MJ, 2006, AM J CARDIOL, V98, P681, DOI 10.1016/j.amjcard.2006.03.054; Price MJ, 2009, AM J CARDIOL, V103, P1339, DOI 10.1016/j.amjcard.2009.01.341; Price MJ, 2009, CIRCULATION, V119, P2625, DOI 10.1161/CIRCULATIONAHA.107.696732; Price MJ, 2009, AM HEART J, V157, P818, DOI 10.1016/j.ahj.2009.02.012; Schork NJ, 2010, J BIOPHARM STAT, V20, P315, DOI 10.1080/10543400903572779; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Siller-Matula JM, 2008, J AM COLL CARDIOL, V52, P1557, DOI 10.1016/j.jacc.2008.07.055; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Trenk D, 2008, J AM COLL CARDIOL, V51, P1925, DOI 10.1016/j.jacc.2007.12.056; von Beckerath N, 2005, CIRCULATION, V112, P2946, DOI 10.1161/CIRCULATIONAHA.105.559088	42	1027	1089	0	44	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2011	305	11					1097	1105		10.1001/jama.2011.290	http://dx.doi.org/10.1001/jama.2011.290			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	734ZF	21406646				2022-12-28	WOS:000288381900021
J	Beaglehole, R; Bonita, R; Horton, R; Adams, C; Alleyne, G; Asaria, P; Baugh, V; Bekedam, H; Billo, N; Casswell, S; Cecchini, M; Colagiuri, R; Colagiuri, S; Collins, T; Ebrahim, S; Engelgau, M; Galea, G; Gaziano, T; Geneau, R; Haines, A; Hospedales, J; Jha, P; Keeling, A; Leeder, S; Lincoln, P; McKee, M; Mackay, J; Magnusson, R; Moodie, R; Mwatsama, M; Nishtar, S; Norrving, B; Patterson, D; Piot, P; Ralston, J; Rani, M; Reddy, KS; Sassi, F; Sheron, N; Stuckler, D; Suh, I; Torode, J; Varghese, C; Watt, J				Beaglehole, Robert; Bonita, Ruth; Horton, Richard; Adams, Cary; Alleyne, George; Asaria, Perviz; Baugh, Vanessa; Bekedam, Henk; Billo, Nils; Casswell, Sally; Cecchini, Michele; Colagiuri, Ruth; Colagiuri, Stephen; Collins, Tea; Ebrahim, Shah; Engelgau, Michael; Galea, Gauden; Gaziano, Thomas; Geneau, Robert; Haines, Andy; Hospedales, James; Jha, Prabhat; Keeling, Ann; Leeder, Stephen; Lincoln, Paul; McKee, Martin; Mackay, Judith; Magnusson, Roger; Moodie, Rob; Mwatsama, Modi; Nishtar, Sonia; Norrving, Bo; Patterson, David; Piot, Peter; Ralston, Johanna; Rani, Manju; Reddy, K. Srinath; Sassi, Franco; Sheron, Nick; Stuckler, David; Suh, Il; Torode, Julie; Varghese, Cherian; Watt, Judith		Lancet NCD Action Grp; NCD Alliance	Priority actions for the non-communicable disease crisis	LANCET			English	Article							PREVENTING CHRONIC DISEASES; MIDDLE-INCOME COUNTRIES; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; HEALTH-BENEFITS; CLIMATE-CHANGE; GLOBAL BURDEN; RISK-FACTORS; ALCOHOL; SMOKING	The UN High-Level Meeting on Non-Communicable Diseases (NCDs) in September, 2011, is an unprecedented opportunity to create a sustained global movement against premature death and preventable morbidity and disability from NCDs, mainly heart disease, stroke, cancer, diabetes, and chronic respiratory disease. The increasing global crisis in NCDs is a barrier to development goals including poverty reduction, health equity, economic stability, and human security. The Lancet NCD Action Group and the NCD Alliance propose five overarching priority actions for the response to the crisis leadership, prevention, treatment, international cooperation, and monitoring and accountability and the delivery of five priority interventions tobacco control, salt reduction, improved diets and physical activity, reduction in hazardous alcohol intake, and essential drugs and technologies. The priority interventions were chosen for their health effects, cost-effectiveness, low costs of implementation, and political and financial feasibility. The most urgent and immediate priority is tobacco control. We propose as a goal for 2040, a world essentially free from tobacco where less than 5% of people use tobacco. Implementation of the priority interventions, at an estimated global commitment of about US$9 billion per year, will bring enormous benefits to social and economic development and to the health sector. If widely adopted, these interventions will achieve the global goal of reducing NCD death rates by 2% per year, averting tens of millions of premature deaths in this decade.	[Beaglehole, Robert; Bonita, Ruth] Univ Auckland, Auckland 1, New Zealand; [Horton, Richard] The Lancet, London, England; [Adams, Cary; Torode, Julie] NCD Alliance Union Int Canc Control, Geneva, Switzerland; [Alleyne, George; Hospedales, James] Pan Amer Hlth Org, Washington, DC USA; [Asaria, Perviz] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [Baugh, Vanessa] Commonwealth Secretariat, London, England; [Bekedam, Henk; Rani, Manju; Varghese, Cherian] WHO Western Pacific Reg Off, Manila, Philippines; [Billo, Nils] NCD Alliance Int Union Against TB & Lung Dis, Paris, France; [Casswell, Sally] Massey Univ, Auckland, New Zealand; [Cecchini, Michele; Sassi, Franco] Org Econ Cooperat & Dev, Hlth Div, Paris, France; [Collins, Tea] NCD Alliance, Geneva, Switzerland; [Ebrahim, Shah] S Asia Network Chron Dis, New Delhi, India; [Engelgau, Michael] World Bank, Washington, DC 20433 USA; [Galea, Gauden] WHO European Reg Off, Copenhagen, Denmark; [Gaziano, Thomas] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Geneau, Robert] Univ Ottawa, Ottawa, ON, Canada; [Haines, Andy; McKee, Martin; Piot, Peter] London Sch Hyg & Trop Med, London WC1, England; [Jha, Prabhat] Ctr Global Hlth Res, Toronto, ON, Canada; [Colagiuri, Ruth; Colagiuri, Stephen; Keeling, Ann] NCD Alliance Int Diabet Federat, Brussels, Belgium; [Leeder, Stephen; Magnusson, Roger] Univ Sydney, Sydney, NSW 2006, Australia; [Lincoln, Paul; Mwatsama, Modi] Natl Heart Forum, London, England; [Mackay, Judith] World Lung Fdn, Hong Kong, Hong Kong, Peoples R China; [Moodie, Rob] Univ Melbourne, Melbourne, Vic, Australia; [Nishtar, Sonia] HeartFile, Islamabad, Pakistan; [Norrving, Bo] World Stroke Org, Geneva, Switzerland; [Patterson, David] Int Dev Law Org, Rome, Italy; [Ralston, Johanna] NCD Alliance World Heart Federat, Geneva, Switzerland; [Reddy, K. Srinath] Publ Hlth Fdn India, New Delhi, India; [Sheron, Nick] Univ Southampton, Southampton, Hants, England; [Stuckler, David] Harvard Univ, Boston, MA USA; [Suh, Il] Yonsei Univ, Coll Med, Seoul, South Korea	University of Auckland; Pan American Health Organization; Imperial College London; WHO Western Pacific Regional Office; Massey University; Organisation for Economic Co-operation & Development (OECD); The World Bank; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Ottawa; University of London; London School of Hygiene & Tropical Medicine; University of Sydney; University of Melbourne; Public Health Foundation of India; University of Southampton; Harvard University; Yonsei University; Yonsei University Health System	Beaglehole, R (corresponding author), 42 Albert Rd, Auckland 0624, New Zealand.	r.beaglehole@auckland.ac.nz	Galea, Gauden/AAV-4335-2021; McKee, Marc D/E-2187-2011; Stuckler, David/H-2261-2012; McKee, Martin/E-6673-2018	Galea, Gauden/0000-0002-2257-6014; McKee, Marc D/0000-0001-8349-965X; Billo, Nils Eric/0000-0002-5735-5107; Asaria, Perviz/0000-0002-9037-0894; Moodie, Alan/0000-0002-8425-7975; Suh, Il/0000-0002-9689-7849; Reddy, K Srinath/0000-0003-3416-3548; Casswell, Sally/0000-0002-2211-7096; Norrving, Bo/0000-0002-8024-5096; Sheron, Nick/0000-0002-6156-8367; McKee, Martin/0000-0002-0121-9683; Geneau, Robert/0000-0001-6180-2515; Sassi, Franco/0000-0001-9773-2117; Sheron, Nick/0000-0001-5232-8292; Haines, Andy/0000-0002-8053-4605; Stuckler, David/0000-0002-1288-8401; Colagiuri, Stephen/0000-0002-2398-4781	Wellcome Trust; Family Health International; 19 Inter-American Development Bank; Bayer; Allergan; Syngis; Servier; 22 Photothera; Boehringer-Ingelheim; Pfizer; Wiley; Sanofi-Aventis; Varian Medical Systems; Roche; Boehringer Ingelheim; Novartis; Slender; 23 Merck; Eli Lilly; Heng Rui; Irmet; National Heart Forum	Wellcome Trust(Wellcome TrustEuropean Commission); Family Health International; 19 Inter-American Development Bank; Bayer(Bayer AG); Allergan(AbbVieAllergan); Syngis; Servier(Servier); 22 Photothera; Boehringer-Ingelheim(Boehringer Ingelheim); Pfizer(Pfizer); Wiley; Sanofi-Aventis(Sanofi-Aventis); Varian Medical Systems; Roche(Roche Holding); Boehringer Ingelheim(Boehringer Ingelheim); Novartis(Novartis); Slender; 23 Merck; Eli Lilly(Eli Lilly); Heng Rui; Irmet; National Heart Forum	PA has received grants from Wellcome Trust Clinical PhD Fellowship. SE has received grants from the Wellcome Trust, and royalties from 18 McGraw Hill for editing a book. RI-I is the editor of The Lancet. TG has received consultancy payments from Family Health International and 19 Inter-American Development Bank; and payment for lectures, including lectures on speakers bureaus, from Network for Continuing Medical 20 Education. BN has received consultancy payments from Bayer, payment for lectures including service on speakers bureaus from Allergan, and 21 royalties for a book published by Karolinska University Press. BN's institute has received money for consultancy from Syngis, Servier, Bayer, 22 Photothera, and Boehringer-Ingelheim. JT has received or has grants pending from Corporate Partners, Pfizer, Wiley, Sanofi-Aventis, Varian Medical Systems, Roche, Boehringer Ingelheim, Novartis, Slender, 23 Merck, Eli Lilly, Heng Rui, and Irmet. The other authors declare that they have no conflicts of interest.; We thank the National Heart Forum for providing financial, technical, and administrative support for the production of this report. The authors alone are responsible for the views expressed in this report and they do not necessarily represent the decisions, policy, or views of WHO, the World Bank, the OECD, or those of the member countries of these organisations.	Alleyne G, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-15; Alwan A, 2010, LANCET, V376, P1861, DOI 10.1016/S0140-6736(10)61853-3; Anderson P, 2009, LANCET, V373, P2234, DOI 10.1016/S0140-6736(09)60744-3; [Anonymous], 2010, HLTH NUTR POPUL SER; [Anonymous], 2005, PREV CHRON DIS VIT I; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Balabanova D, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-22; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; Beaglehole R, 2010, LANCET, V376, P1619, DOI 10.1016/S0140-6736(10)61929-0; Beaglehole R, 2009, LANCET, V373, P2173, DOI 10.1016/S0140-6736(09)61168-5; Bhutta Z, 2011, LANCET, V377, P969, DOI 10.1016/S0140-6736(11)60169-4; Callaway M, 2007, J PAIN SYMPTOM MANAG, V33, P509, DOI 10.1016/j.jpainsymman.2007.02.003; Capewell S, 2011, LANCET, V378, P752, DOI 10.1016/S0140-6736(10)62302-1; Casswell S, 2011, ADDICTION, V106, P1087, DOI 10.1111/j.1360-0443.2011.03361.x; Casswell S, 2009, LANCET, V373, P2247, DOI 10.1016/S0140-6736(09)60745-5; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Chow CK, 2009, INT J EPIDEMIOL, V38, P1580, DOI 10.1093/ije/dyn258; Cobiac LJ, 2010, HEART, V96, P1920, DOI 10.1136/hrt.2010.199240; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; ENGELAU MM, CAPITALIZING DEMOGRA; Epping-Jordan JE, 2005, LANCET, V366, P1667, DOI 10.1016/S0140-6736(05)67342-4; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; FIDLER DP, 2008, REVOLUTION GLOBAL HL; Freeman B, 2010, TOB CONTROL, V19, pE1, DOI 10.1136/tc.2009.032847; Gaziano TA, 2008, LANCET, V371, P923, DOI 10.1016/S0140-6736(08)60418-3; Gaziano TA, 2007, LANCET, V370, P1939, DOI 10.1016/S0140-6736(07)61697-3; Geneau R, 2010, LANCET, V376, P1689, DOI 10.1016/S0140-6736(10)61414-6; Gill GV, 2011, DIABETOLOGIA, V54, P19, DOI 10.1007/s00125-010-1897-3; GLUCKMAN P, 2006, WHY OUR WORLD NO LON; Haines A, 2009, LANCET, V374, P2104, DOI 10.1016/S0140-6736(09)61759-1; Horton R, 2005, LANCET, V366, P1514, DOI 10.1016/S0140-6736(05)67454-5; Horton R, 2007, LANCET, V370, P1881, DOI 10.1016/S0140-6736(07)61701-2; HOSPEDALES CJ, PAN AM J PU IN PRESS; Institute of Medicine, 2010, PROM CARD HLTH DEV W; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Jha P., 1999, CURBING EPIDEMIC GOV; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Jha P, 2006, LANCET, V368, P367, DOI 10.1016/S0140-6736(06)68975-7; Joffres MR, 2007, CAN J CARDIOL, V23, P437, DOI 10.1016/S0828-282X(07)70780-8; Knai C, 2010, LANCET, V376, P75, DOI 10.1016/S0140-6736(09)62063-8; Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6; Li N, 2007, J HYPERTENS, V25, P2011, DOI 10.1097/HJH.0b013e3282b9714b; Lightwood JM, 1997, CIRCULATION, V96, P1089, DOI 10.1161/01.CIR.96.4.1089; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Lindholm LH, 2007, LANCET, V370, P720, DOI 10.1016/S0140-6736(07)61356-7; Lock K, 2005, B WORLD HEALTH ORGAN, V83, P100; Magnusson RS, 2009, PUBLIC HEALTH, V123, P265, DOI 10.1016/j.puhe.2008.12.023; MALONE R, 2010, BOTTOM LINE PUBLIC H; New Zealand Government, GOV RESP REP MAOR AF; Outterson K, 2008, HEALTH AFFAIR, V27, P130, DOI 10.1377/hlthaff.27.1.130; Piot Peter, 2010, BMJ, V341, pc4865, DOI 10.1136/bmj.c4865; Rayner G, 2006, HEALTH PROMOT INT, V21, P67, DOI 10.1093/heapro/dal053; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; *RGI CGHR, 2009, CAUS DEATH IND 2001; Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7; Sims M, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2161; SRIDHAR D, 2011, GETTING POLITICS RIG; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; Stuckler D, 2010, POLITICAL EC UNIVERS; Stuckler D, 2008, MILBANK Q, V86, P273, DOI 10.1111/j.1468-0009.2008.00522.x; Stuckler D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000241; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; *UN, 2010, PREV CONTR NONC DIS; *UN, 2008, COMPR FRAM ACT HIGH; *UN FRAM CONV CLIM, 2009, C PART 15 SESS COP A; Verkaik-Kloosterman J, 2010, BRIT J NUTR, V104, P1712, DOI 10.1017/S0007114510002722; WHO, 2010, WOR HEALT REP, P1; WHO, 2008, COMM SOC DET HLTH; World Economic Forum, 2011, GLOB RISKS 2011; World Health Organization, 2004, TOB POV VIC CYCL; World Health Organization, 2008, ACT PLAN GLOB STRAT; World Health Organization, 2007, PREV CARD DIS GUID A; World Health Organization, 2009, WHO REP GLOB TOB EP; World Health Organization, 2010, PACK ESS NONC PEN DI; World health organization, RISK FACT EST 2004; World Health Organization, 2009, MORT BURD DIS EST WH; World Health Organization, 2004, GLOB STRAT DIET PHYS; World Health Organization (WHO), STEPWISE APPR SURV S; Yang Gonghuan, 2005, Popul Health Metr, V3, P3, DOI 10.1186/1478-7954-3-3; Younger M, 2008, AM J PREV MED, V35, P517, DOI 10.1016/j.amepre.2008.08.017; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; 2011, LANCET, V377, P783	84	1093	1131	7	359	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2011	377	9775					1438	1447		10.1016/S0140-6736(11)60393-0	http://dx.doi.org/10.1016/S0140-6736(11)60393-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755UF	21474174				2022-12-28	WOS:000289963000033
J	Cooper, MA; Shlaes, D				Cooper, Matthew A.; Shlaes, David			Fix the antibiotics pipeline	NATURE			English	Editorial Material									[Cooper, Matthew A.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia	University of Queensland	Cooper, MA (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.	m.cooper@imb.uq.edu.au; shlaes.david@earthlink.net	Cooper, Matthew A./C-7988-2009	Cooper, Matthew A./0000-0003-3147-3460				[Anonymous], REPORT EUROPEAN COMM; Morel Chantal M, 2010, BMJ, V340, pc2115, DOI 10.1136/bmj.c2115; Mossialos E, 2009, POLICIES INCENTIVES	3	345	353	3	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 7	2011	472	7341					32	32		10.1038/472032a	http://dx.doi.org/10.1038/472032a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	745VV	21475175	Bronze			2022-12-28	WOS:000289199400018
J	Dunbar-Rees, R; McGough, R				Dunbar-Rees, Rupert; McGough, Robert			Challenges of EU competition law for general practice commissioning Rupert Dunbar-Rees and Robert McGough explore the choice and competition issues facing general practice commissioners	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Dunbar-Rees, Rupert] BDO, Healthcare Advisory Practice, London W1U 7EU, England; [McGough, Robert] Beachcroft, Leeds LS1 2LW, W Yorkshire, England		Dunbar-Rees, R (corresponding author), BDO, Healthcare Advisory Practice, London W1U 7EU, England.	Rupert.Dunbar-Rees@bdo.co.uk						*DEP HLTH, 2010, LIB NHS COMM PAT; *DEP HLTH, 2010, HLTH SOC CAR BILL 20; *DEP HLTH, 2010, PROC GUID COMM NHS F; Department of Health, 2010, PAYM RES GUID 2010 1; Department of Health, 2010, EQ EXC LIB NHS; Department of Health, 2010, OP FRAM NHS ENGL 201; McGough Robert, 2010, Health Serv J, V120, P25; Nicholson D.S., 2011, EQUITY EXCELLENCE LI; *OFF GOV COMM, 2010, EU PROC THRESH; Print Melanie, 2010, Health Serv J, V120, P38	10	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 7	2011	342								d2071	10.1136/bmj.d2071	http://dx.doi.org/10.1136/bmj.d2071			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	749JT	21474526				2022-12-28	WOS:000289462400005
J	North, RA; McCowan, LME; Dekker, GA; Poston, L; Chan, EHY; Stewart, AW; Black, MA; Taylor, RS; Walker, JJ; Baker, PN; Kenny, LC				North, Robyn A.; McCowan, Lesley M. E.; Dekker, Gustaaf A.; Poston, Lucilla; Chan, Eliza H. Y.; Stewart, Alistair W.; Black, Michael A.; Taylor, Rennae S.; Walker, James J.; Baker, Philip N.; Kenny, Louise C.			Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; UTERINE ARTERY DOPPLER; FAMILY-HISTORY; BLOOD-PRESSURE; PREGNANCY; HYPERTENSION; DISORDERS; ACCURACY; ABORTION; OUTCOMES	Objectives To develop a predictive model for pre-eclampsia based on clinical risk factors for nulliparous women and to identify a subgroup at increased risk, in whom specialist referral might be indicated. Design Prospective multicentre cohort. Setting Five centres in Auckland, New Zealand; Adelaide, Australia; Manchester and London, United Kingdom; and Cork, Republic of Ireland. Participants 3572 "healthy" nulliparous women with a singleton pregnancy from a large international study; data on pregnancy outcome were available for 3529 (99%). Main outcome measure Pre-eclampsia defined as >= 140 mm Hg or diastolic blood pressure >= 90 mm Hg, or both, on at least two occasions four hours apart after 20 weeks' gestation but before the onset of labour, or postpartum, with either proteinuria or any multisystem complication. Preterm pre-eclampsia was defined as women with pre-eclampsia delivered before 37(+0) weeks' gestation. In the stepwise logistic regression the comparison group was women without pre-eclampsia. Results Of the 3529 women, 186 (5.3%) developed pre-eclampsia, including 47 (1.3%) with pre-term pre-eclampsia. Clinical risk factors at 14-16 weeks' gestation were age, mean arterial blood pressure, body mass index (BMI), family history of pre-eclampsia, family history of coronary heart disease, maternal birth weight, and vaginal bleeding for at least five days. Factors associated with reduced risk were a previous single miscarriage with the same partner, taking at least 12 months to conceive, high intake of fruit, cigarette smoking, and alcohol use in the first trimester. The area under the receiver operating characteristics curve (AUC), under internal validation, was 0.71. Addition of uterine artery Doppler indices did not improve performance (internal validation AUC 0.71). A framework for specialist referral was developed based on a probability of pre-eclampsia generated by the model of at least 15% or an abnormal uterine artery Doppler waveform in a subset of women with single risk factors. Nine per cent of nulliparous women would be referred for a specialist opinion, of whom 21% would develop pre-eclampsia. The relative risk for developing pre-eclampsia and preterm pre-eclampsia in women referred to a specialist compared with standard care was 5.5 and 12.2, respectively. Conclusions The ability to predict pre-eclampsia in healthy nulliparous women using clinical phenotype is modest and requires external validation in other populations. If validated, it could provide a personalised clinical risk profile for nulliparous women to which biomarkers could be added.	[North, Robyn A.; Poston, Lucilla] Kings Coll London, Div Womens Hlth, London WC2R 2LS, England; [McCowan, Lesley M. E.; Chan, Eliza H. Y.; Taylor, Rennae S.] Univ Auckland, Dept Obstet & Gynaecol, Fac Med & Hlth Sci, Auckland 1, New Zealand; [Dekker, Gustaaf A.] Univ Adelaide, Dept Obstet & Gynaecol, Lyell McEwin Hosp, Adelaide, SA 5001, Australia; [Stewart, Alistair W.] Univ Auckland, Dept Epidemiol & Biostat, Fac Med & Hlth Sci, Sch Populat Hlth, Auckland 1, New Zealand; [Black, Michael A.] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Walker, James J.] Univ Leeds, Leeds Inst Mol Med, Leeds, W Yorkshire, England; [Baker, Philip N.] Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada; [Baker, Philip N.] Univ Manchester, Dept Obstet & Gynaecol, Manchester M13 9PL, Lancs, England; [Kenny, Louise C.] Univ Coll Cork, Dept Obstet & Gynaecol, Anu Res Ctr, Cork, Ireland	University of London; King's College London; University of Auckland; Lyell McEwin Hospital; University of Adelaide; University of Auckland; University of Otago; University of Leeds; University of Alberta; University of Manchester; University College Cork	North, RA (corresponding author), Kings Coll London, Div Womens Hlth, London WC2R 2LS, England.	robyn.north@kcl.ac.uk	McCowan, Lesley/C-2215-2009; Kenny, Louise C/G-1112-2011; Kenny, Louise/X-6329-2019; Black, Michael/F-1484-2010	Kenny, Louise C/0000-0002-9011-759X; Kenny, Louise/0000-0002-9011-759X; Walker, James/0000-0002-8922-083X; Taylor, Rennae/0000-0003-1718-9332; Black, Michael/0000-0003-1174-6054; McCowan, Lesley/0000-0001-9915-7873; Baker, Philip/0000-0002-4592-6427	Foundation for Research Science and Technology; Health Research Council [04/198]; Auckland District Health Board Charitable Trust; South Australian Government; Guy's and St Thomas' Charity, Tommy's the baby Charity; Biotechnology and Biological Sciences Research Council [GT084]; UK National Health Services [FSD025]; University of Manchester, NIHR; Health Research Board, Ireland [CSA/2007/2]; University of Auckland; New Zealand Health Research Council	Foundation for Research Science and Technology(New Zealand Foundation for Research, Science and Technology); Health Research Council; Auckland District Health Board Charitable Trust; South Australian Government; Guy's and St Thomas' Charity, Tommy's the baby Charity; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK National Health Services; University of Manchester, NIHR(National Institute for Health Research (NIHR)); Health Research Board, Ireland; University of Auckland; New Zealand Health Research Council(Health Research Council of New Zealand)	This study was funded by New Enterprise Research Fund, Foundation for Research Science and Technology; Health Research Council (04/198); Evelyn Bond Fund, Auckland District Health Board Charitable Trust; Premier's Science and Research Fund, South Australian Government; Guy's and St Thomas' Charity, Tommy's the baby Charity; Biotechnology and Biological Sciences Research Council (GT084), UK National Health Services (NEAT grant FSD025), University of Manchester Proof of Concept Funding, NIHR; Health Research Board, Ireland (CSA/2007/2). The study sponsors had no role in study design, data analysis or writing this report. MAB received consultancy fees from the SCO PE Study, University of Auckland, which were funded by the New Zealand Health Research Council and the New Enterprise Research Fund, Foundation for Research Science and Technology.	Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Barry D, 2009, ADDICT BEHAV, V34, P51, DOI 10.1016/j.addbeh.2008.08.008; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Brantsaeter AL, 2009, J NUTR, V139, P1162, DOI 10.3945/jn.109.104968; Brown MA, 2000, AUST NZ J OBSTET GYN, V40, P139, DOI 10.1111/j.1479-828X.2000.tb01137.x; Carr DB, 2005, AM J OBSTET GYNECOL, V193, P965, DOI 10.1016/j.ajog.2005.06.034; Chappell LC, 2008, HYPERTENSION, V51, P1002, DOI 10.1161/HYPERTENSIONAHA.107.107565; Cnossen JS, 2007, BJOG-INT J OBSTET GY, V114, P1477, DOI 10.1111/j.1471-0528.2007.01483.x; Cnossen JS, 2008, BMJ-BRIT MED J, V336, P1117, DOI 10.1136/bmj.39540.522049.BE; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Conde-Agudelo A, 1999, AM J OBSTET GYNECOL, V181, P1026, DOI 10.1016/S0002-9378(99)70341-8; Dempsey JC, 2003, AM J OBSTET GYNECOL, V189, P494, DOI 10.1067/S0002-9378(03)00491-5; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Duley L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004659.pub2; Gardosi J, GESTATION NETWORK; Gearhardt AN, 2009, PSYCHOL ADDICT BEHAV, V23, P216, DOI 10.1037/a0015011; Groom KM, 2009, OBSTET GYNECOL, V113, P332, DOI 10.1097/AOG.0b013e318195b223; Hernandez-Diaz S, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2255; Herraiz I, 2009, PRENATAL DIAG, V29, P1123, DOI 10.1002/pd.2383; Hofmeyr GJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001059.pub3; Klemmensen AK, 2007, AM J EPIDEMIOL, V166, P117, DOI 10.1093/aje/kwm139; Klonoff-Cohen H.S., 1996, J WOMENS HEALTH, V5, P225; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; McCowan L, 2004, AUST NZ J OBSTET GYN, V44, P428, DOI 10.1111/j.1479-828X.2004.00272.x; McCowan L, 2007, ACTRN12607000551493; Milne F, 2005, BRIT MED J, V330, P576, DOI 10.1136/bmj.330.7491.576; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Mostello D, 2002, AM J OBSTET GYNECOL, V187, P425, DOI 10.1067/mob.2002.123608; National Institute for Health and Clinical Excellence, 2010, NICE CLIN GUID 107 H; National Institute for Health and Clinical Excellence, 2010, NICE CLIN GUID 62 AN; Ness RB, 2003, OBSTET GYNECOL, V102, P1366, DOI 10.1016/j.obstetgynecol.2003.08.011; Papageorghiou AT, 2005, BJOG-INT J OBSTET GY, V112, P703, DOI 10.1111/j.1471-0528.2005.00519.x; Peindl KS, 2004, J AFFECT DISORDERS, V80, P37, DOI 10.1016/S0165-0327(03)00052-1; Poon LCY, 2010, J HUM HYPERTENS, V24, P104, DOI 10.1038/jhh.2009.45; Poon LCY, 2008, HYPERTENSION, V51, P1027, DOI 10.1161/HYPERTENSIONAHA.107.104646; Poon LCY, 2009, HYPERTENSION, V53, P812, DOI 10.1161/HYPERTENSIONAHA.108.127977; R Core Team, 2020, R LANG ENV STAT COMP; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Rigo J, 2006, EUR J OBSTET GYN R B, V128, P148, DOI 10.1016/j.ejogrb.2006.02.019; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Saftlas AF, 2003, AM J EPIDEMIOL, V157, P1108, DOI 10.1093/aje/kwg101; Schafer J. L., 1996, ANAL INCOMPLETE MULT; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Sibai BM, 1997, AM J OBSTET GYNECOL, V177, P1003, DOI 10.1016/S0002-9378(97)70004-8; Sibai BM, 1998, NEW ENGL J MED, V339, P667, DOI 10.1056/NEJM199809033391004; Silva LM, 2008, HYPERTENSION, V52, P645, DOI 10.1161/HYPERTENSIONAHA.108.116632; Silva LM, 2008, J HYPERTENS, V26, P1200, DOI 10.1097/HJH.0b013e3282fcc36e; Skjaerven R, 2005, BRIT MED J, V331, P877, DOI 10.1136/bmj.38555.462685.8F; Spence M, 2005, PSYCHOL MED, V35, P583, DOI 10.1017/S0033291704003484; Trogstad L, 2009, BJOG-INT J OBSTET GY, V116, P108, DOI 10.1111/j.1471-0528.2008.01978.x; Weiss JL, 2004, AM J OBSTET GYNECOL, V190, P745, DOI 10.1016/j.ajog.2003.09.023; Yu CKH, 2005, AM J OBSTET GYNECOL, V193, P429, DOI 10.1016/j.ajog.2004.12.014	52	278	287	0	32	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2011	342								d1875	10.1136/bmj.d1875	http://dx.doi.org/10.1136/bmj.d1875			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749JT	21474517	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000289462400004
J	Reddy, RA; Zhu, CH; Shao, RF; Korblova, E; Gong, T; Shen, YQ; Garcia, E; Glaser, MA; Maclennan, JE; Walba, DM; Clark, NA				Reddy, R. Amaranatha; Zhu, Chenhui; Shao, Renfan; Korblova, Eva; Gong, Tao; Shen, Yongqiang; Garcia, Edgardo; Glaser, Matthew A.; Maclennan, Joseph E.; Walba, David M.; Clark, Noel A.			Spontaneous Ferroelectric Order in a Bent-Core Smectic Liquid Crystal of Fluid Orthorhombic Layers	SCIENCE			English	Article							HOMOLOGOUS SERIES; PHASE; MOLECULES; TRANSITION	Macroscopic polarization density, characteristic of ferroelectric phases, is stabilized by dipolar intermolecular interactions. These are weakened as materials become more fluid and of higher symmetry, limiting ferroelectricity to crystals and to smectic liquid crystal stackings of fluid layers. We report the SmAP(F), the smectic of fluid polar orthorhombic layers that order into a three-dimensional ferroelectric state, the highest-symmetry layered ferroelectric possible and the highest-symmetry ferroelectric material found to date. Its bent-core molecular design employs a single flexible tail that stabilizes layers with untilted molecules and in-plane polar ordering, evident in monolayer-thick freely suspended films. Electro-optic response reveals the three-dimensional orthorhombic ferroelectric structure, stabilized by silane molecular terminations that promote parallel alignment of the molecular dipoles in adjacent layers.	[Zhu, Chenhui; Shao, Renfan; Shen, Yongqiang; Glaser, Matthew A.; Maclennan, Joseph E.; Clark, Noel A.] Univ Colorado, Dept Phys, Liquid Crystal Mat Res Ctr, Boulder, CO 80309 USA; [Reddy, R. Amaranatha; Korblova, Eva; Gong, Tao; Garcia, Edgardo; Walba, David M.] Univ Colorado, Dept Chem & Biochem, Liquid Crystal Mat Res Ctr, Boulder, CO 80309 USA; [Garcia, Edgardo] Univ Brasilia, Lab Quim Computac, Inst Quim, BR-70910900 Brasilia, DF, Brazil	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Universidade de Brasilia	Clark, NA (corresponding author), Univ Colorado, Dept Phys, Liquid Crystal Mat Res Ctr, Boulder, CO 80309 USA.	noel.clark@colorado.edu	Clark, Noel A./E-9011-2010; Korblova, Eva/AAC-3502-2021; Gong, Tao/I-3011-2013; Maclennan, Joseph E/A-9836-2013; Walba, David/F-7284-2013; Shen, Yongqiang/N-7902-2013; Clark, Noel A/AAP-9116-2020; Glaser, Matthew/H-2345-2016	Clark, Noel A./0000-0001-9301-5540; Korblova, Eva/0000-0002-3818-4373; Maclennan, Joseph E/0000-0002-3587-554X; Shen, Yongqiang/0000-0001-8696-5433; Glaser, Matthew/0000-0002-8366-5598	NSF Materials Research Science and Engineering Center [DMR 0820579]; NSF [DMR 0606528, DMR 0603223]; NASA [NAG-NNC04GA50G]; U.S. Department of Energy, Divisions of Materials and Chemical Sciences	NSF Materials Research Science and Engineering Center(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); U.S. Department of Energy, Divisions of Materials and Chemical Sciences(United States Department of Energy (DOE))	This work was supported by NSF Materials Research Science and Engineering Center grant DMR 0820579, NSF grant DMR 0606528, NSF grant DMR 0603223, and NASA grant NAG-NNC04GA50G. Use of the National Synchrotron Light Source was supported by the U.S. Department of Energy, Divisions of Materials and Chemical Sciences.	Ashcroft NW, 1978, SOLID STATE PHYS; Born M., 1916, SITZUNGSBER PREUSS A, V30, P614; Brand HR, 2000, INT J ENG SCI, V38, P1099, DOI 10.1016/S0020-7225(99)00110-X; Clark NA, 2000, LIQ CRYST, V27, P985, DOI 10.1080/02678290050043941; Eremin A, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051707; Glettner B, 2007, CHEM COMMUN, P2596, DOI 10.1039/b703907g; Hegmann T, 2001, ANGEW CHEM INT EDIT, V40, P887, DOI 10.1002/1521-3773(20010302)40:5<887::AID-ANIE887>3.0.CO;2-0; Johnson PM, 1999, PHYS REV LETT, V83, P4073, DOI 10.1103/PhysRevLett.83.4073; Keith C, 2010, CHEM COMMUN, V46, P3702, DOI 10.1039/c001736a; Link DR, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021704; Link DR, 1996, PHYS REV LETT, V77, P2237, DOI 10.1103/PhysRevLett.77.2237; MEYER RB, 1978, PHYS REV LETT, V41, P1393, DOI 10.1103/PhysRevLett.41.1393; Nakata M, 2001, LIQ CRYST, V28, P1301, DOI 10.1080/0267890110048741; Niori T, 1996, J MATER CHEM, V6, P1231, DOI 10.1039/jm9960601231; O'Callaghan MJ, 2004, APPL PHYS LETT, V85, P6344, DOI 10.1063/1.1842372; PINDAK R, 1980, PHYS REV LETT, V45, P1193, DOI 10.1103/PhysRevLett.45.1193; Pratibha R, 2000, SCIENCE, V288, P2184, DOI 10.1126/science.288.5474.2184; Radzihovsky L, 2008, ANN PHYS-NEW YORK, V323, P2376, DOI 10.1016/j.aop.2008.05.008; Reddy RA, 2006, J MATER CHEM, V16, P907, DOI 10.1039/b504400f; Reddy RA, 2004, J MATER CHEM, V14, P310, DOI 10.1039/b309262c; Robinson WK, 1998, LIQ CRYST, V25, P301, DOI 10.1080/026782998206092; Sadashiva BK, 2002, J MATER CHEM, V12, P943, DOI 10.1039/b109546c; Shimbo Y, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.113901; Walba DM, 2000, SCIENCE, V288, P2181, DOI 10.1126/science.288.5474.2181; Wang ST, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.061705; Wirth I, 2001, J MATER CHEM, V11, P1642, DOI 10.1039/b100924i	26	122	123	4	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2011	332	6025					72	77		10.1126/science.1197248	http://dx.doi.org/10.1126/science.1197248			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21454782				2022-12-28	WOS:000289000000039
J	Soriano, ME; Scorrano, L				Soriano, Maria Eugenia; Scorrano, Luca			Traveling Bax and Forth from Mitochondria to Control Apoptosis	CELL			English	Editorial Material							CELL-DEATH; BCL-2; CA2+	Antiapoptotic Bcl-2 proteins on mitochondria inhibit prodeath proteins, such as Bax, which are found primarily in the cytosol. In this issue, Edlich et al., (2011) show that Bax and Bcl-xL interact on the mitochondrial surface and then retrotranslocate to the cytosol, effectively preventing Bax-induced permeabilization of mitochondria.	[Soriano, Maria Eugenia; Scorrano, Luca] Venetian Inst Mol Med, Dulbecco Telethon Inst, I-35129 Padua, Italy; [Scorrano, Luca] Univ Geneva, Dept Cell Physiol & Med, CH-1205 Geneva, Switzerland	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine; University of Geneva	Scorrano, L (corresponding author), Venetian Inst Mol Med, Dulbecco Telethon Inst, Via Orus 2, I-35129 Padua, Italy.	luca.scorrano@unige.ch	Scorrano, Luca/A-6652-2008; Scorrano, Luca/K-3967-2019	Scorrano, Luca/0000-0002-8515-8928; Scorrano, Luca/0000-0002-8515-8928; Soriano, Maria Eugenia/0000-0002-7971-2961	Telethon [GPP10005] Funding Source: Medline	Telethon(Fondazione Telethon)		Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Hoppins S, 2011, MOL CELL, V41, P150, DOI 10.1016/j.molcel.2010.11.030; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Nutt LK, 2002, J BIOL CHEM, V277, P9219, DOI 10.1074/jbc.M106817200; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	10	48	55	1	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 1	2011	145	1					15	17		10.1016/j.cell.2011.03.025	http://dx.doi.org/10.1016/j.cell.2011.03.025			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458662	Green Published, hybrid			2022-12-28	WOS:000289053900003
J	Schreiber, RD; Old, LJ; Smyth, MJ				Schreiber, Robert D.; Old, Lloyd J.; Smyth, Mark J.			Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion	SCIENCE			English	Review							TUMOR-INFILTRATING LYMPHOCYTES; T-CELL RESPONSES; IFN-GAMMA; IMMUNOSURVEILLANCE; INFLAMMATION; SURVEILLANCE; MELANOMA; SYSTEM; IMMUNOLOGY; REJECTION	Understanding how the immune system affects cancer development and progression has been one of the most challenging questions in immunology. Research over the past two decades has helped explain why the answer to this question has evaded us for so long. We now appreciate that the immune system plays a dual role in cancer: It can not only suppress tumor growth by destroying cancer cells or inhibiting their outgrowth but also promote tumor progression either by selecting for tumor cells that are more fit to survive in an immunocompetent host or by establishing conditions within the tumor microenvironment that facilitate tumor outgrowth. Here, we discuss a unifying conceptual framework called "cancer immunoediting," which integrates the immune system's dual host-protective and tumor-promoting roles.	[Schreiber, Robert D.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Old, Lloyd J.] Mem Sloan Kettering Canc Ctr, Ludwig Inst Canc Res, New York Branch, New York, NY 10021 USA; [Smyth, Mark J.] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic 3002, Australia; [Smyth, Mark J.] Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia	Washington University (WUSTL); Ludwig Institute for Cancer Research; Memorial Sloan Kettering Cancer Center; Peter Maccallum Cancer Center; University of Melbourne	Schreiber, RD (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	schreiber@immunology.wustl.edu	Schreiber, Robert/Q-7550-2019; Schreiber, Robert D/A-1276-2013; Smyth, Mark J/H-8709-2014	Schreiber, Robert D/0000-0001-6311-0432; Smyth, Mark J/0000-0001-7098-7240; Schreiber, Robert/0000-0003-1590-2341; J, Garcia-Foncillas/0000-0002-7591-8006	National Cancer Institute; Cancer Research Institute; Ludwig Institute for Cancer Research; National Health and Medical Research Council of Australia (NHMRC) Australia; Association for International Cancer Research	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research Institute; Ludwig Institute for Cancer Research; National Health and Medical Research Council of Australia (NHMRC) Australia(National Health and Medical Research Council (NHMRC) of Australia); Association for International Cancer Research	We thank M. D. Vesely and M. H. Kershaw for invaluable advice and contributions to this review and E. R. Unanue and P. M. Allen for constructive suggestions. R.D.S. is supported by grants from the National Cancer Institute, the Cancer Research Institute, and the Ludwig Institute for Cancer Research. L.J.O. is supported by The Ludwig Institute for Cancer Research and grants from the Cancer Research Institute. M.J.S. is supported by a National Health and Medical Research Council of Australia (NH&MRC) Australia Fellowship and Program Grant and a grant from the Association for International Cancer Research. We apologize to all the investigators whose research could not be appropriately cited because of the journal's space limitations. R.D.S. is a co-founder and member of the Board of Directors of and is a paid scientific advisor for Igenica, a biopharmaceutical company dedicated to the discovery and development of antibody-based therapeutics for the treatment of cancer.	Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Albert ML, 2004, NAT REV CANCER, V4, P36, DOI 10.1038/nrc1255; Albert ML, 1998, NAT MED, V4, P1321, DOI 10.1038/3315; Apetoh L, 2007, NAT MED, V13, P1050, DOI 10.1038/nm1622; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bui JD, 2007, CURR OPIN IMMUNOL, V19, P203, DOI 10.1016/j.coi.2007.02.001; BURNET M, 1957, BMJ-BRIT MED J, V1, P841, DOI 10.1136/bmj.1.5023.841; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; CLARK WH, 1989, JNCI-J NATL CANCER I, V81, P1893, DOI 10.1093/jnci/81.24.1893; Clemente CG, 1996, CANCER, V77, P1303, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5; Cordero JB, 2010, DEV CELL, V18, P999, DOI 10.1016/j.devcel.2010.05.014; DIGHE AS, 1994, IMMUNITY, V1, P447, DOI 10.1016/1074-7613(94)90087-6; Dougan M, 2009, ANNU REV IMMUNOL, V27, P83, DOI 10.1146/annurev.immunol.021908.132544; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; DuPage M, 2011, CANCER CELL, V19, P72, DOI 10.1016/j.ccr.2010.11.011; Ehrlich P., 1909, NED TIJDSCHR GENEES, V5, P273; Eyles J, 2010, J CLIN INVEST, V120, P2030, DOI 10.1172/JCI42002; Farrar JD, 1999, J IMMUNOL, V162, P2842; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kauffman HM, 2002, TRANSPLANTATION, V74, P358, DOI 10.1097/00007890-200208150-00011; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; KNUTH A, 1984, P NATL ACAD SCI-BIOL, V81, P3511, DOI 10.1073/pnas.81.11.3511; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Korman AJ, 2006, ADV IMMUNOL, V90, P297, DOI 10.1016/S0065-2776(06)90008-X; Krelin Y, 2007, CANCER RES, V67, P1062, DOI 10.1158/0008-5472.CAN-06-2956; Loeser S, 2007, J EXP MED, V204, P879, DOI 10.1084/jem.20061699; MacKie RM, 2003, NEW ENGL J MED, V348, P567, DOI 10.1056/NEJM200302063480620; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Naito Y, 1998, CANCER RES, V58, P3491; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; OLD LJ, 1964, ANNU REV MED, V15, P167, DOI 10.1146/annurev.me.15.020164.001123; OLD LJ, 1981, CANCER RES, V41, P361; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Pardoll D, 2003, ANNU REV IMMUNOL, V21, P807, DOI 10.1146/annurev.immunol.21.120601.141135; Radoja S, 2000, J IMMUNOL, V164, P2619, DOI 10.4049/jimmunol.164.5.2619; Rakhra K, 2010, CANCER CELL, V18, P485, DOI 10.1016/j.ccr.2010.10.002; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; SAHIN U, 1995, P NATL ACAD SCI USA, V92, P11810, DOI 10.1073/pnas.92.25.11810; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; Smyth MJ, 2006, ADV IMMUNOL, V90, P1, DOI 10.1016/S0065-2776(06)90001-7; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; Street SEA, 2002, J EXP MED, V196, P129, DOI 10.1084/jem.20020063; Stutman O, 1975, Adv Cancer Res, V22, P261; STUTMAN O, 1974, SCIENCE, V183, P534, DOI 10.1126/science.183.4124.534; Swann JB, 2008, P NATL ACAD SCI USA, V105, P652, DOI 10.1073/pnas.0708594105; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Teng MWL, 2010, P NATL ACAD SCI USA, V107, P8328, DOI 10.1073/pnas.1003251107; Thomas L., 1959, CELLULAR HUMORAL ASP; van Houdt IS, 2008, INT J CANCER, V123, P609, DOI 10.1002/ijc.23543; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Vesely M. D., 2011, ANNU REV IMMUNOL, DOI [10.1146/annurev-immunol-031210-101324, DOI 10.1146/ANNUREV-IMMUNOL-031210-101324]; Yuan Jianda, 2010, Cancer Immun, V10, P1; Zaidi MR, 2011, NATURE, V469, P548, DOI 10.1038/nature09666; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936	70	3791	4017	37	1129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2011	331	6024					1565	1570		10.1126/science.1203486	http://dx.doi.org/10.1126/science.1203486			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21436444				2022-12-28	WOS:000288754500045
J	Mozaffarian, D; Shi, PL; Morris, JS; Spiegelman, D; Grandjean, P; Siscovick, DS; Willett, WC; Rimm, EB				Mozaffarian, Dariush; Shi, Peilin; Morris, J. Steven; Spiegelman, Donna; Grandjean, Philippe; Siscovick, David S.; Willett, Walter C.; Rimm, Eric B.			Mercury Exposure and Risk of Cardiovascular Disease in Two U.S. Cohorts	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; FOOD FREQUENCY QUESTIONNAIRE; POLYUNSATURATED FATTY-ACIDS; MYOCARDIAL-INFARCTION; FISH INTAKE; SELENIUM INTAKE; SERUM SELENIUM; DIETARY-INTAKE; WHOLE-BLOOD; WOMEN	BACKGROUND Exposure to methylmercury from fish consumption has been linked to a potentially increased risk of cardiovascular disease, but evidence from prior studies is equivocal. Beneficial effects of the ingestion of fish and selenium may also modify such effects. METHODS Among subjects from two U. S. cohorts (a total of 51,529 men and 121,700 women) whose toenail clippings had been stored, we prospectively identified incident cases of cardiovascular disease (coronary heart disease and stroke) in 3427 participants and matched them to risk-set-sampled controls according to age, sex, race, and smoking status. Toenail mercury and selenium concentrations were assessed with the use of neutron-activation analysis. Other demographic characteristics, cardiovascular risk factors, fish consumption, and lifestyle habits were assessed by means of validated questionnaires. Associations between mercury exposure and incident cardiovascular disease were evaluated with the use of conditional logistic regression. RESULTS Median toenail mercury concentrations were 0.23 mu g per gram (interdecile range, 0.06 to 0.94) in the case participants and 0.25 mu g per gram (interdecile range, 0.07 to 0.97) in the controls. In multivariate analyses, participants with higher mercury exposures did not have a higher risk of cardiovascular disease. For comparisons of the fifth quintile of mercury exposure with the first quintile, the relative risks were as follows: coronary heart disease, 0.85 (95% confidence interval [CI], 0.69 to 1.04; P = 0.10 for trend); stroke, 0.84 (95% CI, 0.62 to 1.14; P = 0.27 for trend); and total cardiovascular disease, 0.85 (95% CI, 0.72 to 1.01; P = 0.06 for trend). Findings were similar in analyses of participants with low selenium concentrations or low overall fish consumption and in several additional sensitivity analyses. CONCLUSIONS We found no evidence of any clinically relevant adverse effects of mercury exposure on coronary heart disease, stroke, or total cardiovascular disease in U. S. adults at the exposure levels seen in this study.	[Mozaffarian, Dariush] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Mozaffarian, Dariush; Willett, Walter C.; Rimm, Eric B.] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; [Mozaffarian, Dariush; Shi, Peilin; Spiegelman, Donna; Willett, Walter C.; Rimm, Eric B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Mozaffarian, Dariush; Willett, Walter C.; Rimm, Eric B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Spiegelman, Donna] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Grandjean, Philippe] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Morris, J. Steven] Univ Missouri, Columbia, MO 65211 USA; [Siscovick, David S.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Siscovick, David S.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Missouri System; University of Missouri Columbia; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Mozaffarian, D (corresponding author), 665 Huntington Ave,Bldg 2-319, Boston, MA 02115 USA.	dmozaffa@hsph.harvard.edu	Mozaffarian, Dariush/B-2276-2008; Grandjean, Philippe/I-2962-2014	Grandjean, Philippe/0000-0003-4046-9658	National Institute of Environmental Health Sciences [R01-ES014433, ES013692]; National Heart, Lung, and Blood Institute [HL34594, HL088521, HL35464]; National Cancer Institute [CA87969, CA55075]; National Institutes of Health; NATIONAL CANCER INSTITUTE [P01CA087969, P01CA055075] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594, R01HL035464, R01HL088521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014433, R01ES013692] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by grants from the National Institute of Environmental Health Sciences (R01-ES014433 and ES013692), the National Heart, Lung, and Blood Institute (HL34594, HL088521, and HL35464), and the National Cancer Institute (CA87969 and CA55075).; Funded by the National Institutes of Health.	Ahlqwist M, 1999, ACTA ODONTOL SCAND, V57, P168; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; [Anonymous], 1997, MERC STUD REP C; [Anonymous], 2010, JOINT FAO WHO EXP CO; [Anonymous], 2004, WHAT YOU NEED KNOW M; Bleys J, 2009, AM J EPIDEMIOL, V169, P996, DOI 10.1093/aje/kwn414; Chan HM, 2004, NUTR REV, V62, P68, DOI 10.1301/nr.2004.janr.68-72; Choi AL, 2009, ENVIRON HEALTH PERSP, V117, P367, DOI 10.1289/ehp.11608; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Fillion Myriam, 2006, Environ Health, V5, P29, DOI 10.1186/1476-069X-5-29; GARLAND M, 1993, CANCER EPIDEM BIOMAR, V2, P493; Groth E, 2010, ENVIRON RES, V110, P226, DOI 10.1016/j.envres.2009.12.006; Guallar E, 2002, NEW ENGL J MED, V347, P1747, DOI 10.1056/NEJMoa020157; Hallgren CG, 2001, BRIT J NUTR, V86, P397, DOI 10.1079/BJN2001415; HARRIS M, 1979, DIABETES, V28, P1039; Hu FB, 2000, JAMA-J AM MED ASSOC, V283, P2961, DOI 10.1001/jama.283.22.2961; Hu FB, 2002, JAMA-J AM MED ASSOC, V287, P1815, DOI 10.1001/jama.287.14.1815; Iso H, 2001, JAMA-J AM MED ASSOC, V285, P304, DOI 10.1001/jama.285.3.304; Joshi A, 2003, J PUBLIC HEALTH DENT, V63, P52, DOI 10.1111/j.1752-7325.2003.tb03474.x; Konig A, 2005, AM J PREV MED, V29, P335, DOI 10.1016/j.amepre.2005.07.001; Lim S, 2010, NEUROTOXICOLOGY, V31, P10, DOI 10.1016/j.neuro.2009.10.001; Longnecker MP, 1996, EPIDEMIOLOGY, V7, P384, DOI 10.1097/00001648-199607000-00008; LONGNECKER MP, 1993, AM J CLIN NUTR, V57, P408, DOI 10.1093/ajcn/57.3.408; MacIntosh DL, 1997, CANCER EPIDEM BIOMAR, V6, P1043; Mason MM, 1998, J RADIOANAL NUCL CH, V236, P29, DOI 10.1007/BF02386313; McDowell MA, 2004, ENVIRON HEALTH PERSP, V112, P1165, DOI 10.1289/ehp.7046; Morton J, 2004, BIOMARKERS, V9, P47, DOI 10.1080/13547500410001670312; Mozaffarian D, 2005, CIRCULATION, V111, P157, DOI 10.1161/01.CIR.0000152099.87287.83; Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885; Mozaffarian D, 2009, INT J ENV RES PUB HE, V6, P1894, DOI 10.3390/ijerph6061894; Ohno T, 2007, ENVIRON RES, V103, P191, DOI 10.1016/j.envres.2006.06.009; Rice DC, 2004, ENVIRON RES, V95, P406, DOI 10.1016/j.envres.2003.08.013; Rose GA, 1982, WHO MONOGRAPH SERIES, V56; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; Suzuki T, 1989, Sangyo Igaku, V31, P235; VARO P, 1988, AM J CLIN NUTR, V48, P324, DOI 10.1093/ajcn/48.2.324; Virtanen JK, 2005, ARTERIOSCL THROM VAS, V25, P228, DOI 10.1161/01.ATV.0000150040.20950.61; Walker A E, 1981, Stroke, V12, pI13; Wennberg M, 2007, BRIT J NUTR, V98, P1038, DOI 10.1017/S0007114507756519; Yaginuma-Sakurai K, 2010, NEUROTOXICOL TERATOL, V32, P240, DOI 10.1016/j.ntt.2009.08.009; Yorifuji T, 2010, ENVIRON RES, V110, P40, DOI 10.1016/j.envres.2009.10.011; Yoshizawa K, 2002, NEW ENGL J MED, V347, P1755, DOI 10.1056/NEJMoa021437	43	130	132	1	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2011	364	12					1116	1125		10.1056/NEJMoa1006876	http://dx.doi.org/10.1056/NEJMoa1006876			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739FY	21428767	Green Accepted, Green Published			2022-12-28	WOS:000288701100006
J	Dahabreh, IJ; Paulus, JK				Dahabreh, Issa J.; Paulus, Jessica K.			Association of Episodic Physical and Sexual Activity With Triggering of Acute Cardiac Events Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ACUTE MYOCARDIAL-INFARCTION; CASE-CROSSOVER ANALYSIS; ACUTE CARDIOVASCULAR-DISEASE; EPIDEMIOLOGY PROGRAM SHEEP; AMERICAN-HEART-ASSOCIATION; ACUTE CORONARY SYNDROMES; CIRCADIAN VARIATION; UNITED-STATES; EXERTION; RISK	Context Evidence has suggested that physical and sexual activity might be triggers of acute cardiac events. Objective To assess the effect of episodic physical and sexual activity on acute cardiac events using data from case-crossover studies. Data Sources MEDLINE and EMBASE (through February 2, 2011) and Web of Science (through October 6, 2010). Study Selection Case-crossover studies investigating the association between episodic physical or sexual activity and myocardial infarction (MI) or sudden cardiac death (SCD). Data Extraction Two reviewers extracted descriptive and quantitative information from each study. We calculated summary relative risks (RRs) using random-effects meta-analysis and absolute event rates based on US data for the incidence of MI and SCD. We used the Fisher P value synthesis method to test whether habitual physical activity levels modify the triggering effect and meta-regression to quantify the interaction between habitual levels of physical activity and the triggering effect. Results We identified 10 studies investigating episodic physical activity, 3 studies investigating sexual activity, and 1 study investigating both exposures. The outcomes of interest were MI (10 studies), acute coronary syndrome (1 study), and SCD (3 studies). Episodic physical and sexual activity were associated with an increase in the risk of MI (RR=3.45; 95% confidence interval [CI], 2.33-5.13, and RR=2.70; 95% CI, 1.48-4.91, respectively). Episodic physical activity was associated with SCD (RR=4.98; 95% CI, 1.47-16.91). The effect of triggers on the absolute rate of events was limited because exposure to physical and sexual activity is infrequent and their effect is transient; the absolute risk increase associated with 1 hour of additional physical or sexual activity per week was estimated as 2 to 3 per 10 000 person-years for MI and 1 per 10 000 person-years for SCD. Habitual activity levels significantly affected the association of episodic physical activity and MI (P<.001), episodic physical activity and SCD (P<.001), and sexual activity and MI (P=.04); in all cases, individuals with lower habitual activity levels had an increased RR for the triggering effect. For every additional time per week an individual was habitually exposed to physical activity, the RR for MI decreased by approximately 45%, and the RR for SCD decreased by 30%. Conclusion Acute cardiac events were significantly associated with episodic physical and sexual activity; this association was attenuated among persons with high levels of habitual physical activity. JAMA. 2011; 305(12): 1225-1233	[Dahabreh, Issa J.] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Ctr Clin Evidence Synth, Boston, MA 02111 USA; [Paulus, Jessica K.] Tufts Univ, Tufts Clin & Translat Sci Inst, Medford, MA 02155 USA; [Paulus, Jessica K.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Tufts Medical Center; Tufts University; Harvard University; Harvard T.H. Chan School of Public Health	Dahabreh, IJ (corresponding author), Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Ctr Clin Evidence Synth, 800 Washington St,Box 63, Boston, MA 02111 USA.	idahabreh@tuftsmedicalcenter.org			National Center for Research Resources [UL1RR025752]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025752] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by award UL1RR025752 from the National Center for Research Resources.	Albert CM, 2000, NEW ENGL J MED, V343, P1355, DOI 10.1056/NEJM200011093431902; [Anonymous], 1932, STAT METHODS RES WOR; Baylin A, 2007, ANN EPIDEMIOL, V17, P112, DOI 10.1016/j.annepidem.2006.05.004; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1998, BRIT MED J, V316, P140; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FELDMANN U, 1993, BIOMETRICS, V49, P419, DOI 10.2307/2532555; Giri S, 1999, JAMA-J AM MED ASSOC, V282, P1731, DOI 10.1001/jama.282.18.1731; GLASS RI, 1979, LANCET, V1, P485; Gunby P, 1979, JAMA, V241, P1987, DOI 10.1001/jama.241.19.1987; Hallqvist J, 2000, AM J EPIDEMIOL, V151, P459, DOI 10.1093/oxfordjournals.aje.a010231; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; Il'yasova D, 2005, CANCER CAUSE CONTROL, V16, P383, DOI 10.1007/s10552-004-5025-x; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Maclure M, 2000, ANNU REV PUBL HEALTH, V21, P193, DOI 10.1146/annurev.publhealth.21.1.193; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Maclure M, 2007, PHARMACOEPIDEM DR S, V16, P850, DOI 10.1002/pds.1438; MARSHALL RJ, 1993, STAT MED, V12, P2333, DOI 10.1002/sim.4780122409; Masoomi M, 2010, J CARDIOVASC MED, V11, P723, DOI 10.2459/JCM.0b013e32833892da; MITTLEMAN MA, 1993, NEW ENGL J MED, V329, P1677, DOI 10.1056/NEJM199312023292301; MITTLEMAN MA, 1995, AM J EPIDEMIOL, V142, P91, DOI 10.1093/oxfordjournals.aje.a117550; Moller J, 2005, J EPIDEMIOL COMMUN H, V59, P23, DOI 10.1136/jech.2003.019349; Moller J, 1999, PSYCHOSOM MED, V61, P842; Moller J, 2001, HEART, V86, P387, DOI 10.1136/heart.86.4.387; MULLER JE, 1977, AM J CARDIOL, V40, P269, DOI 10.1016/0002-9149(77)90018-2; MULLER JE, 1994, J AM COLL CARDIOL, V23, P809, DOI 10.1016/0735-1097(94)90772-2; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; Muller JE, 1996, JAMA-J AM MED ASSOC, V275, P1405, DOI 10.1001/jama.275.18.1405; MULLER JE, 1989, CIRCULATION, V79, P733, DOI 10.1161/01.CIR.79.4.733; OBRAZTSOV VP, 1910, WORKS 1 C RUSS THER, P26; Redelmeier DA, 1997, J CLIN EPIDEMIOL, V50, P1281, DOI 10.1016/S0895-4356(97)00196-0; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Selb Semerl J, 2003, J CLIN BASIC CARDIOL, V6, P63; Shiroma EJ, 2010, CIRCULATION, V122, P743, DOI 10.1161/CIRCULATIONAHA.109.914721; Strike PC, 2006, HEART, V92, P1035, DOI 10.1136/hrt.2005.077362; Thompson PD, 2007, CIRCULATION, V115, P2358, DOI 10.1161/CIRCULATIONAHA.107.181485; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Tofler GH, 2006, CIRCULATION, V114, P1863, DOI 10.1161/CIRCULATIONAHA.105.596189; Tofler GH, 1997, AM HEART J, V134, pS55, DOI 10.1016/S0002-8703(97)70010-3; TOFLER GH, 1987, NEW ENGL J MED, V316, P1514, DOI 10.1056/NEJM198706113162405; TRICHOPOULOS D, 1983, LANCET, V1, P441; von Klot S, 2008, EUR HEART J, V29, P1881, DOI 10.1093/eurheartj/ehn235; Wallace BC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-80; Whang W, 2006, JAMA-J AM MED ASSOC, V295, P1399, DOI 10.1001/jama.295.12.1399; WILLICH SN, 1993, NEW ENGL J MED, V329, P1684, DOI 10.1056/NEJM199312023292302; Yeh RW, 2010, ARCH INTERN MED, V170, P759, DOI 10.1001/archinternmed.2010.88; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254; 2006, INCIDENCE PREVALENCE	51	123	133	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2011	305	12					1225	1233		10.1001/jama.2011.336	http://dx.doi.org/10.1001/jama.2011.336			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738PA	21427375	Green Accepted			2022-12-28	WOS:000288652100018
J	Smith, LJE; Murphy, SM; Holmes, P; Reilly, MM; Reiniger, L; Thom, M; Lunn, MP				Smith, Laura-Jane E; Murphy, Sinead M; Holmes, Paul; Reilly, Mary M; Reiniger, Lilla; Thom, Maria; Lunn, Michael P			Picture Quiz A painful right leg The clinical signs suggest involvement of spinal nerves L5-S3	BRITISH MEDICAL JOURNAL			English	Editorial Material							PROSTATE-CANCER; PERINEURAL SPACE; TUMOR; SPREAD; ADENOCARCINOMA; METASTASIS; PLEXOPATHY; DIAGNOSIS; INVASION; THERAPY					michael.lunn@uclh.nhs.uk		Lunn, Michael/0000-0003-3174-6027; Reilly, Mary/0000-0003-0686-905X; Murphy, Sinead/0000-0002-7277-414X; Smith, Laura-Jane E/0000-0002-3396-5541	Medical Research Council [G0601943] Funding Source: Medline; MRC [G0601943] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ansari MS, 2003, UROL INT, V70, P77, DOI 10.1159/000067696; Astigueta JC, 2010, ACTAS UROL ESP, V34, P327, DOI 10.1016/S2173-5786(10)70078-0; Ayala GE, 2001, PROSTATE, V49, P213, DOI 10.1002/pros.1137; Brazis PW., 2001, LOCALIZATION CLIN NE, V4th ed, P242; DeAngelis LM, 2002, NEUROLOGY, V58, P339, DOI 10.1212/WNL.58.3.339; Fizazi K, 2010, BJU INT, V105, P748, DOI 10.1111/j.1464-410X.2010.09236.x; HASSAN MO, 1980, AM J SURG PATHOL, V4, P143, DOI 10.1097/00000478-198004000-00006; JAECKLE KA, 1985, NEUROLOGY, V35, P8, DOI 10.1212/WNL.35.1.8; Kim DH, 2005, J NEUROSURG, V102, P246, DOI 10.3171/jns.2005.102.2.0246; Ladha SS, 2006, MUSCLE NERVE, V34, P659, DOI 10.1002/mus.20597; Malloy Kelly A, 2007, Optometry, V78, P55, DOI 10.1016/j.optm.2006.08.015; Sato T, 2010, OTOL NEUROTOL, V31, P703, DOI 10.1097/MAO.0b013e3181b04f00; Schulz M, 2009, SPINE, V34, pE735, DOI 10.1097/BRS.0b013e3181ae26cc; Shields JA, 2000, ARCH OPHTHALMOL-CHIC, V118, P217; Tazawa KI, 2008, INTERNAL MED, V47, P2019, DOI 10.2169/internalmedicine.47.1272; THOMAS JE, 1985, NEUROLOGY, V35, P1; Verhagen PCMS, 2010, EUR UROL, V58, P261, DOI 10.1016/j.eururo.2010.05.027; VILLERS A, 1989, J UROLOGY, V142, P763, DOI 10.1016/S0022-5347(17)38881-X; Wigfield CC, 2003, BRIT J NEUROSURG, V17, P459, DOI 10.1080/02688690310001611260	19	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 16	2011	342								d1009	10.1136/bmj.d1009	http://dx.doi.org/10.1136/bmj.d1009			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739FK	21411806				2022-12-28	WOS:000288699200015
J	Watts, G				Watts, Geoff			John Raymond McClean Obituary	LANCET			English	Biographical-Item												geoff@scileg.freeserve.co.uk						MCCLEAN JR, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2011	377	9771					1070	1070		10.1016/S0140-6736(11)60423-6	http://dx.doi.org/10.1016/S0140-6736(11)60423-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	743QY	21449086	Bronze			2022-12-28	WOS:000289035000016
J	Alavez, S; Vantipalli, MC; Zucker, DJS; Klang, IM; Lithgow, GJ				Alavez, Silvestre; Vantipalli, Maithili C.; Zucker, David J. S.; Klang, Ida M.; Lithgow, Gordon J.			Amyloid-binding compounds maintain protein homeostasis during ageing and extend lifespan	NATURE			English	Article							CAENORHABDITIS-ELEGANS; DISEASE; STRESS; DAF-16; PROTEOSTASIS; INHIBITION; ALZHEIMER; LONGEVITY; SELECTION	Genetic studies indicate that protein homeostasis is a major contributor to metazoan longevity(1). Collapse of protein homeostasis results in protein misfolding cascades and the accumulation of insoluble protein fibrils and aggregates, such as amyloids(2). A group of small molecules, traditionally used in histopathology to stain amyloid in tissues, bind protein fibrils and slow aggregationin vitro and in cell culture(3,4). We proposed that treating animals with such compounds would promote protein homeostasis in vivo and increase longevity. Here we show that exposure of adult Caenorhabditis elegans to the amyloid-binding dye Thioflavin T (ThT) resulted in a profoundly extended lifespan and slowed ageing. ThT also suppressed pathological features of mutant metastable proteins and human beta-amyloid-associated toxicity. These beneficial effects of ThT depend on the protein homeostasis network regulator heat shock factor 1 (HSF-1), the stress resistance and longevity transcription factor SKN-1, molecular chaperones, autophagy and proteosomal functions. Our results demonstrate that pharmacological maintenance of the protein homeostatic network has a profound impact on ageing rates, prompting the development of novel therapeutic interventions against ageing and age-related diseases.	[Alavez, Silvestre; Vantipalli, Maithili C.; Zucker, David J. S.; Klang, Ida M.; Lithgow, Gordon J.] Buck Inst Res Aging, Novato, CA 94945 USA; [Zucker, David J. S.] Dominican Univ Calif, Dept Nat Sci & Math, San Rafael, CA 94901 USA; [Klang, Ida M.] Karolinska Inst, Ctr Biosci, Novum, Dept Biosci & Nutr, S-14183 Huddinge, Sweden	Buck Institute for Research on Aging; Karolinska Institutet	Lithgow, GJ (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	salavez@buckinstitute.org; glithgow@buckinstitute.org	Alavez, Silvestre/AAM-4894-2021	Alavez, Silvestre/0000-0002-9220-0696; Zucker, David/0000-0001-7476-8299	National Institutes of Health (NIH) National Center for Research Resources; Larry L. Hillblom Foundation; NIH [UL1024917, 1R01AG029631-01A1, AG21069, AG22868, AG029631-01A1, ES016655]; Larry L. Hillblom Foundation [UL1 RR024917]; Longevity Consortium [U19AGO231222]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [RL1ES016655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022868, R01AG029631, R01AG021069] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Larry L. Hillblom Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Larry L. Hillblom Foundation; Longevity Consortium; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. A. Gerencser for expert assistance with the confocal microscopy; A. M. Cuervo, M. S. Gill, M. Lucanic, J. Campisi, S. Melov, V. Lunyak and P. Kapahi for suggestions on the manuscript, members of the G.J.L. and P. Kapahi laboratories for helpful discussion and members of the Paper Polishing Club. Nematode strains were provided by the Ceanorhabditis Genetics Center, funded by the National Institutes of Health (NIH) National Center for Research Resources. CF2189 was a gift from C. Kenyon's laboratory. This work was supported by grants from the Larry L. Hillblom Foundation and the NIH (UL1024917, supporting the Interdisciplinary Research Consortium on Geroscience and 1R01AG029631-01A1). G.J.L. is supported by the NIH AG21069, AG22868, AG029631-01A1, ES016655, the Larry L. Hillblom Foundation and UL1 RR024917. S.A. was supported by the U19AGO231222 from the Longevity Consortium.	ANDERSON P, 1984, P NATL ACAD SCI-BIOL, V81, P4470, DOI 10.1073/pnas.81.14.4470; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Chen D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000486; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Drake J, 2003, NEUROBIOL AGING, V24, P415, DOI 10.1016/S0197-4580(02)00225-7; Frid P, 2007, BRAIN RES REV, V53, P135, DOI 10.1016/j.brainresrev.2006.08.001; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Groenning Minna, 2010, J Chem Biol, V3, P1, DOI 10.1007/s12154-009-0027-5; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Li WS, 2007, DEV CELL, V12, P235, DOI 10.1016/j.devcel.2006.12.002; McColl G, 2008, J BIOL CHEM, V283, P350, DOI 10.1074/jbc.M705028200; McColl G, 2010, CELL METAB, V12, P260, DOI 10.1016/j.cmet.2010.08.004; Mccoll G, 2009, J BIOL CHEM, V284, P22697, DOI 10.1074/jbc.C109.028514; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; Rodriguez-Rodriguez C, 2009, J AM CHEM SOC, V131, P1436, DOI 10.1021/ja806062g; Temussi PA, 2003, EMBO J, V22, P355, DOI 10.1093/emboj/cdg044; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Walker GA, 2003, AGING CELL, V2, P131, DOI 10.1046/j.1474-9728.2003.00045.x; ZENGEL JM, 1980, CELL MOTIL CYTOSKEL, V1, P73, DOI 10.1002/cm.970010107	26	274	284	3	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2011	472	7342					226	229		10.1038/nature09873	http://dx.doi.org/10.1038/nature09873			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21451522	Green Accepted			2022-12-28	WOS:000289469100044
J	Manson, JE; Mayne, ST; Clinton, SK				Manson, JoAnn E.; Mayne, Susan T.; Clinton, Steven K.			Vitamin D and Prevention of Cancer - Ready for Prime Time?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Manson, JoAnn E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Mayne, Susan T.] Yale Univ, Sch Publ Hlth, Dept Epidemiol & Publ Hlth, New Haven, CT USA; [Mayne, Susan T.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Clinton, Steven K.] Ohio State Univ, Div Med Oncol, Columbus, OH 43210 USA; [Manson, JoAnn E.; Mayne, Susan T.; Clinton, Steven K.] Comm Dietary Reference Intakes Vitamin D & Calciu, Inst Med, Washington, DC USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Yale University; Yale University; University System of Ohio; Ohio State University	Manson, JE (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA.							Byers T, 2010, AM J EPIDEMIOL, V172, P1, DOI 10.1093/aje/kwq112; Chung M., 2009, AHRQ PUBLICATION; Helzlsouer KJ, 2010, AM J EPIDEMIOL, V172, P4, DOI 10.1093/aje/kwq119; Institute of Medicine, 2011, DIETARY REFERENCE IN; International Agency for Research on Cancer, 2008, VIT D CANC REP IARC	5	112	119	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 14	2011	364	15					1385	1387		10.1056/NEJMp1102022	http://dx.doi.org/10.1056/NEJMp1102022			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749LD	21428761				2022-12-28	WOS:000289467200001
J	Zhou, Z; Feng, HQ; Zhou, BR; Ghirlando, R; Hu, KF; Zwolak, A; Jenkins, LMM; Xiao, H; Tjandra, N; Wu, C; Bai, YW				Zhou, Zheng; Feng, Hanqiao; Zhou, Bing-Rui; Ghirlando, Rodolfo; Hu, Kaifeng; Zwolak, Adam; Jenkins, Lisa M. Miller; Xiao, Hua; Tjandra, Nico; Wu, Carl; Bai, Yawen			Structural basis for recognition of centromere histone variant CenH3 by the chaperone Scm3	NATURE			English	Article							FISSION YEAST SCM3; SACCHAROMYCES-CEREVISIAE; SEDIMENTATION-VELOCITY; ANALYTICAL ULTRACENTRIFUGATION; PROTEIN; NMR; NUCLEOSOMES; CHROMATIN; HJURP; CSE4	The centromere is a unique chromosomal locus that ensures accurate segregation of chromosomes during cell division by directing the assembly of a multiprotein complex, the kinetochore(1). The centromere is marked by a conserved variant of conventional histone H3 termed CenH3 or CENP-A (ref. 2). A conserved motif of CenH3, the CATD, defined by loop 1 and helix 2 of the histone fold, is necessary and sufficient for specifying centromere functions of CenH3 (refs 3, 4). The structural basis of this specification is of particular interest. Yeast Scm3 and human HJURP are conserved non-histone proteins that interact physically with the (CenH3-H4) 2 heterotetramer and are required for the deposition of CenH3 at centromeres in vivo(5-13). Here we have elucidated the structural basis for recognition of budding yeast (Saccharomyces cerevisiae) CenH3 (called Cse4) by Scm3. We solved the structure of the Cse4-binding domain (CBD) of Scm3 in complex with Cse4 and H4 in a single chain model. An alpha-helix and an irregular loop at the conserved amino terminus and a shorter alpha-helix at the carboxy terminus of Scm3(CBD) wraps around the Cse4-H4 dimer. Four Cse4-specific residues in the N-terminal region of helix 2 are sufficient for specific recognition by conserved and functionally important residues in the N-terminal helix of Scm3 through formation of a hydrophobic cluster. Scm3(CBD) induces major conformational changes and sterically occludes DNA-binding sites in the structure of Cse4 and H4. These findings have implications for the assembly and architecture of the centromeric nucleosome.	[Zhou, Zheng; Feng, Hanqiao; Zhou, Bing-Rui; Xiao, Hua; Wu, Carl; Bai, Yawen] NCI, Biochem & Mol Biol Lab, Bethesda, MD 20892 USA; [Ghirlando, Rodolfo] NIDDKD, Mol Biol Lab, Bethesda, MD 20892 USA; [Hu, Kaifeng] Univ Wisconsin, Natl Magnet Resonance Facil Madison, Madison, WI 53706 USA; [Zwolak, Adam; Tjandra, Nico] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Jenkins, Lisa M. Miller] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Wisconsin System; University of Wisconsin Madison; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bai, YW (corresponding author), NCI, Biochem & Mol Biol Lab, Bethesda, MD 20892 USA.	yawen@helix.nih.gov	Jenkins, Lisa/AAI-2490-2021; Zhou, Bing-Rui/D-4766-2009; Ghirlando, Rodolfo/A-8880-2009	Zhou, Bing-Rui/0000-0002-5375-7977	NCI; NIDDK; NHLBI; NATIONAL CANCER INSTITUTE [ZIABC005263, ZIABC010808] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001048, ZIAHL006064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033007] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Ying, K. Varney, J. F. Ellena and J. Gruschus for help collecting NMR spectra, A. Bax for discussion, C. Klee and M. Lichten for comments on the manuscript, and D. Cleveland for plasmids of human CENP-A and H4 histones. This work is supported by the intramural research programs of NCI, NIDDK and NHLBI.	Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black BE, 2008, CURR OPIN CELL BIOL, V20, P91, DOI 10.1016/j.ceb.2007.11.007; Black BE, 2007, MOL CELL, V25, P309, DOI 10.1016/j.molcel.2006.12.018; Camahort R, 2007, MOL CELL, V26, P853, DOI 10.1016/j.molcel.2007.05.013; Camahort R, 2009, MOL CELL, V35, P794, DOI 10.1016/j.molcel.2009.07.022; CLARKE L, 1980, NATURE, V287, P504, DOI 10.1038/287504a0; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; COTTAREL G, 1989, MOL CELL BIOL, V9, P3342, DOI 10.1128/MCB.9.8.3342; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Furuyama T, 2009, CELL, V138, P104, DOI 10.1016/j.cell.2009.04.049; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Houtman JCD, 2004, BIOCHEMISTRY-US, V43, P4170, DOI 10.1021/bi0357311; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Keith KC, 1999, MOL CELL BIOL, V19, P6130; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Malik HS, 2009, CELL, V138, P1067, DOI 10.1016/j.cell.2009.08.036; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Pidoux AL, 2009, MOL CELL, V33, P299, DOI 10.1016/j.molcel.2009.01.019; Sanchez-Pulido L, 2009, CELL, V137, P1173, DOI 10.1016/j.cell.2009.06.010; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Shuaib M, 2010, P NATL ACAD SCI USA, V107, P1349, DOI 10.1073/pnas.0913709107; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; Stoler S, 2007, P NATL ACAD SCI USA, V104, P10571, DOI 10.1073/pnas.0703178104; Tugarinov V, 2006, NAT PROTOC, V1, P749, DOI 10.1038/nprot.2006.101; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Wieland G, 2004, MOL CELL BIOL, V24, P6620, DOI 10.1128/mcb.24.15.6620-6630.2004; Williams JS, 2009, MOL CELL, V33, P287, DOI 10.1016/j.molcel.2009.01.017; Wood CM, 2005, ACTA CRYSTALLOGR F, V61, P541, DOI 10.1107/S1744309105013813; Zhou Z, 2008, NAT STRUCT MOL BIOL, V15, P868, DOI 10.1038/nsmb.1465	39	99	102	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 14	2011	472	7342					234	237		10.1038/nature09854	http://dx.doi.org/10.1038/nature09854			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21412236	Green Accepted			2022-12-28	WOS:000289469100046
J	Roland, M; Rosen, R				Roland, Martin; Rosen, Rebecca			English NHS Embarks on Controversial and Risky Market-Style Reforms in Health Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SERVICE; CALIFORNIA; BRITAIN		[Roland, Martin] Univ Cambridge, Inst Publ Hlth, Cambridge Ctr Hlth Serv Res, Cambridge, England; [Rosen, Rebecca] Nuffield Trust, London, England	University of Cambridge	Roland, M (corresponding author), Univ Cambridge, Inst Publ Hlth, Cambridge Ctr Hlth Serv Res, Cambridge, England.			Roland, Martin/0000-0002-8533-3060				Black N, 2010, NEW ENGL J MED, V363, P1103, DOI 10.1056/NEJMp1009188; Brereton L, 2010, IMPACT NHS MARKET OV; *BROOK I, 2010, ISS BRIEF ACC CAR OR; CASALINO L, 2011, GP COMMISSI IN PRESS; Checkland K, 2009, J HEALTH SERV RES PO, V14, P20, DOI 10.1258/jhsrp.2008.008043; *COMM HIGH PERF HL, 2009, PATH HIGH PERF US HL; CRUMP B, 2009, IMPROVING PRODUCTIVI; Department of Health, 2010, EQ EXC LIB NHS; Dixon A., 2010, PATIENT CHOICE PATIE; Dixon J, 2004, MANAGING CHRONIC DIS; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; Gillam S, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b832; House of Commons Public Administration Select Committee, 2003, TARG GOV MEAS; Hunter DJ, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6022; Kammerling RM, 1996, BRIT MED J, V312, P1399; Kay A, 2002, BRIT J GEN PRACT, V52, P141; Klein R, 2006, NEW ENGL J MED, V355, P409, DOI 10.1056/NEJMhpr062747; Lewis R, 2009, J HEALTH SERV RES PO, V14, P44, DOI 10.1258/jhsrp.2008.008054; Mannion R, 2005, HLTH POLICY MATTERS, V11, P1; Mays N, 2000, J Health Serv Res Policy, V5, P49; Oxman AD, 2005, J ROY SOC MED, V98, P563, DOI 10.1258/jrsm.98.12.563; Rittenhouse DR, 2009, NEW ENGL J MED, V361, P2301, DOI 10.1056/NEJMp0909327; ROBINSON JC, 1995, NEW ENGL J MED, V333, P1684, DOI 10.1056/NEJM199512213332506; Robinson JC, 2001, HEALTH AFFAIR, V20, P81, DOI 10.1377/hlthaff.20.4.81; Roland M, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3985; Sheaff R, 2003, SOCIOL HEALTH ILL, V25, P408, DOI 10.1111/1467-9566.00352; Smith J, 2001, BRIT MED J, V323, P1262, DOI 10.1136/bmj.323.7324.1262; Smith J, 2010, NEXT COMMISSIONING E; Smith J, 2004, REV EFFECTIVENESS PR; SMITH R, 2010, DAILY TELEGRAPH 1112; Stevens S, 2004, HEALTH AFFAIR, V23, P37, DOI 10.1377/hlthaff.23.3.37; Thorlby R, 2010, HIGH PERFORMING NHS; Walshe K, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3843; Wyke S, 2003, HEALTH POLICY, V65, P243, DOI 10.1016/S0168-8510(03)00040-X	34	22	22	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 7	2011	364	14					1360	1366		10.1056/NEJMhpr1009757	http://dx.doi.org/10.1056/NEJMhpr1009757			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	745WS	21470015				2022-12-28	WOS:000289202800014
J	Loewenberg, S				Loewenberg, Samuel			Profile Mitch Besser-helping mothers with HIV become mentors	LANCET			English	Biographical-Item																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2011	377	9772					1145	1145		10.1016/S0140-6736(11)60452-2	http://dx.doi.org/10.1016/S0140-6736(11)60452-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750IH	21459200				2022-12-28	WOS:000289539300015
J	Lazzaro, BP; Rolff, J				Lazzaro, Brian P.; Rolff, Jens			Danger, Microbes, and Homeostasis	SCIENCE			English	Editorial Material							INNATE IMMUNE-SYSTEM; ANTIMICROBIAL PEPTIDE; BACTERIAL-INFECTION; HOST-DEFENSE; DROSOPHILA; SELF; PATTERNS; INSECTS; GENES; SENSE		[Lazzaro, Brian P.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Rolff, Jens] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Cornell University; University of Sheffield	Lazzaro, BP (corresponding author), Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA.	jor@sheffield.ac.uk	hongbo, yi/G-9615-2011	Rolff, Jens/0000-0002-1529-5409				Anselme C, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-43; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Gambaryan S, 2010, J BIOL CHEM, V285, P18352, DOI 10.1074/jbc.M109.077602; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Haine ER, 2008, SCIENCE, V322, P1257, DOI 10.1126/science.1165265; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lazzaro BP, 2009, PHILOS T R SOC B, V364, P15, DOI 10.1098/rstb.2008.0141; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Liehl P, 2006, PLOS PATHOG, V2, P551, DOI 10.1371/journal.ppat.0020056; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; OTTI O, UNPUB; Ragan Emily J., 2009, P34; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007; Vilcinskas A, 2010, VIRULENCE, V1, P206, DOI 10.4161/viru.1.3.12072; Wang JW, 2009, P NATL ACAD SCI USA, V106, P12133, DOI 10.1073/pnas.0901226106; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012	20	43	48	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2011	332	6025					43	44		10.1126/science.1200486	http://dx.doi.org/10.1126/science.1200486			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21454776				2022-12-28	WOS:000289000000030
J	Moszynski, P				Moszynski, Peter			RESPIRATORY DISEASES Tuberculosis: a clear and present danger	BRITISH MEDICAL JOURNAL			English	Editorial Material												globewisecom@hotmail.com						LAWN SD, 2011, LANCET          0317; Moszynski P, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1937; *PUBL HLTH ACT SUP, 2010, LOND TB SERV REV HLT; STOP TB Partnership, GLOB PLAN STOP TB 20	4	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 1	2011	342								d2089	10.1136/bmj.d2089	http://dx.doi.org/10.1136/bmj.d2089			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	745WJ	21459967				2022-12-28	WOS:000289201700007
J	Wiseman, RL; Kelly, JW				Wiseman, R. Luke; Kelly, Jeffery W.			Phosphatase Inhibition Delays Translational Recovery	SCIENCE			English	Editorial Material							UNFOLDED PROTEIN RESPONSE; STRESS-RESPONSE; PROTEOSTASIS; DISEASES		[Wiseman, R. Luke; Kelly, Jeffery W.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Kelly, Jeffery W.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Kelly, Jeffery W.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Wiseman, RL (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wiseman@scripps.edu; jkelly@scripps.edu	Schneeweiss, Gerald M./B-4344-2013; Schönswetter, Peter/T-8241-2017; Albach, Dirk C./D-8309-2013	Schneeweiss, Gerald M./0000-0003-2811-3317; Schönswetter, Peter/0000-0001-9225-4566; Albach, Dirk C./0000-0001-9056-7382; Wiseman, Luke/0000-0001-9287-6840				Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Volchuk A, 2010, DIABETES OBES METAB, V12, P48, DOI 10.1111/j.1463-1326.2010.01271.x; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946	13	41	41	3	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2011	332	6025					44	45		10.1126/science.1204505	http://dx.doi.org/10.1126/science.1204505			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21454777				2022-12-28	WOS:000289000000031
J	Gooren, LJ				Gooren, Louis J.			Care of Transsexual Persons	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENDER IDENTITY DISORDER; CROSS-SEX HORMONES; DSM DIAGNOSTIC-CRITERIA; TO-MALE TRANSSEXUALS; FOLLOW-UP; ADOLESCENT TRANSSEXUALS; ENDOCRINE TREATMENT; DYSPHORIC CHILDREN; REASSIGNMENT; THERAPY	A healthy and successful 40-year-old man finds it increasingly difficult to live as a male. In childhood he preferred playing with girls and recalls feeling that he should have been one. Over time he has come to regard himself more and more as a female personality inhabiting a male body. After much agonizing, he has concluded that only sex reassignment can offer the peace of mind he craves. What would you advise?	[Gooren, Louis J.] Vrije Univ Amsterdam, Med Ctr, Dept Endocrinol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Gooren, LJ (corresponding author), 72-1 Mool, Chiang Mai 50220, Thailand.	louisjgooren@gmail.com			Bayer Schering Pharma	Bayer Schering Pharma(Bayer AG)	Dr. Gooren reports receiving consulting fees and compensation for travel from Bayer Schering Pharma. No other potential conflict of interest relevant to this article was reported.	Allen NE, 2008, ENDOCR-RELAT CANCER, V15, P485, DOI 10.1677/ERC-07-0064; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; ASSCHEMAN H, 2011, EUR J ENDOCRINO 0125; Bentz EK, 2010, FERTIL STERIL, V94, P2688, DOI 10.1016/j.fertnstert.2010.04.024; Cohen-Kettenis PT, 2008, J SEX MED, V5, P1892, DOI 10.1111/j.1743-6109.2008.00870.x; Cohen-Kettenis PT, 2010, ARCH SEX BEHAV, V39, P499, DOI 10.1007/s10508-009-9562-y; Cohen-Kettenis PT, 1999, J PSYCHOSOM RES, V46, P315, DOI 10.1016/S0022-3999(98)00085-3; Cohen-Kettenis PT, 1998, EUR CHILD ADOLES PSY, V7, P246, DOI 10.1007/s007870050073; CohenKettenis PT, 1997, J AM ACAD CHILD PSY, V36, P263, DOI 10.1097/00004583-199702000-00017; de Vries ALC, 2010, J AUTISM DEV DISORD, V40, P930, DOI 10.1007/s10803-010-0935-9; Delemarre-van de Waal HA, 2006, EUR J ENDOCRINOL, V155, pS131, DOI 10.1530/eje.1.02231; DEVRIES AL, 2010, J SEX MED       0714; DEVRIES AL, 2010, PSYCHIAT RES    0827; Dittrich R, 2005, EXP CLIN ENDOCR DIAB, V113, P586, DOI 10.1055/s-2005-865900; Elamin MB, 2010, CLIN ENDOCRINOL, V72, P1, DOI 10.1111/j.1365-2265.2009.03632.x; Elbers JMH, 1999, AM J PHYSIOL-ENDOC M, V276, pE317, DOI 10.1152/ajpendo.1999.276.2.E317; Elbers JMH, 2003, CLIN ENDOCRINOL, V58, P562, DOI 10.1046/j.1365-2265.2003.01753.x; Giltay EJ, 2000, J CLIN ENDOCR METAB, V85, P2913, DOI 10.1210/jc.85.8.2913; Gooren L, 2006, HORM BEHAV, V50, P589, DOI 10.1016/j.yhbeh.2006.06.011; Gooren LJ, 2008, J CLIN ENDOCR METAB, V93, P19, DOI 10.1210/jc.2007-1809; Gooren LJG, 2008, J SEX MED, V5, P765, DOI 10.1111/j.1743-6109.2007.00646.x; *H BENJ INT GEN DY, 2001, H BENJ INT GEND DYSP; Hage JJ, 2006, ANN PLAS SURG, V57, P312, DOI 10.1097/01.sap.0000221625.38212.2e; Hakimian P, 2008, BJU INT, V102, P1509, DOI 10.1111/j.1464-410X.2008.07933.x; Hembree WC, 2009, J CLIN ENDOCR METAB, V94, P3132, DOI 10.1210/jc.2009-0345; Ito K, 2007, TOHOKU J EXP MED, V212, P1, DOI 10.1620/tjem.212.1; Lawrence AA, 2003, ARCH SEX BEHAV, V32, P299, DOI 10.1023/A:1024086814364; Meyer-Bahlburg HFL, 2010, ARCH SEX BEHAV, V39, P461, DOI 10.1007/s10508-009-9532-4; Mieszczak Jakub, 2007, Pediatr Endocrinol Rev, V4 Suppl 4, P419; Monstrey S, 2009, PLAST RECONSTR SURG, V124, P510, DOI 10.1097/PRS.0b013e3181aeeb06; Mueller A, 2008, EUR J ENDOCRINOL, V159, P197, DOI 10.1530/EJE-08-0289; Murad MH, 2010, CLIN ENDOCRINOL, V72, P214, DOI 10.1111/j.1365-2265.2009.03625.x; Okabe N, 2008, PSYCHIAT RES, V157, P315, DOI 10.1016/j.psychres.2007.07.022; Perovic S, 2009, CURR OPIN UROL, V19, P571, DOI 10.1097/MOU.0b013e3283312eb3; Savic I, 2010, PROG BRAIN RES, V186, P41, DOI 10.1016/B978-0-444-53630-3.00004-X; Smith YLS, 2005, PSYCHOL MED, V35, P89, DOI 10.1017/S0033291704002776; Toorians AWFT, 2003, J CLIN ENDOCR METAB, V88, P5723, DOI 10.1210/jc.2003-030520; van Kesteren P, 1998, CLIN ENDOCRINOL, V48, P347, DOI 10.1046/j.1365-2265.1998.00396.x; vanKesteren PJ, 1996, ARCH SEX BEHAV, V25, P589, DOI 10.1007/BF02437841; vanKesteren PJM, 1997, CLIN ENDOCRINOL, V47, P337, DOI 10.1046/j.1365-2265.1997.2601068.x; Vujovic S, 2009, J SEX MED, V6, P1018, DOI 10.1111/j.1743-6109.2008.00799.x; Wallien MSC, 2008, J AM ACAD CHILD PSY, V47, P1413, DOI 10.1097/CHI.0b013e31818956b9; WENNINK JMB, 1989, CLIN ENDOCRINOL, V31, P551, DOI 10.1111/j.1365-2265.1989.tb01279.x; Weyers S, 2009, J SEX MED, V6, P752, DOI 10.1111/j.1743-6109.2008.01082.x; Zitzmann M, 2005, J CLIN ENDOCR METAB, V90, P6603, DOI 10.1210/jc.2005-0847; Zucker KJ, 2009, INT J TRANSGENDERISM, V11, P8, DOI 10.1080/15532730902799946; Zucker KJ, 2010, ARCH SEX BEHAV, V39, P477, DOI 10.1007/s10508-009-9540-4; Zucker KJ, 2004, CHILD ADOL PSYCH CL, V13, P551, DOI 10.1016/j.chc.2004.02.006	49	149	153	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2011	364	13					1251	1257		10.1056/NEJMcp1008161	http://dx.doi.org/10.1056/NEJMcp1008161			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	742NO	21449788				2022-12-28	WOS:000288951300009
J	Greving, JP; Visseren, FLJ; de Wit, GA; Algra, A				Greving, J. P.; Visseren, F. L. J.; de Wit, G. A.; Algra, A.			Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIALS; ACUTE MYOCARDIAL-INFARCTION; CORONARY-HEART-DISEASE; LONG-TERM SURVIVAL; CARDIOVASCULAR-DISEASE; LOWERING MEDICATIONS; DRUG-TREATMENT; RISK; STROKE; METAANALYSIS	Objective To assess the cost-effectiveness of low dose statins for primary prevention of vascular disease, incorporating current prices, non-adherence (reduced clinical efficacy while maintaining healthcare costs), and the results of the recently published JUPITER trial. Design Cost-effectiveness analysis using a Markov model. Sensitivity analyses and Monte Carlo simulation evaluated the robustness of the results. Setting Primary care in The Netherlands. Participants Hypothetical populations of men and women aged 45 to 75 years without a history of vascular disease at different levels of risk for vascular disease (myocardial infarction and stroke) over 10 years. Interventions Low dose statin treatment daily versus no treatment for 10 years. Main outcome measures Number of fatal and nonfatal vascular events prevented, quality-adjusted life-years (QALYs), costs, and incremental cost-effectiveness ratios over 10 years. Results Over a 10-year period, statin treatment cost (sic)35 000 (30 pound 000, $49 000) per QALY gained for men aged 55 years with a 10-year vascular risk of 10%. The incremental cost-effectiveness ratio improved as risk for vascular disease increased. The cost per QALY ranged from approximately (sic)5000 to (sic)125 000 when the 10-year vascular risk for men aged 55 years was varied from 25% to 5%. The incremental cost-effectiveness ratio slightly decreased with age after the level of vascular risk was specified. Results were sensitive to the costs of statin treatment, statin effectiveness, non-adherence, disutility of taking medication daily, and the time horizon of the model. Conclusions In daily practice, statin treatment seemed not to be cost-effective for primary prevention in populations at low risk of vascular disease, despite low costs of generic drug pills. Adherence to statin treatment needs to be improved to enhance the cost-effectiveness of the use of statins for primary prevention.	[Greving, J. P.; de Wit, G. A.; Algra, A.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3584 CX Utrecht, Netherlands; [Visseren, F. L. J.] Univ Med Ctr Utrecht, Dept Vasc Med, NL-3584 CX Utrecht, Netherlands; [de Wit, G. A.] Natl Inst Publ Hlth & Environm, Ctr Prevent & Hlth Serv Res, NL-3720 BA Bilthoven, Netherlands; [Algra, A.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosc, Dept Neurol & Neurosurg, Utrecht Stroke Ctr, NL-3584 CX Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center	Greving, JP (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3584 CX Utrecht, Netherlands.	J.P.Greving@umcutrecht.nl	Visseren, Frank LJ/I-4855-2013	Visseren, Frank/0000-0003-3951-5223; de Wit, G. Ardine/0000-0002-1375-7657	Netherlands Organisation for Health Research and Development (ZonMW) [6120.0019]; Merck; Catharijne foundation Utrecht; AstraZeneca	Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); Merck(Merck & Company); Catharijne foundation Utrecht; AstraZeneca(AstraZeneca)	This study was supported by an unconditional grant from the Netherlands Organisation for Health Research and Development (ZonMW, project number 6120.0019). The funding source had no involvement in study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit an article for publication.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that: the submitted work was supported only by ZonMW; JPG, GAdW, and AA have no relationships with companies that might have an interest in the submitted work in the previous three years; the department of FLV has received research grants from Merck, the Netherlands Organisation for Health research and Development and from the Catharijne foundation Utrecht and speaker fees from Merck and AstraZeneca; none of the authors has non-financial interests that may be relevant to the submitted work.	American Heart Association, 2008, HEART DIS STROK STAT; Augustovski FA, 1998, J GEN INTERN MED, V13, P824, DOI 10.1046/j.1525-1497.1998.00246.x; Avorn J, 1998, JAMA-J AM MED ASSOC, V279, P1458, DOI 10.1001/jama.279.18.1458; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bates TR, 2009, EXPERT OPIN PHARMACO, V10, P2973, DOI 10.1517/14656560903376186; Bronnum-Hansen H, 2001, J CLIN EPIDEMIOL, V54, P1244, DOI 10.1016/S0895-4356(01)00405-X; Bronnum-Hansen H, 2001, STROKE, V32, P2131, DOI 10.1161/hs0901.094253; Brugts JJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2376; Buskens E, 2004, RADIOLOGY, V233, P101, DOI 10.1148/radiol.2331030863; Christie Bryan, 2006, BMJ, V333, P988, DOI 10.1136/bmj.39024.405602.DB; DEBOER MJ, 1995, AM J CARDIOL, V76, P830, DOI 10.1016/S0002-9149(99)80238-0; DENNIS MS, 1993, STROKE, V24, P796, DOI 10.1161/01.STR.24.6.796; Dutch Health Care Insurance Board, 2009, DRUG COSTS; Dutch Healthcare Authority, 2009, RAT VAR PROF VAR LAB; Greving JP, 2008, CIRCULATION, V117, P2875, DOI 10.1161/CIRCULATIONAHA.107.735340; Grover SA, 2003, ARCH INTERN MED, V163, P333, DOI 10.1001/archinte.163.3.333; Helin-Salmivaara A, 2008, CLIN THER, V30, P2228, DOI 10.1016/j.clinthera.2008.12.003; Hiatt JG, 1999, AM J MANAG CARE, V5, P437; Huse DM, 1998, AM J CARDIOL, V82, P1357, DOI 10.1016/S0002-9149(98)00641-9; JAGERGEURTS MH, 2006, CARDIOVASCULAR DIS N; Johannesson M, 1997, NEW ENGL J MED, V336, P332, DOI 10.1056/NEJM199701303360503; Johannesson M, 2001, EUR HEART J, V22, P919, DOI 10.1053/euhj.2000.2484; Koek HL, 2007, NETH J MED, V65, P434; Koek HL, 2006, AM J CARDIOL, V98, P993, DOI 10.1016/j.amjcard.2006.05.016; Lampe FC, 2000, EUR HEART J, V21, P1052, DOI 10.1053/euhj.1999.1866; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; Law M, 2006, AM J CARDIOL, V97, p52C, DOI 10.1016/j.amjcard.2005.12.010; Mills EJ, 2008, J AM COLL CARDIOL, V52, P1769, DOI 10.1016/j.jacc.2008.08.039; NAGLIE IG, 1992, MED DECIS MAKING, V12, P239, DOI 10.1177/0272989X9201200401; OOSTENBRINK JB, 2004, GUIDELINE COSTING RE; Perreault S, 2009, AM J MED, V122, P647, DOI 10.1016/j.amjmed.2009.01.032; Pickin DM, 1999, HEART, V82, P325, DOI 10.1136/hrt.82.3.325; Pignone M, 2006, ANN INTERN MED, V144, P326, DOI 10.7326/0003-4819-144-5-200603070-00007; Post PN, 2001, STROKE, V32, P1425, DOI 10.1161/01.STR.32.6.1425; Prosser LA, 2000, ANN INTERN MED, V132, P769, DOI 10.7326/0003-4819-132-10-200005160-00002; Ray KK, 2010, ARCH INTERN MED, V170, P1024, DOI 10.1001/archinternmed.2010.182; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Statistics Netherlands, 2002, LIF DUTCH POP AG SEX; Stolk E, 2007, P PLEN M EUROQOL GRO, V153, P65; Thavendiranathan P, 2006, ARCH INTERN MED, V166, P2307, DOI 10.1001/archinte.166.21.2307; TSEVAT J, 1993, MED DECIS MAKING, V13, P161, DOI 10.1177/0272989X9301300210; Vaartjes I, 2008, EUR J NEUROL, V15, P1315, DOI 10.1111/j.1468-1331.2008.02309.x; Ward S, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11140; Wolfe CDA, 2000, BRIT MED BULL, V56, P275, DOI 10.1258/0007142001903120	45	75	75	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 30	2011	342								d1672	10.1136/bmj.d1672	http://dx.doi.org/10.1136/bmj.d1672			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745WF	21450800	hybrid			2022-12-28	WOS:000289201200002
J	Cisneros, JC; Abdala, F; Rubidge, BS; Dentzien-Dias, PC; Bueno, AD				Cisneros, Juan Carlos; Abdala, Fernando; Rubidge, Bruce S.; Dentzien-Dias, Paula Camboim; Bueno, Ana de Oliveira			Dental Occlusion in a 260-Million-Year-Old Therapsid with Saber Canines from the Permian of Brazil	SCIENCE			English	Article							EVOLUTION; ORIGIN	Anomodonts, a group of herbivorous therapsid "mammal-like reptiles," were the most abundant tetrapods of the Permian. We present a basal anomodont from South America, a new taxon that has transversally expanded palatal teeth and long saber canines. The function of the saber teeth is unknown, but probable uses include deterring attack from predators and intraspecific display or combat. The complex palatal teeth were used to process high-fiber food and represent early evidence of dental occlusion in a therapsid. This discovery provides new insight into the evolution of heterogeneous dentition in therapsids and broadens our understanding of ecological interactions at the end of the Paleozoic.	[Cisneros, Juan Carlos] Univ Fed Piaui, Ctr Ciencias Nat, BR-64049550 Teresina, Piaui, Brazil; [Cisneros, Juan Carlos; Bueno, Ana de Oliveira] Univ Fed Rio Grande do Sul, Dept Paleontol & Estratig, Porto Alegre, RS, Brazil; [Abdala, Fernando; Rubidge, Bruce S.] Univ Witwatersrand, Bernard Price Inst Palaeontol Res, ZA-2050 Johannesburg, Johannesburg, South Africa; [Dentzien-Dias, Paula Camboim] Univ Fed Piaui, Picos, Piaui, Brazil	Universidade Federal do Piaui; Universidade Federal do Rio Grande do Sul; University of Witwatersrand; Universidade Federal do Piaui	Cisneros, JC (corresponding author), Univ Fed Piaui, Ctr Ciencias Nat, BR-64049550 Teresina, Piaui, Brazil.		Dentzien-Dias, Paula/AAZ-3945-2020; Abdala, Fernando/I-8054-2019; Rubidge, Bruce/AAE-7021-2019	Rubidge, Bruce/0000-0003-2477-1873; Cisneros, Juan Carlos/0000-0001-6159-1981	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [478914/2006-77]; Department of Science and Technology; National Research Foundation; Palaeontological Scientific Trust	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Department of Science and Technology(Department of Science & Technology (India)); National Research Foundation; Palaeontological Scientific Trust	We thank A. E. Figueiredo, M. A. Franca, T. P. Melo, and W. Velasques-Alves for field support. V. Abdala, K. Angielczyk, L. Backwell, P. Backwell, M. Jennions, T. Kemp, and R. Reisz, are acknowledged for discussion and valuable comments. J.C.C., P. C. D. D., and A.O.B. were funded by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); F. A. and B. S. R. were funded by the Department of Science and Technology, National Research Foundation, and Palaeontological Scientific Trust. Fieldwork was funded by a CNPq grant (478914/2006-77) awarded to C. L. Schultz.	Angielczyk KD, 2004, PALEOBIOLOGY, V30, P268, DOI 10.1666/0094-8373(2004)030<0268:PEFAIO>2.0.CO;2; BARGHUSEN H R, 1975, Paleobiology, V1, P295; Caro Tim, 2005, pXIII; Cisneros Juan Carlos, 2005, Revista Brasileira de Paleontologia, V8, P13; Darwin C., 1871, P475; Emlen DJ, 2008, ANNU REV ECOL EVOL S, V39, P387, DOI 10.1146/annurev.ecolsys.39.110707.173502; Frobisch J, 2009, P ROY SOC B-BIOL SCI, V276, P3611, DOI 10.1098/rspb.2009.0911; Frobisch J, 2009, EARTH-SCI REV, V95, P119, DOI 10.1016/j.earscirev.2009.04.001; Geist V., 1998, DEER WORLD THEIR EVO; Ivakhnenko M.F., 2005, Paleontological Journal, V39, pS393; Ivakhnenko M, 2008, PALEONTOL J+, V42, P859, DOI 10.1134/S0031030108090013; Kemp TS, 2006, J EVOLUTION BIOL, V19, P1231, DOI 10.1111/j.1420-9101.2005.01076.x; KING GM, 1981, PHILOS T R SOC B, V291, P244; Liu J, 2010, P ROY SOC B-BIOL SCI, V277, P285, DOI 10.1098/rspb.2009.0883; Liu J, 2009, ACTA PALAEONTOL POL, V54, P393, DOI 10.4202/app.2008.0071; Modesto S, 1999, P ROY SOC B-BIOL SCI, V266, P331, DOI 10.1098/rspb.1999.0642; Modesto S. P., 2000, AGE DINOSAURS RUSSIA; MODESTO SP, 1995, PALAEONTOLOGY, V38, P213; Ogg G.J., 2008, CONCISE GEOLOGIC TIM; POOLE DFG, 1956, Q J MICROSC SCI, V97, P303; Reisz RR, 2006, J EXP ZOOL PART B, V306B, P261, DOI 10.1002/jez.b.21115; ROSE KD, 2006, BEGINNING AGE MAMMAL; Rubidge BS, 2001, ANNU REV ECOL SYST, V32, P449, DOI 10.1146/annurev.ecolsys.32.081501.114113; Rybczynski N, 2001, NATURE, V411, P684, DOI 10.1038/35079567; Sues H.-D., 2000, EVOLUTION HERBIVORY, P9; Sullivan C, 2003, P ROY SOC B-BIOL SCI, V270, P173, DOI 10.1098/rspb.2002.2189	26	38	39	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2011	331	6024					1603	1605		10.1126/science.1200305	http://dx.doi.org/10.1126/science.1200305			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21436452				2022-12-28	WOS:000288754500055
J	Nakashima, PNH; Smith, AE; Etheridge, J; Muddle, BC				Nakashima, Philip N. H.; Smith, Andrew E.; Etheridge, Joanne; Muddle, Barrington C.			The Bonding Electron Density in Aluminum	SCIENCE			English	Article							SCATTERING FACTORS; X-RAY; DIFFRACTION; CRYSTALS	Aluminum is considered to approach an "ideal" metal or free electron gas. The valence electrons move freely, as if unaffected by the presence of the metal ions. Therefore, the electron redistribution due to chemical bonding is subtle and has proven extremely difficult to determine. Experimental measurements and ab initio calculations have yielded substantially different results. We applied quantitative convergent-beam electron diffraction to aluminum to provide an experimental determination of the bonding electron distribution. Calculation of the electron distribution based on density functional theory is shown to be in close agreement. Our results yield an accurate quantitative correlation between the anisotropic elastic properties of aluminum and the bonding electron and electrostatic potential distributions.	[Nakashima, Philip N. H.; Smith, Andrew E.; Muddle, Barrington C.] Monash Univ, ARC Ctr Excellence Design Light Met, Clayton, Vic 3800, Australia; [Nakashima, Philip N. H.; Etheridge, Joanne; Muddle, Barrington C.] Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia; [Nakashima, Philip N. H.; Etheridge, Joanne] Monash Univ, Monash Ctr Electron Microscopy, Clayton, Vic 3800, Australia; [Smith, Andrew E.] Monash Univ, Sch Phys, Clayton, Vic 3800, Australia	Monash University; Monash University; Monash University; Monash University	Nakashima, PNH (corresponding author), Monash Univ, ARC Ctr Excellence Design Light Met, Clayton, Vic 3800, Australia.	philip.nakashima@eng.monash.edu.au	Nakashima, Philip N. H./B-1357-2008	Nakashima, Philip N. H./0000-0002-7495-1349; Etheridge, Joanne/0000-0002-3199-3936	Australian Research Council (ARC) [LEO454166]	Australian Research Council (ARC)(Australian Research Council)	We thank M. Weyland for assisting in the collection of the liquid helium-temperature CBED data; A. F. Moodie and A. W. S. Johnson for their expert readership and valuable suggestions; J. M. Zuo for sharing his RefineCB code, which we have modified to execute our QCBED analysis; J. Shih for electropolishing some of the specimens; the Victorian Partnership for Advanced Computing (VPAC); and the Australian Research Council (ARC) for infrastructure grant LEO454166. P.A. thanks V. A. Streltsov, A. W. S. Johnson, and the late E. N. Maslen for their guidance.	BLAHA P, 1990, COMPUT PHYS COMMUN, V59, P399, DOI 10.1016/0010-4655(90)90187-6; BROCKHOUSE NB, 1955, PHYS REV, V100, P756; Clugston M., 2008, ADV CHEM, P83; Coppens P., 1997, XRAY CHARGE DENSITIE; Cottrell A., 1988, INTRO MODERN THEORY; DOYLE PA, 1968, ACTA CRYSTALL A-CRYS, VA 24, P390, DOI 10.1107/S0567739468000756; Eberhart ME, 1996, ACTA MATER, V44, P2495, DOI 10.1016/1359-6454(95)00347-9; FOX AG, 1990, J PHYS CHEM SOLIDS, V51, P1323, DOI 10.1016/0022-3697(90)90011-4; HAFNER J, 1975, Z PHYS B CON MAT, V22, P351, DOI 10.1007/BF01312805; HONJO G, 1964, J PHYS SOC JPN, V19, P351, DOI 10.1143/JPSJ.19.351; HOPPE W, 1975, ADV STRUCTURE RES DI, P221; Kioussis N, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.125501; LEIGH RS, 1951, PHILOS MAG, V42, P139; MACLAREN JM, 1989, PHYS REV LETT, V63, P2586, DOI 10.1103/PhysRevLett.63.2586; MCDONALD DL, 1967, ACTA CRYSTALLOGR, V23, P185, DOI 10.1107/S0365110X67002439; MEDLIN EH, 1969, NATURE, V224, P581, DOI 10.1038/224581a0; Momma K, 2008, J APPL CRYSTALLOGR, V41, P653, DOI 10.1107/S0021889808012016; MOODIE AF, 1978, ELECT DIFFRACTION 19, pCH3; MOODIE AF, 1977, J ELECT MICROSC S, V26, P191; MORINAGA M, 1991, J PHYS-CONDENS MAT, V3, P6817, DOI 10.1088/0953-8984/3/35/011; Nakashima PNH, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.115135; Nye JF, 1985, PHYS PROPERTIES CRYS; Ogata S, 2002, SCIENCE, V298, P807, DOI 10.1126/science.1076652; SIROTA NN, 1969, ACTA CRYSTALL A-CRYS, VA 25, P223, DOI 10.1107/S0567739469000386; Somoza JR, 2001, ACTA CRYSTALLOGR A, V57, P678, DOI 10.1107/S0108767301010650; SPROSSERPROU J, 1989, PHYS REV B, V40, P5799, DOI 10.1103/PhysRevB.40.5799; Woodward C, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.045507; *WORLD BUR MET STA, 2006, WORLD MET STAT YB, P12; Zuo JM, 1999, NATURE, V401, P49, DOI 10.1038/43403; Zuo JM, 2004, REP PROG PHYS, V67, P2053, DOI 10.1088/0034-4885/67/11/R03	30	121	122	4	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 25	2011	331	6024					1583	1586		10.1126/science.1198543	http://dx.doi.org/10.1126/science.1198543			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21436448				2022-12-28	WOS:000288754500049
J	Brower, V				Brower, Vicki			BIOMARKERS Portents of malignancy	NATURE			English	Editorial Material																		Diamandis EP, 2010, J NATL CANCER I, V102, P1462, DOI 10.1093/jnci/djq306; Gustafson AM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000251; Lam S, 2006, CANCER EPIDEM BIOMAR, V15, P1526, DOI 10.1158/1055-9965.EPI-06-0128; Paz-Elizur T, 2006, CANCER RES, V66, P11683, DOI 10.1158/0008-5472.CAN-06-2294; Qui J., 2008, J CLIN ONCOL, V26, P5060; Zhang XL, 2010, PHYSIOL GENOMICS, V41, P1, DOI 10.1152/physiolgenomics.00167.2009	6	33	33	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					S19	S21		10.1038/471S19a	http://dx.doi.org/10.1038/471S19a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430715	Bronze			2022-12-28	WOS:000288702200016
J	Meek, SJ; O'Brien, RV; Llaveria, J; Schrock, RR; Hoveyda, AH				Meek, Simon J.; O'Brien, Robert V.; Llaveria, Josep; Schrock, Richard R.; Hoveyda, Amir H.			Catalytic Z-selective olefin cross-metathesis for natural product synthesis	NATURE			English	Article							RING-CLOSING METATHESIS; EFFICIENT; COMPLEXES; PLASMALOGEN; MOLYBDENUM; KRN7000	Alkenes are found in many biologically active molecules, and there are a large number of chemical transformations in which alkenes act as the reactants or products (or both) of the reaction. Many alkenes exist as either the E or the higher-energy Z stereoisomer. Catalytic procedures for the stereoselective formation of alkenes are valuable, yet methods enabling the synthesis of 1,2-disubstituted Z alkenes are scarce. Here we report catalytic Z-selective cross-metathesis reactions of terminal enol ethers, which have not been reported previously, and of allylic amides, used until now only in E-selective processes. The corresponding disubstituted alkenes are formed in up to >98% Z selectivity and 97% yield. These transformations, promoted by catalysts that contain the highly abundant and inexpensive metal molybdenum, are amenable to gram-scale operations. Use of reduced pressure is introduced as a simple and effective strategy for achieving high stereoselectivity. The utility of this method is demonstrated by its use in syntheses of an anti-oxidant plasmalogen phospholipid, found in electrically active tissues and implicated in Alzheimer's disease, and the potent immunostimulant KRN7000.	[Meek, Simon J.; O'Brien, Robert V.; Llaveria, Josep; Hoveyda, Amir H.] Boston Coll, Merkert Chem Ctr, Dept Chem, Chestnut Hill, MA 02467 USA; [Schrock, Richard R.] MIT, Dept Chem, Cambridge, MA 02139 USA	Boston College; Massachusetts Institute of Technology (MIT)	Hoveyda, AH (corresponding author), Boston Coll, Merkert Chem Ctr, Dept Chem, Chestnut Hill, MA 02467 USA.	amir.hoveyda@bc.edu	Cros, Josep Llaveria/W-1021-2019	Cros, Josep Llaveria/0000-0003-2260-3657	US National Institutes of Health, Institute of General Medical Sciences [GM-59426]; National Science Foundation [CHE-0715138]; US National Science Foundation [DBI-0619576]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059426] Funding Source: NIH RePORTER; Division Of Chemistry [1111074] Funding Source: National Science Foundation	US National Institutes of Health, Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); US National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This research was supported by the US National Institutes of Health, Institute of General Medical Sciences (GM-59426 to A.H.H. and R.R.S.) and the National Science Foundation (CHE-0715138 to A.H.H.). R.V.O. and J.L. were LaMattina and Spanish government Visiting Scholar Fellows, respectively. We thank S. Castillon, S. J. Malcolmson and M. Yu for discussions. Mass spectrometry facilities at Boston College are supported by the US National Science Foundation (DBI-0619576).	Alexander JB, 1998, J AM CHEM SOC, V120, P4041, DOI 10.1021/ja974353i; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; CHATTERJEE AK, 2003, HDB METATHESIS, V2, P246, DOI DOI 10.1002/9783527619481.CH20; CROWE WE, 1995, J AM CHEM SOC, V117, P5162, DOI 10.1021/ja00123a023; Garber SB, 2000, J AM CHEM SOC, V122, P8168, DOI 10.1021/ja001179g; Hansen EC, 2004, ORG LETT, V6, P2035, DOI 10.1021/ol049378i; Hoveyda AH, 2007, NATURE, V450, P243, DOI 10.1038/nature06351; Hoveyda AH, 2010, ANGEW CHEM INT EDIT, V49, P34, DOI 10.1002/anie.200904491; Ibrahem I, 2009, J AM CHEM SOC, V131, P3844, DOI 10.1021/ja900097n; Jiang AJ, 2009, J AM CHEM SOC, V131, P16630, DOI 10.1021/ja908098t; Kim S, 2004, SYNTHESIS-STUTTGART, P847, DOI 10.1055/s-2004-822315; La DS, 2001, J AM CHEM SOC, V123, P7767, DOI 10.1021/ja010684q; Lankalapalli RS, 2009, ORG LETT, V11, P2784, DOI 10.1021/ol9009078; Lee YJ, 2009, J AM CHEM SOC, V131, P10652, DOI 10.1021/ja904098h; Lee Y, 2009, J AM CHEM SOC, V131, P18234, DOI 10.1021/ja9089928; Llaveria J, 2009, ORG LETT, V11, P205, DOI 10.1021/ol802379b; Malcolmson SJ, 2008, NATURE, V456, P933, DOI 10.1038/nature07594; Meek SJ, 2009, J AM CHEM SOC, V131, P16407, DOI 10.1021/ja907805f; Michieletti M, 2008, J ORG CHEM, V73, P9192, DOI 10.1021/jo8019994; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; Negishi EI, 2008, ACCOUNTS CHEM RES, V41, P1474, DOI 10.1021/ar800038e; Nicolaou K. C., 1997, LIEBIGS ANN CHEM, P1283; Nicolaou KC, 2005, ANGEW CHEM INT EDIT, V44, P4490, DOI 10.1002/anie.200500369; Prunet J., 2010, METATHESIS NATURAL P, P287; Qin DH, 1999, J AM CHEM SOC, V121, P662, DOI 10.1021/ja982837o; SCHRADER TO, 2003, HDB METATHESIS, V2, P205; Schrock RR, 2003, ANGEW CHEM INT EDIT, V42, P4592, DOI 10.1002/anie.200300576; Solans-Monfort X, 2005, J AM CHEM SOC, V127, P14015, DOI 10.1021/ja053528i; Trappeniers M, 2008, CHEMMEDCHEM, V3, P1061, DOI 10.1002/cmdc.200800021	30	285	305	3	215	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					461	466		10.1038/nature09957	http://dx.doi.org/10.1038/nature09957			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21430774	Green Accepted			2022-12-28	WOS:000288702200052
J	Murali, MR; Castells, MC; Song, JY; Dudzinski, DM; Hasserjian, RP				Murali, Mandakolathur R.; Castells, Mariana C.; Song, James Y.; Dudzinski, David M.; Hasserjian, Robert P.			A Man with Flushing and Hypotension Indolent systemic mastocytosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							KOUNIS-SYNDROME; SM-AHNMD; TRYPTASE; ANAPHYLAXIS; DISEASE		[Murali, Mandakolathur R.] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA; [Dudzinski, David M.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Song, James Y.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Hasserjian, Robert P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Castells, Mariana C.] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Murali, Mandakolathur R.; Castells, Mariana C.; Dudzinski, David M.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Song, James Y.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Hasserjian, Robert P.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Murali, MR (corresponding author), Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA.							Bone RC, 1996, ANN INTERN MED, V125, P680, DOI 10.7326/0003-4819-125-8-199610150-00009; Castells M, 2002, INT ARCH ALLERGY IMM, V127, P147, DOI 10.1159/000048188; Dhir V, 2007, INTERNAL MED, V46, P899, DOI 10.2169/internalmedicine.46.6129; Ditto AM, 1996, ANN ALLERG ASTHMA IM, V77, P285, DOI 10.1016/S1081-1206(10)63322-4; Escribano Luis, 2006, Inflammation & Allergy Drug Targets, V5, P61, DOI 10.2174/187152806775269303; Fukuoka Y, 2007, INT IMMUNOPHARMACOL, V7, P1900, DOI 10.1016/j.intimp.2007.07.007; HORAN RF, 1991, J INVEST DERMATOL, V96, pS5, DOI 10.1111/1523-1747.ep12468899; Horny AC, 2008, WHO CLASSIFICATION T, P53; Izikson L, 2006, J AM ACAD DERMATOL, V55, P193, DOI 10.1016/j.jaad.2005.07.057; KALINER M, 1981, J ALLERGY CLIN IMMUN, V68, P365, DOI 10.1016/0091-6749(81)90134-2; Kounis NG, 2006, INT J CARDIOL, V110, P7, DOI 10.1016/j.ijcard.2005.08.007; Kounis NG, 2006, J AM COLL CARDIOL, V48, P592, DOI 10.1016/j.jacc.2006.05.007; LIEBERMAN PL, 2009, MIDDLETONS ALLERGY P, V2, P1027; Miranda RN, 2010, MODERN PATHOL, V23, p311A; Modlin IM, 2005, GASTROENTEROLOGY, V128, P1717, DOI 10.1053/j.gastro.2005.03.038; MR H, 2007, CLIN CARDIOL, V30, P251; Pardanani A, 2009, BLOOD, V114, P3769, DOI 10.1182/blood-2009-05-220145; PELLIKKA PA, 1993, CIRCULATION, V87, P1188, DOI 10.1161/01.CIR.87.4.1188; Rohr SM, 2005, ANN EMERG MED, V45, P592, DOI 10.1016/j.annemergmed.2005.02.002; Schwartz LB, 2006, IMMUNOL ALLERGY CLIN, V26, P451, DOI 10.1016/j.iac.2006.05.010; SCHWARTZ LB, 1983, J IMMUNOL, V130, P1891; SOTER NA, 1979, NEW ENGL J MED, V301, P465, DOI 10.1056/NEJM197908303010903; Sotlar K, 2010, J PATHOL, V220, P586, DOI 10.1002/path.2677; TRAVIS WD, 1988, CANCER, V62, P965, DOI 10.1002/1097-0142(19880901)62:5<965::AID-CNCR2820620520>3.0.CO;2-M; WEYMAN AE, 1977, CIRCULATION, V56, P769, DOI 10.1161/01.CIR.56.5.769; WILKIN JK, 1981, ANN INTERN MED, V95, P468, DOI 10.7326/0003-4819-95-4-468	26	13	13	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2011	364	12					1155	1165		10.1056/NEJMcpc1013929	http://dx.doi.org/10.1056/NEJMcpc1013929			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739FY	21428772				2022-12-28	WOS:000288701100012
J	White, RM; Cech, J; Ratanasirintrawoot, S; Lin, CY; Rahl, PB; Burke, CJ; Langdon, E; Tomlinson, ML; Mosher, J; Kaufman, C; Chen, F; Long, HK; Kramer, M; Datta, S; Neuberg, D; Granter, S; Young, RA; Morrison, S; Wheeler, GN; Zon, LI				White, Richard Mark; Cech, Jennifer; Ratanasirintrawoot, Sutheera; Lin, Charles Y.; Rahl, Peter B.; Burke, Christopher J.; Langdon, Erin; Tomlinson, Matthew L.; Mosher, Jack; Kaufman, Charles; Chen, Frank; Long, Hannah K.; Kramer, Martin; Datta, Sumon; Neuberg, Donna; Granter, Scott; Young, Richard A.; Morrison, Sean; Wheeler, Grant N.; Zon, Leonard I.			DHODH modulates transcriptional elongation in the neural crest and melanoma	NATURE			English	Article							CARBAMOYL-PHOSPHATE SYNTHETASE; ZEBRAFISH; LEFLUNOMIDE; EXPRESSION; INHIBITOR; DISCOVERY; KINASE; CELLS; GENE	Melanoma is a tumour of transformed melanocytes, which are originally derived from the embryonic neural crest. It is unknown to what extent the programs that regulate neural crest development interact with mutations in the BRAF oncogene, which is the most commonly mutated gene in human melanoma(1). We have used zebrafish embryos to identify the initiating transcriptional events that occur on activation of human BRAF(V600E) (which encodes an amino acid substitution mutant of BRAF) in the neural crest lineage. Zebrafish embryos that are transgenic for mitfa:BRAF(V600E) and lack p53 (also known as tp53) have a gene signature that is enriched for markers of multipotent neural crest cells, and neural crest progenitors from these embryos fail to terminally differentiate. To determine whether these early transcriptional events are important for melanoma pathogenesis, we performed a chemical genetic screen to identify small-molecule suppressors of the neural crest lineage, which were then tested for their effects on melanoma. One class of compound, inhibitors of dihydroorotate dehydrogenase (DHODH), for example leflunomide, led to an almost complete abrogation of neural crest development in zebrafish and to a reduction in the self-renewal of mammalian neural crest stem cells. Leflunomide exerts these effects by inhibiting the transcriptional elongation of genes that are required for neural crest development and melanoma growth. When used alone or in combination with a specific inhibitor of the BRAF(V600E) oncogene, DHODH inhibition led to a marked decrease in melanoma growth both in vitro and in mouse xenograft studies. Taken together, these studies highlight developmental pathways in neural crest cells that have a direct bearing on melanoma formation.	[White, Richard Mark; Cech, Jennifer; Ratanasirintrawoot, Sutheera; Burke, Christopher J.; Langdon, Erin; Kaufman, Charles; Datta, Sumon; Zon, Leonard I.] Harvard Univ, Stem Cell Program & Hematol Oncol, Childrens Hosp Boston,Med Sch, Howard Hughes Med Inst,Harvard Stem Cell Inst, Boston, MA 02115 USA; [White, Richard Mark; Kaufman, Charles] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Lin, Charles Y.; Rahl, Peter B.; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lin, Charles Y.; Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Tomlinson, Matthew L.; Wheeler, Grant N.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Mosher, Jack; Morrison, Sean] Univ Michigan, Howard Hughes Med Inst, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA; [Chen, Frank] Harvard Univ, Cambridge, MA 02138 USA; [Long, Hannah K.] Univ Cambridge, Cambridge CB2 1TN, England; [Kramer, Martin] Genzyme Corp, Cambridge, MA 02142 USA; [Neuberg, Donna] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Granter, Scott] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of East Anglia; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Harvard University; University of Cambridge; Sanofi-Aventis; Genzyme Corporation; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital	Zon, LI (corresponding author), Harvard Univ, Stem Cell Program & Hematol Oncol, Childrens Hosp Boston,Med Sch, Howard Hughes Med Inst,Harvard Stem Cell Inst, Boston, MA 02115 USA.	zon@enders.tch.harvard.edu	Wheeler, Grant N/D-3023-2009; Long, Hannah/A-6301-2013; Young, Richard A/F-6495-2012; Morrison, Sean/ABD-5326-2021; Long, Hannah/X-9731-2019; , Charles/ABC-8259-2020	Wheeler, Grant N/0000-0002-4335-8577; Long, Hannah/0000-0002-5694-0398; Young, Richard A/0000-0001-8855-8647; Long, Hannah/0000-0002-5694-0398; Kaufman, Charles/0000-0003-3122-1677; Burke, Christopher/0000-0001-7609-1146; Morrison, Sean/0000-0003-1587-8329; Ratanasirintrawoot, Sutheera/0000-0002-0641-5106	Howard Hughes Medical Institute; National Cancer Institute (National Institutes of Health); American Society for Clinical Oncology; National Institute of Arthritis and Musculoskeletal and SkinDiseases (National Institutes of Health); Biotechnology and Biological Sciences Research Council/Pfizer; NATIONAL CANCER INSTITUTE [T32CA009172, R01CA103846] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR055368] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Society for Clinical Oncology; National Institute of Arthritis and Musculoskeletal and SkinDiseases (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Biotechnology and Biological Sciences Research Council/Pfizer(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)Pfizer); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank G. Bollag and P. Lin for supplying PLX4720. The melanoma xenografts were performed with the assistance of T. Venezia-Bowman. In situ hybridization probes for crestin were supplied by P. Henion. We thank S. Lacadie, C. Ceol, Y. Houvras, T. Bowman, X. Bai and R. Field for discussions and/or comments on the manuscript. This work was supported by the Howard Hughes Medical Institute and the National Cancer Institute (National Institutes of Health) (L.I.Z.), Aid for Cancer Research, the American Society for Clinical Oncology and the National Institute of Arthritis and Musculoskeletal and SkinDiseases (National Institutes of Health) (R.M.W.). M.L.T. was a Biotechnology and Biological Sciences Research Council/Pfizer Industrial CASE award recipient.	AOKI T, 1982, J BIOL CHEM, V257, P432; Bai XY, 2010, CELL, V142, P133, DOI 10.1016/j.cell.2010.05.028; Bakos RM, 2010, EXP DERMATOL, V19, pE89, DOI 10.1111/j.1600-0625.2009.00991.x; Bixby S, 2002, NEURON, V35, P643, DOI 10.1016/S0896-6273(02)00825-5; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Chen YL, 2007, PLOS COMPUT BIOL, V3, P602, DOI 10.1371/journal.pcbi.0030063; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Graves LM, 2000, NATURE, V403, P328, DOI 10.1038/35002111; Guo S, 2000, NATURE, V408, P366, DOI 10.1038/35042590; Hong SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002029; Kaplan M J, 2001, Curr Opin Investig Drugs, V2, P222; Keegan BR, 2002, DEVELOPMENT, V129, P1623; Krishnan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003621; Loffler M, 1997, MOL CELL BIOCHEM, V174, P125, DOI 10.1023/A:1006859115450; Luo RS, 2001, DEV DYNAM, V220, P169, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1097>3.0.CO;2-1; McLean JE, 2001, BIOCHEMISTRY-US, V40, P2194, DOI 10.1021/bi001810q; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Mueller D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000249; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nguyen CT, 2010, DEV BIOL, V341, P167, DOI 10.1016/j.ydbio.2010.02.020; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rubinstein AL, 2000, GENESIS, V26, P86, DOI 10.1002/(SICI)1526-968X(200001)26:1<86::AID-GENE11>3.0.CO;2-Q; Schiff MH, 2000, DRUGS TODAY, V36, P383, DOI 10.1358/dot.2000.36.6.584259; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wheeler GN, 2009, DEV DYNAM, V238, P1287, DOI 10.1002/dvdy.21967	26	331	343	8	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					518	522		10.1038/nature09882	http://dx.doi.org/10.1038/nature09882			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21430780	Green Accepted, Green Submitted			2022-12-28	WOS:000288702200063
J	McCartney, M				McCartney, Margaret			Medicine and the Media Panic about nuclear apocalypse overshadows Japan's real plight	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				2011, BRIT MED J, V342, pD1859, DOI DOI 10.1136/BMJ.D1859	1	4	4	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 22	2011	342								d1845	10.1136/bmj.d1845	http://dx.doi.org/10.1136/bmj.d1845			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	742MF	21427033				2022-12-28	WOS:000288947500013
J	Vidal, M; Cusick, ME; Barabasi, AL				Vidal, Marc; Cusick, Michael E.; Barabasi, Albert-Laszlo			Interactome Networks and Human Disease	CELL			English	Review							PROTEIN-PROTEIN INTERACTIONS; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; INTERACTION MAP; EVOLUTIONARY RATE; MAPPING DATA; LINKAGE MAP; YEAST; GENOME; SCALE	Complex biological systems and cellular networks may underlie most genotype to phenotype relationships. Here, we review basic concepts in network biology, discussing different types of interactome networks and the insights that can come from analyzing them. We elaborate on why interactome networks are important to consider in biology, how they can be mapped and integrated with each other, what global properties are starting to emerge from interactome network models, and how these properties may relate to human disease.	[Vidal, Marc; Cusick, Michael E.; Barabasi, Albert-Laszlo] Dana Farber Canc Inst, Ctr Canc Syst Biol CCSB, Boston, MA 02215 USA; [Vidal, Marc; Cusick, Michael E.; Barabasi, Albert-Laszlo] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Vidal, Marc; Cusick, Michael E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Barabasi, Albert-Laszlo] Northeastern Univ, Ctr Complex Network Res CCNR, Boston, MA 02115 USA; [Barabasi, Albert-Laszlo] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Barabasi, Albert-Laszlo] Northeastern Univ, Dept Biol & Comp Sci, Boston, MA 02115 USA; [Barabasi, Albert-Laszlo] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Northeastern University; Northeastern University; Northeastern University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Vidal, M (corresponding author), Dana Farber Canc Inst, Ctr Canc Syst Biol CCSB, Boston, MA 02215 USA.	marc_vidal@dfci.harvard.edu; alb@neu.edu	Barabasi, Albert-Laszlo/S-6474-2017	Barabasi, Albert/0000-0002-4028-3522	National Institutes of Health [R01-HG001715]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001715] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank David E. Hill, Matija Dreze, Anne-Ruxandra Carvunis, Benoit Charloteaux, Quan Zhong, Balaji Santhanam, Sam Pevzner, Song Yi, Nidhi Sahni, Jean Vandenhaute, and Roseann Vidal for careful reading of the manuscript. Interactome mapping efforts at CCSB have been supported mainly by National Institutes of Health grant R01-HG001715. M.V. is grateful to Nadia Rosenthal for the peaceful Suttonian environment. We apologize to those in the field whose important work was not cited here due to space limitation.	Agarwal S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000817; Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bartel PL, 1996, NAT GENET, V12, P72, DOI 10.1038/ng0196-72; Beadle GW, 1941, P NATL ACAD SCI USA, V27, P499, DOI 10.1073/pnas.27.11.499; Beltrao P, 2010, CELL, V141, P739, DOI 10.1016/j.cell.2010.05.019; Bertin N, 2007, PLOS BIOL, V5, P1206, DOI 10.1371/journal.pbio.0050153; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Boulton SJ, 2002, SCIENCE, V295, P127, DOI 10.1126/science.1065986; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Charbonnier S, 2008, BIOTECHNOL ANN REV, V14, P1, DOI 10.1016/S1387-2656(08)00001-X; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cusick ME, 2009, NAT METHODS, V6, P39, DOI [10.1038/NMETH.1284, 10.1038/nmeth.1284]; Davis RH, 2004, NAT REV GENET, V5, p69A, DOI 10.1038/nrg1250; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; DeCaprio JA, 2009, VIROLOGY, V384, P274, DOI 10.1016/j.virol.2008.12.010; Deplancke B, 2004, GENOME RES, V14, P2093, DOI 10.1101/gr.2445504; Deplancke B, 2006, CELL, V125, P1193, DOI 10.1016/j.cell.2006.04.038; Dreze M, 2010, METHOD ENZYMOL, V470, P281, DOI 10.1016/S0076-6879(10)70012-4; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Ekman D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r45; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ergun A, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100125; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FINLEY RL, 1994, P NATL ACAD SCI USA, V91, P12980, DOI 10.1073/pnas.91.26.12980; Fraser HB, 2005, NAT GENET, V37, P351, DOI 10.1038/ng1530; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Fraser HB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r252; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; Ge H, 2003, TRENDS GENET, V19, P551, DOI 10.1016/j.tig.2003.08.009; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Grigoriev A, 2001, NUCLEIC ACIDS RES, V29, P3513, DOI 10.1093/nar/29.17.3513; Grove CA, 2009, CELL, V138, P314, DOI 10.1016/j.cell.2009.04.058; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Hidalgo CA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000353; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Ivanic J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005815; Jager S, 2011, METHODS, V53, P13, DOI 10.1016/j.ymeth.2010.08.007; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Johannsen W, 1909, ELEMENTE EXAKTEN ERB; Jonsson PF, 2006, BIOINFORMATICS, V22, P2291, DOI 10.1093/bioinformatics/btl390; Jordan IK, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-1; Kahali B, 2009, GENE, V429, P18, DOI 10.1016/j.gene.2008.09.032; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104; Kemmeren P, 2002, MOL CELL, V9, P1133, DOI 10.1016/S1097-2765(02)00531-2; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee DS, 2008, P NATL ACAD SCI USA, V105, P9880, DOI 10.1073/pnas.0802208105; Lee I, 2010, GENOME RES, V20, P1143, DOI 10.1101/gr.102749.109; Lee Rosalind, 2004, Cell, VS116, pS89, DOI 10.1016/S0092-8674(04)00035-2; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Ma HW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100177; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Marcotte E, 2001, Brief Bioinform, V2, P363, DOI 10.1093/bib/2.4.363; Martinez NJ, 2008, GENE DEV, V22, P2535, DOI 10.1101/gad.1678608; Mendez-Rios J, 2010, FUTURE MICROBIOL, V5, P289, DOI 10.2217/FMB.10.7; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mo ML, 2009, TRENDS BIOTECHNOL, V27, P37, DOI 10.1016/j.tibtech.2008.09.007; Mohr S, 2010, ANNU REV BIOCHEM, V79, P37, DOI 10.1146/annurev-biochem-060408-092949; NOVICK P, 1989, GENETICS, V121, P659; Nurse P, 2003, CLIN MED, V3, P560, DOI 10.7861/clinmedicine.3-6-560; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Pan XW, 2004, MOL CELL, V16, P487, DOI 10.1016/j.molcel.2004.09.035; Park J, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.16; Pastor-Satorras R, 2003, J THEOR BIOL, V222, P199, DOI 10.1016/S0022-5193(03)00028-6; Perlis RH, 2010, AM J PSYCHIAT, V167, P574, DOI 10.1176/appi.ajp.2009.09070973; Piano F, 2002, CURR BIOL, V12, P1959, DOI 10.1016/S0960-9822(02)01301-5; Plewczynski D, 2009, CELL MOL BIOL LETT, V14, P1, DOI 10.2478/s11658-008-0024-7; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Reece-Hoyes JS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r110; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Roberts PM, 2006, BRIEF BIOINFORM, V7, P399, DOI 10.1093/bib/bbl037; Robinson CV, 2007, NATURE, V450, P973, DOI 10.1038/nature06523; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruvkun Gary, 2004, Cell, VS116, pS93, DOI 10.1016/S0092-8674(04)00034-0; Rzhetsky A, 2007, P NATL ACAD SCI USA, V104, P11694, DOI 10.1073/pnas.0704820104; Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786; Schuster-Bockler B, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r9; Seebacher J, 2011, CELL, V144, P1000, DOI 10.1016/j.cell.2011.02.025; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Shoval O, 2010, CELL, V143, P326, DOI 10.1016/j.cell.2010.09.050; Simonis N, 2009, NAT METHODS, V6, P47, DOI 10.1038/NMETH.1279; Singh GP, 2007, PROTEINS, V66, P761, DOI 10.1002/prot.21281; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; STURTEVANT AH, 1956, GENETICS, V41, P118; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; TURINSKY AL, 2010, LIT CURATION PROTEIN; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Vazquez Alexei, 2003, ComPlexUs, V1, P38, DOI 10.1159/000067642; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vermeirssen V, 2007, GENOME RES, V17, P1061, DOI 10.1101/gr.6148107; Vidal M, 1997, ADV MOLEC BIOL, P109; Vidal M, 2001, CELL, V104, P333, DOI 10.1016/S0092-8674(01)00221-5; Vidal M, 2009, FEBS LETT, V583, P3891, DOI 10.1016/j.febslet.2009.11.024; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wachi S, 2005, BIOINFORMATICS, V21, P4205, DOI 10.1093/bioinformatics/bti688; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Walhout AJM, 2002, CURR BIOL, V12, P1952, DOI 10.1016/S0960-9822(02)01279-4; Walhout AJM, 2001, NAT REV MOL CELL BIO, V2, P55, DOI 10.1038/35048107; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Wuchty S, 2003, NAT GENET, V35, P176, DOI 10.1038/ng1242; Yeger-Lotem E, 2004, P NATL ACAD SCI USA, V101, P5934, DOI 10.1073/pnas.0306752101; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; ZHANG LV, 2005, J BIOL LONDON, V4, pNIL1; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	156	1085	1109	13	326	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 18	2011	144	6					986	998		10.1016/j.cell.2011.02.016	http://dx.doi.org/10.1016/j.cell.2011.02.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	737BQ	21414488	Green Accepted, Bronze			2022-12-28	WOS:000288543500015
J	Welch, HG; Sharp, SM; Gottlieb, DJ; Skinner, JS; Wennberg, JE				Welch, H. Gilbert; Sharp, Sandra M.; Gottlieb, Dan J.; Skinner, Jonathan S.; Wennberg, John E.			Geographic Variation in Diagnosis Frequency and Risk of Death Among Medicare Beneficiaries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADJUSTMENT	Context Because diagnosis is typically thought of as purely a patient attribute, it is considered a critical factor in risk-adjustment policies designed to reward efficient and high-quality care. Objective To determine the association between frequency of diagnoses for chronic conditions in geographic areas and case-fatality rate among Medicare beneficiaries. Design, Setting, and Participants Cross-sectional analysis of the mean number of 9 serious chronic conditions (cancer, chronic obstructive pulmonary disease, coronary artery disease, congestive heart failure, peripheral artery disease, severe liver disease, diabetes with end-organ disease, chronic renal failure, and dementia) diagnosed in 306 hospital referral regions (HRRs) in the United States; HRRs were divided into quintiles of diagnosis frequency. Participants were 5 153 877 fee-for-service Medicare beneficiaries in 2007. Main Outcome Measures Age/sex/race-adjusted case-fatality rates. Results Diagnosis frequency ranged across HRRs from 0.58 chronic conditions in Grand Junction, Colorado, to 1.23 in Miami, Florida (mean, 0.90 [95% confidence interval {CI}, 0.89-0.91]; median, 0.87 [interquartile range, 0.80-0.96]). The number of conditions diagnosed was related to risk of death: among patients diagnosed with 0, 1, 2, and 3 conditions the case-fatality rate was 16, 45, 93, and 154 per 1000, respectively. As regional diagnosis frequency increased, however, the case fatality associated with a chronic condition became progressively less. Among patients diagnosed with 1 condition, the case-fatality rate decreased in a stepwise fashion across quintiles of diagnosis frequency, from 51 per 1000 in the lowest quintile to 38 per 1000 in the highest quintile (relative rate, 0.74 [95% CI, 0.72-0.76]). For patients diagnosed with 3 conditions, the corresponding case-fatality rates were 168 and 137 per 1000 (relative rate, 0.81 [95% CI, 0.79-0.84]). Conclusion Among fee-for-service Medicare beneficiaries, there is an inverse relationship between the regional frequency of diagnoses and the case-fatality rate for chronic conditions. JAMA. 2011;305(11):1113-1118 www.jama.com	[Welch, H. Gilbert; Sharp, Sandra M.; Gottlieb, Dan J.; Skinner, Jonathan S.; Wennberg, John E.] Dartmouth Med Sch, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03766 USA; [Welch, H. Gilbert] Dept Vet Affairs Med Ctr, White River Jct, VT USA; [Skinner, Jonathan S.] Dartmouth Coll, Dept Econ, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College	Welch, HG (corresponding author), Dartmouth Med Sch, Dartmouth Inst Hlth Policy & Clin Practice, 35 Centerra Pkwy,Ste 202, Lebanon, NH 03766 USA.	h.gilbert.welch@dartmouth.edu			National Institute on Aging [PO1-AG19783]; NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was partially supported by grant PO1-AG19783 from the National Institute on Aging.	Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; IEZZONI LI, 1994, HEALTH SERV RES, V29, P435; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; MedPAC (Medicare Payment Advisory Commission), 2011, REG VAR MED SERV US; MORREIM EH, 1991, ARCH INTERN MED, V151, P443, DOI 10.1001/archinte.151.3.443; Ong MK, 2009, CIRC-CARDIOVASC QUAL, V2, P548, DOI 10.1161/CIRCOUTCOMES.108.825612; Pine M, 2009, MED DECIS MAKING, V29, P69, DOI 10.1177/0272989X08323297; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; Welch WP, 1995, HEALTH AFFAIR, V14, P104, DOI 10.1377/hlthaff.14.4.104	10	111	112	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2011	305	11					1113	1118		10.1001/jama.2011.307	http://dx.doi.org/10.1001/jama.2011.307			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	734ZF	21406648	Bronze, Green Accepted			2022-12-28	WOS:000288381900023
J	Roberts, I; Shakur, H; Afolabi, A; Brohi, K; Coats, T; Dewan, Y; Gando, S; Guyatt, G; Hunt, BJ; Morales, C; Perel, P; Prieto-Merino, D; Woolley, T				Roberts, Ian; Shakur, Haleema; Afolabi, Adefemi; Brohi, Karim; Coats, Tim; Dewan, Yashbir; Gando, Satoshi; Guyatt, Gordon; Hunt, B. J.; Morales, Carlos; Perel, Pablo; Prieto-Merino, David; Woolley, Tom		CRASH-2 Collaborators	The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial	LANCET			English	Article							COAGULOPATHY	Background The aim of the CRASH-2 trial was to assess the effects of early administration of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage. Tranexamic acid significantly reduced all-cause mortality. Because tranexamic acid is thought to exert its effect through inhibition of fibrinolysis, we undertook exploratory analyses of its effect on death due to bleeding. Methods The CRASH-2 trial was undertaken in 274 hospitals in 40 countries. 20 211 adult trauma patients with, or at risk of, significant bleeding were randomly assigned within 8 h of injury to either tranexamic acid (loading dose 1 g over 10 min followed by infusion of 1 g over 8 h) or placebo. Patients were randomly assigned by selection of the lowest numbered treatment pack from a box containing eight numbered packs that were identical apart from the pack number. Both participants and study staff (site investigators and trial coordinating centre staff) were masked to treatment allocation. We examined the effect of tranexamic acid on death due to bleeding according to time to treatment, severity of haemorrhage as assessed by systolic blood pressure, Glasgow coma score (GCS), and type of injury. All analyses were by intention to treat. The trial is registered as ISRCTN86750102, ClinicalTrials.gov NCT00375258, and South African Clinical Trial Register/Department of Health DOH-27-0607-1919. Findings 10 096 patients were allocated to tranexamic acid and 10 115 to placebo, of whom 10 060 and 10067, respectively, were analysed. 1063 deaths (35%) were due to bleeding. We recorded strong evidence that the effect of tranexamic acid on death due to bleeding varied according to the time from injury to treatment (test for interaction p<0.0001). Early treatment (<= 1 h from injury) significantly reduced the risk of death due to bleeding (198/3747 [5.3%] events in tranexamic acid group vs 286/3704 [7.7%] in placebo group; relative risk [RR] 0.68, 95% CI 0.57-0.82; p<0.0001). Treatment given between land 3 h also reduced the risk of death due to bleeding (147/3037 [4.8%] vs 184/2996 [6.1%]; RR 0.79, 0.64-0.97; p=0.03). Treatment given after 3 h seemed to increase the risk of death due to bleeding (144/3272 [4.4%] vs 103/3362 [3.1%]; RR 1.44, 1.12-1.84; p=0.004). We recorded no evidence that the effect of tranexamic acid on death due to bleeding varied by systolic blood pressure, Glasgow coma score, or type of injury. Interpretation Tranexamic acid should be given as early as possible to bleeding trauma patients. For trauma patients admitted late after injury, tranexamic acid is less effective and could be harmful.	[Roberts, Ian] Univ London London Sch Hyg & Trop Med, Clin Trials Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Roberts, I (corresponding author), Univ London London Sch Hyg & Trop Med, Clin Trials Unit, Keppel St, London WC1E 7HT, England.		Woolley, Tom/D-8110-2012; Roslani, April Camilla/B-8245-2010; Gando, Satoshi/T-7407-2019; Dharap, Satish/AAE-8565-2020; Miranda, J. Jaime/A-8482-2008; LORIA-CASTELLANOS, JORGE/N-2363-2019; Coats, Timothy/AAW-1254-2021; Mohammad, Bassim/AAE-3715-2020; Dewan, Yashbir/C-6503-2013; Nottidge, Timothy/ACH-9894-2022; Gando, Satoshi/A-6686-2012; ZA, TABRANI./F-6709-2014; LORIA-CASTELLANOS, JORGE/J-2410-2016; Trochez, Adolfo Leon/Z-1749-2019; Balogh, Zsolt/A-2002-2010; Anyanwu, Stanley/W-2514-2019; Mohammad, Bassim Irheim/G-3715-2019; Mbuagbaw, Lawrence/D-9381-2015	Woolley, Tom/0000-0001-9957-6453; Roslani, April Camilla/0000-0003-2458-965X; Gando, Satoshi/0000-0002-3525-0750; Dharap, Satish/0000-0002-9304-9617; Miranda, J. Jaime/0000-0002-4738-5468; LORIA-CASTELLANOS, JORGE/0000-0001-9269-0034; Coats, Timothy/0000-0003-2736-2784; Dewan, Yashbir/0000-0002-7154-1301; Nottidge, Timothy/0000-0002-5245-8115; ZA, TABRANI./0000-0003-1014-3841; LORIA-CASTELLANOS, JORGE/0000-0001-9269-0034; Trochez, Adolfo Leon/0000-0002-3621-6036; Balogh, Zsolt/0000-0002-0277-4822; Mbuagbaw, Lawrence/0000-0001-5855-5461; Shakur-Still, Haleema/0000-0002-6511-109X; Goodacre, Steve/0000-0003-0803-8444; Volpi, Annalisa/0000-0001-5337-9155; Moradi, Ehsan/0000-0002-1403-0150; Mohammad, Bassim/0000-0001-6732-5940; Prieto-Merino, David/0000-0001-5001-0061; Mankar, Dr. Sushil/0000-0002-7432-2761; Hokkam, Emad/0000-0003-1532-6655; YUSUF, AYODEJI SALMAN/0000-0002-6002-8641; ABUBAKAR, MUHAMMAD LAWAL/0000-0002-5536-873X; RUBIANO ESCOBAR, ANDRES MARIANO/0000-0001-8931-3254; Kumar, Dinesh/0000-0003-3602-4023; JAMALUDDIN, SABARIAH/0000-0002-3788-7915; Wattanakrai, Kamol/0000-0003-4383-0795; Wallis, Lee/0000-0003-2711-3139; komolafe, edward/0000-0003-1261-3501; Sandercock, Peter/0000-0001-8484-0135; Chaudhuri, pratyush/0000-0001-9766-728X; Okwen, Patrick/0000-0002-9017-7496; RAMANA, P V/0000-0003-4654-0590; Pangi, Ashok/0000-0002-3417-3976; Soto, Alonso/0000-0001-8648-8032; Aminu Balarabe, Muhammad/0000-0001-5607-5480; Caballero-Alvarado, Jose/0000-0001-8297-6901; /0000-0002-2342-301X	J P Moulton Charitable Foundation; BUPA Foundation; Pfizer; UK NIHR; National Institute for Health Research [06/303/20] Funding Source: researchfish	J P Moulton Charitable Foundation; BUPA Foundation; Pfizer(Pfizer); UK NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The London School of Hygiene and Tropical Medicine supported the core trial coordinating staff during the first year of the trial set-up. Funding for the run-in stage was provided by J P Moulton Charitable Foundation and the BUPA Foundation. A grant-in-aid for purchasing the tranexamic acid and placebo was provided by Pfizer. The main phase of this trial was funded by the UK NIHR Health Technology Assessment programme and will be published in full in the Health Technology Assessment journal series. The views and opinions expressed therein are those of the authors and do riot necessarily reflect those of the Department of Health.	Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Henry DA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001886.pub2; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Lauer MS, 1999, J AM COLL CARDIOL, V34, P618, DOI 10.1016/S0735-1097(99)00250-8; Levy JH, 2010, LANCET, V376, P3, DOI 10.1016/S0140-6736(10)60939-7; NIHR Health Technology Assessment Programme, 2010, DEV VAL RISK SCOR TR; Prentice C R, 1980, J Clin Pathol Suppl (R Coll Pathol), V14, P35; Roberts I, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004896.pub3; Sawamura A, 2009, THROMB RES, V124, P608, DOI 10.1016/j.thromres.2009.06.034; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Sun X, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c117; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93	13	663	690	0	50	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2011	377	9771					1096	1101		10.1016/S0140-6736(11)60278-X	http://dx.doi.org/10.1016/S0140-6736(11)60278-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	743QY	21439633	Green Accepted			2022-12-28	WOS:000289035000030
J	Graham, WJ; Varghese, B				Graham, Wendy J.; Varghese, Beena			Quality, quality, quality: gaps in the continuum of care	LANCET			English	Editorial Material							HEALTH		[Graham, Wendy J.] Univ Aberdeen, Sch Med & Dent, Aberdeen AB25 2ZD, Scotland; [Varghese, Beena] Publ Hlth Fdn India, New Delhi, India	University of Aberdeen; Public Health Foundation of India	Graham, WJ (corresponding author), Univ Aberdeen, Sch Med & Dent, Aberdeen AB25 2ZD, Scotland.	w.graham@abdn.ac.uk		Graham, Wendy/0000-0003-1473-5342				Bell JS., 2003, TRENDS DELIVERY CARE; Bradshaw D, 2008, LANCET, V371, P1294, DOI 10.1016/S0140-6736(08)60564-4; Godlee F, 2009, BMJ-BRIT MED J, V339, pb4346, DOI DOI 10.1136/bmj.b4346; Institute of Medicine, 2001, CROSS QUAL CHASM; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Neal S, 2010, WHITE RIBBON ALLIANC; Nehru, 1962, GLIMPSES WORLD HIST; Pan American Health Organization/WHO, 2003, MON RED MAT MORB MOR; The Earth Institute Columbia University, 2010, BARR GAPS AFF MHEALT; United Nations, 2010, GLOB STRAT WOM CHILD; United Nations Population Fund, 2009, CONC ASS JAN SUR YOJ; van den Broek NR, 2009, BJOG-INT J OBSTET GY, V116, P18, DOI 10.1111/j.1471-0528.2009.02333.x; WHO, 2010, WOR HEALT REP, P1; WHO, 2008, FACTSH SKILL ATT; COUNTDOWN 2015 MATER; 2010, PARTNERSHIP MATERNAL	16	56	56	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 14	2012	379	9811					E5	E6		10.1016/S0140-6736(10)62267-2	http://dx.doi.org/10.1016/S0140-6736(10)62267-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	879GM	21474173				2022-12-28	WOS:000299317700001
J	Kocher, R; Sahni, NR				Kocher, Robert; Sahni, Nikhil R.			Hospitals' Race to Employ Physicians - The Logic behind a Money-Losing Proposition	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kocher, Robert] Brookings Inst, McKinsey Ctr US Hlth Syst Reform, Washington, DC 20036 USA; [Kocher, Robert] Brookings Inst, Engleberg Ctr Hlth Care Reform, Washington, DC 20036 USA; [Sahni, Nikhil R.] Harvard Univ, Sch Business, Boston, MA 02163 USA; [Sahni, Nikhil R.] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Brookings Institution; Brookings Institution; Harvard University; Harvard University	Kocher, R (corresponding author), Brookings Inst, McKinsey Ctr US Hlth Syst Reform, Washington, DC 20036 USA.							Berenson RA, 2010, HEALTH AFFAIR, V29, P699, DOI 10.1377/hlthaff.2009.0715; Cantlupe J., 2010, PHYS ALIGNMENT ERA C; Carreyrou J., 2008, WALL STREET J E 0404, pA1; Kocher R, 2010, NEW ENGL J MED, V363, P2579, DOI 10.1056/NEJMp1011712; Office of Attorney General Martha Coakley, 2010, ATT GEN M COAKL OFF	5	155	155	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 12	2011	364	19					1790	1793		10.1056/NEJMp1101959	http://dx.doi.org/10.1056/NEJMp1101959			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	762MM	21449774				2022-12-28	WOS:000290483000004
J	Laurent, P; Rodriguez, J; Wilms, J; Bel, MC; Pottschmidt, K; Grinberg, V				Laurent, P.; Rodriguez, J.; Wilms, J.; Bel, M. Cadolle; Pottschmidt, K.; Grinberg, V.			Polarized Gamma-Ray Emission from the Galactic Black Hole Cygnus X-1	SCIENCE			English	Article							BROAD-BAND SPECTRUM; X-RAY; ACCRETION DISKS; LOW/HARD STATE; RADIATION; JETS; TELESCOPE; IBIS	Because of their inherently high flux allowing the detection of clear signals, black hole x-ray binaries are interesting candidates for polarization studies, even if no polarization signals have been observed from them before. Such measurements would provide further detailed insight into these sources' emission mechanisms. We measured the polarization of the gamma-ray emission from the black hole binary system Cygnus X-1 with the International Gamma-Ray Astrophysics Laboratory Imager on Board the Integral Satellite (INTEGRAL/IBIS) telescope. Spectral modeling of the data reveals two emission mechanisms: The 250- to 400-keV ( kilo-electron volt) data are consistent with emission dominated by Compton scattering on thermal electrons and are weakly polarized. The second spectral component seen in the 400-keV to 2-MeV band is by contrast strongly polarized, revealing that the MeV emission is probably related to the jet first detected in the radio band.	[Laurent, P.] Commissariat Energie Atom & Energies Alternat, Inst Rech Lois Fondamentales Univers CEA IRFU, F-75205 Paris 13, France; [Rodriguez, J.] Univ Paris Diderot, Inst Natl Sci Univers, CEA Saclay, DSM,IRFU,SAp,CEA,Lab AIM,CNRS, F-91191 Gif Sur Yvette, France; [Wilms, J.; Grinberg, V.] Univ Erlangen Nurnberg, Dr Karl Remeis Sternwarte & Erlangen Ctr Astropar, D-96049 Bamberg, Germany; [Bel, M. Cadolle] European Space Astron Ctr, Sci Operat Dept, Int Gamma Ray Astrophys Lab INTEGRAL Sci Operat C, E-28691 Madrid, Spain; [Pottschmidt, K.] CRESST, Greenbelt, MD 20771 USA; [Pottschmidt, K.] NASA, Goddard Space Flight Ctr, Astrophys Sci Div, Greenbelt, MD 20771 USA; [Pottschmidt, K.] Univ Maryland Baltimore Cty, Ctr Space Sci & Technol, Baltimore, MD 21250 USA	CEA; UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; University of Erlangen Nuremberg; European Space Agency; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland Baltimore County	Laurent, P (corresponding author), Commissariat Energie Atom & Energies Alternat, Inst Rech Lois Fondamentales Univers CEA IRFU, 10 Rue Alice Domon & Leonie Duquet, F-75205 Paris 13, France.	plaurent@cea.fr	Rodriguez, Jerome/GMX-5000-2022; Wilms, Joern/C-8116-2013	Wilms, Joern/0000-0003-2065-5410; Rodriguez, Jerome/0000-0002-4151-4468; Grinberg, Victoria/0000-0003-2538-0188	European Commission [ITN 215212]; Bundesministerium fur Wirtschaft und Technologie under Deutsches Zentrum fur Luftund Raumfahrt [50 OR 1007]; NASA [NNX08AE84G, NNX08AY24G, NX09AT28G]	European Commission(European CommissionEuropean Commission Joint Research Centre); Bundesministerium fur Wirtschaft und Technologie under Deutsches Zentrum fur Luftund Raumfahrt; NASA(National Aeronautics & Space Administration (NASA))	ISGRI has been realized and maintained in flight by CEA-Saclay/IRFU with the support of Centre National d'Etudes Spatiales. Based on observations with INTEGRAL, a European Space Agency (ESA) project with instruments and science data center funded by ESA member states (especially the Principal Investigator countries: Denmark, France, Germany, Italy, Switzerland, and Spain), Czech Republic and Poland, and with the participation of Russia and the United States. We acknowledge partial funding from the European Commission under contract ITN 215212 "Black Hole Universe" and from the Bundesministerium fur Wirtschaft und Technologie under Deutsches Zentrum fur Luftund Raumfahrt grant 50 OR 1007. K. P. acknowledges support by NASA's INTEGRAL Guest Observer grants NNX08AE84G, NNX08AY24G, and NX09AT28G. We thank S. Corbel for useful comments.	Abdo AA, 2009, SCIENCE, V326, P1512, DOI 10.1126/science.1182174; Albert J, 2007, ASTROPHYS J, V665, pL51, DOI 10.1086/521145; BALUCINSKACHURCH M, 1995, ASTRON ASTROPHYS, V302, pL5; Begelman MC, 2006, MON NOT R ASTRON SOC, V370, P399, DOI 10.1111/j.1365-2966.2006.10469.x; Bel MC, 2006, ASTRON ASTROPHYS, V446, P591, DOI 10.1051/0004-6361:20053068; Cui W, 1997, ASTROPHYS J, V474, pL57, DOI 10.1086/310419; Di Salvo T, 2001, ASTROPHYS J, V547, P1024, DOI 10.1086/318396; Dove JB, 1997, ASTROPHYS J, V487, P759, DOI 10.1086/304647; Ebisawa K, 1996, ASTROPHYS J, V467, P419, DOI 10.1086/177616; Fender RP, 2004, MON NOT R ASTRON SOC, V355, P1105, DOI 10.1111/j.1365-2966.2004.08384.x; Fender RP, 2006, MON NOT R ASTRON SOC, V369, P603, DOI 10.1111/j.1365-2966.2006.10193.x; Forot M, 2007, ASTROPHYS J, V668, P1259, DOI 10.1086/521325; Forot M, 2008, ASTROPHYS J LETT, V688, pL29, DOI 10.1086/593974; Gallo E, 2003, MON NOT R ASTRON SOC, V344, P60, DOI 10.1046/j.1365-8711.2003.06791.x; Gierlinski M, 1997, MON NOT R ASTRON SOC, V288, P958, DOI 10.1093/mnras/288.4.958; GIES DR, 1986, ASTROPHYS J, V304, P371, DOI 10.1086/164172; GINZBURG VL, 1965, ANNU REV ASTRON ASTR, V3, P297, DOI 10.1146/annurev.aa.03.090165.001501; Gotz D, 2009, ASTROPHYS J LETT, V695, pL208, DOI 10.1088/0004-637X/695/2/L208; Hawley J, 2009, ASTROPHYS SPACE SCI, V320, P107, DOI 10.1007/s10509-008-9799-2; Lei F, 1997, SPACE SCI REV, V82, P309, DOI 10.1023/A:1005027107614; Lister ML, 2005, ASTRON J, V130, P1389, DOI 10.1086/432969; MASSEY P, 1995, ASTROPHYS J, V454, P151, DOI 10.1086/176474; McConnell ML, 2002, ASTROPHYS J, V572, P984, DOI 10.1086/340436; Rodriguez LF, 1999, ASTROPHYS J, V511, P398, DOI 10.1086/306642; Sabatini S, 2010, ASTROPHYS J LETT, V712, pL10, DOI 10.1088/2041-8205/712/1/L10; Stirling AM, 2001, MON NOT R ASTRON SOC, V327, P1273, DOI 10.1046/j.1365-8711.2001.04821.x; SUNYAEV RA, 1985, ASTRON ASTROPHYS, V143, P374; SUNYAEV RA, 1979, NATURE, V279, P506, DOI 10.1038/279506a0; Ubertini P, 2003, ASTRON ASTROPHYS, V411, pL131, DOI 10.1051/0004-6361:20031224; Vedrenne G, 2003, ASTRON ASTROPHYS, V411, pL63, DOI 10.1051/0004-6361:20031482; Winkler C, 2003, ASTRON ASTROPHYS, V411, pL1, DOI 10.1051/0004-6361:20031288	31	170	170	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2011	332	6028					438	439		10.1126/science.1200848	http://dx.doi.org/10.1126/science.1200848			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21436402	Green Submitted			2022-12-28	WOS:000289784900035
J	Suter, DM; Molina, N; Gatfield, D; Schneider, K; Schibler, U; Naef, F				Suter, David M.; Molina, Nacho; Gatfield, David; Schneider, Kim; Schibler, Ueli; Naef, Felix			Mammalian Genes Are Transcribed with Widely Different Bursting Kinetics	SCIENCE			English	Article							EXPRESSION; CELLS; TIME	In prokaryotes and eukaryotes, most genes appear to be transcribed during short periods called transcriptional bursts, interspersed by silent intervals. We describe how such bursts generate gene-specific temporal patterns of messenger RNA (mRNA) synthesis in mammalian cells. To monitor transcription at high temporal resolution, we established various gene trap cell lines and transgenic cell lines expressing a short-lived luciferase protein from an unstable mRNA, and recorded bioluminescence in real time in single cells. Mathematical modeling identified gene-specific on-and off-switching rates in transcriptional activity and mean numbers of mRNAs produced during the bursts. Transcriptional kinetics were markedly altered by cis-regulatory DNA elements. Our analysis demonstrated that bursting kinetics are highly gene-specific, reflecting refractory periods during which genes stay inactive for a certain time before switching on again.	[Suter, David M.; Gatfield, David; Schneider, Kim; Schibler, Ueli] Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland; [Suter, David M.; Gatfield, David; Schneider, Kim; Schibler, Ueli] Natl Ctr Competence Res Frontiers Genet, CH-1211 Geneva, Switzerland; [Molina, Nacho; Naef, Felix] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Molina, Nacho; Naef, Felix] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Gatfield, David] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland	University of Geneva; University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics; University of Lausanne	Schibler, U (corresponding author), Univ Geneva, Dept Mol Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva, Switzerland.	ueli.schibler@unige.ch; felix.naef@epfl.ch	Naef, Felix/C-9527-2011; Gatfield, David/C-2354-2011; Suter, David/S-9210-2019; Molina, Nacho/F-2244-2010	Gatfield, David/0000-0001-5114-2824; Suter, David/0000-0001-5644-4899; Naef, Felix/0000-0001-9786-3037; Molina, Nacho/0000-0003-0233-3055	Swiss National Science Foundation [SNF 31-113565, SNF 31-128656/1, 3100A0-113617, 31-130714]; NCCR; European Research Council [ERC-2009-AdG 20090506]; State of Geneva; Louis Jeantet Foundation of Medicine; Ecole Polytechnique Federale de Lausanne (EPFL)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR(Swiss National Science Foundation (SNSF)); European Research Council(European Research Council (ERC)European Commission); State of Geneva; Louis Jeantet Foundation of Medicine; Ecole Polytechnique Federale de Lausanne (EPFL)	We thank A. Liani and Y.-A. Poget for building a bioluminescence reader, C. Bauer and J. Bosset for help with time-lapse imaging, P. Salmon and D. Trono for providing lentiviral constructs, A. Oates for critical reading of the manuscript, and N. Roggli for the artwork. The computations were performed at Vital-IT (www.vital-it.ch). The U.S.'s laboratory was supported by the Swiss National Science Foundation (SNF 31-113565, SNF 31-128656/1, and the NCCR program grant Frontiers in Genetics), the European Research Council (ERC-2009-AdG 20090506), the State of Geneva, and the Louis Jeantet Foundation of Medicine. F. N.'s laboratory was supported by the Swiss National Science Foundation (SNF grants 3100A0-113617 and 31-130714) and the Ecole Polytechnique Federale de Lausanne (EPFL).	Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Darzacq X, 2009, ANNU REV BIOPHYS, V38, P173, DOI 10.1146/annurev.biophys.050708.133728; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Larson DR, 2009, TRENDS CELL BIOL, V19, P630, DOI 10.1016/j.tcb.2009.08.008; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; Octavio LM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000673; Pare A, 2009, CURR BIOL, V19, P2037, DOI 10.1016/j.cub.2009.10.028; PECCOUD J, 1995, THEOR POPUL BIOL, V48, P222, DOI 10.1006/tpbi.1995.1027; Pedraza JM, 2008, SCIENCE, V319, P339, DOI 10.1126/science.1144331; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Raj A, 2009, ANNU REV BIOPHYS, V38, P255, DOI 10.1146/annurev.biophys.37.032807.125928; RYAN MD, 1994, EMBO J, V13, P928, DOI 10.1002/j.1460-2075.1994.tb06337.x; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; Tan RZ, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.14; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yunger S, 2010, NAT METHODS, V7, P631, DOI [10.1038/nmeth.1482, 10.1038/NMETH.1482]; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	24	572	584	2	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2011	332	6028					472	474		10.1126/science.1198817	http://dx.doi.org/10.1126/science.1198817			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21415320				2022-12-28	WOS:000289784900045
J	Xu, GZ; Lo, YC; Li, QB; Napolitano, G; Wu, XF; Jiang, XL; Dreano, M; Karin, M; Wu, H				Xu, Guozhou; Lo, Yu-Chih; Li, Qiubai; Napolitano, Gennaro; Wu, Xuefeng; Jiang, Xuliang; Dreano, Michel; Karin, Michael; Wu, Hao			Crystal structure of inhibitor of kappa B kinase beta	NATURE			English	Article							UBIQUITIN-LIKE DOMAIN; PROTEIN-KINASE; CATALYTIC SUBUNIT; IKK-BETA; DOCKING INTERACTIONS; COMPLEX; PHOSPHORYLATION; ACTIVATION; ALPHA; BINDING	Inhibitor of kappa B (I kappa B) kinase (IKK) phosphorylates I kappa B proteins, leading to their degradation and the liberation of nuclear factor kappa B for gene transcription. Here we report the crystal structure of IKK beta in complex with an inhibitor, at a resolution of 3.6 angstrom. The structure reveals a trimodular architecture comprising the kinase domain, a ubiquitin-like domain (ULD) and an elongated, alpha-helical scaffold/dimerization domain (SDD). Unexpectedly, the predicted leucine zipper and helix-loop-helix motifs do not form these structures but are part of the SDD. The ULD and SDD mediate a critical interaction with I kappa B alpha that restricts substrate specificity, and the ULD is also required for catalytic activity. The SDD mediates IKK beta dimerization, but dimerization per se is not important for maintaining IKK beta activity and instead is required for IKK beta activation. Other IKK family members, IKK alpha, TBK1 and IKK-i, may have a similar trimodular architecture and function.	[Xu, Guozhou; Lo, Yu-Chih; Li, Qiubai; Wu, Hao] Weill Cornell Med Coll, Dept Biochem, New York, NY 10021 USA; [Napolitano, Gennaro; Wu, Xuefeng; Karin, Michael] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Jiang, Xuliang] EMD Serono Res Inst, Billerica, MA 01821 USA; [Dreano, Michel] Merck Serono, CH-1211 Geneva, Switzerland	Cornell University; University of California System; University of California San Diego; Merck KGaA; EMD Serono Inc.	Wu, H (corresponding author), Weill Cornell Med Coll, Dept Biochem, New York, NY 10021 USA.	haowu@med.cornell.edu	Napolitano, Gennaro/O-5377-2016; Wu, Xuefeng/F-5003-2011	Napolitano, Gennaro/0000-0002-8615-4654	National Institutes of Health; American Heart Association; Cancer Research Institute; American Cancer Society; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079260, R01AI050872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Cancer Research Institute; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. Rajashankar and N. Sukumar for data collection at the NE-CAT of APS, B. Schwer for help with the kinase assay, P. Gaillard for help with the chemistry and G. Ahlsen, L. Shapiro and B. Honig for the ultracentrifugation experiments. This work was supported by the National Institutes of Health (H. W. and M. K.), the American Heart Association (G. X. and Y.-C.L.) and the Cancer Research Institute (Y.-C.L.). M. K. is an American Cancer Society Research Professor.	Bagneris C, 2008, MOL CELL, V30, P620, DOI 10.1016/j.molcel.2008.04.029; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARROGA CF, 1995, P NATL ACAD SCI USA, V92, P7637, DOI 10.1073/pnas.92.17.7637; BOSSEMEYER D, 1993, EMBO J, V12, P849, DOI 10.1002/j.1460-2075.1993.tb05725.x; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brown K, 2005, J MOL BIOL, V354, P1013, DOI 10.1016/j.jmb.2005.09.098; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Cordier F, 2008, J MOL BIOL, V377, P1419, DOI 10.1016/j.jmb.2008.01.048; DeLano W.L., 2002, PYMOL MOL VIEWER; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Goldsmith EJ, 2007, CHEM REV, V107, P5065, DOI 10.1021/cr068221w; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Ikeda F, 2007, EMBO J, V26, P3451, DOI 10.1038/sj.emboj.7601773; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; May MJ, 2004, J BIOL CHEM, V279, P45528, DOI 10.1074/jbc.M408579200; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Remenyi A, 2006, CURR OPIN STRUC BIOL, V16, P676, DOI 10.1016/j.sbi.2006.10.008; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Rushe M, 2008, STRUCTURE, V16, P798, DOI 10.1016/j.str.2008.02.012; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shaul JD, 2008, BIOCHEM BIOPH RES CO, V374, P592, DOI 10.1016/j.bbrc.2008.07.082; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Tang ED, 2003, J BIOL CHEM, V278, P49661; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Xu RM, 1996, P NATL ACAD SCI USA, V93, P6308, DOI 10.1073/pnas.93.13.6308; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423	50	141	145	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					325	U222		10.1038/nature09853	http://dx.doi.org/10.1038/nature09853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21423167	Green Accepted			2022-12-28	WOS:000289724600034
J	Buiting, HM; Rurup, ML; Wijsbek, H; van Zuylen, L; den Hartogh, G				Buiting, Hilde M.; Rurup, Mette L.; Wijsbek, Henri; van Zuylen, Lia; den Hartogh, Govert			Understanding provision of chemotherapy to patients with end stage cancer: qualitative interview study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To examine health professionals' experiences of and attitudes towards the provision of chemotherapy to patients with end stage cancer. Design Purposive, qualitative design based on in-depth interviews. Setting Oncology departments at university hospitals and general hospitals in the Netherlands. Participants 14 physicians and 13 nurses who cared for patients with metastatic cancer. Results Physicians and nurses reported trying to inform patients fully about their poor prognosis and treatment options. They would carefully consider the (side) effects of chemotherapy and sometimes doubted whether further treatment would contribute to patients' quality of life. Both groups considered the patients' wellbeing to be important, and physicians seemed inclined to try to preserve this by offering further chemotherapy, often followed by the patient. Nurses were more often inclined to express their doubts about further treatment, preferring to allow patients to make the best use of the time that is left. When confronted with a treatment dilemma and a patient's wish for treatment, physicians preferred to make compromises, such as by "trying out one dose." Discussing death or dying with patients while at the same time administering chemotherapy was considered contradictory as this could diminish the patients' hope. Conclusions The trend to greater use of chemotherapy at the end of life could be explained by patients' and physicians' mutually reinforcing attitudes of "not giving up" and by physicians' broad interpretation of patients' quality of life, in which taking away patients' hope by withholding treatment is considered harmful. To rebalance the ratio of quantity of life to quality of life, input from other health professionals, notably nurses, may be necessary.	[Buiting, Hilde M.; Rurup, Mette L.; Wijsbek, Henri; den Hartogh, Govert] Univ Amsterdam, Dept Philosophy, Oude Turfmarkt 141-147, NL-1012 GC Amsterdam, Netherlands; [van Zuylen, Lia] Univ Med Ctr, Erasmus MC, Dept Med Oncol, POB 2040, NL-3000 CA Rotterdam, Netherlands	University of Amsterdam; Erasmus University Rotterdam; Erasmus MC	Buiting, HM (corresponding author), Univ Amsterdam, Dept Philosophy, Oude Turfmarkt 141-147, NL-1012 GC Amsterdam, Netherlands.	h.m.buiting@uva.nl			ZonMw, the Netherlands Organization for Health Research and Development [70-71300-98-048]	ZonMw, the Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and DevelopmentNetherlands Government)	This study was supported by a grant from ZonMw, the Netherlands Organization for Health Research and Development ( grant No 70-71300-98-048). The study sponsor had no role in the study design; collection, analysis, and interpretation of the data; or in the writing of the article and decision to submit the article for publication.	Ablin RJ, 2010, ARCH INTERN MED, V170, P1397, DOI 10.1001/archinternmed.2010.290; Barnato AE, 2004, HEALTH SERV RES, V39, P363, DOI 10.1111/j.1475-6773.2004.00232.x; Beauchamp T L, 2012, PRINCIPLES BIOMEDICA; Braga S, 2007, PSYCHO-ONCOL, V16, P863, DOI 10.1002/pon.1140; Breier-Mackie S, 2001, NURS ETHICS, V8, P510, DOI 10.1191/096973301682553805; Buiting HM, 2008, EUR J PUBLIC HEALTH, V18, P681, DOI 10.1093/eurpub/ckn084; de Kort SJ, 2010, HEALTH CARE ANAL, V18, P164, DOI 10.1007/s10728-009-0121-4; Dreyer A, 2009, J MED ETHICS, V35, P672, DOI 10.1136/jme.2009.030668; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; Earle CC, 2008, J CLIN ONCOL, V26, P3860, DOI 10.1200/JCO.2007.15.8253; Emanuel EJ, 2003, ANN INTERN MED, V138, P639, DOI 10.7326/0003-4819-138-8-200304150-00011; Fishman J, 2010, ARCH INTERN MED, V170, P515, DOI 10.1001/archinternmed.2010.11; Grady D, 2010, ARCH INTERN MED, V170, P749, DOI 10.1001/archinternmed.2010.90; Grant L, 2010, BMJ-BRIT MED J, V341, pc4859; Kirk P, 2004, BMJ-BRIT MED J, V328, P1343, DOI 10.1136/bmj.38103.423576.55; LANTOS JD, 1989, AM J MED, V87, P81; Mack JW, 2010, J CLIN ONCOL, V28, P1203, DOI 10.1200/JCO.2009.25.4672; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Punt CJA, 1998, CANCER-AM CANCER SOC, V83, P679, DOI 10.1002/(SICI)1097-0142(19980815)83:4<679::AID-CNCR8>3.0.CO;2-F; Ritchie J, 2007, QUALITATIVE RES PRAC; SCHNEIDERMAN LJ, 1993, ARCH INTERN MED, V153, P437, DOI 10.1001/archinte.153.4.437; SLEVIN ML, 1990, BRIT MED J, V300, P1458, DOI 10.1136/bmj.300.6737.1458; Spencer L, 2007, QUALITATIVE RES PRAC; STEWARD WP, 1995, ANN ONCOL, V6, P49; The AM, 2000, BRIT MED J, V321, P1376, DOI 10.1136/bmj.321.7273.1376; van Leeunven AF, 2004, J PAIN SYMPTOM MANAG, V28, P351, DOI 10.1016/j.jpainsymman.2004.01.005; Vos T, 2009, THESIS U AMSTERDAM; Zanchetta Margareth S, 2006, Clin J Oncol Nurs, V10, P803, DOI 10.1188/06.CJON.803-807	28	70	70	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 4	2011	342								d1933	10.1136/bmj.d1933	http://dx.doi.org/10.1136/bmj.d1933			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V44GZ	21464103	Green Published			2022-12-28	WOS:000209738800001
J	Rizzini, L; Favory, JJ; Cloix, C; Faggionato, D; O'Hara, A; Kaiserli, E; Baumeister, R; Schafer, E; Nagy, F; Jenkins, GI; Ulm, R				Rizzini, Luca; Favory, Jean-Jacques; Cloix, Catherine; Faggionato, Davide; O'Hara, Andrew; Kaiserli, Eirini; Baumeister, Ralf; Schaefer, Eberhard; Nagy, Ferenc; Jenkins, Gareth I.; Ulm, Roman			Perception of UV-B by the Arabidopsis UVR8 Protein	SCIENCE			English	Article							CHROMOSOME CONDENSATION; SIGNAL-TRANSDUCTION; RADIATION; LIGHT; PHOTOMORPHOGENESIS; COMPLEMENTATION; TRANSCRIPTION; ACCUMULATION; PROTECTION; REGULATOR	To optimize their growth and survival, plants perceive and respond to ultraviolet-B ( UV-B) radiation. However, neither the molecular identity of the UV-B photoreceptor nor the photoperception mechanism is known. Here we show that dimers of the UVR8 protein perceive UV-B, probably by a tryptophan-based mechanism. Absorption of UV-B induces instant monomerization of the photoreceptor and interaction with COP1, the central regulator of light signaling. Thereby this signaling cascade controlled by UVR8 mediates UV-B photomorphogenic responses securing plant acclimation and thus promotes survival in sunlight.	[Rizzini, Luca; Favory, Jean-Jacques; Faggionato, Davide; Baumeister, Ralf; Schaefer, Eberhard; Ulm, Roman] Univ Freiburg, Fac Biol, Inst Biol 2, D-79104 Freiburg, Germany; [Cloix, Catherine; O'Hara, Andrew; Kaiserli, Eirini; Jenkins, Gareth I.] Univ Glasgow, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland; [Faggionato, Davide; Baumeister, Ralf] Univ Freiburg, Fac Med, ZBMZ, D-79104 Freiburg, Germany; [Baumeister, Ralf; Schaefer, Eberhard; Ulm, Roman] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Nagy, Ferenc] Biol Res Ctr, Inst Plant Biol, H-6726 Szeged, Hungary; [Nagy, Ferenc] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland; [Ulm, Roman] Univ Geneva, Dept Bot & Plant Biol, CH-1211 Geneva 4, Switzerland	University of Freiburg; University of Glasgow; University of Freiburg; University of Freiburg; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Edinburgh; University of Geneva	Ulm, R (corresponding author), Univ Freiburg, Fac Biol, Inst Biol 2, D-79104 Freiburg, Germany.	roman.ulm@unige.ch	Nagy, Ferenc/D-3532-2015; Jenkins, Gareth I/B-4785-2010; Rizzini, Luca/AAV-4799-2020	Nagy, Ferenc/0000-0002-6157-9269; Rizzini, Luca/0000-0001-6950-0167; Faggionato, Davide/0000-0003-1999-4706; Cloix, Catherine/0000-0001-5666-7558; Faggionato, Davide/0000-0003-0877-5479; KAISERLI, EIRINI/0000-0003-1517-4591	UK Biotechnology and Biological Sciences Research Council; Leverhulme Trust; Scottish Universities Life Science Alliance and the Hungarian Scientific Research Fund [OTKA-81399]; Excellence Initiative of the German Federal and State Governments [EXC 294]; Deutsche Forschungsgemeinschaft [UL341/1-1];  [Sonderforschungsbereich (SFB) 592];  [SFB 746]; Biotechnology and Biological Sciences Research Council [BB/F014961/1] Funding Source: researchfish; BBSRC [BB/F014961/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Trust(Leverhulme Trust); Scottish Universities Life Science Alliance and the Hungarian Scientific Research Fund; Excellence Initiative of the German Federal and State Governments; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ; ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank L.-O. Essen, J. Paszkowski, and T. Kunkel for helpful comments and advice, and P. King for editing the manuscript. This research was supported by grants from the UK Biotechnology and Biological Sciences Research Council and the Leverhulme Trust to G. I. J.; the Scottish Universities Life Science Alliance and the Hungarian Scientific Research Fund (OTKA-81399) to F.N.; the Sonderforschungsbereich (SFB) 592 to R. B.; the Excellence Initiative of the German Federal and State Governments (EXC 294) and the SFB 746 to R. B., E. S., and R. U.; and the Emmy Noether Programme of the Deutsche Forschungsgemeinschaft (grant UL341/1-1) to R. U.	Brown BA, 2005, P NATL ACAD SCI USA, V102, P18225, DOI 10.1073/pnas.0507187102; Brown BA, 2009, PHOTOCHEM PHOTOBIOL, V85, P1147, DOI 10.1111/j.1751-1097.2009.00579.x; CREED D, 1984, PHOTOCHEM PHOTOBIOL, V39, P537; Favory JJ, 2009, EMBO J, V28, P591, DOI 10.1038/emboj.2009.4; FLEISCHMANN M, 1991, MOL GEN GENET, V227, P417, DOI 10.1007/BF00273932; Fritsche E, 2007, P NATL ACAD SCI USA, V104, P8851, DOI 10.1073/pnas.0701764104; Frohnmeyer H, 2003, PLANT PHYSIOL, V133, P1420, DOI 10.1104/pp.103.030049; Hiltbrunner A, 2005, CURR BIOL, V15, P2125, DOI 10.1016/j.cub.2005.10.042; Jenkins GI, 2009, ANNU REV PLANT BIOL, V60, P407, DOI 10.1146/annurev.arplant.59.032607.092953; Kaiserli E, 2007, PLANT CELL, V19, P2662, DOI 10.1105/tpc.107.053330; Kami C, 2010, CURR TOP DEV BIOL, V91, P29, DOI 10.1016/S0070-2153(10)91002-8; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kliebenstein DJ, 2002, PLANT PHYSIOL, V130, P234, DOI 10.1104/pp.005041; Liu HT, 2008, SCIENCE, V322, P1535, DOI 10.1126/science.1163927; Oravecz A, 2006, PLANT CELL, V18, P1975, DOI 10.1105/tpc.105.040097; Paul ND, 2003, TRENDS ECOL EVOL, V18, P48, DOI 10.1016/S0169-5347(02)00014-9; Renault L, 1998, NATURE, V392, P97, DOI 10.1038/32204; Rozema J, 1997, TRENDS ECOL EVOL, V12, P22, DOI 10.1016/S0169-5347(96)10062-8; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; Tong HY, 2008, P NATL ACAD SCI USA, V105, P21039, DOI 10.1073/pnas.0809942106; Ulm R, 2005, CURR OPIN PLANT BIOL, V8, P477, DOI 10.1016/j.pbi.2005.07.004; Ulm R, 2004, P NATL ACAD SCI USA, V101, P1397, DOI 10.1073/pnas.0308044100; Wargent JJ, 2009, NEW PHYTOL, V183, P315, DOI 10.1111/j.1469-8137.2009.02855.x; Yi CL, 2005, TRENDS CELL BIOL, V15, P618, DOI 10.1016/j.tcb.2005.09.007	24	736	804	21	375	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2011	332	6025					103	106		10.1126/science.1200660	http://dx.doi.org/10.1126/science.1200660			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21454788				2022-12-28	WOS:000289000000047
J	Sleeman, JP; Thiery, JP				Sleeman, Jonathan P.; Thiery, Jean Paul			SnapShot: The Epithelial-Mesenchymal Transition	CELL			English	Editorial Material							PROGRESSION; CANCER		[Thiery, Jean Paul] Biopolis ASTAR, IMCB, Singapore 138673, Singapore; [Thiery, Jean Paul] Biopolis ASTAR, Expt Therapeut Ctr, Singapore 138673, Singapore; [Thiery, Jean Paul] Canc Sci Inst, Singapore 117456, Singapore; [Sleeman, Jonathan P.] Heidelberg Univ, Med Fac Mannheim, D-68167 Mannheim, Germany; [Sleeman, Jonathan P.] Karlsruhe Inst Technol, D-76021 Karlsruhe, Germany	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Experimental Drug Development Centre (EDDC); Experimental Therapeutics Centre; Ruprecht Karls University Heidelberg; Helmholtz Association; Karlsruhe Institute of Technology	Sleeman, JP (corresponding author), Biopolis ASTAR, IMCB, Singapore 138673, Singapore.		Sleeman, Jonathan P/H-2515-2013; Thiery, Jean Paul/M-9387-2019; Thiery, Jean Paul/H-1550-2011	Sleeman, Jonathan P/0000-0003-1718-7687; Thiery, Jean Paul/0000-0003-0478-5020				Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hidalgo-Carcedo C, 2011, NAT CELL BIOL, V13, P49, DOI 10.1038/ncb2133; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Whipple RA, 2010, CANCER RES, V70, P8127, DOI 10.1158/0008-5472.CAN-09-4613; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0	10	97	102	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2011	145	1							162.e1	10.1016/j.cell.2011.03.029	http://dx.doi.org/10.1016/j.cell.2011.03.029			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458675	Bronze			2022-12-28	WOS:000289053900020
J	Gaston, MA; Zhang, LW; Green-Church, KB; Krzycki, JA				Gaston, Marsha A.; Zhang, Liwen; Green-Church, Kari B.; Krzycki, Joseph A.			The complete biosynthesis of the genetically encoded amino acid pyrrolysine from lysine	NATURE			English	Article							TRANSFER-RNA SYNTHETASE; M METHYL TRANSFER; METHANOSARCINA-BARKERI; CORRINOID PROTEIN; METHYLTRANSFERASES; CODE; RECONSTITUTION; UAG; EXPANSION; ANALOGS	Pyrrolysine, the twenty-second amino acid found to be encoded in the natural genetic code(1-4), is necessary for all of the known pathways by which methane is formed from methylamines(5,6). Pyrrolysine comprises a methylated pyrroline carboxylate in amide linkage to the e-amino group of L-lysine(2,7,8). In certain Archaea, three methyltransferases initiate methanogenesis from the various methylamines(9-11), and these enzymes are encoded by genes with an in-frame amber codon(12,13) that is translated as pyrrolysine(2,7,8). Escherichia coli that has been transformed with the pylTSBCD genes from methanogenic Archaea can incorporate endogenously biosynthesized pyrrolysine into proteins(14). The decoding of UAG as pyrrolysine requires pylT(1,6), which produces tRNA(Pyl) (also called tRNA(CUA)), and pylS(1), which encodes a pyrrolysyl-tRNA synthetase(4,15,16). The pylB, pylC and pylD genes(1) are each required for tRNA-independent pyrrolysine synthesis(14). Pyrrolysine is the last remaining genetically encoded amino acid with an unknown biosynthetic pathway. Here we provide genetic and mass spectrometric evidence for a pylBCD-dependent pathway in which pyrrolysine arises from two lysines. We show that a newly uncovered UAG-encoded amino acid, desmethylpyrrolysine, is made from lysine and exogenous D-ornithine in a pylC-dependent process followed by a pylD-dependent process, but it is not further converted to pyrrolysine. These results indicate that the radical S-adenosyl-L-methionine (SAM) protein PylB mediates a lysine mutase reaction that produces 3-methylornithine, which is then ligated to a second molecule of lysine by PylC before oxidation by PylD results in pyrrolysine. The discovery of lysine as the sole precursor to pyrrolysine will further inform discussions of the evolution of the genetic code and amino acid biosynthetic pathways. Furthermore, intermediates of the pathway may provide new avenues by which the pyl system can be exploited to produce recombinant proteins with useful modified residues.	[Gaston, Marsha A.; Krzycki, Joseph A.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Zhang, Liwen; Green-Church, Kari B.] Ohio State Univ, Mass Spectrometry & Prote Facil, CCIC, Columbus, OH 43210 USA; [Krzycki, Joseph A.] Ohio State Univ, Biochem Program, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Krzycki, JA (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.	krzycki.1@osu.edu	Zhang, Liwen/P-1111-2016; Green, Kari B/H-3541-2011		National Institutes of Health; US Department of Energy; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institutes of Health to K.B.G.-C. and by grants from the US Department of Energy and the National Institutes of Health to J.A.K. The authors are grateful to D. Longstaff for preparing the tagged mtmB1 version of pDLBAD.	Ambrogelly A, 2007, NAT CHEM BIOL, V3, P29, DOI 10.1038/nchembio847; Atkins JF, 2002, SCIENCE, V296, P1409, DOI 10.1126/science.1073339; Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; Blight SK, 2004, NATURE, V431, P333, DOI 10.1038/nature02895; Burke SA, 1997, J BIOL CHEM, V272, P16570, DOI 10.1074/jbc.272.26.16570; Burke SA, 1998, J BACTERIOL, V180, P3432, DOI 10.1128/JB.180.13.3432-3440.1998; Chen PR, 2009, ANGEW CHEM INT EDIT, V48, P4052, DOI 10.1002/anie.200900683; Fekner T, 2009, ANGEW CHEM INT EDIT, V48, P1633, DOI 10.1002/anie.200805420; Ferguson DJ, 1997, J BACTERIOL, V179, P846, DOI 10.1128/jb.179.3.846-852.1997; Ferguson DJ, 2000, J BIOL CHEM, V275, P29053, DOI 10.1074/jbc.M910218199; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Hao B, 2004, CHEM BIOL, V11, P1317, DOI 10.1016/j.chembiol.2004.07.011; Hao B, 2002, SCIENCE, V296, P1462, DOI 10.1126/science.1069556; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; Krzycki JA, 2004, CURR OPIN CHEM BIOL, V8, P484, DOI 10.1016/j.cbpa.2004.08.012; Krzycki JA, 2005, CURR OPIN MICROBIOL, V8, P706, DOI 10.1016/j.mib.2005.10.009; Li WT, 2009, J MOL BIOL, V385, P1156, DOI 10.1016/j.jmb.2008.11.032; Longstaff DG, 2007, P NATL ACAD SCI USA, V104, P1021, DOI 10.1073/pnas.0610294104; Mahapatra A, 2006, MOL MICROBIOL, V59, P56, DOI 10.1111/j.1365-2958.2005.04927.x; Namy O, 2007, FEBS LETT, V581, P5282, DOI 10.1016/j.febslet.2007.10.022; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Paul L, 2000, J BACTERIOL, V182, P2520, DOI 10.1128/JB.182.9.2520-2529.2000; Polycarpo C, 2004, P NATL ACAD SCI USA, V101, P12450, DOI 10.1073/pnas.0405362101; Polycarpo CR, 2006, FEBS LETT, V580, P6695, DOI 10.1016/j.febslet.2006.11.028; Rother M, 2010, ARCHAEA, V2010, DOI 10.1155/2010/453642; Soares JA, 2005, J BIOL CHEM, V280, P36962, DOI 10.1074/jbc.M506402200; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Wong JTF, 2005, BIOESSAYS, V27, P416, DOI 10.1002/bies.20208; Xu H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-133; Yanagisawa T, 2008, CHEM BIOL, V15, P1187, DOI 10.1016/j.chembiol.2008.10.004	30	82	92	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 31	2011	471	7340					647	U131		10.1038/nature09918	http://dx.doi.org/10.1038/nature09918			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21455182	Green Accepted			2022-12-28	WOS:000288951200045
J	Treadway, K; Chatterjee, N				Treadway, Katharine; Chatterjee, Neal			BECOMING A PHYSICIAN Into the Water - The Clinical Clerkships	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MEDICAL-EDUCATION		[Treadway, Katharine] Massachusetts Gen Hosp, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Treadway, K (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.							Coulehan J, 2001, ACAD MED, V76, P598, DOI 10.1097/00001888-200106000-00008; FOX RC, 2006, TRAINING CARING COMP; HAFFERTY FW, 1994, ACAD MED, V69, P861, DOI 10.1097/00001888-199411000-00001; Newton BW, 2008, ACAD MED, V83, P244, DOI 10.1097/ACM.0b013e3181637837; Wallace David Foster, 2009, THIS IS WATER SOME T	5	33	33	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2011	364	13					1190	1193		10.1056/NEJMp1100674	http://dx.doi.org/10.1056/NEJMp1100674			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	742NO	21449782				2022-12-28	WOS:000288951300003
J	Hocking, MD; Reynolds, JD				Hocking, Morgan D.; Reynolds, John D.			Impacts of Salmon on Riparian Plant Diversity	SCIENCE			English	Article							PACIFIC SALMON; MYCORRHIZAL FUNGI; FRESH-WATER; NITROGEN; NUTRIENT; FORESTS; PRODUCTIVITY; ECOSYSTEMS; ABUNDANCE; DYNAMICS	The study of natural gradients in nutrient subsidies between ecosystems allows for predictions of how changes in one system can affect biodiversity in another. We performed a large-scale empirical test of the role of Pacific salmon (Oncorhynchus spp.) in structuring riparian plant communities. A comparison of 50 watersheds in the remote Great Bear Rainforest of British Columbia's central coast in Canada shows that salmon influence nutrient loading to plants, shifting plant communities toward nutrient-rich species, which in turn decreases plant diversity. These effects are mediated by interactions between salmon density and the physical characteristics of watersheds. Predicting how salmon affect terrestrial ecosystems is central to conservation plans that aim to better integrate ecosystem values into resource management.	[Hocking, Morgan D.; Reynolds, John D.] Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Hocking, MD (corresponding author), Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	mhocking@sfu.ca	Reynolds, John D/L-6345-2015	Reynolds, John D/0000-0002-0459-0074	Simon Fraser University (SFU); Natural Science and Engineering Research Council of Canada (NSERC); B.C. Leading Edge Endowment Fund; Pacific Salmon Foundation; B.C. Pacific Salmon Forum; Mountain Equipment Co-op	Simon Fraser University (SFU); Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); B.C. Leading Edge Endowment Fund; Pacific Salmon Foundation; B.C. Pacific Salmon Forum; Mountain Equipment Co-op	Supported by the Tom Buell Endowment Fund at Simon Fraser University (SFU), a Natural Science and Engineering Research Council of Canada (NSERC) postdoctoral fellowship (M. D. H.), NSERC Discovery and Accelerator grants (J.D.R.), the B.C. Leading Edge Endowment Fund, the Pacific Salmon Foundation, the B.C. Pacific Salmon Forum, and Mountain Equipment Co-op. We thank C. Aries for plant surveys; D. Braun, A. Cooper, E. Darling, N. Dulvy, R. Field, J. Harding, J. Linton, M. Stubbs, W. Palen, J. Verspoor, and the Earth<INF>2</INF>Ocean Research Group at SFU for discussions and analytical support; A. Albright, J. Barlow, J. Beaudin, J. Gordon-Walker, I. Jansma, E. Nelson, M. Spoljaric, J. Wilson, and the Raincoast Conservation Foundation for field support; R. Carpenter, M. Reid, and others at the Heiltsuk Integrated Resource Management Department; L. Jorgenson from Qqs Projects Society in Bella Bella; and the Heiltsuk Nation for research partnerships in their traditional territory.	ALABACK PB, 1982, ECOLOGY, V63, P1932, DOI 10.2307/1940131; Bartz KK, 2005, ECOSYSTEMS, V8, P529, DOI 10.1007/s10021-005-0064-z; Bilby RE, 1996, CAN J FISH AQUAT SCI, V53, P164, DOI 10.1139/cjfas-53-1-164; Bilby RE, 2001, FISHERIES, V26, P6, DOI 10.1577/1548-8446(2001)026<0006:PEOTUO>2.0.CO;2; Craine JM, 2009, NEW PHYTOL, V183, P980, DOI 10.1111/j.1469-8137.2009.02917.x; Croll DA, 2005, SCIENCE, V307, P1959, DOI 10.1126/science.1108485; Darimont CT, 2010, CONSERV LETT, V3, P379, DOI 10.1111/j.1755-263X.2010.00145.x; Darimont Chris T., 2008, BMC Ecology, V8, P14, DOI 10.1186/1472-6785-8-14; DFO, 2005, FISH OC CAN; Diez JM, 2007, ECOLOGY, V88, P3144, DOI 10.1890/07-0047.1; Gende SM, 2002, BIOSCIENCE, V52, P917, DOI 10.1641/0006-3568(2002)052[0917:PSIAAT]2.0.CO;2; Helfield JM, 2002, OECOLOGIA, V133, P573, DOI 10.1007/s00442-002-1070-x; Hobbie EA, 2008, ECOSYSTEMS, V11, P815, DOI 10.1007/s10021-008-9159-7; Hocking MD, 2009, OIKOS, V118, P1307, DOI 10.1111/j.1600-0706.2009.17302.x; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Janetski DJ, 2009, OECOLOGIA, V159, P583, DOI 10.1007/s00442-008-1249-x; Klinka K., 1989, INDICATOR PLANTS COA; Kranabetter JM, 2010, ECOSYSTEMS, V13, P108, DOI 10.1007/s10021-009-9304-y; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Marczak LB, 2007, ECOLOGY, V88, P140, DOI 10.1890/0012-9658(2007)88[140:MTLHAP]2.0.CO;2; Maron JL, 2006, ECOL MONOGR, V76, P3, DOI 10.1890/05-0496; Moore JW, 2007, ECOLOGY, V88, P1278, DOI 10.1890/06-0782; Moore JW, 2004, CAN J FISH AQUAT SCI, V61, P1582, DOI [10.1139/f04-103, 10.1139/F04-103]; Naiman RJ, 2002, ECOSYSTEMS, V5, P399, DOI 10.1007/s10021-001-0083-3; Pinay G, 2003, ECOSYSTEMS, V6, P336, DOI 10.1007/s10021-002-0169-6; POJAR J, 1987, FOREST ECOL MANAG, V22, P119, DOI 10.1016/0378-1127(87)90100-9; Polis GA, 1996, AM NAT, V147, P396, DOI 10.1086/285858; Price MHH, 2008, CAN J FISH AQUAT SCI, V65, P2712, DOI 10.1139/F08-174; Reimchen TE, 2000, CAN J ZOOL, V78, P448, DOI 10.1139/cjz-78-3-448; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Tiegs SD, 2008, ECOL APPL, V18, P4, DOI 10.1890/07-0655.1; Verspoor JJ, 2010, ECOSYSTEMS, V13, P1020, DOI 10.1007/s10021-010-9371-0; Wilkinson CE, 2005, OIKOS, V108, P85, DOI 10.1111/j.0030-1299.2005.13277.x; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zuur Alain F., 2009, P1	35	134	139	4	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2011	331	6024					1609	1612		10.1126/science.1201079	http://dx.doi.org/10.1126/science.1201079			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21442794				2022-12-28	WOS:000288754500057
J	Chabner, BA				Chabner, Bruce A.			Early Accelerated Approval for Highly Targeted Cancer Drugs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INHIBITION		Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Chabner, BA (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.							Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Kwak EL, 2011, NEW ENGL J MED, V364, P588; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; McClellan M, 2011, NAT REV DRUG DISCOV, V10, P79, DOI 10.1038/nrd3360; Miller FG, 2011, NEW ENGL J MED, V364, P476, DOI 10.1056/NEJMsb1011301; Sequist, 2008, J CLIN ONCOL, V26, P3472, DOI 10.1200/JCO.2008.18.4747; Sequist LV, 2008, J CLIN ONCOL, V26, P2442, DOI 10.1200/JCO.2007.14.8494	7	64	65	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2011	364	12					1087	1089		10.1056/NEJMp1100548	http://dx.doi.org/10.1056/NEJMp1100548			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	739FY	21428763				2022-12-28	WOS:000288701100002
J	Appleby, J				Appleby, John			Databriefing How satisfied are we with the NHS?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund Inst, London W1G 0AN, England		Appleby, J (corresponding author), Kings Fund Inst, London W1G 0AN, England.	j.appleby@kingsfund.org.uk						Appleby J, 2010, BRIT SOCIAL ATTITUDE; *IPS MOR, 2011, ISS IND TRENDS 1997; LAWSON N, 1992, VIEW NO 11 MEMOIRS T, P11; *NATCEN, 2011, BRIT SOC ATT SURV	4	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 21	2011	342								d1836	10.1136/bmj.d1836	http://dx.doi.org/10.1136/bmj.d1836			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	742ME	21427029				2022-12-28	WOS:000288947400003
J	Brown, NJ; Newell, CA; Stanley, S; Chen, JE; Perrin, AJ; Kajala, K; Hibberd, JM				Brown, Naomi J.; Newell, Christine A.; Stanley, Susan; Chen, Jit E.; Perrin, Abigail J.; Kajala, Kaisa; Hibberd, Julian M.			Independent and Parallel Recruitment of Preexisting Mechanisms Underlying C-4 Photosynthesis	SCIENCE			English	Article							GENE-EXPRESSION; PHOSPHOENOLPYRUVATE CARBOXYLASE; MAIZE; FLAVERIA; PLANT; MESOPHYLL; EVOLUTION; PROMOTER; RICE; GRASSES	C-4 photosynthesis allows increased photosynthetic efficiency because carbon dioxide (CO2) is concentrated around the key enzyme RuBisCO. Leaves of C-4 plants exhibit modified biochemistry, cell biology, and leaf development, but despite this complexity, C-4 photosynthesis has evolved independently in at least 45 lineages of plants. We found that two independent lineages of C-4 plant, whose last common ancestor predates the divergence of monocotyledons and dicotyledons about 180 million years ago, show conserved mechanisms controlling the expression of genes important for release of CO2 around RuBisCO in bundle sheath (BS) cells. Orthologous genes from monocotyledonous and dicotyledonous C-3 species also contained conserved regulatory elements that conferred BS specificity when placed into C-4 species. We conclude that these conserved functional genetic elements likely facilitated the repeated evolution of C-4 photosynthesis.	[Brown, Naomi J.; Newell, Christine A.; Stanley, Susan; Chen, Jit E.; Perrin, Abigail J.; Kajala, Kaisa; Hibberd, Julian M.] Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England	University of Cambridge	Hibberd, JM (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England.	julian.hibberd@plantsci.cam.ac.uk	Kajala, Kaisa/E-8345-2011	Kajala, Kaisa/0000-0001-6483-7473; Perrin, Abigail/0000-0001-6682-4297; Chen, Jit Ern/0000-0003-4779-7275	Leverhulme Trust; BBSRC; Biotechnology and Biological Sciences Research Council [P19982, BB/I002243/1] Funding Source: researchfish; BBSRC [BB/I002243/1] Funding Source: UKRI	Leverhulme Trust(Leverhulme Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the Leverhulme Trust and BBSRC for funding; C. Weil for B73; and M. Patel, J. Berry, S. Brockington, and D. Bradley for advice. N.J.B., J. E. C., and K. K. generated constructs; N.J.B., S. S., J. E. C., and A. J. P. performed microprojectile bombardment; C.A.N. and N.J.B. generated and analyzed stable transformants; N.J.B. and S. S. performed hybridization in situ; and N.J.B. and J. M. H. designed the experiments, analyzed the data, and wrote the paper. The complete study was supervised by J. M. H. All authors discussed the results and commented on the manuscript.	Akyildiz M, 2007, PLANT CELL, V19, P3391, DOI 10.1105/tpc.107.053322; BANSAL KC, 1992, P NATL ACAD SCI USA, V89, P3654, DOI 10.1073/pnas.89.8.3654; BOWES G, 1971, BIOCHEM BIOPH RES CO, V45, P716, DOI 10.1016/0006-291X(71)90475-X; Brown NJ, 2010, PLANT J, V61, P122, DOI 10.1111/j.1365-313X.2009.04040.x; Brown NJ, 2005, TRENDS PLANT SCI, V10, P215, DOI 10.1016/j.tplants.2005.03.003; Christin PA, 2007, CURR BIOL, V17, P1241, DOI 10.1016/j.cub.2007.06.036; HATCH MD, 1987, BIOCHIM BIOPHYS ACTA, V895, P81, DOI 10.1016/S0304-4173(87)80009-5; Hibberd JM, 2002, NATURE, V415, P451, DOI 10.1038/415451a; Hibberd JM, 2008, CURR OPIN PLANT BIOL, V11, P228, DOI 10.1016/j.pbi.2007.11.002; Hibberd JM, 2010, ANNU REV PLANT BIOL, V61, P181, DOI 10.1146/annurev-arplant-042809-112238; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Majeran W, 2009, TRENDS PLANT SCI, V14, P100, DOI 10.1016/j.tplants.2008.11.006; Matsuoka M, 2001, ANNU REV PLANT PHYS, V52, P297, DOI 10.1146/annurev.arplant.52.1.297; MATSUOKA M, 1991, MOL GEN GENET, V228, P143, DOI 10.1007/BF00282459; Nomura M, 2005, PLANT CELL PHYSIOL, V46, P754, DOI 10.1093/pcp/pci078; Nomura M, 2000, PLANT MOL BIOL, V44, P99, DOI 10.1023/A:1006461812053; Patel M, 2006, J BIOL CHEM, V281, P25485, DOI 10.1074/jbc.M604162200; PRENDERGAST HDV, 1987, AUST J PLANT PHYSIOL, V14, P403, DOI 10.1071/PP9870403; Sage RF, 2004, NEW PHYTOL, V161, P341, DOI 10.1111/j.1469-8137.2004.00974.x; Sawers RJH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-12; Sheen J, 1999, ANNU REV PLANT PHYS, V50, P187, DOI 10.1146/annurev.arplant.50.1.187; Sinha NR, 1996, AM J BOT, V83, P1458, DOI 10.2307/2446101; Stockhaus J, 1997, PLANT CELL, V9, P479; Voznesenskaya EV, 2001, NATURE, V414, P543, DOI 10.1038/35107073; Westhoff P, 2004, ANN BOT-LONDON, V93, P13, DOI 10.1093/aob/mch003	25	96	97	2	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2011	331	6023					1436	1439		10.1126/science.1201248	http://dx.doi.org/10.1126/science.1201248			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21415351				2022-12-28	WOS:000288504000041
J	Im, SH; Taghert, PH				Im, Seol Hee; Taghert, Paul H.			A CRY to Rise	SCIENCE			English	Editorial Material							CIRCADIAN CLOCK; DROSOPHILA; CRYPTOCHROMES; AROUSAL; NEURONS; SLEEP; CELLS		[Im, Seol Hee; Taghert, Paul H.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Im, SH (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	taghertp@pcg.wustl.edu		Im, Seol Hee/0000-0002-0777-3466	NIMH NIH HHS [R01 MH067122] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067122] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Chung BY, 2009, CURR BIOL, V19, P386, DOI 10.1016/j.cub.2009.01.040; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Fogle KJ, 2011, SCIENCE, V331, P1409, DOI 10.1126/science.1199702; Gegear RJ, 2010, NATURE, V463, P804, DOI 10.1038/nature08719; Hirsh J, 2010, CURR BIOL, V20, P209, DOI 10.1016/j.cub.2009.11.037; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; Nitabach MN, 2008, CURR BIOL, V18, pR84, DOI 10.1016/j.cub.2007.11.061; Peschel N, 2009, CURR BIOL, V19, P241, DOI 10.1016/j.cub.2008.12.042; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Van Gelder RN, 2003, SCIENCE, V299, P222, DOI 10.1126/science.1079536; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Yoshii T, 2009, PLOS BIOL, V7, P813, DOI 10.1371/journal.pbio.1000086; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011	16	1	1	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2011	331	6023					1394	1395		10.1126/science.1204293	http://dx.doi.org/10.1126/science.1204293			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21415342				2022-12-28	WOS:000288504000026
J	Yosef, N; Regev, A				Yosef, Nir; Regev, Aviv			Impulse Control: Temporal Dynamics in Gene Transcription	CELL			English	Article							INCOHERENT FEEDFORWARD LOOP; NETWORK MOTIFS; SACCHAROMYCES-CEREVISIAE; ENVIRONMENTAL-CHANGES; REGULATORY NETWORKS; ESCHERICHIA-COLI; EXPRESSION RESPONSES; METABOLIC NETWORK; EUKARYOTIC GENOME; SYSTEMS BIOLOGY	Regulatory circuits controlling gene expression constantly rewire to adapt to environmental stimuli, differentiation cues, and disease. We review our current understanding of the temporal dynamics of gene expression in eukaryotes and prokaryotes and the molecular mechanisms that shape them. We delineate several prototypical temporal patterns, including "impulse" (or single-pulse) patterns in response to transient environmental stimuli, sustained (or state-transitioning) patterns in response to developmental cues, and oscillating patterns. We focus on impulse responses and their higher-order temporal organization in regulons and cascades and describe how core protein circuits and cis-regulatory sequences in promoters integrate with chromatin architecture to generate these responses.	[Yosef, Nir; Regev, Aviv] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Yosef, Nir] Harvard Univ, Sch Med, Ctr Neurol Dis, Brigham & Womens Hosp, Boston, MA 02115 USA; [Regev, Aviv] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Regev, A (corresponding author), Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA.	aregev@broad.mit.edu			OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003958] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIH HHS [DP1 OD003958-03, DP1 OD003958] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Amit I, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100195; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Bolouri H, 2003, P NATL ACAD SCI USA, V100, P9371, DOI 10.1073/pnas.1533293100; Braun E, 2004, PHYS BIOL, V1, P67, DOI 10.1088/1478-3967/1/2/003; Bruce AW, 2009, GENOME RES, V19, P994, DOI 10.1101/gr.089086.108; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Camas FM, 2006, P NATL ACAD SCI USA, V103, P12718, DOI 10.1073/pnas.0602119103; Cantone I, 2009, CELL, V137, P172, DOI 10.1016/j.cell.2009.01.055; Capaldi AP, 2008, NAT GENET, V40, P1300, DOI 10.1038/ng.235; Chechik G, 2008, NAT BIOTECHNOL, V26, P1251, DOI 10.1038/nbt.1499; Chechik G, 2009, J COMPUT BIOL, V16, P279, DOI 10.1089/cmb.2008.13TT; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Davidson EH, 2009, CURR OPIN GENET DEV, V19, P535, DOI 10.1016/j.gde.2009.10.007; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Eng KH, 2010, GENETICS, V184, P587, DOI 10.1534/genetics.109.107268; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Friedman N, 2005, PLOS BIOL, V3, P1261, DOI 10.1371/journal.pbio.0030238; Friedrichsen S, 2006, ENDOCRINOLOGY, V147, P773, DOI 10.1210/en.2005-0967; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Goentoro L, 2009, MOL CELL, V36, P894, DOI 10.1016/j.molcel.2009.11.018; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Ihmels J, 2004, NAT BIOTECHNOL, V22, P86, DOI 10.1038/nbt918; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Ishihara S, 2005, GENES CELLS, V10, P1025, DOI 10.1111/j.1365-2443.2005.00897.x; Kalir S, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100010; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kaplan S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.43; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Kern D, 1996, J CLIN MICROBIOL, V34, P3196, DOI 10.1128/JCM.34.12.3196-3202.1996; Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kittisopikul M, 2010, P NATL ACAD SCI USA, V107, P13300, DOI 10.1073/pnas.1003975107; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Li J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r244; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Loewer A, 2010, CELL, V142, P89, DOI 10.1016/j.cell.2010.05.031; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Ma HW, 2004, NUCLEIC ACIDS RES, V32, P6643, DOI 10.1093/nar/gkh1009; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; Macia J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-84; Mangan S, 2006, J MOL BIOL, V356, P1073, DOI 10.1016/j.jmb.2005.12.003; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Mitchell A, 2009, NATURE, V460, P220, DOI 10.1038/nature08112; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murray JI, 2004, MOL BIOL CELL, V15, P2361, DOI 10.1091/mbc.E03-11-0799; Muzzey D, 2009, ANNU REV CELL DEV BI, V25, P301, DOI 10.1146/annurev.cellbio.042308.113408; Nachman I, 2007, CELL, V131, P544, DOI 10.1016/j.cell.2007.09.044; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Oliveri P, 2008, P NATL ACAD SCI USA, V105, P5955, DOI 10.1073/pnas.0711220105; Paszek P, 2010, P NATL ACAD SCI USA, V107, P11644, DOI 10.1073/pnas.0913798107; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Rappaport N, 2005, THEOR BIOL MED MODEL, V2, DOI 10.1186/1742-4682-2-22; Raveh-Sadka T, 2009, GENOME RES, V19, P1480, DOI 10.1101/gr.088260.108; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shalem O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.59; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065; Simon I, 2005, NAT BIOTECHNOL, V23, P1503, DOI 10.1038/nbt1164; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Springer M, 2003, PLOS BIOL, V1, P261, DOI 10.1371/journal.pbio.0000028; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Szita N, 2010, CURR OPIN BIOTECH, V21, P517, DOI 10.1016/j.copbio.2010.08.002; Tagkopoulos I, 2008, SCIENCE, V320, P1313, DOI 10.1126/science.1154456; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Walczak AM, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.041905; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509; Yuh CH, 2001, DEVELOPMENT, V128, P617; Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	100	173	177	0	53	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 18	2011	144	6					886	896		10.1016/j.cell.2011.02.015	http://dx.doi.org/10.1016/j.cell.2011.02.015			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	737BQ	21414481	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000288543500008
J	Leonhardt, U				Leonhardt, Ulf			To invisibility and beyond	NATURE			English	Editorial Material							CLOAK		Univ St Andrews, St Andrews KY16 9SS, Fife, Scotland	University of St Andrews	Leonhardt, U (corresponding author), Univ St Andrews, St Andrews KY16 9SS, Fife, Scotland.	ulf@st-andrews.ac.uk						Ergin T, 2010, SCIENCE, V328, P337, DOI 10.1126/science.1186351; Leonhardt U, 2010, GEOMETRY LIGHT SCI I; Leonhardt U, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/10/247; Leonhardt U, 2006, SCIENCE, V312, P1777, DOI 10.1126/science.1126493; Ma YG, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/3/033016; Maxwell J. C., 1854, CAMBRIDGE DUBLIN MAT, V8, P188; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Schurig D, 2006, SCIENCE, V314, P977, DOI 10.1126/science.1133628; Service RF, 2010, SCIENCE, V330, P1622, DOI 10.1126/science.330.6011.1622	10	15	16	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2011	471	7338					292	293		10.1038/471292a	http://dx.doi.org/10.1038/471292a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	735UE	21412311	Bronze			2022-12-28	WOS:000288444000013
J	Horwitz, LI; Detsky, AS				Horwitz, Leora I.; Detsky, Allan S.			Physician Communication in the 21st Century To Talk or to Text?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Horwitz, Leora I.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Horwitz, Leora I.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Detsky, Allan S.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Yale University; Yale University; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, 600 Univ Ave,Room 249, Toronto, ON M5G 1X5, Canada.	adetsky@mtsinai.on.ca	Horwitz, Leora/ABD-1292-2020; Horwitz, Leora/A-6959-2009	Horwitz, Leora/0000-0003-1800-6040	NIA NIH HHS [K08 AG038336] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K08AG038336] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 2010, ANDR SOARS IPHONE ST; Behara R, 2005, ADV PATIENT SAFETY R, V2, P309; Coiera E, 1998, BRIT MED J, V316, P673, DOI 10.1136/bmj.316.7132.673; Horwitz LI, 2009, ANN EMERG MED, V54, P368, DOI 10.1016/j.annemergmed.2009.01.034; Littlejohn S. W., 2007, THEORIES HUMAN COMMU; Patterson ES, 2008, QUAL SAF HEALTH CARE, V17, P4, DOI 10.1136/qshc.2007.022772; Patterson ES, 2004, INT J QUAL HEALTH C, V16, P125, DOI 10.1093/intqhc/mzh026; Shanker T., 2011, NY TIMES, pA1; Spiegelman J, 2008, JAMA-J AM MED ASSOC, V299, P1179, DOI 10.1001/jama.299.10.1179; US, 2008, US SMS TEXT MESS TOP	10	26	26	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2011	305	11					1128	1129		10.1001/jama.2011.324	http://dx.doi.org/10.1001/jama.2011.324			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	734ZF	21406650				2022-12-28	WOS:000288381900025
J	Iglehart, JK				Iglehart, John K.			Medicaid at a Crossroads	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Cunningham PJ, 2011, STATE VARIATION PRIM; Lambrew JM, 2005, MILBANK Q, V83, P41, DOI 10.1111/j.0887-378X.2005.00335.x; Medicaid and CHIP Payment and Access Commission, REP C MED CHIP; Smith V., 2010, HOPING EC RECOVERY P	4	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 28	2011	364	17					1585	1587		10.1056/NEJMp1103305	http://dx.doi.org/10.1056/NEJMp1103305			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755NW	21470005				2022-12-28	WOS:000289940400001
J	Michard, E; Lima, PT; Borges, F; Silva, AC; Portes, MT; Carvalho, JE; Gilliham, M; Liu, LH; Obermeyer, G; Feijo, JA				Michard, Erwan; Lima, Pedro T.; Borges, Filipe; Silva, Ana Catarina; Portes, Maria Teresa; Carvalho, Joao E.; Gilliham, Matthew; Liu, Lai-Hua; Obermeyer, Gerhard; Feijo, Jose A.			Glutamate Receptor-Like Genes Form Ca2+ Channels in Pollen Tubes and Are Regulated by Pistil D-Serine	SCIENCE			English	Article							D-AMINO ACIDS; ARABIDOPSIS-THALIANA; PLASMA-MEMBRANE; CALCIUM-CHANNELS; ROOT HAIRS; GROWTH; PLANTS; REVEALS; GLR3.3; CELLS	Elevations in cytosolic free calcium concentration ([Ca2+](cyt)) constitute a fundamental signal transduction mechanism in eukaryotic cells, but the molecular identity of Ca2+ channels initiating this signal in plants is still under debate. Here, we show by pharmacology and loss-of-function mutants that in tobacco and Arabidopsis, glutamate receptor-like channels (GLRs) facilitate Ca2+ influx across the plasma membrane, modulate apical [Ca2+] cyt gradient, and consequently affect pollen tube growth and morphogenesis. Additionally, wild-type pollen tubes grown in pistils of knock-out mutants for serine-racemase (SR1) displayed growth defects consistent with a decrease in GLR activity. Our findings reveal a novel plant signaling mechanism between male gametophyte and pistil tissue similar to amino acid-mediated communication commonly observed in animal nervous systems.	[Michard, Erwan; Lima, Pedro T.; Borges, Filipe; Silva, Ana Catarina; Portes, Maria Teresa; Carvalho, Joao E.; Feijo, Jose A.] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal; [Gilliham, Matthew] Univ Adelaide, Waite Res Inst, Glen Osmond, SA 5064, Australia; [Gilliham, Matthew] Univ Adelaide, Sch Agr Food & Wine, Glen Osmond, SA 5064, Australia; [Liu, Lai-Hua] China Agr Univ, Coll Resources & Environm Sci, Key Lab Plant & Soil Interact, Beijing 100193, Peoples R China; [Obermeyer, Gerhard] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Feijo, Jose A.] Univ Lisbon, Fac Ciencias, Dept Biol Vegetal, P-1749016 Lisbon, Portugal	Instituto Gulbenkian de Ciencia; University of Adelaide; University of Adelaide; China Agricultural University; Salzburg University; Universidade de Lisboa	Feijo, JA (corresponding author), Inst Gulbenkian Ciencias, Rua Quinta Grande 6, P-2780156 Oeiras, Portugal.	jfeijo@fc.ul.pt	Obermeyer, Gerhard/G-4061-2013; Gilliham, Matthew/Y-4403-2019; michard, erwan/GXH-1685-2022; Gilliham, Matthew/C-1998-2013; Portes, Maria Teresa/AAC-1353-2019; Carvalho, João E/AAQ-1456-2020; Feijo, Jose A./ADM-0262-2022; Obermeyer, Gerhard/M-5942-2019	Obermeyer, Gerhard/0000-0001-8102-6322; Gilliham, Matthew/0000-0003-0666-3078; Gilliham, Matthew/0000-0003-0666-3078; Portes, Maria Teresa/0000-0001-5668-0605; Carvalho, João E/0000-0002-7770-4351; Feijo, Jose A./0000-0002-1100-5478; Obermeyer, Gerhard/0000-0001-8102-6322; Borges, Filipe/0000-0002-7388-2118; Michard, Erwan/0000-0001-7997-3822	Fundacao para a Ciencia e a Tecnologia [SFRH/BPD 21056/2004]; European Molecular Biology Organization [ASTF 193-2007]; Agropolis fellowships; Centro de Biologia do Desenvolvimento [FCT U664]; FCT [BIA-BCM/108044/2008, QUI/64339/2006]; Austrian Science Fund [P21298]; China National Science Foundation [30771288]; Austrian Science Fund (FWF) [P 21298] Funding Source: researchfish	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Agropolis fellowships; Centro de Biologia do Desenvolvimento; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Austrian Science Fund(Austrian Science Fund (FWF)); China National Science Foundation(National Natural Science Foundation of China (NSFC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	E. M. acknowledges Fundacao para a Ciencia e a Tecnologia (SFRH/BPD 21056/2004), European Molecular Biology Organization (ASTF 193-2007), and Agropolis fellowships. We thank M. Watahiki (University of Hokkaido) for the YC3.1 construct and M. Iwano (Nara Institute of Science and Technology, Japan) for the YC3.6C Arabidopsis line. glr1.2-1 and glr3.7-1 insertion lines were originally characterized by P. Walch-Liu, X. Q. Qu, and Y. Y. Gong in L.-H. L.'s laboratory, in collaboration with M. Tester (University of Adelaide) and B. Forde (University of Lancaster). We thank N. Moreno and P. Almada for imaging support, A. Sommer for protoplast preparation, C. E. Tadokoro for immunofluorescence advice, J. Becker for helpful discussions on the genetic design of the experiments, P. Dias for help in oscillation analysis, and J. B. Thibaud (Institut National de la Recherche Agronomique-Supagro, Montpellier) for other institutional support to E. M. J.A.F.' s laboratory is supported by the Centro de Biologia do Desenvolvimento (FCT U664) and FCT grants BIA-BCM/108044/2008 and QUI/64339/2006. G.O.'s laboratory is supported by Austrian Science Fund grant P21298. L.-H. L. was supported by China National Science Foundation grant 30771288.	Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; BOAVIDA LC, 2011, PLANT PHYSL; Bruckner H, 2003, AMINO ACIDS, V24, P43, DOI 10.1007/s00726-002-0322-8; Davenport R, 2002, ANN BOT-LONDON, V90, P549, DOI 10.1093/aob/mcf228; Demidchik V, 2004, PLANTA, V219, P167, DOI 10.1007/s00425-004-1207-8; Dennison KL, 2000, PLANT PHYSIOL, V124, P1511, DOI 10.1104/pp.124.4.1511; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dubos C, 2003, PLANT J, V35, P800, DOI 10.1046/j.1365-313X.2003.01849.x; Feijo JA, 2001, BIOESSAYS, V23, P86, DOI 10.1002/1521-1878(200101)23:1&lt;86::AID-BIES1011&gt;3.0.CO;2-D; Feijo Jose A., 2010, Journal of Biology (London), V9, P18, DOI 10.1186/jbiol233; Frietsch S, 2007, P NATL ACAD SCI USA, V104, P14531, DOI 10.1073/pnas.0701781104; Fujitani Y, 2006, PHYTOCHEMISTRY, V67, P668, DOI 10.1016/j.phytochem.2006.01.003; Iwano M, 2009, PLANT PHYSIOL, V150, P1322, DOI 10.1104/pp.109.139329; MALHO R, 1995, PLANT CELL, V7, P1173, DOI 10.1105/tpc.7.8.1173; McAinsh MR, 2009, NEW PHYTOL, V181, P275, DOI 10.1111/j.1469-8137.2008.02682.x; Meyerhoff O, 2005, PLANTA, V222, P418, DOI 10.1007/s00425-005-1551-3; Michard E, 2008, SEX PLANT REPROD, V21, P169, DOI 10.1007/s00497-008-0076-x; Michard E, 2009, INT J DEV BIOL, V53, P1609, DOI 10.1387/ijdb.072296em; Miedema H, 2008, NEW PHYTOL, V179, P378, DOI 10.1111/j.1469-8137.2008.02465.x; Monshausen GB, 2008, PLANT PHYSIOL, V147, P1690, DOI 10.1104/pp.108.123638; Moreno N., 2007, Rhythms in plants: phenomenology, mechanisms, and adaptive significance, P39, DOI 10.1007/978-3-540-68071-0_2; Okuda S, 2009, NATURE, V458, P357, DOI 10.1038/nature07882; Palanivelu R, 2003, CELL, V114, P47, DOI 10.1016/S0092-8674(03)00479-3; Peiter E, 2005, NATURE, V434, P404, DOI 10.1038/nature03381; Pierson ES, 1996, DEV BIOL, V174, P160, DOI 10.1006/dbio.1996.0060; Pina C, 2005, PLANT PHYSIOL, V138, P744, DOI 10.1104/pp.104.057935; Prado AM, 2008, MOL PLANT, V1, P703, DOI 10.1093/mp/ssn034; Qi Z, 2006, PLANT PHYSIOL, V142, P963, DOI 10.1104/pp.106.088989; Qu HY, 2007, NEW PHYTOL, V174, P524, DOI 10.1111/j.1469-8137.2007.02069.x; ROBINSON T, 1976, LIFE SCI, V19, P1097, DOI 10.1016/0024-3205(76)90244-7; Roy SJ, 2008, PLANT CELL ENVIRON, V31, P861, DOI 10.1111/j.1365-3040.2008.01801.x; Shang ZL, 2005, PLANT CELL PHYSIOL, V46, P598, DOI 10.1093/pcp/pci063; Stephens NR, 2008, PLANT PHYSIOL, V146, P529, DOI 10.1104/pp.107.108134; Wolosker H, 2008, FEBS J, V275, P3514, DOI 10.1111/j.1742-4658.2008.06515.x; Wu JY, 2010, PLANT J, V63, P1042, DOI 10.1111/j.1365-313X.2010.04301.x	35	282	304	4	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2011	332	6028					434	437		10.1126/science.1201101	http://dx.doi.org/10.1126/science.1201101			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21415319				2022-12-28	WOS:000289784900034
J	Harmer, MP				Harmer, Martin P.			The Phase Behavior of Interfaces	SCIENCE			English	Editorial Material							TRANSITIONS		[Harmer, Martin P.] Ctr Adv Mat & Nanotechnol, Bethlehem, PA 18015 USA; [Harmer, Martin P.] Dept Mat Sci & Engn, Bethlehem, PA 18015 USA		Harmer, MP (corresponding author), Ctr Adv Mat & Nanotechnol, 5 E Packer Ave, Bethlehem, PA 18015 USA.	mph2@lehigh.edu						Baram M, 2011, SCIENCE, V332, P206, DOI 10.1126/science.1201596; Bishop CM, 2006, MAT SCI ENG A-STRUCT, V422, P102, DOI 10.1016/j.msea.2006.01.013; CAHN JW, 1977, J CHEM PHYS, V66, P3667, DOI 10.1063/1.434402; Chua ALS, 2010, NAT MATER, V9, P418, DOI [10.1038/nmat2712, 10.1038/NMAT2712]; Cockayne D, 2009, PHILOS T R SOC A, V367, P3633, DOI 10.1098/rsta.2009.0135; Dillon SJ, 2007, ACTA MATER, V55, P6208, DOI 10.1016/j.actamat.2007.07.029; Harmer MP, 2010, J AM CERAM SOC, V93, P301, DOI 10.1111/j.1551-2916.2009.03545.x; Luo J, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2892631; Luo J, 2007, CRIT REV SOLID STATE, V32, P67, DOI 10.1080/10408430701364388; Tang M, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.024102	10	125	125	3	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					182	183		10.1126/science.1204204	http://dx.doi.org/10.1126/science.1204204			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474743				2022-12-28	WOS:000289251100032
J	He, HL; Liyanarachchi, S; Akagi, K; Nagy, R; Li, JF; Dietrich, RC; Li, W; Sebastian, N; Wen, B; Xin, BZ; Singh, J; Yan, P; Alder, H; Haan, E; Wieczorek, D; Albrecht, B; Puffenberger, E; Wang, H; Westman, JA; Padgett, RA; Symer, DE; de la Chapelle, A				He, Huiling; Liyanarachchi, Sandya; Akagi, Keiko; Nagy, Rebecca; Li, Jingfeng; Dietrich, Rosemary C.; Li, Wei; Sebastian, Nikhil; Wen, Bernard; Xin, Baozhong; Singh, Jarnail; Yan, Pearlly; Alder, Hansjuerg; Haan, Eric; Wieczorek, Dagmar; Albrecht, Beate; Puffenberger, Erik; Wang, Heng; Westman, Judith A.; Padgett, Richard A.; Symer, David E.; de la Chapelle, Albert			Mutations in U4atac snRNA, a Component of the Minor Spliceosome, in the Developmental Disorder MOPD I	SCIENCE			English	Article							PRIMORDIAL DWARFISM; INTRONS; RNA; U4; PROTEIN; VIVO; PCNT	Small nuclear RNAs (snRNAs) are essential factors in messenger RNA splicing. By means of homozygosity mapping and deep sequencing, we show that a gene encoding U4atac snRNA, a component of the minor U12-dependent spliceosome, is mutated in individuals with microcephalic osteodysplastic primordial dwarfism type I (MOPD I), a severe developmental disorder characterized by extreme intrauterine growth retardation and multiple organ abnormalities. Functional assays showed that mutations (30G>A, 51G>A, 55G>A, and 111G>A) associated with MOPD I cause defective U12-dependent splicing. Endogenous U12-dependent but not U2-dependent introns were found to be poorly spliced in MOPD I patient fibroblast cells. The introduction of wild-type U4atac snRNA into MOPD I cells enhanced U12-dependent splicing. These results illustrate the critical role of minor intron splicing in human development.	[He, Huiling; Liyanarachchi, Sandya; Akagi, Keiko; Nagy, Rebecca; Li, Jingfeng; Li, Wei; Sebastian, Nikhil; Wen, Bernard; Yan, Pearlly; Alder, Hansjuerg; Westman, Judith A.; Symer, David E.; de la Chapelle, Albert] Ohio State Univ, Human Canc Genet Program, Columbus, OH 43210 USA; [He, Huiling; Liyanarachchi, Sandya; Akagi, Keiko; Li, Jingfeng; Li, Wei; Sebastian, Nikhil; Wen, Bernard; Yan, Pearlly; Alder, Hansjuerg; Symer, David E.; de la Chapelle, Albert] Ohio State Univ, Sch Biomed Sci, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Nagy, Rebecca; Westman, Judith A.; Symer, David E.] Ohio State Univ, Ctr Comprehens Canc, Dept Internal Med, Columbus, OH 43210 USA; [Dietrich, Rosemary C.; Singh, Jarnail; Padgett, Richard A.] Cleveland Clin, Lerner Res Inst, Dept Mol Genet, Cleveland, OH 44195 USA; [Xin, Baozhong; Wang, Heng] DDC Clin Special Needs Children, Middlefield, OH 44062 USA; [Haan, Eric] SA Pathol Womens & Childrens Hosp, S Australian Clin Genet Serv, Adelaide, SA 5006, Australia; [Haan, Eric] Univ Adelaide, Dept Pediat, Adelaide, SA 5005, Australia; [Wieczorek, Dagmar; Albrecht, Beate] Univ Klinikum Essen, Inst Humangenet, Essen, Germany; [Puffenberger, Erik] Clin Special Children, Strasburg, PA 17579 USA; [Symer, David E.] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Cleveland Clinic Foundation; SA Pathology; University of Adelaide; University of Duisburg Essen; University System of Ohio; Ohio State University	de la Chapelle, A (corresponding author), Ohio State Univ, Human Canc Genet Program, Columbus, OH 43210 USA.	albert.delachapelle@osumc.edu	Yan, Pearlly S/E-4339-2011; Nagy, Rebecca Shrigley/E-4088-2011; Symer, David E./E-4173-2011; Wieczorek, Dagmar/AAU-6008-2021; Westman, Judith/E-4294-2011	Yan, Pearlly S/0000-0003-1965-4920; Wieczorek, Dagmar/0000-0003-2812-6492; Puffenberger, Erik/0000-0002-6388-9148	Ohio Supercomputing Center [PAS0425-2]; Cleveland Foundation [L2009-0078]; NIH [GM093074, GM079527]; National Cancer Institute [P30 CA16058]; OSU Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093074, R01GM079527] Funding Source: NIH RePORTER	Ohio Supercomputing Center; Cleveland Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OSU Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Mehlen and M.-M. Coissieux for the French control sample set, P. Meinecke for information on patients, J. Palatini for sharing equipment and advice, J. Lockman for technical support, and the Microarray Shared Resource and Nucleic Acid Shared Resource of the OSU Comprehensive Cancer Center for genotyping and sequencing. Supported by Ohio Supercomputing Center grant PAS0425-2 for computational resources (K. A. and D. E. S.), Leonard Krieger Fund of the Cleveland Foundation grant L2009-0078 (H. W.), NIH grants GM093074 and GM079527 (R. A. P.), National Cancer Institute grant P30 CA16058 (H. H., S. L., K. A., J. L., R.N., W. L., N.S., B. W., P.Y., H. W., D. E. S., J. A. W., and A.dlC.), and the OSU Comprehensive Cancer Center.	Alioto TS, 2007, NUCLEIC ACIDS RES, V35, pD110, DOI 10.1093/nar/gkl796; Boulisfane N, 2011, HUM MOL GENET, V20, P641, DOI 10.1093/hmg/ddq508; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Hall SL, 1996, SCIENCE, V271, P1716, DOI 10.1126/science.271.5256.1716; Liu S, 2007, SCIENCE, V316, P115, DOI 10.1126/science.1137924; MAJEWSKI F, 1982, AM J MED GENET, V12, P37, DOI 10.1002/ajmg.1320120105; MAJEWSKI F, 1976, MONATSSCHR KINDERH, V124, P499; Matter N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni041; Nottrott S, 1999, EMBO J, V18, P6119, DOI 10.1093/emboj/18.21.6119; Otake LR, 2002, MOL CELL, V9, P439, DOI 10.1016/S1097-2765(02)00441-0; Pessa HKJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013215; Piane M, 2009, AM J MED GENET A, V149A, P2452, DOI 10.1002/ajmg.a.33035; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Shukla GC, 2002, NUCLEIC ACIDS RES, V30, P4650, DOI 10.1093/nar/gkf609; Sigaudy S, 1998, AM J MED GENET, V80, P16, DOI 10.1002/(SICI)1096-8628(19981102)80:1<16::AID-AJMG4>3.3.CO;2-X; Tarn WY, 1996, SCIENCE, V273, P1824, DOI 10.1126/science.273.5283.1824; TAYBI H, 1967, RADIOLOGY, V89, P275, DOI 10.1148/89.2.275; Will CL, 2005, BIOL CHEM, V386, P713, DOI 10.1515/BC.2005.084; Willems M, 2010, J MED GENET, V47, P797, DOI 10.1136/jmg.2009.067298; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	21	155	159	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					238	240		10.1126/science.1200587	http://dx.doi.org/10.1126/science.1200587			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474760	Green Accepted			2022-12-28	WOS:000289251100052
J	Hippen, BE; Thistlethwaite, JR; Ross, LF				Hippen, Benjamin E.; Thistlethwaite, J. Richard, Jr.; Ross, Lainie Friedman			Risk, Prognosis, and Unintended Consequences in Kidney Allocation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LIMITATIONS		[Hippen, Benjamin E.] Carolinas Med Ctr, Charlotte, NC 28203 USA; [Thistlethwaite, J. Richard, Jr.; Ross, Lainie Friedman] Univ Chicago, Dept Surg, Sect Transplantat, Chicago, IL 60637 USA; [Ross, Lainie Friedman] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Ross, Lainie Friedman] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Ross, Lainie Friedman] Univ Chicago, MacLean Ctr Clin Med Eth, Chicago, IL 60637 USA	Carolinas Medical Center; University of Chicago; University of Chicago; University of Chicago; University of Chicago	Hippen, BE (corresponding author), Carolinas Med Ctr, Charlotte, NC 28203 USA.			HIPPEN, BENJAMIN/0000-0003-1827-415X				Organ Procurement and Transplantation Network, CONC KIDN ALL; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Rao PS, 2009, TRANSPLANTATION, V88, P231, DOI 10.1097/TP.0b013e3181ac620b; Wald NJ, 1999, BMJ-BRIT MED J, V319, P1562, DOI 10.1136/bmj.319.7224.1562; Ware JH, 2006, NEW ENGL J MED, V355, P2615, DOI 10.1056/NEJMp068249	5	33	33	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 7	2011	364	14					1285	1287		10.1056/NEJMp1102583	http://dx.doi.org/10.1056/NEJMp1102583			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	745WS	21410392				2022-12-28	WOS:000289202800001
J	Richter, FM				Richter, Frank M.			Isotope fractionation in silicate melts by thermal diffusion	NATURE			English	Letter									Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	University of Chicago	Richter, FM (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60637 USA.	richter@geosci.uchicago.edu			Directorate For Geosciences [0944169] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Huang F, 2010, NATURE, V464, P396, DOI 10.1038/nature08840; Richter FM, 2008, GEOCHIM COSMOCHIM AC, V72, P206, DOI 10.1016/j.gca.2007.10.016; Richter FM, 2009, GEOCHIM COSMOCHIM AC, V73, P4250, DOI 10.1016/j.gca.2009.04.011	3	5	6	4	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 7	2011	472	7341					E1	E1		10.1038/nature09954	http://dx.doi.org/10.1038/nature09954			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21475147				2022-12-28	WOS:000289199400001
J	Gulland, A				Gulland, Anne			Welcome to the century of the patient	BRITISH MEDICAL JOURNAL			English	Editorial Material												annecgulland@yahoo.co.uk							0	9	9	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 6	2011	342								d2057	10.1136/bmj.d2057	http://dx.doi.org/10.1136/bmj.d2057			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	749JR	21471162				2022-12-28	WOS:000289462100008
J	Hartling, L; Fernandes, RM; Bialy, L; Milne, A; Johnson, D; Plint, A; Klassen, TP; Vandermeer, B				Hartling, Lisa; Fernandes, Ricardo M.; Bialy, Liza; Milne, Andrea; Johnson, David; Plint, Amy; Klassen, Terry P.; Vandermeer, Ben			Steroids and bronchodilators for acute bronchiolitis in the first two years of life: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NEONATAL DEXAMETHASONE TREATMENT; PEDIATRIC EMERGENCY-DEPARTMENTS; CHRONIC LUNG-DISEASE; MANAGEMENT; CHILDREN; EFFICACY; COMBINATION; GUIDELINES; STRENGTH; INFANTS	Objective To evaluate and compare the efficacy and safety of bronchodilators and steroids, alone or combined, for the acute management of bronchiolitis in children aged less than 2 years. Design Systematic review and meta-analysis. Data sources Medline, Embase, Central, Scopus, PubMed, LILACS, IranMedEx, conference proceedings, and trial registers. Inclusion criteria Randomised controlled trials of children aged 24 months or less with a first episode of bronchiolitis with wheezing comparing any bronchodilator or steroid, alone or combined, with placebo or another intervention (other bronchodilator, other steroid, standard care). Review methods Two reviewers assessed studies for inclusion and risk of bias and extracted data. Primary outcomes were selected by clinicians a priori based on clinical relevance: rate of admission for outpatients (day 1 and up to day 7) and length of stay for inpatients. Direct meta-analyses were carried out using random effects models. A mixed treatment comparison using a Bayesian network model was used to compare all interventions simultaneously. Results 48 trials (4897 patients, 13 comparisons) were included. Risk of bias was low in 17% (n=8), unclear in 52% (n=25), and high in 31% (n=15). Only adrenaline (epinephrine) reduced admissions on day 1 (compared with placebo: pooled risk ratio 0.67, 95% confidence interval 0.50 to 0.89; number needed to treat 15, 95% confidence interval 10 to 45 for a baseline risk of 20%; 920 patients). Unadjusted results from a single large trial with low risk of bias showed that combined dexamethasone and adrenaline reduced admissions on day 7 (risk ratio 0.65, 0.44 to 0.95; number needed to treat 11, 7 to 76 for a baseline risk of 26%; 400 patients). A mixed treatment comparison supported adrenaline alone or combined with steroids as the preferred treatments for outpatients (probability of being the best treatment based on admissions at day 1 were 45% and 39%, respectively). The incidence of reported harms did not differ. None of the interventions examined showed clear efficacy for length of stay among inpatients. Conclusions Evidence shows the effectiveness and superiority of adrenaline for outcomes of most clinical relevance among outpatients with acute bronchiolitis, and evidence from a single precise trial for combined adrenaline and dexamethasone.	[Hartling, Lisa; Bialy, Liza; Milne, Andrea; Vandermeer, Ben] Univ Alberta, Alberta Res Ctr Hlth Evidence, Dept Pediat, Edmonton, AB T6G 2J3, Canada; [Fernandes, Ricardo M.] Hosp Santa Maria, Gulbenkian Program Adv Med Educ, Child & Family Dept, Inst Mol Med, Lisbon, Portugal; [Johnson, David] Univ Calgary, Dept Pediat, Calgary, AB T2N 1N4, Canada; [Johnson, David] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB T2N 1N4, Canada; [Plint, Amy] Univ Ottawa, Dept Pediat, Ottawa, ON K1N 6N5, Canada; [Plint, Amy] Univ Ottawa, Dept Emergency Med, Ottawa, ON K1N 6N5, Canada; [Klassen, Terry P.] Univ Manitoba, Dept Pediat & Child Hlth, Manitoba Inst Child Hlth, Winnipeg, MB R3T 2N2, Canada	University of Alberta; Universidade de Lisboa; Hospital Santa Maria; University of Calgary; University of Calgary; University of Ottawa; University of Ottawa; University of Manitoba	Hartling, L (corresponding author), Univ Alberta, Alberta Res Ctr Hlth Evidence, Dept Pediat, 11402 Univ Ave, Edmonton, AB T6G 2J3, Canada.	hartling@ualberta.ca	Plint, Amy/AAE-2250-2020; Fernandes, Ricardo M/C-7501-2015	Fernandes, Ricardo M/0000-0002-7253-6475; Klassen, Terry/0000-0002-5309-7091	Canadian Institutes of Health Research; Calouste Gulbenkian Foundation; Fundacao Ciencia e Tecnologia	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Calouste Gulbenkian Foundation; Fundacao Ciencia e Tecnologia(Portuguese Foundation for Science and Technology)	This research was supported by the Canadian Institutes of Health Research knowledge synthesis grant programme. The funding agency was not involved with the study design or collection, analysis, and interpretation of the data. RMF is supported by the Calouste Gulbenkian Foundation (Programme for Advanced Medical Education; www.gulbenkian.pt), and Fundacao Ciencia e Tecnologia.	Babl FE, 2008, PEDIATR EMERG CARE, V24, P656, DOI 10.1097/PEC.0b013e318188498c; Barben J, 2008, THORAX, V63, P1103, DOI 10.1136/thx.2007.094706; Barbi E, 2004, ARCH PEDIAT ADOL MED, V158, P403, DOI 10.1001/archpedi.158.4.403-a; BIALY L, 2006, EVIDENCE BASED CHILD, V1, P939; Black JL, 2009, CHEST, V136, P1095, DOI 10.1378/chest.09-0354; Bush A, 2009, NEW ENGL J MED, V360, P409, DOI 10.1056/NEJMe0808951; Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Christakis DA, 2005, PEDIATRICS, V115, P878, DOI 10.1542/peds.2004-1299; Corneli HM, 2007, NEW ENGL J MED, V357, P331, DOI 10.1056/NEJMoa071255; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Flores G, 1997, PEDIATRICS, V100, P233, DOI 10.1542/peds.100.2.233; Frey U, 2009, NEW ENGL J MED, V360, P2130, DOI 10.1056/NEJMe0902242; Giembycz MA, 2008, BRIT J PHARMACOL, V153, P1090, DOI 10.1038/sj.bjp.0707627; Glasziou PP, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-23; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Halliday HL, 2010, COCHRANE DB SYST REV, V1; Hartling L, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003123.pub2, DOI 10.1002/14651858.CD003123.PUB2]; Higgins J.P.T., 2021, COCHRANE HDB SYSTEMA, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Higgins JPT, 1996, STAT MED, V15, P2733, DOI 10.1002/(SICI)1097-0258(19961230)15:24<2733::AID-SIM562>3.0.CO;2-0; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ioannidis JPA, 2009, CAN MED ASSOC J, V181, P488, DOI 10.1503/cmaj.081086; Karemaker R, 2008, PEDIATRICS, V122, P978, DOI 10.1542/peds.2007-3409; Karemaker R, 2008, PEDIATRICS, V121, pE870, DOI 10.1542/peds.2007-2454; King VJ, 2004, ARCH PEDIAT ADOL MED, V158, P127, DOI 10.1001/archpedi.158.2.127; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Muething S, 2004, J PEDIATR-US, V144, P703, DOI 10.1016/j.jpeds.2004.01.058; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Onland W, 2008, PEDIATRICS, V122, P92, DOI 10.1542/peds.2007-2258; Openshaw Peter J M, 2005, Proc Am Thorac Soc, V2, P121, DOI 10.1513/pats.200504-032AW; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Plint AC, 2004, ACAD EMERG MED, V11, P353, DOI 10.1197/j.aem.2003.12.003; Plint AC, 2009, NEW ENGL J MED, V360, P2079, DOI 10.1056/NEJMoa0900544; Scarfone RJ, 2005, CURR OPIN PEDIATR, V17, P62, DOI 10.1097/01.mop.0000149604.98591.9a; Schuh S, 2002, J PEDIATR-US, V140, P27, DOI 10.1067/mpd.2002.120271; Schunemann HJ, 2009, GRADE HDB GRADING QU; Scottish Intercollegiate Guidelines Network (SIGN), 2006, 91 SIGN; Shojania KG, 2007, ANN INTERN MED, V147, P224, DOI 10.7326/0003-4819-147-4-200708210-00179; Smith TC, 1995, STAT MED, V14, P2685, DOI 10.1002/sim.4780142408; Smyth RL, 2006, LANCET, V368, P312, DOI 10.1016/S0140-6736(06)69077-6; Thomas LH, 2002, PEDIATR RES, V52, P368, DOI [10.1203/00006450-200209000-00010, 10.1203/01.PDR.0000030716.99576.3C]; Touzet S, 2007, J EVAL CLIN PRACT, V13, P651, DOI 10.1111/j.1365-2753.2007.00781.x; Turner T, 2008, Aust Fam Physician, V37, P6; Viswanathan M, 2003, Evid Rep Technol Assess (Summ), P1; Wilson-Costello D, 2009, PEDIATRICS, V123, pe430, DOI 10.1542/peds.2008-1928; WOHL MEB, 1978, AM REV RESPIR DIS, V118, P759, DOI 10.1164/arrd.1978.118.4.759; WRIGHT AL, 1989, AM J EPIDEMIOL, V129, P1232, DOI 10.1093/oxfordjournals.aje.a115243; Zhang Linjie, 2005, J. Pediatr. (Rio J.), V81, P193, DOI 10.1590/S0021-75572005000400004	50	86	96	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 6	2011	342								d1714	10.1136/bmj.d1714	http://dx.doi.org/10.1136/bmj.d1714			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749JR	21471175	Green Published, hybrid			2022-12-28	WOS:000289462100004
J	Binic, I; Jankovic, A				Binic, Ivana; Jankovic, Aleksandar			Coral-Red Fluorescence	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Binic, Ivana; Jankovic, Aleksandar] Clin Ctr Nis, Nish, Serbia		Binic, I (corresponding author), Clin Ctr Nis, Nish, Serbia.								0	0	0	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2011	364	13					E25	E25		10.1056/NEJMicm1008223	http://dx.doi.org/10.1056/NEJMicm1008223			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	742NO	21449776				2022-12-28	WOS:000288951300012
J	Kane, B; Turkington, PM; Howard, LS; Davison, AG; Gibson, GJ; O'Driscoll, BR				Kane, Binita; Turkington, Peter M.; Howard, Luke S.; Davison, Anthony G.; Gibson, G. John; O'Driscoll, B. Ronan			LESSON OF THE WEEK Rebound hypoxaemia after administration of oxygen in an acute exacerbation of chronic obstructive pulmonary disease	BMJ-BRITISH MEDICAL JOURNAL			English	Article									[Kane, Binita; Turkington, Peter M.; O'Driscoll, B. Ronan] Univ Manchester, Salford Royal Fdn Trust, Manchester Acad Hlth Sci Ctr, Salford M6 8HD, Lancs, England; [Howard, Luke S.] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, London, England; [Davison, Anthony G.] Southend Univ Hosp, Westcliff On Sea, England; [Gibson, G. John] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Salford Royal NHS Foundation Trust; University of Manchester; Imperial College London; Newcastle University - UK	O'Driscoll, BR (corresponding author), Salford Royal Univ Hosp, Dept Resp Med, Stott Lane, Salford M6 8HD, Lancs, England.	ronan.o'driscoll@srft.nhs.uk		Howard, Luke/0000-0003-2822-210X				CAMPBELL EJM, 1960, LANCET, V2, P10; FARHI LE, 1955, J APPL PHYSIOL, V7, P472, DOI 10.1152/jappl.1955.7.5.472; Hale KE, 2008, EMERG MED J, V25, P773, DOI 10.1136/emj.2008.059287; MASSARO D J, 1962, Br Med J, V2, P627; O'Driscoll BR, 2008, THORAX, V63, DOI 10.1136/thx.2008.102947; REFSUM HE, 1963, CLIN SCI, V25, P361	6	14	14	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2011	342								d1557	10.1136/bmj.d1557	http://dx.doi.org/10.1136/bmj.d1557			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745WI	21454455				2022-12-28	WOS:000289201600002
J	Savage, N				Savage, Neil			EARLY DETECTION Spotting the first signs	NATURE			English	Editorial Material																		Gatsonis CA, 2011, RADIOLOGY, V258, P243, DOI 10.1148/radiol.10091808; Peng G, 2010, BRIT J CANCER, V103, P542, DOI 10.1038/sj.bjc.6605810; Wax A, 2011, GASTROENTEROLOGY, V141, P443, DOI 10.1053/j.gastro.2011.06.020; Willmann JK, 2010, J NUCL MED, V51, P433, DOI 10.2967/jnumed.109.068007	4	26	27	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					S14	S15		10.1038/471S14a	http://dx.doi.org/10.1038/471S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430712				2022-12-28	WOS:000288702200013
J	Roquilly, A; Mahe, PJ; Seguin, P; Guitton, C; Floch, H; Tellier, AC; Merson, L; Renard, B; Malledant, Y; Flet, L; Sebille, V; Volteau, C; Masson, D; Nguyen, JM; Lejus, C; Asehnoune, K				Roquilly, Antoine; Mahe, Pierre Joachim; Seguin, Philippe; Guitton, Christophe; Floch, Herve; Tellier, Anne Charlotte; Merson, Laurent; Renard, Benoit; Malledant, Yannick; Flet, Laurent; Sebille, Veronique; Volteau, Christelle; Masson, Damien; Nguyen, Jean Michel; Lejus, Corinne; Asehnoune, Karim			Hydrocortisone Therapy for Patients With Multiple Trauma The Randomized Controlled HYPOLYTE Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; INFLAMMATORY RESPONSE SYNDROME; COMMUNITY-ACQUIRED PNEUMONIA; RISK-FACTORS; SEPTIC SHOCK; MORTALITY; INSUFFICIENCY; STIMULATION; MANAGEMENT; INFECTION	Context The role of stress-dose hydrocortisone in the management of trauma patients is currently unknown. Objective To test the efficacy of hydrocortisone therapy in trauma patients. Design, Setting, and Patients Multicenter, randomized, double-blind, placebo-controlled HYPOLYTE (Hydrocortisone Polytraumatise) study. From November 2006 to August 2009, 150 patients with severe trauma were included in 7 intensive care units in France. Intervention Patients were randomly assigned to a continuous intravenous infusion of either hydrocortisone (200 mg/d for 5 days, followed by 100 mg on day 6 and 50 mg on day 7) or placebo. The treatment was stopped if patients had an appropriate adrenal response. Main Outcome Measure Hospital-acquired pneumonia within 28 days. Secondary outcomes included the duration of mechanical ventilation, hyponatremia, and death. Results One patient withdrew consent. An intention-to-treat (ITT) analysis included the 149 patients, a modified ITT analysis included 113 patients with corticosteroid insufficiency. In the ITT analysis, 26 of 73 patients (35.6%) treated with hydrocortisone and 39 of 76 patients (51.3%) receiving placebo developed hospital-acquired pneumonia by day 28 (hazard ratio [HR], 0.51; 95% confidence interval [CI], 0.30-0.83; P=.007). In the modified ITT analysis, 20 of 56 patients (35.7%) in the hydrocortisone group and 31 of 57 patients (54.4%) in the placebo group developed hospital-acquired pneumonia by day 28 (HR, 0.47; 95% CI, 0.25-0.86; P=.01). Mechanical ventilation-free days increased with hydrocortisone by 4 days (95% CI, 2-7; P=.001) in the ITT analysis and 6 days (95% CI, 2-11; P<.001) in the modified ITT analysis. Hyponatremia was observed in 7 of 76 (9.2%) in the placebo group vs none in the hydrocortisone group (absolute difference, -9%; 95% CI, -16% to -3%; P=.01). Four of 76 patients (5.3%) in the placebo group and 6 of 73 (8.2%) in the hydrocortisone group died (absolute difference, 3%; 95% CI, -5% to 11%; P=.44). Conclusion In intubated trauma patients, the use of an intravenous stress-dose of hydrocortisone, compared with placebo, resulted in a decreased risk of hospital-acquired pneumonia.	[Roquilly, Antoine; Mahe, Pierre Joachim; Lejus, Corinne; Asehnoune, Karim] Univ Nantes, Univ Hosp Nantes, Dept Anesthesiol & Intens Care Med, F-44035 Nantes, France; [Guitton, Christophe] Univ Nantes, Univ Hosp Nantes, Dept Med Intens Care, F-44035 Nantes, France; [Flet, Laurent] Univ Nantes, Univ Hosp Nantes, Dept Pharm, F-44035 Nantes, France; [Sebille, Veronique; Volteau, Christelle] Univ Nantes, Univ Hosp Nantes, Dept Biostat & Biometry, F-44035 Nantes, France; [Masson, Damien] Univ Nantes, Univ Hosp Nantes, Dept Biol, F-44035 Nantes, France; [Nguyen, Jean Michel] Univ Nantes, Univ Hosp Nantes, Dept Epidemiol & Biostat, F-44035 Nantes, France; [Sebille, Veronique] Univ Nantes, Univ Pharm, F-44035 Nantes, France; [Seguin, Philippe; Malledant, Yannick] Univ Rennes, Univ Hosp Rennes, Dept Anesthesiol & Intens Care Med, Rennes, France; [Floch, Herve] Univ Brest, Univ Hosp Brest, Dept Anesthesiol & Intens Care Med, Brest, France; [Tellier, Anne Charlotte] Univ Tours, Univ Hosp Tours, Dept Anesthesiol & Intens Care Med, F-37041 Tours, France; [Merson, Laurent] Univ Bordeaux, Univ Hosp Bordeaux, Dept Anesthesiol & Intens Care Med, Bordeaux, France; [Renard, Benoit] Gen Hosp La Roche Sur Yon, Dept Crit Care, La Roche Sur Yon, France; [Renard, Benoit] Dept Internal Med, Les Sables Olonne, France	Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Nantes Universite; CHU Rennes; Universite de Rennes; CHU Brest; Universite de Bretagne Occidentale; CHU Tours; Universite de Tours; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; CHD Vendee	Asehnoune, K (corresponding author), CHU Nantes, Serv Anesthesie Reanimat, 1 Pl, F-44093 Nantes 1, France.	karim.asehnoune@chu-nantes.fr	Masson, Damien/K-2730-2015; Roquilly, Antoine/P-9826-2017; Sebille, Veronique/I-3309-2015; Sébille, Véronique/L-8761-2015; NGUYEN, JEAN-MICHEL/K-7665-2015; Seguin, Philippe/P-9487-2019; FLET, Laurent/X-1192-2019	NGUYEN, JEAN-MICHEL/0000-0001-8815-7640; Seguin, Philippe/0000-0002-7774-4257; FLET, Laurent/0000-0001-8305-7085; Sebille, Veronique/0000-0002-0780-7742; Malledant, yannick/0000-0001-6680-5184; Roquilly, Antoine/0000-0002-1029-6242	University Hospital of Nantes; French Ministry of Health	University Hospital of Nantes; French Ministry of Health	The University Hospital of Nantes was the study sponsor. The French Ministry of Health provided financial support (2006 Clinical Research Hospital Programme PHRC 2006, inter-region Ouest). The laboratory SERB provided hydrocortisone.	Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Barie PS, 2004, J TRAUMA, V56, P301; Bochicchio GV, 2004, J TRAUMA, V56, P296, DOI 10.1097/01.TA.0000109857.22312.DF; Bochicchio GV, 2001, J TRAUMA, V50, P817, DOI 10.1097/00005373-200105000-00007; Brain Trauma Foundation; American Association of Neurological Surgeons; Congress of Neurological Surgeons, 2008, J NEUROTRAUM, V25, P276; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Confalonieri M, 2005, AM J RESP CRIT CARE, V171, P242, DOI 10.1164/rccm.200406-808OC; Cook DJ, 1998, ANN INTERN MED, V129, P433, DOI 10.7326/0003-4819-129-6-199809150-00002; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Edwards P, 2005, LANCET, V365, P1957; Gibot S, 2004, NEW ENGL J MED, V350, P451, DOI 10.1056/NEJMoa031544; Hamrahian AH, 2004, NEW ENGL J MED, V350, P1629, DOI 10.1056/NEJMoa020266; Heyland D, 2006, NEW ENGL J MED, V355, P2619, DOI 10.1056/NEJMoa052904; Hoen S, 2005, CRIT CARE MED, V33, P2737, DOI 10.1097/01.CCM.0000189743.55352.0E; Hoen S, 2002, ANESTHESIOLOGY, V97, P807, DOI 10.1097/00000542-200210000-00010; Hoover L, 2006, J TRAUMA, V61, P310, DOI 10.1097/01.ta.0000229052.75460.c2; Jabre P, 2009, LANCET, V374, P293, DOI 10.1016/S0140-6736(09)60949-1; Kaufmann I, 2008, INTENS CARE MED, V34, P344, DOI 10.1007/s00134-007-0868-8; Keh D, 2003, AM J RESP CRIT CARE, V167, P512, DOI 10.1164/rccm.200205-446OC; Klompas M, 2009, CRIT CARE, V13, DOI 10.1186/cc8036; Leone M, 2005, INTENS CARE MED, V31, P64, DOI 10.1007/s00134-004-2514-z; Lepelletier D, 2010, J NEUROSURG ANESTH, V22, P32, DOI 10.1097/ANA.0b013e3181bdf52f; Malerba G, 2005, INTENS CARE MED, V31, P388, DOI 10.1007/s00134-004-2550-8; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Marik PE, 2008, CRIT CARE MED, V36, P1937, DOI 10.1097/CCM.0b013e31817603ba; Muehlstedt SG, 2002, CRIT CARE MED, V30, P1322, DOI 10.1097/00003246-200206000-00029; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Offner PJ, 2002, AM J SURG, V184, P649, DOI 10.1016/S0002-9610(02)01101-7; Osborn TM, 2004, CRIT CARE MED, V32, P2234, DOI 10.1097/01.CCM.0000145586.23276.0F; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Steinberg KP, 2006, NEW ENGL J MED, V354, P1671; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914	36	125	136	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2011	305	12					1201	1209		10.1001/jama.2011.360	http://dx.doi.org/10.1001/jama.2011.360			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738PA	21427372	Bronze			2022-12-28	WOS:000288652100015
J	Ideker, T; Dutkowski, J; Hood, L				Ideker, Trey; Dutkowski, Janusz; Hood, Leroy			Boosting Signal-to-Noise in Complex Biology: Prior Knowledge Is Power	CELL			English	Review							REGULATORY NETWORKS; MODELS; YEAST; CELL	A major difficulty in the analysis of complex biological systems is dealing with the low signal-to-noise inherent to nearly all large biological datasets. We discuss powerful bioinformatic concepts for boosting signal-to-noise through external knowledge incorporated in processing units we call filters and integrators. These concepts are illustrated in four landmark studies that have provided model implementations of filters, integrators, or both.	[Ideker, Trey; Dutkowski, Janusz] Univ Calif San Diego, Dept Med, San Diego, CA 92093 USA; [Ideker, Trey; Dutkowski, Janusz] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92093 USA; [Ideker, Trey] Univ Calif San Diego, Inst Genom Med, San Diego, CA 92093 USA; [Hood, Leroy] Inst Syst Biol, Seattle, WA 98103 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Institute for Systems Biology (ISB)	Ideker, T (corresponding author), Univ Calif San Diego, Dept Med, San Diego, CA 92093 USA.	tideker@ucsd.edu		Ideker, Trey/0000-0002-1708-8454	National Center for Research Resources [RR031228]; National Institute of General Medical Sciences [GM076547, GM070743, GM085764]; Department of Defense [W911SR-07-C-0101]; Luxembourg strategic partnership; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR031228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547, R01GM070743, P50GM085764] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Defense(United States Department of Defense); Luxembourg strategic partnership; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge G. Hannum, S. Choi, I. Shmulevich, D. Galas, J. Roach, and N. Price for helpful comments and feedback. This work was funded by grants from the National Center for Research Resources (RR031228, T.I., J.D.), the National Institute of General Medical Sciences (GM076547, L.H.; GM070743 and GM085764, T.I.), the Department of Defense (W911SR-07-C-0101, L.H.), and the Luxembourg strategic partnership (L.H.).	Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Erwin DH, 2009, NAT REV GENET, V10, P141, DOI 10.1038/nrg2499; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Hwang D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.10; McGary KL, 2010, P NATL ACAD SCI USA, V107, P6544, DOI 10.1073/pnas.0910200107; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Park MY, 2007, BIOSTATISTICS, V8, P212, DOI 10.1093/biostatistics/kxl002; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167	15	123	130	2	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 18	2011	144	6					860	863		10.1016/j.cell.2011.03.007	http://dx.doi.org/10.1016/j.cell.2011.03.007			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	737BQ	21414478	Bronze, Green Accepted			2022-12-28	WOS:000288543500005
J	Tokano, T				Tokano, Tetsuya			Precipitation Climatology on Titan	SCIENCE			English	Editorial Material							DRIZZLE		Univ Cologne, Inst Geophys & Meteorol, D-50923 Cologne, Germany	University of Cologne	Tokano, T (corresponding author), Univ Cologne, Inst Geophys & Meteorol, D-50923 Cologne, Germany.	tokano@geo.uni-koeln.de						Adamkovics M, 2007, SCIENCE, V318, P962, DOI 10.1126/science.1146244; Barth EL, 2010, PLANET SPACE SCI, V58, P1740, DOI 10.1016/j.pss.2010.07.013; Barth EL, 2010, ICARUS, V206, P467, DOI 10.1016/j.icarus.2009.01.032; Graves SDB, 2008, PLANET SPACE SCI, V56, P346, DOI 10.1016/j.pss.2007.11.001; Hueso R, 2006, NATURE, V442, P428, DOI 10.1038/nature04933; Koppen W., 1923, KLIMATE ERDE; Lorenz RD, 2008, PLANET SPACE SCI, V56, P1132, DOI 10.1016/j.pss.2008.02.009; Mitchell JL, 2006, P NATL ACAD SCI USA, V103, P18421, DOI 10.1073/pnas.0605074103; Tokano T, 2006, NATURE, V442, P432, DOI 10.1038/nature04948; Tokano T, 2009, ICARUS, V204, P619, DOI 10.1016/j.icarus.2009.07.032; Turtle EP, 2011, SCIENCE, V331, P1414, DOI 10.1126/science.1201063; WILLIAMS GP, 1988, CLIM DYNAM, V3, P45, DOI 10.1007/BF01080901	12	10	10	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2011	331	6023					1393	1394		10.1126/science.1204092	http://dx.doi.org/10.1126/science.1204092			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21415341				2022-12-28	WOS:000288504000025
J	Needleman, J; Buerhaus, P; Pankratz, VS; Leibson, CL; Stevens, SR; Harris, M				Needleman, Jack; Buerhaus, Peter; Pankratz, V. Shane; Leibson, Cynthia L.; Stevens, Susanna R.; Harris, Marcelline			Nurse Staffing and Inpatient Hospital Mortality	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-CARE; PATIENT OUTCOMES; ADMINISTRATIVE DATA; ADVERSE EVENTS; US HOSPITALS; ASSOCIATION; RATIOS	BACKGROUND Cross-sectional studies of hospital-level administrative data have shown an association between lower levels of staffing of registered nurses (RNs) and increased patient mortality. However, such studies have been criticized because they have not shown a direct link between the level of staffing and individual patient experiences and have not included sufficient statistical controls. METHODS We used data from a large tertiary academic medical center involving 197,961 admissions and 176,696 nursing shifts of 8 hours each in 43 hospital units to examine the association between mortality and patient exposure to nursing shifts during which staffing by RNs was 8 hours or more below the staffing target. We also examined the association between mortality and high patient turnover owing to admissions, transfers, and discharges. We used Cox proportional-hazards models in the analyses with adjustment for characteristics of patients and hospital units. RESULTS Staffing by RNs was within 8 hours of the target level for 84% of shifts, and patient turnover was within 1 SD of the day-shift mean for 93% of shifts. Overall mortality was 61% of the expected rate for similar patients on the basis of modified diagnosis-related groups. There was a significant association between increased mortality and increased exposure to unit shifts during which staffing by RNs was 8 hours or more below the target level (hazard ratio per shift 8 hours or more below target, 1.02; 95% confidence interval [CI], 1.01 to 1.03; P<0.001). The association between increased mortality and high patient turnover was also significant (hazard ratio per high-turnover shift, 1.04; 95% CI, 1.02 to 1.06; P<0.001). CONCLUSIONS In this retrospective observational study, staffing of RNs below target levels was associated with increased mortality, which reinforces the need to match staffing with patients' needs for nursing care.	[Pankratz, V. Shane; Leibson, Cynthia L.; Harris, Marcelline] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Needleman, Jack] Univ Calif Los Angeles, Sch Publ Hlth, Dept Hlth Serv, Los Angeles, CA 90024 USA; [Buerhaus, Peter] Vanderbilt Univ, Nashville, TN USA; [Stevens, Susanna R.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA	Mayo Clinic; University of California System; University of California Los Angeles; Vanderbilt University; Duke University	Harris, M (corresponding author), Mayo Clin, Dept Hlth Sci Res, 200 1st St SW, Rochester, MN 55905 USA.	harris.marcelline@mayo.edu	Needleman, Jack/I-5461-2013	Needleman, Jack/0000-0002-2875-0589	Agency for Healthcare Research and Quality [R01-HS015508]; Johnson Johnson; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS015508] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Supported by a grant (R01-HS015508) from the Agency for Healthcare Research and Quality.; Dr. Buerhaus reports serving on an unpaid advisory board for the Johnson & Johnson Campaign for the Future of Nursing and reports that his institution has received grant support from the Johnson & Johnson Campaign for the Future of Nursing on his behalf. No other potential conflict of interest relevant to this article was reported.	*AG HEALTHC RES Q, 2002, PAT SAF IND HOSP DAT; Aiken LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI 10.1001/jama.288.16.1987; Blegen MA, 1998, NURS RES, V47, P43, DOI 10.1097/00006199-199801000-00008; Blegen MA, 1998, NURS ECON, V16, P196; Carpenter Dave, 2007, Hosp Health Netw, V81, P34; CHO SH, 2008, NEW ENGL J MED, V359, P1921; Dall TM, 2009, MED CARE, V47, P97, DOI 10.1097/MLR.0b013e3181844da8; Dang D, 2002, HEART LUNG, V31, P219, DOI 10.1067/mhl.2002.122838; de Brantes F, 2009, NEW ENGL J MED, V361, P1033, DOI 10.1056/NEJMp0906121; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Evans WN, 2006, J HEALTH ECON, V25, P365, DOI 10.1016/j.jhealeco.2005.10.003; *JOINT COMM, 2007, HLTH CAR STAFF SERV; Kaestner R, 2006, HEALTH AFFAIR, V25, P882, DOI 10.1377/hlthaff.25.3.882-a; Kane RL, 2007, MED CARE, V45, P1195, DOI 10.1097/MLR.0b013e3181468ca3; Kovner C, 1998, Image J Nurs Sch, V30, P315, DOI 10.1111/j.1547-5069.1998.tb01326.x; Kovner C, 2002, HEALTH SERV RES, V37, P611; Landon BE, 2006, ARCH INTERN MED, V166, P2511, DOI 10.1001/archinte.166.22.2511; Lang TA, 2004, J NURS ADMIN, V34, P326, DOI 10.1097/00005110-200407000-00005; Litvak E., 2010, MANAGING PATIENT FLO; Mark BA, 2004, HEALTH SERV RES, V39, P1629, DOI 10.1111/j.1475-6773.2004.00307.x; Mark BA, 2004, HEALTH SERV RES, V39, P279, DOI 10.1111/j.1475-6773.2004.00228.x; Mark BA, 2006, WESTERN J NURS RES, V28, P694, DOI 10.1177/0193945905277354; National Quality Forum, 2004, NAT VOL CONS STAND N; Needleman J, 2006, HEALTH AFFAIR, V25, P204, DOI 10.1377/hlthaff.25.1.204; Needleman J, 2002, NEW ENGL J MED, V346, P1715, DOI 10.1056/NEJMsa012247; Sales A, 2008, MED CARE, V46, P938, DOI 10.1097/MLR.0b013e3181791a0a; Unruh L, 2003, MED CARE, V41, P142, DOI 10.1097/00005650-200301000-00016; Unruh LY, 2006, HEALTH SERV RES, V41, P599, DOI 10.1111/j.1475-6773.2005.00496.x; 2007, COVARIATES PDI VERSI	29	521	529	1	74	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2011	364	11					1037	1045		10.1056/NEJMsa1001025	http://dx.doi.org/10.1056/NEJMsa1001025			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	735SX	21410372				2022-12-28	WOS:000288439000009
J	Weitenberg, C; Endres, M; Sherson, JF; Cheneau, M; Schauss, P; Fukuhara, T; Bloch, I; Kuhr, S				Weitenberg, Christof; Endres, Manuel; Sherson, Jacob F.; Cheneau, Marc; Schauss, Peter; Fukuhara, Takeshi; Bloch, Immanuel; Kuhr, Stefan			Single-spin addressing in an atomic Mott insulator	NATURE			English	Article							OPTICALLY TRAPPED ATOMS; CONTROLLED COLLISIONS; TRANSITION; SUPERFLUID; ENTANGLEMENT; MICROSCOPY; MICROTRAP; LATTICES	Ultracold atoms in optical lattices provide a versatile tool with which to investigate fundamental properties of quantum many-body systems. In particular, the high degree of control of experimental parameters has allowed the study of many interesting phenomena, such as quantum phase transitions and quantum spin dynamics. Here we demonstrate how such control can be implemented at the most fundamental level of a single spin at a specific site of an optical lattice. Using a tightly focused laser beam together with a microwave field, we were able to flip the spin of individual atoms in a Mott insulator with sub-diffraction-limited resolution, well below the lattice spacing. The Mott insulator provided us with a large two-dimensional array of perfectly arranged atoms, in which we created arbitrary spin patterns by sequentially addressing selected lattice sites after freezing out the atom distribution. We directly monitored the tunnelling quantum dynamics of single atoms in the lattice prepared along a single line, and observed that our addressing scheme leaves the atoms in the motional ground state. The results should enable studies of entropy transport and the quantum dynamics of spin impurities, the implementation of novel cooling schemes, and the engineering of quantum many-body phases and various quantum information processing applications.	[Weitenberg, Christof; Endres, Manuel; Sherson, Jacob F.; Cheneau, Marc; Schauss, Peter; Fukuhara, Takeshi; Bloch, Immanuel; Kuhr, Stefan] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Bloch, Immanuel] Univ Munich, D-80799 Munich, Germany	Max Planck Society; University of Munich	Kuhr, S (corresponding author), Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany.	stefan.kuhr@mpq.mpg.de	Kuhr, Stefan/F-7296-2011; Bloch, Immanuel/G-3174-2010; Schauss, Peter/AAV-1298-2020; Cheneau, Marc/O-9312-2014; Kuhr, Stefan/ABC-8654-2020; Fukuhara, Takeshi/A-6254-2014; Bloch, Immanuel/N-9169-2019	Kuhr, Stefan/0000-0001-8386-5357; Bloch, Immanuel/0000-0002-0679-4759; Schauss, Peter/0000-0002-8505-5195; Cheneau, Marc/0000-0001-7261-566X; Kuhr, Stefan/0000-0001-8386-5357; Fukuhara, Takeshi/0000-0002-6702-9882; 	MPG; DFG; Stiftung Rheinland-Pfalzfur Innovation; Carl-Zeiss Stiftung; EU; JSPS	MPG(Max Planck Society); DFG(German Research Foundation (DFG)); Stiftung Rheinland-Pfalzfur Innovation; Carl-Zeiss Stiftung; EU(European Commission); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank W. Ketterle for discussions and ideas. We acknowledge the help of R. Glockner and R. Labouvie during the construction of the experiment. We acknowledge funding by MPG, DFG, Stiftung Rheinland-Pfalzfur Innovation, Carl-Zeiss Stiftung, EU(NAMEQUAM, AQUTE, MarieCurie Fellowships to J. F. S. and M. C.), and JSPS (Postdoctoral Fellowship for Research Abroad to T. F.).	Bakr WS, 2010, SCIENCE, V329, P547, DOI 10.1126/science.1192368; Bergamini S, 2004, J OPT SOC AM B, V21, P1889, DOI 10.1364/JOSAB.21.001889; Bernier JS, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.061601; BINNIG G, 1987, REV MOD PHYS, V59, P615, DOI 10.1103/RevModPhys.59.615; Blatt R, 2008, NATURE, V453, P1008, DOI 10.1038/nature07125; Calarco T, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.012306; Campbell GK, 2006, SCIENCE, V313, P649, DOI 10.1126/science.1130365; Cho J, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.020502; Dumke R, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.097903; FISHER MPA, 1989, PHYS REV B, V40, P546, DOI 10.1063/1.38820; Folling S, 2007, NATURE, V448, P1029, DOI 10.1038/nature06112; Folling S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.060403; Garwood M, 2001, J MAGN RESON, V153, P155, DOI 10.1006/jmre.2001.2340; Giessibl FJ, 2003, REV MOD PHYS, V75, P949, DOI 10.1103/RevModPhys.75.949; Gorshkov AV, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.093005; Grunzweig T, 2010, NAT PHYS, V6, P951, DOI 10.1038/NPHYS1778; Isenhower L, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.010503; Jaksch D, 1999, PHYS REV LETT, V82, P1975, DOI 10.1103/PhysRevLett.82.1975; Joo J, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.042344; Karski M, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/6/065027; Karski M, 2009, SCIENCE, V325, P174, DOI 10.1126/science.1174436; Kleine A, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.013607; Kuhr S, 2001, SCIENCE, V293, P278, DOI 10.1126/science.1062725; Lundblad N, 2009, NAT PHYS, V5, P575, DOI 10.1038/NPHYS1330; Mandel O, 2003, NATURE, V425, P937, DOI 10.1038/nature02008; Micheli A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.140408; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Perets HB, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.170506; Peruzzo A, 2010, SCIENCE, V329, P1500, DOI 10.1126/science.1193515; Recati A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.020401; Saffman M, 2004, OPT LETT, V29, P1016, DOI 10.1364/OL.29.001016; Scheunemann R, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.051801; Schlosser N, 2001, NATURE, V411, P1024, DOI 10.1038/35082512; Schneider U., 2010, BREAKDOWN DIFFUSION; Schrader D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.150501; Sherson J. F., 2010, SHAKING ENTROPY OUT; Sherson JF, 2010, NATURE, V467, P68, DOI 10.1038/nature09378; Shibata K, 2009, APPL PHYS B-LASERS O, V97, P753, DOI 10.1007/s00340-009-3696-4; Weimer H, 2010, NAT PHYS, V6, P382, DOI 10.1038/NPHYS1614; Weiss DS, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.040302; Wilk T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.010502; Winkler K, 2006, NATURE, V441, P853, DOI 10.1038/nature04918; Wurtz P, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.080404; Zahringer F, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.100503; Zhang CW, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.042316; Zvonarev MB, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.240404	50	516	517	4	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2011	471	7338					319	+		10.1038/nature09827	http://dx.doi.org/10.1038/nature09827			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21412333	Green Submitted, Green Accepted			2022-12-28	WOS:000288444000033
J	Das, P				Das, Pamela			Lucica Ditiu: putting people at the forefront of tuberculosis care	LANCET			English	Biographical-Item												pamela.das@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2011	377	9771					1067	1067		10.1016/S0140-6736(11)60397-8	http://dx.doi.org/10.1016/S0140-6736(11)60397-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	743QY	21439635	Bronze			2022-12-28	WOS:000289035000014
J	Scagnoli, V; Staub, U; Bodenthin, Y; de Souza, RA; Garcia-Fernandez, M; Garganourakis, M; Boothroyd, AT; Prabhakaran, D; Lovesey, SW				Scagnoli, V.; Staub, U.; Bodenthin, Y.; de Souza, R. A.; Garcia-Fernandez, M.; Garganourakis, M.; Boothroyd, A. T.; Prabhakaran, D.; Lovesey, S. W.			Observation of Orbital Currents in CuO	SCIENCE			English	Article							COPPER-OXIDE METALS; HIGH-T-C; CUPRIC OXIDE; SCATTERING; PSEUDOGAP	Orbital currents are proposed to be the order parameter of the pseudo-gap phase of cuprate high-temperature superconductors. We used resonant x-ray diffraction to observe orbital currents in a copper-oxygen plaquette, the basic building block of cuprate superconductors. The confirmation of the existence of orbital currents is an important step toward the understanding of the cuprates as well as materials lacking inversion symmetry, such as magnetically induced multiferroics. Although observed in the antiferromagnetic state of cupric oxide, we show that orbital currents can occur even in the absence of long-range magnetic moment ordering.	[Scagnoli, V.; Staub, U.; Bodenthin, Y.; de Souza, R. A.; Garcia-Fernandez, M.; Garganourakis, M.] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Boothroyd, A. T.; Prabhakaran, D.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Lovesey, S. W.] Rutherford Appleton Lab, ISIS Facil, Didcot OX11 0QX, Oxon, England; [Lovesey, S. W.] Diamond Light Source Ltd, Oxford OX11 0DE, England	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Oxford; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Diamond Light Source	Scagnoli, V (corresponding author), Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland.	valerio.scagnoli@psi.ch	scagnoli, valerio/T-1355-2019; Boothroyd, Andrew/AAA-7883-2021; Garcia-Fernandez, Mirian/B-6018-2013; scagnoli, valerio/C-6833-2008; Staub, Urs/C-4914-2015	scagnoli, valerio/0000-0002-8116-8870; Boothroyd, Andrew/0000-0002-3575-7471; Garcia-Fernandez, Mirian/0000-0001-9945-1327; scagnoli, valerio/0000-0002-8116-8870; Staub, Urs/0000-0003-2035-3367; Lovesey, Stephen/0000-0003-3677-7324; Garcia Fernandez, Mirian/0000-0002-6982-9066; de Souza, Raquel/0000-0001-9305-9690	Swiss National Science Foundation; National Centre of Competence in Research Materials with Novel Electrical Properties; UK Engineering and Physical Sciences Research Council; EPSRC [EP/H033939/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H033939/1] Funding Source: researchfish	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Centre of Competence in Research Materials with Novel Electrical Properties; UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors acknowledge stimulating discussions with G. van der Laan, S. Di Matteo, A. Mirone, and F. de Bergevin. This work has been supported by the Swiss National Science Foundation, National Centre of Competence in Research Materials with Novel Electrical Properties, and the UK Engineering and Physical Sciences Research Council. Part of this work was carried out at the SIM beamline at the Swiss Light Source, Paul. Scherrer Institute, Villigen, Switzerland.	ASBRINK S, 1991, J PHYS-CONDENS MAT, V3, P8173, DOI 10.1088/0953-8984/3/42/012; BROUDER C, 1990, J PHYS-CONDENS MAT, V2, P701, DOI 10.1088/0953-8984/2/3/018; BROWN PJ, 1991, J PHYS-CONDENS MAT, V3, P4281, DOI 10.1088/0953-8984/3/23/016; Di Matteo S, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.134502; DUBOVIK VM, 1990, PHYS REP, V187, P145, DOI 10.1016/0370-1573(90)90042-Z; FORSYTH JB, 1988, J PHYS C SOLID STATE, V21, P2917, DOI 10.1088/0022-3719/21/15/023; Ginges JSM, 2004, PHYS REP, V397, P63, DOI 10.1016/j.physrep.2004.03.005; KAO C, 1990, PHYS REV LETT, V65, P373, DOI 10.1103/PhysRevLett.65.373; Khomskii D, 2009, PHYSICS, V2, P20, DOI 10.1103/Physics.2.20; Kimura T, 2008, NAT MATER, V7, P291, DOI 10.1038/nmat2125; Lovesey SW, 2005, PHYS REP, V411, P233, DOI 10.1016/j.physrep.2005.01.003; Norman MR, 2005, ADV PHYS, V54, P715, DOI [10.1080/00018730500459906, 10.1080/00018730500489906]; Simon ME, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.247003; Varma CM, 1997, PHYS REV B, V55, P14554, DOI 10.1103/PhysRevB.55.14554; Varma CM, 1999, PHYS REV LETT, V83, P3538, DOI 10.1103/PhysRevLett.83.3538; YANG BX, 1989, PHYS REV B, V39, P4343, DOI 10.1103/PhysRevB.39.4343; Zeldovich Ya. B., 1958, ZH EKSP TEOR FIZ, V6, P1184	17	92	92	0	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2011	332	6030					696	698		10.1126/science.1201061	http://dx.doi.org/10.1126/science.1201061			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21474711				2022-12-28	WOS:000290265800036
J	Himler, AG; Adachi-Hagimori, T; Bergen, JE; Kozuch, A; Kelly, SE; Tabashnik, BE; Chiel, E; Duckworth, VE; Dennehy, TJ; Zchori-Fein, E; Hunter, MS				Himler, Anna G.; Adachi-Hagimori, Tetsuya; Bergen, Jacqueline E.; Kozuch, Amaranta; Kelly, Suzanne E.; Tabashnik, Bruce E.; Chiel, Elad; Duckworth, Victoria E.; Dennehy, Timothy J.; Zchori-Fein, Einat; Hunter, Martha S.			Rapid Spread of a Bacterial Symbiont in an Invasive Whitefly Is Driven by Fitness Benefits and Female Bias	SCIENCE			English	Article							BEMISIA-TABACI; HEMIPTERA ALEYRODIDAE; AEDES-AEGYPTI; INFECTION; WOLBACHIA; RICKETTSIA; POPULATIONS; DROSOPHILA; DIVERSITY; INCOMPATIBILITY	Maternally inherited bacterial symbionts of arthropods are common, yet symbiont invasions of host populations have rarely been observed. Here, we show that Rickettsia sp. nr. bellii swept into a population of an invasive agricultural pest, the sweet potato whitefly, Bemisia tabaci, in just 6 years. Compared with uninfected whiteflies, Rickettsia-infected whiteflies produced more offspring, had higher survival to adulthood, developed faster, and produced a higher proportion of daughters. The symbiont thus functions as both mutualist and reproductive manipulator. The observed increased performance and sex-ratio bias of infected whiteflies are sufficient to explain the spread of Rickettsia across the southwestern United States. Symbiont invasions such as this represent a sudden evolutionary shift for the host, with potentially large impacts on its ecology and invasiveness.	[Himler, Anna G.; Adachi-Hagimori, Tetsuya; Bergen, Jacqueline E.; Kozuch, Amaranta; Kelly, Suzanne E.; Tabashnik, Bruce E.; Chiel, Elad; Duckworth, Victoria E.; Dennehy, Timothy J.; Hunter, Martha S.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Himler, Anna G.] Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA; [Chiel, Elad; Zchori-Fein, Einat] Agr Res Org, Newe Yaar Res Ctr, Entomol Lab, IL-30095 Ramat Yishay, Israel; [Adachi-Hagimori, Tetsuya] Osaka Prefectural Govt, Res Inst Environm Agr & Fisheries, Osaka 5830862, Japan; [Dennehy, Timothy J.] Bayer Crop Sci Ltd Partnership, Global Insecticide Resistance Management, Res Triangle Pk, NC 27709 USA	University of Arizona; University of Arizona; Bayer AG; Bayer CropScience	Hunter, MS (corresponding author), Univ Arizona, Dept Entomol, Forbes 410, Tucson, AZ 85721 USA.	mhunter@ag.arizona.edu	Hunter, Martha/B-7307-2012; Hunter, Martha/AAF-5288-2020	Hunter, Martha/0000-0002-6342-675X; Hunter, Martha/0000-0002-6342-675X; Chiel, Elad/0000-0002-7146-3219	NIH [1K 12 GM00708]; United States-Israel Binational Agricultural Research and Development fellowship [GS-1-2007]; Binational (US-Israel) Science Foundation [2004416]; U.S. Department of Agriculture National Research Initiative Cooperative State Research, Education, and Extension Service [2006-35302-17165]; NSF [DEB-1020460]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States-Israel Binational Agricultural Research and Development fellowship; Binational (US-Israel) Science Foundation(US-Israel Binational Science Foundation); U.S. Department of Agriculture National Research Initiative Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Kim, N. Doidge, N. Dowdy, and J. Garcia for technical help and V. Corby-Harris and M. Torabi for advice on analyses. We are grateful to K. Oliver for helpful comments on an earlier version of the manuscript. A. G. H. was funded by NIH training grant 1K 12 GM00708, and E. C. was funded in part by the United States-Israel Binational Agricultural Research and Development fellowship (GS-1-2007). This research was supported by Binational (US-Israel) Science Foundation grant 2004416 and U.S. Department of Agriculture National Research Initiative Cooperative State Research, Education, and Extension Service grant 2006-35302-17165 to M. S. H. and E.Z.-F. and NSF grant DEB-1020460 to M. S. H. and A. G. H. Sequences have been deposited in GenBank under accession numbers HQ439024 to HQ439027, HQ997365, and JF288560.	Aksoy S, 2008, ADV EXP MED BIOL, V627, P35, DOI 10.1007/978-0-387-78225-6_3; Behar A, 2010, APPL ENVIRON MICROB, V76, P2280, DOI 10.1128/AEM.00026-10; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; Chiel E, 2009, ANN ENTOMOL SOC AM, V102, P413, DOI 10.1603/008.102.0309; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Dobson SL, 2002, GENETICS, V160, P1087; DOUGLAS AE, 1989, BIOL REV, V64, P409, DOI 10.1111/j.1469-185X.1989.tb00682.x; Engelstadter J, 2009, ANNU REV ECOL EVOL S, V40, P127, DOI 10.1146/annurev.ecolsys.110308.120206; Giorgini M, 2010, APPL ENVIRON MICROB, V76, P2589, DOI 10.1128/AEM.03154-09; Goodacre SL, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-32; Gueguen G, 2010, MOL ECOL, V19, P4365, DOI 10.1111/j.1365-294X.2010.04775.x; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; HOFFMANN AA, 1994, GENETICS, V136, P993; Jiu M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000182; McMeniman CJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000748; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Oliveira MRV, 2001, CROP PROT, V20, P709, DOI 10.1016/S0261-2194(01)00108-9; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Palumbo JC, 2001, CROP PROT, V20, P739, DOI 10.1016/S0261-2194(01)00117-X; Perlman SJ, 2006, P ROY SOC B-BIOL SCI, V273, P2097, DOI 10.1098/rspb.2006.3541; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Rodriguez RJ, 2008, ISME J, V2, P404, DOI 10.1038/ismej.2007.106; Schulenburg JHGV, 2002, GENETICS, V160, P1075; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0; Walker DH, 2008, NAT REV MICROBIOL, V6, P375, DOI 10.1038/nrmicro1866; Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114; Weinert LA, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-6; Zchori-Fein E, 2002, ANN ENTOMOL SOC AM, V95, P711, DOI 10.1603/0013-8746(2002)095[0711:DOPAWB]2.0.CO;2	30	331	366	7	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					254	256		10.1126/science.1199410	http://dx.doi.org/10.1126/science.1199410			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474763				2022-12-28	WOS:000289251100057
J	Kaiser, D				Kaiser, David			The search for clean cash	NATURE			English	Editorial Material									MIT, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Kaiser, D (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dikaiser@mit.edu	Kaiser, David/C-7149-2014	Kaiser, David/0000-0002-5054-6744					0	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 7	2011	472	7341					30	31		10.1038/472030a	http://dx.doi.org/10.1038/472030a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	745VV	21475174	Bronze, Green Submitted			2022-12-28	WOS:000289199400017
J	Blumle, A; Meerpohl, JJ; Rucker, G; Antes, G; Schumacher, M; von Elm, E				Bluemle, Anette; Meerpohl, Joerg J.; Ruecker, Gerta; Antes, Gerd; Schumacher, Martin; von Elm, Erik			Reporting of eligibility criteria of randomised trials: cohort study comparing trial protocols with subsequent articles	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EXTERNAL VALIDITY; PUBLISHED REPORTS; PUBLICATIONS; OUTCOMES; SAMPLE; WOMEN	Objective To determine whether and how eligibility criteria of participants prespecified in protocols of randomised trials are reported in subsequent articles. Design Cohort study. Setting Protocols submitted to the ethics committee of a German medical faculty. Data sources 52 trial protocols and 78 subsequent publications published between 2000 and 2006. Main outcome measure Proportion of matching, missing, modified, or newly added eligibility criteria between trial protocols and subsequent publications. Results Differences were found between protocols and subsequent publications for all 52 trials. Information on eligibility criteria was missing in the publications for all 52 trials (100%, 95% confidence interval 93% to 100%), modified for 44 (85%, 72% to 93%), and newly added for 21 (41%, 27% to 55%). The mean number of eligibility criteria for each trial was 25 (range 7-43) and the mean proportion of matching eligibility criteria per trial was 50% (95% confidence interval 44% to 55%, range 13-93). Of 1248 eligibility criteria prespecified in the protocols, 606 (49%, 46% to 51%) were matching in subsequent publications, 479 (38%, 36% to 41%) were missing, and 163 (13%, 11% to 15%) were modified. 51 eligibility criteria were added to publications. Most prespecified eligibility criteria were about comorbidity (42%, 39% to 45%), treatment (20%, 18% to 22%), or type or severity of illness (17%, 15% to 19%). Most of the missing eligibility criteria (96%, 94% to 97%) and modified eligibility criteria (54%, 46% to 62%) suggested broader study populations and most of the added eligibility criteria (86%, 74% to 94%) suggested narrower study populations. Conclusions Many users of trial information rely on published journal articles. These articles generally do not reflect the exact definition of the study population as prespecified in the protocol. Incomplete or inadequate reporting of eligibility criteria hampers a proper assessment of the applicability of trial results.	[Bluemle, Anette; Meerpohl, Joerg J.; Ruecker, Gerta; Antes, Gerd; Schumacher, Martin; von Elm, Erik] Univ Med Ctr Freiburg, German Cochrane Ctr, Dept Med Biometry & Stat, Inst Med Biometry & Med Informat, D-79110 Freiburg, Germany; [Meerpohl, Joerg J.] Univ Med Ctr Freiburg, Dept Pediat, Div Pediat Hematol & Oncol, Freiburg, Germany; [von Elm, Erik] Swiss Parapleg Res, Nottwil, Switzerland	University of Freiburg; University of Freiburg; Swiss Paraplegic Research	Blumle, A (corresponding author), Univ Med Ctr Freiburg, German Cochrane Ctr, Dept Med Biometry & Stat, Inst Med Biometry & Med Informat, Berliner Allee 29, D-79110 Freiburg, Germany.	bluemle@cochrane.de	Meerpohl, Joerg J/J-4224-2013; Rücker, Gerta/B-2965-2009	Meerpohl, Joerg J/0000-0002-1333-5403; Rücker, Gerta/0000-0002-2192-2560; von Elm, Erik/0000-0002-7412-0406; Blumle, Anette/0000-0003-2877-1029	German Research Foundation (DFG) [EL 544/1-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	Funding: This study was funded by the German Research Foundation (DFG) (EL 544/1-1). The funder had no role in the design and conduct of the study, data collection and analysis, interpretation of the data, writing of the manuscript, and decision to submit the manuscript for publication	Ahmad N, 2009, ARTHRIT RHEUM-ARTHR, V61, P361, DOI 10.1002/art.24279; [Anonymous], 2010, LANCET, V375, P1225, DOI 10.1016/S0140-6736(10)60523-5; Antes G, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1432; Blumle A, 2008, J MED ETHICS, V34, DOI 10.1136/jme.2008.024521; Chan AW, 2008, PLOS MED, V5, P1533, DOI 10.1371/journal.pmed.0050230; Chan AW, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2299; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; De Angelis CD, 2005, JAMA-J AM MED ASSOC, V293, P2927, DOI 10.1001/jama.293.23.jed50037; Dekkers OM, 2010, INT J EPIDEMIOL, V39, P89, DOI 10.1093/ije/dyp174; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Fuks A, 1998, J CLIN EPIDEMIOL, V51, P69, DOI 10.1016/S0895-4356(97)00240-0; Gandhi M, 2005, AIDS, V19, P1885, DOI 10.1097/01.aids.0000189866.67182.f7; Glasziou P, 2008, BMJ-BRIT MED J, V336, P1472, DOI 10.1136/bmj.39590.732037.47; Godwin Marshall, 2003, BMC Med Res Methodol, V3, P28, DOI 10.1186/1471-2288-3-28; Humphreys K, 2007, ALCOHOL CLIN EXP RES, V31, P988, DOI 10.1111/j.1530-0277.2007.00391.x; Jones R, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-5; Lee PY, 2001, JAMA-J AM MED ASSOC, V286, P708, DOI 10.1001/jama.286.6.708; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Pildal J, 2005, BMJ-BRIT MED J, V330, P1049, DOI 10.1136/bmj.38414.422650.8F; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Rothwell PM, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010009; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Scharf O, 2006, J CLIN ONCOL, V24, P3933, DOI 10.1200/JCO.2005.05.3959; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Sinha S, 2009, J AM COLL SURGEONS, V209, P565, DOI 10.1016/j.jamcollsurg.2009.07.019; THOMPSON SG, 1994, BMJ-BRIT MED J, V309, P1351, DOI 10.1136/bmj.309.6965.1351; Uijen AA, 2007, J CLIN EPIDEMIOL, V60, P330, DOI 10.1016/j.jclinepi.2006.05.015; Van Spall HGC, 2007, JAMA-J AM MED ASSOC, V297, P1233, DOI 10.1001/jama.297.11.1233; YUSUF S, 1990, STAT MED, V9, P73, DOI 10.1002/sim.4780090114	29	32	33	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	APR 5	2011	342								d1828	10.1136/bmj.d1828	http://dx.doi.org/10.1136/bmj.d1828			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749JL	21467104	Green Published, hybrid			2022-12-28	WOS:000289461200015
J	Philips, JA; Ernst, JD				Philips, Jennifer A.; Ernst, Joel D.			Directly Observing Therapy: A New View of Drug Tolerance in Tuberculosis	CELL			English	Editorial Material							BACTERIAL PERSISTENCE	Drug tolerance in bacteria is widely believed to be due to metabolic changes that accompany growth arrest. A study in this issue of Cell reveals a drug tolerance mechanism in replicating mycobacteria that is induced by residence in macrophages and depends on drug efflux.	[Philips, Jennifer A.; Ernst, Joel D.] NYU, Sch Med, Dept Med, Div Infect Dis, New York, NY 10016 USA; [Philips, Jennifer A.; Ernst, Joel D.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Philips, Jennifer A.; Ernst, Joel D.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	New York University; New York University; New York University	Ernst, JD (corresponding author), NYU, Sch Med, Dept Med, Div Infect Dis, 522 1st Ave,Smilow 901, New York, NY 10016 USA.	joel.ernst@med.nyu.edu		Ernst, Joel/0000-0001-9951-6207				Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bryk R, 2008, CELL HOST MICROBE, V3, P137, DOI 10.1016/j.chom.2008.02.003; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; Salomon JA, 2006, PLOS MED, V3, P1302, DOI 10.1371/journal.pmed.0030273	5	1	2	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 1	2011	145	1					13	14		10.1016/j.cell.2011.02.041	http://dx.doi.org/10.1016/j.cell.2011.02.041			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458661	Bronze			2022-12-28	WOS:000289053900002
J	Chen, CF; Park, CH; Boudouris, BW; Horng, J; Geng, BS; Girit, C; Zettl, A; Crommie, MF; Segalman, RA; Louie, SG; Wang, F				Chen, Chi-Fan; Park, Cheol-Hwan; Boudouris, Bryan W.; Horng, Jason; Geng, Baisong; Girit, Caglar; Zettl, Alex; Crommie, Michael F.; Segalman, Rachel A.; Louie, Steven G.; Wang, Feng			Controlling inelastic light scattering quantum pathways in graphene	NATURE			English	Article							GEL GATE DIELECTRICS; CARBON NANOTUBES; RAMAN-SPECTROSCOPY; TRANSISTORS; ELECTRONS	Inelastic light scattering spectroscopy has, since its first discovery(1,2), been an indispensable tool in physical science for probing elementary excitations, such as phonons(3), magnons(4) and plasmons(5) in both bulk and nanoscale materials. In the quantum mechanical picture of inelastic light scattering, incident photons first excite a set of intermediate electronic states, which then generate crystal elementary excitations and radiate energy-shifted photons(6). The intermediate electronic excitations therefore have a crucial role as quantum pathways in inelastic light scattering, and this is exemplified by resonant Raman scattering(6) and Raman interference(7,8). The ability to control these excitation pathways can open up new opportunities to probe, manipulate and utilize inelastic light scattering. Here we achieve excitation pathway control in graphene with electrostatic doping. Our study reveals quantum interference between different Raman pathways in graphene: when some of the pathways are blocked, the one-phonon Raman intensity does not diminish, as commonly expected, but increases dramatically. This discovery sheds new light on the understanding of resonance Raman scattering in graphene. In addition, we demonstrate hot-electron luminescence9 in graphene as the Fermi energy approaches half the laser excitation energy. This hot luminescence, which is another form of inelastic light scattering, results from excited-state relaxation channels that become available only in heavily doped graphene.	[Chen, Chi-Fan; Park, Cheol-Hwan; Horng, Jason; Geng, Baisong; Girit, Caglar; Zettl, Alex; Crommie, Michael F.; Louie, Steven G.; Wang, Feng] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Boudouris, Bryan W.; Segalman, Rachel A.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Boudouris, Bryan W.; Zettl, Alex; Crommie, Michael F.; Segalman, Rachel A.; Louie, Steven G.; Wang, Feng] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Wang, F (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	fengwang76@berkeley.edu	Girit, Çağlar/D-4845-2014; Girit, Çağlar/AFT-1507-2022; wang, Feng/I-5727-2015; Park, Cheol-Hwan/A-1543-2009; 5.4, ALS Beamline/I-2863-2014; Zettl, Alex K/O-4925-2016; 1.4, ALS Beamline/I-1886-2014	Girit, Çağlar/0000-0001-8953-9261; Girit, Çağlar/0000-0001-8953-9261; wang, Feng/0000-0001-8369-6194; Park, Cheol-Hwan/0000-0003-1584-6896; Zettl, Alex K/0000-0001-6330-136X; Segalman, Rachel/0000-0002-4292-5103	US Department of Energy, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Office of Basic Energy Sciences [DE-AC02-05CH11231, DE-AC03-76SF0098]; ONR MURI [N00014-09-1-1066]; National Science Council; National Tsing Hua University, Taiwan [NSC98-2811-M-007-008, NSC98-2120-M-007-004]	US Department of Energy, Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Office of Basic Energy Sciences(United States Department of Energy (DOE)); ONR MURI(MURIOffice of Naval Research); National Science Council(Ministry of Science and Technology, Taiwan); National Tsing Hua University, Taiwan	This work was supported by the US Department of Energy, Laboratory Directed Research and Development Program of Lawrence Berkeley National Laboratory under contract no. DE-AC02-05CH11231 (C.-F.C. and F.W.), by the Office of Basic Energy Sciences under contract nos DE-AC02-05CH11231 (B.W.B. and R.A.S.), DE-AC03-76SF0098 (Materials Science Division) (C.G., A.Z.) and DE-AC02-05CH11231 (Advanced Light Source), and by ONR MURI award N00014-09-1-1066 (J.H., C.-H.P., S.G.L., M.F.C.). C.-F.C. also acknowledges fellowship support from the National Science Council and National Tsing Hua University, Taiwan, under awards NSC98-2811-M-007-008 and NSC98-2120-M-007-004.	Basko DM, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.165413; Basko DM, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/9/095011; CARDONA M, 1982, LIGHT SCATTERING SOL, V1; Cho JH, 2008, NAT MATER, V7, P900, DOI 10.1038/nmat2291; Das A, 2008, NAT NANOTECHNOL, V3, P210, DOI 10.1038/nnano.2008.67; Devereaux TP, 2007, REV MOD PHYS, V79, P175, DOI 10.1103/RevModPhys.79.175; Dresselhaus MS, 2010, NANO LETT, V10, P751, DOI 10.1021/nl904286r; Dresselhaus MS, 2005, PHYS REP, V409, P47, DOI 10.1016/j.physrep.2004.10.006; ELSAESSER T, 1991, PHYS REV LETT, V66, P1757, DOI 10.1103/PhysRevLett.66.1757; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; GONI AR, 1991, PHYS REV LETT, V67, P3298, DOI 10.1103/PhysRevLett.67.3298; Ilani S, 2006, NAT PHYS, V2, P687, DOI 10.1038/nphys412; Kashuba O, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.241404; Kim BJ, 2010, NANO LETT, V10, P3464, DOI 10.1021/nl101559n; Landsberg G, 1928, NATURWISSENSCHAFTEN, V16, P557; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Li ZQ, 2008, NAT PHYS, V4, P532, DOI 10.1038/nphys989; LUI CH, 2010, ULTRAFAST PHOTOLUMIN; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Pimenta MA, 2007, PHYS CHEM CHEM PHYS, V9, P1276, DOI 10.1039/b613962k; Pisana S, 2007, NAT MATER, V6, P198, DOI 10.1038/nmat1846; RALSTON JM, 1970, PHYS REV LETT, V25, P814, DOI 10.1103/PhysRevLett.25.814; Raman CV, 1928, NATURE, V121, P619, DOI 10.1038/121619b0; Rao AM, 1997, SCIENCE, V275, P187, DOI 10.1126/science.275.5297.187; STOEHR RJ, 2010, FLUORESCENCE LASER C; Wang CJ, 2001, SCIENCE, V291, P2390, DOI 10.1126/science.291.5512.2390; Wang F, 2008, SCIENCE, V320, P206, DOI 10.1126/science.1152793; Yan J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.166802; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Zhang YB, 2009, NATURE, V459, P820, DOI 10.1038/nature08105	30	450	459	8	325	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 31	2011	471	7340					617	620		10.1038/nature09866	http://dx.doi.org/10.1038/nature09866			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21412234				2022-12-28	WOS:000288951200038
J	Hsiao, WC				Hsiao, William C.			State-Based Single-Payer Health Care - A Solution for the United States?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hsiao, William C.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Hsiao, WC (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.							STOLBERG SG, 2011, NY TIMES        0228	1	7	7	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2011	364	13					1188	1190		10.1056/NEJMp1100972	http://dx.doi.org/10.1056/NEJMp1100972			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	742NO	21410389				2022-12-28	WOS:000288951300002
J	Brower, V				Brower, Vicki			EPIGENETICS Unravelling the cancer code	NATURE			English	Editorial Material							METHYLATION; CARCINOMA; GENE											Brait M, 2009, CANCER EPIDEM BIOMAR, V18, P2984, DOI 10.1158/1055-9965.EPI-08-1245; Christensen BC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001043; Frank B., 2010, CANC GENETICS, V127, P2822; HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700, DOI 10.1073/pnas.91.21.9700; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; McLean MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015366; Slattery ML, 2011, CANCER EPIDEM BIOMAR, V20, P57, DOI 10.1158/1055-9965.EPI-10-0843	7	48	49	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					S12	S13		10.1038/471S12a	http://dx.doi.org/10.1038/471S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430711	Bronze			2022-12-28	WOS:000288702200012
J	Wang, LW; McLeod, HL; Weinshilboum, RM				Wang, Liewei; McLeod, Howard L.; Weinshilboum, Richard M.			Genomic Medicine Genomics and Drug Response	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HYPERSENSITIVITY REACTIONS; ACTIVE METABOLITE; CYP2C19 GENOTYPE; WIDE ASSOCIATION; INTERFERON-ALPHA; LUNG-CANCER; CLOPIDOGREL; RISK; THERAPY; MUTATIONS		[Wang, Liewei; Weinshilboum, Richard M.] Mayo Clin, Div Clin Pharmacol, Dept Mol Pharmacol & Expt Therapeut, Mayo Med Sch, Rochester, MN 55905 USA; [McLeod, Howard L.] Univ N Carolina, UNC Inst Pharmacogenom & Individualized Therapy, Chapel Hill, NC USA	Mayo Clinic; University of North Carolina; University of North Carolina Chapel Hill	Weinshilboum, RM (corresponding author), Mayo Clin, Div Clin Pharmacol, Dept Mol Pharmacol & Expt Therapeut, Mayo Med Sch, 200 1st SW, Rochester, MN 55905 USA.	weinshilboum.richard@mayo.edu	McLeod, Howard/ABD-8364-2021	McLeod, Howard/0000-0002-9004-9232	National Institutes of Health [K22-CA130828, R01-CA138461, R01-GM28157, R01-CA132780, U01-HG005137, U19-GM61388, U01-GM63340, UL1RR025747]; PhRMA Foundation Center of Excellence; American Society for Pharmacology and Experimental Therapeutics (ASPET); NATIONAL CANCER INSTITUTE [K22CA130828, R01CA132780, R01CA138461] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025747] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG005137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U19GM061388, R01GM028157, U01GM063340] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PhRMA Foundation Center of Excellence; American Society for Pharmacology and Experimental Therapeutics (ASPET); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported in part by grants (K22-CA130828, R01-CA138461, R01-GM28157, R01-CA132780, U01-HG005137, U19-GM61388, U01-GM63340, and UL1RR025747) from the National Institutes of Health, a PhRMA Foundation Center of Excellence in Clinical Pharmacology Award, and an American Society for Pharmacology and Experimental Therapeutics (ASPET)-Astellas Award.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Aithal GP, 1999, LANCET, V353, P717, DOI 10.1016/S0140-6736(98)04474-2; [Anonymous], 2010, NATURE, V464, P649, DOI 10.1038/464649a; [Anonymous], INFORM HEALTHCARE PR; [Anonymous], FDA DRUG SAF COMMN R; Budnitz DS, 2007, ANN INTERN MED, V147, P755, DOI 10.7326/0003-4819-147-11-200712040-00006; Chen P, 2011, NEW ENGL J MED, V364, P1126, DOI 10.1056/NEJMoa1009717; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Collins F, 2010, NATURE, V464, P674, DOI 10.1038/464674a; Daly AK, 2003, PHARMACOGENETICS, V13, P247, DOI 10.1097/00008571-200305000-00002; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DEMORAIS SMF, 1994, J BIOL CHEM, V269, P15419; Eisenhauer EA, 2001, NEW ENGL J MED, V344, P841, DOI 10.1056/NEJM200103153441110; Epstein RS, 2010, J AM COLL CARDIOL, V55, P2804, DOI 10.1016/j.jacc.2010.03.009; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; FAIRLEY CK, 1993, BRIT MED J, V306, P233, DOI 10.1136/bmj.306.6872.233; FAIRLEY CK, 1993, BRIT MED J, V307, P1179; Feero WG, 2010, NEW ENGL J MED, V362, P2001, DOI 10.1056/NEJMra0907175; Ferrell PB, 2008, PHARMACOGENOMICS, V9, P1543, DOI 10.2217/14622416.9.10.1543; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Freedman RA, 2010, BREAST, V19, P69, DOI 10.1016/j.breast.2009.11.009; Fuster V, 2010, JAMA-J AM MED ASSOC, V304, P1839, DOI 10.1001/jama.2010.1566; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ginsburg GS, 2010, J AM COLL CARDIOL, V55, P2813, DOI 10.1016/j.jacc.2010.04.006; Hetherington S, 2001, CLIN THER, V23, P1603, DOI 10.1016/S0149-2918(01)80132-6; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Holmes DR, 2010, J AM COLL CARDIOL, V56, P321, DOI 10.1016/j.jacc.2010.05.013; Ingle JN, 2010, J CLIN ONCOL, V28, P4674, DOI 10.1200/JCO.2010.28.5064; Iyer L, 1998, J CLIN INVEST, V101, P847, DOI 10.1172/JCI915; Janni W, 2010, CANCER TREAT REV, V36, P249, DOI 10.1016/j.ctrv.2009.12.010; King SB, 2008, CIRCULATION, V117, P261, DOI 10.1161/CIRCULATIONAHA.107.188208; Klein TE, 2009, NEW ENGL J MED, V361, P1613; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Li T, 2004, NATURE, V427, P541, DOI 10.1038/nature02254; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; MANN R, 2006, PHARMACOVIGILANCE; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Manolopoulos VG, 2010, PHARMACOGENOMICS, V11, P493, DOI [10.2217/pgs.10.31, 10.2217/PGS.10.31]; McCormack M, 2011, NEW ENGL J MED, V364, P1134, DOI 10.1056/NEJMoa1013297; McDonald MG, 2009, MOL PHARMACOL, V75, P1337, DOI 10.1124/mol.109.054833; Mega JL, 2010, JAMA-J AM MED ASSOC, V304, P1821, DOI 10.1001/jama.2010.1543; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; National Institutes of Health, 2002, NIH CONSENS STATE SC, V19, P1; O'Brien TR, 2009, NAT GENET, V41, P1048, DOI 10.1038/ng.453; OLSSON R, 1992, J HEPATOL, V15, P154, DOI 10.1016/0168-8278(92)90029-O; P Kanagasabapathy, 2010, CARDIOVASC THER 0708; Pachkoria K, 2009, J HEPATOL, V50, P636, DOI 10.1016/j.jhep.2009.01.001; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pare G, 2010, NEW ENGL J MED, V363, P1704, DOI 10.1056/NEJMoa1008410; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Rost S, 2004, NATURE, V427, P537, DOI 10.1038/nature02214; Russmann S, 2005, BRIT J CLIN PHARMACO, V60, P76, DOI 10.1111/j.1365-2125.2005.02370.x; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Sagrieya H, 2010, PHARMACOGENET GENOM, V20, P407, DOI 10.1097/FPC.0b013e328338bac2; Savi P, 2000, THROMB HAEMOSTASIS, V84, P891, DOI 10.1055/s-0037-1614133; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Takeuchi F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000433; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Teichert M, 2009, HUM MOL GENET, V18, P3758, DOI 10.1093/hmg/ddp309; Varmus H, 2010, NEW ENGL J MED, V362, P2028, DOI 10.1056/NEJMe0911933; Venter JC, 2010, NATURE, V464, P676, DOI 10.1038/464676a; Wade N., 2010, NY TIMES        0612; Wallentin L, 2010, LANCET, V376, P1320, DOI 10.1016/S0140-6736(10)61274-3; Weinshilboum R, 2003, NEW ENGL J MED, V348, P529, DOI 10.1056/NEJMra020021; Weinshilboum RM, 2006, ANNU REV GENOM HUM G, V7, P223, DOI 10.1146/annurev.genom.6.080604.162315; Woodcock J, 2010, CLIN PHARMACOL THER, V88, P765, DOI 10.1038/clpt.2010.230; Wysowski DK, 2007, ARCH INTERN MED, V167, P1414, DOI 10.1001/archinte.167.13.1414; Yusuf S, 2001, NEW ENGL J MED, V345, P1716; Zambon CF, 2011, PHARMACOGENOMICS, V12, P15, DOI [10.2217/pgs.10.162, 10.2217/PGS.10.162]	76	413	435	1	69	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2011	364	12					1144	1153		10.1056/NEJMra1010600	http://dx.doi.org/10.1056/NEJMra1010600			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739FY	21428770	Green Accepted, Bronze			2022-12-28	WOS:000288701100009
J	Fleming, S; Thompson, M; Stevens, R; Heneghan, C; Pluddemann, A; Maconochie, I; Tarassenko, L; Mant, D				Fleming, Susannah; Thompson, Matthew; Stevens, Richard; Heneghan, Carl; Plueddemann, Annette; Maconochie, Ian; Tarassenko, Lionel; Mant, David			Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studies	LANCET			English	Article							EARLY WARNING SCORE; INFANTS; EMERGENCY; SEVERITY; ILLNESS; TRIAGE	Background Although heart rate and respiratory rate in children are measured routinely in acute settings, current reference ranges are not based on evidence. We aimed to derive new centile charts for these vital signs and to compare these centiles with existing international ranges. Methods We searched Medline, Embase, CINAHL, and reference lists for studies that reported heart rate or respiratory rate of healthy children between birth and 18 years of age. We used non-parametric kernel regression to create centile charts for heart rate and respiratory rate in relation to age. We compared existing reference ranges with those derived from our centile charts. Findings We identified 69 studies with heart rate data for 143 346 children and respiratory rate data for 3881 children. Our centile charts show decline in respiratory rate from birth to early adolescence, with the steepest fall apparent in infants under 2 years of age; decreasing from a median of 44 breaths per min at birth to 26 breaths per min at 2 years. Heart rate shows a small peak at age 1 month. Median heart rate increases from 127 beats per min at birth to a maximum of 145 beats per min at about 1 month, before decreasing to 113 beats per min by 2 years of age. Comparison of our centile charts with existing published reference ranges for heart rate and respiratory rate show striking disagreement, with limits from published ranges frequently exceeding the 99th and 1st centiles, or crossing the median. Interpretation Our evidence-based centile charts for children from birth to 18 years should help clinicians to update clinical and resuscitation guidelines.	[Fleming, Susannah; Thompson, Matthew; Stevens, Richard; Heneghan, Carl; Plueddemann, Annette; Mant, David] Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England; [Thompson, Matthew] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA; [Maconochie, Ian] St Marys Hosp, London, England; [Fleming, Susannah; Tarassenko, Lionel] Univ Oxford, Inst Biomed Engn, Dept Engn, Oxford OX3 7LF, England	University of Oxford; Oregon Health & Science University; Imperial College London; University of Oxford	Thompson, M (corresponding author), Univ Oxford, Dept Primary Hlth Care, Rosemary Rue Bldg,Old Rd Campus, Oxford OX3 7LF, England.	matthew.thompson@dphpc.ox.ac.uk	Zixuan, Huang/ABI-3557-2020; Fleming, Susannah/T-5314-2018	Fleming, Susannah/0000-0001-7205-2051; Stevens, Richard/0000-0002-9258-4060; Pluddemann, Annette/0000-0003-2101-0390; Maconochie, Ian/0000-0001-6319-8550	National Institute of Health Research (NIHR) school for primary care research; Engineering and Physical Sciences Research Council; NIHR Biomedical Research Centre; NIHR [RP-PG-0407-10347]; EPSRC [EP/F058845/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F058845/1, EP/H019944/1] Funding Source: researchfish	National Institute of Health Research (NIHR) school for primary care research(National Institute for Health Research (NIHR)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank Nia Roberts, Ruth Davis, Robert Oakey, Lee Wallis, and Jill Mant for assistance and advice, and the National Institute of Health Research (NIHR) school for primary care research, the Engineering and Physical Sciences Research Council, and the NIHR Biomedical Research Centre Programme for their support. This study was funded by the NIHR programme grant RP-PG-0407-10347: Development and Implementation of New Diagnostic Processes and Technologies in Primary Care.	*ADV LIF SUPP GROU, 2004, ADV PAED LIF SUPP PR; Akre M, 2010, PEDIATRICS, V125, pE763, DOI 10.1542/peds.2009-0338; American Heart Association, 2006, PED ADV LIF SUPP PRO; [Anonymous], 2004, ATLS ADV TRAUM LIF S; Balasubramanian S, 2006, ANN TROP PAEDIATR, V26, P95, DOI 10.1179/146532806X107421; BETAU H, 1980, CHUNG HUN MIN KUO HS, V21, P247; Biarent D., 2006, EUROPEAN PAEDIAT LIF; Bradman K, 2008, EUR J EMERG MED, V15, P359, DOI 10.1097/MEJ.0b013e3283026208; DAVIGNON A, 1980, PEDIATR CARDIOL, V1, P123, DOI 10.1007/BF02083144; Duncan H, 2006, J CRIT CARE, V21, P271, DOI 10.1016/j.jcrc.2006.06.007; Egdell P, 2008, EMERG MED J, V25, P745, DOI 10.1136/emj.2007.054965; GEMELLI M, 1990, EUR J PEDIATR, V149, P318, DOI 10.1007/BF02171556; Gilboy N, 2005, EMERGENCY SEVERITY I; Hazinski MF, 1999, MANUAL PEDIAT CRITIC; Heymann MA., 1989, HEART DISEASE INFANT, V4th, P210; LINDNER W, 1985, PEDIATR CARDIOL, V6, P117, DOI 10.1007/BF02336549; MACFARLANE PW, 1994, J ELECTROCARDIOL, V27, P14, DOI 10.1016/S0022-0736(94)80039-1; Monaghan Alan, 2005, Paediatr Nurs, V17, P32; MORLEY CJ, 1990, ARCH DIS CHILD, V65, P834, DOI 10.1136/adc.65.8.834; *NAT COLL CTR WOM, 2007, CG47 NAT COLL CTR WO; Panik M. J., 2005, ADV STAT ELEMENTARY; Parshuram CS, 2009, CRIT CARE, V13, DOI 10.1186/cc7998; Semizel E, 2008, CARDIOL YOUNG, V18, P26, DOI 10.1017/S1047951107001722; Thompson M, 2009, ARCH DIS CHILD, V94, P361, DOI 10.1136/adc.2008.145011; *UN STAT DIV, 1999, STAND COUNTR AR CO M, V49; Wand M.P., 1994, KERNEL SMOOTHING; WARD SLD, 1986, J PEDIATR-US, V109, P631; Warren DW, 2008, CAN J EMERG MED, V10, P224; *WHO, 1991, WHOARI9120	29	643	653	2	64	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 19	2011	377	9770					1011	1018		10.1016/S0140-6736(10)62226-X	http://dx.doi.org/10.1016/S0140-6736(10)62226-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	740FA	21411136	Green Accepted, Green Submitted			2022-12-28	WOS:000288775800030
J	Woods, RJ; Barrick, JE; Cooper, TF; Shrestha, U; Kauth, MR; Lenski, RE				Woods, Robert J.; Barrick, Jeffrey E.; Cooper, Tim F.; Shrestha, Utpala; Kauth, Mark R.; Lenski, Richard E.			Second-Order Selection for Evolvability in a Large Escherichia coli Population	SCIENCE			English	Article							TERM EXPERIMENTAL EVOLUTION; ASEXUAL POPULATIONS; CLONAL INTERFERENCE; BENEFICIAL MUTATIONS; ADAPTATION; GENERATIONS; EPISTASIS; VIRUS	In theory, competition between asexual lineages can lead to second-order selection for greater evolutionary potential. To test this hypothesis, we revived a frozen population of Escherichia coli from a long-term evolution experiment and compared the fitness and ultimate fates of four genetically distinct clones. Surprisingly, two clones with beneficial mutations that would eventually take over the population had significantly lower competitive fitness than two clones with mutations that later went extinct. By replaying evolution many times from these clones, we showed that the eventual winners likely prevailed because they had greater potential for further adaptation. Genetic interactions that reduce the benefit of certain regulatory mutations in the eventual losers appear to explain, at least in part, why they were outcompeted.	[Woods, Robert J.; Lenski, Richard E.] Michigan State Univ, Dept Zool, E Lansing, MI 48824 USA; [Barrick, Jeffrey E.; Kauth, Mark R.; Lenski, Richard E.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Cooper, Tim F.; Shrestha, Utpala] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	Michigan State University; Michigan State University; University of Houston System; University of Houston	Barrick, JE (corresponding author), Univ Texas Austin, Dept Chem & Biochem, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	jbarrick@cm.utexas.edu; lenski@msu.edu	Barrick, Jeffrey/A-3046-2012	Barrick, Jeffrey/0000-0003-0888-7358; Cooper, Timothy/0000-0001-5038-9366; Lenski, Richard/0000-0002-1064-8375; Woods, Robert/0000-0002-0679-9998	NSF [DEB1019989]; Defense Advanced Research Projects Agency [HR0011-09-1-0055]; NIH [K99GM087550]; McDonnell Foundation [220020174]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM087550, R00GM087550] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McDonnell Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NSF (DEB1019989 to R. E. L.), Defense Advanced Research Projects Agency (HR0011-09-1-0055 to R. E. L. and T. F. C), the NIH (K99GM087550 to J.E.B.), and the McDonnell Foundation (220020174 to T. F. C). We thank N. Hajela for laboratory assistance, staff at the Michigan State University (MSU) Research Technology Support Facility for assistance with genome sequencing, and the MSU High-Performance Computing Cluster for computational support. Genome sequencing data have been deposited in the NCBI Short Read Archive (SRA024331).	Barrick JE, 2009, COLD SH Q B, V74, P119, DOI 10.1101/sqb.2009.74.018; Barrick JE, 2010, MOL BIOL EVOL, V27, P1338, DOI 10.1093/molbev/msq024; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Burch CL, 2000, NATURE, V406, P625, DOI 10.1038/35020564; CHAO L, 1983, EVOLUTION, V37, P125, DOI 10.1111/j.1558-5646.1983.tb05521.x; Colegrave N, 2008, HEREDITY, V100, P464, DOI 10.1038/sj.hdy.6801095; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; Cooper TF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040035; Cooper VS, 2001, J BACTERIOL, V183, P2834, DOI 10.1128/JB.183.9.2834-2841.2001; Crozat E, 2005, GENETICS, V169, P523, DOI 10.1534/genetics.104.035717; da Silva J, 2010, GENETICS, V185, P293, DOI 10.1534/genetics.109.112458; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; Elena SF, 1997, EVOLUTION, V51, P1058, DOI 10.1111/j.1558-5646.1997.tb03953.x; Fogle CA, 2008, GENETICS, V180, P2163, DOI 10.1534/genetics.108.090019; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Hansen TF, 2006, ANNU REV ECOL EVOL S, V37, P123, DOI 10.1146/annurev.ecolsys.37.091305.110224; Hegreness M, 2006, SCIENCE, V311, P1615, DOI 10.1126/science.1122469; Kao KC, 2008, NAT GENET, V40, P1499, DOI 10.1038/ng.280; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; McBride RC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-231; Park SC, 2007, P NATL ACAD SCI USA, V104, P18135, DOI 10.1073/pnas.0705778104; Philippe N, 2007, BIOESSAYS, V29, P846, DOI 10.1002/bies.20629; Pigliucci M, 2008, NAT REV GENET, V9, P75, DOI 10.1038/nrg2278; Rozen DE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001715; Sniegowski PD, 2010, PHILOS T R SOC B, V365, P1255, DOI 10.1098/rstb.2009.0290; Stanek MT, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-302; Tenaillon O, 1999, GENETICS, V152, P485; Weinreich DM, 2005, EVOLUTION, V59, P1165; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103; Xu YB, 2001, J BIOL CHEM, V276, P17373, DOI 10.1074/jbc.M100195200	30	221	225	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2011	331	6023					1433	1436		10.1126/science.1198914	http://dx.doi.org/10.1126/science.1198914			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21415350	Green Accepted, Green Submitted			2022-12-28	WOS:000288504000040
J	Di Sabatino, A; Carsetti, R; Corazza, GR				Di Sabatino, Antonio; Carsetti, Rita; Corazza, Gino Roberto			Post-splenectomy and hyposplenic states	LANCET			English	Review							PNEUMOCOCCAL CONJUGATE VACCINE; MEMORY B-CELLS; BONE-MARROW-TRANSPLANTATION; SPLENIC FUNCTION; FUNCTIONAL HYPOSPLENISM; POLYSACCHARIDE VACCINE; ANTIBODY-RESPONSE; STREPTOCOCCUS-PNEUMONIAE; ASPLENIC PATIENTS; CELIAC-DISEASE	The spleen is crucial in regulating immune homoeostasis through its ability to link innate and adaptive immunity and in protecting against infections. The impairment of splenic function is defined as hyposplenism, an acquired disorder caused by several haematological and immunological diseases. The term asplenia refers to the absence of the spleen, a condition that is rarely congenital and mostly post-surgical. Although hyposplenism and asplenia might predispose individuals to thromboembolic events, in this Review we focus on infectious complications, which are the most widely, recognised consequences of these states. Because of the high mortality, the fulminant course, and the refractoriness to common treatment of overwhelming infections caused by encapsulated bacteria, prevention through vaccination and antibiotic prophylaxis is the basis of the management of patients who have had splenectomy or have hyposplenism. In this Review, we critically assess clinical and diagnostic aspects of splenic dysfunction and highlight new perspectives in the prevention of overwhelming post-splenectomy infections.	[Di Sabatino, Antonio; Corazza, Gino Roberto] Univ Pavia, Med Clin, Fdn IRCCS Policlin S Matteo, Dept Med 1, I-27100 Pavia, Italy; [Carsetti, Rita] Bambino Gesu Children Hosp, Cell Dev Lab B, Rome, Italy	IRCCS Fondazione San Matteo; University of Pavia; IRCCS Bambino Gesu	Corazza, GR (corresponding author), Univ Pavia, Med Clin, Fdn IRCCS Policlin S Matteo, Dept Med 1, Piazzale Golgi 5, I-27100 Pavia, Italy.	gr.corazza@smatteo.pv.it	Corazza, Gino Roberto/K-8500-2016; Di Sabatino, Antonio/K-8015-2016; Carsetti, Rita/K-7616-2016	Corazza, Gino Roberto/0000-0001-9532-0573; Di Sabatino, Antonio/0000-0002-0302-8645; Carsetti, Rita/0000-0002-2632-1078				AHONKHAI VI, 1979, NEW ENGL J MED, V301, P26, DOI 10.1056/NEJM197907053010106; Alanee SRJ, 2007, CLIN INFECT DIS, V45, P46, DOI 10.1086/518538; ANAND AJ, 1994, SEMIN ARTHRITIS RHEU, V24, P211, DOI 10.1016/0049-0172(94)90076-0; Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P794; Bader-Meunier B, 2001, BLOOD, V97, P399, DOI 10.1182/blood.V97.2.399; BARRIOS NJ, 1993, J NATL MED ASSOC, V85, P677; BENDER BS, 1985, J INFECT DIS, V152, P409, DOI 10.1093/infdis/152.2.409; Bisharat N, 2001, J INFECTION, V43, P182, DOI 10.1053/jinf.2001.0904; Borrow R, 2001, INFECT IMMUN, V69, P1568, DOI 10.1128/IAI.69.3.1568-1573.2001; Breukels MA, 2001, INFECT IMMUN, V69, P7583, DOI 10.1128/IAI.69.12.7583-7587.2001; Brigden ML, 1999, CRIT CARE MED, V27, P836, DOI 10.1097/00003246-199904000-00050; Brigden ML, 2000, AM J HEMATOL, V65, P25, DOI 10.1002/1096-8652(200009)65:1<25::AID-AJH4>3.3.CO;2-#; Buchbinder JH, 1939, SURGERY, V6, P927; Carsetti R, 2006, J INFECT DIS, V193, P1189, DOI 10.1086/501375; Chan CY, 1996, J INFECT DIS, V173, P256, DOI 10.1093/infdis/173.1.256; Cimaz R, 2001, J INFECT DIS, V183, P1819, DOI 10.1086/320727; CORAZZA GR, 1983, GUT, V24, P228, DOI 10.1136/gut.24.3.228; CORAZZA GR, 1990, CLIN LAB HAEMATOL, V12, P269; CORAZZA GR, 1984, BRIT MED J, V289, P861, DOI 10.1136/bmj.289.6449.861; CORAZZA GR, 1981, CLIN SCI, V60, P109, DOI 10.1042/cs0600109; Corazza GR, 1999, AM J GASTROENTEROL, V94, P391; CORAZZA GR, 1991, LANCET, V337, P12, DOI 10.1016/0140-6736(91)93331-3; Crary SE, 2009, BLOOD, V114, P2861, DOI 10.1182/blood-2009-04-210112; Croxtall Jamie D, 2009, Paediatr Drugs, V11, P349, DOI 10.2165/11202760-000000000-00000; CUTHBERT RJG, 1995, J CLIN PATHOL, V48, P257, DOI 10.1136/jcp.48.3.257; D'Orsogna L, 2009, BIOL BLOOD MARROW TR, V15, P795, DOI 10.1016/j.bbmt.2008.11.024; D'Orsogna LJ, 2007, AIDS, V21, P1747, DOI 10.1097/QAD.0b013e32828642c7; Dagan R, 2008, LANCET INFECT DIS, V8, P785, DOI 10.1016/S1473-3099(08)70281-0; DAMESHEK W, 1955, JAMA-J AM MED ASSOC, V157, P613, DOI 10.1001/jama.1955.02950240051023; Dhawan V, 1977, CLIN NUCL MED, V2, P395; Di Sabatino A, 2006, CLIN GASTROENTEROL H, V4, P179, DOI 10.1016/S1542-3565(05)00982-1; Di Sabatino A, 2005, AM J GASTROENTEROL, V100, P1788, DOI 10.1111/j.1572-0241.2005.41939.x; Di Sabatino A, 2009, AM J GASTROENTEROL, V104, P2641, DOI 10.1038/ajg.2009.349; Di Sabatino A, 2009, LANCET, V373, P1480, DOI 10.1016/S0140-6736(09)60254-3; El-Alfy MS, 2004, HEMATOL J, V5, P77, DOI 10.1038/sj.thj.6200328; Engelhard D, 2002, BRIT J HAEMATOL, V117, P444, DOI 10.1046/j.1365-2141.2002.03457.x; FERGUSON A, 1970, LANCET, V1, P163; FOSTER KJ, 1982, GUT, V23, P630, DOI 10.1136/gut.23.7.630; Fremont RD, 2007, SOUTH MED J, V100, P589, DOI 10.1097/SMJ.0b013e318038d1f8; French N, 2003, J INFECTION, V46, P78, DOI 10.1053/jinf.2002.1113; GASTON MH, 1986, NEW ENGL J MED, V314, P1593, DOI 10.1056/NEJM198606193142501; GROTTO HZW, 1991, AIDS, V5, P1538, DOI 10.1097/00002030-199112000-00024; Hansen K, 2001, PEDIATR DEVEL PATHOL, V4, P105, DOI 10.1007/s100240010145; Harrod VL, 2007, EXP HEMATOL, V35, P179, DOI 10.1016/j.exphem.2006.09.013; Hart M, 2007, J IMMUNOL, V178, P8212, DOI 10.4049/jimmunol.178.12.8212; HOLDSWORTH RJ, 1991, BRIT J SURG, V78, P1031, DOI 10.1002/bjs.1800780904; HOLROYDE CP, 1969, NEW ENGL J MED, V281, P516, DOI 10.1056/NEJM196909042811002; Jansen AGSC, 2009, CLIN INFECT DIS, V49, pE23, DOI 10.1086/600045; JOHN AB, 1984, BRIT MED J, V288, P1567, DOI 10.1136/bmj.288.6430.1567; KALHS P, 1988, ANN INTERN MED, V109, P461, DOI 10.7326/0003-4819-109-6-461; Kaplinsky C, 2006, PEDIATR BLOOD CANCER, V47, P740, DOI 10.1002/pbc.21014; KING H, 1952, ANN SURG, V136, P239, DOI 10.1097/00000658-195208000-00006; KONRADSEN HB, 1991, ACTA PAEDIATR SCAND, V80, P423, DOI 10.1111/j.1651-2227.1991.tb11877.x; Kroon FP, 2000, VACCINE, V19, P886, DOI 10.1016/S0264-410X(00)00232-2; Kruetzmann S, 2003, J EXP MED, V197, P939, DOI 10.1084/jem.20022020; Kulkarni S, 2000, BLOOD, V95, P3683; LANE PA, 1995, BLOOD, V85, P2238, DOI 10.1182/blood.V85.8.2238.bloodjournal8582238; Leach A, 1997, J INFECT DIS, V175, P200, DOI 10.1093/infdis/175.1.200; Lee CJ, 2001, VACCINE, V19, P3216, DOI 10.1016/S0264-410X(01)00033-0; Ludvigsson JF, 2008, GUT, V57, P1074, DOI 10.1136/gut.2007.133868; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Melles DC, 2004, NETH J MED, V62, P45; Mikoluc B, 2008, EUR J CLIN MICROBIOL, V27, P923, DOI 10.1007/s10096-008-0523-5; Moens L, 2008, J IMMUNOL, V181, P5306, DOI 10.4049/jimmunol.181.8.5306; Morris DH, 1919, ANN SURG, V70, P513, DOI 10.1097/00000658-191911000-00001; MULLEN CA, 1993, BLOOD, V82, P2961; MULLER AF, 1994, GUT, V35, P679, DOI 10.1136/gut.35.5.679; Musher DM, 2005, J INFECT DIS, V191, P1063, DOI 10.1086/428135; NEILAN BA, 1983, J RHEUMATOL, V10, P332; OGRADY JG, 1984, GASTROENTEROLOGY, V87, P1326; Orthopoulos GV, 2009, VACCINE, V27, P350, DOI 10.1016/j.vaccine.2008.10.070; PEARSON HA, 1979, BLOOD, V53, P358; PEARSON HA, 1978, NEW ENGL J MED, V298, P1389, DOI 10.1056/NEJM197806222982504; PEARSON HA, 1985, PEDIATRICS, V76, P392; PEARSON HA, 1969, NEW ENGL J MED, V281, P923, DOI 10.1056/NEJM196910232811703; Pebody RG, 2008, EPIDEMIOL INFECT, V136, P360, DOI 10.1017/S0950268807008436; PEDERSEN FK, 1982, ACTA PAEDIATR SCAND, V71, P451, DOI 10.1111/j.1651-2227.1982.tb09451.x; PETERS AM, 1981, SCAND J HAEMATOL, V27, P374; Peters U, 2003, ARCH INTERN MED, V163, P1566, DOI 10.1001/archinte.163.13.1566; Picardi M, 1999, BONE MARROW TRANSPL, V24, P173, DOI 10.1038/sj.bmt.1701861; POWARS D, 1990, SEMIN HEMATOL, V27, P360; POWARS DR, 1984, BLOOD, V63, P921, DOI 10.1182/blood.V63.4.921.921; Powsner RA, 1998, J NUCL MED, V39, P221; Quinn CT, 2010, BLOOD, V115, P3447, DOI 10.1182/blood-2009-07-233700; ROBINETTE CD, 1977, LANCET, V2, P127; Santos A, 2002, EUR J NUCL MED MOL I, V29, P536, DOI 10.1007/s00259-001-0738-5; SCHWARTZ PE, 1982, JAMA-J AM MED ASSOC, V248, P2279, DOI 10.1001/jama.248.18.2279; Scott DA, 2007, VACCINE, V25, P6164, DOI 10.1016/j.vaccine.2007.06.004; Shatz DV, 2005, EXPERT REV VACCINES, V4, P27, DOI 10.1586/14760584.4.1.27; Shatz DV, 2002, J TRAUMA, V53, P1037, DOI 10.1097/00005373-200212000-00001; Sheikha AK, 2007, CAN J SURG, V50, P382; Shi YH, 2005, J IMMUNOL, V175, P3262, DOI 10.4049/jimmunol.175.5.3262; SILLS RH, 1987, CRC CR REV ONCOL-HEM, V7, P1, DOI 10.1016/S1040-8428(87)80012-4; SPENCER RP, 1989, CRIT REV CL LAB SCI, V27, P299, DOI 10.3109/10408368909105717; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Thomas HJ, 2008, EUR J GASTROEN HEPAT, V20, P624, DOI 10.1097/MEG.0b013e3282f45764; TIMENS W, 1992, ANN SURG, V215, P256, DOI 10.1097/00000658-199203000-00010; TRAUB A, 1987, NEW ENGL J MED, V317, P1559, DOI 10.1056/NEJM198712173172503; Vernacchio L, 1998, J PEDIATR-US, V133, P275, DOI 10.1016/S0022-3476(98)70235-5; Vernacchio L, 2000, J INFECT DIS, V181, P1162, DOI 10.1086/315307; Waghorn DJ, 2001, J CLIN PATHOL, V54, P214, DOI 10.1136/jcp.54.3.214; Wang WC, 2001, J PEDIATR-US, V139, P790, DOI 10.1067/mpd.2001.119590; Wasserstrom H, 2008, J IMMUNOL, V181, P3684, DOI 10.4049/jimmunol.181.5.3684; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Weller S, 2001, P NATL ACAD SCI USA, V98, P1166, DOI 10.1073/pnas.98.3.1166; William BM, 2007, HEMATOLOGY, V12, P89, DOI 10.1080/10245330600938463; William BM, 2007, HEMATOLOGY, V12, P1, DOI 10.1080/10245330600938422; Woolley I, 2006, AUST NZ J PUBL HEAL, V30, P558, DOI 10.1111/j.1467-842X.2006.tb00786.x	108	374	384	2	39	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 2	2011	378	9785					86	97		10.1016/S0140-6736(10)61493-6	http://dx.doi.org/10.1016/S0140-6736(10)61493-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791IU	21474172				2022-12-28	WOS:000292659700037
J	Safavi-Naeini, AH; Alegre, TPM; Chan, J; Eichenfield, M; Winger, M; Lin, Q; Hill, JT; Chang, DE; Painter, O				Safavi-Naeini, A. H.; Alegre, T. P. Mayer; Chan, J.; Eichenfield, M.; Winger, M.; Lin, Q.; Hill, J. T.; Chang, D. E.; Painter, O.			Electromagnetically induced transparency and slow light with optomechanics	NATURE			English	Article							RESONATOR; STATE	Controlling the interaction between localized optical and mechanical excitations has recently become possible following advances in micro-and nanofabrication techniques(1,2). So far, most experimental studies of optomechanics have focused on measurement and control of the mechanical subsystem through its interaction with optics, and have led to the experimental demonstration of dynamical back-action cooling and optical rigidity of the mechanical system(1,3). Conversely, the optical response of these systems is also modified in the presence of mechanical interactions, leading to effects such as electromagnetically induced transparency(4) (EIT) and parametric normal-mode splitting(5). In atomic systems, studies(6,7) of slow and stopped light (applicable to modern optical networks(8) and future quantum networks(9)) have thrust EIT to the forefront of experimental study during the past two decades. Here we demonstrate EIT and tunable optical delays in a nanoscale optomechanical crystal, using the optomechanical nonlinearity to control the velocity of light by way of engineered photon-phonon interactions. Our device is fabricated by simply etching holes into a thin film of silicon. At low temperature (8.7 kelvin), we report an optically tunable delay of 50 nanoseconds with near-unity optical transparency, and superluminal light with a 1.4 microsecond signal advance. These results, while indicating significant progress towards an integrated quantum optomechanical memory(10), are also relevant to classical signal processing applications. Measurements at room temperature in the analogous regime of electromagnetically induced absorption show the utility of these chip-scale optomechanical systems for optical buffering, amplification, and filtering of microwave-over-optical signals.	[Safavi-Naeini, A. H.; Alegre, T. P. Mayer; Chan, J.; Eichenfield, M.; Winger, M.; Lin, Q.; Hill, J. T.; Painter, O.] CALTECH, Thomas J Watson Sr Lab Appl Phys, Pasadena, CA 91125 USA; [Chang, D. E.] CALTECH, Inst Quantum Informat, Pasadena, CA 91125 USA; [Chang, D. E.] CALTECH, Ctr Phys Informat, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology	Painter, O (corresponding author), CALTECH, Thomas J Watson Sr Lab Appl Phys, Pasadena, CA 91125 USA.	opainter@caltech.edu	Chan, Jasper/E-6801-2011; Alegre, Thiago/B-1505-2012; Hill, Jeffrey/A-5027-2013	Alegre, Thiago/0000-0002-8999-8369; Hill, Jeffrey/0000-0001-6330-2354; Safavi-Naeini, Amir H./0000-0001-6176-1274; Painter, Oskar/0000-0002-1581-9209	DARPA/MTO ORCHID through AFOSR; Kavli Nanoscience Institute at Caltech; NSERC	DARPA/MTO ORCHID through AFOSR(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Kavli Nanoscience Institute at Caltech; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank K. Schwab for providing the microwave modulation source used in this work. This work was supported by the DARPA/MTO ORCHID programme through a grant from AFOSR, and the Kavli Nanoscience Institute at Caltech. A.H.S.-N. and J.C. acknowledge support from NSERC.	Afzelius M, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.052329; Bigelow MS, 2003, SCIENCE, V301, P200, DOI 10.1126/science.1084429; Boyd RW, 2009, SCIENCE, V326, P1074, DOI 10.1126/science.1170885; Braginsky V. B., 1977, MEASUREMENT WEAK FOR; Chang DE, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/023003; de Riedmatten H, 2008, NATURE, V456, P773, DOI 10.1038/nature07607; Eichenfield M, 2009, NATURE, V462, P78, DOI 10.1038/nature08524; Favero I, 2009, NAT PHOTONICS, V3, P201, DOI 10.1038/NPHOTON.2009.42; Fleischhauer M, 2005, REV MOD PHYS, V77, P633, DOI 10.1103/RevModPhys.77.633; Groblacher S, 2009, NATURE, V460, P724, DOI 10.1038/nature08171; Hau LV, 1999, NATURE, V397, P594, DOI 10.1038/17561; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Kippenberg TJ, 2008, SCIENCE, V321, P1172, DOI 10.1126/science.1156032; Lakin KM, 1995, IEEE T MICROW THEORY, V43, P2933, DOI 10.1109/22.475658; Lezama A, 1999, PHYS REV A, V59, P4732, DOI 10.1103/PhysRevA.59.4732; Li M, 2008, NATURE, V456, P480, DOI 10.1038/nature07545; Nguyen CTC, 2007, IEEE T ULTRASON FERR, V54, P251, DOI 10.1109/TUFFC.2007.240; Notomi M, 2008, NAT PHOTONICS, V2, P741, DOI 10.1038/nphoton.2008.226; Phillips MC, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.183602; Rocheleau T, 2010, NATURE, V463, P72, DOI 10.1038/nature08681; Safavi-Naeini AH, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/1/013017; Santori C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.247401; Stannigel K, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.220501; Teufel J. D., 2011, NATURE          0310, DOI [10.1038/nature09898, DOI 10.1038/NATURE09898]; Thevenaz L, 2008, NAT PHOTONICS, V2, P474, DOI 10.1038/nphoton.2008.147; Weis S, 2010, SCIENCE, V330, P1520, DOI 10.1126/science.1195596; Xu QF, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.123901; Xu XD, 2008, NAT PHYS, V4, P692, DOI 10.1038/nphys1054; Yanik MF, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.173903; Zhang R, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.233602	30	1034	1050	10	453	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2011	472	7341					69	73		10.1038/nature09933	http://dx.doi.org/10.1038/nature09933			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21412237	Green Accepted, Green Submitted			2022-12-28	WOS:000289199400038
J	Ashworth, A; Lord, CJ; Reis, JS				Ashworth, Alan; Lord, Christopher J.; Reis-Filho, Jorge S.			Genetic Interactions in Cancer Progression and Treatment	CELL			English	Article							ONCOGENE-INDUCED SENESCENCE; BREAST-CANCER; EXPRESSION PROFILES; STEM-CELLS; GENOME; TUMORS; RESISTANCE; MUTATIONS; THERAPY; INHIBITORS	As cancer cell genomes are unveiled at a breathtaking pace, the genetic principles at play in cancer are emerging in all their complexity, prompting the assessment of classical genetic interaction models. Here, we discuss the implications of these findings for cancer progression and heterogeneity and for the development of new therapeutic approaches.	[Ashworth, Alan; Lord, Christopher J.; Reis-Filho, Jorge S.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Ashworth, A (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, Fulham Rd, London SW3 6JB, England.	alan.ashworth@icr.ac.uk; chris.lord@icr.ac.uk; jorge.reis-filho@icr.ac.uk	Lord, Christopher/AAX-7130-2021; Lord, Christopher J/B-3295-2012	Lord, Christopher J/0000-0002-3226-0515	NHS; CRUK	NHS; CRUK(Cancer Research UK)	We thank Breakthrough Breast Cancer, Cancer Research UK, The Breast Cancer Campaign, The Breast Cancer Research Foundation, AACR, and The Komen Foundation for their continued support. We acknowledge NHS funding to the NIHR Royal Marsden Hospital Biomedical Research Centre. J.S.R.-F. is the recipient of the 2010 CRUK Future Leaders Prize.	Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Ashworth A, 2008, J CLIN ONCOL, V26, P3785, DOI 10.1200/JCO.2008.16.0812; Ashworth A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003327; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Calbo J, 2011, CANCER CELL, V19, P244, DOI 10.1016/j.ccr.2010.12.021; Connor F, 1997, NAT GENET, V17, P423, DOI 10.1038/ng1297-423; Davies MA, 2010, ONCOGENE, V29, P5545, DOI 10.1038/onc.2010.323; Davies M, 2006, EXPERT OPIN PHARMACO, V7, P2243, DOI 10.1517/14656566.7.16.2243; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; DOBZHANSKY T, 1946, GENETICS, V31, P269; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Foulkes WD, 2010, NAT REV CLIN ONCOL, V7, P348, DOI 10.1038/nrclinonc.2010.39; Geyer FC, 2010, J PATHOL, V220, P562, DOI 10.1002/path.2675; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gibson G, 2000, BIOESSAYS, V22, P372, DOI 10.1002/(SICI)1521-1878(200004)22:4<372::AID-BIES7>3.0.CO;2-J; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Janeway KA, 2011, P NATL ACAD SCI USA, V108, P314, DOI 10.1073/pnas.1009199108; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Johnston SRD, 2003, NAT REV CANCER, V3, P821, DOI 10.1038/nrc1211; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lannon CL, 2005, SEMIN CANCER BIOL, V15, P215, DOI 10.1016/j.semcancer.2005.01.003; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Lord CJ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-38; LUCCHESI JC, 1968, GENETICS, V59, P37; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Michor F, 2004, NAT REV CANCER, V4, P197, DOI 10.1038/nrc1295; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Santarosa M, 2004, BBA-REV CANCER, V1654, P105, DOI 10.1016/j.bbcan.2004.01.001; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Tischler J, 2008, NAT GENET, V40, P390, DOI 10.1038/ng.114; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; WADDINGTON CH, 1959, NATURE, V183, P1654, DOI 10.1038/1831654a0; Weigelt B, 2003, P NATL ACAD SCI USA, V100, P15901, DOI 10.1073/pnas.2634067100; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Young AP, 2008, NAT CELL BIOL, V10, P361, DOI 10.1038/ncb1699	61	292	299	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2011	145	1					30	38		10.1016/j.cell.2011.03.020	http://dx.doi.org/10.1016/j.cell.2011.03.020			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458666	Bronze			2022-12-28	WOS:000289053900007
J	Hecht, SS				Hecht, Stephen S.			PERSPECTIVE Tackling the real issues	NATURE			English	Editorial Material									Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Hecht, SS (corresponding author), Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA.	hecht002@umn.edu		Hecht, Stephen/0000-0001-7228-1356				Boyle P., 2008, World Cancer Report 2008; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; United States Department of Health and Human Services, 2010, TOB SMOK CAUS DIS, P221	4	0	0	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					S18	S18		10.1038/471S18a	http://dx.doi.org/10.1038/471S18a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430714	Bronze			2022-12-28	WOS:000288702200015
J	Leinwand, LA; Moss, RL				Leinwand, Leslie A.; Moss, Richard L.			Chemically Tuned Myosin Motors	SCIENCE			English	Editorial Material							HEAVY-CHAIN; CONTRACTILE KINETICS; EXPRESSION; MYOCARDIUM; HEART		[Leinwand, Leslie A.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Moss, Richard L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, Madison, WI 53705 USA	University of Colorado System; University of Colorado Boulder; University of Wisconsin System; University of Wisconsin Madison	Leinwand, LA (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	leinwand@colorado.edu		LEINWAND, LESLIE/0000-0003-1470-4810				BARANY M, 1967, J GEN PHYSIOL, V50, P197, DOI 10.1085/jgp.50.6.197; Korte FS, 2005, AM J PHYSIOL-HEART C, V289, pH801, DOI 10.1152/ajpheart.01227.2004; Locher MR, 2011, AM J PHYSIOL-HEART C, V300, pH869, DOI 10.1152/ajpheart.00452.2010; Locher MR, 2009, AM J PHYSIOL-HEART C, V297, pH247, DOI 10.1152/ajpheart.00922.2008; Lowes BD, 2002, NEW ENGL J MED, V346, P1357, DOI 10.1056/NEJMoa012630; Malik FI, 2011, SCIENCE, V331, P1439, DOI 10.1126/science.1200113; Miyata S, 2000, CIRC RES, V86, P386, DOI 10.1161/01.RES.86.4.386; Peterson JN, 1996, ANN NY ACAD SCI, V793, P54, DOI 10.1111/j.1749-6632.1996.tb33504.x; Sweeney HL, 2010, ANNU REV BIOPHYS, V39, P539, DOI 10.1146/annurev.biophys.050708.133751	9	6	7	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2011	331	6023					1392	1393		10.1126/science.1204207	http://dx.doi.org/10.1126/science.1204207			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21415340				2022-12-28	WOS:000288504000024
J	Boothroyd, AT; Babkevich, P; Prabhakaran, D; Freeman, PG				Boothroyd, A. T.; Babkevich, P.; Prabhakaran, D.; Freeman, P. G.			An hour-glass magnetic spectrum in an insulating, hole-doped antiferromagnet	NATURE			English	Article							HIGH-TEMPERATURE SUPERCONDUCTOR; COPPER-OXIDE SUPERCONDUCTORS; SPIN DYNAMICS; EXCITATIONS; STRIPES; TRANSITION; STATE	Superconductivity in layered copper oxide compounds emerges when charge carriers are added to antiferromagnetically ordered CuO(2) layers(1). The carriers destroy the antiferromagnetic order, but strong spin fluctuations persist throughout the superconducting phase and are intimately linked to superconductivity(2). Neutron scattering measurements of spin fluctuations in hole-doped copper oxides have revealed an unusual 'hour-glass' feature in the momentum-resolved magnetic spectrum that is present in a wide range of superconducting and non-superconducting materials(3-15). There is no widely accepted explanation for this feature. One possibility is that it derives from a pattern of alternating spin and charge stripes(16), and this idea is supported by measurements on stripe-ordered La(1.875)Ba(0.125)CuO(4) (ref. 15). Many copper oxides without stripe order, however, also exhibit an hour-glass spectrum(3-12). Here we report the observation of an hour-glass magnetic spectrum in a hole-doped antiferromagnet from outside the family of superconducting copper oxides. Our system has stripe correlations and is an insulator, which means that its magnetic dynamics can conclusively be ascribed to stripes. The results provide compelling evidence that the hour-glass spectrum in the copper oxide superconductors arises from fluctuating stripes.	[Boothroyd, A. T.; Babkevich, P.; Prabhakaran, D.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Babkevich, P.] Paul Scherrer Inst, Neutron Scattering Lab, CH-5232 Villigen, Switzerland; [Freeman, P. G.] Inst Max Von Laue Paul Langevin, F-38042 Grenoble 9, France	University of Oxford; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Institut Laue-Langevin (ILL)	Boothroyd, AT (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England.	a.boothroyd@physics.ox.ac.uk	Freeman, Paul G/F-5372-2014; Prabhakaran, Dorairaj/B-4147-2011; Boothroyd, Andrew/AAA-7883-2021	Freeman, Paul G/0000-0002-5376-8940; Prabhakaran, Dorairaj/0000-0002-3172-834X; Boothroyd, Andrew/0000-0002-3575-7471	Engineering and Physical Sciences Research Council of Great Britain; Paul Scherrer Institut, Switzerland; Engineering and Physical Sciences Research Council [EP/H033939/1, EP/F001266/1] Funding Source: researchfish; EPSRC [EP/H033939/1, EP/F001266/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council of Great Britain(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Paul Scherrer Institut, Switzerland; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank F. Essler and E. W. Carlson for discussions. This work was supported by the Engineering and Physical Sciences Research Council of Great Britain and the Paul Scherrer Institut, Switzerland.	Arai M, 1999, PHYS REV LETT, V83, P608, DOI 10.1103/PhysRevLett.83.608; Babkevich P, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.184425; Bourges P, 2000, SCIENCE, V288, P1234, DOI 10.1126/science.288.5469.1234; CHEN CH, 1993, PHYS REV LETT, V71, P2461, DOI 10.1103/PhysRevLett.71.2461; Christensen NB, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.147002; Chubukov AV, 2003, PHYSICS OF SUPERCONDUCTORS, VOL I, P495; Cwik M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.057201; Fauque B, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.214512; Hayden SM, 2004, NATURE, V429, P531, DOI 10.1038/nature02576; HAYDEN SM, 2008, SUPERCONDUCTIVITY CO, V2, P993; Helme LM, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.134414; Hinkov V, 2007, NAT PHYS, V3, P780, DOI 10.1038/nphys720; Hollmann N, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/2/023018; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Lipscombe OJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.167002; Matsuda M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.197001; Moritomo Y, 1997, PHYS REV B, V55, P14725, DOI 10.1103/PhysRevB.55.R14725; Reznik D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.207003; Stock C, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.024522; TRANQUADA JM, 1994, PHYS REV LETT, V73, P1003, DOI 10.1103/PhysRevLett.73.1003; Tranquada JM, 2004, NATURE, V429, P534, DOI 10.1038/nature02574; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Vignolle B, 2007, NAT PHYS, V3, P163, DOI 10.1038/nphys546; Vojta M, 2009, ADV PHYS, V58, P699, DOI 10.1080/00018730903122242; Xu GY, 2009, NAT PHYS, V5, P642, DOI 10.1038/NPHYS1360; YAMADA K, 1989, PHYS REV B, V39, P2336, DOI 10.1103/PhysRevB.39.2336; Yao DX, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.017003; Yoshizawa H, 2000, PHYS REV B, V61, pR854, DOI 10.1103/PhysRevB.61.R854	29	51	51	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2011	471	7338					341	344		10.1038/nature09902	http://dx.doi.org/10.1038/nature09902			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21412334	Green Submitted			2022-12-28	WOS:000288444000037
J	Rubinow, KB; Hirsch, IB				Rubinow, Katya B.; Hirsch, Irl B.			Reexamining Metrics for Glucose Control	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ESTIMATED AVERAGE GLUCOSE; BLOOD-GLUCOSE; 1,5-ANHYDROGLUCITOL; RISK		[Rubinow, Katya B.; Hirsch, Irl B.] Univ Washington, Dept Internal Med, Div Metab Endocrinol & Nutr, Seattle, WA 98095 USA	University of Washington; University of Washington Seattle	Hirsch, IB (corresponding author), Univ Washington, Dept Internal Med, Div Metab Endocrinol & Nutr, 4225 Roosevelt Ave NE,Ste 101, Seattle, WA 98095 USA.	ihirsch@uw.edu						Cohen RM, 2008, DIABETES CARE, V31, P151, DOI 10.2337/dc07-1465; Hempe JM, 2010, DIABETES CARE, V33, P1449, DOI 10.2337/dc09-1498; Herman WH, 2009, J CLIN ENDOCR METAB, V94, P1689, DOI 10.1210/jc.2008-1940; Lachin JM, 2007, DIABETES, V56, P1913, DOI 10.2337/db07-0028; Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545; Roohk H Vernon, 2008, J Diabetes Sci Technol, V2, P1114; Saudek CD, 2006, JAMA-J AM MED ASSOC, V295, P1688, DOI 10.1001/jama.295.14.1688; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; YAMANOUCHI T, 1991, DIABETES, V40, P52, DOI 10.2337/diabetes.40.1.52	10	25	25	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2011	305	11					1132	1133		10.1001/jama.2011.314	http://dx.doi.org/10.1001/jama.2011.314			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734ZF	21406652				2022-12-28	WOS:000288381900027
J	McGilchrist, I				McGilchrist, Iain			The Art of Medicine Paying attention to the bipartite brain	LANCET			English	Editorial Material												iain.mcgilchrist@all-souls.ox.ac.uk						MCGILCHRIST I, 2010, DIALOG CLIN NEUROSCI, V12, P317; McGilchrist I., 2009, MASTER HIS EMISSARY; McNeill D, 1992, HAND MIND WHAT GESTU; Rogers LJ, 2002, COMP VERTEBRATE LATE; Vallortigara G, 2000, BRAIN LANG, V73, P189, DOI 10.1006/brln.2000.2303	5	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2011	377	9771					1068	1069		10.1016/S0140-6736(11)60422-4	http://dx.doi.org/10.1016/S0140-6736(11)60422-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	743QY	21449085				2022-12-28	WOS:000289035000015
J	DeSantis, A				DeSantis, Anthony			Update in endocrinology: evidence published in 2010	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Washington, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	DeSantis, A (corresponding author), Univ Washington, Seattle, WA 98195 USA.	ad29@u.washington.edu							0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 17	2011	154	10					684	689		10.7326/0003-4819-154-10-201105170-00340	http://dx.doi.org/10.7326/0003-4819-154-10-201105170-00340			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	764HK	21464340				2022-12-28	WOS:000290620300030
J	Huh, JR; Leung, MWL; Huang, PX; Ryan, DA; Krout, MR; Malapaka, RRV; Chow, J; Manel, N; Ciofani, M; Kim, SV; Cuesta, A; Santori, FR; Lafaille, JJ; Xu, HE; Gin, DY; Rastinejad, F; Littman, DR				Huh, Jun R.; Leung, Monica W. L.; Huang, Pengxiang; Ryan, Daniel A.; Krout, Michael R.; Malapaka, Raghu R. V.; Chow, Jonathan; Manel, Nicolas; Ciofani, Maria; Kim, Sangwon V.; Cuesta, Adolfo; Santori, Fabio R.; Lafaille, Juan J.; Xu, H. Eric; Gin, David Y.; Rastinejad, Fraydoon; Littman, Dan R.			Digoxin and its derivatives suppress T(H)17 cell differentiation by antagonizing ROR gamma t activity	NATURE			English	Article							GENOME-WIDE ASSOCIATION; CARDIAC-GLYCOSIDES; THERAPEUTIC APPLICATIONS; AUTOIMMUNE INFLAMMATION; SODIUM/POTASSIUM-ATPASE; LIGAND-BINDING; BETA; IL-23; ALPHA; POPULATIONS	CD4(+) T helper lymphocytes that express interleukin-17 (T(H)17 cells) have critical roles in mouse models of autoimmunity, and there is mounting evidence that they also influence inflammatory processes in humans. Genome-wide association studies in humans have linked genes involved in T(H)17 cell differentiation and function with susceptibility to Crohn's disease, rheumatoid arthritis and psoriasis(1-3). Thus, the pathway towards differentiation of T(H)17 cells and, perhaps, of related innate lymphoid cells with similar effector functions(4,5), is an attractive target for therapeutic applications. Mouse and human T(H)17 cells are distinguished by expression of the retinoic acid receptor-related orphan nuclear receptor ROR gamma t, which is required for induction of IL-17 transcription and for the manifestation of T(H)17-dependent autoimmune disease in mice(6). By performing a chemical screen with an insect cell-based reporter system, we identified the cardiac glycoside digoxin as a specific inhibitor of ROR gamma t transcriptional activity. Digoxin inhibited murine T(H)17 cell differentiation without affecting differentiation of other T cell lineages and was effective in delaying the onset and reducing the severity of autoimmune disease in mice. At high concentrations, digoxin is toxic for human cells, but non-toxic synthetic derivatives 20,22-dihydrodigoxin-21,23-diol and digoxin-21-salicylidene specifically inhibited induction of IL-17 in human CD4(+) T cells. Using these small-molecule compounds, we demonstrate that ROR gamma t is important for the maintenance of IL-17 expression in mouse and human effector T cells. These data indicate that derivatives of digoxin can be used as chemical templates for the development of ROR gamma t-targeted therapeutic agents that attenuate inflammatory lymphocyte function and autoimmune disease.	[Huh, Jun R.; Leung, Monica W. L.; Chow, Jonathan; Manel, Nicolas; Ciofani, Maria; Kim, Sangwon V.; Cuesta, Adolfo; Santori, Fabio R.; Lafaille, Juan J.; Littman, Dan R.] NYU, Sch Med, Mol Pathogenesis Program, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY 10016 USA; [Huang, Pengxiang; Rastinejad, Fraydoon] Sanford Burnham Med Res Inst Lake Nona, Orlando, FL 32827 USA; [Ryan, Daniel A.; Krout, Michael R.; Gin, David Y.] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10065 USA; [Malapaka, Raghu R. V.; Xu, H. Eric] Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Chow, Jonathan; Cuesta, Adolfo; Littman, Dan R.] NYU, Howard Hughes Med Inst, Sch Med, New York, NY 10016 USA	New York University; Sanford Burnham Prebys Medical Discovery Institute; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; New York University	Littman, DR (corresponding author), NYU, Sch Med, Mol Pathogenesis Program, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY 10016 USA.	Dan.Littman@med.nyu.edu	Santori, Fabio/GRF-1002-2022; Manel, Nicolas/E-2128-2011; Malapaka, Raghu/B-6185-2012; Xu, H. Eric/ABD-7487-2021; Kim, Sangwon V./S-1166-2016	Manel, Nicolas/0000-0002-1481-4430; Ciofani, Maria/0000-0001-6472-5260; Santori, Fabio/0000-0002-0220-8935; Krout, Michael/0000-0002-0539-6986; Chow, Jonathan/0000-0002-4321-2420; Xu, H. Eric/0000-0002-6829-8144; Kim, Sangwon V./0000-0001-8453-7080	Jane Coffin Childs Memorial Funds; Howard Hughes Medical Institute; National Institutes of Health [F32GM0860552, RO1GM058833, RO1GM067659, 2RO1GM55217, RO1AI080885]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058833, R01GM055217, R01GM067659] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Funds; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Shamu at ICCB-Longwood for screening small-compound libraries. We also thank the New York Cord Blood Center for providing samples, the Developmental Studies Hybridoma Bank for beta-tubulin antibody, the NYU Cancer Institute Genomics Facility for expert assistance with microarray experiments, V. Kuchroo and M. Oukka for the IL-23R GFP reporter mice, T. Iwaki, C. Thummel and R. Dasgupta for plasmids, M. Garabedian for R1881 and plasmids, D. Mangelsdorf for dafachronic acid and plasmids, G. Diehl and M. Sellars for reading the manuscript, M. Menager and J. Johnson for sharing peripheral blood mononuclear cells, and members of the D. R. L. laboratory for their suggestions. Supported by the Jane Coffin Childs Memorial Funds (J. R. H.), the Howard Hughes Medical Institute (D. R. L.) and National Institutes of Health grants F32GM0860552 (M. R. K.), RO1GM058833 (D.Y.G.), RO1GM067659 (D.Y.G), 2RO1GM55217 (F. R.) and RO1AI080885 (D.R.L.).	Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Bagrov AY, 2008, NAT CLIN PRACT NEPHR, V4, P378, DOI 10.1038/ncpneph0848; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jin LH, 2010, MOL ENDOCRINOL, V24, P923, DOI 10.1210/me.2009-0507; Johansson S, 2001, ANTI-CANCER DRUG, V12, P475, DOI 10.1097/00001813-200106000-00009; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; LINDENBAUM J, 1981, NEW ENGL J MED, V305, P789, DOI 10.1056/NEJM198110013051403; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mijatovic T, 2007, BBA-REV CANCER, V1776, P32, DOI 10.1016/j.bbcan.2007.06.002; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nesher M, 2007, LIFE SCI, V80, P2093, DOI 10.1016/j.lfs.2007.03.013; Paula S, 2005, BIOCHEMISTRY-US, V44, P498, DOI 10.1021/bi048680w; Prassas I, 2008, NAT REV DRUG DISCOV, V7, P926, DOI 10.1038/nrd2682; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; ROBERTSON LW, 1986, APPL ENVIRON MICROB, V51, P1300, DOI 10.1128/AEM.51.6.1300-1303.1986; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Stehlin C, 2001, EMBO J, V20, P5822, DOI 10.1093/emboj/20.21.5822; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zavareh RB, 2008, CANCER RES, V68, P6688, DOI 10.1158/0008-5472.CAN-07-6833; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	30	397	431	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2011	472	7344					486	490		10.1038/nature09978	http://dx.doi.org/10.1038/nature09978			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21441909	Green Accepted			2022-12-28	WOS:000289949600037
J	Oh, JS; Susor, A; Conti, M				Oh, Jeong Su; Susor, Andrej; Conti, Marco			Protein Tyrosine Kinase Wee1B Is Essential for Metaphase II Exit in Mouse Oocytes	SCIENCE			English	Article							ACTIVATION; EGG; PHOSPHORYLATION; RESUMPTION; ARREST; CDC20	Waves of cyclin synthesis and degradation regulate the activity of Cdc2 protein kinase during the cell cycle. Cdc2 inactivation by Wee1B-mediated phosphorylation is necessary for arrest of the oocyte at G2-prophase, but it is unclear whether this regulation functions later during the metaphase-to-anaphase transition. We show that reactivation of a Wee1B pathway triggers the decrease in Cdc2 activity during egg activation. When Wee1B is down-regulated, oocytes fail to form a pronucleus in response to Ca2+ signals. Calcium-calmodulin-dependent kinase II (CaMKII) activates Wee1B, and CaMKII-driven exit from metaphase II is inhibited by Wee1B down-regulation, demonstrating that exit from metaphase requires not only a proteolytic degradation of cyclin B but also the inhibitory phosphorylation of Cdc2 by Wee1B.	[Conti, Marco] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Ctr Reprod Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Conti, M (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Ctr Reprod Sci, San Francisco, CA 94143 USA.	contim@obgyn.ucsf.edu			NIH [GM080527-05, HD052909]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD052909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080527] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. J. Han for Wee1B plasmids, K. T. Jones for cyclin B plasmids, and T. Lorca for the CaMKII plasmid. This work was supported by NIH grants GM080527-05 and HD052909. J.O. designed, performed, and analyzed most of the experiments in this study. A. S. performed immunostaining. M.C. conceived the project and supervised the study. J.O. and M.C. wrote the manuscript.	BACHVAROVA R, 1985, DEV BIOL, V108, P325, DOI 10.1016/0012-1606(85)90036-3; D'Angiolella V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000247; Han SJ, 2005, CURR BIOL, V15, P1670, DOI 10.1016/j.cub.2005.07.056; Hutchins JRA, 2003, MOL BIOL CELL, V14, P4003, DOI 10.1091/mbc.E03-02-0061; Jones KT, 2005, REPRODUCTION, V130, P813, DOI 10.1530/rep.1.00710; KLINE D, 1992, DEV BIOL, V149, P80, DOI 10.1016/0012-1606(92)90265-I; Lew DJ, 1996, CURR OPIN CELL BIOL, V8, P795, DOI 10.1016/S0955-0674(96)80080-9; Madgwick S, 2005, J CELL SCI, V118, P3849, DOI 10.1242/jcs.02506; Oh JS, 2010, J CELL BIOL, V188, P199, DOI 10.1083/jcb.200907161; Pomerening JR, 2008, MOL BIOL CELL, V19, P3426, DOI 10.1091/mbc.E08-02-0172; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Shoji S, 2006, EMBO J, V25, P834, DOI 10.1038/sj.emboj.7600953; Sveiczer A, 1999, J CELL SCI, V112, P1085; Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856; Yin S, 2007, CELL CYCLE, V6, P2990, DOI 10.4161/cc.6.23.4993	15	77	90	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 22	2011	332	6028					462	465		10.1126/science.1199211	http://dx.doi.org/10.1126/science.1199211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21454751	Green Accepted			2022-12-28	WOS:000289784900042
J	Bloomfield, HE; Krause, A; Greer, N; Taylor, BC; MacDonald, R; Rutks, I; Reddy, P; Wilt, TJ				Bloomfield, Hanna E.; Krause, Ange; Greer, Nancy; Taylor, Brent C.; MacDonald, Roderick; Rutks, Indulis; Reddy, Preetham; Wilt, Timothy J.			Meta-analysis: Effect of Patient Self-testing and Self-management of Long-Term Anticoagulation on Major Clinical Outcomes	ANNALS OF INTERNAL MEDICINE			English	Review							INTERNATIONAL NORMALIZED RATIO; RANDOMIZED CONTROLLED-TRIAL; ORAL ANTICOAGULATION; ATRIAL-FIBRILLATION; WARFARIN THERAPY; BLEEDING COMPLICATIONS; OLDER PATIENTS; QUALITY; TIME; DABIGATRAN	Background: Anticoagulation with vitamin K antagonists reduces major thromboembolic complications in at-risk patients. With portable monitoring devices, patients can conduct their own international normalized ratio testing and dose adjustment at home. Purpose: To determine whether patient self-testing (PST), alone or in combination with self-adjustment of doses (patient selfmanagement [PSM]), is associated with a reduction in thromboembolic complications and all-cause mortality without an increase in major bleeding events compared with usual care. Data Sources: MEDLINE and the Cochrane Central Register of Controlled Trials. Study Selection: Studies published in English from 1966 to October 2010 that enrolled outpatient adults receiving long-term (> 3 months) oral anticoagulant therapy and that compared PST or PSM with care in a physician's office or an anticoagulation clinic were included. Data Extraction: Two investigators reviewed each article. Three investigators extracted data from articles that met inclusion criteria by using standardized data abstraction forms. Studies were assessed for quality, and the overall strength of evidence was rated for each clinical outcome. Data Synthesis: Twenty-two trials, with a total of 8413 patients, were included. In one half of the trials, fewer than 50% of potentially eligible persons successfully completed the training and agreed to be randomly assigned. Patients randomly assigned to PST or PSM had lower total mortality (Peto odds ratio [OR], 0.74 [95% CI, 0.63 to 0.87]), lower risk for major thromboembolism (Peto OR, 0.58 [CI, 0.45 to 0.75]), and no increased risk for a major bleeding event (Peto OR, 0.89 [CI, 0.75 to 1.05]). The strength of evidence was moderate for the bleeding and thromboembolism outcomes but low for mortality. Eight of 11 trials reported that patient satisfaction, quality of life, or both was better with PST or PSM than with usual care. Limitations: In one half of the trials, fewer than 50% of the potentially eligible patients were randomly assigned. Only 5 trials were considered high quality, and only 2 were conducted in the United States. No studies addressed whether PST or PSM is safe during the high-risk initiation phase. Conclusion: Compared with usual care, PST with or without PSM is associated with significantly fewer deaths and thromboembolic events, without increased risk for a serious bleeding event, for a highly selected group of motivated adult patients requiring long-term anticoagulation with vitamin K antagonists. Whether this care model is cost-effective and can be implemented successfully in typical U. S. health care settings requires further study.	[Bloomfield, Hanna E.] Minneapolis Vet Affairs Hlth Care Syst, Ctr Chron Dis Outcomes Res, US Dept Vet Affairs Evidence Based Synth Program, Minneapolis, MN 55417 USA; Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities	Bloomfield, HE (corresponding author), Minneapolis Vet Affairs Hlth Care Syst, Ctr Chron Dis Outcomes Res, US Dept Vet Affairs Evidence Based Synth Program, 1 Vet Dr,Mail Code 152-2E, Minneapolis, MN 55417 USA.	hanna.bloomfield@va.gov	Taylor, Brent C/A-8069-2009	Taylor, Brent C/0000-0002-2140-8377; Jeitler, Klaus/0000-0002-1520-8061; bloomfield, hanna/0000-0002-0756-7064	U.S. Department of Veterans Affairs Health Services Research and Development Service	U.S. Department of Veterans Affairs Health Services Research and Development Service(US Department of Veterans Affairs)	U.S. Department of Veterans Affairs Health Services Research and Development Service.	Ansell J, 2005, INT J CARDIOL, V99, P37, DOI 10.1016/j.ijcard.2003.11.008; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Beyth RJ, 2000, ANN INTERN MED, V133, P687, DOI 10.7326/0003-4819-133-9-200011070-00010; Christensen TD, 2007, INT J CARDIOL, V118, P54, DOI 10.1016/j.ijcard.2006.06.018; Christensen TD, 2007, AM J CARDIOVASC DRUG, V7, P191, DOI 10.2165/00129784-200707030-00005; Cios DA, 2009, AM J HEALTH-SYST PH, V66, P916, DOI 10.2146/ajhp080507; *CMS MED COV DAT, 2008, DEC MEM PROTHR TIM I; Connock M, 2007, HEALTH TECHNOL ASSES, V11, P1; Connolly SJ, 2008, CIRCULATION, V118, P2029, DOI 10.1161/CIRCULATIONAHA.107.750000; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Cromheecke ME, 2000, LANCET, V356, P97, DOI 10.1016/S0140-6736(00)02470-3; Dauphin C, 2008, ARCH CARDIOVASC DIS, V101, P753, DOI 10.1016/j.acvd.2008.10.007; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eitz T, 2008, ANN THORAC SURG, V85, P949, DOI 10.1016/j.athoracsur.2007.08.071; Fitzmaurice DA, 2005, BRIT MED J, V331, P1057, DOI 10.1136/bmj.38618.580903.AE; Fitzmaurice DA, 2002, J CLIN PATHOL, V55, P845, DOI 10.1136/jcp.55.11.845; Gadisseur APA, 2003, ARCH INTERN MED, V163, P2639, DOI 10.1001/archinte.163.21.2639; Gadisseur APA, 2004, J THROMB HAEMOST, V2, P584, DOI 10.1111/j.1538-7836.2004.00659.x; Garcia-Alamino JM, 2010, COCHRANE DB SYST REV; Gardiner C, 2006, BRIT J HAEMATOL, V132, P598, DOI 10.1111/j.1365-2141.2005.05899.x; Gardiner C, 2005, BRIT J HAEMATOL, V128, P242, DOI 10.1111/j.1365-2141.2004.05300.x; Hamad MAS, 2009, EUR J CARDIO-THORAC, V35, P265, DOI 10.1016/j.ejcts.2008.10.020; Heneghan C, 2006, LANCET, V367, P404, DOI 10.1016/S0140-6736(06)68139-7; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hirsh J, 2008, CHEST, V133, p71S, DOI 10.1378/chest.08-0693; Horstkotte, 1998, J Thromb Thrombolysis, V5 Suppl 1, P19, DOI 10.1023/A:1013228718768; Horstkotte D., 1996, European Heart Journal, V17, P230; Jones M, 2005, HEART, V91, P472, DOI 10.1136/hrt.2004.042465; Jowett S, 2006, BRIT J HAEMATOL, V134, P632, DOI 10.1111/j.1365-2141.2006.06243.x; Khan TI, 2004, BRIT J HAEMATOL, V126, P557, DOI 10.1111/j.1365-2141.2004.05074.x; Koertke H, 2007, ANN THORAC SURG, V83, P24, DOI 10.1016/j.athoracsur.2006.08.036; Kortke H, 2001, ANN THORAC SURG, V72, P44, DOI 10.1016/S0003-4975(01)02656-X; Kortke H, 2001, Z KARDIOL, V90, P118; Matchar DB, 2010, NEW ENGL J MED, V363, P1608, DOI 10.1056/NEJMoa1002617; Menendez-Jandula B, 2005, ANN INTERN MED, V142, P1, DOI 10.7326/0003-4819-142-1-200501040-00006; Oake N, 2008, CAN MED ASSOC J, V179, P235, DOI 10.1503/cmaj.080171; Oertel LB, 2010, J THROMB THROMBOLYS, V29, P214, DOI 10.1007/s11239-009-0414-3; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; Ryan F, 2009, J THROMB HAEMOST, V7, P1284, DOI 10.1111/j.1538-7836.2009.03497.x; Sawicki PT, 1999, JAMA-J AM MED ASSOC, V281, P145, DOI 10.1001/jama.281.2.145; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Sidhu P, 2001, ANN THORAC SURG, V72, P1523, DOI 10.1016/S0003-4975(01)03049-1; Siebenhofer A, 2007, THROMB HAEMOSTASIS, V97, P408, DOI 10.1160/TH06-08-0482; Siebenhofer A, 2008, THROMB HAEMOSTASIS, V100, P1089, DOI 10.1160/TH08-06-0361; Sunderji R, 2004, CAN J CARDIOL, V20, P1117; van Walraven C, 2007, CHEST, V131, P1508, DOI 10.1378/chest.06-2628; Veeger NJGM, 2005, BRIT J HAEMATOL, V128, P513, DOI 10.1111/j.1365-2141.2004.05348.x; Voller H, 2005, Z KARDIOL, V94, P182, DOI 10.1007/s00392-005-0199-0; White HD, 2007, ARCH INTERN MED, V167, P239, DOI 10.1001/archinte.167.3.239; Wittkowsky AK, 2005, PHARMACOTHERAPY, V25, P265, DOI 10.1592/phco.25.2.265.56949	52	124	128	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 5	2011	154	7							472	10.7326/0003-4819-154-7-201104050-00005	http://dx.doi.org/10.7326/0003-4819-154-7-201104050-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744EX	21464349				2022-12-28	WOS:000289078700004
J	Joshi, D; O'Grady, J; Dieterich, D; Gazzard, B; Agarwal, K				Joshi, Deepak; O'Grady, John; Dieterich, Doug; Gazzard, Brian; Agarwal, Kosh			Increasing burden of liver disease in patients with HIV infection	LANCET			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C VIRUS; NONCIRRHOTIC PORTAL-HYPERTENSION; NODULAR REGENERATIVE HYPERPLASIA; ACTIVE ANTIRETROVIRAL THERAPY; ALPHA-2A PLUS RIBAVIRIN; B-VIRUS; RISK-FACTORS; HEPATOCELLULAR-CARCINOMA; PEGYLATED INTERFERON	Introduction of effective combined antiretroviral therapy has made HIV infection a chronic illness. Substantial reductions in the number of AIDS-related deaths have been accompanied by an increase in liver-related morbidity and mortality due to co-infection with chronic hepatitis B and C viruses. Increases in non-alcoholic fatty liver disease and drug-induced hepatotoxicity, together with development of hepatocellular carcinoma, also potentiate the burden of liver disease in individuals with HIV infection. We provide an overview of the key causes, disease mechanisms of pathogenesis, and recommendations for treatment options including the evolving role of liver transplantation.	[Joshi, Deepak; O'Grady, John; Agarwal, Kosh] Kings Coll Hosp London, Inst Liver Studies, London SE5 9RS, England; [Dieterich, Doug] Mt Sinai Hosp, Dept Med, New York, NY 10029 USA; [Gazzard, Brian] Chelsea & Westminster Hosp, Dept HIV Med, London, England	King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; Icahn School of Medicine at Mount Sinai; Imperial College London	Agarwal, K (corresponding author), Kings Coll Hosp London, Inst Liver Studies, Denmark Hill, London SE5 9RS, England.	kosh.agarwal@nhs.net	Agarwal, Kosh/ABH-8721-2020	Agarwal, Kosh/0000-0002-4754-828X	Gilead Sciences; Merck Sharpe and Dohme; AIDS Research Trust; Bristol-Myers Squibb; Johnson and Johnson	Gilead Sciences(Gilead Sciences); Merck Sharpe and Dohme(Merck & Company); AIDS Research Trust; Bristol-Myers Squibb(Bristol-Myers Squibb); Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA)	BC and BG's institution have received consultancy fees from Gilead Sciences, and Merck Sharpe and Dohme; BG's institution has received grants from AIDS Research Trust; and BC has received payment for development of educational presentations from Bristol-Myers Squibb, and Johnson and Johnson. All other authors declare that they have no conflicts of interest.	Altavilla G, 2000, AM J PATHOL, V157, P1081, DOI 10.1016/S0002-9440(10)64622-6; Angulo P, 2007, ALIMENT PHARM THER, V25, P883, DOI 10.1111/j.1365-2036.2007.03246.x; [Anonymous], 1999, VIR NELF PRESCR INF; [Anonymous], 2001, CRIX IND SULF PRESCR; [Anonymous], 1998, FORT SAQ PRESCR INF; [Anonymous], 2003, REYAT AT SULF PRESCR; [Anonymous], 1999, NORV RIT PRESCR INF; Aranzabal L, 2005, CLIN INFECT DIS, V40, P588, DOI 10.1086/427216; Balagopal A, 2008, GASTROENTEROLOGY, V135, P226, DOI 10.1053/j.gastro.2008.03.022; Bani- Sadr F, 2005, CLIN INFECT DIS, V41, P1806, DOI 10.1086/498312; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Benhamou Y, 2004, 11 C RETR OPP INF FE; Berenguer J, 2009, HEPATOLOGY, V50, P407, DOI 10.1002/hep.23020; Blackard JT, 2006, J MED VIROL, V78, P202, DOI 10.1002/jmv.20528; Blanco F, 2011, J VIRAL HEPATITIS, V18, P11, DOI 10.1111/j.1365-2893.2009.01261.x; Bollepalli S, 2007, SEX TRANSM DIS, V34, P367, DOI 10.1097/01.olq.0000240295.35457.b1; Bonnard P, 2007, J VIRAL HEPATITIS, V14, P806, DOI 10.1111/j.1365-2893.2007.00874.x; Bossi P, 2000, CLIN INFECT DIS, V30, P227, DOI 10.1086/313629; Brau N, 2007, J HEPATOL, V47, P527, DOI 10.1016/j.jhep.2007.06.010; Brook G, 2010, HIV MED, V11, P1, DOI 10.1111/j.1468-1293.2009.00781.x; Bruno R, 2010, GUT, V59, P513, DOI 10.1136/gut.2008.163287; Cargnel A, 2005, ANTIVIR THER, V10, P309; Carrat F, 2004, JAMA-J AM MED ASSOC, V292, P2839, DOI 10.1001/jama.292.23.2839; Chander G, 2006, JAIDS-J ACQ IMM DEF, V43, P411, DOI 10.1097/01.qai.0000243121.44659.a4; Chapman Louisa E., 2008, Morbidity and Mortality Weekly Report, V57, P1; Chaudhry AA, 2009, HIV MED, V10, P133, DOI 10.1111/j.1468-1293.2008.00662.x; Chung RT, 2004, NEW ENGL J MED, V351, P451, DOI 10.1056/NEJMoa032653; Colin JF, 1999, HEPATOLOGY, V29, P1306, DOI 10.1002/hep.510290447; Cooper CL, 2002, CLIN INFECT DIS, V34, P1259, DOI 10.1086/339867; Crum-Cianflone N, 2009, JAIDS-J ACQ IMM DEF, V50, P464, DOI 10.1097/QAI.0b013e318198a88a; Danta M, 2007, AIDS, V21, P983, DOI 10.1097/QAD.0b013e3281053a0c; de Vera ME, 2006, AM J TRANSPLANT, V6, P2983, DOI 10.1111/j.1600-6143.2006.01546.x; den Brinker M, 2000, AIDS, V14, P2895, DOI 10.1097/00002030-200012220-00011; Dominguez S, 2006, AIDS, V20, P1157, DOI 10.1097/01.aids.0000226956.02719.fd; Dore GJ, 1999, J INFECT DIS, V180, P607, DOI 10.1086/314942; Dore GJ, 2010, AIDS, V24, P857, DOI 10.1097/QAD.0b013e328334bddb; DORRUCCI M, 1995, J INFECT DIS, V172, P1503, DOI 10.1093/infdis/172.6.1503; Duclos-Vallee JC, 2008, HEPATOLOGY, V47, P407, DOI 10.1002/hep.21990; Ena J, 2003, INT J STD AIDS, V14, P776, DOI 10.1258/09564620360719840; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fox J, 2008, AIDS, V22, P666, DOI 10.1097/QAD.0b013e3282f5f4cf; Garba ML, 2002, J IMMUNOL, V168, P2247, DOI 10.4049/jimmunol.168.5.2247; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gilson RJC, 1997, AIDS, V11, P597, DOI 10.1097/00002030-199705000-00007; Gotz HM, 2005, AIDS, V19, P969, DOI 10.1097/01.aids.0000171412.61360.f8; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Graham CS, 2004, HEPATOLOGY, V40, P125, DOI 10.1002/hep.20258; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Guaraldi G, 2008, CLIN INFECT DIS, V47, P250, DOI 10.1086/589294; Hadziyannis SJ, 2005, NEW ENGL J MED, V352, P2673, DOI 10.1056/NEJMoa042957; Haydon GH, 1998, EUR J GASTROEN HEPAT, V10, P485, DOI 10.1097/00042737-199806000-00009; Hoffmann CJ, 2009, AIDS, V23, P1881, DOI 10.1097/QAD.0b013e32832e463a; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Ingiliz P, 2009, HEPATOLOGY, V49, P436, DOI 10.1002/hep.22665; Joint UN Programme on HIV/AIDS, 2006 REP GLOB AIDS E; Joshi D, 2008, 59 ANN M AM ASS STUD; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Kellerman SE, 2003, J INFECT DIS, V188, P571, DOI 10.1086/377135; Kovari H, 2010, CLIN INFECT DIS, V50, P502, DOI 10.1086/649922; Kovari H, 2009, CLIN INFECT DIS, V49, P626, DOI 10.1086/603559; Koziel MJ, 2007, NEW ENGL J MED, V356, P1445, DOI 10.1056/NEJMra065142; Lafeuillade A, 2001, LANCET, V357, P280, DOI 10.1016/S0140-6736(00)03618-7; Laguno M, 2005, ANTIVIR THER, V10, P423; Laguno M, 2009, HEPATOLOGY, V49, P22, DOI 10.1002/hep.22598; Lin W, 2008, GASTROENTEROLOGY, V134, P803, DOI 10.1053/j.gastro.2008.01.005; Maida I, 2006, JAIDS-J ACQ IMM DEF, V42, P177, DOI 10.1097/01.qai.0000221683.44940.62; Mallet V, 2007, HEPATOLOGY, V46, p576A; Mallet V, 2007, AIDS, V21, P187, DOI 10.1097/QAD.0b013e3280119e47; Marcellin P, 2009, J HEPATOL, V50, P227, DOI 10.1016/j.jhep.2008.10.001; Martin-Carbonero L, 2009, J VIRAL HEPATITIS, V16, P790, DOI 10.1111/j.1365-2893.2009.01133.x; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Mauss S, 2004, AIDS, V18, pF21, DOI 10.1097/00002030-200409030-00002; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Miailhes P, 2011, J VIRAL HEPATITIS, V18, P61, DOI 10.1111/j.1365-2893.2010.01275.x; Miller MF, 2005, CLIN INFECT DIS, V41, P713, DOI 10.1086/432618; Mindikoglu AL, 2008, TRANSPLANTATION, V85, P359, DOI 10.1097/TP.0b013e3181605fda; Mocroft A, 2002, AIDS, V16, P1663, DOI 10.1097/00002030-200208160-00012; Mohammed SS, 2007, JAIDS-J ACQ IMM DEF, V45, P432, DOI 10.1097/QAI.0b013e318074efe3; Moreno A, 2006, J VIRAL HEPATITIS, V13, P466, DOI 10.1111/j.1365-2893.2005.00710.x; Moyle Graeme, 2002, HIV Clin Trials, V3, P89; Murillas J, LIVER TRANSPL, V15, P1133; Nunez M, 2006, J HEPATOL, V44, pS132, DOI 10.1016/j.jhep.2005.11.027; Nunez M, 2007, AIDS RES HUM RETROV, V23, P972, DOI 10.1089/aid.2007.0011; O'Grady J, 2005, HIV MED, V6, P149, DOI 10.1111/j.1468-1293.2005.00303.x; Pasquier C, 2003, J MED VIROL, V69, P344, DOI 10.1002/jmv.10295; Peters MG, 2006, HEPATOLOGY, V44, P1110, DOI 10.1002/hep.21388; Pineda JA, 2005, HEPATOLOGY, V41, P779, DOI 10.1002/hep.20626; Pineda JA, 2007, HEPATOLOGY, V46, P622, DOI 10.1002/hep.21757; Puoti M, 2004, AIDS, V18, P2285, DOI 10.1097/00002030-200411190-00009; Ragni MV, 2003, J INFECT DIS, V188, P1412, DOI 10.1086/379254; Rallon NI, 2010, AIDS, V24, pF23, DOI 10.1097/QAD.0b013e3283391d6d; Rauch A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/j.gastro.2009.12.056; Rivero A, 2007, J ANTIMICROB CHEMOTH, V59, P342, DOI 10.1093/jac/dkl524; Rosenthal E, 2007, J VIRAL HEPATITIS, V14, P183, DOI 10.1111/j.1365-2893.2006.00791.x; Safadi R, 2004, GASTROENTEROLOGY, V127, P870, DOI 10.1053/j.gastro.2004.04.062; Saifee S, 2008, CLIN GASTROENTEROL H, V6, P1167, DOI 10.1016/j.cgh.2008.04.023; Salmon-Ceron D, 2005, J HEPATOL, V42, P799, DOI 10.1016/j.jhep.2005.01.022; Salmon-Ceron D, 2009, J HEPATOL, V50, P736, DOI 10.1016/j.jhep.2008.11.018; Sandrine PF, 2007, AIDS, V21, P1498, DOI 10.1097/QAD.0b013e328235a54c; Sanne I, 2005, J INFECT DIS, V191, P825, DOI 10.1086/428093; Sauleda S, 2006, HAEMOPHILIA, V12, P228, DOI 10.1111/j.1365-2516.2006.01211.x; Schiano TD, 2007, AM J GASTROENTEROL, V102, P2536, DOI 10.1111/j.1572-0241.2007.01428.x; Servoss JC, 2006, JAIDS-J ACQ IMM DEF, V43, P320, DOI 10.1097/01.qai.0000243054.58074.59; Shintani Y, 2004, GASTROENTEROLOGY, V126, P840, DOI 10.1053/j.gastro.2003.11.056; Shlay JC, 2007, JAIDS-J ACQ IMM DEF, V44, P506, DOI 10.1097/QAI.0b013e31804216cf; Soriano V, 2008, AIDS, V22, P1399, DOI 10.1097/QAD.0b013e3282f8b46f; Soto B, 1997, J HEPATOL, V26, P1, DOI 10.1016/S0168-8278(97)80001-3; Subramanian A, 2010, GASTROENTEROLOGY, V138, P159, DOI 10.1053/j.gastro.2009.09.053; Sulkowski MS, 2004, CLIN INFECT DIS, V38, pS90, DOI 10.1086/381444; Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P2526; Sulkowski MS, 2002, HEPATOLOGY, V35, P182, DOI 10.1053/jhep.2002.30319; Sulkowski MS, 2005, AIDS, V19, P585, DOI 10.1097/01.aids.0000163935.99401.25; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Terrault NA, 2009, 60 ANN M AM ASS STUD; Terrault NA, 2006, LIVER TRANSPLANT, V12, P801, DOI 10.1002/lt.20776; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842; Tricot L, 2009, AM J TRANSPLANT, V9, P1946, DOI 10.1111/j.1600-6143.2009.02684.x; Trotti R, 2001, Minerva Gastroenterol Dietol, V47, P205; Tuma P, 2010, AIDS, V24, P745, DOI 10.1097/QAD.0b013e3283366602; Vergara S, 2007, CLIN INFECT DIS, V45, P969, DOI 10.1086/521857; Vispo E, 2010, AIDS, V24, P1171, DOI 10.1097/QAD.0b013e3283389e26; Wang CC, 2007, J INFECT DIS, V196, P1474, DOI 10.1086/522608; Wasley Annemarie, 2008, Morbidity and Mortality Weekly Report, V57, P1; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Wolters LMM, 2002, J CLIN VIROL, V24, P173, DOI 10.1016/S1386-6532(01)00245-1; Worm SW, 2010, AIDS, V24, P427, DOI 10.1097/QAD.0b013e328334344e	127	202	210	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2011	377	9772					1198	1209		10.1016/S0140-6736(10)62001-6	http://dx.doi.org/10.1016/S0140-6736(10)62001-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750IH	21459211				2022-12-28	WOS:000289539300036
J	Sheikh, Z; Khan, AS; Khan, S				Sheikh, Zishan; Khan, Afroze Shah; Khan, Shahnawaz			Lingua villosa nigra	LANCET			English	Editorial Material									[Sheikh, Zishan] Stoke Mandeville Hosp, Dept Cardiol, Aylesbury HP21 8AL, Bucks, England; [Khan, Afroze Shah] Charing Cross Hosp, Dept Otolaryngol, London, England; [Khan, Shahnawaz] Royal Marsden, Surrey, England	Imperial College London; Royal Marsden NHS Foundation Trust	Khan, AS (corresponding author), 89 Lewin Rd, London SW16 6JX, England.	afroze.khan@nhs.net							0	13	14	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2011	377	9772					1183	1183		10.1016/S0140-6736(10)60930-0	http://dx.doi.org/10.1016/S0140-6736(10)60930-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750IH	21440293				2022-12-28	WOS:000289539300034
J	Cao, YC				Cao, Y. Charles			Impurities Enhance Semiconductor Nanocrystal Performance	SCIENCE			English	Editorial Material							QUANTUM DOTS		Univ Florida, Dept Chem, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Cao, YC (corresponding author), Univ Florida, Dept Chem, Gainesville, FL 32611 USA.	cao@chem.ufl.edu						Alivisatos AP, 2005, ANNU REV BIOMED ENG, V7, P55, DOI 10.1146/annurev.bioeng.7.060804.100432; Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; Beaulac R, 2009, SCIENCE, V325, P973, DOI 10.1126/science.1174419; Gur I, 2005, SCIENCE, V310, P462, DOI 10.1126/science.1117908; Mocatta D, 2011, SCIENCE, V332, P77, DOI 10.1126/science.1196321; Norris DJ, 2008, SCIENCE, V319, P1776, DOI 10.1126/science.1143802; Shim M, 2000, NATURE, V407, P981, DOI 10.1038/35039577; Talapin DV, 2005, SCIENCE, V310, P86, DOI 10.1126/science.1116703; Yang YA, 2006, J AM CHEM SOC, V128, P12428, DOI 10.1021/ja064818h	9	43	45	3	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2011	332	6025					48	49		10.1126/science.1203702	http://dx.doi.org/10.1126/science.1203702			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21454779				2022-12-28	WOS:000289000000033
J	Uytterhoeven, V; Kuenen, S; Kasprowicz, J; Miskiewicz, K; Verstreken, P				Uytterhoeven, Valerie; Kuenen, Sabine; Kasprowicz, Jaroslaw; Miskiewicz, Katarzyna; Verstreken, Patrik			Loss of Skywalker Reveals Synaptic Endosomes as Sorting Stations for Synaptic Vesicle Proteins	CELL			English	Article							FROG NEUROMUSCULAR JUNCTION; NEUROTRANSMITTER RELEASE; BULK ENDOCYTOSIS; RAB PROTEINS; MEMBRANE; TRANSMITTER; EXOCYTOSIS; TRANSPORT; MACHINERY; ELEGANS	Exchange of proteins at sorting endosomes is not only critical to numerous signaling pathways but also to receptor-mediated signaling and to pathogen entry into cells; however, how this process is regulated in synaptic vesicle cycling remains unexplored. In this work, we present evidence that loss of function of a single neuronally expressed GTPase activating protein (GAP), Skywalker (Sky) facilitates endosomal trafficking of synaptic vesicles at Drosophila neuromuscular junction boutons, chiefly by controlling Rab35 GTPase activity. Analyses of genetic interactions with the ESCRT machinery as well as chimeric ubiquitinated synaptic vesicle proteins indicate that endosomal trafficking facilitates the replacement of dysfunctional synaptic vesicle components. Consequently, sky mutants harbor a larger readily releasable pool of synaptic vesicles and show a dramatic increase in basal neurotransmitter release. Thus, the trafficking of vesicles via endosomes uncovered using sky mutants provides an elegant mechanism by which neurons may regulate synaptic vesicle rejuvenation and neurotransmitter release.	[Uytterhoeven, Valerie; Kuenen, Sabine; Kasprowicz, Jaroslaw; Miskiewicz, Katarzyna; Verstreken, Patrik] VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [Uytterhoeven, Valerie; Kuenen, Sabine; Kasprowicz, Jaroslaw; Miskiewicz, Katarzyna; Verstreken, Patrik] Katholieke Univ Leuven, Ctr Human Genet, Program Mol & Dev Genet, Program Cognit & Mol Neurosci,Lab Neuronal Commun, B-3000 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven	Verstreken, P (corresponding author), VIB, Dept Mol & Dev Genet, Herestr 49, B-3000 Louvain, Belgium.	patrik.verstreken@med.kuleuven.be	Uytterhoeven, Valerie/ABB-6274-2021; Verstreken, Patrik/AAC-7591-2022	Verstreken, Patrik/0000-0002-5073-5393	Marie Curie Excellence grant [MEXT-CT-2006-042267]; ERC [260678]; FWO [G074709, G094011]; Research Fund; Flemish Government; Francqui Foundation; VIB; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)	Marie Curie Excellence grant(European Commission); ERC(European Research Council (ERC)European Commission); FWO(FWO); Research Fund; Flemish Government(European Commission); Francqui Foundation; VIB; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	We thank H. Bellen for reagents and access to screen mutants and A. Di Antonio, M. Scott, K. Suyama, M. Gonzalez-Gaitan, G. Davis, Harvard University, the Bloomington and Harvard Drosophila stock centers, and the Developmental Studies Hybridoma bank for reagents. We thank S. Munck (LiMoNe), P. Baatsen (EM-facility of the CME, VIB-KULeuven), V. Morais, W. Annaert, B. Hassan and members of the Verstreken lab for help and comments. Support was provided by a Marie Curie Excellence grant (MEXT-CT-2006-042267); and ERC Starting Grant (260678), FWO grants G074709 and G094011; the Research Fund KU Leuven; a Methusalem grant of the Flemish Government; the Francqui Foundation; VIB and an Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen), fellowship to VU.	Akbergenova Y, 2009, MOL CELL NEUROSCI, V40, P199, DOI 10.1016/j.mcn.2008.10.005; Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Clayton EL, 2008, NEUROCHEM INT, V53, P51, DOI 10.1016/j.neuint.2008.06.002; Clayton EL, 2009, J NEUROSCI METH, V185, P76, DOI 10.1016/j.jneumeth.2009.09.016; Corbett MA, 2010, AM J HUM GENET, V87, P371, DOI 10.1016/j.ajhg.2010.08.001; Daniels RW, 2006, NEURON, V49, P11, DOI 10.1016/j.neuron.2005.11.032; Dyer N, 2007, DEVELOPMENT, V134, P4437, DOI 10.1242/dev.010983; Falace A, 2010, AM J HUM GENET, V87, P365, DOI 10.1016/j.ajhg.2010.07.020; Glyvuk N, 2010, EMBO J, V29, P1318, DOI 10.1038/emboj.2010.15; Harata N, 2001, P NATL ACAD SCI USA, V98, P12748, DOI 10.1073/pnas.171442798; Hendel T, 2008, J NEUROSCI, V28, P7399, DOI 10.1523/JNEUROSCI.1038-08.2008; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HOOPMANN P, 2010, P NATL ACAD SCI US; Kasprowicz J, 2008, J CELL BIOL, V182, P1007, DOI 10.1083/jcb.200804162; Khuong TM, 2010, P NATL ACAD SCI USA, V107, P17379, DOI 10.1073/pnas.1001794107; Kim S, 2010, J CELL BIOL, V188, P717, DOI 10.1083/jcb.200911126; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Mahoney TR, 2006, MOL BIOL CELL, V17, P2617, DOI 10.1091/mbc.E05-12-1170; Meunier FA, 2010, J CELL SCI, V123, P1131, DOI 10.1242/jcs.049296; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; Opazo F, 2010, TRAFFIC, V11, P800, DOI 10.1111/j.1600-0854.2010.01058.x; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; Rizzoli SO, 2006, TRAFFIC, V7, P1163, DOI 10.1111/j.1600-0854.2006.00466.x; Rosenmund C, 1997, J NEUROSCI METH, V76, P1, DOI 10.1016/S0165-0270(97)00061-7; Sato M, 2008, EMBO J, V27, P1183, DOI 10.1038/emboj.2008.54; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Schluter OM, 2006, J NEUROSCI, V26, P1239, DOI 10.1523/JNEUROSCI.3553-05.2006; Shim J, 2010, MOL CELL BIOL, V30, P1421, DOI 10.1128/MCB.01463-09; Shimizu H, 2003, J CELL SCI, V116, P3583, DOI 10.1242/jcs.00676; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Venken KJT, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn486; Verstreken Patrik, 2008, V440, P349, DOI 10.1007/978-1-59745-178-9_26; Verstreken P, 2009, NEURON, V63, P203, DOI 10.1016/j.neuron.2009.06.017; Vijayakrishnan N, 2009, J CELL SCI, V122, P114, DOI 10.1242/jcs.036673; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Yao CK, 2009, CELL, V138, P947, DOI 10.1016/j.cell.2009.06.033; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761; Zhang J, 2009, SCIENCE, V325, P1250, DOI 10.1126/science.1174921	49	137	144	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 1	2011	145	1					117	132		10.1016/j.cell.2011.02.039	http://dx.doi.org/10.1016/j.cell.2011.02.039			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458671	Bronze			2022-12-28	WOS:000289053900014
J	Zettl, M; Adrain, C; Strisovsky, K; Lastun, V; Freeman, M				Zettl, Markus; Adrain, Colin; Strisovsky, Kvido; Lastun, Viorica; Freeman, Matthew			Rhomboid Family Pseudoproteases Use the ER Quality Control Machinery to Regulate Intercellular Signaling	CELL			English	Article							INTRAMEMBRANE PROTEOLYSIS; SUBSTRATE-SPECIFICITY; DROSOPHILA RHOMBOID-1; SLEEP; PROTEASES; PATHWAY; IDENTIFICATION; ACTIVATION; PEPTIDASE; RESIDUES	Intramembrane proteolysis governs many cellular control processes, but little is known about how intramembrane proteases are regulated. iRhoms are a conserved subfamily of proteins related to rhomboid intramembrane serine proteases that lack key catalytic residues. We have used a combination of genetics and cell biology to determine that these "pseudoproteases'' inhibit rhomboid-dependent signaling by the epidermal growth factor receptor pathway in Drosophila, thereby regulating sleep. iRhoms prevent the cleavage of potential rhomboid substrates by promoting their destabilization by endoplasmic reticulum (ER)-associated degradation; this mechanism has been conserved in mammalian cells. The exploitation of the intrinsic quality control machinery of the ER represents a new mode of regulation of intercellular signaling. Inactive cognates of enzymes are common, but their functions are mostly unclear; our data indicate that pseudoenzymes can readily evolve into regulatory proteins, suggesting that this may be a significant evolutionary mechanism.	[Zettl, Markus; Adrain, Colin; Strisovsky, Kvido; Lastun, Viorica; Freeman, Matthew] MRC Lab Mol Biol, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Freeman, M (corresponding author), MRC Lab Mol Biol, Hills Rd, Cambridge CB2 0QH, England.	mf1@mrc-lmb.cam.ac.uk	Strisovsky, Kvido/H-6284-2014; Adrain, Colin/I-6259-2013	Strisovsky, Kvido/0000-0003-3677-0907; Adrain, Colin/0000-0001-7597-4393; Freeman, Matthew/0000-0003-0410-5451	Austrian FWF; Austrian Academy of Science; International Human Frontier Science Program Organization; EMBO Long-Term Fellowship; Marie Curie Intraeuropean Fellowship; MRC [MC_U105178780] Funding Source: UKRI; Medical Research Council [MC_U105178780] Funding Source: researchfish	Austrian FWF(Austrian Science Fund (FWF)); Austrian Academy of Science; International Human Frontier Science Program Organization(Human Frontier Science Program); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Marie Curie Intraeuropean Fellowship(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Yonka Christova, Marius Lemberg, Marc de la Roche, Amita Sehgal, Sean Munro, Don Ryoo, and Simon Bullock for reagents, discussion, and unpublished data. M.Z. was supported by an Erwin-Schrodinger fellowship from the Austrian FWF and an APART fellowship from the Austrian Academy of Science. C. A. was supported by a long-term fellowship from The International Human Frontier Science Program Organization and was the recipient of an EMBO Long-Term Fellowship. K. S. acknowledges support from Marie Curie Intraeuropean Fellowship and an EMBO Long-Term Fellowship.	Adrain C, 2011, EMBO REP, V12, P421, DOI 10.1038/embor.2011.50; Andretic R, 2005, METHOD ENZYMOL, V393, P759, DOI 10.1016/S0076-6879(05)93040-1; Bartlett GJ, 2003, J MOL BIOL, V331, P829, DOI 10.1016/S0022-2836(03)00734-4; Blobel CR, 2009, EXP CELL RES, V315, P671, DOI 10.1016/j.yexcr.2008.10.011; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Brodsky JL, 2009, CURR OPIN CELL BIOL, V21, P516, DOI 10.1016/j.ceb.2009.04.006; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Cirelli C, 2008, ANN NY ACAD SCI, V1129, P323, DOI 10.1196/annals.1417.017; CUBAS P, 1991, GENE DEV, V5, P996, DOI 10.1101/gad.5.6.996; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Freeman M, 2008, ANNU REV GENET, V42, P191, DOI 10.1146/annurev.genet.42.110807.091628; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Greenspan RJ, 2001, TRENDS NEUROSCI, V24, P142, DOI 10.1016/S0166-2236(00)01719-7; Haass C, 1999, SCIENCE, V286, P916, DOI 10.1126/science.286.5441.916; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; Makinoshima H, 2006, MICROBES INFECT, V8, P1882, DOI 10.1016/j.micinf.2006.02.021; McQuibban GA, 2003, NATURE, V423, P537, DOI 10.1038/nature01633; Nakagawa T, 2005, DEV DYNAM, V233, P1315, DOI 10.1002/dvdy.20450; Pils B, 2004, J MOL BIOL, V340, P399, DOI 10.1016/j.jmb.2004.04.063; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Sakai J, 2001, CURR OPIN LIPIDOL, V12, P261, DOI 10.1097/00041433-200106000-00004; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Shilo BZ, 2003, EXP CELL RES, V284, P140, DOI 10.1016/S0014-4827(02)00094-0; Stevenson LG, 2007, P NATL ACAD SCI USA, V104, P1003, DOI 10.1073/pnas.0608140104; Strisovsky K, 2009, MOL CELL, V36, P1048, DOI 10.1016/j.molcel.2009.11.006; Urban S, 2003, MOL CELL, V11, P1425, DOI 10.1016/S1097-2765(03)00181-3; Urban S, 2002, EMBO J, V21, P4277, DOI 10.1093/emboj/cdf434; Urban S, 2002, CURR BIOL, V12, P1507, DOI 10.1016/S0960-9822(02)01092-8; Urban S, 2001, CELL, V107, P173, DOI 10.1016/S0092-8674(01)00525-6; Urban S, 2009, NAT REV MICROBIOL, V7, P411, DOI 10.1038/nrmicro2130; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Wasserman JD, 2000, GENE DEV, V14, P1651; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Yan ZW, 2008, MOL CANCER THER, V7, P1355, DOI 10.1158/1535-7163.MCT-08-0104; Yogev S, 2008, EMBO J, V27, P1219, DOI 10.1038/emboj.2008.58; Zou HF, 2009, FASEB J, V23, P425, DOI 10.1096/fj.08-112771	42	123	133	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2011	145	1					79	91		10.1016/j.cell.2011.02.047	http://dx.doi.org/10.1016/j.cell.2011.02.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21439629	Green Published, hybrid			2022-12-28	WOS:000289053900011
J	Baker, M				Baker, Monya			A LIVING SYSTEM ON A CHIP	NATURE			English	Editorial Material																		Domansky K, 2010, LAB CHIP, V10, P51, DOI 10.1039/b913221j; Gunther A, 2010, LAB CHIP, V10, P2341, DOI 10.1039/c004675b; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Imura Y, 2010, ANAL CHEM, V82, P9983, DOI 10.1021/ac100806x; Mahler GJ, 2009, BIOTECHNOL BIOENG, V104, P193, DOI 10.1002/bit.22366; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Sonntag F, 2010, J BIOTECHNOL, V148, P70, DOI 10.1016/j.jbiotec.2010.02.001; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Sung JH, 2011, LAB CHIP, V11, P389, DOI [10.1039/c0lc00273a, 10.1039/c01c00273a]; Sung JH, 2010, LAB CHIP, V10, P446, DOI 10.1039/b917763a	10	153	165	0	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 31	2011	471	7340					661	665		10.1038/471661a	http://dx.doi.org/10.1038/471661a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21455183	Bronze			2022-12-28	WOS:000288951200047
J	Arnaud-Haond, S; Arrieta, JM; Duarte, CM				Arnaud-Haond, Sophie; Arrieta, Jesus M.; Duarte, Carlos M.			Marine Biodiversity and Gene Patents	SCIENCE			English	Editorial Material							DISTRIBUTIONS; RESOURCES; LAW		[Arnaud-Haond, Sophie] Ifremer French Res Inst Explorat Sea, Ctr Brest, Dept DEEP LEP, F-29280 Plouzane, France; [Arrieta, Jesus M.; Duarte, Carlos M.] CSIC UIB, Dept Global Change Resarch, Mediterranean Inst Adv Studies, IMEDEA, Esporles 07190, Mallorca, Spain; [Duarte, Carlos M.] Univ Western Australia, Oceans Inst, Crawley, WA 6009, Australia	Ifremer; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Barcelona; University of Western Australia	Arnaud-Haond, S (corresponding author), Ifremer French Res Inst Explorat Sea, Ctr Brest, Dept DEEP LEP, F-29280 Plouzane, France.	sophie.arnaud@ifremer.fr	Duarte Quesada, Carlos Manuel/ABD-6208-2021; Arnaud-Haond, Sophie/B-2479-2008; Duarte, Carlos M/A-7670-2013; Arrieta, Jesus M/B-1226-2008	Arnaud-Haond, Sophie/0000-0001-5814-8452; Duarte, Carlos M/0000-0002-1213-1361; Arrieta, Jesus M/0000-0002-0190-6950				[Anonymous], 2007, REP WORK UN OP END I; Arico S., 2005, REP WORK UN OP END I; Arico S., 2005, BIOPROSPECTING GENET; Arrieta JM, 2010, P NATL ACAD SCI USA, V107, P18318, DOI 10.1073/pnas.0911897107; Bermudez Jorge, 2010, Open AIDS J, V4, P37, DOI 10.2174/1874613601004020037; Blaustein RJ, 2010, BIOSCIENCE, V60, P408, DOI 10.1525/bio.2010.60.6.3; Caulfield T, 2006, NAT BIOTECHNOL, V24, P1352, DOI 10.1038/nbt1106-1352; Clark J., 2000, PATENT POOLS SOLUTIO; Douglas-Westwood Limited, 2005, MAR FOR SER, V1; Dragulescu A, 2001, PHYSICA A, V299, P213, DOI 10.1016/S0378-4371(01)00298-9; Francisco M., 2010, BIOTECHNIQUES, V28, P300; FRANCISCO M, 2010, NAT BIOTECHNOL, V28, P300; GARRISON C, 2007, KESTUDIES, V1, P1, DOI DOI 10.1038/NRD2487; GROSSMAN GM, 1994, J ECON PERSPECT, V8, P23, DOI 10.1257/jep.8.1.23; Hu MB, 2006, EUR PHYS J B, V53, P273, DOI 10.1140/epjb/e2006-00365-8; Leary D, 2009, MAR POLICY, V33, P183, DOI 10.1016/j.marpol.2008.05.010; Martinez SI, 2010, CURR OPIN ENV SUST, V2, P27, DOI 10.1016/j.cosust.2010.03.004; Molinski TF, 2009, NAT REV DRUG DISCOV, V8, P69, DOI 10.1038/nrd2487; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Ossorio PN, 2007, J LAW MED ETHICS, V35, P425, DOI 10.1111/j.1748-720X.2007.00165.x; ROMER PM, 1990, J POLIT ECON, V98, pS71, DOI 10.1086/261725; ZEWERS K, 2007, LOYOLA U CHICAGO INT, V5, P151	22	50	50	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2011	331	6024					1521	1522		10.1126/science.1200783	http://dx.doi.org/10.1126/science.1200783			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739XH	21436424				2022-12-28	WOS:000288754500027
J	Chretien, JP				Chretien, Jean-Paul			US Global Health Strategy Promoting Healthy Development	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Chretien, Jean-Paul] USN, Washington, DC USA; [Chretien, Jean-Paul] Truman Natl Secur Project, Washington, DC USA	United States Department of Defense; United States Navy	Chretien, JP (corresponding author), 11220 Upton Dr, Kensington, MD 20895 USA.	JPChretien@gmail.com		Chretien, Jean-Paul/0000-0001-8143-6823				Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; [Anonymous], 2003, CITIES TRANSFORMED D; Bollen J, PBL NETHERLANDS ENV; Chamon M, IMPLICATIONS MASS CA; Goldman Sachs, GLOB EC OUTL EXP MID; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Nugent RA, 228 CTR GLOB DEV; White House, FACT SHEET US GLOB D; World Health Organization, GLOB HLTH RISKS; Yach D, 2003, J PUBLIC HEALTH POL, V24, P274, DOI 10.2307/3343374	10	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2011	305	12					1238	1239		10.1001/jama.2011.362	http://dx.doi.org/10.1001/jama.2011.362			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738PA	21427377				2022-12-28	WOS:000288652100021
J	Fine, DR				Fine, David R.			Personal View We need a simple test for prosopagnosia	BRITISH MEDICAL JOURNAL			English	Editorial Material									Southampton Univ Hosp NHS Trust, Southampton, Hants, England	University of Southampton; University Hospital Southampton NHS Foundation Trust	Fine, DR (corresponding author), Southampton Univ Hosp NHS Trust, Southampton, Hants, England.	davidrfine@gmail.com		Fine, David/0000-0001-8041-3275					0	6	6	1	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 23	2011	342								d1736	10.1136/bmj.d1736	http://dx.doi.org/10.1136/bmj.d1736			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	742MJ	21429993				2022-12-28	WOS:000288948000030
J	Turi, L; Madarasz, A				Turi, Laszlo; Madarasz, Adam			Comment on "Does the Hydrated Electron Occupy a Cavity?"	SCIENCE			English	Editorial Material								Larsen et al. (Reports, 2 July 2010, p. 65) challenged the long-standing model of the solvent geometry surrounding a free electron in water using molecular dynamics simulations based on a newly derived electron-water pseudopotential. We illustrate that, in contrast to the model they used, the true electron-water interaction is repulsive in the region relevant to the reported extended electron distribution, consistent with the cavity model.	[Turi, Laszlo; Madarasz, Adam] Eotvos Lorand Univ, Dept Phys Chem, H-1518 Budapest 112, Hungary	Eotvos Lorand University	Turi, L (corresponding author), Eotvos Lorand Univ, Dept Phys Chem, POB 32, H-1518 Budapest 112, Hungary.	turi@chem.elte.hu	Madarasz, Adam/J-9475-2017; Turi, László/A-1811-2012	Madarasz, Adam/0000-0002-9408-318X; Turi, László/0000-0001-8238-7816				Jacobson LD, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3490479; Madarasz A, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3094732; SCHNITKER J, 1987, J CHEM PHYS, V86, P3462, DOI 10.1063/1.452002; Shreve AT, 2010, CHEM PHYS LETT, V493, P216, DOI 10.1016/j.cplett.2010.05.059; Tang Y, 2010, PHYS CHEM CHEM PHYS, V12, P3653, DOI 10.1039/b925741a; Turi L, 2002, J CHEM PHYS, V117, P6186, DOI 10.1063/1.1503308; Turi L, 2001, J CHEM PHYS, V114, P7805, DOI 10.1063/1.1365084	9	7	7	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2011	331	6023					1387	1387		10.1126/science.1197559	http://dx.doi.org/10.1126/science.1197559			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21415337				2022-12-28	WOS:000288504000047
J	Yanovski, SZ; Yanovski, JA				Yanovski, Susan Z.; Yanovski, Jack A.			Obesity Prevalence in the United States - Up, Down, or Sideways?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ADULTS		[Yanovski, Susan Z.] NIDDKD, Off Obes Res, Bethesda, MD 20892 USA; [Yanovski, Jack A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Growth & Obes, Program Dev Endocrinol & Genet, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Yanovski, SZ (corresponding author), NIDDKD, Off Obes Res, Bethesda, MD 20892 USA.			Yanovski, Jack/0000-0001-8542-1637	Intramural NIH HHS [Z99 HD999999, ZIA HD000641-16] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000641] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		[Anonymous], 2010, MMWR MORB MORTAL WKL, V59, P951; EATON DK, 2007, OBES REV, V8, P307; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012	4	114	121	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2011	364	11					987	989		10.1056/NEJMp1009229	http://dx.doi.org/10.1056/NEJMp1009229			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	735SX	21410367	Green Accepted, Bronze			2022-12-28	WOS:000288439000002
J	Sillesen, H; Falk, E				Sillesen, Henrik; Falk, Erling			Why not screen for subclinical atherosclerosis?	LANCET			English	Editorial Material							PRIMARY PREVENTION; TASK-FORCE; DISEASE; RISK; INTERVENTIONS; ASSOCIATION		[Sillesen, Henrik] Rigshosp, Dept Vasc Surg, DK-2100 Copenhagen, Denmark; [Sillesen, Henrik] Univ Copenhagen, DK-2100 Copenhagen, Denmark; [Falk, Erling] Aarhus Univ Hosp, Dept Cardiol, Skejby, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; Aarhus University	Sillesen, H (corresponding author), Rigshosp, Dept Vasc Surg, DK-2100 Copenhagen, Denmark.	sillesen@mac.com	Sillesen, Henrik/ABB-5668-2020					Fuster V, 2009, NAT REV CARDIOL, V6, P669, DOI 10.1038/nrcardio.2009.187; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Hecht HS, 2008, AM J CARDIOL, V101, P1805, DOI 10.1016/j.amjcard.2008.02.086; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Muntendam P, 2010, AM HEART J, V160, P49, DOI 10.1016/j.ahj.2010.02.021; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; Naghavi M, 2006, AM J CARDIOL, V98, p2H, DOI 10.1016/j.amjcard.2006.03.002; Pletcher MJ, 2009, ANN INTERN MED, V150, P243, DOI 10.7326/0003-4819-150-4-200902170-00005; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Shah PK, 2010, J AM COLL CARDIOL, V56, P98, DOI 10.1016/j.jacc.2009.09.081; Taylor AJ, 2010, J AM COLL CARDIOL, V56, P1864, DOI 10.1016/j.jacc.2010.07.005; WISLOFF T, 2008, COSTS LIFE YEAR GAIN	12	44	44	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 20	2011	378	9792					645	646		10.1016/S0140-6736(11)60059-7	http://dx.doi.org/10.1016/S0140-6736(11)60059-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	815EW	21440933				2022-12-28	WOS:000294509900007
J	Shimojima, T; Sakaguchi, F; Ishizaka, K; Ishida, Y; Kiss, T; Okawa, M; Togashi, T; Chen, CT; Watanabe, S; Arita, M; Shimada, K; Namatame, H; Taniguchi, M; Ohgushi, K; Kasahara, S; Terashima, T; Shibauchi, T; Matsuda, Y; Chainani, A; Shin, S				Shimojima, T.; Sakaguchi, F.; Ishizaka, K.; Ishida, Y.; Kiss, T.; Okawa, M.; Togashi, T.; Chen, C. -T.; Watanabe, S.; Arita, M.; Shimada, K.; Namatame, H.; Taniguchi, M.; Ohgushi, K.; Kasahara, S.; Terashima, T.; Shibauchi, T.; Matsuda, Y.; Chainani, A.; Shin, S.			Orbital-Independent Superconducting Gaps in Iron Pnictides	SCIENCE			English	Article								The origin of superconductivity in the iron pnictides has been attributed to antiferromagnetic spin ordering that occurs in close combination with a structural transition, but there are also proposals that link superconductivity to orbital ordering. We used bulk-sensitive laser angle-resolved photoemission spectroscopy on BaFe2(As0.65P0.35)(2) and Ba0.6K0.4Fe2As2 to elucidate the role of orbital degrees of freedom on the electron-pairing mechanism. In strong contrast to previous studies, an orbital-independent superconducting gap magnitude was found for the hole Fermi surfaces. Our result is not expected from the superconductivity associated with spin fluctuations and nesting, but it could be better explained invoking magnetism-induced interorbital pairing, orbital fluctuations, or a combination of orbital and spin fluctuations. Regardless of the interpretation, our results impose severe constraints on theories of iron pnictides.	[Shimojima, T.; Sakaguchi, F.; Ishizaka, K.; Ishida, Y.; Kiss, T.; Okawa, M.; Watanabe, S.; Ohgushi, K.; Shin, S.] Univ Tokyo, ISSP, Chiba 2778581, Japan; [Shimojima, T.; Ishizaka, K.; Shin, S.] Japan Sci & Technol Agcy JST, Core Res Evolut Sci & Technol CREST, Chiyoda Ku, Tokyo 1020075, Japan; [Ishida, Y.; Ohgushi, K.; Shin, S.] JST, Transformat Res Project Iron Pnictides, Chiyoda Ku, Tokyo 1020075, Japan; [Togashi, T.; Chainani, A.; Shin, S.] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan; [Chen, C. -T.] Chinese Acad Sci, Beijing Ctr Crystal Res & Dev, Beijing 100190, Peoples R China; [Arita, M.; Shimada, K.; Namatame, H.; Taniguchi, M.] Hiroshima Univ, Hiroshima Synchrotron Radiat Ctr, Hiroshima 7398526, Japan; [Arita, M.; Shimada, K.; Namatame, H.; Taniguchi, M.] Hiroshima Univ, Grad Sch Sci, Hiroshima 7398526, Japan; [Kasahara, S.; Terashima, T.] Kyoto Univ, Res Ctr Low Temp & Mat Sci, Sakyo Ku, Kyoto 6068501, Japan; [Shibauchi, T.; Matsuda, Y.] Kyoto Univ, Dept Phys, Sakyo Ku, Kyoto 6068502, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); RIKEN; Chinese Academy of Sciences; Hiroshima University; Hiroshima University; Kyoto University; Kyoto University	Shimojima, T (corresponding author), Univ Tokyo, Grad Sch Engn, Dept Appl Phys, Chiba 2778581, Japan.	shimojima@ap.t.u-tokyo.ac.jp; shin@issp.u-tokyo.ac.jp	Chainani, Ashish/B-3071-2011; Shimada, Kenya/ABG-8603-2021; Matsuda, Yuji/ABH-7166-2020; Shibauchi, Takasada/B-9349-2008; Ishida, Yukiaki/D-4261-2016; Okawa, Mario/C-5610-2012; Ohgushi, Kenya/K-5319-2012; SHIN, SHIK/ABH-1500-2020; Chainani, Ashish/ABH-8078-2020; Kasahara, Shigeru/H-3064-2014; Ishizaka, Kyoko/M-7643-2016; Shimada, Kenya/G-5080-2016; Shimojima, Takahiro/D-3888-2017	Chainani, Ashish/0000-0002-5639-5393; Shimada, Kenya/0000-0002-1945-2352; Matsuda, Yuji/0000-0001-9947-9418; Shibauchi, Takasada/0000-0001-5831-4924; Ishida, Yukiaki/0000-0002-0980-7041; Okawa, Mario/0000-0001-6540-8988; Kasahara, Shigeru/0000-0002-6007-9617; Ishizaka, Kyoko/0000-0002-1710-7176; Shimada, Kenya/0000-0002-1945-2352; Shimojima, Takahiro/0000-0002-2162-4539	Special Coordination Funds for Promoting Science and Technology, Promotion of Environmental Improvement for Independence of Young Researchers; Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [22684017] Funding Source: KAKEN	Special Coordination Funds for Promoting Science and Technology, Promotion of Environmental Improvement for Independence of Young Researchers; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank W. Malaeb for experimental supports and valuable discussions. We acknowledge T. Yoshida, R. Arita, H. Kontani, S. Onari, M. Ogata, and Y. Yanase for valuable discussions. We acknowledge K. Kuroki, H. Usui, Y. Suzuki, and A. Carrington for valuable discussions and first-principles band calculations. Part of this work was performed at the Hiroshima Synchrotron Radiation Center, Hiroshima university, Japan (proposal 10-B-24). Support for this work was provided by Special Coordination Funds for Promoting Science and Technology, Promotion of Environmental Improvement for Independence of Young Researchers (to K.O.). This research is supported by the Japan Society for the Promotion of Science (JSPS) through its Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST) Program.	Boeri L, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.026403; Christianson AD, 2008, NATURE, V456, P930, DOI 10.1038/nature07625; Daghofer M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.180514; Daghofer M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.014511; Evtushinsky DV, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.054517; Fletcher JD, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.147001; Hanaguri T, 2010, SCIENCE, V328, P474, DOI 10.1126/science.1187399; Hashimoto K, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.220501; Kamihara Y, 2008, J AM CHEM SOC, V130, P3296, DOI 10.1021/ja800073m; Kasahara S, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.184519; Kemper AF, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/7/073030; Kontani H, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.157001; Kuroki K, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.224511; Kuroki K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.087004; Lee CC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.267001; Lee SH, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.220502; Lv WC, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.224506; Mazin II, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.057003; Moreo A, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.104507; Nakai Y, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.020503; Nandi S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.057006; Reid JP, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.064501; Ren ZA, 2008, CHINESE PHYS LETT, V25, P2215, DOI 10.1088/0256-307X/25/6/080; Rotter M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.107006; Saito T, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.144510; Sato M, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.014710; Shimojima T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.057002; Stanescu TD, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195114; Suzuki K, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.013710; Yanagi Y, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.054518; Yoshida T, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.117001; Zhang JH, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.220502	33	120	120	3	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2011	332	6029					564	567		10.1126/science.1202150	http://dx.doi.org/10.1126/science.1202150			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21474714				2022-12-28	WOS:000289991100041
J	Frakt, A; Carroll, AE; Pollack, HA; Reinhardt, U				Frakt, Austin; Carroll, Aaron E.; Pollack, Harold A.; Reinhardt, Uwe			Our Flawed but Beneficial Medicaid Program	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MORTALITY		[Frakt, Austin] VA Boston Healthcare Syst, Hlth Care Financing & Econ, Boston, MA USA; [Frakt, Austin] Boston Univ, Boston, MA 02215 USA; [Carroll, Aaron E.] Indiana Univ, Sch Med, Ctr Hlth Policy & Professionalism Res, Indianapolis, IN USA; [Pollack, Harold A.] Univ Chicago, Sch Social Serv Adm, Chicago, IL 60637 USA; [Reinhardt, Uwe] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; Indiana University System; Indiana University-Purdue University Indianapolis; University of Chicago; Princeton University	Frakt, A (corresponding author), VA Boston Healthcare Syst, Hlth Care Financing & Econ, Boston, MA USA.		Pollack, Harold A/A-1166-2007	Frakt, Austin/0000-0002-0795-5462				Bhattacharya J, 2003, J HEALTH ECON, V22, P1105, DOI 10.1016/j.jhealeco.2003.07.001; Currie J, 1996, J POLIT ECON, V104, P1263, DOI 10.1086/262059; Gaglia MA, 2011, AM J CARDIOL, V107, P675, DOI 10.1016/j.amjcard.2010.10.041; GOTTLIEB S, 2011, WALL STREET J   0310; LaPar DJ, 2010, ANN SURG, V252, P544, DOI 10.1097/SLA.0b013e3181e8fd75	5	20	20	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 21	2011	364	16								10.1056/NEJMp1103168	http://dx.doi.org/10.1056/NEJMp1103168			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	752VH	21470001				2022-12-28	WOS:000289722700004
J	Gibbs, SJ; Robinson, SA; Bown, PR; Dunkley Jones, T; Henderiks, J				Gibbs, Samantha J.; Robinson, Stuart A.; Bown, Paul R.; Dunkley Jones, Tom; Henderiks, Jorijntje			Comment on "Calcareous Nannoplankton Response to Surface-Water Acidification Around Oceanic Anoxic Event 1a"	SCIENCE			English	Editorial Material							MARINE CALCIFIERS; CALCITE	Erba et al. (Reports, 23 July 2010, p. 428) attributed calcareous nannofossil morphology and assemblage changes across Cretaceous Oceanic Anoxic Event 1a to the effects of surface ocean acidification. We argue that the quality of carbonate preservation in these sequences, the unsupported assumptions of the biotic response to acidity, and the absence of independent proxy estimates for ocean pH or atmospheric pCO(2) render this conclusion questionable.	[Gibbs, Samantha J.] Natl Oceanog Ctr, Sch Ocean & Earth Sci, Southampton SO14 3ZH, Hants, England; [Robinson, Stuart A.; Bown, Paul R.] UCL, Dept Earth Sci, London WC1E 6BT, England; [Dunkley Jones, Tom] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London SW7 2AZ, England; [Henderiks, Jorijntje] Uppsala Univ, Dept Earth Sci, SE-75236 Uppsala, Sweden	NERC National Oceanography Centre; University of London; University College London; Imperial College London; Uppsala University	Gibbs, SJ (corresponding author), Natl Oceanog Ctr, Sch Ocean & Earth Sci, European Way, Southampton SO14 3ZH, Hants, England.	sxg@noc.soton.ac.uk	Bown, Paul/C-5235-2011; Robinson, Stuart/C-4808-2011; Jones, Tom Dunkley/A-8441-2008; Henderiks, Jorijntje/ABB-1080-2020	Bown, Paul/0000-0001-6777-4463; Robinson, Stuart/0000-0003-4329-1058; Jones, Tom Dunkley/0000-0002-9518-8143; Henderiks, Jorijntje/0000-0001-9486-6275				Bown PR, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P481; Dore JE, 2009, P NATL ACAD SCI USA, V106, P12235, DOI 10.1073/pnas.0906044106; Erba E, 2004, MAR MICROPALEONTOL, V52, P85, DOI 10.1016/j.marmicro.2004.04.007; Erba E, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000884; Erba E, 2010, SCIENCE, V329, P428, DOI 10.1126/science.1188886; Fabry VJ, 2008, SCIENCE, V320, P1020, DOI 10.1126/science.1157130; Frank TD, 1999, J FORAMIN RES, V29, P340; Gibbs SJ, 2010, EARTH PLANET SC LETT, V295, P583, DOI 10.1016/j.epsl.2010.04.044; Henderiks J, 2008, MAR MICROPALEONTOL, V67, P143, DOI 10.1016/j.marmicro.2008.01.005; Leckie RM, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000623; Ridgwell A, 2010, NAT GEOSCI, V3, P196, DOI 10.1038/NGEO755; *ROYAL SOC, 2006, 1205 ROYAL SOC; SASS E, 1991, GEOLOGY, V19, P839, DOI 10.1130/0091-7613(1991)019<0839:OICODC>2.3.CO;2; Weissert H, 1998, PALAEOGEOGR PALAEOCL, V137, P189, DOI 10.1016/S0031-0182(97)00109-0; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004	15	12	12	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026								10.1126/science.1199459	http://dx.doi.org/10.1126/science.1199459			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474738				2022-12-28	WOS:000289251100025
J	Parker, S				Parker, Stephen			The art of medicine Diagnosing Bertolt Brecht	LANCET			English	Editorial Material									Univ Manchester, Sch Languages Linguist & Cultures, Manchester M13 9PL, Lancs, England	University of Manchester	Parker, S (corresponding author), Univ Manchester, Sch Languages Linguist & Cultures, Manchester M13 9PL, Lancs, England.	stephen.parker@manchester.ac.uk		Parker, Stephen/0000-0002-7414-0765					0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2011	377	9772					1146	1147		10.1016/S0140-6736(11)60453-4	http://dx.doi.org/10.1016/S0140-6736(11)60453-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	750IH	21465701				2022-12-28	WOS:000289539300016
J	Warriner, IK; Wang, DL; Huong, NTM; Thapa, K; Tamang, A; Shah, I; Baird, DT; Meirik, O				Warriner, I. K.; Wang, Duolao; Huong, N. T. My; Thapa, Kusum; Tamang, Anand; Shah, Iqbal; Baird, David T.; Meirik, Olav			Can midlevel health-care providers administer early medical abortion as safely and effectively as doctors? A randomised controlled equivalence trial in Nepal	LANCET			English	Article							ADVANCED PRACTICE CLINICIAN; MIFEPRISTONE; AVAILABILITY; MISOPROSTOL	Background Medical abortion is under-used in developing countries. We assessed whether early first-trimester medical abortion provided by midlevel providers (government-trained, certified nurses and auxiliary nurse midwives) was as safe and effective as that provided by doctors in Nepal. Methods This multicentre randomised controlled equivalence trial was done in five rural district hospitals in Nepal. Women were eligible for medical abortion if their pregnancy was of less than 9 weeks (63 days) and if they resided less than 90 min journey away from the study clinic Women were ineligible if they had any contraindication to medical abortion. We used a computer-generated randomisation scheme stratified by study centre with a block size of six. Women were randomly assigned to a doctor or a midlevel provider for oral administration of 200 mg mifepristone followed by 800 mu g misoprostol vaginally 2 days later, and followed up 10-14 days later. The primary endpoint was complete abortion without manual vacuum aspiration within 30 days of treatment. The study was not masked. Abortions were recorded at; complete, incomplete, or failed (continuing pregnancy). Analyses for primary and secondary endpoints were by intention to treat, supplemented by per-protocol analysis of the primary endpoint. This trial is registered with ClinicalTrials.gov, NCT01186302. Findings Of 1295 women screened, 535 were randomly assigned to a doctor and 542 to a midlevel provider. 514 and 518, respectively, were included in the analyses of the primary endpoint. Abortions were judged complete in 504 (97.3%) women assigned to midlevel providers and in 494 (96.1%) assigned to physicians. The risk difference for complete abortion was 1.24% (95% Cl -0.53 to 3.02), which falls within the predefined equivalence range (-5% to 5%). Five cases (1%) were recorded as failed abortion in the doctor cohort and none in the midlevel provider cohort; the remaining cases were recorded as incomplete abortions. No serious complications were noted. Interpretation The provision of medical abortion up to 9 weeks' gestation by midlevel providers and doctors was similar in safety and effectiveness. Where permitted by law, appropriately trained midlevel health-care providers can provide safe, low-technology medical abortion services for women independently from doctors.	[Warriner, I. K.; Huong, N. T. My; Shah, Iqbal; Meirik, Olav] WHO, UNDP UNFPA WHO World Bank Special Programme Res D, Dept Reprod Hlth & Res, CH-1211 Geneva 27, Switzerland; [Wang, Duolao] London Sch Hyg & Trop Med, London WC1, England; [Thapa, Kusum] Paropakar Matern & Womens Hosp, Dept Obstet & Gynaecol, Kathmandu, Nepal; [Tamang, Anand] CREHPA, Kathmandu, Nepal; [Baird, David T.] Univ Edinburgh, Ctr Reprod Biol, Simpson Ctr Reprod Hlth, Edinburgh EH3 9EW, Midlothian, Scotland	United Nations Population Fund; World Health Organization; University of London; London School of Hygiene & Tropical Medicine; University of Edinburgh	Warriner, IK (corresponding author), WHO, Special Programme Res Dev & Res Training Human Re, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	warrineri@who.int			UNDP/UNFPA/WHO/World Bank; Development and Research Training in Human Reproduction (HRP); Department of Reproductive Health and Research (RHR); World Health Organization	UNDP/UNFPA/WHO/World Bank(World Health Organization); Development and Research Training in Human Reproduction (HRP); Department of Reproductive Health and Research (RHR); World Health Organization(World Health Organization)	UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), Department of Reproductive Health and Research (RHR), World Health Organization.	[Anonymous], 2007, TASK SHIFT GLOB REC; Ashok PW, 2002, BJOG-INT J OBSTET GY, V109, P1281, DOI 10.1016/S1470-0328(02)02956-7; Baird DT, 2002, BEST PRACT RES CL OB, V16, P221, DOI 10.1053/beog.2001.0272; Berer M, 2009, B WORLD HEALTH ORGAN, V87, P58, DOI 10.2471/BLT.07.050138; FHD/Ipas/CREHPA, 2006, SUMM REP NEP COMPR A; Ganatra B, 2004, REPROD HEALTH MATTER, V12, P105, DOI 10.1016/S0968-8080(04)24022-8; Iyengar SD, 2005, REPROD HEALTH MATTER, V13, P13, DOI 10.1016/S0968-8080(05)26217-1; Joffe C, 2004, REPROD HEALTH MATTER, V12, P198, DOI 10.1016/S0968-8080(04)24008-3; Karki C, 2009, INT J GYNECOL OBSTET, V106, P39, DOI 10.1016/j.ijgo.2009.02.007; McPake B, 2008, LANCET, V372, P870, DOI 10.1016/S0140-6736(08)61375-6; Medical Abortion Task Force, 2009, MED AB 6 PIL DISTR N; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1172; Pradhan A, 2010, NEPAL MATERNAL MORTA; RODGER MW, 1987, LANCET, V2, P1415; Samora JB, 2007, JOGNN-J OBST GYN NEO, V36, P471, DOI 10.1111/J.1552-6909.2007.00169.x; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; SINGH Susheela, 2009, ABORTION WORLDWIDE D; Tamang A, 2005, REPROD HEALTH MATTER, V13, P110, DOI 10.1016/S0968-8080(05)26194-3; Tang OS, 2003, HUM REPROD, V18, P2315, DOI 10.1093/humrep/deg475; von Hertzen H, 2003, BJOG-INT J OBSTET GY, V110, P808, DOI 10.1016/S1470-0328(03)02430-3; von Hertzen H, 2007, LANCET, V369, P1938, DOI 10.1016/S0140-6736(07)60914-3; Warriner IK, 2006, LANCET, V368, P1965, DOI 10.1016/S0140-6736(06)69742-0; WHO, 2011, UNS AB GLOB IN PRESS; WHO, 2003, SAF AB TECHN POL GUI; Wiens BL, 2002, CONTROL CLIN TRIALS, V23, P2, DOI 10.1016/S0197-2456(01)00196-9; Yarnall J, 2009, REPROD HEALTH MATTER, V17, P61, DOI 10.1016/S0968-8080(09)33445-X	27	109	109	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2011	377	9772					1155	1161		10.1016/S0140-6736(10)62229-5	http://dx.doi.org/10.1016/S0140-6736(10)62229-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750IH	21458058				2022-12-28	WOS:000289539300031
J	Rajab, TK; Gallegos, RP				Rajab, Taufiek Konrad; Gallegos, Robert P.			Giant Syphilitic Aortic Aneurysm	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rajab, Taufiek Konrad; Gallegos, Robert P.] Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Rajab, TK (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.								0	7	7	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2011	364	13					1258	1258		10.1056/NEJMicm1008124	http://dx.doi.org/10.1056/NEJMicm1008124			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	742NO	21449789				2022-12-28	WOS:000288951300011
J	Ham, C; Dixon, J; Chantler, C				Ham, Chris; Dixon, Jennifer; Chantler, Cyril			Clinically integrated systems: the future of NHS reform in England?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ham, Chris] Kings Fund, London W1G OAN, England; [Dixon, Jennifer] Nuffield Trust, London, England; [Chantler, Cyril] UCL Partners, London, England	University of London; University College London	Ham, C (corresponding author), Kings Fund, London W1G OAN, England.	c.ham@kingsfund.org.uk						[Anonymous], 2008, INNOVATORS PRESCRIPT; Ashton CM, 2003, NEW ENGL J MED, V349, P1637, DOI 10.1056/NEJMsa003299; Casalino L, 2011, COMMISSIONING 10 SUG; Curry N, 2010, CLIN SERVICE INTEGRA; Department of Health, INT CAR NETW; Enthoven AC, 2002, INTRO MARKET FORCES; Feachem RGA, 2002, BMJ-BRIT MED J, V324, P135, DOI 10.1136/bmj.324.7330.135; Ham C, 2003, BRIT MED J, V327, P1257, DOI 10.1136/bmj.327.7426.1257; Ham C., 2010, WORKING TOGETHER HLT; Ham C, 2010, REMOVING POLICY BARR; Ham C, 2007, CLIN INTEGRATED SYST; Ham C, 2008, BRIT MED J, V336, P805, DOI 10.1136/bmj.39532.445197.AD; *KINGS FUND, 2010, IMP HLTH WHIT PAP WH; [RAND Europe Ernst and Young Department of Health], 2010, PROGR REP EV NAT INT; ROBINSON JC, 1999, CALIF MILBANK S, P1; Smith J, 2009, PRACTICE BASED COMMI; Wagner E, 2009, INTEGRATED CARE WHAT; Weeks WB, 2010, HEALTH AFFAIR, V29, P991, DOI 10.1377/hlthaff.2009.0388	18	15	15	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2011	342								d905	10.1136/bmj.d905	http://dx.doi.org/10.1136/bmj.d905			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	745WB	21444642				2022-12-28	WOS:000289200200001
J	He, RH; Hashimoto, M; Karapetyan, H; Koralek, JD; Hinton, JP; Testaud, JP; Nathan, V; Yoshida, Y; Yao, H; Tanaka, K; Meevasana, W; Moore, RG; Lu, DH; Mo, SK; Ishikado, M; Eisaki, H; Hussain, Z; Devereaux, TP; Kivelson, SA; Orenstein, J; Kapitulnik, A; Shen, ZX				He, Rui-Hua; Hashimoto, M.; Karapetyan, H.; Koralek, J. D.; Hinton, J. P.; Testaud, J. P.; Nathan, V.; Yoshida, Y.; Yao, Hong; Tanaka, K.; Meevasana, W.; Moore, R. G.; Lu, D. H.; Mo, S. -K.; Ishikado, M.; Eisaki, H.; Hussain, Z.; Devereaux, T. P.; Kivelson, S. A.; Orenstein, J.; Kapitulnik, A.; Shen, Z. -X.			From a Single-Band Metal to a High-Temperature Superconductor via Two Thermal Phase Transitions	SCIENCE			English	Article							T-C SUPERCONDUCTOR; PSEUDOGAP STATE; BI2SR2CACU2O8+DELTA; SYMMETRY; TIME; FLUCTUATIONS; BREAKING; DENSITY; ORDER	The nature of the pseudogap phase of cuprate high-temperature superconductors is a major unsolved problem in condensed matter physics. We studied the commencement of the pseudogap state at temperature T* using three different techniques (angle-resolved photoemission spectroscopy, polar Kerr effect, and time-resolved reflectivity) on the same optimally doped Bi2201 crystals. We observed the coincident, abrupt onset at T* of a particle-hole asymmetric antinodal gap in the electronic spectrum, a Kerr rotation in the reflected light polarization, and a change in the ultrafast relaxational dynamics, consistent with a phase transition. Upon further cooling, spectroscopic signatures of superconductivity begin to grow close to the superconducting transition temperature (T-c), entangled in an energy-momentum-dependent manner with the preexisting pseudogap features, ushering in a ground state with coexisting orders.	[He, Rui-Hua; Hashimoto, M.; Karapetyan, H.; Testaud, J. P.; Nathan, V.; Yao, Hong; Tanaka, K.; Meevasana, W.; Moore, R. G.; Lu, D. H.; Devereaux, T. P.; Kivelson, S. A.; Kapitulnik, A.; Shen, Z. -X.] Stanford Univ, Dept Phys, Geballe Lab Adv Mat, Stanford, CA 94305 USA; [He, Rui-Hua; Hashimoto, M.; Karapetyan, H.; Testaud, J. P.; Nathan, V.; Yao, Hong; Tanaka, K.; Meevasana, W.; Moore, R. G.; Lu, D. H.; Devereaux, T. P.; Kivelson, S. A.; Kapitulnik, A.; Shen, Z. -X.] Stanford Univ, Dept Appl Phys, Geballe Lab Adv Mat, Stanford, CA 94305 USA; [He, Rui-Hua; Hashimoto, M.; Karapetyan, H.; Testaud, J. P.; Nathan, V.; Tanaka, K.; Meevasana, W.; Moore, R. G.; Lu, D. H.; Devereaux, T. P.; Kapitulnik, A.; Shen, Z. -X.] SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA; [He, Rui-Hua; Hashimoto, M.; Koralek, J. D.; Hinton, J. P.; Testaud, J. P.; Yao, Hong; Tanaka, K.; Mo, S. -K.; Hussain, Z.; Orenstein, J.] Univ Calif Berkeley, Lawrence Berkeley Lab, Adv Light Source, Berkeley, CA 94720 USA; [He, Rui-Hua; Hashimoto, M.; Koralek, J. D.; Hinton, J. P.; Testaud, J. P.; Yao, Hong; Tanaka, K.; Mo, S. -K.; Hussain, Z.; Orenstein, J.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Koralek, J. D.; Hinton, J. P.; Yao, Hong; Orenstein, J.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Yoshida, Y.; Eisaki, H.] Natl Inst Adv Ind Sci & Technol, Nanoelect Res Inst, Tsukuba 3058568, Japan; [Tanaka, K.] Osaka Univ, Dept Phys, Osaka 5600043, Japan; [Meevasana, W.] Suranaree Univ Technol, Sch Phys, Nakhon Ratchasima 30000, Thailand; [Meevasana, W.] Synchrotron Light Res Inst, Nakhon Ratchasima 30000, Thailand; [Ishikado, M.] Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan	Stanford University; Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; National Institute of Advanced Industrial Science & Technology (AIST); Osaka University; Suranaree University of Technology; Japan Atomic Energy Agency	Devereaux, TP (corresponding author), Stanford Univ, Dept Phys, Geballe Lab Adv Mat, Stanford, CA 94305 USA.	tpd@stanford.edu; kivelson@stanford.edu; jworenstein@lbl.gov; aharonk@stanford.edu; zxshen@stanford.edu	Yoshida, Yoshiyuki/L-6221-2018; Mo, Sung-Kwan/F-3489-2013; Eisaki, Hiroshi/F-6317-2018; Orenstein, Joseph W/I-3451-2015; He, Ruihua/A-6975-2010; Moore, Rob/CAG-8039-2022; Yao, Hong/D-3202-2011	Yoshida, Yoshiyuki/0000-0001-7998-1873; Mo, Sung-Kwan/0000-0003-0711-8514; Eisaki, Hiroshi/0000-0002-8299-6416; Moore, Rob/0000-0002-1608-5411; Yao, Hong/0000-0003-2867-6144; TANAKA, Kiyohisa/0000-0003-2779-5870; Koralek, Jake/0000-0001-8289-0497; kapitulnik, aharon/0000-0002-2569-3582; Hashimoto, Makoto/0000-0003-1689-8997; Kivelson, Steven/0000-0001-9149-9502	SGF; Department of Energy, Office of Basic Energy Sciences [DE-AC02-76SF00515, DE-AC02-05CH11231]	SGF; Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE))	We thank I. Vishik, W.-S. Lee, L. Taillefer, and M. Greven for helpful discussions, Y. Li and G. Yu for experimental assistance on SQUID, and J.-H. Chu on resistivity measurements. R.-H.H. thanks the SGF for financial support. This work at the Stanford Institute for Materials and Energy Sciences, the Stanford Synchrotron Radiation Lightsource, and the Advanced Light Source is supported by the Department of Energy, Office of Basic Energy Sciences under contracts DE-AC02-76SF00515 and DE-AC02-05CH11231.	Borisenko SV, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.166402; Chakravarty S, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.094503; Chia EEM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.147008; Damascelli A, 2003, REV MOD PHYS, V75, P473, DOI 10.1103/RevModPhys.75.473; Daou R, 2010, NATURE, V463, P519, DOI 10.1038/nature08716; Demsar J, 1999, PHYS REV LETT, V82, P4918, DOI 10.1103/PhysRevLett.82.4918; EESLEY GL, 1990, PHYS REV LETT, V65, P3445, DOI 10.1103/PhysRevLett.65.3445; Fedorov AV, 1999, PHYS REV LETT, V82, P2179, DOI 10.1103/PhysRevLett.82.2179; Gay P, 1999, J LOW TEMP PHYS, V117, P1025, DOI 10.1023/A:1022561904373; Gedik N, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.014504; Grilli M, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.125111; Hashimoto M, 2010, NAT PHYS, V6, P414, DOI 10.1038/NPHYS1632; Hinkov V, 2008, SCIENCE, V319, P597, DOI 10.1126/science.1152309; Hoffman JE, 2002, SCIENCE, V295, P466, DOI 10.1126/science.1066974; Howald C, 2003, P NATL ACAD SCI USA, V100, P9705, DOI 10.1073/pnas.1233768100; Kaindl RA, 2000, SCIENCE, V287, P470, DOI 10.1126/science.287.5452.470; Kaminski A, 2002, NATURE, V416, P610, DOI 10.1038/416610a; Kawasaki S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.137002; Kivelson SA, 1998, NATURE, V393, P550, DOI 10.1038/31177; Kohsaka Y, 2007, SCIENCE, V315, P1380, DOI 10.1126/science.1138584; Kondo T, 2011, NAT PHYS, V7, P21, DOI 10.1038/NPHYS1851; Lawler MJ, 2010, NATURE, V466, P347, DOI 10.1038/nature09169; Li Y, 2008, NATURE, V455, P372, DOI 10.1038/nature07251; Liu YH, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.137003; Ma JH, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.207002; Meng JQ, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.024514; Nakayama K, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.227006; Parker CV, 2010, NATURE, V468, P677, DOI 10.1038/nature09597; Tanaka K, 2006, SCIENCE, V314, P1910, DOI 10.1126/science.1133411; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Varma CM, 1997, PHYS REV B, V55, P14554, DOI 10.1103/PhysRevB.55.14554; Vershinin M, 2004, SCIENCE, V303, P1995, DOI 10.1126/science.1093384; Wise WD, 2008, NAT PHYS, V4, P696, DOI 10.1038/nphys1021; Xia J, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.167002	38	264	268	3	205	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 25	2011	331	6024					1579	1583		10.1126/science.1198415	http://dx.doi.org/10.1126/science.1198415			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21436447	Green Submitted			2022-12-28	WOS:000288754500048
J	Ferguson, CD				Ferguson, Charles D.			Do not phase out nuclear power - yet	NATURE			English	Editorial Material									Federat Amer Scientists, Washington, DC 20036 USA		Ferguson, CD (corresponding author), Federat Amer Scientists, Washington, DC 20036 USA.	cferguson@fas.org							0	8	8	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					411	411		10.1038/471411a	http://dx.doi.org/10.1038/471411a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430730				2022-12-28	WOS:000288702200022
J	Lapolla, W; Tyring, SK				Lapolla, Whitney; Tyring, Stephen K.			Podoconiosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lapolla, Whitney; Tyring, Stephen K.] Ctr Clin Studies, Webster, TX 77598 USA		Lapolla, W (corresponding author), Ctr Clin Studies, Webster, TX 77598 USA.	whitneylapolla@gmail.com							0	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2011	364	12					E23	E23		10.1056/NEJMicm1008802	http://dx.doi.org/10.1056/NEJMicm1008802			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739FY	21428762				2022-12-28	WOS:000288701100011
J	Lam, JKY; Lam, CW; Kung, AWC; Tan, KCB; Lau, KS; Lam, KSL				Lam, Joanne K. Y.; Lam, C. W.; Kung, Annie W. C.; Tan, Kathryn C. B.; Lau, K. S.; Lam, Karen S. L.			Case report A man with hypophosphataemia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TUMOR-INDUCED OSTEOMALACIA; LOCALIZATION					kyjoanne414@yahoo.com.hk						Avila NA, 1996, AM J ROENTGENOL, V167, P343, DOI 10.2214/ajr.167.2.8686600; Berndt TJ, 2005, AM J PHYSIOL-RENAL, V289, pF1170, DOI 10.1152/ajprenal.00072.2005; de Beur SMJ, 2005, JAMA-J AM MED ASSOC, V294, P1260; de Beur SMJ, 2002, LANCET, V359, P761, DOI 10.1016/S0140-6736(02)07846-7; Drezner M K, 2001, Rev Endocr Metab Disord, V2, P175, DOI 10.1023/A:1010006811394; Payne RB, 1998, ANN CLIN BIOCHEM, V35, P201, DOI 10.1177/000456329803500203; PRADER A, 1959, Helv Paediatr Acta, V14, P554; Roarke MC, 2007, CLIN NUCL MED, V32, P300, DOI 10.1097/01.rlu.0000257180.03964.51; Seufert J, 2001, NEW ENGL J MED, V345, P1883, DOI 10.1056/NEJMoa010839; Takeuchi Y, 2004, J CLIN ENDOCR METAB, V89, P3979, DOI 10.1210/jc.2004-0406; Wat WZM, 2007, ANN NUTR METAB, V51, P59, DOI 10.1159/000100822	11	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2011	342								d773	10.1136/bmj.d773	http://dx.doi.org/10.1136/bmj.d773			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	742MJ	21436116	Green Submitted			2022-12-28	WOS:000288948000002
J	Peca, J; Feliciano, C; Ting, JT; Wang, WT; Wells, MF; Venkatraman, TN; Lascola, CD; Fu, ZY; Feng, GP				Peca, Joao; Feliciano, Catia; Ting, Jonathan T.; Wang, Wenting; Wells, Michael F.; Venkatraman, Talaignair N.; Lascola, Christopher D.; Fu, Zhanyan; Feng, Guoping			Shank3 mutant mice display autistic-like behaviours and striatal dysfunction	NATURE			English	Article							22Q13 DELETION SYNDROME; SPECTRUM DISORDERS; SYNAPTIC-TRANSMISSION; MUTATIONS; PROTEIN; BRAIN; GENE; NEUROLIGINS; SAPAPS; FAMILY	Autismspectrum disorders (ASDs) comprise a range of disorders that share a core of neurobehavioural deficits characterized by widespread abnormalities in social interactions, deficits in communication as well as restricted interests and repetitive behaviours. The neurological basis and circuitry mechanisms underlying these abnormal behaviours are poorly understood. SHANK3 is a postsynaptic protein, whose disruption at the genetic level is thought to be responsible for the development of 22q13 deletion syndrome (Phelan-McDermid syndrome) and other non-syndromic ASDs. Here we show that mice with Shank3 gene deletions exhibit self-injurious repetitive grooming and deficits in social interaction. Cellular, electrophysiological and biochemical analyses uncovered defects at striatal synapses and cortico-striatal circuits in Shank3 mutant mice. Our findings demonstrate a critical role for SHANK3 in the normal development of neuronal connectivity and establish causality between a disruption in the Shank3 gene and the genesis of autistic-like behaviours in mice.	[Peca, Joao; Feliciano, Catia; Ting, Jonathan T.; Wang, Wenting; Wells, Michael F.; Lascola, Christopher D.; Fu, Zhanyan; Feng, Guoping] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Peca, Joao] Univ Coimbra, Ctr Neurosci & Cell Biol, PhD Programme Biomed & Expt Biol, Coimbra, Portugal; [Feliciano, Catia] Gulbenkian Inst Sci, Gulbenkian PhD Programme Biomed, P-2781901 Oeiras, Portugal; [Venkatraman, Talaignair N.; Lascola, Christopher D.] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA; [Venkatraman, Talaignair N.; Lascola, Christopher D.] Duke Univ, Med Ctr, Brain Imaging & Anal Ctr, Durham, NC 27710 USA; [Fu, Zhanyan] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; [Fu, Zhanyan; Feng, Guoping] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Feng, Guoping] Stanley Ctr Psychiat Res, Broad Inst, Cambridge, MA 02142 USA	Duke University; Universidade de Coimbra; Duke University; Duke University; Duke University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Feng, GP (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	fengg@mit.edu	Lascola, Christopher D/B-9126-2017; Peça, João/K-7900-2013; Feng, Guoping/Y-2827-2019	Lascola, Christopher D/0000-0002-8031-782X; Peça, João/0000-0003-4989-2129; Ting, Jonathan/0000-0001-8266-0392; Wang, Wenting/0000-0002-8344-0102; Wells, Michael/0000-0002-1367-2565; Feliciano, Catia/0000-0001-7545-6924	NIMH/NIH [R01MH081201]; Hartwell Foundation; Simons Foundation Autism Research Initiative (SFARI); NARSAD; NIH [F32MH084460, R03MH085224]; Portuguese Foundation for Science and Technology [SFRH/BD/15231/2004, SFRH/BD/15855/2005]; "Programa Gulbenkian de Doutoramento em Biomedicina'' (PGDB, Oeiras, Portugal); "Programa Doutoral em Biologia Experimental e Biomedicina'' (CNC, Coimbra, Portugal); NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH085224, F32MH084460, R01MH081201] Funding Source: NIH RePORTER	NIMH/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Hartwell Foundation; Simons Foundation Autism Research Initiative (SFARI); NARSAD(NARSAD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); "Programa Gulbenkian de Doutoramento em Biomedicina'' (PGDB, Oeiras, Portugal); "Programa Doutoral em Biologia Experimental e Biomedicina'' (CNC, Coimbra, Portugal); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank C. Duarte, S. Chaterjee and A. Oliveira-Maia for discussions; L. Kruger and Q. Liu for technical assistance; A. Hadiono for assistance in behavioural annotation; D. Bredt for the PSD-93 antibody; T. Boeckers for the anti-SHANK3 antibody; S. Miller and P. Christopher for advice and assistance with electron microscopy techniques; J. Crawley for the demonstration of social behaviour tests; N. Calakos and Y. Wan for advice on electrophysiology studies; A. Graybiel for critical comments of the manuscript; D. Wang and the other members of the G. F. laboratory for their support. We thank The Poitras Center for Affective Disorders Research. This work was funded by a grant from NIMH/NIH (R01MH081201), a Hartwell Individual Biomedical Research Award from The Hartwell Foundation, and a Simons Foundation Autism Research Initiative (SFARI) grant Award to G. F.; a NARSAD Young Investigator Award and NIH Ruth L. Kirschstein National Research Service Award (F32MH084460) to J. T. T.; a NIH (R03MH085224) grant to Z.F.; and doctoral fellowships from the Portuguese Foundation for Science and Technology to J. P. (SFRH/BD/15231/2004) and C. F. (SFRH/BD/15855/2005). C. F. would like to acknowledge the support from the "Programa Gulbenkian de Doutoramento em Biomedicina'' (PGDB, Oeiras, Portugal) and J. P. the "Programa Doutoral em Biologia Experimental e Biomedicina'' (CNC, Coimbra, Portugal).	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; American Psychiatric Association. American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Bonaglia MC, 2006, J MED GENET, V43, P822, DOI 10.1136/jmg.2005.038604; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Ebstein RP, 2010, NEURON, V65, P831, DOI 10.1016/j.neuron.2010.02.020; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Gauthier J, 2009, AM J MED GENET B, V150B, P421, DOI 10.1002/ajmg.b.30822; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Hollander E, 2005, BIOL PSYCHIAT, V58, P226, DOI 10.1016/j.biopsych.2005.03.040; HORWITZ B, 1988, ARCH NEUROL-CHICAGO, V45, P749, DOI 10.1001/archneur.1988.00520310055018; Hung AY, 2008, J NEUROSCI, V28, P1697, DOI 10.1523/JNEUROSCI.3032-07.2008; Insel TR, 2004, ANNU REV NEUROSCI, V27, P697, DOI 10.1146/annurev.neuro.27.070203.144148; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Langen M, 2009, BIOL PSYCHIAT, V66, P327, DOI 10.1016/j.biopsych.2009.03.017; MALENKA RC, 1988, J NEUROSCI, V8, P3750; McFarlane HG, 2008, GENES BRAIN BEHAV, V7, P152, DOI 10.1111/j.1601-183X.2007.00330.x; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Myme CIO, 2003, J NEUROPHYSIOL, V90, P771, DOI 10.1152/jn.00070.2003; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Prasad C, 2000, CLIN GENET, V57, P103, DOI 10.1034/j.1399-0004.2000.570203.x; Redcay E, 2005, BIOL PSYCHIAT, V58, P1, DOI 10.1016/j.biopsych.2005.03.026; Rosenberg RE, 2009, ARCH PEDIAT ADOL MED, V163, P907, DOI 10.1001/archpediatrics.2009.98; Sears LL, 1999, PROG NEURO-PSYCHOPH, V23, P613, DOI 10.1016/S0278-5846(99)00020-2; Shmelkov SV, 2010, NAT MED, V16, P598, DOI 10.1038/nm.2125; Silk TJ, 2006, AM J PSYCHIAT, V163, P1440, DOI 10.1176/appi.ajp.163.8.1440; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Welch JM, 2004, J COMP NEUROL, V472, P24, DOI 10.1002/cne.20060; Wilson HL, 2003, J MED GENET, V40, P575, DOI 10.1136/jmg.40.8.575; Yin HH, 2006, J NEUROSCI, V26, P11811, DOI 10.1523/JNEUROSCI.3196-06.2006; Zoghbi HY, 2010, NEURON, V68, P165, DOI 10.1016/j.neuron.2010.10.015; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	42	907	950	5	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2011	472	7344					437	U534		10.1038/nature09965	http://dx.doi.org/10.1038/nature09965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21423165	Green Accepted, Green Submitted			2022-12-28	WOS:000289949600027
J	Lu, FR; Li, S; Jiang, Y; Jiang, J; Fan, H; Lu, GF; Deng, D; Dang, SY; Zhang, X; Wang, JW; Yan, NE				Lu, Feiran; Li, Shuo; Jiang, Yang; Jiang, Jing; Fan, He; Lu, Guifeng; Deng, Dong; Dang, Shangyu; Zhang, Xu; Wang, Jiawei; Yan, Nieng			Structure and mechanism of the uracil transporter UraA	NATURE			English	Article							SIGNATURE MOTIF; FUNCTIONAL-CHARACTERIZATION; SUBSTRATE RECOGNITION; XANTHINE PERMEASE; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MOLECULAR-BASIS; FAMILY; CLONING; PROTEINS	The nucleobase/ascorbate transporter (NAT) proteins, also known as nucleobase/cation symporter 2 (NCS2) proteins, are responsible for the uptake of nucleobases in all kingdoms of life and for the transport of vitamin C in mammals(1,2). Despite functional characterization of the NAT family members in bacteria, fungi and mammals, detailed structural information remains unavailable. Here we report the crystal structure of a representative NAT protein, the Escherichia coli uracil/H+ symporter UraA, in complex with uracil at a resolution of 2.8 angstrom. UraA has a novel structural fold, with 14 transmembrane segments (TMs) divided into two inverted repeats. A pair of antiparallel beta-strands is located between TM3 and TM10 and has an important role in structural organization and substrate recognition. The structure is spatially arranged into a core domain and a gate domain. Uracil, located at the interface between the two domains, is coordinated mainly by residues from the core domain. Structural analysis suggests that alternating access of the substrate may be achieved through conformational changes of the gate domain.	[Lu, Feiran; Li, Shuo; Jiang, Yang; Jiang, Jing; Fan, He; Lu, Guifeng; Deng, Dong; Dang, Shangyu; Zhang, Xu; Wang, Jiawei; Yan, Nieng] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Lu, Feiran; Li, Shuo; Jiang, Yang; Jiang, Jing; Fan, He; Lu, Guifeng; Deng, Dong; Dang, Shangyu; Zhang, Xu; Wang, Jiawei; Yan, Nieng] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Yan, NE (corresponding author), Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	nyan@tsinghua.edu.cn	Wang, Jiawei/D-1144-2010	Wang, Jiawei/0000-0001-9893-8539; Lu, Feiran/0000-0002-1757-2895; Dang, Shangyu/0000-0001-9141-1865	Ministry of Science and Technology [2009CB918802, 2011CB910501]; Tsinghua University; National Natural Science Foundation of China [91017011]; Yuyuan Foundation; Li Foundation	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Tsinghua University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yuyuan Foundation; Li Foundation	We thank N. Shimizu at the Spring-8 beamline BL41XU, and J. He and S. Huang at the Shanghai Synchrotron Radiation Facility for on-site assistance. We thank Y. Shi and Y. Yan for critical discussions. This work was supported by funds from the Ministry of Science and Technology (grant numbers 2009CB918802 and 2011CB910501), Tsinghua University 985 Phase II funds and Project 91017011 supported by the National Natural Science Foundation of China. N.Y. acknowledges support from the Yuyuan Foundation and the Li Foundation.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ANDERSEN PS, 1995, J BACTERIOL, V177, P2008, DOI 10.1128/jb.177.8.2008-2013.1995; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; de Koning H, 2000, MOL MEMBR BIOL, V17, P75; DeLano W.L., 2002, PYMOL MOL VIEWER; DIALLINAS G, 1989, GENETICS, V122, P341; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Georgopoulou E, 2010, J BIOL CHEM, V285, P19422, DOI 10.1074/jbc.M110.120543; Gournas C, 2008, MOL BIOSYST, V4, P404, DOI 10.1039/b719777b; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Karatza P, 2005, MOL MEMBR BIOL, V22, P251, DOI 10.1080/09687860500092927; Karatza P, 2006, J BIOL CHEM, V281, P39881, DOI 10.1074/jbc.M605748200; Koukaki M, 2005, J MOL BIOL, V350, P499, DOI 10.1016/j.jmb.2005.04.076; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Saier MH, 1999, BBA-REV BIOMEMBRANES, V1422, P1, DOI 10.1016/S0304-4157(98)00023-9; Savini I, 2008, AMINO ACIDS, V34, P347, DOI 10.1007/s00726-007-0555-7; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; Wang Y, 2009, NATURE, V462, P467, DOI 10.1038/nature08610; Wang YX, 2000, BIOCHEM BIOPH RES CO, V267, P488, DOI 10.1006/bbrc.1999.1929; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamamoto S, 2010, J BIOL CHEM, V285, P6522, DOI 10.1074/jbc.M109.032961; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	35	140	141	3	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2011	472	7342					243	246		10.1038/nature09885	http://dx.doi.org/10.1038/nature09885			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21423164				2022-12-28	WOS:000289469100048
J	Ruuskanen, O; Lahti, E; Jennings, LC; Murdoch, DR				Ruuskanen, Olli; Lahti, Elina; Jennings, Lance C.; Murdoch, David R.			Viral pneumonia	LANCET			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; RESPIRATORY-TRACT INFECTIONS; HUMAN METAPNEUMOVIRUS INFECTION; INFLUENZA A(H1N1) INFECTION; POLYMERASE-CHAIN-REACTION; SYNCYTIAL VIRUS; PANDEMIC INFLUENZA; REQUIRING HOSPITALIZATION; STAPHYLOCOCCUS-AUREUS; ETIOLOGIC DIAGNOSIS	About 200 million cases of viral community-acquired pneumonia occur every year-100 million in children and 100 million in adults. Molecular diagnostic tests have greatly increased our uwnderstanding of the role of viruses in pneumonia, and findings indicate that the incidence of viral pneumonia has been underestimated. In children, respiratory syncytial virus, rhinovirus, human metapneumovirus, human bocavirus, and parainfluenza viruses are the agents identified most frequently in both developed and developing countries. Dual viral infections are common, and a third of children have evidence of viral-bacterial co-infection. In adults, viruses are the putative causative agents in a third of cases of community-acquired pneumonia, in particular influenza viruses, rhinoviruses, and coronaviruses. Bacteria continue to have a predominant role in adults with pneumonia. Presence of viral epidemics in the community, patient's age, speed of onset of illness, symptoms, biomarkers, radiographic changes, and response to treatment can help differentiate viral from bacterial pneumonia. However, no clinical algorithm exists that will distinguish clearly the cause of pneumonia. No clear consensus has been reached about whether patients with obvious viral community-acquired pneumonia need to be treated with antibiotics. Apart from neuraminidase inhibitors for pneumonia caused by influenza viruses, there is no clear role for use of specific antivirals to treat viral community-acquired pneumonia. Influenza vaccines are the only available specific preventive measures. Further studies are needed to better understand the cause and pathogenesis of community-acquired pneumonia. Furthermore, regional differences in cause of pneumonia should be investigated, in particular to obtain more data from developing countries.	[Ruuskanen, Olli; Lahti, Elina] Turku Univ Hosp, Dept Paediat, Turku 20521, Finland; [Jennings, Lance C.; Murdoch, David R.] Univ Otago, Microbiol Unit, Canterbury Hlth Labs, Christchurch, New Zealand; [Jennings, Lance C.; Murdoch, David R.] Univ Otago, Dept Pathol, Christchurch, New Zealand	University of Turku; Canterbury Health Laboratories; University of Otago; University of Otago	Ruuskanen, O (corresponding author), Turku Univ Hosp, Dept Paediat, PL 52, Turku 20521, Finland.	olli.ruuskanen@tyks.fi	Murdoch, David/A-2012-2009		Hoffmann La-Roche	Hoffmann La-Roche(Hoffmann-La Roche)	EL and DRM declare that they have no conflicts of interest. OR has been a consultant to Novartis Vaccines and Abbot. LCJ has received grant support from Hoffmann La-Roche and honoraria or travel assistance from Hoffmann La-Roche, GlaxoSmithKline, Sanofi Pasteur, Baxter, Novartis, Wyeth, and CSL for participation in advisory groups and scientific meetings.	ADEGBOLA RA, 1994, PEDIATR INFECT DIS J, V13, P975, DOI 10.1097/00006454-199411000-00008; Agarwal PP, 2009, AM J ROENTGENOL, V193, P1488, DOI 10.2214/AJR.09.3599; Almirall J, 2007, RESP MED, V101, P2168, DOI 10.1016/j.rmed.2007.05.007; Marcos MA, 2006, ANTIVIR THER, V11, P351; Arens MQ, 2010, J CLIN MICROBIOL, V48, P2387, DOI 10.1128/JCM.00220-10; Arnold JC, 2008, PEDIATRICS, V121, pE631, DOI 10.1542/peds.2006-3073; AUSINA V, 1988, EUR J CLIN MICROBIOL, V7, P343, DOI 10.1007/BF01962334; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Birnkrant D, 2009, NEW ENGL J MED, V361, P2204, DOI 10.1056/NEJMp0910479; Bishop JF, 2009, NEW ENGL J MED, V361, P2591, DOI 10.1056/NEJMp0910445; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bocchini JA, 2009, PEDIATRICS, V124, P1216, DOI [10.1542/peds.2009-1806, 10.1542/peds.2009-2345]; Boivin G, 2007, CLIN INFECT DIS, V44, P1152, DOI 10.1086/513204; Bonney D, 2009, BRIT J HAEMATOL, V145, P667, DOI 10.1111/j.1365-2141.2009.07654.x; Bustamante-Calvillo ME, 2001, PEDIATR INFECT DIS J, V20, P495, DOI 10.1097/00006454-200105000-00005; Calvo C, 2008, J CLIN VIROL, V42, P268, DOI 10.1016/j.jcv.2008.03.012; Calvo C, 2007, PEDIATR INFECT DIS J, V26, P904, DOI 10.1097/INF.0b013e31812e52e6; Camps M, 2008, J MED VIROL, V80, P1452, DOI 10.1002/jmv.21209; Carballal Guadalupe, 2002, BMC Pediatr, V2, P6, DOI 10.1186/1471-2431-2-6; Cevey-Macherel M, 2009, EUR J PEDIATR, V168, P1429, DOI 10.1007/s00431-009-0943-y; Charles PGP, 2008, CLIN INFECT DIS, V46, P1513, DOI 10.1086/586749; Cheng VCC, 2004, J INFECTION, V49, P262, DOI 10.1016/j.jinf.2004.07.010; Cheuk DKL, 2007, PEDIATR INFECT DIS J, V26, P995, DOI 10.1097/INF.0b013e3181586b63; Cilla G, 2008, J MED VIROL, V80, P1843, DOI 10.1002/jmv.21271; CLAESSON BA, 1989, PEDIATR INFECT DIS J, V8, P856, DOI 10.1097/00006454-198912000-00006; Dare RK, 2007, J INFECT DIS, V196, P1321, DOI 10.1086/521308; De Wals P, 2008, PEDIATR INFECT DIS J, V27, P963, DOI 10.1097/INF.0b013e31817cf76f; Debur MD, 2010, J CLIN PATHOL, V63, P930, DOI 10.1136/jcp.2010.077867; Diederen B, 2009, SCAND J INFECT DIS, V41, P45, DOI 10.1080/00365540802448799; Doan ML, 2007, J HEART LUNG TRANSPL, V26, P883, DOI 10.1016/j.healun.2007.06.009; Don M, 2005, SCAND J INFECT DIS, V37, P806, DOI 10.1080/00365540500262435; Don M, 2010, PEDIATR PULM, V45, P120, DOI 10.1002/ppul.21151; Donoso AF, 2008, PEDIATR INT, V50, P589, DOI 10.1111/j.1442-200X.2008.02673.x; Drews AL, 1997, CLIN INFECT DIS, V25, P1421, DOI 10.1086/516137; DURRINGTON S, 2008, BMJ-BRIT MED J, V336, P1429; Empey KM, 2010, CLIN INFECT DIS, V50, P1258, DOI 10.1086/651603; Esper F, 2003, PEDIATRICS, V111, P1407, DOI 10.1542/peds.111.6.1407; Esposito DH, 2010, J INFECT DIS, V202, P214, DOI 10.1086/653498; Falagas ME, 2010, INT J ANTIMICROB AG, V35, P421, DOI 10.1016/j.ijantimicag.2010.01.006; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; File TM, 2010, POSTGRAD MED, V122, P130, DOI 10.3810/pgm.2010.03.2130; File TM, 2003, LANCET, V362, P1991, DOI 10.1016/S0140-6736(03)15021-0; Finelli L, 2008, PEDIATRICS, V122, P805, DOI 10.1542/peds.2008-1336; Fitzpatrick M, 2002, THORAX, V57, P1, DOI 10.1136/thorax.57.1.1; Flood RG, 2008, PEDIATR INFECT DIS J, V27, P95, DOI 10.1097/INF.0b013e318157aced; FORGIE IM, 1991, PEDIATR INFECT DIS J, V10, P42, DOI 10.1097/00006454-199101000-00009; Frangides Christos Y, 2004, Eur J Intern Med, V15, P364, DOI 10.1016/j.ejim.2004.04.016; FRIIS B, 1984, ARCH DIS CHILD, V59, P1038, DOI 10.1136/adc.59.11.1038; Fry AM, 2007, J INFECT DIS, V195, P1038, DOI 10.1086/512163; Gilbert DN, 2010, J CLIN MICROBIOL, V48, P2325, DOI 10.1128/JCM.00655-10; Harter G, 2010, CLIN INFECT DIS, V50, P1249, DOI 10.1086/651604; Hamano-Hasegawa Keiko, 2008, Journal of Infection and Chemotherapy, V14, P424, DOI 10.1007/s10156-008-0648-6; Han LL, 1999, J INFECT DIS, V179, P25, DOI 10.1086/314567; Harper SA, 2009, CLIN INFECT DIS, V48, P1003, DOI 10.1086/598513; Hayden FG, 2004, REV MED VIROL, V14, P17, DOI 10.1002/rmv.406; Heikkinen T, 2002, J CLIN MICROBIOL, V40, P4337, DOI 10.1128/JCM.40.11.4337-4339.2002; Heinonen S, 2011, LANCET INFECT DIS, V11, P23, DOI 10.1016/S1473-3099(10)70255-3; Heiskanen-Kosma T, 1998, PEDIATR INFECT DIS J, V17, P986, DOI 10.1097/00006454-199811000-00004; Heugel J, 2007, PEDIATR INFECT DIS J, V26, P753, DOI 10.1097/INF.0b013e318054e31b; Hicks LA, 2006, J AM GERIATR SOC, V54, P284, DOI 10.1111/j.1532-5415.2005.00529.x; Hohenthal U, 2008, THORAX, V63, P658; Hohenthal U, 2008, SCAND J INFECT DIS, V40, P131, DOI 10.1080/00365540701534525; Hopkins P, 2008, AM J RESP CRIT CARE, V178, P876, DOI 10.1164/rccm.200711-1657OC; Imakita M, 2000, CLIN INFECT DIS, V30, P611, DOI 10.1086/313723; Jartti T, 2002, PEDIATR INFECT DIS J, V21, P873, DOI 10.1097/00006454-200209000-00019; Jartti T, 2008, PEDIATR INFECT DIS J, V27, P1103, DOI 10.1097/INF.0b013e31817e695d; Jennings LC, 2008, THORAX, V63, P42, DOI 10.1136/thx.2006.075077; Jennings LC, 2004, PEDIATR INFECT DIS J, V23, P1003, DOI 10.1097/01.inf.0000143648.04673.6c; Johansson N, 2010, CLIN INFECT DIS, V50, P202, DOI 10.1086/648678; Johnson AWBR, 2008, J NATL MED ASSOC, V100, P370, DOI 10.1016/S0027-9684(15)31269-4; Johnson JE, 2007, MODERN PATHOL, V20, P108, DOI 10.1038/modpathol.3800725; Johnstone J, 2008, CHEST, V134, P1141, DOI 10.1378/chest.08-0888; JOKINEN C, 1993, AM J EPIDEMIOL, V137, P977, DOI 10.1093/oxfordjournals.aje.a116770; Juven T, 2004, EUR J PEDIATR, V163, P140, DOI 10.1007/s00431-003-1397-2; Juven T, 2000, PEDIATR INFECT DIS J, V19, P293, DOI 10.1097/00006454-200004000-00006; Korteweg C, 2008, AM J PATHOL, V172, P1155, DOI 10.2353/ajpath.2008.070791; Kotsimbos T, 2010, AM J RESP CRIT CARE, V181, P300, DOI 10.1164/rccm.200912-1878CP; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Lahti E, 2009, THORAX, V64, P252, DOI 10.1136/thx.2008.099051; Lau SKP, 2006, J CLIN MICROBIOL, V44, P2063, DOI 10.1128/JCM.02614-05; Lauderdale TL, 2005, RESP MED, V99, P1079, DOI 10.1016/j.rmed.2005.02.026; Levy MM, 2005, AM J RESP CRIT CARE, V171, P518, DOI 10.1164/rccm.200405-621WS; Lieberman D, 2010, CHEST, V138, P811, DOI 10.1378/chest.09-2717; Lieberman D, 2009, J CLIN MICROBIOL, V47, P3439, DOI 10.1128/JCM.00886-09; Lim WS, 2009, THORAX, V64, P1, DOI 10.1136/thx.2009.121434; Lim WS, 2001, THORAX, V56, P296, DOI 10.1136/thorax.56.4.296; Loens K, 2009, J CLIN MICROBIOL, V47, P21, DOI 10.1128/JCM.02037-08; Longtin J, 2010, EMERG INFECT DIS, V16, P1463, DOI 10.3201/eid1609.100476; Louie JK, 2007, J INFECT DIS, V196, P705, DOI 10.1086/519846; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Louie JK, 2009, PEDIATR INFECT DIS J, V28, P337, DOI 10.1097/INF.0b013e31818ffc1b; Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077; Makela MJ, 1998, J CLIN MICROBIOL, V36, P539; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Mauad T, 2010, AM J RESP CRIT CARE, V181, P72, DOI 10.1164/rccm.200909-1420OC; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; McIntosh K, 2002, NEW ENGL J MED, V346, P429, DOI 10.1056/NEJMra011994; Midulla F, 2010, ARCH DIS CHILD, V95, P35, DOI 10.1136/adc.2008.153361; Miller EK, 2007, J INFECT DIS, V195, P773, DOI 10.1086/511821; Miller EK, 2009, J ALLERGY CLIN IMMUN, V123, P98, DOI 10.1016/j.jaci.2008.10.007; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Murdoch DR, 2010, INFECT DIS CLIN N AM, V24, P791, DOI 10.1016/j.idc.2010.04.006; Murdoch DR, 2009, J CLIN MICROBIOL, V47, P3405, DOI 10.1128/JCM.01685-09; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nascimento-Carvalho CM, 2008, PEDIATR INFECT DIS J, V27, P939, DOI 10.1097/INF.0b013e3181723751; Nguyen-Van-Tam JS, 2010, THORAX, V65, P645, DOI 10.1136/thx.2010.135210; Nicholls JM, 2003, LANCET, V361, P1773, DOI 10.1016/S0140-6736(03)13413-7; Ou ZY, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-122; Palacios G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008540; Peltola V, 2008, J INFECT DIS, V197, P382, DOI 10.1086/525542; Peltola V, 2009, J MED VIROL, V81, P1831, DOI 10.1002/jmv.21590; Pierangeli A, 2007, J MED VIROL, V79, P463, DOI 10.1002/jmv.20832; Poggensee G, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-155; Reed C, 2009, PEDIATR INFECT DIS J, V28, P572, DOI 10.1097/INF.0b013e31819d8b71; Renwick N, 2007, J INFECT DIS, V196, P1754, DOI 10.1086/524312; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Ruiz M, 1999, AM J RESP CRIT CARE, V160, P397, DOI 10.1164/ajrccm.160.2.9808045; Ruohola A, 2009, EMERG INFECT DIS, V15, P344, DOI 10.3201/eid1502.081468; Saito Atsushi, 2006, Journal of Infection and Chemotherapy, V12, P63, DOI 10.1007/s10156-005-0425-8; Samransamruajkit R, 2008, JPN J INFECT DIS, V61, P446; Schildgen O, 2008, CLIN MICROBIOL REV, V21, P291, DOI 10.1128/CMR.00030-07; Schuetz P, 2010, EXPERT REV ANTI-INFE, V8, P575, DOI [10.1586/eri.10.25, 10.1586/ERI.10.25]; Seki M, 2007, INTERNAL MED, V46, P953, DOI 10.2169/internalmedicine.46.6364; She RC, 2010, DIAGN MICR INFEC DIS, V67, P246, DOI 10.1016/j.diagmicrobio.2010.02.020; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; Shiley KT, 2010, J THORAC IMAG, V25, P68, DOI 10.1097/RTI.0b013e3181b0ba8b; Shun-Shin M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3172; Simpson JCG, 2000, THORAX, V55, P1040, DOI 10.1136/thorax.55.12.1040; Soderlund-Venermo M, 2009, EMERG INFECT DIS, V15, P1423, DOI 10.3201/eid1509.090204; Stockman LJ, 2006, PLOS MED, V3, P1525, DOI 10.1371/journal.pmed.0030343; Talbot HK, 2010, CLIN INFECT DIS, V50, P747, DOI 10.1086/650486; Templeton KE, 2005, CLIN INFECT DIS, V41, P345, DOI 10.1086/431588; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tivejung-Lindell A, 2009, J MED VIROL, V81, P167, DOI 10.1002/jmv.21368; Toikka P, 1999, CLIN INFECT DIS, V29, P568, DOI 10.1086/598635; Tsolia MN, 2004, CLIN INFECT DIS, V39, P681, DOI 10.1086/422996; Tucker SN, 2008, EXPERT REV VACCINES, V7, P25, DOI 10.1586/14760584.7.1.25; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Soto-Abraham MV, 2009, NEW ENGL J MED, V361, P2001, DOI 10.1056/NEJMc0907171; Virkki R, 2002, THORAX, V57, P438, DOI 10.1136/thorax.57.5.438; Vuori-Holopainen E, 2001, CLIN INFECT DIS, V32, P715, DOI 10.1086/319213; Walsh EE, 2008, ARCH INTERN MED, V168, P2489, DOI 10.1001/archinte.168.22.2489; Werno AM, 2004, J PAEDIATR CHILD H, V40, P549, DOI 10.1111/j.1440-1754.2004.00461.x; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Wolf DG, 2010, J PEDIATR-US, V156, P115, DOI 10.1016/j.jpeds.2009.07.014; Wong SSY, 2008, RESPIROLOGY, V13, P950, DOI 10.1111/j.1440-1843.2008.01404.x; Woo PCY, 2005, J INFECT DIS, V192, P1898, DOI 10.1086/497151; World Health Organization, 2004, REV GLOB BURD DIS 20; Yin MT, 2009, CLIN VIROLOGY, P217; Yu HJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4779	152	721	776	5	140	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2011	377	9773					1264	1275		10.1016/S0140-6736(10)61459-6	http://dx.doi.org/10.1016/S0140-6736(10)61459-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751DI	21435708	Green Published, Bronze			2022-12-28	WOS:000289597300033
J	Silber, S; Windecker, S; Vranckx, P; Serruys, PW				Silber, Sigmund; Windecker, Stephan; Vranckx, Pascal; Serruys, Patrick W.		RESOLUTE All Corners Investigators	Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial	LANCET			English	Article							NATURAL-HISTORY; THROMBOSIS; POLYMER; SYSTEM; REVASCULARIZATION; IMPLANTATION; MULTICENTER; EFFICACY; LEADERS; SAFETY	Background In the RESOLUTE All Corners trial, the Resolute zotarolimus-eluting stent was non-inferior to the Xience V everolimus-eluting stent for the primary stent-related endpoint of target lesion failure (cardiac death, target vessel myocardial infarction, and ischaemia-driven target lesion revascularisation) at 1 year. However, data for long-term safety and efficacy from randomised studies of new generation drug-eluting coronary stents in patients treated in routine clinical practice are scarce. We report the prespecified 2-year clinical outcomes from the RESOLUTE All Corners trial. Methods In 2008, patients with at least one coronary lesion 2.25-4.0 mm in diameter, with greater than 50% stenosis, were randomly assigned to a Resolute zotarolimus-eluting stent or a Xience V everolimus-eluting stent at 17 centres in Europe and Israel. Randomisation was by an interactive voice response system stratified by centre. Study investigators were not masked to treatment allocation; but those who did data management and analysis, and patients were masked. There were no restrictions as to the number of vessels or lesions treated, or the number of stents implanted. We assessed prespecified safety and efficacy outcomes at 2 years with specific focus on patient-related composite (all death, all myocardial infarction, all revascularisation) and stent-related composite outcomes. Analyses were by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00617084. Findings 1140 patients were assigned to the zotarolimus-eluting stent and 1152 to the everolimus-eluting stent; 1121 and 1128 patients, respectively, completed 2-year follow-up. The patient-related outcome (231 [20.6%] zotarolimus vs 231 [20.5%] everolimus; difference 0.1%, 95% CI -3.2 to 3.5; p=0.958) and stent-related outcome (126 [11.2%] vs 121 [10.7%]; difference 0.5%, -2.1 to 3.1; p=0.736) did not differ between groups, although rates of the stent-related outcome were substantially lower than were those for the patient-related outcome. Three patients in each group (0.3%) had very late (after 1 year) stent thrombosis. Interpretation Similar safety and efficacy outcomes were sustained between two new generation drug-eluting stents at 2-year follow-up. The greater number of patient-related than stent-related events in patients with complex clinical and lesion characteristics emphasises that during long-term follow-up, the optimisation of secondary prevention is at least as important as the selection of which new generation drug-eluting stent to implant in a specific lesion.	[Silber, Sigmund] Heart Ctr Isar, D-81379 Munich, Germany; [Windecker, Stephan] Univ Hosp Bern, CH-3010 Bern, Switzerland; [Serruys, Patrick W.] Univ Med Ctr Rotterdam, Erasmus MC, Thoraxctr, Dept Intervent Cardiol, Rotterdam, Netherlands; [Vranckx, Pascal] Hartctr Hasselt, Dept Cardiol & Crit Care Med, Hasselt, Belgium	University of Bern; University Hospital of Bern; Erasmus University Rotterdam; Erasmus MC	Silber, S (corresponding author), Heart Ctr Isar, Isarkanal 36, D-81379 Munich, Germany.	sigmund@silber.com		Wijns, William/0000-0002-7267-4376	Medtronic (USA); Abbott Vascular; Boston Scientific; Medtronic; Abbott; Biosensors; Cordis; Medtronic, Santa Rosa, CA, USA	Medtronic (USA)(Medtronic); Abbott Vascular(Abbott Laboratories); Boston Scientific(Boston Scientific); Medtronic(Medtronic); Abbott(Abbott Laboratories); Biosensors; Cordis; Medtronic, Santa Rosa, CA, USA(Medtronic)	Funding Medtronic (USA).; S Silber has received research grants and lecture fees from Abbott Vascular, Boston Scientific, and Medtronic. S Windecker has received research grants, consultancy fees, and payment for lectures from Abbott, Biosensors, Boston Scientific, Cordis, and Medtronic. P Vranckx and P W Serruys declare that they have no conflicts of interest.; This study was funded by Medtronic, Santa Rosa, CA, USA. Jane Moore, a Medtronic employee, drafted the introduction, methods, results, tables, and figures under the guidance of the authors, and facilitated author reviews.	Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Daemen J, 2006, AM J CARDIOL, V98, P895, DOI 10.1016/j.amjcard.2006.04.031; Farb A, 2007, NEW ENGL J MED, V356, P984, DOI 10.1056/NEJMp068304; GARG S, JACC CARDIO IN PRESS; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Kedhi E, 2010, LANCET, V375, P201, DOI 10.1016/S0140-6736(09)62127-9; Kirtane AJ, 2009, CIRCULATION, V119, P3198, DOI 10.1161/CIRCULATIONAHA.108.826479; Leon MB, 2009, JACC-CARDIOVASC INTE, V2, P504, DOI 10.1016/j.jcin.2009.04.004; Meredith IT, 2009, JACC-CARDIOVASC INTE, V2, P977, DOI 10.1016/j.jcin.2009.07.007; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Park SJ, 2010, NEW ENGL J MED, V362, P1374, DOI 10.1056/NEJMoa1001266; RABER L, 2009, ANN M TRANSC CARD TH; Rasmussen K, 2010, LANCET, V375, P1090, DOI 10.1016/S0140-6736(10)60208-5; Serruys PW, 2010, NEW ENGL J MED, V363, P136, DOI 10.1056/NEJMoa1004130; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; SERRUYS PW, 2010, ANN M TRANSC CARD TH; Silber S, 2009, CIRCULATION, V120, P1498, DOI 10.1161/CIRCULATIONAHA.109.849877; Slottow TLP, 2007, CATHETER CARDIO INTE, V69, P1064, DOI 10.1002/ccd.21179; SMITS PC, 2010, J AM COLL CARDIOL  S, V56, pR12; STEFANINI GG, J AM COLL C IN PRESS; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Udipi K, 2008, J BIOMED MATER RES A, V85A, P1064, DOI 10.1002/jbm.a.31664; Windecker S, 2005, NEW ENGL J MED, V353, P653, DOI 10.1056/NEJMoa051175; Windecker S, 2008, LANCET, V372, P1163, DOI 10.1016/S0140-6736(08)61244-1; Wykrzykowska JJ, 2010, J AM COLL CARDIOL, V56, P272, DOI 10.1016/j.jacc.2010.03.044	29	192	195	1	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2011	377	9773					1241	1247		10.1016/S0140-6736(11)60395-4	http://dx.doi.org/10.1016/S0140-6736(11)60395-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751DI	21459430				2022-12-28	WOS:000289597300030
J	Barriopedro, D; Fischer, EM; Luterbacher, J; Trigo, R; Garcia-Herrera, R				Barriopedro, David; Fischer, Erich M.; Luterbacher, Juerg; Trigo, RicardoM.; Garcia-Herrera, Ricardo			The Hot Summer of 2010: Redrawing the Temperature Record Map of Europe	SCIENCE			English	Article							CLIMATE-CHANGE; VARIABILITY; REANALYSIS; TRENDS	The summer of 2010 was exceptionally warm in eastern Europe and large parts of Russia. We provide evidence that the anomalous 2010 warmth that caused adverse impacts exceeded the amplitude and spatial extent of the previous hottest summer of 2003. "Mega-heatwaves" such as the 2003 and 2010 events likely broke the 500-year-long seasonal temperature records over approximately 50% of Europe. According to regional multi-model experiments, the probability of a summer experiencing mega-heatwaves will increase by a factor of 5 to 10 within the next 40 years. However, the magnitude of the 2010 event was so extreme that despite this increase, the likelihood of an analog over the same region remains fairly low until the second half of the 21st century.	[Barriopedro, David; Trigo, RicardoM.] Univ Lisbon, Inst Dom Luiz, P-1749016 Lisbon, Portugal; [Fischer, Erich M.] ETH, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland; [Luterbacher, Juerg] Univ Giessen, Dept Geog, D-35390 Giessen, Germany; [Garcia-Herrera, Ricardo] Agencia Estatal Meteorol AEMET, Madrid 28071, Spain	Universidade de Lisboa; Swiss Federal Institutes of Technology Domain; ETH Zurich; Justus Liebig University Giessen; Agencia Estatal de Meteorologia (AEMET)	Barriopedro, D (corresponding author), Univ Lisbon, Inst Dom Luiz, P-1749016 Lisbon, Portugal.	dbarriopedro@fc.ul.pt	Trigo, Ricardo M/B-7044-2008; Fischer, Erich/B-6067-2011; Trigo, Ricardo/Q-8391-2019; Barriopedro, David/C-1421-2008	Trigo, Ricardo M/0000-0002-4183-9852; Fischer, Erich/0000-0003-1931-6737; Trigo, Ricardo/0000-0002-4183-9852; Barriopedro, David/0000-0001-6476-944X; Luterbacher, Juerg/0000-0002-8569-0973; GARCIA HERRERA, RICARDO FRANCISCO/0000-0002-3845-7458	EU [036961, 212250, 505539]; Instituto Dom Luiz-Faculdade de Ciencias da Universidade de Lisboa [PTDC/AAC-CLI/103567/2008]; Swiss National Science Foundation (Swiss National Center of Competence in Research-Climate); Deutsche Forschungsgemeinschaft [LU1608/1-1, AOBJ: 568460, LU 1608/2-1, AOBJ 575150]; Hessian Centre on Climate Change and Geology	EU(European Commission); Instituto Dom Luiz-Faculdade de Ciencias da Universidade de Lisboa; Swiss National Science Foundation (Swiss National Center of Competence in Research-Climate)(Swiss National Science Foundation (SNSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hessian Centre on Climate Change and Geology	This study was supported by the EU/FP6 project CIRCE (#036961) (D. B., J.L., R. T., and R. G.), the Instituto Dom Luiz-Faculdade de Ciencias da Universidade de Lisboa project ENAC (PTDC/AAC-CLI/103567/2008) (D. B., R. T.), the Swiss National Science Foundation (Swiss National Center of Competence in Research-Climate) (E. F.), the EU/FP7 project ACQWA (#212250) (J.L.), the Deutsche Forschungsgemeinschaft project PRIME (LU1608/1-1, AOBJ: 568460) within the Priority Program 'INTERDYNAMIK' (J.L.), the project "Historical climatology of the Middle East based on Arabic sources back to ad 800" (LU 1608/2-1 AOBJ 575150) (J.L.) and the project "Climate Change and Extreme Weather in Hesse-Analysis of observation data and ensemble projections for the 21st century" funded by the Hessian Centre on Climate Change and Geology (J.L.). The ENSEMBLES data used in this work was funded by the European Union/FP6 project ENSEMBLES (#505539), whose support is gratefully acknowledged. 20th Century and National Centers for Environmental Prediction (NCEP)/National Center for Atmospheric Research (NCAR) reanalyses data were provided by the National Oceanic and Atmospheric Administration (NOAA)/Office of Oceanic and Atmospheric Research (OAR)/Earth System Research Laboratory (ESRL) Physical Sciences Division, Boulder, Colorado, USA, from their Web site at www.esrl.noaa.gov/psd/.	Beniston M, 2007, CLIMATIC CHANGE, V81, P71, DOI 10.1007/s10584-006-9226-z; Black E, 2004, WEATHER, V59, P217, DOI [10.1256/wea.74.04, DOI 10.1256/WEA.74.04]; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Compo GP, 2011, Q J ROY METEOR SOC, V137, P1, DOI 10.1002/qj.776; Della-Marta PM, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2007JD008510; Fischer EM, 2010, NAT GEOSCI, V3, P398, DOI 10.1038/NGEO866; FISCHER EM, 2007, GEOPHYS RES LETT, V34, DOI DOI 10.1029/2006GL029068; Fischer EM, 2009, CLIM DYNAM, V33, P917, DOI 10.1007/s00382-008-0473-8; Garcia-Herrera R, 2010, CRIT REV ENV SCI TEC, V40, P267, DOI 10.1080/10643380802238137; Giorgi F, 2004, CLIM DYNAM, V23, P839, DOI 10.1007/s00382-004-0467-0; Hansen J, 1999, J GEOPHYS RES-ATMOS, V104, P30997, DOI 10.1029/1999JD900835; Kistler R, 2001, B AM METEOROL SOC, V82, P247, DOI 10.1175/1520-0477(2001)082<0247:TNNYRM>2.3.CO;2; Kuglitsch FG, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041841; Lenderink G, 2007, CLIMATIC CHANGE, V81, P233, DOI 10.1007/s10584-006-9229-9; Luterbacher J, 2004, SCIENCE, V303, P1499, DOI 10.1126/science.1093877; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Robine JM, 2008, CR BIOL, V331, P171, DOI 10.1016/j.crvi.2007.12.001; Schar C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300; Seneviratne SI, 2006, NATURE, V443, P205, DOI 10.1038/nature05095; Tank AMGK, 2005, INT J CLIMATOL, V25, P1, DOI 10.1002/joc.1087; Trigo RM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022410; Van der Linden P., 2009, ENSEMBLES CLIMATE CH; Vautard R, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028001; Xoplaki E, 2003, CLIM DYNAM, V20, P723, DOI 10.1007/s00382-003-0304-x	24	938	972	16	290	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2011	332	6026					220	224		10.1126/science.1201224	http://dx.doi.org/10.1126/science.1201224			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21415316				2022-12-28	WOS:000289251100047
J	Huetteroth, W; Waddell, S				Huetteroth, Wolf; Waddell, Scott			Hungry Flies Tune to Vinegar	CELL			English	Editorial Material							ANTENNAL LOBE; DROSOPHILA; GLOMERULI	Many molecular signals that represent hunger and satiety in the body have been identified, but relatively little is known about how these factors alter the nervous system to change behavior. Root et al. (2011) report that hunger modulates the sensitivity of specific olfactory sensory neurons in Drosophila and facilitates odor-search behavior.	[Huetteroth, Wolf; Waddell, Scott] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Waddell, S (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 364 Plantat St, Worcester, MA 01605 USA.	scott.waddell@umassmed.edu	Huetteroth, Wolf/I-6661-2015; Huetteroth, Wolf/L-5252-2019	Huetteroth, Wolf/0000-0003-3421-9935; Waddell, Scott/0000-0003-4503-6229	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069883, R01MH081982] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH069883-07, R01 MH081982, R01 MH069883, R01 MH081982-04] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Carlsson MA, 2010, J COMP NEUROL, V518, P3359, DOI 10.1002/cne.22405; DasGupta S, 2008, CURR BIOL, V18, P1668, DOI 10.1016/j.cub.2008.08.071; Dekker T, 2006, CURR BIOL, V16, P101, DOI 10.1016/j.cub.2005.11.075; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Root CM, 2011, CELL, V145, P133, DOI 10.1016/j.cell.2011.02.008; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Yaksi E, 2010, NEURON, V67, P1034, DOI 10.1016/j.neuron.2010.08.041	9	0	0	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 1	2011	145	1					17	18		10.1016/j.cell.2011.03.018	http://dx.doi.org/10.1016/j.cell.2011.03.018			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458663	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000289053900004
J	Sun, X; Briel, M; Busse, JW; You, JJ; Akl, EA; Mejza, F; Bala, MM; Bassler, D; Mertz, D; Diaz-Granados, N; Vandvik, PO; Malaga, G; Srinathan, SK; Dahm, P; Johnston, BC; Alonso-Coello, P; Hassouneh, B; Truong, J; Dattani, ND; Walter, SD; Heels-Ansdell, D; Bhatnagar, N; Altman, DG; Guyatt, GH				Sun, Xin; Briel, Matthias; Busse, Jason W.; You, John J.; Akl, Elie A.; Mejza, Filip; Bala, Malgorzata M.; Bassler, Dirk; Mertz, Dominik; Diaz-Granados, Natalia; Vandvik, Per Olav; Malaga, German; Srinathan, Sadeesh K.; Dahm, Philipp; Johnston, Bradley C.; Alonso-Coello, Pablo; Hassouneh, Basil; Truong, Jessica; Dattani, Neil D.; Walter, Stephen D.; Heels-Ansdell, Diane; Bhatnagar, Neera; Altman, Douglas G.; Guyatt, Gordon H.			The influence of study characteristics on reporting of subgroup analyses in randomised controlled trials: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CLINICAL-TRIALS; INDUSTRY SPONSORSHIP; DOUBLE-BLIND; ASSOCIATION; TICLOPIDINE; CONCLUSIONS; ASPIRIN	Objective To investigate the impact of industry funding on reporting of subgroup analyses in randomised controlled trials. Design Systematic review. Data sources Medline. Study selection Randomised controlled trials published in 118 core clinical journals (defined by the National Library of Medicine) in 2007. 1140 study reports in a 1: 1 ratio by high (five general medicine journals with largest number of total citations in 2007) versus lower impact journals, were randomly sampled. Two reviewers, independently and in duplicate, used standardised, piloted forms to screen study reports for eligibility and to extract data. They also used explicit criteria to determine whether a randomised controlled trial reported subgroup analyses. Logistic regression was used to examine the association of prespecified study characteristics with reporting versus not reporting of subgroup analyses. Results 469 randomised controlled trials were included, of which 207 (44%) reported subgroup analyses. High impact journals (adjusted odds ratio 2.64, 95% confidence interval 1.62 to 4.33), non-surgical (versus surgical) trials (2.10, 1.26 to 3.50), and larger sample size (3.38, 1.64 to 6.99) were associated with more frequent reporting of subgroup analyses. The strength of association between trial funding and reporting of subgroups differed in trials with and without statistically significant primary outcomes (interaction P=0.02). In trials without statistically significant results for the primary outcome, industry funded trials were more likely to report subgroup analyses (2.29, 1.30 to 4.72) than non-industry funded trials. This was not true for trials with a statistically significant primary outcome (0.79, 0.46 to 1.36). Industry funded trials were associated with less frequent prespecification of subgroup hypotheses (31.3% v 38.0%, adjusted odds ratio 0.49, 0.26 to 0.94), and less use of the interaction test for analyses of subgroup effects (41.4% v 49.1%, 0.52, 0.28 to 0.97) than non-industry funded trials. Conclusion Industry funded randomised controlled trials, in the absence of statistically significant primary outcomes, are more likely to report subgroup analyses than non-industry funded trials. Industry funded trials less frequently prespecify subgroup hypotheses and less frequently test for interaction than non-industry funded trials. Subgroup analyses from industry funded trials with negative results for the primary outcome should be viewed with caution.	[Sun, Xin; Briel, Matthias; Busse, Jason W.; You, John J.; Akl, Elie A.; Mertz, Dominik; Diaz-Granados, Natalia; Johnston, Bradley C.; Hassouneh, Basil; Walter, Stephen D.; Heels-Ansdell, Diane; Guyatt, Gordon H.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; [Sun, Xin] Sichuan Univ, W China Hosp, Chinese Evidence Based Med Ctr, Chengdu 610064, Peoples R China; [Briel, Matthias] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, Basel, Switzerland; [Busse, Jason W.] Inst Work & Hlth, Toronto, ON, Canada; [You, John J.] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada; [Akl, Elie A.] SUNY Buffalo, Dept Med, Buffalo, NY 14260 USA; [Akl, Elie A.] SUNY Buffalo, Dept Family Med, Buffalo, NY 14260 USA; [Mejza, Filip] Jagiellonian Univ, Sch Med, Dept Pulm Dis, Krakow, Poland; [Bala, Malgorzata M.] Jagiellonian Univ, Sch Med, Dept Internal Med 2, Krakow, Poland; [Bassler, Dirk] Univ Childrens Hosp Tuebingen, Dept Neonatol, Tubingen, Germany; [Bassler, Dirk] Univ Childrens Hosp Tuebingen, Ctr Pediat Clin Studies, Tubingen, Germany; [Mertz, Dominik] McMaster Univ, Michael G DeGroote Inst Infect Dis, Hamilton, ON L8N 3Z5, Canada; [Vandvik, Per Olav] Norwegian Knowledge Ctr Hlth Serv, Oslo, Norway	McMaster University; Sichuan University; University of Basel; Institute for Work & Health; McMaster University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Jagiellonian University; Jagiellonian University; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; McMaster University; Norwegian Knowledge Centre for Health Services	Sun, X (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, 1200 Main St, Hamilton, ON L8N 3Z5, Canada.		Walter, Stephen/AAB-5548-2022; Briel, Matthias/AAT-9284-2021; Altman, Douglas G/A-9714-2012; Akl, Elie/K-5269-2019; Dahm, Philipp/I-1614-2019; Busse, Jason/CAH-3696-2022; Akl, Elie A/R-2079-2016; Bhatnagar, Neera/B-8004-2013	Walter, Stephen/0000-0003-4157-8928; Dahm, Philipp/0000-0003-2819-2553; Busse, Jason/0000-0002-0178-8712; Akl, Elie A/0000-0002-3444-8618; Bhatnagar, Neera/0000-0002-5060-5257; Malaga, German/0000-0002-7828-300X; Alonso-Coello, Pablo/0000-0002-8001-8504; Bassler, Dirk/0000-0003-2358-4419; Briel, Matthias/0000-0002-2070-5230	National Natural Science Foundation of China [70703025]; Ontario graduate scholarship; National Natural Science Foundation of China; santesuisse Foundation; Gottfried Foundation; Julia Bangerter-Rhyner Foundation; Canadian Institutes of Health Research; Canadian Chiropractic Research Foundation; European Union [health-F5-2009-223060]; Swiss National Science Foundation [PBBSP3-124436]; American Geriatrics Society; SickKids Foundation; Instituto de Salud Carlos III [CP09/00137]; Ontario Ministry of Health and Long-Term Care; NATIONAL INSTITUTE ON AGING [P30AG028740] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ontario graduate scholarship(Ontario Graduate Scholarship); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); santesuisse Foundation; Gottfried Foundation; Julia Bangerter-Rhyner Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Chiropractic Research Foundation; European Union(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); American Geriatrics Society; SickKids Foundation; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Natural Science Foundation of China (project No 70703025). XS is supported by the Ontario graduate scholarship and the National Natural Science Foundation of China. MB is supported by santesuisse and the Gottfried and Julia Bangerter-Rhyner Foundation. JWB is funded by a new investigator award from the Canadian Institutes of Health Research and the Canadian Chiropractic Research Foundation. DB is supported by the European Union (grant award health-F5-2009-223060). DM is supported by a research scholarship from the Swiss National Science Foundation (PBBSP3-124436). PD is supported by a Dennis W Jahnigan career development award by the American Geriatrics Society. BCJ holds a SickKids Foundation post-doctoral fellowship. PA-C is funded by a Miguel Servet contract by the Instituto de Salud Carlos III (CP09/00137). JJY is supported by a career scientist award from the Ontario Ministry of Health and Long-Term Care.	Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Aurora SK, 2010, CEPHALALGIA, V30, P793, DOI 10.1177/0333102410364676; Bhandari M, 2006, CLIN ORTHOP RELAT R, P247, DOI 10.1097/01.blo.0000218736.23506.fe; Bodenheimer T, 2000, NEW ENGL J MED, V342, P1539, DOI 10.1056/NEJM200005183422024; Bouchie A, 2006, NAT BIOTECHNOL, V24, P1058, DOI 10.1038/nbt0906-1058; Boutron I, 2010, JAMA-J AM MED ASSOC, V303, P2058, DOI 10.1001/jama.2010.651; Brookes ST, 2004, J CLIN EPIDEMIOL, V57, P229, DOI 10.1016/j.jclinepi.2003.08.009; Canadian Cooperative Study Group, 1978, N Engl J Med, V299, P53; Chan AW, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2299; Djulbegovic B, 2000, LANCET, V356, P635, DOI 10.1016/S0140-6736(00)02605-2; Dodick DW, 2005, HEADACHE, V45, P315, DOI 10.1111/j.1526-4610.2005.05068.x; Fox K, 2008, LANCET, V372, P807, DOI 10.1016/S0140-6736(08)61170-8; Gabler NB, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-43; Gorelick PB, 2003, JAMA-J AM MED ASSOC, V289, P2947, DOI 10.1001/jama.289.22.2947; Guyatt G, 2008, USERS GUIDES MED LIT; Hernandez AV, 2006, AM HEART J, V151, P257, DOI 10.1016/j.ahj.2005.04.020; Jorgensen AW, 2006, BMJ-BRIT MED J, V333, P782, DOI 10.1136/bmj.38973.444699.0B; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; Lesser LI, 2007, PLOS MED, V4, P41, DOI 10.1371/journal.pmed.0040005; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; National Library of Medicine, 2008, ABR IND MED AIM COR; Nkansah N, 2009, PUBLIC HEALTH NUTR, V12, P1931, DOI 10.1017/S136898000900487X; Perlis RH, 2005, AM J PSYCHIAT, V162, P1957, DOI 10.1176/appi.ajp.162.10.1957; POCOCK SJ, 1987, NEW ENGL J MED, V317, P426, DOI 10.1056/NEJM198708133170706; Schulz KF, 2005, LANCET, V365, P1657, DOI 10.1016/S0140-6736(05)66516-6; Sun X, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c117; Sun X, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-101; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; WEISBERG LA, 1993, NEUROLOGY, V43, P27, DOI 10.1212/WNL.43.1_Part_1.27; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93	33	65	67	2	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2011	342								d1569	10.1136/bmj.d1569	http://dx.doi.org/10.1136/bmj.d1569			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745WB	21444636	hybrid, Green Published			2022-12-28	WOS:000289200200002
J	Persha, L; Agrawal, A; Chhatre, A				Persha, Lauren; Agrawal, Arun; Chhatre, Ashwini			Social and Ecological Synergy: Local Rulemaking, Forest Livelihoods, and Biodiversity Conservation	SCIENCE			English	Article							HUMAN-MODIFIED WORLD; DECENTRALIZATION; GOVERNANCE; POVERTY; MANAGEMENT	Causal pathways to achieve social and ecological benefits from forests are unclear, because there are few systematic multicountry empirical analyses that identify important factors and their complex relationships with social and ecological outcomes. This study examines biodiversity conservation and forest-based livelihood outcomes using a data set on 84 sites from six countries in East Africa and South Asia. We find both positive and negative relationships, leading to joint wins, losses, and trade-offs depending on specific contextual factors; participation in forest governance institutions by local forest users is strongly associated with jointly positive outcomes for forests in our study.	[Persha, Lauren; Agrawal, Arun] Univ Michigan, Sch Nat Resources & Environm, Ann Arbor, MI 48109 USA; [Chhatre, Ashwini] Univ Illinois, Dept Geog, Urbana, IL 61801 USA	University of Michigan System; University of Michigan; University of Illinois System; University of Illinois Urbana-Champaign	Persha, L (corresponding author), Univ Michigan, Sch Nat Resources & Environm, 440 Church St, Ann Arbor, MI 48109 USA.	lpersha@umich.edu	Agrawal, Arun/A-4257-2009	Agrawal, Arun/0000-0001-6796-2958; Persha, Lauren/0000-0002-4956-0442; Chhatre, Ashwini/0000-0002-5374-7867	Ford Foundation; MacArthur Foundation; National Science Foundation [BCS-0703073, CNH-0709545]; University of Michigan	Ford Foundation; MacArthur Foundation; National Science Foundation(National Science Foundation (NSF)); University of Michigan(University of Michigan System)	We thank E. Ostrom, T. Hayes, two anonymous reviewers, and members of the Development, Sustainable Livelihoods and Conservation (DESULICO) group for comments on an earlier draft of this paper, and R. Kornak and J. England for assistance with data cleaning. We gratefully acknowledge the many researchers affiliated with IFRI as Collaborating Research Centers for their data contributions and ongoing involvement with the IFRI network. This work was funded by the Ford Foundation, the MacArthur Foundation, National Science Foundation grants BCS-0703073 and CNH-0709545, and a University of Michigan OVPR/Rackham grant for an Annual Institute on Joint Outcomes related to Sustainability.	Adams WM, 2004, SCIENCE, V306, P1146, DOI 10.1126/science.1097920; Agrawal A, 2001, POLIT SOC, V29, P485, DOI 10.1177/0032329201029004002; Agrawal A, 2008, SCIENCE, V320, P1460, DOI 10.1126/science.1155369; Andersson KP, 2006, WORLD DEV, V34, P576, DOI 10.1016/j.worlddev.2005.08.009; BARROW E, 2009, CUTOMARY PRACTICES F; Belcher B, 2005, WORLD DEV, V33, P1435, DOI 10.1016/j.worlddev.2004.10.007; Belcher BM, 2005, INT FOREST REV, V7, P82, DOI 10.1505/ifor.2005.7.2.82; Chazdon RL, 2009, BIOTROPICA, V41, P142, DOI 10.1111/j.1744-7429.2008.00471.x; Gardner TA, 2010, BIOL CONSERV, V143, P2293, DOI 10.1016/j.biocon.2010.05.017; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Hill JL, 2003, J BIOGEOGR, V30, P1391, DOI 10.1046/j.1365-2699.2003.00930.x; Larson AM, 2008, ANNU REV ENV RESOUR, V33, P213, DOI 10.1146/annurev.environ.33.020607.095522; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; Ostrom E, 2007, P NATL ACAD SCI USA, V104, P15181, DOI 10.1073/pnas.0702288104; Putz FE, 2001, CONSERV BIOL, V15, P7, DOI 10.1046/j.1523-1739.2001.00018.x; Ribot JC, 2006, WORLD DEV, V34, P1864, DOI 10.1016/j.worlddev.2005.11.020; Sunderlin WD, 2005, WORLD DEV, V33, P1383, DOI 10.1016/j.worlddev.2004.10.004; Wollenberg E, 2007, INT FOREST REV, V9, P670, DOI 10.1505/ifor.9.2.670; Wunder S, 2001, WORLD DEV, V29, P1817, DOI 10.1016/S0305-750X(01)00070-5	20	365	372	6	177	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 25	2011	331	6024					1606	1608		10.1126/science.1199343	http://dx.doi.org/10.1126/science.1199343			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739XH	21436453				2022-12-28	WOS:000288754500056
J	Wee, JS; Marinaki, A; Smith, CH				Wee, Jamie S.; Marinaki, Anthony; Smith, Catherine H.			Lesson of the Week Life threatening myelotoxicity secondary to azathioprine in a patient with atopic eczema and normal thiopurine methyltransferase activity	BRITISH MEDICAL JOURNAL			English	Article							INFLAMMATORY-BOWEL-DISEASE; S-METHYLTRANSFERASE; MYELOSUPPRESSION; PHARMACOGENETICS; THERAPY					dr.jamie.wee@gmail.com	Smith, Catherine H./G-5268-2012; Smaragdi, Marinaki/AAM-6731-2020	Smith, Catherine H./0000-0001-9918-1144; 				Anstey AV, 2004, BRIT J DERMATOL, V151, P1123, DOI 10.1111/j.1365-2133.2004.06323.x; Colombel JF, 2000, GASTROENTEROLOGY, V118, P1025, DOI 10.1016/S0016-5085(00)70354-4; Gisbert JP, 2008, AM J GASTROENTEROL, V103, P1783, DOI 10.1111/j.1572-0241.2008.01848.x; Heckmann JM, 2005, J NEUROL SCI, V231, P71, DOI 10.1016/j.jns.2005.01.003; Higgs JE, 2010, PHARMACOGENOMICS, V11, P177, DOI 10.2217/PGS.09.155; LENNARD L, 1989, CLIN PHARMACOL THER, V46, P149, DOI 10.1038/clpt.1989.119; Meggitt SJ, 2006, LANCET, V367, P839, DOI 10.1016/S0140-6736(06)68340-2; Sanderson J, 2004, ANN CLIN BIOCHEM, V41, P294, DOI 10.1258/0004563041201455; Uchiyama K, 2009, J GASTROENTEROL, V44, P197, DOI 10.1007/s00535-008-2307-1; WEINSHILBOUM RM, 1980, AM J HUM GENET, V32, P651	10	8	8	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAR 25	2011	342								d1417	10.1136/bmj.d1417	http://dx.doi.org/10.1136/bmj.d1417			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	742MM	21441287				2022-12-28	WOS:000288948300006
J	Di Toro, G; Han, R; Hirose, T; De Paola, N; Nielsen, S; Mizoguchi, K; Ferri, F; Cocco, M; Shimamoto, T				Di Toro, G.; Han, R.; Hirose, T.; De Paola, N.; Nielsen, S.; Mizoguchi, K.; Ferri, F.; Cocco, M.; Shimamoto, T.			Fault lubrication during earthquakes	NATURE			English	Article							COSEISMIC SLIP; ROCK-FRICTION; RATES; PROPAGATION; MECHANISM; SOLIDS; ZONE; LAWS	The determination of rock friction at seismic slip rates (about 1 m s(-1)) is of paramount importance in earthquake mechanics, as fault friction controls the stress drop, the mechanical work and the frictional heat generated during slip(1). Given the difficulty in determining friction by seismological methods(1), elucidating constraints are derived from experimental studies(2-9). Here we review a large set of published and unpublished experiments (similar to 300) performed in rotary shear apparatus at slip rates of 0.1-2.6 ms(-1). The experiments indicate a significant decrease in friction (of up to one order of magnitude), which we term fault lubrication, both for cohesive (silicate-built(4-6), quartz-built(3) and carbonate-built(7,8)) rocks and non-cohesive rocks (clay-rich(9), anhydrite, gypsum and dolomite(10) gouges) typical of crustal seismogenic sources. The available mechanical work and the associated temperature rise in the slipping zone trigger(11,12) a number of physicochemical processes (gelification, decarbonation and dehydration reactions, melting and so on) whose products are responsible for fault lubrication. The similarity between (1) experimental and natural fault products and (2) mechanical work measures resulting from these laboratory experiments and seismological estimates(13,14) suggests that it is reasonable to extrapolate experimental data to conditions typical of earthquake nucleation depths (7-15 km). It seems that faults are lubricated during earthquakes, irrespective of the fault rock composition and of the specific weakening mechanism involved.	[Di Toro, G.; Ferri, F.] Univ Padua, Dipartimento Geosci, I-35131 Padua, Italy; [Di Toro, G.; Nielsen, S.; Cocco, M.] Ist Nazl Geofis & Vulcanol, I-00143 Rome, Italy; [Han, R.] Korea Inst Geosci & Mineral Resources, Taejon 305350, South Korea; [Hirose, T.] JAMSTEC, Kochi Inst Core Sample Res, Kochi 7838502, Japan; [De Paola, N.] Univ Durham, Dept Earth Sci, Durham DH1 3LE, England; [Mizoguchi, K.] Cent Res Inst Elect Power Ind, Civil Engn Res Lab, Chiba 2701194, Japan; [Shimamoto, T.] China Earthquake Adm, Inst Geol, Beijing 100029, Peoples R China	University of Padua; Istituto Nazionale Geofisica e Vulcanologia (INGV); Korea Institute of Geoscience & Mineral Resources (KIGAM); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Durham University; Central Research Institute of Electric Power Industry - Japan; China Earthquake Administration	Di Toro, G (corresponding author), Univ Padua, Dipartimento Geosci, I-35131 Padua, Italy.	giulio.ditoro@unipd.it	Nielsen, Stefan B/F-6210-2011; Cocco, Massimo/G-6872-2012; Han, Raehee/C-6336-2008; De Paola, Nicola/O-7052-2015	Nielsen, Stefan B/0000-0002-9214-2932; Cocco, Massimo/0000-0001-6798-4225; Han, Raehee/0000-0001-9293-6516; Hirose, Takehiro/0000-0002-5397-3346	Progetti di Eccellenza Fondazione Cassa di Risparmio di Padova e Rovigo; European Research Council [205175]	Progetti di Eccellenza Fondazione Cassa di Risparmio di Padova e Rovigo; European Research Council(European Research Council (ERC)European Commission)	G.D.T. thanks T. Tullis and D. Goldsby for introducing him to this topic. G.D.T. was supported by a Progetti di Eccellenza Fondazione Cassa di Risparmio di Padova e Rovigo and by European Research Council Starting Grant Project 205175.	Balaz P., 2008, MECHANOCHEMISTRY NAN, P111, DOI [10.1007/978-3-540-74855-7, DOI 10.1007/978-3-540-74855-7]; Beeler NM, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB004988; BRACE WF, 1966, SCIENCE, V153, P990, DOI 10.1126/science.153.3739.990; Brantut N, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005551; BYERLEE J, 1978, PURE APPL GEOPHYS, V116, P615, DOI 10.1007/BF00876528; Carslaw H., 1959, CONDUCTION HEAT SOLI, V15, P74; Cocco M, 2008, EARTH PLANET SC LETT, V273, P123, DOI 10.1016/j.epsl.2008.06.025; De Paola N, 2011, GEOLOGY, V39, P35, DOI 10.1130/G31398.1; Di Toro G, 2006, SCIENCE, V311, P647, DOI 10.1126/science.1121012; Di Toro G, 2004, NATURE, V427, P436, DOI 10.1038/nature02249; Di Toro G, 2006, GEOPHYS MONOGR SER, V170, P121, DOI 10.1029/170GM13; DIETERICH JH, 1979, J GEOPHYS RES, V84, P2161, DOI 10.1029/JB084iB05p02161; Fisher T. E., 1988, ANNU REV MATER SCI, V18, P303; FOX PG, 1975, J MATER SCI, V10, P340, DOI 10.1007/BF00540358; Goldsby DL, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015240; Han R, 2007, SCIENCE, V316, P878, DOI 10.1126/science.1139763; Han R, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2008JB006136; HEATON TH, 1990, PHYS EARTH PLANET IN, V64, P1, DOI 10.1016/0031-9201(90)90002-F; Heinicke G, 1984, TRIBOCHEMISTRY, P11; Hirono T, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030743; Hirose T, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003207; Hsu SM, 2002, TRIBOL LETT, V13, P131, DOI 10.1023/A:1020112901674; Ma KF, 2006, NATURE, V444, P473, DOI 10.1038/nature05253; Marone C, 1998, ANNU REV EARTH PL SC, V26, P643, DOI 10.1146/annurev.earth.26.1.643; Mizoguchi K, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027931; Mizoguchi K, 2009, TECTONOPHYSICS, V471, P285, DOI 10.1016/j.tecto.2009.02.033; Nielsen S, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005122; Noda Hiroyuki, 2009, Journal of Geophysical Research - Part B - Solid Earth, V114, DOI 10.1029/2008JB006143; Reches Z, 2010, NATURE, V467, P452, DOI 10.1038/nature09348; Rice JR, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004006; Scholz C.H., 2002, MECH EARTHQUAKES FAU, DOI 10.1017/CBO9780511818516; Scholz CH, 1998, NATURE, V391, P37, DOI 10.1038/34097; Shimamoto T., 1994, J TECTONIC RES GROUP, V39, P65; SIBSON RH, 1975, GEOPHYS J ROY ASTR S, V43, P775, DOI 10.1111/j.1365-246X.1975.tb06195.x; Steinike U, 2000, J MATER SYNTH PROCES, V8, P197, DOI 10.1023/A:1011364110355; Yuan FP, 2008, INT J SOLIDS STRUCT, V45, P4247, DOI 10.1016/j.ijsolstr.2008.03.012	36	586	589	7	237	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					494	+		10.1038/nature09838	http://dx.doi.org/10.1038/nature09838			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21430777				2022-12-28	WOS:000288702200058
J	Yu, CW; Lee, CH				Yu, Chin-Wei; Lee, Ching-Hsing			Pyogenic Liver Abscess	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Yu, Chin-Wei; Lee, Ching-Hsing] Chang Gung Mem Hosp, Tao Yuan, Taiwan	Chang Gung Memorial Hospital	Yu, CW (corresponding author), Chang Gung Mem Hosp, Tao Yuan, Taiwan.								0	1	1	2	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2011	364	12					1154	1154		10.1056/NEJMicm1003533	http://dx.doi.org/10.1056/NEJMicm1003533			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739FY	21428771				2022-12-28	WOS:000288701100010
J	Lander, AD				Lander, Arthur D.			Pattern, Growth, and Control	CELL			English	Review							HEDGEHOG MORPHOGEN GRADIENT; WING IMAGINAL DISC; POSITIONAL INFORMATION; OLFACTORY NEUROGENESIS; MECHANICAL FEEDBACK; CELL-PROLIFERATION; LATERAL-INHIBITION; STRIPE FORMATION; SPATIAL-PATTERN; DROSOPHILA	Systems biology seeks not only to discover the machinery of life but to understand how such machinery is used for control, i.e., for regulation that achieves or maintains a desired, useful end. This sort of goal-directed, engineering-centered approach also has deep historical roots in developmental biology. Not surprisingly, developmental biology is currently enjoying an influx of ideas and methods from systems biology. This Review highlights current efforts to elucidate design principles underlying the engineering objectives of robustness, precision, and scaling as they relate to the developmental control of growth and pattern formation. Examples from vertebrate and invertebrate development are used to illustrate general lessons, including the value of integral feedback in achieving set-point control; the usefulness of self-organizing behavior; the importance of recognizing and appropriately handling noise; and the absence of "free lunch." By illuminating such principles, systems biology is helping to create a functional framework within which to make sense of the mechanistic complexity of organismal development.	[Lander, Arthur D.] Univ Calif Irvine, Dept Dev & Cell Biol, Ctr Complex Biol Syst, Irvine, CA 92697 USA; [Lander, Arthur D.] Univ Calif Irvine, Dept Biomed Engn, Ctr Complex Biol Syst, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Lander, AD (corresponding author), Univ Calif Irvine, Dept Dev & Cell Biol, Ctr Complex Biol Syst, Irvine, CA 92697 USA.	adlander@uci.edu	Lander, Arthur D/C-9008-2011; Lander, Arthur/L-2827-2019	Lander, Arthur D/0000-0002-4380-5525; Lander, Arthur/0000-0002-4380-5525	NIH [P50-GM076516, R01-GM067247]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076516, R01GM067247] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH (P50-GM076516 and R01-GM067247). I am grateful to Qing Nie, Anne Calof, and Marcos Nahmad for helpful conversations.	Aegerter-Wilmsen T, 2007, MECH DEVELOP, V124, P318, DOI 10.1016/j.mod.2006.12.005; Aegerter-Wilmsen T, 2010, DEVELOPMENT, V137, P499, DOI 10.1242/dev.041731; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Aquino G, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.021909; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Baena-Lopez LA, 2006, P NATL ACAD SCI USA, V103, P13734, DOI 10.1073/pnas.0606092103; Baena-Lopez LA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000360; Barkai N, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001990; Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031; Ben-Zvi D, 2008, NATURE, V453, P1205, DOI 10.1038/nature07059; Biehs B, 1998, DEVELOPMENT, V125, P4245; Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606; Bokel C, 2006, SCIENCE, V314, P1135, DOI 10.1126/science.1132524; Box G.E.P., 1979, ROBUSTNESS STAT, P201, DOI 10.1016/B978-0-12-438150-6.50018-2; Briscoe J, 2009, EMBO J, V28, P457, DOI 10.1038/emboj.2009.12; Buttitta LA, 2007, NAT CELL BIOL, V9, P1225, DOI 10.1038/ncb1107-1225; Casali A, 2004, NATURE, V431, P76, DOI 10.1038/nature02835; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Cohen M, 2010, DEV CELL, V19, P78, DOI 10.1016/j.devcel.2010.06.006; CRICK F, 1970, NATURE, V225, P420, DOI 10.1038/225420a0; Csikasz-Nagy A, 2008, ADV EXP MED BIOL, V641, P88; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Dessaud E, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000382; Doyle J, 2007, NATURE, V446, P860, DOI 10.1038/446860a; EDGAR BA, 1989, DEV GENET, V10, P124, DOI 10.1002/dvg.1020100303; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Eldar A, 2004, CURR OPIN GENET DEV, V14, P435, DOI 10.1016/j.gde.2004.06.009; Eldar A, 2003, DEV CELL, V5, P635, DOI 10.1016/S1534-5807(03)00292-2; Elgjo K, 2004, CELL CYCLE, V3, P1208; Erdmann T, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.258101; Filmus J, 2008, CELL CYCLE, V7, P2787, DOI 10.4161/cc.7.18.6672; Franch-Marro X, 2005, DEVELOPMENT, V132, P659, DOI 10.1242/dev.01639; Francois P, 2009, NATURE, V461, pE1, DOI 10.1038/nature08305; Galli A, 2003, DEVELOPMENT, V130, P4919, DOI 10.1242/dev.00706; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Gomes FLAF, 2011, DEVELOPMENT, V138, P227, DOI 10.1242/dev.059683; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; Grusche FA, 2011, DEV BIOL, V350, P255, DOI 10.1016/j.ydbio.2010.11.020; Grusche FA, 2010, CURR BIOL, V20, pR574, DOI 10.1016/j.cub.2010.05.023; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Han C, 2005, DEVELOPMENT, V132, P667, DOI 10.1242/dev.01636; Han C, 2004, DEVELOPMENT, V131, P601, DOI 10.1242/dev.00958; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Hoffmann M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002922; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; Ishihara S, 2006, J THEOR BIOL, V238, P683, DOI 10.1016/j.jtbi.2005.06.016; Jiao YL, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.76; Kawauchi S, 2005, DEVELOPMENT, V132, P5211, DOI 10.1242/dev.02143; Kawauchi S, 2009, DEVELOPMENT, V136, P1453, DOI 10.1242/dev.034967; Khammash M, 2008, BIOTECHNIQUES, V44, P323, DOI 10.2144/000112772; Kim J, 2005, SCIENCE, V308, P1927, DOI 10.1126/science.1110175; Kirouac DC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.49; KOCH AJ, 1994, REV MOD PHYS, V66, P1481, DOI 10.1103/RevModPhys.66.1481; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Kreuger J, 2004, DEV CELL, V7, P503, DOI 10.1016/j.devcel.2004.08.005; LACALLI TC, 1988, DEVELOPMENT, V104, P105; LANDER AD, 2011, J MECH MAT IN PRESS; Lander AD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002022; Lander AD, 2009, PLOS BIOL, V7, P84, DOI 10.1371/journal.pbio.1000015; Lauffenburger D. A., 1993, RECEPTORS MODELS BIN; Lek M, 2010, DEVELOPMENT, V137, P4051, DOI 10.1242/dev.054288; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; Lo WC, 2009, MATH BIOSCI ENG, V6, P59, DOI 10.3934/mbe.2009.6.59; Lucchetta EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003651; Mammoto A, 2009, CURR OPIN CELL BIOL, V21, P864, DOI 10.1016/j.ceb.2009.08.001; Manu, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000303; Manu, 2009, PLOS BIOL, V7, P591, DOI 10.1371/journal.pbio.1000049; Marciniak-Czochra A, 2009, STEM CELLS DEV, V18, P377, DOI 10.1089/scd.2008.0143; Martin-Castellanos C, 2002, DEVELOPMENT, V129, P1003; Maves L, 2005, DEV BIOL, V285, P593, DOI 10.1016/j.ydbio.2005.07.015; Meinhardt H, 2000, BIOESSAYS, V22, P753, DOI 10.1002/1521-1878(200008)22:8<753::AID-BIES9>3.3.CO;2-Q; Meir E, 2002, CURR BIOL, V12, P778, DOI 10.1016/S0960-9822(02)00839-4; Mii Y, 2009, DEVELOPMENT, V136, P4083, DOI 10.1242/dev.032524; MOOLTEN FL, 1967, SCIENCE, V158, P272, DOI 10.1126/science.158.3798.272; Nahmad M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000202; Nakamura T, 2006, DEV CELL, V11, P495, DOI 10.1016/j.devcel.2006.08.002; Nienhaus U, 2009, MECH DEVELOP, V126, P942, DOI 10.1016/j.mod.2009.09.002; Nijhout HF, 2010, SCIENCE, V330, P1693, DOI 10.1126/science.1197292; Nowakowski Richard S, 2002, Results Probl Cell Differ, V39, P1; Ochoa-Espinosa A, 2009, P NATL ACAD SCI USA, V106, P3823, DOI 10.1073/pnas.0807878105; Okabe-Oho Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000486; OTHMER HG, 1980, P NATL ACAD SCI-BIOL, V77, P4180, DOI 10.1073/pnas.77.7.4180; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Papatsenko D, 2009, BIOESSAYS, V31, P1172, DOI 10.1002/bies.200900096; Paulsson J, 2000, P NATL ACAD SCI USA, V97, P7148, DOI 10.1073/pnas.110057697; Piddini E, 2009, CELL, V136, P296, DOI 10.1016/j.cell.2008.11.036; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Reddy BVVG, 2008, DEVELOPMENT, V135, P2827, DOI 10.1242/dev.020974; Ren FF, 2010, P NATL ACAD SCI USA, V107, P21064, DOI 10.1073/pnas.1012759107; Reversade B, 2005, CELL, V123, P1147, DOI 10.1016/j.cell.2005.08.047; Rodriguez I, 2008, FLY, V2, P320, DOI 10.4161/fly.7475; Rogulja D, 2008, DEV CELL, V15, P309, DOI 10.1016/j.devcel.2008.06.003; Sahlin P, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-2; Sauro HM, 2004, PROG BIOPHYS MOL BIO, V86, P5, DOI 10.1016/j.pbiomolbio.2004.03.002; Schwank G, 2011, DEV CELL, V20, P123, DOI 10.1016/j.devcel.2010.11.007; Schwank G, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001669; Selleck SB, 1999, AM J HUM GENET, V64, P372, DOI 10.1086/302266; Shraiman BI, 2005, P NATL ACAD SCI USA, V102, P3318, DOI 10.1073/pnas.0404782102; Shvartsman SY, 2001, BIOPHYS J, V81, P1854, DOI 10.1016/S0006-3495(01)75837-7; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Staley BK, 2010, CURR BIOL, V20, P1580, DOI 10.1016/j.cub.2010.07.041; Sun GP, 2011, DEV BIOL, V350, P139, DOI 10.1016/j.ydbio.2010.11.036; Takeo S, 2005, DEV BIOL, V284, P204, DOI 10.1016/j.ydbio.2005.05.014; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Umulis D, 2008, CURR TOP DEV BIOL, V81, P65, DOI 10.1016/S0070-2153(07)81002-7; Umulis DM, 2006, P NATL ACAD SCI USA, V103, P11613, DOI 10.1073/pnas.0510398103; von Dassow G, 2000, NATURE, V406, P188, DOI 10.1038/35018085; Vuilleumier R, 2010, NAT CELL BIOL, V12, P611, DOI 10.1038/ncb2064; Wang YC, 2005, NATURE, V434, P229, DOI 10.1038/nature03318; Williams RW, 2000, RES PRO CEL, V30, P21; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Wolpert L, 2011, J THEOR BIOL, V269, P359, DOI 10.1016/j.jtbi.2010.10.034; Wolpert L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000477; Wolpert Lewis, 2009, Int J Dev Biol, V53, P659, DOI 10.1387/ijdb.072559mr; Wu HH, 2003, NEURON, V37, P197, DOI 10.1016/S0896-6273(02)01172-8; Yamaguchi M, 2007, P NATL ACAD SCI USA, V104, P4790, DOI 10.1073/pnas.0607790104; Yan SJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.35; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649; ZECCA M, 1995, DEVELOPMENT, V121, P2265; Zecca M, 2007, DEVELOPMENT, V134, P3001, DOI 10.1242/dev.006411; Zecca M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000386; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhu H, 2011, J THEOR BIOL, V268, P131, DOI 10.1016/j.jtbi.2010.09.043	127	154	155	0	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 18	2011	144	6					955	969		10.1016/j.cell.2011.03.009	http://dx.doi.org/10.1016/j.cell.2011.03.009			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	737BQ	21414486	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000288543500013
J	Capewell, S; O'Flaherty, M				Capewell, Simon; O'Flaherty, Martin			Rapid mortality falls after risk-factor changes in populations	LANCET			English	Editorial Material							HEART-DISEASE		[Capewell, Simon; O'Flaherty, Martin] Univ Liverpool, Div Publ Hlth, Liverpool L69 3GB, Merseyside, England	University of Liverpool	Capewell, S (corresponding author), Univ Liverpool, Div Publ Hlth, Liverpool L69 3GB, Merseyside, England.	capewell@liverpool.ac.uk		O'Flaherty, Martin/0000-0001-8944-4131				Capewell S, 2011, EUR HEART J, V32, P1187, DOI 10.1093/eurheartj/ehr049; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Franco M, 2007, AM J EPIDEMIOL, V166, P1374, DOI 10.1093/aje/kwm226; Law M, 1999, BRIT MED J, V318, P1471, DOI 10.1136/bmj.318.7196.1471; Meyers DG, 2009, J AM COLL CARDIOL, V54, P1249, DOI 10.1016/j.jacc.2009.07.022; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; National Institute for Health and Clinical Excellence, 2010, PREV CARD DIS POP LE; STROM A, 1951, LANCET, V260, P126, DOI 10.1016/S0140-6736(51)91210-X; Strong JP, 1999, JAMA-J AM MED ASSOC, V281, P727, DOI 10.1001/jama.281.8.727; *WHO, EUR HLTH ALL DAT HFA; Zatonski WA, 2005, BMJ-BRIT MED J, V331, P187, DOI 10.1136/bmj.331.7510.187	11	108	112	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2011	378	9793					752	753		10.1016/S0140-6736(10)62302-1	http://dx.doi.org/10.1016/S0140-6736(10)62302-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	816FY	21414659				2022-12-28	WOS:000294585300010
J	Coles, CH; Shen, YJ; Tenney, AP; Siebold, C; Sutton, GC; Lu, WX; Gallagher, JT; Jones, EY; Flanagan, JG; Aricescu, AR				Coles, Charlotte H.; Shen, Yingjie; Tenney, Alan P.; Siebold, Christian; Sutton, Geoffrey C.; Lu, Weixian; Gallagher, John T.; Jones, E. Yvonne; Flanagan, John G.; Aricescu, A. Radu			Proteoglycan-Specific Molecular Switch for RPTP sigma Clustering and Neuronal Extension	SCIENCE			English	Article							TYROSINE-PHOSPHATASE-SIGMA; HEPARAN-SULFATE PROTEOGLYCANS; MICE LACKING; PTP-SIGMA; RECEPTOR; REGENERATION; LAR; SYNDECAN; SYSTEM; INJURY	Heparan and chondroitin sulfate proteoglycans (HSPGs and CSPGs, respectively) regulate numerous cell surface signaling events, with typically opposite effects on cell function. CSPGs inhibit nerve regeneration through receptor protein tyrosine phosphatase sigma (RPTP sigma). Here we report that RPTPs acts bimodally in sensory neuron extension, mediating CSPG inhibition and HSPG growth promotion. Crystallographic analyses of a shared HSPG-CSPG binding site reveal a conformational plasticity that can accommodate diverse glycosaminoglycans with comparable affinities. Heparan sulfate and analogs induced RPTPs ectodomain oligomerization in solution, which was inhibited by chondroitin sulfate. RPTPs and HSPGs colocalize in puncta on sensory neurons in culture, whereas CSPGs occupy the extracellular matrix. These results lead to a model where proteoglycans can exert opposing effects on neuronal extension by competing to control the oligomerization of a common receptor.	[Coles, Charlotte H.; Siebold, Christian; Sutton, Geoffrey C.; Lu, Weixian; Jones, E. Yvonne; Aricescu, A. Radu] Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Shen, Yingjie; Tenney, Alan P.; Flanagan, John G.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Shen, Yingjie; Tenney, Alan P.; Flanagan, John G.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Tenney, Alan P.] Columbia Univ, Motor Neuron Ctr, New York, NY 10032 USA; [Gallagher, John T.] Univ Manchester, Paterson Inst Canc Res, Fac Med & Hlth Sci, Sch Canc & Imaging Sci, Manchester M20 4BX, Lancs, England	University of Oxford; Wellcome Centre for Human Genetics; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Columbia University; Paterson Institute for Cancer Research; University of Manchester	Jones, EY (corresponding author), Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	yvonne@strubi.ox.ac.uk; flanagan@hms.harvard.edu; radu@strubi.ox.ac.uk	Flanagan, John/AAM-2995-2020; Aricescu, Alexandru/L-3891-2013; Jones, Yvonne/N-8111-2019; Jones, Yvonne/J-2293-2016	Jones, Yvonne/0000-0002-3834-1893; Jones, Yvonne/0000-0002-3834-1893; Coles, Charlotte/0000-0003-4525-7144; Aricescu, Alexandru ARadu/0000-0003-3783-1388; Siebold, Christian/0000-0002-6635-3621	Wellcome Trust; European Research Community Fund [MRTN-CT-2006-035830]; NIH [EY11559, HD29417]; Cancer Research UK; UK Medical Research Council; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029417, R37HD029417] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011559] Funding Source: NIH RePORTER; Cancer Research UK [10976] Funding Source: researchfish; Medical Research Council [G0900084, G0700232] Funding Source: researchfish; MRC [G0700232, G0900084] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Community Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Coordinates and structure factors are deposited in the Protein Data Bank (see table S2). We thank K. Harlos, T. Walter, and staff of the European Synchrotron Radiation Facility and Diamond Light Source for assistance; the Harvard Medical School Nikon Imaging Center for resources and advice; C. Serra-Pages and A. W. Stoker for RPTP sigma cDNAs; M. Tremblay and N. Uetani (McGill Univ.) for the RPTP sigma<SUP>-/-</SUP> mouse; R. J. Gilbert and R. T. Aplin for analytical ultracentrifugation and mass spectrometry; and J. Silver, B. Lang, and A. W. Stoker for advice and discussions. This work was funded by the Wellcome Trust, the European Research Community Fund (MRTN-CT-2006-035830), the NIH (grants EY11559 and HD29417), Cancer Research UK, and the UK Medical Research Council. C. H. C. was the recipient of a Wellcome Trust D. Phil. studentship, C. S. is a Wellcome Trust Research Career Development Fellow, E.Y.J. is a Cancer Research UK Principal Research Fellow, and A. R. A. is a UK Medical Research Council Career Development Award Fellow. Current patent applications related to this work have been filed by Harvard Univ. A provisional patent filed by the University College London, related to the discovery of HSPGs as RPTP sigma ligands, expired in 2001. J. T. G. is the founder, director, and majority shareholder of Iduron, Paterson Institute for Cancer Research, Univ. of Manchester (Manchester, UK).	Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Aricescu AR, 2002, MOL CELL BIOL, V22, P1881, DOI 10.1128/MCB.22.6.1881-1892.2002; Bandtlow CE, 2000, PHYSIOL REV, V80, P1267, DOI 10.1152/physrev.2000.80.4.1267; Case LC, 2005, CURR BIOL, V15, pR749, DOI 10.1016/j.cub.2005.09.008; Duan YT, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3110pe6; Dunah AW, 2005, NAT NEUROSCI, V8, P458, DOI 10.1038/nn1416; Elchebly M, 1999, NAT GENET, V21, P330, DOI 10.1038/6859; Fox AN, 2005, CURR BIOL, V15, P1701, DOI 10.1016/j.cub.2005.08.035; Fry EJ, 2010, GLIA, V58, P423, DOI 10.1002/glia.20934; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Groves JT, 2010, NAT STRUCT MOL BIOL, V17, P659, DOI 10.1038/nsmb.1844; Harmer NJ, 2006, BIOCHEM J, V393, P741, DOI 10.1042/BJ20050985; Johnson KG, 2003, PHYSIOL REV, V83, P1, DOI 10.1152/physrev.00016.2002; Johnson KG, 2006, NEURON, V49, P517, DOI 10.1016/j.neuron.2006.01.026; Kantor DB, 2004, NEURON, V44, P961, DOI 10.1016/j.neuron.2004.12.002; Ledig MM, 1999, J CELL BIOL, V147, P375, DOI 10.1083/jcb.147.2.375; Matsumoto Y, 2007, J NEUROSCI, V27, P4342, DOI 10.1523/JNEUROSCI.0700-07.2007; McLean J, 2002, J NEUROSCI, V22, P5481; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Murphy KJ, 2004, J BIOL CHEM, V279, P27239, DOI 10.1074/jbc.M401774200; Rashid-Doubell F, 2002, J NEUROSCI, V22, P5024, DOI 10.1523/JNEUROSCI.22-12-05024.2002; Robles E, 2005, J NEUROSCI, V25, P7669, DOI 10.1523/JNEUROSCI.2680-05.2005; Sapieha PS, 2005, MOL CELL NEUROSCI, V28, P625, DOI 10.1016/j.mcn.2004.10.011; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; Thompson KM, 2003, MOL CELL NEUROSCI, V23, P681, DOI 10.1016/S1044-7431(03)00120-9; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Uetani N, 2000, EMBO J, V19, P2775, DOI 10.1093/emboj/19.12.2775; Uetani N, 2006, J NEUROSCI, V26, P5872, DOI 10.1523/JNEUROSCI.0386-06.2006; Van Vactor D, 2006, CURR OPIN NEUROBIOL, V16, P40, DOI 10.1016/j.conb.2006.01.011; Wallace MJ, 1999, NAT GENET, V21, P334, DOI 10.1038/6866; Woo J, 2009, NAT NEUROSCI, V12, P428, DOI 10.1038/nn.2279	33	235	247	3	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2011	332	6028					484	488		10.1126/science.1200840	http://dx.doi.org/10.1126/science.1200840			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21454754	Green Accepted			2022-12-28	WOS:000289784900048
J	Redberg, R				Redberg, Rita F.			Update in Cardiology: Evidence Published in 2010	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								This update summarizes 10 cardiology articles published in 2010 that were selected for their novelty, quality, and potential impact on clinical practice. The year was notable in documenting that we have significantly increased the number of procedures using ionizing radiation (computed tomography, myocardial perfusion imaging [MPI], coronary angiography) not uncommonly in asymptomatic persons without evidence of clinical benefit. In addition, several studies highlighted the importance of emphasizing lifestyle changes-diet, exercise, and smoking cessation-as the most effective way to reduce cardiovascular risk.	[Redberg, Rita F.] Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Redberg, R (corresponding author), Univ Calif San Francisco, Dept Med, Div Cardiol, 505 Parnassus Ave, San Francisco, CA 94143 USA.	redberg@medicine.ucsf.edu							0	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 19	2011	154	8					549	553		10.7326/0003-4819-154-8-201104190-00338	http://dx.doi.org/10.7326/0003-4819-154-8-201104190-00338			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751MK	21464339				2022-12-28	WOS:000289622000026
J	Quigley, HA				Quigley, Harry A.			Glaucoma	LANCET			English	Article							OPEN-ANGLE GLAUCOMA; GANGLION-CELL DEGENERATION; ANTERIOR-CHAMBER-DEPTH; OPTIC-NERVE HEAD; OCULAR HYPERTENSION; CLOSURE GLAUCOMA; VISUAL-FIELD; RISK-FACTORS; CLINICAL CHARACTERISTICS; INTRAOCULAR-PRESSURE	Most medical practitioners have regular contact with adults who have one of the two forms of glaucoma: open-angle glaucoma or angle-closure glaucoma. Data from population-based surveys indicate that one in 40 adults older than 40 years has glaucoma with loss of visual function, which equates to 60 million people worldwide being affected and 8.4 million being bilaterally blind. Even in developed countries, half of glaucoma cases are undiagnosed. Glaucoma is mostly asymptomatic until late in the disease when visual problems arise. Vision loss from glaucoma cannot be recovered, and improved case-detection methods for glaucoma are needed. Glaucoma is commonly treated with daily eye-drop drugs, but adherence to treatment is often unsatisfactory. As a usually asymptomatic and chronic disease, glaucoma has similar treatment challenges to chronic systemic diseases. Similarities to the pathogenesis of common CNS diseases mean that common neuroprotective strategies might exist. Successful gene therapy, which has been used for other eye diseases might be possible for the treatment of glaucoma in the future.	[Quigley, Harry A.] Johns Hopkins Sch Med, Wilmer Ophthalmol Inst, Glaucoma Serv, Baltimore, MD USA; [Quigley, Harry A.] Johns Hopkins Sch Med, Wilmer Ophthalmol Inst, Dana Ctr Prevent Ophthalmol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Quigley, HA (corresponding author), Johns Hopkins Univ Hosp, Wilmer 122,600 N Wolfe St, Baltimore, MD 21287 USA.	hquigley@jhmi.edu			Alcon; Allergan; Pfizer; National Institutes of Health	Alcon(Novartis); Allergan(AbbVieAllergan); Pfizer(Pfizer); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	I have received payment for lectures from Alcon, Allergan, and Pfizer, and have received royalties from Eyemaginations and Johns Hopkins University. My institution has received fees for consultancy work from Alcon and grants from the National Institutes of Health.	ALSBIRK PH, 1976, ACTA OPHTHALMOL, P5; ANDERSON DR, 1974, INVEST OPHTH VISUAL, V13, P771; Ang MHN, 2008, J GLAUCOMA, V17, P1, DOI 10.1097/IJG.0b013e318133a81c; [Anonymous], 1995, Am J Ophthalmol, V120, P718; Aponte EP, 2010, ARCH OPHTHALMOL-CHIC, V128, P478, DOI 10.1001/archophthalmol.2010.41; Aptel F, 2010, OPHTHALMOLOGY, V117, pc, DOI 10.1016/j.ophtha.2009.10.030; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bakalash S, 2005, J MOL MED, V83, P904, DOI 10.1007/s00109-005-0689-6; Barnett EM, 2009, P NATL ACAD SCI USA, V106, P9391, DOI 10.1073/pnas.0812884106; Bengtsson B, 2008, OPHTHALMOLOGY, V115, P2044, DOI 10.1016/j.ophtha.2008.05.031; Bielory L, 2006, CURR ALLERGY ASTHM R, V6, P299, DOI 10.1007/s11882-006-0063-y; Boland MV, 2008, OPHTHALMOLOGY, V115, P239, DOI 10.1016/j.ophtha.2007.03.086; Boland MV, 2007, J GLAUCOMA, V16, P406, DOI 10.1097/IJG.0b013e31806540a1; Boland MV, 2008, J GLAUCOMA, V17, P631, DOI 10.1097/IJG.0b013e3181659e6a; Bonomi L, 2000, OPHTHALMOLOGY, V107, P998, DOI 10.1016/S0161-6420(00)00022-1; Brandt JD, 2007, OPHTHALMOLOGY, V114, P1963, DOI 10.1016/j.ophtha.2007.08.031; Broman AT, 2008, INVEST OPHTH VIS SCI, V49, P66, DOI 10.1167/iovs.07-0866; Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008; Buhrmann RR, 2000, INVEST OPHTH VIS SCI, V41, P40; Buie LK, 2010, INVEST OPHTH VIS SCI, V51, P236, DOI 10.1167/iovs.09-3847; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Burr J, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11410; Bussieres JF, 2009, CAN J OPHTHALMOL, V44, P323, DOI 10.3129/i09-065; Caprioli J, 2010, AM J OPHTHALMOL, V149, P704, DOI 10.1016/j.ajo.2010.01.018; Chauhan BC, 2008, BRIT J OPHTHALMOL, V92, P569, DOI 10.1136/bjo.2007.135012; Chauhan BC, 2009, OPHTHALMOLOGY, V116, P2110, DOI 10.1016/j.ophtha.2009.04.031; Coleman AL, 2008, SURV OPHTHALMOL, V53, pS3, DOI 10.1016/j.survophthal.2008.08.006; Dandona L, 2000, OPHTHALMOLOGY, V107, P1710, DOI 10.1016/S0161-6420(00)00274-8; Danesh-Meyer HV, 2010, INVEST OPHTH VIS SCI, V51, P2003, DOI 10.1167/iovs.09-3492; DOUGLAS GR, 1975, ARCH OPHTHALMOL-CHIC, V93, P409, DOI 10.1001/archopht.1975.01010020423004; Ederer F, 2004, OPHTHALMOLOGY, V111, P651, DOI 10.1016/j.ophtha.2003.09.025; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Foster PJ, 2001, BRIT J OPHTHALMOL, V85, P1277, DOI 10.1136/bjo.85.11.1277; Foster PJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P1105, DOI 10.1001/archopht.118.8.1105; Friedman DS, 2007, INVEST OPHTH VIS SCI, V48, P5052, DOI 10.1167/iovs.07-0290; Friedman DS, 2006, OPHTHALMOLOGY, V113, P1087, DOI 10.1016/j.ophtha.2006.02.016; Friedman DS, 2004, AM J OPHTHALMOL, V138, pS19, DOI 10.1016/j.ajo.2004.04.058; Gedde SJ, 2009, AM J OPHTHALMOL, V148, P670, DOI 10.1016/j.ajo.2009.06.018; Grodum K, 2005, OPHTHALMOLOGY, V112, P386, DOI 10.1016/j.ophtha.2004.09.024; Guo L, 2007, P NATL ACAD SCI USA, V104, P13444, DOI 10.1073/pnas.0703707104; Hare W, 2001, SURV OPHTHALMOL, V45, pS284, DOI 10.1016/S0039-6257(01)00200-4; He MG, 2008, INVEST OPHTH VIS SCI, V49, P81, DOI 10.1167/iovs.07-1052; He MG, 2006, INVEST OPHTH VIS SCI, V47, P2782, DOI 10.1167/iovs.06-0051; Heijl A, 2008, OPHTHALMOLOGY, V115, P1557, DOI 10.1016/j.ophtha.2008.02.005; Heijl A, 2009, OPHTHALMOLOGY, V116, P2271, DOI 10.1016/j.ophtha.2009.06.042; Horsley MB, 2010, CURR OPIN OPHTHALMOL, V21, P112, DOI 10.1097/ICU.0b013e3283360aad; Howell GR, 2008, PROG BRAIN RES, V173, P303, DOI 10.1016/S0079-6123(08)01122-9; Huang W, 2005, P NATL ACAD SCI USA, V102, P12242, DOI 10.1073/pnas.0505138102; Jakobs TC, 2005, J CELL BIOL, V171, P313, DOI 10.1083/jcb.200506099; Jampel HD, 1997, J GLAUCOMA, V6, P133; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kielczewski JL, 2005, INVEST OPHTH VIS SCI, V46; Ko ML, 2000, INVEST OPHTH VIS SCI, V41, P2967; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Kymes SM, 2010, ARCH OPHTHALMOL-CHIC, V128, P613, DOI 10.1001/archophthalmol.2010.83; Lam DSC, 2007, CURR OPIN OPHTHALMOL, V18, P146, DOI 10.1097/ICU.0b013e32808374c9; Lavanya R, 2008, ARCH OPHTHALMOL-CHIC, V126, P686, DOI 10.1001/archopht.126.5.686; Leske MC, 2007, OPHTHAL EPIDEMIOL, V14, P166, DOI 10.1080/09286580701501931; Leske MC, 2007, OPHTHALMOLOGY, V114, P1965, DOI 10.1016/j.ophtha.2007.03.016; Leske MC, 2009, CURR OPIN OPHTHALMOL, V20, P73, DOI 10.1097/ICU.0b013e32831eef82; Leske MC, 2003, ARCH OPHTHALMOL-CHIC, V121, P48; Leske MC, 2001, ARCH OPHTHALMOL-CHIC, V119, P89; Levin LA, 2010, JAMA-J AM MED ASSOC, V303, P1533, DOI 10.1001/jama.2010.463; Libby RT, 2005, PLOS GENET, V1, P17, DOI 10.1371/journal.pgen.0010004; Lichter PR, 2001, OPHTHALMOLOGY, V108, P1943, DOI 10.1016/S0161-6420(01)00873-9; Lutjen-Drecoll E, 2000, J GLAUCOMA, V9, P417; Mansberger SL, 2006, J GLAUCOMA, V15, P426, DOI 10.1097/01.ijg.0000212258.02702.0c; Martin KRG, 2003, INVEST OPHTH VIS SCI, V44, P4357, DOI 10.1167/iovs.02-1332; Martinez-de-la-Casa JM, 2009, J GLAUCOMA, V18, P49, DOI 10.1097/IJG.0b013e31816f760c; McKinnon SJ, 2002, MOL THER, V5, P780, DOI 10.1006/mthe.2002.0608; Medeiros FA, 2005, ARCH OPHTHALMOL-CHIC, V123, P1351, DOI 10.1001/archopht.123.10.1351; Mukesh BN, 2002, OPHTHALMOLOGY, V109, P1047, DOI 10.1016/S0161-6420(02)01040-0; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; Neufeld AH, 2002, J GLAUCOMA, V11, P221, DOI 10.1097/00061198-200206000-00010; *NICE, NICE CLIN GUID, V85; Okeke CO, 2009, OPHTHALMOLOGY, V116, P2286, DOI 10.1016/j.ophtha.2009.05.026; Papadopoulos M, 2007, EYE, V21, P1319, DOI 10.1038/sj.eye.6702850; Parisi V, 2001, CLIN NEUROPHYSIOL, V112, P1860, DOI 10.1016/S1388-2457(01)00620-4; Pavlin CJ, 1999, AM J OPHTHALMOL, V128, P288, DOI 10.1016/S0002-9394(99)00149-X; Quigley HA, 2003, J GLAUCOMA, V12, P167, DOI 10.1097/00061198-200304000-00013; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P137; Quigley HA, 2002, AM J OPHTHALMOL, V133, P386, DOI 10.1016/S0002-9394(01)01380-0; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; Quigley HA, 2006, BR J OPHTHALMOL, V90, P151, DOI DOI 10.1136/BJ0.2005.081224; Quigley HA, 2009, J GLAUCOMA, V18, P173, DOI 10.1097/IJG.0b013e31818624ce; Racette L, 2003, SURV OPHTHALMOL, V48, P295, DOI 10.1016/S0039-6257(03)00028-6; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Sakai H, 2005, OPHTHALMOLOGY, V112, P413, DOI 10.1016/j.ophtha.2004.08.026; Sarfarazi Mansoor, 2003, Ophthalmol Clin North Am, V16, P543, DOI 10.1016/S0896-1549(03)00062-2; Schmitz-Valckenberg S, 2008, INVEST OPHTH VIS SCI, V49, P2773, DOI 10.1167/iovs.07-1335; Schulzer M, 1998, AM J OPHTHALMOL, V126, P487; Sharma P, 2008, SURV OPHTHALMOL, V53, pS17, DOI 10.1016/j.survophthal.2008.08.003; Sigal IA, 2009, EXP EYE RES, V88, P799, DOI 10.1016/j.exer.2009.02.003; Sihota R, 2007, EYE, V21, P984, DOI 10.1038/sj.eye.6702375; Suzuki Y, 2006, OPHTHALMOLOGY, V113, P1613, DOI 10.1016/j.ophtha.2006.03.059; Tao W, 2002, INVEST OPHTH VIS SCI, V43, P3292; TEIKARI JM, 1987, ACTA OPHTHALMOL, V65, P715; Thorleifsson G, 2007, SCIENCE, V317, P1397, DOI 10.1126/science.1146554; TIELSCH JM, 1991, JAMA-J AM MED ASSOC, V266, P369, DOI 10.1001/jama.266.3.369; Weisschuh N, 2009, AM J OPHTHALMOL, V147, P744, DOI 10.1016/j.ajo.2008.11.008; Wiggs JL, 2007, ARCH OPHTHALMOL-CHIC, V125, P30, DOI 10.1001/archopht.125.1.30; WILENSKY JT, 1993, AM J OPHTHALMOL, V115, P338, DOI 10.1016/S0002-9394(14)73585-8; Wilson MR, 1997, J GLAUCOMA, V6, P75; Wolfs RCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1640, DOI 10.1001/archopht.116.12.1640; Yip JLY, 2010, EYE, V24, P1128, DOI 10.1038/eye.2010.59; Yip JLY, 2006, CURR OPIN OPHTHALMOL, V17, P175, DOI 10.1097/01.icu.0000193078.47616.aa	106	821	854	4	176	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 16	2011	377	9774					1367	1377		10.1016/S0140-6736(10)61423-7	http://dx.doi.org/10.1016/S0140-6736(10)61423-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755UE	21453963				2022-12-28	WOS:000289962900037
J	Monath, TP; Fowler, E; Johnson, CT; Balser, J; Morin, MJ; Sisti, M; Trent, DW				Monath, Thomas P.; Fowler, Elizabeth; Johnson, Casey T.; Balser, John; Morin, Merribeth J.; Sisti, Maggie; Trent, Dennis W.			An Inactivated Cell-Culture Vaccine against Yellow Fever	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							JAPANESE ENCEPHALITIS VACCINE; IMMUNOGENICITY; SAFETY; MULTICENTER; BLIND; IC51	BACKGROUND Yellow fever is a lethal viral hemorrhagic fever occurring in Africa and South America. A highly effective live vaccine (17D) is widely used for travelers to and residents of areas in which yellow fever is endemic, but the vaccine can cause serious adverse events, including viscerotropic disease, which is associated with a high rate of death. A safer, nonreplicating vaccine is needed. METHODS In a double-blind, placebo-controlled, dose-escalation, phase 1 study of 60 healthy subjects between 18 and 49 years of age, we investigated the safety and immunogenicity of XRX-001 purified whole-virus, beta-propiolactone-inactivated yellow fever vaccine produced in Vero cell cultures and adsorbed to aluminum hydroxide (alum) adjuvant. On two visits 21 days apart, subjects received intramuscular injections of vaccine that contained 0.48 mu g or 4.8 mu g of antigen. Levels of neutralizing antibodies were measured at baseline and on days 21, 31, and 42. RESULTS The vaccine induced the development of neutralizing antibodies in 100% of subjects receiving 4.8 mu g of antigen in each injection and in 88% of subjects receiving 0.48 mu g of antigen in each injection. Antibody levels increased by day 10 after the second injection, at which time levels were significantly higher with the 4.8-mu g formulation than with the 0.48-mu g formulation (geometric mean titer, 146 vs. 39; P<0.001). Three adverse events occurred at a higher incidence in the two vaccine groups than in the placebo group: mild pain, tenderness, and (much less frequently) itching at the injection site. One case of urticaria was observed on day 3 after the second dose of 4.8 mu g of vaccine. CONCLUSIONS A two-dose regimen of the XRX-001 vaccine, containing inactivated yellow fever antigen with an alum adjuvant, induced neutralizing antibodies in a high percentage of subjects. XRX-001 has the potential to be a safer alternative to live attenuated 17D vaccine.	[Monath, Thomas P.; Fowler, Elizabeth; Morin, Merribeth J.; Sisti, Maggie; Trent, Dennis W.] Xcellerex, Marlborough, MA USA; [Johnson, Casey T.] Johnson City Clin Trials, Lenexa, KS USA; [Balser, John] Veristat, Holliston, MA USA		Monath, TP (corresponding author), Kleiner Perkins Caufield & Byers, 2750 Sand Hill Rd, Menlo Pk, CA 94025 USA.	tmonath@kpcb.com			Xcellerex	Xcellerex	Supported by Xcellerex.	[Anonymous], 2009, PRESCR INF IXIARO JA; Defraites RF, 1999, AM J TROP MED HYG, V61, P288, DOI 10.4269/ajtmh.1999.61.288; Freestone DS., 1994, VACCINES, P741; Hayes EB, 2010, VACCINE, V28, P8073, DOI 10.1016/j.vaccine.2010.10.015; Hombach J, 2005, VACCINE, V23, P5205, DOI 10.1016/j.vaccine.2004.11.040; Julander JG, VACCINE IN PRESS; Lang J, 1999, AM J TROP MED HYG, V60, P1045, DOI 10.4269/ajtmh.1999.60.1045; Lindsey NP, 2008, VACCINE, V26, P6077, DOI 10.1016/j.vaccine.2008.09.009; MASON RA, 1973, APPL MICROBIOL, V25, P539, DOI 10.1128/AEM.25.4.539-544.1973; Monath TP, 2010, VACCINE, V28, P3827, DOI 10.1016/j.vaccine.2010.03.023; Monath TP, 2010, AM J TROP MED HYG, V82, P919, DOI 10.4269/ajtmh.2010.10-0001; Monath TP, 2002, AM J TROP MED HYG, V66, P533, DOI 10.4269/ajtmh.2002.66.533; Schondorf I, 2007, VACCINE, V25, P1470, DOI 10.1016/j.vaccine.2006.10.028; Schuller E, 2008, VACCINE, V26, P4382, DOI 10.1016/j.vaccine.2008.05.081; Schuller E, 2009, VACCINE, V27, P2188, DOI 10.1016/j.vaccine.2008.12.062	15	72	76	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 7	2011	364	14					1326	1333		10.1056/NEJMoa1009303	http://dx.doi.org/10.1056/NEJMoa1009303			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745WS	21470010	Bronze			2022-12-28	WOS:000289202800008
J	Ritter, JM				Ritter, J. M.			Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in hypertension	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BLOOD-PRESSURE CONTROL; HEART-FAILURE; RENIN; SYSTEM; TRIAL; BLOCKADE; DRUGS		[Ritter, J. M.] St Thomas Hosp, Dept Clin Pharmacol, London SE1 7EH, England; [Ritter, J. M.] Kings Coll London, London, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Ritter, JM (corresponding author), St Thomas Hosp, Dept Clin Pharmacol, London SE1 7EH, England.	james.ritter@kcl.ac.uk						BROWN JJ, 1965, BMJ-BRIT MED J, V2, P144, DOI 10.1136/bmj.2.5454.144; Brown MJ, 2003, J HUM HYPERTENS, V17, P81, DOI 10.1038/sj.jhh.1001511; Coleman JJ, 2010, BRIT J CLIN PHARMACO, V70, P109, DOI 10.1111/j.1365-2125.2010.03654.x; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Dickerson JEC, 1999, LANCET, V353, P2008, DOI 10.1016/S0140-6736(98)07614-4; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Hermida RC, 2009, HYPERTENSION, V54, P40, DOI 10.1161/HYPERTENSIONAHA.109.130203; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; MACGREGOR GA, 1981, NATURE, V291, P329, DOI 10.1038/291329a0; MACGREGOR GA, 1985, J CARDIOVASC PHARM, V7, pS82, DOI 10.1097/00005344-198507001-00016; McDowell SE, 2006, BMJ-BRIT MED J, V332, P1177, DOI 10.1136/bmj.38803.528113.55; Medical Research Party Working Party, 1985, BMJ-BRIT MED J, V291, P99; Menard J, 1997, CIRCULATION, V96, P3072, DOI 10.1161/01.CIR.96.9.3072; Messerli FH, 2009, J AM COLL CARDIOL, V53, P468, DOI 10.1016/j.jacc.2008.10.036; Mogensen CE, 2000, BRIT MED J, V321, P1440, DOI 10.1136/bmj.321.7274.1440; Nakao N, 2009, LANCET, V374, P1226; National Institute for Health and Clinical Excellence, 2006, HYP MAN HYP AD PRIM; Okin PM, 2007, ANN INTERN MED, V147, P311, DOI 10.7326/0003-4819-147-5-200709040-00006; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Ritter JM, 2008, TXB CLIN PHARM, P185; Salvetti A, 1999, DRUGS, V57, P665, DOI 10.2165/00003495-199957050-00002; Sciarretta S, 2011, ARCH INTERN MED, V171, P384, DOI 10.1001/archinternmed.2010.427; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; The Seventh Report of the Joint National Committee on Prevention Detection Evaluation and Treatment of High Blood Pressure, 2004, 7 JOINT NAT COMM PRE; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	26	10	10	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2011	342								d1673	10.1136/bmj.d1673	http://dx.doi.org/10.1136/bmj.d1673			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749JT	21474511				2022-12-28	WOS:000289462400002
J	Li, JZ; Paredes, R; Ribaudo, HJ; Svarovskaia, ES; Metzner, KJ; Kozal, MJ; Hullsiek, KH; Balduin, M; Jakobsen, MR; Geretti, AM; Thiebaut, R; Ostergaard, L; Masquelier, B; Johnson, JA; Miller, MD; Kuritzkes, DR				Li, Jonathan Z.; Paredes, Roger; Ribaudo, Heather J.; Svarovskaia, Evguenia S.; Metzner, Karin J.; Kozal, Michael J.; Hullsiek, Kathy Huppler; Balduin, Melanie; Jakobsen, Martin R.; Geretti, Anna Maria; Thiebaut, Rodolphe; Ostergaard, Lars; Masquelier, Bernard; Johnson, Jeffrey A.; Miller, Michael D.; Kuritzkes, Daniel R.			Low-Frequency HIV-1 Drug Resistance Mutations and Risk of NNRTI-Based Antiretroviral Treatment Failure A Systematic Review and Pooled Analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							TREATMENT-NAIVE PATIENTS; REVERSE-TRANSCRIPTASE; MINORITY VARIANTS; INFECTED PATIENTS; THERAPY; ADHERENCE; EFAVIRENZ; IMPACT; TRANSMISSION; POPULATIONS	Context Presence of low-frequency, or minority, human immunodeficiency virus type 1 (HIV-1) drug resistance mutations may adversely affect response to antiretroviral treatment (ART), but evidence regarding the effects of such mutations on the effectiveness of first-line ART is conflicting. Objective To evaluate the association of preexisting drug-resistant HIV-1 minority variants with risk of first-line nonnucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral virologic failure. Data Sources Systematic review of published and unpublished studies in PubMed (1966 through December 2010), EMBASE (1974 through December 2010), conference abstracts, and article references. Authors of all studies were contacted for detailed laboratory, ART, and adherence data. Study Selection and Data Abstraction Studies involving ART-naive participants initiating NNRTI-based regimens were included. Participants were included if all drugs in their ART regimen were fully active by standard HIV drug resistance testing. Cox proportional hazard models using pooled patient-level data were used to estimate the risk of virologic failure based on a Prentice weighted case-cohort analysis stratified by study. Data Synthesis Individual data from 10 studies and 985 participants were available for the primary analysis. Low-frequency drug resistance mutations were detected in 187 participants, including 117 of 808 patients in the cohort studies. Low-frequency HIV-1 drug resistance mutations were associated with an increased risk of virologic failure (hazard ratio (HR], 2.3 [95% confidence interval {CI}, 1.7-3.3]; P < .001) after controlling for medication adherence, race/ethnicity, baseline CD4 cell count, and plasma HIV-1 RNA levels. Increased risk of virologic failure was most strongly associated with minority variants resistant to NNRTIs (HR, 2.6 [95% CI, 1.9-3.5]; P < .001). Among participants from the cohort studies, 35% of those with detectable minority variants experienced virologic failure compared with 15% of those without minority variants. The presence of minority variants was associated with 2.5 to 3 times the risk of virologic failure at either 95% or greater or less than 95% overall medication adherence. A dose-dependent increased risk of virologic failure was found in participants with a higher proportion or quantity of drug-resistant variants. Conclusion In a pooled analysis, low-frequency HIV-1 drug resistance mutations, particularly involving NNRTI resistance, were significantly associated with a dose-dependent increased risk of virologic failure with first-line ART. JAMA. 2011;305(13):1327-1335 www.jama.com	[Li, Jonathan Z.; Kuritzkes, Daniel R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Sect Retroviral Therapeut, Boston, MA 02115 USA; [Ribaudo, Heather J.] Harvard Univ, Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA 02115 USA; [Paredes, Roger] Hosp Badalona Germans Trias & Pujol, IrsiCaixa AIDS Res Inst, Badalona, Spain; [Paredes, Roger] Hosp Badalona Germans Trias & Pujol, Lluita SIDA Fdn, Badalona, Spain; [Svarovskaia, Evguenia S.; Miller, Michael D.] Gilead Sci Inc, Foster City, CA 94404 USA; [Metzner, Karin J.] Univ Zurich, Univ Zurich Hosp, Div Infect Dis, Zurich, Switzerland; [Metzner, Karin J.] Univ Zurich, Univ Zurich Hosp, Hosp Epidemiol, Zurich, Switzerland; [Kozal, Michael J.] Yale Univ, Sch Med, AIDS Program, New Haven, CT USA; [Kozal, Michael J.] VA Connecticut Healthcare Syst, New Haven, CT USA; [Hullsiek, Kathy Huppler] Univ Minnesota, Div Biostat, Minneapolis, MN USA; [Balduin, Melanie] Univ Cologne, Inst Virol, Cologne, Germany; [Jakobsen, Martin R.] Aarhus Univ, Dept Med Microbiol, Skejby, Denmark; [Jakobsen, Martin R.] Aarhus Univ, Dept Immunol, Skejby, Denmark; [Ostergaard, Lars] Aarhus Univ Hosp, Skejby, Denmark; [Geretti, Anna Maria] UCL, Sch Med, Dept Virol, London W1N 8AA, England; [Thiebaut, Rodolphe] Bordeaux Sch Publ Hlth, INSERM, Epidemiol & Biostat U897, Bordeaux, France; [Masquelier, Bernard] CHU Bordeaux, Virol Lab, Bordeaux, France; [Masquelier, Bernard] Univ Bordeaux, Bordeaux, France; [Johnson, Jeffrey A.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, Atlanta, GA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Hospital Germans Trias i Pujol; Gilead Sciences; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; University of Minnesota System; University of Minnesota Twin Cities; University of Cologne; Aarhus University; Aarhus University; Aarhus University; University of London; University College London; UCL Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Centers for Disease Control & Prevention - USA	Li, JZ (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Sect Retroviral Therapeut, 65 Landsdowne St,Room 435, Cambridge, MA 02139 USA.	jli22@partners.org; dkuritzkes@partners.org	Metzner, Karin J/G-5319-2011; Thiebaut, Rodolphe/T-6803-2019; Ostergaard, Lars/AAA-3020-2020	Metzner, Karin J/0000-0003-4862-1503; Thiebaut, Rodolphe/0000-0002-5235-3962; Ostergaard, Lars/0000-0003-2459-0511; Kozal, Michael/0000-0002-3100-8254; Ostergaard, Lars/0000-0002-7619-605X; , Michael/0000-0002-7719-7396; , Martin/0000-0001-8847-9201; Geretti, Anna Maria/0000-0002-3670-6588	Bristol-Myers Squibb; Pfizer; Siemens; Merck; Boehringer Ingelheim; Gilead; Roche Diagnostics; GlaxoSmithKline; Tibotec; Abbott; ViiV; Janssen-Cilag; ViiV Healthcare; Avexa; Boehringer-Ingelheim; Human Genome Sciences; Oncolys; Tobira; Vertex; ViroStatistics; Harvard/MIT Health Sciences and Technology-Beth Israel Deaconess Medical Center; Pfizer Inc; Merck Co; National Institutes of Health (NIH) [T32 AI07387]; European Commission [223131]; NIH (Statistical and Data Management Center of the AIDS Clinical Trials Group [ACTG]) [U01 AI068634]; NIH (Harvard University CFAR) [P30 AI060354]; Swiss National Science Foundation [324700-120793, CR32I2-127017]; Gilead Sciences; European Community [223131]; VA Merit Award; NIH [U01 AI 068636, K24 RR016482]; ACTG; NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR016482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068636, U01AI042170, UM1AI068636, P30AI060354, U01AI068634, T32AI007387] Funding Source: NIH RePORTER	Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer); Siemens(Siemens AG); Merck(Merck & Company); Boehringer Ingelheim(Boehringer Ingelheim); Gilead(Gilead Sciences); Roche Diagnostics; GlaxoSmithKline(GlaxoSmithKline); Tibotec; Abbott(Abbott Laboratories); ViiV; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); ViiV Healthcare; Avexa; Boehringer-Ingelheim(Boehringer Ingelheim); Human Genome Sciences(GlaxoSmithKline); Oncolys; Tobira; Vertex(Vertex Pharmaceuticals); ViroStatistics; Harvard/MIT Health Sciences and Technology-Beth Israel Deaconess Medical Center; Pfizer Inc(Pfizer); Merck Co(Merck & Company); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre); NIH (Statistical and Data Management Center of the AIDS Clinical Trials Group [ACTG])(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH (Harvard University CFAR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Gilead Sciences(Gilead Sciences); European Community(European Commission); VA Merit Award(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ACTG; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Li reported receiving research support from Bristol-Myers Squibb and serving as a consultant for Tibotec. Dr Paredes reported having received consulting fees from Pfizer and grant support from Pfizer, Siemens, Merck, and Boehringer Ingelheim. Drs Svarovskaia and Miller are employees of, and report holding stock in, Gilead Sciences Inc. Dr Metzner reported receiving travel grants and honoraria from Gilead, Roche Diagnostics, GlaxoSmithKline, Bristol-Myers Squibb, Tibotec, and Abbott, and receiving a research grant from Gilead. Yale University receives grant support from Merck, Pfizer, Gilead, Abbott, ViiV, and Bristol-Myers Squibb for studies for which Dr Kozal serves as the principal investigator. Dr Kozal reported receiving royalties from patents owned by Stanford University for some human immunodeficiency virus (HIV) diagnostic tests. Dr Ostergaard reported receiving research grants from Tibotec, Roche, Bristol-Myers Squibb, GlaxoSmithKline, and Merck; educational grants from GlaxoSmithKline and Merck; and speaker's fees from Abbott, Tibotec, Bristol-Myers Squibb, Merck, and GlaxoSmithKline. Dr Masquelier reported receiving research grants from Pfizer and Janssen-Cilag and speaker's fees from Merck, Pfizer, Gilead, Janssen-Cilag, and ViiV Healthcare. Dr Kuritzkes reported serving as a consultant to and/or receiving research grant support from Abbott, Avexa, Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Human Genome Sciences, Merck, Oncolys, Pfizer, Roche, Siemens, Tobira, Vertex, ViroStatistics, and ViiV Healthcare. No other authors reported conflicts of interest relevant to this article.; Dr Li is supported by a Clinical Investigator Training Program Fellowship: Harvard/MIT Health Sciences and Technology-Beth Israel Deaconess Medical Center, in collaboration with Pfizer Inc and Merck & Co and by National Institutes of Health (NIH) grant T32 AI07387. Dr Paredes was partly supported by Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN) integrated project No. 223131, funded by the European Commission Framework 7 Program. Dr Ribaudo is supported in part by grants from NIH (Statistical and Data Management Center of the AIDS Clinical Trials Group [ACTG] U01 AI068634 and Harvard University CFAR P30 AI060354). Dr Metzner is supported by Swiss National Science Foundation grants 324700-120793 and CR32I2-127017, Gilead Sciences, and the European Community's Seventh Framework Programme (FP7/2007-2013) under Collaborative HIV and Anti-HIV Drug Resistance Network (CHAIN) grant agreement No. 223131. Dr Kozal is supported by a VA Merit Award. Dr Huppler Hullsiek is supported in part by NIH grant U01 AI042170. Dr Kuritzkes is supported in part by grants from the NIH (U01 AI 068636, K24 RR016482) and an ACTG Virology Specialty Laboratory subcontract from the ACTG.	Arnsten JH, 2001, CLIN INFECT DIS, V33, P1417, DOI 10.1086/323201; Balduin M, 2009, J CLIN VIROL, V45, P34, DOI 10.1016/j.jcv.2009.03.002; Bar KJ, 2010, J VIROL, V84, P6241, DOI 10.1128/JVI.00077-10; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Bertagnolio S, 2011, 18 C RETR OPP INF FE; Charpentier C, 2010, AIDS, V24, P867, DOI 10.1097/QAD.0b013e3283367796; Geretti AM, 2009, JAIDS-J ACQ IMM DEF, V52, P569, DOI 10.1097/QAI.0b013e3181ba11e8; Geretti AM, 2009, CLIN INFECT DIS, V48, P1296, DOI 10.1086/598502; Gianella S, 2010, J INFECT DIS, V202, P657, DOI 10.1086/655397; Goodman DD, 2011, AIDS, V25, P325, DOI 10.1097/QAD.0b013e3283427dcb; Grant RM, 2003, J CLIN MICROBIOL, V41, P1586, DOI 10.1128/JCM.41.4.1586-1593.2003; Horberg MA, 2010, HIV AIDS-RES PALLIAT, V2, P135; Jakobsen MR, 2010, CLIN INFECT DIS, V50, P566, DOI 10.1086/650001; Johnson JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000638; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Kim D, 2010, 17 C RETR OPP INF FE; Lataillade M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010952; Li H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000890; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; Little SJ, 2008, J VIROL, V82, P5510, DOI 10.1128/JVI.02579-07; McKinnell JA, 2010, AIDS PATIENT CARE ST, V24, P79, DOI 10.1089/apc.2009.0220; Metzner KJ, 2011, J CLIN VIROL, V50, P156, DOI 10.1016/j.jcv.2010.10.001; Metzner KJ, 2010, J INFECT DIS, V201, P1063, DOI 10.1086/651136; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Metzner KJ, 2003, J INFECT DIS, V188, P1433, DOI 10.1086/379215; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Paredes R, 2007, J VIROL METHODS, V146, P136, DOI 10.1016/j.jviromet.2007.06.012; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Peuchant O, 2008, AIDS, V22, P1417, DOI 10.1097/QAD.0b013e3283034953; Ribaudo HJ, 2010, J INFECT DIS, V202, P717, DOI 10.1086/655470; Ross LL, 2010, AIDS RES HUM RETROV, V26, P407, DOI 10.1089/aid.2009.0189; Schackman BR, 2007, JAIDS-J ACQ IMM DEF, V46, P547, DOI 10.1097/QAI.0b013e31815ac499; Schuurman R, 1999, J CLIN MICROBIOL, V37, P2291, DOI 10.1128/JCM.37.7.2291-2296.1999; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; VANELTEREN P, 1960, B INT STATIST INST, V37, P351; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; WACHOLDER S, 1987, AM J EPIDEMIOL, V126, P1198, DOI 10.1093/oxfordjournals.aje.a114759	37	276	282	2	46	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2011	305	13					1327	1335		10.1001/jama.2011.375	http://dx.doi.org/10.1001/jama.2011.375			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745JT	21467286	Green Accepted			2022-12-28	WOS:000289162400022
J	Gousseff, M; Arnaud, L; Lambert, M; Hot, A; Hamidou, M; Duhaut, P; Papo, T; Soubrier, M; Ruivard, M; Malizia, G; Tieulie, N; Riviere, S; Ninet, J; Hatron, PY; Amoura, Z				Gousseff, Marie; Arnaud, Laurent; Lambert, Marc; Hot, Arnaud; Hamidou, Mohamed; Duhaut, Pierre; Papo, Thomas; Soubrier, Martin; Ruivard, Marc; Malizia, Giuseppe; Tieulie, Nathalie; Riviere, Sophie; Ninet, Jacques; Hatron, Pierre-Yves; Amoura, Zahir		Capillary Leak Syndrome Registry	The Systemic Capillary Leak Syndrome: A Case Series of 28 Patients From a European Registry	ANNALS OF INTERNAL MEDICINE			English	Article							HYPOVOLEMIC SHOCK; COMPARTMENT SYNDROME; MONOCLONAL GAMMOPATHY; CLARKSONS-DISEASE; MULTIPLE-MYELOMA; RECURRENT SHOCK; RARE CAUSE; PERMEABILITY; EDEMA; TERBUTALINE	Background: The systemic capillary leak syndrome (SCLS) is a rare disease characterized by life-threatening attacks of capillary hyperpermeability. Objective: To describe the clinical characteristics, laboratory findings, treatments, and outcomes of patients with SCLS who were not previously reported in the literature. Design: Case series. Setting: Patients referred to a European multicenter SCLS registry between January 1997 and July 2010. Patients: 28 patients with SCLS. Measurements: Frequency, severity of attacks, and vital status were assessed every 6 months, from diagnosis to the end of the study. Results: 13 men and 15 women referred to the registry who were not previously reported in the literature had 252 attacks. Median age at disease onset was 49.1 years (range, 5.4 to 77.7 years), and median annual frequency of attacks was 1.23 (range, 0.13 to 21.18) per patient. Monoclonal IgG gammopathy was observed in 25 patients (89%). Preventive treatment included intravenous immunoglobulin (n = 18), terbutaline (n = 9), and aminophylline (n = 10). Eight patients died (29%); 1-year survival was 89%, and 5-year survival was 73%. Death was directly related to SCLS attacks in 6 of 8 cases (75%). In 10 patients with a prediagnosis period greater than 6 months who received preventive treatment, the annual frequency of attacks after diagnosis decreased by a median of 1.55 (range, 0.14 to 8.84) per patient. Five years after diagnosis, survival was 85% in 23 patients who had received prophylactic treatment and 20% in 5 patients who had not. Limitation: The benefits of preventive treatment could not be precisely ascertained because of the small sample size and because most patients received several treatments. Conclusion: Clinical experience with these 28 patients with SCLS suggests that prophylactic treatment with beta(2)-agonists or intravenous immunoglobulin may reduce the frequency and severity of attacks and may improve survival.	Hop Bichat Claude Bernard, AP HP, Pitie Salpetriere Hosp, INSERM, F-75877 Paris 18, France; Univ Paris 06, Paris, France; Univ Nord France, Lille, France; Univ Lyon 1, Hop Edouard Herriot, F-69365 Lyon, France; CHU Nantes, Hotel Dieu, F-44035 Nantes 01, France; Hop Nord Amiens, Amiens, France; Ctr Hosp Univ Clermont Ferrand, F-63058 Clermont Ferrand 01, France; Ctr Hosp Univ Estaing, Clermont Ferrand, France; Osped Riuniti Villa Sofia Osped Cervello, Palermo, Italy; Hop Archet, F-06202 Nice 3, France; CHU Montpellier, F-34295 Montpellier 5, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite de Lille - ISITE; Universite de Lille; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Nantes Universite; CHU de Nantes; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; CHU Clermont Ferrand; CHU Clermont Ferrand; CHU Nice; Universite de Montpellier; CHU de Montpellier	Amoura, Z (corresponding author), Grp Hosp Pitie Salpetriere, Serv Med Interne 2, 47-83 Blvd Hop, F-75013 Paris, France.	zahir.amoura@psl.aphp.fr	lambert, marc/V-7380-2017; AMOURA, Zahir/P-5324-2017; Amoura, Zahir/P-5325-2017	lambert, marc/0000-0002-3485-8238; AMOURA, Zahir/0000-0003-0292-9043; Malizia, Giuseppe/0000-0002-0995-8755; ARNAUD, Laurent/0000-0002-8077-8394	Universite Pierre et Marie Curie, Paris, France; Laboratoire Francais du Fractionnement et des Biotechnologies (Les Ulis, France)	Universite Pierre et Marie Curie, Paris, France; Laboratoire Francais du Fractionnement et des Biotechnologies (Les Ulis, France)	Universite Pierre et Marie Curie, Paris, France.r Primarily by Universite Pierre et Marie Curie (Paris, France) and in part by Laboratoire Francais du Fractionnement et des Biotechnologies (Les Ulis, France).	ALEXANIAN R, 1995, SEMIN HEMATOL, V32, P20; Amoura Z, 1997, AM J MED, V103, P514, DOI 10.1016/S0002-9343(97)00272-6; Assaly R, 2001, CHEST, V120, P1301, DOI 10.1378/chest.120.4.1301; ATKINSON JP, 1977, MEDICINE, V56, P225, DOI 10.1097/00005792-197705000-00004; BALASCH J, 1994, ANN INTERN MED, V121, P27, DOI 10.7326/0003-4819-121-1-199407010-00005; BARNADAS MA, 1995, J AM ACAD DERMATOL, V32, P364, DOI 10.1016/0190-9622(95)90405-0; Bayry J, 2006, INT IMMUNOPHARMACOL, V6, P528, DOI 10.1016/j.intimp.2005.11.013; Bonadies N, 2006, EUR J INTERN MED, V17, P363, DOI 10.1016/j.ejim.2005.12.011; BOUHAJA B, 1994, INTENS CARE MED, V20, P307, DOI 10.1007/BF01708975; CAIN JR, 1986, KIDNEY INT, V29, P181; Chihara R, 2002, INTERNAL MED, V41, P953, DOI 10.2169/internalmedicine.41.953; CICARDI M, 1990, ANN INTERN MED, V113, P475, DOI 10.7326/0003-4819-113-6-475; CLARKSON B, 1960, AM J MED, V29, P193, DOI 10.1016/0002-9343(60)90018-8; Crenier L, 1997, ACTA CLIN BELG, V52, P401, DOI 10.1080/17843286.1997.11718607; Dams K, 2007, CHEST, V132, P1393, DOI 10.1378/chest.07-0456; de Barros R T, 1983, Rev Hosp Clin Fac Med Sao Paulo, V38, P170; Deeren DH, 2005, ANN HEMATOL, V84, P89, DOI 10.1007/s00277-004-0946-8; DEREURE O, 1994, DERMATOLOGY, V188, P152, DOI 10.1159/000247123; Dhir V, 2007, INTERNAL MED, V46, P899, DOI 10.2169/internalmedicine.46.6129; DOLBERGSTOLIK OC, 1993, CHEST, V104, P123, DOI 10.1378/chest.104.1.123; DOORENBOS CJ, 1988, NETH J MED, V32, P178; DRODER RM, 1992, AM J MED, V92, P523, DOI 10.1016/0002-9343(92)90749-2; Druey KM, 2010, ANN INTERN MED, V153, P90, DOI 10.7326/0003-4819-153-2-201007200-00005; Elias AD, 2001, BONE MARROW TRANSPL, V27, P269, DOI 10.1038/sj.bmt.1702780; EWAN PW, 1988, LANCET, V2, P1496; FELLOWS IW, 1988, LANCET, V2, P1143; FISHBEIN MC, 1974, AM J SURG, V127, P740, DOI 10.1016/0002-9610(74)90361-4; FOELDVARI I, 1995, J PEDIATR-US, V127, P739, DOI 10.1016/S0022-3476(95)70163-X; GARCIABRAGADO F, 1987, MED CLIN-BARCELONA, V89, P426; Gauvin F, 2000, CRIT CARE MED, V28, P3341, DOI 10.1097/00003246-200009000-00038; GEORGE C, 1978, INTENS CARE MED, V4, P159, DOI 10.1007/BF01700259; Gleich GJ, 2009, BRIT J HAEMATOL, V145, P271, DOI 10.1111/j.1365-2141.2009.07599.x; Gousseff M, 2009, REV MED INTERNE, V30, P754, DOI 10.1016/j.revmed.2009.01.005; GUIDET B, 1990, INTENS CARE MED, V16, P332, DOI 10.1007/BF01706361; Gyger M, 2005, BONE MARROW TRANSPL, V35, P201, DOI 10.1038/sj.bmt.1704730; Hamada Yoshihiro, 2004, Asian Cardiovasc Thorac Ann, V12, P193; Hiraoka E, 1995, INTERNAL MED, V34, P1220, DOI 10.2169/internalmedicine.34.1220; HORWITH M, 1967, J AMER MED ASSOC, V200, P101, DOI 10.1001/jama.200.2.101; JANINMANIFICAT L, 1982, NOUV PRESSE MED, V11, P2716; Jillella AP, 2000, LEUKEMIA LYMPHOMA, V38, P419, DOI 10.3109/10428190009087034; KANG PM, 1995, RENAL FAILURE, V17, P615, DOI 10.3109/08860229509037627; KAO NL, 1993, CHEST, V104, P1637, DOI 10.1378/chest.104.5.1637c; Kaplan MJ, 1999, ARCH DERMATOL, V135, P553, DOI 10.1001/archderm.135.5.553; Kapoor P, 2010, MAYO CLIN PROC, V85, P905, DOI 10.4065/mcp.2010.0159; Karatzios C, 2006, PEDIATR CRIT CARE ME, V7, P377, DOI 10.1097/01.PCC.0000227120.61949.FB; Kawabe S, 2002, INTERNAL MED, V41, P211, DOI 10.2169/internalmedicine.41.211; LAGRUE G, 1986, PRESSE MED, V15, P1554; Lambert M, 2008, CRIT CARE MED, V36, P2184, DOI 10.1097/CCM.0b013e31817d7c71; LARCAN A, 1975, BIBL ANAT, P343; Lassoued K, 1998, INTENS CARE MED, V24, P981, DOI 10.1007/s001340050700; Lee Young Seok, 2007, Korean Journal of Internal Medicine, V22, P130; LOFDAHL CG, 1979, ACTA MED SCAND, V206, P405; LUQUEL L, 1989, REV MED INTERNE, V10, P359, DOI 10.1016/S0248-8663(89)80037-2; Marasini B, 1979, Bibl Anat, P41; Marx G, 2000, INTENS CARE MED, V26, P1252, DOI 10.1007/s001340000601; Matsumura M, 2007, INTERNAL MED, V46, P1585, DOI 10.2169/internalmedicine.46.0254; MCGREGOR JM, 1991, BRIT J DERMATOL, V125, P472, DOI 10.1111/j.1365-2133.1991.tb14777.x; Michiels JJ, 2006, SEMIN THROMB HEMOST, V32, P577, DOI 10.1055/s-2006-949663; Muller M, 2004, INTERNIST, V45, P587, DOI 10.1007/s00108-004-1162-2; OHTA H, 1994, ACTA PAEDIATR, V83, P1113, DOI 10.1111/j.1651-2227.1994.tb13000.x; Onal H, 2007, ANN TROP PAEDIATR, V27, P81, DOI 10.1179/146532807X170556; PURI RK, 1989, CANCER IMMUNOL IMMUN, V28, P267; RONDEAU E, 1987, EUR J CLIN INVEST, V17, P53, DOI 10.1111/j.1365-2362.1987.tb01225.x; Sabbadini D D, 2002, Minerva Anestesiol, V68, P929; SABBADINI DD, 2002, MINERVA ANESTESIOL, V68, P933; Sahnoun I, 2005, REV MED INTERNE, V26, P409, DOI 10.1016/j.revmed.2004.12.009; Sanghavi R, 2006, ANAESTH INTENS CARE, V34, P388, DOI 10.1177/0310057X0603400308; Schmidt S, 1999, NEUROLOGY, V53, P220, DOI 10.1212/WNL.53.1.220; Shimura H, 1999, EUR SURG RES, V31, P390, DOI 10.1159/000008717; Sion-Sarid R, 2010, PEDIATRICS, V125, pE687, DOI 10.1542/peds.2009-1691; Staak JO, 2003, AM J MED, V115, P332, DOI 10.1016/S0002-9343(03)00349-8; SVENSJO E, 1982, ACTA PHYSIOL SCAND, V116, P265, DOI 10.1111/j.1748-1716.1982.tb07140.x; Tahirkheli NK, 1999, ANN INTERN MED, V130, P905, DOI 10.7326/0003-4819-130-11-199906010-00015; TEELUCKSINGH S, 1990, Q J MED, V75, P515; TEELUCKSINGH S, 1989, LANCET, V1, P330; Tieulie N, 2005, REV MED INTERNE, V26, pS223, DOI 10.1016/S0248-8663(05)80032-3; Valderrey FP, 1999, AM J EMERG MED, V17, P743, DOI 10.1016/S0735-6757(99)90179-1; Vigneau U, 2002, NEPHROL DIAL TRANSPL, V17, P492, DOI 10.1093/ndt/17.3.492; Wiest GH, 2001, MED KLIN, V96, P365, DOI 10.1007/PL00002217	79	96	103	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 5	2011	154	7							464	10.7326/0003-4819-154-7-201104050-00004	http://dx.doi.org/10.7326/0003-4819-154-7-201104050-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744EX	21464348				2022-12-28	WOS:000289078700003
J	Boyles, JG; Cryan, PM; McCracken, GF; Kunz, TH				Boyles, Justin G.; Cryan, Paul M.; McCracken, Gary F.; Kunz, Thomas H.			Economic Importance of Bats in Agriculture	SCIENCE			English	Editorial Material							WHITE-NOSE SYNDROME; FREE-TAILED BATS; POLLINATION ECOLOGY; SOUTHERN THAILAND; MYOTIS-LUCIFUGUS; WIND TURBINES; BROWN BAT; HYPOTHESES; FATALITIES; DISEASE		[Boyles, Justin G.] Univ Pretoria, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa; [Cryan, Paul M.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO 80526 USA; [McCracken, Gary F.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Kunz, Thomas H.] Boston Univ, Dept Biol, Ctr Ecol & Conservat Biol, Boston, MA 02215 USA	University of Pretoria; United States Department of the Interior; United States Geological Survey; University of Tennessee System; University of Tennessee Knoxville; Boston University	Boyles, JG (corresponding author), Univ Pretoria, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa.	jgboyles@zoology.up.ac.za	Boyles, Justin G/A-5152-2010	Cryan, Paul/0000-0002-2915-8894; McCracken, Gary/0000-0002-2493-8103				ANTHONY ELP, 1977, ECOLOGY, V58, P775, DOI 10.2307/1936213; Arnett EB, 2011, FRONT ECOL ENVIRON, V9, P209, DOI 10.1890/100103; Baerwald EF, 2009, J WILDLIFE MANAGE, V73, P1077, DOI 10.2193/2008-233; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Boyles JG, 2010, FRONT ECOL ENVIRON, V8, P92, DOI 10.1890/080187; Bumrungsri S, 2008, J TROP ECOL, V24, P467, DOI 10.1017/S0266467408005191; Bumrungsri S, 2009, J TROP ECOL, V25, P85, DOI 10.1017/S0266467408005531; Cleveland CJ, 2006, FRONT ECOL ENVIRON, V4, P238, DOI 10.1890/1540-9295(2006)004[0238:EVOTPC]2.0.CO;2; Cryan PM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-135; Cryan PM, 2009, J MAMMAL, V90, P1330, DOI 10.1644/09-MAMM-S-076R1.1; Elliot D. L., 1986, WIND ENERGY RESOURCE; Federico P, 2008, ECOL APPL, V18, P826, DOI 10.1890/07-0556.1; Foley J, 2011, CONSERV BIOL, V25, P223, DOI 10.1111/j.1523-1739.2010.01638.x; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Hallam TG, 2011, CONSERV BIOL, V25, P189, DOI 10.1111/j.1523-1739.2010.01603.x; Kalka MB, 2008, SCIENCE, V320, P71, DOI 10.1126/science.1153352; Kunz TH, 2007, FRONT ECOL ENVIRON, V5, P315, DOI 10.1890/1540-9295(2007)5[315:EIOWED]2.0.CO;2; KURTA A, 1989, PHYSIOL ZOOL, V62, P804, DOI 10.1086/physzool.62.3.30157928; Pimentel David, 2009, P89, DOI 10.1007/978-1-4020-8992-3_4; Rydell J, 2010, ACTA CHIROPTEROL, V12, P261, DOI 10.3161/150811010X537846; *USDA, 2009, GEOGR AR SER USDA, V1; WHITAKER JO, 1995, AM MIDL NAT, V134, P346, DOI 10.2307/2426304; Williams-Guillen K, 2008, SCIENCE, V320, P70, DOI 10.1126/science.1152944	23	430	468	11	469	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2011	332	6025					41	42		10.1126/science.1201366	http://dx.doi.org/10.1126/science.1201366			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	743EJ	21454775				2022-12-28	WOS:000289000000029
J	Kir, S; Beddow, SA; Samuel, VT; Miller, P; Previs, SF; Suino-Powell, K; Xu, HE; Shulman, GI; Kliewer, SA; Mangelsdorf, DJ				Kir, Serkan; Beddow, Sara A.; Samuel, Varman T.; Miller, Paul; Previs, Stephen F.; Suino-Powell, Kelly; Xu, H. Eric; Shulman, Gerald I.; Kliewer, Steven A.; Mangelsdorf, David J.			FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis	SCIENCE			English	Article							SYNTHASE KINASE-3-BETA; GLUCOSE-HOMEOSTASIS; GROWTH; PHOSPHORYLATION; FIBROBLAST-GROWTH-FACTOR-19; INACTIVATION; KLOTHO; MTORC1; SIGNAL; RSK	Fibroblast growth factor (FGF) 19 is an enterokine synthesized and released when bile acids are taken up into the ileum. We show that FGF19 stimulates hepatic protein and glycogen synthesis but does not induce lipogenesis. The effects of FGF19 are independent of the activity of either insulin or the protein kinase Akt and, instead, are mediated through a mitogen-activated protein kinase signaling pathway that activates components of the protein translation machinery and stimulates glycogen synthase activity. Mice lacking FGF15 (the mouse FGF19 ortholog) fail to properly maintain blood concentrations of glucose and normal postprandial amounts of liver glycogen. FGF19 treatment restored the loss of glycogen in diabetic animals lacking insulin. Thus, FGF19 activates a physiologically important, insulin-independent endocrine pathway that regulates hepatic protein and glycogen metabolism.	[Kir, Serkan; Kliewer, Steven A.; Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Beddow, Sara A.; Samuel, Varman T.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Miller, Paul; Previs, Stephen F.] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Suino-Powell, Kelly; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Kliewer, Steven A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Mangelsdorf, David J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Yale University; Case Western Reserve University; Van Andel Institute; Howard Hughes Medical Institute; Yale University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kliewer, SA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	steven.kliewer@utsouthwestern.edu; davo.mango@utsouthwestern.edu	Xu, H. Eric/ABD-7487-2021; Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668; Mangelsdorf, David/0000-0002-4355-0796; Xu, H. Eric/0000-0002-6829-8144	Howard Hughes Medical Institute; NIH [DK67158, DK62434, DK40936, U24 DK076169]; Robert A. Welch Foundation [I-1275, I-558]; Yale and Case Western Reserve University Mouse Metabolic Phenotyping Centers; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK076169, R01DK067158, U24DK059635, R24DK085638, R01DK040936, U19DK062434] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Yale and Case Western Reserve University Mouse Metabolic Phenotyping Centers; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank T. Inagaki, X. Ding, and A. Bookout for their help with animal experiments and M. Cobb and P. Scherer (University of Texas Southwestern Medical Center) for discussion and comments. This research was supported by the Howard Hughes Medical Institute (G. I. S., D.J.M.), the NIH (DK67158 and DK62434 to S. A. K. and D.J.M., DK40936 and U24 DK076169 to G. I. S.), the Robert A. Welch Foundation (I-1275 to D.J.M. and I-558 to S. A. K.), and the Yale and Case Western Reserve University Mouse Metabolic Phenotyping Centers. A Materials Transfer Agreement is required for sharing materials from the Van Andel Institute.	Anderson SR, 2008, METABOLISM, V57, P347, DOI 10.1016/j.metabol.2007.10.009; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Choi M, 2006, NAT MED, V12, P1253, DOI 10.1038/nm1501; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Dong XC, 2006, J CLIN INVEST, V116, P101, DOI 10.1172/JCI25735; Dufner DA, 2005, AM J PHYSIOL-ENDOC M, V288, pE1277, DOI 10.1152/ajpendo.00580.2004; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Fumagalli S, 2000, COLD SPRING HARBOR M, V39, P695; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Inagaki T, 2005, CELL METAB, V2, P217, DOI 10.1016/j.cmet.2005.09.001; Krssak M, 2004, DIABETES, V53, P3048, DOI 10.2337/diabetes.53.12.3048; Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Lin BC, 2007, J BIOL CHEM, V282, P27277, DOI 10.1074/jbc.M704244200; Lundasen T, 2006, J INTERN MED, V260, P530, DOI 10.1111/j.1365-2796.2006.01731.x; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Rachdaoui N, 2009, MOL CELL PROTEOMICS, V8, P2653, DOI 10.1074/mcp.M900026-MCP200; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Taylor R, 1996, J CLIN INVEST, V97, P126, DOI 10.1172/JCI118379; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004	26	419	446	3	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2011	331	6024					1621	1624		10.1126/science.1198363	http://dx.doi.org/10.1126/science.1198363			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21436455	Green Accepted			2022-12-28	WOS:000288754500060
J	Waters, MR; Forman, SL; Jennings, TA; Nordt, LC; Driese, SG; Feinberg, JM; Keene, JL; Halligan, J; Lindquist, A; Pierson, J; Hallmark, CT; Collins, MB; Wiederhold, JE				Waters, Michael R.; Forman, Steven L.; Jennings, Thomas A.; Nordt, Lee C.; Driese, Steven G.; Feinberg, Joshua M.; Keene, Joshua L.; Halligan, Jessi; Lindquist, Anna; Pierson, James; Hallmark, Charles T.; Collins, Michael B.; Wiederhold, James E.			The Buttermilk Creek Complex and the Origins of Clovis at the Debra L. Friedkin Site, Texas	SCIENCE			English	Article							AMERICA; PROTOCOL; EDGE	Compelling archaeological evidence of an occupation older than Clovis (similar to 12.8 to 13.1 thousand years ago) in North America is present at only a few sites, and the stone tool assemblages from these sites are small and varied. The Debra L. Friedkin site, Texas, contains an assemblage of 15,528 artifacts that define the Buttermilk Creek Complex, which stratigraphically underlies a Clovis assemblage and dates between similar to 13.2 and 15.5 thousand years ago. The Buttermilk Creek Complex confirms the emerging view that people occupied the Americas before Clovis and provides a large artifact assemblage to explore Clovis origins.	[Waters, Michael R.; Jennings, Thomas A.; Keene, Joshua L.; Halligan, Jessi; Wiederhold, James E.] Texas A&M Univ, Dept Anthropol, Ctr Study Amer 1, College Stn, TX 77843 USA; [Waters, Michael R.] Texas A&M Univ, Dept Geog, Ctr Study Amer 1, College Stn, TX 77843 USA; [Forman, Steven L.; Pierson, James] Univ Illinois, Luminescence Dating Res Lab, Dept Earth & Environm Sci, Chicago, IL 60607 USA; [Nordt, Lee C.; Driese, Steven G.] Baylor Univ, Dept Geol, Waco, TX 76798 USA; [Feinberg, Joshua M.; Lindquist, Anna] Univ Minnesota, Dept Geol & Geophys, Inst Rock Magnetism, Minneapolis, MN 55455 USA; [Hallmark, Charles T.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Collins, Michael B.] Texas State Univ, Dept Anthropol, San Marcos, TX 78666 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Baylor University; University of Minnesota System; University of Minnesota Twin Cities; Texas A&M University System; Texas A&M University College Station; Texas State University System; Texas State University San Marcos	Waters, MR (corresponding author), Texas A&M Univ, Dept Anthropol, Ctr Study Amer 1, College Stn, TX 77843 USA.	mwaters@tamu.edu	Waters, Michael R/A-9430-2009; Forman, Steven/ABD-7720-2021; Waters, Michael/ABI-2377-2020	Waters, Michael/0000-0003-2660-3355; Forman, Steven/0000-0002-2080-7915; Halligan, Jessi/0000-0002-1971-9416; Feinberg, Joshua/0000-0002-5845-9848	North Star Archaeological Research Program; Center for the Study of the First Americans; Chair in First Americans Studies	North Star Archaeological Research Program; Center for the Study of the First Americans; Chair in First Americans Studies	We thank the North Star Archaeological Research Program established by J. Cramer and R. Cramer for funding the fieldwork from 2006-2009 and chronological and chemical analyses. Donations from M. Mullins, R. Wilson, R. Shlemon, B. Rotstan, R. Engle, E. Guerri, G. Moore, T. Cloninger, S. Kohntopp, M. Payn, J. Pytkowicz, and the Center for the Study of the First Americans membership and funding from the Chair in First Americans Studies supported the laboratory analyses. L. Pfeiffer and W. Wheless III helped to make the project a reality. D. and D. Friedkin allowed excavations on their property and generously supported our field logistics. M. Thompson, S. Woldhagen, R. Lansford, R. McCulloch, and M. Yalch provided help during the excavation. T. Goebel, K. Graf, S. Fiedel, and T. Stafford, and four anonymous individuals reviewed drafts of this paper.	Adovasio J., 2004, ENTERING AM NE ASIA, P139; [Anonymous], 2010, INT MONOGRAPHS PREHI; Bradley B, 2004, WORLD ARCHAEOL, V36, P459, DOI 10.1080/0043824042000303656; Collins MichaelB., 2008, CURR RES PLEISTOCENE, V25, P70; Dillehay TD, 1997, ARCHAEOLOGICAL CONTE, V2; ERLANDSON JM, 2008, ISLAND COASTAL ARCHA, V3, P277; Gilbert MTP, 2008, SCIENCE, V320, P786, DOI 10.1126/science.1154116; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Hedman B., 2010, RAVEN BLUFF SITE PRE; Jain M, 2003, RADIAT MEAS, V37, P67, DOI 10.1016/S1350-4487(02)00165-8; Joyce DJ, 2006, QUATERN INT, V142, P44, DOI 10.1016/j.quaint.2005.03.004; Lowery DL, 2010, QUATERNARY SCI REV, V29, P1472, DOI 10.1016/j.quascirev.2010.03.007; Maher BA, 2003, QUATERNARY SCI REV, V22, P445, DOI 10.1016/S0277-3791(02)00188-9; McAvoy Joseph M., 1997, RES REPORT SERIES VI, V8; Murray AS, 2003, RADIAT MEAS, V37, P377, DOI 10.1016/S1350-4487(03)00053-2; Singarayer JS, 2003, RADIAT MEAS, V37, P451, DOI 10.1016/S1350-4487(03)00062-3; Soil Survey Staff, 1999, USDA NRCS AGR HDB, V436; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Vidic NJ, 2004, PALAEOGEOGR PALAEOCL, V211, P271, DOI 10.1016/j.palaeo.2004.05.012; Waters MR, 2007, SCIENCE, V315, P1122, DOI 10.1126/science.1137166; WEBB SD, 2005, 1 FLORIDIANS LAST MA; Wilding L. P., 1988, SMSS Technical Monograph, Soil Management Support Services, USA, P55; Wood W.R., 1978, ADV ARCHAEOLOGICAL M, V1, P315, DOI [10.1016/B978-0-12-003101-6.50015-9, DOI 10.1016/B978-0-12-003101-6.50015-9]; Young C, 2007, CURR RES PLEISTOCENE, V24, P154	24	141	145	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 25	2011	331	6024					1599	1603		10.1126/science.1201855	http://dx.doi.org/10.1126/science.1201855			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21436451				2022-12-28	WOS:000288754500054
J	Iheanacho, I				Iheanacho, Ike			Drug Tales and Other Stories Prescription charges: a tax on the English	BRITISH MEDICAL JOURNAL			English	Editorial Material												iiheanacho@bmjgroup.com							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 23	2011	342								d1790	10.1136/bmj.d1790	http://dx.doi.org/10.1136/bmj.d1790			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	742MJ	21429994				2022-12-28	WOS:000288948000020
J	Ferrell, JE; Tsai, TYC; Yang, QO				Ferrell, James E., Jr.; Tsai, Tony Yu-Chen; Yang, Qiong			Modeling the Cell Cycle: Why Do Certain Circuits Oscillate?	CELL			English	Article							POSITIVE FEEDBACK; FISSION YEAST; MATHEMATICAL-MODEL; MITOTIC OSCILLATOR; DIVISION CYCLE; BUDDING YEAST; KAIC PHOSPHORYLATION; NEGATIVE FEEDBACK; RESTRICTION POINT; CIRCADIAN CLOCKS	Computational modeling and the theory of nonlinear dynamical systems allow one to not simply describe the events of the cell cycle, but also to understand why these events occur, just as the theory of gravitation allows one to understand why cannonballs fly in parabolic arcs. The simplest examples of the eukaryotic cell cycle operate like autonomous oscillators. Here, we present the basic theory of oscillatory biochemical circuits in the context of the Xenopus embryonic cell cycle. We examine Boolean models, delay differential equation models, and especially ordinary differential equation (ODE) models. For ODE models, we explore what it takes to get oscillations out of two simple types of circuits (negative feedback loops and coupled positive and negative feedback loops). Finally, we review the procedures of linear stability analysis, which allow one to determine whether a given ODE model and a particular set of kinetic parameters will produce oscillations.	[Ferrell, James E., Jr.; Tsai, Tony Yu-Chen; Yang, Qiong] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Ferrell, James E., Jr.; Tsai, Tony Yu-Chen] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA	Stanford University; Stanford University	Ferrell, JE (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	james.ferrell@stanford.edu	; Yang, Qiong/G-9630-2016	Tsai, Tony/0000-0003-1121-9406; Yang, Qiong/0000-0002-2442-2094	NIH [GM077544]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077544] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Markus Covert for the idea of starting this tutorial with a Boolean analysis instead of plunging right into ODEs and David Dill for helpful discussions. This work was supported by NIH GM077544.	Aguda BD, 1999, CELL PROLIFERAT, V32, P321, DOI 10.1046/j.1365-2184.1999.3250321.x; Alfieri R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S12-S16; Barberis M, 2007, PLOS COMPUT BIOL, V3, P649, DOI 10.1371/journal.pcbi.0030064; Borisuk MT, 1998, J THEOR BIOL, V195, P69, DOI 10.1006/jtbi.1998.0781; Braunewell S, 2007, J THEOR BIOL, V245, P638, DOI 10.1016/j.jtbi.2006.11.012; BUSENBERG S, 1994, J MATH BIOL, V32, P573, DOI 10.1007/BF00573462; Charvin G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000284; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Ciliberto A, 2003, J CELL BIOL, V163, P1243, DOI 10.1083/jcb.200306139; Coudreuse D, 2010, NATURE, V468, P1074, DOI 10.1038/nature09543; DASSO M, 1990, CELL, V61, P811, DOI 10.1016/0092-8674(90)90191-G; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Ferrell JE, 2001, CHAOS, V11, P227, DOI 10.1063/1.1349894; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Ge H, 2008, MATH BIOSCI, V211, P132, DOI 10.1016/j.mbs.2007.10.003; Gilbert D A, 1974, Curr Mod Biol, V5, P197; GLASS L, 1973, J THEOR BIOL, V39, P103, DOI 10.1016/0022-5193(73)90208-7; GOLDBETER A, 1991, P NATL ACAD SCI USA, V88, P9107, DOI 10.1073/pnas.88.20.9107; Goldbeter A, 2002, NATURE, V420, P238, DOI 10.1038/nature01259; Goldbeter A, 1996, EXPERIENTIA, V52, P212, DOI 10.1007/BF01920708; Haase SB, 1999, NATURE, V401, P394, DOI 10.1038/43930; HARA K, 1980, P NATL ACAD SCI-BIOL, V77, P462, DOI 10.1073/pnas.77.1.462; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Holt LJ, 2008, NATURE, V454, P353, DOI 10.1038/nature07050; KAUFFMAN S, 1975, J THEOR BIOL, V55, P47, DOI 10.1016/S0022-5193(75)80108-1; Li B, 2010, J THEOR BIOL, V264, P771, DOI 10.1016/j.jtbi.2010.03.023; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Mangla K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008906; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; Mura I, 2008, J THEOR BIOL, V254, P850, DOI 10.1016/j.jtbi.2008.07.019; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; MURRAY AW, 1989, SCIENCE, V246, P614, DOI 10.1126/science.2683077; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; NOREL R, 1991, SCIENCE, V251, P1076, DOI 10.1126/science.1825521; NOVAK B, 1993, J THEOR BIOL, V165, P101, DOI 10.1006/jtbi.1993.1179; NOVAK B, 1993, J CELL SCI, V106, P1153; Novak B, 1998, BIOPHYS CHEM, V72, P185, DOI 10.1016/S0301-4622(98)00133-1; Novak B, 1997, P NATL ACAD SCI USA, V94, P9147, DOI 10.1073/pnas.94.17.9147; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; OBEYESEKERE MN, 1992, BIOCHEM BIOPH RES CO, V184, P782, DOI 10.1016/0006-291X(92)90658-8; Okabe Y, 2007, BIOPHYS J, V93, P3451, DOI 10.1529/biophysj.107.109991; Orlando DA, 2008, NATURE, V453, P944, DOI 10.1038/nature06955; Pomerening JR, 2008, MOL BIOL CELL, V19, P3426, DOI 10.1091/mbc.E08-02-0172; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; RUSSELL P, 1986, CELL, V45, P145, DOI 10.1016/0092-8674(86)90546-5; RUSSELL P, 1987, CELL, V49, P559, DOI 10.1016/0092-8674(87)90458-2; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; Sel'kov E E, 1970, Biofizika, V15, P1065; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Skotheim JM, 2008, NATURE, V454, P291, DOI 10.1038/nature07118; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Srividhya J, 2006, J THEOR BIOL, V241, P617, DOI 10.1016/j.jtbi.2005.12.020; Steuer R, 2004, J THEOR BIOL, V228, P293, DOI 10.1016/j.jtbi.2004.01.012; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; TYSON J, 1975, J MATH BIOL, V1, P289, DOI 10.1007/BF00279848; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; TYSON JJ, 1991, P NATL ACAD SCI USA, V88, P7328, DOI 10.1073/pnas.88.16.7328; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Zhang YP, 2006, PHYSICA D, V219, P35, DOI 10.1016/j.physd.2006.05.009; Zwicker D, 2010, P NATL ACAD SCI USA, V107, P22540, DOI 10.1073/pnas.1007613107	69	221	222	2	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 18	2011	144	6					874	885		10.1016/j.cell.2011.03.006	http://dx.doi.org/10.1016/j.cell.2011.03.006			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	737BQ	21414480	Bronze			2022-12-28	WOS:000288543500007
J	Wanten, G; Calder, PC; Forbes, A				Wanten, Geert; Calder, Philip C.; Forbes, Alastair			Managing adult patients who need home parenteral nutrition	BRITISH MEDICAL JOURNAL			English	Review							SHORT-BOWEL SYNDROME; INTESTINAL FAILURE; MULTICENTER SURVEY; LIVER-DISEASE; TRANSPLANTATION; EUROPE; HYPERMANGANESEMIA; INFECTIONS; PREVALENCE; SEPSIS		[Wanten, Geert] Nutr Support Team, Osaka, Japan		Wanten, G (corresponding author), Nutr Support Team, Osaka, Japan.	g.wanten@mdl.umcn.nl	Wanten, G.J.A./L-4742-2015; Calder, Philip C/E-9739-2013	Calder, Philip C/0000-0002-6038-710X	Baxter Healthcare; Geistlich Pharma	Baxter Healthcare; Geistlich Pharma	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; GW has received speaking fees from Fresenius Kabi, B Braun, Baxter Healthcare, and Geistlich Pharma and is a consultant to Nycomed and Baxter Healthcare; PCC has received speaking honorariums from Fresenius Kabi, B Braun, Baxter Healthcare, Abbott Nutrition, and Nestle and is a consultant to Danone; AF has received speaking honorariums from all these nutrition companies, performed consultative work for Baxter Healthcare and B Braun, and received support from the UK NIHR through its support of the Comprehensive Biomedical Research Centre at University College London; no other relationships or activities that could appear to have influenced the submitted work.	Acca M, 2007, J Endocrinol Invest, V30, P54; Bisseling TM, 2010, CLIN NUTR, V29, P464, DOI 10.1016/j.clnu.2009.12.005; Bozzetti F, 2002, CLIN NUTR, V21, P475, DOI 10.1054/clnu.2002.0578; Bozzetti F, 2009, CLIN NUTR, V28, P359, DOI 10.1016/j.clnu.2009.05.010; Buchman AL, 2003, GASTROENTEROLOGY, V124, P1111, DOI 10.1053/gast.2003.50139; Calder PC, 2010, P NUTR SOC, V69, P565, DOI 10.1017/S0029665110000157; Cauley JA, 2010, J BONE MINER RES; Cavicchi M, 2000, ANN INTERN MED, V132, P525, DOI 10.7326/0003-4819-132-7-200004040-00003; Clare A, 2008, CLIN NUTR, V27, P552, DOI 10.1016/j.clnu.2008.04.013; Crenn P, 2008, CLIN NUTR, V27, P328, DOI 10.1016/j.clnu.2008.02.005; Fishbein TM, 2009, NEW ENGL J MED, V361, P998, DOI 10.1056/NEJMra0804605; Huisman-de Waal G, 2007, CLIN NUTR, V26, P275, DOI 10.1016/j.clnu.2006.10.002; Jeppesen PB, 1999, GUT, V44, P844, DOI 10.1136/gut.44.6.844; Lal S, 2006, ALIMENT PHARM THER, V24, P19, DOI 10.1111/j.1365-2036.2006.02941.x; Messing B, 1999, GASTROENTEROLOGY, V117, P1043, DOI 10.1016/S0016-5085(99)70388-4; O'Keefe SJD, 2006, CLIN GASTROENTEROL H, V4, P6, DOI 10.1016/j.cgh.2005.10.002; OKEEFE SJD, 1994, JPEN-PARENTER ENTER, V18, P256, DOI 10.1177/0148607194018003256; Pironi L, 2002, CLIN NUTR, V21, P289, DOI 10.1054/clnu.2002.0548; Pironi L, 2006, AM J GASTROENTEROL, V101, P1633, DOI 10.1111/j.1572-0241.2006.00710.x; Pittiruti M, 2009, CLIN NUTR, V28, P365, DOI 10.1016/j.clnu.2009.03.015; Reimund JM, 2000, CLIN NUTR, V19, P343, DOI 10.1054/clnu.2000.0120; Santarpia L, 2010, JPEN-PARENTER ENTER, V34, P254, DOI 10.1177/0148607110362900; Staun M, 2009, CLIN NUTR, V28, P467, DOI 10.1016/j.clnu.2009.04.001; Thomas-Gibson S, 2004, CLIN NUTR, V23, P697, DOI 10.1016/j.clnu.2003.11.007; Ugur A, 2006, SCAND J GASTROENTERO, V41, P401, DOI 10.1080/00365520500441247; Van Gossum A, 1999, CLIN NUTR, V18, P135, DOI 10.1016/S0261-5614(99)80002-8; VanGossum A, 1996, CLIN NUTR, V15, P53, DOI 10.1016/S0261-5614(96)80019-7; Versleijen MWJ, 2009, GASTROENTEROLOGY, V136, P1577, DOI 10.1053/j.gastro.2009.02.005; Hernandez MV, 2010, AM J MED SCI, V339, P225, DOI 10.1097/MAJ.0b013e3181c7c89c; Wallis K, 2009, CURR OPIN CLIN NUTR, V12, P526, DOI 10.1097/MCO.0b013e32832d23cd; Wardle CA, 1999, JPEN-PARENTER ENTER, V23, P350, DOI 10.1177/0148607199023006350; Wengler A, 2006, CLIN NUTR, V25, P693, DOI 10.1016/j.clnu.2006.01.026	32	37	37	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 18	2011	342								d1447	10.1136/bmj.d1447	http://dx.doi.org/10.1136/bmj.d1447			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739FR	21421667				2022-12-28	WOS:000288700400003
J	Struijs, JN; Baan, CA				Struijs, Jeroen N.; Baan, Caroline A.			Integrating Care through Bundled Payments - Lessons from the Netherlands	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Struijs, Jeroen N.; Baan, Caroline A.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment	Struijs, JN (corresponding author), Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands.		Struijs, Jeroen/AAX-6827-2020; Struijs, Jeroen/AAA-8057-2022; Struijs, Jeroen/AAQ-9872-2020	Struijs, Jeroen/0000-0002-7493-6720; 				COORDINATINGCAR.BT, 2008, NEW ENGL J MED, V358, P1064; de Brantes F, 2009, NEW ENGL J MED, V361, P1033, DOI 10.1056/NEJMp0906121; Devers K, 2009, CAN ACCOUNTABLE CARE; Luft HS, 2010, NEW ENGL J MED, V363, P1389, DOI 10.1056/NEJMp1009380; STRUIJS JN, 2010, EXPT BUNDLED PAYMENT	5	104	104	2	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2011	364	11					990	991		10.1056/NEJMp1011849	http://dx.doi.org/10.1056/NEJMp1011849			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	735SX	21410368				2022-12-28	WOS:000288439000003
J	Wennberg, JE				Wennberg, John E.			Time to tackle unwarranted variations in practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SMALL-AREA VARIATIONS					john.wennberg@dartmouth.edu						Baicker K, 2004, HEALTH AFFAIR, V23, pVAR33, DOI 10.1377/hlthaff.var.33; Baicker K, 2004, HEALTH AFFAIR, V23, pW4184, DOI 10.1377/hlthaff.W4.184; Busato A, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-8; Department of Health, 2010, EQ EXC LIB NHS; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2004, HEALTH AFFAIR, V23, pVAR19, DOI 10.1377/hlthaff.var.19; Glover JA, 2008, INT J EPIDEMIOL, V37, P9, DOI 10.1093/ije/dym258; Hawker GA, 2001, MED CARE, V39, P206, DOI 10.1097/00005650-200103000-00002; MCPHERSON K, 1982, NEW ENGL J MED, V307, P1310, DOI 10.1056/NEJM198211183072104; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; PAULSHAHEEN P, 1987, J HEALTH POLIT POLIC, V12, P741, DOI 10.1215/03616878-12-4-741; QIPP/ Right Care, 2010, NHS ATL VAR HEALTHC; Salzburg Global Seminar, 2011, BMJ-BRIT MED J, V342, pd1745; Swart E, 2008, BUNDESGESUNDHEITSBLA, V51, P1183, DOI 10.1007/s00103-008-0653-z; WENNBERG J, 1973, SCIENCE, V182, P1102, DOI 10.1126/science.182.4117.1102; Wennberg JE, TRACKING CARE PATIEN; Wennberg JE, 2010, TRACKING MED RES QUE, P185; Wennberg JE, 2010, TRACKING MED RES QUE; Wennberg John E, 2002, Health Aff (Millwood), VSuppl Web Exclusives, pW96	19	180	180	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2011	342								d1513	10.1136/bmj.d1513	http://dx.doi.org/10.1136/bmj.d1513			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	739FQ	21415111				2022-12-28	WOS:000288700200011
J	Markham, KB; O'Shaughnessy, RW				Markham, Kara B.; O'Shaughnessy, Richard W.			Placental vasa previa	LANCET			English	Editorial Material									[Markham, Kara B.; O'Shaughnessy, Richard W.] Ohio State Univ, Columbus, OH 43210 USA	Ohio State University	Markham, KB (corresponding author), Ohio State Univ, 395 W 12th Ave,5th Floor, Columbus, OH 43210 USA.	kara.markham@osumc.edu	Markham, Kara/F-1084-2015						0	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2011	377	9771					1102	1102		10.1016/S0140-6736(10)60897-5	http://dx.doi.org/10.1016/S0140-6736(10)60897-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	743QY	21440807				2022-12-28	WOS:000289035000031
J	Heuser, RG; Osborne, M; Hall, J				Heuser, Rose G.; Osborne, Molly L.; Hall, Jesse			Update in Pulmonary and Critical Care Medicine: Evidence Published in 2010	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							DISEASE; RISK	This Update summarizes studies published in 2010 that the authors consider highly relevant to the practice of pulmonary and critical care medicine. Topics include anticholinergic therapy in asthma, identification of patients with chronic obstructive pulmonary disease who are at risk for exacerbations, pulmonary vasodilator therapy in idiopathic pulmonary fibrosis, tuberculosis testing, tyrosine kinase inhibitors in non-small cell lung cancer, early palliative care and cancer survival, outcomes of critical illness, sedatives and neuromuscular blockade in critically ill patients, interventions and monitoring in patients with shock, and management of acute hypoxemic respiratory failure.	Oregon Hlth & Sci Univ, Dept Med, Pulm & Crit Care, Portland, OR 97239 USA; Univ Chicago Hosp & Clin, Sect Pulm & Crit Care Med, Chicago, IL 60637 USA	Oregon Health & Science University; University of Chicago; University of Illinois System	Osborne, M (corresponding author), Oregon Hlth & Sci Univ, Dept Med, Pulm & Crit Care, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.							Au DH, 2009, J GEN INTERN MED, V24, P457, DOI 10.1007/s11606-009-0907-y; Collard HR, 2007, CHEST, V131, P897, DOI 10.1378/chest.06-2101; Seemungal TAR, 1998, AM J RESP CRIT CARE, V157, P1418, DOI 10.1164/ajrccm.157.5.9709032; Singh S, 2008, JAMA-J AM MED ASSOC, V300, P1439, DOI 10.1001/jama.300.12.1439; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800	5	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 3	2011	154	9					614	621		10.7326/0003-4819-154-9-201105030-00339	http://dx.doi.org/10.7326/0003-4819-154-9-201105030-00339			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	757UD	21464338				2022-12-28	WOS:000290112300014
J	Sahay, A; Scobie, KN; Hill, AS; O'Carroll, CM; Kheirbek, MA; Burghardt, NS; Fenton, AA; Dranovsky, A; Hen, R				Sahay, Amar; Scobie, Kimberly N.; Hill, Alexis S.; O'Carroll, Colin M.; Kheirbek, Mazen A.; Burghardt, Nesha S.; Fenton, Andre A.; Dranovsky, Alex; Hen, Rene			Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation	NATURE			English	Article							DENTATE GYRUS; SYNAPTIC PLASTICITY; FLUOXETINE; MATURATION; NEURONS; BRAIN; DEPRESSION; DISORDER; MODELS; MEMORY	Adult hippocampal neurogenesis is a unique form of neural circuit plasticity that results in the generation of new neurons in the dentate gyrus throughout life(1,2). Neurons that arise in adults (adult-born neurons) show heightened synaptic plasticity during their maturation(3) and can account for up to ten per cent of the entire granule cell population(4). Moreover, levels of adult hippocampal neurogenesis are increased by interventions that are associated with beneficial effects on cognition and mood, such as learning(5), environmental enrichment(6), exercise(6) and chronic treatment with antidepressants(7-10). Together, these properties of adult neurogenesis indicate that this process could be harnessed to improve hippocampal functions. However, despite a substantial number of studies demonstrating that adult-born neurons are necessary for mediating specific cognitive functions(11), as well as some of the behavioural effects of antidepressants(8-10,12,13), it is unknown whether an increase in adult hippocampal neurogenesis is sufficient to improve cognition and mood. Here we show that inducible genetic expansion of the population of adult-born neurons through enhancing their survival improves performance in a specific cognitive task in which two similar contexts need to be distinguished. Mice with increased adult hippocampal neurogenesis show normal object recognition, spatial learning, contextual fear conditioning and extinction learning but are more efficient in differentiating between overlapping contextual representations, which is indicative of enhanced pattern separation. Furthermore, stimulation of adult hippocampal neurogenesis, when combined with an intervention such as voluntary exercise, produces a robust increase in exploratory behaviour. However, increasing adult hippocampal neurogenesis alone does not produce a behavioural response like that induced by anxiolytic agents or antidepressants. Together, our findings suggest that strategies that are designed to increase adult hippocampal neurogenesis specifically, by targeting the cell death of adult-born neurons or by other mechanisms, may have therapeutic potential for reversing impairments in pattern separation and dentate gyrus dysfunction such as those seen during normal ageing(14,15).	[Sahay, Amar; Scobie, Kimberly N.; Hill, Alexis S.; O'Carroll, Colin M.; Kheirbek, Mazen A.; Burghardt, Nesha S.; Dranovsky, Alex; Hen, Rene] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Sahay, Amar; Scobie, Kimberly N.; Hill, Alexis S.; O'Carroll, Colin M.; Kheirbek, Mazen A.; Burghardt, Nesha S.; Dranovsky, Alex; Hen, Rene] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Sahay, Amar; Scobie, Kimberly N.; Hill, Alexis S.; O'Carroll, Colin M.; Kheirbek, Mazen A.; Burghardt, Nesha S.; Dranovsky, Alex; Hen, Rene] New York State Psychiat Inst & Hosp, Div Integrat Neurosci, New York, NY 10032 USA; [Fenton, Andre A.] SUNY, Downstate Med Ctr, Robert F Furchgott Ctr Neural & Behav Sci, Dept Physiol, Brooklyn, NY 11203 USA; [Fenton, Andre A.] SUNY, Downstate Med Ctr, Dept Pharmacol & Neurol, Brooklyn, NY 11203 USA; [Hen, Rene] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA	Columbia University; Columbia University; New York State Psychiatry Institute; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; SUNY Maritime College; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; SUNY Maritime College; Columbia University	Sahay, A (corresponding author), Columbia Univ, Dept Neurosci, New York, NY 10032 USA.	as2619@columbia.edu; rh95@columbia.edu	Kheirbek, Mazen A/J-3656-2015; Dranovsky, Alex/P-4357-2018; Sahay, Amar/J-3696-2014	Kheirbek, Mazen A/0000-0001-9157-7363; Dranovsky, Alex/0000-0001-7896-3243; Fenton, Andre/0000-0002-5063-1156	National Institute of Mental Health [1K99MH86615-01]; National Alliance for Research on Schizophrenia and Depression (NARSAD); Sackler Institute of Columbia University; Ruth L. Kirschstein National Research Service Award [F31]; New York Stem Cell Initiative (NYSTEM); National Institutes of Health [R01 MH068542]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091844, R01MH068542, K99MH086615, K08MH079088] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Alliance for Research on Schizophrenia and Depression (NARSAD)(French National Research Agency (ANR)NARSAD); Sackler Institute of Columbia University; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Initiative (NYSTEM); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J. Gordon, S. Fusi, C. Kellendonk, H. Scharfman and members of the Hen laboratory for comments on the manuscript and discussions about the project. We thank E. Pavlopoulos for consultation on spatial learning, and M. Drew and C. A. Denny for input on the novel object recognition test. A. S. was supported by a 2009 National Institute of Mental Health Grant (1K99MH86615-01), 2006 and 2008 National Alliance for Research on Schizophrenia and Depression (NARSAD) Young Investigator Awards, and a 2008 Sackler Institute of Columbia University Award. K.N.S. was supported by a Ruth L. Kirschstein National Research Service Award for Individual Predoctoral Fellows (F31). R. H. was supported by grants from NARSAD, the New York Stem Cell Initiative (NYSTEM) and the National Institutes of Health (R01 MH068542).	ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Bessa JM, 2009, MOL PSYCHIATR, V14, P764, DOI 10.1038/mp.2008.119; Chen ACH, 2001, BIOL PSYCHIAT, V49, P753, DOI 10.1016/S0006-3223(00)01114-8; Cimadevilla JM, 2001, P NATL ACAD SCI USA, V98, P3531, DOI 10.1073/pnas.051628398; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Lever C, 2006, REV NEUROSCIENCE, V17, P111; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Lissek S, 2010, AM J PSYCHIAT, V167, P47, DOI 10.1176/appi.ajp.2009.09030410; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Nicholls RE, 2008, NEURON, V58, P104, DOI 10.1016/j.neuron.2008.01.039; Peri T, 2000, BIOL PSYCHIAT, V47, P512, DOI 10.1016/S0006-3223(99)00144-4; Saab BJ, 2009, NEURON, V63, P643, DOI 10.1016/j.neuron.2009.08.014; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Schmidt HD, 2007, BEHAV PHARMACOL, V18, P391, DOI 10.1097/FBP.0b013e3282ee2aa8; Scobie KN, 2009, J NEUROSCI, V29, P9875, DOI 10.1523/JNEUROSCI.2260-09.2009; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Small SA, 2004, P NATL ACAD SCI USA, V101, P7181, DOI 10.1073/pnas.0400285101; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sun W, 2004, J NEUROSCI, V24, P11205, DOI 10.1523/JNEUROSCI.1436-04.2004; Takeuchi O, 2005, P NATL ACAD SCI USA, V102, P11272, DOI 10.1073/pnas.0504783102; Treves A, 2008, NEUROSCIENCE, V154, P1155, DOI 10.1016/j.neuroscience.2008.04.073; TRONEL S, 2010, HIPPOCAMPUS     1103, DOI DOI 10.1002/HIPO.20895; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Wang JW, 2008, J NEUROSCI, V28, P1374, DOI 10.1523/JNEUROSCI.3632-07.2008; YASSA M, 2010, HIPPOCAMPUS     0520, DOI DOI 10.1002/HIPO.20808; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	36	1030	1062	12	253	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 28	2011	472	7344					466	U539		10.1038/nature09817	http://dx.doi.org/10.1038/nature09817			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	755QC	21460835	Green Accepted, Green Submitted			2022-12-28	WOS:000289949600033
J	Jiggins, FM; Hurst, GDD				Jiggins, Francis M.; Hurst, Gregory D. D.			Rapid Insect Evolution by Symbiont Transfer	SCIENCE			English	Editorial Material							BEMISIA-TABACI; SPREAD; WOLBACHIA; VIRUS		[Jiggins, Francis M.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Hurst, Gregory D. D.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England	University of Cambridge; University of Liverpool	Jiggins, FM (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.	fmj1001@cam.ac.uk2	Hurst, Gregory D D/C-2723-2008	Hurst, Gregory D D/0000-0002-7163-7784; Jiggins, Francis Michael/0000-0001-7470-8157	NERC [NE/E010040/1, NE/E003109/1] Funding Source: UKRI; Natural Environment Research Council [NE/E003109/1, NE/E010040/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Engelstadter J, 2009, ANNU REV ECOL EVOL S, V40, P127, DOI 10.1146/annurev.ecolsys.110308.120206; Gottlieb Y, 2010, J VIROL, V84, P9310, DOI 10.1128/JVI.00423-10; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Jaenike J, 2010, SCIENCE, V329, P212, DOI 10.1126/science.1188235; MORAN NA, 1993, P ROY SOC B-BIOL SCI, V253, P167, DOI 10.1098/rspb.1993.0098; Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Tsuchida T, 2004, SCIENCE, V303, P1989, DOI 10.1126/science.1094611; TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0	13	45	47	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2011	332	6026					185	186		10.1126/science.1205386	http://dx.doi.org/10.1126/science.1205386			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474745	Green Published			2022-12-28	WOS:000289251100034
J	Stapel, DA; Lindenberg, S				Stapel, Diederik A.; Lindenberg, Siegwart			Coping with Chaos: How Disordered Contexts Promote Stereotyping and Discrimination	SCIENCE			English	Article							PEOPLE STEREOTYPE; ACTIVATION; PREJUDICE; GOALS; BEHAVIOR; LIFE; SELF	Being the victim of discrimination can have serious negative health-and quality-of-life-related consequences. Yet, could being discriminated against depend on such seemingly trivial matters as garbage on the streets? In this study, we show, in two field experiments, that disordered contexts (such as litter or a broken-up sidewalk and an abandoned bicycle) indeed promote stereotyping and discrimination in real-world situations and, in three lab experiments, that it is a heightened need for structure that mediates these effects (number of subjects: between 40 and 70 per experiment). These findings considerably advance our knowledge of the impact of the physical environment on stereotyping and discrimination and have clear policy implications: Diagnose environmental disorder early and intervene immediately.	[Stapel, Diederik A.; Lindenberg, Siegwart] Tilburg Univ, Tilburg Inst Behav Econ Res, NL-5000 LE Tilburg, Netherlands; [Lindenberg, Siegwart] Univ Groningen, Fac Behav & Social Sci, Interuniv Ctr Social Sci Theory & Methodol, NL-9712 TG Groningen, Netherlands	Tilburg University; University of Groningen	Stapel, DA (corresponding author), Tilburg Univ, Tilburg Inst Behav Econ Res, POB 90153, NL-5000 LE Tilburg, Netherlands.	d.a.stapel@uvt.nl; s.m.lindenberg@rug.nl	Lindenberg, Siegwart/E-2932-2013	Lindenberg, Siegwart/0000-0003-0053-3651				Bargh JA, 1996, J PERS SOC PSYCHOL, V71, P230, DOI 10.1037/0022-3514.71.2.230; Benner AD, 2009, DEV PSYCHOL, V45, P1682, DOI 10.1037/a0016119; Fein S, 1997, J PERS SOC PSYCHOL, V73, P31, DOI 10.1037/0022-3514.73.1.31; Fiske ST., 2004, SOCIAL BEINGS CORE M; Gee GC, 2010, AM J PUBLIC HEALTH, V100, P888, DOI 10.2105/AJPH.2009.178012; GILBERT DT, 1991, J PERS SOC PSYCHOL, V60, P509, DOI 10.1037/0022-3514.60.4.509; Hagendoorn L, 1995, EUR REV SOC PSYCHOL, V6, P199, DOI [10.1080/14792779443000058, DOI 10.1080/14792779443000058]; Judd CM, 2004, J EXP SOC PSYCHOL, V40, P75, DOI 10.1016/S0022-1031(03)00063-5; Keizer K, 2008, SCIENCE, V322, P1681, DOI 10.1126/science.1161405; Kruglanski Arie W., 2004, PSYCHOL CLOSED MINDE; Kunda Z, 2003, PSYCHOL BULL, V129, P522, DOI 10.1037/0033-2909.129.4.522; Lindenberg S, 2007, J SOC ISSUES, V63, P117, DOI 10.1111/j.1540-4560.2007.00499.x; Noordewier MK, 2010, PERS SOC PSYCHOL B, V36, P642, DOI 10.1177/0146167209357746; Pendry LF, 1996, PERS SOC PSYCHOL B, V22, P249, DOI 10.1177/0146167296223003; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Renkema LJ, 2008, PERS SOC PSYCHOL B, V34, P553, DOI 10.1177/0146167207312465; Ruys KI, 2008, PSYCHOL SCI, V19, P385, DOI 10.1111/j.1467-9280.2008.02097.x; Schneider David J., 2005, PSYCHOL STEREOTYPING; Stapel DA, 2001, PERS SOC PSYCHOL B, V27, P915, DOI 10.1177/0146167201278001; Stapel DA, 2009, PSYCHOL INQ, V20, P245, DOI 10.1080/10478400903448516; Thompson Megan M., 1989, ANN M CAN PSYCH ASS; van den Bos A, 2009, PERS SOC PSYCHOL B, V35, P101, DOI 10.1177/0146167208325773; Wheeler ME, 2005, PSYCHOL SCI, V16, P56, DOI 10.1111/j.0956-7976.2005.00780.x	23	25	26	3	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					251	253		10.1126/science.1201068	http://dx.doi.org/10.1126/science.1201068			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	746MM	21474762				2022-12-28	WOS:000289251100056
J	Wang, KC; Yang, YW; Liu, B; Sanyal, A; Corces-Zimmerman, R; Chen, Y; Lajoie, BR; Protacio, A; Flynn, RA; Gupta, RA; Wysocka, J; Lei, M; Dekker, J; Helms, JA; Chang, HY				Wang, Kevin C.; Yang, Yul W.; Liu, Bo; Sanyal, Amartya; Corces-Zimmerman, Ryan; Chen, Yong; Lajoie, Bryan R.; Protacio, Angeline; Flynn, Ryan A.; Gupta, Rajnish A.; Wysocka, Joanna; Lei, Ming; Dekker, Job; Helms, Jill A.; Chang, Howard Y.			A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression	NATURE			English	Article							ANATOMIC DEMARCATION; HISTONE H3; TRANSCRIPTION; ELEMENTS; METHYLATION; DIVERSITY; GENOME; 5C	The genome is extensively transcribed into long intergenic noncoding RNAs (lincRNAs), many of which are implicated in gene silencing(1,2). Potential roles of lincRNAs in gene activation are much less understood(3-5). Development and homeostasis require coordinate regulation of neighbouring genes through a process termed locus control(6). Some locus control elements and enhancers transcribe lincRNAs(7-10), hinting at possible roles in long-range control. In vertebrates, 39 Hox genes, encoding homeodomain transcription factors critical for positional identity, are clustered in four chromosomal loci; the Hox genes are expressed in nested anterior-posterior and proximal-distal patterns colinear with their genomic position from 3' to 5' of the cluster(11). Here we identify HOTTIP, a lincRNA transcribed from the 5' tip of the HOXA locus that coordinates the activation of several 5' HOXA genes in vivo. Chromosomal looping brings HOTTIP into close proximity to its target genes. HOTTIP RNA binds the adaptor protein WDR5 directly and targets WDR5/MLL complexes across HOXA, driving histone H3 lysine 4 trimethylation and gene transcription. Induced proximity is necessary and sufficient for HOTTIP RNA activation of its target genes. Thus, by serving as key intermediates that transmit information from higher order chromosomal looping into chromatin modifications, lincRNAs may organize chromatin domains to coordinate long-range gene activation.	[Wang, Kevin C.; Yang, Yul W.; Corces-Zimmerman, Ryan; Protacio, Angeline; Flynn, Ryan A.; Gupta, Rajnish A.; Chang, Howard Y.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Program Epithelial Biol, Stanford, CA 94305 USA; [Wang, Kevin C.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94115 USA; [Liu, Bo; Helms, Jill A.] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA; [Sanyal, Amartya; Lajoie, Bryan R.; Dekker, Job] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Program Gene Funct & Express, Worcester, MA 01605 USA; [Chen, Yong; Lei, Ming] Univ Michigan, Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Wysocka, Joanna] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; University of California System; University of California San Francisco; Stanford University; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Stanford University	Chang, HY (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Program Epithelial Biol, Stanford, CA 94305 USA.	howchang@stanford.edu	SANYAL, AMARTYA/D-7240-2015; Jha, Rajneesh/L-5606-2017; Chen, Yong/AAF-9915-2020; Corces, M. Ryan/ABG-6947-2020	SANYAL, AMARTYA/0000-0002-2109-4478; Chen, Yong/0000-0001-5857-6086; Corces, M. Ryan/0000-0001-7465-7652; Helms, Jill/0000-0002-0463-396X; Wang, Kevin/0000-0002-5305-6791; Flynn, Ryan/0000-0001-5013-0442	California Institute for Regenerative Medicine; National Institutes of Health [HG003143]; Scleroderma Research Foundation; Dermatology Foundation; W. M. Keck Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scleroderma Research Foundation; Dermatology Foundation; W. M. Keck Foundation(W.M. Keck Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank C. Tabin for chick Hox gene probes, M. Scott and members of our labs for input, and M. Lin for use of the confocal microscope and imaging expertise. Supported by grants from the California Institute for Regenerative Medicine (H.Y.C., J.W.), the National Institutes of Health (HG003143 to J.D.), and the Scleroderma Research Foundation (H.Y.C.). K.C.W. is a recipient of a Dermatology Foundation Career Development Award. J.D. is a recipient of the W. M. Keck Foundation Distinguished Young Scholar Award. H.Y.C. and M.L. are Early Career Scientists of the Howard Hughes Medical Institute.	Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; Baron-Benhamou Julie, 2004, Methods Mol Biol, V257, P135, DOI 10.1385/1-59259-750-5:135; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Chang HY, 2009, SCIENCE, V326, P1206, DOI 10.1126/science.1175686; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; DAVIS AP, 1995, NATURE, V375, P791, DOI 10.1038/375791a0; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Dean A, 2006, TRENDS GENET, V22, P38, DOI 10.1016/j.tig.2005.11.001; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Dostie J, 2007, NAT PROTOC, V2, P988, DOI 10.1038/nprot.2007.116; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Harpavat S, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-2; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kmita M, 2005, NATURE, V435, P1113, DOI 10.1038/nature03648; Kmita M, 2002, NATURE, V420, P145, DOI 10.1038/nature01189; Krajewski WA, 2005, MOL CELL BIOL, V25, P1891, DOI 10.1128/MCB.25.5.1891-1899.2005; Lajoie BR, 2009, NAT METHODS, V6, P690, DOI 10.1038/nmeth1009-690; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Michlewski G, 2010, RNA, V16, P1673, DOI 10.1261/rna.2136010; Nelson CE, 1996, DEVELOPMENT, V122, P1449; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Petruk S, 2006, CELL, V127, P1209, DOI 10.1016/j.cell.2006.10.039; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rinn JL, 2008, J INVEST DERMATOL, V128, P776, DOI 10.1038/sj.jid.5700986; Rinn JL, 2008, GENE DEV, V22, P303, DOI 10.1101/gad.1610508; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sanchez-Elsner T, 2006, SCIENCE, V311, P1118, DOI 10.1126/science.1117705; Sasaki YTF, 2007, BIOCHEM BIOPH RES CO, V357, P724, DOI 10.1016/j.bbrc.2007.03.200; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; SMALL KM, 1993, GENE DEV, V7, P2318, DOI 10.1101/gad.7.12a.2318; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Zhang XQ, 2009, BLOOD, V113, P2526, DOI 10.1182/blood-2008-06-162164	45	1462	1541	3	249	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2011	472	7341					120	U158		10.1038/nature09819	http://dx.doi.org/10.1038/nature09819			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21423168	Green Accepted			2022-12-28	WOS:000289199400049
J	Edlich, F; Banerjee, S; Suzuki, M; Cleland, MM; Arnoult, D; Wang, CX; Neutzner, A; Tjandra, N; Youle, RJ				Edlich, Frank; Banerjee, Soojay; Suzuki, Motoshi; Cleland, Megan M.; Arnoult, Damien; Wang, Chunxin; Neutzner, Albert; Tjandra, Nico; Youle, Richard J.			Bcl-x(L) Retrotranslocates Bax from the Mitochondria into the Cytosol	CELL			English	Article							PROSURVIVAL BCL-2 PROTEINS; CELL-DEATH; MEMBRANE PERMEABILIZATION; CYTOCHROME-C; APOPTOTIC FUNCTION; BH3-ONLY PROTEINS; PROAPOPTOTIC BAX; DISULFIDE BONDS; BH3 DOMAINS; FAMILY	The Bcl-2 family member Bax translocates from the cytosol to mitochondria, where it oligomerizes and permeabilizes the mitochondrial outer membrane to promote apoptosis. Bax activity is counteracted by prosurvival Bcl-2 proteins, but how they inhibit Bax remains controversial because they neither colocalize nor form stable complexes with Bax. We constrained Bax in its native cytosolic conformation within cells using intramolecular disulfide tethers. Bax tethers disrupt interaction with Bcl-x(L) in detergents and cell-free MOMP activity but unexpectedly induce Bax accumulation on mitochondria. Fluorescence loss in photobleaching (FLIP) reveals constant retrotranslocation of WT Bax, but not tethered Bax, from the mitochondria into the cytoplasm of healthy cells. Bax retrotranslocation depends on prosurvival Bcl-2 family proteins, and inhibition of retrotranslocation correlates with Bax accumulation on the mitochondria. We propose that Bcl-x(L) inhibits and maintains Bax in the cytosol by constant retrotranslocation of mitochondrial Bax.	[Edlich, Frank; Banerjee, Soojay; Cleland, Megan M.; Wang, Chunxin; Youle, Richard J.] NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA; [Suzuki, Motoshi; Tjandra, Nico] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Neutzner, Albert] Univ Spital Basel, Augenklin, CH-4031 Basel, Switzerland; [Arnoult, Damien] Hop Paul Brousse, INSERM, U1014, F-94807 Villejuif, France	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Basel; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Youle, RJ (corresponding author), NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA.	youle@helix.nih.gov	Neutzner, Albert/ABC-4368-2020; Wang, Chunxin/B-9312-2016; Arnoult, Damien/R-2032-2018	Wang, Chunxin/0000-0001-6015-6806; Neutzner, Albert/0000-0001-9254-5558; Suzuki, Motoshi/0000-0002-4346-7677; Harwig, Megan/0000-0003-2140-5739	Leopoldina, National Academy of Sciences, Germany; La Ligue contre le Cancer; NHLBI; NINDS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002859] Funding Source: NIH RePORTER	Leopoldina, National Academy of Sciences, Germany; La Ligue contre le Cancer(Ligue nationale contre le cancer); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. D. W. Andrews and Dr. J.-C. Martinou for helpful discussions and comments. We also thank Dr. D. R. Green for the Omi-mCherry construct. This work is supported by the Leopoldina, National Academy of Sciences, Germany (F. E.); La Ligue contre le Cancer (D. A.); the NHLBI (M. S. and N.T.); and the NINDS intramural programs.	Arnoult D, 2004, P NATL ACAD SCI USA, V101, P7988, DOI 10.1073/pnas.0401897101; Bessette PH, 1999, P NATL ACAD SCI USA, V96, P13703, DOI 10.1073/pnas.96.24.13703; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Fletchera JI, 2008, P NATL ACAD SCI USA, V105, P18081, DOI 10.1073/pnas.0808691105; Gavathiotis E, 2010, MOL CELL, V40, P481, DOI 10.1016/j.molcel.2010.10.019; George NM, 2007, GENE DEV, V21, P1937, DOI 10.1101/gad.1553607; Gilmore AP, 2000, J CELL BIOL, V149, P431, DOI 10.1083/jcb.149.2.431; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Jeong SY, 2004, EMBO J, V23, P2146, DOI 10.1038/sj.emboj.7600225; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; KORSMEYER SJ, 1993, SEMIN CANCER BIOL, V4, P327; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Locker JK, 1999, J CELL BIOL, V144, P267, DOI 10.1083/jcb.144.2.267; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Martinou I, 1999, J CELL BIOL, V144, P883, DOI 10.1083/jcb.144.5.883; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schouten A, 2002, J BIOL CHEM, V277, P19339, DOI 10.1074/jbc.M201245200; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Shen ZJ, 2009, NAT IMMUNOL, V10, P257, DOI 10.1038/ni.1697; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Wang GQ, 2001, J BIOL CHEM, V276, P3610, DOI 10.1074/jbc.M006222200; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	41	414	433	6	49	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 1	2011	145	1					104	116		10.1016/j.cell.2011.02.034	http://dx.doi.org/10.1016/j.cell.2011.02.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458670	Green Accepted, Bronze			2022-12-28	WOS:000289053900013
J	Haber, DA; Gray, NS; Baselga, J				Haber, Daniel A.; Gray, Nathanael S.; Baselga, Jose			The Evolving War on Cancer	CELL			English	Article							CELL LUNG-CANCER; KINASE INHIBITORS; MUTATIONS; EGFR; GEFITINIB; IMATINIB; GENE; IDENTIFICATION; CHROMOSOME; RESISTANCE	Building on years of basic scientific discovery, recent advances in the fields of cancer genetics and medicinal chemistry are now converging to revolutionize the treatment of cancer. Starting with serendipitous observations in rare subsets of cancer, a paradigm shift in clinical research is poised to ensure that new molecular insights are rapidly applied to shape emerging cancer therapies. Could this mark a turning point in the "War on Cancer''?	[Haber, Daniel A.; Baselga, Jose] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Gray, Nathanael S.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Haber, Daniel A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Haber, DA (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA.	haber@helix.mgh.harvard.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020; Bailar JC, 1997, NEW ENGL J MED, V336, P1569, DOI 10.1056/NEJM199705293362206; Baselga J, 2010, SAN ANT BREAST CANC, pS3; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Di Cosimo S, 2010, ASCO M, V28, P3008; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Eisen T, 2006, BRIT J CANCER, V95, P581, DOI 10.1038/sj.bjc.6603291; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Fedorov O, 2010, NAT CHEM BIOL, V6, P166, DOI 10.1038/nchembio.297; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Furman RR, 2010, ASCO MEET ABSTR, V28, P3032; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Leaf C., 2004, FORTUNE MAGAZIN 0322; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Marsden BD, 2008, CURR OPIN CHEM BIOL, V12, P40, DOI 10.1016/j.cbpa.2008.01.042; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; NOWELL PC, 1960, SCIENCE, V132, P1497; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; ODAY S, 2010, ASCO M, V28, P4; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Tabernero J, 2008, J CLIN ONCOL, V26, P1603, DOI 10.1200/JCO.2007.14.5482; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	39	165	172	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2011	145	1					19	24		10.1016/j.cell.2011.03.026	http://dx.doi.org/10.1016/j.cell.2011.03.026			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458664	Bronze			2022-12-28	WOS:000289053900005
J	Lachke, SA; Alkuraya, FS; Kneeland, SC; Ohn, T; Aboukhalil, A; Howell, GR; Saadi, I; Cavallesco, R; Yue, YZ; Tsai, ACH; Nair, KS; Cosma, MI; Smith, RS; Hodges, E; AlFadhli, SM; Al-Hajeri, A; Shamseldin, HE; Behbehani, A; Hannon, GJ; Bulyk, ML; Drack, AV; Anderson, PJ; John, SWM; Maas, RL				Lachke, Salil A.; Alkuraya, Fowzan S.; Kneeland, Stephen C.; Ohn, Takbum; Aboukhalil, Anton; Howell, Gareth R.; Saadi, Irfan; Cavallesco, Resy; Yue, Yingzi; Tsai, Anne C-H.; Nair, K. Saidas; Cosma, Mihai I.; Smith, Richard S.; Hodges, Emily; AlFadhli, Suad M.; Al-Hajeri, Amal; Shamseldin, Hanan E.; Behbehani, AbdulMutalib; Hannon, Gregory J.; Bulyk, Martha L.; Drack, Arlene V.; Anderson, Paul J.; John, Simon W. M.; Maas, Richard L.			Mutations in the RNA Granule Component TDRD7 Cause Cataract and Glaucoma	SCIENCE			English	Article							CYTOPLASMIC PROCESSING BODIES; MAMMALIAN STRESS GRANULES; EUKARYOTIC MESSENGER-RNAS; MALE GERM-CELLS; P-BODIES; CHROMATOID BODY; TRANSLATION; PROTEINS; DECAY; LOCALIZATION	The precise transcriptional regulation of gene expression is essential for vertebrate development, but the role of posttranscriptional regulatory mechanisms is less clear. Cytoplasmic RNA granules (RGs) function in the posttranscriptional control of gene expression, but the extent of RG involvement in organogenesis is unknown. We describe two human cases of pediatric cataract with loss-of-function mutations in TDRD7 and demonstrate that Tdrd7 nullizygosity in mouse causes cataracts, as well as glaucoma and an arrest in spermatogenesis. TDRD7 is a Tudor domain RNA binding protein that is expressed in lens fiber cells in distinct TDRD7-RGs that interact with STAU1-ribonucleoproteins (RNPs). TDRD7 coimmunoprecipitates with specific lens messenger RNAs (mRNAs) and is required for the posttranscriptional control of mRNAs that are critical to normal lens development and to RG function. These findings demonstrate a role for RGs in vertebrate organogenesis.	[Kneeland, Stephen C.; Howell, Gareth R.; Nair, K. Saidas; Cosma, Mihai I.; Smith, Richard S.; John, Simon W. M.] Howard Hughes Med Inst, Bar Harbor, ME 04609 USA; [Kneeland, Stephen C.; Howell, Gareth R.; Nair, K. Saidas; Cosma, Mihai I.; Smith, Richard S.; John, Simon W. M.] Jackson Lab, Bar Harbor, ME 04609 USA; [Lachke, Salil A.; Alkuraya, Fowzan S.; Aboukhalil, Anton; Saadi, Irfan; Cavallesco, Resy; Yue, Yingzi; Bulyk, Martha L.; Maas, Richard L.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Bulyk, Martha L.] Harvard Univ, Sch Med, Harvard Massachusetts Inst Technol Div Hlth Sci &, Boston, MA 02115 USA; [Alkuraya, Fowzan S.; Shamseldin, Hanan E.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Alkuraya, Fowzan S.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh 11533, Saudi Arabia; [Alkuraya, Fowzan S.] King Saud Univ, Coll Med, Riyadh 11461, Saudi Arabia; [Alkuraya, Fowzan S.] King Saud Univ, King Khalid Univ Hosp, Dept Pediat, Riyadh 11461, Saudi Arabia; [Ohn, Takbum; Anderson, Paul J.] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Aboukhalil, Anton] MIT, Dept Aeronaut & Astronaut, Cambridge, MA 02139 USA; [Tsai, Anne C-H.] Univ Colorado Denver, Dept Pediat, Aurora, CO 80045 USA; [Cosma, Mihai I.] Maine Med Ctr, Dept Med, Portland, ME 04102 USA; [Hodges, Emily; Hannon, Gregory J.] Watson Sch Biol Sci, Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Hodges, Emily; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [AlFadhli, Suad M.; Al-Hajeri, Amal] Kuwait Univ, Fac Allied Hlth Sci, Kuwait 13060, Kuwait; [Behbehani, AbdulMutalib] Kuwait Univ, Fac Med, Dept Surg, Alsafat 13110, Kuwait; [Bulyk, Martha L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Drack, Arlene V.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA; [John, Simon W. M.] Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA	Howard Hughes Medical Institute; Jackson Laboratory; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Broad Institute; King Faisal Specialist Hospital & Research Center; Alfaisal University; King Saud University; King Saud University; King Khalid University Hospital; Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT); Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Maine Medical Center; Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Kuwait University; Kuwait University; Harvard University; Brigham & Women's Hospital; University of Iowa; Tufts University	John, SWM (corresponding author), Howard Hughes Med Inst, 600 Main St, Bar Harbor, ME 04609 USA.	simon.john@jax.org; maas@genetics.med.harvard.edu	Hannon, Gregory/AAB-3568-2019; Alkuraya, Fowzan S./A-1542-2009; Saadi, Irfan/I-5989-2019	Alkuraya, Fowzan S./0000-0003-4158-341X; Saadi, Irfan/0000-0002-6250-6651; Hodges, Emily/0000-0001-6513-610X; Lachke, Salil/0000-0001-8845-010X; Drack, Arlene/0000-0002-8195-8426	Barbara and Joseph Cohen Foundation; Peace by Pieces Fund; Dubai Harvard Foundation for Medical Research; Kuwait University [YM01/09]; Foundation Fighting Blindness; American Heart Association;  [R01 EY10123];  [R01 HD060050];  [P01 GM061354];  [KACST 08-MED497-20];  [R01 EY11721]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060050] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011721, R01EY010123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER	Barbara and Joseph Cohen Foundation; Peace by Pieces Fund; Dubai Harvard Foundation for Medical Research; Kuwait University; Foundation Fighting Blindness(European Commission); American Heart Association(American Heart Association); ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by R01 EY10123, R01 HD060050, P01 GM061354, KACST 08-MED497-20, R01 EY11721, The Barbara and Joseph Cohen Foundation, The Peace by Pieces Fund, and the Dubai Harvard Foundation for Medical Research. S.M.A. is supported by a grant from Kuwait University (YM01/09). A.V.D. was supported by a Marjorie Carr Adams Career Development Award from the Foundation Fighting Blindness. A.A. is supported by an American Heart Association Predoctoral Fellowship. S.W.M.J. and G.J.H. are Investigators of the Howard Hughes Medical Institute. We thank C. Cepko for advice on the chick experiments, L. Reinholdt for assistance in assessing male sterility, A. Bell for technical assistance, J. Reddan and V. Reddy for their gifts of lens cell lines, and the patients and their families for participating in this research. All microarray data are deposited in the Gene Expression Omnibus database (www.ncbi.nih.gov/geo), and the accession number for the SuperSeries for all data files is GSE25812.	Achermann JC, 1999, NAT GENET, V22, P125, DOI 10.1038/9629; Alkuraya FS, 2010, GENET MED, V12, P236, DOI 10.1097/GIM.0b013e3181ceb95d; Anantharaman V, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-13; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Fu L, 2003, BIOCHEM BIOPH RES CO, V302, P710, DOI 10.1016/S0006-291X(03)00257-2; Fu L, 2002, J BIOL CHEM, V277, P4255, DOI 10.1074/jbc.M110027200; Furic L, 2008, RNA, V14, P324, DOI 10.1261/rna.720308; Gilmour DT, 1998, EMBO J, V17, P1860, DOI 10.1093/emboj/17.7.1860; Haque MSR, 1999, MOL VIS, V5, pU1; Harpavat S, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-2; Higgins AW, 2008, AM J HUM GENET, V82, P712, DOI 10.1016/j.ajhg.2008.01.011; Hosokawa M, 2007, DEV BIOL, V301, P38, DOI 10.1016/j.ydbio.2006.10.046; Jun G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000584; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103; Kotaja N, 2007, NAT REV MOL CELL BIO, V8, P85, DOI 10.1038/nrm2081; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Oleynikov Y, 2003, CURR BIOL, V13, P199, DOI 10.1016/S0960-9822(03)00044-7; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Riazuddin SA, 2005, INVEST OPHTH VIS SCI, V46, P2100, DOI 10.1167/iovs.04-1481; Roegiers F, 2000, TRENDS CELL BIOL, V10, P220, DOI 10.1016/S0962-8924(00)01767-0; Sacca SC, 2008, PROG BRAIN RES, V173, P385, DOI 10.1016/S0079-6123(08)01127-8; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Sinsimer KS, 2008, MOL CELL BIOL, V28, P5223, DOI 10.1128/MCB.00431-08; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Vessey JP, 2008, P NATL ACAD SCI USA, V105, P16374, DOI 10.1073/pnas.0804583105; Zeitelhofer M, 2008, J NEUROSCI, V28, P7555, DOI 10.1523/JNEUROSCI.0104-08.2008	37	132	138	3	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 25	2011	331	6024					1571	1576		10.1126/science.1195970	http://dx.doi.org/10.1126/science.1195970			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21436445	Green Accepted			2022-12-28	WOS:000288754500046
J	Chen, P; Lin, JJ; Lu, CS; Ong, CT; Hsieh, PF; Yang, CC; Tai, CT; Wu, SL; Lu, CH; Hsu, YC; Yu, HY; Ro, LS; Lu, CT; Chu, CC; Tsai, JJ; Su, YH; Lan, SH; Sung, SF; Lin, SY; Chuang, HP; Huang, LC; Chen, YJ; Tsai, PJ; Liao, HT; Lin, YH; Chen, CH; Chung, WH; Hung, SI; Wu, JY; Chang, CF; Chen, L; Chen, YT; Shen, CY				Chen, Pei; Lin, Juei-Jueng; Lu, Chin-Song; Ong, Cheung-Ter; Hsieh, Peiyuan F.; Yang, Chih-Chao; Tai, Chih-Ta; Wu, Shey-Lin; Lu, Cheng-Hsien; Hsu, Yung-Chu; Yu, Hsiang-Yu; Ro, Long-Sun; Lu, Chung-Ta; Chu, Chun-Che; Tsai, Jing-Jane; Su, Yu-Hsiang; Lan, Sheng-Hsing; Sung, Sheng-Feng; Lin, Shu-Yi; Chuang, Hui-Ping; Huang, Li-Chen; Chen, Ying-Ju; Tsai, Pei-Joung; Liao, Hung-Ting; Lin, Yu-Hsuan; Chen, Chien-Hsiun; Chung, Wen-Hung; Hung, Shuen-Iu; Wu, Jer-Yuarn; Chang, Chi-Feng; Chen, Luke; Chen, Yuan-Tsong; Shen, Chen-Yang		Taiwan SJS Consortium	Carbamazepine-Induced Toxic Effects and HLA-B*1502 Screening in Taiwan	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STEVENS-JOHNSON-SYNDROME; ADVERSE DRUG-REACTIONS; EPIDERMAL NECROLYSIS; ASSOCIATION; ALLELE; POPULATION; MARKER; DEATH	BACKGROUND Carbamazepine, an anticonvulsant and a mood-stabilizing drug, is the main cause of the Stevens-Johnson syndrome (SJS) and its related disease, toxic epidermal necrolysis (TEN), in Southeast Asian countries. Carbamazepine-induced SJS-TEN is strongly associated with the HLA B* 1502 allele. We sought to prevent carbamazepine- induced SJS-TEN by using HLA-B*1502 screening to prospectively identify subjects at genetic risk for the condition. METHODS From 23 hospitals in Taiwan, we recruited 4877 candidate subjects who had not taken carbamazepine. We genotyped DNA purified from the subjects' peripheral blood to determine whether they carried the HLA-B*1502 allele. Those testing positive for HLA-B*1502 (7.7% of the total) were advised not to take carbamazepine and were given an alternative medication or advised to continue taking their prestudy medication; those testing negative (92.3%) were advised to take carbamazepine. We interviewed the subjects by telephone once a week for 2 months to monitor them for symptoms. We used the estimated historical incidence of SJS-TEN as a control. RESULTS Mild, transient rash developed in 4.3% of subjects; more widespread rash developed in 0.1% of subjects, who were hospitalized. SJS-TEN did not develop in any of the HLA-B*1502-negative subjects receiving carbamazepine. In contrast, the estimated historical incidence of carbamazepine-induced SJS-TEN (0.23%) would translate into approximately 10 cases among study subjects (P<0.001). CONCLUSIONS The identification of subjects carrying the HLA-B* 1502 allele and the avoidance of carbamazepine therapy in these subjects was strongly associated with a decrease in the incidence of carbamazepine-induced SJS-TEN.	[Chen, Pei; Wu, Shey-Lin; Chuang, Hui-Ping; Huang, Li-Chen; Chen, Ying-Ju; Tsai, Pei-Joung; Liao, Hung-Ting; Lin, Yu-Hsuan; Chen, Chien-Hsiun; Hung, Shuen-Iu; Wu, Jer-Yuarn; Chen, Yuan-Tsong; Shen, Chen-Yang] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Lin, Juei-Jueng] Chu Shang Show Chwan Hosp, Nantou, Taiwan; [Lu, Chin-Song; Ro, Long-Sun; Chu, Chun-Che] Chang Gung Mem Hosp Linkou, Dept Neurol, Kweishan, Taiwan; [Chung, Wen-Hung] Chang Gung Mem Hosp Linkou, Dept Dermatol, Kweishan, Taiwan; Chang Gung Univ, Coll Med, Kweishan, Taiwan; [Ong, Cheung-Ter; Hsu, Yung-Chu; Su, Yu-Hsiang; Sung, Sheng-Feng] Chia Yi Christian Hosp, Chiayi, Taiwan; [Hsieh, Peiyuan F.] Taichung Vet Gen Hosp, Taichung, Taiwan; [Hsieh, Peiyuan F.] Natl Chi Nan Univ, Nantou, Taiwan; [Yang, Chih-Chao] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Tai, Chih-Ta; Lan, Sheng-Hsing] Kaohsiung Med Univ, Chung Ho Mem Hosp, Kaohsiung, Taiwan; [Tai, Chih-Ta; Lan, Sheng-Hsing] Kaohsiung Med Univ, Kaohsiung, Taiwan; [Wu, Shey-Lin] Changhua Christian Hosp, Changhua, Taiwan; [Lu, Cheng-Hsien] Chang Gung Mem Hosp, Kaohsiung, Taiwan; [Yu, Hsiang-Yu] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Yu, Hsiang-Yu] Natl Yang Ming Univ, Taipei 112, Taiwan; [Shen, Chen-Yang] China Med Univ, Coll Publ Hlth, Taichung, Taiwan; [Lu, Chung-Ta] China Med Univ, China Med Univ Hosp, Taichung, Taiwan; [Tsai, Jing-Jane] Natl Cheng Kung Univ Hosp, Tainan 70428, Taiwan; [Chen, Yuan-Tsong] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA	Academia Sinica - Taiwan; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Taichung Veterans General Hospital; National Chi Nan University; National Taiwan University; National Taiwan University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Changhua Christian Hospital; Chang Gung Memorial Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; Duke University	Chen, P (corresponding author), Acad Sinica, Inst Biomed Sci, 128 Acad Rd, Taipei 115, Taiwan.	chen0010@ibms.sinica.edu.tw; bmcys@ibms.sinica.edu.tw	Hung, Shuen-Iu/HHS-9012-2022; Wu, Jer-Yuarn/S-7010-2018; Chen, Chien Hsiun/Q-3826-2018; Hung, Shuen-Iu/ABB-2139-2021; Shen, CY/F-6271-2010	Hung, Shuen-Iu/0000-0001-6531-5538; Yang, Chih-Chao/0000-0002-0352-3144; Yu, Hsiang-Yu/0000-0002-8183-1863; Huang, Ying-Zu/0000-0002-8666-4013; Chen, Pei-Jer/0000-0001-8316-3785	National Science Council of Taiwan; Taiwan Drug Relief Foundation; National Science Council, Taiwan; Academy-Industry Collaboration Program [NSC95-3112- B-001-023, NSC97-3112-B-001-007]; Taiwan Drug Relief Foundation [TDRF9707, TDRF9809]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Taiwan Drug Relief Foundation; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Academy-Industry Collaboration Program; Taiwan Drug Relief Foundation	Funded by the National Science Council of Taiwan and the Taiwan Drug Relief Foundation; Supported by grants from the National Research Program for Genomic Medicine, National Science Council, Taiwan (for the National Clinical Core and the National Genotyping Core) and from the Academy-Industry Collaboration Program (NSC95-3112- B-001-023 and NSC97-3112-B-001-007); and the Taiwan Drug Relief Foundation (TDRF9707 and TDRF9809).	Chung WH, 2008, NAT MED, V14, P1343, DOI 10.1038/nm.1884; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Flockhart DA, 2009, CLIN PHARMACOL THER, V86, P109, DOI 10.1038/clpt.2009.39; Fritsch P O, 2000, Am J Clin Dermatol, V1, P349, DOI 10.2165/00128071-200001060-00003; Garcia-Doval I, 2000, ARCH DERMATOL, V136, P323, DOI 10.1001/archderm.136.3.323; Hung Shuen-Iu, 2005, Per Med, V2, P225, DOI 10.2217/17410541.2.3.225; Hung SL, 2006, PHARMACOGENET GENOM, V16, P297, DOI 10.1097/01.fpc.0000199500.46842.4a; JC R, 1994, NEW ENGL J MED, V331, P1272; Lim KS, 2008, NEUROL ASIA, V13, P15; Locharernkul C, 2009, EPILEPSIA, V50, P971, DOI 10.1111/j.1528-1167.2009.02138_2.x; Lonjou C, 2006, PHARMACOGENOMICS J, V6, P265, DOI 10.1038/sj.tpj.6500356; Man CBL, 2008, EPILEPSIA, V49, P941; Man CBL, 2007, EPILEPSIA, V48, P1015, DOI 10.1111/j.1528-1167.2007.01022.x; McCormack M, 2011, NEW ENGL J MED, V364, P1134, DOI 10.1056/NEJMoa1013297; Mehta TY, 2009, INDIAN J DERMATOL VE, V75, P579, DOI 10.4103/0378-6323.57718; Ozeki T, 2011, HUM MOL GENET, V20, P1034, DOI 10.1093/hmg/ddq537; Tassaneeyakul W, 2010, EPILEPSIA, V51, P926, DOI 10.1111/j.1528-1167.2010.02533.x; WEI CY, 2010, TAIW ACGA 2010 INT C; Yang CWO, 2007, J ALLERGY CLIN IMMUN, V120, P870, DOI 10.1016/j.jaci.2007.06.017	19	472	505	0	74	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2011	364	12					1126	1133		10.1056/NEJMoa1009717	http://dx.doi.org/10.1056/NEJMoa1009717			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739FY	21428768				2022-12-28	WOS:000288701100007
J	Sporn, MB				Sporn, Michael B.			PERSPECTIVE The big C - for Chemoprevention	NATURE			English	Editorial Material							TRIAL		Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03756 USA	Dartmouth College	Sporn, MB (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03756 USA.	michael.b.sporn@dartmouth.edu						Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Issa JPJ, 2011, CANCER PREV RES, V4, P6, DOI 10.1158/1940-6207.CAPR-10-0348; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; LaCroix AZ, 2010, JNCI-J NATL CANCER I, V102, P1706, DOI 10.1093/jnci/djq415; Meyskens FL, 2008, CANCER PREV RES, V1, P32, DOI 10.1158/1940-6207.CAPR-08-0042; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Schmidt C, 2010, J NATL CANCER I, V102, P1690, DOI 10.1093/jnci/djq477; Sporn MB, 2006, NAT CLIN PRACT ONCOL, V3, P364, DOI 10.1038/ncponc0536; Veronesi U, 2006, ANN ONCOL, V17, P1065, DOI 10.1093/annonc/mdl047	10	31	32	0	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					S10	S11		10.1038/471S10a	http://dx.doi.org/10.1038/471S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430710				2022-12-28	WOS:000288702200011
J	Nakamizo, A; Akagi, Y; Amano, T; Suzuki, SO; Otsuka, R; Abe, Y; Yoshimoto, K; Iwaki, T; Sasaki, T				Nakamizo, Akira; Akagi, Yojiro; Amano, Toshiyuki; Suzuki, Satoshi O.; Otsuka, Rie; Abe, Yasunobu; Yoshimoto, Koji; Iwaki, Toru; Sasaki, Tomio			Donor-derived adult T-cell leukaemia	LANCET			English	Editorial Material							TRANSPLANTATION		[Nakamizo, Akira] Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Higashi Ku, Fukuoka 8128582, Japan; [Suzuki, Satoshi O.; Iwaki, Toru] Kyushu Univ, Grad Sch Med Sci, Dept Neuropathol, Fukuoka 8128582, Japan; [Otsuka, Rie; Abe, Yasunobu] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka 8128582, Japan	Kyushu University; Kyushu University; Kyushu University	Nakamizo, A (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	nakamizo@ns.med.kyushu-u.ac.jp	Suzuki, Satoshi O/H-8367-2019	Suzuki, Satoshi O/0000-0002-0742-5680				Dungerwalla M, 2005, BRIT J HAEMATOL, V130, P511, DOI 10.1111/j.1365-2141.2005.05629.x; Hoshida Y, 2001, INT J CANCER, V91, P869, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1125>3.0.CO;2-N; Marshall AG, 1998, J NEUROL SCI, V158, P226, DOI 10.1016/S0022-510X(98)00111-7; Tamaki H, 2006, NEW ENGL J MED, V354, P1758, DOI 10.1056/NEJMc053295; Utsunomiya A, 2001, BONE MARROW TRANSPL, V27, P15, DOI 10.1038/sj.bmt.1702731	5	14	14	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2011	377	9771					1124	1124		10.1016/S0140-6736(11)60315-2	http://dx.doi.org/10.1016/S0140-6736(11)60315-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	743QY	21440808				2022-12-28	WOS:000289035000035
J	Ishizuka, K; Kamiya, A; Oh, EC; Kanki, H; Seshadri, S; Robinson, JF; Murdoch, H; Dunlop, AJ; Kubo, K; Furukori, K; Huang, B; Zeledon, M; Hayashi-Takagi, A; Okano, H; Nakajima, K; Houslay, MD; Katsanis, N; Sawa, A				Ishizuka, Koko; Kamiya, Atsushi; Oh, Edwin C.; Kanki, Hiroaki; Seshadri, Saurav; Robinson, Jon F.; Murdoch, Hannah; Dunlop, Allan J.; Kubo, Ken-ichiro; Furukori, Keiko; Huang, Beverly; Zeledon, Mariela; Hayashi-Takagi, Akiko; Okano, Hideyuki; Nakajima, Kazunori; Houslay, Miles D.; Katsanis, Nicholas; Sawa, Akira			DISC1-dependent switch from progenitor proliferation to migration in the developing cortex	NATURE			English	Article							DEVELOPING MOUSE-BRAIN; NEURONAL MIGRATION; DISC1; PROTEIN; ADULT; GENE; MICE; DIFFERENTIATION; VISUALIZATION; DEFECTS	Regulatory mechanisms governing the sequence from progenitor cell proliferation to neuronal migration during corticogenesis are poorly understood(1-10). Here we report that phosphorylation of DISC1, a major susceptibility factor for several mental disorders, acts as a molecular switch from maintaining proliferation of mitotic progenitor cells to activating migration of postmitotic neurons in mice. Unphosphorylated DISC1 regulates canonical Wnt signalling via an interaction with GSK3 beta, whereas specific phosphorylation at serine 710 (S710) triggers the recruitment of Bardet-Biedl syndrome (BBS) proteins to the centrosome. In support of this model, loss of BBS1 leads to defects in migration, but not proliferation, whereas DISC1 knockdown leads to deficits in both. A phospho-dead mutant can only rescue proliferation, whereas a phospho-mimic mutant rescues exclusively migration defects. These data highlight a dual role for DISC1 in corticogenesis and indicate that phosphorylation of this protein at S710 activates a key developmental switch.	[Ishizuka, Koko; Kamiya, Atsushi; Seshadri, Saurav; Furukori, Keiko; Huang, Beverly; Zeledon, Mariela; Hayashi-Takagi, Akiko; Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21287 USA; [Oh, Edwin C.; Robinson, Jon F.; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Oh, Edwin C.; Robinson, Jon F.; Katsanis, Nicholas] Duke Univ, Dept Cell Biol, Durham, NC 27710 USA; [Oh, Edwin C.; Robinson, Jon F.; Katsanis, Nicholas] Duke Univ, Dept Pediat, Durham, NC 27710 USA; [Kanki, Hiroaki; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan; [Kubo, Ken-ichiro; Nakajima, Kazunori] Keio Univ, Sch Med, Dept Anat, Tokyo 1608582, Japan; [Murdoch, Hannah; Dunlop, Allan J.; Houslay, Miles D.] Univ Glasgow, CMVLS, Inst Neurosci & Psychol, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland; [Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA	Johns Hopkins University; Duke University; Duke University; Duke University; Keio University; Keio University; University of Glasgow; Johns Hopkins University	Sawa, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21287 USA.	katsanis@cellbio.duke.edu; asawa1@jhmi.edu	Houslay, Miles D/A-6825-2011; Okano, Hideyuki/I-7584-2019; Kubo, Ken-ichiro/B-2520-2015; Katsanis, Nicholas/E-1837-2012; Nakajima, Kazunori/L-3396-2013; Houslay, Miles/AAM-5281-2020; kamiya, atsushi/L-8550-2016	Kubo, Ken-ichiro/0000-0003-4023-5069; Nakajima, Kazunori/0000-0003-1864-9425; kamiya, atsushi/0000-0002-4274-5567; Katsanis, Nicholas/0000-0002-2480-0171; Houslay, Miles/0000-0002-3826-8091	USPHS [MH-084018, MH-069853, MH-085226, MH-088753, MH-091230, HD-04260, DK-072301, DK-075972]; Stanley foundation; RUSK foundation; Maryland Stem Cell Research Fund; NARSAD; Macular Vision Research Foundation; Foundation for Fighting Blindness; Health Labor Sciences; MEXT; Takeda; PMAC-PSJ; Fight for Sight Postdoctoral Fellowship; Medical Research Council, UK [G0600765]; Strategic Research Program for Brain Sciences; Medical Research Council [G0600765] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072301, R01DK075972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092443, R01MH069853, P20MH084018, R21MH085226, RC1MH088753, R01MH091230] Funding Source: NIH RePORTER; MRC [G0600765] Funding Source: UKRI	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Stanley foundation; RUSK foundation; Maryland Stem Cell Research Fund; NARSAD(NARSAD); Macular Vision Research Foundation; Foundation for Fighting Blindness; Health Labor Sciences; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda(Takeda Pharmaceutical Company Ltd); PMAC-PSJ; Fight for Sight Postdoctoral Fellowship; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Strategic Research Program for Brain Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Y. Y. Lema for preparing figures and organizing the manuscript and P. Talalay for critical reading of this manuscript. We appreciate J. M. Gerdes, A. K. Mustafa, N. Shahani, T. Boronina, D. Chen and R. N. Cole for scientific discussions and technical support. We thank T. Tomoda, N. Sugiyama, M. Hasegawa, Q. Lu, E. S. Anton and A. Chenn for providing us with constructs. This work was supported by USPHS grants of MH-084018 Silvo O. Conte center (A. S.), MH-069853 (A.S.), MH-085226 (A.S.), MH-088753 (A.S.), MH-091230 (A.K.), HD-04260 (N.K.), DK-072301 (N.K.), and DK-075972 (N.K.); grants from Stanley and RUSK foundations and from Maryland Stem Cell Research Fund (A.S.); grants from NARSAD and S-R foundations (A.S. and A.K.); grants from the Macular Vision Research Foundation and the Foundation for Fighting Blindness as well as the Distinguished George W. Brumley Professorship (N.K.); a grant from Health Labor Sciences (K.-i.K.); grants from Strategic Research Program for Brain Sciences (K.N.), MEXT (K.N.), Takeda (K.N.) and PMAC-PSJ (K.N.); Fight for Sight Postdoctoral Fellowship (E.O.); grant from the Medical Research Council, UK (G0600765; M.D.H.).	Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Bielas S, 2004, ANNU REV CELL DEV BI, V20, P593, DOI 10.1146/annurev.cellbio.20.082503.103047; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Greengard P, 1998, BRAIN RES REV, V26, P274, DOI 10.1016/S0165-0173(97)00057-X; Gupta A, 2002, NAT REV GENET, V3, P342, DOI 10.1038/nrg799; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; Ishizuka K, 2007, MOL PSYCHIATR, V12, P897, DOI 10.1038/sj.mp.4002024; Jaaro-Peled H, 2009, TRENDS NEUROSCI, V32, P485, DOI 10.1016/j.tins.2009.05.007; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kamiya A, 2008, ARCH GEN PSYCHIAT, V65, P996, DOI 10.1001/archpsyc.65.9.996; Kanki H, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-5; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Kulaga HM, 2004, NAT GENET, V36, P994, DOI 10.1038/ng1418; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Mochida GH, 2004, ARCH NEUROL-CHICAGO, V61, P637, DOI 10.1001/archneur.61.5.637; Moudjou M, 1996, J CELL SCI, V109, P875; Niwa M, 2010, NEURON, V65, P480, DOI 10.1016/j.neuron.2010.01.019; Ohshima T, 2007, DEVELOPMENT, V134, P2273, DOI 10.1242/dev.02854; Regad T, 2009, NAT NEUROSCI, V12, P132, DOI 10.1038/nn.2251; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; Schurov IL, 2004, MOL PSYCHIATR, V9, P1100, DOI 10.1038/sj.mp.4001574; Shen SB, 2008, J NEUROSCI, V28, P10893, DOI 10.1523/JNEUROSCI.3299-08.2008; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Tan PL, 2007, P NATL ACAD SCI USA, V104, P17524, DOI 10.1073/pnas.0706618104; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wang X, 2007, J NEUROSCI RES, V85, P3567, DOI 10.1002/jnr.21440; Xie ZG, 2003, CELL, V114, P469, DOI 10.1016/S0092-8674(03)00605-6; Yokota Y, 2009, NEURON, V61, P42, DOI 10.1016/j.neuron.2008.10.053; Zhang JN, 2010, DEV CELL, V18, P472, DOI 10.1016/j.devcel.2009.12.025	38	145	157	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2011	473	7345					92	U107		10.1038/nature09859	http://dx.doi.org/10.1038/nature09859			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21471969	Green Accepted			2022-12-28	WOS:000290218300037
J	Aaron, HJ				Aaron, Henry J.			How Not to Reform Medicare	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Aaron, Henry J.] Brookings Inst, Washington, DC 20036 USA	Brookings Institution	Aaron, HJ (corresponding author), Brookings Inst, Washington, DC 20036 USA.							Aaron HJ, 1995, HEALTH AFFAIR, V14, P8, DOI 10.1377/hlthaff.14.4.8; *C BUDG OFF, 2010, PREL AN RIVL RYAN HL; Congressional Budget Office, 2011, LONG TERM AN BUDG PR; GOLD M, 2010, KAISER FAMILY FDN PU, V8117; *GOP, PATH PROSP REST AM P	5	8	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 28	2011	364	17					1588	1589		10.1056/NEJMp1103764	http://dx.doi.org/10.1056/NEJMp1103764			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755NW	21470002				2022-12-28	WOS:000289940400002
J	Velazquez, EJ; Lee, KL; Deja, MA; Jain, A; Sopko, G; Marchenko, A; Ali, IS; Pohost, G; Gradinac, S; Abraham, WT; Yii, M; Prabhakaran, D; Szwed, H; Ferrazzi, P; Petrie, MC; O'Connor, CM; Panchavinnin, P; She, LL; Bonow, RO; Rankin, GR; Jones, RH; Rouleau, JL				Velazquez, Eric J.; Lee, Kerry L.; Deja, Marek A.; Jain, Anil; Sopko, George; Marchenko, Andrey; Ali, Imtiaz S.; Pohost, Gerald; Gradinac, Sinisa; Abraham, William T.; Yii, Michael; Prabhakaran, Dorairaj; Szwed, Hanna; Ferrazzi, Paolo; Petrie, Mark C.; O'Connor, Christopher M.; Panchavinnin, Pradit; She, Lilin; Bonow, Robert O.; Rankin, Gena Roush; Jones, Robert H.; Rouleau, Jean-Lucien		STICH Investigators	Coronary-Artery Bypass Surgery in Patients with Left Ventricular Dysfunction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SURGICAL-TREATMENT; SURVIVAL; DISEASE; TRIAL; REVASCULARIZATION; GUIDELINES; MANAGEMENT; VIABILITY; UPDATE; ESC	BACKGROUND The role of coronary-artery bypass grafting (CABG) in the treatment of patients with coronary artery disease and heart failure has not been clearly established. METHODS Between July 2002 and May 2007, a total of 1212 patients with an ejection fraction of 35% or less and coronary artery disease amenable to CABG were randomly assigned to medical therapy alone (602 patients) or medical therapy plus CABG (610 patients). The primary outcome was the rate of death from any cause. Major secondary outcomes included the rates of death from cardiovascular causes and of death from any cause or hospitalization for cardiovascular causes. RESULTS The primary outcome occurred in 244 patients (41%) in the medical-therapy group and 218 (36%) in the CABG group (hazard ratio with CABG, 0.86; 95% confidence interval [CI], 0.72 to 1.04; P = 0.12). A total of 201 patients (33%) in the medical-therapy group and 168 (28%) in the CABG group died from an adjudicated cardiovascular cause (hazard ratio with CABG, 0.81; 95% CI, 0.66 to 1.00; P = 0.05). Death from any cause or hospitalization for cardiovascular causes occurred in 411 patients (68%) in the medical-therapy group and 351 (58%) in the CABG group (hazard ratio with CABG, 0.74; 95% CI, 0.64 to 0.85; P<0.001). By the end of the follow-up period (median, 56 months), 100 patients in the medical-therapy group (17%) underwent CABG, and 555 patients in the CABG group (91%) underwent CABG. CONCLUSIONS In this randomized trial, there was no significant difference between medical therapy alone and medical therapy plus CABG with respect to the primary end point of death from any cause. Patients assigned to CABG, as compared with those assigned to medical therapy alone, had lower rates of death from cardiovascular causes and of death from any cause or hospitalization for cardiovascular causes.	[Velazquez, Eric J.; She, Lilin; Rankin, Gena Roush] Duke Univ, Duke Clin Res Inst, Med Ctr, Durham, NC 27705 USA; [Velazquez, Eric J.; O'Connor, Christopher M.] Duke Univ, Div Cardiovasc Med, Med Ctr, Durham, NC 27705 USA; [Lee, Kerry L.] Duke Univ, Dept Biostat, Med Ctr, Durham, NC 27705 USA; [Lee, Kerry L.] Duke Univ, Dept Bioinformat, Med Ctr, Durham, NC 27705 USA; [Jones, Robert H.] Duke Univ, Dept Surg, Med Ctr, Durham, NC 27705 USA; [Deja, Marek A.] Med Univ Silesia, Dept Cardiac Surg 2, Katowice, Poland; [Szwed, Hanna] Natl Inst Cardiol, Warsaw, Poland; [Jain, Anil] SAL Hosp & Med Inst, Ahmadabad, Gujarat, India; [Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India; [Sopko, George] NHLBI, Div Cardiovasc Sci, Bethesda, MD 20892 USA; [Marchenko, Andrey] Res Inst Circulat Pathol, Novosibirsk, Russia; [Ali, Imtiaz S.] Dalhousie Univ, Div Cardiac Surg, Halifax, NS, Canada; [Ali, Imtiaz S.] Queen Elizabeth 2 Hlth Sci Ctr, Halifax, NS, Canada; [Pohost, Gerald] Univ So Calif, Keck Sch Med, Viterbi Sch Engn, Los Angeles, CA 90033 USA; [Gradinac, Sinisa] Univ Belgrade, Dedinje Cardiovasc Inst, Sch Med, Belgrade, Serbia; [Abraham, William T.] Ohio State Univ, Div Cardiovasc Med, Columbus, OH 43210 USA; [Yii, Michael] Univ Melbourne, St Vincents Hosp, Dept Cardiothorac Surg, Melbourne, Vic, Australia; [Yii, Michael] Univ Melbourne, St Vincents Hosp, Dept Surg, Melbourne, Vic, Australia; [Ferrazzi, Paolo] Osped Riuniti Bergamo, Dipartimento Cardiovasc Clin & Ric, I-24100 Bergamo, Italy; [Petrie, Mark C.] Golden Jubilee Natl Hosp, Scottish Natl Adv Heart Failure Serv, Glasgow, Lanark, Scotland; [Panchavinnin, Pradit] Mahidol Univ, Siriraj Hosp, Bangkok 10700, Thailand; [Bonow, Robert O.] Northwestern Univ, Div Cardiol, Chicago, IL 60611 USA; [Rouleau, Jean-Lucien] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada	Duke University; Duke University; Duke University; Duke University; Duke University; Medical University Silesia; Institute of Cardiology - Poland; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Meshalkin National Medical Research Center; Dalhousie University; Queen Elizabeth II Health Sciences Centre; University of Southern California; University of Belgrade; University System of Ohio; Ohio State University; St Vincent's Hospital Melbourne; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; Ospedali Riuniti di Bergamo; Golden Jubilee Hospital; Mahidol University; Northwestern University; Universite de Montreal	Velazquez, EJ (corresponding author), Duke Univ, Duke Clin Res Inst, Med Ctr, Rm 0311 Terrace Level,2400 Pratt St, Durham, NC 27705 USA.	eric.velazquez@duke.edu	Asch, Federico/AAS-7653-2021; Senni, Michele/J-9380-2018; Siepe, Matthias/AAF-9846-2019; Prabhakaran, Dorairaj/B-4147-2011; menicanti, lorenzo/K-5649-2018; Crestanello, Juan/E-2930-2011	Asch, Federico/0000-0002-1744-5271; Senni, Michele/0000-0001-5502-7882; Siepe, Matthias/0000-0003-3305-9343; Prabhakaran, Dorairaj/0000-0002-3172-834X; menicanti, lorenzo/0000-0001-8530-6284; Varga-Szemes, Akos/0000-0002-2781-7462; Plicner, Dariusz/0000-0002-3687-512X; Maurer, Gerald/0000-0002-9043-7657; Golba, Krzysztof/0000-0001-5722-7976; Bochenek, Andrzej/0000-0002-3046-3001; Deja, Marek/0000-0002-2174-1321	National Heart, Lung, and Blood Institute [U01HL69015, U01HL69013]; Abbott Laboratories; Novartis; Gilead; Boehringer Ingelheim Pharmaceuticals; Medtronic; St. Jude Medical; Biotronik; CardioMEMS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL069015, R01HL105853, U01HL069013] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Abbott Laboratories(Abbott Laboratories); Novartis(Novartis); Gilead(Gilead Sciences); Boehringer Ingelheim Pharmaceuticals(Boehringer Ingelheim); Medtronic(Medtronic); St. Jude Medical(St. Jude Medical); Biotronik; CardioMEMS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants (U01HL69015 and U01HL69013) from the National Heart, Lung, and Blood Institute and by Abbott Laboratories.; Dr. Velazquez reports receiving consulting fees from Novartis, Gilead, and Boehringer Ingelheim Pharmaceuticals; Dr. Abraham, consulting fees from Medtronic, St. Jude Medical, Biotronik, and CardioMEMS; and Dr. Rouleau, consulting fees and grant support from Novartis. No other potential conflict of interest relevant to this article was reported.	ALDERMAN EL, 1983, CIRCULATION, V68, P785, DOI 10.1161/01.CIR.68.4.785; Beanlands RSB, 2007, J AM COLL CARDIOL, V50, P2002, DOI 10.1016/j.jacc.2007.09.006; Bonow RO, 2011, NEW ENGL J MED, V364, P1617, DOI 10.1056/NEJMoa1100358; BRAUNWALD E, 1986, J AM COLL CARDIOL, V8, P1467, DOI 10.1016/S0735-1097(86)80325-4; BRESLOW N, 1974, BIOMETRICS, V30, P89, DOI 10.2307/2529620; Chareonthaitawee P, 2005, J AM COLL CARDIOL, V46, P567, DOI 10.1016/j.jacc.2005.03.072; Cleland JGF, 2011, EUR J HEART FAIL, V13, P227, DOI 10.1093/eurjhf/hfq230; COX DR, 1972, J R STAT SOC B, V34, P187; DETRE KM, 1984, NEW ENGL J MED, V311, P1333; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; EAGLE KA, 2005, CIRCULATION, V111, P2014; Eagle Kim A, 2004, Circulation, V110, pe340; FISHER L, 1983, CIRCULATION, V68, P939, DOI 10.1161/01.CIR.68.5.939; Fraker TD, 2007, J AM COLL CARDIOL, V50, P2264, DOI [10.1016/j.jacc.2007.08.002, 10.1161/CIRCULATIONAHA.107.187930]; Gheorghiade M, 2006, CIRCULATION, V114, P1202, DOI 10.1161/CIRCULATIONAHA.106.623199; Hunt SA, 2009, J AM COLL CARDIOL, V54, P2464, DOI 10.1016/j.jacc.2009.11.006; Jones RH, 2010, J AM COLL CARDIOL, V56, P490, DOI 10.1016/j.jacc.2009.11.102; Jones RH, 2009, NEW ENGL J MED, V360, P1705, DOI 10.1056/NEJMoa0900559; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; O'Connor CM, 2002, AM J CARDIOL, V90, P101, DOI 10.1016/S0002-9149(02)02429-3; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; PASSAMANI E, 1985, NEW ENGL J MED, V312, P1665, DOI 10.1056/NEJM198506273122603; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; VARNAUSKAS E, 1988, NEW ENGL J MED, V319, P332, DOI 10.1056/NEJM198808113190603; Velazquez EJ, 2007, J THORAC CARDIOV SUR, V134, P1540, DOI 10.1016/j.jtcvs.2007.05.069; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1	28	762	797	0	65	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 28	2011	364	17					1607	1616		10.1056/NEJMoa1100356	http://dx.doi.org/10.1056/NEJMoa1100356			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755NW	21463150	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000289940400007
J	Angus, DC				Angus, Derek C.			Management of Sepsis A 47-Year-Old Woman With an Indwelling Intravenous Catheter and Sepsis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CRITICALLY-ILL PATIENTS; INTENSIVE INSULIN THERAPY; 2009 INFLUENZA A(H1N1); CRITICAL-CARE SERVICES; SEPTIC SHOCK; ANTIMICROBIAL THERAPY; INFLAMMATORY MARKERS; MORTALITY; EPIDEMIOLOGY; GUIDELINES	Severe sepsis is the term used to describe the host response to infection when complicated by acute organ dysfunction. Severe sepsis occurs in more than 750 000 individuals in the United States each year, with a hospital mortality of about 30%. Although the classic presentation is of florid shock with frank hypotension, fever, and elevated white blood cell count, many patients can present with cryptogenic shock (shock without hypotension) with more subtle signs of vital organ compromise. Using the case of Ms C, a 47-year-old woman with short gut syndrome and an indwelling intravenous catheter who developed an episode of severe sepsis secondary to a central line infection, treatment of sepsis is discussed. Management consists of prompt intervention with broad-spectrum antibiotics and fluid resuscitation, even in the absence of hypotension, and institution of a variety of strategies in the emergency setting to prevent development or worsening of vital organ dysfunction. Although advances in understanding the host immune response have fueled considerable interest in immunomodulatory therapy, the role of such agents in clinical practice remains limited and controversial. JAMA. 2011;305(14):1469-1477 www.jama.com	Univ Pittsburgh, Sch Med, Dept Crit Care Med, CRISMA Ctr, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Angus, DC (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, CRISMA Ctr, 614 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	angusdc@upmc.edu	Angus, Derek C/E-9671-2012					Abraham E, 2003, JAMA-J AM MED ASSOC, V290, P238, DOI 10.1001/jama.290.2.238; Abraham E, 2005, NEW ENGL J MED, V353, P1332, DOI 10.1056/NEJMoa050935; *AC RESP DISTR SYN, 2000, NEW ENGL J MED, V342, P1301, DOI DOI 10.1056/NEJM200005043421801; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2000, JAMA-J AM MED ASSOC, V283, P1723, DOI 10.1001/jama.283.13.1723; Angus DC, 2003, JAMA-J AM MED ASSOC, V290, P256, DOI 10.1001/jama.290.2.256; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Annane D, 2009, JAMA-J AM MED ASSOC, V301, P2362, DOI 10.1001/jama.2009.815; [Anonymous], 2009, CHEST; Australian New Zealand Clinical Trials Registry, AUSTR RES SEPS EV RA; Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Carlbom DJ, 2007, CRIT CARE MED, V35, P2525, DOI 10.1097/01.ccm.0000298122.49245.d7; ClinicalTrials.gov, PROT CAR EARL SEPT S; ClinicalTrials.gov, INV EFF SAF DROTR AL; Cook D, 2003, NEW ENGL J MED, V349, P1123, DOI 10.1056/NEJMoa030083; De Backer D, 2010, NEW ENGL J MED, V362, P779, DOI 10.1056/NEJMoa0907118; Deans KJ, 2005, J TRAUMA, V58, P867, DOI 10.1097/01.TA.0000158244.69179.94; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Doig GS, 2008, JAMA-J AM MED ASSOC, V300, P2731, DOI 10.1001/jama.2008.826; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Ferrer R, 2008, JAMA-J AM MED ASSOC, V299, P2294, DOI 10.1001/jama.299.19.2294; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Friedman G, 1998, CRIT CARE MED, V26, P2078, DOI 10.1097/00003246-199812000-00045; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; ISRCTN, CLIN COST EFF EARL G; Jaeschke R, 2009, JAMA-J AM MED ASSOC, V301, P2388, DOI 10.1001/jama.2009.829; Jones AE, 2010, JAMA-J AM MED ASSOC, V303, P739, DOI 10.1001/jama.2010.158; Jones NE, 2008, JAMA-J AM MED ASSOC, V300, P2798, DOI 10.1001/jama.2008.814; Kaplan V, 2003, ARCH INTERN MED, V163, P317, DOI 10.1001/archinte.163.3.317; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Kumar A, 2009, CHEST, V136, P1237, DOI 10.1378/chest.09-0087; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lin MT, 2004, CRIT CARE MED, V32, P569, DOI 10.1097/01.CCM.0000110878.49476.42; Linde-Zwirble WT, 2004, CRIT CARE, V8, P222, DOI 10.1186/cc2917; Nadel S, 2007, LANCET, V369, P836, DOI 10.1016/S0140-6736(07)60411-5; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Quartin AA, 1997, JAMA-J AM MED ASSOC, V277, P1058, DOI 10.1001/jama.277.13.1058; Reade MC, 2010, EMERG MED J, V27, P110, DOI 10.1136/emj.2008.070912; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Sands KE, 1997, JAMA-J AM MED ASSOC, V278, P234, DOI 10.1001/jama.278.3.234; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Vincent JL, 2006, AM J RESP CRIT CARE, V173, P256, DOI 10.1164/rccm.200510-1604OE; Vinsonneau C, 2006, LANCET, V368, P379, DOI 10.1016/S0140-6736(06)69111-3; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; Weycker D, 2003, CRIT CARE MED, V31, P2316, DOI 10.1097/01.CCM.0000085178.80226.0B; Wheeler AP, 1999, NEW ENGL J MED, V340, P207, DOI 10.1056/NEJM199901213400307; Wunsch H, 2008, CRIT CARE MED, V36, P2787, DOI 10.1097/CCM.0b013e318186aec8; Yende S, 2008, AM J RESP CRIT CARE, V177, P1242, DOI 10.1164/rccm.200712-1777OC; Yende Sachin, 2007, Curr Infect Dis Rep, V9, P382, DOI 10.1007/s11908-007-0059-3	59	14	17	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 13	2011	305	14					1469	1477		10.1001/jama.2011.438	http://dx.doi.org/10.1001/jama.2011.438			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	748WQ	21467273				2022-12-28	WOS:000289424100024
J	Norman, MR				Norman, Michael R.			The Challenge of Unconventional Superconductivity	SCIENCE			English	Review							PHASES; TRANSITION; SYMMETRY; SUPERFLUIDITY; TEMPERATURE; PSEUDOGAP; MECHANISM; INSULATOR; LATTICE; PHYSICS	During the past few decades, several new classes of superconductors have been discovered that do not appear to be related to traditional superconductors. The source of the superconductivity of these materials is likely different from the electron-ion interactions that are at the heart of conventional superconductivity. Developing a rigorous theory for any of these classes of materials has proven to be a difficult challenge and will remain one of the major problems in physics in the decades to come.	Argonne Natl Lab, Div Mat Sci, Argonne, IL 60439 USA	United States Department of Energy (DOE); Argonne National Laboratory	Norman, MR (corresponding author), Argonne Natl Lab, Div Mat Sci, 9700 S Cass Ave, Argonne, IL 60439 USA.	norman@anl.gov	Norman, Michael R/C-3644-2013	Norman, Michael R/0000-0002-9459-078X	U.S. Department of Energy (DOE) Office of Science [DE-AC02-06CH11357]; DOE Office of Science [DE-AC02-98CH1088]	U.S. Department of Energy (DOE) Office of Science(United States Department of Energy (DOE)); DOE Office of Science(United States Department of Energy (DOE))	Supported by the U.S. Department of Energy (DOE) Office of Science under contract DE-AC02-06CH11357, and by the Center for Emergent Superconductivity, an Energy Frontier Research Center funded by the DOE Office of Science under award DE-AC02-98CH1088.	ABRIKOSOV AA, 1961, SOV PHYS JETP-USSR, V12, P1243; AEPPLI G, 1987, PHYS REV LETT, V58, P808, DOI 10.1103/PhysRevLett.58.808; ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; ANDERSON PW, 1973, PHYS REV LETT, V30, P1108, DOI 10.1103/PhysRevLett.30.1108; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; BEALMONOD MT, 1986, PHYS REV B, V34, P7716, DOI 10.1103/PhysRevB.34.7716; BEDNORZ JG, 1986, Z PHYS B CON MAT, V64, P189, DOI 10.1007/BF01303701; Bickers N., 1987, INT J MODERN PHYS B, V1, P687, DOI [10.1142/s0217979287001079, DOI 10.1142/S0217979287001079]; Chu JH, 2010, SCIENCE, V329, P824, DOI 10.1126/science.1190482; COOPER LN, 1956, PHYS REV, V104, P1189, DOI 10.1103/PhysRev.104.1189; Ding H, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/47001; ELIASHBERG GM, 1960, SOV PHYS JETP-USSR, V11, P696; EMERY VJ, 1960, PHYS REV, V119, P43, DOI 10.1103/PhysRev.119.43; Faulkner T, 2010, SCIENCE, V329, P1043, DOI 10.1126/science.1189134; FAY D, 1968, PHYS REV LETT, V20, P187, DOI 10.1103/PhysRevLett.20.187; HERTZ JA, 1976, SOLID STATE COMMUN, V18, P803, DOI 10.1016/0038-1098(76)90209-X; Huxley A, 2000, NATURE, V406, P160, DOI 10.1038/35018020; Joynt R, 2002, REV MOD PHYS, V74, P235, DOI 10.1103/RevModPhys.74.235; Kagawa F, 2005, NATURE, V436, P534, DOI 10.1038/nature038O6; Kirtley JR, 2006, NAT PHYS, V2, P190, DOI 10.1038/nphys215; Kortus J, 2001, PHYS REV LETT, V86, P4656, DOI 10.1103/PhysRevLett.86.4656; KOTLIAR G, 1988, PHYS REV B, V38, P5142, DOI 10.1103/PhysRevB.38.5142; Kurosaki Y, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.177001; Lawler MJ, 2010, NATURE, V466, P347, DOI 10.1038/nature09169; Lee P. A., 1986, Comments on Condensed Matter Physics, V12, P99; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Lee PA, 2008, SCIENCE, V321, P1306, DOI 10.1126/science.1163196; LEGGETT AJ, 1975, REV MOD PHYS, V47, P331, DOI 10.1103/RevModPhys.47.331; London F., 1950, SUPERFLUIDS, VI; MAENO Y, 1994, NATURE, V372, P532, DOI 10.1038/372532a0; Maier TA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.237001; Mathur ND, 1998, NATURE, V394, P39, DOI 10.1038/27838; Mazin II, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.057003; Meissner W, 1933, NATURWISSENSCHAFTEN, V21, P787, DOI 10.1007/BF01504252; MIYAKE K, 1986, PHYS REV B, V34, P6554, DOI 10.1103/PhysRevB.34.6554; Nandi S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.057006; Nelson KD, 2004, SCIENCE, V306, P1151, DOI 10.1126/science.1103881; Norman MR, 2005, ADV PHYS, V54, P715, DOI [10.1080/00018730500459906, 10.1080/00018730500489906]; NORMAN MR, 2008, PHYSICS, V1, P21, DOI DOI 10.1103/PHYSICS.1.21; Okamoto Y, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.137207; Onnes H. Kamerlingh, 1911, COMMUN PHYS LAB U LE, V120, P261; OSHEROFF DD, 1972, PHYS REV LETT, V28, P885, DOI 10.1103/PhysRevLett.28.885; Pfleiderer C, 2009, REV MOD PHYS, V81, P1551, DOI 10.1103/RevModPhys.81.1551; Powell BJ, 2006, J PHYS-CONDENS MAT, V18, pR827, DOI 10.1088/0953-8984/18/45/R03; Reznik D, 2006, NATURE, V440, P1170, DOI 10.1038/nature04704; Sarrao JL, 2002, NATURE, V420, P297, DOI 10.1038/nature01212; SCALAPINO DJ, 1986, PHYS REV B, V34, P8190, DOI 10.1103/PhysRevB.34.8190; Si QM, 2010, SCIENCE, V329, P1161, DOI 10.1126/science.1191195; STEGLICH F, 1979, PHYS REV LETT, V43, P1892, DOI 10.1103/PhysRevLett.43.1892; STEWART GR, 1984, REV MOD PHYS, V56, P755, DOI 10.1103/RevModPhys.56.755; Strand JD, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.197002; Takabayashi Y, 2009, SCIENCE, V323, P1585, DOI 10.1126/science.1169163; Tanatar MA, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.067002; Varma CM, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.155113; Wang F, 2011, SCIENCE, V332, P200, DOI 10.1126/science.1200182; WILSON KG, 1975, REV MOD PHYS, V47, P773, DOI 10.1103/RevModPhys.47.773; Yamanaka S, 1998, NATURE, V392, P580, DOI 10.1038/33362; Yuan HQ, 2003, SCIENCE, V302, P2104, DOI 10.1126/science.1091648	64	265	268	5	284	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2011	332	6026					196	200		10.1126/science.1200181	http://dx.doi.org/10.1126/science.1200181			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474750	Green Submitted			2022-12-28	WOS:000289251100039
J	Biton, S; Ashkenazi, A				Biton, Sharon; Ashkenazi, Avi			NEMO and RIP1 Control Cell Fate in Response to Extensive DNA Damage via TNF-alpha Feedforward Signaling	CELL			English	Article							NF-KAPPA-B; DOMAIN KINASE RIP; IONIZING-RADIATION; IKK ACTIVATION; DEATH; CANCER; ATM; EXPRESSION; APOPTOSIS; NECROSIS	Upon DNA damage, ataxia telangiectasia mutated (ATM) kinase triggers multiple events to promote cell survival and facilitate repair. If damage is excessive, ATM stimulates cytokine secretion to alert neighboring cells and apoptosis to eliminate the afflicted cell. ATM augments cell survival by activating nuclear factor (NF)-kappa B; however, how ATM induces cytokine production and apoptosis remains elusive. Here we uncover a p53-independent mechanism that transmits ATM-driven cytokine and caspase signals upon strong genotoxic damage. Extensive DNA lesions stimulated two sequential NF-kappa B activation phases, requiring ATM and NEMO/IKK-gamma: The first phase induced TNF-alpha-TNFR1 feedforward signaling, promoting the second phase and driving RIP1 phosphorylation. In turn, RIP1 kinase triggered JNK3/MAPK10-dependent interleukin-8 secretion and FADD-mediated proapoptotic caspase-8 activation. Thus, in the context of excessive DNA damage, ATM employs NEMO and RIP1 kinase through autocrine TNF-alpha signaling to switch on cytokine production and caspase activation. These results shed light on cell-fate regulation by ATM.	[Biton, Sharon; Ashkenazi, Avi] Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA	Roche Holding; Genentech	Ashkenazi, A (corresponding author), Genentech Inc, Dept Mol Oncol, 1 DNA Way, San Francisco, CA 94080 USA.	aa@gene.com	Ashkenazi, Avi/ABG-2712-2020	Ashkenazi, Avi/0000-0002-6890-4589				Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bartek J, 2006, SCIENCE, V311, P1110, DOI 10.1126/science.1124540; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Criswell T, 2003, ONCOGENE, V22, P5813, DOI 10.1038/sj.onc.1206680; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Engels IH, 2000, ONCOGENE, V19, P4563, DOI 10.1038/sj.onc.1203824; Fumagalli M, 2009, NAT CELL BIOL, V11, P921, DOI 10.1038/ncb0809-921; HANDE KR, 1984, CANCER RES, V44, P379; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hinz M, 2010, MOL CELL, V40, P63, DOI 10.1016/j.molcel.2010.09.008; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Hur GM, 2003, GENE DEV, V17, P873, DOI 10.1101/gad.1062403; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Janssens S, 2006, CELL DEATH DIFFER, V13, P773, DOI 10.1038/sj.cdd.4401843; Janssens S, 2005, CELL, V123, P1079, DOI 10.1016/j.cell.2005.09.036; Jones DT, 2001, BLOOD, V98, P2800, DOI 10.1182/blood.V98.9.2800; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Li NX, 2001, J BIOL CHEM, V276, P8898, DOI 10.1074/jbc.M009809200; Linard C, 2004, INT J RADIAT ONCOL, V58, P427, DOI 10.1016/j.ijrobp.2003.09.039; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; MIYASHITA T, 1994, ONCOGENE, V9, P1799; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Papa S, 2006, CELL DEATH DIFFER, V13, P712, DOI 10.1038/sj.cdd.4401865; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Piret B, 1999, ONCOGENE, V18, P2261, DOI 10.1038/sj.onc.1202541; Rashi-Elkeles S, 2006, ONCOGENE, V25, P1584, DOI 10.1038/sj.onc.1209189; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Sohn D, 2005, J BIOL CHEM, V280, P5267, DOI 10.1074/jbc.M408585200; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Varfolomeev E, 2005, J BIOL CHEM, V280, P40599, DOI 10.1074/jbc.M509560200; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; von Haefen C, 2003, ONCOGENE, V22, P2236, DOI 10.1038/sj.onc.1206280; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Wertz IE, 2010, CELL DEATH DIFFER, V17, P14, DOI 10.1038/cdd.2009.168; Wesselborg S, 1999, BLOOD, V93, P3053, DOI 10.1182/blood.V93.9.3053; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Wong WWL, 2010, CELL DEATH DIFFER, V17, P482, DOI 10.1038/cdd.2009.178; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Wu ZH, 2010, MOL CELL, V40, P75, DOI 10.1016/j.molcel.2010.09.010; Zhou DH, 2001, INT J RADIAT BIOL, V77, P763, DOI 10.1080/09553000110050047	61	210	214	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2011	145	1					92	103		10.1016/j.cell.2011.02.023	http://dx.doi.org/10.1016/j.cell.2011.02.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458669	Bronze			2022-12-28	WOS:000289053900012
J	DeFronzo, RA; Tripathy, D; Schwenke, DC; Banerji, M; Bray, GA; Buchanan, TA; Clement, SC; Henry, RR; Hodis, HN; Kitabchi, AE; Mack, WJ; Mudaliar, S; Ratner, RE; Williams, K; Stentz, FB; Musi, N; Reaven, PD				DeFronzo, Ralph A.; Tripathy, Devjit; Schwenke, Dawn C.; Banerji, MaryAnn; Bray, George A.; Buchanan, Thomas A.; Clement, Stephen C.; Henry, Robert R.; Hodis, Howard N.; Kitabchi, Abbas E.; Mack, Wendy J.; Mudaliar, Sunder; Ratner, Robert E.; Williams, Ken; Stentz, Frankie B.; Musi, Nicolas; Reaven, Peter D.		ACT NOW Study	Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BETA-CELL FUNCTION; LIFE-STYLE INTERVENTION; INTIMA-MEDIA THICKNESS; INSULIN SENSITIVITY; FOLLOW-UP; FASTING GLUCOSE; TYPE-2; ATHEROSCLEROSIS; ASSOCIATION; GLIMEPIRIDE	BACKGROUND Impaired glucose tolerance is associated with increased rates of cardiovascular disease and conversion to type 2 diabetes mellitus. Interventions that may prevent or delay such occurrences are of great clinical importance. METHODS We conducted a randomized, double-blind, placebo-controlled study to examine whether pioglitazone can reduce the risk of type 2 diabetes mellitus in adults with impaired glucose tolerance. A total of 602 patients were randomly assigned to receive pioglitazone or placebo. The median follow-up period was 2.4 years. Fasting glucose was measured quarterly, and oral glucose tolerance tests were performed annually. Conversion to diabetes was confirmed on the basis of the results of repeat testing. RESULTS Annual incidence rates for type 2 diabetes mellitus were 2.1% in the pioglitazone group and 7.6% in the placebo group, and the hazard ratio for conversion to diabetes in the pioglitazone group was 0.28 (95% confidence interval, 0.16 to 0.49; P<0.001). Conversion to normal glucose tolerance occurred in 48% of the patients in the pioglitazone group and 28% of those in the placebo group (P0.001). Treatment with pioglitazone as compared with placebo was associated with significantly reduced levels of fasting glucose (a decrease of 11.7 mg per deciliter vs. 8.1 mg per deciliter [0.7 mmol per liter vs. 0.5 mmol per liter], P0.001), 2-hour glucose (a decrease of 30.5 mg per deciliter vs. 15.6 mg per deciliter [1.6 mmol per liter vs. 0.9 mmol per liter], P0.001), and HbA(1c) (a decrease of 0.04 percentage points vs. an increase of 0.20 percentage points, P0.001). Pioglitazone therapy was also associated with a decrease in diastolic blood pressure (by 2.0 mm Hg vs. 0.0 mm Hg, P = 0.03), a reduced rate of carotid intima-media thickening (31.5%, P = 0.047), and a greater increase in the level of high-density lipoprotein cholesterol (by 7.35 mg per deciliter vs. 4.5 mg per deciliter [0.4 mmol per liter vs. 0.3 mmol per liter], P = 0.008). Weight gain was greater with pioglitazone than with placebo (3.9 kg vs. 0.77 kg, P0.001), and edema was more frequent (12.9% vs. 6.4%, P = 0.007). CONCLUSIONS As compared with placebo, pioglitazone reduced the risk of conversion of impaired glucose tolerance to type 2 diabetes mellitus by 72% but was associated with significant weight gain and edema.	[DeFronzo, Ralph A.] Univ Texas Hlth Sci Ctr San Antonio, Diabet Div, San Antonio, TX 78229 USA; [DeFronzo, Ralph A.; Tripathy, Devjit; Musi, Nicolas] Texas Diabet Inst, San Antonio, TX USA; [Williams, Ken] KenAnCo Biostat, San Antonio, TX USA; [Schwenke, Dawn C.; Reaven, Peter D.] Phoenix Vet Affairs VA Hlth Care Syst, Phoenix, AZ USA; [Schwenke, Dawn C.] Arizona State Univ, Coll Nursing & Hlth Innovat, Phoenix, AZ USA; [Banerji, MaryAnn] SUNY Hlth Sci Ctr, Brooklyn, NY 11203 USA; [Bray, George A.] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [Buchanan, Thomas A.; Hodis, Howard N.; Mack, Wendy J.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Clement, Stephen C.] Georgetown Univ, Div Endocrinol & Metab, Washington, DC USA; [Henry, Robert R.; Mudaliar, Sunder] Univ Calif San Diego, San Diego, CA 92103 USA; [Henry, Robert R.; Mudaliar, Sunder] VA San Diego Healthcare Syst, San Diego, CA USA; [Kitabchi, Abbas E.; Stentz, Frankie B.] Univ Tennessee, Div Endocrinol Diabet & Metab, Memphis, TN USA; [Ratner, Robert E.] Medstar Res Inst, Hyattsville, MD USA	University of Texas System; University of Texas Health San Antonio; Arizona State University; Arizona State University-Downtown Phoenix; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of Southern California; Georgetown University; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of Tennessee System; University of Tennessee Health Science Center	DeFronzo, RA (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Diabet Div, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	albarado@uthscsa.edu	Mudaliar, Sunder/N-5813-2019; Mudaliar, Sunder/R-2781-2019	Schwenke, Dawn/0000-0003-0920-8441; tripathy, devjit/0000-0003-2797-0659	Takeda Pharmaceuticals; General Clinical Research Center (GCRC) at the University of Tennessee Health Science Center [MO1-RR-00221]; GCRC at the University of Southern California Keck School of Medicine [MO1-RR-00043]; BMS; Novartis; Boehringer Ingelheim; Sanofi-Aventis; Merck; Roche; Takeda; Amylin; Eli Lilly; NovoNordisk; Genentech-Roche; GlaxoSmithKline; Bayhill; Halozyme; Integrium; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000043] Funding Source: NIH RePORTER	Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd); General Clinical Research Center (GCRC) at the University of Tennessee Health Science Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); GCRC at the University of Southern California Keck School of Medicine; BMS(Bristol-Myers Squibb); Novartis(Novartis); Boehringer Ingelheim(Boehringer Ingelheim); Sanofi-Aventis(Sanofi-Aventis); Merck(Merck & Company); Roche(Roche Holding); Takeda(Takeda Pharmaceutical Company Ltd); Amylin; Eli Lilly(Eli Lilly); NovoNordisk(Novo Nordisk); Genentech-Roche(Roche HoldingGenentech); GlaxoSmithKline(GlaxoSmithKline); Bayhill; Halozyme; Integrium; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported by Takeda Pharmaceuticals, grants from the General Clinical Research Center (GCRC) at the University of Tennessee Health Science Center (MO1-RR-00221) and the GCRC at the University of Southern California Keck School of Medicine (MO1-RR-00043), and by the Veterans Affairs institutions in Phoenix and San Diego, which contributed their resources and the use of their facilities.; Dr. Banerji reports receiving consulting fees from BMS, Novartis, Boehringer Ingelheim, Sanofi-Aventis, Merck, and Roche, and lecture fees from Merck and Sanofi-Aventis; Dr. Buchanan reports receiving consulting fees and lecture fees from Takeda and reports that the University of Southern California Keck School of Medicine has received grant support from Takeda; Dr. DeFronzo reports receiving payments for board membership from Amylin, Takeda, ISIS, and Boehringer Ingelheim and reports that the University of Texas Health Science Center at San Antonio has received grant support from Takeda, Amylin, and Eli Lilly; Dr. Henry reports receiving consulting fees, lecture fees, and payment for expert testimony from Takeda; Dr. Musi reports receiving consulting fees from Merck, Daiichi-Sankyo, Takeda, and Novartis; Dr. Ratner reports that the Medstar Research Institute has received consulting fees from Amylin, NovoNordisk, Sanofi-Aventis, and Genentech-Roche and grant support from Amylin, NovoNordisk, GlaxoSmithKline, Bayhill, Halozyme, and Integrium; Dr. Reaven reports receiving consulting fees from BMS, lecture fees from Merck, and payment for the devel-opment of educational presentations from Amylin; Dr. Reaven reports that the Carl T. Hayden Veterans Affairs Medical Center has received grant support from Amylin; and Dr. Tripathy reports receiving grant support from Takeda Pharmaceuticals. No other potential conflict of interest relevant to this article was reported.	Abdul-Ghani MA, 2006, DIABETES, V55, P1430, DOI 10.2337/db05-1200; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS55, DOI 10.2337/dc08-S055; BERGMAN RN, 1981, J CLIN INVEST, V68, P1456, DOI 10.1172/JCI110398; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Buchanan T, 2002, DIABETES, V51, pA35; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cheng YJ, 2009, DIABETES CARE, V32, P2027, DOI 10.2337/dc09-0440; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Crouse JR, 2006, J LIPID RES, V47, P1677, DOI 10.1194/jlr.R600012-JLR200; DeFronzo RA, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-17; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Diabetes Prevention Progam, 2005, DIABETES, V54, P1150; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Edelstein SL, 1997, DIABETES, V46, P701, DOI 10.2337/diabetes.46.4.701; Ferrannini E, 2005, J CLIN ENDOCR METAB, V90, P493, DOI 10.1210/jc.2004-1133; Gastaldelli A, 2007, AM J PHYSIOL-ENDOC M, V292, pE871, DOI 10.1152/ajpendo.00551.2006; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; Hodis HN, 2001, ANN INTERN MED, V135, P939, DOI 10.7326/0003-4819-135-11-200112040-00005; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Kalbfleisch D., 1980, STAT ANAL FAILURE TI; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; LACHIN JM, 1988, BIOMETRICS, V44, P923; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Mazzone T, 2006, JAMA-J AM MED ASSOC, V296, P2572, DOI 10.1001/jama.296.21.joc60158; MIYAZAKI M, 2005, BR J DIABETES VASC D, V5, P28, DOI DOI 10.1177/14746514050050010601; Miyazaki Y, 2001, DIABETES CARE, V24, P710, DOI 10.2337/diacare.24.4.710; Nathan DM, 2007, DIABETIC MED, V24, P137; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nissen SE, 2007, NEW ENGL J MED, V357, P100; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1561, DOI 10.1001/jama.299.13.1561; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; *WHO, 2007, DIAB PROGR FACTS FIG; Xiang AH, 2006, DIABETES, V55, P517, DOI 10.2337/diabetes.55.02.06.db05-1066; Ziegler D, 2008, DIABETES CARE, V31, P464, DOI 10.2337/dc07-1796	40	501	520	0	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2011	364	12					1104	1115		10.1056/NEJMoa1010949	http://dx.doi.org/10.1056/NEJMoa1010949			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739FY	21428766	Bronze			2022-12-28	WOS:000288701100005
J	Monroe, MH				Monroe, Michael H.			Drawer on the Right	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												mmonroe@carolinas.org							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2011	305	12					1176	1177		10.1001/jama.2011.343	http://dx.doi.org/10.1001/jama.2011.343			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738PA	21427364				2022-12-28	WOS:000288652100001
J	Spence, D				Spence, Des			From the Frontline Systematic failures and alternatives to audit	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 23	2011	342								d1840	10.1136/bmj.d1840	http://dx.doi.org/10.1136/bmj.d1840			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	742MJ	21429996				2022-12-28	WOS:000288948000025
J	Arkin, AP; Schaffer, DV				Arkin, Adam P.; Schaffer, David V.			Network News: Innovations in 21st Century Systems Biology	CELL			English	Article							STOCHASTIC GENE-EXPRESSION; MOTIFS; GENOME; CELLS; STRATEGIES; DIVERSITY; PATHWAY; MODULE; MODEL; YEAST	A decade ago, seminal perspectives and papers set a strong vision for the field of systems biology, and a number of these themes have flourished. Here, we describe key technologies and insights that have elucidated the evolution, architecture, and function of cellular networks, ultimately leading to the first predictive genome-scale regulatory and metabolic models of organisms. Can systems approaches bridge the gap between correlative analysis and mechanistic insights?	[Arkin, Adam P.; Schaffer, David V.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Schaffer, David V.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Schaffer, David V.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Arkin, Adam P.; Schaffer, David V.] EO Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Arkin, AP (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	aparkin@lbl.gov	Arkin, Adam/M-9941-2019; Arkin, Adam P/A-6751-2008	Arkin, Adam/0000-0002-4999-2931; Arkin, Adam P/0000-0002-4999-2931	National Institutes of Health [R01 GM073010-01]; Office of Science, Office of Biological and Environmental Research of the US Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science, Office of Biological and Environmental Research of the US Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank our colleagues for suggesting a number of the papers that we reference in this work, and we apologize for not being able to include all of them. The authors would like to acknowledge the National Institutes of Health (R01 GM073010-01), and work conducted by ENIGMA was supported by the Office of Science, Office of Biological and Environmental Research of the US Department of Energy under contract number DE-AC02-05CH11231.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Arkin A, 1997, SCIENCE, V277, P1275, DOI 10.1126/science.277.5330.1275; Arkin A, 1998, GENETICS, V149, P1633; BEKEY GA, 1978, AUTOMATICA, V14, P41, DOI 10.1016/0005-1098(78)90075-4; Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; CANON W, 1939, WISDOM BODY; Carlson Robert, 2003, Biosecur Bioterror, V1, P203, DOI 10.1089/153871303769201851; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Cheng Y., 2000, P 8 INT C INT SYST M, P93; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Earl DJ, 2004, P NATL ACAD SCI USA, V101, P11531, DOI 10.1073/pnas.0404656101; El Samad H, 2005, P 16 IFAC WORLD C; El-Samad H, 2005, P NATL ACAD SCI USA, V102, P2736, DOI 10.1073/pnas.0403510102; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Hartemink A J, 2001, Pac Symp Biocomput, P422; HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; JACOB F, 1961, COLD SPRING HARB SYM, V26, P193, DOI 10.1101/SQB.1961.026.01.024; Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Moore G., 1965, ELECTRONICS, V38, P114, DOI [DOI 10.1109/N-SSC.2006.4785860, DOI 10.1109/JPROC.1998.658762]; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Price MN, 2007, PLOS COMPUT BIOL, V3, P1739, DOI 10.1371/journal.pcbi.0030175; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rao CV, 2001, ANNU REV BIOMED ENG, V3, P391, DOI 10.1146/annurev.bioeng.3.1.391; Rosenblueth A., 1943, PHILOS SCI, V10, P18, DOI 10.1086/286788; Rzhetsky A, 2001, BIOINFORMATICS, V17, P988, DOI 10.1093/bioinformatics/17.10.988; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Singh AH, 2008, P NATL ACAD SCI USA, V105, P7500, DOI 10.1073/pnas.0709764105; Voigt CA, 2005, GENETICS, V169, P1187, DOI 10.1534/genetics.104.031955; WADDINGTON CH, 1954, P 9 INT C GEN, V9, P232; Waddington CH, 1977, TOOLS THOUGHT UNDERS; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Warner JR, 2010, NAT BIOTECHNOL, V28, P856, DOI 10.1038/nbt.1653; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Wolf DM, 2005, J THEOR BIOL, V234, P227, DOI 10.1016/j.jtbi.2004.11.020; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Zhou JZ, 2010, MBIO, V1, DOI 10.1128/mBio.00169-10	54	35	38	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 18	2011	144	6					844	849		10.1016/j.cell.2011.03.008	http://dx.doi.org/10.1016/j.cell.2011.03.008			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	737BQ	21414475	Bronze			2022-12-28	WOS:000288543500002
J	Macilwain, C				Macilwain, Colin			Systems Biology: Evolving into the Mainstream	CELL			English	Editorial Material								Systems approaches to biology are steadily widening their reach, but the road to integration and acceptance has been fraught with skepticism and technical hurdles. Interdisciplinary research teams at systems biology centers around the globe are working to win over the critics.											0	16	18	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 18	2011	144	6					839	841		10.1016/j.cell.2011.02.044	http://dx.doi.org/10.1016/j.cell.2011.02.044			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	737BQ	21414474	Bronze			2022-12-28	WOS:000288543500001
J	Spencer, SL; Sorger, PK				Spencer, Sabrina L.; Sorger, Peter K.			Measuring and Modeling Apoptosis in Single Cells	CELL			English	Review							CYTOCHROME-C; MEMBRANE PERMEABILIZATION; SMAC/DIABLO RELEASE; CASPASE ACTIVATION; BAX-ACTIVATION; CANCER-CELLS; GENE; DYNAMICS; BISTABILITY; SWITCH	Cell death plays an essential role in the development of tissues and organisms, the etiology of disease, and the responses of cells to therapeutic drugs. Here we review progress made over the last decade in using mathematical models and quantitative, often single-cell, data to study apoptosis. We discuss the delay that follows exposure of cells to prodeath stimuli, control of mitochondrial outer membrane permeabilization, switch-like activation of effector caspases, and variability in the timing and probability of death from one cell to the next. Finally, we discuss challenges facing the fields of biochemical modeling and systems pharmacology.	[Spencer, Sabrina L.; Sorger, Peter K.] Harvard Univ, Sch Med, Dept Syst Biol, Ctr Cell Decis Proc, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Sorger, PK (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Ctr Cell Decis Proc, Boston, MA 02115 USA.	peter_sorger@hms.harvard.edu		SPENCER, SABRINA/0000-0002-5798-3007; Sorger, Peter/0000-0002-3364-1838	NIH [GM68762, CA139980]; NATIONAL CANCER INSTITUTE [P01CA139980, R01CA164448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank J. Albeck, J. Bachman, D. Flusberg, S. Gaudet, T. Letai, and C. Lopez for their help and acknowledge NIH grants GM68762 and CA139980 for support.	Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Albeck JG, 2006, NAT REV MOL CELL BIO, V7, P803, DOI 10.1038/nrm2042; Albeck JG, 2008, PLOS BIOL, V6, P2831, DOI 10.1371/journal.pbio.0060299; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Bagci EZ, 2006, BIOPHYS J, V90, P1546, DOI 10.1529/biophysj.105.068122; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Betti CJ, 2005, LEUKEMIA, V19, P2289, DOI 10.1038/sj.leu.2403966; Bhola PD, 2009, J CELL SCI, V122, P4296, DOI 10.1242/jcs.055590; Borges Jorge Luis, 1999, COLLECTED FICTIONS; Calzone L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000702; Chabner B., 2006, CANC CHEMOTHERAPY BI; Chen C, 2007, BIOPHYS J, V92, P4304, DOI 10.1529/biophysj.106.099606; Chen WW, 2010, GENE DEV, V24, P1861, DOI 10.1101/gad.1945410; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Condeelis J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003848; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Dussmann H, 2010, CELL DEATH DIFFER, V17, P278, DOI 10.1038/cdd.2009.123; Edgington LE, 2009, NAT MED, V15, P967, DOI 10.1038/nm.1938; Eissing T, 2005, IEE P SYST BIOL, V152, P221, DOI 10.1049/ip-syb:20050046; Eissing T, 2004, J BIOL CHEM, V279, P36892, DOI 10.1074/jbc.M404893200; Fadeel B, 1999, BIOCHEM BIOPH RES CO, V266, P699, DOI 10.1006/bbrc.1999.1888; Faeder James R., 2009, V500, P113, DOI 10.1007/978-1-59745-525-1_5; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Fricker N, 2010, J CELL BIOL, V190, P377, DOI 10.1083/jcb.201002060; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Fussenegger M, 2000, NAT BIOTECHNOL, V18, P768, DOI 10.1038/77589; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Goldstein JC, 2005, CELL DEATH DIFFER, V12, P453, DOI 10.1038/sj.cdd.4401596; Goldstein JC, 2000, ANN NY ACAD SCI, V926, P132; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Green DR, 2011, MEANS END APOPTOSIS; Hellwig CT, 2008, J BIOL CHEM, V283, P21676, DOI 10.1074/jbc.M802889200; Hellwig CT, 2010, J CELL SCI, V123, P1401, DOI 10.1242/jcs.061143; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hlavacek William S, 2006, Sci STKE, V2006, pre6, DOI 10.1126/stke.3442006re6; Ho KL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000956; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hua F, 2005, J IMMUNOL, V175, P985, DOI 10.4049/jimmunol.175.2.985; Huang HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015724; Jaqaman K, 2006, NAT REV MOL CELL BIO, V7, P813, DOI 10.1038/nrm2030; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; Kim KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-202; KORSMEYER SJ, 1993, SEMIN CANCER BIOL, V4, P327; Krishna S, 2005, P NATL ACAD SCI USA, V102, P4771, DOI 10.1073/pnas.0406415102; Lavrik IN, 2007, J BIOL CHEM, V282, P13664, DOI 10.1074/jbc.M700434200; Lee TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000599; Legewie S, 2006, PLOS COMPUT BIOL, V2, P1061, DOI 10.1371/journal.pcbi.0020120; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Lovric MM, 2010, ONCOGENE, V29, P5048, DOI 10.1038/onc.2010.242; Luan D, 2007, PLOS COMPUT BIOL, V3, P1347, DOI 10.1371/journal.pcbi.0030142; Luo KQ, 2003, BIOCHEM BIOPH RES CO, V304, P217, DOI 10.1016/S0006-291X(03)00559-X; Maas C, 2010, CELL DEATH DIFFER, V17, P1613, DOI 10.1038/cdd.2010.39; Madesh M, 2002, J BIOL CHEM, V277, P5651, DOI 10.1074/jbc.M108171200; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Neumann L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.6; Niepel M, 2009, CURR OPIN CHEM BIOL, V13, P556, DOI 10.1016/j.cbpa.2009.09.015; Orth JD, 2008, MOL CANCER THER, V7, P3480, DOI 10.1158/1535-7163.MCT-08-0684; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Rehm M, 2003, J CELL BIOL, V162, P1031, DOI 10.1083/jcb.200303123; Rehm M, 2002, J BIOL CHEM, V277, P24506, DOI 10.1074/jbc.M110789200; Rehm M, 2009, CELL DEATH DIFFER, V16, P613, DOI 10.1038/cdd.2008.187; Rehm M, 2006, EMBO J, V25, P4338, DOI 10.1038/sj.emboj.7601295; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schile AJ, 2008, GENE DEV, V22, P2256, DOI 10.1101/gad.1663108; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Skeel RT., 2003, HDB CANC CHEMOTHERAP, V6; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; Stennicke HR, 2000, BIOCHEM J, V350, P563, DOI 10.1042/0264-6021:3500563; Sun TZ, 2010, FEBS LETT, V584, P954, DOI 10.1016/j.febslet.2010.01.034; Tait SWG, 2010, DEV CELL, V18, P802, DOI [10.1016/j.devcel.2010.03.014, 10.1016/j.devce1.2010.03.014]; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Tyas L, 2000, EMBO REP, V1, P266, DOI 10.1093/embo-reports/kvd050; Vaughan AT, 2005, CHEM-BIOL INTERACT, V153, P179, DOI 10.1016/j.cbi.2005.03.022; Vaughan ATM, 2002, APOPTOSIS, V7, P173, DOI 10.1023/A:1014374717773; Villalobos Michael J, 2006, Methods Mol Biol, V314, P109; von Ahsen O, 2000, J CELL BIOL, V150, P1027, DOI 10.1083/jcb.150.5.1027; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Wurstle ML, 2010, J BIOL CHEM, V285, P33209, DOI 10.1074/jbc.M110.113860; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792; ZHENG Q, 1991, J CHEM PHYS, V94, P3644, DOI 10.1063/1.459735	93	235	246	1	98	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 18	2011	144	6					926	939		10.1016/j.cell.2011.03.002	http://dx.doi.org/10.1016/j.cell.2011.03.002			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	737BQ	21414484	Bronze, Green Accepted			2022-12-28	WOS:000288543500011
J	Palumbo, A; Anderson, K				Palumbo, Antonio; Anderson, Kenneth			MEDICAL PROGRESS Multiple Myeloma	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							STEM-CELL TRANSPLANTATION; PREDNISONE PLUS THALIDOMIDE; HIGH-DOSE DEXAMETHASONE; LONG-TERM SURVIVAL; ELDERLY-PATIENTS; PHASE-III; MOLECULAR CLASSIFICATION; COMBINATION THERAPY; INITIAL TREATMENT; COMPLETE RESPONSE	Multiple myeloma is a neoplastic plasma-cell disorder that is characterized by clonal proliferation of malignant plasma cells in the bone marrow microenvironment, monoclonal protein in the blood or urine, and associated organ dysfunction.(1) It accounts for approximately 1% of neoplastic diseases and 13% of hematologic cancers. In Western countries, the annual ageadjusted incidence is 5.6 cases per 100,000 persons.(2) The median age at diagnosis is approximately 70 years; 37% of patients are younger than 65 years, 26% are between the ages of 65 and 74 years, and 37% are 75 years of age or older.(2,3) In recent years, the introduction of autologous stem-cell transplantation and the availability of agents such as thalidomide, lenalidomide, and bortezomib have changed the management of myeloma and extended overall survival. 3-5 In patients presenting at an age under 60 years, 10-year survival is approximately 30%.(4)	[Palumbo, Antonio] Univ Turin, Div Hematol, Myeloma Unit, AOU S Giovanni Battista, I-10126 Turin, Italy; [Anderson, Kenneth] Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Hematolg Neoplasia,Dept Med, Boston, MA 02115 USA	A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Palumbo, A (corresponding author), Univ Turin, Div Hematol, Myeloma Unit, AOU S Giovanni Battista, Via Genova 3, I-10126 Turin, Italy.	appalumbo@yahoo.com			Celgene; Janssen-Cilag; Merck; Amgen	Celgene(Bristol-Myers SquibbCelgene Corporation); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); Amgen(Amgen)	Dr. Palumbo reports receiving fees for advisory board membership, consulting fees, and payment for the development of educational presentations from Celgene and Janssen-Cilag and lecture fees from Celgene, Janssen-Cilag, Merck, and Amgen; and Dr. Anderson, receiving fees for advisory board membership from Bristol-Myers Squibb, Celgene, Novartis, Onyx, Merck, and Millennium and being a founder of Acetylon. No other potential conflict of interest relevant to this article was reported.	Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; ALTEKRUSE SF, 1975, SEER CANC STAT REV; Alvares CL, 2006, HAEMATOLOGICA, V91, P141; Anderson KC, 2009, J NATL COMPR CANC NE, V7, P908, DOI 10.6004/jnccn.2009.0061; [Anonymous], 1990, World Health Organ Tech Rep Ser, V804, P1; Attal M, 2003, NEW ENGL J MED, V349, P2495, DOI 10.1056/NEJMoa032290; Attal M, 2004, NEW ENGL J MED, V350, P2628; Attal M, 2010, J CLIN ONCOL S, V28, p577s; Attal M, 2006, BLOOD, V108, P3289, DOI 10.1182/blood-2006-05-022962; Avet-Loiseau H, 2010, LEUKEMIA, V24, P623, DOI 10.1038/leu.2009.273; Avet-Loiseau H, 2007, BLOOD, V109, P3489, DOI 10.1182/blood-2006-08-040410; Avet-Loiseau H, 2010, J CLIN ONCOL, V28, P4630, DOI 10.1200/JCO.2010.28.3945; Barlogie B, 2006, NEW ENGL J MED, V354, P1021, DOI 10.1056/NEJMoa053583; Bergsagel PL, 2005, J CLIN ONCOL, V23, P6333, DOI 10.1200/JCO.2005.05.021; Birgegard G, 2006, EUR J HAEMATOL, V77, P378, DOI 10.1111/j.1600-0609.2006.00739.x; Brenner H, 2008, BLOOD, V111, P2521, DOI 10.1182/blood-2007-08-104984; Bruno B, 2007, NEW ENGL J MED, V356, P1110, DOI 10.1056/NEJMoa065464; Cavo M, 2007, J CLIN ONCOL, V25, P2434, DOI 10.1200/JCO.2006.10.2509; Cavo M, 2009, BLOOD, V114, P148; Dickinson M, 2009, INTERN MED J, V39, P304, DOI 10.1111/j.1445-5994.2008.01824.x; Dimopoulos M, 2009, LEUKEMIA, V23, P1545, DOI 10.1038/leu.2009.89; Dimopoulos M, 2009, NEW ENGL J MED, V361, P544; Dimopoulos MA, 2008, LEUKEMIA, V22, P1485, DOI 10.1038/leu.2008.131; Dispenzieri A, 2009, LEUKEMIA, V23, P215, DOI 10.1038/leu.2008.307; Durie BGM, 2007, LEUKEMIA, V21, P1134, DOI 10.1038/sj.leu.2404582; Durie BGM, 2004, HEMATOL J, V5, P285, DOI 10.1038/sj.thj.6200402; Eleutherakis-Papaiakovou V, 2007, LEUKEMIA LYMPHOMA, V48, P337, DOI 10.1080/10428190601126602; Facon T, 2007, LANCET, V370, P1209, DOI 10.1016/S0140-6736(07)61537-2; Fermand J, 2005, J CLIN ONCOL, V23, P9227, DOI 10.1200/JCO.2005.03.0551; Fonseca R, 2009, LEUKEMIA, V23, P2210, DOI 10.1038/leu.2009.174; Garban F, 2006, BLOOD, V107, P3474, DOI 10.1182/blood-2005-09-3869; Gay F, 2010, HAEMATOL-HEMATOL J, V95, P236; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Harousseau JL, 2010, J CLIN ONCOL, V28, P4621, DOI 10.1200/JCO.2009.27.9158; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; Hulin C, 2009, J CLIN ONCOL, V27, P3664, DOI 10.1200/JCO.2008.21.0948; Hussein MA, 2008, LEUKEMIA, V22, P1479, DOI 10.1038/leu.2008.127; Lahuerta JJ, 2008, J CLIN ONCOL, V26, P5775, DOI 10.1200/JCO.2008.17.9721; Kastritis E, 2009, SEMIN HEMATOL, V46, P143, DOI 10.1053/j.seminhematol.2009.01.004; Kristinsson SY, 2007, J CLIN ONCOL, V25, P1993, DOI 10.1200/JCO.2006.09.0100; Kuehl WM, 2002, NAT REV CANCER, V2, P175, DOI 10.1038/nrc746; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Kumar SK, 2009, MAYO CLIN PROC, V84, P1095, DOI 10.4065/mcp.2009.0603; Kyle RA, 2010, LEUKEMIA, V24, P1121, DOI 10.1038/leu.2010.60; Kyle RA, 2009, LEUKEMIA, V23, P3, DOI 10.1038/leu.2008.291; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Kyle RA, 2003, MAYO CLIN PROC, V78, P21, DOI 10.4065/78.1.21; Kyle RA, 2005, NEW ENGL J MED, V352, P1163; Kyle RA, 2007, NEW ENGL J MED, V356, P2582, DOI 10.1056/NEJMoa070389; Kyle RA, 2009, CLIN LYMPHOMA MYELOM, V9, P278, DOI 10.3816/CLM.2009.n.056; Ladetto M, 2010, J CLIN ONCOL, V28, P2077, DOI 10.1200/JCO.2009.23.7172; LEIGH BR, 1993, INT J RADIAT ONCOL, V25, P801, DOI 10.1016/0360-3016(93)90308-I; Lonial S, 2008, BRIT J HAEMATOL, V143, P222, DOI 10.1111/j.1365-2141.2008.07321.x; Ludwig H, 2010, HAEMATOL-HEMATOL J, V95, P1548, DOI 10.3324/haematol.2009.020586; Mateos MV, 2010, LANCET ONCOL, V11, P934, DOI 10.1016/S1470-2045(10)70187-X; Mateos MV, 2010, J CLIN ONCOL, V28, P2259, DOI 10.1200/JCO.2009.26.0638; McCarthy PL, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.8017; Mikhael JR, 2009, BRIT J HAEMATOL, V144, P169, DOI 10.1111/j.1365-2141.2008.07409.x; Morgan G, 2010, HAEMATOLOGICA S, V95, P232; Morgan GJ, 2008, BLOOD, V112, P656; Nair B, 2010, BLOOD, V115, P4168, DOI 10.1182/blood-2009-11-255620; Nucci M, 2009, CLIN INFECT DIS, V49, P1211, DOI 10.1086/605664; Ocio EM, 2008, LANCET ONCOL, V9, P1157, DOI 10.1016/S1470-2045(08)70304-8; Orlowski RZ, 2007, J CLIN ONCOL, V25, P3892, DOI 10.1200/JCO.2006.10.5460; Paiva B, 2008, BLOOD, V112, P4017, DOI 10.1182/blood-2008-05-159624; Palumbo A, 2008, LEUKEMIA, V22, P414, DOI 10.1038/sj.leu.2405062; Palumbo A, 2010, BLOOD, V116, P2195, DOI 10.1182/blood.V116.21.1940.1940; Palumbo A, 2009, LEUKEMIA, V23, P1716, DOI 10.1038/leu.2009.122; Palumbo A, 2006, LANCET, V367, P825, DOI 10.1016/S0140-6736(06)68338-4; Palumbo A, 2008, BLOOD, V112, P3107, DOI 10.1182/blood-2008-04-149427; Palumbo Antonio, 2009, Hematology Am Soc Hematol Educ Program, P566, DOI 10.1182/asheducation-2009.1.566; Palumbo A, 2010, J CLIN ONCOL, V28, P5101, DOI 10.1200/JCO.2010.29.8216; Palumbo A, 2010, J CLIN ONCOL, V28, P800, DOI 10.1200/JCO.2009.22.7561; Palumbo AP, 2010, J CLIN ONCOL S, V28, p576s; Podar K, 2002, J BIOL CHEM, V277, P7875, DOI 10.1074/jbc.M109068200; Quach H, 2010, LEUKEMIA, V24, P22, DOI 10.1038/leu.2009.236; Rajkumar SV, 2010, LANCET ONCOL, V11, P14; Rajkumar SV, 2008, J CLIN ONCOL, V26, P2171, DOI 10.1200/JCO.2007.14.1853; Reeder CB, 2009, LEUKEMIA, V23, P1337, DOI 10.1038/leu.2009.26; Richardson PG, 2007, BLOOD, V110, P3557, DOI 10.1182/blood-2006-08-036947; Richardson PG, 2010, BLOOD, V116, P679, DOI 10.1182/blood-2010-02-268862; Richardson PG, 2009, BRIT J HAEMATOL, V144, P895, DOI 10.1111/j.1365-2141.2008.07573.x; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Rizzo JD, 2008, J CLIN ONCOL, V26, P132, DOI 10.1200/JCO.2007.14.3396; Roccaro AM, 2009, BLOOD, V113, P6669, DOI 10.1182/blood-2009-01-198408; Roodman GD, 2009, LEUKEMIA, V23, P435, DOI 10.1038/leu.2008.336; San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479; San-Miguel J, 2008, J CLIN ONCOL, V26, P2761, DOI 10.1200/JCO.2007.15.2546; Sonneveld P, 2010, ASH ANN M, V116, P40; Spencer A, 2009, J CLIN ONCOL, V27, P1788, DOI 10.1200/JCO.2008.18.8573; Stewart AK, 2009, BLOOD, V114, P5436, DOI 10.1182/blood-2009-07-204651; Stewart AF, 2005, NEW ENGL J MED, V352, P373, DOI 10.1056/NEJMcp042806; Stewart KA, 2010, BLOOD, V115, P4006; Terpos E, 2009, ANN ONCOL, V20, P1303, DOI 10.1093/annonc/mdn796; van de Donk NWCJ, 2010, BRIT J HAEMATOL, V148, P335, DOI 10.1111/j.1365-2141.2009.07931.x; van de Velde HJK, 2007, HAEMATOLOGICA, V92, P1399, DOI 10.3324/haematol.11534; Waage A, 2010, J CLIN ONCOL S, V28, p605s; Waage A, 2010, BLOOD, V116, P1405, DOI 10.1182/blood-2009-08-237974; Weber DM, 2007, NEW ENGL J MED, V357, P2133, DOI 10.1056/NEJMoa070596; Wijermans P, 2010, J CLIN ONCOL, V28, P3160, DOI 10.1200/JCO.2009.26.1610; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458; Zhou Y, 2009, LEUKEMIA, V23, P1941, DOI 10.1038/leu.2009.160; Zonder JA, 2010, BLOOD, V116, P5838, DOI 10.1182/blood-2010-08-303487	103	1694	1783	3	222	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2011	364	11					1046	1060		10.1056/NEJMra1011442	http://dx.doi.org/10.1056/NEJMra1011442			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735SX	21410373				2022-12-28	WOS:000288439000010
J	Showalter, MR; Hedman, MM; Burns, JA				Showalter, Mark R.; Hedman, Matthew M.; Burns, Joseph A.			The Impact of Comet Shoemaker-Levy 9 Sends Ripples Through the Rings of Jupiter	SCIENCE			English	Article							SIZE; SYSTEM	Jupiter's main ring shows vertical corrugations reminiscent of those recently detected in the rings of Saturn. The Galileo spacecraft imaged a pair of superimposed ripple patterns in 1996 and again in 2000. These patterns behave as two independent spirals, each winding up at a rate defined by Jupiter's gravity field. The dominant pattern originated between July and October 1994, when the entire ring was tilted by about 2 kilometers. We associate this with the Shoemaker-Levy 9 impacts of July 1994. New Horizons images still show this pattern 13 years later and suggest that subsequent events may also have tilted the ring. Impacts by comets or their dust streams are regular occurrences in planetary rings, altering them in ways that remain detectable decades later.	[Showalter, Mark R.] SETI Inst, Mountain View, CA 94043 USA; [Hedman, Matthew M.; Burns, Joseph A.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA	Cornell University	Showalter, MR (corresponding author), SETI Inst, 189 Bernardo Ave, Mountain View, CA 94043 USA.	mshowalter@seti.org		Hedman, Matthew/0000-0002-8592-0812	NASA [NNX09AD97G]	NASA(National Aeronautics & Space Administration (NASA))	M.R.S. acknowledges the support of NASA's Jupiter Data Analysis Program through grant NNX09AD97G. J.A.B. has been funded by NASA's Planetary Geology and Geophysics Program.	Asphaug E, 1996, ICARUS, V121, P225, DOI 10.1006/icar.1996.0083; Brooks SM, 2004, ICARUS, V170, P35, DOI 10.1016/j.icarus.2004.03.003; BURNS JA, 1979, ICARUS, V40, P1, DOI 10.1016/0019-1035(79)90050-2; Burns JA, 2004, CAMB PLANET, P241; CHODAS PW, 1996, COLLISION COMET SHOE, P1; Hahn JM, 2000, ICARUS, V146, P501, DOI 10.1006/icar.2000.6403; Hedman MM, 2011, SCIENCE, V332, P708, DOI 10.1126/science.1202238; Hedman MM, 2007, ICARUS, V188, P89, DOI 10.1016/j.icarus.2006.11.017; Jacobson R., 2001, B AAA, V33, P1039; Ockert-Bell ME, 1999, ICARUS, V138, P188, DOI 10.1006/icar.1998.6072; Sanchez-Lavega A, 2010, ASTROPHYS J LETT, V715, pL155, DOI 10.1088/2041-8205/715/2/L155; Sekanina Z, 1998, PLANET SPACE SCI, V46, P21, DOI 10.1016/S0032-0633(97)00115-3; SEKANINA Z, 1994, ASTRON ASTROPHYS, V289, P607; Showalter MR, 2007, SCIENCE, V318, P232, DOI 10.1126/science.1147647; SHOWALTER MR, 1987, ICARUS, V69, P458, DOI 10.1016/0019-1035(87)90018-2; WEAVER HA, 1994, SCIENCE, V263, P787, DOI 10.1126/science.263.5148.787; Zahnle K, 1998, ICARUS, V136, P202, DOI 10.1006/icar.1998.6015; ZAMARASHKINA M, 2002, P ACM, V500, P457	19	17	17	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 6	2011	332	6030					711	713		10.1126/science.1202241	http://dx.doi.org/10.1126/science.1202241			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21454755				2022-12-28	WOS:000290265800041
J	Cao, Y; Jin, XS; Levin, EJ; Huang, H; Zong, YN; Quick, M; Weng, J; Pan, YP; Love, J; Punta, M; Rost, B; Hendrickson, WA; Javitch, JA; Rajashankar, KR; Zhou, M				Cao, Yu; Jin, Xiangshu; Levin, Elena J.; Huang, Hua; Zong, Yinong; Quick, Matthias; Weng, Jun; Pan, Yaping; Love, James; Punta, Marco; Rost, Burkhard; Hendrickson, Wayne A.; Javitch, Jonathan A.; Rajashankar, Kanagalaghatta R.; Zhou, Ming			Crystal structure of a phosphorylation-coupled saccharide transporter	NATURE			English	Article							COLI MANNITOL PERMEASE; BACTERIAL PHOSPHOTRANSFERASE SYSTEM; ESCHERICHIA-COLI; MEMBRANE TOPOLOGY; CARBOHYDRATE TRANSPORTERS; CHITIN DISACCHARIDE; SUBSTRATE-BINDING; PHOSPHOENOLPYRUVATE; PROTEIN; N,N'-DIACETYLCHITOBIOSE	Saccharides have a central role in the nutrition of all living organisms. Whereas several saccharide uptake systems are shared between the different phylogenetic kingdoms, the phosphoenolpyruvate-dependent phosphotransferase system exists almost exclusively in bacteria. This multi-component system includes an integral membrane protein EIIC that transports saccharides and assists in their phosphorylation. Here we present the crystal structure of an EIIC from Bacillus cereus that transports diacetylchitobiose. The EIIC is a homodimer, with an expansive interface formed between the amino-terminal halves of the two protomers. The carboxy-terminal half of each protomer has a large binding pocket that contains a diacetylchitobiose, which is occluded from both sides of the membrane with its site of phosphorylation near the conserved His 250 and Glu 334 residues. The structure shows the architecture of this important class of transporters, identifies the determinants of substrate binding and phosphorylation, and provides a framework for understanding the mechanism of sugar translocation.	[Cao, Yu; Levin, Elena J.; Huang, Hua; Weng, Jun; Pan, Yaping; Zhou, Ming] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Jin, Xiangshu] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Zong, Yinong] Sanford Burnham Inst, La Jolla, CA 92037 USA; [Quick, Matthias; Javitch, Jonathan A.] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Quick, Matthias; Javitch, Jonathan A.] Columbia Univ, Ctr Mol Recognit, New York, NY 10032 USA; [Quick, Matthias; Javitch, Jonathan A.] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Love, James; Punta, Marco; Rost, Burkhard; Hendrickson, Wayne A.] New York Struct Biol Ctr, New York Consortium Membrane Prot Struct, New York, NY 10027 USA; [Punta, Marco; Rost, Burkhard] Tech Univ Munich, Dept Comp Sci, D-85748 Munich, Germany; [Punta, Marco; Rost, Burkhard] Tech Univ Munich, Inst Adv Study, D-85748 Munich, Germany; [Javitch, Jonathan A.] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Dept Chem & Chem Biol, NE CAT, Adv Photon Source, Argonne, IL 60439 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; Sanford Burnham Prebys Medical Discovery Institute; Columbia University; Columbia University; New York State Psychiatry Institute; Technical University of Munich; Technical University of Munich; Columbia University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory	Zhou, M (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, 630 W 168th St, New York, NY 10032 USA.	mz2140@columbia.edu	Rost, Burkhard/A-1908-2016; Punta, Marco/ABH-4698-2020; Cao, Yu/GNP-6653-2022	Rost, Burkhard/0000-0003-0179-8424; Punta, Marco/0000-0002-0050-0676; Cao, Yu/0000-0003-1409-2068; Jin, Xiangshu/0000-0002-6551-8850; Javitch, Jonathan/0000-0001-7395-2967	US National Institutes of Health [DK088057, GM098878, GM05026-sub0007, T32HL087745];  [GM05026]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL087745, R01HL086392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Data for this study were measured at beamlines X4A, X4C, X25 and X29 of the National Synchrotron Light Source and the NE-CAT 24ID-C and E at the Advanced Photon Source. This work was supported by the US National Institutes of Health (DK088057, GM098878 and GM05026-sub0007 to M.Z., and T32HL087745 to E.J.L.). M.Z. is a Pew Scholar in Biomedical Sciences. The NYCOMPS central facility was supported by GM05026 to W.A.H. as part of the Protein Structure Initiative (PSI-2) established by the National Institute of General Medical Sciences. The authors would like to thank B. Honig for support and M. Saier, B. Erni, R. Kaback and D.-N. Wang for comments on the manuscript and helpful discussions. M.Z. is grateful to R. MacKinnon for advice and encouragement.	Abramson J, 2004, CURR OPIN STRUC BIOL, V14, P413, DOI 10.1016/j.sbi.2004.07.005; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BUHR A, 1993, J BIOL CHEM, V268, P11599; Chen Q, 1998, BIOCHEMISTRY-US, V37, P8714, DOI 10.1021/bi9731652; Cowtan K, 1999, ACTA CRYSTALLOGR D, V55, P1555, DOI 10.1107/S0907444999007416; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERNI B, 1986, BIOCHEMISTRY-US, V25, P305, DOI 10.1021/bi00350a004; Keyhani NO, 2000, J BIOL CHEM, V275, P33084, DOI 10.1074/jbc.M001043200; Keyhani NO, 1997, P NATL ACAD SCI USA, V94, P14367, DOI 10.1073/pnas.94.26.14367; KHANDEKAR SS, 1989, J CELL BIOCHEM, V39, P207, DOI 10.1002/jcb.240390212; Koning RI, 1999, J MOL BIOL, V287, P845, DOI 10.1006/jmbi.1999.2650; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; KUNDIG W, 1964, P NATL ACAD SCI USA, V52, P1067, DOI 10.1073/pnas.52.4.1067; Lemieux MJ, 2004, CURR OPIN STRUC BIOL, V14, P405, DOI 10.1016/j.sbi.2004.06.003; Levin EJ, 2009, NATURE, V462, P757, DOI 10.1038/nature08558; Love James, 2010, Journal of Structural and Functional Genomics, V11, P191, DOI 10.1007/s10969-010-9094-7; MEADOW ND, 1990, ANNU REV BIOCHEM, V59, P497, DOI 10.1146/annurev.biochem.59.1.497; Nguyen TX, 2006, J MOL MICROB BIOTECH, V11, P345, DOI 10.1159/000095636; Opacic M, 2010, J BIOL CHEM, V285, P25324, DOI 10.1074/jbc.M110.122523; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAS HH, 1987, BIOCHEMISTRY-US, V26, P6689, DOI 10.1021/bi00395a019; POSTMA PW, 1985, MICROBIOL REV, V49, P232, DOI 10.1128/MMBR.49.3.232-269.1985; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Punta Marco, 2009, Journal of Structural and Functional Genomics, V10, P255, DOI 10.1007/s10969-009-9071-1; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; REPHAELI AW, 1980, J BACTERIOL, V141, P658, DOI 10.1128/JB.141.2.658-663.1980; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Robillard GT, 1999, BBA-REV BIOMEMBRANES, V1422, P73, DOI 10.1016/S0304-4157(99)00002-7; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Saier MH, 2005, BIOCHEM SOC T, V33, P220, DOI 10.1042/BST0330220; SaraceniRichards CA, 1997, J BACTERIOL, V179, P1135, DOI 10.1128/jb.179.4.1135-1142.1997; SaraceniRichards CA, 1997, J BACTERIOL, V179, P5171, DOI 10.1128/jb.179.16.5171-5177.1997; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Siebold C, 2001, FEBS LETT, V504, P104, DOI 10.1016/S0014-5793(01)02705-3; SUGIYAMA JE, 1991, P NATL ACAD SCI USA, V88, P9603, DOI 10.1073/pnas.88.21.9603; van Montfort BA, 2002, J BIOL CHEM, V277, P14717, DOI 10.1074/jbc.M201533200; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; WENG QP, 1992, J BIOL CHEM, V267, P19529; WENG QP, 1993, BIOCHEMISTRY-US, V32, P11211, DOI 10.1021/bi00092a034; WIDDAS WF, 1952, J PHYSIOL-LONDON, V118, P23, DOI 10.1113/jphysiol.1952.sp004770; Yagur-Kroll S, 2005, J BIOL CHEM, V280, P19306, DOI 10.1074/jbc.M410896200; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zhou M, 2004, J MOL BIOL, V338, P839, DOI 10.1016/j.jmb.2004.03.020	50	67	67	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2011	473	7345					50	U58		10.1038/nature09939	http://dx.doi.org/10.1038/nature09939			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21471968	Green Accepted			2022-12-28	WOS:000290218300028
J	McCormack, FX; Inoue, Y; Moss, J; Singer, LG; Strange, C; Nakata, K; Barker, AF; Chapman, JT; Brantly, ML; Stocks, JM; Brown, KK; Lynch, JP; Goldberg, HJ; Young, LR; Kinder, BW; Downey, GP; Sullivan, EJ; Colby, TV; Mckay, RT; Cohen, MM; Korbee, L; Taveira-DaSilva, AM; Lee, HS; Krischer, JP; Trapnell, BC				McCormack, Francis X.; Inoue, Yoshikazu; Moss, Joel; Singer, Lianne G.; Strange, Charlie; Nakata, Koh; Barker, Alan F.; Chapman, Jeffrey T.; Brantly, Mark L.; Stocks, James M.; Brown, Kevin K.; Lynch, Joseph P., III; Goldberg, Hilary J.; Young, Lisa R.; Kinder, Brent W.; Downey, Gregory P.; Sullivan, Eugene J.; Colby, Thomas V.; Mckay, Roy T.; Cohen, Marsha M.; Korbee, Leslie; Taveira-DaSilva, Angelo M.; Lee, Hye-Seung; Krischer, Jeffrey P.; Trapnell, Bruce C.		Natl Inst Hlth Rare Lung Dis Conso; MILES Trial Grp	Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TUBEROUS SCLEROSIS COMPLEX; PULMONARY LYMPHANGIOLEIOMYOMATOSIS; LUNG-FUNCTION; CELLS; LYMPHANGIOGENESIS; TRANSPLANTATION; PROGESTERONE; PROGRESSION; MECHANISM; DECLINE	BACKGROUND Lymphangioleiomyomatosis (LAM) is a progressive, cystic lung disease in women; it is associated with inappropriate activation of mammalian target of rapamycin (mTOR) signaling, which regulates cellular growth and lymphangiogenesis. Sirolimus (also called rapamycin) inhibits mTOR and has shown promise in phase 1-2 trials involving patients with LAM. METHODS We conducted a two-stage trial of sirolimus involving 89 patients with LAM who had moderate lung impairment - a 12-month randomized, double-blind comparison of sirolimus with placebo, followed by a 12-month observation period. The primary end point was the difference between the groups in the rate of change (slope) in forced expiratory volume in 1 second (FEV1). RESULTS During the treatment period, the FEV1 slope was -12 +/- 2 ml per month in the placebo group (43 patients) and 1 +/- 2 ml per month in the sirolimus group (46 patients) (P<0.001). The absolute between-group difference in the mean change in FEV1 during the treatment period was 153 ml, or approximately 11% of the mean FEV1 at enrollment. As compared with the placebo group, the sirolimus group had improvement from baseline to 12 months in measures of forced vital capacity, functional residual capacity, serum vascular endothelial growth factor D (VEGF-D), and quality of life and functional performance. There was no significant between-group difference in this interval in the change in 6-minute walk distance or diffusing capacity of the lung for carbon monoxide. After discontinuation of sirolimus, the decline in lung function resumed in the sirolimus group and paralleled that in the placebo group. Adverse events were more common with sirolimus, but the frequency of serious adverse events did not differ significantly between the groups. CONCLUSIONS In patients with LAM, sirolimus stabilized lung function, reduced serum VEGF-D levels, and was associated with a reduction in symptoms and improvement in quality of life. Therapy with sirolimus may be useful in selected patients with LAM.	[McCormack, Francis X.; Young, Lisa R.; Kinder, Brent W.; Mckay, Roy T.; Trapnell, Bruce C.] Univ Cincinnati, Cincinnati, OH USA; [Young, Lisa R.; Korbee, Leslie; Trapnell, Bruce C.] Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH USA; [Inoue, Yoshikazu] Natl Hosp Org, Kinki Chuo Chest Med Ctr, Osaka, Japan; [Nakata, Koh] Niigata Univ, Med & Dent Hosp, Niigata, Japan; [Moss, Joel; Taveira-DaSilva, Angelo M.] NHLBI, NIH, Bethesda, MD 20892 USA; [Sullivan, Eugene J.] United Therapeut, Silver Spring, MD USA; [Singer, Lianne G.; Downey, Gregory P.; Cohen, Marsha M.] Univ Toronto, Toronto, ON, Canada; [Strange, Charlie] Med Univ S Carolina, Charleston, SC 29425 USA; [Barker, Alan F.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Chapman, Jeffrey T.] Cleveland Clin Fdn, Cleveland, OH 44195 USA; [Brantly, Mark L.] Univ Florida, Gainesville, FL USA; [Stocks, James M.] Univ Texas Hlth Sci Ctr Tyler, Tyler, TX USA; [Brown, Kevin K.; Downey, Gregory P.] Natl Jewish Hlth, Denver, CO USA; [Lynch, Joseph P., III] Univ Calif Los Angeles, Los Angeles, CA USA; [Goldberg, Hilary J.] Harvard Univ, Sch Med, Boston, MA USA; [Colby, Thomas V.] Mayo Clin, Scottsdale, AZ USA; [Lee, Hye-Seung; Krischer, Jeffrey P.] Univ S Florida, Tampa, FL USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Niigata University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Toronto; Medical University of South Carolina; Oregon Health & Science University; Cleveland Clinic Foundation; State University System of Florida; University of Florida; University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); National Jewish Health; University of California System; University of California Los Angeles; Harvard University; Harvard Medical School; Mayo Clinic; Mayo Clinic Phoenix; State University System of Florida; University of South Florida	McCormack, FX (corresponding author), MSB 6114,231 Albert Sabin Way, Cincinnati, OH 45267 USA.	frank.mccormack@uc.edu	Inoue, Yoshikazu/ABE-9772-2020; Singer, Lianne/E-9962-2019; McCormack, Francis X./ABE-8398-2020; Krischer, Jeffrey P/I-5004-2012; Brown, Kevin/ABF-2544-2020; Brantly, Mark/AAH-2922-2020	Singer, Lianne/0000-0002-2693-8676; McCormack, Francis X./0000-0001-7168-9464; Downey, Gregory P/0000-0003-3253-5862; Strange, Charlie/0000-0002-8109-8067; Fernandez Perez, Evans/0000-0001-7535-1591	NIH Office of Rare Disease Research [RR019498, RR019259]; Food and Drug Administration [FD003362]; Canadian Institutes of Health Research; Pfizer (formerly Wyeth) Pharmaceuticals; Japanese Ministry of Health, Labor, and Welfare [H-19-Rinshoshiken-008]; Tuberous Sclerosis Alliance; Cincinnati Children's Hospital Medical Center [1UL1RR026314-01]; Vi and John Adler; Adler Foundation; Division of Intramural Research, National Heart, Lung, and Blood Institute; Pfizer; FOOD AND DRUG ADMINISTRATION [R01FD003362] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR019498, U54RR019259, UL1RR026314] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002541, R01HL085453] Funding Source: NIH RePORTER	NIH Office of Rare Disease Research; Food and Drug Administration(United States Department of Health & Human Services); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Pfizer (formerly Wyeth) Pharmaceuticals(Pfizer); Japanese Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Tuberous Sclerosis Alliance; Cincinnati Children's Hospital Medical Center; Vi and John Adler; Adler Foundation; Division of Intramural Research, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Pfizer(Pfizer); FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants from the NIH Office of Rare Disease Research, administered by the National Center for Research Resources (RR019498, to Drs. Trapnell and McCormack; and RR019259, to Drs. Lee and Krischer), the Food and Drug Administration (FD003362, to Dr. McCormack), Canadian Institutes of Health Research (to Drs. Downey, Cohen, and Singer), Pfizer (formerly Wyeth) Pharmaceuticals (to Dr. McCormack), the Japanese Ministry of Health, Labor, and Welfare (H-19-Rinshoshiken-008, to Drs. Nakata and Inoue), the LAM Foundation (to Dr. McCormack), the Tuberous Sclerosis Alliance (Rothberg Courage Award, to Dr. McCormack), Cincinnati Children's Hospital Medical Center (Institutional Clinical and Translational Science Award 1UL1RR026314-01, to Drs. Young and McCormack, and Translational Research Initiative Award, to Drs. McCormack and Trapnell), Vi and John Adler, and the Adler Foundation. Drs. Moss and Taveira-DaSilva were supported by the Division of Intramural Research, National Heart, Lung, and Blood Institute. Pfizer provided the study drug and money for study visit costs.	Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Bittmann I, 2003, HUM PATHOL, V34, P95, DOI 10.1053/hupa.2003.50; Carsillo T, 2000, P NATL ACAD SCI USA, V97, P6085, DOI 10.1073/pnas.97.11.6085; Crooks DM, 2004, P NATL ACAD SCI USA, V101, P17462, DOI 10.1073/pnas.0407971101; Davies DM, 2008, NEW ENGL J MED, V358, P200, DOI 10.1056/NEJMc072500; Donohue James F, 2005, COPD, V2, P111; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Henske EP, 2003, GENE CHROMOSOME CANC, V38, P376, DOI 10.1002/gcc.10252; Johnson SR, 1999, AM J RESP CRIT CARE, V160, P628, DOI 10.1164/ajrccm.160.2.9901027; Johnson SR, 2004, THORAX, V59, P800, DOI 10.1136/thx.2004.023283; Karbowniczek M, 2003, AM J RESP CRIT CARE, V167, P976, DOI 10.1164/rccm.200208-969OC; Khanna D, 2010, CLIN EXP RHEUMATOL, V28, pS55; Kumasaka T, 2005, AM J SURG PATHOL, V29, P1356, DOI 10.1097/01.pas.0000172192.25295.45; Kumasaka T, 2004, AM J SURG PATHOL, V28, P1007, DOI 10.1097/01.pas.0000126859.70814.6d; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Larson J L, 1998, J Nurs Meas, V6, P55; Lee L, 2005, GENE CHROMOSOME CANC, V42, P213, DOI 10.1002/gcc.20118; McCormack FX, 2008, CHEST, V133, P507, DOI 10.1378/chest.07-0898; Molken MPMHRV, 2006, CHEST, V130, P1117, DOI 10.1378/chest.130.4.1117; Norman Geoffrey R, 2004, Expert Rev Pharmacoecon Outcomes Res, V4, P581, DOI 10.1586/14737167.4.5.581; Paul E, 2008, NEW ENGL J MED, V358, P190, DOI 10.1056/NEJMe0707153; Ryu JH, 2006, AM J RESP CRIT CARE, V173, P105, DOI 10.1164/rccm.200409-1298OC; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Taveira-DaSilva AM, 2004, CHEST, V126, P1867, DOI 10.1378/chest.126.6.1867; Taveira-DaSilva Angelo M, 2006, Cancer Control, V13, P276; Urban T, 1999, MEDICINE, V78, P321, DOI 10.1097/00005792-199909000-00004; Young LR, 2010, CHEST, V138, P674, DOI 10.1378/chest.10-0573	27	686	719	0	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 28	2011	364	17					1595	1606		10.1056/NEJMoa1100391	http://dx.doi.org/10.1056/NEJMoa1100391			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755NW	21410393	Green Accepted, Bronze			2022-12-28	WOS:000289940400006
J	Read, JL; Shortell, SM				Read, J. Leighton; Shortell, Stephen M.			Interactive Games to Promote Behavior Change in Prevention and Treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VIDEO GAME; TRIAL		[Read, J. Leighton] Alloy Ventures & Serios Inc, Palo Alto, CA USA; [Shortell, Stephen M.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Read, JL (corresponding author), Alloy Ventures, 400 Hamilton Ave,Ste 400, Palo Alto, CA 94301 USA.	leighton@alloyventures.com						Baranowski T, 2003, AM J PREV MED, V24, P52, DOI 10.1016/S0749-3797(02)00570-6; Biddiss E, 2010, ARCH PEDIAT ADOL MED, V164, P664, DOI 10.1001/archpediatrics.2010.104; Brown SJ, 1997, MED INFORM, V22, P77, DOI 10.3109/14639239709089835; Csikszentmihalyi M., 1990, FLOW PSYCHOL OPTIMAL; *HLTH GAM RES, HLTH GAM RES PROGR D; Kato PM, 2008, PEDIATRICS, V122, pE305, DOI 10.1542/peds.2007-3134; Nunez-Smith M., 2008, MEDIA CHILD ADOLESCE; PETERSEN C, 2010, US NAIC ADOPTS MED L; Reeves B., 2009, TOTAL ENGAGEMENT USI	9	68	68	2	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 27	2011	305	16					1704	1705		10.1001/jama.2011.408	http://dx.doi.org/10.1001/jama.2011.408			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	754XG	21447802				2022-12-28	WOS:000289890500025
J	Montpetit, B; Thomsen, ND; Helmke, KJ; Seeliger, MA; Berger, JM; Weis, K				Montpetit, Ben; Thomsen, Nathan D.; Helmke, Kara J.; Seeliger, Markus A.; Berger, James M.; Weis, Karsten			A conserved mechanism of DEAD-box ATPase activation by nucleoporins and InsP(6) in mRNA export	NATURE			English	Article							PROTEIN DBP5; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; HELICASE; COMPLEX; DOMAIN; EIF4A; CRYSTALLOGRAPHY; REVEALS; NUP214	Superfamily 1 and superfamily 2 RNA helicases are ubiquitous messenger-RNA-protein complex (mRNP) remodelling enzymes that have critical roles in all aspects of RNA metabolism(1,2). The superfamily 2 DEAD-box ATPase Dbp5 (human DDX19) functions in mRNA export and is thought to remodel mRNPs at the nuclear pore complex (NPC)(3-8). Dbp5 is localized to the NPC via an interaction with Nup159 (NUP214 in vertebrates)(3-5,8,9) and is locally activated there by Gle1 together with the small-molecule inositol hexakisphosphate (InsP(6))(10,11). Local activation of Dbp5 at the NPC by Gle1 is essential for mRNA export in vivo(10,12); however, the mechanistic role of Dbp5 in mRNP export is poorly understood and it is not known how Gle1(InsP6) and Nup159 regulate the activity of Dbp5. Here we report, from yeast, structures of Dbp5 in complex with Gle1(InsP6), Nup159/Gle1(InsP6) and RNA. These structures reveal that InsP6 functions as a small-molecule tether for the Gle1-Dbp5 interaction. Surprisingly, the Gle1(InsP6)-Dbp5 complex is structurally similar to another DEAD-box ATPase complex essential for translation initiation, eIF4G-eIF4A, and we demonstrate that Gle1(InsP6) and eIF4G both activate their DEAD-box partner by stimulating RNA release. Furthermore, Gle1(InsP6) relieves Dbp5 autoregulation and cooperates with Nup159 in stabilizing an open Dbp5 intermediate that precludes RNA binding. These findings explain how Gle1(InsP6), Nup159 and Dbp5 collaborate in mRNA export and provide a general mechanism for DEAD-box ATPase regulation by Gle1/eIF4G-like activators.	[Montpetit, Ben; Helmke, Kara J.; Weis, Karsten] Univ Calif Berkeley, Div Cell & Dev Biol, Berkeley, CA 94720 USA; [Montpetit, Ben; Thomsen, Nathan D.; Helmke, Kara J.; Seeliger, Markus A.; Berger, James M.; Weis, Karsten] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Montpetit, Ben; Thomsen, Nathan D.; Helmke, Kara J.; Seeliger, Markus A.; Berger, James M.; Weis, Karsten] Univ Calif Berkeley, QB3 Inst, Berkeley, CA 94720 USA; [Thomsen, Nathan D.; Seeliger, Markus A.; Berger, James M.] Univ Calif Berkeley, Div Biochem & Mol Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Weis, K (corresponding author), Univ Calif Berkeley, Div Cell & Dev Biol, Berkeley, CA 94720 USA.	jmberger@berkeley.edu; kweis@berkeley.edu	Weis, Karsten/F-5719-2011; Seeliger, Markus A/D-6409-2013; Montpetit, Ben/L-6456-2019	Weis, Karsten/0000-0001-7224-925X; Montpetit, Ben/0000-0002-8317-983X; Seeliger, Markus/0000-0003-0990-1756	G Harold and Leila Y Mathers foundation; NIH [R01GM58065, RC1GM91533]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007232, R01GM058065, RC1GM091533, R00GM080097] Funding Source: NIH RePORTER	G Harold and Leila Y Mathers foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Kirsch, J. Thorner, M. Welch, D. Wemmer, B. Krantz, J. Zorn and all J.M.B. and K.W. laboratory members for discussions and advice. We also thank J. Kuriyan, M. Welch and S. Marqusee for access to equipment and workspace; J. Tanamachi, G. Meigs and J. Holton at ALS beamline 8.3.1; and N. Echols for assistance with programs from the Yale Morph Server. Research was supported by the G Harold and Leila Y Mathers foundation (J.M.B.) and the NIH (K.W., R01GM58065 and RC1GM91533).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; Alcazar-Roman AR, 2010, J BIOL CHEM, V285, P16683, DOI 10.1074/jbc.M109.082370; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Chamieh H, 2008, NAT STRUCT MOL BIOL, V15, P85, DOI 10.1038/nsmb1330; Collins R, 2009, J BIOL CHEM, V284, P10296, DOI 10.1074/jbc.C900018200; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dossani ZY, 2009, P NATL ACAD SCI USA, V106, P16251, DOI 10.1073/pnas.0902251106; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan JS, 2009, J MOL BIOL, V388, P1, DOI 10.1016/j.jmb.2009.03.004; Flores S, 2006, NUCLEIC ACIDS RES, V34, pD296, DOI 10.1093/nar/gkj046; He F, 1997, MOL CELL BIOL, V17, P1580, DOI 10.1128/MCB.17.3.1580; Henn A, 2008, J MOL BIOL, V377, P193, DOI 10.1016/j.jmb.2007.12.046; Henn A, 2010, P NATL ACAD SCI USA, V107, P4046, DOI 10.1073/pnas.0913081107; Hodge CA, 1999, EMBO J, V18, P5778, DOI 10.1093/emboj/18.20.5778; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Holton J, 2004, P NATL ACAD SCI USA, V101, P1537, DOI 10.1073/pnas.0306241101; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; Kadlec J, 2006, RNA, V12, P1817, DOI 10.1261/rna.177606; Kapust RB, 2000, PROTEIN EXPRES PURIF, V19, P312, DOI 10.1006/prep.2000.1251; Korneeva NL, 2005, J BIOL CHEM, V280, P1872, DOI 10.1074/jbc.M406168200; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2180, DOI 10.1021/bi972430g; Lund MK, 2005, MOL CELL, V20, P645, DOI 10.1016/j.molcel.2005.10.005; MacDowell AA, 2004, J SYNCHROTRON RADIAT, V11, P447, DOI 10.1107/S0909049504024835; Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014; Napetschnig J, 2009, P NATL ACAD SCI USA, V106, P3089, DOI 10.1073/pnas.0813267106; Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schmitt C, 1999, EMBO J, V18, P4332, DOI 10.1093/emboj/18.15.4332; Schutz P, 2008, P NATL ACAD SCI USA, V105, P9564, DOI 10.1073/pnas.0800418105; Snay-Hodge CA, 1998, EMBO J, V17, P2663, DOI 10.1093/emboj/17.9.2663; Sonenberg N, 2003, CURR OPIN STRUC BIOL, V13, P56, DOI 10.1016/S0959-440X(03)00009-5; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; von Moeller H, 2009, NAT STRUCT MOL BIOL, V16, P247, DOI 10.1038/nsmb.1561; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424; Weirich CS, 2004, MOL CELL, V16, P749, DOI 10.1016/j.molcel.2004.10.032	40	178	184	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2011	472	7342					238	242		10.1038/nature09862	http://dx.doi.org/10.1038/nature09862			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21441902	Green Accepted			2022-12-28	WOS:000289469100047
J	Stajic, J; Coontz, R; Osborne, I				Stajic, Jelena; Coontz, Robert; Osborne, Ian			Happy 100th, Superconductivity! INTRODUCTION	SCIENCE			English	Editorial Material																			0	2	2	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					189	189		10.1126/science.332.6026.189	http://dx.doi.org/10.1126/science.332.6026.189			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474747				2022-12-28	WOS:000289251100036
J	Wochner, A; Attwater, J; Coulson, A; Holliger, P				Wochner, Aniela; Attwater, James; Coulson, Alan; Holliger, Philipp			Ribozyme-Catalyzed Transcription of an Active Ribozyme	SCIENCE			English	Article							RNA-POLYMERASE RIBOZYME; MOLECULAR EVOLUTION; POLYMERIZATION; EXTENSION; SELECTION; SEQUENCES; LIGANDS	A critical event in the origin of life is thought to have been the emergence of an RNA molecule capable of replicating a primordial RNA "genome." Here we describe the evolution and engineering of an RNA polymerase ribozyme capable of synthesizing RNAs of up to 95 nucleotides in length. To overcome its sequence dependence, we recombined traits evolved separately in different ribozyme lineages. This yielded a more general polymerase ribozyme that was able to synthesize a wider spectrum of RNA sequences, as we demonstrate by the accurate synthesis of an enzymatically active RNA, a hammerhead endonuclease ribozyme. This recapitulates a central aspect of an RNA-based genetic system: the RNA-catalyzed synthesis of an active ribozyme from an RNA template.	[Wochner, Aniela; Attwater, James; Coulson, Alan; Holliger, Philipp] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Holliger, P (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	ph1@mrc-lmb.cam.ac.uk	daehun, lee/H-2435-2013	Attwater, James/0000-0002-7244-9910	Medical Research Council (MRC) [MC_US_A024_0014]; MRC [MC_U105178804] Funding Source: UKRI; Medical Research Council [MC_U105178804] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to M. Daly for assistance with FACS and to our colleagues V. B. Pinheiro, C. Cozens, A. Taylor, and J. Sutherland for helpful discussions. This work was supported by the Medical Research Council (MRC) program grant MC_US_A024_0014.	Attwater J, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1076; BARTEL DP, 1993, SCIENCE, V261, P1411, DOI 10.1126/science.7690155; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; EKLAND EH, 1995, SCIENCE, V269, P364, DOI 10.1126/science.7618102; Ekland EH, 1996, NATURE, V382, P373, DOI 10.1038/382373a0; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; GESTELAND R, 2005, RNA WORLD NATURE MOD; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; Joyce GF, 2007, SCIENCE, V315, P1507, DOI 10.1126/science.1140736; Joyce GF, 2004, ANNU REV BIOCHEM, V73, P791, DOI 10.1146/annurev.biochem.73.011303.073717; Kun A, 2005, NAT GENET, V37, P1008, DOI 10.1038/ng1621; Lawrence MS, 2003, BIOCHEMISTRY-US, V42, P8748, DOI 10.1021/bi034228l; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; McCall MJ, 2000, MOL BIOTECHNOL, V14, P5, DOI 10.1385/MB:14:1:5; Shechner DM, 2009, SCIENCE, V326, P1271, DOI 10.1126/science.1174676; SHINE J, 1975, NATURE, V254, P34, DOI 10.1038/254034a0; Tawfik DS, 1998, NAT BIOTECHNOL, V16, P652, DOI 10.1038/nbt0798-652; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Valadkhan S, 2001, NATURE, V413, P701, DOI 10.1038/35099500; Wang QS, 2011, RNA, V17, P469, DOI 10.1261/rna.2495011; WEINER AM, 1987, P NATL ACAD SCI USA, V84, P7383, DOI 10.1073/pnas.84.21.7383; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; Zaher HS, 2007, RNA, V13, P1017, DOI 10.1261/rna.548807; Zhao HM, 1998, NAT BIOTECHNOL, V16, P258, DOI 10.1038/nbt0398-258; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	26	236	248	4	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					209	212		10.1126/science.1200752	http://dx.doi.org/10.1126/science.1200752			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474753				2022-12-28	WOS:000289251100043
J	Chiu, HY; Tsai, TF				Chiu, Hsien-Yi; Tsai, Tsen-Fang			Keloidal Morphea	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chiu, Hsien-Yi; Tsai, Tsen-Fang] Natl Taiwan Univ Hosp, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital	Chiu, HY (corresponding author), Natl Taiwan Univ Hosp, Taipei, Taiwan.	tftsai@yahoo.com		Chiu, Hsien-Yi/0000-0002-0493-9707; TSAI, TSEN-FANG/0000-0002-1498-1474					0	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 7	2011	364	14					E28	E28		10.1056/NEJMicm1007601	http://dx.doi.org/10.1056/NEJMicm1007601			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745WS	21470006				2022-12-28	WOS:000289202800011
J	Premsrirut, PK; Dow, LE; Kim, SY; Camiolo, M; Malone, CD; Miething, C; Scuoppo, C; Zuber, J; Dickins, RA; Kogan, SC; Shroyer, KR; Sordella, R; Hannon, GJ; Lowe, SW				Premsrirut, Prem K.; Dow, Lukas E.; Kim, Sang Yong; Camiolo, Matthew; Malone, Colin D.; Miething, Cornelius; Scuoppo, Claudio; Zuber, Johannes; Dickins, Ross A.; Kogan, Scott C.; Shroyer, Kenneth R.; Sordella, Raffaella; Hannon, Gregory J.; Lowe, Scott W.			A Rapid and Scalable System for Studying Gene Function in Mice Using Conditional RNA Interference	CELL			English	Article							TRANSGENIC MICE; STEM-CELLS; MOUSE; EXPRESSION; DIFFERENTIATION; APC; DISRUPTION; ACTIVATION; RAS	RNA interference is a powerful tool for studying gene function, however, the reproducible generation of RNAi transgenic mice remains a significant limitation. By combining optimized fluorescence-coupled miR30-based shRNAs with high efficiency ES cell targeting, we developed a fast, scalable pipeline for the production of shRNA transgenic mice. Using this system, we generated eight tet-regulated shRNA transgenic lines targeting Firefly and Renilla luciferases, Oct4 and tumor suppressors p53, p16(INK4a), p19(ARF) and APC and demonstrate potent gene silencing and GFP-tracked knockdown in a broad range of tissues in vivo. Further, using an shRNA targeting APC, we illustrate how this approach can identify predicted phenotypes and also unknown functions for a well-studied gene. In addition, through regulated gene silencing we validate APC/Wnt and p19(ARF) as potential therapeutic targets in T cell acute lymphoblastic leukemia/lymphoma and lung adenocarcinoma, respectively. This system provides a cost-effective and scalable platform for the production of RNAi transgenic mice targeting any mammalian gene.	[Premsrirut, Prem K.; Dow, Lukas E.; Kim, Sang Yong; Camiolo, Matthew; Malone, Colin D.; Miething, Cornelius; Scuoppo, Claudio; Zuber, Johannes; Dickins, Ross A.; Sordella, Raffaella; Hannon, Gregory J.; Lowe, Scott W.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Malone, Colin D.; Scuoppo, Claudio] Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Hannon, Gregory J.; Lowe, Scott W.] Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Premsrirut, Prem K.; Camiolo, Matthew] SUNY Stony Brook, Med Ctr, Med Scientist Training Program, Stony Brook, NY 11794 USA; [Shroyer, Kenneth R.] SUNY Stony Brook, Med Ctr, Dept Pathol, Stony Brook, NY 11794 USA; [Dickins, Ross A.] Walter & Eliza Hall Inst Med Res, Div Mol Med, Parkville, Vic 3052, Australia; [Kogan, Scott C.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Kogan, Scott C.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Walter & Eliza Hall Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Lowe, SW (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	lowe@cshl.edu	Zuber, Johannes/E-7517-2011; Hannon, Gregory/AAB-3568-2019; Miething, Cornelius/F-9498-2014; Dickins, Ross A/K-2852-2012	Zuber, Johannes/0000-0001-8810-6835; Miething, Cornelius/0000-0003-4699-3805; Dickins, Ross A/0000-0003-4112-5304; Dow, Lukas/0000-0001-7048-1418; Kogan, Scott/0000-0002-2395-8479; Kim, Sang Yong/0000-0001-7326-7505	National Cancer Institute; National Health & Medical Research Council of Australia; Deutsche Forschungsgemeinschaft; AACR-Astellas USA Foundation; NATIONAL CANCER INSTITUTE [P30CA008748, P01CA013106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444, R01GM062534] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); AACR-Astellas USA Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Beard and R. Jaenisch (Whitehead Institute) for pBS31 flp-in and pCAGs-FLPe-Puro vectors, ColA1 3' probe and KH2 ES cells; X. Guo, Y. Park, and P.W.J. Russell for discussions and assistance in procedures; and E. McGlinn and C. Tabin (Harvard Medical School) for advice with the skeletal preparations of embryos. Thanks to L. Bianco, J. Coblentz, E. Earl, and the Cold Spring Harbor Laboratory animal house staff. We gratefully acknowledge Janelle Simon, Danielle Grace, and Jacqueline Cappellani for technical assistance, and members of the Lowe laboratory for advice and discussions. This study was supported by a Mouse Models of Human Cancer Consortium grant, a program project grant from the National Cancer Institute, and philanthropic support from the Don Monti Research Foundation. P. K. P is MSTP Fellow of Stony Brook University, L. E. D. is supported by a National Health & Medical Research Council of Australia overseas Biomedical Training Fellowship, C. M. was supported by a fellowship from the Deutsche Forschungsgemeinschaft and a AACR-Astellas USA Foundation Fellowship in Basic Cancer Research, J.Z. is the Andrew Seligson Memorial Fellow, R. A. D is a VESKI Fellow, and G. J. H and S. W. L. are Howard Hughes Medical Institute investigators. P. K. P, G. J. H, and S. W. L. are founders on the scientific advisory board of Mirimus, Inc., a company that has licensed technology related to this work.	Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Bryja V, 2006, NAT PROTOC, V1, P2082, DOI 10.1038/nprot.2006.355; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Colnot S, 2004, P NATL ACAD SCI USA, V101, P17216, DOI 10.1073/pnas.0404761101; Damalas A, 2001, EMBO J, V20, P4912, DOI 10.1093/emboj/20.17.4912; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Dickins RA, 2007, NAT GENET, V39, P914, DOI 10.1038/ng2045; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Gunther EJ, 2003, GENE DEV, V17, P488, DOI 10.1101/gad.1051603; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; Kado M, 2008, BIOCHEM BIOPH RES CO, V377, P413, DOI 10.1016/j.bbrc.2008.09.160; Kuraguchi M, 2006, PLOS GENET, V2, P1362, DOI 10.1371/journal.pgen.0020146; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Lundberg AS, 2000, CURR OPIN CELL BIOL, V12, P705, DOI 10.1016/S0955-0674(00)00155-1; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Miclea RL, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-26; MOSER AR, 1995, DEV DYNAM, V203, P422, DOI 10.1002/aja.1002030405; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Olson A, 2006, NUCLEIC ACIDS RES, V34, pD153, DOI 10.1093/nar/gkj051; Ozenne P, 2010, INT J CANCER, V127, P2239, DOI 10.1002/ijc.25511; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sadate-Ngatchou PI, 2008, GENESIS, V46, P738, DOI 10.1002/dvg.20437; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Seibler J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm122; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tucker KL, 1997, NUCLEIC ACIDS RES, V25, P3745, DOI 10.1093/nar/25.18.3745; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Yang Y, 2005, LEUKEMIA RES, V29, P47, DOI 10.1016/j.leukres.2004.05.004; Zhou YH, 2010, NAT BIOTECHNOL, V28, P71, DOI 10.1038/nbt.1595; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	43	222	231	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2011	145	1					145	158		10.1016/j.cell.2011.03.012	http://dx.doi.org/10.1016/j.cell.2011.03.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458673	Green Accepted, Bronze			2022-12-28	WOS:000289053900016
J	Deweerdt, S				Deweerdt, Sarah			FOOD The omnivore's labyrinth	NATURE			English	Editorial Material							CANCER INCIDENCE; RISK											ARMSTRONG B, 1975, INT J CANCER, V15, P617, DOI 10.1002/ijc.2910150411; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Fahey JW, 1997, P NATL ACAD SCI USA, V94, P10367, DOI 10.1073/pnas.94.19.10367; Key TJ, 2011, BRIT J CANCER, V104, P6, DOI 10.1038/sj.bjc.6606032; Lampe JW, 2009, AM J CLIN NUTR, V89, pS1553, DOI 10.3945/ajcn.2009.26736D; Maskarinec G, 2004, ETHNIC DIS, V14, P431; Navarro SL, 2009, CANCER PREV RES, V2, P345, DOI 10.1158/1940-6207.CAPR-08-0178; Wu AH, 2008, BRIT J CANCER, V98, P9, DOI 10.1038/sj.bjc.6604145; ZHANG Y, 1994, P NATL ACAD SCI USA, V12; ZHANG Y, 1992, P NATL ACAD SCI USA, V15, P2399	10	18	18	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					S22	S24		10.1038/471S22a	http://dx.doi.org/10.1038/471S22a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430718				2022-12-28	WOS:000288702200018
J	Napolitano, M; Koschorreck, M; Dubost, B; Behbood, N; Sewell, RJ; Mitchell, MW				Napolitano, M.; Koschorreck, M.; Dubost, B.; Behbood, N.; Sewell, R. J.; Mitchell, M. W.			Interaction-based quantum metrology showing scaling beyond the Heisenberg limit	NATURE			English	Article								Quantum metrology aims to use entanglement and other quantum resources to improve precision measurement(1). An interferometer using N independent particles to measure a parameter X can achieve at best the standard quantum limit of sensitivity, delta X proportional to N-1/2. However, using N entangled particles and exotic states(2), such an interferometer(3) can in principle achieve the Heisenberg limit, delta X proportional to N-1. Recent theoretical work(4-6) has argued that interactions among particles may be a valuable resource for quantum metrology, allowing scaling beyond the Heisenberg limit. Specifically, a k-particle interaction will produce sensitivity delta X proportional to N-k with appropriate entangled states and delta X proportional to N-(k-1/2) even without entanglement(7). Here we demonstrate 'super-Heisenberg' scaling of delta X proportional to N-3/2 in a nonlinear, non-destructive(8,9) measurement of the magnetization(10,11) of an atomic ensemble(12). We use fast optical nonlinearities to generate a pairwise photon-photon interaction(13) (corresponding to k = 2) while preserving quantum-noise-limited performance(7,14). We observe super-Heisenberg scaling over two orders of magnitude in N, limited at large numbers by higher order nonlinear effects, in good agreement with theory(13). For a measurement of limited duration, super-Heisenberg scaling allows the nonlinear measurement to overtake in sensitivity a comparable linear measurement with the same number of photons. In other situations, however, higher-order nonlinearities prevent this crossover from occurring, reflecting the subtle relationship between scaling and sensitivity in nonlinear systems. Our work shows that interparticle interactions can improve sensitivity in a quantum-limited measurement, and experimentally demonstrates a new resource for quantum metrology.	[Napolitano, M.; Koschorreck, M.; Dubost, B.; Behbood, N.; Sewell, R. J.; Mitchell, M. W.] ICFO Inst Ciencies Foton, Castelldefels 08860, Barcelona, Spain; [Dubost, B.] Univ Paris Diderot, Lab Mat & Phenomenes Quant, F-75205 Paris 13, France; [Dubost, B.] CNRS, UMR 7162, F-75205 Paris 13, France	Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Cite	Napolitano, M (corresponding author), ICFO Inst Ciencies Foton, Mediterranean Technol Pk, Castelldefels 08860, Barcelona, Spain.	mario.napolitano@icfo.es	Mitchell, Morgan W/I-9027-2012; Koschorreck, Marco/D-1536-2009; Sewell, Robert/C-4718-2013	Mitchell, Morgan W/0000-0001-8949-9407; Koschorreck, Marco/0000-0003-0974-7007; Sewell, Robert/0000-0002-2754-2956	Spanish Ministry of Science and Innovation [FIS2009-07676-E/FIS, FIS2008-01051]; Marie-Curie RTN EMALI; Fundacio CELLEX Barcelona	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Marie-Curie RTN EMALI(European Commission); Fundacio CELLEX Barcelona(Foundation CELLEXEuropean Commission)	We thank I. H. Deutsch and F. Illuminati for comments. We thank C. M. Caves and A. D. Codorniu for inspiration. This work was supported by the Spanish Ministry of Science and Innovation through the Consolider-Ingenio 2010 project QOIT, the Ingenio-Explora project OCHO (ref. FIS2009-07676-E/FIS) and project ILUMA (ref. FIS2008-01051), by the Marie-Curie RTN EMALI, and by Fundacio CELLEX Barcelona.	Beltran J, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.045801; Boixo S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.090401; Boixo S, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.032103; Boixo S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.040403; Braginskii V. B., 1975, Soviet Physics - Uspekhi, V17, P644, DOI 10.1070/PU1975v017n05ABEH004362; Budker D, 2007, NAT PHYS, V3, P227, DOI 10.1038/nphys566; Chase BA, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.022314; Choi S, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.053613; Fleischhauer M, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.013808; Giovannetti V, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.010401; Hammerer K, 2010, REV MOD PHYS, V82, P1041, DOI 10.1103/RevModPhys.82.1041; Kominis IK, 2003, NATURE, V422, P596, DOI 10.1038/nature01484; Koschorreck M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.093602; Kubasik M, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.043815; Lee H, 2002, J MOD OPTIC, V49, P2325, DOI 10.1080/0950034021000011536; Mitchell MW, 2004, NATURE, V429, P161, DOI 10.1038/nature02493; Napolitano M, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/9/093016; Negretti A, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.043606; Roy SM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.220501; SCULLY MO, 1991, NATURE, V351, P111, DOI 10.1038/351111a0; Wasilewski W, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.133601; Wolfgramm F, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.053601; Woolley MJ, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/12/125018	23	156	158	1	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					486	489		10.1038/nature09778	http://dx.doi.org/10.1038/nature09778			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21430776	Green Submitted			2022-12-28	WOS:000288702200056
J	Smolke, CD; Silver, PA				Smolke, Christina D.; Silver, Pamela A.			Informing Biological Design by Integration of Systems and Synthetic Biology	CELL			English	Article							CONSTRUCTION; EXPRESSION; SWITCH	Synthetic biology aims to make the engineering of biology faster and more predictable. In contrast, systems biology focuses on the interaction of myriad components and how these give rise to the dynamic and complex behavior of biological systems. Here, we examine the synergies between these two fields.	[Smolke, Christina D.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Silver, Pamela A.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Silver, Pamela A.] Harvard Univ, Sch Med, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	Stanford University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Smolke, CD (corresponding author), Stanford Univ, Dept Bioengn, 473 Via Ortega, Stanford, CA 94305 USA.	csmolke@stanford.edu; pamela_silver@hms.harvard.edu			NIH; DOD; DOE; NSF; Wyss Institute for Biologically Inspired Engineering; Alfred P. Sloan Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036373, R01GM086663, RC1GM091298] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); DOE(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Wyss Institute for Biologically Inspired Engineering; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	P.A.S. is supported by funds from the NIH, DOD, DOE, NSF, and the Wyss Institute for Biologically Inspired Engineering. C.D.S. is supported by funds from the NIH, NSF, and the Alfred P. Sloan Foundation. The authors thank Drew Endy and Jeff Way for comments.	Alon U, 2007, INTRO SYSTEMS BIOL D; Bayer TS, 2009, J AM CHEM SOC, V131, P6508, DOI 10.1021/ja809461u; Burrill DR, 2010, CELL, V140, P13, DOI 10.1016/j.cell.2009.12.034; Callura JM, 2010, P NATL ACAD SCI USA, V107, P15898, DOI 10.1073/pnas.1009747107; Chen YY, 2010, P NATL ACAD SCI USA, V107, P8531, DOI 10.1073/pnas.1001721107; Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; Deans TL, 2007, CELL, V130, P363, DOI 10.1016/j.cell.2007.05.045; Dougherty MJ, 2009, CURR OPIN BIOTECH, V20, P486, DOI 10.1016/j.copbio.2009.08.005; Ducat DC, 2011, TRENDS BIOTECHNOL, V29, P95, DOI 10.1016/j.tibtech.2010.12.003; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Dunlop Mary J, 2010, Syst Synth Biol, V4, P95, DOI 10.1007/s11693-010-9052-5; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Farmer WR, 2000, NAT BIOTECHNOL, V18, P533, DOI 10.1038/75398; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Haynes KA, 2009, J CELL BIOL, V187, P589, DOI 10.1083/jcb.200908138; Lim WA, 2010, NAT REV MOL CELL BIO, V11, P393, DOI 10.1038/nrm2904; Matzas M, 2010, NAT BIOTECHNOL, V28, P1291, DOI 10.1038/nbt.1710; Mukhopadhyay A, 2008, CURR OPIN BIOTECH, V19, P228, DOI 10.1016/j.copbio.2008.05.003; Norville Julie E, 2010, J Biol Eng, V4, P17, DOI 10.1186/1754-1611-4-17; Pfleger BF, 2006, NAT BIOTECHNOL, V24, P1027, DOI 10.1038/nbt1226; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Savageau MA, 2011, ANN BIOMED ENG, V39, P1278, DOI 10.1007/s10439-010-0220-2; Sprinzak D, 2005, NATURE, V438, P443, DOI 10.1038/nature04335; Tian JD, 2009, MOL BIOSYST, V5, P714, DOI 10.1039/b822268c; VILLAKOMAROFF L, 1978, P NATL ACAD SCI USA, V75, P3727, DOI 10.1073/pnas.75.8.3727; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Win MN, 2007, P NATL ACAD SCI USA, V104, P14283, DOI 10.1073/pnas.0703961104; Win MN, 2009, CHEM BIOL, V16, P298, DOI 10.1016/j.chembiol.2009.02.011	32	65	67	2	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 18	2011	144	6					855	859		10.1016/j.cell.2011.02.020	http://dx.doi.org/10.1016/j.cell.2011.02.020			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	737BQ	21414477	Bronze, Green Accepted			2022-12-28	WOS:000288543500004
J	Lawn, SD; Zumla, AI				Lawn, Stephen D.; Zumla, Alimuddin I.			Tuberculosis	LANCET			English	Article							HIV-ASSOCIATED TUBERCULOSIS; MULTIDRUG-RESISTANT TUBERCULOSIS; HUMAN-IMMUNODEFICIENCY-VIRUS; ACID AMPLIFICATION TESTS; MYCOBACTERIUM-TUBERCULOSIS; ANTIRETROVIRAL THERAPY; PULMONARY TUBERCULOSIS; TREATMENT OUTCOMES; DIAGNOSTIC-ACCURACY; SMEAR MICROSCOPY	Tuberculosis results in an estimated 1.7 million deaths each year and the worldwide number of new cases (more than 9 million) is higher than at any other time in history. 22 low-income and middle-income countries account for more than 80% of the active cases in the world. Due to the devastating effect of HIV on susceptibility to tuberculosis, sub-Saharan Africa has been disproportionately affected and accounts for four of every five cases of HIV-associated tuberculosis. In many regions highly endemic for tuberculosis, diagnosis continues to rely on century-old sputum microscopy; there is no vaccine with adequate effectiveness and tuberculosis treatment regimens are protracted and have a risk of toxic effects. Increasing rates of drug-resistant tuberculosis in eastern Europe, Asia, and sub-Saharan Africa now threaten to undermine the gains made by worldwide tuberculosis control programmes. Moreover, our fundamental understanding of the pathogenesis of this disease is inadequate. However, increased investment has allowed basic science and translational and applied research to produce new data, leading to promising progress in the development of improved tuberculosis diagnostics, biomarkers of disease activity, drugs, and vaccines. The growing scientific momentum must be accompanied by much greater investment and political commitment to meet this huge persisting challenge to public health. Our Seminar presents current perspectives on the scale of the epidemic, the pathogen and the host response, present and emerging methods for disease control (including diagnostics, drugs, biomarkers, and vaccines), and the ongoing challenge of tuberculosis control in adults in the 21st century.	[Zumla, Alimuddin I.] UCL, Sch Med, Dept Infect, Div Infect & Immun, London W1T 4JF, England; [Zumla, Alimuddin I.] Univ Coll London, Univ Zambia, Med Sch Res, Lusaka, Zambia; [Zumla, Alimuddin I.] Univ Teaching Hosp, Training Project, Lusaka, Zambia; [Lawn, Stephen D.] Univ Cape Town, Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Lawn, Stephen D.] Univ London London Sch Hyg & Trop Med, Dept Clin Res, Fac Infect & Trop Dis, London WC1E 7HT, England	University of London; University College London; UCL Medical School; University of Zambia; University of Zambia; University of Cape Town; University of London; London School of Hygiene & Tropical Medicine	Zumla, AI (corresponding author), UCL, Sch Med, Dept Infect, Div Infect & Immun, London W1T 4JF, England.	a.zumla@ucl.ac.uk	ZUMLA, Alimuddin/ABA-8208-2020	ZUMLA, Alimuddin/0000-0002-5111-5735	UK-MRC; EU.FW7; EuropeAlD (ADAT); EDCTP (TB Neat, Remox, PANACEA); UK NIHR UCLH-CBRC; Wellcome Trust, London, UK	UK-MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU.FW7; EuropeAlD (ADAT); EDCTP (TB Neat, Remox, PANACEA); UK NIHR UCLH-CBRC; Wellcome Trust, London, UK(Wellcome Trust)	AZ receives grant support from the UK-MRC, EU.FW7, EuropeAlD (ADAT), EDCTP (TB Neat, Remox, PANACEA), and the UK NIHR UCLH-CBRC. SDL is funded by the Wellcome Trust, London, UK. We thank Stefan Kauffman, Colleen Wright, Miles Stanford, and Sebastian Lucas for their kind permission to use their figures.	Adetifa IMO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012502; Aerts A, 2000, INT J TUBERC LUNG D, V4, P1104; Agranoff D, 2006, LANCET, V368, P1012, DOI 10.1016/S0140-6736(06)69342-2; Aiken AM, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-66; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Atun R, 2010, LANCET, V375, P2169, DOI 10.1016/S0140-6736(10)60493-X; Baeke F, 2010, CURR OPIN PHARMACOL, V10, P482, DOI 10.1016/j.coph.2010.04.001; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Bates I, 2004, LANCET INFECT DIS, V4, P267, DOI 10.1016/S1473-3099(04)01002-3; Bates MN, 2007, ARCH INTERN MED, V167, P335, DOI 10.1001/archinte.167.4.335; Behar SM, 2010, NAT REV MICROBIOL, V8, P668, DOI 10.1038/nrmicro2387; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bezuidenhout J., 2009, TUBERCULOSIS COMPREH, P117; Black GF, 2009, CLIN VACCINE IMMUNOL, V16, P1203, DOI 10.1128/CVI.00111-09; BLANC FX, 2010, 18 INT AIDS C VIENN; Boehme CC, 2007, J CLIN MICROBIOL, V45, P1936, DOI 10.1128/JCM.02352-06; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Brassard P, 2006, CLIN INFECT DIS, V43, P717, DOI 10.1086/506935; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Cegielski JP, 2004, INT J TUBERC LUNG D, V8, P286; Chocano-Bedoya P, 2009, NUTR REV, V67, P289, DOI 10.1111/j.1753-4887.2009.00195.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Coulombe F, 2009, J EXP MED, V206, P1709, DOI 10.1084/jem.20081779; COWIE RL, 1994, AM J RESP CRIT CARE, V150, P1460, DOI 10.1164/ajrccm.150.5.7952577; Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; Domenech P, 2010, J BACTERIOL, V192, P4562, DOI 10.1128/JB.00536-10; Donald PR, 2010, LANCET, V375, P1852, DOI 10.1016/S0140-6736(10)60580-6; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Eley BS., 2009, TUBERCULOSIS COMPREH, P75; ELLIOTT AM, 1993, J TROP MED HYG, V96, P1; Eum SY, 2010, CHEST, V137, P122, DOI 10.1378/chest.09-0903; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gajalakshmi V, 2003, LANCET, V362, P507, DOI 10.1016/S0140-6736(03)14109-8; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; GILKS CF, 1990, AIDS, V4, P981, DOI 10.1097/00002030-199010000-00006; Grange JM., 2009, TUBERCULOSISA COMPRE, V5th ed, P44, DOI [10.1016/b978-1-4160-3988-4.00006-8, DOI 10.1016/B978-1-4160-3988-4.00006-8]; Greco S, 2006, THORAX, V61, P783, DOI 10.1136/thx.2005.054908; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; Harries AD, 2009, INT J TUBERC LUNG D, V13, P6; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hernandez-Pando R, 2000, LANCET, V356, P2133, DOI 10.1016/S0140-6736(00)03493-0; Hillemann D, 2009, J CLIN MICROBIOL, V47, P1767, DOI 10.1128/JCM.00081-09; Hoffmann CJ, 2007, AIDS, V21, P1301, DOI 10.1097/QAD.0b013e32814e6b08; Hussein MM, 2003, SEMIN DIALYSIS, V16, P38, DOI 10.1046/j.1525-139X.2003.03010.x; Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Jindani A, 2004, LANCET, V364, P1244, DOI 10.1016/S0140-6736(04)17141-9; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Kaufmann SHE, 2010, LANCET, V375, P2110, DOI 10.1016/S0140-6736(10)60393-5; Kim HR, 2008, RESPIROLOGY, V13, P413, DOI 10.1111/j.1440-1843.2008.01282.x; Kranzer K, 2010, LANCET INFECT DIS, V10, P93, DOI 10.1016/S1473-3099(09)70326-3; Lambert PH, 2009, CLIN CHEST MED, V30, P811, DOI 10.1016/j.ccm.2009.08.014; Lawn SD, 2005, LANCET INFECT DIS, V5, P361, DOI 10.1016/S1473-3099(05)70140-7; Lawn SD, 2002, MICROBES INFECT, V4, P635, DOI 10.1016/S1286-4579(02)01582-4; Lawn SD, S AFR MED J IN PRESS; Lawn SD, 2009, TUBERCULOSIS COMPREH, P96; Lawn SD, INT J TUBER IN PRESS; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lawn SD, 2011, CURR OPIN INFECT DIS, V24, P34, DOI 10.1097/QCO.0b013e3283420f76; Lawn SD, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/980594; Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5; Lawn SD, 2009, CLIN CHEST MED, V30, P685, DOI 10.1016/j.ccm.2009.08.010; Lawn SD, 2009, CURR OPIN HIV AIDS, V4, P325, DOI 10.1097/COH.0b013e32832c7d61; Lawn SD, 2009, AIDS, V23, P1875, DOI 10.1097/QAD.0b013e32832e05c8; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Ling DI, 2008, EUR RESPIR J, V32, P1165, DOI 10.1183/09031936.00061808; Ling DI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001536; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Losi M, 2007, EUR RESPIR J, V30, P1173, DOI 10.1183/09031936.00067307; Ma ZK, 2010, LANCET, V375, P2100, DOI 10.1016/S0140-6736(10)60359-9; Maartens G, 2009, ANTIVIR THER, V14, P1039, DOI 10.3851/IMP1455; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Mak A, 2008, AM J RESP CRIT CARE, V178, P306, DOI 10.1164/rccm.200802-240OC; Marais BJ, 2010, LANCET, V375, P2179, DOI 10.1016/S0140-6736(10)60554-5; Martineau AR, 2007, J CLIN INVEST, V117, P1988, DOI 10.1172/JCI31097; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; Mazurek GH, 2007, CLIN INFECT DIS, V45, P837, DOI 10.1086/521107; McIlleron H, 2007, J INFECT DIS, V196, pS63, DOI 10.1086/518655; Meintjes G, 2010, AIDS, V24, P2381, DOI 10.1097/QAD.0b013e32833dfc68; Menzies D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000150, 10.1371/journal.pmed.1000146]; Migliori GB, 2007, EUROSURVEILLANCE, V12; Mistry R, 2007, J INFECT DIS, V195, P357, DOI 10.1086/510397; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Moller M, 2010, FEMS IMMUNOL MED MIC, V58, P3, DOI 10.1111/j.1574-695X.2009.00600.x; Monkongdee P, 2009, AM J RESP CRIT CARE, V180, P903, DOI 10.1164/rccm.200905-0692OC; Morgan M, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-62; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Neyrolles O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000199; Nguyen BH, 2010, B WORLD HEALTH ORGAN, V88, P273, DOI 10.2471/BLT.09.067801; O'Grady J, 2011, TUBERCULOSIS, V91, P173, DOI 10.1016/j.tube.2010.12.002; Odhiambo J, 2008, INT J TUBERC LUNG D, V12, pS63; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Ottenhoff THM, 2005, TUBERCULOSIS, V85, P53, DOI 10.1016/j.tube.2004.09.011; Oxlade O, 2009, INT J TUBERC LUNG D, V13, P1238; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2009, CLIN CHEST MED, V30, P701, DOI 10.1016/j.ccm.2009.08.016; Paige C, 2010, CELL MICROBIOL, V12, P301, DOI 10.1111/j.1462-5822.2009.01424.x; Persson YAZ, 2008, MICROBES INFECT, V10, P233, DOI 10.1016/j.micinf.2007.11.007; Peter J, 2010, CURR OPIN PULM MED, V16, P262, DOI 10.1097/MCP.0b013e328337f23a; Pillay M, 2007, CLIN INFECT DIS, V45, P1409, DOI 10.1086/522987; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Repsilber D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-27; Ribeiro S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-23; Rubin EJ, 2009, NEW ENGL J MED, V360, P2471, DOI 10.1056/NEJMcibr0902539; Ruhwald M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002858; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Russell DG, 2010, CELL HOST MICROBE, V8, P68, DOI 10.1016/j.chom.2010.06.002; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Shah M, 2009, JAIDS-J ACQ IMM DEF, V52, P145, DOI 10.1097/QAI.0b013e3181b98430; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Silva FA, 2005, HAEMATOLOGICA, V90, P1110; Smith NH, 2009, NAT REV MICROBIOL, V7, P537, DOI 10.1038/nrmicro2165; Stanford J, 2004, FRONT BIOSCI-LANDMRK, V9, P1701, DOI 10.2741/1292; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Stevenson CR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-234; Stop TB Partnership, 2006, GLOB PLAN STOP TB 20; Stop TB Partnership, 2010, GLOB PLAN STOP TB 20; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Sutherland JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012365; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; von Reyn CF, 2010, AIDS, V24, P675, DOI 10.1097/QAD.0b013e3283350f1b; Vynnycky E, 1999, INT J EPIDEMIOL, V28, P327, DOI 10.1093/ije/28.2.327; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Wallis RS, 2009, LANCET INFECT DIS, V9, P162, DOI 10.1016/S1473-3099(09)70042-8; Walls RS, 2008, LANCET INFECT DIS, V8, P601, DOI 10.1016/S1473-3099(08)70227-5; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Watt CJ, 2009, TUBERCULOSIS COMPREH, P17; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WHO, 2010, ANT THER HIV INF AD; *WHO, 2009, GLOB TUB CONTR SHORT; WHO, 2009, GLOB TUB CONTR 2009; WHO, 2009, 9 M STRAT TECHN ADV; World Health Organization,, 2008, NEW LAB DIAGN TOOLS; World Health Organization, 2010, GLOB TUB CONTR; World Health Organization, 2010, UN ACC SCAL PRIOR HI; World Health Organization Stop TB Partnership, 2006, STOP TB STRAT BUILD; World Health Organization (WHO), WHO 3 IS M INT CAS F; Young DB, 2009, TRENDS MICROBIOL, V17, P183, DOI 10.1016/j.tim.2009.02.005; Zumla, 2009, TUBERCULOSIS COMPREH, P1; Zumla A, 1996, CLIN INFECT DIS, V23, P146, DOI 10.1093/clinids/23.1.146; Zumla A, 2011, TROP MED INT HEALTH, V16, P79, DOI 10.1111/j.1365-3156.2010.02665.x	152	576	601	2	231	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 2	2011	378	9785					57	72		10.1016/S0140-6736(10)62173-3	http://dx.doi.org/10.1016/S0140-6736(10)62173-3			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	791IU	21420161				2022-12-28	WOS:000292659700035
J	Liu, Q; Wang, B; Kong, YY; Cheng, KK				Liu, Qian; Wang, Bin; Kong, Yuyan; Cheng, K. K.			China's primary health-care reform	LANCET			English	Editorial Material									[Liu, Qian; Wang, Bin] Minist Hlth, Beijing, Peoples R China; [Kong, Yuyan; Cheng, K. K.] Univ Birmingham Edgebaston, Dept Publ Hlth & Epidemiol, Birmingham, W Midlands, England	University of Birmingham	Liu, Q (corresponding author), Minist Hlth, Beijing, Peoples R China.	qianliumoh@yahoo.cn	Cheng, Kar/AAL-8899-2021	Cheng, Kar/0000-0002-1516-1857				[Anonymous], ECONOMIST; Central Committee of the Communist Party and State Council People's Republic of China, 2010, STAND C STAT COUNC C; DENG LF, 2010, LINGNAN J, V4, P115; DU SL, 2009, J CHONGQING TECHNOL, V19, P55; LI W, 2001, CHIN GEN PRAC, V4, P112; *MIN HLTH GEN OFF, 2010, REP SUP CHIN ESS PUB; *MIN HLTH NAT DEV, PLAN EST GEN PRACT L; Ren X., 2010, CHIN HLTH EC, V29, P44; *STAT COUNC PEOPL, 2010, CURR MAJ PROJ HLTH C; XU XH, 2010, JIANGSU HLTH CARE, V4, P26; Zhou LZ, 2010, CHONGQING MED, V39, P250; 马健, 2010, [中华老年医学杂志, Chinese Journal of Geriatrics], V29, P51	12	111	114	3	51	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 18	2011	377	9783					2064	2066		10.1016/S0140-6736(11)60167-0	http://dx.doi.org/10.1016/S0140-6736(11)60167-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	783XI	21453962				2022-12-28	WOS:000292117800008
J	Park, SJ; Kim, YH; Park, DW; Yun, SC; Ahn, JM; Song, HG; Lee, JY; Kim, WJ; Kang, SJ; Lee, SW; Lee, CW; Park, SW; Chung, CH; Lee, JW; Lim, DS; Rha, SW; Lee, SG; Gwon, HC; Kim, HS; Chae, IH; Jang, Y; Jeong, MH; Tahk, SJ; Seung, KB				Park, Seung-Jung; Kim, Young-Hak; Park, Duk-Woo; Yun, Sung-Cheol; Ahn, Jung-Min; Song, Hae Geun; Lee, Jong-Young; Kim, Won-Jang; Kang, Soo-Jin; Lee, Seung-Whan; Lee, Cheol Whan; Park, Seong-Wook; Chung, Cheol-Hyun; Lee, Jae-Won; Lim, Do-Sun; Rha, Seung-Woon; Lee, Sang-Gon; Gwon, Hyeon-Cheol; Kim, Hyo-Soo; Chae, In-Ho; Jang, Yangsoo; Jeong, Myung-Ho; Tahk, Seung-Jea; Seung, Ki Bae			Randomized Trial of Stents versus Bypass Surgery for Left Main Coronary Artery Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PACLITAXEL-ELUTING STENTS; CARDIOLOGY-HOSPITAL REGISTRIES; BARE-METAL STENTS; ONE-YEAR OUTCOMES; SURGICAL REVASCULARIZATION; AMERICAN-COLLEGE; CLINICAL-TRIALS; TASK-FORCE; T-SEARCH; INTERVENTION	BACKGROUND Percutaneous coronary intervention (PCI) is increasingly used to treat unprotected left main coronary artery stenosis, although coronary-artery bypass grafting (CABG) has been considered to be the treatment of choice. METHODS We randomly assigned patients with unprotected left main coronary artery stenosis to undergo CABG (300 patients) or PCI with sirolimus-eluting stents (300 patients). Using a wide margin for noninferiority, we compared the groups with respect to the primary composite end point of major adverse cardiac or cerebrovascular events (death from any cause, myocardial infarction, stroke, or ischemia-driven target-vessel revascularization) at 1 year. Event rates at 2 years were also compared between the two groups. RESULTS The primary end point occurred in 26 patients assigned to PCI as compared with 20 patients assigned to CABG (cumulative event rate, 8.7% vs. 6.7%; absolute risk difference, 2.0 percentage points; 95% confidence interval [CI], -1.6 to 5.6; P=0.01 for noninferiority). By 2 years, the primary end point had occurred in 36 patients in the PCI group as compared with 24 in the CABG group (cumulative event rate, 12.2% vs. 8.1%; hazard ratio with PCI, 1.50; 95% CI, 0.90 to 2.52; P=0.12). The composite rate of death, myocardial infarction, or stroke at 2 years occurred in 13 and 14 patients in the two groups, respectively (cumulative event rate, 4.4% and 4.7%, respectively; hazard ratio, 0.92; 95% CI, 0.43 to 1.96; P=0.83). Ischemia-driven target-vessel revascularization occurred in 26 patients in the PCI group as compared with 12 patients in the CABG group (cumulative event rate, 9.0% vs. 4.2%; hazard ratio, 2.18; 95% CI, 1.10 to 4.32; P=0.02). CONCLUSIONS In this randomized trial involving patients with unprotected left main coronary artery stenosis, PCI with sirolimus-eluting stents was shown to be noninferior to CABG with respect to major adverse cardiac or cerebrovascular events. However, the noninferiority margin was wide, and the results cannot be considered clinically directive.	[Park, Seung-Jung; Kim, Young-Hak; Park, Duk-Woo; Ahn, Jung-Min; Song, Hae Geun; Lee, Jong-Young; Kim, Won-Jang; Kang, Soo-Jin; Lee, Seung-Whan; Lee, Cheol Whan; Park, Seong-Wook; Chung, Cheol-Hyun; Lee, Jae-Won] Univ Ulsan, Coll Med, Asan Med Ctr, Ctr Med Res & Informat,Heart Inst, Seoul 138736, South Korea; [Yun, Sung-Cheol] Univ Ulsan, Coll Med, Asan Med Ctr, Ctr Med Res & Informat,Div Biostat, Seoul 138736, South Korea; [Lim, Do-Sun] Korea Univ, Anam Hosp, Seoul, South Korea; [Rha, Seung-Woon] Korea Univ, Guro Hosp, Seoul, South Korea; [Gwon, Hyeon-Cheol] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea; [Kim, Hyo-Soo] Seoul Natl Univ Hosp, Seoul 110744, South Korea; [Jang, Yangsoo] Yonsei Univ, Severance Hosp, Seoul 120749, South Korea; [Seung, Ki Bae] Catholic Univ Korea, St Marys Hosp, Seoul, South Korea; [Lee, Sang-Gon] Ulsan Univ Hosp, Ulsan, South Korea; [Chae, In-Ho] Seoul Natl Univ Hosp, Bundang, South Korea; [Jeong, Myung-Ho] Chonnam Natl Univ Hosp, Kwangju, South Korea; [Tahk, Seung-Jea] Ajou Univ, Med Ctr, Suwon 441749, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Seoul National University Hospital; Yonsei University; Yonsei University Health System; Catholic University of Korea; Catholic University Korea Hospital; Seoul St. Mary's Hospital; University of Ulsan; Ulsan University Hospital; Seoul National University (SNU); Seoul National University Hospital; Chonnam National University; Chonnam National University Hospital; Ajou University	Park, SJ (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Ctr Med Res & Informat,Heart Inst, 388-1 Pungnap Dong, Seoul 138736, South Korea.	sjpark@amc.seoul.kr	Rha, Seung-Woon/AGE-5810-2022	Rha, Seung-Woon/0000-0001-9456-9852; Song, Haegeun/0000-0002-9709-209X	Cardiovascular Research Foundation (Seoul, Korea); Cordis; Johnson and Johnson; Ministry of Health and Welfare, Korea [0412-CR02-0704-0001]	Cardiovascular Research Foundation (Seoul, Korea); Cordis; Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); Ministry of Health and Welfare, Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	Supported by the Cardiovascular Research Foundation (Seoul, Korea), Cordis, Johnson and Johnson, and a grant (0412-CR02-0704-0001) from Health 21 R&D Project, Ministry of Health and Welfare, Korea.	Biondi-Zoccai GGL, 2008, AM HEART J, V155, P274, DOI 10.1016/j.ahj.2007.10.009; Boudriot E, 2011, J AM COLL CARDIOL, V57, P538, DOI 10.1016/j.jacc.2010.09.038; Buszman PE, 2008, J AM COLL CARDIOL, V51, P538, DOI 10.1016/j.jacc.2007.09.054; CAIN KC, 1984, BIOMETRICS, V40, P493, DOI 10.2307/2531402; Chieffo A, 2010, JACC-CARDIOVASC INTE, V3, P595, DOI 10.1016/j.jcin.2010.03.014; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; D'Agostino RB, 2003, STAT MED, V22, P169, DOI 10.1002/sim.1425; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Kimura T, 2009, CIRCULATION, V119, P987, DOI 10.1161/CIRCULATIONAHA.108.808311; Kushner FG, 2010, J AM COLL CARDIOL, V55, P612, DOI 10.1016/j.jacc.2010.01.003; Kushner FG, 2009, J AM COLL CARDIOL, V54, P2205, DOI [10.1016/j.jacc.2009.10.015, 10.1002/ccd.22351]; Mehilli J, 2009, J AM COLL CARDIOL, V53, pA66; Mercado N, 2005, J THORAC CARDIOV SUR, V130, P512, DOI 10.1016/j.jtcvs.2004.12.049; Moller CH, 2008, EUR HEART J, V29, P2601, DOI 10.1093/eurheartj/ehn335; Morice MC, 2010, CIRCULATION, V121, P2645, DOI 10.1161/CIRCULATIONAHA.109.899211; Naik H, 2009, JACC-CARDIOVASC INTE, V2, P739, DOI 10.1016/j.jcin.2009.05.020; Nashef SAM, 1999, EUR J CARDIO-THORAC, V16, P9, DOI 10.1016/S1010-7940(99)00134-7; Onuma Y, 2010, JACC-CARDIOVASC INTE, V3, P584, DOI 10.1016/j.jcin.2010.03.017; Pandya SB, 2010, JACC-CARDIOVASC INTE, V3, P602, DOI 10.1016/j.jcin.2010.03.019; Park DW, 2010, J AM COLL CARDIOL, V56, P1187, DOI 10.1016/j.jacc.2010.03.086; Park DW, 2010, J AM COLL CARDIOL, V56, P117, DOI 10.1016/j.jacc.2010.04.004; Park DW, 2008, JACC-CARDIOVASC INTE, V1, P494, DOI 10.1016/j.jcin.2008.06.011; Park SJ, 2009, CIRC-CARDIOVASC INTE, V2, P167, DOI 10.1161/CIRCINTERVENTIONS.108.799494; Schomig A, 2007, J AM COLL CARDIOL, V50, P1373, DOI 10.1016/j.jacc.2007.06.047; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Seung KB, 2008, NEW ENGL J MED, V358, P1781, DOI 10.1056/NEJMoa0801441; Shaw LJ, 2008, CIRCULATION, V117, P1787, DOI 10.1161/CIRCULATIONAHA.107.726562; Sianos Georgios, 2005, EuroIntervention, V1, P219; Valgimigli M, 2005, CIRCULATION, V111, P1383, DOI 10.1161/01.CIR.0000158486.20865.8B; Vander Salm TJ, 2002, J AM COLL CARDIOL, V39, P565, DOI 10.1016/S0735-1097(01)01806-X; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Wijns W, 2010, EUR HEART J, V31, P2501, DOI 10.1093/eurheartj/ehq277	33	452	485	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2011	364	18					1718	1727		10.1056/NEJMoa1100452	http://dx.doi.org/10.1056/NEJMoa1100452			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	759DC	21463149	Bronze			2022-12-28	WOS:000290219800008
J	Qureshi, OS; Zheng, Y; Nakamura, K; Attridge, K; Manzotti, C; Schmidt, EM; Baker, J; Jeffery, LE; Kaur, S; Briggs, Z; Hou, TZ; Futter, CE; Anderson, G; Walker, LSK; Sansom, DM				Qureshi, Omar S.; Zheng, Yong; Nakamura, Kyoko; Attridge, Kesley; Manzotti, Claire; Schmidt, Emily M.; Baker, Jennifer; Jeffery, Louisa E.; Kaur, Satdip; Briggs, Zoe; Hou, Tie Z.; Futter, Clare E.; Anderson, Graham; Walker, Lucy S. K.; Sansom, David M.			Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4	SCIENCE			English	Article							T-CELL; DENDRITIC CELLS; SURFACE EXPRESSION; TARGET-CELLS; B-CELLS; ACTIVATION; PROTEINS; LYMPHOPROLIFERATION; TROGOCYTOSIS; SECRETION	Cytotoxic T lymphocyte antigen 4 (CTLA-4) is an essential negative regulator of T cell immune responses whose mechanism of action is the subject of debate. CTLA-4 shares two ligands (CD80 and CD86) with a stimulatory receptor, CD28. Here, we show that CTLA-4 can capture its ligands from opposing cells by a process of trans-endocytosis. After removal, these costimulatory ligands are degraded inside CTLA-4-expressing cells, resulting in impaired costimulation via CD28. Acquisition of CD86 from antigen-presenting cells is stimulated by T cell receptor engagement and observed in vitro and in vivo. These data reveal a mechanism of immune regulation in which CTLA-4 acts as an effector molecule to inhibit CD28 costimulation by the cell-extrinsic depletion of ligands, accounting for many of the known features of the CD28-CTLA-4 system.	[Qureshi, Omar S.; Zheng, Yong; Nakamura, Kyoko; Attridge, Kesley; Manzotti, Claire; Schmidt, Emily M.; Baker, Jennifer; Jeffery, Louisa E.; Kaur, Satdip; Briggs, Zoe; Hou, Tie Z.; Anderson, Graham; Walker, Lucy S. K.; Sansom, David M.] Univ Birmingham, Sch Med, Inst Biomed Res, Sch Immun & Infect,MRC,Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England; [Futter, Clare E.] UCL, Dept Cell Biol, Inst Ophthalmol, London EC1V 9EL, England	University of Birmingham; University of London; University College London	Sansom, DM (corresponding author), Univ Birmingham, Sch Med, Inst Biomed Res, Sch Immun & Infect,MRC,Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England.	d.m.sansom@bham.ac.uk	Qureshi, Omar/CAF-4545-2022; HOU, TIEZHENG/B-4848-2015; Nakamura, Kyoko/B-4184-2013	Futter, Clare/0000-0001-5559-9389; anderson, graham/0000-0002-2917-4085; Walker, Lucy/0000-0001-5986-5015; Attridge, Kesley/0000-0003-4521-9009; Kaur, Satdip/0000-0002-0901-9141; Sansom, David/0000-0001-6506-3115; Manzotti, Claire/0000-0001-5894-5435	UK Biotechnology and Biological Sciences Research Council; MRC; Wellcome Trust; Arthritis Research UK; BBSRC [BB/H013598/1, BB/D011000/1] Funding Source: UKRI; MRC [G9818340, G0802382, G1000213, G0401620, G0400931] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D011000/1, BB/H013598/1] Funding Source: researchfish; Medical Research Council [G0401620, G0802382, G0400931, G9818340B, G9818340, G1000213] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Arthritis Research UK(Versus Arthritis); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank A. Sharpe for the generous gift of Ctla4<SUP>-/-</SUP> mice, W. Heath for the rip-mOVA mice, and G. Freeman for the I-A<SUP>d</SUP>-expressing CHO cells. This work was supported by the UK Biotechnology and Biological Sciences Research Council (O.Q.), MRC (L. S. K. W., Y.Z., K. A., E. S., and K.N.), Wellcome Trust (C. M., T. H., and Z.B.), and Arthritis Research UK (L.J.). L. S. K. W. is an MRC Senior Fellow. Cell lines expressing CD80, CD86, and CTLA-4 are available under a material transfer agreement for noncommercial use.	Aucher A, 2008, BLOOD, V111, P5621, DOI 10.1182/blood-2008-01-134155; Bachmann MF, 1999, J IMMUNOL, V163, P1128; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; CAGAN RL, 1992, CELL, V69, P393, DOI 10.1016/0092-8674(92)90442-F; Catalfamo M, 2008, IMMUNOLOGY, V125, P70, DOI 10.1111/j.1365-2567.2008.02822.x; Chambers CA, 1997, IMMUNITY, V7, P885, DOI 10.1016/S1074-7613(00)80406-9; Choi JM, 2006, NAT MED, V12, P574, DOI 10.1038/nm1385; Chuang E, 1997, J IMMUNOL, V159, P144; Daubeuf S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008716; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; Friedline RH, 2009, J EXP MED, V206, P421, DOI 10.1084/jem.20081811; Homann D, 2006, J VIROL, V80, P270, DOI 10.1128/JVI.80.1.270-280.2006; Hudrisier D, 2007, J IMMUNOL, V178, P3637, DOI 10.4049/jimmunol.178.6.3637; Iida T, 2000, J IMMUNOL, V165, P5062, DOI 10.4049/jimmunol.165.9.5062; Kusakari S, 2008, J CELL SCI, V121, P1213, DOI 10.1242/jcs.025015; Marston DJ, 2003, NAT CELL BIOL, V5, P879, DOI 10.1038/ncb1044; Mead KI, 2005, J IMMUNOL, V174, P4803, DOI 10.4049/jimmunol.174.8.4803; Oderup C, 2006, IMMUNOLOGY, V118, P240, DOI 10.1111/j.1365-2567.2006.02362.x; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Peggs KS, 2009, J EXP MED, V206, P1717, DOI 10.1084/jem.20082492; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Read S, 2006, J IMMUNOL, V177, P4376, DOI 10.4049/jimmunol.177.7.4376; Rudd CE, 2009, IMMUNOL REV, V229, P12, DOI 10.1111/j.1600-065X.2009.00770.x; Schmidt EM, 2009, J IMMUNOL, V182, P274, DOI 10.4049/jimmunol.182.1.274; Serra P, 2003, IMMUNITY, V19, P877, DOI 10.1016/S1074-7613(03)00327-3; Teft WA, 2006, ANNU REV IMMUNOL, V24, P65, DOI 10.1146/annurev.immunol.24.021605.090535; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Williams GS, 2007, TRAFFIC, V8, P1190, DOI 10.1111/j.1600-0854.2007.00603.x; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Zheng Y, 2008, J IMMUNOL, V181, P1683, DOI 10.4049/jimmunol.181.3.1683	31	1010	1059	2	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2011	332	6029					600	603		10.1126/science.1202947	http://dx.doi.org/10.1126/science.1202947			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21474713	Green Accepted			2022-12-28	WOS:000289991100052
J	Young, IR; Zieger, S; Babanin, AV				Young, I. R.; Zieger, S.; Babanin, A. V.			Global Trends in Wind Speed and Wave Height	SCIENCE			English	Article							NORTH-ATLANTIC; OCEAN WIND; CLIMATE; VARIABILITY; REANALYSIS; VALIDATION; SEA	Studies of climate change typically consider measurements or predictions of temperature over extended periods of time. Climate, however, is much more than temperature. Over the oceans, changes in wind speed and the surface gravity waves generated by such winds play an important role. We used a 23-year database of calibrated and validated satellite altimeter measurements to investigate global changes in oceanic wind speed and wave height over this period. We find a general global trend of increasing values of wind speed and, to a lesser degree, wave height, over this period. The rate of increase is greater for extreme events as compared to the mean condition.	[Young, I. R.; Zieger, S.; Babanin, A. V.] Swinburne Univ Technol, Melbourne, Vic, Australia	Swinburne University of Technology	Young, IR (corresponding author), Swinburne Univ Technol, Melbourne, Vic, Australia.	ir.young@anu.edu.au	Babanin, Alexander V/A-6676-2008; Young, Ian/E-7385-2011	Young, Ian/0000-0003-2233-9227; Zieger, Stefan/0000-0002-6051-8085; Babanin, Alexander/0000-0002-8595-8204	Australian Research Council (ARC) [LP0882422]	Australian Research Council (ARC)(Australian Research Council)	This research was supported by an Australian Research Council (ARC) Linkage Grant (LP0882422). We gratefully acknowledge the support of the ARC and our industry partner RPS MetOcean.	Alexandrov T, 2008, RRS200803 US CENS BU; Babanin AV, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027308; Babanin AV, 2009, OCEAN MODEL, V29, P189, DOI 10.1016/j.ocemod.2009.04.003; Bouws E, 1996, B AM METEOROL SOC, V77, P2275, DOI 10.1175/1520-0477(1996)077<2275:TIWHIT>2.0.CO;2; Cox AT, 2001, J GEOPHYS RES-OCEANS, V106, P2313, DOI 10.1029/2001JC000301; Donelan MA, 1997, J PHYS OCEANOGR, V27, P2087, DOI 10.1175/1520-0485(1997)027<2087:TASMFI>2.0.CO;2; Esterby SR, 1996, HYDROL PROCESS, V10, P127; Gulev S.K., 1998, PHYS CHEM EARTH, V23, P587, DOI [DOI 10.1016/S0079-1946(98)00075-5, 10.1016/S0079-1946(98)00075-5]; Gulev SK, 2006, J CLIMATE, V19, P5667, DOI 10.1175/JCLI3936.1; Gulev SK, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021040; Gulev SK, 1999, INT J CLIMATOL, V19, P1091, DOI 10.1002/(SICI)1097-0088(199908)19:10<1091::AID-JOC403>3.0.CO;2-U; Hemer MA, 2010, INT J CLIMATOL, V30, P475, DOI 10.1002/joc.1900; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kushnir Y, 1997, J CLIMATE, V10, P2107, DOI 10.1175/1520-0442(1997)010<2107:TRIINA>2.0.CO;2; Queffeulou P, 2004, MAR GEOD, V27, P495, DOI 10.1080/01490410490883478; Sterl A, 1998, J GEOPHYS RES-OCEANS, V103, P5477, DOI 10.1029/97JC03431; Thomas BR, 2008, INT J CLIMATOL, V28, P747, DOI 10.1002/joc.1570; Vikebo F, 2003, CONT SHELF RES, V23, P251, DOI 10.1016/S0278-4343(02)00210-8; Wang XLL, 2006, CLIM DYNAM, V26, P109, DOI 10.1007/s00382-005-0080-x; Wang XLL, 2004, J CLIMATE, V17, P2368, DOI 10.1175/1520-0442(2004)017<2368:NAOWCC>2.0.CO;2; Woolf DK, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001124; Young I.R., 1999, WIND GENERATED OCEAN; Young I. R., 1996, ATLAS OCEANS WIND WA; YOUNG IR, 1994, APPL OCEAN RES, V16, P235, DOI 10.1016/0141-1187(94)90023-X; YOUNG IR, 1993, J GEOPHYS RES-OCEANS, V98, P20275, DOI 10.1029/93JC02117; Young IR, 1999, INT J CLIMATOL, V19, P931, DOI 10.1002/(SICI)1097-0088(199907)19:9<931::AID-JOC412>3.0.CO;2-O; Zieger S, 2009, J ATMOS OCEAN TECH, V26, P2549, DOI 10.1175/2009JTECHA1303.1; [No title captured]	28	683	696	9	222	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 22	2011	332	6028					451	455		10.1126/science.1197219	http://dx.doi.org/10.1126/science.1197219			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	753NG	21436400				2022-12-28	WOS:000289784900039
J	Okamoto, I; Patrat, C; Thepot, D; Peynot, N; Fauque, P; Daniel, N; Diabangouaya, P; Wolf, JP; Renard, JP; Duranthon, V; Heard, E				Okamoto, Ikuhiro; Patrat, Catherine; Thepot, Dominique; Peynot, Nathalie; Fauque, Patricia; Daniel, Nathalie; Diabangouaya, Patricia; Wolf, Jean-Philippe; Renard, Jean-Paul; Duranthon, Veronique; Heard, Edith			Eutherian mammals use diverse strategies to initiate X-chromosome inactivation during development	NATURE			English	Article							EARLY MOUSE DEVELOPMENT; NUCLEAR TRANSFER; XIST EXPRESSION; CLONED RABBITS; SOMATIC-CELLS; GENE; EMBRYOS; MICE; ESTABLISHMENT; METHYLATION	X-chromosome inactivation (XCI) in female mammals allows dosage compensation for X-linked gene products between the sexes(1). The developmental regulation of this process has been extensively investigated in mice, where the X chromosome of paternal origin (Xp) is silenced during early embryogenesis owing to imprinted expression of the regulatory RNA, Xist (X-inactive specific transcript). Paternal XCI is reversed in the inner cell mass of the blastocyst and random XCI subsequently occurs in epiblast cells. Here we show that other eutherian mammals have very different strategies for initiating XCI. In rabbits and humans, the Xist homologue is not subject to imprinting and XCI begins later than in mice. Furthermore, Xist is upregulated on both X chromosomes in a high proportion of rabbit and human embryo cells, even in the inner cell mass. In rabbits, this triggers XCI on both X chromosomes in some cells. In humans, chromosome-wide XCI has not initiated even by the blastocyst stage, despite the upregulation of XIST. The choice of which X chromosome will finally become inactive thus occurs downstream of Xist upregulation in both rabbits and humans, unlike in mice. Our study demonstrates the remarkable diversity in XCI regulation and highlights differences between mammals in their requirement for dosage compensation during early embryogenesis.	[Okamoto, Ikuhiro; Patrat, Catherine; Diabangouaya, Patricia; Heard, Edith] Inst Curie, Mammalian Dev Epigenet Grp, CNRS UMR 3215, INSERM,U934, F-75248 Paris, France; [Patrat, Catherine] Univ Paris Diderot, Hop Bichat Claude Bernard, Assistance Publ Hop Paris, Serv Biol Reprod, F-75018 Paris, France; [Thepot, Dominique; Peynot, Nathalie; Daniel, Nathalie; Renard, Jean-Paul; Duranthon, Veronique] INRA, UMR Biol Dev & Reprod 1198, F-78352 Jouy En Josas, France; [Diabangouaya, Patricia] Univ Bourgogne, CHU Dijon, Lab Biol Reprod CECOS, F-21079 Dijon, France; [Fauque, Patricia] Inst Curie, INSERM, CNRS UMR 3215, F-75248 Paris, France; [Wolf, Jean-Philippe] Univ Paris 05, Unite 1016, INSERM, Assistance Publ Hop Paris,Serv Biol,Hop Cochin, F-75014 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; CHU Dijon Bourgogne; Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Heard, E (corresponding author), Inst Curie, Mammalian Dev Epigenet Grp, CNRS UMR 3215, INSERM,U934, F-75248 Paris, France.	veronique.duranthon@jouy.inra.fr; edith.heard@curie.fr	Duranthon, Véronique/D-8855-2019; Heard, Edith/D-7197-2017	Duranthon, Véronique/0000-0001-8120-7481; Heard, Edith/0000-0001-8052-7117; DANIEL, Nathalie/0000-0002-2251-1296	FRM (Equipe FRM); ANR; ERC; Agence de Biomedecine; INRA PHASE department	FRM (Equipe FRM)(Fondation pour la Recherche Medicale); ANR(French National Research Agency (ANR)); ERC(European Research Council (ERC)European Commission); Agence de Biomedecine; INRA PHASE department	We thank members of the Heard lab for advice and discussions, V. Colot for comments on the manuscript, and P. Jouannet and Hopital Cochin's IVF unit for support and advice on human embryo experiments. We are indebted to the Unite Commune d'Experimentation Animale in charge of the rabbit colonies, C. Archilla for technical help in sexing rabbit embryos, C. Rogel-Gaillard for providing rabbit bacterial artificial chromosomes before publication, and the UMR3215 PICT-IBiSA imaging facility. Funding is from the FRM (Equipe FRM), the ANR and the ERC (E. H.); the Agence de Biomedecine (C. P. and P. F.); and the INRA PHASE department (ACI 2007) (V. D. and J.-P.R.).	BARLOW P, 1970, NATURE, V226, P961, DOI 10.1038/226961a0; Challah-Jacques M, 2003, CLONING STEM CELLS, V5, P295, DOI 10.1089/153623003772032808; Chang SC, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-20; Chantry-Darmon C, 2003, CYTOGENET GENOME RES, V103, P192, DOI 10.1159/000076310; Chesne P, 2002, NAT BIOTECHNOL, V20, P366, DOI 10.1038/nbt0402-366; Chow JC, 2007, P NATL ACAD SCI USA, V104, P10104, DOI 10.1073/pnas.0610946104; CHRISTIANS E, 1994, DEV BIOL, V164, P160, DOI 10.1006/dbio.1994.1188; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; Fauque P, 2010, FERTIL STERIL, V94, P927, DOI 10.1016/j.fertnstert.2009.03.105; FLACH G, 1982, EMBO J, V1, P681, DOI 10.1002/j.1460-2075.1982.tb01230.x; Gardner DK, 1999, TOWARDS REPRODUCTIVE CERTAINTY, P378; Hajoubi S, 2006, GENE, V370, P104, DOI 10.1016/j.gene.2005.11.025; Hayes H, 2002, CYTOGENET GENOME RES, V98, P199, DOI 10.1159/000069807; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; KAY GF, 1994, CELL, V77, P639, DOI 10.1016/0092-8674(94)90049-3; Lee JT, 2005, SCIENCE, V309, P768, DOI 10.1126/science.1113673; LENGER CJ, 2010, CELL, V141, P1; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; MANES C, 1973, DEV BIOL, V32, P453, DOI 10.1016/0012-1606(73)90254-6; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Migeon BR, 2002, CYTOGENET GENOME RES, V99, P8, DOI 10.1159/000071568; Monkhorst K, 2008, CELL, V132, P410, DOI 10.1016/j.cell.2007.12.036; de Mello JCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010947; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Navarro P, 2010, BIOESSAYS, V32, P581, DOI 10.1002/bies.201000019; Okamoto I, 2000, DEVELOPMENT, V127, P4137; Okamoto I, 2005, NATURE, V438, P369, DOI 10.1038/nature04155; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Okamoto I, 2009, CHROMOSOME RES, V17, P659, DOI 10.1007/s10577-009-9057-7; Patrat C, 2009, P NATL ACAD SCI USA, V106, P5198, DOI 10.1073/pnas.0810683106; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; SHARMAN GB, 1971, NATURE, V230, P231, DOI 10.1038/230231a0; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; van den Berg IM, 2009, AM J HUM GENET, V84, P771, DOI 10.1016/j.ajhg.2009.05.003	38	296	305	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					370	U141		10.1038/nature09872	http://dx.doi.org/10.1038/nature09872			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21471966	Green Submitted			2022-12-28	WOS:000289724600044
J	Lockner, DA; Morrow, C; Moore, D; Hickman, S				Lockner, David A.; Morrow, Carolyn; Moore, Diane; Hickman, Stephen			Low strength of deep San Andreas fault gouge from SAFOD core	NATURE			English	Article							HEAT-FLOW; STRESS; SERPENTINITE; FRICTION; ZONE	The San Andreas fault accommodates 28-34 mm yr(-1) of right lateral motion of the Pacific crustal plate northwestward past the North American plate. In California, the fault is composed of two distinct locked segments that have produced great earthquakes in historical times, separated by a 150-km-long creeping zone. The San Andreas Fault Observatory at Depth (SAFOD) is a scientific borehole located northwest of Parkfield, California, near the southern end of the creeping zone. Core was recovered from across the actively deforming San Andreas fault at a vertical depth of 2.7 km (ref. 1). Here we report laboratory strength measurements of these fault core materials at in situ conditions, demonstrating that at this locality and this depth the San Andreas fault is profoundly weak (coefficient of friction, 0.15) owing to the presence of the smectite clay mineral saponite, which is one of the weakest phyllosilicates known. This Mg-rich clay is the low-temperature product of metasomatic reactions between the quartzofeldspathic wall rocks and serpentinite blocks in the fault(2,3). These findings provide strong evidence that deformation of the mechanically unusual creeping portions of the San Andreas fault system is controlled by the presence of weak minerals rather than by high fluid pressure or other proposed mechanisms(1). The combination of these measurements of fault core strength with borehole observations(1,4,5) yields a self-consistent picture of the stress state of the San Andreas fault at the SAFOD site, in which the fault is intrinsically weak in an otherwise strong crust.	[Lockner, David A.; Morrow, Carolyn; Moore, Diane; Hickman, Stephen] US Geol Survey, Menlo Pk, CA 94025 USA	United States Department of the Interior; United States Geological Survey	Lockner, DA (corresponding author), US Geol Survey, 345 Middlefield Rd, Menlo Pk, CA 94025 USA.	dlockner@usgs.gov						Boness NL, 2006, GEOPHYSICS, V71, pF131, DOI 10.1190/1.2231107; BRUNE JN, 1969, J GEOPHYS RES, V74, P3821, DOI 10.1029/JB074i015p03821; Collettini C, 2009, NATURE, V462, P907, DOI 10.1038/nature08585; Crawford BR, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2006JB004634; DIETERICH JH, 1979, J GEOPHYS RES, V84, P2161, DOI 10.1029/JB084iB05p02161; Hickman S, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020043; HICKMAN SH, 1991, REV GEOPHYS, V29, P759, DOI 10.1002/rog.1991.29.s2.759; Holdsworth RE, 2011, J STRUCT GEOL, V33, P132, DOI 10.1016/j.jsg.2010.11.010; INOUE A, 1991, AM MINERAL, V76, P628; LACHENBRUCH AH, 1992, J GEOPHYS RES-SOL EA, V97, P4995, DOI 10.1029/91JB01506; LACHENBRUCH AH, 1980, J GEOPHYS RES, V85, P6185, DOI 10.1029/JB085iB11p06185; Moore D. E., 2010, EOS S            FAL; Moore DE, 2004, INT GEOL REV, V46, P385, DOI 10.2747/0020-6814.46.5.385; Moore DE, 1997, J GEOPHYS RES-SOL EA, V102, P14787, DOI 10.1029/97JB00995; Moore DE, 2007, NATURE, V448, P795, DOI 10.1038/nature06064; Moore DE, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007881; Rice J., 1992, FAULT MECH TRANSPORT, P475, DOI DOI 10.1016/S0074-6142(08)62835-1; Saffer DM, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001849; Scholz CH, 2000, GEOLOGY, V28, P163, DOI 10.1130/0091-7613(2000)28<163:EFASSA>2.0.CO;2; Solum JG, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027285; Tembe S, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027626; Tembe S, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006383; Tembe S, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005883; Tobin H., 2007, IODP ICDP WORKSH FAU, P5; Zoback M., 2010, EOS T AGU, V91, P197, DOI [10.1029/2010EO220001, DOI 10.1029/2010EO220001]; Zoback M. D., 2007, TREATISE GEOPHYS, V4, P649; Zoback MD, 2000, NATURE, V405, P31, DOI 10.1038/35011181; ZOBACK MD, 1987, SCIENCE, V238, P1105, DOI 10.1126/science.238.4830.1105	28	274	283	3	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2011	472	7341					82	U107		10.1038/nature09927	http://dx.doi.org/10.1038/nature09927			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21441903				2022-12-28	WOS:000289199400041
J	Khan, F; Curtice, M				Khan, Farooq; Curtice, Martin			Diagnostic dilemma in an elderly woman	BRITISH MEDICAL JOURNAL			English	Editorial Material							ALZHEIMERS-DISEASE; SEIZURES; DEMENTIA		[Khan, Farooq; Curtice, Martin] Staffordshire Univ, Ctr Ageing & Mental Hlth, Stafford, England; [Khan, Farooq] Birmingham & Solihull Mental Hlth NHS Fdn Trust, Birmingham, W Midlands, England	Staffordshire University	Khan, F (corresponding author), Staffordshire Univ, Ctr Ageing & Mental Hlth, Stafford, England.	farooqkhandr@gmail.com						[Anonymous], 2006, DEM SUPP PEOPL DEM T; BELOV VP, 1987, ZH NEVROPATOL PSIKH, V87, P817; HAUSER WA, 1986, NEUROLOGY, V36, P1226, DOI 10.1212/WNL.36.9.1226; Hesdorffer DC, 1996, NEUROLOGY, V46, P727, DOI 10.1212/WNL.46.3.727; Horoupian DS, 1999, ACTA NEUROPATHOL, V98, P317, DOI 10.1007/s004010051087; Mendez M F, 1994, J Geriatr Psychiatry Neurol, V7, P230; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; ROMANELLI MF, 1990, ARCH NEUROL-CHICAGO, V47, P847, DOI 10.1001/archneur.1990.00530080029006; Scarmeas N, 2009, ARCH NEUROL-CHICAGO, V66, P992, DOI 10.1001/archneurol.2009.130	9	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 6	2011	342								d969	10.1136/bmj.d969	http://dx.doi.org/10.1136/bmj.d969			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	749JR	21471183				2022-12-28	WOS:000289462100020
J	Bedding, TR; Mosser, B; Huber, D; Montalban, J; Beck, P; Christensen-Dalsgaard, J; Elsworth, YP; Garcia, RA; Miglio, A; Stello, D; White, TR; De Ridder, J; Hekker, S; Aerts, C; Barban, C; Belkacem, K; Broomhall, AM; Brown, TM; Buzasi, DL; Carrier, F; Chaplin, WJ; Di Mauro, MP; Dupret, MA; Frandsen, S; Gilliland, RL; Goupil, MJ; Jenkins, JM; Kallinger, T; Kawaler, S; Kjeldsen, H; Mathur, S; Noels, A; Aguirre, VS; Ventura, P				Bedding, Timothy R.; Mosser, Benoit; Huber, Daniel; Montalban, Josefina; Beck, Paul; Christensen-Dalsgaard, Jorgen; Elsworth, Yvonne P.; Garcia, Rafael A.; Miglio, Andrea; Stello, Dennis; White, Timothy R.; De Ridder, Joris; Hekker, Saskia; Aerts, Conny; Barban, Caroline; Belkacem, Kevin; Broomhall, Anne-Marie; Brown, Timothy M.; Buzasi, Derek L.; Carrier, Fabien; Chaplin, William J.; Di Mauro, Maria Pia; Dupret, Marc-Antoine; Frandsen, Soren; Gilliland, Ronald L.; Goupil, Marie-Jo; Jenkins, Jon M.; Kallinger, Thomas; Kawaler, Steven; Kjeldsen, Hans; Mathur, Savita; Noels, Arlette; Aguirre, Victor Silva; Ventura, Paolo			Gravity modes as a way to distinguish between hydrogen- and helium-burning red giant stars	NATURE			English	Article							SOLAR-LIKE OSCILLATIONS; STELLAR OSCILLATIONS; COROT; ASTEROSEISMOLOGY; KEPLER; CODE; MASS	Red giants are evolved stars that have exhausted the supply of hydrogenin their cores and instead burn hydrogen in a surrounding shell(1,2). Once a red giant is sufficiently evolved, the helium in the core also undergoes fusion(3). Outstanding issues in our understanding of red giants include uncertainties in the amount of mass lost at the surface before helium ignition and the amount of internal mixing from rotation and other processes(4). Progress is hampered by our inability to distinguish between red giants burning helium in the core and those still only burning hydrogen in a shell. Asteroseismology offers a way forward, being a powerful tool for probing the internal structures of stars using their natural oscillation frequencies(5). Here we report observations of gravity-mode period spacings in red giants(6) that permit a distinction between evolutionary stages to be made. We use high-precision photometry obtained by the Kepler spacecraft over more than a year to measure oscillations in several hundred red giants. We find many stars whose dipole modes show sequences with approximately regular period spacings. These stars fall into two clear groups, allowing us to distinguish unambiguously between hydrogen-shell-burning stars (period spacing mostly similar to 50 seconds) and those that are also burning helium (period spacing similar to 100 to 300 seconds).	[Bedding, Timothy R.; Huber, Daniel; Stello, Dennis; White, Timothy R.] Univ Sydney, Sch Phys, Sydney Inst Astron SIfA, Sydney, NSW 2006, Australia; [Mosser, Benoit; Barban, Caroline; Goupil, Marie-Jo] Univ Paris 07, Univ Paris 06, CNRS, LESIA,Observ Paris, F-92195 Meudon, France; [Montalban, Josefina; Miglio, Andrea; Dupret, Marc-Antoine; Noels, Arlette] Univ Liege, Inst Astrophys & Geophys, B-4000 Cointe Ougree, Belgium; [Beck, Paul; De Ridder, Joris; Aerts, Conny; Carrier, Fabien] Katholieke Univ Leuven, Inst Sterrenkunde, B-3001 Louvain, Belgium; [Christensen-Dalsgaard, Jorgen; Frandsen, Soren] Aarhus Univ, Dept Phys & Astron, DASC, DK-8000 Aarhus C, Denmark; [Elsworth, Yvonne P.; Miglio, Andrea; Hekker, Saskia; Broomhall, Anne-Marie; Chaplin, William J.] Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England; [Garcia, Rafael A.] Univ Paris 07, Ctr Saclay, IRFU SAp, Lab AIM,CEA DSM CNRS, F-91191 Gif Sur Yvette, France; [Hekker, Saskia] Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1098 XH Amsterdam, Netherlands; [Aerts, Conny] Radboud Univ Nijmegen, Dept Astrophys, IMAPP, NL-6500 GL Nijmegen, Netherlands; [Belkacem, Kevin] Univ Paris 11, Inst Astrophys Spatiale, UMR 8617, F-91405 Orsay, France; [Brown, Timothy M.] Las Cumbres Observ Global Telescope, Goleta, CA 93117 USA; [Buzasi, Derek L.] Eureka Sci, Oakland, CA 94602 USA; [Di Mauro, Maria Pia] Ist Astrofis Spaziale & Fis Cosm, INAF IASF, I-00133 Rome, Italy; [Gilliland, Ronald L.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Jenkins, Jon M.] NASA, Ames Res Ctr, SETI Inst, Moffett Field, CA 94035 USA; [Kallinger, Thomas] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Kawaler, Steven] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA; [Mathur, Savita] NCAR, High Altitude Observ, Boulder, CO 80307 USA; [Aguirre, Victor Silva] Max Planck Inst Astrophys, D-85748 Garching, Germany; [Ventura, Paolo] Osserv Astron Roma, INAF, I-00040 Monte Porzio Catone, RM, Italy	University of Sydney; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; University of Liege; KU Leuven; Aarhus University; University of Birmingham; UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; University of Amsterdam; Radboud University Nijmegen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Eureka Scientific; Istituto Nazionale Astrofisica (INAF); Space Telescope Science Institute; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of British Columbia; Iowa State University; National Center Atmospheric Research (NCAR) - USA; Max Planck Society; Istituto Nazionale Astrofisica (INAF)	Bedding, TR (corresponding author), Univ Sydney, Sch Phys, Sydney Inst Astron SIfA, Sydney, NSW 2006, Australia.	t.bedding@physics.usyd.edu.au	miglio, andrea/O-9594-2019; Huber, Daniel/AAE-9440-2019; Stello, Dennis/Q-9754-2019; Bedding, Timothy/AAU-9400-2021; Kallinger, Thomas/N-7501-2019; Miglio, Andrea/M-5789-2018; Mathur, Savita/AAA-3102-2019; Di Mauro, Maria Pia/AAL-6117-2020; Chaplin, William/M-9160-2018	miglio, andrea/0000-0001-5998-8533; Huber, Daniel/0000-0001-8832-4488; Stello, Dennis/0000-0002-4879-3519; Bedding, Timothy/0000-0001-5222-4661; Kallinger, Thomas/0000-0003-3627-2561; Miglio, Andrea/0000-0001-5998-8533; Hekker, Saskia/0000-0002-1463-726X; White, Timothy/0000-0002-6980-3392; Mosser, Benoit/0000-0002-7547-1208; Garcia, Rafael A./0000-0002-8854-3776; Buzasi, Derek/0000-0002-1988-143X; Mathur, Savita/0000-0002-0129-0316; Aguirre Borsen-Koch, Victor/0000-0002-6137-903X; Christensen-Dalsgaard, Jorgen/0000-0001-5137-0966; Kawaler, Steven/0000-0002-6536-6367; Ventura, Paolo/0000-0002-5026-6400; Di Mauro, Maria Pia/0000-0001-7801-7484; Aerts, Conny/0000-0003-1822-7126; Bedding, Timothy/0000-0001-5943-1460; Beck, Paul G./0000-0003-4745-2242; Chaplin, William/0000-0002-5714-8618	NASA's Science Mission Directorate; Australian Research Council; European Community; Netherlands Organisation for Scientific Research (NWO); National Science Foundation; STFC [ST/F002041/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/F002041/1] Funding Source: researchfish	NASA's Science Mission Directorate; Australian Research Council(Australian Research Council); European Community(European Commission); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Science Foundation(National Science Foundation (NSF)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We acknowledge the entire Kepler team, whose efforts made these results possible. We thank M. Biercuk for comments. Funding for this Discovery mission was provided by NASA's Science Mission Directorate. T.R.B and D.S. were supported by the Australian Research Council; P.B. and C.A. were supported by European Community's 7th Framework Programme (PROSPERITY); S.H. was supported by the Netherlands Organisation for Scientific Research (NWO). The National Center for Atmospheric Research is sponsored by the National Science Foundation.	Aerts C., 2010, ASTRON ASTROPHYS LIB; AIZENMAN M, 1977, ASTRON ASTROPHYS, V58, P41; Beck P. G., SCIENCE IN PRESS; Bedding TR, 2010, ASTROPHYS J LETT, V713, pL176, DOI 10.1088/2041-8205/713/2/L176; Charbonnel C, 2005, ASTR SOC P, V336, P119; Christensen-Dalsgaard J, 2004, SOL PHYS, V220, P137, DOI 10.1023/B:SOLA.0000031392.43227.7d; Christensen-Dalsgaard J, 2008, ASTROPHYS SPACE SCI, V316, P13, DOI 10.1007/s10509-007-9675-5; De Ridder J, 2009, NATURE, V459, P398, DOI 10.1038/nature08022; Deheuvels S, 2010, ASTROPHYS SPACE SCI, V328, P259, DOI 10.1007/s10509-009-0216-2; DiMauro M. P., MON NOT R ASTR UNPUB; Dupret MA, 2009, ASTRON ASTROPHYS, V506, P57, DOI 10.1051/0004-6361/200911713; Dziembowski WA, 2001, MON NOT R ASTRON SOC, V328, P601, DOI 10.1046/j.1365-8711.2001.04894.x; Girardi L, 1999, MON NOT R ASTRON SOC, V308, P818, DOI 10.1046/j.1365-8711.1999.02746.x; Gough D. O., 1986, HYDRODYNAMIC MAGNETO, P117; Huber D, 2010, ASTROPHYS J, V723, P1607, DOI 10.1088/0004-637X/723/2/1607; IBEN I, 1968, ASTROPHYS J, V154, P581, DOI 10.1086/149782; Jenkins JM, 2010, ASTROPHYS J LETT, V713, pL120, DOI 10.1088/2041-8205/713/2/L120; Kallinger T, 2010, ASTRON ASTROPHYS, V509, DOI 10.1051/0004-6361/200811437; KJELDSEN H, 1995, ASTRON ASTROPHYS, V293, P87; Kjeldsen H, 2008, ASTROPHYS J LETT, V683, pL175, DOI 10.1086/591667; Miglio A, 2008, ASTRON NACHR, V329, P529, DOI 10.1002/asna.200710991; Miglio A, 2009, ASTRON ASTROPHYS, V503, pL21, DOI 10.1051/0004-6361/200912822; Montalban J, 2010, ASTROPHYS J LETT, V721, pL182, DOI 10.1088/2041-8205/721/2/L182; Mosser B, 2011, ASTRON ASTROPHYS, V525, DOI 10.1051/0004-6361/201015440; Mosser B, 2009, ASTRON ASTROPHYS, V508, P877, DOI 10.1051/0004-6361/200912944; Pietrinferni A, 2004, ASTROPHYS J, V612, P168, DOI 10.1086/422498; SCHWARZSCHILD M, 1962, ASTROPHYS J, V136, P158, DOI 10.1086/147361; SWEIGART AV, 1978, ASTROPHYS J SUPPL S, V36, P405, DOI 10.1086/190506; TASSOUL M, 1980, ASTROPHYS J SUPPL S, V43, P469, DOI 10.1086/190678; Ventura P, 2008, ASTROPHYS SPACE SCI, V316, P93, DOI 10.1007/s10509-007-9672-8	30	411	414	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2011	471	7340					608	611		10.1038/nature09935	http://dx.doi.org/10.1038/nature09935			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21455175	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000288951200036
J	Sandison, TG; Homsy, J; Arinaitwe, E; Wanzira, H; Kakuru, A; Bigira, V; Kalamya, J; Vora, N; Kublin, J; Kamya, MR; Dorsey, G; Tappero, JW				Sandison, Taylor G.; Homsy, Jaco; Arinaitwe, Emmanuel; Wanzira, Humphrey; Kakuru, Abel; Bigira, Victor; Kalamya, Julius; Vora, Neil; Kublin, James; Kamya, Moses R.; Dorsey, Grant; Tappero, Jordan W.			Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRIMETHOPRIM-SULFAMETHOXAZOLE PROPHYLAXIS; FALCIPARUM DIHYDROFOLATE-REDUCTASE; INSECTICIDE-TREATED BEDNETS; POLYMERASE CHAIN-REACTION; PLASMODIUM-FALCIPARUM; SULFADOXINE-PYRIMETHAMINE; DIHYDROPTEROATE SYNTHASE; ANTIRETROVIRAL THERAPY; HIV-1-INFECTED ADULTS; MOZAMBICAN CHILDREN	Objective To evaluate the protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children (uninfected children born to HIV infected mothers) in Africa. Design Non-blinded randomised control trial Setting Tororo district, rural Uganda, an area of high malaria transmission intensity Participants 203 breastfeeding HIV exposed infants enrolled between 6 weeks and 9 months of age Intervention Co-trimoxazole prophylaxis from enrolment until cessation of breast feeding and confirmation of negative HIV status. All children who remained HIV uninfected (n=185) were then randomised to stop co-trimoxazole prophylaxis immediately or continue co-trimoxazole until 2 years old. Main outcome measure Incidence of malaria, calculated as the number of antimalarial treatments per person year. Results The incidence of malaria and prevalence of genotypic mutations associated with antifolate resistance were high throughout the study. Among the 98 infants randomised to continue co-trimoxazole, 299 malaria cases occurred in 92.28 person years (incidence 3.24 cases/person year). Among the 87 infants randomised to stop co-trimoxazole, 400 malaria cases occurred in 71.81 person years (5.57 cases/person year). Co-trimoxazole prophylaxis yielded a 39% reduction in malaria incidence, after adjustment for age at randomisation (incidence rate ratio 0.61 (95% CI 0.46 to 0.81), P=0.001). There were no significant differences in the incidence of complicated malaria, diarrhoea, pneumonia, hospitalisations, or deaths between the two treatment arms. Conclusions Co-trimoxazole prophylaxis was moderately protective against malaria in HIV exposed infants when continued beyond the period of HIV exposure despite the high prevalence of Plasmodium genotypes associated with antifolate resistance.	[Sandison, Taylor G.] Univ Washington, Dept Med, UW FHCRC Clin Res, Seattle, WA 98195 USA; [Homsy, Jaco] Univ Calif San Francisco, Inst Global Hlth, San Francisco, CA 94143 USA; [Arinaitwe, Emmanuel; Wanzira, Humphrey; Kakuru, Abel; Bigira, Victor] Infect Dis Res Collaborat, Kampala, Uganda; [Kalamya, Julius] Ctr Dis Control Uganda, PMTCT, Entebbe, Uganda; [Vora, Neil; Dorsey, Grant] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Kublin, James] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Seattle, WA 98104 USA; [Kublin, James] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Kamya, Moses R.] Makerere Univ, Sch Med, Dept Med, Kampala, Uganda; [Tappero, Jordan W.] Ctr Dis Control & Prevent, Global AIDS Program, Atlanta, GA USA	University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Makerere University; Centers for Disease Control & Prevention - USA	Sandison, TG (corresponding author), Univ Washington, Dept Med, UW FHCRC Clin Res, Box 358080, Seattle, WA 98195 USA.	tgsand@u.washington.edu	Vora, Neil Manhar/AAJ-7269-2021; Wanzira, Humphrey/AAF-1373-2020	Vora, Neil Manhar/0000-0002-4989-3108; Wanzira, Humphrey/0000-0003-1074-5340; Kakuru, Abel/0000-0001-9941-1309	US President's Emergency Plan for AIDS Relief; Centers for Disease Control and Prevention (CDC); National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP); Global AIDS Program (GAP); Doris Duke Charitable Foundation; NIH/NIAID [K23-AI082553]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI082553] Funding Source: NIH RePORTER	US President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP); Global AIDS Program (GAP); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Participants in this study were enrolled in programmes supported by the US President's Emergency Plan for AIDS Relief and by Cooperative Agreement No U62P024421 from the Centers for Disease Control and Prevention (CDC); National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP); and Global AIDS Program (GAP). Funding was also provided by the Doris Duke Charitable Foundation (GD is a recipient of the Clinical Scientist Development Award, and NV is a recipient of the Clinical Research Fellowship). TS was funded through the Puget Sound Partners in Global Health and NIH/NIAID K23-AI082553. The funders were not involved with study design, data analysis, or manuscript preparation. The contents of the manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the CDC or Doris Duke Charitable Foundation.	Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Anglaret X, 1999, LANCET, V353, P1463, DOI 10.1016/S0140-6736(98)07399-1; [Anonymous], 1994, ICH HARM TRIP GUID C; [Anonymous], 2004, MAL HIV INT THEIR IM; [Anonymous], 2005, AIDS EP UPD DEC 2005; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Aponte JJ, 2009, LANCET, V374, P1533, DOI 10.1016/S0140-6736(09)61258-7; Arinaitwe E, 2009, CLIN INFECT DIS, V49, P1629, DOI 10.1086/647946; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Brahmbhatt H, 2006, JAIDS-J ACQ IMM DEF, V41, P504, DOI 10.1097/01.qai.0000188122.15493.0a; Cairns M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009467; Chatterjee A, 2007, JAIDS-J ACQ IMM DEF, V46, P599, DOI 10.1097/QAI.0b013e31815a5703; Chintu C, 2004, LANCET, V364, P1865, DOI 10.1016/S0140-6736(04)17442-4; Crampin AC, 2003, AIDS, V17, P389, DOI 10.1097/00002030-200302140-00013; Dorsey G, 2004, AM J TROP MED HYG, V71, P758, DOI 10.4269/ajtmh.2004.71.758; Duraisingh MT, 1998, EXP PARASITOL, V89, P1, DOI 10.1006/expr.1998.4274; Faucher JF, 2002, CLIN INFECT DIS, V35, P1147, DOI 10.1086/342908; Gasasira AF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-177; Gill CJ, 2004, B WORLD HEALTH ORGAN, V82, P290; GREENWOOD BM, 1988, LANCET, V1, P1121; HOGH B, 1994, ACTA TROP, V57, P265, DOI 10.1016/0001-706X(94)90072-8; Iyer JK, 2001, LANCET, V358, P1066, DOI 10.1016/S0140-6736(01)06201-8; [Joint United Nations Programme on HIV/AIDS (UNAIDS) World Health Organization (WHO)], 2009, AIDS EP UPD NOV 2009; Kamya MR, 2007, AIDS, V21, P2059, DOI 10.1097/QAD.0b013e3282ef6da1; Kublin JG, 2002, J INFECT DIS, V185, P380, DOI 10.1086/338566; Kuhn L, 2005, CLIN INFECT DIS, V41, P1654, DOI 10.1086/498029; Kuhn L, 2007, JAIDS-J ACQ IMM DEF, V46, P517, DOI 10.1097/QAI.0b013e31814d6600; Kyabayinze D, 2003, AM J TROP MED HYG, V69, P247, DOI 10.4269/ajtmh.2003.69.247; Lynen L, 2007, T ROY SOC TROP MED H, V101, P1059, DOI 10.1016/j.trstmh.2007.07.001; Malamba S, 2010, AM J TROP MED HYG, V82, P766, DOI 10.4269/ajtmh.2010.08-0408; Marinda E, 2007, PEDIATR INFECT DIS J, V26, P519, DOI 10.1097/01.inf.0000264527.69954.4c; McIntyre J, 2010, CURR OPIN HIV AIDS, V5, P48, DOI 10.1097/COH.0b013e328333b8ab; Menendez C, 1997, LANCET, V350, P844, DOI 10.1016/S0140-6736(97)04229-3; Mermin J, 2006, LANCET, V367, P1256, DOI 10.1016/S0140-6736(06)68541-3; Mermin J, 2005, AIDS, V19, P1035, DOI 10.1097/01.aids.0000174449.32756.c7; Ministry of Health, 2005, UG NAT POL GUID HIV; Nahum A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-37; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Okello PE, 2006, AM J TROP MED HYG, V75, P219, DOI 10.4269/ajtmh.2006.75.219; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Sacarlal J, 2009, J INFECT DIS, V200, P329, DOI 10.1086/600119; Santmyire BR, 2001, OBSTET GYNECOL SURV, V56, P306, DOI 10.1097/00006254-200105000-00026; Sibley CH, 2001, TRENDS PARASITOL, V17, P582, DOI 10.1016/S1471-4922(01)02085-2; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Thera MA, 2005, J INFECT DIS, V192, P1823, DOI 10.1086/498249; Tinto H, 2007, AM J TROP MED HYG, V76, P608, DOI 10.4269/ajtmh.2007.76.608; Triglia T, 1997, P NATL ACAD SCI USA, V94, P13944, DOI 10.1073/pnas.94.25.13944; WATKINS WM, 1987, LANCET, V1, P125; WHO, 2006, WHO GUID TREATM MAL; Wiktor SZ, 1999, LANCET, V353, P1469, DOI 10.1016/S0140-6736(99)03465-0; Wilfert CM, 2007, J INFECT DIS, V195, P165, DOI 10.1086/510255; WOLDE B, 1994, J TROP MED HYG, V97, P215; World Health Organization, 2010, WHO GUID INF FEED PR; World Health Organization (WHO), 2006, GUID COTR PROPH HIV	55	56	56	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2011	342								d1617	10.1136/bmj.d1617	http://dx.doi.org/10.1136/bmj.d1617			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745WI	21454456	hybrid, Green Published			2022-12-28	WOS:000289201600003
J	Dennell, R				Dennell, Robin			An Earlier Acheulian Arrival in South Asia	SCIENCE			English	Editorial Material									Univ Sheffield, Dept Archaeol, Sheffield S1 4ET, S Yorkshire, England	University of Sheffield	Dennell, R (corresponding author), Univ Sheffield, Dept Archaeol, Sheffield S1 4ET, S Yorkshire, England.	r.dennell@sheffield.ac.uk						Anton SC, 2004, ANNU REV ANTHROPOL, V33, P271, DOI 10.1146/annurev.anthro.33.070203.144024; Bar-Yosef O, 1993, LITHIC ASSEMBLAGES U; Chauhan PR, 2010, QUATERN INT, V223, P248, DOI 10.1016/j.quaint.2010.01.021; Dennell RW, 2009, PALAEOLITHIC SETTLEM; Gaillard C, 2010, QUATERN INT, V223, P234, DOI 10.1016/j.quaint.2009.08.021; Goren-Inbar N, 2000, SCIENCE, V289, P944, DOI 10.1126/science.289.5481.944; Hou YM, 2000, SCIENCE, V287, P1622, DOI 10.1126/science.287.5458.1622; Paddayya K, 2002, CURR SCI INDIA, V83, P641; Pappu S, 2011, SCIENCE, V331, P1596, DOI 10.1126/science.1200183; Rightmire G.P, 2001, HUMAN ROOTS AFRICA A, P123; Rightmire GP, 2006, J HUM EVOL, V50, P115, DOI 10.1016/j.jhevol.2005.07.009; Roebroeks W, 2001, J HUM EVOL, V41, P437, DOI 10.1006/jhev.2001.0499	12	9	9	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2011	331	6024					1532	1533		10.1126/science.1203806	http://dx.doi.org/10.1126/science.1203806			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739XH	21436430				2022-12-28	WOS:000288754500033
J	Tulaczyk, S; Hossainzadeh, S				Tulaczyk, Slawek; Hossainzadeh, Saffia			Antarctica's Deep Frozen "Lakes"	SCIENCE			English	Editorial Material							ICE-SHEET		[Tulaczyk, Slawek; Hossainzadeh, Saffia] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Tulaczyk, S (corresponding author), Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA.	tulaczyk@pmc.ucsc.edu	Tulaczyk, Slawek/O-7375-2018	Tulaczyk, Slawek/0000-0002-9711-4332				Allison I, 2009, ANTARCT SCI, V21, P413, DOI 10.1017/S0954102009990137; Bell RE, 2011, SCIENCE, V331, P1592, DOI 10.1126/science.1200109; Christner BC, 2006, LIMNOL OCEANOGR, V51, P2485, DOI 10.4319/lo.2006.51.6.2485; Christoffersen P, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001430; Gow A.J., 1979, J GLACIOL, V23, P185, DOI DOI 10.1017/S0022143000029828; Lanoil B, 2009, ENVIRON MICROBIOL, V11, P609, DOI 10.1111/j.1462-2920.2008.01831.x; Pattyn F, 2010, EARTH PLANET SC LETT, V295, P451, DOI 10.1016/j.epsl.2010.04.025; Priscu J. C, 2008, POLAR LAKES RIVERS, P119, DOI DOI 10.1093/ACPROF:OSO/9780199213887.003.0007; Severinghaus J., 2010, EOS T AM GEOPHYS UN, V91, P357	9	7	7	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 25	2011	331	6024					1524	1525		10.1126/science.1202888	http://dx.doi.org/10.1126/science.1202888			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21436426				2022-12-28	WOS:000288754500029
J	Chapman, MA; Lawrence, MS; Keats, JJ; Cibulskis, K; Sougnez, C; Schinzel, AC; Harview, CL; Brunet, JP; Ahmann, GJ; Adli, M; Anderson, KC; Ardlie, KG; Auclair, D; Baker, A; Bergsagel, PL; Bernstein, BE; Drier, Y; Fonseca, R; Gabriel, SB; Hofmeister, CC; Jagannath, S; Jakubowiak, AJ; Krishnan, A; Levy, J; Liefeld, T; Lonial, S; Mahan, S; Mfuko, B; Monti, S; Perkins, LM; Onofrio, R; Pugh, TJ; Rajkumar, SV; Ramos, AH; Siegel, DS; Sivachenko, A; Stewart, AK; Trudel, S; Vij, R; Voet, D; Winckler, W; Zimmerman, T; Carpten, J; Trent, J; Hahn, WC; Garraway, LA; Meyerson, M; Lander, ES; Getz, G; Golub, TR				Chapman, Michael A.; Lawrence, Michael S.; Keats, Jonathan J.; Cibulskis, Kristian; Sougnez, Carrie; Schinzel, Anna C.; Harview, Christina L.; Brunet, Jean-Philippe; Ahmann, Gregory J.; Adli, Mazhar; Anderson, Kenneth C.; Ardlie, Kristin G.; Auclair, Daniel; Baker, Angela; Bergsagel, P. Leif; Bernstein, Bradley E.; Drier, Yotam; Fonseca, Rafael; Gabriel, Stacey B.; Hofmeister, Craig C.; Jagannath, Sundar; Jakubowiak, Andrzej J.; Krishnan, Amrita; Levy, Joan; Liefeld, Ted; Lonial, Sagar; Mahan, Scott; Mfuko, Bunmi; Monti, Stefano; Perkins, Louise M.; Onofrio, Robb; Pugh, Trevor J.; Rajkumar, S. Vincent; Ramos, Alex H.; Siegel, David S.; Sivachenko, Andrey; Stewart, A. Keith; Trudel, Suzanne; Vij, Ravi; Voet, Douglas; Winckler, Wendy; Zimmerman, Todd; Carpten, John; Trent, Jeff; Hahn, William C.; Garraway, Levi A.; Meyerson, Matthew; Lander, Eric S.; Getz, Gad; Golub, Todd R.			Initial genome sequencing and analysis of multiple myeloma	NATURE			English	Article							B-CELL LYMPHOMA; HUMAN CANCER; SOMATIC MUTATIONS; STRESS-RESPONSE; GENE; PATHOGENESIS; BLIMP-1; EXOSOME; DIFFERENTIATION; CLASSIFICATION	Multiple myeloma is an incurable malignancy of plasma cells, and its pathogenesis is poorly understood. Here we report the massively parallel sequencing of 38 tumour genomes and their comparison to matched normal DNAs. Several new and unexpected oncogenic mechanisms were suggested by the pattern of somatic mutation across the data set. These include the mutation of genes involved in protein translation (seen in nearly half of the patients), genes involved in histone methylation, and genes involved in blood coagulation. In addition, a broader than anticipated role of NF-kappa B signalling was indicated by mutations in 11 members of the NF-kappa B pathway. Of potential immediate clinical relevance, activating mutations of the kinase BRAF were observed in 4% of patients, suggesting the evaluation of BRAF inhibitors in multiple myeloma clinical trials. These results indicate that cancer genome sequencing of large collections of samples will yield new insights into cancer not anticipated by existing knowledge.	[Chapman, Michael A.; Lawrence, Michael S.; Cibulskis, Kristian; Sougnez, Carrie; Harview, Christina L.; Brunet, Jean-Philippe; Adli, Mazhar; Ardlie, Kristin G.; Bernstein, Bradley E.; Drier, Yotam; Gabriel, Stacey B.; Liefeld, Ted; Mahan, Scott; Monti, Stefano; Onofrio, Robb; Pugh, Trevor J.; Ramos, Alex H.; Sivachenko, Andrey; Voet, Douglas; Winckler, Wendy; Hahn, William C.; Garraway, Levi A.; Meyerson, Matthew; Lander, Eric S.; Getz, Gad; Golub, Todd R.] Eli & Edythe L Broad Inst, Cambridge Ctr 7, Cambridge, MA 02412 USA; [Keats, Jonathan J.; Ahmann, Gregory J.; Bergsagel, P. Leif; Fonseca, Rafael; Stewart, A. Keith] Mayo Clin Arizona, Scottsdale, AZ 85259 USA; [Keats, Jonathan J.; Ahmann, Gregory J.; Anderson, Kenneth C.; Auclair, Daniel; Bergsagel, P. Leif; Fonseca, Rafael; Hofmeister, Craig C.; Jagannath, Sundar; Jakubowiak, Andrzej J.; Krishnan, Amrita; Levy, Joan; Lonial, Sagar; Mfuko, Bunmi; Perkins, Louise M.; Rajkumar, S. Vincent; Siegel, David S.; Stewart, A. Keith; Trudel, Suzanne; Vij, Ravi; Zimmerman, Todd] Multiple Myeloma Res Consortium, Norwalk, CT 06581 USA; [Schinzel, Anna C.; Anderson, Kenneth C.; Hahn, William C.; Garraway, Levi A.; Meyerson, Matthew; Golub, Todd R.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Adli, Mazhar; Bernstein, Bradley E.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Auclair, Daniel; Levy, Joan; Mfuko, Bunmi; Perkins, Louise M.] Multiple Myeloma Res Fdn, Norwalk, CT 06581 USA; [Baker, Angela; Carpten, John; Trent, Jeff] Translat Genom Res Inst, Phoenix, AZ 85004 USA; [Bernstein, Bradley E.; Hahn, William C.; Meyerson, Matthew; Lander, Eric S.; Golub, Todd R.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Bernstein, Bradley E.; Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Drier, Yotam] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; [Hofmeister, Craig C.] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA; [Jagannath, Sundar] St Vincents Comprehens Canc Ctr, New York, NY 11001 USA; [Jakubowiak, Andrzej J.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Krishnan, Amrita] City Hope Comprehens Canc Ctr, Duarte, CA 91010 USA; [Lonial, Sagar] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Rajkumar, S. Vincent] Mayo Clin Rochester, Rochester, MN 55905 USA; [Siegel, David S.] Hackensack Univ, Med Ctr, John Theurer Canc Ctr, Hackensack, NJ 07601 USA; [Trudel, Suzanne] Princess Margaret Hosp, Toronto, ON M5G 2M9, Canada; [Vij, Ravi] Washington Univ, Sch Med, St Louis, MO 63110 USA; [Zimmerman, Todd] Univ Chicago, Med Ctr, Chicago, IL 60637 USA; [Lander, Eric S.] MIT, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Mayo Clinic; Mayo Clinic Phoenix; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Translational Genomics Research Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Weizmann Institute of Science; University System of Ohio; Ohio State University; Saint Vincents Hospital Manhattan; University of Michigan System; University of Michigan; City of Hope; Emory University; Mayo Clinic; Hackensack University Medical Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Washington University (WUSTL); University of Chicago; University of Chicago Medical Center; Massachusetts Institute of Technology (MIT)	Golub, TR (corresponding author), Eli & Edythe L Broad Inst, Cambridge Ctr 7, Cambridge, MA 02412 USA.	gadgetz@broadinstitute.org; golub@broadinstitute.org	Hofmeister, Craig/E-3256-2011; Pugh, Trevor/Y-2535-2019; Meyerson, Matthew L/E-7123-2012; Lawrence, Michael/AAC-8202-2020; Drier, Yotam/K-5208-2012; Rajkumar, S. Vincent/AAV-1834-2021; Cibulskis, Kristian/AAC-7380-2019; Hofmeister, Craig/O-4988-2019; Bergsagel, Peter Leif/A-7842-2011	Hofmeister, Craig/0000-0003-4816-1607; Pugh, Trevor/0000-0002-8073-5888; Drier, Yotam/0000-0003-1725-2995; Rajkumar, S. Vincent/0000-0002-5862-1833; Hofmeister, Craig/0000-0003-4816-1607; Bergsagel, Peter Leif/0000-0003-1523-7388; Fonseca, Rafael/0000-0002-5938-3769; Cibulskis, Kristian/0000-0003-1343-1582; Monti, Stefano/0000-0002-9376-0660; Harview, Christina/0000-0002-5003-8539; Meyerson, Matthew/0000-0002-9133-8108; Keats, Jonathan/0000-0003-4375-7399; Perkins, Louise/0000-0003-3945-8927	Multiple Myeloma Research Foundation; Leukaemia and Lymphoma Research (UK); NATIONAL CANCER INSTITUTE [R01CA133966, K12CA133250, R01CA133115] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020686] Funding Source: NIH RePORTER	Multiple Myeloma Research Foundation; Leukaemia and Lymphoma Research (UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was funded by a grant from the Multiple Myeloma Research Foundation. M.A.C. was supported by a Clinician Scientist Fellowship from Leukaemia and Lymphoma Research (UK). We are grateful to all members of the Broad Institute's Biological Samples Platform, Genetic Analysis Platform, and Genome Sequencing Platform, without whom this work would not have been possible.	Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Barbas A, 2009, J BIOL CHEM, V284, P20486, DOI 10.1074/jbc.M109.020693; Bergsagel PL, 2005, J CLIN ONCOL, V23, P6333, DOI 10.1200/JCO.2005.05.021; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Carbone A, 2008, GENE CHROMOSOME CANC, V47, P1067, DOI 10.1002/gcc.20601; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; Cenci S, 2007, FEBS LETT, V581, P3652, DOI 10.1016/j.febslet.2007.04.031; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; ESUMI N, 1991, CANCER RES, V51, P4549; Flaherty K., 2009, 2009 ASCO M AM SOC C; Forman MS, 2003, TRENDS NEUROSCI, V26, P407, DOI 10.1016/S0166-2236(03)00197-8; Ibrahim H, 2008, BBA-GENE REGUL MECH, V1779, P256, DOI 10.1016/j.bbagrm.2007.11.004; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kim K, 2010, BRIT J HAEMATOL, V149, P537, DOI 10.1111/j.1365-2141.2010.08127.x; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Lessard J, 2003, EXP HEMATOL, V31, P567, DOI 10.1016/S0301-472X(03)00081-X; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Mandelbaum J, 2010, CANCER CELL, V18, P568, DOI 10.1016/j.ccr.2010.10.030; Masciarelli S, 2010, MOL IMMUNOL, V47, P1356, DOI 10.1016/j.molimm.2009.12.003; Migliazza A, 1995, P NATL ACAD SCI USA, V92, P12520, DOI 10.1073/pnas.92.26.12520; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Pasqualucci L, 2006, J EXP MED, V203, P311, DOI 10.1084/jem.20052204; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Reva B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r232; Ruf W, 2006, SEMIN THROMB HEMOST, V32, P61, DOI 10.1055/s-2006-939555; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Schneider C, 2007, MOL CELL, V27, P324, DOI 10.1016/j.molcel.2007.06.006; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Zani VJ, 1996, BLOOD, V87, P3124, DOI 10.1182/blood.V87.8.3124.bloodjournal8783124; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458; Zhang W, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-332; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	47	1092	1135	0	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					467	472		10.1038/nature09837	http://dx.doi.org/10.1038/nature09837			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21430775	Green Accepted, hybrid, Green Submitted			2022-12-28	WOS:000288702200053
J	Parolini, O				Parolini, Ornella			In Utero Hematopoietic Stem-Cell Transplantation - A Match for Mom	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SEVERE COMBINED IMMUNODEFICIENCY		Fdn Poliambulanza Ist Osped, Ctr Ric E Menni, Brescia, Italy		Parolini, O (corresponding author), Fdn Poliambulanza Ist Osped, Ctr Ric E Menni, Brescia, Italy.		PAROLINI, ORNELLA/C-7946-2013; PAROLINI, ORNELLA/ABI-7862-2020	PAROLINI, ORNELLA/0000-0002-5211-6430; PAROLINI, ORNELLA/0000-0002-5211-6430				Flake AW, 1996, NEW ENGL J MED, V335, P1806, DOI 10.1056/NEJM199612123352404; Nijagal A, 2011, J CLIN INVEST, V121, P582, DOI 10.1172/JCI44907; Peranteau WH, 2007, BLOOD, V109, P1331, DOI 10.1182/blood-2006-04-018606; Wengler GS, 1996, LANCET, V348, P1484, DOI 10.1016/S0140-6736(96)09392-0	4	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2011	364	12					1174	1175		10.1056/NEJMcibr1100692	http://dx.doi.org/10.1056/NEJMcibr1100692			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739FY	21428775				2022-12-28	WOS:000288701100015
J	Pollock, AM; Price, D				Pollock, Allyson M.; Price, David			How the secretary of state for health proposes to abolish the NHS in England	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RISK ADJUSTMENT					allyson.pollock@gmail.com		pollock, allyson/0000-0002-7388-3110				Anderson GF, 2005, HEALTH AFFAIR, V24, P903, DOI 10.1377/hlthaff.24.4.903; [Anonymous], 2007, EC ANAL HLTH CARE; [Anonymous], 2010, CIRCLE NEWS     0715; [Anonymous], 2010, HLTH ADVISER, V3, P5; ARROW KJ, 1963, AM ECON REV, V53, P941; Campbell D, 2010, GUARDIAN        1119; Dawson D, 2008, HLTH CARE SERVICES S; Department of Health, 2011, HLTH SOC BILL 2011 I; Department of Health, 2011, HLTH SOC BILL 2011 E; Department of Health, 2010, COMM PAT; Department of Health, 2010, CM7881; Department of Health, 2010, LIB NHS LEG FRAM NEX; Department of Health, 2010, LIB NHS REG HEALTHC; Department of Health, 2010, ADV COMM RES ALL SUM; Himmelstein DU, 2001, BLEEDING PATIENT CON; House of Commons, 2011, HLTH SOC CAR BILL 20; House of Commons Health Committee, 2009, TOP UP FEES WRITT EV; House of Commons Health Committee, 2011, COMM 3 REP SESS 2010; Kutzin J, 2002, FUNDING HLTH CARE OP; Laja S, 2011, GUARDIAN        0223; Marini G, 2007, HEALTH POLICY, V83, P17, DOI 10.1016/j.healthpol.2006.11.007; Melhado EM, 2000, J HEALTH POLIT POLIC, V25, P233, DOI 10.1215/03616878-25-1-233; Office of Fair Trading, 2010, CHOIC COMP PUBL SERV; Person Based Resource Allocation Team, 2009, DEV PERS BAS RES ALL; Pollock A.M., 2005, NHS PLC PRIVATISATIO; Quinn I, 2011, PULSE           0224; Rowland D, 2004, LANCET, V364, P1200, DOI 10.1016/S0140-6736(04)17158-4; van de Ven WPMM, 2003, HEALTH POLICY, V65, P75, DOI 10.1016/S0168-8510(02)00118-5; Van de Ven WPMM, 2011, HEALTH ECON POLICY L, V6, P147, DOI 10.1017/S1744133110000319	29	31	31	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2011	342								d1695	10.1136/bmj.d1695	http://dx.doi.org/10.1136/bmj.d1695			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	742MF	21427047				2022-12-28	WOS:000288947500009
J	Takeuchi, D; Hirabayashi, T; Tamura, K; Miyashita, Y				Takeuchi, Daigo; Hirabayashi, Toshiyuki; Tamura, Keita; Miyashita, Yasushi			Reversal of Interlaminar Signal Between Sensory and Memory Processing in Monkey Temporal Cortex	SCIENCE			English	Article							AUDITORY-CORTEX; MACAQUE MONKEY; OSCILLATIONS; NETWORK; LOBE; ORGANIZATION; RECOGNITION; INFORMATION; PERCEPTION; MECHANISMS	The primate temporal cortex implements visual long-term memory. However, how its interlaminar circuitry executes cognitive computations is poorly understood. Using linear-array multicontact electrodes, we simultaneously recorded unit activities across cortical layers in the perirhinal cortex of macaques performing a pair-association memory task. Cortical layers were estimated on the basis of current source density profiles with histological verifications, and the interlaminar signal flow was determined with cross-correlation analysis between spike trains. During the cue period, canonical "feed-forward" signals flowed from granular to supragranular layers and from supragranular to infragranular layers. During the delay period, however, the signal flow reversed to the "feed-back" direction: from infragranular to supragranular layers. This reversal of signal flow highlights how the temporal cortex differentially recruits its laminar circuits for sensory and mnemonic processing.	[Takeuchi, Daigo; Hirabayashi, Toshiyuki; Tamura, Keita; Miyashita, Yasushi] Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Miyashita, Y (corresponding author), Univ Tokyo, Sch Med, Dept Physiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	yasushi_miyashita@m.u-tokyo.ac.jp	Tamura, Keita/I-2931-2012; Miyashita, Yasushi/B-7171-2019	Tamura, Keita/0000-0003-2697-1510; Miyashita, Yasushi/0000-0003-3496-8637	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [19002010, 18700378]; Takeda Science Foundation; Japan Society for the Promotion of Science (JSPS) [1811234, 211438]; Grants-in-Aid for Scientific Research [19002010] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Specially Promoted Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) to Y.M. (19002010) and Grant-in-Aid for Young Scientists from MEXT to T. H. (18700378); a grant from Takeda Science Foundation to Y.M.; and Japan Society for the Promotion of Science (JSPS) Research Fellowships for Young Scientists to D. T. (1811234) and K. T. (211438). This work was also supported in part by Global Center of Excellence Program from MEXT. We thank M. Takeda for discussions and comments and H. Kasahara, R. Fujimichi, T. Matsui, and K. W. Koyano for advice and help with experiments.	Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; Atencio CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009521; Bollimunta A, 2008, J NEUROSCI, V28, P9976, DOI 10.1523/JNEUROSCI.2699-08.2008; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Hirabayashi T, 2005, J NEUROSCI, V25, P10299, DOI 10.1523/JNEUROSCI.3036-05.2005; Hirabayashi T, 2010, J NEUROSCI, V30, P10407, DOI 10.1523/JNEUROSCI.0135-10.2010; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Miyashita Y, 2004, SCIENCE, V306, P435, DOI 10.1126/science.1101864; Murray EA, 2007, ANNU REV NEUROSCI, V30, P99, DOI 10.1146/annurev.neuro.29.051605.113046; Nassi JJ, 2009, NAT REV NEUROSCI, V10, P360, DOI 10.1038/nrn2619; Naya Y, 2003, J NEUROSCI, V23, P2861; Ohiorhenuan IE, 2010, NATURE, V466, P617, DOI 10.1038/nature09178; Reid RC, 1996, CURR OPIN NEUROBIOL, V6, P475, DOI 10.1016/S0959-4388(96)80052-3; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; Saleem KS, 1996, J NEUROSCI, V16, P4757; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; Suzuki WA, 2003, J COMP NEUROL, V463, P67, DOI 10.1002/cne.10744; Suzuki WA, 2009, NEURON, V61, P657, DOI 10.1016/j.neuron.2009.02.008; Tomita M, 2005, J NEUROPHYSIOL, V93, P378, DOI 10.1152/jn.00643.2004; Wang SH, 2010, ANNU REV PSYCHOL, V61, P49, DOI 10.1146/annurev.psych.093008.100523; Weiler N, 2008, NAT NEUROSCI, V11, P360, DOI 10.1038/nn2049; Witter MP, 2006, TRENDS NEUROSCI, V29, P671, DOI 10.1016/j.tins.2006.10.003	28	91	92	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2011	331	6023					1443	1447		10.1126/science.1199967	http://dx.doi.org/10.1126/science.1199967			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21415353				2022-12-28	WOS:000288504000043
J	Walton, GM; Cohen, GL				Walton, Gregory M.; Cohen, Geoffrey L.			A Brief Social-Belonging Intervention Improves Academic and Health Outcomes of Minority Students	SCIENCE			English	Article							SOCIOECONOMIC-STATUS; PHYSICAL HEALTH; ACHIEVEMENT; REJECTION; MORTALITY; RACE	A brief intervention aimed at buttressing college freshmen's sense of social belonging in school was tested in a randomized controlled trial (N = 92), and its academic and health-related consequences over 3 years are reported. The intervention aimed to lessen psychological perceptions of threat on campus by framing social adversity as common and transient. It used subtle attitude-change strategies to lead participants to self-generate the intervention message. The intervention was expected to be particularly beneficial to African-American students (N = 49), a stereotyped and socially marginalized group in academics, and less so to European-American students (N = 43). Consistent with these expectations, over the 3-year observation period the intervention raised African Americans' grade-point average (GPA) relative to multiple control groups and halved the minority achievement gap. This performance boost was mediated by the effect of the intervention on subjective construal: It prevented students from seeing adversity on campus as an indictment of their belonging. Additionally, the intervention improved African Americans' self-reported health and well-being and reduced their reported number of doctor visits 3 years postintervention. Senior-year surveys indicated no awareness among participants of the intervention's impact. The results suggest that social belonging is a psychological lever where targeted intervention can have broad consequences that lessen inequalities in achievement and health.	[Walton, Gregory M.; Cohen, Geoffrey L.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Cohen, Geoffrey L.] Stanford Univ, Sch Educ, Stanford, CA 94305 USA; [Cohen, Geoffrey L.] Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Walton, GM (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	gwalton@stanford.edu			American Psychological Association; Society for the Psychological Study of Social Issues; Spencer Foundation; Russell Sage Foundation	American Psychological Association; Society for the Psychological Study of Social Issues; Spencer Foundation; Russell Sage Foundation	We thank participating students and helpful administrators at an anonymous university for their involvement. We also thank P. Carr, E. Chen, C. Dweck, C. Logel, G. Miller, D. Paunesku, D. Sherman, S. Spencer, C. Steele, and D. Yeager for input and L. Cai, K. Crockett, J. Darwall, L. Egan, A. Master, M. Silverio, and R. Titcombe for assistance. This research was supported by grants from the American Psychological Association, the Society for the Psychological Study of Social Issues, and the Spencer Foundation awarded to G. M. W. and by a grant from the Russell Sage Foundation awarded to G.L.C.	Aronson J, 2002, J EXP SOC PSYCHOL, V38, P113, DOI 10.1006/jesp.2001.1491; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Baumeister RF, 2002, J PERS SOC PSYCHOL, V83, P817, DOI 10.1037//0022-3514.83.4.817; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; Blackwell LS, 2007, CHILD DEV, V78, P246, DOI 10.1111/j.1467-8624.2007.00995.x; Blascovich J, 2001, PSYCHOL SCI, V12, P225, DOI 10.1111/1467-9280.00340; Cacioppo JT., 2008, LONELINESS HUMAN NAT; Cohen GL, 2006, SCIENCE, V313, P1307, DOI 10.1126/science.1128317; Cohen GL, 2009, SCIENCE, V324, P400, DOI 10.1126/science.1170769; Cohen S, 2008, HEALTH PSYCHOL, V27, P268, DOI 10.1037/0278-6133.27.2.268; Cohen S, 2009, PERSPECT PSYCHOL SCI, V4, P375, DOI 10.1111/j.1745-6924.2009.01141.x; Cole SW, 1997, J PERS SOC PSYCHOL, V72, P320, DOI 10.1037/0022-3514.72.2.320; Crocker J, 2001, PSYCHOL REV, V108, P593, DOI 10.1037//0033-295X.108.3.593; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Goffman Erving., 1963, STIGMA NOTES MANAGEM, P8; Gross J.J., 2007, HDB EMOTION REGULATI, P3, DOI DOI 10.1080/00140130600971135; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jamieson JP, 2010, J EXP SOC PSYCHOL, V46, P208, DOI 10.1016/j.jesp.2009.08.015; Lyubomirsky S, 2005, REV GEN PSYCHOL, V9, P111, DOI 10.1037/1089-2680.9.2.111; Magnuson K., 2008, STEADY GAINS STALLED; Mendoza-Denton R, 2002, J PERS SOC PSYCHOL, V83, P896, DOI 10.1037//0022-3514.83.4.896; Miller GE, 2009, PSYCHOSOM MED, V71, P57, DOI 10.1097/PSY.0b013e318190d7de; Ross L., 1991, PERSON SITUATION; Sherman DK, 2009, J PERS SOC PSYCHOL, V97, P745, DOI 10.1037/a0015451; Steele CM, 2002, ADV EXP SOC PSYCHOL, V34, P379, DOI 10.1016/S0065-2601(02)80009-0; Uchino BN, 2006, J BEHAV MED, V29, P377, DOI 10.1007/s10865-006-9056-5; Walton GM, 2007, J PERS SOC PSYCHOL, V92, P82, DOI 10.1037/0022-3514.92.1.82; Williams DR, 1999, ANN NY ACAD SCI, V896, P173, DOI 10.1111/j.1749-6632.1999.tb08114.x; Williams KD, 2009, ADV EXP SOC PSYCHOL, V41, P275, DOI 10.1016/S0065-2601(08)00406-1; Wilson T. D., 2002, IMPROVING ACAD ACHIE, P91, DOI DOI 10.1016/B978-012064455-1/50008-7; Wilson T. D., 2002, STRANGERS OURSELVES; Wilson TD, 2006, SCIENCE, V313, P1251, DOI 10.1126/science.1133017	32	800	808	6	285	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2011	331	6023					1447	1451		10.1126/science.1198364	http://dx.doi.org/10.1126/science.1198364			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	736OM	21415354				2022-12-28	WOS:000288504000044
J	Wang, J; Genack, AZ				Wang, Jing; Genack, Azriel Z.			Transport through modes in random media	NATURE			English	Article							NONLINEAR LEAST-SQUARES; ANDERSON LOCALIZATION; INTENSITY DISTRIBUTIONS; DISORDERED-SYSTEMS; TRANSMISSION; WAVES; ULTRASOUND; DIFFUSION; LATTICES; ABSENCE	Excitations in complex media are superpositions of eigenstates that are referred to as 'levels' for quantum systems and 'modes' for classical waves. Although the Hamiltonian of a complex system may not be known or solvable, Wigner conjectured(1) that the statistics of energy level spacings would be the same as for the eigenvalues of large randommatrices. This has explained key characteristics of neutron scattering spectra(2). Subsequently, Thouless and co-workers argued(3,4) that the metal-insulator transition in disordered systems(4-6) could be described by a single parameter, the ratio of the average width and spacing of electronic energy levels: when this dimension-less ratio falls below unity, conductivity is suppressed by Anderson localization(5) of the electronic wave function. However, because of spectral congestion due to the overlap of modes(7-9), even for localized waves, a comprehensive modal description of wave propagation has not been realized. Here we show that the field speckle pattern(10) of transmitted radiation-in this case, a microwave field transmitted through randomly packed alumina spheres-can be decomposed into a sum of the patterns of the individual modes of the medium and the central frequency and linewidth of each mode can be found. We find strong correlation between modal field speckle patterns, which leads to destructive interference between modes. This allows us to explain complexities of steady state and pulsed transmission of localized waves and to harmonize wave and particle descriptions of diffusion.	[Wang, Jing; Genack, Azriel Z.] CUNY Queens Coll, Dept Phys, Flushing, NY 11367 USA	City University of New York (CUNY) System; Queens College NY (CUNY)	Genack, AZ (corresponding author), CUNY Queens Coll, Dept Phys, Flushing, NY 11367 USA.	genack@qc.edu	Wang, Jing/D-6495-2014	Wang, Jing/0000-0001-7234-4388	National Science Foundation [DMR0907285]	National Science Foundation(National Science Foundation (NSF))	This research was supported by the National Science Foundation (DMR0907285).	Abrahams E., 2010, 50 YEARS ANDERSON LO; Altshuler B. L., 1986, Soviet Physics - JETP, V64, P127; ANDERSON PW, 1958, PHYS REV, V109, P1492, DOI 10.1103/PhysRev.109.1492; Aspect A, 2009, PHYS TODAY, V62, P30, DOI 10.1063/1.3206092; AZBEL MY, 1983, PHYS REV B, V28, P4106, DOI 10.1103/PhysRevB.28.4106; BERRY MV, 1985, PROC R SOC LON SER-A, V400, P229, DOI 10.1098/rspa.1985.0078; Cao H, 1999, PHYS REV LETT, V82, P2278, DOI 10.1103/PhysRevLett.82.2278; Chabanov AA, 2000, NATURE, V404, P850, DOI 10.1038/35009055; Ching ESC, 1998, REV MOD PHYS, V70, P1545, DOI 10.1103/RevModPhys.70.1545; Cohen L., 1995, TIME FREQUENCY ANAL; DYSON FJ, 1962, J MATH PHYS, V3, P140, DOI 10.1063/1.1703773; EDWARDS JT, 1972, J PHYS PART C SOLID, V5, P807, DOI 10.1088/0022-3719/5/8/007; FENG SC, 1988, PHYS REV LETT, V61, P834, DOI 10.1103/PhysRevLett.61.834; Golub G, 2003, INVERSE PROBL, V19, pR1, DOI 10.1088/0266-5611/19/2/201; Gresillon S, 1999, PHYS REV LETT, V82, P4520, DOI 10.1103/PhysRevLett.82.4520; Hu HF, 2008, NAT PHYS, V4, P945, DOI 10.1038/nphys1101; JOHN S, 1984, PHYS REV LETT, V53, P2169, DOI 10.1103/PhysRevLett.53.2169; KOGAN E, 1995, PHYS REV B, V52, pR3813, DOI 10.1103/PhysRevB.52.R3813; MELLO PA, 1988, PHYS REV LETT, V61, P459, DOI 10.1103/PhysRevLett.61.459; MOTT NF, 1961, ADV PHYS, V10, P107, DOI 10.1080/00018736100101271; NIEUWENHUIZEN TM, 1995, PHYS REV LETT, V74, P2674, DOI 10.1103/PhysRevLett.74.2674; NYE JF, 1974, P ROY SOC LOND A MAT, V336, P165, DOI 10.1098/rspa.1974.0012; PENDRY JB, 1987, J PHYS C SOLID STATE, V20, P733, DOI 10.1088/0022-3719/20/5/009; Schwartz T, 2007, NATURE, V446, P52, DOI 10.1038/nature05623; Sima DM, 2007, J COMPUT APPL MATH, V203, P264, DOI 10.1016/j.cam.2006.03.025; Stoytchev M, 1997, PHYS REV LETT, V79, P309, DOI 10.1103/PhysRevLett.79.309; THOULESS DJ, 1977, PHYS REV LETT, V39, P1167, DOI 10.1103/PhysRevLett.39.1167; WEAVER RL, 1990, WAVE MOTION, V12, P129, DOI 10.1016/0165-2125(90)90034-2; WIGNER EP, 1951, ANN MATH, V53, P36, DOI 10.2307/1969342; Zhang ZQ, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.144203	33	97	99	0	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2011	471	7338					345	+		10.1038/nature09824	http://dx.doi.org/10.1038/nature09824			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21412335	Green Submitted			2022-12-28	WOS:000288444000038
J	Ernst, J; Kheradpour, P; Mikkelsen, TS; Shoresh, N; Ward, LD; Epstein, CB; Zhang, XL; Wang, L; Issner, R; Coyne, M; Ku, MC; Durham, T; Kellis, M; Bernstein, BE				Ernst, Jason; Kheradpour, Pouya; Mikkelsen, Tarjei S.; Shoresh, Noam; Ward, Lucas D.; Epstein, Charles B.; Zhang, Xiaolan; Wang, Li; Issner, Robbyn; Coyne, Michael; Ku, Manching; Durham, Timothy; Kellis, Manolis; Bernstein, Bradley E.			Mapping and analysis of chromatin state dynamics in nine human cell types	NATURE			English	Article							GENOME-WIDE ASSOCIATION; TRANSCRIPTION-FACTOR-BINDING; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; HISTONE MODIFICATIONS; SUSCEPTIBILITY LOCI; ENHANCERS; POPULATION; METAANALYSIS; PROMOTERS	Chromatin profiling has emerged as a powerful means of genome annotation and detection of regulatory activity. The approach is especially well suited to the characterization of non-coding portions of the genome, which critically contribute to cellular phenotypes yet remain largely uncharted. Here we map nine chromatin marks across nine cell types to systematically characterize regulatory elements, their cell-type specificities and their functional interactions. Focusing on cell-type-specific patterns of promoters and enhancers, we define multicell activity profiles for chromatin state, gene expression, regulatory motif enrichment and regulator expression. We use correlations between these profiles to link enhancers to putative target genes, and predict the cell-type-specific activators and repressors that modulate them. The resulting annotations and regulatory predictions have implications for the interpretation of genome-wide association studies. Top-scoring disease single nucleotide polymorphisms are frequently positioned within enhancer elements specifically active in relevant cell types, and in some cases affect a motif instance for a predicted regulator, thus suggesting a mechanism for the association. Our study presents a general framework for deciphering cis-regulatory connections and their roles in disease.	[Ernst, Jason; Kheradpour, Pouya; Mikkelsen, Tarjei S.; Shoresh, Noam; Ward, Lucas D.; Epstein, Charles B.; Zhang, Xiaolan; Wang, Li; Issner, Robbyn; Coyne, Michael; Ku, Manching; Durham, Timothy; Kellis, Manolis; Bernstein, Bradley E.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Ernst, Jason; Kheradpour, Pouya; Ward, Lucas D.; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Ku, Manching; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Howard Hughes Med Inst, Boston, MA 02114 USA; [Ku, Manching; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Ku, Manching; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Ku, Manching; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Kellis, M (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	manoli@mit.edu	Kellis, Manolis/ABE-7385-2020; Mikkelsen, Tarjei S/A-1306-2007	Kellis, Manolis/0000-0001-7113-9630; Mikkelsen, Tarjei S/0000-0002-8133-3135; Issner, Robbyn/0000-0003-4132-9219; Epstein, Charles B./0000-0001-8358-8345; Ward, Lucas/0000-0002-8017-809X	National Human Genome Research Institute [U54 HG004570, R01 HG004037, RC1 HG005334]; Howard Hughes Medical Institute; National Science Foundation [0644282, 0905968]; Sloan Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004570, R01HG004037, RC1HG005334] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank members of the epigenomics community at the Broad Institute and the Bernstein and Kellis laboratories, and M. Daly, D. Altshuler and E. Lander for discussions and criticisms. We also thank M. Suva, E. Mendenhall and S. Gillespie for assistance with experiments, and L. Goff and A. Chess for critical reading of the manuscript. We acknowledge the Broad Institute Genome Sequencing Platform for their expertise and assistance with data production. This research was supported by the National Human Genome Research Institute under an ENCODE grant (U54 HG004570; B.E.B.), R01 HG004037 (M. Kellis), RC1 HG005334 (M. Kellis), the Howard Hughes Medical Institute (B.E.B.), the National Science Foundation (awards 0644282 (M. Kellis) and 0905968 (J.E.)) and the Sloan Foundation (M. Kellis).	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bartel FO, 2000, ONCOGENE, V19, P6443, DOI 10.1038/sj.onc.1204038; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Forte E, 2009, J VIROL, V83, P2491, DOI 10.1128/JVI.01681-08; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hon G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000566; Hoshino H, 2007, J BIOCHEM, V141, P719, DOI 10.1093/jb/mvm073; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; LAW JC, 1993, LEUKEMIA RES, V17, P1045, DOI 10.1016/0145-2126(93)90161-D; Lemaigre F, 2004, CURR OPIN GENET DEV, V14, P582, DOI 10.1016/j.gde.2004.08.004; Liu XD, 2010, NAT GENET, V42, P658, DOI 10.1038/ng.627; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Naumova N, 2010, J CELL SCI, V123, P1979, DOI 10.1242/jcs.051631; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Raha D, 2010, P NATL ACAD SCI USA, V107, P3639, DOI 10.1073/pnas.0911315106; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Solozobova V, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-46; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Touzet H, 2007, ALGORITHM MOL BIOL, V2, DOI 10.1186/1748-7188-2-15; Vassen L, 2006, EMBO J, V25, P2409, DOI 10.1038/sj.emboj.7601124; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043	65	1995	2046	6	199	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 5	2011	473	7345					43	U52		10.1038/nature09906	http://dx.doi.org/10.1038/nature09906			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21441907	Green Submitted, Green Accepted			2022-12-28	WOS:000290218300027
J	Radu, I; Vahaplar, K; Stamm, C; Kachel, T; Pontius, N; Durr, HA; Ostler, TA; Barker, J; Evans, RFL; Chantrell, RW; Tsukamoto, A; Itoh, A; Kirilyuk, A; Rasing, T; Kimel, AV				Radu, I.; Vahaplar, K.; Stamm, C.; Kachel, T.; Pontius, N.; Duerr, H. A.; Ostler, T. A.; Barker, J.; Evans, R. F. L.; Chantrell, R. W.; Tsukamoto, A.; Itoh, A.; Kirilyuk, A.; Rasing, Th.; Kimel, A. V.			Transient ferromagnetic-like state mediating ultrafast reversal of antiferromagnetically coupled spins	NATURE			English	Article							NICKEL	Ferromagnetic or antiferromagnetic spin ordering is governed by the exchange interaction, the strongest force in magnetism(1-4). Understanding spin dynamics in magnetic materials is an issue of crucial importance for progress in information processing and recording technology. Usually the dynamics are studied by observing the collective response of exchange-coupled spins, that is, spin resonances, after an external perturbation by a pulse of magnetic field, current or light. The periods of the corresponding resonances range from one nanosecond for ferromagnets down to one picosecond for antiferromagnets. However, virtually nothing is known about the behaviour of spins in a magnetic material after being excited on a timescale faster than that corresponding to the exchange interaction (10-100 fs), that is, in a non-adiabatic way. Here we use the element-specific technique X-ray magnetic circular dichroism to study spin reversal in GdFeCo that is optically excited on a timescale pertinent to the characteristic time of the exchange interaction between Gd and Fe spins. We unexpectedly find that the ultrafast spin reversal in this material, where spins are coupled antiferromagnetically, occurs by way of a transient ferromagnetic-like state. Following the optical excitation, the net magnetizations of the Gd and Fe sublattices rapidly collapse, switch their direction and rebuild their net magnetic moments at substantially different timescales; the net magnetic moment of the Gd sublattice is found to reverse within 1.5 picoseconds, which is substantially slower than the Fe reversal time of 300 femtoseconds. Consequently, a transient state characterized by a temporary parallel alignment of the net Gd and Fe moments emerges, despite their ground-state antiferromagnetic coupling. These surprising observations, supported by atomistic simulations, provide a concept for the possibility of manipulating magnetic order on the timescale of the exchange interaction.	[Radu, I.; Vahaplar, K.; Kirilyuk, A.; Rasing, Th.; Kimel, A. V.] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 AJ Nijmegen, Netherlands; [Radu, I.; Stamm, C.; Kachel, T.; Pontius, N.; Duerr, H. A.] BESSY II, Helmholtz Zentrum Berlin Mat & Energie, D-12489 Berlin, Germany; [Duerr, H. A.] SLAC Natl Accelerator Lab, Menlo Pk, CA 94025 USA; [Ostler, T. A.; Barker, J.; Evans, R. F. L.; Chantrell, R. W.] Univ York, Dept Phys, York YO10 5DD, N Yorkshire, England; [Tsukamoto, A.; Itoh, A.] Nihon Univ, Coll Sci & Technol, Chiba, Japan; [Tsukamoto, A.] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	Radboud University Nijmegen; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of York - UK; Nihon University; Japan Science & Technology Agency (JST)	Radu, I (corresponding author), Radboud Univ Nijmegen, Inst Mol & Mat, Heyendaalseweg 135, NL-6525 AJ Nijmegen, Netherlands.	i.radu@science.ru.nl; a.kimel@science.ru.nl	Kimel, Alexey/D-5112-2012; Kirilyuk, Andrei/D-7798-2012; Rasing, Theo/D-5207-2012; Durr, Hermann A/F-6205-2012; Chantrell, Roy/J-9898-2015; Radu, Ilie/B-8703-2012; Evans, Richard F L/F-4230-2010; Pontius, Niko/I-1804-2013; Stamm, Christian/G-4814-2013; Ostler, Thomas A/F-9170-2011; Barker, Joseph/C-5640-2012	Kimel, Alexey/0000-0002-0709-042X; Kirilyuk, Andrei/0000-0003-1479-9872; Rasing, Theo/0000-0002-6656-5528; Chantrell, Roy/0000-0001-5410-5615; Radu, Ilie/0000-0002-6388-729X; Evans, Richard F L/0000-0002-2378-8203; Stamm, Christian/0000-0001-5611-9084; Ostler, Thomas A/0000-0002-1328-1839; Barker, Joseph/0000-0003-4843-5516; RADU, Dr. Ilie/0000-0001-8503-3503; Tsukamoto, Arata/0000-0003-1219-1732; Durr, Hermann/0000-0001-9680-8730; Radu, Iuliana/0000-0002-7230-7218; Pontius, Niko/0000-0002-5658-1751	European Community [NMP3-SL-2008-214469, 214810, 226716]; Foundation for Fundamental Research on Matter (FOM); Netherlands Organization for Scientific Research (NWO); Nihon University; US Department of Energy [DE-AC02-76SF00515]	European Community(European Commission); Foundation for Fundamental Research on Matter (FOM)(FOM (The Netherlands)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Nihon University; US Department of Energy(United States Department of Energy (DOE))	We acknowledge technical support provided by R. Mitzner, K. Holldack and T. Quast during the slicing measurements. We thank F. Radu and R. Abrudan for their support and help with the static XMCD measurements as well as for discussions. This work was supported by the European Community's Seventh Framework Programme FP7/2007-2013 (grants NMP3-SL-2008-214469 (UltraMagnetron) and 214810 (FANTOMAS) as well as grant no. 226716), the Foundation for Fundamental Research on Matter (FOM), the Netherlands Organization for Scientific Research (NWO), the Nihon University Strategic Projects for Academic Research and the US Department of Energy under contract DE-AC02-76SF00515.	AESCHLIMANN M, 1990, J APPL PHYS, V67, P4438, DOI 10.1063/1.344924; Anisimov S I, 1974, SOV PHYS JETP, V39, P375, DOI DOI 10.1016/J.JMATPROTEC.2009.05.031; Bartelt AF, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2724911; Beaurepaire E, 1996, PHYS REV LETT, V76, P4250, DOI 10.1103/PhysRevLett.76.4250; Kazantseva N, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/27006; Kazantseva N, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/27004; Khan S, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.074801; Kirilyuk A, 2010, REV MOD PHYS, V82, P2731, DOI 10.1103/RevModPhys.82.2731; Koopmans B, 2010, NAT MATER, V9, P259, DOI [10.1038/NMAT2593, 10.1038/nmat2593]; NEEL L, 1971, SCIENCE, V174, P985, DOI 10.1126/science.174.4013.985; Neel L, 1932, ANN PHYS-PARIS, V17, P5; Stamm C, 2007, NAT MATER, V6, P740, DOI 10.1038/nmat1985; Stanciu CD, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.217204; Stanciu CD, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.220402; Stohr J., 2006, MAGNETISM FUNDAMENTA; Weiss P, 1907, J PHYS, V6, P661, DOI [10.1051/jphystap:019070060066100, DOI 10.1051/JPHYSTAP:019070060066100]; WIETSTRUK M, HOT ELECT DRIVEN ENH	18	658	670	14	343	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 14	2011	472	7342					205	208		10.1038/nature09901	http://dx.doi.org/10.1038/nature09901			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21451521				2022-12-28	WOS:000289469100039
J	Sack, DA				Sack, David A.			How many cholera deaths can be averted in Haiti?	LANCET			English	Editorial Material									Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sack, DA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	dsack@jhsph.edu						Andrews JR, 2011, LANCET, V377, P1248, DOI 10.1016/S0140-6736(11)60273-0; Bompangue D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000436; CLEMENS JD, 1990, LANCET, V335, P270, DOI 10.1016/0140-6736(90)90080-O; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; *COTS PROGR, CHOL OUTBR TRAIN SHI; LINDENBA.J, 1967, B WORLD HEALTH ORGAN, V36, P871; Luby SP, 2008, AM J TROP MED HYG, V78, P382, DOI 10.4269/ajtmh.2008.78.382; Nelson EJ, 2011, NEW ENGL J MED, V364, P5, DOI 10.1056/NEJMp1013771; QUICK RE, 1993, AM J TROP MED HYG, V48, P597, DOI 10.4269/ajtmh.1993.48.597; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; Sur D, 2009, LANCET, V374, P1694, DOI 10.1016/S0140-6736(09)61297-6; Waldor MK, 2010, NEW ENGL J MED, V363, P2279, DOI 10.1056/NEJMp1012300; World Health Organization, 2010, WKLY EPIDEMIOL REC, V85, P117	13	9	9	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2011	377	9773					1214	1216		10.1016/S0140-6736(11)60356-5	http://dx.doi.org/10.1016/S0140-6736(11)60356-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	751DI	21414660				2022-12-28	WOS:000289597300005
J	Edery, P; Marcaillou, C; Sahbatou, M; Labalme, A; Chastang, J; Touraine, R; Tubacher, E; Senni, F; Bober, MB; Nampoothiri, S; Jouk, PS; Steichen, E; Berland, S; Toutain, A; Wise, CA; Sanlaville, D; Rousseau, F; Clerget-Darpoux, F; Leutenegger, AL				Edery, Patrick; Marcaillou, Charles; Sahbatou, Mourad; Labalme, Audrey; Chastang, Joelle; Touraine, Renaud; Tubacher, Emmanuel; Senni, Faiza; Bober, Michael B.; Nampoothiri, Sheela; Jouk, Pierre-Simon; Steichen, Elisabeth; Berland, Siren; Toutain, Annick; Wise, Carol A.; Sanlaville, Damien; Rousseau, Francis; Clerget-Darpoux, Francoise; Leutenegger, Anne-Louise			Association of TALS Developmental Disorder with Defect in Minor Splicing Component U4atac snRNA	SCIENCE			English	Article							NONSENSE-MEDIATED DECAY; INBREEDING COEFFICIENT; RNA SURVEILLANCE; U4 SNRNA; PROTEIN; INTRONS; U12-TYPE; SPLICEOSOME; DWARFISM	The spliceosome, a ribonucleoprotein complex that includes proteins and small nuclear RNAs (snRNAs), catalyzes RNA splicing through intron excision and exon ligation to produce mature messenger RNAs, which, in turn serve as templates for protein translation. We identified four point mutations in the U4atac snRNA component of the minor spliceosome in patients with brain and bone malformations and unexplained postnatal death [microcephalic osteodysplastic primordial dwarfism type 1 (MOPD 1) or Taybi-Linder syndrome (TALS); Mendelian Inheritance in Man ID no. 210710]. Expression of a subgroup of genes, possibly linked to the disease phenotype, and minor intron splicing were affected in cell lines derived from TALS patients. Our findings demonstrate a crucial role of the minor spliceosome component U4atac snRNA in early human development and postnatal survival.	[Edery, Patrick; Labalme, Audrey; Chastang, Joelle; Senni, Faiza; Sanlaville, Damien] Hosp Civils Lyon, Serv Cytogenet Constitut, F-69677 Bron, France; [Edery, Patrick; Sanlaville, Damien] INSERM, U1028, F-69000 Lyon, France; [Edery, Patrick; Sanlaville, Damien] CNRS, UMR5292, F-69000 Lyon, France; [Edery, Patrick; Sanlaville, Damien] Univ Lyon 1, F-69000 Lyon, France; [Edery, Patrick; Sanlaville, Damien] Ctr Rech Neurosci Lyon, Translat & Integrat Grp Epilepsy Res, F-69000 Lyon, France; [Marcaillou, Charles; Rousseau, Francis] IntegraGen, F-91030 Evry, France; [Sahbatou, Mourad; Tubacher, Emmanuel] Fdn Jean Dausset, Ctr Etud Polymorphisme Humain, F-75010 Paris, France; [Touraine, Renaud] Hop Nord St Etienne, CHU, Serv Genet, F-42055 St Etienne, France; [Bober, Michael B.] Alfred I DuPont Hosp Children, Dept Pediat, Div Med Genet, Wilmington, DE 19803 USA; [Nampoothiri, Sheela] Amrita Inst Med Sci & Res Ctr, Dept Pediat Genet, Cochin 682041, Kerala, India; [Jouk, Pierre-Simon] CHU Grenoble, Dept Genet & Procreat, F-38043 Grenoble 9, France; [Jouk, Pierre-Simon] Univ Grenoble 1, CNRS, UMR 5525, F-38041 Grenoble, France; [Steichen, Elisabeth] Univ Innsbruck Hosp, Dept Pediat, A-6020 Innsbruck, Austria; [Berland, Siren] St Olavs Hosp, Dept Pathol, Clin Genet Sect, N-7006 Trondheim, Norway; [Berland, Siren] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Toutain, Annick] Hop Bretonneau, CHRU, Serv Genet, F-37044 Tours, France; [Toutain, Annick] Univ Tours, INSERM, U930, Tours, France; [Wise, Carol A.] Texas Scottish Rite Hosp Children, Ctr Musculoskeletal Res, Dallas, TX 75219 USA; [Clerget-Darpoux, Francoise] INSERM, U669, F-94804 Villejuif, France; [Clerget-Darpoux, Francoise] Univ Paris 11, UMR S669, F-94804 Villejuif, France; [Leutenegger, Anne-Louise] INSERM, U946, F-75010 Paris, France; [Leutenegger, Anne-Louise] Univ Paris Diderot, Inst Univ Hematol, UMR S946, F-75010 Paris, France	CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Foundation Jean Dausset-CEPH; CHU de St Etienne; Nemours Alfred I. duPont Hospital for Children; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Kochi; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Medical University of Innsbruck; Norwegian University of Science & Technology (NTNU); University of Bergen; Haukeland University Hospital; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Texas Scottish Rite Hospital for Children; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Edery, P (corresponding author), Hosp Civils Lyon, Serv Cytogenet Constitut, F-69677 Bron, France.	patrick.edery@chu-lyon.fr	Nampoothiri, Sheela/AAQ-4854-2021; Bober, Michael/AAH-4553-2021; Edery, Patrick/B-6407-2012; Sanlaville, Damien/M-4716-2014; Jouk, Pierre-Simon/M-7367-2014; Jouk, Pierre-Simon/AAB-5262-2022; Leutenegger, Anne-Louise/B-5597-2009; Touraine, Renaud/AAV-1605-2020; Clerget-Darpoux, Francoise/I-4825-2017	Nampoothiri, Sheela/0000-0002-9575-0722; Sanlaville, Damien/0000-0001-9939-2849; Jouk, Pierre-Simon/0000-0001-8301-320X; Leutenegger, Anne-Louise/0000-0002-1302-4357; Clerget-Darpoux, Francoise/0000-0003-4816-6619; Wise, Carol/0000-0002-6790-2194; Berland, Siren/0000-0002-8048-6682; Bober, Michael/0000-0002-6178-1264; Toutain, Annick/0000-0002-5999-5300	Fondation Yves Cotrel-Institut de France; Hospices Civils de Lyon; French Ministry of Health; Lyon 1 University; INSERM; Association GEN'HOM; Texas Scottish Rite Hospital for Children	Fondation Yves Cotrel-Institut de France; Hospices Civils de Lyon; French Ministry of Health; Lyon 1 University; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association GEN'HOM; Texas Scottish Rite Hospital for Children	We express our heartfelt thanks to the patients and families who participated in this study. We thank M. Gallagher-Gambarelli for her editorial assistance and R. Hennekam for his assistance during the project; M. Letexier for her assistance in analyzing high-throughput sequencing data; T. Rio Frio for helpful discussions on splicing analyses; M. de Tayrac and C. Depienne for helpful discussions on expression data analysis; I. Rouvet and M.-T. Zabot for fibroblast banking; and R. Padgett for providing us with the hand-built U4atac/U6atac bimolecular structure reflecting mfold software predictions. This work was supported by the Fondation Yves Cotrel-Institut de France, the Hospices Civils de Lyon, the French Ministry of Health (Direction de l'Hospitalisation et de l'Organisation des Soins, Plan Maladies Rares 2004), Lyon 1 University, the INSERM, the Association GEN'HOM, and the Texas Scottish Rite Hospital for Children Research Fund.	Alioto TS, 2007, NUCLEIC ACIDS RES, V35, pD110, DOI 10.1093/nar/gkl796; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Leutenegger AL, 2003, AM J HUM GENET, V73, P516, DOI 10.1086/378207; Leutenegger AL, 2006, AM J HUM GENET, V79, P62, DOI 10.1086/504640; Levine A, 2001, NUCLEIC ACIDS RES, V29, P4006, DOI 10.1093/nar/29.19.4006; Liu S, 2007, SCIENCE, V316, P115, DOI 10.1126/science.1137924; Nottrott S, 1999, EMBO J, V18, P6119, DOI 10.1093/emboj/18.21.6119; Nottrott S, 2002, EMBO J, V21, P5527, DOI 10.1093/emboj/cdf544; Otake LR, 2002, MOL CELL, V9, P439, DOI 10.1016/S1097-2765(02)00441-0; Padgett RA, 2002, RNA, V8, P125, DOI 10.1017/S1355838202017156; Pessa HKJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013215; Schultz A, 2006, J BIOL CHEM, V281, P28278, DOI 10.1074/jbc.M603350200; Sharp PA, 1997, CELL, V91, P875, DOI 10.1016/S0092-8674(00)80479-1; Shukla GC, 2002, NUCLEIC ACIDS RES, V30, P4650, DOI 10.1093/nar/gkf609; Sigaudy S, 1998, AM J MED GENET, V80, P16, DOI 10.1002/(SICI)1096-8628(19981102)80:1<16::AID-AJMG4>3.3.CO;2-X; Tarn WY, 1996, SCIENCE, V273, P1824, DOI 10.1126/science.273.5283.1824; Tarn WY, 1996, CELL, V84, P801, DOI 10.1016/S0092-8674(00)81057-0; TAYBI H, 1967, RADIOLOGY, V89, P275, DOI 10.1148/89.2.275; Vidovic I, 2000, MOL CELL, V6, P1331, DOI 10.1016/S1097-2765(00)00131-3	20	140	142	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2011	332	6026					240	243		10.1126/science.1202205	http://dx.doi.org/10.1126/science.1202205			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474761				2022-12-28	WOS:000289251100053
J	Cook, D; Meade, M; Guyatt, G; Walter, S; Heels-Ansdell, D; Warkentin, TE; Zytaruk, N; Crowther, M; Geerts, W; Cooper, DJ; Vallance, S; Qushmaq, I; Rocha, M; Berwanger, O; Vlahakis, NE				Cook, Deborah; Meade, Maureen; Guyatt, Gordon; Walter, Stephen; Heels-Ansdell, Diane; Warkentin, Theodore E.; Zytaruk, Nicole; Crowther, Mark; Geerts, William; Cooper, D. Jamie; Vallance, Shirley; Qushmaq, Ismael; Rocha, Marcelo; Berwanger, Otavio; Vlahakis, Nicholas E.		PROTECT Investigators Canadian Cri; Australian New Zealand Intensive C	Dalteparin versus Unfractionated Heparin in Critically Ill Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEEP-VEIN THROMBOSIS; MOLECULAR-WEIGHT HEPARIN; VENOUS THROMBOSIS; CLINICAL-TRIALS; PROPHYLAXIS; THROMBOEMBOLISM; PREVENTION; RISK	BACKGROUND The effects of thromboprophylaxis with low-molecular-weight heparin, as compared with unfractionated heparin, on venous thromboembolism, bleeding, and other outcomes are uncertain in critically ill patients. METHODS In this multicenter trial, we tested the superiority of dalteparin over unfractionated heparin by randomly assigning 3764 patients to receive either subcutaneous dalteparin (at a dose of 5000 IU once daily) plus placebo once daily (for parallel-group twice-daily injections) or unfractionated heparin (at a dose of 5000 IU twice daily) while they were in the intensive care unit. The primary outcome, proximal leg deep-vein thrombosis, was diagnosed on compression ultrasonography performed within 2 days after admission, twice weekly, and as clinically indicated. Additional testing for venous thromboembolism was performed as clinically indicated. Data were analyzed according to the intention-to-treat principle. RESULTS There was no significant between-group difference in the rate of proximal leg deep-vein thrombosis, which occurred in 96 of 1873 patients (5.1%) receiving dalteparin versus 109 of 1873 patients (5.8%) receiving unfractionated heparin (hazard ratio in the dalteparin group, 0.92; 95% confidence interval [CI], 0.68 to 1.23; P = 0.57). The proportion of patients with pulmonary emboli was significantly lower with dalteparin (24 patients, 1.3%) than with unfractionated heparin (43 patients, 2.3%) (hazard ratio, 0.51; 95% CI, 0.30 to 0.88; P = 0.01). There was no significant between-group difference in the rates of major bleeding (hazard ratio, 1.00; 95% CI, 0.75 to 1.34; P = 0.98) or death in the hospital (hazard ratio, 0.92; 95% CI, 0.80 to 1.05; P = 0.21). In prespecified per-protocol analyses, the results were similar to those of the main analyses, but fewer patients receiving dalteparin had heparin-induced thrombocytopenia (hazard ratio, 0.27; 95% CI, 0.08 to 0.98; P = 0.046). CONCLUSIONS Among critically ill patients, dalteparin was not superior to unfractionated heparin in decreasing the incidence of proximal deep-vein thrombosis.	[Cook, Deborah] McMaster Univ, Hlth Sci Ctr, Dept Med, Hamilton, ON L8N 3Z5, Canada; [Geerts, William] Univ Toronto, Toronto, ON, Canada; [Cooper, D. Jamie; Vallance, Shirley] Alfred Hosp, Melbourne, Vic, Australia; [Qushmaq, Ismael] King Faisal Specialist & Res Ctr, Jeddah, Saudi Arabia; [Rocha, Marcelo] Santa Casa Hosp, Porto Alegre, RS, Brazil; [Berwanger, Otavio] Hosp Coracao, Sao Paulo, Brazil; [Vlahakis, Nicholas E.] Mayo Clin, Rochester, MN USA	McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Florey Institute of Neuroscience & Mental Health; King Faisal Specialist Hospital & Research Center; Hospital do Coracao - HCor; Mayo Clinic	Cook, D (corresponding author), McMaster Univ, Hlth Sci Ctr, Dept Med, Rm 2C10,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	debcook@mcmaster.ca	Cooper, D. James/G-7961-2013; Mehta, Sangeeta/C-4623-2015; Walter, Stephen/AAB-5548-2022; Edgeworth, Cathrine/AAB-7428-2020	Cooper, D. James/0000-0002-5872-9051; Walter, Stephen/0000-0003-4157-8928; Edgeworth, Cathrine/0000-0002-5190-9711; Warkentin, Theodore Earl/0000-0002-8046-7588	Canadian Institutes of Health Research [MCT78568]; Heart and Stroke Foundation of Canada [T6157, T6950, NA6186]; Australian and New Zealand College of Anesthetists Research Foundation [07/23]; Arjo Huntleigh; Bayer Healthcare; Boehringer Ingelheim; Daiichi Sankyo; Pfizer; Sanofi-Aventis; Covidien; Leo Pharma; Canyon Pharma; GlaxoSmithKline; Paringenix; Schering-Plough/Organon; GTI Diagnostics	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Australian and New Zealand College of Anesthetists Research Foundation; Arjo Huntleigh; Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Boehringer Ingelheim(Boehringer Ingelheim); Daiichi Sankyo(Daiichi Sankyo Company Limited); Pfizer(Pfizer); Sanofi-Aventis(Sanofi-Aventis); Covidien; Leo Pharma(LEO Pharma); Canyon Pharma; GlaxoSmithKline(GlaxoSmithKline); Paringenix; Schering-Plough/Organon(Merck & CompanySchering Plough Corporation); GTI Diagnostics	Supported by grants from the Canadian Institutes of Health Research (MCT78568), the Heart and Stroke Foundation of Canada (T6157, T6950, and NA6186), and the Australian and New Zealand College of Anesthetists Research Foundation (07/23).; Dr. Geerts reports receiving consulting fees from Arjo Huntleigh, Bayer Healthcare, Boehringer Ingelheim, Daiichi Sankyo, Pfizer, Sanofi-Aventis, and Covidien, grant support from Bayer Healthcare and Sanofi-Aventis, lecture fees from Bayer Healthcare, Boehringer Ingelheim, Leo Pharma, Pfizer, and Sanofi-Aventis, payment for educational presentations from Bayer Healthcare and Pfizer, payment for preceptorship from Bayer Healthcare, Pfizer, and Sanofi-Aventis, and program support from Bayer Healthcare, Boehringer Ingelheim, Pfizer, and Sanofi-Aventis; Dr. Warkentin, consulting fees from Canyon Pharma, GlaxoSmithKline, Paringenix, Schering-Plough/Organon, and GTI Diagnostics, grant support from GlaxoSmithKline and GTI Diagnostics, lecture fees from Sanofi-Aventis, Pfizer, Schering-Plough/Organon, and GlaxoSmithKline, and royalties from Informa and providing expert testimony for heparin-induced thrombocytopenia; and Dr. Crowther, fees for serving on an advisory board from Pfizer and Alexion, grant support from Leo Pharma, payment for developing educational presentations and reimbursement for travel expenses from Pfizer, and a research chair at McMaster University from Leo Pharma. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 22 AG HEALTHC RES QU; Arnold D, 2009, BLOOD, V114, P2471; Arnold DM, 2007, CLIN INVEST MED, V30, pE93; CADE JF, 1982, CRIT CARE MED, V10, P448, DOI 10.1097/00003246-198207000-00006; Cook D, 2005, CRIT CARE MED, V33, P1565, DOI 10.1097/01.CCM.0000171207.95319.B2; Cook D, J CRIT CARE IN PRESS; Cook DJ, 2005, J CRIT CARE, V20, P364, DOI 10.1016/j.jcrc.2005.09.010; Crowther MA, 2005, J CRIT CARE, V20, P334, DOI 10.1016/j.jcrc.2005.09.011; Crowther MA, 2005, INTENS CARE MED, V31, P48, DOI 10.1007/s00134-004-2467-2; De A, 2010, BLOOD COAGUL FIBRIN, V21, P57, DOI 10.1097/MBC.0b013e3283333505; Douketis J, 2008, ARCH INTERN MED, V168, P1805, DOI 10.1001/archinte.168.16.1805; Fraisse F, 2000, AM J RESP CRIT CARE, V161, P1109, DOI 10.1164/ajrccm.161.4.9807025; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Ginsberg JS, 2001, ARCH INTERN MED, V161, P1268; HAYBITTLE JL, 1971, BRIT J RADIOL, V44, P793, DOI 10.1259/0007-1285-44-526-793; KAKKAR VV, 1969, LANCET, V2, P230; Kearon C, 1998, ANN INTERN MED, V129, P425, DOI 10.7326/0003-4819-128-8-199804150-00011; King CS, 2007, CHEST, V131, P507, DOI 10.1378/chest.06-1861; Kunz R, 2008, USERS GUIDE MED LIT, P703; Lamontagne F, 2009, CANADIAN CRITICAL CA; LENSING AWA, 1989, NEW ENGL J MED, V320, P342, DOI 10.1056/NEJM198902093200602; Lubenow N, 2010, BLOOD, V115, P1797, DOI 10.1182/blood-2009-07-231506; MONREAL M, 1989, ANGIOLOGY, V40, P527, DOI 10.1177/000331978904000603; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Phung OJ, 2011, CHEST           0224; Rabbat CG, 2005, J CRIT CARE, V20, P357, DOI 10.1016/j.jcrc.2005.09.009; SHERIDAN D, 1986, BLOOD, V67, P27; Shorr AF, 2009, THROMB HAEMOSTASIS, V101, P139, DOI 10.1160/TH08-07-0468; Southon J, 2009, MCMASTER RES DAY ABS; WARKENTIN TE, 1995, NEW ENGL J MED, V332, P1330, DOI 10.1056/NEJM199505183322003; Warkentin TE, 2008, CHEST, V133, p340S, DOI 10.1378/chest.08-0677; Zytaruk N, 2009, AM J RESP CRIT CARE, V179	32	296	303	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 7	2011	364	14					1305	1314		10.1056/NEJMoa1014475	http://dx.doi.org/10.1056/NEJMoa1014475			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745WS	21417952				2022-12-28	WOS:000289202800006
J	Deodhar, A				Deodhar, Atul			Update in Rheumatology: Evidence Published in 2010	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								This Update summarizes studies published in 2010 that the author considers highly relevant to the practice of rheumatology. Topics include osteoporosis, antineutrophil cytoplasmic antibody-associated vasculitis, rheumatoid arthritis, drug-free remission in rheumatoid arthritis, the spleen tyrosine kinase inhibitor r788, gout, reactive arthritis, and interleukin-17A inhibitors.	Oregon Hlth & Sci Univ, Div Arthritis & Rheumat Dis OP09, Portland, OR 97239 USA	Oregon Health & Science University	Deodhar, A (corresponding author), Oregon Hlth & Sci Univ, Div Arthritis & Rheumat Dis OP09, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	deodhara@ohsu.edu						Bolland MJ, 2008, BMJ-BRIT MED J, V336, P262, DOI 10.1136/bmj.39440.525752.BE; Choi HK, 2008, BMJ-BRIT MED J, V336, P309, DOI 10.1136/bmj.39449.819271.BE	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 5	2011	154	7								10.7326/0003-4819-154-7-201104050-00008	http://dx.doi.org/10.7326/0003-4819-154-7-201104050-00008			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744EX	21464352				2022-12-28	WOS:000289078700015
J	Sims, RJ; Rojas, LA; Beck, D; Bonasio, R; Schuller, R; Drury, WJ; Eick, D; Reinberg, D				Sims, Robert J., III; Rojas, Luis Alejandro; Beck, David; Bonasio, Roberto; Schueller, Roland; Drury, William J., III; Eick, Dirk; Reinberg, Danny			The C-Terminal Domain of RNA Polymerase II Is Modified by Site-Specific Methylation	SCIENCE			English	Article							TRANSCRIPTION; CARM1; INTEGRATOR; EXPRESSION; IICTD	The carboxy-terminal domain (CTD) of RNA polymerase II (RNAPII) in mammals undergoes extensive posttranslational modification, which is essential for transcriptional initiation and elongation. Here, we show that the CTD of RNAPII is methylated at a single arginine (R1810) by the coactivator-associated arginine methyltransferase 1 (CARM1). Although methylation at R1810 is present on the hyperphosphorylated form of RNAPII in vivo, Ser2 or Ser5 phosphorylation inhibits CARM1 activity toward this site in vitro, suggesting that methylation occurs before transcription initiation. Mutation of R1810 results in the misexpression of a variety of small nuclear RNAs and small nucleolar RNAs, an effect that is also observed in Carm1(-/-) mouse embryo fibroblasts. These results demonstrate that CTD methylation facilitates the expression of select RNAs, perhaps serving to discriminate the RNAPII-associated machinery recruited to distinct gene types.	[Sims, Robert J., III; Rojas, Luis Alejandro; Beck, David; Bonasio, Roberto; Drury, William J., III; Reinberg, Danny] NYU, Sch Med, HHMI, Dept Biochem, New York, NY 10016 USA; [Schueller, Roland; Eick, Dirk] CIPSM, Dept Mol Epigenet, Helmholtz Ctr Munich, D-81377 Munich, Germany	Howard Hughes Medical Institute; New York University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Reinberg, D (corresponding author), NYU, Sch Med, HHMI, Dept Biochem, 522 1st Ave,Smilow 211, New York, NY 10016 USA.	danny.reinberg@nyumc.org	Bonasio, Roberto/P-1356-2014; Rojas, Luis/C-2204-2011	Bonasio, Roberto/0000-0002-0767-0889; Rojas, Luis Alejandro/0000-0001-6445-1562; Reinberg, Danny/0000-0003-4288-2016	HHMI; NIH [GM-37120, GM-71166]; Deutsche Forschungsgemeinschaft [SFB/Transregio-5, SFB684]; Jose Carreras Leukmiestiftung eV; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037120, F32GM071166, R37GM037120] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Jose Carreras Leukmiestiftung eV; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	These studies were supported by the HHMI (to D. R.) and grants from NIH (GM-37120 to D. R. and GM-71166 to R.J.S.). R. B. is a fellow of the Helen Hay Whitney foundation. D. E. was supported by Deutsche Forschungsgemeinschaft (SFB/Transregio-5, SFB684) and Jose Carreras Leukmiestiftung eV. We thank L. Vales, E. Lecona, and P. Voigt for careful reading of the manuscript; R. D. Chapman and K. Burger for technical support; and members of the Reinberg lab for critical commentaries during the development of this project. RNA-seq data have been deposited in the National Center for Biotechnology Information's Gene Expression Omnibus as GEO series GSE27315.	An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Baillat D, 2005, CELL, V123, P265, DOI 10.1016/j.cell.2005.08.019; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Cote J, 2005, J BIOL CHEM, V280, P28476, DOI 10.1074/jbc.M414328200; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Egloff S, 2010, J BIOL CHEM, V285, P20564, DOI 10.1074/jbc.M110.132530; Fong N, 2001, GENE DEV, V15, P1783, DOI 10.1101/gad.889101; Meininghaus M, 2000, J BIOL CHEM, V275, P24375, DOI 10.1074/jbc.M001883200; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Misteli T, 1999, MOL CELL, V3, P697, DOI 10.1016/S1097-2765(01)80002-2; Ohkura N, 2005, J BIOL CHEM, V280, P28927, DOI 10.1074/jbc.M502173200; Ryan K, 2002, MOL CELL BIOL, V22, P1684, DOI 10.1128/MCB.22.6.1684-1692.2002; Shaw N, 2007, NAT STRUCT MOL BIOL, V14, P779, DOI 10.1038/nsmb1269; Sprangers R, 2003, J MOL BIOL, V327, P507, DOI 10.1016/S0022-2836(03)00148-7; Yang YZ, 2010, MOL CELL, V40, P1016, DOI 10.1016/j.molcel.2010.11.024	16	151	153	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2011	332	6025					99	103		10.1126/science.1202663	http://dx.doi.org/10.1126/science.1202663			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21454787	Green Accepted			2022-12-28	WOS:000289000000046
J	McMinn, J; Steel, C; Bowman, A				McMinn, Jenna; Steel, Claire; Bowman, Adam			Investigation and management of unintentional weight loss in older adults	BMJ-BRITISH MEDICAL JOURNAL			English	Review							LONG-TERM-CARE; NURSING-HOME; DEPRESSION; COMMUNITY; MORTALITY; SYMPTOMS		[McMinn, Jenna] So Gen Hosp, Dept Med, Queen Elizabeth Natl Spinal Injuries Unit, Glasgow G51 4TF, Lanark, Scotland; [Steel, Claire] Monklands Hosp, Dept Med Elderly, Airdrie, Scotland; [Bowman, Adam] Glasgow Royal Infirm, Dept Med Elderly, Glasgow G4 0SF, Lanark, Scotland	University of Glasgow; Monklands Hospital; University of Glasgow	McMinn, J (corresponding author), So Gen Hosp, Dept Med, Queen Elizabeth Natl Spinal Injuries Unit, Glasgow G51 4TF, Lanark, Scotland.	jennamcminn@gmail.com						Alibhai SMH, 2005, CAN MED ASSOC J, V172, P773, DOI 10.1503/cmaj.1031527; Beekman ATF, 1999, BRIT J PSYCHIAT, V174, P307, DOI 10.1192/bjp.174.4.307; Bilbao-Garay J, 2002, Eur J Intern Med, V13, P240, DOI 10.1016/S0953-6205(02)00032-8; Bouras EP, 2001, MAYO CLIN PROC, V76, P923; Boylston E, 1995, AM J ALZHEIMERS DIS, V10, P37, DOI DOI 10.1177/153331759501000606; Carr-Lopez SM, 1996, DRUGS AGING, V8, P221; CHAPMAN KM, 1994, GERIATRICS, V49, P54; Clarkston WK, 1997, AM J PHYSIOL-REG I, V272, pR243, DOI 10.1152/ajpregu.1997.272.1.R243; Ensrud KE, 2003, J AM GERIATR SOC, V51, P1740, DOI 10.1046/j.1532-5415.2003.51558.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hernandez JL, 2003, AM J MED, V114, P631, DOI 10.1016/S0002-9343(03)00115-3; Lankisch PG, 2001, J INTERN MED, V249, P41, DOI 10.1046/j.1365-2796.2001.00771.x; MARTON KI, 1981, ANN INTERN MED, V95, P568, DOI 10.7326/0003-4819-95-5-568; Metalidis C, 2008, EUR J INTERN MED, V19, P345, DOI 10.1016/j.ejim.2007.09.019; MORLEY JE, 1995, ANN INTERN MED, V123, P850, DOI 10.7326/0003-4819-123-11-199512010-00008; MORLEY JE, 1994, J AM GERIATR SOC, V42, P583, DOI 10.1111/j.1532-5415.1994.tb06853.x; Newman AB, 2001, J AM GERIATR SOC, V49, P1309, DOI 10.1046/j.1532-5415.2001.49258.x; RABINOVITZ M, 1986, ARCH INTERN MED, V146, P186, DOI 10.1001/archinte.146.1.186; ROBBINS LJ, 1989, GERIATRICS, V44, P31; RYAN C, 1995, SOUTHERN MED J, V88, P721, DOI 10.1097/00007611-199507000-00005; Saz P, 2001, INT J GERIATR PSYCH, V16, P622, DOI 10.1002/gps.396; Smith K, 2007, GERIATR AGING, V10, P91; Sturgeon CM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3527; Wallace JI, 2002, INT J CARDIOL, V85, P15, DOI 10.1016/S0167-5273(02)00246-2; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Young KWH, 2001, J GERONTOL A-BIOL, V56, pM656, DOI 10.1093/gerona/56.10.M656	26	85	87	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 29	2011	342								d1732	10.1136/bmj.d1732	http://dx.doi.org/10.1136/bmj.d1732			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	745WE	21447571				2022-12-28	WOS:000289200800003
J	Myles, PS; Peyton, P; Silbert, B; Hunt, J; Rigg, JRA; Sessler, DI				Myles, Paul S.; Peyton, Philip; Silbert, Brendan; Hunt, Jennifer; Rigg, John R. A.; Sessler, Daniel I.		ANZCA Trials Grp Investigators	Perioperative epidural analgesia for major abdominal surgery for cancer and recurrence-free survival: randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RADICAL PROSTATECTOMY; ANESTHETIC TECHNIQUE; STRESS; IMMUNOSUPPRESSION; ANGIOGENESIS; METASTASIS; MORPHINE; GROWTH; RATES; PAIN	Objective To compare long term recurrence of cancer and survival of patients having major abdominal surgery for cancer. Design Long term follow-up of prospective randomised controlled clinical trial in which patients were randomly assigned to receive general anaesthesia with or without epidural block for at least three postoperative days. Setting 23 hospitals in Australia, New Zealand, and Asia. Participants 503 adult patients who had potentially curative surgery for cancer. Main outcome measure Cancer-free survival (analysis was by intention to treat). Results Long term follow-up data were available for 94% (n=446) of eligible participants. The median time to recurrence of cancer or death was 2.8 (95% confidence interval 0.7 to 8.7) years in the control group and 2.6 (0.7 to 8.7) years in the epidural group (P=0.61). Recurrence-free survival was similar in both epidural and control groups (hazard ratio 0.95, 95% confidence interval 0.76 to 1.17; P=0.61). Conclusion Use of epidural block in abdominal surgery for cancer is not associated with improved cancer-free survival.	[Myles, Paul S.; Hunt, Jennifer] Alfred Hosp, Dept Anaesthesia & Perioperat Med, Melbourne, Vic, Australia; [Myles, Paul S.] Monash Univ, Acad Board Anaesthesia & Perioperat Med, Melbourne, Vic, Australia; [Peyton, Philip] Austin Hosp, Dept Anaesthesia, Heidelberg, Vic 3084, Australia; [Hunt, Jennifer] St Vincents Hosp, Dept Anaesthesia, Fitzroy, Vic 3065, Australia; [Rigg, John R. A.] Australian & New Zealand Coll Anaesthetists Trial, Melbourne, Vic, Australia; [Sessler, Daniel I.] Cleveland Clin, Dept Outcomes Res, Cleveland, OH 44106 USA	Florey Institute of Neuroscience & Mental Health; Monash University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; St Vincent's Hospital Melbourne; Cleveland Clinic Foundation	Myles, PS (corresponding author), Alfred Hosp, Dept Anaesthesia & Perioperat Med, Melbourne, Vic, Australia.	p.myles@alfred.org.au	Sessler, Daniel/D-3504-2011; van Os, Jim/C-2113-2014; Myles, Paul/AAU-9524-2020	Sessler, Daniel/0000-0001-9932-3077; Myles, Paul/0000-0002-3324-5456; Hunt, Jennifer/0000-0002-3740-6851	The Australian National Health and Medical Research Council; Australian and New Zealand College of Anaesthetists; Alfred Hospital Research Trust (Melbourne, Australia); Department of Outcomes Research at the Cleveland Clinic (OH, USA); Australian National Health; Medical Research Council	The Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian and New Zealand College of Anaesthetists; Alfred Hospital Research Trust (Melbourne, Australia); Department of Outcomes Research at the Cleveland Clinic (OH, USA); Australian National Health(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Australian National Health and Medical Research Council funded the MASTER trial. The cancer follow-up study was funded by the Australian and New Zealand College of Anaesthetists, the Alfred Hospital Research Trust (Melbourne, Australia), and the Department of Outcomes Research at the Cleveland Clinic (OH, USA). PSM is funded by an Australian National Health and Medical Research Council practitioner fellowship. The funders had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	Ahlers O, 2008, BRIT J ANAESTH, V101, P781, DOI 10.1093/bja/aen287; *AM JOINT COMM CAN, 2002, AJCC CANC STAG MAN; Antoni MH, 2006, NAT REV CANCER, V6, P240, DOI 10.1038/nrc1820; Australian Institute of Health and Welfare Australasian Association of Cancer Registries, 2010, CANC SER AIHW, V60; Bar-Yosef S, 2001, ANESTHESIOLOGY, V94, P1066, DOI 10.1097/00000542-200106000-00022; Ben-Eliyahu S, 1999, INT J CANCER, V80, P880; Biki B, 2008, ANESTHESIOLOGY, V109, P180, DOI 10.1097/ALN.0b013e31817f5b73; Breslow NE, 1980, IARC SCI PUBL, P5; Chae BK, 1998, SURG TODAY, V28, P727, DOI 10.1007/BF02484619; Christopherson R, 2008, ANESTH ANALG, V107, P325, DOI 10.1213/ane.0b013e3181770f55; de Leon-Casasola OA, 2003, ANESTH ANALG, V96, P315, DOI 10.1097/00000539-200302000-00002; Denis MG, 1997, INT J CANCER, V74, P540, DOI 10.1002/(SICI)1097-0215(19971021)74:5<540::AID-IJC11>3.0.CO;2-A; Exadaktylos AK, 2006, ANESTHESIOLOGY, V105, P660, DOI 10.1097/00000542-200610000-00008; Gottschalk A, 2010, ANESTHESIOLOGY, V113, P27, DOI 10.1097/ALN.0b013e3181de6d0d; Gupta K, 2002, CANCER RES, V62, P4491; Hodgson PS, 2001, ANESTHESIOLOGY, V94, P799, DOI 10.1097/00000542-200105000-00018; Ismail H, 2010, BRIT J ANAESTH, V105, P145, DOI 10.1093/bja/aeq156; MacMahon S, 2001, LANCET, V357, P455, DOI 10.1016/S0140-6736(00)04017-4; O'Riain SC, 2005, ANESTH ANALG, V100, P244, DOI 10.1213/01.ANE.0000143336.37946.7D; Page GG, 2001, PAIN, V90, P191, DOI 10.1016/S0304-3959(00)00403-6; Peyton PJ, 2003, ANESTH ANALG, V96, P548, DOI 10.1097/00000539-200302000-00046; Rigg JRA, 2000, CONTROL CLIN TRIALS, V21, P244, DOI 10.1016/S0197-2456(00)00045-3; Rigg JRA, 2002, LANCET, V359, P1276, DOI 10.1016/S0140-6736(02)08266-1; Sacerdote P, 2000, ANESTH ANALG, V90, P1411, DOI 10.1097/00000539-200006000-00028; Shakhar G, 2003, ANN SURG ONCOL, V10, P972, DOI 10.1245/ASO.2003.02.007; Tsui BCH, 2010, CAN J ANAESTH, V57, P107, DOI 10.1007/s12630-009-9214-7; Wuethrich PY, 2010, ANESTHESIOLOGY, V113, P570, DOI 10.1097/ALN.0b013e3181e4f6ec; Zetter BR, 1998, ANNU REV MED, V49, P407, DOI 10.1146/annurev.med.49.1.407	28	188	194	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 29	2011	342								d1491	10.1136/bmj.d1491	http://dx.doi.org/10.1136/bmj.d1491			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745WE	21447587	Green Published, hybrid			2022-12-28	WOS:000289200800001
J	Stratton, MR				Stratton, Michael R.			Exploring the Genomes of Cancer Cells: Progress and Promise	SCIENCE			English	Review							KINASE GENE FAMILY; SOMATIC MUTATIONS; HUMAN BREAST; LUNG-CANCER; POLYCYTHEMIA-VERA; FREQUENT MUTATION; INHIBITION; PATTERNS; EVOLUTION; REARRANGEMENT	The description and interpretation of genomic abnormalities in cancer cells have been at the heart of cancer research for more than a century. With exhaustive sequencing of cancer genomes across a wide range of human tumors well under way, we are now entering the end game of this mission. In the forthcoming decade, essentially complete catalogs of somatic mutations will be generated for tens of thousands of human cancers. Here, I provide an overview of what these efforts have revealed to date about the origin and behavioral features of cancer cells and how this genomic information is being exploited to improve diagnosis and therapy of the disease.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Wellcome Trust Sanger Institute	Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	mrs@sanger.ac.uk			Wellcome Trust [077012/Z/05/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	M.R.S. thanks A. Futreal, P. Campbell, U. McDermott, N. Rahman, and many other colleagues for conversations over the years that have clarified ideas that have found their way into this Review. Supported by the Wellcome Trust under grant reference 077012/Z/05/Z.	Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Bodmer W, 2008, CANCER RES, V68, P3558, DOI 10.1158/0008-5472.CAN-07-6544; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Esteva FJ, 2010, NAT REV CLIN ONCOL, V7, P98, DOI 10.1038/nrclinonc.2009.216; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Hornsby C, 2007, LANCET ONCOL, V8, P1030, DOI 10.1016/S1470-2045(07)70343-1; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Hunter C, 2006, CANCER RES, V66, P3987, DOI 10.1158/0008-5472.CAN-06-0127; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Laird PW, 2005, HUM MOL GENET, V14, pR65, DOI 10.1093/hmg/ddi113; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Loeb LA, 2010, SEMIN CANCER BIOL, V20, P279, DOI 10.1016/j.semcancer.2010.10.006; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; McBride DJ, 2010, GENE CHROMOSOME CANC, V49, P1062, DOI 10.1002/gcc.20815; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Pfeifer GP, 2000, MUTAT RES-FUND MOL M, V450, P1, DOI 10.1016/S0027-5107(00)00012-9; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Rehman FL, 2010, NAT REV CLIN ONCOL, V7, P718, DOI 10.1038/nrclinonc.2010.172; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shah SP, 2009, NEW ENGL J MED, V360, P2719, DOI 10.1056/NEJMoa0902542; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Stuart D, 2009, CURR OPIN CELL BIOL, V21, P304, DOI 10.1016/j.ceb.2009.02.001; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhao JH, 2011, CURR PHARM BIOTECHNO, V12, P293, DOI 10.2174/138920111794295729	70	459	502	0	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2011	331	6024					1553	1558		10.1126/science.1204040	http://dx.doi.org/10.1126/science.1204040			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21436442				2022-12-28	WOS:000288754500043
J	Vernooij-Dassen, M; Leatherman, S; Rikkert, MO				Vernooij-Dassen, Myrra; Leatherman, Sheila; Rikkert, Marcel Olde			Quality of care in frail older people: the fragile balance between receiving and giving	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PSYCHOSOCIAL INTERVENTIONS; OCCUPATIONAL-THERAPY; DEMENTIA; CAREGIVERS; PATIENT; CANCER; ADULTS; NEEDS					M.Vernooij-Dassen@IQ.umcn.nl	Rikkert, M.G.M. Olde/H-8078-2014; Vernooij-Dassen, M.J.F.J./H-8107-2014	Rikkert, M.G.M. Olde/0000-0003-1397-1677; 	Nuffield Trust	Nuffield Trust	MV-D is a medical sociologist and chair of Interdem, a European group on research in psychosocial interventions in dementia care. She is codirector of the Nijmegen Alzheimer Centre and senior fellow at the Scientific Institute for Quality of Healthcare of the Radboud University Nijmegen Medical Centre. SL is senior fellow at the School of Public Health, University of Minnesota, USA, and the University of Cambridge, UK. She is a senior adviser to the Nuffield Trust, which commissioned her to evaluate the NHS capacity for quality of care management. MOR is codirector of the Radboud University Nijmegen Medical Centre and has a chair in research and development in geriatrics. He is chair of the working group of science and education of the Dutch Geriatric Society and a member of a working group on health services research in geriatrics of the British Geriatrics Society. MV-D prepared the manuscript with assistance and critical input from SL and MOR. MV-D is guarantor.	Anderberg P, 2007, J ADV NURS, V59, P635, DOI 10.1111/j.1365-2648.2007.04375.x; Bolger N, 2007, J PERS SOC PSYCHOL, V92, P458, DOI 10.1037/0022-3514.92.3.458; Brodaty H, 2003, J AM GERIATR SOC, V51, P657, DOI 10.1034/j.1600-0579.2003.00210.x; Fillit H, 2009, J AM GERIATR SOC, V57, P348, DOI 10.1111/j.1532-5415.2008.02104.x; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Glazier SR, 2004, J AM GERIATR SOC, V52, P284, DOI 10.1111/j.1532-5415.2004.52072.x; Gobbens RJJ, 2010, J AM MED DIR ASSOC, V11, P356, DOI 10.1016/j.jamda.2009.11.008; GOULDNER AW, 1960, AM SOCIOL REV, V25, P161, DOI 10.2307/2092623; Graff MJL, 2007, J GERONTOL A-BIOL, V62, P1002, DOI 10.1093/gerona/62.9.1002; Graff MJL, 2006, BMJ-BRIT MED J, V333, P1196, DOI 10.1136/bmj.39001.688843.BE; Hancock GA, 2003, INT J GERIATR PSYCH, V18, P803, DOI 10.1002/gps.924; Meier DE, 2002, NEW ENGL J MED, V346, P1087, DOI 10.1056/NEJM200204043461413; Mulley G, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1844; Murray CJL, 2010, NEW ENGL J MED, V362, P98, DOI 10.1056/NEJMp0910064; Osse BHP, 2005, SUPPORT CARE CANCER, V13, P722, DOI 10.1007/s00520-004-0771-6; Santos-Eggimann B, 2009, J GERONTOL A-BIOL, V64, P675, DOI 10.1093/gerona/glp012; Spijker A, 2008, J AM GERIATR SOC, V56, P1116, DOI 10.1111/j.1532-5415.2008.01705.x; Strawbridge WJ, 1998, J GERONTOL B-PSYCHOL, V53, pS9, DOI 10.1093/geronb/53B.1.S9; Uitterhoeve RJ, 2004, BRIT J CANCER, V91, P1050, DOI 10.1038/sj.bjc.6602103; Vernooij-Dassen MJFJ, 2005, J PAIN SYMPTOM MANAG, V30, P264, DOI 10.1016/j.jpainsymman.2005.03.010	20	41	41	1	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2011	342								d403	10.1136/bmj.d403	http://dx.doi.org/10.1136/bmj.d403			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	742MM	21441296				2022-12-28	WOS:000288948300010
J	Busse, WW; Morgan, WJ; Gergen, PJ; Mitchell, HE; Gern, JE; Liu, AH; Gruchalla, RS; Kattan, M; Teach, SJ; Pongracic, JA; Chmiel, JF; Steinbach, SF; Calatroni, A; Togias, A; Thompson, KM; Szefler, SJ; Sorkness, CA				Busse, William W.; Morgan, Wayne J.; Gergen, Peter J.; Mitchell, Herman E.; Gern, James E.; Liu, Andrew H.; Gruchalla, Rebecca S.; Kattan, Meyer; Teach, Stephen J.; Pongracic, Jacqueline A.; Chmiel, James F.; Steinbach, Suzanne F.; Calatroni, Agustin; Togias, Alkis; Thompson, Katherine M.; Szefler, Stanley J.; Sorkness, Christine A.			Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MONOCLONAL-ANTIBODY; COST-EFFECTIVENESS; CHILDHOOD ASTHMA; ALLERGEN; EXACERBATIONS; ADULTS; ADOLESCENTS; EPITHELIUM; RESPONSES; EXPOSURE	BACKGROUND Research has underscored the effects of exposure and sensitization to allergens on the severity of asthma in inner-city children. It has also revealed the limitations of environmental remediation and guidelines-based therapy in achieving greater disease control. METHODS We enrolled inner-city children, adolescents, and young adults with persistent asthma in a randomized, double-blind, placebo-controlled, parallel-group trial at multiple centers to assess the effectiveness of omalizumab, as compared with placebo, when added to guidelines-based therapy. The trial was conducted for 60 weeks, and the primary outcome was symptoms of asthma. RESULTS Among 419 participants who underwent randomization (at which point 73% had moderate or severe disease), omalizumab as compared with placebo significantly reduced the number of days with asthma symptoms, from 1.96 to 1.48 days per 2-week interval, a 24.5% decrease (P<0.001). Similarly, omalizumab significantly reduced the proportion of participants who had one or more exacerbations from 48.8 to 30.3% (P<0.001). Improvements occurred with omalizumab despite reductions in the use of inhaled glucocorticoids and long-acting beta-agonists. CONCLUSIONS When added to a regimen of guidelines-based therapy for inner-city children, adolescents, and young adults, omalizumab further improved asthma control, nearly eliminated seasonal peaks in exacerbations, and reduced the need for other medications to control asthma.	[Busse, William W.; Gern, James E.; Sorkness, Christine A.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53719 USA; [Morgan, Wayne J.] Univ Arizona, Coll Med, Tucson, AZ USA; [Gergen, Peter J.; Togias, Alkis; Thompson, Katherine M.] NIAID, Bethesda, MD 20892 USA; [Mitchell, Herman E.; Calatroni, Agustin] Rho Fed Syst Div, Chapel Hill, NC USA; [Liu, Andrew H.; Szefler, Stanley J.] Natl Jewish Hlth, Denver, CO USA; [Liu, Andrew H.; Szefler, Stanley J.] Univ Colorado Hlth Sci, Denver, CO USA; [Gruchalla, Rebecca S.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Kattan, Meyer] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Teach, Stephen J.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Pongracic, Jacqueline A.] Childrens Mem Hosp, Chicago, IL 60614 USA; [Chmiel, James F.] Rainbow Babies & Childrens Hosp, Cleveland, OH USA; [Steinbach, Suzanne F.] Boston Univ, Sch Med, Boston, MA 02118 USA	University of Wisconsin System; University of Wisconsin Madison; University of Arizona; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Texas System; University of Texas Southwestern Medical Center Dallas; Columbia University; Children's National Health System; Ann & Robert H. Lurie Children's Hospital of Chicago; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Boston University	Busse, WW (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth K4 910 CSC, MC 9988,600 Highland Ave, Madison, WI 53719 USA.	wwb@medicine.wisc.edu		Szefler, Stanley/0000-0002-6911-3199	National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) [NO1-AI-25496, NO1-AI-25482]; National Center for Research Resources, NIH [M01RR00533, 1UL1RR025771, M01RR00071, 1UL1RR024156, 5M01RR020359-040]; Novartis Pharmaceuticals; Dey Pharma; Boehringer Ingelheim; Teva; Amgen; Pfizer; Genentech; AstraZeneca; GlaxoSmithKline; MedImmune; Novartis; Ception; Phadia; Vertex; Biota; Centocor; Synairgen; Merck; 3V BioSciences; EraGen Biosciences; Ross Abbott; Sandoz; ScheringPlough; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD061221] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000533, UL1RR025771, M01RR000071, UL1RR024156, M01RR020359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK027651] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Novartis Pharmaceuticals(Novartis); Dey Pharma; Boehringer Ingelheim(Boehringer Ingelheim); Teva(Teva Pharmaceutical Industries); Amgen(Amgen); Pfizer(Pfizer); Genentech(Roche HoldingGenentech); AstraZeneca(AstraZeneca); GlaxoSmithKline(GlaxoSmithKline); MedImmune(AstraZenecaMedimmune); Novartis(Novartis); Ception; Phadia(Phadia); Vertex(Vertex Pharmaceuticals); Biota; Centocor; Synairgen; Merck(Merck & Company); 3V BioSciences; EraGen Biosciences; Ross Abbott; Sandoz(Novartis); ScheringPlough(Merck & CompanySchering Plough Corporation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by contracts with the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) (NO1-AI-25496 and NO1-AI-25482); grants from the National Center for Research Resources, NIH (M01RR00533, 1UL1RR025771, M01RR00071, 1UL1RR024156, and 5M01RR020359-040); Novartis Pharmaceuticals, under a clinical trial agreement with the University of Wisconsin-Madison; Dey Pharma (which provided EpiPens), and SC Johnson (which provided household pest control).; Dr. Busse reports receiving board membership fees from Centocor and Merck, consulting fees from Boehringer Ingelheim, Teva, Amgen, Pfizer, and Genentech; consulting fees and grant support from AstraZeneca, GlaxoSmithKline, MedImmune, and Novartis; and grant support from Ception. Dr. Morgan reports receiving consulting fees from Novartis, lecture fees from Phadia and Vertex, royalties from Elsevier, consulting fees from Genentech, and payment to his institution for development of educational presentations from Genentech. Dr Gern reports receiving consulting fees from GlaxoSmithKline, Biota, Centocor, Synairgen, and Boehringer Ingelheim; grant support from Merck and AstraZeneca; stock options and consulting fees from 3V BioSciences; and stock payments from EraGen Biosciences. Dr. Liu reports receiving consulting fees from AstraZeneca and Novartis and lecture fees from Glaxo-SmithKline, Merck and Phadia. Dr. Teach reports receiving consulting fees from AstraZeneca. Dr. Steinbach reports providing expert testimony for Harvard Medical Institutions. Dr. Szefler reports receiving consulting fees from Schering, Boehringer Ingelheim, and Novartis, consulting fees and grant support from Merck and Genentech, and grant support from GlaxoSmithKline and Ross Abbott. Dr. Sorkness reports receiving consulting fees from GlaxoSmithKline and AstraZeneca, grant support from Pharmaxis and Sandoz, and consulting fees and grant support from ScheringPlough. No other potential conflict of interest relevant to this article was reported. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.	[Anonymous], 2010, R LANG ENV STAT COMP; Arbes SJ, 2005, ENVIRON HEALTH PERSP, V113, P665, DOI 10.1289/ehp.7648; Bisgaard H, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4978; Bousquet J, 2004, CHEST, V125, P1378, DOI 10.1378/chest.125.4.1378; Busse W, 2001, J ALLERGY CLIN IMMUN, V108, P184, DOI 10.1067/mai.2001.117880; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Campbell JD, 2010, ALLERGY, V65, P1141, DOI 10.1111/j.1398-9995.2010.02336.x; Corren J, 2009, CLIN EXP ALLERGY, V39, P788, DOI 10.1111/j.1365-2222.2009.03214.x; Cox L, 2007, J ALLERGY CLIN IMMUN, V120, P1373, DOI 10.1016/j.jaci.2007.09.032; Eckman JA, 2010, J ALLERGY CLIN IMMUN, V125, p889e7; Fahy JV, 1997, AM J RESP CRIT CARE, V155, P1828, DOI 10.1164/ajrccm.155.6.9196082; Gergen PJ, 2002, J PEDIATR-US, V141, P631, DOI 10.1067/mpd.2002.127510; Gern James E, 2009, BMC Pulm Med, V9, P17, DOI 10.1186/1471-2466-9-17; Gill MA, 2010, J IMMUNOL, V184, P5999, DOI 10.4049/jimmunol.0901194; Green RM, 2002, BMJ-BRIT MED J, V324, P763, DOI 10.1136/bmj.324.7340.763; Gruchalla RS, 2005, J ALLERGY CLIN IMMUN, V115, P478, DOI 10.1016/j.jaci.2004.12.006; Holgate ST, 2005, CLIN EXP ALLERGY, V35, P408, DOI 10.1111/j.1365-2222.2005.02191.x; Humbert M, 2005, ALLERGY, V60, P309, DOI 10.1111/j.1398-9995.2004.00772.x; Jakiela B, 2008, AM J RESP CELL MOL, V38, P517, DOI 10.1165/rcmb.2007-0050OC; Johnston NW, 2005, J ALLERGY CLIN IMMUN, V115, P132, DOI 10.1016/j.jaci.2004.09.025; Lanier B, 2009, J ALLERGY CLIN IMMUN, V124, P1210, DOI 10.1016/j.jaci.2009.09.021; Lee WM, 2007, J CLIN MICROBIOL, V45, P2626, DOI 10.1128/JCM.02501-06; Liu AH, 2007, J ALLERGY CLIN IMMUN, V119, P817, DOI 10.1016/j.jaci.2006.12.662; Lopez-Souza N, 2004, AM J PHYSIOL-LUNG C, V286, pL373, DOI 10.1152/ajplung.00300.2003; MacGlashan DW, 1997, J IMMUNOL, V158, P1438; National Heart Lung and Blood Institute, 2007, EPR3 NAT HEART LUNG; Oba Y, 2004, J ALLERGY CLIN IMMUN, V114, P265, DOI 10.1016/j.jaci.2004.05.049; Ong YE, 2005, J ALLERGY CLIN IMMUN, V116, P558, DOI 10.1016/j.jaci.2005.05.035; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Schatz M, 2006, J ALLERGY CLIN IMMUN, V117, P549, DOI 10.1016/j.jaci.2006.01.011; Schatz M, 2009, J ALLERGY CLIN IMMUN, V124, p719e1; Sears MR, 2007, J ALLERGY CLIN IMMUN, V120, P526, DOI 10.1016/j.jaci.2007.05.047; Soler M, 2001, EUR RESPIR J, V18, P254, DOI 10.1183/09031936.01.00092101; Soler M, 2001, EUR RESPIR J, V18, P739; Szefler S, 2008, LANCET, V372, P1065, DOI 10.1016/S0140-6736(08)61448-8; Wahn U, 2009, ALLERGY, V64, P1780, DOI 10.1111/j.1398-9995.2009.02119.x; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Wu AC, 2007, J ALLERGY CLIN IMMUN, V120, P1146, DOI 10.1016/j.jaci.2007.07.055; [No title captured]; [No title captured]	42	627	659	3	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2011	364	11					1005	1015		10.1056/NEJMoa1009705	http://dx.doi.org/10.1056/NEJMoa1009705			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735SX	21410369	Green Accepted			2022-12-28	WOS:000288439000006
J	Palmer, SC; Hayen, A; Macaskill, P; Pellegrini, F; Craig, JC; Elder, GJ; Strippoli, GFM				Palmer, Suetonia C.; Hayen, Andrew; Macaskill, Petra; Pellegrini, Fabio; Craig, Jonathan C.; Elder, Grahame J.; Strippoli, Giovanni F. M.			Serum Levels of Phosphorus, Parathyroid Hormone, and Calcium and Risks of Death and Cardiovascular Disease in Individuals With Chronic Kidney Disease A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							MINERAL-BONE DISORDER; HEMODIALYSIS-PATIENTS; MORTALITY RISK; DIALYSIS PATIENTS; VITAMIN-D; PRACTICE PATTERNS; RETROSPECTIVE COHORT; PERITONEAL-DIALYSIS; PHOSPHATE PRODUCT; PATIENT SURVIVAL	Context Clinical practice guidelines on the management of mineral and bone disorders due to chronic kidney disease recommend specific treatment target levels for serum phosphorus, parathyroid hormone, and calcium. Objective To assess the quality of evidence for the association between levels of serum phosphorus, parathyroid hormone, and calcium and risks of death, cardiovascular mortality, and nonfatal cardiovascular events in individuals with chronic kidney disease. Data Sources The databases of MEDLINE (1948 to December 2010) and EMBASE (1947 to December 2010) were searched without language restriction. Hand searches also were conducted of the reference lists of primary studies, review articles, and clinical guidelines along with full-text review of any citation that appeared relevant. Study Selection Of 8380 citations identified in the original search, 47 cohort studies (N=327 644 patients) met the inclusion criteria. Data Extraction The characteristics of study design, participants, exposures, and covariates together with the outcomes of all-cause mortality, cardiovascular mortality, and nonfatal cardiovascular events at different levels of serum phosphorus, parathyroid hormone, and calcium were analyzed within studies. Data were summarized across studies (when possible) using random-effects meta-regression. Data Synthesis The risk of death increased 18% for every 1-mg/dL increase in serum phosphorus (relative risk [RR], 1.18 [95% confidence interval {CI}, 1.12-1.25]). There was no significant association between all-cause mortality and serum level of parathyroid hormone (RR per 100-pg/mL increase, 1.01 [95% CI, 1.00-1.02]) or serum level of calcium (RR per 1-mg/dL increase, 1.08 [95% CI, 1.00-1.16]). Data for the association between serum level of phosphorus, parathyroid hormone, and calcium and cardiovascular death were each available in only 1 adequately adjusted cohort study. Lack of adjustment for confounding variables was not a major limitation of the available studies. Conclusions The evidentiary basis for a strong, consistent, and independent association between serum levels of calcium and parathyroid hormone and the risk of death and cardiovascular events in chronic kidney disease is poor. There appears to be an association between higher serum levels of phosphorus and mortality in this population. JAMA. 2011;305(11):1119-1127 www.jama.com	[Pellegrini, Fabio; Strippoli, Giovanni F. M.] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Clin Pharmacol & Epidemiol, I-66030 Santa Maria Imbaro, Italy; [Palmer, Suetonia C.] Univ Otago, Dept Med, Christchurch, New Zealand; [Palmer, Suetonia C.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Hayen, Andrew; Macaskill, Petra; Craig, Jonathan C.; Strippoli, Giovanni F. M.] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Pellegrini, Fabio] Sci Inst Casa Sollievo della Sofferenza, Foggia, Italy; [Craig, Jonathan C.; Strippoli, Giovanni F. M.] Cochrane Renal Grp, Sydney, NSW, Australia; [Elder, Grahame J.] Westmead Hosp, Dept Renal Med, Sydney, NSW, Australia; [Elder, Grahame J.] Garvan Inst Med Res, Bone & Mineral Program, Sydney, NSW, Australia; [Strippoli, Giovanni F. M.] Diaverum, Med Sci Off, Lund, Sweden	Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Otago; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Sydney; IRCCS Casa Sollievo Della Sofferenza; University of Sydney; Garvan Institute of Medical Research; Diaverum	Strippoli, GFM (corresponding author), Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Dept Clin Pharmacol & Epidemiol, Via Nazl 8-A, I-66030 Santa Maria Imbaro, Italy.	strippoli@negrisud.it	Craig, Jonathan/E-2813-2013	Craig, Jonathan/0000-0002-2548-4035; Strippoli, Giovanni/0000-0002-6936-0616; Macaskill, Petra/0000-0001-5879-6193; Hayen, Andrew/0000-0003-4046-8030	Roche Pharmaceuticals; Royal Australasian College of Physicians; Amgen Dompe Consorzio Mario Negri Fellowship; University of Sydney	Roche Pharmaceuticals(Roche Holding); Royal Australasian College of Physicians(General Electric); Amgen Dompe Consorzio Mario Negri Fellowship; University of Sydney(University of Sydney)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Palmer reported receiving assistance to travel for study supervision from the Amgen Dompe fellowship to the Consorzio Mario Negri Sud. Dr Elder reported being on the advisory boards of Amgen Australia and Shire Australia, being on the speakers bureaus for Amgen Australia, Genzyme Australia, Shire Australia, and Abbott Australia, and receiving a research grant from Roche Pharmaceuticals. No other disclosures were reported.; Dr Palmer was the recipient of a Don and Lorraine Jacquot Fellowship from the Royal Australasian College of Physicians and received support from an unrestricted Amgen Dompe Consorzio Mario Negri Fellowship. Dr Macaskill reported receiving grant support administered through the University of Sydney to fund a program of research in screening and diagnostic testing from the Australian National Health and Medical Research Council.	[Anonymous], 1989, NEW ENGL J MED, V321, P406; [Anonymous], 2004, NEPHROL DIAL TRANSPL, V19, pii6; Avram MM, 2001, AM J KIDNEY DIS, V37, pS77, DOI 10.1053/ajkd.2001.20754; BERLIN JA, 1993, EPIDEMIOLOGY, V4, P218, DOI 10.1097/00001648-199305000-00005; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Blayney MJ, 2009, J RENAL CARE, V35, P7, DOI 10.1111/j.1755-6686.2009.00048.x; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Block GA, 1998, AM J KIDNEY DIS, V31, P607, DOI 10.1053/ajkd.1998.v31.pm9531176; Block GA, 2009, HEMODIAL INT, V13, P360, DOI 10.1111/j.1542-4758.2009.00387.x; Bodyak N, 2007, P NATL ACAD SCI USA, V104, P16810, DOI 10.1073/pnas.0611202104; Chiu YW, 2009, CLIN J AM SOC NEPHRO, V4, P1089, DOI 10.2215/CJN.00290109; Coco M, 2000, AM J KIDNEY DIS, V36, P1115, DOI 10.1053/ajkd.2000.19812; Connolly GM, 2009, TRANSPLANTATION, V87, P1040, DOI 10.1097/TP.0b013e31819cd122; Cueto-Manzano AM, 2001, PERITON DIALYSIS INT, V21, P148; Dimkovic NB, 2002, PERITON DIALYSIS INT, V22, P204; Drechsler C, 2009, NEPHROL DIAL TRANSPL, V24, P3151, DOI 10.1093/ndt/gfp260; Dukkipati R, 2010, J RENAL NUTR, V20, P243, DOI 10.1053/j.jrn.2009.10.006; Dussol B, 2007, RENAL FAILURE, V29, P579, DOI 10.1080/08860220701392447; Egbuna OI, 2007, CLIN TRANSPLANT, V21, P558, DOI 10.1111/j.1399-0012.2007.00690.x; Fellah H, 2009, CLIN BIOCHEM, V42, P648, DOI 10.1016/j.clinbiochem.2008.12.023; Foley RN, 1996, AM J NEPHROL, V16, P386, DOI 10.1159/000169030; Ganesh SK, 2001, J AM SOC NEPHROL, V12, P2131, DOI 10.1681/ASN.V12102131; Guh JY, 2002, AM J KIDNEY DIS, V39, P1245, DOI 10.1053/ajkd.2002.33398; Hakemi MS, 2010, IRAN J KIDNEY DIS, V4, P44; Hartemink N, 2006, AM J EPIDEMIOL, V163, P1042, DOI 10.1093/aje/kwj141; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Isakova T, 2009, J AM SOC NEPHROL, V20, P388, DOI 10.1681/ASN.2008060609; Jassal V, 1996, NEPHROL DIAL TRANSPL, V11, P1052; Kalantar-Zadeh K, 2006, KIDNEY INT, V70, P771, DOI 10.1038/sj.ki.5001514; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Kilkkinen A, 2009, AM J EPIDEMIOL, V170, P1032, DOI 10.1093/aje/kwp227; Kimata Naoki, 2007, Hemodial Int, V11, P340, DOI 10.1111/j.1542-4758.2007.00190.x; Komaba H, 2008, THER APHER DIAL, V12, P42, DOI 10.1111/j.1744-9987.2007.00539.x; Kovesdy CP, 2008, KIDNEY INT, V73, P1296, DOI 10.1038/ki.2008.64; Kovesdy CP, 2010, CLIN NEPHROL, V73, P268; Kruger B, 2006, TRANSPL P, V38, P697, DOI 10.1016/j.transproceed.2006.01.032; Lacson E, 2009, AM J KIDNEY DIS, V53, P79, DOI 10.1053/j.ajkd.2008.07.031; Lebner AC, 2011, NEPHROL DIAL TRANSPL, V26, P156, DOI 10.1093/ndt/gfq459; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Locatelli F, 1998, NEPHROL DIAL TRANSPL, V13, P1642, DOI 10.1093/ndt/13.7.1642; Ma JZ, 1999, J AM SOC NEPHROL, V10, P610; Marco MP, 2003, KIDNEY INT, V63, pS111, DOI 10.1046/j.1523-1755.63.s85.26.x; Mehrotra R, 2009, KIDNEY INT, V76, P977, DOI 10.1038/ki.2009.288; Melamed ML, 2006, KIDNEY INT, V70, P351, DOI 10.1038/sj.ki.5001542; Menon V, 2005, AM J KIDNEY DIS, V46, P455, DOI 10.1053/j.ajkd.2005.05.025; Moe SM, 2007, ADV CHRONIC KIDNEY D, V14, P3, DOI 10.1053/j.ackd.2006.10.005; Morrone LF, 2009, NEPHROL DIAL TRANSPL, V24, P2859, DOI 10.1093/ndt/gfp170; National Kidney Foundation, 2003, AM J KIDNEY DIS J NA, V42, pS1, DOI [DOI 10.1016/S0272-6386(03)00905-3, 10.1016/S0272-6386(03)00905-3]; National Kidney Foundation Kidney Disease Outcomes Quality Initiative, 2000, GUID AN CHRON KIDN D; Navaneethan SD, 2009, AM J KIDNEY DIS, V54, P619, DOI 10.1053/j.ajkd.2009.06.004; Noordzij M, 2005, AM J KIDNEY DIS, V46, P925, DOI 10.1053/j.ajkd.2005.08.013; Osawa Yutaka, 2005, Clin Calcium, V15 Suppl 1, P167; Palmer SC, 2007, ANN INTERN MED, V147, P840, DOI 10.7326/0003-4819-147-12-200712180-00004; Peter WLS, 2009, PHARMACOTHERAPY, V29, P154, DOI 10.1592/phco.29.2.154; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Phelan PJ, 2008, RENAL FAILURE, V30, P423, DOI 10.1080/08860220801964236; Port FK, 2004, BLOOD PURIFICAT, V22, P175, DOI 10.1159/000074938; Rodriguez-Benot A, 2005, AM J KIDNEY DIS, V46, P68, DOI 10.1053/j.ajkd.2005.04.006; Roodnat JI, 2006, TRANSPLANTATION, V82, P362, DOI 10.1097/01.tp.0000228923.75739.88; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rubel JR, 2003, AM J KIDNEY DIS, V41, P411, DOI 10.1053/ajkd.2003.50050; Saran R, 2003, KIDNEY INT, V64, P254, DOI 10.1046/j.1523-1755.2003.00064.x; Schaeffner ES, 2007, TRANSPLANT INT, V20, P247, DOI 10.1111/j.1432-2277.2006.00436.x; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Slinin Y, 2005, J AM SOC NEPHROL, V16, P1788, DOI 10.1681/ASN.2004040275; Smith DH, 2010, NEPHROL DIAL TRANSPL, V25, P166, DOI 10.1093/ndt/gfp387; Smith DH, 2009, J BONE MINER METAB, V27, P287, DOI 10.1007/s00774-009-0048-8; Spiegel DM, 2007, NEPHROL DIAL TRANSPL, V22, P3568, DOI 10.1093/ndt/gfm424; Stevens LA, 2004, J AM SOC NEPHROL, V15, P770, DOI 10.1097/01.ASN.0000113243.24155.2F; Strippoli GFM, 2006, AM J KIDNEY DIS, V47, P715, DOI 10.1053/j.ajkd.2006.01.015; Sugiura S, 2010, CLIN EXP NEPHROL, V14, P43, DOI 10.1007/s10157-009-0233-z; Suki WN, 2007, KIDNEY INT, V72, P1130, DOI 10.1038/sj.ki.5002466; Teng M, 2005, J AM SOC NEPHROL, V16, P1115, DOI 10.1681/ASN.2004070573; Tentori F, 2008, AM J KIDNEY DIS, V52, P519, DOI 10.1053/j.ajkd.2008.03.020; Tonelli M, 2009, CIRCULATION, V120, P1784, DOI 10.1161/CIRCULATIONAHA.109.851873; Voormolen N, 2007, NEPHROL DIAL TRANSPL, V22, P2909, DOI 10.1093/ndt/gfm286; Wald R, 2008, AM J KIDNEY DIS, V52, P531, DOI 10.1053/j.ajkd.2008.05.020; Young EW, 2005, KIDNEY INT, V67, P1179, DOI 10.1111/j.1523-1755.2005.00185.x	79	485	538	2	74	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2011	305	11					1119	1127		10.1001/jama.2011.308	http://dx.doi.org/10.1001/jama.2011.308			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734ZF	21406649	Green Published			2022-12-28	WOS:000288381900024
J	Amato, S; Liu, XX; Zheng, B; Cantley, L; Rakic, P; Man, HY				Amato, Stephen; Liu, Xiuxin; Zheng, Bin; Cantley, Lewis; Rakic, Pasko; Man, Heng-Ye			AMP-Activated Protein Kinase Regulates Neuronal Polarization by Interfering with PI 3-Kinase Localization	SCIENCE			English	Article							HIPPOCAMPAL-NEURONS; BRAIN-DEVELOPMENT; AXONAL-TRANSPORT; POLARITY; TRANSLOCATION; KINESIN-1; MIGRATION; CULTURE; GROWTH; ENERGY	Axon-dendrite polarization is crucial for neural network wiring and information processing in the brain. Polarization begins with the transformation of a single neurite into an axon and its subsequent rapid extension, which requires coordination of cellular energy status to allow for transport of building materials to support axon growth. We found that activation of the energy-sensing adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK) pathway suppressed axon initiation and neuronal polarization. Phosphorylation of the kinesin light chain of the Kif5 motor protein by AMPK disrupted the association of the motor with phosphatidylinositol 3-kinase (PI3K), preventing PI3K targeting to the axonal tip and inhibiting polarization and axon growth.	[Amato, Stephen; Man, Heng-Ye] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Liu, Xiuxin; Rakic, Pasko] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Liu, Xiuxin; Rakic, Pasko] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Zheng, Bin; Cantley, Lewis] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Zheng, Bin; Cantley, Lewis] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Boston University; Yale University; Yale University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Man, HY (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	hman@bu.edu	Cantley, Lewis C/D-1800-2014	Cantley, Lewis C/0000-0002-1298-7653; Zheng, Bin/0000-0002-0998-7177	Kavli Institute; NAAR/Autism Speaks fellowship;  [MH07907];  [GM56203];  [GM41890];  [K99CA133245]; NATIONAL CANCER INSTITUTE [R00CA133245, K99CA133245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041890, R01GM056203, R01GM041890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014841] Funding Source: NIH RePORTER	Kavli Institute; NAAR/Autism Speaks fellowship; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. R. Luo for providing EGFP-PH, K. Hasimoto-Torii for GFP virus, and J. Asara for assistance with mass spectrometry. This research was supported by MH07907 (H.-Y.M), GM56203 and GM41890 (L. C. C.), K99CA133245 (B.Z.), the Kavli Institute (P. R.), and a NAAR/Autism Speaks fellowship (X.L.).	Ageta-Ishihara N, 2009, J NEUROSCI, V29, P13720, DOI 10.1523/JNEUROSCI.3018-09.2009; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Dasgupta B, 2009, DEV CELL, V16, P256, DOI 10.1016/j.devcel.2009.01.005; DOTTI CG, 1988, J NEUROSCI, V8, P1454; FERREIRA A, 1992, J CELL BIOL, V117, P595, DOI 10.1083/jcb.117.3.595; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Jareb M, 1997, J NEUROSCI, V17, P8955; Jia YH, 2007, IMMUNITY, V27, P453, DOI 10.1016/j.immuni.2007.07.016; Katagiri H, 1996, J BIOL CHEM, V271, P16987, DOI 10.1074/jbc.271.29.16987; Kemphues K, 2000, CELL, V101, P345, DOI 10.1016/S0092-8674(00)80844-2; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; LoTurco JJ, 2006, TRENDS NEUROSCI, V29, P407, DOI 10.1016/j.tins.2006.05.006; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; NAKATA T, 2007, SCI STKE, pPE6; RAKIC P, 1974, NATURE, V250, P31, DOI 10.1038/250031a0; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; SABINA RL, 1985, J BIOL CHEM, V260, P6107; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Tabata H, 2003, J NEUROSCI, V23, P9996; Tashiro A, 2006, NAT PROTOC, V1, P3049, DOI 10.1038/nprot.2006.473; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Wayman GA, 2004, J NEUROSCI, V24, P3786, DOI 10.1523/JNEUROSCI.3294-03.2004; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010	29	102	104	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					247	251		10.1126/science.1201678	http://dx.doi.org/10.1126/science.1201678			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21436401	Green Accepted			2022-12-28	WOS:000289251100055
J	Kivimaki, M; Batty, GD; Hamer, M; Ferrie, JE; Vahtera, J; Virtanen, M; Marmot, MG; Singh-Manoux, A; Shipley, MJ				Kivimaeki, Mika; Batty, G. David; Hamer, Mark; Ferrie, Jane E.; Vahtera, Jussi; Virtanen, Marianna; Marmot, Michael G.; Singh-Manoux, Archana; Shipley, Martin J.			Using Additional Information on Working Hours to Predict Coronary Heart Disease	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; JAPANESE WORKERS; OVERTIME WORK; RISK-FACTOR; PREVENTION; STATEMENT; CURVE; SCORE; AREA	Background: Long working hours are associated with increased risk for coronary heart disease (CHD). Adding information on long hours to traditional risk factors for CHD may help to improve risk prediction for this condition. Objective: To examine whether information on long working hours improves the ability of the Framingham risk model to predict CHD in a low-risk, employed population. Design: Cohort study with baseline medical examination performed between 1991 and 1993 and prospective follow-up for incident CHD performed until 2004. Setting: Civil service departments in London (the Whitehall II study). Participants: 7095 adults (2109 women and 4986 men) aged 39 to 62 years working full-time without CHD at baseline. Measurements: Working hours and the Framingham risk score were measured at baseline. Coronary death and nonfatal myocardial infarction were ascertained from medical screenings every 5 years, hospital data, and registry linkage. Results: 192 participants had incident CHD during a median 12.3-year follow-up. After adjustment for their Framingham risk score, participants working 11 hours or more per day had a 1.67-fold (95% CI, 1.10-to 2.55-fold) increased risk for CHD compared with participants working 7 to 8 hours per day. Adding working hours to the Framingham risk score led to a net reclassification improvement of 4.7% (P = 0.034) due to better identification of persons who later developed CHD (sensitivity gain). Limitation: The findings may not be generalizable to populations with a larger proportion of high-risk persons and were not validated in an independent cohort. Conclusion: Information on working hours may improve risk prediction of CHD on the basis of the Framingham risk score in low-risk, working populations.	[Kivimaeki, Mika] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; Univ Turku, FI-20520 Turku, Finland; Turku Univ Hosp, FI-20520 Turku, Finland; Finnish Inst Occupat Hlth, FI-00250 Helsinki, Finland; Univ Helsinki, FI-00250 Helsinki, Finland; INSERM, F-75654 Paris 13, France	University of London; University College London; University of Turku; University of Turku; Finnish Institute of Occupational Health; University of Helsinki; Institut National de la Sante et de la Recherche Medicale (Inserm)	Kivimaki, M (corresponding author), UCL, Dept Epidemiol & Publ Hlth, 1-19 Torrington Pl, London WC1E 6BT, England.	m.kivimaki@ucl.ac.uk	Marmot, M G/Y-3920-2019; Ferrie, Jane/AAZ-2009-2020; Hamer, Mark/C-1602-2008; Hamer, Mark/AAJ-6814-2021; Vahtera, Jussi/J-3271-2013; Singh-Manoux, Archana/F-6804-2013; Kivimaki, Mika/B-3607-2012; Batty, GD/Y-4401-2018	Marmot, M G/0000-0002-2431-6419; Hamer, Mark/0000-0002-8726-7992; Hamer, Mark/0000-0002-8726-7992; Singh-Manoux, Archana/0000-0002-1244-5037; Kivimaki, Mika/0000-0002-4699-5627; Batty, GD/0000-0003-1822-5753; Vahtera, Jussi/0000-0002-6036-061X	Medical Research Council; British Heart Foundation; Bupa Foundation; National Heart, Lung, and Blood Institute and National Institute on Aging of the National Institutes of Health; Wellcome Trust; Health and Safety Executive; Department of Health; Agency for Health Care Policy and Research; John D. and Catherine T. MacArthur Foundation Research Networks on Successful Midlife Development and Socioeconomic Status and Health; Academy of Finland; NEW OSH ERA; European Science Foundation; MRC [G0902037] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013196, R01AG034454] Funding Source: NIH RePORTER; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [G0902037, G8802774, G0100222, G19/35] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Bupa Foundation; National Heart, Lung, and Blood Institute and National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Heart Lung & Blood Institute (NHLBI)); Wellcome Trust(Wellcome Trust); Health and Safety Executive; Department of Health; Agency for Health Care Policy and Research(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); John D. and Catherine T. MacArthur Foundation Research Networks on Successful Midlife Development and Socioeconomic Status and Health; Academy of Finland(Academy of Finland); NEW OSH ERA; European Science Foundation(European Science Foundation (ESF)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Medical Research Council; British Heart Foundation; Bupa Foundation; and the National Heart, Lung, and Blood Institute and National Institute on Aging of the National Institutes of Health.r By the Medical Research Council; British Heart Foundation; Wellcome Trust; Health and Safety Executive; Department of Health; Agency for Health Care Policy and Research; John D. and Catherine T. MacArthur Foundation Research Networks on Successful Midlife Development and Socioeconomic Status and Health; National Heart, Lung, and Blood Institute and National Institute on Aging of the National Institutes of Health; Academy of Finland; NEW OSH ERA Research Programme; and European Science Foundation. Drs. Kivimaki and Vahtera are supported by the Academy of Finland, Dr. Batty is a Wellcome Trust Fellow, Dr. Ferrie is supported by the Medical Research Council, Dr. Marmot is a Medical Research Council professor, Dr. Singh-Manoux is supported by a European Young Investigator Award from the European Science Foundation, and Mr. Shipley is supported by the British Heart Foundation.	ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; ARMITAGE P, 1977, STAT METHODS MED RES; BRESLOW NE, 1980, STATISTICAL METHODS, V1, P1; BUELL P, 1960, J Chronic Dis, V11, P615, DOI 10.1016/0021-9681(60)90060-6; Caruso CC, 2004, DHHS NIOSH PUBLICATI, DOI 10.26616/NIOSHPUB2004143; Cook NR, 2010, CURR CARDIOVASC RISK, V4, P112, DOI 10.1007/s12170-010-0084-x; Cook NR, 2009, ANN INTERN MED, V150, P795, DOI 10.7326/0003-4819-150-11-200906020-00007; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Eller NH, 2009, CARDIOL REV, V17, P83, DOI 10.1097/CRD.0b013e318198c8e9; FALGER PRJ, 1992, J PSYCHOSOM RES, V36, P777, DOI 10.1016/0022-3999(92)90136-P; Fukuoka Y, 2005, INT J CARDIOL, V100, P29, DOI 10.1016/j.ijcard.2004.04.003; Graham I, 2007, EUR J CARDIOV PREV R, V14, pS1, DOI 10.1097/01.hjr.0000277983.23934.c9; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Helfand M, 2009, ANN INTERN MED, V151, P496, DOI 10.7326/0003-4819-151-7-200910060-00010; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Holtermann A, 2010, HEART, V96, P1638, DOI 10.1136/hrt.2010.197145; HOSMER DW, 1989, APPL LOGISTIC REGRES; Kim HC, 2010, J AM COLL CARDIOL, V55, P2080, DOI 10.1016/j.jacc.2009.12.047; LIU L, 2009, SAS GLOB FOR 2009 WA; Liu Y, 2002, OCCUP ENVIRON MED, V59, P447, DOI 10.1136/oem.59.7.447; Mannan H, 2010, J EVAL CLIN PRACT, V16, P756, DOI 10.1111/j.1365-2753.2009.01190.x; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Nambi V, 2010, J AM COLL CARDIOL, V55, P1600, DOI 10.1016/j.jacc.2009.11.075; *ORG EC COOP DEV, 2004, OECD EMPL OUTL REC L; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Pignone M, 2010, DIABETES CARE, V33, P1395, DOI 10.2337/dc10-0555; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Rose G, 1982, CARDIOVASCULAR SURVE; *SAS I, JACKKN BOOTSTR AN; SHAFER JL, 1997, ANAL INCOMPLETE MULT; Sokejima S, 1998, BRIT MED J, V317, P775, DOI 10.1136/bmj.317.7161.775; Steyerberg EW, 2010, ANN INTERN MED, V152, P195, DOI 10.7326/0003-4819-152-3-201002020-00019; Tarumi K, 2003, IND HEALTH, V41, P101, DOI 10.2486/indhealth.41.101; THEORELL T, 1972, J CHRON DIS, V25, P139, DOI 10.1016/0021-9681(72)90170-1; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Uchiyama S, 2005, J OCCUP HEALTH, V47, P102, DOI 10.1539/joh.47.102; Virtanen M, 2010, EUR HEART J, V31, P1737, DOI 10.1093/eurheartj/ehq124; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167	43	60	61	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 5	2011	154	7							457	10.7326/0003-4819-154-7-201104050-00003	http://dx.doi.org/10.7326/0003-4819-154-7-201104050-00003			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744EX	21464347	Green Accepted			2022-12-28	WOS:000289078700002
J	Lammens, K; Bemeleit, DJ; Mockel, C; Clausing, E; Schele, A; Hartung, S; Schiller, CB; Lucas, M; Angermuller, C; Soding, J; Strasser, K; Hopfner, KP				Lammens, Katja; Bemeleit, Derk J.; Moeckel, Carolin; Clausing, Emanuel; Schele, Alexandra; Hartung, Sophia; Schiller, Christian B.; Lucas, Maria; Angermueller, Christof; Soeding, Johannes; Straesser, Katja; Hopfner, Karl-Peter			The Mre11:Rad50 Structure Shows an ATP-Dependent Molecular Clamp in DNA Double-Strand Break Repair	CELL			English	Article							MRE11 COMPLEX; ESCHERICHIA-COLI; DAMAGE RESPONSE; PROTEIN COMPLEX; KINASE-ACTIVITY; RECOMBINATION; CHROMOSOME; RAD50; SBCCD; MECHANISMS	The MR (Mre11 nuclease and Rad50 ABC ATPase) complex is an evolutionarily conserved sensor for DNA double-strand breaks, highly genotoxic lesions linked to cancer development. MR can recognize and process DNA ends even if they are blocked and mis-folded. To reveal its mechanism, we determined the crystal structure of the catalytic head of Thermotoga maritima MR and analyzed ATP-dependent conformational changes. MR adopts an open form with a central Mre11 nuclease dimer and two peripheral Rad50 molecules, a form suited for sensing obstructed breaks. The Mre11 C-terminal helix-loophelix domain binds Rad50 and attaches flexibly to the nuclease domain, enabling large conformational changes. ATP binding to the two Rad50 subunits induces a rotation of the Mre11 helix-loop-helix and Rad50 coiled-coil domains, creating a clamp conformation with increased DNA-binding activity. The results suggest that MR is an ATP-controlled transient molecular clamp at DNA double-strand breaks.	[Lammens, Katja; Straesser, Katja; Hopfner, Karl-Peter] Univ Munich, CIPSM, D-81377 Munich, Germany; [Lammens, Katja; Bemeleit, Derk J.; Moeckel, Carolin; Clausing, Emanuel; Schele, Alexandra; Hartung, Sophia; Schiller, Christian B.; Lucas, Maria; Angermueller, Christof; Soeding, Johannes; Straesser, Katja; Hopfner, Karl-Peter] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Lammens, Katja; Bemeleit, Derk J.; Moeckel, Carolin; Clausing, Emanuel; Schele, Alexandra; Hartung, Sophia; Schiller, Christian B.; Lucas, Maria; Angermueller, Christof; Soeding, Johannes; Straesser, Katja; Hopfner, Karl-Peter] Univ Munich, Dept Biochem, D-81377 Munich, Germany; [Hopfner, Karl-Peter] Univ Munich, Munich Ctr Adv Photon, D-81377 Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich	Hopfner, KP (corresponding author), Univ Munich, CIPSM, Feodor Lynen Str 25, D-81377 Munich, Germany.	hopfner@lmb.uni-muenchen.de	Lucas, Maria/G-9788-2012; Söding, Johannes/A-3341-2013; Hopfner, Karl-Peter/B-6864-2014	Lucas, Maria/0000-0002-7854-4249; Söding, Johannes/0000-0001-9642-8244; Hopfner, Karl-Peter/0000-0002-4528-8357; Strasser, Katja/0000-0003-3533-5516	German Research Council [SFBs 684, 646, TR5]; German Excellence Initiative (CIPSM); European Commission; NIH [U19AI83025]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083025] Funding Source: NIH RePORTER	German Research Council(German Research Foundation (DFG)); German Excellence Initiative (CIPSM); European Commission(European CommissionEuropean Commission Joint Research Centre); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank John Petrini for his gift of an alpha-Mre11 antibody. We thank Britta Coordes for help with the yeast work and members of the Hopfner lab, especially Matthew Bennett, Gregor Witte, and Alfred Lammens, for discussions. We thank the staffs of the Swiss Light Source (Villingen), European Synchrotron Radiation Facility (Grenoble), German Electron Synchrotron (Hamburg), and Advanced Light Source (Berkeley) for technical support. We thank the Max-Planck-Crystallization Facility (Martinsried) for crystallization trials. This work was funded by grants from the German Research Council (SFBs 684, 646, and TR5), the German Excellence Initiative (CIPSM), European Commission (IP DNA repair), and NIH U19AI83025.	Bentchikou E, 2007, J BACTERIOL, V189, P4784, DOI 10.1128/JB.00452-07; Bhaskara V, 2007, MOL CELL, V25, P647, DOI 10.1016/j.molcel.2007.01.028; Borde V, 2007, CHROMOSOME RES, V15, P551, DOI 10.1007/s10577-007-1147-9; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Budd ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004267; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Chamankhah M, 1999, NUCLEIC ACIDS RES, V27, P2072, DOI 10.1093/nar/27.10.2072; Connelly JC, 2003, DNA REPAIR, V2, P795, DOI 10.1016/S1568-7864(03)00063-6; Costanzo V, 2001, MOL CELL, V8, P137, DOI 10.1016/S1097-2765(01)00294-5; Cromie GA, 2001, MOL CELL, V8, P1163, DOI 10.1016/S1097-2765(01)00419-1; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; Eykelenboom JK, 2008, MOL CELL, V29, P644, DOI 10.1016/j.molcel.2007.12.020; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; Lavin MF, 2007, ONCOGENE, V26, P7749, DOI 10.1038/sj.onc.1210880; Leach DRF, 1997, MOL MICROBIOL, V26, P597, DOI 10.1046/j.1365-2958.1997.6071957.x; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lee K, 2008, NATURE, V454, P543, DOI 10.1038/nature07054; Lobachev K, 2004, CURR BIOL, V14, P2107, DOI 10.1016/j.cub.2004.11.051; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; Mascarenhas J, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-20; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Petrini JHJ, 2000, CURR OPIN CELL BIOL, V12, P293, DOI 10.1016/S0955-0674(00)00091-0; Putnam CD, 2009, NATURE, V460, P984, DOI 10.1038/nature08217; RAYMOND WE, 1993, NUCLEIC ACIDS RES, V21, P3851, DOI 10.1093/nar/21.16.3851; SHARPLES GJ, 1995, MOL MICROBIOL, V17, P1215, DOI 10.1111/j.1365-2958.1995.mmi_17061215_1.x; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wang JH, 2009, NATURE, V460, P231, DOI 10.1038/nature08159; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Zahradka K, 2009, J BACTERIOL, V191, P1677, DOI 10.1128/JB.01877-07; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	47	157	160	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 1	2011	145	1					54	66		10.1016/j.cell.2011.02.038	http://dx.doi.org/10.1016/j.cell.2011.02.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458667	Green Published, Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000289053900009
J	Avorn, J				Avorn, Jerry			Teaching Clinicians about Drugs - 50 Years Later, Whose Job Is It?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Avorn, Jerry] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Avorn, Jerry] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Avorn, J (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							[Anonymous], 1961, NEW ENGL J MED, V265, P910; Avorn J, 2005, POWERFUL MED BENEFIT, P313; Carpenter D, 2010, PRINC STUD AM POLIT, P1; Gray BH, 2003, HLTH AFF MILLWOOD S, pW3; Greene JA, 2009, B HIST MED, V83, P331, DOI 10.1353/bhm.0.0218	5	24	24	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2011	364	13					1185	1187		10.1056/NEJMp1011713	http://dx.doi.org/10.1056/NEJMp1011713			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	742NO	21449781				2022-12-28	WOS:000288951300001
J	Deltcheva, E; Chylinski, K; Sharma, CM; Gonzales, K; Chao, YJ; Pirzada, ZA; Eckert, MR; Vogel, J; Charpentier, E				Deltcheva, Elitza; Chylinski, Krzysztof; Sharma, Cynthia M.; Gonzales, Karine; Chao, Yanjie; Pirzada, Zaid A.; Eckert, Maria R.; Vogel, Joerg; Charpentier, Emmanuelle			CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III	NATURE			English	Article							PROVIDES ACQUIRED-RESISTANCE; IMMUNE-SYSTEM; BACTERIA; REPEATS; GENE; ENDORIBONUCLEASE; MECHANISMS; VIRULENCE; PHAGES; DNA	CRISPR/Cas systems constitute a widespread class of immunity systems that protect bacteria and archaea against phages and plasmids, and commonly use repeat/spacer-derived short crRNAs to silence foreign nucleic acids in a sequence-specific manner. Although the maturation of crRNAs represents a key event in CRISPR activation, the responsible endoribonucleases (CasE, Cas6, Csy4) are missing in many CRISPR/Cas subtypes. Here, differential RNA sequencing of the human pathogen Streptococcus pyogenes uncovered tracrRNA, a trans-encoded small RNA with 24-nucleotide complementarity to the repeat regions of crRNA precursor transcripts. We show that tracrRNA directs the maturation of crRNAs by the activities of the widely conserved endogenous RNase III and the CRISPR-associated Csn1 protein; all these components are essential to protect S. pyogenes against prophage-derived DNA. Our study reveals a novel pathway of small guide RNA maturation and the first example of a host factor (RNase III) required for bacterial RNA-mediated immunity against invaders.	[Deltcheva, Elitza; Chylinski, Krzysztof; Charpentier, Emmanuelle] Umea Univ, Dept Mol Biol, UCMR, Lab Mol Infect Med Sweden MIMS, S-90187 Umea, Sweden; [Deltcheva, Elitza; Chylinski, Krzysztof; Gonzales, Karine; Pirzada, Zaid A.; Eckert, Maria R.; Charpentier, Emmanuelle] Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; [Sharma, Cynthia M.; Chao, Yanjie; Vogel, Joerg] Univ Wurzburg, ZINF Res Ctr Infect Dis, D-97080 Wurzburg, Germany; [Chao, Yanjie; Vogel, Joerg] Univ Wurzburg, RNA Biol Grp, Inst Mol Infect Biol, D-97080 Wurzburg, Germany	Umea University; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Wurzburg; University of Wurzburg	Charpentier, E (corresponding author), Umea Univ, Dept Mol Biol, UCMR, Lab Mol Infect Med Sweden MIMS, S-90187 Umea, Sweden.	emmanuelle.charpentier@mims.umu.se	Vogel, Jörg/D-5574-2011; Sharma, Cynthia/D-2869-2013; Chao, Yanjie/J-1931-2014	Vogel, Jörg/0000-0003-2220-1404; Chao, Yanjie/0000-0002-5735-7954; Sharma, Cynthia Mira/0000-0002-2321-9705; Chylinski, Krzysztof/0000-0001-7029-8090; Kohrer, Karine Anne/0000-0001-6713-2540	European Community [BACRNAs-018618]; Austrian Science Fund (FWF) [P17238-B09, W1207-B09]; Austrian Agency for Research Promotion (FFG) [812138-SCK/KUG]; Theodor Korner Fonds; Umea University; Swedish Research Council; IMPRS-IDI; German Research Council (DFG) [SPP1258, Vo875/4]; German Ministry of Education and Research (BMBF) [01GS0806/JV-BMBF-01, 0315836]	European Community(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Agency for Research Promotion (FFG); Theodor Korner Fonds; Umea University; Swedish Research Council(Swedish Research CouncilEuropean Commission); IMPRS-IDI; German Research Council (DFG)(German Research Foundation (DFG)); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	We thank D. Veit for technical help. This work was funded by the European Community (FP6, BACRNAs-018618; E.C.), the Austrian Science Fund (FWF, P17238-B09 (E.C.) and W1207-B09 (E.C., K.C.)), the Austrian Agency for Research Promotion (FFG, 812138-SCK/KUG; E.C.), the Theodor Korner Fonds (E.C.), Umea University (E.C.), the Swedish Research Council (E.C.), IMPRS-IDI (Y.C.), the German Research Council (DFG Priority Program "Sensory and Regulatory RNAs in Prokaryotes'' SPP1258, Vo875/4; J.V.), and the German Ministry of Education and Research (BMBF, 01GS0806/JV-BMBF-01 and 0315836; J.V.).	Aliyari R, 2009, IMMUNOL REV, V227, P176, DOI 10.1111/j.1600-065X.2008.00722.x; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Aziz RK, 2005, J BACTERIOL, V187, P3311, DOI 10.1128/JB.187.10.3311-3318.2005; Banks DJ, 2002, TRENDS MICROBIOL, V10, P515, DOI 10.1016/S0966-842X(02)02461-7; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; CAPARON MG, 1991, METHOD ENZYMOL, V204, P556; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Carte J, 2010, RNA, V16, P2181, DOI 10.1261/rna.2230110; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Condon C, 2007, CURR OPIN MICROBIOL, V10, P271, DOI 10.1016/j.mib.2007.05.008; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; DENMAN RB, 1993, BIOTECHNIQUES, V15, P1090; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Drider D, 2004, J MOL MICROB BIOTECH, V8, P195, DOI 10.1159/000086700; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fischetti VA, 2007, TRENDS MICROBIOL, V15, P297, DOI 10.1016/j.tim.2007.05.003; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Herbert S, 2001, INFECT IMMUN, V69, P2996, DOI 10.1128/IAI.69.5.2996-3003.2001; Hofacker IL, 2006, BIOINFORMATICS, V22, P1172, DOI 10.1093/bioinformatics/btl023; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Huntzinger E, 2005, EMBO J, V24, P824, DOI 10.1038/sj.emboj.7600572; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Kingsford CL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r22; Koonin Eugene V, 2009, F1000 Biol Rep, V1, P95; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2002, NUCLEIC ACIDS RES, V30, P482, DOI 10.1093/nar/30.2.482; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Mangold M, 2004, MOL MICROBIOL, V53, P1515, DOI 10.1111/j.1365-2958.2004.04222.x; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; MOJICA FJM, 1995, MOL MICROBIOL, V17, P85, DOI 10.1111/j.1365-2958.1995.mmi_17010085.x; NAKATA A, 1989, J BACTERIOL, V171, P3553, DOI 10.1128/jb.171.6.3553-3556.1989; Nicholson AW, 1999, FEMS MICROBIOL REV, V23, P371, DOI 10.1016/S0168-6445(99)00013-3; Opdyke JA, 2011, J MOL BIOL, V406, P29, DOI 10.1016/j.jmb.2010.12.009; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Papenfort K, 2006, MOL MICROBIOL, V62, P1674, DOI 10.1111/j.1365-2958.2006.05524.x; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Roberts C, 2006, J BACTERIOL, V188, P2593, DOI 10.1128/JB.188.7.2593-2603.2006; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Siller M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-188; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; van der Oost J, 2009, CELL, V139, P863, DOI 10.1016/j.cell.2009.11.018; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Vogel J, 2004, CURR BIOL, V14, P2271, DOI 10.1016/j.cub.2004.12.003; Vojtek I, 2008, J INFECT DIS, V197, P225, DOI 10.1086/524687; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043	66	1489	1967	38	804	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2011	471	7340					602	+		10.1038/nature09886	http://dx.doi.org/10.1038/nature09886			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21455174	Green Accepted			2022-12-28	WOS:000288951200035
J	Walshe, K; Ham, C				Walshe, Kieran; Ham, Chris			Can the government's proposals for NHS reform be made to work?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Walshe, Kieran] Manchester Business Sch, Manchester M15 6PB, Lancs, England; [Ham, Chris] Kings Fund, London W1G 0AN, England	University of Manchester	Walshe, K (corresponding author), Manchester Business Sch, Manchester M15 6PB, Lancs, England.	Kieran.walshe@mbs.ac.uk		Walshe, Kieran/0000-0002-0696-480X				Cooperation and Competition Panel, 2011, REV OP AN WILL PROV; Delamothe T, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d408; Department of Health, 2010, PRINC RUL COOP COMP; Department of Health, 2010, EQ EXC LIB NHS; GAYNOR M, 2004, COMPETITION QUALITY; Ham C, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d905; Ham Chris, 2011, BMJ, V342, pd1035, DOI 10.1136/bmj.d1035; *HLTH SEL COMM, 2011, HC132 HLTH SEL COMM; *MON, 2010, ANN REP ACC 2009 10; Naylor C, 2010, BUILDING HIGH QUALIT; NHS Confederation, 2011, LIB NHS WHAT MIGHT H; Nuffield Trust, 2022, CHART WEEK WELLB 4 U; Nuffield Trust, 2010, GIV GPS BUDG COMM WH; Palmer K, 2011, RECONFIGURING HOSP S; Porter M, 2006, REDEFINING HEALTHCAR; SMITH J, 2011, MANAGING TRANSITION; SMITH P, 2009, ACHIEVING BETTER VAL, P53; Thorlby R., 2011, GP COMMISSIONING INS	18	9	9	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 31	2011	342								d2038	10.1136/bmj.d2038	http://dx.doi.org/10.1136/bmj.d2038			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	745WI	21454458				2022-12-28	WOS:000289201600005
J	Davies, P				Davies, Peter			Service Integration: A glimpse of the future of healthcare at the seaside	BRITISH MEDICAL JOURNAL			English	Editorial Material												petergdavies@ntlworld.com							0	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 28	2011	342								d1917	10.1136/bmj.d1917	http://dx.doi.org/10.1136/bmj.d1917			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	745WB	21444637				2022-12-28	WOS:000289200200004
J	Kim-Muller, JY; Accili, D				Kim-Muller, Ja Young; Accili, Domenico			Selective Insulin Sensitizers	SCIENCE			English	Editorial Material									[Kim-Muller, Ja Young] Columbia Presbyterian Med Ctr, Dept Med, New York, NY 10032 USA; Columbia Presbyterian Med Ctr, Berrie Diabet Ctr, New York, NY 10032 USA	Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital	Kim-Muller, JY (corresponding author), Columbia Presbyterian Med Ctr, Dept Med, New York, NY 10032 USA.	da230@columbia.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058282, R01DK064819] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL087123] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; Adiels M, 2008, ARTERIOSCL THROM VAS, V28, P1225, DOI 10.1161/ATVBAHA.107.160192; Brufau G, 2010, HEPATOLOGY, V52, P1455, DOI 10.1002/hep.23831; Caro JJ, 2002, DIABETES CARE, V25, P476, DOI 10.2337/diacare.25.3.476; Haeusler RA, 2008, CELL METAB, V8, P7, DOI 10.1016/j.cmet.2008.06.010; Itoh N, 2010, CELL TISSUE RES, V342, P1, DOI 10.1007/s00441-010-1024-2; Kir S, 2011, SCIENCE, V331, P1621, DOI 10.1126/science.1198363; Shin DJ, 2009, J BIOL CHEM, V284, P11110, DOI 10.1074/jbc.M808747200	8	15	16	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 25	2011	331	6024					1529	1531		10.1126/science.1204504	http://dx.doi.org/10.1126/science.1204504			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21436429				2022-12-28	WOS:000288754500032
J	Raiborg, C; Stenmark, H				Raiborg, Camilla; Stenmark, Harald			A Helix for the Final Cut	SCIENCE			English	Editorial Material							ESCRT-III; STRUCTURAL BASIS; CYTOKINESIS; PROTEIN; MIDBODY; MACHINERY; FILAMENTS; SPASTIN		[Raiborg, Camilla; Stenmark, Harald] Univ Oslo, Ctr Canc Biomed, Fac Med, N-0310 Oslo, Norway; [Raiborg, Camilla; Stenmark, Harald] Oslo Univ Hosp, Dept Biochem, Inst Canc Res, Norwegian Radium Hosp, N-0310 Oslo, Norway	University of Oslo; University of Oslo	Raiborg, C (corresponding author), Univ Oslo, Ctr Canc Biomed, Fac Med, N-0310 Oslo, Norway.	stenmark@ulrik.uio.no	Stenmark, Harald/B-8868-2008					Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Ghazi-Tabatabai S, 2008, STRUCTURE, V16, P1345, DOI 10.1016/j.str.2008.06.010; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Sagona AP, 2010, FEBS LETT, V584, P2652, DOI 10.1016/j.febslet.2010.03.044; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512	15	11	11	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 25	2011	331	6024					1533	1534		10.1126/science.1204208	http://dx.doi.org/10.1126/science.1204208			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21436431				2022-12-28	WOS:000288754500034
J	Buchen, L				Buchen, Lizzie			MISSING THE MARK	NATURE			English	News Item							DIAGNOSTIC MARKERS; BIOMARKERS; READY											Berg AO, 2009, GENET MED, V11, P66, DOI 10.1097/GIM.0b013e3181928f56; Coates RJ, 2008, CLIN CANCER RES, V14, P7575, DOI 10.1158/1078-0432.CCR-08-2296; Cramer DW, 2011, CANCER PREV RES, V4, P365, DOI 10.1158/1940-6207.CAPR-10-0195; Greene MH, 2008, CLIN CANCER RES, V14, P7574, DOI 10.1158/1078-0432.CCR-08-2232; Mai PL, 2011, CANCER PREV RES, V4, P303, DOI 10.1158/1940-6207.CAPR-11-0053; McIntosh M, 2008, CLIN CANCER RES, V14, P7574, DOI 10.1158/1078-0432.CCR-08-0623; Mor G, 2005, P NATL ACAD SCI USA, V102, P7677, DOI 10.1073/pnas.0502178102; Mor G., 2009, P AM ASS CANC RES AA; Mor G, 2008, CLIN CANCER RES, V14, P7577, DOI 10.1158/1078-0432.CCR-08-2621; Schweitzer B, 2000, P NATL ACAD SCI USA, V97, P10113, DOI 10.1073/pnas.170237197; Thorpe JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001281; Visintin I, 2008, CLIN CANCER RES, V14, P1065, DOI 10.1158/1078-0432.CCR-07-1569; Zhu CS, 2011, CANCER PREV RES, V4, P375, DOI 10.1158/1940-6207.CAPR-10-0193	13	56	56	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					428	432		10.1038/471428a	http://dx.doi.org/10.1038/471428a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21430749	Bronze			2022-12-28	WOS:000288702200030
J	Mills, NL; Churchhouse, AMD; Lee, KK; Anand, A; Gamble, D; Shah, ASV; Paterson, E; MacLeod, M; Graham, C; Walker, S; Denvir, MA; Fox, KAA; Newby, DE				Mills, Nicholas L.; Churchhouse, Antonia M. D.; Lee, Kuan Ken; Anand, Atul; Gamble, David; Shah, Anoop S. V.; Paterson, Elspeth; MacLeod, Margaret; Graham, Catriona; Walker, Simon; Denvir, Martin A.; Fox, Keith A. A.; Newby, David E.			Implementation of a Sensitive Troponin I Assay and Risk of Recurrent Myocardial Infarction and Death in Patients With Suspected Acute Coronary Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LONG-TERM MORTALITY; ARTERY-DISEASE; ST-ELEVATION; EARLY-DIAGNOSIS; PERFORMANCE; PREDICT	Context Although troponin assays have become increasingly more sensitive, it is unclear whether further reductions in the threshold of detection for plasma troponin concentrations will improve clinical outcomes in patients with suspected acute coronary syndrome (ACS). Objective To determine whether lowering the diagnostic threshold for myocardial infarction (MI) with a sensitive troponin assay could improve clinical outcomes. Design, Setting, and Patients All consecutive patients admitted with suspected ACS to the Royal Infirmary of Edinburgh, Edinburgh, Scotland, before (n=1038; February 1-July 31, 2008, during the validation phase) and after (n=1054; February 1-July 31, 2009, during the implementation phase) lowering the threshold of detection for myocardial necrosis from 0.20 to 0.05 ng/mL with a sensitive troponin I assay were stratified into 3 groups (<0.05 ng/mL, 0.05-0.19 ng/mL, and >= 0.20 ng/mL). During the validation phase, only concentrations above the original diagnostic threshold of 0.20 ng/mL were reported to clinicians. Main Outcome Measure Event-free survival (recurrent MI and death) at 1 year in patients grouped by plasma troponin concentrations. Results Plasma troponin concentrations were less than 0.05 ng/mL in 1340 patients (64%), 0.05 to 0.19 ng/mL in 170 patients (8%), and 0.20 ng/mL or more in 582 patients (28%). During the validation phase, 39% of patients with plasma troponin concentrations of 0.05 to 0.19 ng/mL were dead or had recurrent MI at 1 year compared with 7% and 24% of those patients with troponin concentrations of less than 0.05 ng/mL (P<.001) or 0.20 ng/mL or more (P=.007), respectively. During the implementation phase, lowering the diagnostic threshold to 0.05 ng/mL was associated with a lower risk of death and recurrent MI (from 39% to 21%) in patients with troponin concentrations of 0.05 to 0.19 ng/mL (odds ratio, 0.42; 95% confidence interval, 0.24-0.84; P=.01). Conclusions In patients with suspected ACS, implementation of a sensitive troponin assay increased the diagnosis of MI and identified patients at high risk of recurrent MI and death. Lowering the diagnostic threshold of plasma troponin was associated with major reductions in morbidity and mortality. JAMA. 2011; 305(12): 1210-1216	[Mills, Nicholas L.; Churchhouse, Antonia M. D.; Lee, Kuan Ken; Anand, Atul; Gamble, David; Shah, Anoop S. V.; Paterson, Elspeth; Denvir, Martin A.; Fox, Keith A. A.; Newby, David E.] Univ Edinburgh, Ctr Cardiovasc Sci, Univ British Heart Fdn, Edinburgh EH16 4SB, Midlothian, Scotland; [MacLeod, Margaret] Royal Infirm Edinburgh NHS Trust, Edinburgh Heart Ctr, Edinburgh, Midlothian, Scotland; [Graham, Catriona] Wellcome Trust Clin Res Facil, Edinburgh, Midlothian, Scotland; [Walker, Simon] Royal Infirm Edinburgh NHS Trust, Dept Clin Biochem, Edinburgh, Midlothian, Scotland	University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Mills, NL (corresponding author), Univ Edinburgh, Ctr Cardiovasc Sci, Univ British Heart Fdn, Chancellors Bldg, Edinburgh EH16 4SB, Midlothian, Scotland.	nick.mills@ed.ac.uk	Newby, David Ernest/AAB-1364-2019; Denvir, Martin A/ABA-3141-2021; Fox, keith A A/I-3742-2013; Anand, Atul/ABC-1393-2020	Anand, Atul/0000-0002-6428-4554; Mills, Nicholas/0000-0003-0533-7991; Fox, Keith/0000-0002-0140-2752; Shah, Anoop/0000-0002-2825-3419; Churchhouse, Antonia/0000-0002-2321-2140	British Heart Foundation [FS/10/024/28266]; British Heart Foundation Centre of Research Excellence; National Health Service Research Scotland through National Health Service Lothian	British Heart Foundation(British Heart Foundation); British Heart Foundation Centre of Research Excellence(British Heart Foundation); National Health Service Research Scotland through National Health Service Lothian	This work was supported by a British Heart Foundation Intermediate Clinical Research Fellowship (FS/10/024/28266) (Dr Mills) and the British Heart Foundation Centre of Research Excellence award. The Wellcome Trust Clinical Research Facility is supported by National Health Service Research Scotland through National Health Service Lothian.	Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; Bonaca M, 2010, J AM COLL CARDIOL, V55, P2118, DOI 10.1016/j.jacc.2010.01.044; Chan MY, 2009, CIRCULATION, V119, P3110, DOI 10.1161/CIRCULATIONAHA.108.799981; Keller T, 2009, NEW ENGL J MED, V361, P868, DOI 10.1056/NEJMoa0903515; Lindahl B, 2000, NEW ENGL J MED, V343, P1139, DOI 10.1056/NEJM200010193431602; Lindahl B, 1996, CIRCULATION, V93, P1651, DOI 10.1161/01.CIR.93.9.1651; Morrow DA, 2001, JAMA-J AM MED ASSOC, V286, P2405, DOI 10.1001/jama.286.19.2405; Morrow DA, 2003, CLIN CHEM, V49, P1396, DOI 10.1373/49.8.1396; Morrow DA, 2009, NEW ENGL J MED, V361, P913, DOI 10.1056/NEJMe0905790; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Venge P, 2002, AM J CARDIOL, V89, P1035, DOI 10.1016/S0002-9149(02)02271-3; Waxman DA, 2006, J AM COLL CARDIOL, V48, P1755, DOI 10.1016/j.jacc.2006.05.075; White HD, 2008, LANCET, V372, P570, DOI 10.1016/S0140-6736(08)61237-4	15	247	260	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2011	305	12					1210	1216		10.1001/jama.2011.338	http://dx.doi.org/10.1001/jama.2011.338			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738PA	21427373				2022-12-28	WOS:000288652100016
J	Dillner, L				Dillner, Luisa			Long term conditions How services for long term conditions could be reborn	BRITISH MEDICAL JOURNAL			English	Editorial Material																		Department of Health, 2011, FUNCT GP COMM CONS W	1	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 22	2011	342								d1730	10.1136/bmj.d1730	http://dx.doi.org/10.1136/bmj.d1730			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	742MF	21427039				2022-12-28	WOS:000288947500008
J	Li, HZ; Guo, J; Lin, H; Li, ZY				Li, Hong-zeng; Guo, Jun; Lin, Hong; Li, Zhuyi			Silk road occlusion	LANCET			English	Editorial Material							BEHCETS-DISEASE		[Li, Hong-zeng; Guo, Jun; Lin, Hong; Li, Zhuyi] Fourth Mil Med Univ, Tangdu Hosp, Dept Neurol, Xian 710038, Peoples R China	Air Force Military Medical University	Li, ZY (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Neurol, 1 Xin Si Rd, Xian 710038, Peoples R China.	guojun_81@163.com; lizhuyi@fmmu.edu.cn	Guo, Jun/AAC-3573-2021	Guo, Jun/0000-0001-8053-881X				Duzgun N, 2006, SCAND J RHEUMATOL, V35, P65, DOI 10.1080/03009740500255761; Ho Bo-Lin, 2008, Acta Neurol Taiwan, V17, P253; Mendes D, 2009, J AUTOIMMUN, V32, P178, DOI 10.1016/j.jaut.2009.02.011; Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; SILMAN AJ, 1990, LANCET, V335, P1078	5	2	4	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 19	2011	377	9770					1046	1046		10.1016/S0140-6736(11)60056-1	http://dx.doi.org/10.1016/S0140-6736(11)60056-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	740FA	21420556				2022-12-28	WOS:000288775800033
J	Jacobson, LD; Herbert, JM				Jacobson, Leif D.; Herbert, John M.			Comment on "Does the Hydrated Electron Occupy a Cavity?"	SCIENCE			English	Editorial Material							ENERGIES	Larsen et al. (Reports, 2 July 2010, p. 65) suggest that, contrary to the established paradigm, the aqueous electron does not carve out and occupy a cavity in liquid water. Closer examination of their theoretical model, however, reveals that many of its predictions differ substantively from established benchmarks and that its behavior differs qualitatively from Hartree-Fock theory, upon which the model is based.	[Jacobson, Leif D.; Herbert, John M.] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Herbert, JM (corresponding author), Ohio State Univ, Dept Chem, 100 West,18th Ave, Columbus, OH 43210 USA.	herbert@chemistry.ohio-state.edu	Herbert, John/A-9573-2008	Herbert, John/0000-0002-1663-2278	Division Of Chemistry [0748448] Funding Source: National Science Foundation	Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Coe JV, 2008, INT REV PHYS CHEM, V27, P27, DOI 10.1080/01442350701783543; HART EJ, 1970, HYDRATED ELECTRON; Herbert JM, 2006, PHYS CHEM CHEM PHYS, V8, P68, DOI 10.1039/b513098k; Jacobson LD, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3490479; Jacobson LD, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3089425; Ma L, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3245859; SCHNITKER J, 1987, J CHEM PHYS, V86, P3471, DOI 10.1063/1.452003; Shreve AT, 2010, CHEM PHYS LETT, V493, P216, DOI 10.1016/j.cplett.2010.05.059; Siefermann KR, 2010, NAT CHEM, V2, P274, DOI [10.1038/NCHEM.580, 10.1038/nchem.580]; Smallwood CJ, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2218834; Tang Y, 2010, PHYS CHEM CHEM PHYS, V12, P3653, DOI 10.1039/b925741a; Turi L, 2002, J CHEM PHYS, V117, P6186, DOI 10.1063/1.1503308; Turi L, 2001, J CHEM PHYS, V114, P7805, DOI 10.1063/1.1365084	14	77	78	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2011	331	6023								10.1126/science.1198191	http://dx.doi.org/10.1126/science.1198191			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21415336	Bronze			2022-12-28	WOS:000288504000048
J	Pe'er, D; Hacohen, N				Pe'er, Dana; Hacohen, Nir			Principles and Strategies for Developing Network Models in Cancer	CELL			English	Article							TRANSCRIPTIONAL NETWORK; IDENTIFICATION; INHIBITION; GENE; MAP; ACTIVATION; REGULATORS; DYNAMICS; GENOME; MODULE	The flood of genome-wide data generated by high-throughput technologies currently provides biologists with an unprecedented opportunity: to manipulate, query, and reconstruct functional molecular networks of cells. Here, we outline three underlying principles and six strategies to infer network models from genomic data. Then, using cancer as an example, we describe experimental and computational approaches to infer "differential" networks that can identify genes and processes driving disease phenotypes. In conclusion, we discuss how a network-level understanding of cancer can be used to predict drug response and guide therapeutics.	[Pe'er, Dana] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Pe'er, Dana] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Hacohen, Nir] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Hacohen, Nir] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Columbia University; Columbia University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Pe'er, D (corresponding author), Columbia Univ, Dept Biol Sci, 1212 Amsterdam Ave, New York, NY 10027 USA.	dpeer@biology.columbia.edu	Califano, Andrea/F-7239-2012	Pe'er, Dana/0000-0002-9259-8817	NIH [DP2-OD002414-01, DP2 OD002230]; NIAID [U54 AI057159]; Burroughs Wellcome Fund; Packard Fellowship for Science and Engineering; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002414, DP2OD002230] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Packard Fellowship for Science and Engineering; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to thank Arnon Arazi, Andrea Califano, William Hahn, Andreja Jovic, Oren Litvin, Neal Rosen, Sagi Shapira, and Cathy Wu for valuable comments. The authors would like to thank Oren Litvin for help with the illustrations. This research was supported by the NIH Director's New Innovator Award Program through grant numbers DP2-OD002414-01 (D.P.) and DP2 OD002230 (N.H.), as well as NIAID U54 AI057159 (N.H.). D.P. holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund and Packard Fellowship for Science and Engineering.	Akavia UD, 2010, CELL, V143, P1005, DOI 10.1016/j.cell.2010.11.013; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Carter H, 2009, CANCER RES, V69, P6660, DOI 10.1158/0008-5472.CAN-09-1133; Chen BJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.69; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Cohen-Saidon C, 2009, MOL CELL, V36, P885, DOI 10.1016/j.molcel.2009.11.025; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Holzel M, 2010, CELL, V142, P218, DOI 10.1016/j.cell.2010.06.004; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Lee SI, 2006, P NATL ACAD SCI USA, V103, P14062, DOI 10.1073/pnas.0601852103; Litvin O, 2009, P NATL ACAD SCI USA, V106, P6441, DOI 10.1073/pnas.0810208106; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Mani KM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.2; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Ornatsky OI, 2008, ANAL CHEM, V80, P2539, DOI 10.1021/ac702128m; Pe'er D, 2001, Bioinformatics, V17 Suppl 1, pS215; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Ridky TW, 2010, NAT MED, V16, P1450, DOI 10.1038/nm.2265; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Sachs K, 2009, J COMPUT BIOL, V16, P201, DOI 10.1089/cmb.2008.07TT; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697	48	132	133	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 18	2011	144	6					864	873		10.1016/j.cell.2011.03.001	http://dx.doi.org/10.1016/j.cell.2011.03.001			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	737BQ	21414479	Green Accepted, Bronze			2022-12-28	WOS:000288543500006
J	Turtle, EP; Perry, JE; Hayes, AG; Lorenz, RD; Barnes, JW; McEwen, AS; West, RA; Del Genio, AD; Barbara, JM; Lunine, JI; Schaller, EL; Ray, TL; Lopes, RMC; Stofan, ER				Turtle, E. P.; Perry, J. E.; Hayes, A. G.; Lorenz, R. D.; Barnes, J. W.; McEwen, A. S.; West, R. A.; Del Genio, A. D.; Barbara, J. M.; Lunine, J. I.; Schaller, E. L.; Ray, T. L.; Lopes, R. M. C.; Stofan, E. R.			Rapid and Extensive Surface Changes Near Titan's Equator: Evidence of April Showers	SCIENCE			English	Article							REFLECTANCE; CONSTRAINTS; ATMOSPHERE; STORMS; RAIN; WET; DRY	Although there is evidence that liquids have flowed on the surface at Titan's equator in the past, to date, liquids have only been confirmed on the surface at polar latitudes, and the vast expanses of dunes that dominate Titan's equatorial regions require a predominantly arid climate. We report the detection by Cassini's Imaging Science Subsystem of a large low-latitude cloud system early in Titan's northern spring and extensive surface changes (spanning more than 500,000 square kilometers) in the wake of this storm. The changes are most consistent with widespread methane rainfall reaching the surface, which suggests that the dry channels observed at Titan's low latitudes are carved by seasonal precipitation.	[Turtle, E. P.; Lorenz, R. D.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Perry, J. E.; McEwen, A. S.; Schaller, E. L.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Hayes, A. G.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Barnes, J. W.] Univ Idaho, Dept Phys, Moscow, ID 83844 USA; [West, R. A.; Ray, T. L.; Lopes, R. M. C.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Del Genio, A. D.; Barbara, J. M.] NASA, Goddard Inst Space Studies, New York, NY 10025 USA; [Lunine, J. I.] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy; [Stofan, E. R.] Proxemy Res, Rectortown, VA 20140 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Arizona; California Institute of Technology; Idaho; University of Idaho; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Rome Tor Vergata	Turtle, EP (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA.	elizabeth.turtle@jhuapl.edu	Turtle, Elizabeth/K-8673-2012; Lorenz, Ralph D/B-8759-2016; Hayes, Alexander G/P-2024-2014; Barnes, Jason W/B-1284-2009; Lopes, Rosaly M.C./D-1608-2016; Del Genio, Anthony/D-4663-2012	Turtle, Elizabeth/0000-0003-1423-5751; Lorenz, Ralph D/0000-0001-8528-4644; Hayes, Alexander G/0000-0001-6397-2630; Barnes, Jason W/0000-0002-7755-3530; Lopes, Rosaly M.C./0000-0002-7928-3167; Del Genio, Anthony/0000-0001-7450-1359; Lunine, Jonathan/0000-0003-2279-4131; Barbara, John/0000-0002-2190-4290; Schaller, Emily/0000-0001-8967-5423	Cassini-Huygens mission; NASA; ESA; ASI; Hubble Postdoctoral Fellowship	Cassini-Huygens mission; NASA(National Aeronautics & Space Administration (NASA)); ESA(European Space Agency); ASI(Agenzia Spaziale Italiana (ASI)); Hubble Postdoctoral Fellowship	We are grateful to all who developed and operate the Cassini-Huygens mission and to two very helpful anonymous reviewers. Research was supported by the Cassini-Huygens mission, a cooperative project of NASA, ESA, and ASI, managed by JPL, a division of the California Institute of Technology, under a contract with NASA. Supported by a Hubble Postdoctoral Fellowship (E.L.S.).	Almeida MP, 2008, P NATL ACAD SCI USA, V105, P6222, DOI 10.1073/pnas.0800202105; Brown ME, 2009, ASTROPHYS J LETT, V706, pL110, DOI 10.1088/0004-637X/706/1/L110; Clark RN, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003369; Collins GC, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024551; Griffith CA, 2009, ASTROPHYS J LETT, V702, pL105, DOI 10.1088/0004-637X/702/2/L105; Griffith CA, 2008, ASTROPHYS J LETT, V687, pL41, DOI 10.1086/593117; Hayes A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033409; Hayes AG, 2011, ICARUS, V211, P655, DOI 10.1016/j.icarus.2010.08.017; Jaumann R, 2008, ICARUS, V197, P526, DOI 10.1016/j.icarus.2008.06.002; Karkoschka E, 2009, ICARUS, V199, P442, DOI 10.1016/j.icarus.2008.09.020; Lopes RMC, 2010, ICARUS, V205, P540, DOI 10.1016/j.icarus.2009.08.010; Lorenz RD, 2008, PLANET SPACE SCI, V56, P1132, DOI 10.1016/j.pss.2008.02.009; Lorenz RD, 2006, METEORIT PLANET SCI, V41, P1705, DOI 10.1111/j.1945-5100.2006.tb00446.x; Lorenz RD, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036850; Lorenz RD, 1995, J GEOPHYS RES-PLANET, V100, P26377, DOI 10.1029/95JE02708; Lorenz RD, 2006, SCIENCE, V312, P724, DOI 10.1126/science.1123257; Lorenz RD, 1996, PLANET SPACE SCI, V44, P1021, DOI 10.1016/0032-0633(95)00139-5; Mitchell JL, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003017; Niemann HB, 2005, NATURE, V438, P779, DOI 10.1038/nature04122; Roe HG, 2005, SCIENCE, V310, P477, DOI 10.1126/science.1116760; Schaller EL, 2009, NATURE, V460, P873, DOI 10.1038/nature08193; Schaller EL, 2006, ICARUS, V182, P224, DOI 10.1016/j.icarus.2005.12.021; Self S., 1997, GEOPH MONOG SERIES, V100, P381; Soderblom LA, 2007, PLANET SPACE SCI, V55, P2025, DOI 10.1016/j.pss.2007.04.014; Soderblom LA, 2007, PLANET SPACE SCI, V55, P2015, DOI 10.1016/j.pss.2007.04.015; Stofan ER, 2007, NATURE, V445, P61, DOI 10.1038/nature05438; Tokano T, 2006, NATURE, V442, P432, DOI 10.1038/nature04948; Tokano T, 2010, AEOLIAN RES, V2, P113, DOI 10.1016/j.aeolia.2010.04.003; Tomasko MG, 2005, NATURE, V438, P765, DOI 10.1038/nature04126; Turtle EP, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046266; Turtle EP, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036186; TWOMEY SA, 1986, APPL OPTICS, V25, P431, DOI 10.1364/AO.25.000431; YUNG YL, 1984, ASTROPHYS J SUPPL S, V55, P465, DOI 10.1086/190963; Zhang H, 2006, APPL OPTICS, V45, P8753, DOI 10.1364/AO.45.008753	34	147	149	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2011	331	6023					1414	1417		10.1126/science.1201063	http://dx.doi.org/10.1126/science.1201063			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21415347				2022-12-28	WOS:000288504000034
J	Schenker, Y; Meisel, A				Schenker, Yael; Meisel, Alan			Informed Consent in Clinical Care Practical Considerations in the Effort to Achieve Ethical Goals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PATIENT COMPREHENSION		[Schenker, Yael] Univ Pittsburgh, Div Gen Internal Med, Sect Palliat Care & Med Eth, Pittsburgh, PA 15213 USA; [Schenker, Yael] Univ Pittsburgh, Ctr Res Hlth Care, Pittsburgh, PA 15213 USA; [Meisel, Alan] Univ Pittsburgh, Sch Law, Pittsburgh, PA 15213 USA; [Meisel, Alan] Univ Pittsburgh, Ctr Bioeth & Hlth Law, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Schenker, Y (corresponding author), Univ Pittsburgh, Div Gen Internal Med, Sect Palliat Care & Med Eth, 230 McKee Pl,Ste 600, Pittsburgh, PA 15213 USA.	schenkery@upmc.edu						Chassin MR, 2002, ANN INTERN MED, V136, P826, DOI 10.7326/0003-4819-136-11-200206040-00012; Fink AS, 2010, ANN SURG, V252, P27, DOI 10.1097/SLA.0b013e3181e3ec61; Hall MA, 2000, JAMA-J AM MED ASSOC, V283, P2390; LANDRO L, 2008, WALL STREET J   0206; Lo B.., 2020, RESOLVING ETHICAL DI; Meisel A, 1996, ARCH INTERN MED, V156, P2521, DOI 10.1001/archinte.156.22.2521; Rothberg MB, 2010, ANN INTERN MED, V153, P307, DOI 10.7326/0003-4819-153-5-201009070-00005; Schenker Y, 2011, MED DECIS MAKING, V31, P151, DOI 10.1177/0272989X10364247; Tait AR, 2009, ARCH INTERN MED, V169, P1907, DOI 10.1001/archinternmed.2009.390	9	59	61	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2011	305	11					1130	1131		10.1001/jama.2011.333	http://dx.doi.org/10.1001/jama.2011.333			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734ZF	21406651				2022-12-28	WOS:000288381900026
J	Sun, JR; Singh, V; Kajino-Sakamoto, R; Aballay, A				Sun, Jingru; Singh, Varsha; Kajino-Sakamoto, Rie; Aballay, Alejandro			Neuronal GPCR Controls Innate Immunity by Regulating Noncanonical Unfolded Protein Response Genes	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TOLL-LIKE RECEPTOR; CAENORHABDITIS-ELEGANS; ACTIVATION; DISEASE	The unfolded protein response (UPR), which is activated when unfolded or misfolded proteins accumulate in the endoplasmic reticulum, has been implicated in the normal physiology of immune defense and in several human diseases, including diabetes, cancer, neurodegenerative disease, and inflammatory disease. In this study, we found that the nervous system controlled the activity of a noncanonical UPR pathway required for innate immunity in Caenorhabditis elegans. OCTR-1, a putative octopamine G protein-coupled catecholamine receptor (GPCR, G protein-coupled receptor), functioned in sensory neurons designated ASH and ASI to actively suppress innate immune responses by down-regulating the expression of noncanonical UPR genes pqn/abu in nonneuronal tissues. Our findings suggest a molecular mechanism by which the nervous system may sense inflammatory responses and respond by controlling stress-response pathways at the organismal level.	[Sun, Jingru; Singh, Varsha; Kajino-Sakamoto, Rie; Aballay, Alejandro] Duke Univ, Dept Mol Genet & Microbiol, Med Ctr, Durham, NC 27705 USA	Duke University	Aballay, A (corresponding author), Duke Univ, Dept Mol Genet & Microbiol, Med Ctr, Durham, NC 27705 USA.	a.aballay@duke.edu			Dana Foundation; NIH [GM070977]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM070977, R01GM070977] Funding Source: NIH RePORTER	Dana Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Caenorhabditis Genetics Center (Univ. of Minnesota) for strains used in this study, R. Komuniecki (Univ. of Toledo) for providing FY745 and FY746, and D. Ron for providing the abu-1 transgenic strain. A.A. is funded by the Dana Foundation and the NIH (grant GM070977).	Aballay A, 2009, CELL CYCLE, V8, P966, DOI 10.4161/cc.8.7.8074; Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; Faber PW, 2002, P NATL ACAD SCI USA, V99, P17131, DOI 10.1073/pnas.262544899; Fuhrman LE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000657; Haskins KA, 2008, DEV CELL, V15, P87, DOI 10.1016/j.devcel.2008.05.006; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Richardson CE, 2010, NATURE, V463, P1092, DOI 10.1038/nature08762; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Styer KL, 2008, SCIENCE, V322, P460, DOI 10.1126/science.1163673; Tenor JL, 2008, EMBO REP, V9, P103, DOI 10.1038/sj.embor.7401104; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Tracey KJ, 2010, NAT IMMUNOL, V11, P561, DOI 10.1038/ni0710-561; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996; Wragg RT, 2007, J NEUROSCI, V27, P13402, DOI 10.1523/JNEUROSCI.3495-07.2007	18	162	181	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2011	332	6030					729	732		10.1126/science.1203411	http://dx.doi.org/10.1126/science.1203411			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21474712	Green Accepted			2022-12-28	WOS:000290265800046
J	Baratoux, D; Toplis, MJ; Monnereau, M; Gasnault, O				Baratoux, David; Toplis, Michael J.; Monnereau, Marc; Gasnault, Olivier			Thermal history of Mars inferred from orbital geochemistry of volcanic provinces	NATURE			English	Article							THARSIS REGION; GUSEV CRATER; MANTLE; RICH; EQUILIBRIUM; LITHOSPHERE; CONSTRAINTS; TOPOGRAPHY; PLAINS; IRON	Reconstruction of the geological history of Mars has been the focus of considerable attention over the past four decades, with important discoveries being made about variations in surface conditions(1). However, despite a significant increase in the amount of data related to the morphology, mineralogy and chemistry of the martian surface, there is no clear global picture of how magmatism has evolved over time and how these changes relate to the internal workings and thermal evolution of the planet. Here we present geochemical data derived from the Gamma Ray Spectrometer on board NASA's Mars Odyssey spacecraft(2), focusing on twelve major volcanic provinces of variable age. Our analysis reveals clear trends in composition that are found to be consistent with varying degrees of melting of the martian mantle. There is evidence for thickening of the lithosphere (17-25 km Gyr(-1)) associated with a decrease in mantle potential temperature over time (30-40 K Gyr(-1)). Our inferred thermal history of Mars, unlike that of the Earth, is consistent with simple models of mantle convection(3-6).	[Baratoux, David; Toplis, Michael J.; Monnereau, Marc; Gasnault, Olivier] Univ Toulouse, UPS OMP, IRAP, F-31400 Toulouse, France; [Baratoux, David; Toplis, Michael J.; Monnereau, Marc; Gasnault, Olivier] CNRS, IRAP, F-31400 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Baratoux, D (corresponding author), Univ Toulouse, UPS OMP, IRAP, F-31400 Toulouse, France.	baratoux@dtp.obs-mip.fr	Monnereau, Marc/A-3594-2014; Baratoux, David/AAB-8531-2019; Baratoux, David/H-6006-2012; Gasnault, Olivier/F-4327-2010	Monnereau, Marc/0000-0002-4094-5581; Baratoux, David/0000-0002-1785-5262; Baratoux, David/0000-0002-1785-5262; Gasnault, Olivier/0000-0002-6979-9012	INSU-CNRS	INSU-CNRS(Centre National de la Recherche Scientifique (CNRS))	H. Y. McSween Jr is thanked for his formal review. This work was financially supported by the Programme National de Planetologie of INSU-CNRS.	Belleguic V, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002437; BERTKA CM, 1994, CONTRIB MINERAL PETR, V115, P323, DOI 10.1007/BF00310771; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; BOGARD DD, 1983, SCIENCE, V221, P651, DOI 10.1126/science.221.4611.651; Boynton WV, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2007JE002887; DREIBUS G, 1985, METEORITICS, V20, P367; El Maarry MR, 2009, J VOLCANOL GEOTH RES, V185, P116, DOI 10.1016/j.jvolgeores.2008.11.027; Filiberto J, 2006, AM MINERAL, V91, P471, DOI 10.2138/am.2006.2110; Filiberto J, 2009, GEOCHIM COSMOCHIM AC, V73, pA376; Gasnault O, 2010, ICARUS, V207, P226, DOI 10.1016/j.icarus.2009.11.010; Ghiorso MS, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000217; Haskin LA, 2005, NATURE, V436, P66, DOI 10.1038/nature03640; Hauber E, 2009, J VOLCANOL GEOTH RES, V185, P69, DOI 10.1016/j.jvolgeores.2009.04.015; Hauck SA, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001801; Herzberg C, 2010, EARTH PLANET SC LETT, V292, P79, DOI 10.1016/j.epsl.2010.01.022; Jaupart C., 2007, MANTLE DYNAMICS TREA, V7, P253, DOI [10.1016/B978-0-444-53802-4.00126-3, DOI 10.1016/B978-0-444-53802-4.00126-3, 10.1016/B978-044452748-6/00114-0, DOI 10.1016/B978-044452748-6/00114-0, DOI 10.1016/B978-044452748-6.00114-0]; Karunatillake S, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2008JE003303; Korenaga J, 2008, REV GEOPHYS, V46, DOI 10.1029/2007RG000241; Labrosse S, 2007, NATURE, V450, P866, DOI 10.1038/nature06356; MANGOLD N, 2009, EARTH PLANET SC LETT, V194, P440; McGovern PJ, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2002JE001854; MCKENZIE D, 1988, J PETROL, V29, P625, DOI 10.1093/petrology/29.3.625; McSween HY, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002477; MOCQUET A, PLANET SPAC IN PRESS; Monders AG, 2007, METEORIT PLANET SCI, V42, P131, DOI 10.1111/j.1945-5100.2007.tb00222.x; Neukum G, 2004, NATURE, V432, P971, DOI 10.1038/nature03231; NISBET EG, 1993, LITHOS, V30, P291, DOI 10.1016/0024-4937(93)90042-B; Taylor GJ, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002645; Taylor GJ, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002676; Toplis MJ, 2005, CONTRIB MINERAL PETR, V149, P22, DOI 10.1007/s00410-004-0629-4; Zuber MT, 2001, NATURE, V412, P220, DOI 10.1038/35084163	31	97	97	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					338	U235		10.1038/nature09903	http://dx.doi.org/10.1038/nature09903			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21471967				2022-12-28	WOS:000289724600037
J	Sridhar, D; Gostin, LO				Sridhar, Devi; Gostin, Lawrence O.			Reforming the World Health Organization	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; [Sridhar, Devi] Univ Oxford, Dept Polit & Int Relat, Oxford, England	Georgetown University; University of Oxford	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Chow JC, WHO BECOMING IRRELEV; Department for International Development, MULT AID REV; GODLEE F, 1994, BRIT MED J, V309, P1424, DOI 10.1136/bmj.309.6966.1424; Gostin LO, 2010, B WORLD HEALTH ORGAN, V88, P719, DOI 10.2471/BLT.10.082636; Sridhar D, 2011, INT STUD ASS 52 ANN; WHO, 2010, GLOB BURD DIS, P48; World Health Organization, 2010, WHO LAB MAN EX HUM S, P70; World Health Organization, FUT FIN WHO	8	41	43	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 20	2011	305	15					1585	1586		10.1001/jama.2011.418	http://dx.doi.org/10.1001/jama.2011.418			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752HU	21447801	Green Published			2022-12-28	WOS:000289683000028
J	Paul, P; van den Hoorn, T; Jongsma, MLM; Bakker, MJ; Hengeveld, R; Janssen, L; Cresswell, P; Egan, DA; van Ham, M; ten Brinke, A; Ovaa, H; Beijersbergen, RL; Kuijl, C; Neefjes, J				Paul, Petra; van den Hoorn, Tineke; Jongsma, Marlieke L. M.; Bakker, Mark J.; Hengeveld, Rutger; Janssen, Lennert; Cresswell, Peter; Egan, David A.; van Ham, Marieke; ten Brinke, Anja; Ovaa, Huib; Beijersbergen, Roderick L.; Kuijl, Coenraad; Neefjes, Jacques			A Genome-wide Multidimensional RNAi Screen Reveals Pathways Controlling MHC Class II Antigen Presentation	CELL			English	Article							HLA-DR MOLECULES; DENDRITIC CELLS; MYOSIN 1E; TRANSPORT; PROTEIN; EXPRESSION; MEMBRANE; INHIBITION; MATURATION; COMPLEXES	MHC class II molecules (MHC-II) present peptides to T helper cells to facilitate immune responses and are strongly linked to autoimmune diseases. To unravel processes controlling MHC-II antigen presentation, we performed a genome-wide flow cytometry-based RNAi screen detecting MHC-II expression and peptide loading followed by additional high-throughput assays. All data sets were integrated to answer two fundamental questions: what regulates tissue-specific MHC-II transcription, and what controls MHC-II transport in dendritic cells? MHC-II transcription was controlled by nine regulators acting in feedback networks with higher-order control by signaling pathways, including TGF beta. MHC-II transport was controlled by the GTPase ARL14/ARF7, which recruits the motor myosin 1E via an effector protein ARF7EP. This complex controls movement of MHC-II vesicles along the actin cytoskeleton in human dendritic cells (DCs). These genome-wide systems analyses have thus identified factors and pathways controlling MHC-II transcription and transport, defining targets for manipulation of MHC-II antigen presentation in infection and autoimmunity.	[Paul, Petra; van den Hoorn, Tineke; Jongsma, Marlieke L. M.; Bakker, Mark J.; Hengeveld, Rutger; Janssen, Lennert; Ovaa, Huib; Kuijl, Coenraad; Neefjes, Jacques] Netherlands Canc Inst, Div Cell Biol, NL-1066 CX Amsterdam, Netherlands; [Paul, Petra; van den Hoorn, Tineke; Jongsma, Marlieke L. M.; Bakker, Mark J.; Hengeveld, Rutger; Janssen, Lennert; Ovaa, Huib; Kuijl, Coenraad; Neefjes, Jacques] Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; [Egan, David A.; Beijersbergen, Roderick L.] Netherlands Canc Inst, Robot & Screening Ctr, NL-1066 CX Amsterdam, Netherlands; [Cresswell, Peter] Yale Univ, Howard Hughes Med Inst, Dept Immunobiol, Sch Med, New Haven, CT 06520 USA; [van Ham, Marieke; ten Brinke, Anja] Univ Amsterdam, Acad Med Ctr, Dept Immunopathol, Sanquin Res & Landsteiner Lab, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Howard Hughes Medical Institute; Yale University; University of Amsterdam; Academic Medical Center Amsterdam	Kuijl, C (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	kuijl.coenraad@gene.com; j.neefjes@nki.nl	Yang, Chen/G-1379-2010; Neefjes, Jacques J.C./H-8780-2017; ovaa, huib/M-2334-2016	Neefjes, Jacques J.C./0000-0001-6763-2211; Paul, Petra/0000-0003-1187-7994; Kuijl, Coen/0000-0003-4378-1428; Janssen, Lennert/0000-0001-9705-0204; ovaa, huib/0000-0002-0068-054X; Beijersbergen, Roderick/0000-0003-0116-4130; ten Brinke, Anja/0000-0002-0135-7496	NWO ALW and CW; Dutch Cancer Society; Centre for Biomedical Genetics (CBG); EEC MC RTN; ERC; Organon/Merck	NWO ALW and CW; Dutch Cancer Society(KWF Kankerbestrijding); Centre for Biomedical Genetics (CBG); EEC MC RTN; ERC(European Research Council (ERC)European Commission); Organon/Merck(Merck & Company)	We thank the NKI Central Microarray and Protein Production Facility and the NKI Robotics and Screening Center, as well as A. Pfauth and F. van Diepen for help with the flow cytometry; L. Oomen and L. Brocks for support with the confocal microscope; D. Logan (Broad Institute, Cambridge, MA) for support in operating CellProfiler; P. van Veelen for mass spec analyses; I. Lee (Network Biotechnology Lab, Seoul, Korea) and E. Marcotte (University of Texas, Austin, TX) for access to the Humannet v. 1 software; and Y. Souwer for samples of human primary B cells. This work was supported by grants from NWO ALW and CW, the Dutch Cancer Society, the Centre for Biomedical Genetics (CBG), EEC MC RTN, and an ERC program grant. The NKI Robotics and Screening Center is supported by Organon/Merck.	Agrawal S, 2004, NAT BIOTECHNOL, V22, P1533, DOI 10.1038/nbt1042; Anderson HA, 1998, J IMMUNOL, V160, P4850; Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Breton G, 2009, J CLIN IMMUNOL, V29, P637, DOI 10.1007/s10875-009-9313-9; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Cerf ME, 2006, EUR J ENDOCRINOL, V155, P671, DOI 10.1530/eje.1.02277; Chaplin D D, 1988, Year Immunol, V3, P179; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; DENZIN LK, 1994, IMMUNITY, V1, P595, DOI 10.1016/1074-7613(94)90049-3; Derrien V, 2002, J CELL SCI, V115, P2867; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Dong YS, 2001, J IMMUNOL, V167, P311, DOI 10.4049/jimmunol.167.1.311; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Imai A, 2007, EUR J IMMUNOL, V37, P1730, DOI 10.1002/eji.200636392; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; Kamine J, 1996, VIROLOGY, V216, P357, DOI 10.1006/viro.1996.0071; Kanazawa S, 2000, IMMUNITY, V12, P61, DOI 10.1016/S1074-7613(00)80159-4; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kim WK, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s5; Koppelman B, 1997, IMMUNITY, V7, P861, DOI 10.1016/S1074-7613(00)80404-5; Krendel M, 2007, FEBS LETT, V581, P644, DOI 10.1016/j.febslet.2007.01.021; Kuipers HF, 2005, HUM IMMUNOL, V66, P653, DOI 10.1016/j.humimm.2005.04.004; LAMPSON LA, 1980, J IMMUNOL, V125, P293; Mao YS, 2009, J CELL BIOL, V184, P281, DOI 10.1083/jcb.200806121; NEEFJES JJ, 1990, CELL, V61, P171, DOI 10.1016/0092-8674(90)90224-3; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Reith W, 2005, NAT REV IMMUNOL, V5, P793, DOI 10.1038/nri1708; Reynolds A, 2006, RNA, V12, P988, DOI 10.1261/rna.2340906; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; Ribet D, 2010, NATURE, V464, P1192, DOI 10.1038/nature08963; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; Schietroma C, 2007, J BIOL CHEM, V282, P29504, DOI 10.1074/jbc.M705825200; Seabra MC, 2004, TRAFFIC, V5, P393, DOI 10.1111/j.1398-9219.2004.00190.x; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Souwer Y, 2009, J IMMUNOL, V182, P7473, DOI 10.4049/jimmunol.0802831; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Tang BL, 1997, MOL CELL BIOL, V17, P256, DOI 10.1128/MCB.17.1.256; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; ten Brinke A, 2007, VACCINE, V25, P7145, DOI 10.1016/j.vaccine.2007.07.031; Thibodeau J, 2008, EUR J IMMUNOL, V38, P1225, DOI 10.1002/eji.200737902; Vascotto F, 2007, J CELL BIOL, V176, P1007, DOI 10.1083/jcb.200611147; Vicinanza M, 2008, EMBO J, V27, P2457, DOI 10.1038/emboj.2008.169; Voong LN, 2008, J BIOL CHEM, V283, P9031, DOI 10.1074/jbc.M706487200; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Wubbolts R, 1996, J CELL BIOL, V135, P611, DOI 10.1083/jcb.135.3.611; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; ZIEGLER HK, 1982, P NATL ACAD SCI-BIOL, V79, P175, DOI 10.1073/pnas.79.1.175; Zwart W, 2005, IMMUNITY, V22, P221, DOI 10.1016/j.immuni.2005.01.006	58	97	102	2	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 15	2011	145	2					268	283		10.1016/j.cell.2011.03.023	http://dx.doi.org/10.1016/j.cell.2011.03.023			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	750MA	21458045	Bronze			2022-12-28	WOS:000289549900015
J	Ghosh, S; Larson, SD; Hefzi, H; Marnoy, Z; Cutforth, T; Dokka, K; Baldwin, KK				Ghosh, Sulagna; Larson, Stephen D.; Hefzi, Hooman; Marnoy, Zachary; Cutforth, Tyler; Dokka, Kartheek; Baldwin, Kristin K.			Sensory maps in the olfactory cortex defined by long-range viral tracing of single neurons	NATURE			English	Article							ODOR REPRESENTATIONS; MONOMERIC RED; MITRAL CELLS; BULB; NUCLEUS; PROJECTIONS; ORGANIZATION; INFORMATION; RECEPTORS; CIRCUITRY	Sensory information may be represented in the brain by stereotyped mapping of axonal inputs or by patterning that varies between individuals. In olfaction, a stereotyped map is evident in the first sensory processing centre, the olfactory bulb (OB), where different odours elicit activity in unique combinatorial patterns of spatially invariant glomeruli(1,2). Activation of each glomerulus is relayed to higher cortical processing centres by a set of similar to 20-50 'homotypic' mitral and tufted (MT) neurons(3). In the cortex, target neurons integrate information from multiple glomeruli to detect distinct features of chemically diverse odours(4-6). How this is accomplished remains unclear, perhaps because the cortical mapping of glomerular information by individual MT neurons has not been described. Here we use new viral tracing and three-dimensional brain reconstruction methods to compare the cortical projections of defined sets of MT neurons. We show that the gross-scale organization of the OB is preserved in the patterns of axonal projections to one processing centre yet reordered in another, suggesting that distinct coding strategies may operate in different targets. However, at the level of individual neurons neither glomerular order nor stereotypy is preserved in either region. Rather, homotypic MT neurons from the same glomerulus innervate broad regions that differ between individuals. Strikingly, even in the same animal, MT neurons exhibit extensive diversity in wiring; axons of homotypic MT pairs diverge from each other, emit primary branches at distinct locations and 70-90% of branches of homotypic and heterotypic pairs are non-overlapping. This pronounced reorganization of sensory maps in the cortex offers an anatomic substrate for expanded combinatorial integration of information from spatially distinct glomeruli and predicts an unanticipated role for diversification of otherwise similar output neurons.	[Ghosh, Sulagna; Hefzi, Hooman; Marnoy, Zachary; Dokka, Kartheek; Baldwin, Kristin K.] Scripps Res Inst, Dept Cell Biol, Dorris Neurosci Ctr, La Jolla, CA 92037 USA; [Larson, Stephen D.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, Program Neurosci, La Jolla, CA 92037 USA; [Cutforth, Tyler] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California Santa Cruz	Baldwin, KK (corresponding author), Scripps Res Inst, Dept Cell Biol, Dorris Neurosci Ctr, La Jolla, CA 92037 USA.	kbaldwin@scripps.edu		Baldwin, Kristin/0000-0002-6137-030X	Pew Scholars Award; California Institute of Regenerative Medicine; Whitehall Foundation; O'Keefe Foundation; Shapiro Family Foundation; Dorris Neuroscience Center	Pew Scholars Award; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Whitehall Foundation; O'Keefe Foundation; Shapiro Family Foundation; Dorris Neuroscience Center	We wish to thank G. Patrick for the gift of pSin2gene virus and S. Djakovic for help with viral production. We thank O. Kwon and K. Spencer for assistance with imaging. We thank A. Maximov and J. Hazen for critical reading of the manuscript. We thank T. Cutforth for generating and R. Axel for supporting the generation of the ORT mouse strain, which was a gift. We thank the NCMIR, the Waitt Foundation and M. Ellisman for providing access to state-of-the-art imaging equipment and image processing tools. We thank the Baldwin and Cline lab members for providing laboratory support and advice. This work was supported by a Pew Scholars Award (K.K.B.) and support from the California Institute of Regenerative Medicine, the Whitehall Foundation, the O'Keefe Foundation, the Shapiro Family Foundation and the Dorris Neuroscience Center.	Apicella A, 2010, J NEUROSCI, V30, P14255, DOI 10.1523/JNEUROSCI.2747-10.2010; Belluscio L, 2002, NATURE, V419, P296, DOI 10.1038/nature01001; Brunjes PC, 2010, J COMP NEUROL, V518, P1603, DOI 10.1002/cne.22293; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; BUONVISO N, 1991, EUR J NEUROSCI, V3, P493, DOI 10.1111/j.1460-9568.1991.tb00836.x; Chen TW, 2009, P NATL ACAD SCI USA, V106, P2401, DOI 10.1073/pnas.0810151106; Christie JM, 2005, NEURON, V46, P761, DOI 10.1016/j.neuron.2005.04.030; Dhawale AK, 2010, NAT NEUROSCI, V13, P1404, DOI 10.1038/nn.2673; HABERLY LB, 1977, BRAIN RES, V129, P152, DOI 10.1016/0006-8993(77)90978-7; Khan AG, 2010, WIRES SYST BIOL MED, V2, P603, DOI 10.1002/wsbm.85; Kikuta S, 2010, P NATL ACAD SCI USA, V107, P12363, DOI 10.1073/pnas.1003999107; Lei HM, 2006, J NEUROSCI, V26, P12023, DOI 10.1523/JNEUROSCI.2598-06.2006; LUSKIN MB, 1982, J COMP NEUROL, V209, P249, DOI 10.1002/cne.902090304; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Miyasaka N, 2009, J NEUROSCI, V29, P4756, DOI 10.1523/JNEUROSCI.0118-09.2009; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nagayama S, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00120; OJIMA H, 1984, J COMP NEUROL, V230, P77, DOI 10.1002/cne.902300107; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Schreiner CE, 2007, NEURON, V56, P356, DOI 10.1016/j.neuron.2007.10.013; SCOTT JW, 1985, J COMP NEUROL, V242, P415, DOI 10.1002/cne.902420309; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Sosulski DL, 2011, NATURE, V472, P213, DOI 10.1038/nature09868; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; White LE, 2007, NEURON, V56, P327, DOI 10.1016/j.neuron.2007.10.011; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yan ZQ, 2008, NEURON, V58, P613, DOI 10.1016/j.neuron.2008.03.012	33	182	187	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2011	472	7342					217	220		10.1038/nature09945	http://dx.doi.org/10.1038/nature09945			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21451523				2022-12-28	WOS:000289469100042
J	Baram, M; Chatain, D; Kaplan, WD				Baram, Mor; Chatain, Dominique; Kaplan, Wayne D.			Nanometer-Thick Equilibrium Films: The Interface Between Thermodynamics and Atomistics	SCIENCE			English	Article							GRAIN-BOUNDARIES; INTERGRANULAR FILMS; SILICON-NITRIDE; AMORPHOUS FILMS; GLASSY FILM; CHEMISTRY; SAPPHIRE; CERAMICS; ALUMINA; ENERGY	Nanometer-thick films at interfaces and surfaces exist in various materials and can substantially influence their properties. Whether these films are an equilibrium or transient state is debated. To address this question, we equilibrated 1.2-nanometer-thick films at gold-sapphire interfaces in the presence of anorthite glass and measured the solid-solid interface energy. The equilibrated film significantly reduced the interfacial energy and could be described by the Gibbs adsorption isotherm expanded to include structure in addition to chemical excess. Unlike artificially made conventional thin films, these films do not break up during equilibration and offer an alternative design criterion for thin-film technology. These results demonstrate that nanometer-thick films at interfaces and surfaces can be an equilibrium state and included in phase diagrams with dedicated tie-lines.	[Baram, Mor; Kaplan, Wayne D.] Technion Israel Inst Technol, Dept Mat Engn, IL-32000 Haifa, Israel; [Chatain, Dominique] Aix Marseille Univ, CNRS, CINAM UPR3118, F-13288 Marseille, France	Technion Israel Institute of Technology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Kaplan, WD (corresponding author), Technion Israel Inst Technol, Dept Mat Engn, IL-32000 Haifa, Israel.	kaplan@tx.technion.ac.il	Kaplan, Wayne D./C-9100-2011	Kaplan, Wayne D./0000-0001-9202-391X; Chatain, Dominique/0000-0002-9654-7291	Israel Science Foundation [163/05]; Russell Berrie Nanotechnology Institute at the Technion; Israeli Ministry of Science; European Community [FP7-NMP-2009-CSA-233484]	Israel Science Foundation(Israel Science Foundation); Russell Berrie Nanotechnology Institute at the Technion; Israeli Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel); European Community(European Commission)	We thank H. Meltzman, P. Wynblatt, and W. C. Carter for fruitful discussions and invaluable comments. This work was supported by the Israel Science Foundation (#163/05) and the Russell Berrie Nanotechnology Institute at the Technion. M. B. acknowledges support from the Israeli Ministry of Science via an Eshkol Fellowship. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement FP7-NMP-2009-CSA-233484.	Avishai A, 2005, ACTA MATER, V53, P1559, DOI 10.1016/j.actamat.2004.12.009; Avishai A, 2005, ACTA MATER, V53, P1571, DOI 10.1016/j.actamat.2004.12.008; Avishai A, 2003, Z METALLKD, V94, P272, DOI 10.3139/146.030272; Baram M, 2008, J MICROSC-OXFORD, V232, P395, DOI 10.1111/j.1365-2818.2008.02134.x; BARAM M, 2010, THESIS TECHNION ISRA; Baram M, 2006, J MATER SCI, V41, P7775, DOI 10.1007/s10853-006-0897-7; Bishop CM, 2006, MAT SCI ENG A-STRUCT, V422, P102, DOI 10.1016/j.msea.2006.01.013; Bishop CM, 2005, ACTA MATER, V53, P4755, DOI 10.1016/j.actamat.2005.07.008; Brada MP, 1997, ACTA MATER, V45, P2501, DOI 10.1016/S1359-6454(96)00339-4; Brydson R, 1998, J AM CERAM SOC, V81, P369, DOI 10.1111/j.1151-2916.1998.tb02343.x; CAHN JW, 1977, J CHEM PHYS, V66, P3667, DOI 10.1063/1.434402; CHIANG YM, 1994, J AM CERAM SOC, V77, P1143, DOI 10.1111/j.1151-2916.1994.tb05386.x; CLARKE DR, 1977, J AM CERAM SOC, V60, P491, DOI 10.1111/j.1151-2916.1977.tb14089.x; CLARKE DR, 1987, J AM CERAM SOC, V70, P15, DOI 10.1111/j.1151-2916.1987.tb04846.x; CLARKE DR, 1987, ANNU REV MATER SCI, V17, P57; Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232; Dillon SJ, 2007, ACTA MATER, V55, P6208, DOI 10.1016/j.actamat.2007.07.029; Dillon SJ, 2010, J AM CERAM SOC, V93, P1796, DOI 10.1111/j.1551-2916.2010.03642.x; Falk LKL, 1997, J EUR CERAM SOC, V17, P983, DOI 10.1016/S0955-2219(96)00198-7; FECHT HJ, 1985, ACTA METALL MATER, V33, P557, DOI 10.1016/0001-6160(85)90019-7; GIBBS JW, 1961, SCIENTIFIC PAPERS J, V1, P219; Gupta VK, 2007, ACTA MATER, V55, P3131, DOI 10.1016/j.actamat.2007.01.017; Harmer MP, 2010, J AM CERAM SOC, V93, P301, DOI 10.1111/j.1551-2916.2009.03545.x; Johnston K, 2002, J AM CERAM SOC, V85, P2562, DOI 10.1111/j.1151-2916.2002.tb00496.x; Kaplan WD, 2006, ANNU REV MATER RES, V36, P1, DOI 10.1146/annurev.matsci.36.020105.104035; KLEEBE HJ, 1992, Z METALLKD, V83, P610; Kobayashi R, 2000, PHYSICA D, V140, P141, DOI 10.1016/S0167-2789(00)00023-3; Kuna JJ, 2009, NAT MATER, V8, P837, DOI [10.1038/NMAT2534, 10.1038/nmat2534]; Lipkin DM, 1997, PHILOS MAG A, V76, P715, DOI 10.1080/01418619708214205; Luo J, 2007, CRIT REV SOLID STATE, V32, P67, DOI 10.1080/10408430701364388; Oh SH, 2005, SCIENCE, V310, P661, DOI 10.1126/science.1118611; Qian H, 2008, ACTA MATER, V56, P4702, DOI 10.1016/j.actamat.2008.05.027; Qian HJ, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2768315; Qian HJ, 2008, ACTA MATER, V56, P862, DOI 10.1016/j.actamat.2007.10.049; Rosenberg R, 2005, PHYS TODAY, V58, P50, DOI 10.1063/1.2169444; Sadan H, 2006, J MATER SCI, V41, P5099, DOI 10.1007/s10853-006-0437-5; Scheu C, 2001, J AM CERAM SOC, V84, P623, DOI 10.1111/j.1151-2916.2001.tb00710.x; Tang M, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.024102; Tang M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.075502; Wettlaufer JS, 1999, PHYS REV LETT, V82, P2516, DOI 10.1103/PhysRevLett.82.2516; Winkelman GB, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2009067; Wynblatt P, 2008, MAT SCI ENG A-STRUCT, V495, P119, DOI 10.1016/j.msea.2007.09.091; Wynblatt P, 2006, METALL MATER TRANS A, V37A, P2595, DOI 10.1007/BF02586096; Yoshiya M, 2010, INT J MATER RES, V101, P57, DOI 10.3139/146.110240	44	115	124	4	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					206	209		10.1126/science.1201596	http://dx.doi.org/10.1126/science.1201596			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474752				2022-12-28	WOS:000289251100042
J	Bushnell, D; Garneau, M; Logsdon, JM; Sagdeev, R; Lu, E; Mountain, M; Stephenson, N				Bushnell, Dennis; Garneau, Marc; Logsdon, John M.; Sagdeev, Roald; Lu, Ed; Mountain, Matt; Stephenson, Neal			NASA: what now?	NATURE			English	Editorial Material									[Bushnell, Dennis] NASA, Langley Res Ctr, Washington, DC 20546 USA; [Logsdon, John M.] George Washington Univ, Washington, DC 20052 USA; [Sagdeev, Roald] Russian Space Res Inst, Moscow, Russia; [Mountain, Matt] NASA, Space Telescope Sci Inst, Washington, DC USA	National Aeronautics & Space Administration (NASA); NASA Langley Research Center; George Washington University; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; National Aeronautics & Space Administration (NASA)	Bushnell, D (corresponding author), NASA, Langley Res Ctr, Washington, DC 20546 USA.								0	1	1	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 7	2011	472	7341					27	29		10.1038/472027a	http://dx.doi.org/10.1038/472027a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	745VV	21475173	Bronze			2022-12-28	WOS:000289199400016
J	Faden, RR; Chalkidou, K				Faden, Ruth R.; Chalkidou, Kalipso			Determining the Value of Drugs - The Evolving British Experience	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Faden, Ruth R.; Chalkidou, Kalipso] Johns Hopkins Univ, Johns Hopkins Berman Inst Bioeth, Baltimore, MD 21218 USA; [Chalkidou, Kalipso] Britains Natl Inst Hlth & Clin Excellence, Int Div, London, England	Johns Hopkins University; National Institute for Health & Care Excellence	Faden, RR (corresponding author), Johns Hopkins Univ, Johns Hopkins Berman Inst Bioeth, Baltimore, MD 21218 USA.							Chalkidou K, 2010, PHARMACOECONOMICS, V28, P799, DOI 10.2165/11535260-000000000-00000; Department of Health, 2010, NEW VAL BAS APPR PRI; Faden RR, 2009, MILBANK Q, V87, P789, DOI 10.1111/j.1468-0009.2009.00579.x; National Institute for Health and Clinical Excellence, 2008, SOC VAL JUDG PRINC D, V2nd; Rawlins MD, 2004, BRIT MED J, V329, P224, DOI 10.1136/bmj.329.7459.224	5	16	16	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 7	2011	364	14					1289	1291		10.1056/NEJMp1101047	http://dx.doi.org/10.1056/NEJMp1101047			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	745WS	21470007				2022-12-28	WOS:000289202800003
J	LaCroix, AZ; Chlebowski, RT; Manson, JE; Aragaki, AK; Johnson, KC; Martin, L; Margolis, KL; Stefanick, ML; Brzyski, R; Curb, JD; Howard, BV; Lewis, CE; Wactawski-Wende, J				LaCroix, Andrea Z.; Chlebowski, Rowan T.; Manson, JoAnn E.; Aragaki, Aaron K.; Johnson, Karen C.; Martin, Lisa; Margolis, Karen L.; Stefanick, Marcia L.; Brzyski, Robert; Curb, J. David; Howard, Barbara V.; Lewis, Cora E.; Wactawski-Wende, Jean		WHI Investigators	Health Outcomes After Stopping Conjugated Equine Estrogens Among Postmenopausal Women With Prior Hysterectomy A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; HORMONE-REPLACEMENT THERAPY; INITIATIVE CLINICAL-TRIAL; INVASIVE BREAST-CANCER; PLUS PROGESTIN; RISK; MENOPAUSE; MAMMOGRAPHY; EXPRESSION; PATTERN	Context The Women's Health Initiative Estrogen-Alone Trial was stopped early after a mean of 7.1 years of follow-up because of an increased risk of stroke and little likelihood of altering the balance of risk to benefit by the planned trial termination date. Postintervention health outcomes have not been reported. Objective To examine health outcomes associated with randomization to treatment with conjugated equine estrogens (CEE) among women with prior hysterectomy after a mean of 10.7 years of follow-up through August 2009. Design, Setting, and Participants The intervention phase was a double-blind, placebo-controlled, randomized clinical trial of 0.625 mg/d of CEE compared with placebo in 10 739 US postmenopausal women aged 50 to 79 years with prior hysterectomy. Follow-up continued after the planned trial completion date among 7645 surviving participants (78%) who provided written consent. Main Outcome Measures The primary outcomes were coronary heart disease (CHD) and invasive breast cancer. A global index of risks and benefits included these primary outcomes plus stroke, pulmonary embolism, colorectal cancer, hip fracture, and death. Results The postintervention risk (annualized rate) for CHD among women assigned to CEE was 0.64% compared with 0.67% in the placebo group (hazard ratio [HR], 0.97; 95% confidence interval [CI], 0.75-1.25), 0.26% vs 0.34%, respectively, for breast cancer (HR, 0.75; 95% CI, 0.51-1.09), and 1.47% vs 1.48%, respectively, for total mortality (HR, 1.00; 95% CI, 0.84-1.18). The risk of stroke was no longer elevated during the postintervention follow-up period and was 0.36% among women receiving CEE compared with 0.41% in the placebo group (HR, 0.89; 95% CI, 0.64-1.24), the risk of deep vein thrombosis was lower at 0.17% vs 0.27%, respectively (HR, 0.63; 95% CI, 0.41-0.98), and the risk of hip fracture did not differ significantly and was 0.36% vs 0.28%, respectively (HR, 1.27; 95% CI, 0.88-1.82). Over the entire follow-up, lower breast cancer incidence in the CEE group persisted and was 0.27% compared with 0.35% in the placebo group (HR, 0.77; 95% CI, 0.62-0.95). Health outcomes were more favorable for younger compared with older women for CHD (P=.05 for interaction), total myocardial infarction (P=.007 for interaction), colorectal cancer (P=.04 for interaction), total mortality (P=.04 for interaction), and global index of chronic diseases (P=.009 for interaction). Conclusions Among postmenopausal women with prior hysterectomy followed up for 10.7 years, CEE use for a median of 5.9 years was not associated with an increased or decreased risk of CHD, deep vein thrombosis, stroke, hip fracture, colorectal cancer, or total mortality. A decreased risk of breast cancer persisted.	[LaCroix, Andrea Z.; Aragaki, Aaron K.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Chlebowski, Rowan T.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Manson, JoAnn E.] Harvard Univ, Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; [Johnson, Karen C.] Univ Tennessee, Dept Prevent Med, Hlth Sci Ctr, Memphis, TN USA; [Martin, Lisa] George Washington Univ, Dept Cardiol, Washington, DC USA; [Margolis, Karen L.] Univ Minnesota, Berman Ctr Clin Res, Minneapolis, MN USA; [Stefanick, Marcia L.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Brzyski, Robert] Univ Texas San Antonio, Hlth Sci Ctr, San Antonio, TX USA; [Curb, J. David] Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA; [Curb, J. David] Pacific Hlth Res Inst, Honolulu, HI USA; [Howard, Barbara V.] MedStar Res Inst, Hyattsville, MD USA; [Lewis, Cora E.] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA; [Wactawski-Wende, Jean] SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA	Fred Hutchinson Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Harvard University; Brigham & Women's Hospital; University of Tennessee System; University of Tennessee Health Science Center; George Washington University; University of Minnesota System; University of Minnesota Twin Cities; Stanford University; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas Health San Antonio; University of Hawaii System; Pacific Health Research & Education Institute; University of Alabama System; University of Alabama Birmingham; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	LaCroix, AZ (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N,M3-A410,PO 19024, Seattle, WA 98109 USA.	alacroix@whi.org	LaCroix, Andrea/N-9880-2018; Wactawski-Wende, Jean/AGH-5457-2022; Hug, Balthasar L./G-1568-2010; Stafford, Randall/F-3974-2017	LaCroix, Andrea/0000-0002-9532-976X; Wactawski-Wende, Jean/0000-0003-3096-9595; Martin, Lisa Warsinger/0000-0003-4352-0914; Margolis, Karen/0000-0003-1862-7402; Caan, Bette/0000-0002-5803-310X; Stafford, Randall/0000-0003-1805-1271	Warner Chilcott; sanofi-aventis; Amgen; Pfizer; National Heart, Lung, and Blood Institute; National Institutes of Health; US Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221]; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH032112, N01WH042123, N01WH042115, N01WH032105, N01WH032106, N01WH042116, N01WH032101, N01WH042130, N01WH032100, N01WH032108, N01WH032111, N01WH022110, N01WH042132, N01WH042119, N01WH042120, N01WH032113, N01WH042129, N01WH042109, N01WH042114, N01WH032118, N01WH032109, N01WH042125, N01WH042126, N01WH042131, N01WH032115, N01WH042113, N01WH042124, N01WH042112, N01WH042111, N01WH032122, N01WH042121, N01WH042117, N01WH032119, N01WH032102, N01WH042108, N01WH042107, N01WH042110, N01WH042118, N01WH042122] Funding Source: NIH RePORTER	Warner Chilcott; sanofi-aventis(Sanofi-Aventis); Amgen(Amgen); Pfizer(Pfizer); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Health and Human Services; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr LaCroix reported serving on scientific advisory committees for research studies funded by Warner Chilcott and sanofi-aventis, Amgen, and Pfizer. Dr Chlebowski reported being a consultant for AstraZeneca, Novartis, Amgen, and Pfizer; receiving funding support from Amgen; and serving on speaker's bureaus for AstraZeneca and Novartis. Dr Howard reported receiving payment for lectures, serving on a speaker's bureau, and being a consultant for Merck/Schering-Plough Wyeth Research; and receiving research support through the donation of drugs from Merck/Schering-Plough. None of the other authors reported any financial disclosures.; Wyeth Ayerst donated the study drugs. The Women's Health Initiative program is funded by the National Heart, Lung, and Blood Institute, the National Institutes of Health, and the US Department of Health and Human Services through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, and 44221.	Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Banks E, 2004, JAMA-J AM MED ASSOC, V291, P2212, DOI 10.1001/jama.291.18.2212; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Beral V, 2011, JNCI-J NATL CANCER I, V103, P296, DOI 10.1093/jnci/djq527; Calle EE, 2009, CANCER-AM CANCER SOC, V115, P936, DOI 10.1002/cncr.24101; CAULEY JA, 1995, ANN INTERN MED, V122, P9, DOI 10.7326/0003-4819-122-1-199501010-00002; Chen WY, 2006, ARCH INTERN MED, V166, P1027, DOI 10.1001/archinte.166.9.1027; Chlebowski RT, 2011, J NATL CANCER I, V103, P284, DOI 10.1093/jnci/djq561; Chlebowski RT, 2010, JAMA-J AM MED ASSOC, V304, P1684, DOI 10.1001/jama.2010.1500; Chlebowski RT, 2010, J CLIN ONCOL, V28, P2690, DOI 10.1200/JCO.2009.24.8799; Chlebowski RT, 2009, NEW ENGL J MED, V360, P573, DOI 10.1056/NEJMoa0807684; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; COLDITZ GA, 1995, NEW ENGL J MED, V332, P1589, DOI 10.1056/NEJM199506153322401; COX DR, 1972, J R STAT SOC B, V34, P187; Curb JD, 2003, ANN EPIDEMIOL, V13, pS122, DOI 10.1016/S1047-2797(03)00048-6; Dunbier AK, 2010, J CLIN ONCOL, V28, P1161, DOI 10.1200/JCO.2009.23.9616; Ellis MJ, 2009, JAMA-J AM MED ASSOC, V302, P774, DOI 10.1001/jama.2009.1204; Fournier A, 2009, J CLIN ONCOL, V27, P5138, DOI 10.1200/JCO.2008.21.6432; Greendale GA, 2002, ARCH INTERN MED, V162, P665, DOI 10.1001/archinte.162.6.665; Grodstein F, 2006, J WOMENS HEALTH, V15, P35, DOI 10.1089/jwh.2006.15.35; Grodstein F, 2003, NEW ENGL J MED, V348, P645, DOI 10.1056/NEJMsb022365; Heiss G, 2008, JAMA-J AM MED ASSOC, V299, P1036, DOI 10.1001/jama.299.9.1036; Hernan MA, 2008, EPIDEMIOLOGY, V19, P766, DOI 10.1097/EDE.0b013e3181875e61; Jeng MH, 1998, ENDOCRINOLOGY, V139, P4164, DOI 10.1210/en.139.10.4164; Kerlikowske K, 2003, J CLIN ONCOL, V21, P4314, DOI 10.1200/JCO.2003.05.151; Li CI, 2003, JAMA-J AM MED ASSOC, V289, P3254, DOI 10.1001/jama.289.24.3254; Manson JE, 2007, AM J EPIDEMIOL, V166, P511, DOI 10.1093/aje/kwm213; Manson JE, 2007, NEW ENGL J MED, V356, P2591, DOI 10.1056/NEJMoa071513; McTiernan A, 2009, J CLIN ONCOL, V27, P6135, DOI 10.1200/JCO.2008.21.7166; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Mikkola TS, 2002, CARDIOVASC RES, V53, P605, DOI 10.1016/S0008-6363(01)00466-7; Prentice RL, 2006, JAMA-J AM MED ASSOC, V295, P629, DOI 10.1001/jama.295.6.629; Prentice RL, 2008, AM J EPIDEMIOL, V167, P1407, DOI 10.1093/aje/kwn090; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Santen RJ, 2005, J STEROID BIOCHEM, V95, P155, DOI 10.1016/j.jsbmb.2005.04.025; Schairer C, 2000, JAMA-J AM MED ASSOC, V283, P485, DOI 10.1001/jama.283.4.485; Stefanick ML, 2006, JAMA-J AM MED ASSOC, V295, P1647, DOI 10.1001/jama.295.14.1647; Yates J, 2004, OBSTET GYNECOL, V103, P440, DOI 10.1097/01.AOG.0000114986.14806.37	40	414	425	2	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2011	305	13					1305	1314		10.1001/jama.2011.382	http://dx.doi.org/10.1001/jama.2011.382			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745JT	21467283	Green Accepted			2022-12-28	WOS:000289162400019
J	Schrijvers, EMC; Koudstaal, PJ; Hofman, A; Breteler, MMB				Schrijvers, Elisabeth M. C.; Koudstaal, Peter J.; Hofman, Albert; Breteler, Monique M. B.			Plasma Clusterin and the Risk of Alzheimer Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENOME-WIDE ASSOCIATION; IDENTIFIES VARIANTS; APOLIPOPROTEIN-J; MENTAL STATE; DIAGNOSIS; DEMENTIA; CLU	Context Variants in the clusterin gene are associated with the risk of Alzheimer disease (AD) and clusterin levels have been found to be increased in brain and cerebrospinal fluid of patients with AD. Plasma clusterin was reported to be associated with brain atrophy, baseline disease severity, and rapid clinical progression in patients with AD. Objective To evaluate the potential of plasma clusterin as a biomarker of the presence, severity, and risk of AD. Design, Setting, and Participants A case-cohort study nested within the Rotterdam Study, a prospective population-based cohort study conducted in Rotterdam, the Netherlands. Plasma levels of clusterin were measured at baseline (1997-1999) in 60 individuals with prevalent AD, a random subcohort of 926 participants, and an additional 156 participants diagnosed with AD during follow-up until January 1, 2007 (mean [SD], 7.2 [2.3] years). Main Outcome Measures Prevalent AD, severity of AD measured by the Mini-Mental State Examination (MMSE) score, and the risk of developing AD during follow-up. Results The likelihood of prevalent AD increased with increasing plasma levels of clusterin (odds ratio [OR] per SD increase of plasma clusterin level, 1.63; 95% confidence interval [CI], 1.21-2.20; adjusted for age, sex, education level, apolipoprotein E status, diabetes, smoking, coronary heart disease, and hypertension). Among patients with AD, higher clusterin levels were associated with more severe disease (adjusted difference in MMSE score per SD increase in clusterin levels, -1.36; 95% CI, -2.70 to -0.02; P=.047). Plasma clusterin levels were not related to the risk of incident AD during total follow-up (adjusted HR, 1.00; 95% CI, 0.85-1.17; P for trend=.77) or within 3 years of baseline (adjusted HR, 1.09; 95% CI, 0.84-1.42; P for trend=.65). Conclusion Plasma clusterin levels were significantly associated with baseline prevalence and severity of AD, but not with incidence of AD. JAMA. 2011;305(13):1322-1326 www.jama.com	[Schrijvers, Elisabeth M. C.; Hofman, Albert; Breteler, Monique M. B.] Univ Med Ctr, Erasmus MC, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands; [Schrijvers, Elisabeth M. C.; Koudstaal, Peter J.] Univ Med Ctr, Erasmus MC, Dept Neurol, NL-3000 CA Rotterdam, Netherlands; [Breteler, Monique M. B.] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Breteler, MMB (corresponding author), Univ Med Ctr, Erasmus MC, Dept Epidemiol, POB 2040, NL-3000 CA Rotterdam, Netherlands.	m.breteler@erasmusmc.nl	Breteler, Monique M.B./J-5058-2014	Breteler, Monique M.B./0000-0002-0626-9305	Erasmus MC University Medical Center; Erasmus University Rotterdam; Netherlands Organization for Scientific Research (NWO); Netherlands Organization for Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture, and Science; Ministry of Health, Welfare, and Sports; European Commission; Municipality of Rotterdam; Alzheimer's Association [IIRG-06-27261]; Pfizer	Erasmus MC University Medical Center; Erasmus University Rotterdam; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture, and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Welfare, and Sports; European Commission(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Alzheimer's Association(Alzheimer's Association); Pfizer(Pfizer)	The Rotterdam Study is supported by the Erasmus MC University Medical Center and Erasmus University Rotterdam; the Netherlands Organization for Scientific Research (NWO); the Netherlands Organization for Health Research and Development (ZonMw); the Research Institute for Diseases in the Elderly (RIDE); the Ministry of Education, Culture, and Science; the Ministry of Health, Welfare, and Sports; the European Commission (DG XII); and the Municipality of Rotterdam. This study was financially supported by grant IIRG-06-27261 from the Alzheimer's Association and by an unrestricted research grant from Pfizer (Dr Breteler).	American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; COPELAND JRM, 1976, PSYCHOL MED, V6, P439, DOI 10.1017/S0033291700015889; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GOLDEN CJ, 1976, J CLIN PSYCHOL, V32, P654, DOI 10.1002/1097-4679(197607)32:3<654::AID-JCLP2270320336>3.0.CO;2-Z; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hofman A, 2009, EUR J EPIDEMIOL, V24, P553, DOI 10.1007/s10654-009-9386-z; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Lidstrom AM, 1998, EXP NEUROL, V154, P511, DOI 10.1006/exnr.1998.6892; MAY PC, 1990, NEURON, V5, P831, DOI 10.1016/0896-6273(90)90342-D; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Nuutinen T, 2009, BRAIN RES REV, V61, P89, DOI 10.1016/j.brainresrev.2009.05.007; Ott A, 1998, AM J EPIDEMIOL, V147, P574; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Sihlbom C, 2008, NEUROCHEM RES, V33, P1332, DOI 10.1007/s11064-008-9588-x; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; WELSH KA, 1994, NEUROLOGY, V44, P609, DOI 10.1212/WNL.44.4.609; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com	22	158	167	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2011	305	13					1322	1326		10.1001/jama.2011.381	http://dx.doi.org/10.1001/jama.2011.381			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745JT	21467285	Bronze			2022-12-28	WOS:000289162400021
J	Baheti, NN; Cherian, A; Menon, R; Radhakrishnan, A				Baheti, Neeraj N.; Cherian, Ajith; Menon, Ramshekhar; Radhakrishnan, Ashalatha			The nursing instructor's speech	LANCET			English	Editorial Material							READING EPILEPSY		[Baheti, Neeraj N.; Cherian, Ajith; Menon, Ramshekhar; Radhakrishnan, Ashalatha] Sree Chitra Tirunal Inst Med Sci & Technol, Dept Neurol, Trivandrum 695011, Kerala, India	Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST)	Radhakrishnan, A (corresponding author), Sree Chitra Tirunal Inst Med Sci & Technol, Dept Neurol, Trivandrum 695011, Kerala, India.	drashalatha@sctimst.ac.in	Cherian, Ajith/AAZ-1778-2021	Cherian, Ajith/0000-0001-8743-9793				BICKFORD REGINALD G., 1956, TRANS AMER NEUROL ASSOC, V81, P100; Koutroumanidis M, 1998, BRAIN, V121, P1409, DOI 10.1093/brain/121.8.1409; MATTHEWS WB, 1967, NEUROLOGY, V17, P919, DOI 10.1212/WNL.17.9.919; RADHAKRISHNAN K, 1995, BRAIN, V118, P75, DOI 10.1093/brain/118.1.75; Salek-Haddadi A, 2009, EPILEPSIA, V50, P256, DOI 10.1111/j.1528-1167.2008.01737.x	5	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2011	377	9772					1210	1210		10.1016/S0140-6736(10)62053-3	http://dx.doi.org/10.1016/S0140-6736(10)62053-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	750IH	21459212				2022-12-28	WOS:000289539300037
J	Magenau, AJD; Strandwitz, NC; Gennaro, A; Matyjaszewski, K				Magenau, Andrew J. D.; Strandwitz, Nicholas C.; Gennaro, Armando; Matyjaszewski, Krzysztof			Electrochemically Mediated Atom Transfer Radical Polymerization	SCIENCE			English	Article							COPPER-COMPLEXES; LIVING POLYMERS; RAFT; CATALYSTS; AGENTS; ATRP	Atom transfer radical polymerization is a versatile technique for exerting precise control over polymer molecular weights, molecular weight distributions, and complex architectures. Here, we show that an externally applied electrochemical potential can reversibly activate the copper catalyst for this process by a one-electron reduction of an initially added air-stable cupric species (Cu-II/Ligand). Modulation of polymerization kinetics is thereby tunable in real time by varying the magnitude of applied potential. Application of multistep intermittent potentials successfully triggers initiation of polymerization and subsequently toggles the polymerization between dormant and active states in a living manner. Catalyst concentrations down to 50 parts per million are demonstrated to maintain polymerization control manifested in linear first-order kinetics, a linear increase in polymer molecular weight with monomer conversion, and narrow polymer molecular weight distributions over a range of applied potentials.	[Magenau, Andrew J. D.; Matyjaszewski, Krzysztof] Carnegie Mellon Univ, Ctr Macromol Engn, Dept Chem, Pittsburgh, PA 15213 USA; [Strandwitz, Nicholas C.] CALTECH, Kavli Nanosci Inst, Pasadena, CA 91125 USA; [Strandwitz, Nicholas C.] CALTECH, Beckman Inst, Pasadena, CA 91125 USA; [Strandwitz, Nicholas C.] CALTECH, Div Chem & Chem Engn, Noyes Lab 127 72 210, Pasadena, CA 91125 USA; [Gennaro, Armando] Univ Padua, Dept Chem Sci, I-35131 Padua, Italy	Carnegie Mellon University; California Institute of Technology; California Institute of Technology; California Institute of Technology; University of Padua	Matyjaszewski, K (corresponding author), Carnegie Mellon Univ, Ctr Macromol Engn, Dept Chem, 4400 5th Ave, Pittsburgh, PA 15213 USA.	km3b@andrew.cmu.edu	Matyjaszewski, Krzysztof/A-2508-2008; Magenau, Andrew/AAO-5034-2020	Matyjaszewski, Krzysztof/0000-0003-1960-3402; Magenau, Andrew/0000-0002-7565-9075; Strandwitz, Nicholas/0000-0001-6159-9430	U.S. National Science Foundation [DMR 09-69301, CHE 10-26060, CHE-1042006]; Carnegie Mellon University; Division Of Chemistry [1042006] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); Carnegie Mellon University; Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge the U.S. National Science Foundation ( grants DMR 09-69301 and CHE 10-26060) and the members of the CRP Consortium at Carnegie Mellon University for financial support. N.C.S. acknowledges the U.S. National Science Foundation for an American Competitiveness in Chemistry postdoctoral fellowship (CHE-1042006). A.J.D.M. and K. M. filed a U. S. provisional patent application (61/459,724) related to this work.	Benaglia M, 2009, J AM CHEM SOC, V131, P6914, DOI 10.1021/ja901955n; Bonometti V, 2009, J ELECTROANAL CHEM, V633, P99, DOI 10.1016/j.jelechem.2009.04.030; Braunecker WA, 2007, PROG POLYM SCI, V32, P93, DOI 10.1016/j.progpolymsci.2006.11.002; Chiefari J, 1998, MACROMOLECULES, V31, P5559, DOI 10.1021/ma9804951; Cunningham MF, 2008, PROG POLYM SCI, V33, P365, DOI 10.1016/j.progpolymsci.2007.11.002; GEORGES MK, 1993, MACROMOLECULES, V26, P2987, DOI 10.1021/ma00063a054; Gregson CKA, 2006, J AM CHEM SOC, V128, P7410, DOI 10.1021/ja061398n; Hong V, 2008, CHEMBIOCHEM, V9, P1481, DOI 10.1002/cbic.200700768; Isse AA, 2004, J PHYS CHEM A, V108, P4180, DOI 10.1021/jp036782a; Isse AA, 2011, J AM CHEM SOC, V133, P6254, DOI 10.1021/ja110538b; Jakubowski W., 2006, ANGEW CHEM, V118, P4594, DOI DOI 10.1002/ANGE.200600272; Kamigaito M, 2001, CHEM REV, V101, P3689, DOI 10.1021/cr9901182; KATO M, 1995, MACROMOLECULES, V28, P1721, DOI 10.1021/ma00109a056; Kwak Y, 2010, MACROMOLECULES, V43, P5180, DOI 10.1021/ma100850a; Lin CY, 2008, J AM CHEM SOC, V130, P12762, DOI 10.1021/ja8038823; Matyjaszewski K, 2001, CHEM REV, V101, P2921, DOI 10.1021/cr940534g; Matyjaszewski K., 2002, HDB RADICAL POLYM; Matyjaszewski K, 2007, LANGMUIR, V23, P4528, DOI 10.1021/la063402e; Matyjaszewski K, 2006, P NATL ACAD SCI USA, V103, P15309, DOI 10.1073/pnas.0602675103; Matyjaszewski K, 2009, NAT CHEM, V1, P276, DOI [10.1038/NCHEM.257, 10.1038/nchem.257]; Min K, 2005, J AM CHEM SOC, V127, P3825, DOI 10.1021/ja0429364; Min K, 2009, CENT EUR J CHEM, V7, P657, DOI 10.2478/s11532-009-0092-1; Muller AHE, 2009, CONTROLLED LIVING PO; Nasser-Eddine M, 2004, MACROMOL MATER ENG, V289, P204, DOI 10.1002/mame.200300221; Patten TE, 1996, SCIENCE, V272, P866, DOI 10.1126/science.272.5263.866; Peeck LH, 2010, ORGANOMETALLICS, V29, P4339, DOI 10.1021/om100628f; Pintauer T, 2008, CHEM SOC REV, V37, P1087, DOI 10.1039/b714578k; Qiu J, 2000, MACROMOL CHEM PHYSIC, V201, P1625, DOI 10.1002/1521-3935(20000901)201:14<1625::AID-MACP1625>3.0.CO;2-9; Rzayev J, 2004, ANGEW CHEM INT EDIT, V43, P1691, DOI 10.1002/anie.200353025; SZWARC M, 1956, NATURE, V178, P1168, DOI 10.1038/1781168a0; Tanabe M, 2006, NAT MATER, V5, P467, DOI 10.1038/nmat1649; WANG JS, 1995, J AM CHEM SOC, V117, P5614, DOI 10.1021/ja00125a035; Yoon HJ, 2010, SCIENCE, V330, P66, DOI 10.1126/science.1193928	33	621	631	13	538	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2011	332	6025					81	84		10.1126/science.1202357	http://dx.doi.org/10.1126/science.1202357			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21454784				2022-12-28	WOS:000289000000041
J	Mocatta, D; Cohen, G; Schattner, J; Millo, O; Rabani, E; Banin, U				Mocatta, David; Cohen, Guy; Schattner, Jonathan; Millo, Oded; Rabani, Eran; Banin, Uri			Heavily Doped Semiconductor Nanocrystal Quantum Dots	SCIENCE			English	Article							ELECTRICAL-PROPERTIES; INDIUM ARSENIDE; DIFFUSION; IMPURITY; EMITTERS; DEVICES; SOLIDS; INP	Doping of semiconductors by impurity atoms enabled their widespread technological application in microelectronics and optoelectronics. However, doping has proven elusive for strongly confined colloidal semiconductor nanocrystals because of the synthetic challenge of how to introduce single impurities, as well as a lack of fundamental understanding of this heavily doped limit under strong quantum confinement. We developed a method to dope semiconductor nanocrystals with metal impurities, enabling control of the band gap and Fermi energy. A combination of optical measurements, scanning tunneling spectroscopy, and theory revealed the emergence of a confined impurity band and band-tailing. Our method yields n- and p-doped semiconductor nanocrystals, which have potential applications in solar cells, thin-film transistors, and optoelectronic devices.	[Mocatta, David; Schattner, Jonathan; Millo, Oded; Banin, Uri] Hebrew Univ Jerusalem, Ctr Nanosci & Nanotechnol, IL-91904 Jerusalem, Israel; [Mocatta, David; Banin, Uri] Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel; [Cohen, Guy; Rabani, Eran] Tel Aviv Univ, Sch Chem, Sackler Fac Exact Sci, IL-69978 Tel Aviv, Israel; [Schattner, Jonathan; Millo, Oded] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Tel Aviv University; Hebrew University of Jerusalem	Millo, O (corresponding author), Hebrew Univ Jerusalem, Ctr Nanosci & Nanotechnol, IL-91904 Jerusalem, Israel.	milode@vms.huji.ac.il; rabani@tau.ac.il; uri.banin@huji.ac.il	Cohen, Guy/C-8331-2011; Rabani, Eran/M-1263-2013	Cohen, Guy/0000-0001-7404-4055; Rabani, Eran/0000-0003-2031-3525; Banin, Uri/0000-0003-1698-2128	European Research Council under European Community [203413]; Israel Science Foundation; Harry de Jur Chair in Applied Science; Alfred and Erica Larisch Memorial Chair; Azrieli Foundation; Centre for Scientific Absorption, Ministry of Absorption, State of Israel	European Research Council under European Community(European Research Council (ERC)); Israel Science Foundation(Israel Science Foundation); Harry de Jur Chair in Applied Science; Alfred and Erica Larisch Memorial Chair; Azrieli Foundation; Centre for Scientific Absorption, Ministry of Absorption, State of Israel	We thank the staff of the Unit for Nanocharacterization of the Center for Nanoscience and Nanotechnology in the Hebrew University, Jerusalem, headed by I. Popov, as well as V. Gutkin for help in the XPS studies. Supported by a grant from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement 203413 (U. B.); the Israel Science Foundation (O.M.); Seventh Framework Programme Marie Curie International Outgoing Fellowships for Career Development project Hierarchical Junction Solar Cells (E. R.); the Harry de Jur Chair in Applied Science (O.M.); the Alfred and Erica Larisch Memorial Chair (U. B.); an Azrieli Foundation fellowship (G. C.); and the Centre for Scientific Absorption, Ministry of Absorption, State of Israel (D. M.).	ABRAM RA, 1978, ADV PHYS, V27, P799, DOI 10.1080/00018737800101484; Banin U, 2003, ANNU REV PHYS CHEM, V54, P465, DOI 10.1146/annurev.physchem.54.011002.103838; Barati M, 2007, PHYS STATUS SOLIDI B, V244, P2605, DOI 10.1002/pssb.200642543; BHARGAVA RN, 1994, PHYS REV LETT, V72, P416, DOI 10.1103/PhysRevLett.72.416; Chan TL, 2008, NANO LETT, V8, P596, DOI 10.1021/nl072997a; Coe S, 2002, NATURE, V420, P800, DOI 10.1038/nature01217; Dalpian GM, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.226802; DIXON JR, 1959, J APPL PHYS, V30, P753, DOI 10.1063/1.1735227; Erwin SC, 2005, NATURE, V436, P91, DOI 10.1038/nature03832; Gur I, 2005, SCIENCE, V310, P462, DOI 10.1126/science.1117908; Leschkies KS, 2010, J PHYS CHEM C, V114, P9988, DOI 10.1021/jp101695s; Li SS, 2007, J APPL PHYS, V101, DOI 10.1063/1.2734097; Melnikov DV, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.046802; Mokari T, 2006, ANGEW CHEM INT EDIT, V45, P8001, DOI 10.1002/anie.200602559; Norris DJ, 2008, SCIENCE, V319, P1776, DOI 10.1126/science.1143802; PORRASMONTENEGRO N, 1993, J APPL PHYS, V74, P7624, DOI 10.1063/1.354943; Pradhan N, 2005, J AM CHEM SOC, V127, P17586, DOI 10.1021/ja055557z; Roy S, 2009, J PHYS CHEM C, V113, P13008, DOI 10.1021/jp8113946; Shim M, 2000, NATURE, V407, P981, DOI 10.1038/35039577; Stowell CA, 2003, NANO LETT, V3, P1441, DOI 10.1021/nl034419+; SZE SM, 1981, PHYSICS SEMICONDUCTO, pCH7; Talapin DV, 2005, SCIENCE, V310, P86, DOI 10.1126/science.1116703; Tauc J., 1976, AMORPHOUS LIQUID SEM; TUCK B, 1978, J PHYS D APPL PHYS, V11, P1413, DOI 10.1088/0022-3727/11/10/007; Tuinenga C, 2008, ACS NANO, V2, P1411, DOI 10.1021/nn700377q; TURNBULL D, 1950, J APPL PHYS, V21, P1022, DOI 10.1063/1.1699435; Wang CJ, 2001, SCIENCE, V291, P2390, DOI 10.1126/science.291.5512.2390; Xie RG, 2009, J AM CHEM SOC, V131, P10645, DOI 10.1021/ja903558r; Yang YA, 2006, J AM CHEM SOC, V128, P12428, DOI 10.1021/ja064818h; Yu D, 2003, SCIENCE, V300, P1277, DOI 10.1126/science.1084424	30	595	607	18	663	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2011	332	6025					77	81		10.1126/science.1196321	http://dx.doi.org/10.1126/science.1196321			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21454783	Green Submitted			2022-12-28	WOS:000289000000040
J	Bacon, BR; Gordon, SC; Lawitz, E; Marcellin, P; Vierling, JM; Zeuzem, S; Poordad, F; Goodman, ZD; Sings, HL; Poordad, F; Goodman, ZD; Sings, HL; Boparai, N; Burroughs, M; Brass, CA; Albrecht, JK; Esteban, R				Bacon, Bruce R.; Gordon, Stuart C.; Lawitz, Eric; Marcellin, Patrick; Vierling, John M.; Zeuzem, Stefan; Poordad, Fred; Goodman, Zachary D.; Sings, Heather L.; Poordad, Fred; Goodman, Zachary D.; Sings, Heather L.; Boparai, Navdeep; Burroughs, Margaret; Brass, Clifford A.; Albrecht, Janice K.; Esteban, Rafael		HCV RESPOND2-Investigators	Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC HEPATITIS-C; PEGINTERFERON ALPHA-2B; PROTEASE INHIBITOR; RIBAVIRIN; INTERFERON; THERAPY	BACKGROUND In patients with chronic infection with hepatitis C virus (HCV) genotype 1 who do not have a sustained response to therapy with peginterferon-ribavirin, outcomes after retreatment are suboptimal. Boceprevir, a protease inhibitor that binds to the HCV nonstructural 3 (NS3) active site, has been suggested as an additional treatment. METHODS To assess the effect of the combination of boceprevir and peginterferon-ribavirin for retreatment of patients with chronic HCV genotype 1 infection, we randomly assigned patients (in a 1: 2: 2 ratio) to one of three groups. In all three groups, peginterferon alfa-2b and ribavirin were administered for 4 weeks (the lead-in period). Subsequently, group 1 (control group) received placebo plus peginterferon-ribavirin for 44 weeks; group 2 received boceprevir plus peginterferon-ribavirin for 32 weeks, and patients with a detectable HCV RNA level at week 8 received placebo plus peginterferon-ribavirin for an additional 12 weeks; and group 3 received boceprevir plus peginterferon-ribavirin for 44 weeks. RESULTS A total of 403 patients were treated. The rate of sustained virologic response was significantly higher in the two boceprevir groups (group 2, 59%; group 3, 66%) than in the control group (21%, P<0.001). Among patients with an undetectable HCV RNA level at week 8, the rate of sustained virologic response was 86% after 32 weeks of triple therapy and 88% after 44 weeks of triple therapy. Among the 102 patients with a decrease in the HCV RNA level of less than 1 log(10) IU per milliliter at treatment week 4, the rates of sustained virologic response were 0%, 33%, and 34% in groups 1, 2, and 3, respectively. Anemia was significantly more common in the boceprevir groups than in the control group, and erythropoietin was administered in 41 to 46% of boceprevir-treated patients and 21% of controls. CONCLUSIONS The addition of boceprevir to peginterferon-ribavirin resulted in significantly higher rates of sustained virologic response in previously treated patients with chronic HCV genotype 1 infection, as compared with peginterferon-ribavirin alone.	[Bacon, Bruce R.] St Louis Univ, Sch Med, St Louis, MO 63110 USA; [Gordon, Stuart C.] Henry Ford Hosp, Detroit, MI 48202 USA; [Lawitz, Eric] Alamo Med Res, San Antonio, TX USA; [Marcellin, Patrick] Univ Paris Diderot, Hop Beaujon, Clichy, France; [Vierling, John M.] Baylor Coll Med, Houston, TX 77030 USA; [Zeuzem, Stefan] JW Goethe Univ Hosp, Dept Med, Frankfurt, Germany; [Poordad, Fred] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Goodman, Zachary D.] Inova Fairfax Hosp, Falls Church, VA USA; [Goodman, Zachary D.] Betty & Guy Beatty Ctr Integrat Res, Falls Church, VA USA; [Sings, Heather L.; Boparai, Navdeep; Burroughs, Margaret; Brass, Clifford A.; Albrecht, Janice K.] Merck, Sharp & Dohme, Whitehouse Stn, NJ USA; [Esteban, Rafael] Hosp Gen Univ Vall Hebron, Barcelona, Spain; [Esteban, Rafael] Inst Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain	Saint Louis University; Henry Ford Health System; Henry Ford Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Baylor College of Medicine; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Cedars Sinai Medical Center; Inova Fairfax Hospital; Merck & Company; Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Bacon, BR (corresponding author), St Louis Univ, Sch Med, 3635 Vista Ave & Grand Blvd, St Louis, MO 63110 USA.	baconbr@slu.edu	Zeuzem, Stefan/AAE-7435-2019; Hezode, Christophe/U-4659-2018	esteban, rafael/0000-0001-5280-392X; Afdhal, Nezam/0000-0002-7342-6593; Albert, TRAN/0000-0003-0003-5361	Schering-Plough, Merck; NATIONAL CANCER INSTITUTE [K24CA139570] Funding Source: NIH RePORTER	Schering-Plough, Merck(Merck & CompanySchering Plough Corporation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Sponsored by Schering-Plough (now part of Merck).	Berman K, 2009, CLIN LIVER DIS, V13, P429, DOI 10.1016/j.cld.2009.05.008; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Germer JJ, 2004, J CLIN MICROBIOL, V42, P3911, DOI 10.1128/JCM.42.8.3911.2004; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Heathcote EJ, 2000, NEW ENGL J MED, V343, P1673, DOI 10.1056/NEJM200012073432302; Hofmann WP, 2008, LIVER INT, V28, P1332, DOI 10.1111/j.1478-3231.2008.01896.x; Hoofnagle JH, 2006, NEW ENGL J MED, V355, P2444, DOI 10.1056/NEJMct061675; Jacobson IM, 2007, HEPATOLOGY, V46, P971, DOI 10.1002/hep.21932; McHutchison JG, 2009, NEW ENGL J MED, V361, P1516; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Mederacke I, 2009, CURR OPIN INVEST DR, V10, P181; Muir AJ, 2004, NEW ENGL J MED, V351, P1268; Negro F, 2010, BEST PRACT RES CL GA, V24, P183, DOI 10.1016/j.bpg.2009.10.012; POORDAD F, 2010, 61 ANN M AM ASS STUD; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; World Health Organization (WHO), HEP C FACT SHEET; Zeuzem S, 2004, ANN INTERN MED, V140, P370, DOI 10.7326/0003-4819-140-5-200403020-00033; REBETOL RIBAVIRIN US; PEGINTRON PEGINTERFE	20	1324	1381	0	58	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2011	364	13					1207	1217		10.1056/NEJMoa1009482	http://dx.doi.org/10.1056/NEJMoa1009482			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	742NO	21449784	Green Accepted			2022-12-28	WOS:000288951300005
J	Sandblom, G; Varenhorst, E; Rosell, J; Lofman, O; Carlsson, P				Sandblom, Gabriel; Varenhorst, Eberhard; Rosell, Johan; Lofman, Owe; Carlsson, Per			Randomised prostate cancer screening trial: 20 year follow-up	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DIGITAL RECTAL EXAMINATION; CARCINOMA; OVERDETECTION; MORTALITY; REGISTER; BENEFITS; SWEDEN; IMPACT; COSTS	Objective To assess whether screening for prostate cancer reduces prostate cancer specific mortality. Design Population based randomised controlled trial. Setting Department of Urology, Norrkoping, and the South-East Region Prostate Cancer Register. Participants All men aged 50-69 in the city of Norrkoping, Sweden, identified in 1987 in the National Population Register (n=9026). Intervention From the study population, 1494 men were randomly allocated to be screened by including every sixth man from a list of dates of birth. These men were invited to be screened every third year from 1987 to 1996. On the first two occasions screening was done by digital rectal examination only. From 1993, this was combined with prostate specific antigen testing, with 4 mu g/L as cut off. On the fourth occasion (1996), only men aged 69 or under at the time of the investigation were invited. Main outcome measures Data on tumour stage, grade, and treatment from the South East Region Prostate Cancer Register. Prostate cancer specific mortality up to 31 December 2008. Results In the four screenings from 1987 to 1996 attendance was 1161/1492 (78%), 957/1363 (70%), 895/1210 (74%), and 446/606 (74%), respectively. There were 85 cases (5.7%) of prostate cancer diagnosed in the screened group and 292 (3.9%) in the control group. The risk ratio for death from prostate cancer in the screening group was 1.16 (95% confidence interval 0.78 to 1.73). In a Cox proportional hazard analysis comparing prostate cancer specific survival in the control group with that in the screened group, the hazard ratio for death from prostate cancer was 1.23 (0.94 to 1.62; P=0.13). After adjustment for age at start of the study, the hazard ratio was 1.58 (1.06 to 2.36; P=0.024). Conclusions After 20 years of follow-up the rate of death from prostate cancer did not differ significantly between men in the screening group and those in the control group.	[Sandblom, Gabriel] Karolinska Inst, CLINTEC, S-14186 Stockholm, Sweden; [Varenhorst, Eberhard] Linkoping Univ Hosp, Dept Urol, S-58185 Linkoping, Sweden; [Rosell, Johan] Linkoping Univ Hosp, Ctr Oncol, S-58185 Linkoping, Sweden; [Lofman, Owe] Norwegian Univ Life Sci, Dept Math Sci & Technol, N-1432 As, Norway; [Carlsson, Per] Linkoping Univ, Ctr Hlth Technol Assessment, Linkoping, Sweden	Karolinska Institutet; Linkoping University; Linkoping University; Norwegian University of Life Sciences; Linkoping University	Sandblom, G (corresponding author), Karolinska Inst, CLINTEC, S-14186 Stockholm, Sweden.	gabriel.sandblom@ki.se			Research Council of the South-East Region of Sweden [F97-318]; Swedish Cancer Foundation; County Council of Ostergotland	Research Council of the South-East Region of Sweden; Swedish Cancer Foundation; County Council of Ostergotland	This study was funded by the Research Council of the South-East Region of Sweden (No F97-318), the Swedish Cancer Foundation, and the County Council of Ostergotland.	Albertsen PC, 2010, UROLOGY, V75, P399, DOI 10.1016/j.urology.2009.08.078; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Bill-Axelson A, 2008, J NATL CANCER I, V100, P1144, DOI 10.1093/jnci/djn255; Britton M, 2002, INT J TECHNOL ASSESS, V18, P824, DOI 10.1017/S0266462302000636; CARLSSON P, 1990, HEALTH POLICY, V16, P241, DOI 10.1016/0168-8510(90)90425-D; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; Esserman L, 2009, JAMA-J AM MED ASSOC, V302, P1685, DOI 10.1001/jama.2009.1498; Fall K, 2008, SCAND J UROL NEPHROL, V42, P352, DOI 10.1080/00365590802078583; Heijnsdijk EAM, 2009, BRIT J CANCER, V101, P1833, DOI 10.1038/sj.bjc.6605422; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Johansson JE, 2004, JAMA-J AM MED ASSOC, V291, P2713, DOI 10.1001/jama.291.22.2713; Lin K, 2008, ANN INTERN MED, V149, P192, DOI 10.7326/0003-4819-149-3-200808050-00009; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; PEDERSEN KV, 1990, BRIT MED J, V300, P1041, DOI 10.1136/bmj.300.6731.1041; Sandblom G, 2003, SCAND J UROL NEPHROL, V37, P112, DOI 10.1080/00365590310008839; Sandblom G, 2004, EUR UROL, V46, P717, DOI 10.1016/j.eururo.2004.08.011; Sandblom G, 2008, CANCER, V112, P813, DOI 10.1002/cncr.23235; Schroder FH, 2010, EUR UROL, V58, P46, DOI 10.1016/j.eururo.2010.03.033; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Sennfalt K, 2006, EUR UROL, V49, P1028, DOI 10.1016/j.eururo.2005.12.018; Socialstyrelsen, 2010, SWED CENTR DEATH REG; Stattin P, 2003, SCAND J UROL NEPHROL, V37, P461, DOI 10.1080/00365590310015778; VARENHORST E, 1992, ACTA ONCOL, V31, P815, DOI 10.3109/02841869209089713; VARENHORST E, 1993, BRIT J UROL, V72, P173, DOI 10.1111/j.1464-410X.1993.tb00682.x	25	91	94	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 31	2011	342								d1539	10.1136/bmj.d1539	http://dx.doi.org/10.1136/bmj.d1539			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745WI	21454449	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000289201600001
J	Gott, M; Ingleton, C; Bennett, MI; Gardiner, C				Gott, Merryn; Ingleton, Christine; Bennett, Michael I.; Gardiner, Clare			Transitions to palliative care in acute hospitals in England: qualitative study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OF-LIFE CARE; HEART-FAILURE; CANCER; END; SPOTLIGHT; PEOPLE	Objective To explore how transitions to a palliative care approach are perceived to be managed in acute hospital settings in England. Design Qualitative study. Setting Secondary or primary care settings in two contrasting areas of England. Participants 58 health professionals involved in the provision of palliative care in secondary or primary care. Results Participants identified that a structured transition to a palliative care approach of the type advocated in UK policy guidance is seldom evident in acute hospital settings. In particular they reported that prognosis is not routinely discussed with inpatients. Achieving consensus among the clinical team about transition to palliative care was seen as fundamental to the transition being effected; however, this was thought to be insufficiently achieved in practice. Secondary care professionals reported that discussions about adopting a palliative care approach to patient management were not often held with patients; primary care professionals confirmed that patients were often discharged from hospital with "false hope" of cure because this information had not been conveyed. Key barriers to ensuring a smooth transition to palliative care included the difficulty of "standing back" in an acute hospital situation, professional hierarchies that limited the ability of junior medical and nursing staff to input into decisions on care, and poor communication. Conclusion Significant barriers to implementing a policy of structured transitions to palliative care in acute hospitals were identified by health professionals in both primary and secondary care. These need to be addressed if current UK policy on management of palliative care in acute hospitals is to be established.	[Gott, Merryn] Univ Auckland, Fac Med & Hlth Sci, Sch Nursing, Auckland 1, New Zealand; [Ingleton, Christine] Univ Sheffield, No Gen Hosp, Sch Nursing & Midwifery, Sheffield S10 2TN, S Yorkshire, England; [Bennett, Michael I.] Univ Lancaster, Sch Hlth & Med, Int Observ End Life Care, Lancaster LA1 4YW, England; [Gardiner, Clare] Univ Sheffield, St Lukes Hosp, Sch Nursing & Midwifery, Sheffield S10 2TN, S Yorkshire, England	University of Auckland; Northern General Hospital; University of Sheffield; Lancaster University; University of Sheffield	Gott, M (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Sch Nursing, Auckland 1, New Zealand.	m.gott@auckland.ac.nz	Harding, Richard/G-9729-2012; Bennett, Michael I/A-1620-2009	Bennett, Michael I/0000-0002-8369-8349; Gott, Merryn/0000-0003-4399-962X; Gardiner, Clare/0000-0003-1785-7054	National Institute of Health Research; National Institute for Health Research [08/1809/233] Funding Source: researchfish	National Institute of Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The study was funded by the National Institute of Health Research under the Service Delivery and Organisation programme. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the Department of Health. All authors declare independence from the study funders.	Barclay S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4862; Barnes S, 2006, HEALTH SOC CARE COMM, V14, P482, DOI 10.1111/j.1365-2524.2006.00636.x; Bell D, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3231; Bennett MI, 2010, PALLIATIVE MED, V24, P456, DOI 10.1177/0269216310366064; Boyd K, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4863; Burt R.S., 2005, BROKERAGE CLOSURE IN; Department of Health, 2008, END LIF CAR STRAT EN; Department of Health, 2010, ROUT SUCC END LIF CA; Doug M, 2009, ARCH DIS CHILD; General Medical Council, 2010, TREATM CAR END LIF G; Gold Standards Framework, 2010, GSF AC HOSP; Gomes B, 2008, PALLIATIVE MED, V22, P33, DOI 10.1177/0269216307084606; Gott M, 2009, PALLIATIVE MED, V23, P642, DOI 10.1177/0269216309106790; Gott M, 2007, PALLIATIVE MED, V21, P95, DOI 10.1177/0269216307076348; Grande G, 2009, PALLIATIVE MED, V23, P187, DOI 10.1177/0269216309102697; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Morgan D.L, 1996, FOCUS GROUPS QUALITA; Murray SA, 2008, BRIT MED J, V336, P958, DOI 10.1136/bmj.39535.491238.94; National Audit Office, 2008, END LIF CAR; O'Leary N, 2009, EUR J HEART FAIL, V11, P406, DOI 10.1093/eurjhf/hfp007; Schofield P, 2006, PALLIATIVE MED, V20, P397, DOI 10.1191/0269216306pm1156oa; Selman L, 2007, HEART, V93, P963, DOI 10.1136/hrt.2006.106518; Seymour J, 2011, LIVING AGEING DYING; The Gold Standards Framework, 2010, GSF PROGN IND GUID; van Walraven C, 2004, J GEN INTERN MED, V19, P624, DOI 10.1111/j.1525-1497.2004.30082.x	25	91	91	1	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 29	2011	342								d1773	10.1136/bmj.d1773	http://dx.doi.org/10.1136/bmj.d1773			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745WE	21447572	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000289200800004
J	Kiberstis, P; Marshall, E				Kiberstis, Paula; Marshall, Eliot			Celebrating an Anniversary INTRODUCTION	SCIENCE			English	Editorial Material																			0	10	10	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 25	2011	331	6024					1539	1539		10.1126/science.331.6024.1539-a	http://dx.doi.org/10.1126/science.331.6024.1539-a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739XH	21436434				2022-12-28	WOS:000288754500036
J	Kendall, T; Tyrer, P; Whittington, C; Taylor, C				Kendall, Tim; Tyrer, Peter; Whittington, Craig; Taylor, Clare		Guideline Dev Grp	Guidelines Assessment and management of psychosis with coexisting substance misuse: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DISORDERS; ALCOHOL					tim2.kendall@virgin.net	Whittington, Craig/B-1380-2008	Whittington, Craig/0000-0002-1950-0334				[Anonymous], 2007, CLIN GUID NAT I HLTH; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Cerullo MA, 2007, SUBST ABUSE TREAT PR, V2, DOI 10.1186/1747-597X-2-29; Gregg L, 2007, CLIN PSYCHOL REV, V27, P494, DOI 10.1016/j.cpr.2006.09.004; Jackson CT, 2007, PSYCHIAT SERV, V58, P270, DOI 10.1176/appi.ps.58.2.270; Kavanagh DJ, 2004, SCHIZOPHR RES, V66, P115, DOI 10.1016/S0920-9964(03)00130-0; Loubser I., 2009, J PSYCHIAT INTENSIVE, V5, P33, DOI [https://doi.org/10.1017/S1742646408001386, DOI 10.1017/S1742646408001386]; McCreadie RG, 2002, BRIT J PSYCHIAT, V181, P321, DOI 10.1192/bjp.181.4.321; Moolchan ET, 2001, J ADDICT DIS, V20, P55, DOI 10.1300/J069v20n02_05; National Institute for Health and Clinical Excellence, 2009, GUID MAN; National Institute for Health and Clinical Excellence, 2011, CLIN GUID NAT I HLTH; National Institute for Health and Clinical Excellence, 2009, CLIN GUID NAT I HLTH; National Institute for Health and Clinical Excellence, 2006, CLIN GUID NAT I HLTH; Noordsy DL, 2003, SUBSTANCE MISUSE PSY, P159; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; Ries RK, 2004, PSYCHIAT SERV, V55, P445, DOI 10.1176/appi.ps.55.4.445; Tracy K, 2007, AM J DRUG ALCOHOL AB, V33, P253, DOI 10.1080/00952990601174931; Urichuk L, 2008, CURR DRUG METAB, V9, P410, DOI 10.2174/138920008784746373	18	6	6	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2011	342								d1351	10.1136/bmj.d1351	http://dx.doi.org/10.1136/bmj.d1351			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	742MJ	21430003				2022-12-28	WOS:000288948000003
J	Tan, T; Shaw, EJ; Siddiqui, F; Kandaswamy, P; Barry, PW; Baker, M				Tan, T.; Shaw, E. J.; Siddiqui, F.; Kandaswamy, P.; Barry, P. W.; Baker, M.		Guideline Dev Grp	Guidelines Inpatient management of diabetic foot problems: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material												pwb1@leicester.ac.uk						Diabetes UK, 2009, PUTT FEET 1 COMM SPE; *NAT I HLTH CLIN E, 2011, CLIN GUID NAT I HLTH, V114; *NAT I HLTH CLIN E, 2011, CLIN GUID NAT I HLTH, V119; *NAT I HLTH CLIN E, 2008, CLIN GUID NAT I HLTH, V73; *NAT I HLTH CLIN E, 2004, CLIN GUID NAT I HLTH, V10; Reiber GE, 1999, DIABETES CARE, V22, P157, DOI 10.2337/diacare.22.1.157	6	19	25	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 23	2011	342								d1280	10.1136/bmj.d1280	http://dx.doi.org/10.1136/bmj.d1280			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	742MJ	21430002				2022-12-28	WOS:000288948000014
J	Bradforth, S				Bradforth, Stephen			Tracking State-to-State Bimolecular Reaction Dynamics in Solution	SCIENCE			English	Editorial Material							RELAXATION; SPECTROSCOPY; LIQUIDS; ICN		Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA	University of Southern California	Bradforth, S (corresponding author), Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA.	stephen.bradforth@usc.edu	Bradforth, Stephen E/B-5186-2008; Bradforth, Stephen/GSM-7470-2022	Bradforth, Stephen E/0000-0002-6164-3347; 				BENJAMIN I, 1995, J CHEM PHYS, V103, P2459, DOI 10.1063/1.470695; Crim FF, 2008, P NATL ACAD SCI USA, V105, P12654, DOI 10.1073/pnas.0803010105; Deng YQ, 2002, J CHEM PHYS, V117, P10752, DOI 10.1063/1.1517300; Dong WR, 2010, SCIENCE, V327, P1501, DOI 10.1126/science.1185694; Greaves SJ, 2011, SCIENCE, V331, P1423, DOI 10.1126/science.1197796; KOMPA KL, 1967, J CHEM PHYS, V47, P857, DOI 10.1063/1.1711963; Larsen J, 2002, J CHEM PHYS, V116, P7997, DOI 10.1063/1.1467897; Moskun AC, 2006, SCIENCE, V311, P1907, DOI 10.1126/science.1123738; OWRUTSKY JC, 1994, ANNU REV PHYS CHEM, V45, P519, DOI 10.1146/annurev.pc.45.100194.002511; POLANYI JC, 1972, ACCOUNTS CHEM RES, V5, P161, DOI 10.1021/ar50053a001; RAFTERY D, 1994, J CHEM PHYS, V101, P8572, DOI 10.1063/1.468052; Voth GA, 1996, J PHYS CHEM-US, V100, P13034, DOI 10.1021/jp960317e; Wang FY, 2011, SCIENCE, V331, P900, DOI 10.1126/science.1199771	13	4	4	3	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2011	331	6023					1398	1399		10.1126/science.1203629	http://dx.doi.org/10.1126/science.1203629			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21415344				2022-12-28	WOS:000288504000029
J	Grecco, HE; Schmick, M; Bastiaens, PIH				Grecco, Heman E.; Schmick, Malte; Bastiaens, Philippe I. H.			Signaling from the Living Plasma Membrane	CELL			English	Review							EPIDERMAL-GROWTH-FACTOR; PROTEIN-TYROSINE-PHOSPHATASE; BIOLOGICAL-MEMBRANES; RECEPTOR COMPLEXES; LATERAL DIFFUSION; RAS LOCALIZATION; POLARIZED CELLS; KINASE-ACTIVITY; BETA-RECEPTOR; A431 CELLS	Our understanding of the plasma membrane, once viewed simply as a static barrier, has been revolutionized to encompass a complex, dynamic organelle that integrates the cell with its extracellular environment. Here, we discuss how bidirectional signaling across the plasma membrane is achieved by striking a delicate balance between restriction and propagation of information over different scales of time and space and how underlying dynamic mechanisms give rise to rich, context-dependent signaling responses. In this Review, we show how computer simulations can generate counterintuitive predictions about the spatial organization of these complex processes.	[Grecco, Heman E.; Schmick, Malte; Bastiaens, Philippe I. H.] Max Planck Inst Mol Physiol, Dept Syst Cell Biol, D-44227 Dortmund, Germany; [Bastiaens, Philippe I. H.] TU Dortmund, Fac Chem, Dept Biol Chem, D-44227 Dortmund, Germany	Max Planck Society; Dortmund University of Technology	Bastiaens, PIH (corresponding author), Max Planck Inst Mol Physiol, Dept Syst Cell Biol, Otto Hahn Str 11, D-44227 Dortmund, Germany.	philippe.bastiaens@mpi-dortmund.mpg.de						Augsten M, 2006, EMBO REP, V7, P46, DOI 10.1038/sj.embor.7400560; BAASS PC, 1995, TRENDS CELL BIOL, V5, P465, DOI 10.1016/S0962-8924(00)89116-3; Birtwistle MR, 2009, MOL ONCOL, V3, P308, DOI 10.1016/j.molonc.2009.05.009; Bohdanowicz M, 2010, CURR BIOL, V20, pR311, DOI 10.1016/j.cub.2010.02.030; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; BUDAY L, 1995, ONCOGENE, V11, P1327; Chen YS, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001131; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Cosker KE, 2008, CURR OPIN NEUROBIOL, V18, P270, DOI 10.1016/j.conb.2008.08.005; Dehmelt L, 2010, NAT REV MOL CELL BIO, V11, P440, DOI 10.1038/nrm2903; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Del Conte-Zerial P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.45; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Devaux PF, 2004, TRAFFIC, V5, P241, DOI 10.1111/j.1600-0854.2004.0170.x; EHLERS MD, 1995, J CELL BIOL, V130, P149, DOI 10.1083/jcb.130.1.149; Finkel T, 2006, ANTIOXID REDOX SIGN, V8, P1857, DOI 10.1089/ars.2006.8.1857; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; Frank C, 2004, J BIOL CHEM, V279, P11375, DOI 10.1074/jbc.M309096200; Freedman TS, 2006, P NATL ACAD SCI USA, V103, P16692, DOI 10.1073/pnas.0608127103; Garrenton LS, 2010, P NATL ACAD SCI USA, V107, P11805, DOI 10.1073/pnas.1005817107; Goentoro L, 2009, MOL CELL, V36, P894, DOI 10.1016/j.molcel.2009.11.018; Griffiths G, 2007, NAT REV MOL CELL BIO, V8, P1018, DOI 10.1038/nrm2287; Grimes ML, 1996, J NEUROSCI, V16, P7950; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Harding AS, 2008, TRENDS CELL BIOL, V18, P364, DOI 10.1016/j.tcb.2008.05.006; Howe CL, 2005, THEOR BIOL MED MODEL, V2, DOI 10.1186/1742-4682-2-43; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; Innocenti M, 2002, J CELL BIOL, V156, P125, DOI 10.1083/jcb.200108035; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Jang IK, 2010, P NATL ACAD SCI USA, V107, P10620, DOI 10.1073/pnas.0905039107; Janmey PA, 2006, TRENDS CELL BIOL, V16, P538, DOI 10.1016/j.tcb.2006.08.009; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Karlsson S, 2006, MOL BIOL CELL, V17, P4846, DOI 10.1091/mbc.E06-04-0306; Kholodenko BN, 2008, CELL, V133, P566, DOI 10.1016/j.cell.2008.04.033; Kusumi A, 1996, CURR OPIN CELL BIOL, V8, P566, DOI 10.1016/S0955-0674(96)80036-6; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Lim WA, 2010, CELL, V142, P661, DOI 10.1016/j.cell.2010.08.023; Linder ME, 2003, BIOCHEMISTRY-US, V42, P4311, DOI 10.1021/bi034159a; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lonhienne TGA, 2010, P NATL ACAD SCI USA, V107, P12883, DOI 10.1073/pnas.1001085107; Lorentzen A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.20001370; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; Markus M, 1999, MATH BIOSCI, V156, P191, DOI 10.1016/S0025-5564(98)10066-4; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Matheos D, 2004, J CELL BIOL, V165, P99, DOI 10.1083/jcb.200309089; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Muth TR, 2003, ANNU REV CELL DEV BI, V19, P333, DOI 10.1146/annurev.cellbio.19.110701.161425; Nakakuki T, 2010, CELL, V141, P884, DOI 10.1016/j.cell.2010.03.054; Nelson S, 1999, ENDOCRINOLOGY, V140, P950, DOI 10.1210/en.140.2.950; Niethammer P, 2004, SCIENCE, V303, P1862, DOI 10.1126/science.1094108; Niethammer P, 2007, PLOS BIOL, V5, P190, DOI 10.1371/journal.pbio.0050029; Oakley FD, 2009, ANTIOXID REDOX SIGN, V11, P1313, DOI 10.1089/ARS.2008.2363; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Ramadurai S, 2010, BIOPHYS J, V99, P1482, DOI 10.1016/j.bpj.2010.06.036; Rashid S, 2009, J BIOL CHEM, V284, P18115, DOI 10.1074/jbc.M109.007237; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Reynolds AR, 2003, NAT CELL BIOL, V5, P447, DOI 10.1038/ncb981; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Sawano A, 2002, DEV CELL, V3, P245, DOI 10.1016/S1534-5807(02)00224-1; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; SILVIUS JR, 1994, BIOCHEMISTRY-US, V33, P3014, DOI 10.1021/bi00176a034; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Smotrys JE, 2004, ANNU REV BIOCHEM, V73, P559, DOI 10.1146/annurev.biochem.73.011303.073954; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; SORKIN A, 1991, J CELL BIOL, V112, P55, DOI 10.1083/jcb.112.1.55; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Spang A, 2009, BIOL CHEM, V390, P753, DOI 10.1515/BC.2009.056; Stelling J, 2009, J MATH BIOL, V58, P35, DOI 10.1007/s00285-008-0162-6; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tischer C, 2003, NAT REV MOL CELL BIO, V4, P971, DOI 10.1038/nrm1258; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; UCHIDA T, 1994, J BIOL CHEM, V269, P12220; van den Bogaart G, 2010, NAT STRUCT MOL BIOL, V17, P358, DOI 10.1038/nsmb.1748; van der Wouden JM, 2003, INT REV CYTOL, V226, P127, DOI 10.1016/S0074-7696(03)01003-9; van Drogen F, 2001, NAT CELL BIOL, V3, P1051, DOI 10.1038/ncb1201-1051; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vartak N, 2010, EMBO J, V29, P2689, DOI 10.1038/emboj.2010.184; Wiley HS, 2001, TRAFFIC, V2, P12, DOI 10.1034/j.1600-0854.2001.020103.x; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Wouters FS, 1999, CURR BIOL, V9, P1127, DOI 10.1016/S0960-9822(99)80484-9; ZIDOVETZKI R, 1981, P NATL ACAD SCI-BIOL, V78, P6981, DOI 10.1073/pnas.78.11.6981; Zimmerberg J, 2006, NAT CHEM BIOL, V2, P564, DOI 10.1038/nchembio1106-564	100	166	168	4	57	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 18	2011	144	6					897	909		10.1016/j.cell.2011.01.029	http://dx.doi.org/10.1016/j.cell.2011.01.029			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	737BQ	21414482	Bronze			2022-12-28	WOS:000288543500009
J	Ooi, T				Ooi, Takashi			Heat and Light Switch a Chiral Catalyst and Its Products	SCIENCE			English	Editorial Material							MICHAEL ADDITION		Nagoya Univ, Aichi 4648603, Japan	Nagoya University	Ooi, T (corresponding author), Nagoya Univ, Aichi 4648603, Japan.	tooi@apchem.nagoya-u.ac.jp	Ooi, Takashi/AAD-2730-2022; Ooi, Takashi/E-2364-2012	Ooi, Takashi/0000-0003-2332-0472; Ooi, Takashi/0000-0003-2332-0472				Connon SJ, 2006, CHEM-EUR J, V12, P5418, DOI 10.1002/chem.200501076; Dalko P. I., 2007, ENANTIOSELECTIVE ORG; Jacobsen E. N., 1999, COMPREHENSIVE ASYMME, V1-3; Koumura N, 1999, NATURE, V401, P152, DOI 10.1038/43646; Nojiri A, 2009, J AM CHEM SOC, V131, P3779, DOI 10.1021/ja900084k; Rabalakos C, 2008, J AM CHEM SOC, V130, P13524, DOI 10.1021/ja805390k; Rana NK, 2010, J ORG CHEM, V75, P2089, DOI 10.1021/jo902634a; Sohtome Y, 2010, ANGEW CHEM INT EDIT, V49, P9254, DOI 10.1002/anie.201005109; Stoll RS, 2010, ANGEW CHEM INT EDIT, V49, P5054, DOI 10.1002/anie.201000146; Wang JB, 2011, SCIENCE, V331, P1429, DOI 10.1126/science.1199844; Wurz RP, 2007, CHEM REV, V107, P5570, DOI 10.1021/cr068370e; Yoon TP, 2003, SCIENCE, V299, P1691, DOI 10.1126/science.1083622	12	9	9	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2011	331	6023					1395	1396		10.1126/science.1203272	http://dx.doi.org/10.1126/science.1203272			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21415343				2022-12-28	WOS:000288504000027
J	Bindman, AB; Schneider, AG				Bindman, Andrew B.; Schneider, Andreas G.			Catching a Wave - Implementing Health Care Reform in California	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bindman, Andrew B.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Bindman, Andrew B.] Univ Calif San Francisco, Dept Hlth Policy, San Francisco, CA 94143 USA; [Bindman, Andrew B.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Schneider, Andreas G.] George Washington Sch Publ Hlth, Washington, DC USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; George Washington University	Bindman, AB (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.							Bindman A. B., 2010, PHYS PARTICIPATION M; Hadley J, 2008, HEALTH AFFAIR, V27, pW399, DOI 10.1377/hlthaff.27.5.w399; Katz MH, 2008, NEW ENGL J MED, V358, P327, DOI 10.1056/NEJMp0706590; Long P, 2011, HEALTH AFFAIR, V30, P63, DOI 10.1377/hlthaff.2010.0961; Zuckerman S, 2009, HEALTH AFFAIR, V28, pW510, DOI 10.1377/hlthaff.28.3.w510	5	10	10	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 21	2011	364	16					1487	1489		10.1056/NEJMp1014109	http://dx.doi.org/10.1056/NEJMp1014109			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	752VH	21449773				2022-12-28	WOS:000289722700002
J	Smagulova, F; Gregoretti, IV; Brick, K; Khil, P; Camerini-Otero, RD; Petukhova, GV				Smagulova, Fatima; Gregoretti, Ivan V.; Brick, Kevin; Khil, Pavel; Camerini-Otero, R. Daniel; Petukhova, Galina V.			Genome-wide analysis reveals novel molecular features of mouse recombination hotspots	NATURE			English	Article							MEIOTIC RECOMBINATION; HOT-SPOT; PRDM9; GENE; MAP; INSTABILITY	Meiotic recombination predominantly occurs at discrete genomic loci called recombination hotspots, but the features defining these areas are still largely unknown (reviewed in refs 1-5). To allow a comprehensive analysis of hotspot-associated DNA and chromatin characteristics, we developed a direct molecular approach for mapping meiotic DNA double-strand breaks that initiate recombination. Here we present the genome-wide distribution of recombination initiation sites in the mouse genome. Hotspot centres are mapped with approximately 200-nucleotide precision, which allows analysis of the fine structural details of the preferred recombination sites. We determine that hotspots share a centrally distributed consensus motif, possess a nucleotide skew that changes polarity at the centres of hotspots and have an intrinsic preference to be occupied by a nucleosome. Furthermore, we find that the vast majority of recombination initiation sites in mouse males are associated with testis-specific trimethylation of lysine 4 on histone H3 that is distinct from histone H3 lysine 4 trimethylation marks associated with transcription. The recombination map presented here has been derived from a homogeneous mouse population with a defined genetic background and therefore lends itself to extensive future experimental exploration. We note that the mapping technique developed here does not depend on the availability of genetic markers and hence can be easily adapted to other species with complex genomes. Our findings uncover several fundamental features of mammalian recombination hotspots and underline the power of the new recombination map for future studies of genetic recombination, genome stability and evolution.	[Smagulova, Fatima; Petukhova, Galina V.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Gregoretti, Ivan V.; Brick, Kevin; Khil, Pavel; Camerini-Otero, R. Daniel] NIDDKD, NIH, Bethesda, MD 20892 USA	Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Petukhova, GV (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.	rdcamerini@mail.nih.gov; gpetukhova@usuhs.mil	Brick, Kevin/N-1156-2019; Smagulova, Fatima/K-5459-2015	Brick, Kevin/0000-0002-9596-6400; Khil, Pavel/0000-0002-4903-8777; Smagulova, Fatima/0000-0001-6883-1968; Mott, Richard/0000-0002-1022-9330	March of Dimes Foundation [5-FY07-667]; NIGMS, NIH [1R01GM084104-01A1]; USUHS [FS71HU, R071HU, CS71HU]; NIDDK (NIH); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK052034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084104] Funding Source: NIH RePORTER	March of Dimes Foundation(March of Dimes); NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); USUHS; NIDDK (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Lichten (NCI, NIH) and P. Hsieh (NIDDK, NIH) for comments and discussion. We are grateful to S. Sharmeen for her help with high-throughput sequencing. This work was supported in part by Basil O'Connor Starter Scholar Research Award Grant No. 5-FY07-667 from the March of Dimes Foundation (G. V. P.); NIH grant 1R01GM084104-01A1 from NIGMS (G. V. P.); New Investigator Start-up Grants FS71HU, R071HU and CS71HU from USUHS (G. V. P.); and the NIDDK (NIH) Intramural Research Program (R.D.C.-O.).	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Arnheim N, 2007, ANNU REV GENET, V41, P369, DOI 10.1146/annurev.genet.41.110306.130301; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Buard J, 2007, TRENDS GENET, V23, P301, DOI 10.1016/j.tig.2007.03.014; Buard J, 2009, EMBO J, V28, P2616, DOI 10.1038/emboj.2009.207; BURGOYNE PS, 1982, HUM GENET, V61, P85, DOI 10.1007/BF00274192; Clark AG, 2010, ANNU REV GENOM HUM G, V11, P45, DOI 10.1146/annurev-genom-082908-150031; Cox A, 2009, GENETICS, V182, P1335, DOI 10.1534/genetics.109.105486; Francino MP, 1997, TRENDS GENET, V13, P240, DOI 10.1016/S0168-9525(97)01118-9; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kauppi L, 2009, METHODS MOL BIOL, V557, P323, DOI 10.1007/978-1-59745-527-5_20; Khambata S, 1996, GENOME RES, V6, P195, DOI 10.1101/gr.6.3.195; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Lichten Michael, 2008, V3, P165, DOI 10.1007/7050_2008_040; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; Paigen K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000119; Paigen K, 2010, NAT REV GENET, V11, P221, DOI 10.1038/nrg2712; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Petukhova GV, 2003, DEV CELL, V5, P927, DOI 10.1016/S1534-5807(03)00369-1; Qin J, 2004, MOL CELL BIOL, V24, P1655, DOI 10.1128/MCB.24.4.1655-1666.2004; Wang ZB, 2009, CURR OPIN GENET DEV, V19, P127, DOI 10.1016/j.gde.2009.02.001	30	235	237	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					375	378		10.1038/nature09869	http://dx.doi.org/10.1038/nature09869			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21460839	Green Accepted			2022-12-28	WOS:000289724600045
J	Wu, D; Molofsky, AB; Liang, HE; Ricardo-Gonzalez, RR; Jouihan, HA; Bando, JK; Chawla, A; Locksley, RM				Wu, Davina; Molofsky, Ari B.; Liang, Hong-Erh; Ricardo-Gonzalez, Roberto R.; Jouihan, Hani A.; Bando, Jennifer K.; Chawla, Ajay; Locksley, Richard M.			Eosinophils Sustain Adipose Alternatively Activated Macrophages Associated with Glucose Homeostasis	SCIENCE			English	Article							T-CELLS; IN-VIVO; INSULIN-RESISTANCE; TISSUE; INFLAMMATION; OBESITY; POLARIZATION; EXPRESSION; CYTOKINES; DISEASE	Eosinophils are associated with helminth immunity and allergy, often in conjunction with alternatively activated macrophages (AAMs). Adipose tissue AAMs are necessary to maintain glucose homeostasis and are induced by the cytokine interleukin-4 (IL-4). Here, we show that eosinophils are the major IL-4-expressing cells in white adipose tissues of mice, and, in their absence, AAMs are greatly attenuated. Eosinophils migrate into adipose tissue by an integrin-dependent process and reconstitute AAMs through an IL-4- or IL-13-dependent process. Mice fed a high-fat diet develop increased body fat, impaired glucose tolerance, and insulin resistance in the absence of eosinophils, and helminth-induced adipose tissue eosinophilia enhances glucose tolerance. Our results suggest that eosinophils play an unexpected role in metabolic homeostasis through maintenance of adipose AAMs.	[Wu, Davina; Liang, Hong-Erh; Bando, Jennifer K.; Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Molofsky, Ari B.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Ricardo-Gonzalez, Roberto R.; Jouihan, Hani A.] Stanford Univ, Sch Med, Dept Med, Div Endocrinol Metab & Gerontol, Stanford, CA 94305 USA; [Chawla, Ajay] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94107 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94107 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Med, San Francisco, CA 94107 USA; [Locksley, Richard M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Locksley, Richard M.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Locksley, RM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	locksley@medicine.ucsf.edu		Bando, Jennifer/0000-0002-1331-7424; Molofsky, Ari/0000-0003-0764-3175; Ricardo-Gonzalez, Roberto/0000-0002-6135-4035	Howard Hughes Medical Institute; NIH [AI026918, 5F30DK083194-02]; Juvenile Diabetes Research Foundation; Larry L. Hillblom Foundation; Sandler Asthma Basic Research Center; Diabetes Endocrinology Research Center [DK063720]; UCSF; UCSF Department of Laboratory Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026918, R37AI026918, R01AI030663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720, F30DK083194, R01DK081405, R01DK076760] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006415] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Larry L. Hillblom Foundation; Sandler Asthma Basic Research Center; Diabetes Endocrinology Research Center; UCSF; UCSF Department of Laboratory Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank J. Cyster, D. Erle, C. Gerard, J. Lee, and A. McKenzie for reagents and mice; N. Flores for animal husbandry; Z. Wang for technical assistance; and M. Anderson and C. Lowell for constructive review of the manuscript. This work was supported by the Howard Hughes Medical Institute and grants from the NIH (AI026918), Juvenile Diabetes Research Foundation Innovative Grant, Larry L. Hillblom Foundation Network Grant and the Sandler Asthma Basic Research Center. Support was provided by the Diabetes Endocrinology Research Center grant DK063720, UCSF Medical Scientist Training Program (D. W.), UCSF Department of Laboratory Medicine (A. B. M.), and 5F30DK083194-02 from the National Institutes of Health (D. W.). Animal care was in accordance with UCSF Laboratory Animal Resource Center committee guidelines. Mouse strains described are available upon completion of standard institutional Material Transfer Agreements.	Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Jeninga EH, 2009, TRENDS ENDOCRIN MET, V20, P380, DOI 10.1016/j.tem.2009.04.005; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Karita E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004401; Lee NA, 1997, J IMMUNOL, V158, P1332; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; McKenzie GJ, 1999, J EXP MED, V189, P1565, DOI 10.1084/jem.189.10.1565; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Voehringer D, 2007, J LEUKOCYTE BIOL, V81, P1434, DOI 10.1189/jlb.1106686; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Zu LX, 2009, J BIOL CHEM, V284, P5915, DOI 10.1074/jbc.M807852200	25	923	943	1	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					243	247		10.1126/science.1201475	http://dx.doi.org/10.1126/science.1201475			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21436399	Green Accepted			2022-12-28	WOS:000289251100054
J	Douglas, I; Evans, S; Smeeth, L				Douglas, Ian; Evans, Stephen; Smeeth, Liam			Effect of statin treatment on short term mortality after pneumonia episode: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							C-REACTIVE PROTEIN; THERAPY	Objective To determine whether statins protect against all cause mortality after a diagnosis of pneumonia. Design Cohort study using propensity score based method to control for differences between people prescribed and not prescribed statins. Setting United Kingdom Health Improvement Network database, which contains electronic primary care medical records of more than six million patients. Participants Every patient starting a statin between 1995 and 2006 (129 288) matched with up to five non-statin users (n=600 241); 9073 patients had a recorded diagnosis of pneumonia, of whom 1398 were using a statin. Main outcome measure All cause mortality within six months of diagnosis of pneumonia. Results Among users and non-users of statins with comparable propensity scores, 95/942 users and 686/ 3615 non-users died on the day that pneumonia was diagnosed. In the following six month period, 109/847 statin users died compared with 578/2927 non-users, giving an adjusted hazard ratio of 0.67 (0.49 to 0.91). If these observed benefits translated into clinical practice, 15 patients would need to be treated with a statin for six months after pneumonia to prevent one death. Conclusions Compared with people who were not taking statins, the risk of dying in the six month period after pneumonia was substantially lower among people who were already established on long term statin treatment when the pneumonia occurred. Whether some or all of this protective effect would be obtained if statin treatment begins when a patient first develops pneumonia is not known. However, given that statins are cheap, safe, and well tolerated, a clinical trial in which people with pneumonia are randomised to a short period of statin treatment is warranted.	[Douglas, Ian; Evans, Stephen; Smeeth, Liam] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Douglas, I (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	ian.douglas@lshtm.ac.uk	; Smeeth, Liam/X-5862-2018	Evans, Stephen/0000-0002-1474-2596; Smeeth, Liam/0000-0002-9168-6022	Wellcome Trust; Medical Research Council; MRC [G0802403] Funding Source: UKRI; Medical Research Council [G0802403] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	During this work, ID was funded by grants from the Wellcome Trust and the Medical Research Council paid to the London School of Hygiene and Tropical Medicine. LS was funded by a grant from the Wellcome Trust. Sponsors played no role in the study design; the collection, analysis, and interpretation of data; the writing of the article; or the decision to submit it for publication	Almog Y, 2004, CIRCULATION, V110, P880, DOI 10.1161/01.CIR.0000138932.17956.F1; Armitage J, 2007, LANCET, V370, P1781, DOI 10.1016/S0140-6736(07)60716-8; Bourke Alison, 2004, Inform Prim Care, V12, P171; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Frost FJ, 2007, CHEST, V131, P1006, DOI 10.1378/chest.06-1997; Hackam DG, 2006, LANCET, V367, P413, DOI 10.1016/S0140-6736(06)68041-0; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Laufs U, 2001, AM J CARDIOL, V88, P1306, DOI 10.1016/S0002-9149(01)02095-1; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P1195, DOI 10.1002/pds.1441; Li JJ, 2006, ANGIOLOGY, V57, P1, DOI 10.1177/000331970605700101; Liao JK, 2005, AM J CARDIOL, V96, p24F, DOI 10.1016/j.amjcard.2005.06.009; Lodi S, 2010, BRIT J CLIN PHARMACO, V69, P85, DOI 10.1111/j.1365-2125.2009.03560.x; Majumdar SR, 2006, BMJ-BRIT MED J, V333, P999, DOI 10.1136/BMJ.38992.565972.7C; Mortensen EM, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-82; Myles PR, 2009, PHARMACOEPIDEM DR S, V18, P697, DOI 10.1002/pds.1769; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Office for National Statistics, 2008, GUID DOCT COMPL MED; Smeeth L, 2009, BRIT J CLIN PHARMACO, V67, P99, DOI 10.1111/j.1365-2125.2008.03308.x; Sturmer T, 2010, AM J EPIDEMIOL, V172, P843, DOI 10.1093/aje/kwq198; Sturmer T, 2006, J CLIN EPIDEMIOL, V59, P437, DOI 10.1016/j.jclinepi.2005.07.004; Terblanche M, 2006, LANCET INFECT DIS, V6, P242, DOI 10.1016/S1473-3099(06)70439-X; Tleyjeh IM, 2009, ARCH INTERN MED, V169, P1658, DOI 10.1001/archinternmed.2009.286	22	61	61	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 6	2011	342								d1642	10.1136/bmj.d1642	http://dx.doi.org/10.1136/bmj.d1642			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749JR	21471172	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000289462100001
J	Moynihan, R				Moynihan, Ray			Power to the people	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Newcastle, Callaghan, NSW 2308, Australia	University of Newcastle	Moynihan, R (corresponding author), Univ Newcastle, Callaghan, NSW 2308, Australia.	Ray.Moynihan@newcastle.edu.au	Moynihan, Ray/ABC-3010-2020						0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 6	2011	342								d2002	10.1136/bmj.d2002	http://dx.doi.org/10.1136/bmj.d2002			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	749JR	21471161				2022-12-28	WOS:000289462100007
J	Kim, S; Grant, RA; Sauer, RT				Kim, Seokhee; Grant, Robert A.; Sauer, Robert T.			Covalent Linkage of Distinct Substrate Degrons Controls Assembly and Disassembly of DegP Proteolytic Cages	CELL			English	Article							ESCHERICHIA-COLI; SERINE-PROTEASE; HTRA GENE; CHAPERONE; PDZ; TRANSCRIPTION; ACTIVATION; PROTEINS; ENVELOPE; TEMPERATURES	Protein quality control requires careful regulation of intracellular proteolysis. For DegP, a periplasmic protease, substrates promote assembly of inactive hexamers into proteolytically active cages with 12, 18, 24, or 30 subunits. Here, we show that sensitive activation and cage assembly require covalent linkage of distinct substrate sequences that affect degradation (degrons). One degron binds the DegP active site, and another degron binds a separate tethering site in PDZ1 in the crystal structure of a substrate-bound DegP dodecamer. FRET experiments demonstrate that active cages assemble rapidly in a reaction that is positively cooperative in substrate concentration, remain stably assembled while uncleaved substrate is present, and dissociate once degradation is complete. Thus, the energy of binding of linked substrate degrons drives assembly of the proteolytic machine responsible for subsequent degradation. Substrate cleavage and depletion results in disassembly, ensuring that DegP is proteolytically active only when sufficient quantities of protein substrates are present.	[Kim, Seokhee; Grant, Robert A.; Sauer, Robert T.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Sauer, RT (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	bobsauer@mit.edu	Kim, Seokhee/C-2303-2018	Kim, Seokhee/0000-0003-0806-583X; Sauer, Robert/0000-0002-1719-5399	NIH [AI-16892]; NIH-NCRR [RR-15301]; DOE Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI016892] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DOE Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Cezairliyan, A. de Regt, S. Glynn, D. Kahne, H. Kim, I. Levchenko, S. Lima, A. Olivares, I. Papayannopoulos, D. Pheasant, K. Schmitz, T. Schwartz, J. Sohn, and S. F. Sui for help, information, and discussions. Supported by NIH-grant AI-16892. Studies at the NE-CAT beamlines of the Advanced Photon Source were supported by NIH-NCRR award RR-15301 and by the DOE Office of Basic Energy Sciences under contract DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; DANESE PN, 1995, GENE DEV, V9, P387, DOI 10.1101/gad.9.4.387; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Duguay AR, 2004, BBA-MOL CELL RES, V1694, P121, DOI 10.1016/j.bbamcr.2004.04.012; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Iwanczyk J, 2007, J BACTERIOL, V189, P3176, DOI 10.1128/JB.01788-06; Jiang JS, 2008, P NATL ACAD SCI USA, V105, P11939, DOI 10.1073/pnas.0805464105; Jomaa A, 2007, J BACTERIOL, V189, P706, DOI 10.1128/JB.01334-06; Kolmar H, 1996, J BACTERIOL, V178, P5925, DOI 10.1128/jb.178.20.5925-5929.1996; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; Krojer T, 2008, P NATL ACAD SCI USA, V105, P7702, DOI 10.1073/pnas.0803392105; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Krojer T, 2010, NAT STRUCT MOL BIOL, V17, P844, DOI 10.1038/nsmb.1840; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; LIPINSKA B, 1988, NUCLEIC ACIDS RES, V16, P10053, DOI 10.1093/nar/16.21.10053; LIPINSKA B, 1989, J BACTERIOL, V171, P1574, DOI 10.1128/jb.171.3.1574-1584.1989; LIPINSKA B, 1990, J BACTERIOL, V172, P1791, DOI 10.1128/jb.172.4.1791-1797.1990; Merdanovic M, 2010, NAT STRUCT MOL BIOL, V17, P837, DOI 10.1038/nsmb.1839; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Rizzitello AE, 2001, J BACTERIOL, V183, P6794, DOI 10.1128/JB.183.23.6794-6800.2001; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; Sohn J, 2007, CELL, V131, P572, DOI 10.1016/j.cell.2007.08.044; Sohn J, 2009, MOL CELL, V33, P64, DOI 10.1016/j.molcel.2008.12.017; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; STRAUCH KL, 1989, J BACTERIOL, V171, P2689, DOI 10.1128/jb.171.5.2689-2696.1989; SWAMY KHS, 1983, ARCH BIOCHEM BIOPHYS, V224, P543, DOI 10.1016/0003-9861(83)90242-4; Vande Walle L, 2008, CELL DEATH DIFFER, V15, P453, DOI 10.1038/sj.cdd.4402291; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4	35	60	63	3	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2011	145	1					67	78		10.1016/j.cell.2011.02.024	http://dx.doi.org/10.1016/j.cell.2011.02.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458668	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000289053900010
J	Crow, MM				Crow, Michael M.			Time to rethink the NIH	NATURE			English	Editorial Material									[Crow, Michael M.] Arizona State Univ, Tempe, AZ 85287 USA; [Crow, Michael M.] Columbia Univ, New York, NY 10027 USA	Arizona State University; Arizona State University-Tempe; Columbia University	Crow, MM (corresponding author), Arizona State Univ, Tempe, AZ 85287 USA.	michael.crow@asu.edu						Algazy J, 2010, HLTH INT, V10, P88; Cutler DM, 2003, MEASURING THE GAINS FROM MEDICAL RESEARCH, P110; KAISER J, 2011, SCI INSIDER     0217; *NIH COMM ORG STRU, 2003, ENH VIT NAT I HLTH O; *NIH SCI MAN REV B, 2010, REP TRANSL MED THER; Organisation for Economic and Co-Operative Development [OECD],, 2009, HLTH GLANC OECD IND; Sampat BhavenN., 2009, NEW EC TECHNOLOGY PO, P148; Varmus H, 2001, SCIENCE, V291, P1903, DOI 10.1126/science.1059063	8	10	11	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 31	2011	471	7340					569	571		10.1038/471569a	http://dx.doi.org/10.1038/471569a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	742NN	21455153	Bronze			2022-12-28	WOS:000288951200014
J	Pratt, FL; Baker, PJ; Blundell, SJ; Lancaster, T; Ohira-Kawamura, S; Baines, C; Shimizu, Y; Kanoda, K; Watanabe, I; Saito, G				Pratt, F. L.; Baker, P. J.; Blundell, S. J.; Lancaster, T.; Ohira-Kawamura, S.; Baines, C.; Shimizu, Y.; Kanoda, K.; Watanabe, I.; Saito, G.			Magnetic and non-magnetic phases of a quantum spin liquid	NATURE			English	Article							STATE; KAPPA-(BEDT-TTF)(2)CU-2(CN)(3)	A quantum spin-liquid phase is an intriguing possibility for a system of strongly interacting magnetic units in which the usual magnetically ordered ground state is avoided owing to strong quantum fluctuations. It was first predicted theoretically for a triangular-lattice model with antiferromagnetically coupled S = 1/2 spins(1). Recently, materials have become available showing persuasive experimental evidence for such a state(2). Although many studies show that the ideal triangular lattice of S = 1/2 Heisenberg spins actually orders magnetically into a three-sublattice, non-collinear 1206 arrangement, quantum fluctuations significantly reduce the size of the ordered moment(3). This residual ordering can be completely suppressed when higher-order ring-exchange magnetic interactions are significant, as found in nearly metallic Mott insulators(4). The layered molecular system kappa-(BEDT-TTF)(2)Cu(2)(CN)(3) is a Mott insulator with an almost isotropic, triangular magnetic lattice of spin-1/2 BEDT-TTF dimers(5) that provides a prime example of a spin liquid formed in this way(6-11). Despite a high-temperature exchange coupling, J, of 250 K (ref. 6), no obvious signature of conventional magnetic ordering is seen down to 20 mK (refs 7, 8). Here we show, using muon spin rotation, that applying a small magnetic field to this system produces a quantum phase transition between the spin-liquid phase and an antiferromagnetic phase with a strongly suppressed moment. This can be described as Bose-Einstein condensation of spin excitations with an extremely small spin gap. At higher fields, a second transition is found that suggests a threshold for deconfinement of the spin excitations. Our studies reveal the low-temperature magnetic phase diagram and enable us to measure characteristic critical properties. We compare our results closely with current theoretical models, and this gives some further insight into the nature of the spin-liquid phase.	[Pratt, F. L.; Baker, P. J.] Rutherford Appleton Lab, ISIS Facil, Chilton OX11 0QX, England; [Blundell, S. J.; Lancaster, T.] Univ Oxford, Clarendon Lab, Dept Phys, Oxford OX1 3PU, England; [Ohira-Kawamura, S.] Japan Atom Energy Agcy, J PARC Ctr, Neutron Sci Sect, Tokai, Ibaraki 3191195, Japan; [Shimizu, Y.] Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4648601, Japan; [Baines, C.] Paul Scherrer Inst, Lab Muon Spin Spect, CH-5232 Villigen, Switzerland; [Kanoda, K.] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1138656, Japan; [Watanabe, I.] RIKEN, Meson Sci Lab, Wako, Saitama 3510198, Japan; [Saito, G.] Kyoto Univ, Grad Sch Sci, Div Chem, Sakyo Ku, Kyoto 6068502, Japan	UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Oxford; Japan Atomic Energy Agency; Nagoya University; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Tokyo; RIKEN; Kyoto University	Pratt, FL (corresponding author), Rutherford Appleton Lab, ISIS Facil, Chilton OX11 0QX, England.	francis.pratt@stfc.ac.uk	Kanoda, Kazushi/ABA-8572-2021; Lancaster, Tom/Y-5379-2018; Baker, Peter J/E-4216-2010; SHIMIZU, Yasuhiro/I-7504-2014	Lancaster, Tom/0000-0002-6714-4215; Baker, Peter J/0000-0002-2306-2648; Pratt, Francis/0000-0002-5919-3885; Shimizu, Yasuhiro/0000-0003-2268-1575	EPSRC (UK); Engineering and Physical Sciences Research Council [EP/G003092/1] Funding Source: researchfish; EPSRC [EP/G003092/1] Funding Source: UKRI	EPSRC (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We acknowledge discussions with S. Sachdev, J. Schmalian and T. Senthil. Part of this work was performed at the Swiss Muon Source, Paul Scherrer Institute, Villigen, Switzerland. This work is supported by EPSRC (UK).	Al-Hassanieh KA, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.216402; Balents L, 2010, NATURE, V464, P199, DOI 10.1038/nature08917; Ballesteros HG, 1996, PHYS LETT B, V387, P125, DOI 10.1016/0370-2693(96)00984-7; Blundell SJ, 1999, CONTEMP PHYS, V40, P175, DOI 10.1080/001075199181521; Bulaevskii LN, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.024402; Galitski V, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.266403; Ghosh S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.157205; Gregor K, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.024421; Isakov SV, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.174417; Kaul RK, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.155105; Lee SS, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.067006; Manna RS, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.016403; Motrunich OI, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.155115; Motrunich OI, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.045105; Ohira S, 2006, J LOW TEMP PHYS, V142, P153, DOI [10.1007/BF02679485, 10.1007/s10909-006-9115-x]; Pratt FL, 2010, PHYSICA B, V405, pS205, DOI 10.1016/j.physb.2010.01.125; Pratt FL, 2000, PHYSICA B, V289, P710, DOI 10.1016/S0921-4526(00)00328-8; Qi Y, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.176401; SCHIFFER P, 1994, PHYS REV LETT, V73, P2500, DOI 10.1103/PhysRevLett.73.2500; Schmalian J, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.094406; Sebastian SE, 2006, NATURE, V441, P617, DOI 10.1038/nature04732; Senthil T, 2000, PHYS REV B, V62, P7850, DOI 10.1103/PhysRevB.62.7850; Shimizu Y, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.140407; Shimizu Y, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.107001; Xu CK, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.064405; Yamashita M, 2010, SCIENCE, V328, P1246, DOI 10.1126/science.1188200; Yamashita M, 2009, NAT PHYS, V5, P44, DOI 10.1038/NPHYS1134; Yamashita S, 2008, NAT PHYS, V4, P459, DOI 10.1038/nphys942; Zheng WH, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.224420	30	140	142	4	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 31	2011	471	7340					612	616		10.1038/nature09910	http://dx.doi.org/10.1038/nature09910			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21455176				2022-12-28	WOS:000288951200037
J	Ross, JL; Quigley, CA; Cao, DC; Feuillan, P; Kowal, K; Chipman, JJ; Cutler, GB				Ross, Judith L.; Quigley, Charmian A.; Cao, Dachuang; Feuillan, Penelope; Kowal, Karen; Chipman, John J.; Cutler, Gordon B., Jr.			Growth Hormone plus Childhood Low-Dose Estrogen in Turner's Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADULT HEIGHT; ETHINYL ESTRADIOL; FINAL HEIGHT; SHORT-TERM; GIRLS; THERAPY; MANAGEMENT; CHILDREN; WOMEN; DEFICIENCY	BACKGROUND Short stature and ovarian failure are characteristic features of Turner's syndrome. Although recombinant human growth hormone is commonly used to treat the short stature associated with this syndrome, a randomized, placebo-controlled trial is needed to document whether such treatment increases adult height. Furthermore, it is not known whether childhood estrogen replacement combined with growth hormone therapy provides additional benefit. We examined the independent and combined effects of growth hormone and early, ultra-low-dose estrogen on adult height in girls with Turner's syndrome. METHODS In this double-blind, placebo-controlled trial, we randomly assigned 149 girls, 5.0 to 12.5 years of age, to four groups: double placebo (placebo injection plus childhood oral placebo, 39 patients), estrogen alone (placebo injection plus childhood oral low-dose estrogen, 40), growth hormone alone (growth hormone injection plus childhood oral placebo, 35), and growth hormone-estrogen (growth hormone injection plus childhood oral low-dose estrogen, 35). The dose of growth hormone was 0.1 mg per kilogram of body weight three times per week. The doses of ethinyl estradiol (or placebo) were adjusted for chronologic age and pubertal status. At the first visit after the age of 12.0 years, patients in all treatment groups received escalating doses of ethinyl estradiol. Growth hormone injections were terminated when adult height was reached. RESULTS The mean standard-deviation scores for adult height, attained at an average age of 17.0 +/- 1.0 years, after an average study period of 7.2 +/- 2.5 years were -2.81 +/- 0.85, -3.39 +/- 0.74, -2.29 +/- 1.10, and -2.10 +/- 1.02 for the double-placebo, estrogen-alone, growth hormone-alone, and growth hormone-estrogen groups, respectively (P<0.001). The overall effect of growth hormone treatment (vs. placebo) on adult height was a 0.78 +/- 0.13 increase in the height standard-deviation score (5.0 cm) (P<0.001); adult height was greater in the growth hormone-estrogen group than in the growth hormone-alone group, by 0.32 +/- 0.17 standard-deviation score (2.1 cm) (P = 0.059), suggesting a modest synergy between childhood low-dose ethinyl estradiol and growth hormone. CONCLUSIONS Our study shows that growth hormone treatment increases adult height in patients with Turner's syndrome. In addition, the data suggest that combining childhood ultra-low-dose estrogen with growth hormone may improve growth and provide other potential benefits associated with early initiation of estrogen replacement.	[Ross, Judith L.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Pediat, Philadelphia, PA 19107 USA; [Ross, Judith L.; Kowal, Karen] Alfred I DuPont Hosp Children, Wilmington, DE USA; [Quigley, Charmian A.; Cao, Dachuang; Chipman, John J.; Cutler, Gordon B., Jr.] Lilly Res Labs, Indianapolis, IN USA; [Feuillan, Penelope; Cutler, Gordon B., Jr.] NICHHD, Bethesda, MD 20892 USA	Jefferson University; Nemours Alfred I. duPont Hospital for Children; Eli Lilly; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Ross, JL (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Pediat, 1025 Walnut St, Philadelphia, PA 19107 USA.	judith.ross@jefferson.edu		Ross, Judith/0000-0002-8613-2498	National Institute of Child Health and Human Development; Eli Lilly	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Eli Lilly(Eli Lilly)	Supported by the National Institute of Child Health and Human Development and Eli Lilly.	Baxter L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003887.pub2; Bondy CA, 2007, J CLIN ENDOCR METAB, V92, P10, DOI 10.1210/jc.2006-1374; Carel JC, 1998, J CLIN ENDOCR METAB, V83, P1462, DOI 10.1210/jc.83.5.1462; Carel JC, 2006, J CLIN ENDOCR METAB, V91, P2972, DOI 10.1210/jc.2005-2652; CARUSONICOLETTI M, 1985, J CLIN ENDOCR METAB, V61, P896, DOI 10.1210/jcem-61-5-896; Chernausek SD, 2000, J CLIN ENDOCR METAB, V85, P2439, DOI 10.1210/jc.85.7.2439; CONTE FA, 1975, J CLIN ENDOCR METAB, V40, P670, DOI 10.1210/jcem-40-4-670; Courant F, 2010, J CLIN ENDOCR METAB, V95, P82, DOI 10.1210/jc.2009-1140; Cutler GB, 1997, J STEROID BIOCHEM, V61, P141; Davenport ML, 2002, HORM RES, V57, P157, DOI 10.1159/000058376; Donaldson MDC, 2006, ARCH DIS CHILD, V91, P513, DOI 10.1136/adc.2003.035907; Greulich WW., 1959, CALIF MED, V91, P53; HOPWOOD NJ, 1993, J PEDIATR-US, V123, P215, DOI 10.1016/S0022-3476(05)81691-9; KLEIN KO, 1994, J CLIN INVEST, V94, P2475, DOI 10.1172/JCI117616; KUCZMARSKI RJ, 2000, ADV DATA VITAL HLTH, V246; LYON AJ, 1985, ARCH DIS CHILD, V60, P932, DOI 10.1136/adc.60.10.932; MAURAS N, 1990, PEDIATR RES, V28, P626, DOI 10.1203/00006450-199012000-00018; *NAT CTR HLTH STAT, 1976, NCHS GROWTH CHARTS; NIELSEN J, 1991, HUM GENET, V87, P81, DOI 10.1007/BF01213097; Nilsson O, 2005, HORM RES, V64, P157, DOI 10.1159/000088791; Quigley CA, 2002, J CLIN ENDOCR METAB, V87, P2033, DOI 10.1210/jc.87.5.2033; Ranke MB, 2002, EUR J ENDOCRINOL, V147, P625, DOI 10.1530/eje.0.1470625; Rosenfeld RG, 1998, J PEDIATR-US, V132, P319, DOI 10.1016/S0022-3476(98)70452-4; Rosenfield RL, 2005, J CLIN ENDOCR METAB, V90, P6424, DOI 10.1210/jc.2005-1081; Ross JL, 2000, NEUROLOGY, V54, P164, DOI 10.1212/WNL.54.1.164; Ross JL, 1998, J CLIN ENDOCR METAB, V83, P3198, DOI 10.1210/jc.83.9.3198; Ross JL, 1996, J CLIN ENDOCR METAB, V81, P926, DOI 10.1210/jc.81.3.926; ROSS JL, 1988, J CLIN ENDOCR METAB, V67, P515, DOI 10.1210/jcem-67-3-515; ROSS JL, 1983, NEW ENGL J MED, V309, P1104, DOI 10.1056/NEJM198311033091806; ROSS JL, 1986, J PEDIATR-US, V109, P950, DOI 10.1016/S0022-3476(86)80274-8; SACKS H, 1982, AM J MED, V72, P233, DOI 10.1016/0002-9343(82)90815-4; Saenger P, 2001, J CLIN ENDOCR METAB, V86, P3061, DOI 10.1210/jc.86.7.3061; Sherwin BB, 1996, J CLIN ENDOCR METAB, V81, P2545, DOI 10.1210/jc.81.7.2545; Siddiqui O, 2009, J BIOPHARM STAT, V19, P227, DOI 10.1080/10543400802609797; Soriano-Guillen L, 2005, J CLIN ENDOCR METAB, V90, P5197, DOI 10.1210/jc.2005-0470; Stephure DK, 2005, J CLIN ENDOCR METAB, V90, P3360, DOI 10.1210/jc.2004-2187; TANNER JM, 1976, J PEDIATR-US, V89, P1000, DOI 10.1016/S0022-3476(76)80620-8; TANNER JM, 1971, ARCH DIS CHILD, V46, P745, DOI 10.1136/adc.46.250.745; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; van Pareren YK, 2003, J CLIN ENDOCR METAB, V88, P1119, DOI 10.1210/jc.2002-021171; VANDERSCHUERENLODEWEYCKX M, 1990, J CLIN ENDOCR METAB, V70, P122, DOI 10.1210/jcem-70-1-122	41	118	133	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2011	364	13					1230	1242		10.1056/NEJMoa1005669	http://dx.doi.org/10.1056/NEJMoa1005669			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	742NO	21449786	Green Accepted			2022-12-28	WOS:000288951300007
J	Jackevicius, CA; Tu, JV; Ross, JS; Ko, DT; Carreon, D; Krumholz, HM				Jackevicius, Cynthia A.; Tu, Jack V.; Ross, Joseph S.; Ko, Dennis T.; Carreon, Daniel; Krumholz, Harlan M.			Use of Fibrates in the United States and Canada	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR OUTCOMES; GEMFIBROZIL; RHABDOMYOLYSIS; PREVENTION; EVENTS; TRENDS; TRIAL; RISK; MEN	Context Interest in the role of fibrates intensified after the publication of the negative results from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial, which assessed therapy with fenofibrate plus statins. The evidence for clinical benefit in outcomes with the use of fibrates is heavily weighted on the use of the older fibrates such as gemfibrozil and clofibrate. Objectives To examine trends in the current use of fibrates and to examine the relationship between differences in the availability and use of brand-name vs generic formulations of fenofibrate and the economic implications in the United States compared with Canada. Design, Setting, and Patients Population-level, observational cohort study using IMS Health data from the United States and Canada of patients prescribed fibrates between January 2002 and December 2009. Main Outcome Measures Fibrate prescriptions dispensed and expenditures. Results In the United States, fibrate prescriptions dispensed increased from 336 prescriptions/100 000 population in January 2002 to 730 prescriptions/100 000 population in December 2009, an increase of 117.1% (95% confidence interval [CI], 116.0%-117.9%), whereas in Canada, fibrate prescriptions increased from 402 prescriptions/100 000 population in January 2002 to 474 prescriptions/100 000 population in December 2009, an increase of 18.1% (95% CI, 17.9%-18.3%) (P<.001). In the United States, fenofibrate prescriptions dispensed increased from 150 prescriptions/100 000 population in January 2002 to 440 prescriptions/100 000 population in December 2009, an increase of 159.3% (95% CI, 157.7%-161.0%), comprising 47.9% of total fibrate prescriptions in 2002 and 65.2% in 2009. In Canada, fenofibrate prescriptions increased from 321 prescriptions/100 000 population in January 2002 to 429 prescriptions/100 000 population in December 2009. The annual ratio of generic to brand-name fenofibrate use in the United States ranged from 0:1 to 0.09:1 between 2002 and 2008, while the ratio in Canada steadily increased from 0.51:1 to 1.89:1 between 2005 and 2008. In the United States, crude fenofibrate expenditures increased from $11 535/100 000 population/month in 2002 to $44 975/100 000 population/month in 2009, while the rates in Canada declined from $17 695/100 000 population/month in 2002 to $16 112/100 000 population/month in 2009. Fibrate expenditures per 100 000 population were 3-fold higher in 2009 in the United States compared with Canada. Conclusion During the past decade, prescriptions for fibrates (particularly fenofibrate) increased in the United States, while prescriptions for fibrates in Canada remained stable. JAMA. 2011; 305(12): 1217-1224	[Jackevicius, Cynthia A.; Carreon, Daniel] Western Univ Hlth Sci, Coll Pharm, Dept Pharm Practice & Adm, Pomona, CA 91766 USA; [Jackevicius, Cynthia A.; Tu, Jack V.; Ko, Dennis T.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Jackevicius, Cynthia A.; Tu, Jack V.] Univ Toronto, Fac Med, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Tu, Jack V.; Ko, Dennis T.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Schulich Heart Ctr, Div Cardiol, Toronto, ON, Canada; [Jackevicius, Cynthia A.] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Jackevicius, Cynthia A.] Univ Hlth Network, Toronto, ON, Canada; [Ross, Joseph S.] Yale Univ, Sch Med, Dept Med,Sect Gen Internal Med, Ctr Outcomes Res & Evaluat,Yale New Haven Hosp, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth,Sect Hlth Policy & Adm, Ctr Outcomes Res & Evaluat,Yale New Haven Hosp, New Haven, CT 06510 USA; [Ross, Joseph S.; Krumholz, Harlan M.] Yale Univ, Sch Med, Sect Cardiovasc Med, Ctr Outcomes Res & Evaluat,Yale New Haven Hosp, New Haven, CT USA; [Krumholz, Harlan M.] Robert Wood Johnson Clin Scholars Program, New Haven, CT USA	Western University of Health Sciences; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Yale University; Yale University; Yale University	Jackevicius, CA (corresponding author), Western Univ Hlth Sci, Coll Pharm, Dept Pharm Practice & Adm, 309 E 2nd St, Pomona, CA 91766 USA.	cjackevicius@westernu.edu	, Harlan/AAI-2875-2020	Ko, Dennis/0000-0001-6840-8051; Ross, Joseph/0000-0002-9218-3320; Tu, Jack/0000-0003-0111-722X	College of Pharmacy of Western University of Health Sciences, Pomona, California; Canadian Institutes of Health Research; Canada Research Chair in Health Services Research; Heart and Stroke Foundation of Ontario, Toronto; National Institute on Aging [K08 AG032886]; American Federation of Aging Research; National Heart, Lung, and Blood Institute [U01-HL105270]; Ontario Ministry of Health and Long-Term Care, Toronto; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	College of Pharmacy of Western University of Health Sciences, Pomona, California; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Health Services Research(Canada Research Chairs); Heart and Stroke Foundation of Ontario, Toronto(Heart & Stroke Foundation of Ontario); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Federation of Aging Research; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Ontario Ministry of Health and Long-Term Care, Toronto(Ministry of Health and Long-Term Care, Ontario); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded in part by the College of Pharmacy of Western University of Health Sciences, Pomona, California, and in part by a Canadian Institutes of Health Research team grant in cardiovascular outcomes research awarded to the Canadian Cardiovascular Outcomes Research Team. Dr Tu is supported by a Canada Research Chair in Health Services Research and by a Career Investigator award of the Heart and Stroke Foundation of Ontario, Toronto. Dr Ross is currently supported by the National Institute on Aging grant K08 AG032886 and by the American Federation of Aging Research through the Paul B. Beeson Career Development Award Program. Dr Ko is supported by a new investigator award from the Canadian Institutes of Health Research. Dr Krumholz is supported by grant U01-HL105270 (awarded to the Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute. The Institute for Clinical Evaluative Sciences is supported by an operating grant from the Ontario Ministry of Health and Long-Term Care, Toronto.	Abourbih S, 2009, AM J MED, V122, DOI 10.1016/j.amjmed.2009.03.030; Alsheikh-Ali AA, 2004, AM J CARDIOL, V94, P935, DOI 10.1016/j.amjcard.2004.06.033; [Anonymous], ABB SUES LUP AMD APP; [Anonymous], WALL STREET J; Backman JT, 2000, CLIN PHARMACOL THER, V68, P122, DOI 10.1067/mcp.2000.108507; Brody H, 2010, NEW ENGL J MED, V362, P283, DOI 10.1056/NEJMp0911423; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Danzon PM, 2008, HEALTH AFFAIR, V27, P221, DOI 10.1377/hlthaff.27.1.221; Drugs@FDA, APPR DRUG PROD; Fischer MA, 2003, HEALTH SERV RES, V38, P1051, DOI 10.1111/1475-6773.00162; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Graham DJ, 2004, JAMA-J AM MED ASSOC, V292, P2585, DOI 10.1001/jama.292.21.2585; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Health Canada, NOT COMPL; IMS Health Inc, IMS DAT ASS DAT INF; Institute of Medicine, 2010, EV BIOM SURR ENDP CH; Jackevicius CA, 2008, NEW ENGL J MED, V358, P1819, DOI 10.1056/NEJMsa0801461; Jackevicius CA, 2009, CAN MED ASSOC J, V181, pE19, DOI 10.1503/cmaj.081913; Jones PH, 2005, AM J CARDIOL, V95, P120, DOI 10.1016/j.amjcard.2004.08.076; Jun M, 2010, LANCET, V375, P1875, DOI 10.1016/S0140-6736(10)60656-3; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Majumdar SR, 2003, AM J MED, V115, P467, DOI 10.1016/S0002-9343(03)00422-4; Office of the Attorney General State of California, TRICOR SETTL AGR; Office of the Attorney General State of New York, ATT GEN CUOM ANN SET; Omar MA, 2002, ANN PHARMACOTHER, V36, P288, DOI 10.1345/aph.1A289; Orange Book Blog, ANT CAS ABB MOV FORW; Redberg RF, 2010, ARCH INTERN MED, V170, P384, DOI 10.1001/archinternmed.2010.48; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Staffa JA, 2002, NEW ENGL J MED, V346, P539, DOI 10.1056/NEJM200202143460721; Stafford RS, 2004, JAMA-J AM MED ASSOC, V291, P54, DOI 10.1001/jama.291.1.54; *STAT CAN, 2001 CENS CAN; US Census Bureau, TABL 1 POP EST; Vachris MA, 1999, MON LABOR REV, V122, P3; VHA Pharmacy Benefits Management, STAT REP	35	63	64	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2011	305	12					1217	1224		10.1001/jama.2011.353	http://dx.doi.org/10.1001/jama.2011.353			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738PA	21427374	Green Accepted, Bronze			2022-12-28	WOS:000288652100017
J	Moonesinghe, SR; Lowery, J; Shahi, N; Millen, A; Beard, JD				Moonesinghe, S. R.; Lowery, J.; Shahi, N.; Millen, A.; Beard, J. D.			Impact of reduction in working hours for doctors in training on postgraduate medical education and patients' outcomes: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RESIDENT OPERATIVE EXPERIENCE; GENERAL-SURGERY RESIDENCY; 80-HOUR WORKWEEK; ACCREDITATION COUNCIL; IMPLEMENTATION; RESTRICTIONS; MORTALITY; CARE; TRAUMA; SAFETY	Objectives To determine whether a reduction in working hours of doctors in postgraduate medical training has had an effect on objective measures of medical education and clinical outcome. Design Systematic review. Data sources Medline, Embase, ISI Web of Science, Google Scholar, ERIC, and SIGLE were searched without language restriction for articles published between 1990 and December 2010. Reference lists and citations of selected articles. Study selection Studies that assessed the impact of a change in duty hours using any objective measure of outcome related to postgraduate medical training, patient safety, or clinical outcome. Any study design was eligible for inclusion. Results 72 studies were eligible for inclusion: 38 reporting training outcomes, 31 reporting outcomes in patients, and three reporting both. A reduction in working hours from greater than 80 hours a week (in accordance with US recommendations) does not seem to have adversely affected patient safety and has had limited effect on postgraduate training. Reports on the impact of European legislation limiting working hours to less than 56 or 48 a week are of poor quality and have conflicting results, meaning that firm conclusions cannot be made. Conclusions Reducing working hours to less than 80 a week has not adversely affected outcomes in patient or postgraduate training in the US. The impact of reducing hours to less than 56 or 48 a week in the UK has not yet been sufficiently evaluated in high quality studies. Further work is required, particularly in the European Union, using large multicentre evaluations of the impact of duty hours' legislation on objective educational and clinical outcomes.	[Moonesinghe, S. R.] Univ Coll Hosp, London NW1 6BU, England; [Moonesinghe, S. R.] Joint UCL UCLH Comprehens Biomed Res Ctr, Surg Outcomes Res Ctr, London WC1E 6BT, England; [Lowery, J.] Cent London Sch Anaesthesia, Ctr Anaesthesia, London NW1 2BU, England; [Shahi, N.] Diana Princess Wales Hosp, Dept Surg, Grimsby DN33 2BA, Lincs, England; [Millen, A.] Doncaster Royal Infirm, Dept Vasc Surg, Doncaster DN2 5LT, England; [Beard, J. D.] No Gen Hosp, Dept Surg, Sheffield S5 7AU, S Yorkshire, England	University of London; University College London; University of London; University College London; Northern General Hospital	Moonesinghe, SR (corresponding author), Univ Coll Hosp, London NW1 6BU, England.	ramani.moonesinghe@uclh.nhs.uk		Moonesinghe, Suneetha Ramani/0000-0002-6730-5824	National Institute for Health Research; NIAA's Health Services Research Centre by the Frances and Augustus Newman Foundation	National Institute for Health Research(National Institute for Health Research (NIHR)); NIAA's Health Services Research Centre by the Frances and Augustus Newman Foundation	SRM works within the UCL/UCLH Joint Comprehensive Biomedical Research Centre, which received a proportion of funding from the National Institute for Health Research's funding scheme. Part of this work was conducted while SRM was a National Institute for Academic Anaesthesia (NIAA) Research Fellow, supported by a grant awarded to the NIAA's Health Services Research Centre by the Frances and Augustus Newman Foundation. This study was not commissioned and no project specific funding was received. The funders had no role in the study design, data collection, analysis, and interpretation; writing the manuscript; or the decision to submit the research for publication.	*ACCR COUNC GRAD M, 2002, REP ACGME WORK GROUP; Afessa B, 2005, CHEST, V128, P3910, DOI 10.1378/chest.128.6.3910; Aiken LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI 10.1001/jama.288.16.1987; Al-Rawi S, 2009, ANAESTHESIA, V64, P297, DOI 10.1111/j.1365-2044.2008.05778.x; Bacharach Samuel., 1983, REPORT NATL CTR PROD; Bailit JL, 2004, OBSTET GYNECOL, V103, P613, DOI 10.1097/01.AOG.0000119225.57285.c1; Barden CB, 2002, J AM COLL SURGEONS, V195, P531, DOI 10.1016/S1072-7515(02)01242-5; Baskies MA, 2008, J BONE JOINT SURG AM, V90A, P924, DOI 10.2106/JBJS.G.00918; Bell EF, 2010, PEDIATRICS, V126, P222, DOI 10.1542/peds.2010-0456; Blanchard MH, 2004, AM J OBSTET GYNECOL, V191, P1746, DOI 10.1016/j.ajog.2004.07.060; Bland KI, 2005, AM J SURG, V190, P345, DOI 10.1016/j.amjsurg.2005.06.036; Bould MD, 2009, BRIT J ANAESTH, V103, P472, DOI 10.1093/bja/aep241; British Medical Association, 2006, IMPL HLTH SAF JUN DO; Browne JA, 2009, J BONE JOINT SURG AM, V91A, P2079, DOI 10.2106/JBJS.H.01240; Bruce D, 2010, MED TEACH, V32, P524, DOI 10.3109/01421591003680636; Cappuccio FP, 2009, QJM-INT J MED, V102, P271, DOI 10.1093/qjmed/hcp004; Carlin AM, 2007, AM J SURG, V193, P326, DOI 10.1016/j.amjsurg.2006.09.014; Chung Raphael, 2004, Curr Surg, V61, P609, DOI 10.1016/j.cursur.2004.07.010; Collum J, 2010, QJM-INT J MED, V103, P929, DOI 10.1093/qjmed/hcq139; Connors RC, 2009, J THORAC CARDIOV SUR, V137, P710, DOI 10.1016/j.jtcvs.2008.11.038; Damadi Amir, 2007, J Surg Educ, V64, P256, DOI 10.1016/j.jsurg.2007.07.008; de Virgilio Christian, 2006, Curr Surg, V63, P435, DOI 10.1016/j.cursur.2006.03.006; Department of Health, 2010, EUR WORK TIM DIR; Durkin ET, 2008, J SURG EDUC, V65, P54, DOI 10.1016/j.jsurg.2007.08.008; Elbadrawy M, 2008, J OBSTET GYNAECOL, V28, P474, DOI 10.1080/01443610802083930; Feanny MA, 2005, AM J SURG, V190, P947, DOI 10.1016/j.amjsurg.2005.08.025; Ferguson Charles M, 2005, Curr Surg, V62, P535, DOI 10.1016/j.cursur.2005.04.001; Fernandez E, 2009, BRIT J ANAESTH, V103, P566, DOI 10.1093/bja/aep170; Froelich J, 2009, J SURG EDUC, V66, P85, DOI 10.1016/j.jsurg.2008.12.007; Ghaferi AA, 2010, J AM COLL SURGEONS, V211, P325, DOI 10.1016/j.jamcollsurg.2010.04.025; Ghaferi AA, 2009, ANN SURG, V250, P1029, DOI 10.1097/SLA.0b013e3181bef697; Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; Gopaldas RR, 2010, J SURG RES, V163, P201, DOI 10.1016/j.jss.2010.03.014; GOTTLIEB DJ, 1991, ARCH INTERN MED, V151, P2065, DOI 10.1001/archinte.151.10.2065; Helling TS, 2010, J TRAUMA, V69, P607, DOI 10.1097/TA.0b013e3181e51211; Horwitz LI, 2007, ANN INTERN MED, V147, P97, DOI 10.7326/0003-4819-147-2-200707170-00163; Howard DL, 2004, J GEN INTERN MED, V19, P1, DOI 10.1111/j.1525-1497.2004.30336.x; Hutter MM, 2006, ANN SURG, V243, P864, DOI 10.1097/01.sla.0000220042.48310.66; Iglehart JK, 2008, NEW ENGL J MED, V359, P2633, DOI 10.1056/NEJMp0808736; Kaafarani HMA, 2005, J SURG RES, V126, P167, DOI 10.1016/j.jss.2004.12.024; Kairys JC, 2008, J AM COLL SURGEONS, V206, P804, DOI 10.1016/j.jamcollsurg.2007.12.055; Kara N, 2008, B ROY COLL SURG ENGL, V90, P60; KELLY A, 1991, OBSTET GYNECOL, V78, P468; Kilminster SM, 2000, MED EDUC, V34, P827, DOI 10.1046/j.1365-2923.2000.00758.x; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; LAINE C, 1993, JAMA-J AM MED ASSOC, V269, P374, DOI 10.1001/jama.269.3.374; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Lim E, 2006, EUR J CARDIO-THORAC, V30, P574, DOI 10.1016/j.ejcts.2006.04.024; LOFGREN RP, 1990, J GEN INTERN MED, V5, P501, DOI 10.1007/BF02600880; Malangoni MA, 2005, J TRAUMA, V58, P758, DOI 10.1097/01.TA.0000159248.66521.7E; Mallen C, 2006, J CLIN EPIDEMIOL, V59, P765, DOI 10.1016/j.jclinepi.2005.12.010; Marron C, 2005, BULLETIN, V87, P246, DOI [10.1308/147363505x46880, DOI 10.1308/147363505X46880]; Maxwell AJ, 2010, ACTA NEUROCHIR, V152, P1207, DOI 10.1007/s00701-010-0648-z; McBurney PG, 2008, CLIN PEDIATR, V47, P803, DOI 10.1177/0009922808318341; McIntyre HF, 2010, CLIN MED, V10, P134, DOI 10.7861/clinmedicine.10-2-134; Morrison CA, 2009, J SURG RES, V154, P157, DOI 10.1016/j.jss.2008.06.004; Mycyk MB, 2005, AM J HEALTH-SYST PH, V62, P1592, DOI 10.2146/ajhp040527; Nasca TJ, 2010, NEW ENGL J MED, V363, DOI 10.1056/NEJMsb1005800; Naylor RA, 2005, J AM COLL SURGEONS, V201, P724, DOI 10.1016/j.jamcollsurg.2005.06.271; Oakley JE., 2005, B R COLL SURG ENGL, V87, P320, DOI [10.1308/147363505X70847, DOI 10.1308/147363505X70847]; Pappas AJ, 2007, J BONE JOINT SURG AM, V89A, P904, DOI 10.2106/JBJS.F.01083; Poulose BK, 2005, ANN SURG, V241, P847, DOI 10.1097/01.sla.0000164075.18748.38; Privette AR, 2009, ANN SURG, V250, P316, DOI 10.1097/SLA.0b013e3181ae332a; Roedling S, 2008, CLIN MED, V8, P116; Rogers F, 2005, J TRAUMA, V58, P911, DOI 10.1097/01.TA.0000162140.00181.04; Rosen AK, 2009, MED CARE, V47, P723, DOI 10.1097/MLR.0b013e31819a588f; Salim A, 2007, ARCH SURG-CHICAGO, V142, P708, DOI 10.1001/archsurg.142.8.708; Schenarts P, 2005, AM J SURG, V190, P147, DOI 10.1016/j.amjsurg.2005.03.026; Schneider JR, 2007, J AM COLL SURGEONS, V205, P393, DOI 10.1016/j.jamcollsurg.2007.05.013; Searle RD, 2008, INT J OBSTET ANESTH, V17, P233, DOI 10.1016/j.ijoa.2008.01.007; Shetty KD, 2007, ANN INTERN MED, V147, P73, DOI 10.7326/0003-4819-147-2-200707170-00161; Shonka DC, 2009, LARYNGOSCOPE, V119, P635, DOI 10.1002/lary.20144; Short AC, 2006, J MATERN-FETAL NEO M, V19, P791, DOI 10.1080/14767050601023277; Silber JH, 2009, MED CARE, V47, P1191, DOI 10.1097/MLR.0b013e3181adcbff; Sim DJ, 2004, ANAESTHESIA, V59, P781, DOI 10.1111/j.1365-2044.2004.03808.x; Simien C, 2010, ANN SURG, V252, P383, DOI 10.1097/SLA.0b013e3181e62299; Smith RP, 2010, OBSTET GYNECOL, V115, P1166, DOI 10.1097/AOG.0b013e3181de8cdb; Sneider EB, 2009, J SURG EDUC, V66, P140, DOI 10.1016/j.jsurg.2008.10.005; Spencer AU, 2005, J AM COLL SURGEONS, V200, P670, DOI 10.1016/j.jamcollsurg.2005.01.008; Stephens M, 2004, B ANN ROYAL COLL SUR, V86, P120; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Temple J., 2010, TIME TRAINING REV IM; Tran J, 2006, AM SURGEON, V72, P924; Underwood SM, 2005, BRIT J ANAESTH, V95, P616, DOI 10.1093/bja/aei232; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P984, DOI 10.1001/jama.298.9.984; Watson DR, 2010, J SURG EDUC, V67, P283, DOI 10.1016/j.jsurg.2010.07.012; White ML, 2005, ANAESTHESIA, V60, P870, DOI 10.1111/j.1365-2044.2005.04286.x; Yaghoubian A, 2008, ARCH SURG-CHICAGO, V143, P847, DOI 10.1001/archsurg.143.9.847; Zwarentein M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000072.pub2	89	128	128	0	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2011	342								d1580	10.1136/bmj.d1580	http://dx.doi.org/10.1136/bmj.d1580			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	742MF	21427046	hybrid			2022-12-28	WOS:000288947500002
J	Schaffer, S				Schaffer, Simon			The laird of physics	NATURE			English	Editorial Material									Univ Cambridge, Dept Hist & Philosophy Sci, Cambridge CB2 3RH, England	University of Cambridge	Schaffer, S (corresponding author), Univ Cambridge, Dept Hist & Philosophy Sci, Cambridge CB2 3RH, England.	sjs16@hermes.cam.ac.uk							0	2	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2011	471	7338					289	291		10.1038/471289a	http://dx.doi.org/10.1038/471289a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	735UE	21412310	Bronze			2022-12-28	WOS:000288444000012
J	Sims, KB; Cole, AJ; Sherman, JC; Caruso, PA; Snuderl, M				Sims, Katherine B.; Cole, Andrew J.; Sherman, Janet C.; Caruso, Paul A.; Snuderl, Matija			Case 8-2011: A 32-Year-Old Woman with Seizures and Cognitive Decline Kufs' disease (autosomal dominant, Parry type, young-adult-onset neuronal ceroid lipofuscinosis)	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROGRESSIVE MYOCLONUS EPILEPSIES; DIAGNOSIS; FORM		[Sims, Katherine B.; Cole, Andrew J.; Sherman, Janet C.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Sherman, Janet C.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Caruso, Paul A.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Snuderl, Matija] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Sims, Katherine B.; Cole, Andrew J.; Sherman, Janet C.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Caruso, Paul A.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Snuderl, Matija] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Sims, KB (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.			Snuderl, Matija/0000-0003-0752-0917				Adam M. P., 1993, GENEREVIEWS R; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Arzimanoglou A, 2009, LANCET NEUROL, V8, P82, DOI 10.1016/S1474-4422(08)70292-8; Beghi M, 2006, EPILEPSIA, V47, P107, DOI 10.1111/j.1528-1167.2006.00706.x; BERKOVIC SF, 1986, NEW ENGL J MED, V315, P296, DOI 10.1056/NEJM198607313150506; BOEHME DH, 1971, BRAIN, V94, P745, DOI 10.1093/brain/94.4.745; Burneo JG, 2003, EPILEPSIA, V44, P841, DOI 10.1046/j.1528-1157.2003.39802.x; Crunelli V, 2002, NAT REV NEUROSCI, V3, P371, DOI 10.1038/nrn811; FERRER I, 1980, J NEUROL, V222, P183, DOI 10.1007/BF00313117; Ivan CS, 2005, MOVEMENT DISORD, V20, P752, DOI 10.1002/mds.20406; Jalanko A, 2009, BBA-MOL CELL RES, V1793, P697, DOI 10.1016/j.bbamcr.2008.11.004; Josephson SA, 2001, J NEUROL SCI, V188, P51, DOI 10.1016/S0022-510X(01)00546-9; Kertesz A, 2003, MOVEMENT DISORD, V18, pS57, DOI 10.1002/mds.10564; Martin JJ, 1999, BIOM HLTH R, V33, P77; de Siqueira LFM, 2010, J NEUROL, V257, P1612, DOI 10.1007/s00415-010-5641-1; Miranda E, 2008, HUM MOL GENET, V17, P1527, DOI 10.1093/hmg/ddn041; Mole SE, 1993, GENEREVIEWS; Nijssen PCG, 2002, MOVEMENT DISORD, V17, P482, DOI 10.1002/mds.10104; Ramachandran N, 2009, EPILEPSIA, V50, P29, DOI 10.1111/j.1528-1167.2009.02117.x; Shahwan A, 2005, LANCET NEUROL, V4, P239, DOI 10.1016/S1474-4422(05)70043-0; van Swieten JC, 1993, GENEREVIEWS; WIENKER TF, 1979, HUM GENET, V49, P83, DOI 10.1007/BF00277689; Winawer MR, 2003, NEUROLOGY, V61, P1576, DOI 10.1212/WNL.61.11.1576; Zifkin B, 2005, CURR OPIN NEUROL, V18, P147, DOI 10.1097/01.wco.0000162856.75391.b1; Zupanc ML, 2009, J CHILD NEUROL, V24, p6S, DOI 10.1177/0883073809338151	25	8	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2011	364	11					1062	1074		10.1056/NEJMcpc1013927	http://dx.doi.org/10.1056/NEJMcpc1013927			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735SX	21410375				2022-12-28	WOS:000288439000013
J	Westert, GP; Faber, M				Westert, Gert P.; Faber, Marjan			Commentary: the Dutch approach to unwarranted medical practice variation	BRITISH MEDICAL JOURNAL			English	Editorial Material							NETHERLANDS					g.westert@iq.umcn.nl	Meinders, Marjan J/L-4302-2015; Westert, G.P./H-8115-2014	Meinders, Marjan J/0000-0001-6491-7035; Westert, G.P./0000-0003-3744-8207				*DUTCH HEALTHC AUT, 2010, MON MED SPEC ZORG 20; *MIN VOLKSG SPORT, 2010, PLEX RED PRACT VAR; *NVEL, 2010, JAARR KLANT ZORG 200; Struijs JN, 2011, NEW ENGL J MED, V364, P990, DOI 10.1056/NEJMp1011849; Stubbe J H, 2007, BMC Ophthalmol, V7, P14, DOI 10.1186/1471-2415-7-14; Verkleij H., 2010, DUTCH HLTH CARE PERF; Wennberg JE, 2010, TRACKING MED RES QUE; Westert GP, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3397	8	9	9	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 17	2011	342								d1429	10.1136/bmj.d1429	http://dx.doi.org/10.1136/bmj.d1429			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	739FQ	21415103				2022-12-28	WOS:000288700200003
J	Wu, H; D'Alessio, AC; Ito, S; Xia, K; Wang, ZB; Cui, KR; Zhao, KJ; Sun, YE; Zhang, Y				Wu, Hao; D'Alessio, Ana C.; Ito, Shinsuke; Xia, Kai; Wang, Zhibin; Cui, Kairong; Zhao, Keji; Sun, Yi Eve; Zhang, Yi			Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells	NATURE			English	Article							DNA METHYLATION; HISTONE H3; DEVELOPMENTAL REGULATORS; CHROMATIN-STRUCTURE; POLYCOMB; GENOME; GENES; COMPLEX; BINDING; PROTEIN	Epigenetic modification of the mammalian genome by DNA methylation (5-methylcytosine) has a profound impact on chromatin structure, gene expression and maintenance of cellular identity(1). The recent demonstration that members of the Ten-eleven translocation (Tet) family of proteins can convert 5-methylcytosine to 5-hydroxymethylcytosine raised the possibility that Tet proteins are capable of establishing a distinct epigenetic state(2,3). We have recently demonstrated that Tet1 is specifically expressed in murine embryonic stem (ES) cells and is required for ES cell maintenance(2). Using chromatin immunoprecipitation coupled with high-throughput DNA sequencing, here we show in mouse ES cells that Tet1 is preferentially bound to CpG-rich sequences at promoters of both transcriptionally active and Polycomb-repressed genes. Despite an increase in levels of DNA methylation at many Tet1-binding sites, Tet1 depletion does not lead to downregulation of all the Tet1 targets. Interestingly, although Tet1-mediated promoter hypomethylation is required for maintaining the expression of a group of transcriptionally active genes, it is also involved in repression of Polycomb-targeted developmental regulators. Tet1 contributes to silencing of this group of genes by facilitating recruitment of PRC2 to CpG-rich gene promoters. Thus, our study not only establishes a role for Tet1 in modulating DNA methylation levels at CpG-rich promoters, but also reveals a dual function of Tet1 in promoting transcription of pluripotency factors as well as participating in the repression of Polycomb-targeted developmental regulators.	[D'Alessio, Ana C.; Ito, Shinsuke; Xia, Kai; Zhang, Yi] Univ N Carolina, Dept Biochem & Biophys, Howard Hughes Med Inst, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Wu, Hao; Sun, Yi Eve] Univ Calif Los Angeles, David Geffen Sch Med, IDDRC Semel Inst Neurosci & Human Behav, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Wu, Hao; Sun, Yi Eve] Univ Calif Los Angeles, David Geffen Sch Med, IDDRC Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Wang, Zhibin] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Lab Human Environm Epigenomes, Baltimore, MD 21025 USA; [Cui, Kairong; Zhao, Keji] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Zhang, Y (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Howard Hughes Med Inst, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu	Xia, Kai/B-7214-2014; Wu, Hao/G-4145-2013	Wu, Hao/0000-0002-1256-6891; Zhang, Yi/0000-0002-2789-0811; Xia, Kai/0000-0003-1326-0891; Wu, Hao/0000-0003-4395-6929	NIH [GM68804, R56MH082068]; Division of Intramural Research of National Heart, Lung and Blood Institute, NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005801, ZIAHL006031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH082068] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research of National Heart, Lung and Blood Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank B. Abraham and I. Chepelev for Illumina sequencing and data transfer; J. He and A. T. Nguyen for FACS sorting; O. Taranova for discussion; S. Wu for critical reading of the manuscript. This work was supported by NIH grants GM68804 (to Y.Z.), R56MH082068 (to Y.E.S.) and support from the Division of Intramural Research Program of National Heart, Lung and Blood Institute, NIH (K.Z.). S. I. is a research fellow of the Japan Society for the Promotion of Science. Y.Z. is an Investigator of the Howard Hughes Medical Institute.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blackledge NP, 2010, MOL CELL, V38, P179, DOI 10.1016/j.molcel.2010.04.009; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Pelizzola M, 2008, GENOME RES, V18, P1652, DOI 10.1101/gr.080721.108; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Wu SC, 2010, CELL RES, V20, P1109, DOI 10.1038/cr.2010.114; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	30	488	507	1	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2011	473	7347					389	U578		10.1038/nature09934	http://dx.doi.org/10.1038/nature09934			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765QA	21451524	Green Accepted, Green Published			2022-12-28	WOS:000290722400052
J	Rohrbach, A; Schmidt, MW				Rohrbach, Arno; Schmidt, Max W.			Redox freezing and melting in the Earth's deep mantle resulting from carbon-iron redox coupling	NATURE			English	Article							PHASE-TRANSFORMATIONS; OXYGEN FUGACITY; FERRIC IRON; METAL; PERIDOTITE; MAGNESIOWUSTITE; BENEATH; GARNET; THERMODYNAMICS; SOLUBILITY	Very low seismic velocity anomalies in the Earth's mantle(1,2) may reflect small amounts of melt present in the peridotite matrix, and the onset of melting in the Earth's upper mantle is likely to be triggered by the presence of small amounts of carbonate(3). Such carbonates stem from subducted oceanic lithosphere in part buried to depths below the 660-kilometre discontinuity and remixed into the mantle. Here we demonstrate that carbonate-induced melting may occur in deeply subducted lithosphere at near-adiabatic temperatures in the Earth's transition zone and lower mantle. We show experimentally that these carbonatite melts are unstable when infiltrating ambient mantle and are reduced to immobile diamond when recycled at depths greater than similar to 250 kilometres, where mantle redox conditions are determined by the presence of an (Fe,Ni) metal phase(4-6). This 'redox freezing' process leads to diamond-enriched mantle domains in which the Fe-0, resulting from Fe2+ disproportionation in perovskites and garnet, is consumed but the Fe3+ preserved. When such carbon-enriched mantle heterogeneities become part of the upwelling mantle, diamond will inevitably react with the Fe3+ leading to true carbonatite redox melting at similar to 660 and similar to 250 kilometres depth to form deep-seated melts in the Earth's mantle.	[Rohrbach, Arno; Schmidt, Max W.] ETH, Inst Geochem & Petrol, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Rohrbach, A (corresponding author), ETH, Inst Geochem & Petrol, Sonneggstr 5, CH-8092 Zurich, Switzerland.	arno.rohrbach@gmail.com		Schmidt, Max W./0000-0002-3870-5781	Swiss National Science Foundation (SNSF) [2-777-86-06]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	Discussions with P. Ulmer, U. Mann and C. Ballhaus stimulated this work. Comments and suggestions from T. Stachel improved the manuscript. Financial support by Swiss National Science Foundation (SNSF) grant 2-777-86-06 is acknowledged.	ALLEGRE CJ, 1986, NATURE, V323, P123, DOI 10.1038/323123a0; Bagdassarov N, 2009, EARTH PLANET SC LETT, V288, P84, DOI 10.1016/j.epsl.2009.09.010; BALLHAUS C, 1995, EARTH PLANET SC LETT, V132, P75, DOI 10.1016/0012-821X(95)00047-G; Barin I, 1989, THERMOCHEMICAL DATA, DOI DOI 10.1002/ANGE.19901020738; Barin I., 1989, THERMOCHEMICAL DAT 2; Brey GP, 2008, J PETROL, V49, P797, DOI 10.1093/petrology/egn002; Campbell A.J., 2007, COMPRES ANN M; Campbell AJ, 2009, EARTH PLANET SC LETT, V286, P556, DOI 10.1016/j.epsl.2009.07.022; Connolly JAD, 2009, NATURE, V462, P209, DOI 10.1038/nature08517; Dalton JA, 1998, CONTRIB MINERAL PETR, V131, P123, DOI 10.1007/s004100050383; Dasgupta R, 2006, NATURE, V440, P659, DOI 10.1038/nature04612; Dasgupta R, 2010, EARTH PLANET SC LETT, V298, P1, DOI 10.1016/j.epsl.2010.06.039; Eggler DH., 1982, HIGH PRESSURE RES GE, P237, DOI [10.1007/978-94-009-7867-6_19, DOI 10.1007/978-94-009-7867-6_19]; Forsyth DW, 1998, SCIENCE, V280, P1215, DOI 10.1126/science.280.5367.1235; Frost DJ, 2008, ANNU REV EARTH PL SC, V36, P389, DOI 10.1146/annurev.earth.36.031207.124322; Frost DJ, 2002, EARTH PLANET SC LETT, V199, P227, DOI 10.1016/S0012-821X(02)00558-7; Frost DJ, 2004, NATURE, V428, P409, DOI 10.1038/nature02413; Frost DJ, 2003, EARTH PLANET SC LETT, V216, P313, DOI 10.1016/S0012-821X(03)00533-8; Frost DJ, 2003, AM MINERAL, V88, P387; Frost DJ, 2001, PHYS CHEM MINER, V28, P455, DOI 10.1007/s002690100181; Ghosh S, 2009, CHEM GEOL, V262, P17, DOI 10.1016/j.chemgeo.2008.12.030; Gu YJ, 2005, EARTH PLANET SC LETT, V232, P259, DOI 10.1016/j.epsl.2005.01.019; GUDMUNDSSON G, 1995, CONTRIB MINERAL PETR, V119, P56, DOI 10.1007/BF00310717; HIRSCHMANN M, 1991, AM MINERAL, V76, P1232; HIRSCHMANN MM, 1994, GEOCHIM COSMOCHIM AC, V58, P4109, DOI 10.1016/0016-7037(94)90268-2; Hofmann AW, 1997, NATURE, V385, P219, DOI 10.1038/385219a0; HUNTER RH, 1989, EARTH PLANET SC LETT, V92, P347, DOI 10.1016/0012-821X(89)90059-9; Keppler H, 2006, REV MINERAL GEOCHEM, V62, P193, DOI 10.2138/rmg.2006.62.9; Kohn SC, 1996, AM MINERAL, V81, P1523; Litasov KD, 2009, PHYS EARTH PLANET IN, V177, P46, DOI 10.1016/j.pepi.2009.07.008; Lord OT, 2009, EARTH PLANET SC LETT, V284, P157, DOI 10.1016/j.epsl.2009.04.017; Luth R.W., 1999, MANTLE PETROLOGY FIE, P297; McCammon C, 1998, GEOPHYS RES LETT, V25, P1589, DOI 10.1029/98GL01178; MINARIK WG, 1995, EARTH PLANET SC LETT, V133, P423, DOI 10.1016/0012-821X(95)00085-Q; MUKHOPADHYAY B, 1993, GEOCHIM COSMOCHIM AC, V57, P277, DOI 10.1016/0016-7037(93)90430-5; O'Neill HS, 1998, J GEOPHYS RES-SOL EA, V103, P12239, DOI 10.1029/97JB02601; ONEILL HS, 1987, J PETROL, V28, P1169, DOI 10.1093/petrology/28.6.1169; ONEILL HSC, 1993, GEOPH MONOG SERIES, V74, P73; Palme H., 2003, TREATISE GEOCHEMISTR, V2, P1, DOI DOI 10.1016/B978-0-08-095975-7.00201-1; Predel B., 1995, LANDOLTBORNSTEIN DAT, DOI [10.1007/10474837_1321, DOI 10.1007/10474837_1321]; RINGWOOD AE, 1967, EARTH PLANET SC LETT, V2, P255, DOI 10.1016/0012-821X(67)90138-0; Rohrbach A, 2007, NATURE, V449, P456, DOI 10.1038/nature06183; SEIFERT S, 1987, GEOCHIM COSMOCHIM AC, V51, P97, DOI 10.1016/0016-7037(87)90010-X; Smith J.F., 1984, B ALLOY PHASE DIAGR, V5, P184, DOI [DOI 10.1007/BF02868724, 10.1007/BF02868958, DOI 10.1007/BF02868958]; Stachel T, 2005, ELEMENTS, V1, P73, DOI 10.2113/gselements.1.2.73; Stagno V, 2010, EARTH PLANET SC LETT, V300, P72, DOI 10.1016/j.epsl.2010.09.038; Stewart AJ, 2006, HIGH PRESSURE RES, V26, P293, DOI 10.1080/08957950600835237; Stixrude L, 2007, EARTH PLANET SC LETT, V263, P45, DOI 10.1016/j.epsl.2007.08.027; Taylor W. R., 1987, SPECIAL PUBLICATION, P121; Wang JH, 2005, CALPHAD, V29, P263, DOI 10.1016/j.calphad.2005.09.004; Wood B.J., 1976, ELEMENTARY THERMODYN; Woodland AB, 2003, EARTH PLANET SC LETT, V214, P295, DOI 10.1016/S0012-821X(03)00379-0; Woodland AB, 1997, GEOCHIM COSMOCHIM AC, V61, P4359, DOI 10.1016/S0016-7037(97)00247-0	53	314	343	8	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2011	472	7342					209	212		10.1038/nature09899	http://dx.doi.org/10.1038/nature09899			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21441908				2022-12-28	WOS:000289469100040
J	Derekas, A; Kiss, LL; Borkovits, T; Huber, D; Lehmann, H; Southworth, J; Bedding, TR; Balam, D; Hartmann, M; Hrudkova, M; Ireland, MJ; Kovacs, J; Mezo, G; Moor, A; Niemczura, E; Sarty, GE; Szabo, GM; Szabo, R; Telting, JH; Tkachenko, A; Uytterhoeven, K; Benko, JM; Bryson, ST; Maestro, V; Simon, AE; Stello, D; Schaefer, G; Aerts, C; ten Brummelaar, TA; De Cat, P; McAlister, HA; Maceroni, C; Merand, A; Still, M; Sturmann, J; Sturmann, L; Turner, N; Tuthill, PG; Christensen-Dalsgaard, J; Gilliland, RL; Kjeldsen, H; Quintana, EV; Tenenbaum, P; Twicken, JD				Derekas, A.; Kiss, L. L.; Borkovits, T.; Huber, D.; Lehmann, H.; Southworth, J.; Bedding, T. R.; Balam, D.; Hartmann, M.; Hrudkova, M.; Ireland, M. J.; Kovacs, J.; Mezo, Gy.; Moor, A.; Niemczura, E.; Sarty, G. E.; Szabo, Gy. M.; Szabo, R.; Telting, J. H.; Tkachenko, A.; Uytterhoeven, K.; Benko, J. M.; Bryson, S. T.; Maestro, V.; Simon, A. E.; Stello, D.; Schaefer, G.; Aerts, C.; ten Brummelaar, T. A.; De Cat, P.; McAlister, H. A.; Maceroni, C.; Merand, A.; Still, M.; Sturmann, J.; Sturmann, L.; Turner, N.; Tuthill, P. G.; Christensen-Dalsgaard, J.; Gilliland, R. L.; Kjeldsen, H.; Quintana, E. V.; Tenenbaum, P.; Twicken, J. D.			HD 181068: A Red Giant in a Triply Eclipsing Compact Hierarchical Triple System	SCIENCE			English	Article							STARS; BINARIES; SCIENCE	Hierarchical triple systems comprise a close binary and a more distant component. They are important for testing theories of star formation and of stellar evolution in the presence of nearby companions. We obtained 218 days of Kepler photometry of HD 181068 (magnitude of 7.1), supplemented by ground-based spectroscopy and interferometry, which show it to be a hierarchical triple with two types of mutual eclipses. The primary is a red giant that is in a 45-day orbit with a pair of red dwarfs in a close 0.9-day orbit. The red giant shows evidence for tidally induced oscillations that are driven by the orbital motion of the close pair. HD 181068 is an ideal target for studies of dynamical evolution and testing tidal friction theories in hierarchical triple systems.	[Derekas, A.] Eotvos Lorand Univ, Dept Astron, Budapest, Hungary; [Derekas, A.; Kiss, L. L.; Mezo, Gy.; Moor, A.; Szabo, Gy. M.; Szabo, R.; Benko, J. M.; Simon, A. E.] Hungarian Acad Sci, Konkoly Observ Budapest, H-1525 Budapest, Hungary; [Kiss, L. L.; Huber, D.; Bedding, T. R.; Ireland, M. J.; Maestro, V.; Stello, D.; Tuthill, P. G.] Univ Sydney, Sch Phys, Sydney Inst Astron, Sydney, NSW 2006, Australia; [Borkovits, T.] Baja Astron Observ, H-6500 Baja, Hungary; [Borkovits, T.] Eotvos Jozsef Coll, H-6500 Baja, Hungary; [Lehmann, H.; Hartmann, M.; Hrudkova, M.; Tkachenko, A.] Thuringer Landessternwarte TLS Tautenburg, Karl Schwarzschild Observ, D-07778 Tautenburg, Germany; [Southworth, J.] Univ Keele, Astrophys Grp, Newcastle Under Lyme ST5 5BG, Staffs, England; [Balam, D.] Dominion Astrophys Observ, Herzberg Inst Astrophys, Victoria, BC V9E 2E7, Canada; [Kovacs, J.] Eotvos Lorand Univ, Gothard Observ, H-9704 Szombathely, Hungary; [Niemczura, E.] Univ Wroclaw, Astron Inst, PL-51622 Wroclaw, Poland; [Sarty, G. E.] Univ Saskatchewan, Dept Phys & Engn Phys, Saskatoon, SK S7N 5A5, Canada; [Telting, J. H.] Nord Opt Telescope, Santa Cruz De La Palma 38700, Spain; [Uytterhoeven, K.] Univ Paris Diderot, Lab Astrophys Instrumentat & Modelisat, Inst Rech Lois Fondamentales Univers, Direct Sci Mat,CEA,CNRS,Serv Astrophys, F-91191 Gif Sur Yvette, France; [Uytterhoeven, K.] Kiepenheuer Inst Sonnenphys, D-79104 Freiburg, Germany; [Bryson, S. T.; Still, M.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Schaefer, G.; ten Brummelaar, T. A.; McAlister, H. A.; Sturmann, J.; Sturmann, L.; Turner, N.] Georgia State Univ, Ctr High Angular Resolut Astron, Atlanta, GA 30302 USA; [Aerts, C.] Katholieke Univ Leuven, Inst Sterrenkunde, B-3001 Louvain, Belgium; [Aerts, C.] Radboud Univ Nijmegen, Dept Astrophys, IMAPP, NL-6500 GL Nijmegen, Netherlands; [De Cat, P.] Royal Observ Belgium, B-1180 Brussels, Belgium; [Maceroni, C.] Osserv Astron Roma, Ist Nazl Astrofis INAF, I-00040 Monteporzio C, Italy; [Merand, A.] European So Observ, Santiago 19, Chile; [Christensen-Dalsgaard, J.; Kjeldsen, H.] Aarhus Univ, Dept Phys & Astron, DK-8000 Aarhus C, Denmark; [Gilliland, R. L.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Quintana, E. V.; Tenenbaum, P.; Twicken, J. D.] SETI Inst, Moffett Field, CA 94035 USA	Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Astronomy & Earth Sciences; University of Sydney; Keele University; National Research Council Canada; Eotvos Lorand University; University of Wroclaw; University of Saskatchewan; UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; Kiepenheuer Institut fur Sonnenphysik; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University System of Georgia; Georgia State University; KU Leuven; Radboud University Nijmegen; Istituto Nazionale Astrofisica (INAF); European Southern Observatory; Aarhus University; Space Telescope Science Institute	Derekas, A (corresponding author), Eotvos Lorand Univ, Dept Astron, Budapest, Hungary.	derekas@konkoly.hu	Niemczura, Ewa/X-9089-2019; Sarty, Gordon/ABG-6260-2021; Stello, Dennis/Q-9754-2019; Szabo, Robert/AAF-1565-2020; Niemczura, Ewa/L-4689-2019; Szabo, Gyula/A-8310-2012; Bedding, Timothy/AAU-9400-2021; Derekas, Aliz/G-2091-2016; Karjalainen, Marie/AAA-4957-2019; Huber, Daniel/AAE-9440-2019	Stello, Dennis/0000-0002-4879-3519; Szabo, Robert/0000-0002-3258-1909; Bedding, Timothy/0000-0001-5222-4661; Derekas, Aliz/0000-0002-6526-9444; Karjalainen, Marie/0000-0003-0751-3231; Huber, Daniel/0000-0001-8832-4488; Niemczura, Ewa/0000-0001-7290-5800; Merand, Antoine/0000-0003-2125-0183; Ireland, Michael/0000-0002-6194-043X; Tuthill, Peter/0000-0001-7026-6291; Bedding, Timothy/0000-0001-5943-1460; Aerts, Conny/0000-0003-1822-7126; Sarty, Gordon/0000-0001-5516-7869; Christensen-Dalsgaard, Jorgen/0000-0001-5137-0966; De Cat, Peter/0000-0001-5419-2042; Mezo, Gyorgy/0000-0002-0686-7479; Maceroni, Carla/0000-0002-5802-0667; Borkovits, Tamas/0000-0002-8806-496X; Kiss, Laszlo/0000-0002-3234-1374; Benko, Jozsef/0000-0003-3851-6603	NASA's Science Mission Directorate; Hungarian Scientific Research Fund (OTKA) [K76816, K83790, MB08C 81013]; Hungarian Academy of Sciences; Magyary Zoltan Higher Educational Public Foundation; American Astronomical Society; NSF [AST09-08253]; W. M. Keck Foundation; NASA Exoplanet Science Center; Deutsche Forschungsgemeinschaft [HA 3279/5-1]; European Research Council (ERC) under the European Community [227224]; STFC [ST/G002355/1, ST/J000035/1, PP/F000057/1, PP/D000955/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/D000955/1, ST/J000035/1, PP/F000057/1, ST/G002355/1] Funding Source: researchfish	NASA's Science Mission Directorate; Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); Magyary Zoltan Higher Educational Public Foundation; American Astronomical Society; NSF(National Science Foundation (NSF)); W. M. Keck Foundation(W.M. Keck Foundation); NASA Exoplanet Science Center; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council (ERC) under the European Community(European Research Council (ERC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	A.D. is a Magyary Zoltan Postdoctoral Research Fellow. Funding for this Discovery mission is provided by NASA's Science Mission Directorate. The authors gratefully acknowledge the entire Kepler team, whose outstanding efforts have made these results possible. This project has been supported by Hungarian Scientific Research Fund (OTKA) grants K76816, K83790, and MB08C 81013; the "Lendulet" Program of the Hungarian Academy of Sciences; and the Magyary Zoltan Higher Educational Public Foundation. The DAO observations were supported by an American Astronomical Society Small Research Grant. The CHARA Array is owned by Georgia State University. Additional funding for the CHARA Array is provided by NSF under grant AST09-08253, the W. M. Keck Foundation, and the NASA Exoplanet Science Center. TLS observations were done as a part of the Deutsche Forschungsgemeinschaft grant HA 3279/5-1. For her research, C. A. received funding from the European Research Council (ERC) under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 227224 (Prosperity).	Borucki WJ, 2010, SCIENCE, V327, P977, DOI 10.1126/science.1185402; Brown EW, 1936, MON NOT R ASTRON SOC, V97, P0056, DOI 10.1093/mnras/97.1.56; BROWN RH, 1974, MON NOT R ASTRON SOC, V167, P121; Carter JA, 2011, SCIENCE, V331, P562, DOI 10.1126/science.1201274; Girardi L, 1999, MON NOT R ASTRON SOC, V308, P818, DOI 10.1046/j.1365-8711.1999.02746.x; Guillout P, 2009, ASTRON ASTROPHYS, V504, P829, DOI 10.1051/0004-6361/200811313; Jenkins JM, 2010, ASTROPHYS J LETT, V713, pL120, DOI 10.1088/2041-8205/713/2/L120; Jenkins JM, 2010, ASTROPHYS J LETT, V713, pL87, DOI 10.1088/2041-8205/713/2/L87; Koch DG, 2010, ASTROPHYS J LETT, V713, pL79, DOI 10.1088/2041-8205/713/2/L79; Pace G, 2003, ASTRON ASTROPHYS, V401, P997, DOI 10.1051/0004-6361:20030163; Pietrinferni A, 2004, ASTROPHYS J, V612, P168, DOI 10.1086/422498; Southworth J, 2005, MON NOT R ASTRON SOC, V363, P529, DOI 10.1111/j.1365-2966.2005.09462.x; Southworth J, 2004, MON NOT R ASTRON SOC, V355, P986, DOI 10.1111/j.1365-2966.2004.08389.x; ten Brummelaar TA, 2005, ASTROPHYS J, V628, P453, DOI 10.1086/430729; Tokovinin A, 2008, MON NOT R ASTRON SOC, V389, P925, DOI 10.1111/j.1365-2966.2008.13613.x; van Leeuwen F., 2007, HIPPARCOS NEW REDUCT, P350; WILSON OC, 1957, ASTROPHYS J, V125, P661, DOI 10.1086/146339; [No title captured]	19	85	85	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2011	332	6026					216	218		10.1126/science.1201762	http://dx.doi.org/10.1126/science.1201762			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474755	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000289251100045
J	Studdert, DM; Spittal, MJ; Mello, MM; O'Malley, AJ; Stevenson, DG				Studdert, David M.; Spittal, Matthew J.; Mello, Michelle M.; O'Malley, A. James; Stevenson, David G.			Relationship between Quality of Care and Negligence Litigation in Nursing Homes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MEDICAL-MALPRACTICE LITIGATION; PERFORMANCE ASSESSMENT; PREDICTING LAWSUITS; BIRTH OUTCOMES; ERRORS; REFORM	BACKGROUND It is unclear whether high-quality health care institutions are less likely to be sued for negligence than their low-performing counterparts. METHODS We linked information on tort claims brought against 1465 nursing homes between 1998 and 2006 to 10 indicators of nursing home quality drawn from two U. S. national data sets: the Online Survey, Certification, and Reporting system and the Minimum Data Set Quality Measure/Indicator Report. We tested for associations between the incidence of claims and the quality measures at the facility calendar-quarter level, correcting for facility clustering and adjusting for case mix, ownership, occupancy, year, and state. Odds ratios were calculated for the effect of a change of 1 SD in each quality measure on the odds of one or more claims in each facility calendar-quarter. RESULTS Nursing homes with more deficiencies (odds ratio, 1.09; 95% confidence interval [CI], 1.05 to 1.13) and those with more serious deficiencies (odds ratio, 1.04; 95% CI, 1.00 to 1.08) had higher odds of being sued; this was also true for nursing homes that had more residents with weight loss (odds ratio, 1.05; 95% CI, 1.01 to 1.10) and with pressure ulcers (odds ratio, 1.09; 95% CI, 1.05 to 1.14). The odds of being sued were lower in nursing homes with more nurse's aide-hours per resident-day (odds ratio, 0.95; 95% CI, 0.91 to 0.99). However, all these effects were relatively small. For example, nursing homes with the best deficiency records (10th percentile) had a 40% annual risk of being sued, as compared with a 47% risk among nursing homes with the worst deficiency records (90th percentile). CONCLUSIONS The best-performing nursing homes are sued only marginally less than the worst-performing ones. Such weak discrimination may subvert the capacity of litigation to provide incentives to deliver safer care.	[Studdert, David M.; Spittal, Matthew J.] Univ Melbourne, Melbourne Sch Populat Hlth, Melbourne, Vic, Australia; [Studdert, David M.] Univ Melbourne, Melbourne Law Sch, Melbourne, Vic, Australia; [Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [O'Malley, A. James; Stevenson, David G.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	University of Melbourne; University of Melbourne; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School	Studdert, DM (corresponding author), Melbourne Sch Populat Hlth, 207 Bouverie St, Carlton, Vic 3053, Australia.	d.studdert@unimelb.edu.au	Studdert, David/AAF-3116-2021	Studdert, David/0000-0003-0585-5537; Spittal, Matthew/0000-0002-2841-1536; Mello, Michelle/0000-0003-2877-4270	Australian Research Council; Harvard Interfaculty Program for Health Systems Improvement	Australian Research Council(Australian Research Council); Harvard Interfaculty Program for Health Systems Improvement	Supported by a Federation Fellowship from the Australian Research Council (to Dr. Studdert) and the Harvard Interfaculty Program for Health Systems Improvement.	AR L, 1991, NEW ENGL J MED, V325, P245; Bostick JE, 2006, J AM MED DIR ASSOC, V7, P366, DOI 10.1016/j.jamda.2006.01.024; Brennan TA, 1996, NEW ENGL J MED, V335, P1963, DOI 10.1056/NEJM199612263352606; Castle NG, 2008, J APPL GERONTOL, V27, P375, DOI 10.1177/0733464808321596; Currie J, 2008, Q J ECON, V123, P795, DOI 10.1162/qjec.2008.123.2.795; Dubay L, 2001, J HEALTH ECON, V20, P591, DOI 10.1016/S0167-6296(01)00082-0; GREENBERG MD, 2010, TR824ICJ RAND; Institute of Medicine Committee on Quality of Health Care in America, 2001, CROSS QUAL CHASM NEW; Jha AK, 2006, HEALTH AFFAIR, V25, P844, DOI 10.1377/hlthaff.25.3.844; Johnson CE, 2004, HEALTH SERV RES, V39, P1713, DOI 10.1111/j.1475-6773.2004.00314.x; Johnson CE, 2004, GERONTOLOGIST, V44, P339, DOI 10.1093/geront/44.3.339; Kaplan SH, 2009, MED CARE, V47, P378, DOI 10.1097/MLR.0b013e31818dce07; Karon SL, 1999, MED CARE, V37, P570, DOI 10.1097/00005650-199906000-00006; Kessler D, 1996, Q J ECON, V111, P353, DOI 10.2307/2946682; Landon BE, 2003, JAMA-J AM MED ASSOC, V290, P1183, DOI 10.1001/jama.290.9.1183; Mello MM, 2004, SOC SCI MED, V59, P39, DOI 10.1016/j.socscimed.2003.09.034; Mello MM, 2002, TEX LAW REV, V80, P1595; Mor V, 2003, GERONTOLOGIST, V43, P37, DOI 10.1093/geront/43.suppl_2.37; Morris JN, 1997, J AM GERIATR SOC, V45, P1011, DOI 10.1111/j.1532-5415.1997.tb02974.x; SLOAN FA, 1995, MED CARE, V33, P700, DOI 10.1097/00005650-199507000-00006; SLOAN FA, 1990, AM ECON REV, V80, P128; Stevenson DG, 2008, HEALTH AFFAIR, V27, P1399, DOI 10.1377/hlthaff.27.5.1399; Stevenson DG, 2005, MED CARE, V43, P102, DOI 10.1097/00005650-200502000-00003; Stevenson DG, 2003, HEALTH AFFAIR, V22, P219, DOI 10.1377/hlthaff.22.2.219; Studdert DM, 2006, NEW ENGL J MED, V354, P2024, DOI 10.1056/NEJMsa054479; Studdert DM, 2000, MED CARE, V38, P250, DOI 10.1097/00005650-200003000-00002; Troyer JL, 2004, J HEALTH POLIT POLIC, V29, P11, DOI 10.1215/03616878-29-1-11; Wakefield J, 2008, ANNU REV PUBL HEALTH, V29, P75, DOI 10.1146/annurev.publhealth.29.020907.090821; Weiler PC, 1993, MEASURE MALPRACTICE; Yang YT, 2009, MED CARE, V47, P234, DOI 10.1097/MLR.0b013e31818475de; Zimmerman D R, 1995, Health Care Financ Rev, V16, P107	32	29	29	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2011	364	13					1243	1250		10.1056/NEJMsa1009336	http://dx.doi.org/10.1056/NEJMsa1009336			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	742NO	21449787				2022-12-28	WOS:000288951300008
J	Duncan, MK				Duncan, Melinda K.			A New Focus on RNA in the Lens	SCIENCE			English	Editorial Material							EXPRESSION; PROTEIN; CELLS		Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA	University of Delaware	Duncan, MK (corresponding author), Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA.	duncanm@udel.edu		Duncan, Melinda/0000-0003-1570-322X	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016472, S10RR027273] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015279, R01EY012221] Funding Source: NIH RePORTER; NCRR NIH HHS [RR027273-01, RR016472-10] Funding Source: Medline; NEI NIH HHS [EY15279, R01 EY015279, R01 EY012221, EY12221] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Arkov AL, 2010, TRENDS CELL BIOL, V20, P482, DOI 10.1016/j.tcb.2010.05.004; Donaldson P, 2001, NEWS PHYSIOL SCI, V16, P118; Duncan MK, 2004, DEV OCULAR LENS, P119; FAGERHOLM PP, 1981, EXP EYE RES, V33, P615, DOI 10.1016/S0014-4835(81)80101-7; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Lachke SA, 2011, SCIENCE, V331, P1571, DOI 10.1126/science.1195970; Lampi KJ, 1997, J BIOL CHEM, V272, P2268; LAND MF, 1988, CONTEMP PHYS, V29, P435, DOI 10.1080/00107518808222601; Miki T, 2005, CELL STRUCT FUNCT, V30, P51, DOI 10.1247/csf.30.51; Pierscionek B K, 1991, Lens Eye Toxic Res, V8, P229; Song SH, 2009, J CLIN INVEST, V119, P1837, DOI 10.1172/JCI38277; Taube JR, 2002, TRANSGENIC RES, V11, P397, DOI 10.1023/A:1016364001095; Wang XH, 2004, INVEST OPHTH VIS SCI, V45, P3608, DOI 10.1167/iovs.04-0423; Wistow G, 2002, MOL VIS, V8, P171	15	1	2	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 25	2011	331	6024					1523	1524		10.1126/science.1204205	http://dx.doi.org/10.1126/science.1204205			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21436425				2022-12-28	WOS:000288754500028
J	Bivona, TG; Hieronymus, H; Parker, J; Chang, K; Taron, M; Rosell, R; Moonsamy, P; Dahlman, K; Miller, VA; Costa, C; Hannon, G; Sawyers, CL				Bivona, Trever G.; Hieronymus, Haley; Parker, Joel; Chang, Kenneth; Taron, Miquel; Rosell, Rafael; Moonsamy, Philicia; Dahlman, Kimberly; Miller, Vincent A.; Costa, Carlota; Hannon, Gregory; Sawyers, Charles L.			FAS and NF-kappa B signalling modulate dependence of lung cancers on mutant EGFR	NATURE			English	Article							ACQUIRED-RESISTANCE; MET AMPLIFICATION; ERLOTINIB; MUTATIONS; KINASE; CELLS; ADENOCARCINOMA; INHIBITION; GEFITINIB; APOPTOSIS	Human lung adenocarcinomas with activating mutations in EGFR (epidermal growth factor receptor) often respond to treatment with EGFR tyrosine kinase inhibitors (TKIs), but the magnitude of tumour regression is variable and transient(1,2). This heterogeneity in treatment response could result from genetic modifiers that regulate the degree to which tumour cells are dependent on mutant EGFR. Through a pooled RNA interference screen, we show that knockdown of FAS and several components of the NF-kappa B pathway specifically enhanced cell death induced by the EGFR TKI erlotinib in EGFR-mutant lung cancer cells. Activation of NF-kappa B through overexpression of c-FLIP or IKK (also known as CFLAR and IKBKB, respectively), or silencing of I kappa B (also known as NFKBIA), rescued EGFR-mutant lung cancer cells from EGFR TKI treatment. Genetic or pharmacologic inhibition of NF-kappa B enhanced erlotinib-induced apoptosis in erlotinib-sensitive and erlotinib-resistant EGFR-mutant lung cancer models. Increased expression of the NF-kappa B inhibitor I kappa B predicted for improved response and survival in EGFR-mutant lung cancer patients treated with EGFR TKI. These data identify NF-kappa B as a potential companion drug target, together with EGFR, in EGFR-mutant lung cancers and provide insight into the mechanisms by which tumour cells escape from oncogene dependence.	[Bivona, Trever G.; Hieronymus, Haley; Moonsamy, Philicia; Dahlman, Kimberly; Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Parker, Joel] Express Anal Inc, Durham, NC 27713 USA; [Chang, Kenneth; Hannon, Gregory] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Taron, Miquel; Rosell, Rafael; Costa, Carlota] Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol, Barcelona 08916, Spain; [Taron, Miquel; Rosell, Rafael; Costa, Carlota] USP Dexeus Univ Inst, Barcelona 08028, Spain; [Hannon, Gregory; Sawyers, Charles L.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Memorial Sloan Kettering Cancer Center; Cold Spring Harbor Laboratory; Catalan Institute of Oncology; Hospital Germans Trias i Pujol; Howard Hughes Medical Institute	Sawyers, CL (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave,Box 20, New York, NY 10065 USA.	sawyersc@mskcc.org	Parker, Joel/AAG-1108-2019; Sawyers, Charles/G-5327-2016; Hannon, Gregory/AAB-3568-2019		Charles A. Dana Foundation; ASCO YIA; Caine Halter Lung Cancer Research Fund/Uniting Against Lung Cancer; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER	Charles A. Dana Foundation; ASCO YIA; Caine Halter Lung Cancer Research Fund/Uniting Against Lung Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank W. Pao, H. Varmus and members of the MSKCC Lung Cancer Oncogenome group for intellectual support. We thank J. Javier Sanchez for analysing human lung cancer gene expression data. We thank J. Wongvipat and E. Philips for technical assistance and W. Polkinghorn and members of the Sawyers Laboratory for critique of the manuscript. T.G.B. is supported by the MSKCC Clinical Scholars Fellowship funded by the Charles A. Dana Foundation, an ASCO YIA, and the Caine Halter Lung Cancer Research Fund/Uniting Against Lung Cancer Research Grant. C.L.S. and G.H. are Investigators of the Howard Hughes Medical Institute.	Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Chen L, 2010, NATURE, V465, P492, DOI 10.1038/nature09075; Chitale D, 2009, ONCOGENE, V28, P2773, DOI 10.1038/onc.2009.135; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Gong YX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007273; Green DR, 2010, NATURE, V465, P433, DOI 10.1038/465433a; Haber DA, 2005, COLD SH Q B, V70, P419, DOI 10.1101/sqb.2005.70.043; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; Miller VA, 2008, J CLIN ONCOL, V26, P1472, DOI 10.1200/JCO.2007.13.0062; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Sos ML, 2009, CANCER RES, V69, P3256, DOI 10.1158/0008-5472.CAN-08-4055; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Yang JM, 2006, CLIN CANCER RES, V12, P950, DOI 10.1158/1078-0432.CCR-05-1220	23	314	331	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					523	526		10.1038/nature09870	http://dx.doi.org/10.1038/nature09870			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21430781	Green Published, Green Accepted			2022-12-28	WOS:000288702200064
J	Gravitz, L				Gravitz, Lauren			CHEMOPREVENTION First line of defence	NATURE			English	Editorial Material							CANCER PREVENTION; CELLS											Bode AM, 2009, NAT REV CANCER, V9, P508, DOI 10.1038/nrc2646; Gerner EW, 2009, CLIN CANCER RES, V15, P758, DOI 10.1158/1078-0432.CCR-08-2235; Lippman SM, 2009, CANCER RES, V69, P5269, DOI 10.1158/0008-5472.CAN-09-1750; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Xu L, 2009, JNCI-J NATL CANCER I, V101, P1141, DOI 10.1093/jnci/djp227; Zhang L, 2010, NATURE, V464, P1058, DOI 10.1038/nature08871	6	29	31	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					S5	S7		10.1038/471S5a	http://dx.doi.org/10.1038/471S5a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430719				2022-12-28	WOS:000288702200009
J	Mann, A				Mann, Adam			THE HUNTING OF THE DARK	NATURE			English	News Item														Waldrop, M Mitchell/0000-0002-8063-1472				AALSETH CE, 2010, PREPRINT; Ahmed Z, 2010, SCIENCE, V327, P1619, DOI 10.1126/science.1186112; BERNABEI R, 2010, PREPRINT; HOOPER D, 2010, PREPRINT; REICH ES, 2011, NATURE, DOI DOI 10.1038/NEWS.2011.125; Waldrop MM, 2011, NATURE, V471, P286, DOI 10.1038/471286a	6	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					433	435		10.1038/471433a	http://dx.doi.org/10.1038/471433a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21430750	Bronze			2022-12-28	WOS:000288702200031
J	Negre, N; Brown, CD; Ma, LJ; Bristow, CA; Miller, SW; Wagner, U; Kheradpour, P; Eaton, ML; Loriaux, P; Sealfon, R; Li, ZR; Ishii, H; Spokony, RF; Chen, J; Hwang, L; Cheng, C; Auburn, RP; Davis, MB; Domanus, M; Shah, PK; Morrison, CA; Zieba, J; Suchy, S; Senderowicz, L; Victorsen, A; Bild, NA; Grundstad, AJ; Hanley, D; MacAlpine, DM; Mannervik, M; Venken, K; Bellen, H; White, R; Gerstein, M; Russell, S; Grossman, RL; Ren, B; Posakony, JW; Kellis, M; White, KP				Negre, Nicolas; Brown, Christopher D.; Ma, Lijia; Bristow, Christopher Aaron; Miller, Steven W.; Wagner, Ulrich; Kheradpour, Pouya; Eaton, Matthew L.; Loriaux, Paul; Sealfon, Rachel; Li, Zirong; Ishii, Haruhiko; Spokony, Rebecca F.; Chen, Jia; Hwang, Lindsay; Cheng, Chao; Auburn, Richard P.; Davis, Melissa B.; Domanus, Marc; Shah, Parantu K.; Morrison, Carolyn A.; Zieba, Jennifer; Suchy, Sarah; Senderowicz, Lionel; Victorsen, Alec; Bild, Nicholas A.; Grundstad, A. Jason; Hanley, David; MacAlpine, David M.; Mannervik, Mattias; Venken, Koen; Bellen, Hugo; White, Robert; Gerstein, Mark; Russell, Steven; Grossman, Robert L.; Ren, Bing; Posakony, James W.; Kellis, Manolis; White, Kevin P.			A cis-regulatory map of the Drosophila genome	NATURE			English	Article							TRANSCRIPTION FACTOR; ENHANCERS; MELANOGASTER; EXPRESSION; BLASTODERM; PROTEINS	Systematic annotation of gene regulatory elements is a major challenge in genome science. Direct mapping of chromatin modification marks and transcriptional factor binding sites genome-wide(1,2) has successfully identified specific subtypes of regulatory elements(3). In Drosophila several pioneering studies have provided genome-wide identification of Polycomb response elements(4), chromatin states(5), transcription factor binding sites(6-9), RNA polymerase II regulation(8) and insulator elements(10); however, comprehensive annotation of the regulatory genome remains a significant challenge. Here we describe results from the modENCODE cis-regulatory annotation project. We produced a map of the Drosophila melanogaster regulatory genome on the basis of more than 300 chromatin immunoprecipitation data sets for eight chromatin features, five histone deacetylases and thirty-eight site-specific transcription factors at different stages of development. Using these data we inferred more than 20,000 candidate regulatory elements and validated a subset of predictions for promoters, enhancers and insulators in vivo. We identified also nearly 2,000 genomic regions of dense transcription factor binding associated with chromatin activity and accessibility. We discovered hundreds of new transcription factor co-binding relationships and defined a transcription factor network with over 800 potential regulatory relationships.	[Negre, Nicolas; Brown, Christopher D.; Ma, Lijia; Spokony, Rebecca F.; Davis, Melissa B.; Domanus, Marc; Morrison, Carolyn A.; Zieba, Jennifer; Suchy, Sarah; Senderowicz, Lionel; Victorsen, Alec; Bild, Nicholas A.; Grundstad, A. Jason; Grossman, Robert L.; White, Kevin P.] Univ Chicago, Inst Genom & Syst Biol, Dept Human Genet, Chicago, IL 60637 USA; [Bristow, Christopher Aaron; Kheradpour, Pouya; Sealfon, Rachel; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Broad Inst MIT & Harvard, Cambridge, MA 02139 USA; [Miller, Steven W.; Ishii, Haruhiko; Posakony, James W.] Univ Calif San Diego, Div Biol Sci CDB, La Jolla, CA 92093 USA; [Wagner, Ulrich; Li, Zirong; Hwang, Lindsay; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Eaton, Matthew L.] Duke Univ, Dept Pharmacol & Canc Biol, Med Ctr, Durham, NC 27710 USA; [Loriaux, Paul] Univ Calif San Diego, Signaling Syst Lab, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Chen, Jia; Hanley, David; Grossman, Robert L.] Univ Illinois, Natl Ctr Data Min, Chicago, IL 60607 USA; [Cheng, Chao; Gerstein, Mark] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Cheng, Chao; Gerstein, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Cheng, Chao] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; [Auburn, Richard P.; Russell, Steven] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Auburn, Richard P.; Russell, Steven] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge CB2 3EH, England; [Shah, Parantu K.] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Mannervik, Mattias] Stockholm Univ, Dept Dev Biol, Wenner Gren Inst, Arrhenius Labs E3, S-10691 Stockholm, Sweden; [Venken, Koen; Bellen, Hugo] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [White, Robert] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England; [Grossman, Robert L.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Ren, Bing] Inst Genom Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ren, Bing] Moores Canc Ctr, La Jolla, CA 92093 USA	University of Chicago; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; Duke University; University of California System; University of California San Diego; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Yale University; Yale University; Yale University; University of Cambridge; University of Cambridge; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Stockholm University; Baylor College of Medicine; University of Cambridge; University of Chicago	White, KP (corresponding author), Univ Chicago, Inst Genom & Syst Biol, Dept Human Genet, 900 E 57th St, Chicago, IL 60637 USA.	kpwhite@uchicago.edu	Spokony, Rebecca/AAD-3014-2020; Zieba, Jennifer/ABE-1077-2020; White, Rob A H/G-4835-2012; Eaton, Matthew/C-4408-2011; Kellis, Manolis/ABE-7385-2020; Venken, Koen/B-9909-2013; Russell, Steve/A-4072-2011; Grossman, Robert/B-1865-2009	Zieba, Jennifer/0000-0003-1650-1830; Kellis, Manolis/0000-0001-7113-9630; Venken, Koen/0000-0003-0741-4698; Russell, Steve/0000-0003-0546-3031; Miller, Steven/0000-0001-7610-6336; Brown, Christopher/0000-0002-3785-5008; Davis, Melissa/0000-0002-6124-6923; Negre, Nicolas/0000-0001-9727-3416; Mannervik, Mattias/0000-0003-4999-9655; Ishii, Haruhiko/0000-0002-1593-096X; Bellen, Hugo/0000-0001-5992-5989; Grossman, Robert/0000-0003-3741-5739	National Human Genome Research Institute [U01HG004264]; Chicago Biomedical Consortium; Chicago Community Trust; Lilly-Life Sciences Research Foundation; NIH NRSA; Isaac Newton Trust; Department of Energy; NHGRI [U01 HG004279]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037, U01HG004279, RC2HG005639, U01HG004264] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM081892, F32GM074364] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Chicago Biomedical Consortium; Chicago Community Trust; Lilly-Life Sciences Research Foundation; NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Isaac Newton Trust; Department of Energy(United States Department of Energy (DOE)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U01HG004264 from the National Human Genome Research Institute to K.P.W. and also funded by the Chicago Biomedical Consortium with support from the Searle Funds at the Chicago Community Trust. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Human Genome Research Institute (NHGRI) or the National Institutes of Health (NIH). C.D.B. is supported by a Lilly-Life Sciences Research Foundation fellowship. C.A.B. is supported by a NIH NRSA postdoctoral fellowship. R.P.A. is in part supported by an Isaac Newton Trust award to R.W.P.L. was supported by a grant from the Department of Energy Computational Sciences Graduate Fellowship (DOE CSGF). M.E.L. and D.M.M. work was supported by NHGRI grant U01 HG004279. We thank the Functional Genomics Facility at the University of Chicago and the High-Throughput Genome Analysis Core at Argonne National Laboratory for processing of microarrays and of Illumina sequence. We thank T.-R. Li, J.D. Lambert, S. Rifkin, T. Herreman, C. Mason, L. Sun and Z. Gauhar for producing the developmental expression microarray data. We also thank the many members of the Drosophila community who contributed to this work by providing reagents. A complete list of community participants is included in the Supplementary Methods.	Agger K, 2008, CURR OPIN GENET DEV, V18, P159, DOI 10.1016/j.gde.2007.12.003; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Gebelein B, 2004, NATURE, V431, P653, DOI 10.1038/nature02946; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Haecker A, 2007, PLOS BIOL, V5, P1298, DOI 10.1371/journal.pbio.0050145; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Kwong C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000178; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; Moorman C, 2006, P NATL ACAD SCI USA, V103, P12027, DOI 10.1073/pnas.0605003103; Negre N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000814; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; RIVERAPOMAR R, 1995, NATURE, V376, P253, DOI 10.1038/376253a0; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; TRUMAN JW, 1990, J NEUROBIOL, V21, P1072, DOI 10.1002/neu.480210711; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531; Zraly CB, 2003, DEV BIOL, V253, P291, DOI 10.1016/S0012-1606(02)00011-8	27	371	379	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					527	531		10.1038/nature09990	http://dx.doi.org/10.1038/nature09990			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21430782	Green Accepted, Green Submitted			2022-12-28	WOS:000288702200065
J	Mateen, FJ; Brook, RD				Mateen, Farrah J.; Brook, Robert D.			Air Pollution as an Emerging Global Risk Factor for Stroke	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DISEASES		[Mateen, Farrah J.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21287 USA; [Mateen, Farrah J.] Johns Hopkins Univ, Dept Int Hlth, Baltimore, MD 21287 USA; [Brook, Robert D.] Univ Michigan, Div Cardiovasc Med, Ann Arbor, MI 48109 USA	Johns Hopkins University; Johns Hopkins University; University of Michigan System; University of Michigan	Mateen, FJ (corresponding author), Johns Hopkins Univ, Dept Neurol, 600 N Wolfe St,Pathol Bldg,Room 627, Baltimore, MD 21287 USA.	fmateen@jhsph.edu		Mateen, Farrah/0000-0002-4293-8115				[Anonymous], 2009, REUTERS         0217; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Hong YC, 2002, ENVIRON HEALTH PERSP, V110, P187, DOI 10.1289/ehp.02110187; LOGAN WPD, 1953, LANCET, V264, P336; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Narayan KMV, 2010, NEW ENGL J MED, V363, P1196, DOI 10.1056/NEJMp1002024; Oudin A, 2010, NEUROEPIDEMIOLOGY, V34, P131, DOI 10.1159/000274807; *WHO, 2008, 310 WHO; Zhou PP, 2005, CLIMATE CHANGE AFRIC, P140	10	57	60	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2011	305	12					1240	1241		10.1001/jama.2011.352	http://dx.doi.org/10.1001/jama.2011.352			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738PA	21427378				2022-12-28	WOS:000288652100022
J	Jia, CL; Urban, KW; Alexe, M; Hesse, D; Vrejoiu, I				Jia, Chun-Lin; Urban, Knut W.; Alexe, Marin; Hesse, Dietrich; Vrejoiu, Ionela			Direct Observation of Continuous Electric Dipole Rotation in Flux-Closure Domains in Ferroelectric Pb(Zr,Ti)O-3	SCIENCE			English	Article							FILMS; MICROSCOPY; SCALE; LAYER	Low-dimensional ferroelectric structures are a promising basis for the next generation of ultrahigh-density nonvolatile memory devices. Depolarization fields, created by incompletely compensated charges at the surfaces and interfaces, depress the polarization of such structures. Theory suggests that under conditions of uncompensated surface charges, local dipoles can organize in flux-closure structures in thin films and vortex structures in nano-sized ferroelectrics, reducing depolarization fields. However, the continuous rotation of the dipoles required in vortex structures and the behavior of unit cell dipoles in flux-closure structures have never been experimentally established. By aberration-corrected transmission electron microscopy, we obtained experimental evidence for continuous rotation of the dipoles closing the flux of 180 domains in a ferroelectric perovskite thin film.	[Jia, Chun-Lin; Urban, Knut W.] Forschungszentrum Julich, Peter Grunberg Inst, D-52425 Julich, Germany; [Jia, Chun-Lin; Urban, Knut W.] Forschungszentrum Julich, Ernst Ruska Ctr Microscopy & Spect Electrons, D-52425 Julich, Germany; [Alexe, Marin; Hesse, Dietrich; Vrejoiu, Ionela] Max Planck Inst Microstruct Phys, D-06120 Halle, Germany	Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Max Planck Society	Jia, CL (corresponding author), Forschungszentrum Julich, Peter Grunberg Inst, D-52425 Julich, Germany.	c.jia@fz-juelich.de	Alexe, Marin/K-3882-2016; Kim, Yu Jin/A-2433-2012	Alexe, Marin/0000-0002-0386-3026; 	Deutsche Forschungsgemeinschaft [SFB 762]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by Deutsche Forschungsgemeinschaft grant SFB 762 (M. A., D. H., and I.V.).	Aguado-Puente P, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.177601; Alpay SP, 1999, J APPL PHYS, V85, P3271, DOI 10.1063/1.369670; Balke N, 2009, NAT NANOTECHNOL, V4, P868, DOI [10.1038/nnano.2009.293, 10.1038/NNANO.2009.293]; Chang YJ, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.057201; Herranz G, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.174423; Ivry Y, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.207602; Jia CL, 2010, ULTRAMICROSCOPY, V110, P500, DOI 10.1016/j.ultramic.2009.10.006; Jia CL, 2008, NAT MATER, V7, P57, DOI 10.1038/nmat2080; Jia CL, 2007, NAT MATER, V6, P64, DOI 10.1038/nmat1808; Jia CL, 2003, SCIENCE, V299, P870, DOI 10.1126/science.1079121; Kornev I, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.196104; Lai BK, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.137602; Lai BK, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2799252; Lee D, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.060102; Lentzen M, 2008, MICROSC MICROANAL, V14, P16, DOI 10.1017/S1431927608080045; Lines M.E., 2001, PRINCIPLES APPL FERR; McGilly LJ, 2010, NANO LETT, V10, P4200, DOI 10.1021/nl102566y; Naumov II, 2004, NATURE, V432, P737, DOI 10.1038/nature03107; Naumov I, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.107601; Nelson CT, 2011, NANO LETT, V11, P828, DOI 10.1021/nl1041808; Prosandeev S, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.094102; Rabe K. M., 2007, PHYS FERROELECTRICS; Rodriguez BJ, 2009, NANO LETT, V9, P1127, DOI 10.1021/nl8036646; Schilling A, 2009, NANO LETT, V9, P3359, DOI 10.1021/nl901661a; Scott JF, 2007, SCIENCE, V315, P954, DOI 10.1126/science.1129564; Scott J.F., 2000, FERROELECTRIC MEMORI; Setter N, 2000, ACTA MATER, V48, P151, DOI 10.1016/S1359-6454(99)00293-1; Stephenson GB, 2006, J APPL PHYS, V100, DOI 10.1063/1.2337360; Streiffer SK, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.067601; Toyota D, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2108123; Urban KW, 2008, SCIENCE, V321, P506, DOI 10.1126/science.1152800; Vrejoiu I, 2006, ADV MATER, V18, P1657, DOI 10.1002/adma.200502711; Xia J, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.140407	34	323	329	10	427	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2011	331	6023					1420	1423		10.1126/science.1200605	http://dx.doi.org/10.1126/science.1200605			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21415348				2022-12-28	WOS:000288504000036
J	Nurse, P; Hayles, J				Nurse, Paul; Hayles, Jacqueline			The Cell in an Era of Systems Biology	CELL			English	Article							YEAST SCHIZOSACCHAROMYCES-POMBE; PROTEIN INTERACTION NETWORK; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; GLOBAL ANALYSIS; BUDDING YEAST; SIZE CONTROL; GENOME; CYCLE	The increasing use of high-throughput technologies and computational modeling is revealing new levels of biological function and organization. How are these features of systems biology influencing our view of the cell?	[Nurse, Paul; Hayles, Jacqueline] Cancer Res UK, London Res Inst, London WC2A 3LY, England; [Nurse, Paul] Rockefeller Univ, New York, NY 10021 USA	Cancer Research UK; Rockefeller University	Nurse, P (corresponding author), Cancer Res UK, London Res Inst, 44 Lincolns Inn Fields, London WC2A 3LY, England.	janet.bonner@royalsociety.org			Wellcome Trust [093917] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alon U, 2003, SCIENCE, V301, P1866, DOI 10.1126/science.1089072; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Bray, 2009, WETWARE COMPUTER EVE; BRENNER S, 1961, NATURE, V190, P576, DOI 10.1038/190576a0; Brenner S, 2010, PHILOS T R SOC B, V365, P207, DOI 10.1098/rstb.2009.0221; Choi JK, 2009, NAT GENET, V41, P498, DOI 10.1038/ng.319; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Coudreuse D, 2010, NATURE, V468, P1074, DOI 10.1038/nature09543; Danino T, 2010, NATURE, V463, P326, DOI 10.1038/nature08753; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; Deibler RW, 2010, MOL CELL, V37, P753, DOI 10.1016/j.molcel.2010.02.023; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; DICKSON RC, 1975, SCIENCE, V187, P27, DOI 10.1126/science.1088926; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Ezov TK, 2006, GENETICS, V174, P1455, DOI 10.1534/genetics.106.062745; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; Guo YB, 2010, GENOME RES, V20, P239, DOI 10.1101/gr.099648.109; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; LIN SY, 1975, CELL, V4, P107, DOI 10.1016/0092-8674(75)90116-6; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Monod J., 1972, CHANCE NECESSITY ESS; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Novak B, 1997, P NATL ACAD SCI USA, V94, P9147, DOI 10.1073/pnas.94.17.9147; Nurse P, 2008, NATURE, V454, P424, DOI 10.1038/454424a; OHKI M, 1975, NATURE, V253, P654, DOI 10.1038/253654a0; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; SAUNDERS PT, 1976, J THEOR BIOL, V63, P375, DOI 10.1016/0022-5193(76)90040-0; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sioud M, 2011, METHODS MOL BIOL, V703, P173, DOI 10.1007/978-1-59745-248-9_12; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Towers M, 2009, INT J DEV BIOL, V53, P805, DOI 10.1387/ijdb.072499mt; TYSON JJ, 1983, J THEOR BIOL, V104, P617, DOI 10.1016/0022-5193(83)90250-3; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; von Kriegsheim A, 2009, NAT CELL BIOL, V11, P1458, DOI 10.1038/ncb1994; Wang Y, 2010, J PROTEOME RES, V9, P6665, DOI 10.1021/pr100808n; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80	54	52	56	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 18	2011	144	6					850	854		10.1016/j.cell.2011.02.045	http://dx.doi.org/10.1016/j.cell.2011.02.045			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	737BQ	21414476	Bronze			2022-12-28	WOS:000288543500003
J	Pierce, JP; Messer, K; White, MM; Cowling, DW; Thomas, DP				Pierce, John P.; Messer, Karen; White, Martha M.; Cowling, David W.; Thomas, David P.			Prevalence of Heavy Smoking in California and the United States, 1965-2007	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CIGARETTE-SMOKING; LUNG-CANCER; CONSUMPTION; CESSATION; REDUCTION; DECLINE; HEALTH; RATES; RISK; SELF	Context The intensity of smoking, not just prevalence, is associated with future health consequences. Objective To estimate smoking intensity patterns over time and by age within birth cohorts for California and the remaining United States. Design, Setting, and Participants Two large population-based surveys with state estimates: National Health Interview Surveys, 1965-1994; and Current Population Survey Tobacco Supplements, 1992-2007. There were 139 176 total respondents for California and 1 662 353 for the remaining United States. Main Outcome Measure Number of cigarettes smoked per day (CPD), high-intensity smokers (>= 20 CPD); moderate-intensity smokers (10-19 CPD); low-intensity smokers (0-9 CPD). Results In 1965, 23.2% of adults in California (95% confidence interval [CI], 19.6%-26.8%) and 22.9% of adults in the remaining United States (95% CI, 22.1%-23.6%) were high-intensity smokers, representing 56% of all smokers. By 2007, this prevalence was 2.6% (95% CI, 0.0%-5.6%) or 23% of smokers in California and 7.2% (95% CI, 6.4%-8.0%) or 40% of smokers in the remaining United States. Among individuals (US residents excluding California) born between 1920-1929, the prevalence of moderate/high-intensity smoking (>= 10 CPD) was 40.5% (95% CI, 38.3%-42.7%) in 1965. Moderate/high-intensity smoking declined across successive birth cohorts, and for the 1970-1979 birth cohort, the highest rate of moderate/high-intensity smoking was 9.7% (95% CI, 7.7%-11.7%) in California and 18.3% (95% CI, 16.4%-20.2%) in the remaining United States. There was a marked decline in moderate/high-intensity smoking at older ages in all cohorts, but this was greater in California. By age 35 years, the prevalence of moderate/high-intensity smoking in the 19701979 birth cohort was 4.6% (95% CI, 3.0%-6.1%) in California and 13.5% (95% CI, 11.8%-15.1%) in the remaining United States. Conclusions Between 1965 and 2007, the prevalence of high-intensity smoking decreased greatly in the United States. The greater decline in high-intensity smoking prevalence in California was related to reduced smoking initiation and a probable increase in smoking cessation. JAMA. 2011;305(11):1106-1112 www.jama.com	[Pierce, John P.] Univ Calif San Diego, Moores UCSD Canc Ctr, Canc Prevent & Control Program, La Jolla, CA 92093 USA; [Cowling, David W.] Calif Dept Publ Hlth, Calif Tobacco Control Program, Sacramento, CA USA; [Thomas, David P.] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0909, Australia; [Thomas, David P.] Charles Darwin Univ, Lowitja Inst, Darwin, NT 0909, Australia	University of California System; University of California San Diego; California Department of Public Health; Charles Darwin University; Menzies School of Health Research; Charles Darwin University	Pierce, JP (corresponding author), Univ Calif San Diego, Moores UCSD Canc Ctr, Canc Prevent & Control Program, La Jolla, CA 92093 USA.	jppierce@ucsd.edu		Pierce, John/0000-0002-0075-7471	University of California [18CA-0134, 18ST-0202, 19ST-0181]; Carol Vassiliadis and family	University of California(University of California System); Carol Vassiliadis and family	This study was funded by the University of California Tobacco-Related Disease Research Program grants 18CA-0134, 18ST-0202, and 19ST-0181, and through gift money to the Moores UCSD Cancer Center from Carol Vassiliadis and family. During his time at UCSD, Dr Thomas reports being supported by the Australian National Heart Foundation Research Fellowship CR 09D 4712.	Al-Delaimy W, CALIFORNIA TOBACCO C; BAL DG, 1990, JAMA-J AM MED ASSOC, V264, P1570, DOI 10.1001/jama.264.12.1570; Biener L, 2004, AM J PREV MED, V27, P254, DOI 10.1016/j.amepre.2004.05.006; Centers for Disease Control and Prevention (CDC), 1994, MMWR Morb Mortal Wkly Rep, V43, P342; DOLL R, 1978, J EPIDEMIOL COMMUN H, V32, P303, DOI 10.1136/jech.32.4.303; Farkas AJ, 1999, ANN BEHAV MED, V21, P71, DOI 10.1007/BF02895036; Flanders WD, 2003, CANCER RES, V63, P6556; Freedman ND, 2008, LANCET ONCOL, V9, P649, DOI 10.1016/S1470-2045(08)70154-2; Gilpin EA, 1999, J ADOLESCENT HEALTH, V25, P248, DOI 10.1016/S1054-139X(99)00024-5; Gilpin EA, 2004, TOB CONTROL, V13, P38, DOI 10.1136/tc.2003.004739; GILPIN EA, 1994, AM J PUBLIC HEALTH, V84, P1576, DOI 10.2105/AJPH.84.10.1576; Gilpin EA, 2002, AM J PUBLIC HEALTH, V92, P785, DOI 10.2105/AJPH.92.5.785; Gilpin EA, 2006, TOB CONTROL, V15, DOI 10.1136/tc.2005.015370; Glantz SA, 2000, TOBACCO WAR INSIDE C; Godtfredsen NS, 2005, JAMA-J AM MED ASSOC, V294, P1505, DOI 10.1001/jama.294.12.1505; Hedrick JL, 1969, PHS PUBL; Messer K, 2008, AM J PREV MED, V35, P210, DOI 10.1016/j.amepre.2008.05.023; Messer K, 2010, AM J PUBLIC HEALTH, V100, P1298, DOI 10.2105/AJPH.2009.160416; Pierce JP, 2010, CANCER EPIDEM BIOMAR, V19, P2801, DOI 10.1158/1055-9965.EPI-10-0563; PIERCE JP, 1987, J CHRON DIS, V40, P689, DOI 10.1016/0021-9681(87)90105-6; Pierce JP, 2001, TOB CONTROL, V10, P145, DOI 10.1136/tc.10.2.145; Rock V. J., 2007, Morbidity and Mortality Weekly Report, V56, P1157; Roeseler A, 2010, TOB CONTROL, V19, pI3, DOI 10.1136/tc.2009.030809; Schane RE, 2009, AM J PREV MED, V37, P124, DOI 10.1016/j.amepre.2009.03.020; Song YM, 2008, J CLIN ONCOL, V26, P5101, DOI 10.1200/JCO.2008.17.0498; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; Thorndike AN, 2002, AM J PUBLIC HEALTH, V92, P437, DOI 10.2105/AJPH.92.3.437; U.S. Dep. Health Hum. Serv, 1989, 898411 CDC US DEP HL; US Department of Commerce, 2007, CPS07 US DEP COMM BU; US Department of Commerce, 2002, CURR POP SURV DES ME; US Department of Health Education and Welfare, 1964, SMOK HLTH REP ADV CO; US Dept of Health and Human Services, 1989, DES EST NHIS 1985 2; Wakefield MA, 2008, AM J PUBLIC HEALTH, V98, P1443, DOI 10.2105/AJPH.2007.128991	33	98	101	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2011	305	11					1106	1112		10.1001/jama.2011.334	http://dx.doi.org/10.1001/jama.2011.334			0	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	734ZF	21406647	Bronze			2022-12-28	WOS:000288381900022
J	Gruen, RL; Mitra, B				Gruen, Russell L.; Mitra, Biswadev			Tranexamic acid for trauma	LANCET			English	Editorial Material							FRESH-FROZEN PLASMA		[Gruen, Russell L.] Monash Univ, Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic 3004, Australia; [Mitra, Biswadev] Monash Univ, Alfred Hosp, Emergency & Trauma Ctr, Melbourne, Vic 3004, Australia	Florey Institute of Neuroscience & Mental Health; Monash University; Florey Institute of Neuroscience & Mental Health; Monash University	Gruen, RL (corresponding author), Monash Univ, Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic 3004, Australia.	r.gruen@alfred.org.au	Mitra, Biswadev/AAC-3724-2019; D'Angelo, Armando/K-2583-2018	Mitra, Biswadev/0000-0002-0508-2450; D'Angelo, Armando/0000-0002-9857-4509				Bolliger D, 2010, BRIT J ANAESTH, V104, P318, DOI 10.1093/bja/aeq001; Bolliger D, 2010, ANESTHESIOLOGY, V113, P1205, DOI 10.1097/ALN.0b013e3181f22b5a; Davenport R, 2011, J TRAUMA, V70, P90, DOI 10.1097/TA.0b013e318202e486; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Levy JH, 2010, LANCET, V376, P3, DOI 10.1016/S0140-6736(10)60939-7; Lockey D, 2005, BJA EDUC, V5, P191, DOI 10.1093/bjaceaccp/mki054; Mitra B, 2012, INJURY, V43, P22, DOI 10.1016/j.injury.2010.10.015; Paran H, 2005, AM J SURG, V190, P463, DOI 10.1016/j.amjsurg.2005.03.032; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5	10	17	17	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2011	377	9771					1052	1054		10.1016/S0140-6736(11)60396-6	http://dx.doi.org/10.1016/S0140-6736(11)60396-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	743QY	21439636				2022-12-28	WOS:000289035000006
J	Avinoam, O; Fridman, K; Valansi, C; Abutbul, I; Zeev-Ben-Mordehai, T; Maurer, UE; Sapir, A; Danino, D; Grunewald, K; White, JM; Podbilewicz, B				Avinoam, Ori; Fridman, Karen; Valansi, Clari; Abutbul, Inbal; Zeev-Ben-Mordehai, Tzviya; Maurer, Ulrike E.; Sapir, Amir; Danino, Dganit; Gruenewald, Kay; White, Judith M.; Podbilewicz, Benjamin			Conserved Eukaryotic Fusogens Can Fuse Viral Envelopes to Cells	SCIENCE			English	Article							VESICULAR STOMATITIS-VIRUS; MEMBRANE-FUSION; C-ELEGANS; GLYCOPROTEIN; MECHANISMS; EFF-1; PROTEINS	Caenorhabditis elegans proteins AFF-1 and EFF-1 [C. elegans fusion family (CeFF) proteins] are essential for developmental cell-to-cell fusion and can merge insect cells. To study the structure and function of AFF-1, we constructed vesicular stomatitis virus (VSV) displaying AFF-1 on the viral envelope, substituting the native fusogen VSV glycoprotein. Electron microscopy and tomography revealed that AFF-1 formed distinct supercomplexes resembling pentameric and hexameric "flowers" on pseudoviruses. Viruses carrying AFF-1 infected mammalian cells only when CeFFs were on the target cell surface. Furthermore, we identified fusion family (FF) proteins within and beyond nematodes, and divergent members from the human parasitic nematode Trichinella spiralis and the chordate Branchiostoma floridae could also fuse mammalian cells. Thus, FF proteins are part of an ancient family of cellular fusogens that can promote fusion when expressed on a viral particle.	[Avinoam, Ori; Fridman, Karen; Valansi, Clari; Sapir, Amir; Podbilewicz, Benjamin] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel; [Abutbul, Inbal; Danino, Dganit] Technion Israel Inst Technol, Dept Biotechnol & Food Engn, IL-32000 Haifa, Israel; [Abutbul, Inbal; Danino, Dganit] Technion Israel Inst Technol, Russell Berrie Nanotechnol Inst, IL-32000 Haifa, Israel; [Zeev-Ben-Mordehai, Tzviya; Gruenewald, Kay] Univ Oxford, Oxford Particle Imaging Ctr, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Maurer, Ulrike E.; Gruenewald, Kay] Max Planck Inst Biochem, Dept Mol Struct Biol, D-82152 Martinsried, Germany; [White, Judith M.] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22908 USA	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Technion Israel Institute of Technology; University of Oxford; Wellcome Centre for Human Genetics; Max Planck Society; University of Virginia	Podbilewicz, B (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.	podbilew@technion.ac.il	Zeev-Ben-Mordehai, Tzviya/D-7112-2014; Podbilewicz, Benjamin/N-4825-2014; Sapir, Amir/C-5758-2015; Danino, Dganit/D-6832-2016; Avinoam, Ori/AAX-7382-2020; Grünewald, Kay/AAW-3652-2020; Zeev-Ben-Mordehai, Tzviya/AAD-3270-2021	Zeev-Ben-Mordehai, Tzviya/0000-0002-2571-550X; Sapir, Amir/0000-0001-9888-1800; Danino, Dganit/0000-0002-9782-4940; Avinoam, Ori/0000-0003-3543-168X; Grünewald, Kay/0000-0002-4788-2691; Zeev-Ben-Mordehai, Tzviya/0000-0002-2571-550X; Podbilewicz, Benjamin/0000-0002-0411-4182	Israel Science Foundation [ISF 1542/07]; Human Frontier Science Program [RG0079/2009-C]; NIH [AI22470]; Wellcome Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI022470] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); Human Frontier Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank I. Nagano, M. Whitt, A. Fire, C. Giraudo, and J. Rothman for reagents; F. Glaser, M. Glickman, A. Harel, O. Kleifeld, T. Schwartz, I. Sharon, E. Spooner, R. Sommer, and members of the White and Podbilewicz labs for discussions; the Smoler Proteomics Center at the Technion and the Whitehead Institute for Biomedical Research for mass spectrometry; T. Ziv for proteomics analysis; the Caenorhabditis Genetics Center for nematode strains; and I. Yanai and A. de Silva for critically reading the manuscript. This work was supported by grants from the FIRST Program of the Israel Science Foundation (ISF 1542/07 to B.P.), the Human Frontier Science Program (RG0079/2009-C to K.G.), and the NIH (AI22470 to J.M.W.), as well as a Wellcome Trust Senior Research Fellowship to K. G. The Technion Research and Development Foundation has filed a patent relating to methods and compositions useful in cell-cell fusion using FF proteins of nematode origin and to antinematodal methods and compositions, using proteins of the nematode fusion family.	Chen EH, 2007, FEBS LETT, V581, P2181, DOI 10.1016/j.febslet.2007.03.033; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; LEFRANCOIS L, 1982, VIROLOGY, V121, P157, DOI 10.1016/0042-6822(82)90125-8; Libersou S, 2010, J CELL BIOL, V191, P199, DOI 10.1083/jcb.201006116; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Matsuura Y, 2001, VIROLOGY, V286, P263, DOI 10.1006/viro.2001.0971; Mohler WA, 2002, DEV CELL, V2, P355, DOI 10.1016/S1534-5807(02)00129-6; Oren-Suissa M, 2007, TRENDS CELL BIOL, V17, P537, DOI 10.1016/j.tcb.2007.09.004; Podbilewicz B, 2006, DEV CELL, V11, P471, DOI 10.1016/j.devcel.2006.09.004; Sapir A, 2008, DEV CELL, V14, P11, DOI 10.1016/j.devcel.2007.12.008; Sapir A, 2007, DEV CELL, V12, P683, DOI 10.1016/j.devcel.2007.03.003; Schnell MJ, 1996, P NATL ACAD SCI USA, V93, P11359, DOI 10.1073/pnas.93.21.11359; Shemer G, 2004, CURR BIOL, V14, P1587, DOI 10.1016/j.cub.2004.07.059; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; ZAVADA J, 1972, J GEN VIROL, V15, P183, DOI 10.1099/0022-1317-15-3-183	17	51	55	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2011	332	6029					589	592		10.1126/science.1202333	http://dx.doi.org/10.1126/science.1202333			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21436398	Green Accepted			2022-12-28	WOS:000289991100049
J	Beardmore, RE; Gudelj, I; Lipson, DA; Hurst, LD				Beardmore, Robert E.; Gudelj, Ivana; Lipson, David A.; Hurst, Laurence D.			Metabolic trade-offs and the maintenance of the fittest and the flattest	NATURE			English	Article							LETHAL MUTAGENESIS; ESCHERICHIA-COLI; PERIODIC SELECTION; GROWTH-RATE; EVOLUTION; YIELD; POPULATIONS; MECHANISMS; TRANSPORT; DIVERSITY	How is diversity maintained? Environmental heterogeneity is considered to be important(1), yet diversity in seemingly homogeneous environments is nonetheless observed(2). This, it is assumed, must either be owing to weak selection, mutational input or a fitness advantage to genotypes when rare(1). Here we demonstrate the possibility of a new general mechanism of stable diversity maintenance, one that stems from metabolic and physiological trade-offs(3). The model requires that such trade-offs translate into a fitness landscape in which the most fit has unfit near-mutational neighbours, and a lower fitness peak also exists that is more mutationally robust. The 'survival of the fittest' applies at low mutation rates, giving way to 'survival of the flattest'(4-6) at high mutation rates. However, as a consequence of quasispecies-level negative frequency-dependent selection and differences in mutational robustness we observe a transition zone in which both fittest and flattest coexist. Although diversity maintenance is possible for simple organisms in simple environments, the more trade-offs there are, the wider the maintenance zone becomes. The principle may be applied to lineages within a species or species within a community, potentially explaining why competitive exclusion need not be observed in homogeneous environments. This principle predicts the enigmatic richness of metabolic strategies in clonal bacteria(7) and questions the safety of lethal mutagenesis(8,9) as an antimicrobial treatment.	[Hurst, Laurence D.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Beardmore, Robert E.; Gudelj, Ivana] Univ London Imperial Coll Sci Technol & Med, Dept Math, London SW7 2A7, England; [Lipson, David A.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA	University of Bath; Imperial College London; California State University System; San Diego State University	Hurst, LD (corresponding author), Univ Bath, Dept Biol & Biochem, Claverton Down, Bath BA2 7AY, Avon, England.	l.d.hurst@bath.ac.uk	Hurst, Laurence/F-9215-2010	Hurst, Laurence/0000-0002-1002-1054	Royal Society; EPSRC; NERC; EPSRC [EP/F037856/1, EP/I018263/1] Funding Source: UKRI; MRC [G0802611] Funding Source: UKRI; NERC [NE/E013007/2, NE/E013007/1, NE/E013007/3] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I018263/1, EP/F037856/1] Funding Source: researchfish; Medical Research Council [G0802611] Funding Source: researchfish; Natural Environment Research Council [NE/E013007/3, NE/E013007/1, NE/E013007/2] Funding Source: researchfish	Royal Society(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank C. Burch, M. Doebeli and T. Ferenci for discussions. L. D. H. is a Royal Society Wolfson Research Merit Award Holder, R. E. B. holds an EPSRC Leadership Fellowship, and I. G. holds a NERC Advanced Research Fellowship.	Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Bull JJ, 2008, GENETICS, V180, P1061, DOI 10.1534/genetics.108.091413; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Codoner FM, 2006, PLOS PATHOG, V2, P1187, DOI 10.1371/journal.ppat.0020136; Gillies RJ, 2007, J BIOENERG BIOMEMBR, V39, P251, DOI 10.1007/s10863-007-9085-y; Gudelj I, 2007, J EVOLUTION BIOL, V20, P1882, DOI 10.1111/j.1420-9101.2007.01376.x; Keller H.B., 1977, APPL BIFURCATION THE; KOCH AL, 1974, GENETICS, V77, P127; Krak N, 2008, MOL IMAGING BIOL, V10, P356, DOI 10.1007/s11307-008-0163-2; Kreft JU, 2004, MICROBIOL-SGM, V150, P2751, DOI 10.1099/mic.0.26829-0; LEVIN BR, 1981, GENETICS, V99, P1; Lipson DA, 2009, BIOGEOCHEMISTRY, V95, P23, DOI 10.1007/s10533-008-9252-1; Loeb LA, 1999, P NATL ACAD SCI USA, V96, P1492, DOI 10.1073/pnas.96.4.1492; Maharjan R, 2006, SCIENCE, V313, P514, DOI 10.1126/science.1129865; Maharjan RP, 2007, J BACTERIOL, V189, P2350, DOI 10.1128/JB.01414-06; Martin G, 2010, PHILOS T R SOC B, V365, P1953, DOI 10.1098/rstb.2010.0058; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Molenaar D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.82; Novak M, 2006, AM NAT, V168, P242, DOI 10.1086/506527; Pfeiffer T, 2004, AM NAT, V163, pE126, DOI 10.1086/383593; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Sanjuan R, 2007, PLOS GENET, V3, P939, DOI 10.1371/journal.pgen.0030093; Turner PE, 1996, ECOLOGY, V77, P2119, DOI 10.2307/2265706; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WEUSTHUIS RA, 1994, MICROBIOL REV, V58, P616, DOI 10.1128/MMBR.58.4.616-630.1994; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569	27	72	75	0	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					342	346		10.1038/nature09905	http://dx.doi.org/10.1038/nature09905			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21441905	Green Submitted			2022-12-28	WOS:000289724600038
J	Berwick, DM				Berwick, Donald M.			Launching Accountable Care Organizations - The Proposed Rule for the Medicare Shared Savings Program	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Ctr Medicare & Medicaid Serv, Baltimore, MD USA	Centers for Medicare & Medicaid Services	Berwick, DM (corresponding author), Ctr Medicare & Medicaid Serv, Baltimore, MD USA.							Berenson RA, 2010, AM J MANAG CARE, V16, P721; DeVore S, 2011, HEALTH AFFAIR, V30, P41, DOI 10.1377/hlthaff.2010.0935; Haywood TT, 2011, NEW ENGL J MED, V364, DOI 10.1056/NEJMp1100950; Iglehart JK, 2011, NEW ENGL J MED, V364, P198, DOI 10.1056/NEJMp1013896	4	169	169	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 21	2011	364	16								10.1056/NEJMp1103602	http://dx.doi.org/10.1056/NEJMp1103602			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	752VH	21452999				2022-12-28	WOS:000289722700005
J	Weiss, J; Pyrski, M; Jacobi, E; Bufe, B; Willnecker, V; Schick, B; Zizzari, P; Gossage, SJ; Greer, CA; Leinders-Zufall, T; Woods, CG; Wood, JN; Zufall, F				Weiss, Jan; Pyrski, Martina; Jacobi, Eric; Bufe, Bernd; Willnecker, Vivienne; Schick, Bernhard; Zizzari, Philippe; Gossage, Samuel J.; Greer, Charles A.; Leinders-Zufall, Trese; Woods, C. Geoffrey; Wood, John N.; Zufall, Frank			Loss-of-function mutations in sodium channel Na(v)1.7 cause anosmia	NATURE			English	Article							MOUSE OLFACTORY-BULB; PAIN; EXPRESSION; SYSTEM; RAT; RECEPTOR; ORGANIZATION; DELETION; SUBUNIT; REVEALS	Loss of function of the gene SCN9A, encoding the voltage-gated sodium channel Na(v)1.7, causes a congenital inability to experience pain in humans. Here we show that Na(v)1.7 is not only necessary for pain sensation but is also an essential requirement for odour perception in both mice and humans. We examined human patients with loss-of-function mutations in SCN9A and show that they are unable to sense odours. To establish the essential role of Na(v)1.7 in odour perception, we generated conditional null mice in which Na(v)1.7 was removed from all olfactory sensory neurons. In the absence of Na(v)1.7, these neurons still produce odour-evoked action potentials but fail to initiate synaptic signalling from their axon terminals at the first synapse in the olfactory system. The mutant mice no longer display vital, odour-guided behaviours such as innate odour recognition and avoidance, short-term odour learning, and maternal pup retrieval. Our study creates a mouse model of congenital general anosmia and provides new strategies to explore the genetic basis of the human sense of smell.	[Weiss, Jan; Pyrski, Martina; Jacobi, Eric; Bufe, Bernd; Leinders-Zufall, Trese; Zufall, Frank] Univ Saarland, Dept Physiol, Sch Med, D-66421 Homburg, Germany; [Willnecker, Vivienne; Schick, Bernhard] Univ Saarland, Dept Otolaryngol, Sch Med, D-66421 Homburg, Germany; [Zizzari, Philippe] Univ Paris 05, Fac Med, INSERM, Ctr Psychiat & Neurosci,UMR 894, F-75014 Paris, France; [Gossage, Samuel J.; Wood, John N.] UCL, Wolfson Inst Biomed Res, Mol Nocicept Grp, London WC1E 6BT, England; [Greer, Charles A.] Yale Univ, Sch Med, Dept Neurosurg, New Haven, CT 06520 USA; [Woods, C. Geoffrey] Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England; [Wood, John N.] Seoul Natl Univ, Dept Mol Med & Biopharmaceut Sci, Seoul 151742, South Korea	Saarland University; Saarland University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of London; University College London; Yale University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Seoul National University (SNU)	Zufall, F (corresponding author), Univ Saarland, Dept Physiol, Sch Med, D-66421 Homburg, Germany.	frank.zufall@uks.eu	Leinders-Zufall, Trese/S-3664-2019; Zufall, Frank/AAE-5290-2021; Leinders-Zufall, Trese/B-4103-2009; Bufe, Bernd/N-6685-2018	Leinders-Zufall, Trese/0000-0002-0678-362X; Zufall, Frank/0000-0002-4383-8618; Leinders-Zufall, Trese/0000-0002-0678-362X; Jacobi, Eric/0000-0003-0055-3476; Bufe, Bernd/0000-0003-1610-0658; Zizzari, Philippe/0000-0001-8838-0762; Pyrski, Martina/0000-0002-5751-178X	Deutsche Forschungsgemeinschaft (DFG) [SFB 530, SFB 894, GK 1326]; Biotechnology and Biological Sciences Research Council; Medical Research Council; Wellcome Trust; Korean Ministry of Education, Science and Technology [R31-2008-000-10103-0]; National Research Foundation of Korea; BBSRC [BB/F000227/1] Funding Source: UKRI; MRC [G0901905] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F000227/1] Funding Source: researchfish; Medical Research Council [G0901905] Funding Source: researchfish; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000210] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank the individuals who participated in this study, P. Mombaerts for supplying OMP-Cre and OMP-GFP mice, F. Margolis for anti-OMP antibodies, J. Epelbaum for supporting the IGF-1 measurements, P. Hammes for assistance with the immunohistochemistry and C. Kaliszewski for assistance with the electron microscopy. This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) to F.Z. (SFB 530 and SFB 894) and T.L.-Z. (SFB 894). E.J. was supportedby the DFG-funded International Graduate School GK 1326. T.L.-Z. is a Lichtenberg Professor of the Volkswagen Foundation. J.N.W. was supported by the Biotechnology and Biological Sciences Research Council, Medical Research Council, Wellcome Trust and grant number R31-2008-000-10103-0 from the World Class University project of the Korean Ministry of Education, Science and Technology and the National Research Foundation of Korea.	Ahmad S, 2007, HUM MOL GENET, V16, P2114, DOI 10.1093/hmg/ddm160; Au WW, 2002, J COMP NEUROL, V446, P68, DOI 10.1002/cne.10182; BAKER H, 1989, J COMP NEUROL, V285, P246, DOI 10.1002/cne.902850207; Baker H, 1999, J NEUROSCI, V19, P9313; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cho JY, 1996, J COMP NEUROL, V369, P264; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Dib-Hajj SD, 2007, TRENDS NEUROSCI, V30, P555, DOI 10.1016/j.tins.2007.08.004; Feldmesser E, 2007, CHEM SENSES, V32, P21, DOI 10.1093/chemse/bjl032; Gabellec MM, 2007, EUR J NEUROSCI, V25, P1373, DOI 10.1111/j.1460-9568.2007.05400.x; Goldberg YP, 2007, CLIN GENET, V71, P311, DOI 10.1111/j.1399-0004.2007.00790.x; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; Hasin-Brumshtein Y, 2009, TRENDS GENET, V25, P178, DOI 10.1016/j.tig.2009.02.002; Keller A, 2008, CURR OPIN NEUROBIOL, V18, P364, DOI 10.1016/j.conb.2008.09.020; KLUGBAUER N, 1995, EMBO J, V14, P1084, DOI 10.1002/j.1460-2075.1995.tb07091.x; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Leinders-Zufall T, 2007, P NATL ACAD SCI USA, V104, P14507, DOI 10.1073/pnas.0704965104; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Morinville A, 2007, J COMP NEUROL, V504, P680, DOI 10.1002/cne.21484; Munger SD, 2001, SCIENCE, V294, P2172, DOI 10.1126/science.1063224; Munger SD, 2009, ANNU REV PHYSIOL, V71, P115, DOI 10.1146/annurev.physiol.70.113006.100608; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Nickell WT, 1996, BRAIN RES BULL, V39, P57, DOI 10.1016/0361-9230(95)02042-X; Nilsen KB, 2009, PAIN, V145, P264, DOI 10.1016/j.pain.2009.06.025; Papes F, 2010, CELL, V141, P692, DOI 10.1016/j.cell.2010.03.037; Puche AC, 1999, J NEUROSCI, V19, P1359; Pyrski M, 2007, J COMP NEUROL, V501, P944, DOI 10.1002/cne.21290; Richard MB, 2010, P NATL ACAD SCI USA, V107, P15613, DOI 10.1073/pnas.1007931107; Sakano H, 2010, NEURON, V67, P530, DOI 10.1016/j.neuron.2010.07.003; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, DOI [DOI 10.1093/ACPROF:OSO/9780195159561.001.1, 10.1093/acprof:oso/9780195159561.001.1]; Spehr M, 2006, J NEUROSCI, V26, P1961, DOI 10.1523/JNEUROSCI.4939-05.2006; Ukhanov K, 2007, J NEUROPHYSIOL, V98, P2357, DOI 10.1152/jn.00642.2007; Wachowiak M, 2006, SEMIN CELL DEV BIOL, V17, P411, DOI 10.1016/j.semcdb.2006.04.007; Wesson DW, 2010, J NEUROSCI, V30, P505, DOI 10.1523/JNEUROSCI.4622-09.2010; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8	37	209	217	4	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 14	2011	472	7342					186	190		10.1038/nature09975	http://dx.doi.org/10.1038/nature09975			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21441906	Green Accepted			2022-12-28	WOS:000289469100035
J	Rachner, TD; Khosla, S; Hofbauer, LC				Rachner, Tilman D.; Khosla, Sundeep; Hofbauer, Lorenz C.			Osteoporosis: now and the future	LANCET			English	Article							CALCIUM-SENSING RECEPTOR; BONE-MINERAL DENSITY; CATHEPSIN-K INHIBITOR; POSTMENOPAUSAL WOMEN; OSTEOPROTEGERIN LIGAND; SCLEROSTIN ANTIBODY; VERTEBRAL FRACTURE; DOUBLE-BLIND; NONVERTEBRAL FRACTURES; TARGETED DISRUPTION	Osteoporosis is a common disease characterised by a systemic impairment of bone mass and microarchitecture that results in fragility fractures. With an ageing population, the medical and socioeconomic effect of osteoporosis, particularly postmenopausal osteoporosis, will increase further. A detailed knowledge of bone biology with molecular insights into the communication between bone-forming osteoblasts and bone-resorbing osteoclasts and the orchestrating signalling network has led to the identification of novel therapeutic targets. Novel treatment strategies have been developed that aim to inhibit excessive bone resorption and increase bone formation. The most promising novel treatments include: denosumab, a monoclonal antibody for receptor activator of NF-kappa B ligand, a key osteoclast cytokine; odanacatib, a specific inhibitor of the osteoclast protease cathepsin K; and antibodies against the proteins sclerostin and dickkopf-1, two endogenous inhibitors of bone formation. This overview discusses these novel therapies and explains their underlying physiology.	[Rachner, Tilman D.; Hofbauer, Lorenz C.] Tech Univ Dresden, Med Ctr, Div Endocrinol Diabet & Bone Dis, D-01307 Dresden, Germany; [Khosla, Sundeep] Mayo Clin, Rochester, MN USA; [Hofbauer, Lorenz C.] Ctr Regenerat Therapies Dresden, Dresden, Germany	Technische Universitat Dresden; Mayo Clinic; Technische Universitat Dresden	Hofbauer, LC (corresponding author), Tech Univ Dresden, Med Ctr, Div Endocrinol Diabet & Bone Dis, Fetscherstr 74, D-01307 Dresden, Germany.	lorenz.hofbauer@uniklinikum-dresden.de	Khosla, Sundeep/AAE-6170-2020; Hofbauer, Lorenz C/G-2490-2010	Khosla, Sundeep/0000-0002-2936-4372; Hofbauer, Lorenz C/0000-0002-8691-8423	Amgen; Daiichi Sankyo; Merck; Novartis; Nycomed; Servier; NATIONAL INSTITUTE ON AGING [P01AG004875] Funding Source: NIH RePORTER	Amgen(Amgen); Daiichi Sankyo(Daiichi Sankyo Company Limited); Merck(Merck & Company); Novartis(Novartis); Nycomed; Servier(Servier); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	TDR has received reimbursement of travel and accommodation expenses from Novartis. SK has received honoraria for serving on advisory boards for Bone Therapeutics and Pfizer. LCH has received honoraria and speakers fees, including reimbursement of travel and accommodation expenses, from Amgen, Daiichi Sankyo, Merck, Novartis, Nycomed, and Servier.	[Anonymous], 2001, JAMA-J AM MED ASSOC, V285, P785, DOI [DOI 10.1001/JAMA.285.6.785, 10.1001/jama.285.6.785]; Balan G, 2009, BIOORG MED CHEM LETT, V19, P3328, DOI 10.1016/j.bmcl.2009.04.044; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Baron R, 2007, ENDOCRINOLOGY, V148, P2635, DOI 10.1210/en.2007-0270; Bekker PJ, 2001, J BONE MINER RES, V16, P348, DOI 10.1359/jbmr.2001.16.2.348; Bekker PJ, 2004, J BONE MINER RES, V19, P1059, DOI 10.1359/JBMR.040305; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; BLACK DM, 2007, NEW ENGL J MED, V356, P1809, DOI [DOI 10.1056/NEJMOA067312, 10.1056/NEJMoa067312]; Bolland MJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3691; Bone HG, 2008, J CLIN ENDOCR METAB, V93, P2149, DOI 10.1210/jc.2007-2814; Bone HG, 2010, J BONE MINER RES, V25, P937, DOI 10.1359/jbmr.091035; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Brown E. M., 2007, V45, P139; Brown JP, 2009, J BONE MINER RES, V24, P153, DOI [10.1359/JBMR.0809010, 10.1359/jbmr.080901]; Brown JP, 2002, CAN MED ASSOC J, V167, pS1; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Canalis E, 2007, NEW ENGL J MED, V357, P905, DOI 10.1056/NEJMra067395; Canalis E, 2010, J CLIN ENDOCR METAB, V95, P1496, DOI 10.1210/jc.2009-2677; Center JR, 1999, LANCET, V353, P878, DOI 10.1016/S0140-6736(98)09075-8; Chesnut CH, 2004, J BONE MINER RES, V19, P1241, DOI 10.1359/JBMR.040325; Compston J, 2009, MATURITAS, V62, P105, DOI 10.1016/j.maturitas.2008.11.022; Cummings SR, 2002, JAMA-J AM MED ASSOC, V288, P1889, DOI 10.1001/jama.288.15.1889; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; Daddona PE, 2011, PHARM RES-DORDR, V28, P159, DOI 10.1007/s11095-010-0192-9; Delmas PD, 2002, J CLIN ENDOCR METAB, V87, P3609, DOI 10.1210/jc.87.8.3609; Diarra D, 2007, NAT MED, V13, P156, DOI 10.1038/nm1538; Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215; Ellis GK, 2008, J CLIN ONCOL, V26, P4875, DOI 10.1200/JCO.2008.16.3832; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Fromigue O, 2009, J CELL MOL MED, V13, P2189, DOI 10.1111/j.1582-4934.2009.00673.x; Fulciniti M, 2009, BLOOD, V114, P371, DOI 10.1182/blood-2008-11-191577; Gauthier JY, 2008, BIOORG MED CHEM LETT, V18, P923, DOI 10.1016/j.bmcl.2007.12.047; Gelb BD, 1996, SCIENCE, V273, P1236, DOI 10.1126/science.273.5279.1236; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gowen M, 2000, J CLIN INVEST, V105, P1595, DOI 10.1172/JCI9038; Greenspan SL, 2007, ANN INTERN MED, V146, P326, DOI 10.7326/0003-4819-146-5-200703060-00005; Hannon RA, 2010, J BONE MINER RES, V25, P463, DOI 10.1359/jbmr.090830; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; Heath DJ, 2009, J BONE MINER RES, V24, P425, DOI 10.1359/JBMR.081104; Henriksen DB, 2003, J BONE MINER RES, V18, pS54; Henriksen DB, 2009, BONE, V45, P833, DOI 10.1016/j.bone.2009.07.008; Hodgson Stephen F, 2003, Endocr Pract, V9, P544; Hoeppner LH, 2009, EXPERT OPIN THER TAR, V13, P485, DOI [10.1517/14728220902841961, 10.1517/14728220902841961 ]; Hofbauer LC, 1999, ENDOCRINOLOGY, V140, P4382, DOI 10.1210/en.140.10.4382; Hofbauer LC, 1999, BONE, V25, P255, DOI 10.1016/S8756-3282(99)00162-3; Hofbauer LC, 1999, ENDOCRINOLOGY, V140, P4367, DOI 10.1210/en.140.9.4367; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hsia J, 2007, CIRCULATION, V115, P846, DOI 10.1161/CIRCULATIONAHA.106.673491; Kanis JA, 2002, LANCET, V359, P1929, DOI 10.1016/S0140-6736(02)08761-5; Kansara M, 2009, J CLIN INVEST, V119, P837, DOI 10.1172/JCI37175; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kumar S, 2010, BONE, V46, P534, DOI 10.1016/j.bone.2009.09.028; Lewiecki EM, 2007, J BONE MINER RES, V22, P1832, DOI 10.1359/JBMR.070809; Li XD, 2009, J BONE MINER RES, V24, P578, DOI 10.1359/JBMR.081206; Loots GG, 2005, GENOME RES, V15, P928, DOI 10.1101/gr.3437105; Marzia M, 2000, J CELL BIOL, V151, P311, DOI 10.1083/jcb.151.2.311; McClung MR, 2006, NEW ENGL J MED, V354, P821, DOI 10.1056/NEJMoa044459; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; MELTON LJ, 1992, J BONE MINER RES, V7, P1005, DOI 10.1002/jbmr.5650070902; Meunier PJ, 2004, NEW ENGL J MED, V350, P459, DOI 10.1056/NEJMoa022436; Miller PD, 2008, BONE, V43, P222, DOI 10.1016/j.bone.2008.04.007; Morony S, 2001, CANCER RES, V61, P4432; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Ominsky MS, 2010, J BONE MINER RES, V25, P948, DOI 10.1002/jbmr.14; Padhi D, 2007, J BONE MINER RES, V22, pS37; Pearse RN, 2001, P NATL ACAD SCI USA, V98, P11581, DOI 10.1073/pnas.201394498; Peroni A, 2008, J AM ACAD DERMATOL, V59, P125, DOI 10.1016/j.jaad.2008.03.009; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Ray NF, 1997, J BONE MINER RES, V12, P24, DOI 10.1359/jbmr.1997.12.1.24; Reginster JY, 2005, J CLIN ENDOCR METAB, V90, P2816, DOI 10.1210/jc.2004-1774; Reid IR, 2010, J BONE MINER RES, V25, P2256, DOI 10.1002/jbmr.149; Saftig P, 2000, ADV EXP MED BIOL, V477, P293; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Schaller S, 2004, J BONE MINER RES, V19, P1144, DOI 10.1359/JBMR.040302; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Siris ES, 2009, AM J MED, V122, P3, DOI 10.1016/j.amjmed.2008.12.002; Smith MR, 2009, NEW ENGL J MED, V361, P745, DOI 10.1056/NEJMoa0809003; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Steddon S, 2005, LANCET, V365, P2237, DOI 10.1016/S0140-6736(05)66782-7; Stoch SA, 2009, CLIN PHARMACOL THER, V86, P175, DOI 10.1038/clpt.2009.60; Stolina M, 2007, ADV EXP MED BIOL, V602, P143; Stopeck AT, 2010, J CLIN ONCOL, V28, P5132, DOI 10.1200/JCO.2010.29.7101; Teng YTA, 2000, J CLIN INVEST, V106, pR59, DOI 10.1172/JCI10763; Unnanuntana A, 2010, J BONE JOINT SURG AM, V92A, P743, DOI 10.2106/JBJS.I.00919; Vestergaard P, 2005, OSTEOPOROSIS INT, V16, P134, DOI 10.1007/s00198-004-1680-8; Weinstein RS, 2009, NEW ENGL J MED, V360, P53, DOI 10.1056/NEJMoa0802633; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Zebaze RMD, 2010, LANCET, V375, P1729, DOI 10.1016/S0140-6736(10)60320-0	92	1524	1705	14	658	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2011	377	9773					1276	1287		10.1016/S0140-6736(10)62349-5	http://dx.doi.org/10.1016/S0140-6736(10)62349-5			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751DI	21450337	Green Accepted			2022-12-28	WOS:000289597300034
J	Pessa, HKJ; Frilander, MJ				Pessa, Heli K. J.; Frilander, Mikko J.			Minor Splicing, Disrupted	SCIENCE			English	Editorial Material							RNA; SPLICEOSOME; PROTEINS		[Pessa, Heli K. J.; Frilander, Mikko J.] Univ Helsinki, Inst Biotechnol, Program Genome Biol, FIN-00014 Helsinki, Finland	University of Helsinki	Pessa, HKJ (corresponding author), Univ Helsinki, Inst Biotechnol, Program Genome Biol, PL 56,Viikinkaari 9, FIN-00014 Helsinki, Finland.	mikko.frilander@helsinki.fi	Frilander, Mikko J/B-6660-2009	Frilander, Mikko J/0000-0002-1732-4808				Burge CB, 1998, MOL CELL, V2, P773, DOI 10.1016/S1097-2765(00)80292-0; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041; Edery P, 2011, SCIENCE, V332, P240, DOI 10.1126/science.1202205; He HL, 2011, SCIENCE, V332, P238, DOI 10.1126/science.1200587; Makarova OV, 2002, EMBO J, V21, P1148, DOI 10.1093/emboj/21.5.1148; Nottrott S, 2002, EMBO J, V21, P5527, DOI 10.1093/emboj/cdf544; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; Pessa HKJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013215; Sheth N, 2006, NUCLEIC ACIDS RES, V34, P3955, DOI 10.1093/nar/gkl556; Will CL, 2004, RNA, V10, P929, DOI 10.1261/rna.7320604	11	11	11	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					184	185		10.1126/science.1205503	http://dx.doi.org/10.1126/science.1205503			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474744				2022-12-28	WOS:000289251100033
J	Lee, SJ; Eng, C				Lee, Sei J.; Eng, Catherine			Goals of Glycemic Control in Frail Older Patients With Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DISABILITY; CARE		[Lee, Sei J.] San Francisco VA Med Ctr, Div Geriatr, San Francisco, CA 94121 USA; [Lee, Sei J.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Eng, Catherine] On Lok Lifeways, San Francisco, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco	Lee, SJ (corresponding author), San Francisco VA Med Ctr, Div Geriatr, 4150 Clement St,Bldg 1,Room 211A, San Francisco, CA 94121 USA.	sei.lee@ucsf.edu			NCRR NIH HHS [KL2 RR024130] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS4; Araki A, 2009, GERIATR GERONTOL INT, V9, P105, DOI 10.1111/j.1447-0594.2008.00495.x; Berlie HD, 2010, ANN PHARMACOTHER, V44, P712, DOI 10.1345/aph.1M551; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Flacker JM, 2003, J AM GERIATR SOC, V51, P213, DOI 10.1046/j.1532-5415.2003.51060.x; Guralnik JM, 1996, ANNU REV PUBL HEALTH, V17, P25, DOI 10.1146/annurev.pu.17.050196.000325; Hobbs C, 2010, VA DOD CLIN PRACTICE; Ickowicz E, 2003, J AM GERIATR SOC, V51, pS265; MANTON KG, 1993, J GERONTOL, V48, pS153, DOI 10.1093/geronj/48.4.S153; Resnick HE, 2008, DIABETES CARE, V31, P287, DOI 10.2337/dc07-1425	10	35	44	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2011	305	13					1350	1351		10.1001/jama.2011.404	http://dx.doi.org/10.1001/jama.2011.404			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	745JT	21467289	Green Accepted			2022-12-28	WOS:000289162400026
J	Stillman, MD				Stillman, Michael D.			Melancholy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												michael.stillman@bmc.org						Quill TE, 2001, ANN INTERN MED, V135, P551, DOI 10.7326/0003-4819-135-7-200110020-00022	1	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2011	305	13					1277	1278		10.1001/jama.2011.364	http://dx.doi.org/10.1001/jama.2011.364			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745JT	21467275				2022-12-28	WOS:000289162400001
J	Chong, YS; Tan, EK				Chong, Yap-Seng; Tan, Eng-Kien			Midlevel health-care providers key to MDG 5	LANCET			English	Editorial Material							MIFEPRISTONE; MISOPROSTOL		[Chong, Yap-Seng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Natl Univ Hlth Syst, Singapore 119228, Singapore; [Tan, Eng-Kien] Natl Univ Singapore Hosp, Dept Obstet & Gynaecol, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Chong, YS (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Natl Univ Hlth Syst, Singapore 119228, Singapore.	obgcys@nus.edu.sg		Chong, Yap Seng/0000-0002-7232-8473				Chong YS, 2006, LANCET, V368, P1939, DOI 10.1016/S0140-6736(06)69743-2; Figo Safe Motherhood And Newborn H, 2009, INT J GYNECOL OBSTET, V105, P74, DOI 10.1016/j.ijgo.2008.11.007; Hogberg U, 2010, SEX REPROD HEALTHC, V1, P3, DOI 10.1016/j.srhc.2009.11.002; Laurant M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001271.pub2; Sakr M, 1999, LANCET, V354, P1321, DOI 10.1016/S0140-6736(99)02447-2; SINGH Susheela, 2009, ABORTION WORLDWIDE D; Tang OS, 2003, HUM REPROD, V18, P2315, DOI 10.1093/humrep/deg475; ten Hoope-Bender P, 2006, INT J GYNECOL OBSTET, V94, P226, DOI 10.1016/j.ijgo.2006.04.003; von Hertzen H, 2010, BJOG-INT J OBSTET GY, V117, P1186, DOI 10.1111/j.1471-0528.2010.02636.x; Warriner IK, 2006, LANCET, V368, P1965, DOI 10.1016/S0140-6736(06)69742-0; Warriner IK, 2011, LANCET, V377, P1155, DOI 10.1016/S0140-6736(10)62229-5; World Health Organization, 2003, SAF AB TECHN POL GUI	12	4	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2011	377	9772					1127	1128		10.1016/S0140-6736(11)60166-9	http://dx.doi.org/10.1016/S0140-6736(11)60166-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	750IH	21458059				2022-12-28	WOS:000289539300004
J	Sarafoglou, K; Rodgers, J; Hietala, A; Matern, D; Bentler, K				Sarafoglou, Kyriakie; Rodgers, John; Hietala, Amy; Matern, Dietrich; Bentler, Kristi			Expanded Newborn Screening for Detection of Vitamin B-12 Deficiency	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							METHYLMALONIC ACID; TOTAL HOMOCYSTEINE; COBALAMIN		[Sarafoglou, Kyriakie; Rodgers, John; Bentler, Kristi] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; [Hietala, Amy] Minnesota Dept Hlth, St Paul, MN USA; [Matern, Dietrich] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Minnesota Department of Health (MHD); Mayo Clinic	Sarafoglou, K (corresponding author), Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA.	saraf010@umn.edu		Sarafoglou, Kyriakie/0000-0002-5741-3629				Campbell C D, 2005, Haematologica, V90, pECR45; Hinton CF, 2010, J PEDIATR-US, V157, P162, DOI 10.1016/j.jpeds.2010.03.006; Monsen ALB, 2001, PEDIATRICS, V108, P624, DOI 10.1542/peds.108.3.624; Rasmussen SA, 2001, J PEDIATR-US, V138, P10, DOI 10.1067/mpd.2001.112160; SAVAGE DG, 1994, AM J MED, V96, P239, DOI 10.1016/0002-9343(94)90149-X; Turgeon CT, 2010, CLIN CHEM, V56, P1686, DOI 10.1373/clinchem.2010.148957	6	36	37	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2011	305	12					1198	1200		10.1001/jama.2011.310	http://dx.doi.org/10.1001/jama.2011.310			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738PA	21427371	Bronze			2022-12-28	WOS:000288652100013
J	Conde, DA; Flesness, N; Colchero, F; Jones, OR; Scheuerlein, A				Conde, D. A.; Flesness, N.; Colchero, F.; Jones, O. R.; Scheuerlein, A.			An Emerging Role of Zoos to Conserve Biodiversity	SCIENCE			English	Editorial Material							POPULATION VIABILITY ANALYSIS; VERTEBRATES		[Conde, D. A.; Colchero, F.; Jones, O. R.; Scheuerlein, A.] Max Planck Inst Demog Res, D-18057 Rostock, Germany; [Flesness, N.] Int Species Informat Syst, Eagan, MN 55121 USA	Max Planck Society	Conde, DA (corresponding author), Max Planck Inst Demog Res, D-18057 Rostock, Germany.	conde@demogr.mpg.de	Colchero, Fernando/A-9368-2015; Scheuerlein, Alexander/AAK-1111-2021; Jones, Owen/B-8439-2008	Colchero, Fernando/0000-0001-8613-4568; Jones, Owen/0000-0001-5720-4686; Conde, Dalia A./0000-0002-7923-8163				Barnett R, 2006, CONSERV GENET, V7, P507, DOI 10.1007/s10592-005-9062-0; BELANT J, 2010, IUCN RED LIST THREAT; BISBY FA, ISIS IUCN INFORM WER; Conway WG, 2011, ZOO BIOL, V30, P1, DOI 10.1002/zoo.20352; Coulson T, 2001, TRENDS ECOL EVOL, V16, P219, DOI 10.1016/S0169-5347(01)02137-1; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; GUSSET M, 2010, ZOO BIOL        1206; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; *IUCN, 2002, IUCN TECHN GUID MAN, P4; IUCN, 2014, IUCN RED LIST THREAT; Meretsky VJ, 2000, CONSERV BIOL, V14, P957, DOI 10.1046/j.1523-1739.2000.99113.x; Morell V, 2008, SCIENCE, V320, P742, DOI 10.1126/science.320.5877.742; NORMILE D, 2010, SCI INSIDER     1029; Reed JM, 2002, CONSERV BIOL, V16, P7, DOI 10.1046/j.1523-1739.2002.99419.x; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Spalton JA, 1999, ORYX, V33, P168, DOI 10.1046/j.1365-3008.1999.00062.x; Thibault JC, 2001, ORYX, V35, P73, DOI 10.1017/S0030605300031550; VanDierendonck MC, 1996, CONSERV BIOL, V10, P728, DOI 10.1046/j.1523-1739.1996.10030728.x; WAZA (World Association of Zoos and Aquariums), 2005, BUILD FUT WILDL WORL; White TH, 2005, CONDOR, V107, P424, DOI 10.1650/7672	20	187	195	8	286	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2011	331	6023					1390	1391		10.1126/science.1200674	http://dx.doi.org/10.1126/science.1200674			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	736OM	21415339				2022-12-28	WOS:000288504000023
J	Blackman, T				Blackman, Tim			Personal View Public health reforms won't mitigate the cuts	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Durham, Durham DH1 3HP, England	Durham University	Blackman, T (corresponding author), Univ Durham, Durham DH1 3HP, England.	tim.blackman@durham.ac.uk							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 16	2011	342								d1597	10.1136/bmj.d1597	http://dx.doi.org/10.1136/bmj.d1597			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	739FK	21411483				2022-12-28	WOS:000288699200008
J	Janssens, ACJW; Ioannidis, JPA; van Duijn, CM; Little, J; Khoury, MJ				Janssens, A. Cecile J. W.; Ioannidis, John P. A.; van Duijn, Cornelia M.; Little, Julian; Khoury, Muin J.		GRIPS Grp	Research Methods & Reporting Strengthening the reporting of genetic risk prediction studies: the GRIPS statement	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EPIDEMIOLOGY; ASSOCIATION; MODELS; MARKER; CURVE					a.janssens@erasmusmc.nl	Little, Julian/AAR-6117-2020; Ioannidis, John P. A./G-9836-2011	Little, Julian/0000-0001-5026-5531; Janssens, A Cecile/0000-0002-6153-4976; Dolan, Siobhan/0000-0001-8890-8045; Van Duijn, Cornelia/0000-0002-2374-9204	Centers for Disease Control and Prevention on behalf of Human Genome Epidemiology Network; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025752] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention on behalf of Human Genome Epidemiology Network; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The workshop was sponsored by the Centers for Disease Control and Prevention on behalf of the Human Genome Epidemiology Network. Opinions in this paper do not necessarily represent the official position or policies of the authors' employers, and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Freedman AN, 2005, JNCI-J NATL CANCER I, V97, P715, DOI 10.1093/jnci/dji128; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Janssens ACJW, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000420; Janssens ACJW, 2010, CIRC-CARDIOVASC GENE, V3, P3, DOI 10.1161/CIRCGENETICS.110.938092; Janssens ACJW, 2009, GENOME MED, V1, DOI 10.1186/gm20; Khoury MJ, 1998, AM J EPIDEMIOL, V148, P1; Khoury MJ, 2007, GENET MED, V9, P665, DOI 10.1097/GIM.0b013e31815699d0; Khoury MJ, 2010, AM J EPIDEMIOL, V172, P517, DOI 10.1093/aje/kwq211; Kyzas PA, 2005, JNCI-J NATL CANCER I, V97, P1043, DOI 10.1093/jnci/dji184; Kyzas PA, 2007, EUR J CANCER, V43, P2559, DOI 10.1016/j.ejca.2007.08.030; Kyzas PA, 2007, JNCI-J NATL CANCER I, V99, P236, DOI 10.1093/jnci/djk032; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Little J, 2009, PLOS MED, V6, P151, DOI 10.1371/journal.pmed.1000022; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Simera I, 2010, EUR J CLIN INVEST, V40, P35, DOI 10.1111/j.1365-2362.2009.02234.x; Tzoulaki I, 2009, JAMA-J AM MED ASSOC, V302, P2345, DOI 10.1001/jama.2009.1757; Vandenbroucke JP, 2007, PLOS MED, V4, P1628, DOI 10.1371/journal.pmed.0040297; Vandenbrouke JP, 2009, J CLIN EPIDEMIOL, V62, P594, DOI 10.1016/j.jclinepi.2008.12.003; von Elm E, 2004, BMJ-BRIT MED J, V329, P868, DOI 10.1136/bmj.329.7471.868; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]	26	15	15	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2011	342								d631	10.1136/bmj.d631	http://dx.doi.org/10.1136/bmj.d631			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V41KW	21411493	Green Published, Green Submitted			2022-12-28	WOS:000209546100001
J	Xu, SY; Xia, Y; Wray, LA; Jia, S; Meier, F; Dil, JH; Osterwalder, J; Slomski, B; Bansil, A; Lin, H; Cava, RJ; Hasan, MZ				Xu, Su-Yang; Xia, Y.; Wray, L. A.; Jia, S.; Meier, F.; Dil, J. H.; Osterwalder, J.; Slomski, B.; Bansil, A.; Lin, H.; Cava, R. J.; Hasan, M. Z.			Topological Phase Transition and Texture Inversion in a Tunable Topological Insulator	SCIENCE			English	Article							SURFACE-STATES	The recently discovered three-dimensional or bulk topological insulators are expected to exhibit exotic quantum phenomena. It is believed that a trivial insulator can be twisted into a topological state by modulating the spin-orbit interaction or the crystal lattice, driving the system through a topological quantum phase transition. By directly measuring the topological quantum numbers and invariants, we report the observation of a phase transition in a tunable spin-orbit system, BiTl(S1-delta Se delta)(2), in which the topological state formation is visualized. In the topological state, vortex-like polarization states are observed to exhibit three-dimensional vectorial textures, which collectively feature a chirality transition as the spin momentum-locked electrons on the surface go through the zero carrier density point. Such phase transition and texture inversion can be the physical basis for observing fractional charge (+/- e/2) and other fractional topological phenomena.	[Xu, Su-Yang; Xia, Y.; Wray, L. A.; Hasan, M. Z.] Princeton Univ, Dept Phys, Joseph Henry Lab Phys, Princeton, NJ 08544 USA; [Wray, L. A.; Hasan, M. Z.] Lawrence Berkeley Lab, Adv Light Source, Stanford, CA 94305 USA; [Jia, S.; Cava, R. J.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Meier, F.; Dil, J. H.; Slomski, B.] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Meier, F.; Dil, J. H.; Osterwalder, J.; Slomski, B.] Univ Zurich Irchel, Inst Phys, CH-8057 Zurich, Switzerland; [Bansil, A.; Lin, H.] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Hasan, M. Z.] Princeton Univ, Princeton Inst Sci & Technol Mat, Princeton Sch Engn & Appl Sci, Princeton, NJ 08544 USA; [Hasan, M. Z.] Princeton Univ, Princeton Ctr Complex Mat, Princeton, NJ 08544 USA	Princeton University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Princeton University; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Zurich; Northeastern University; Princeton University; Princeton University	Hasan, MZ (corresponding author), Princeton Univ, Dept Phys, Joseph Henry Lab Phys, Princeton, NJ 08544 USA.	mzhasan@princeton.edu	Jia, Shuang/AFH-9416-2022; Lin, Hsin/F-9568-2012; HASAN, M. Zahid/D-8237-2012; Dil, Hugo/F-6995-2012	Lin, Hsin/0000-0002-4688-2315; Dil, Hugo/0000-0002-6016-6120; Wray, L. Andrew/0000-0001-8977-0201	Office of Basic Energy Sciences, U.S. Department of Energy [DE-FG-02-05ER46200, AC03-76SF00098, DE-FG02-07ER46352]; NSF [DMR-1006492]; Division Of Materials Research [1006492] Funding Source: National Science Foundation	Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We acknowledge discussions with M. Neupane, D. Huse, and D. Haldane. Synchrotron x-ray-based measurements are supported by the Office of Basic Energy Sciences, U.S. Department of Energy (grants DE-FG-02-05ER46200, AC03-76SF00098, and DE-FG02-07ER46352). M.Z.H. acknowledges visiting-scientist support from Lawrence Berkeley National Laboratory and additional support from the A. P. Sloan Foundation. Materials growth and characterization are supported by NSF grant DMR-1006492.	Blaha P., 2001, COMPUTER CODE WIEN2K; Bray-Ali N, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.180504; Chen J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.176602; Chen YL, 2010, SCIENCE, V329, P659, DOI 10.1126/science.1189924; Dil JH, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/40/403001; Eremeev SV, 2010, JETP LETT+, V91, P594, DOI 10.1134/S0021364010110111; Fu L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.106803; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Hasan M. Z., 2009, PHYSICS, V2, P108; Hoesch M, 2002, J ELECTRON SPECTROSC, V124, P263, DOI 10.1016/S0368-2048(02)00058-0; Hsieh D, 2008, NATURE, V452, P970, DOI 10.1038/nature06843; Hsieh D, 2009, NATURE, V460, P1101, DOI 10.1038/nature08234; Hsieh D, 2009, SCIENCE, V323, P919, DOI 10.1126/science.1167733; Linder J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.067001; Moore J, 2009, NAT PHYS, V5, P378, DOI 10.1038/nphys1294; Ohta T, 2006, SCIENCE, V313, P951, DOI 10.1126/science.1130681; Pesin D, 2010, NAT PHYS, V6, P376, DOI 10.1038/NPHYS1606; Qi XL, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195424; Qu DX, 2010, SCIENCE, V329, P821, DOI 10.1126/science.1189792; Roushan P, 2009, NATURE, V460, P1106, DOI 10.1038/nature08308; Sato T, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136802; Seradjeh B, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.066402; Witczak-Krempa W, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.165122; Wray LA, 2011, NAT PHYS, V7, P32, DOI 10.1038/NPHYS1838; Wray LA, 2010, NAT PHYS, V6, P855, DOI [10.1038/NPHYS1762, 10.1038/nphys1762]; Xia Y, 2009, NAT PHYS, V5, P398, DOI 10.1038/NPHYS1274	28	366	368	4	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 29	2011	332	6029					560	564		10.1126/science.1201607	http://dx.doi.org/10.1126/science.1201607			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21454752	Green Accepted, Green Submitted			2022-12-28	WOS:000289991100040
J	Feldman, T; Foster, E; Glower, DG; Kar, S; Rinaldi, MJ; Fail, PS; Smalling, RW; Siegel, R; Rose, GA; Engeron, E; Loghin, C; Trento, A; Skipper, ER; Fudge, T; Letsou, GV; Massaro, JM; Mauri, L				Feldman, Ted; Foster, Elyse; Glower, Donald G.; Kar, Saibal; Rinaldi, Michael J.; Fail, Peter S.; Smalling, Richard W.; Siegel, Robert; Rose, Geoffrey A.; Engeron, Eric; Loghin, Catalin; Trento, Alfredo; Skipper, Eric R.; Fudge, Tommy; Letsou, George V.; Massaro, Joseph M.; Mauri, Laura		EVEREST II Investigators	Percutaneous Repair or Surgery for Mitral Regurgitation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOUBLE-ORIFICE TECHNIQUE; TO-EDGE TECHNIQUE; VALVE REPAIR; EVALVE MITRACLIP; MANAGEMENT; SEVERITY; DISEASE; UPDATE; TRIAL	BACKGROUND Mitral-valve repair can be accomplished with an investigational procedure that involves the percutaneous implantation of a clip that grasps and approximates the edges of the mitral leaflets at the origin of the regurgitant jet. METHODS We randomly assigned 279 patients with moderately severe or severe (grade 3+ or 4+) mitral regurgitation in a 2: 1 ratio to undergo either percutaneous repair or conventional surgery for repair or replacement of the mitral valve. The primary composite end point for efficacy was freedom from death, from surgery for mitral-valve dysfunction, and from grade 3+ or 4+ mitral regurgitation at 12 months. The primary safety end point was a composite of major adverse events within 30 days. RESULTS At 12 months, the rates of the primary end point for efficacy were 55% in the percutaneous-repair group and 73% in the surgery group (P = 0.007). The respective rates of the components of the primary end point were as follows: death, 6% in each group; surgery for mitral-valve dysfunction, 20% versus 2%; and grade 3+ or 4+ mitral regurgitation, 21% versus 20%. Major adverse events occurred in 15% of patients in the percutaneous-repair group and 48% of patients in the surgery group at 30 days (P<0.001). At 12 months, both groups had improved left ventricular size, New York Heart Association functional class, and quality-of-life measures, as compared with baseline. CONCLUSIONS Although percutaneous repair was less effective at reducing mitral regurgitation than conventional surgery, the procedure was associated with superior safety and similar improvements in clinical outcomes.	[Feldman, Ted] NorthShore Univ Hlth Syst, Evanston Hosp, Div Cardiol, Evanston, IL 60201 USA; [Foster, Elyse] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Glower, Donald G.] Duke Univ, Med Ctr, Durham, NC 27706 USA; [Rinaldi, Michael J.; Rose, Geoffrey A.; Skipper, Eric R.] Carolinas Med Ctr, Sanger Heart & Vasc Inst, Charlotte, NC 28203 USA; [Kar, Saibal; Siegel, Robert; Trento, Alfredo] Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA; [Fail, Peter S.; Engeron, Eric; Fudge, Tommy] Terrebonne Gen Med Ctr, Houma, LA USA; [Smalling, Richard W.; Loghin, Catalin; Letsou, George V.] UT Hlth, Mem Hermann Heart & Vasc Inst, Houston, TX USA; [Massaro, Joseph M.] Boston Univ, Sch Publ Hlth, Harvard Clin Res Inst, Boston, MA 02215 USA; [Mauri, Laura] Harvard Univ, Brigham & Womens Hosp, Sch Med, Harvard Clin Res Inst, Boston, MA 02115 USA	NorthShore University Health System; University of California System; University of California San Francisco; Duke University; Carolinas Medical Center; Cedars Sinai Medical Center; Boston University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Feldman, T (corresponding author), NorthShore Univ Hlth Syst, Evanston Hosp, Div Cardiol, Walgreen Bldg,3rd Fl,2650 Ridge Ave, Evanston, IL 60201 USA.	tfeldman@northshore.org	Letsou, George/AAP-4187-2020; mauri, laura/GPS-4868-2022; Loghin, Catalin/AAU-9519-2020	Massaro, Joseph/0000-0002-2682-4812	Abbott Vascular	Abbott Vascular(Abbott Laboratories)	Supported by Abbott Vascular.	Alfieri O, 2001, J THORAC CARDIOV SUR, V122, P674, DOI 10.1067/mtc.2001.117277; American College of Cardiology, 2006, J Am Coll Cardiol, V48, pe1, DOI 10.1016/j.jacc.2006.05.021; Bonow RO, 1998, J AM COLL CARDIOL, V32, P1486, DOI 10.1016/S0735-1097(98)00454-9; Carabello BA, 2008, J AM COLL CARDIOL, V52, P319, DOI 10.1016/j.jacc.2008.02.084; Carabello Blase A, 2009, Curr Treat Options Cardiovasc Med, V11, P419; Fann JI, 2004, CIRCULATION, V110, P988, DOI 10.1161/01.CIR.0000139855.12616.15; FARRINGTON CP, 1990, STAT MED, V9, P1447, DOI 10.1002/sim.4780091208; Feldman T, 2005, J AM COLL CARDIOL, V46, P2134, DOI 10.1016/j.jacc.2005.07.065; Feldman T, 2009, J AM COLL CARDIOL, V54, P686, DOI 10.1016/j.jacc.2009.03.077; Foster E, 2007, AM J CARDIOL, V100, P1577, DOI 10.1016/j.amjcard.2007.06.066; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Maisano F, 1998, EUR J CARDIO-THORAC, V13, P240, DOI 10.1016/S1010-7940(98)00014-1; Maisano F, 2000, EUR J CARDIO-THORAC, V17, P201, DOI 10.1016/S1010-7940(00)00351-1; Maisano Francesco, 2006, EuroIntervention, V2, P181; Mauri L, 2010, AM HEART J, V160, P23, DOI 10.1016/j.ahj.2010.04.009; Murphy GJ, 2007, CIRCULATION, V116, P2544, DOI 10.1161/CIRCULATIONAHA.107.698977; Silvestry FE, 2007, J AM SOC ECHOCARDIOG, V20, P1131, DOI 10.1016/j.echo.2007.02.003; St Goar FG, 2003, CIRCULATION, V108, P1990, DOI 10.1161/01.CIR.0000096052.78331.CA; Trichon BH, 2003, AM J CARDIOL, V91, P538, DOI 10.1016/S0002-9149(02)03301-5; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Warnes CA, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	22	1339	1361	1	72	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 14	2011	364	15					1395	1406		10.1056/NEJMoa1009355	http://dx.doi.org/10.1056/NEJMoa1009355			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749LD	21463154				2022-12-28	WOS:000289467200004
J	Tedsree, K; Chan, CWA; Jones, S; Cuan, QA; Li, WK; Gong, XQ; Tsang, SCE				Tedsree, Karaked; Chan, Chun Wong Aaron; Jones, Simon; Cuan, Qian; Li, Wei-Kun; Gong, Xue-Qing; Tsang, Shik Chi Edman			C-13 NMR Guides Rational Design of Nanocatalysts via Chemisorption Evaluation in Liquid Phase	SCIENCE			English	Article							FORMIC-ACID; DECOMPOSITION; NANOPARTICLES; TRANSITION; ADSORPTION; CATALYSTS; SURFACES; METALS	The search for more efficient heterogeneous catalysts remains critical to the chemical industry. The Sabatier principle of maximizing catalytic activity by optimizing the adsorption energy of the substrate molecule could offer pivotal guidance to otherwise random screenings. Here we show that the chemical shift value of an adsorbate (formic acid) on metal colloid catalysts measured by C-13 nuclear magnetic resonance (NMR) spectroscopy in aqueous suspension constitutes a simple experimental descriptor for adsorption strength. Avoiding direct contact between the C-13 atom and the metal surface eliminates peak broadening that has confounded prior efforts to establish such correlations. The data can guide rational design of improved catalysts, as demonstrated here for the cases of formic acid decomposition and formic acid electro-oxidation reactions.	[Tedsree, Karaked; Chan, Chun Wong Aaron; Jones, Simon; Tsang, Shik Chi Edman] Univ Oxford, Dept Chem, Wolfson Catalysis Ctr, Oxford OX1 3QR, England; [Cuan, Qian; Li, Wei-Kun; Gong, Xue-Qing] E China Univ Sci & Technol, Res Inst Ind Catalysis, Labs Adv Mat, Shanghai 200237, Peoples R China	University of Oxford; East China University of Science & Technology	Tsang, SCE (corresponding author), Univ Oxford, Dept Chem, Wolfson Catalysis Ctr, Oxford OX1 3QR, England.	edman.tsang@chem.ox.ac.uk	gong, xue/GYQ-8649-2022	Gong, Xueqing/0000-0002-9566-7427	Engineering and Physical Sciences Research Council of the United Kingdom; 111 project	Engineering and Physical Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); 111 project(Ministry of Education, China - 111 Project)	The financial support of this work from the Engineering and Physical Sciences Research Council of the United Kingdom is acknowledged. The authors thank N. Rees, K. Yu, and A. Kong for technical assistance; K. Harrison of Oxford for providing simulated images; and B. Murrer and P. Collier of Johnson Matthey Technology Centre, UK, for helpful discussions. Support to the East China University of Science and Technology group from the 111 project is also acknowledged.	AAS N, 1991, J PHYS-CONDENS MAT, V3, pS281, DOI 10.1088/0953-8984/3/S/044; Akiya N, 1998, AICHE J, V44, P405, DOI 10.1002/aic.690440217; BARTEAU MA, 1991, CATAL LETT, V8, P175, DOI 10.1007/BF00764114; BRADLEY JS, 1991, FARADAY DISCUSS, V92, P255, DOI 10.1039/fd9919200255; Chen YX, 2007, CHEMPHYSCHEM, V8, P380, DOI 10.1002/cphc.200600520; Du BC, 2009, PHYS CHEM CHEM PHYS, V11, P8231, DOI 10.1039/b816531a; Duncan TM, 1981, SURF SCI REP, V1, P157, DOI 10.1016/0167-5729(81)90002-9; FRITSCHE HG, 1993, Z PHYS D ATOM MOL CL, V26, pS15, DOI 10.1007/BF01425603; Hughes MD, 2005, NATURE, V437, P1132, DOI 10.1038/nature04190; Larsen R, 2006, J POWER SOURCES, V157, P78, DOI 10.1016/j.jpowsour.2005.07.066; Masel R.I., 1996, PRINCIPLES ADSORPTIO, VVolume 3; NEWMARK RD, 1988, J ELECTROANAL CHEM, V255, P325, DOI 10.1016/0022-0728(88)80025-1; Norskov JK, 2006, MRS BULL, V31, P669, DOI 10.1557/mrs2006.175; Rice C, 2002, J POWER SOURCES, V111, P83, DOI 10.1016/S0378-7753(02)00271-9; Rigsby MA, 2008, J PHYS CHEM C, V112, P15595, DOI 10.1021/jp805374p; Ruban A, 1997, J MOL CATAL A-CHEM, V115, P421, DOI 10.1016/S1381-1169(96)00348-2; SLICHTER CP, 1986, ANNU REV PHYS CHEM, V37, P25; Somorjai G.A., 2010, INTRO SURFACE CHEM C; Stamenkovic V, 2006, ANGEW CHEM INT EDIT, V45, P2897, DOI 10.1002/anie.200504386; Tan FT, 2008, FARADAY DISCUSS, V140, P139, DOI 10.1039/b803073a; Tedsree K, 2009, ANGEW CHEM INT EDIT, V48, P1443, DOI 10.1002/anie.200805240; Thomas J. M., 1996, PRINCIPLES PRACTICE; Tong YY, 2002, J AM CHEM SOC, V124, P468, DOI 10.1021/ja011729q; Tong YY, 2002, J PHYS CHEM B, V106, P2434, DOI 10.1021/jp0129939; van der Klink JJ, 2000, PROG NUCL MAG RES SP, V36, P89, DOI 10.1016/S0079-6565(99)00020-5; VANHARDE.R, 1969, SURF SCI, V15, P189, DOI 10.1016/0039-6028(69)90148-4; Wang HF, 2009, J PHYS CHEM C, V113, P17502, DOI 10.1021/jp9059888; Wang JX, 2009, J AM CHEM SOC, V131, P17298, DOI 10.1021/ja9067645; Wu JJ, 1997, J CHEM SOC FARADAY T, V93, P1017, DOI 10.1039/a603611b; Zhou WJ, 2007, ELECTROCHEM COMMUN, V9, P1725, DOI 10.1016/j.elecom.2007.03.016	30	100	101	6	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2011	332	6026					224	228		10.1126/science.1202364	http://dx.doi.org/10.1126/science.1202364			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474757				2022-12-28	WOS:000289251100048
J	Murakoshi, H; Wang, H; Yasuda, R				Murakoshi, Hideji; Wang, Hong; Yasuda, Ryohei			Local, persistent activation of Rho GTPases during plasticity of single dendritic spines	NATURE			English	Article							LONG-TERM POTENTIATION; KINASE; PROTEINS; DYNAMICS; ACTIN; CULTURES; BINDING	The Rho family of GTPases have important roles in the morphogenesis of the dendritic spines(1-3) of neurons in the brain and synaptic plasticity(4-9) by modulating the organization of the actin cytoskeleton(10). Here we used two-photon fluorescence lifetime imaging microscopy(11-13) to monitor the activity of two Rho GTPases-RhoA and Cdc42-in single dendritic spines undergoing structural plasticity associated with long-term potentiation in CA1 pyramidal neurons in cultured slices of rat hippocampus. When long-term volume increase was induced in a single spine using two-photon glutamate uncaging(14,15), RhoA and Cdc42 were rapidly activated in the stimulated spine. These activities decayed over about five minutes, and were then followed by a phase of persistent activation lasting more than half an hour. Although active RhoA and Cdc42 were similarly mobile, their activity patterns were different. RhoA activation diffused out of the stimulated spine and spread over about 5 mm along the dendrite. In contrast, Cdc42 activation was restricted to the stimulated spine, and exhibited a steep gradient at the spine necks. Inhibition of the Rho-Rock pathway preferentially inhibited the initial spine growth, whereas the inhibition of the Cdc42-Pak pathway blocked the maintenance of sustained structural plasticity. RhoA and Cdc42 activation depended on Ca2+/calmodulin-dependent kinase (CaMKII). Thus, RhoA and Cdc42 relay transient CaMKII activation(13) to synapse-specific, long-term signalling required for spine structural plasticity.	[Murakoshi, Hideji; Wang, Hong; Yasuda, Ryohei] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Yasuda, Ryohei] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute	Yasuda, R (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	yasuda@neuro.duke.edu	Murakoshi, Hideji/W-9266-2018; Yasuda, Ryohei/E-7726-2011	Yasuda, Ryohei/0000-0001-6263-9297	Howard Hughes Medical Institute; National Institute of Mental Health; National Institute of Neurological Disorders and Stroke; National Institute of Drug Abuse; Alzheimer's Association; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS068410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027807] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Alzheimer's Association(Alzheimer's Association); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank K. Hahn, G. Bokock, A. Aplin, S. Soderling, M. Matsuda and Y. Hayashi for plasmids and reagents, S.-J. Lee for CaMKII activation data, S. Soderling, S. Raghavachari, L. van Aelst, Y. Hayashi, H. Kasai and M. Ehlers for discussion, and H. Hedrick and M. Patterson for comments on the manuscript. We also thank A. Wan for preparing cultured slices and D. Kloetzer for laboratory management. This study was funded by the Howard Hughes Medical Institute, the National Institute of Mental Health, the National Institute of Neurological Disorders and Stroke, the National Institute of Drug Abuse, the Alzheimer's Association and the Japan Society for the Promotion of Science (H.M.).	Asrar S, 2009, NEUROPHARMACOLOGY, V56, P73, DOI 10.1016/j.neuropharm.2008.06.055; Deacon SW, 2008, CHEM BIOL, V15, P322, DOI 10.1016/j.chembiol.2008.03.005; Elliot-Smith AE, 2005, BIOCHEMISTRY-US, V44, P12373, DOI 10.1021/bi0506021; Fortin DA, 2010, J NEUROSCI, V30, P11565, DOI 10.1523/JNEUROSCI.1746-10.2010; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Kasri NN, 2008, PFLUG ARCH EUR J PHY, V455, P787, DOI 10.1007/s00424-007-0385-1; Kreis P, 2007, J BIOL CHEM, V282, P21497, DOI 10.1074/jbc.M703298200; LAKOWICZ JR, 2006, PRINCIPLES FLUORESCE, pCH8, DOI DOI 10.1007/978-0-387-46312-4; Lee S. J., 2010, CAMKII RAS OPEN NEUR, V3, P117; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; McAllister A K, 2000, Sci STKE, V2000, ppl1, DOI 10.1126/stke.2000.51.pl1; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Murakoshi H, 2008, BRAIN CELL BIOL, V36, P31, DOI 10.1007/s11068-008-9024-9; Nikolic M, 2008, MOL NEUROBIOL, V37, P187, DOI 10.1007/s12035-008-8032-1; O'Brien JA, 2006, NAT PROTOC, V1, P977, DOI 10.1038/nprot.2006.145; O'Kane EM, 2003, J NEUROCHEM, V87, P1309, DOI 10.1046/j.1471-4159.2003.02102.x; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Rex CS, 2009, J CELL BIOL, V186, P85, DOI 10.1083/jcb.200901084; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Saneyoshi T, 2010, CURR OPIN NEUROBIOL, V20, P108, DOI 10.1016/j.conb.2009.09.013; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tamura M, 2005, BBA-PROTEINS PROTEOM, V1754, P245, DOI 10.1016/j.bbapap.2005.06.015; Tashiro A, 2004, MOL CELL NEUROSCI, V26, P429, DOI 10.1016/j.mcn.2004.04.001; Wang HG, 2005, NEURON, V45, P389, DOI 10.1016/j.neuron.2005.01.011; Wilde C, 2000, J BIOL CHEM, V275, P16478, DOI 10.1074/jbc.M910362199; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Yasuda R, 2006, CURR OPIN NEUROBIOL, V16, P551, DOI 10.1016/j.conb.2006.08.012; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhao J, 2002, BIOCHEM BIOPH RES CO, V297, P653, DOI 10.1016/S0006-291X(02)02257-X	40	380	388	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2011	472	7341					100	U132		10.1038/nature09823	http://dx.doi.org/10.1038/nature09823			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21423166	Green Accepted			2022-12-28	WOS:000289199400045
J	Schilsky, RL; Crowther, M				Schilsky, Richard L.; Crowther, Mark			Update in Hematology and Oncology: Evidence Published in 2010	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CANCER	This Update summarizes studies published in 2010 that the authors consider highly relevant to the practice of hematology and oncology. Topics include oral rivaroxaban to treat symptomatic venous thromboembolism; anticoagulants, aspirin, and successful pregnancy outcome in patients with recurrent miscarriage; inexpensive interventions to reduce morbidity and increase survival in patients with sickle cell disease; fondaparinux in the treatment of selected patients with superficial thrombophlebitis; cancer prevention and management; and new drugs for cancer.	Univ Chicago, Sect Hematol Oncol, Chicago, IL 60637 USA; Univ Chicago, Comprehens Canc Ctr, Chicago, IL 60637 USA; McMaster Univ, Hamilton Reg Lab Med Program, Hamilton, ON, Canada; St Josephs Healthcare, Hamilton, ON, Canada	University of Chicago; Robert H. Lurie Comprehensive Cancer Center; University of Chicago; McMaster University	Schilsky, RL (corresponding author), Univ Chicago, Sect Hematol Oncol, 5841 S Maryland Ave,MC 2115, Chicago, IL 60637 USA.	schilsk@medicine.bsd.uchicago.edu						Drews RE, 2010, ANN INTERN MED, V152, P655, DOI 10.7326/0003-4819-152-10-201005180-00244; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 5	2011	154	7					487	494		10.7326/0003-4819-154-7-201104050-00007	http://dx.doi.org/10.7326/0003-4819-154-7-201104050-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744EX	21464351				2022-12-28	WOS:000289078700014
J	Tokunaga, F; Nakagawa, T; Nakahara, M; Saeki, Y; Taniguchi, M; Sakata, S; Tanaka, K; Nakano, H; Iwai, K				Tokunaga, Fuminori; Nakagawa, Tomoko; Nakahara, Masaki; Saeki, Yasushi; Taniguchi, Masami; Sakata, Shin-ichi; Tanaka, Keiji; Nakano, Hiroyasu; Iwai, Kazuhiro			SHARPIN is a component of the NF-kappa B-activating linear ubiquitin chain assembly complex	NATURE			English	Article							CHRONIC PROLIFERATIVE DERMATITIS; INCONTINENTIA PIGMENTI; IMMUNE-DEFICIENCY; SIGNALING PATHWAY; MUTATIONS; NEMO; PROTEIN; LIGASE; IDENTIFICATION; ALPHA	Cpdm (chronic proliferative dermatitis) mice develop chronic dermatitis and an immunodeficiency with increased serum IgM(1-3), symptoms that resemble those of patients with X-linked hyper-IgM syndrome and hypohydrotic ectodermal dysplasia (XHM-ED), which is caused by mutations in NEMO (NF-kappa B essential modulator; also known as IKBKG)(4-6). Spontaneous null mutations in the Sharpin (SHANK-associated RH domain interacting protein in postsynaptic density)(7) gene are responsible for the cpdm phenotype in mice(8). SHARPIN shows significant similarity to HOIL-1L (also known as RBCK1)(8,9), a component of linear ubiquitin chain assembly complex (LUBAC), which induces NF-kappa B activation through conjugation of linear polyubiquitin chains to NEMO10-13. Here, we identify SHARPIN as an additional component of LUBAC. SHARPIN-containing complexes can linearly ubiquitinate NEMO and activated NF-kappa B. Thus, we re-define LUBAC as a complex containing SHARPIN, HOIL-1L, and HOIP (also known as RNF31). Deletion of SHARPIN drastically reduced the amount of LUBAC, which resulted in attenuated TNF-alpha- and CD40-mediated activation of NF-kappa B in mouse embryonic fibroblasts (MEFs) or B cells from cpdm mice. Considering the pleomorphic phenotype of cpdm mice, these results confirm the predicted role of LUBAC-mediated linear polyubiquitination in NF-kappa B activation induced by various stimuli, and strongly suggest the involvement of LUBAC-induced NF-kappa B activation in various disorders.	[Tokunaga, Fuminori; Nakagawa, Tomoko; Nakahara, Masaki; Taniguchi, Masami; Sakata, Shin-ichi; Iwai, Kazuhiro] Osaka Univ, Grad Sch Med, Dept Biophys & Biochem, Suita, Osaka 5650871, Japan; [Saeki, Yasushi; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, Tokyo 1568506, Japan; [Nakano, Hiroyasu] Juntendo Univ, Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1138421, Japan; [Iwai, Kazuhiro] Osaka Univ, Grad Sch Frontier Biosci, Cell Biol & Metab Grp, Suita, Osaka 5650871, Japan	Osaka University; Tokyo Metropolitan Institute of Medical Science; Juntendo University; Osaka University	Iwai, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Biophys & Biochem, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kiwai@cellbio.med.osaka-u.ac.jp	Saeki, Yasushi/AAR-8198-2021; IWAI, KAZUHIRO/GSN-7385-2022	Saeki, Yasushi/0000-0002-9202-5453; Tokunaga, Fuminori/0000-0003-3626-9119; Iwai, Kazuhiro/0000-0001-5620-5951; Nakano, Hiroyasu/0000-0003-4843-1427	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [23659404, 22117006] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank T. Kitamura, S. Sugano, P. Rennert and J. Browning for reagents; O. Takeuchi for comments; and K. Kamei and K. Fukunaga for technical assistance. This work was partly supported by Grants-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (F.T. and K.I.).	Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Gerondakis S, 2006, ONCOGENE, V25, P6781, DOI 10.1038/sj.onc.1209944; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; HogenEsch H, 1999, J IMMUNOL, V162, P3890; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Iwai K, 2009, EMBO REP, V10, P706, DOI 10.1038/embor.2009.144; Jain A, 2004, J CLIN INVEST, V114, P1593, DOI 10.1172/JCI200421345; Jain A, 2001, NAT IMMUNOL, V2, P223, DOI 10.1038/85277; Jung J, 2010, MOL CELL BIOCHEM, V340, P161, DOI 10.1007/s11010-010-0413-x; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; Lim S, 2001, MOL CELL NEUROSCI, V17, P385, DOI 10.1006/mcne.2000.0940; Piao JH, 2007, J IMMUNOL, V178, P2272, DOI 10.4049/jimmunol.178.4.2272; Renninger ML, 2010, EXP DERMATOL, V19, P252, DOI 10.1111/j.1600-0625.2009.00944.x; Seymour R, 2006, VET PATHOL, V43, P401, DOI 10.1354/vp.43-4-401; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Smahi A, 2002, HUM MOL GENET, V11, P2371, DOI 10.1093/hmg/11.20.2371; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Torres HIG, 1995, PATHOBIOLOGY, V63, P341; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Yamanaka K, 2003, NAT CELL BIOL, V5, P336, DOI 10.1038/ncb952; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Zonana J, 2000, AM J HUM GENET, V67, P1555, DOI 10.1086/316914	26	462	481	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2011	471	7340					633	U113		10.1038/nature09815	http://dx.doi.org/10.1038/nature09815			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21455180				2022-12-28	WOS:000288951200042
J	Watts, G				Watts, Geoff			Profile Joseph Murray: innovative surgeon and pioneer of transplantation	LANCET			English	Biographical-Item												geoff@scileg.freeserve.co.uk							0	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 19	2011	377	9770					987	987		10.1016/S0140-6736(11)60375-9	http://dx.doi.org/10.1016/S0140-6736(11)60375-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	740FA	21420544	Bronze			2022-12-28	WOS:000288775800014
J	Malik, FI; Hartman, JJ; Elias, KA; Morgan, BP; Rodriguez, H; Brejc, K; Anderson, RL; Sueoka, SH; Lee, KH; Finer, JT; Sakowicz, R; Baliga, R; Cox, DR; Garard, M; Godinez, G; Kawas, R; Kraynack, E; Lenzi, D; Lu, PP; Muci, A; Niu, CR; Qian, XP; Pierce, DW; Pokrovskii, M; Suehiro, I; Sylvester, S; Tochimoto, T; Valdez, C; Wang, WY; Katori, T; Kass, DA; Shen, YT; Vatner, SF; Morgans, DJ				Malik, Fady I.; Hartman, James J.; Elias, Kathleen A.; Morgan, Bradley P.; Rodriguez, Hector; Brejc, Katjusa; Anderson, Robert L.; Sueoka, Sandra H.; Lee, Kenneth H.; Finer, Jeffrey T.; Sakowicz, Roman; Baliga, Ramesh; Cox, David R.; Garard, Marc; Godinez, Guillermo; Kawas, Raja; Kraynack, Erica; Lenzi, David; Lu, Pu Ping; Muci, Alexander; Niu, Congrong; Qian, Xiangping; Pierce, Daniel W.; Pokrovskii, Maria; Suehiro, Ion; Sylvester, Sheila; Tochimoto, Todd; Valdez, Corey; Wang, Wenyue; Katori, Tatsuo; Kass, David A.; Shen, You-Tang; Vatner, Stephen F.; Morgans, David J.			Cardiac Myosin Activation: A Potential Therapeutic Approach for Systolic Heart Failure	SCIENCE			English	Article							CONSCIOUS DOGS; SUBFRAGMENT-1; ACTOMYOSIN; MECHANISM; ATPASE; MOTOR; 1ST	Decreased cardiac contractility is a central feature of systolic heart failure. Existing drugs increase cardiac contractility indirectly through signaling cascades but are limited by their mechanism-related adverse effects. To avoid these limitations, we previously developed omecamtiv mecarbil, a small-molecule, direct activator of cardiac myosin. Here, we show that it binds to the myosin catalytic domain and operates by an allosteric mechanism to increase the transition rate of myosin into the strongly actin-bound force-generating state. Paradoxically, it inhibits adenosine 5'-triphosphate turnover in the absence of actin, which suggests that it stabilizes an actin-bound conformation of myosin. In animal models, omecamtiv mecarbil increases cardiac function by increasing the duration of ejection without changing the rates of contraction. Cardiac myosin activation may provide a new therapeutic approach for systolic heart failure.	[Malik, Fady I.; Hartman, James J.; Elias, Kathleen A.; Morgan, Bradley P.; Rodriguez, Hector; Brejc, Katjusa; Anderson, Robert L.; Sueoka, Sandra H.; Lee, Kenneth H.; Finer, Jeffrey T.; Sakowicz, Roman; Baliga, Ramesh; Cox, David R.; Garard, Marc; Godinez, Guillermo; Kawas, Raja; Kraynack, Erica; Lenzi, David; Lu, Pu Ping; Muci, Alexander; Niu, Congrong; Qian, Xiangping; Pierce, Daniel W.; Pokrovskii, Maria; Suehiro, Ion; Sylvester, Sheila; Tochimoto, Todd; Valdez, Corey; Wang, Wenyue; Morgans, David J.] Cytokinetics Inc, Preclin Res & Dev, San Francisco, CA 94080 USA; [Katori, Tatsuo; Kass, David A.] Johns Hopkins Med Inst, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; [Shen, You-Tang; Vatner, Stephen F.] CV Dynam, N Brunswick, NJ 08902 USA; [Vatner, Stephen F.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA; [Vatner, Stephen F.] Univ Med & Dent New Jersey, New Jersey Med Sch, Cardiovasc Res Inst, Newark, NJ 07103 USA; [Shen, You-Tang] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Shen, You-Tang] Univ Penn, Sch Med, Div Cardiovasc Med, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Pennsylvania; University of Pennsylvania	Malik, FI (corresponding author), Cytokinetics Inc, Preclin Res & Dev, San Francisco, CA 94080 USA.	fmalik@cytokinetics.com		Brejc, Katjusa/0000-0002-4562-6109	Cytokinetics; NIH [1-R43-HL-66647-1]; Cytokinetics, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL066647, R01HL106511] Funding Source: NIH RePORTER	Cytokinetics; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cytokinetics, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank J. Chabala, C. Homcy, T. A. Pollard, J. H. Sabry, R. J. Solaro, J. A. Spudich, J. R. Teerlink, and R. D. Vale for their advice over the course of this work; A. Franklin and S. Hollenbach for their contributions to the conduct of some of these studies; and M. Rowley and J. Goldstein for assistance in preparing the manuscript. Y.-T.S., D. A. K., and S. F. V. are members of the Scientific Advisory Board and received research support, compensation, and stock options (D. A. K. and S. F. V.) from Cytokinetics. Cytokinetics holds a patent on omecamtiv mecarbil (U. S. Patent no. 7,507,735); Amgen is a licensee of this patent. Support provided by Small Business Innovation Research grant, NIH (1-R43-HL-66647-1) and Cytokinetics, Inc.	Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005; Banfor PN, 2008, AM J PHYSIOL-HEART C, V294, pH238, DOI 10.1152/ajpheart.01181.2007; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; CLEEMANN L, 1991, J PHYSIOL-LONDON, V432, P283, DOI 10.1113/jphysiol.1991.sp018385; De La Cruz EM, 2009, METHOD ENZYMOL, V455, P157, DOI 10.1016/S0076-6879(08)04206-7; Grimsby J, 2003, SCIENCE, V301, P370, DOI 10.1126/science.1084073; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Kass DA, 2006, CIRCULATION, V113, P305, DOI 10.1161/CIRCULATIONAHA.105.542407; KOMAMURA K, 1992, J CLIN INVEST, V89, P1825, DOI 10.1172/JCI115787; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Loehr LR, 2008, AM J CARDIOL, V101, P1016, DOI 10.1016/j.amjcard.2007.11.061; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; McMurray JJV, 2010, NEW ENGL J MED, V362, P228, DOI 10.1056/NEJMcp0909392; Morgan BP, 2010, ACS MED CHEM LETT, V1, P472, DOI 10.1021/ml100138q; Petersen John W, 2008, Crit Care Med, V36, pS106, DOI 10.1097/01.CCM.0000296273.72952.39; Pollard TD, 2008, CELL BIOL, V2nd, P705; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Shen YT, 2010, CIRC-HEART FAIL, V3, P522, DOI 10.1161/CIRCHEARTFAILURE.109.930321; Shen YT, 1999, AM J PHYSIOL-HEART C, V277, pH388, DOI 10.1152/ajpheart.1999.277.1.H388; Stasch JP, 2002, BRIT J PHARMACOL, V136, P773, DOI 10.1038/sj.bjp.0704778; SUGA H, 1974, CIRC RES, V35, P117, DOI 10.1161/01.RES.35.1.117; Suzuki T, 2009, CIRC-HEART FAIL, V2, P334, DOI 10.1161/CIRCHEARTFAILURE.108.802298; Sweeney HL, 2010, ANNU REV BIOPHYS, V39, P539, DOI 10.1146/annurev.biophys.050708.133751; Zorn JA, 2010, NAT CHEM BIOL, V6, P179, DOI 10.1038/NCHEMBIO.318	24	364	376	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2011	331	6023					1439	1443		10.1126/science.1200113	http://dx.doi.org/10.1126/science.1200113			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21415352	Green Accepted			2022-12-28	WOS:000288504000042
J	Hamilton, HK; Tonkovic-Capin, V				Hamilton, Heather Klein; Tonkovic-Capin, Viseslav			Facial Angiofibromas Associated with Tuberous Sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hamilton, Heather Klein; Tonkovic-Capin, Viseslav] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Hamilton, HK (corresponding author), Univ Kansas, Med Ctr, Kansas City, KS 66103 USA.	hhamilton@kumc.edu							0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2011	364	11					1061	1061		10.1056/NEJMicm1005598	http://dx.doi.org/10.1056/NEJMicm1005598			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735SX	21410374				2022-12-28	WOS:000288439000011
J	Hedman, MM; Burns, JA; Evans, MW; Tiscareno, MS; Porco, CC				Hedman, M. M.; Burns, J. A.; Evans, M. W.; Tiscareno, M. S.; Porco, C. C.			Saturn's Curiously Corrugated C Ring	SCIENCE			English	Article							ECLIPTIC COMETS; TIDAL BREAKUP; SYSTEM; SIZE; JUPITER; IMPACT; RATES	In August 2009 the Sun illuminated Saturn's rings from almost exactly edge-on, revealing a subtle corrugation that extends across the entire C ring. This corrugation's amplitude is 2 to 20 meters and its wavelength is 30 to 80 kilometers, Radial trends in the corrugation's wavelength indicate that this structure-like a similar corrugation previously identified in the D ring-results from differential nodal regression within a ring that became tilted relative to Saturn's equator plane in 1983. We suggest that this initial tilt arose because interplanetary debris struck the rings. The corrugation's radial extent implies that the impacting material was a dispersed cloud of debris instead of a single object, and the corrugation's amplitude indicates that the debris' total mass was similar to 10(11) to 10(13) kilograms.	[Hedman, M. M.; Burns, J. A.; Evans, M. W.; Tiscareno, M. S.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Burns, J. A.] Cornell Univ, Dept Mech Engn, Ithaca, NY 14853 USA; [Porco, C. C.] CICLOPS Space Sci Inst, Boulder, CO 80301 USA	Cornell University; Cornell University	Hedman, MM (corresponding author), Cornell Univ, Dept Astron, Ithaca, NY 14853 USA.	mmhedman@astro.cornell.edu	Tiscareno, Matthew/D-6963-2011; Evans, Michael W/AAG-4117-2020	Hedman, Matthew/0000-0002-8592-0812	Imaging Science Subsystem tennis and the Cassini Project; NASA's Planetary Geology and Geophysics; Cassini Data Analysis programs	Imaging Science Subsystem tennis and the Cassini Project; NASA's Planetary Geology and Geophysics; Cassini Data Analysis programs	We acknowledge the support of the Imaging Science Subsystem tennis and the Cassini Project, as well as NASA's Planetary Geology and Geophysics, and Cassini Data Analysis programs. We also thank M. R. Showalter, P. D. Nicholson, S. Charnoz, L. Dunes, and D. P. Hamilton for useful conversations.	Asphaug E, 1996, ICARUS, V121, P225, DOI 10.1006/icar.1996.0083; Charnoz S, 2009, ICARUS, V199, P413, DOI 10.1016/j.icarus.2008.10.019; Cuzzi J, 2009, SATURN FROM CASSINI-HUYGENS, P459, DOI 10.1007/978-1-4020-9217-6_15; Hedman MM, 2007, ICARUS, V188, P89, DOI 10.1016/j.icarus.2006.11.017; Jacobson RA, 2006, ASTRON J, V132, P2520, DOI 10.1086/508812; KARP DM, 1996, ICARUS, V121, P207; Levison HF, 2000, ICARUS, V143, P415, DOI 10.1006/icar.1999.6313; Levison HF, 1997, ICARUS, V127, P13, DOI 10.1006/icar.1996.5637; Montalto M, 2008, ASTRON ASTROPHYS, V479, pL45, DOI 10.1051/0004-6361:20079130; Murray C. D., 1999, SOLAR SYSTEM DYNAMIC; Ockert-Bell ME, 1999, ICARUS, V138, P188, DOI 10.1006/icar.1998.6072; Porco CC, 2004, SPACE SCI REV, V115, P363, DOI 10.1007/s11214-004-1456-7; ROSEN PA, 1991, ICARUS, V93, P25, DOI 10.1016/0019-1035(91)90161-L; Sanchez-Lavega A, 2010, ASTROPHYS J LETT, V715, pL155, DOI 10.1088/2041-8205/715/2/L155; Showalter MR, 2011, SCIENCE, V332, P711, DOI 10.1126/science.1202241; Zahnle K, 2003, ICARUS, V163, P263, DOI 10.1016/S0019-1035(03)00048-4; ZEBKER HA, 1985, ICARUS, V64, P531, DOI 10.1016/0019-1035(85)90074-0	18	26	26	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 6	2011	332	6030					708	711		10.1126/science.1202238	http://dx.doi.org/10.1126/science.1202238			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759RK	21454753				2022-12-28	WOS:000290265800040
J	Lassen, JF				Lassen, Jens Flensted			Long-term safety and efficacy of drug-eluting stents	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; SIROLIMUS; CORONARY; ENDEAVOR; LESIONS; SYSTEM; SORT		Aarhus Univ Hosp, Dept Cardiol B, DK-8200 Aarhus N, Denmark	Aarhus University	Lassen, JF (corresponding author), Aarhus Univ Hosp, Dept Cardiol B, DK-8200 Aarhus N, Denmark.	jens.lassen@ki.au.dk	Lassen, Jens Flensted/AAY-2127-2021	Lassen, Jens Flensted/0000-0001-7972-9192				Camenzind E, 2009, AM HEART J, V158, P902, DOI 10.1016/j.ahj.2009.10.002; Cook S, 2009, CIRCULATION, V120, P391, DOI 10.1161/CIRCULATIONAHA.109.854398; Eisenstein EL, 2009, JACC-CARDIOVASC INTE, V2, P1199, DOI 10.1016/j.jcin.2009.10.009; Galloe AM, 2008, JAMA-J AM MED ASSOC, V299, P409, DOI 10.1001/jama.299.4.409; Kandzari DE, 2006, J AM COLL CARDIOL, V48, P2440, DOI 10.1016/j.jacc.2006.08.035; Kedhi E, 2010, LANCET, V375, P201, DOI 10.1016/S0140-6736(09)62127-9; Leon MB, 2009, JACC-CARDIOVASC INTE, V2, P1208, DOI 10.1016/j.jcin.2009.10.008; Meredith IT, 2009, JACC-CARDIOVASC INTE, V2, P977, DOI 10.1016/j.jcin.2009.07.007; Morice MC, 2006, JAMA-J AM MED ASSOC, V295, P895, DOI 10.1001/jama.295.8.895; Rasmussen K, 2010, LANCET, V375, P1090, DOI 10.1016/S0140-6736(10)60208-5; Schomig A, 2007, J AM COLL CARDIOL, V50, P1373, DOI 10.1016/j.jacc.2007.06.047; Serruys PW, 2010, NEW ENGL J MED, V363, P136, DOI 10.1056/NEJMoa1004130; Silber S, 2011, LANCET, V377, P1241, DOI 10.1016/S0140-6736(11)60395-4; Silber S, 2009, CIRCULATION, V120, P1498, DOI 10.1161/CIRCULATIONAHA.109.849877	14	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2011	377	9773					1213	1214		10.1016/S0140-6736(11)60468-6	http://dx.doi.org/10.1016/S0140-6736(11)60468-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751DI	21459431				2022-12-28	WOS:000289597300004
J	Haywood, TT; Kosel, KC				Haywood, Trent T.; Kosel, Keith C.			The ACO Model - A Three-Year Financial Loss?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ACCOUNTABLE CARE ORGANIZATIONS		[Haywood, Trent T.; Kosel, Keith C.] VHA Network Hlth Care Org, Irving, TX USA		Haywood, TT (corresponding author), VHA Network Hlth Care Org, Irving, TX USA.							Berenson RA, 2010, AM J MANAG CARE, V16, P721; Fisher ES, 2009, HEALTH AFFAIR, V28, pW219, DOI 10.1377/hlthaff.28.2.w219; Goldsmith J, 2011, HEALTH AFFAIR, V30, P32, DOI 10.1377/hlthaff.2010.0782; Hackbarth GM, 2009, REPORT C IMPROVING I; Sebelius Kathleen, 2009, REPORT C PHYS GROUP	5	22	22	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 7	2011	364	14								10.1056/NEJMp1100950	http://dx.doi.org/10.1056/NEJMp1100950			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	745WS	21428759				2022-12-28	WOS:000289202800004
J	Tirosh, A; Shai, I; Afek, A; Dubnov-Raz, G; Ayalon, N; Gordon, B; Derazne, E; Tzur, D; Shamis, A; Vinker, S; Rudich, A				Tirosh, Amir; Shai, Iris; Afek, Arnon; Dubnov-Raz, Gal; Ayalon, Nir; Gordon, Barak; Derazne, Estela; Tzur, Dorit; Shamis, Ari; Vinker, Shlomo; Rudich, Assaf			Adolescent BMI Trajectory and Risk of Diabetes versus Coronary Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BODY-MASS INDEX; INSULIN-RESISTANCE SYNDROME; HEART-DISEASE; YOUNG ADULTHOOD; FOLLOW-UP; CARDIOVASCULAR-DISEASE; TRIGLYCERIDE LEVELS; METABOLIC SYNDROME; CHILDHOOD; CHILDREN	BACKGROUND The association of body-mass index (BMI) from adolescence to adulthood with obesity-related diseases in young adults has not been completely delineated. METHODS We conducted a prospective study in which we followed 37,674 apparently healthy young men for incident angiography-proven coronary heart disease and diabetes through the Staff Periodic Examination Center of the Israeli Army Medical Corps. The height and weight of participants were measured at regular intervals, with the first measurements taken when they were 17 years of age. RESULTS During approximately 650,000 person-years of follow-up (mean follow-up, 17.4 years), we documented 1173 incident cases of type 2 diabetes and 327 of coronary heart disease. In multivariate models adjusted for age, family history, blood pressure, lifestyle factors, and biomarkers in blood, elevated adolescent BMI (the weight in kilograms divided by the square of the height in meters; mean range for the first through last deciles, 17.3 to 27.6) was a significant predictor of both diabetes (hazard ratio for the highest vs. the lowest decile, 2.76; 95% confidence interval [CI], 2.11 to 3.58) and angiography-proven coronary heart disease (hazard ratio, 5.43; 95% CI, 2.77 to 10.62). Further adjustment for BMI at adulthood completely ablated the association of adolescent BMI with diabetes (hazard ratio, 1.01; 95% CI, 0.75 to 1.37) but not the association with coronary heart disease (hazard ratio, 6.85; 95% CI, 3.30 to 14.21). After adjustment of the BMI values as continuous variables in multivariate models, only elevated BMI in adulthood was significantly associated with diabetes (beta = 1.115, P = 0.003; P = 0.89 for interaction). In contrast, elevated BMI in both adolescence (beta = 1.355, P = 0.004) and adulthood (beta = 1.207, P = 0.03) were independently associated with angiography-proven coronary heart disease (P = 0.048 for interaction). CONCLUSIONS An elevated BMI in adolescence - one that is well within the range currently considered to be normal - constitutes a substantial risk factor for obesity-related disorders in midlife. Although the risk of diabetes is mainly associated with increased BMI close to the time of diagnosis, the risk of coronary heart disease is associated with an elevated BMI both in adolescence and in adulthood, supporting the hypothesis that the processes causing incident coronary heart disease, particularly atherosclerosis, are more gradual than those resulting in incident diabetes.	[Tirosh, Amir] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Boston, MA 02115 USA; [Tirosh, Amir] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Afek, Arnon] Boston Univ, Med Ctr, Cardiovasc Med Sect, Boston, MA USA; [Tirosh, Amir] Chaim Sheba Med Ctr, Talpiot Med Leadership Program, IL-52621 Tel Hashomer, Israel; [Afek, Arnon; Shamis, Ari] Chaim Sheba Med Ctr, Chaim Sheba Med Ctr Management, IL-52621 Tel Hashomer, Israel; [Dubnov-Raz, Gal] Edmond & Lily Safra Childrens Hosp, Chaim Sheba Med Ctr, Exercise Nutr & Lifestyle Clin, Tel Hashomer, Israel; [Shai, Iris; Rudich, Assaf] Ben Gurion Univ Negev, S Daniel Abraham Ctr Hlth & Nutr, IL-84105 Beer Sheva, Israel; [Shai, Iris] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Epidemiol, Beer Sheva, Israel; [Rudich, Assaf] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Clin Biochem, Beer Sheva, Israel; [Rudich, Assaf] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Afek, Arnon; Shamis, Ari] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Gordon, Barak; Derazne, Estela; Tzur, Dorit; Vinker, Shlomo] Israel Def Forces Med Corps, Jerusalem, Israel	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Boston University; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Ben Gurion University; Ben Gurion University; Ben Gurion University; Ben Gurion University; Tel Aviv University; Sackler Faculty of Medicine	Tirosh, A (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, 221 Longwood Ave, Boston, MA 02115 USA.	atirosh@partners.org	Dubnov-Raz, Gal/L-3297-2016; Gordon, Barak/L-6139-2018	Dubnov-Raz, Gal/0000-0003-1469-8043; Gordon, Barak/0000-0002-5283-722X; Ayalon, Nir/0000-0002-0480-1249; Rudich, Assaf/0000-0002-1366-1444; Tirosh, Amir/0000-0003-2210-5906; Shai, Iris/0000-0001-9050-4605	Chaim Sheba Medical Center, Tel-Hashomer, Israel; Israel Defense Forces Medical Corps; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007529] Funding Source: NIH RePORTER	Chaim Sheba Medical Center, Tel-Hashomer, Israel; Israel Defense Forces Medical Corps; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by a grant from the Talpiot Medical Leadership Program, Chaim Sheba Medical Center, Tel-Hashomer, Israel (to Dr. Tirosh), and by the Israel Defense Forces Medical Corps.	ABRAHAM S, 1971, HSMHA HEALTH REP, V86, P273, DOI 10.2307/4594149; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Bjorge T, 2008, AM J EPIDEMIOL, V168, P30, DOI 10.1093/aje/kwn096; Deshmukh-Taskar P, 2006, EUR J CLIN NUTR, V60, P48, DOI 10.1038/sj.ejcn.1602266; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Field AE, 2005, OBES RES, V13, P163, DOI 10.1038/oby.2005.21; Forsen T, 1999, BRIT MED J, V319, P1403, DOI 10.1136/bmj.319.7222.1403; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Lawlor DA, 2005, CIRCULATION, V111, P1891, DOI 10.1161/01.CIR.0000161798.45728.4D; Lawlor DA, 2006, AM J CLIN NUTR, V83, P767, DOI 10.1093/ajcn/83.4.767; Maynard LM, 2001, PEDIATRICS, V107, P344, DOI 10.1542/peds.107.2.344; MOSSBERG HO, 1989, LANCET, V2, P491; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; Oren A, 2003, INT J OBESITY, V27, P1383, DOI 10.1038/sj.ijo.0802404; Osler M, 2009, EUR J EPIDEMIOL, V24, P57, DOI 10.1007/s10654-008-9301-z; POPKIN BM, 2006, OBESITY SILVER SPRIN, V14, P846; Rodriguez G, 2004, INT J OBESITY, V28, pS54, DOI 10.1038/sj.ijo.0802805; ROLLANDCACHERA MF, 1984, AM J CLIN NUTR, V39, P129, DOI 10.1093/ajcn/39.1.129; Shai I, 2010, CIRCULATION, V121, P1200, DOI 10.1161/CIRCULATIONAHA.109.879254; Sinha R, 2002, NEW ENGL J MED, V346, P802, DOI 10.1056/NEJMoa012578; Srinivasan SR, 2002, DIABETES, V51, P204, DOI 10.2337/diabetes.51.1.204; Srinivasan SR, 1996, METABOLISM, V45, P235, DOI 10.1016/S0026-0495(96)90060-8; Steinberger J, 2009, CIRCULATION, V119, P628, DOI 10.1161/CIRCULATIONAHA.108.191394; Thompson DR, 2007, J PEDIATR-US, V150, P18, DOI 10.1016/j.jpeds.2006.09.039; Tirosh A, 2006, NEW ENGL J MED, V354, P2401; Tirosh A, 2008, DIABETES CARE, V31, P2032, DOI 10.2337/dc08-0825; Tirosh A, 2007, ANN INTERN MED, V147, P377, DOI 10.7326/0003-4819-147-6-200709180-00007; Tirosh A, 2010, HYPERTENSION, V56, P203, DOI 10.1161/HYPERTENSIONAHA.109.146415; Tounian P, 2001, LANCET, V358, P1400, DOI 10.1016/S0140-6736(01)06525-4; Viner RM, 2005, ARCH DIS CHILD, V90, P10, DOI 10.1136/adc.2003.036467; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049	31	438	447	1	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 7	2011	364	14					1315	1325		10.1056/NEJMoa1006992	http://dx.doi.org/10.1056/NEJMoa1006992			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745WS	21470009	Green Accepted, Bronze			2022-12-28	WOS:000289202800007
J	Wang, JM; Chang, SC				Wang, Jia-Ming; Chang, Shih-Chieh			Acute Mesenteric Infarction Associated with Atrial Fibrillation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wang, Jia-Ming; Chang, Shih-Chieh] Natl Yang Ming Univ Hosp, Yilan City, Taiwan		Wang, JM (corresponding author), Natl Yang Ming Univ Hosp, Yilan City, Taiwan.	dtsurga9@yahoo.com.tw							0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 7	2011	364	14					1349	1349		10.1056/NEJMicm1001885	http://dx.doi.org/10.1056/NEJMicm1001885			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745WS	21470012				2022-12-28	WOS:000289202800010
J	Ludwig, DS				Ludwig, David S.			Technology, Diet, and the Burden of Chronic Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CORONARY-HEART-DISEASE; PREVENTION		Childrens Hosp, Dept Med, Optimal Weight Life Program, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital	Ludwig, DS (corresponding author), Childrens Hosp, Dept Med, Optimal Weight Life Program, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu		Ludwig, David/0000-0003-3307-8544	NIDDK NIH HHS [K24DK082730] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CNN Health, WE AR WHAT WE EAT AM; COHEN MN, 1984, PALEOPATHOLOGY ORIGI; Hu FB, 2002, JAMA-J AM MED ASSOC, V288, P2569, DOI 10.1001/jama.288.20.2569; Larsen TM, 2010, NEW ENGL J MED, V363, P2102, DOI 10.1056/NEJMoa1007137; Monteiro CA, 2011, PUBLIC HEALTH NUTR, V14, P5, DOI 10.1017/S1368980010003241; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Pollan Michael, 2006, OMNIVORES DILEMMA NA; Rolls BJ, 2009, PHYSIOL BEHAV, V97, P609, DOI 10.1016/j.physbeh.2009.03.011; Rolls BJ, 2000, J AM DIET ASSOC, V100, P232, DOI 10.1016/S0002-8223(00)00070-5; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103	10	104	109	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2011	305	13					1352	1353		10.1001/jama.2011.380	http://dx.doi.org/10.1001/jama.2011.380			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745JT	21467290				2022-12-28	WOS:000289162400027
J	Viner, RM; Coffey, C; Mathers, C; Bloem, P; Costello, A; Santelli, J; Patton, GC				Viner, Russell M.; Coffey, Carolyn; Mathers, Colin; Bloem, Paul; Costello, Anthony; Santelli, John; Patton, George C.			50-year mortality trends in children and young people: a study of 50 low-income, middle-income, and high-income countries	LANCET			English	Article							SYSTEMATIC ANALYSIS; HEALTH; ADOLESCENT; SUICIDE; UNEMPLOYMENT; DECLINE; YOUTH	Background Global attention has focused on mortality in children younger than 5 years. We analysed global mortality data for people aged 1-24 years across a 50-year period. Methods The WHO mortality database was used to obtain mortality data from 1955 to 2004, by age-group (1-4, 5-9, 10-14, 15-19, and 20-24 years) and stratified by sex. To analyse change in mortality, we calculated mortality rates averaged over three 5-year periods (1955-59, 1978-82, and 2000-04) to investigate trends in deaths caused by communicable and non-communicable diseases and injury. Findings Data were available for 50 countries (ten high income, 22 middle income, eight low income, seven very low income, and three unclassified), grouped as Organisation for Economic Co-operation and Development (OECD) countries, Central and South American countries, eastern European countries and ex-Soviet states, and other countries. In 1955, mortality was highest in the 1-4-year age-group. Across the study period, all-cause mortality reduced by 85-93% in children aged 1-4 years, 80-87% in children aged 5-9 years, and 68-78% in young people aged 10-14 years in OECD, Central and South American, and other countries. Smaller declines (41-48%) were recorded in young men (15-24 years), and by 2000-04, mortality in this group was two-to-three times higher than that in young boys (1-4 years). Mortality in young women (15-24 years) was equal to that of young girls (1-4 years) from 2000 onwards. Substantial declines in death caused by communicable diseases were seen in all age-groups and regions, although communicable and non-communicable diseases remained the main causes of death in children (1-9 years) and young women (10-24 years). Injury was the dominant cause of death in young men (10-24 years) in all regions by the late 1970s. Interpretation Adolescents and young adults have benefited from the epidemiological transition less than children have, with a reversal of traditional mortality patterns over the past 50 years. Future global health targets should include a focus on the health problems of people aged 10-24 years.	[Viner, Russell M.; Costello, Anthony] UCL, Inst Child Hlth, London WC1N 3EH, England; [Coffey, Carolyn; Patton, George C.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Ctr Adolescent Hlth, Melbourne, Vic, Australia; [Coffey, Carolyn; Patton, George C.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia; [Mathers, Colin; Bloem, Paul] WHO, CH-1211 Geneva, Switzerland; [Santelli, John] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	University of London; University College London; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; World Health Organization; Columbia University	Viner, RM (corresponding author), UCL, Inst Child Hlth, 30 Guilford St, London WC1N 3EH, England.	r.viner@ucl.ac.uk	Santelli, John/AAG-3046-2021; Patton, George C/B-5246-2013; Ribeiro, Ana Cristina/HHN-7466-2022; Viner, Russell M/A-1441-2009	Patton, George C/0000-0001-5039-8326; Ribeiro, Ana Cristina/0000-0002-0493-8376; Viner, Russell M/0000-0003-3047-2247; Mathers, Colin/0000-0002-0617-6731	Esai; WHO Department of Child and Adolescent Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD058486] Funding Source: NIH RePORTER	Esai; WHO Department of Child and Adolescent Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	RMV has received consultancy fees from Esai. GCP was a member of a technical steering committee for WHO Department of Child and Adolescent Health, for which he received travel, living, and accommodation expenses. CC, CM, PB, AC, and IS have no conflicts of interest to declare.	Ahmad OB, 2000, B WORLD HEALTH ORGAN, V78, P1175; Blum RW, 2007, J ADOLESCENT HEALTH, V41, P230, DOI 10.1016/j.jadohealth.2007.04.005; Blum RW, 2004, J ADOLESCENT HEALTH, V35, P402, DOI [10.1016/j.jadohealth.2003.10.007, 10.1016/S1054-139X(03)00537-8]; Blumstein A, 2000, ANNU REV PUBL HEALTH, V21, P505, DOI 10.1146/annurev.publhealth.21.1.505; Branche C., 2008, WORLD REPORT CHILD I; BRENNER MH, 1983, SOC SCI MED, V17, P1125, DOI 10.1016/0277-9536(83)90005-9; Gunnell D, 1999, BRIT J PSYCHIAT, V175, P263, DOI 10.1192/bjp.175.3.263; Heuveline P, 2002, J ADOLESCENT HEALTH, V30, P29, DOI 10.1016/S1054-139X(01)00329-9; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Kleinert S, 2007, LANCET, V369, P1057, DOI 10.1016/S0140-6736(07)60374-2; Kopits E., 2003, 3035 WORLD BANK; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P45; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Patton GC, 2010, J ADOLESCENT HEALTH, V47, P427, DOI 10.1016/j.jadohealth.2010.08.019; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Patton GC, 2007, LANCET, V369, P1130, DOI 10.1016/S0140-6736(07)60366-3; Pritchard C, 2008, CRISIS, V29, P145, DOI 10.1027/0227-5910.29.3.145; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rajaratnam JK, 2010, LANCET, V375, P1704, DOI 10.1016/S0140-6736(10)60517-X; Rutz EM, 2004, EUR CHILD ADOLES PSY, V13, P321, DOI 10.1007/s00787-004-0406-y; Sells CW, 1996, AM J PUBLIC HEALTH, V86, P513, DOI 10.2105/AJPH.86.4.513; Shkolnikov V, 2001, LANCET, V357, P917, DOI 10.1016/S0140-6736(00)04212-4; Steinberg L, 2010, BRAIN COGNITION, V72, P160, DOI 10.1016/j.bandc.2009.11.003; Stuckler D, 2008, LANCET, V372, P1563, DOI 10.1016/S0140-6736(08)61656-6; The United Nations Population Division, 2007, WORLD POP PROSP 2006; Viner RM, 2005, BRIT MED J, V330, P901, DOI 10.1136/bmj.330.7496.901; WHO, 2010, TRENDS MAT MORT 1990; WHO UNICEF, 2010, COUNTD 2015 DEC REP; Wilf-Miron R, 2001, ISRAEL MED ASSOC J, V3, P610; World Bank, 2007, WORLD DEV REP DEV NE; You D, 2010, LANCET, V375, P100, DOI 10.1016/S0140-6736(09)61601-9	32	147	155	1	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2011	377	9772					1162	1174		10.1016/S0140-6736(11)60106-2	http://dx.doi.org/10.1016/S0140-6736(11)60106-2			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	750IH	21450338				2022-12-28	WOS:000289539300032
J	Dominguez-Villar, M; Hafler, DA				Dominguez-Villar, Margarita; Hafler, David A.			An Innate Role for IL-17	SCIENCE			English	Editorial Material							CHRONIC MUCOCUTANEOUS CANDIDIASIS; TH17 CELLS; MUTATIONS		[Dominguez-Villar, Margarita; Hafler, David A.] Yale Univ, Sch Med, Dept Neurol & Immunobiol, New Haven, CT 06520 USA	Yale University	Dominguez-Villar, M (corresponding author), Yale Univ, Sch Med, Dept Neurol & Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	david.hafler@yale.edu		Dominguez-Villar, Margarita/0000-0002-9719-0028				Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Antachopoulos C, 2010, CLIN MICROBIOL INFEC, V16, P1335, DOI 10.1111/j.1469-0691.2010.03289.x; Auja SJ, 2007, SEMIN IMMUNOL, V19, P377, DOI 10.1016/j.smim.2007.10.009; Conti HR, 2010, MICROBES INFECT, V12, P518, DOI 10.1016/j.micinf.2010.03.013; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; De Moraes-Vasconcelos D, 2001, CLIN EXP IMMUNOL, V123, P247, DOI 10.1046/j.1365-2249.2001.01430.x; de Repentigny L, 2004, CLIN MICROBIOL REV, V17, P729, DOI 10.1128/CMR.17.4.729-759.2004; Eyerich K, 2008, J INVEST DERMATOL, V128, P2640, DOI 10.1038/jid.2008.139; Eyerich K, 2010, EUR J DERMATOL, V20, P260, DOI 10.1684/ejd.2010.0910; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lin L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000703; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Romani L, 1996, RES IMMUNOL, V147, P512, DOI 10.1016/S0923-2494(97)85216-9; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579	15	21	23	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2011	332	6025					47	48		10.1126/science.1205311	http://dx.doi.org/10.1126/science.1205311			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21454778				2022-12-28	WOS:000289000000032
J	Shuster, DL; Cuffey, KM; Sanders, JW; Balco, G				Shuster, David L.; Cuffey, Kurt M.; Sanders, Johnny W.; Balco, Greg			Thermochronometry Reveals Headward Propagation of Erosion in an Alpine Landscape	SCIENCE			English	Article							SURFACE	Glacial erosion of mountain ranges produces spectacular alpine landscapes and, by linking climate with tectonics, influences a broad array of geophysical phenomena. Although the resultant landforms are easily identified, the timing and spatial pattern of topographic adjustment to Pleistocene glaciations remain poorly known. We investigated topographic evolution in the archetypal glacial landscape of Fiordland, New Zealand, using (U-Th)/He thermochronometry. We find that erosion during the past 2 million years removed the entire pre-Pleistocene landscape and fundamentally reshaped the topography. Erosion focused on steep valley segments and propagated from trunk valleys toward the heads of drainage basins, a behavior expected if subglacial erosion rate depends on ice sliding velocity. The Fiordland landscape illustrates complex effects of climate on Earth's surface morphology.	[Shuster, David L.; Balco, Greg] Berkeley Geochronol Ctr, Berkeley, CA 94709 USA; [Shuster, David L.; Cuffey, Kurt M.; Sanders, Johnny W.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Cuffey, Kurt M.] Univ Calif Berkeley, Dept Geog, Berkeley, CA 94720 USA	Berkeley Geochronolgy Center; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Shuster, DL (corresponding author), Berkeley Geochronol Ctr, 2455 Ridge Rd, Berkeley, CA 94709 USA.	dshuster@bgc.org	Shuster, David/A-4838-2011		NSF [EAR-0642869, EAR-0642830]; Ann and Gordon Getty Foundation	NSF(National Science Foundation (NSF)); Ann and Gordon Getty Foundation	We thank Milford Helicopters, B. Lum, and the Caltech Noble Gas Lab for field and laboratory support; J. Braun and F. Herman for modeling guidance; and three anonymous referees for constructive comments. This work was supported by NSF grants EAR-0642869 (to D. L. S.) and EAR-0642830 (to K. M. C.) and by the Ann and Gordon Getty Foundation.	Alley RB, 1999, GEOL SOC AM SPEC PAP, P1; Anderson RS, 2006, J GEOPHYS RES-EARTH, V111, DOI 10.1029/2005JF000344; Bintanja R, 2008, NATURE, V454, P869, DOI 10.1038/nature07158; Braun J, 2003, COMPUT GEOSCI-UK, V29, P787, DOI 10.1016/S0098-3004(03)00052-9; Claypool AL, 2002, TECTONOPHYSICS, V359, P329, DOI 10.1016/S0040-1951(02)00532-2; Egholm DL, 2009, NATURE, V460, P884, DOI 10.1038/nature08263; Flowers RM, 2009, GEOCHIM COSMOCHIM AC, V73, P2347, DOI 10.1016/j.gca.2009.01.015; Hallet B, 1996, ANN GLACIOL, V22, P1; Hallet B., 1981, ANN GLACIOL, V2, p23?28, DOI [10.3189/172756481794352487, DOI 10.3189/172756481794352487]; Herman F, 2009, TECTONICS, V28, DOI 10.1029/2008TC002367; HOOKE RL, 1991, GEOL SOC AM BULL, V103, P1104, DOI 10.1130/0016-7606(1991)103<1104:PFAWEO>2.3.CO;2; Penck A, 1905, J GEOL, V13, P1, DOI 10.1086/621202; PORTER SC, 1989, QUATERNARY RES, V32, P245, DOI 10.1016/0033-5894(89)90092-6; Schildgen TF, 2010, EARTH PLANET SC LETT, V293, P377, DOI 10.1016/j.epsl.2010.03.009; Shuster DL, 2004, EARTH PLANET SC LETT, V217, P19, DOI 10.1016/S0012-821X(03)00594-6; Sugden D.E., 1976, GLACIERS LANDSCAPE; SUGGATE RP, 1990, QUATERNARY SCI REV, V9, P175, DOI 10.1016/0277-3791(90)90017-5; Tomkin JH, 2009, GEOMORPHOLOGY, V103, P180, DOI 10.1016/j.geomorph.2008.04.021; Valla PG, 2010, EARTH PLANET SC LETT, V295, P511, DOI 10.1016/j.epsl.2010.04.033; Walcott RI, 1998, REV GEOPHYS, V36, P1, DOI 10.1029/97RG03084; Whipple KX, 2004, ANNU REV EARTH PL SC, V32, P151, DOI 10.1146/annurev.earth.32.101802.120356; Whipple KX, 1999, NATURE, V401, P39, DOI 10.1038/43375	22	67	71	5	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2011	332	6025					84	88		10.1126/science.1198401	http://dx.doi.org/10.1126/science.1198401			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21454785				2022-12-28	WOS:000289000000042
J	Gerlach, B; Cordier, SM; Schmukle, AC; Emmerich, CH; Rieser, E; Haas, TL; Webb, AI; Rickard, JA; Anderton, H; Wong, WWL; Nachbur, U; Gangoda, L; Warnken, U; Purcell, AW; Silke, J; Walczak, H				Gerlach, Bjoern; Cordier, Stefanie M.; Schmukle, Anna C.; Emmerich, Christoph H.; Rieser, Eva; Haas, Tobias L.; Webb, Andrew I.; Rickard, James A.; Anderton, Holly; Wong, Wendy W-L.; Nachbur, Ueli; Gangoda, Lahiru; Warnken, Uwe; Purcell, Anthony W.; Silke, John; Walczak, Henning			Linear ubiquitination prevents inflammation and regulates immune signalling	NATURE			English	Article							CHRONIC PROLIFERATIVE DERMATITIS; K11-LINKED POLYUBIQUITINATION; MEDIATED REGULATION; STRUCTURAL BASIS; TNF; ACTIVATION; NEMO; RECOGNITION; MECHANISMS; CHAINS	Members of the tumour necrosis factor (TNF) receptor superfamily have important functions in immunity and inflammation. Recently linear ubiquitin chains assembled by a complex containing HOIL-1 and HOIP (also known as RBCK1 and RNF31, respectively) were implicated in TNF signalling, yet their relevance in vivo remained uncertain. Here we identify SHARPIN as a third component of the linear ubiquitin chain assembly complex, recruited to the CD40 and TNF receptor signalling complexes together with its other constituents, HOIL-1 and HOIP. Mass spectrometry of TNF signalling complexes revealed RIP1 (also known as RIPK1) and NEMO (also known as IKK gamma or IKBKG) to be linearly ubiquitinated. Mutation of the Sharpin gene (Sharpin(cpdm/cpdm)) causes chronic proliferative dermatitis (cpdm) characterized by inflammatory skin lesions and defective lymphoid organogenesis. Gene induction by TNF, CD40 ligand and interleukin-1 beta was attenuated in cpdm-derived cells which were rendered sensitive to TNF-induced death. Importantly, Tnf gene deficiency prevented skin lesions in cpdm mice. We conclude that by enabling linear ubiquitination in the TNF receptor signalling complex, SHARPIN interferes with TNF-induced cell death and, thereby, prevents inflammation. Our results provide evidence for the relevance of linear ubiquitination in vivo in preventing inflammation and regulating immune signalling.	[Gerlach, Bjoern; Cordier, Stefanie M.; Schmukle, Anna C.; Emmerich, Christoph H.; Rieser, Eva; Walczak, Henning] Univ London Imperial Coll Sci Technol & Med, Dept Med, Tumour Immunol Unit, London W12 0NN, England; [Gerlach, Bjoern; Emmerich, Christoph H.; Haas, Tobias L.; Walczak, Henning] German Canc Res Ctr, Div Apoptosis Regulat, D-69120 Heidelberg, Germany; [Haas, Tobias L.] Mediterranean Inst Oncol, Dept Expt Oncol, I-95029 Viagrande, Italy; [Webb, Andrew I.; Purcell, Anthony W.] Bio21 Melbourne Univ, Dept Biochem, Melbourne, Vic 3010, Australia; [Rickard, James A.; Anderton, Holly; Wong, Wendy W-L.; Nachbur, Ueli; Gangoda, Lahiru; Silke, John] La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia; [Warnken, Uwe] German Canc Res Ctr, Prot Anal Core Facil, D-69120 Heidelberg, Germany	Imperial College London; Helmholtz Association; German Cancer Research Center (DKFZ); Mediterranean Institute of Oncology; University of Melbourne; La Trobe University; Helmholtz Association; German Cancer Research Center (DKFZ)	Walczak, H (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Tumour Immunol Unit, London W12 0NN, England.	h.walczak@imperial.ac.uk	Walczak, Henning/AAV-2214-2020; Purcell, Anthony/AAH-1942-2019; Silke, John/B-7622-2008; Wong, W. Wei-Lynn/A-6851-2015	Walczak, Henning/0000-0002-6312-4591; Purcell, Anthony/0000-0003-0532-8331; Silke, John/0000-0002-7611-5774; Wong, W. Wei-Lynn/0000-0003-3155-1211; Gerlach, Bjorn/0000-0002-4900-6302; Gangoda, Lahiru/0000-0003-1931-6809; Haas, Tobias/0000-0003-2336-0263; Nachbur, Ueli/0000-0001-5968-2235; Anderton, Holly/0000-0003-3913-9686	Cancer Research UK; AICR; BBSRC (ERASysBio PLUS); Ovarian Cancer Action; EU; NHMRC [541901, 541902, 602516]; HGF/SBCancer; Schweizer Nationalfonds (SNF); BBSRC [BB/I004580/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I004580/1] Funding Source: researchfish; Cancer Research UK [10950] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); AICR; BBSRC (ERASysBio PLUS)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ovarian Cancer Action(Ovarian Cancer Action); EU(European Commission); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); HGF/SBCancer; Schweizer Nationalfonds (SNF); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	We thank M. Miasari for developing the cIAP2 antibody, M. Leverkus for advice on skin histology, J. Lokan for advice on liver histology, C. Rappl, N. Barboza, S. Kupka, D. Heinze, J. Zipprich, J. Corbin, S. Wiegelmann and A. Bankovacki for excellent technical assistance, M. Bolognesi and P. Seneci for SM-164, H. Koerner for Tnf<SUP>-/-</SUP> mice, and all past and present members of the Walczak and Silke laboratories for continuous stimulating scientific discussions and support. Research in the Walczak lab is supported by grants from Cancer Research UK, AICR, BBSRC (ERASysBio PLUS), Ovarian Cancer Action and the EU Marie Curie Research Training Network ApopTRAIN. Work in the Silke lab is supported by NHMRC grants 541901, 541902 and 602516. Work in the Purcell lab is supported by the NHMRC (Senior Research Fellowships for A.W.P. and a C.J. Martin Overseas Biomedical Fellowship to A.I.W.), and by grants from the NHMRC and ARC. U.W. is funded by HGF/SBCancer. E.R. and T.L.H. are ApopTRAIN fellows and U.N. is supported by the Schweizer Nationalfonds (SNF).	Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Arimoto K, 2010, P NATL ACAD SCI USA, V107, P15856, DOI 10.1073/pnas.1004621107; Bianchi K, 2009, MOL CELL, V36, P736, DOI 10.1016/j.molcel.2009.11.029; Cossu F, 2009, J MOL BIOL, V392, P630, DOI 10.1016/j.jmb.2009.04.033; Diessenbacher P, 2008, J INVEST DERMATOL, V128, P1134, DOI 10.1038/sj.jid.5701141; Dynek JN, 2010, EMBO J, V29, P4198, DOI 10.1038/emboj.2010.300; GIJBELS MJJ, 1995, J INVEST DERMATOL, V105, P769, DOI 10.1111/1523-1747.ep12325599; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; HOGENESCH H, 1993, AM J PATHOL, V143, P972; HogenEsch H, 1999, J IMMUNOL, V162, P3890; HogenEsch H, 2001, EUR J IMMUNOL, V31, P734, DOI 10.1002/1521-4141(200103)31:3<734::AID-IMMU734>3.0.CO;2-9; Huang HN, 2010, IMMUNITY, V33, P60, DOI 10.1016/j.immuni.2010.07.002; Ikeda F, 2010, CELL, V143, P677, DOI 10.1016/j.cell.2010.10.026; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; Laplantine E, 2009, EMBO J, V28, P2885, DOI 10.1038/emboj.2009.241; Liang YH, 2011, J INVEST DERMATOL, V131, P141, DOI 10.1038/jid.2010.259; Liu SQ, 2011, CELL RES, V21, P6, DOI 10.1038/cr.2010.170; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martin MU, 2002, BBA-MOL CELL RES, V1592, P265, DOI 10.1016/S0167-4889(02)00320-8; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Sacre Sandra M., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009488; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Silke J, 2005, P NATL ACAD SCI USA, V102, P16182, DOI 10.1073/pnas.0502828102; Silke J, 2010, CELL DEATH DIFFER, V17, P35, DOI 10.1038/cdd.2009.114; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Taylor PC, 2009, NAT REV RHEUMATOL, V5, P578, DOI 10.1038/nrrheum.2009.181; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Ware CF, 2003, CYTOKINE GROWTH F R, V14, P181, DOI 10.1016/S1359-6101(03)00032-7; Wertz IE, 2008, CYTOKINE GROWTH F R, V19, P313, DOI 10.1016/j.cytogfr.2008.04.014; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002	37	656	672	0	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2011	471	7340					591	+		10.1038/nature09816	http://dx.doi.org/10.1038/nature09816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21455173				2022-12-28	WOS:000288951200033
J	Wakim, LM; Bevan, MJ				Wakim, Linda M.; Bevan, Michael J.			Cross-dressed dendritic cells drive memory CD8(+) T-cell activation after viral infection	NATURE			English	Article							IMMUNE-RESPONSES; LIVE CELLS; IN-VIVO; COMPLEXES; ANTIGENS	After an infection, cytotoxic T lymphocyte precursors proliferate and become effector cells by recognizing foreign peptides in the groove of major histocompatibility complex (MHC) class I molecules expressed by antigen-presenting cells (APCs)(1). Professional APCs specialized for T-cell activation acquire viral antigen either by becoming infected themselves (direct presentation) or by phagocytosis of infected cells, followed by transfer of antigen to the cytosol, processing and MHC class I loading in a process referred to as cross-presentation(2). An alternative way, referred to as 'cross-dressing', by which an uninfected APC could present antigen was postulated to be by the transfer of preformed peptide-MHC complexes from the surface of an infected cell to the APC without the need of further processing(3). Here we show that this mechanism exists and boosts the antiviral response of mouse memory CD8(+) T cells. A number of publications have demonstrated sharing of peptide-loaded MHC molecules in vitro(4-7). Our in vitro experiments demonstrate that cross-dressing APCs do not acquire peptide-MHC complexes in the form of exosomes released by donor cells. Rather, the APCs and donor cells have to contact each other for the transfer to occur. After a viral infection, we could isolate cross-dressed APCs able to present viral antigen in vitro. Furthermore, using the diphtheria toxin system to selectively eliminate APCs that could only acquire viral peptide-MHC complexes by cross-dressing, we show that such presentation can promote the expansion of resting memory T cells. Notably, naive T cells were excluded from taking part in the response. Cross-dressing is a mechanism of antigen presentation used by dendritic cells that may have a significant role in activating previously primed CD8(+) T cells.	[Wakim, Linda M.; Bevan, Michael J.] Univ Washington, Howard Hughes Med Inst, Dept Immunol, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Bevan, MJ (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Immunol, Box 357370, Seattle, WA 98195 USA.	mbevan@u.washington.edu		Wakim, Linda/0000-0003-1752-9579	Howard Hughes Medical Institute; National Institutes of Health; National Health and Medical Research Council of Australia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019335] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Howard Hughes Medical Institute and National Institutes of Health. L.M.W is supported by an Overseas Biomedical Fellowship from the National Health and Medical Research Council of Australia.	Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; Dolan BP, 2006, J IMMUNOL, V176, P1447, DOI 10.4049/jimmunol.176.3.1447; Dolan BP, 2006, J IMMUNOL, V177, P6018, DOI 10.4049/jimmunol.177.9.6018; Harshyne LA, 2001, J IMMUNOL, V166, P3717, DOI 10.4049/jimmunol.166.6.3717; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Lin ML, 2008, IMMUNOL CELL BIOL, V86, P353, DOI 10.1038/icb.2008.3; Matheoud D, 2010, BLOOD, V115, P4412, DOI 10.1182/blood-2009-11-255935; Qu CF, 2009, J IMMUNOL, V182, P3650, DOI 10.4049/jimmunol.0801532; Smyth LA, 2008, J IMMUNOL, V181, P3212, DOI 10.4049/jimmunol.181.5.3212; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Turner MJ, 2008, J EXP MED, V205, P1859, DOI 10.1084/jem.20072390; Vyas JM, 2008, NAT REV IMMUNOL, V8, P607, DOI 10.1038/nri2368; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Yewdell JW, 2005, ANNU REV IMMUNOL, V23, P651, DOI 10.1146/annurev.immunol.23.021704.115702	18	198	200	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 31	2011	471	7340					629	632		10.1038/nature09863	http://dx.doi.org/10.1038/nature09863			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21455179	Green Accepted			2022-12-28	WOS:000288951200041
J	Simpson, JK; Timmis, AL; Siddiqi, S				Simpson, Jacqueline K.; Timmis, Anna L.; Siddiqi, Shahab			PICTURE QUIZ Chronic diarrhoea in an elderly woman	BRITISH MEDICAL JOURNAL			English	Editorial Material							COLOVESICAL FISTULA; DIVERTICULAR-DISEASE; DIAGNOSIS; MANAGEMENT		[Simpson, Jacqueline K.; Timmis, Anna L.; Siddiqi, Shahab] Chase Farm Hosp, London EN2 8JL, England	University of London; University College London; Royal Free London NHS Foundation Trust	Simpson, JK (corresponding author), Chase Farm Hosp, London EN2 8JL, England.	jacquelinesimpson@doctors.org.uk	Siddiqi, Shahab/AAK-7531-2020					ALSCHER DM, 2006, INTERNIST BERL, V47, P115; ALSCHER DM, 2006, INTERNIST BERL, V47, P112; Chin BS, 2011, ARCH GERONTOL GERIAT, V52, pE50, DOI 10.1016/j.archger.2010.05.011; EISEMAN B, 1952, ANN SURG, V136, P762; Freeman HJ, 2008, WORLD J GASTROENTERO, V14, P6442, DOI 10.3748/wjg.14.6442; Garcea G, 2006, COLORECTAL DIS, V8, P347, DOI 10.1111/j.1463-1318.2005.00928.x; Gledhill A, 1998, GUT, V42, P392, DOI 10.1136/gut.42.3.392; Halligan S, 2006, RADIOLOGY, V239, P18, DOI 10.1148/radiol.2391041043; JARRETT TW, 1995, J UROLOGY, V153, P44, DOI 10.1097/00005392-199501000-00018; Joseph RC, 1996, RADIOGRAPHICS, V16, P295, DOI 10.1148/radiographics.16.2.8966288; Khanna A, 2001, Respir Care, V46, P354; LOCKHARTMUMMERY HE, 1958, P ROY SOC MED, V51, P1032; Melchior S, 2009, J UROLOGY, V182, P978, DOI 10.1016/j.juro.2009.05.022; Najjar SF, 2004, AM J SURG, V188, P617, DOI 10.1016/j.amjsurg.2004.08.016; POLLARD SG, 1987, ANN ROY COLL SURG, V69, P163; Rastergar A, 2001, POSTGRAD MED J, V77, P759, DOI 10.1136/pmj.77.914.759; Ravichandran S, 2008, UROLOGY, V72, P832, DOI 10.1016/j.urology.2008.06.036; Rieber A, 2000, EUR RADIOL, V10, P1377, DOI 10.1007/s003300000354; Schuster M R, 1992, J Vasc Interv Radiol, V3, P359, DOI 10.1016/S1051-0443(92)72044-2; Scozzari G, 2010, TECH COLOPROCTOL, V14, P293, DOI 10.1007/s10151-010-0602-3; Shah G S, 2007, Kathmandu Univ Med J (KUMJ), V5, P60; Shinjo T, 2009, J PALLIAT MED, V12, P965, DOI 10.1089/jpm.2009.0086; Stocchi L, 2010, WORLD J GASTROENTERO, V16, P804, DOI 10.3748/wjg.v16.i7.804	23	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 30	2011	342								c7339	10.1136/bmj.c7339	http://dx.doi.org/10.1136/bmj.c7339			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745WF	21450798				2022-12-28	WOS:000289201200001
J	Beatty, GL; Chiorean, EG; Fishman, MP; Saboury, B; Teitelbaum, UR; Sun, WJ; Huhn, RD; Song, WR; Li, DG; Sharp, LL; Torigian, DA; O'Dwyer, PJ; Vonderheide, RH				Beatty, Gregory L.; Chiorean, Elena G.; Fishman, Matthew P.; Saboury, Babak; Teitelbaum, Ursina R.; Sun, Weijing; Huhn, Richard D.; Song, Wenru; Li, Dongguang; Sharp, Leslie L.; Torigian, Drew A.; O'Dwyer, Peter J.; Vonderheide, Robert H.			CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans	SCIENCE			English	Article							T-CELL HELP; CANCER; CHEMOTHERAPY; IMMUNOTHERAPY; ACTIVATION; TOLERANCE; ANTIBODY; THERAPY; VACCINE; TRIAL	Immunosuppressive tumor microenvironments can restrain antitumor immunity, particularly in pancreatic ductal adenocarcinoma (PDA). Because CD40 activation can reverse immune suppression and drive antitumor T cell responses, we tested the combination of an agonist CD40 antibody with gemcitabine chemotherapy in a small cohort of patients with surgically incurable PDA and observed tumor regressions in some patients. We reproduced this treatment effect in a genetically engineered mouse model of PDA and found unexpectedly that tumor regression required macrophages but not T cells or gemcitabine. CD40-activated macrophages rapidly infiltrated tumors, became tumoricidal, and facilitated the depletion of tumor stroma. Thus, cancer immune surveillance does not necessarily depend on therapy-induced T cells; rather, our findings demonstrate a CD40-dependent mechanism for targeting tumor stroma in the treatment of cancer.	[Beatty, Gregory L.; Fishman, Matthew P.; Vonderheide, Robert H.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Beatty, Gregory L.; Teitelbaum, Ursina R.; Sun, Weijing; Torigian, Drew A.; O'Dwyer, Peter J.; Vonderheide, Robert H.] Univ Penn, Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Chiorean, Elena G.] Indiana Univ Sch Med, Dept Med, Div Hematol Oncol, Indianapolis, IN 46202 USA; [Huhn, Richard D.; Song, Wenru; Li, Dongguang; Sharp, Leslie L.] Pfizer Corp, New London, CT 06320 USA; [Saboury, Babak; Torigian, Drew A.] Univ Penn, Dept Med, Dept Radiol, Sch Med, Philadelphia, PA 19104 USA; [Beatty, Gregory L.; Teitelbaum, Ursina R.; Sun, Weijing; O'Dwyer, Peter J.; Vonderheide, Robert H.] Univ Penn, Dept Med, Div Hematol Oncol, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Indiana University System; Indiana University Bloomington; Pfizer; University of Pennsylvania; University of Pennsylvania	Vonderheide, RH (corresponding author), Univ Penn, Sch Med, Abramson Family Canc Res Inst, 421 Curie Blvd, Philadelphia, PA 19104 USA.	rhv@exchange.upenn.edu	Saboury, Babak/F-1769-2018; Saboury, Babak/F-7453-2011	Saboury, Babak/0000-0002-8632-6292; Beatty, Gregory/0000-0001-7165-5993	Abramson Family Cancer Research Institute of the University of Pennsylvania School of Medicine; NIH [P30 CA016520, K12 CA076931]; Pfizer Corp; NATIONAL CANCER INSTITUTE [K12CA076931, P30CA016520, K08CA138907] Funding Source: NIH RePORTER	Abramson Family Cancer Research Institute of the University of Pennsylvania School of Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer Corp; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank C. Abrams, E. Furth, C. June, B. Keith, G. Koretzky, C. Simon, and B. Stanger for helpful discussions. This research was supported by the Abramson Family Cancer Research Institute of the University of Pennsylvania School of Medicine (R. H. V.) and by NIH grants P30 CA016520 (P.J.O. and R. H. V.) and K12 CA076931 (G. L. B.). The clinical study and part of the preclinical studies were supported by funding from Pfizer Corp (to R. H. V. and P.J.D). W. Song, D. Li, and L. L. Sharp are employees of Pfizer Corp. P. J. O'Dwyer discloses receiving honoraria from Pfizer; D. A. Torigian owns stock in Pfizer. CP-870,893 is owned and patented by Pfizer Corp., which manages its distribution. Although now at a new address, R. D. Huhn was affiliated with Pfizer Corp. during the conduct and analysis of this study. Some of the clinical data were presented at the 2010 American Society of Clinical Oncology Annual Meeting.	Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Diehl L, 1999, NAT MED, V5, P774, DOI 10.1038/10495; Gabrilovich DI, 2007, LANCET ONCOL, V8, P2, DOI 10.1016/S1470-2045(06)70985-8; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Jaffee EM, 2001, J CLIN ONCOL, V19, P145, DOI 10.1200/JCO.2001.19.1.145; Lake RA, 2005, NAT REV CANCER, V5, P397, DOI 10.1038/nrc1613; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Nowak AK, 2003, CANCER RES, V63, P4490; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Sotomayor EM, 1999, NAT MED, V5, P780, DOI 10.1038/10503; Van Dyke T, 2010, NAT MED, V16, P976, DOI 10.1038/nm0910-976; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Vonderheide RH, 2007, J CLIN ONCOL, V25, P876, DOI 10.1200/JCO.2006.08.3311; Vonderheide RH, 2007, CLIN CANCER RES, V13, P1083, DOI 10.1158/1078-0432.CCR-06-1893; Zitvogel L, 2008, J CLIN INVEST, V118, P1991, DOI 10.1172/JCI35180	22	1119	1164	10	199	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 25	2011	331	6024					1612	1616		10.1126/science.1198443	http://dx.doi.org/10.1126/science.1198443			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21436454	Green Accepted			2022-12-28	WOS:000288754500058
J	Simionescu, A; Allen, SW; Mantz, A; Werner, N; Takei, Y; Morris, RG; Fabian, AC; Sanders, JS; Nulsen, PEJ; George, MR; Taylor, GB				Simionescu, Aurora; Allen, Steven W.; Mantz, Adam; Werner, Norbert; Takei, Yoh; Morris, R. Glenn; Fabian, Andrew C.; Sanders, Jeremy S.; Nulsen, Paul E. J.; George, Matthew R.; Taylor, Gregory B.			Baryons at the Edge of the X-ray-Brightest Galaxy Cluster	SCIENCE			English	Article							VIRIAL RADIUS; INTRACLUSTER MEDIUM; MASS FRACTION; DARK ENERGY; SUZAKU; CONSTRAINTS; TEMPERATURE; GAS; ENTROPY; PROFILE	Studies of the diffuse x-ray-emitting gas in galaxy clusters have provided powerful constraints on cosmological parameters and insights into plasma astrophysics. However, measurements of the faint cluster outskirts have become possible only recently. Using data from the Suzaku x-ray telescope, we determined an accurate, spatially resolved census of the gas, metals, and dark matter out to the edge of the Perseus Cluster. Contrary to previous results, our measurements of the cluster baryon fraction are consistent with the expected universal value at half of the virial radius. The apparent baryon fraction exceeds the cosmic mean at larger radii, suggesting a clumpy distribution of the gas, which is important for understanding the ongoing growth of clusters from the surrounding cosmic web.	[Simionescu, Aurora; Allen, Steven W.; Werner, Norbert; Morris, R. Glenn] Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, Stanford, CA 94305 USA; [Mantz, Adam] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Takei, Yoh] Japan Aerosp Explorat Agcy JAXA, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan; [Fabian, Andrew C.; Sanders, Jeremy S.] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Nulsen, Paul E. J.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [George, Matthew R.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Taylor, Gregory B.] Univ New Mexico, Dept Phys & Astron, Albuquerque, NM 87131 USA; [Taylor, Gregory B.] Natl Radio Astron Observ, Socorro, NM 87801 USA	Stanford University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); University of Cambridge; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of California System; University of California Berkeley; University of New Mexico; National Radio Astronomy Observatory (NRAO)	Simionescu, A (corresponding author), Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, 452 Lomita Mall, Stanford, CA 94305 USA.	asimi@stanford.edu	Werner, Norbert/AAW-2434-2021; Werner, Norbert/G-2832-2019	Werner, Norbert/0000-0003-0392-0120; Werner, Norbert/0000-0003-0392-0120; Nulsen, Paul/0000-0003-0297-4493; Taylor, Greg/0000-0001-6495-7731; Allen, Steven/0000-0003-0667-5941; Sanders, Jeremy/0000-0003-2189-4501; Morris, Glenn/0000-0003-2985-9962; Mantz, Adam/0000-0002-8031-1217; Takei, Yoh/0000-0003-2517-3904; Simionescu, Aurora/0000-0002-9714-3862; Neligeorge, Matt/0000-0002-7028-4569	NASA [PF9-00070, PF8-90056, NAS8-03060, NNX09AV64G, NNX10AR48G, NNX08AZ88G]; JAXA; U.S. Department of Energy [DE-AC02-76SF00515]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [22111513]; Chandra award [GO0-11138B]; Science and Technology Facilities Council [ST/H00243X/1, ST/G002339/1] Funding Source: researchfish	NASA(National Aeronautics & Space Administration (NASA)); JAXA; U.S. Department of Energy(United States Department of Energy (DOE)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Chandra award; Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank P. Thomas and O. Young for kindly providing the simulation results shown in Fig. 4. Support for this work was provided by NASA through Einstein Postdoctoral Fellowship grants number PF9-00070 and PF8-90056 awarded by the Chandra X-ray Center, which is operated by the Smithsonian Astrophysical Observatory for NASA under contract NAS8-03060. We acknowledge NASA grants NNX09AV64G and NNX10AR48G, issued through the Suzaku Guest Observer program, and grant NNX08AZ88G. The authors thank the Suzaku operation team and Guest Observer Facility, supported by JAXA and NASA. This work was supported in part by the U.S. Department of Energy under contract number DE-AC02-76SF00515. We also acknowledge the Grant-in-Aid for Scientific Research of the Ministry of Education, Culture, Sports, Science, and Technology of Japan (KAKENHI no. 22111513) and Chandra award GO0-11138B.	Afshordi N, 2007, MON NOT R ASTRON SOC, V378, P293, DOI 10.1111/j.1365-2966.2007.11776.x; Allen SW, 2008, MON NOT R ASTRON SOC, V383, P879, DOI 10.1111/j.1365-2966.2007.12610.x; Allen SW, 2004, MON NOT R ASTRON SOC, V353, P457, DOI 10.1111/j.1365-2966.2004.08080.x; Andreon S, 2010, MON NOT R ASTRON SOC, V407, P263, DOI 10.1111/j.1365-2966.2010.16856.x; Bautz MW, 2009, PUBL ASTRON SOC JPN, V61, P1117, DOI 10.1093/pasj/61.5.1117; Ettori S, 2003, MON NOT R ASTRON SOC, V344, pL13, DOI 10.1046/j.1365-8711.2003.06810.x; Ettori S, 1998, MON NOT R ASTRON SOC, V300, P837, DOI 10.1046/j.1365-8711.1998.01952.x; FELDMAN U, 1992, PHYS SCRIPTA, V46, P202, DOI 10.1088/0031-8949/46/3/002; Fujita Y, 2008, PUBL ASTRON SOC JPN, V60, pS343, DOI 10.1093/pasj/60.sp1.S343; George MR, 2009, MON NOT R ASTRON SOC, V395, P657, DOI 10.1111/j.1365-2966.2009.14547.x; Gonzalez AH, 2007, ASTROPHYS J, V666, P147, DOI 10.1086/519729; Hoshino A, 2010, PUBL ASTRON SOC JPN, V62, P371, DOI 10.1093/pasj/62.2.371; Kawaharada M, 2010, ASTROPHYS J, V714, P423, DOI 10.1088/0004-637X/714/1/423; Komatsu E, 2011, ASTROPHYS J SUPPL S, V192, DOI 10.1088/0067-0049/192/2/18; LaRoque SJ, 2006, ASTROPHYS J, V652, P917, DOI 10.1086/508139; Lin YT, 2004, ASTROPHYS J, V617, P879, DOI 10.1086/425412; Mantz A, 2010, MON NOT R ASTRON SOC, V406, P1759, DOI 10.1111/j.1365-2966.2010.16992.x; Markevitch M, 2007, PHYS REP, V443, P1, DOI 10.1016/j.physrep.2007.01.001; McCarthy IG, 2007, MON NOT R ASTRON SOC, V377, P1457, DOI 10.1111/j.1365-2966.2007.11733.x; Navarro JF, 1997, ASTROPHYS J, V490, P493, DOI 10.1086/304888; Reiprich TH, 2009, ASTRON ASTROPHYS, V501, P899, DOI 10.1051/0004-6361/200810404; Roncarelli M, 2006, MON NOT R ASTRON SOC, V373, P1339, DOI 10.1111/j.1365-2966.2006.11143.x; Sanders JS, 2007, MON NOT R ASTRON SOC, V381, P1381, DOI 10.1111/j.1365-2966.2007.12347.x; Sato K, 2010, PUBL ASTRON SOC JPN, V62, P1423, DOI 10.1093/pasj/62.6.1423; Tozzi P, 2001, ASTROPHYS J, V546, P63, DOI 10.1086/318237; Vikhlinin A, 2009, ASTROPHYS J, V692, P1060, DOI 10.1088/0004-637X/692/2/1060; Voit GM, 2005, MON NOT R ASTRON SOC, V364, P909, DOI 10.1111/j.1365-2966.2005.09621.x; WHITE SDM, 1993, NATURE, V366, P429, DOI 10.1038/366429a0	28	220	220	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2011	331	6024					1576	1579		10.1126/science.1200331	http://dx.doi.org/10.1126/science.1200331			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21436446	Green Submitted			2022-12-28	WOS:000288754500047
J	Willyard, C				Willyard, Cassandra			LIFESTYLE Breaking the cancer habit	NATURE			English	Editorial Material							PHYSICAL-ACTIVITY; INTERVENTION; PREVENTION; MORTALITY; SURGERY; TRIAL											Adams TD, 2009, OBESITY, V17, P796, DOI 10.1038/oby.2008.610; Ashrafian H, 2010, CANCER          1129; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Epstein LH, 2010, PSYCHOL SCI, V21, P406, DOI 10.1177/0956797610361446; Friedenreich CM, 2010, EUR J CANCER, V46, P2593, DOI 10.1016/j.ejca.2010.07.028; Friedenreich CM, 2010, J CLIN ONCOL, V28, P1458, DOI 10.1200/JCO.2009.24.9557; Katz DL, 2010, AM J CLIN NUTR, V91, p1102S, DOI 10.3945/ajcn.2010.28450E; Pollak M, 2010, CANCER PREV RES, V3, P1060, DOI 10.1158/1940-6207.CAPR-10-0175; Sjostrom L, 2009, LANCET ONCOL, V10, P653, DOI 10.1016/S1470-2045(09)70159-7	9	4	4	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					S16	S17		10.1038/471S16a	http://dx.doi.org/10.1038/471S16a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430713	Bronze			2022-12-28	WOS:000288702200014
J	Andrews, PJD; Avenell, A; Noble, DW; Campbell, MK; Croal, BL; Simpson, WG; Vale, LD; Battison, CG; Jenkinson, DJ; Cook, JA				Andrews, Peter J. D.; Avenell, Alison; Noble, David W.; Campbell, Marion K.; Croal, Bernard L.; Simpson, William G.; Vale, Luke D.; Battison, Claire G.; Jenkinson, David J.; Cook, Jonathan A.		SIGNET Scottish Intensive Care	Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ENTERAL NUTRITION; FACTORIAL TRIALS; QUALITY	Objective To determine whether inclusion of glutamine, selenium, or both in a standard isonitrogenous, isocaloric preparation of parenteral nutrition influenced new infections and mortality among critically ill patients. Design Randomised, double blinded, factorial, controlled trial. Setting Level 2 and 3 (or combined) critical care units in Scotland. All 22 units were invited, and 10 participated. Participants 502 adults in intensive care units and high dependency units for >= 48 hours, with gastrointestinal failure and requiring parenteral nutrition. Interventions Parenteral glutamine (20.2 g/day) or selenium (500 mu g/day), or both, for up to seven days. Main outcome measures Primary outcomes were participants with new infections in the first 14 days and mortality. An intention to treat analysis and a prespecified analysis of patients who received >= 5 days of the trial intervention are presented. Secondary outcomes included critical care unit and acute hospital lengths of stay, days of antibiotic use, and modified SOFA (Sepsis-related Organ Failure Assessment) score. Results Selenium supplementation did not significantly affect patients developing a new infection (126/251 v 139/251, odds ratio 0.81 (95% CI 0.57 to 1.15)), except for those who had received >= 5 days of supplementation (odds ratio 0.53 (0.30 to 0.93)). There was no overall effect of glutamine on new infections (134/250 v 131/252, odds ratio 1.07 (0.75 to 1.53)), even if patients received >= 5 days of supplementation (odds ratio 0.99 (0.56 to 1.75)). Six month mortality was not significantly different for selenium (107/251 v 114/251, odds ratio 0.89 (0.62 to 1.29)) or glutamine (115/250 v 106/252, 1.18 (0.82 to 1.70)). Length of stay, days of antibiotic use, and modified SOFA score were not significantly affected by selenium or glutamine supplementation. Conclusions The primary (intention to treat) analysis showed no effect on new infections or on mortality when parenteral nutrition was supplemented with glutamine or selenium. Patients who received parenteral nutrition supplemented with selenium for >= 5 days did show a reduction in new infections. This finding requires confirmation.	[Andrews, Peter J. D.; Battison, Claire G.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh EH4 2XU, Midlothian, Scotland; [Andrews, Peter J. D.] Lothian Univ, Western Gen Hosp, Hosp Div, Edinburgh EH4 2XU3, Midlothian, Scotland; [Avenell, Alison; Campbell, Marion K.; Vale, Luke D.; Jenkinson, David J.; Cook, Jonathan A.] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland; [Noble, David W.] Aberdeen Royal Infirm, Dept Anaesthet & Intens Care, Aberdeen AB25 2ZN, Scotland; [Croal, Bernard L.; Simpson, William G.] Aberdeen Royal Infirm, Dept Clin Biochem, Aberdeen AB25 2ZN, Scotland; [Vale, Luke D.] Univ Aberdeen, Hlth Econ Res Unit, Aberdeen AB25 2ZD, Scotland	University of Edinburgh; University of Edinburgh; University of Aberdeen; University of Aberdeen; University of Aberdeen; University of Aberdeen	Andrews, PJD (corresponding author), Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh EH4 2XU, Midlothian, Scotland.	p.andrews@ed.ac.uk	Cook, Jonathan/A-3474-2012; Cook, Jonathan/D-3648-2015; Campbell, Marion/ABB-7063-2020	Cook, Jonathan/0000-0002-4156-6989; Murray, Gordon/0000-0001-9866-4734; Vale, Luke/0000-0001-8574-8429; Campbell, Marion/0000-0001-5386-4097; Battison, Claire/0000-0001-9549-4522	Chief Scientist Office of the Scottish Government Health Directorates; Medical Research Council; Fresenius-Kabi and Oxford Nutrition; MRC [G0601938, G0401633] Funding Source: UKRI; Medical Research Council [G0401633, G0601938] Funding Source: researchfish; Chief Scientist Office [HSRU1] Funding Source: researchfish	Chief Scientist Office of the Scottish Government Health Directorates; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fresenius-Kabi and Oxford Nutrition; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	A pilot trial was funded by the Chief Scientist Office of the Scottish Government Health Directorates, followed by funding from the Medical Research Council for the full trial. Funding was also provided by Fresenius-Kabi and Oxford Nutrition as unrestricted grants for the trial nutrition components. Health Services Research Unit is funded by the Chief Scientist Office of the Scottish Government Health Directorates. JC holds a MRC fellowship. AA was funded by a career scientist award of the Chief Scientist Office of the Scottish Government Health Directorates. The trial was managed in accordance with MRC guidelines and independent of industry. The trial was conducted under the auspices of independent trial steering and data monitoring committees. The views expressed are those of the authors alone.	Allan R, 2007, CLIN MED, V7, P429, DOI 10.7861/clinmedicine.7-5-429; Altman DG, 2000, STAT MED, V19, P3275, DOI 10.1002/1097-0258(20001215)19:23<3275::AID-SIM626>3.0.CO;2-M; Andrews PJD, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-25; ASPEN Board of Directors and the Clinical Guidelines Task Force, 2002, JPEN S1, V26, P1; Avenell A, 2004, COCHRANE DB SYST REV, V4; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Doig GS, 2005, ANESTH ANALG, V100, P527, DOI 10.1213/01.ANE.0000141676.12552.D0; Doig GS, 2010, INTENS CARE MED, V36, P1087; Forceville X, 1998, CRIT CARE MED, V26, P1536, DOI 10.1097/00003246-199809000-00021; Hennekens CH, 2009, JAMA-J AM MED ASSOC, V302, P2361, DOI 10.1001/jama.2009.1756; Heyland DK, 2007, CRIT CARE, V11, DOI 10.1186/cc5975; Heyland DK, 2007, JPEN-PARENTER ENTER, V31, P109, DOI 10.1177/0148607107031002109; Heyland DK, 2005, INTENS CARE MED, V31, P327, DOI 10.1007/s00134-004-2522-z; Kochevar M, 2007, JPEN-PARENTER ENTER, V31, P441, DOI 10.1177/0148607107031005441; Kreymann KG, 2006, CLIN NUTR, V25, P210, DOI 10.1016/j.clnu.2006.01.021; LUBSEN J, 1994, EUR HEART J, V15, P585, DOI 10.1093/oxfordjournals.eurheartj.a060552; McAlister FA, 2003, JAMA-J AM MED ASSOC, V289, P2545, DOI 10.1001/jama.289.19.2545; Mead GE, 1998, INT J CLIN PRACT, V52, P316; Sheiner LB, 2002, BRIT J CLIN PHARMACO, V54, P203, DOI 10.1046/j.1365-2125.2002.01628.x; Simpson F, 2005, INTENS CARE MED, V31, P12, DOI 10.1007/s00134-004-2511-2; Singer P, 2009, CLIN NUTR, V28, P387, DOI 10.1016/j.clnu.2009.04.024; Treasure T, 1998, BRIT MED J, V317, P362; Ziegler TR, 2009, NEW ENGL J MED, V361, P1088, DOI 10.1056/NEJMct0806956	23	213	225	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2011	342								d1542	10.1136/bmj.d1542	http://dx.doi.org/10.1136/bmj.d1542			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739FQ	21415104	hybrid, Green Submitted			2022-12-28	WOS:000288700200002
J	Harrop, T; Aird, J; Thwaites, G				Harrop, Tara; Aird, James; Thwaites, Guy			Practice Pointer How to minimise risk of acquiring tuberculosis when working in a high prevalence setting: a guide for healthcare workers	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RESISTANT TUBERCULOSIS; N95 RESPIRATORS; TRANSMISSION; TB		[Harrop, Tara] Sandground Cottage, Bristol BS39 4BZ, Avon, England		Harrop, T (corresponding author), Sandground Cottage, Bristol BS39 4BZ, Avon, England.	taraharrop@hotmail.com	Thwaites, Guy E/R-4993-2019	Thwaites, Guy E/0000-0002-2858-2087				Al-Orainey IO, 2009, ANN THORAC MED, V4, P5, DOI 10.4103/1817-1737.44778; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; [Anonymous], 2009, GLOB TUB CONTR; [Anonymous], 2007, GUIDELINE ISOLATION; Atkinson J, 2009, NATURAL VENTILATION FOR INFECTION CONTROL IN HEALTH-CARE SETTINGS, P1; Balazy A, 2006, AM J INFECT CONTROL, V34, P51, DOI 10.1016/j.ajic.2005.08.018; Basu S, 2008, EPIDEMIOL INFECT, V136, P1585, DOI 10.1017/S0950268808000964; Bonifacio N, 2002, EMERG INFECT DIS, P8; Centers for Disease Control and Prevention, 2010, BCG VACC FACTSH; Escombe A Roderick, 2007, PLoS Med, V4, pe68, DOI 10.1371/journal.pmed.0040068; Escombe AR, 2008, PLOS MED, V5, P1387, DOI 10.1371/journal.pmed.0050188; European Centre for Disease Prevention and Control, 2008, ECDC SUMM GUID XDR T; Fraser A, 2006, INT J TUBERC LUNG D, V10, P19; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Grant A, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1110; Havlir DV, 2008, JAMA-J AM MED ASSOC, V300, P423, DOI 10.1001/jama.300.4.423; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; MENZIES D, 1995, NEW ENGL J MED, V332, P92, DOI 10.1056/NEJM199501123320206; National Institute of Health and Clinical Excellence, 2006, CG33 NAT I HLTH CLIN; Qian YG, 1998, AM IND HYG ASSOC J, V59, P128, DOI 10.1080/15428119891010389; Shenoi S, 2009, ANNU REV MED, V60, P307, DOI 10.1146/annurev.med.60.053107.103955; Smieja M J, 2000, Cochrane Database Syst Rev, pCD001363; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; WOLDEHANNA S, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000171.PUB2; Yassi A, 2004, PROTECTING FACES HLT	25	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2011	342								d1544	10.1136/bmj.d1544	http://dx.doi.org/10.1136/bmj.d1544			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739FK	21411488				2022-12-28	WOS:000288699200003
J	Body, R				Body, Richard			Acute MI: triple-markers resurrected or Bayesian dice?	LANCET			English	Editorial Material							CHEST-PAIN PATIENTS; EARLY-DIAGNOSIS; MYOCARDIAL-INFARCTION; RAPID DIAGNOSIS; TROPONIN-I		Univ Manchester, Cardiovasc Sci Res Grp, Manchester M13 9WL, Lancs, England	University of Manchester	Body, R (corresponding author), Univ Manchester, Cardiovasc Sci Res Grp, Manchester M13 9WL, Lancs, England.	richard.body@manchester.ac.uk	Body, Richard/C-2736-2010	Body, Richard/0000-0001-9089-8130	National Institute for Health Research [CL-2009-06-001] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Allender S., 2008, CORONARY HEART DIS S; Body R, 2010, RESUSCITATION, V81, P281, DOI 10.1016/j.resuscitation.2009.11.014; Body R, 2009, EMERG MED J, V26, P519, DOI 10.1136/emj.2009.076182; Brown AM, 2007, ANN EMERG MED, V49, P153, DOI 10.1016/j.annemergmed.2006.08.024; Fitzgerald P, ACAD EMERG IN PRESS; Goodacre S, 2005, HEART, V91, P229, DOI 10.1136/hrt.2003.027599; Goodacre SW, 2011, HEART, V97, P190, DOI 10.1136/hrt.2010.203166; Keller T, 2010, J AM COLL CARDIOL, V55, P2096, DOI 10.1016/j.jacc.2010.01.029; Keller T, 2009, NEW ENGL J MED, V361, P868, DOI 10.1056/NEJMoa0903515; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Silverman ME., 2008, THE QUOTABLE OSLER; Straface AL, 2008, AM J CLIN PATHOL, V129, P788, DOI 10.1309/9GGNMURLJWJD88W3; Than M, 2011, LANCET, V377, P1077, DOI 10.1016/S0140-6736(11)60310-3	13	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2011	377	9771					1049	1050		10.1016/S0140-6736(11)60392-9	http://dx.doi.org/10.1016/S0140-6736(11)60392-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	743QY	21435710				2022-12-28	WOS:000289035000004
J	Ficz, G; Branco, MR; Seisenberger, S; Santos, F; Krueger, F; Hore, TA; Marques, CJ; Andrews, S; Reik, W				Ficz, Gabriella; Branco, Miguel R.; Seisenberger, Stefanie; Santos, Fatima; Krueger, Felix; Hore, Timothy A.; Marques, C. Joana; Andrews, Simon; Reik, Wolf			Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation	NATURE			English	Article							DNA METHYLATION; SELF-RENEWAL; STEM-CELLS; GENOME; WIDE; PLURIPOTENT; CONVERSION; PROTEINS	Methylation at the 59 position of cytosine in DNA has important roles in genome function and is dynamically reprogrammed during early embryonic and germ cell development(1). The mammalian genome also contains 5-hydroxymethylcytosine (5hmC), which seems to be generated by oxidation of 5-methylcytosine (5mC) by the TET family of enzymes that are highly expressed in embryonic stem(ES) cells(2-4). Here we use antibodies against 5hmC and 5mC together with high throughput sequencing to determine genome-wide patterns of methylation and hydroxymethylation in mouse wild-type and mutant ES cells and differentiating embryoid bodies. We find that 5hmC is mostly associated with euchromatin and that whereas 5mC is under-represented at gene promoters and CpG islands, 5hmC is enriched and is associated with increased transcriptional levels. Most, if not all, 5hmC in the genome depends on pre-existing 5mC and the balance between these two modifications is different between genomic regions. Knockdown of Tet1 and Tet2 causes downregulation of a group of genes that includes pluripotency-related genes (including Esrrb, Prdm14, Dppa3, Klf2, Tcl1 and Zfp42) and a concomitant increase in methylation of their promoters, together with an increased propensity of ES cells for extraembryonic lineage differentiation. Declining levels of TETs during differentiation are associated with decreased hydroxymethylation levels at the promoters of ES cell-specific genes together with increased methylation and gene silencing. We propose that the balance between hydroxymethylation and methylation in the genome is inextricably linked with the balance between pluripotency and lineage commitment.	[Ficz, Gabriella; Branco, Miguel R.; Seisenberger, Stefanie; Santos, Fatima; Hore, Timothy A.; Marques, C. Joana; Reik, Wolf] Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB22 3AT, England; [Krueger, Felix; Andrews, Simon] Babraham Inst, Bioinformat Grp, Cambridge CB22 3AT, England; [Reik, Wolf] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 3EG, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge	Reik, W (corresponding author), Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB22 3AT, England.	wolf.reik@bbsrc.ac.uk	Marques, Joana/B-5564-2008; Krueger, Felix/J-3340-2019; Ficz, Gabriella/HCH-3771-2022; Reik, Wolf/I-6794-2012; Branco, Miguel/H-9509-2019	Marques, Joana/0000-0002-5658-3773; Branco, Miguel/0000-0001-9447-1548; Ficz, Gabriella/0000-0001-9313-9578; Reik, Wolf/0000-0003-0216-9881; Santos, Fatima/0000-0002-3854-4084; Hore, Timothy/0000-0002-6735-225X; Krueger, Felix/0000-0002-5513-3324	BBSRC; MRC; EU NoE The Epigenome; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000M236] Funding Source: researchfish; Medical Research Council [G0801156, G0801727] Funding Source: researchfish; BBSRC [BBS/E/B/0000M236] Funding Source: UKRI; MRC [G0801156, G0801727] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU NoE The Epigenome; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank A. Bird for discussions and input, K. Tabbada for help with epigenomics and transcriptomics sequencing, and M. Okano for providing the TKO ES cells. We would like to thank H. Stuart for her dedicated contribution to gene expression analyses, and all Reik lab members for advice and discussion. This work was funded by the BBSRC, MRC and the EU NoE The Epigenome.	Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Davis T, 2011, JOVE-J VIS EXP, DOI 10.3791/2661; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Glover CH, 2006, PLOS COMPUT BIOL, V2, P1463, DOI 10.1371/journal.pcbi.0020158; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Iacovino M, 2009, STEM CELLS DEV, V18, P783, DOI 10.1089/scd.2008.0227; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liutkeviciute Z, 2009, NAT CHEM BIOL, V5, P400, DOI 10.1038/nchembio.172; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma ZY, 2011, NAT STRUCT MOL BIOL, V18, P120, DOI 10.1038/nsmb.2000; Mallanna SK, 2010, STEM CELLS, V28, P1715, DOI 10.1002/stem.494; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Santos F, 2003, CURR BIOL, V13, P1116, DOI 10.1016/S0960-9822(03)00419-6; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Ting DT, 2004, METH MOLEC MED, V105, P23; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240	37	846	905	4	173	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	2011	473	7347					398	U589		10.1038/nature10008	http://dx.doi.org/10.1038/nature10008			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	765QA	21460836				2022-12-28	WOS:000290722400054
J	Wang, F; Lee, DH				Wang, Fa; Lee, Dung-Hai			The Electron-Pairing Mechanism of Iron-Based Superconductors	SCIENCE			English	Review							PHASE-DIAGRAM; GAPS; DENSITY	The past three years have witnessed the discovery of a series of novel high-temperature superconductors. Trailing behind the cuprates, these iron-based compounds are the second-highest-temperature superconducting material family known to date. Despite the marked differences in the chemical composition, these materials share many properties with the cuprates and offer the hope of finally unveiling the secret of high-temperature superconductivity. The main theme of this review is the electron-pairing mechanism responsible for their superconductivity. We discuss the progress in this young field and point out the open issues.	[Lee, Dung-Hai] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Wang, Fa] MIT, Dept Phys, Cambridge, MA 02139 USA; [Lee, Dung-Hai] Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Lee, DH (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.	dunghai@berkeley.edu	Wang, Fa/D-3817-2015	Wang, Fa/0000-0002-6220-5349	MIT; U.S. Department of Energy [DE-AC02-05CH11231]	MIT; U.S. Department of Energy(United States Department of Energy (DOE))	We thank H. Zhai, F. Yang, Y. Ran, and A. Vishwanath for collaborations. F. W. is supported by the Pappalardo Fellowship of MIT, and D.-H. L. is supported by U.S. Department of Energy grant number DE-AC02-05CH11231.	ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; Bao W, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.247001; BARDEEN J, 1957, PHYS REV, V108, P1175, DOI 10.1103/PhysRev.108.1175; Chen CT, 2010, NAT PHYS, V6, P260, DOI 10.1038/NPHYS1531; Chen WQ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.047006; Chu JH, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.014506; Chubukov AV, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.060504; Chubukov A, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.060509; de la Cruz C, 2008, NATURE, V453, P899, DOI 10.1038/nature07057; Ding H, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/47001; Dong J, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/27006; Fletcher JD, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.147001; Gordon RT, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.127004; Grafe HJ, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.047003; Graser S, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/2/025016; Guo JG, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.180520; Hanaguri T, 2010, SCIENCE, V328, P474, DOI 10.1126/science.1187399; Hicks CW, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.013708; Honerkamp C, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.035109; Hsu FC, 2008, P NATL ACAD SCI USA, V105, P14262, DOI 10.1073/pnas.0807325105; Huang Q, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.257003; Inosov DS, 2010, NAT PHYS, V6, P178, DOI 10.1038/NPHYS1483; Kamerlingh Onnes H., 1911, COMMUN PHYS LAB U LE, P120; Kamihara Y, 2008, J AM CHEM SOC, V130, P3296, DOI 10.1021/ja800073m; Korshunov MM, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.140509; Kuroki K, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.224511; Kuroki K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.087004; Lauchli A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.037006; Luan L, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.100501; Luetkens H, 2009, NAT MATER, V8, P305, DOI [10.1038/NMAT2397, 10.1038/nmat2397]; Lumsden MD, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.107005; Maier TA, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.020514; Matano K, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/57001; Mazin II, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.057003; Nakai Y, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.073701; Ning F, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.103705; Park T, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/32/322204; Prozorov R, 2009, PHYSICA C, V469, P582, DOI 10.1016/j.physc.2009.03.012; Qazilbash MM, 2009, NAT PHYS, V5, P647, DOI 10.1038/NPHYS1343; Ren ZA, 2008, CHINESE PHYS LETT, V25, P2215, DOI 10.1088/0256-307X/25/6/080; Rotter M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.107006; Seo KJ, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.206404; SHANKAR R, 1994, REV MOD PHYS, V66, P129, DOI 10.1103/RevModPhys.66.129; Si QM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.076401; Singh DJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.237003; Sknepnek R, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.054511; SUHL H, 1959, PHYS REV LETT, V3, P552, DOI 10.1103/PhysRevLett.3.552; Thomale R, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.180505; Torikachvili MS, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.057006; Vorontsov AB, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.187004; Wang F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.047005; Wang F, 2009, EPL-EUROPHYS LETT, V85, DOI 10.1209/0295-5075/85/37005; Wang XC, 2008, SOLID STATE COMMUN, V148, P538, DOI 10.1016/j.ssc.2008.09.057; Yang F., PHYS REV B; Yildirim T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.057010; Yildirim T, 2009, PHYSICA C, V469, P425, DOI 10.1016/j.physc.2009.03.038; Yin Y, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.097002; Zeng B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1115; Zhai H, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.064517; Zhang XH, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.147002; Zhang YY, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.094528; Zhao J, 2008, NAT MATER, V7, P953, DOI 10.1038/nmat2315; Zhao L, 2008, CHINESE PHYS LETT, V25, P4402, DOI 10.1088/0256-307X/25/12/061	63	203	204	9	251	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2011	332	6026					200	204		10.1126/science.1200182	http://dx.doi.org/10.1126/science.1200182			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474751				2022-12-28	WOS:000289251100040
J	Dawson, TP; Jackson, ST; House, JI; Prentice, IC; Mace, GM				Dawson, Terence P.; Jackson, Stephen T.; House, Joanna I.; Prentice, Iain Colin; Mace, Georgina M.			Beyond Predictions: Biodiversity Conservation in a Changing Climate	SCIENCE			English	Review							EXTINCTION RISK; POPULATIONS; RESPONSES; MODELS; RANGE; PLANT; COMMUNITIES; VARIABILITY; SUSTAINABILITY; DISTRIBUTIONS	Climate change is predicted to become a major threat to biodiversity in the 21st century, but accurate predictions and effective solutions have proved difficult to formulate. Alarming predictions have come from a rather narrow methodological base, but a new, integrated science of climate-change biodiversity assessment is emerging, based on multiple sources and approaches. Drawing on evidence from paleoecological observations, recent phenological and microevolutionary responses, experiments, and computational models, we review the insights that different approaches bring to anticipating and managing the biodiversity consequences of climate change, including the extent of species' natural resilience. We introduce a framework that uses information from different sources to identify vulnerability and to support the design of conservation responses. Although much of the information reviewed is on species, our framework and conclusions are also applicable to ecosystems, habitats, ecological communities, and genetic diversity, whether terrestrial, marine, or fresh water.	[Prentice, Iain Colin; Mace, Georgina M.] Univ London Imperial Coll Sci Technol & Med, Grantham Inst Climate Change, London SW7 2AZ, England; [Prentice, Iain Colin; Mace, Georgina M.] Univ London Imperial Coll Sci Technol & Med, Div Biol, London SW7 2AZ, England; [Prentice, Iain Colin] Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia; [Mace, Georgina M.] Univ London Imperial Coll Sci Technol & Med, Ctr Populat Biol, Ascot SL5 7PY, Berks, England; [Dawson, Terence P.] Univ Dundee, Sch Environm, Dundee DD1 4HN, Scotland; [Jackson, Stephen T.] Univ Wyoming, Dept Bot, Program Ecol, Laramie, WY 82071 USA; [Jackson, Stephen T.] Univ Wyoming, Berry Biodivers Conservat Ctr, Laramie, WY 82071 USA; [House, Joanna I.; Prentice, Iain Colin] Univ Bristol, Dept Earth Sci, QUEST, Bristol BS8 1RJ, Avon, England	Imperial College London; Imperial College London; Macquarie University; Imperial College London; University of Dundee; University of Wyoming; University of Wyoming; University of Bristol	Mace, GM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Grantham Inst Climate Change, London SW7 2AZ, England.	g.mace@imperial.ac.uk	Mace, Georgina M/I-3072-2016; Dawson, Terence Peter/E-4724-2011; House, Joanna I/B-6477-2016	Mace, Georgina M/0000-0001-8965-5211; Dawson, Terence Peter/0000-0002-4314-1378; House, Joanna I/0000-0003-4576-3960; Jackson, Stephen/0000-0002-1487-4652	QUEST; NSF [0949308]; UK Natural Environment Research Council; Royal Botanic Gardens, Kew; NERC [cpb010001, quest010001] Funding Source: UKRI; Natural Environment Research Council [quest010001, cpb010001] Funding Source: researchfish	QUEST; NSF(National Science Foundation (NSF)); UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Botanic Gardens, Kew; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank three anonymous reviewers for helpful comments. Some of the ideas presented here emerged from discussions among the participants at the NERC QUEST (Quantifying and Understanding the Earth System) Working Group on Biodiversity and Climate Change, which was cosponsored by and held at the Royal Botanic Gardens, Kew, in September 2009. Supported by QUEST (J.I.H. and I. C. P.), NSF grant 0949308 (S.T.J.), and the UK Natural Environment Research Council ( G. M. M.).	Altermatt F, 2010, ECOL LETT, V13, P1475, DOI 10.1111/j.1461-0248.2010.01534.x; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Beale CM, 2008, P NATL ACAD SCI USA, V105, P14908, DOI 10.1073/pnas.0803506105; Beier P, 2010, CONSERV BIOL, V24, P701, DOI 10.1111/j.1523-1739.2009.01422.x; Betancourt J.L., 1990, PACKRAT MIDDENS LAST; Blois JL, 2010, NATURE, V465, P771, DOI 10.1038/nature09077; Both C, 2010, P ROY SOC B-BIOL SCI, V277, P1259, DOI 10.1098/rspb.2009.1525; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Boys J, 2005, AM J BOT, V92, P833, DOI 10.3732/ajb.92.5.833; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Chin A, 2010, GLOBAL CHANGE BIOL, V16, P1936, DOI 10.1111/j.1365-2486.2009.02128.x; Dalen L, 2007, P NATL ACAD SCI USA, V104, P6726, DOI 10.1073/pnas.0701341104; Davies ZG, 2006, J ANIM ECOL, V75, P247, DOI 10.1111/j.1365-2656.2006.01044.x; Dawson TP, 2010, BIODIVERS CONSERV, V19, P2843, DOI 10.1007/s10531-010-9892-z; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Doak DF, 2010, NATURE, V467, P959, DOI 10.1038/nature09439; Dormann CF, 2007, BASIC APPL ECOL, V8, P387, DOI 10.1016/j.baae.2006.11.001; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Foden W., 2008, 2008 REV IUCN RED LI, P77, DOI DOI 10.1128/AEM.01630-08; Franks SJ, 2007, P NATL ACAD SCI USA, V104, P1278, DOI 10.1073/pnas.0608379104; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hannah L, 2010, CONSERV BIOL, V24, P70, DOI 10.1111/j.1523-1739.2009.01405.x; Harrison SP, 2010, QUATERNARY SCI REV, V29, P2957, DOI 10.1016/j.quascirev.2010.07.016; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hodgson JA, 2009, J APPL ECOL, V46, P964, DOI 10.1111/j.1365-2664.2009.01695.x; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; IPCC, 2007, CONTRIBUTION WORKING; IPCC (Intergovernmental Panel on Climate Change), 2007, CLIM CHANG 2007 PHYS; Jackson ST, 2000, PALEOBIOLOGY, V26, P194, DOI 10.1666/0094-8373(2000)26[194:ROPPAC]2.0.CO;2; Jackson ST, 1999, P NATL ACAD SCI USA, V96, P13847, DOI 10.1073/pnas.96.24.13847; Jackson ST, 2010, TRENDS ECOL EVOL, V25, P153, DOI 10.1016/j.tree.2009.10.001; Jackson ST, 2009, P NATL ACAD SCI USA, V106, P19685, DOI 10.1073/pnas.0901644106; Jenouvrier S, 2009, P NATL ACAD SCI USA, V106, P1844, DOI 10.1073/pnas.0806638106; Jeschke JM, 2008, ANN NY ACAD SCI, V1134, P1, DOI 10.1196/annals.1439.002; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Jiguet F, 2006, ECOL LETT, V9, P1321, DOI 10.1111/j.1461-0248.2006.00986.x; Johnson CN, 2002, P ROY SOC B-BIOL SCI, V269, P2221, DOI 10.1098/rspb.2002.2130; Johnson DM, 2010, P NATL ACAD SCI USA, V107, P20576, DOI 10.1073/pnas.1010270107; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Kuch M, 2002, MOL ECOL, V11, P913, DOI 10.1046/j.1365-294X.2002.01492.x; Kullman L, 1996, GLOBAL ECOL BIOGEOGR, V5, P94, DOI 10.2307/2997447; Leadley P., 2010, BIODIVERSITY SCENARI; Lister AM, 2008, CR GEOSCI, V340, P615, DOI 10.1016/j.crte.2008.04.001; Lyford ME, 2003, ECOL MONOGR, V73, P567, DOI 10.1890/03-4011; MacDonald GM, 2008, PROG PHYS GEOG, V32, P139, DOI 10.1177/0309133308094081; Magri D, 2006, NEW PHYTOL, V171, P199, DOI 10.1111/j.1469-8137.2006.01740.x; McLachlan JS, 2005, ECOLOGY, V86, P2088, DOI 10.1890/04-1036; Menendez R, 2006, P ROY SOC B-BIOL SCI, V273, P1465, DOI 10.1098/rspb.2006.3484; Morin X, 2008, BIOL LETTERS, V4, P573, DOI 10.1098/rsbl.2008.0181; Ozgul A, 2010, NATURE, V466, P482, DOI 10.1038/nature09210; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2005, BIOL CONSERV, V123, P389, DOI 10.1016/j.biocon.2004.12.006; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Phillimore AB, 2010, P NATL ACAD SCI USA, V107, P8292, DOI 10.1073/pnas.0913792107; Ricciardi A, 2009, TRENDS ECOL EVOL, V24, P248, DOI 10.1016/j.tree.2008.12.006; Richardson DM, 2009, P NATL ACAD SCI USA, V106, P9721, DOI 10.1073/pnas.0902327106; Rowe KC, 2004, P NATL ACAD SCI USA, V101, P10355, DOI 10.1073/pnas.0401338101; Sandler R, 2010, CONSERV BIOL, V24, P424, DOI 10.1111/j.1523-1739.2009.01351.x; Shapiro B, 2004, SCIENCE, V306, P1561, DOI 10.1126/science.1101074; Shuman B, 2009, ECOLOGY, V90, P2792, DOI 10.1890/08-0985.1; Solomon S, 2009, P NATL ACAD SCI USA, V106, P1704, DOI 10.1073/pnas.0812721106; Thackeray SJ, 2010, GLOBAL CHANGE BIOL, V16, P3304, DOI 10.1111/j.1365-2486.2010.02165.x; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; THOMPSON RS, 1988, VEGETATION HIST, P415; Turner BL, 2003, P NATL ACAD SCI USA, V100, P8074, DOI 10.1073/pnas.1231335100; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Walther GR, 2005, J VEG SCI, V16, P541, DOI 10.1111/j.1654-1103.2005.tb02394.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wiens JA, 2009, P NATL ACAD SCI USA, V106, P19729, DOI 10.1073/pnas.0901639106; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Williams JW, 2002, GEOLOGY, V30, P971, DOI 10.1130/0091-7613(2002)030<0971:RAWVRT>2.0.CO;2; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Willis KJ, 2010, SYST BIODIVERS, V8, P3, DOI 10.1080/14772000903495833; Willis KJ, 2009, SCIENCE, V326, P806, DOI 10.1126/science.1178838	82	1130	1177	44	1246	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2011	332	6025					53	58		10.1126/science.1200303	http://dx.doi.org/10.1126/science.1200303			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21454781				2022-12-28	WOS:000289000000035
J	Zhu, WL; Gaetani, GA; Fusseis, F; Montesi, LGJ; De Carlo, F				Zhu, Wenlu; Gaetani, Glenn A.; Fusseis, Florian; Montesi, Laurent G. J.; De Carlo, Francesco			Microtomography of Partially Molten Rocks: Three-Dimensional Melt Distribution in Mantle Peridotite	SCIENCE			English	Article							OCEAN-RIDGE BASALT; EAST PACIFIC RISE; MIDOCEAN RIDGES; BENEATH; EXTRACTION; PERMEABILITY; TRANSPORT; FLOW; CONSEQUENCES; SEGREGATION	The permeability of the upper mantle controls melt segregation beneath spreading centers. Reconciling contradictory geochemical and geophysical observations at ocean ridges requires a better understanding of transport properties in partially molten rocks. Using x-ray synchrotron microtomography, we obtained three-dimensional data on melt distribution for mantle peridotite with various melt fractions. At melt fractions as low as 0.02, triple junctions along grain edges dominated the melt network; there was no evidence of an abrupt change in the fundamental character of melt extraction as melt fraction increased to 0.2. The porosity of the partially molten region beneath ocean ridges is therefore controlled by a balance between viscous compaction and melting rate, not by a change in melt topology.	[Zhu, Wenlu; Montesi, Laurent G. J.] Univ Maryland, Dept Geog, College Pk, MD 20742 USA; [Gaetani, Glenn A.] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; [Fusseis, Florian] Univ Western Australia, Western Australian Geothermal Ctr Excellence, Crawley, WA, Australia; [De Carlo, Francesco] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA	University System of Maryland; University of Maryland College Park; Woods Hole Oceanographic Institution; University of Western Australia; United States Department of Energy (DOE); Argonne National Laboratory	Zhu, WL (corresponding author), Univ Maryland, Dept Geog, College Pk, MD 20742 USA.	wzhu@umd.edu	Fusseis, Florian/M-5321-2016; Montesi, Laurent G. J./C-5216-2009; Gaetani, Glenn/P-3870-2019; Gaetani, Glenn/B-8809-2015	Fusseis, Florian/0000-0002-3104-8109; Montesi, Laurent G. J./0000-0002-3519-1412; Gaetani, Glenn/0000-0002-6026-2534; Gaetani, Glenn/0000-0002-6026-2534	NSF [EAR 0753505, OCE 0937277]; Western Australian State Government; Commonwealth of Australia; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Directorate For Geosciences [0937277] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Western Australian State Government; Commonwealth of Australia(Australian Government); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work is supported by NSF-EAR 0753505 (W.Z. and G. A. G.) and NSF-OCE 0937277 (L.G.J.M.). F. F. was supported by the Western Australian State Government through the Premier's Fellowship Program and the Australian Synchrotron Research Program, funded by the Commonwealth of Australia under the Major National Research Facilities Program. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-06CH11357. We thank X. Xiao and J. Liu for their assistance. We furthermore acknowledge the Centre for Microscopy, Characterisation and Analysis for use of an electron microprobe and iVEC for use of their data storage and visualization facilities.	ASIMOW PD, 1995, GEOCHIM COSMOCHIM AC, V59, P4489, DOI 10.1016/0016-7037(95)00252-U; Cheadle MJ, 2004, GEOLOGY, V32, P757, DOI 10.1130/G20495.1; Cmiral M, 1998, CONTRIB MINERAL PETR, V130, P336, DOI 10.1007/s004100050369; Connolly JAD, 2009, NATURE, V462, P209, DOI 10.1038/nature08517; DAINES MJ, 1988, GEOPHYS RES LETT, V15, P1459, DOI 10.1029/GL015i013p01459; Evans RL, 1999, SCIENCE, V286, P752, DOI 10.1126/science.286.5440.752; Faul UH, 2001, NATURE, V410, P920, DOI 10.1038/35073556; Forsyth DW, 1998, SCIENCE, V280, P1215, DOI 10.1126/science.280.5367.1235; Fredrich JT, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003774; HART SR, 1993, P NATL ACAD SCI USA, V90, P11914, DOI 10.1073/pnas.90.24.11914; Hebert LB, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003270; Holtzman BK, 2003, SCIENCE, V301, P1227, DOI 10.1126/science.1087132; Jull M, 2002, GEOCHIM COSMOCHIM AC, V66, P4133, DOI 10.1016/S0016-7037(02)00984-5; KELEMEN PB, 1995, NATURE, V375, P747, DOI 10.1038/375747a0; KLEIN EM, 1987, J GEOPHYS RES-SOLID, V92, P8089, DOI 10.1029/JB092iB08p08089; LAPORTE D, 1991, J GEOL, V99, P873, DOI 10.1086/629558; LUNDSTROM CC, 1995, SCIENCE, V270, P1958, DOI 10.1126/science.270.5244.1958; McKenzie D, 2000, CHEM GEOL, V162, P81, DOI 10.1016/S0009-2541(99)00126-6; Sims KWW, 2002, GEOCHIM COSMOCHIM AC, V66, P3481, DOI 10.1016/S0016-7037(02)00909-2; Smith C. E., 1964, MET REV, V9, P1, DOI DOI 10.1179/MTLR.1964.9.1.1; SOBOLEV AV, 1993, NATURE, V363, P151, DOI 10.1038/363151a0; SPARKS DW, 1993, GEOPHYS J INT, V112, P81, DOI 10.1111/j.1365-246X.1993.tb01438.x; SPIEGELMAN M, 1993, EARTH PLANET SC LETT, V118, P1, DOI 10.1016/0012-821X(93)90155-3; SPIEGELMAN M, 1987, EARTH PLANET SC LETT, V83, P137, DOI 10.1016/0012-821X(87)90057-4; vanGenabeek O, 1996, ANNU REV EARTH PL SC, V24, P63, DOI 10.1146/annurev.earth.24.1.63; VONBARGEN N, 1986, J GEOPHYS RES-SOLID, V91, P9261, DOI 10.1029/JB091iB09p09261; Wark DA, 1998, EARTH PLANET SC LETT, V164, P591, DOI 10.1016/S0012-821X(98)00252-0; Wark DA, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001575; Zhu WL, 2003, EARTH PLANET SC LETT, V212, P407, DOI 10.1016/S0012-821X(03)00264-4	29	119	124	2	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 1	2011	332	6025					88	91		10.1126/science.1202221	http://dx.doi.org/10.1126/science.1202221			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21454786				2022-12-28	WOS:000289000000043
J	Hein, CM; Engels, S; Kishkinev, D; Mouritsen, H				Hein, Christine Maira; Engels, Svenja; Kishkinev, Dmitry; Mouritsen, Henrik			Robins have a magnetic compass in both eyes	NATURE			English	Letter							LATERALIZATION; ORIENTATION; BIRDS		[Hein, Christine Maira; Engels, Svenja; Kishkinev, Dmitry; Mouritsen, Henrik] Carl von Ossietzky Univ Oldenburg, IBU, AG Neurosensor Anim Nav, D-26111 Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg	Hein, CM (corresponding author), Carl von Ossietzky Univ Oldenburg, IBU, AG Neurosensor Anim Nav, D-26111 Oldenburg, Germany.	henrik.mouritsen@uni-oldenburg.de	Mouritsen, Henrik/A-5401-2010; Kishkinev, Dmitry/S-1547-2016	Mouritsen, Henrik/0000-0001-7082-4839; Kishkinev, Dmitry/0000-0002-2619-1197				Feenders G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001768; Gunturkun O, 2003, ASYMMETRICAL BRAIN, P3; Hein CM, 2010, J R SOC INTERFACE, V7, pS227, DOI 10.1098/rsif.2009.0376.focus; Heyers D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000937; Liedvogel M, 2007, EUR J NEUROSCI, V25, P1166, DOI 10.1111/j.1460-9568.2007.05350.x; Mouritsen H, 2005, P NATL ACAD SCI USA, V102, P8339, DOI 10.1073/pnas.0409575102; Mouritsen H, 2004, P NATL ACAD SCI USA, V101, P14294, DOI 10.1073/pnas.0405968101; Mouritsen H, 2003, AVIAN MIGRATION, P493; Prior H, 2004, BEHAV BRAIN RES, V154, P301, DOI 10.1016/j.bbr.2004.02.018; Wiltschko R, 2010, J R SOC INTERFACE, V7, pS163, DOI 10.1098/rsif.2009.0367.focus; Wiltschko W, 2003, AUST J ZOOL, V51, P597, DOI 10.1071/ZO03022; Wiltschko W, 2002, NATURE, V419, P467, DOI 10.1038/nature00958; Wiltschko W, 2007, J ORNITHOL, V148, pS61, DOI 10.1007/s10336-007-0233-2; Wilzeck C, 2010, J R SOC INTERFACE, V7, pS235, DOI 10.1098/rsif.2009.0436.focus; Zapka M, 2009, NATURE, V461, P1274, DOI 10.1038/nature08528	15	55	58	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2011	471	7340					E11	E12		10.1038/nature09875	http://dx.doi.org/10.1038/nature09875			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21455128				2022-12-28	WOS:000288951200001
J	Poordad, F; McCone, J; Bacon, BR; Bruno, S; Manns, MP; Sulkowski, MS; Jacobson, IM; Reddy, KR; Goodman, ZD; Boparai, N; DiNubile, MJ; Sniukiene, V; Brass, CA; Albrecht, JK; Bronowicki, JP; Colombato, L; Curciarello, J; Silva, M; Tanno, H; Terg, R; Adler, M; Langlet, P; Lasser, L; Nevens, F; Anderson, F; Bailey, R; Bilodeau, M; Cooper, C; Feinman, S; Heathcote, J; Levstik, M; Ramji, A; Sherman, M; Shafran, S; Yoshida, E; Achim, A; Ben Ali, S; Bigard, MA; Bonny, C; Bourliere, M; Boyer-Darrigrand, N; Bronowicki, JP; Canva, V; Couzigou, P; De Ledinghen, V; Guyader, D; Hezode, C; Larrey, D; Latournerie, M; Marcellin, P; Mathurin, P; Maynard-Muet, M; Moussalli, J; Poupon, R; Poynard, T; Serfaty, L; Tran, A; Trepo, C; Truchi, R; Zarski, JP; Berg, T; Dikopoulos, N; Eisenbach, C; Galle, PR; Gerken, G; Goeser, T; Gregor, M; Klass, D; Kraus, MR; Niederau, C; Schlaak, JF; Schmid, R; Thies, P; Schmidt, K; Thimme, R; Weidenbach, H; Zeuzem, S; Angelico, M; Bruno, S; Carosi, G; Craxi, A; Mangia, A; Pirisi, M; Rizzetto, M; Taliani, G; Zignego, A; Reesink, H; Serejo, F; Reymunde, A; Rosado, B; Torres, E; Marugan, RB; De La Mata, M; Calleja, J; Castellano, G; Diago, M; Esteban, R; Fernandez-Rodriguez, C; Tapias, JS; Desfilis, MAS; Afdhal, N; Al-Osaimi, A; Bacon, B; Balart, L; Bennett, M; Bernstein, D; Black, M; Bowlus, C; Boyer, T; Dalke, D; Davis, C; Davis, G; Davis, M; Everson, G; Felizarta, F; Flamm, S; Freilich, B; Galati, J; Galler, G; Ghalib, R; Gibas, A; Godofsky, E; Gordon, F; Gordon, S; Gross, J; Harrison, S; Herrera, J; Herrine, S; Hu, KQ; Imperial, J; Jacobson, I; Jones, D; Kilby, A; King, J; Koch, A; Kowdley, K; Krawitt, E; Kwo, P; Lambiase, L; Lawitz, E; Lee, W; Levin, J; Levine, R; Li, X; Lok, A; Luketic, V; Mailliard, M; McCone, J; McHutchison, J; Mikolich, D; Morgan, T; Muir, A; Nelson, D; Nunes, F; Nyberg, A; Nyberg, L; Pandya, P; Pauly, M; Peine, C; Poleynard, G; Poordad, F; Pound, D; Poulos, J; Rabinovitz, M; Ravendhran, N; Ready, J; Reddy, K; Reindollar, R; Reuben, A; Riley, T; Rossaro, L; Rubin, R; Ryan, M; Santoro, J; Schiff, E; Sepe, T; Sherman, K; Shiffman, M; Sjogren, M; Sjogren, R; Smith, C; Stein, L; Strauss, R; Sulkowski, M; Szyjkowski, R; Vargas, H; Vierling, J; Witt, D; Yapp, R; Younes, Z				Poordad, Fred; McCone, Jonathan, Jr.; Bacon, Bruce R.; Bruno, Savino; Manns, Michael P.; Sulkowski, Mark S.; Jacobson, Ira M.; Reddy, K. Rajender; Goodman, Zachary D.; Boparai, Navdeep; DiNubile, Mark J.; Sniukiene, Vilma; Brass, Clifford A.; Albrecht, Janice K.; Bronowicki, Jean-Pierre; Colombato, L.; Curciarello, J.; Silva, M.; Tanno, H.; Terg, R.; Adler, M.; Langlet, P.; Lasser, L.; Nevens, F.; Anderson, F.; Bailey, R.; Bilodeau, M.; Cooper, C.; Feinman, S. V.; Heathcote, J.; Levstik, M.; Ramji, A.; Sherman, M.; Shafran, S.; Yoshida, E.; Achim, A.; Ben Ali, S.; Bigard, M-A.; Bonny, C.; Bourliere, M.; Boyer-Darrigrand, N.; Bronowicki, J-P.; Canva, V.; Couzigou, P.; De Ledinghen, V.; Guyader, D.; Hezode, C.; Larrey, D.; Latournerie, M.; Marcellin, P.; Mathurin, P.; Maynard-Muet, M.; Moussalli, J.; Poupon, R.; Poynard, T.; Serfaty, L.; Tran, A.; Trepo, C.; Truchi, R.; Zarski, J-P.; Berg, T.; Dikopoulos, N.; Eisenbach, C.; Galle, P. R.; Gerken, G.; Goeser, T.; Gregor, M.; Klass, D.; Kraus, M. R.; Niederau, C.; Schlaak, J. F.; Schmid, R.; Thies, P.; Schmidt, K.; Thimme, R.; Weidenbach, H.; Zeuzem, S.; Angelico, M.; Bruno, S.; Carosi, G.; Craxi, A.; Mangia, A.; Pirisi, M.; Rizzetto, M.; Taliani, G.; Zignego, A. L.; Reesink, H. W.; Serejo, F.; Reymunde, A.; Rosado, B.; Torres, E.; Barcena Marugan, R.; De La Mata, M.; Calleja, J. L.; Castellano, G.; Diago, M.; Esteban, R.; Fernandez-Rodriguez, C.; Sanchez Tapias, J.; Serra Desfilis, M. A.; Afdhal, N.; Al-Osaimi, A.; Bacon, B.; Balart, L.; Bennett, M.; Bernstein, D.; Black, M.; Bowlus, C.; Boyer, T.; Dalke, D.; Davis, C.; Davis, G.; Davis, M.; Everson, G.; Felizarta, F.; Flamm, S.; Freilich, B.; Galati, J.; Galler, G.; Ghalib, R.; Gibas, A.; Godofsky, E.; Gordon, F.; Gordon, S.; Gross, J.; Harrison, S.; Herrera, J.; Herrine, S.; Hu, K-Q.; Imperial, J.; Jacobson, I.; Jones, D.; Kilby, A.; King, J.; Koch, A.; Kowdley, K.; Krawitt, E.; Kwo, P.; Lambiase, L.; Lawitz, E.; Lee, W.; Levin, J.; Levine, R.; Li, X.; Lok, A.; Luketic, V.; Mailliard, M.; McCone, J.; McHutchison, J.; Mikolich, D.; Morgan, T.; Muir, A.; Nelson, Don.; Nunes, F.; Nyberg, A.; Nyberg, L.; Pandya, P.; Pauly, M. P.; Peine, C.; Poleynard, G.; Poordad, F.; Pound, D.; Poulos, J.; Rabinovitz, M.; Ravendhran, N.; Ready, J.; Reddy, K.; Reindollar, R.; Reuben, A.; Riley, T.; Rossaro, L.; Rubin, R.; Ryan, M.; Santoro, J.; Schiff, E.; Sepe, T.; Sherman, K.; Shiffman, M.; Sjogren, M.; Sjogren, R.; Smith, C.; Stein, L.; Strauss, R.; Sulkowski, M.; Szyjkowski, R.; Vargas, H.; Vierling, J.; Witt, D.; Yapp, R.; Younes, Z.		SPRINT2-Investigators	Boceprevir for Untreated Chronic HCV Genotype 1 Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC HEPATITIS-C; ALPHA-2A PLUS RIBAVIRIN; PEGINTERFERON ALPHA-2A; TELAPREVIR; INTERFERON-ALPHA-2B; SCH-503034; INHIBITOR	BACKGROUND Peginterferon-ribavirin therapy is the current standard of care for chronic infection with hepatitis C virus (HCV). The rate of sustained virologic response has been below 50% in cases of HCV genotype 1 infection. Boceprevir, a potent oral HCV-protease inhibitor, has been evaluated as an additional treatment in phase 1 and phase 2 studies. METHODS We conducted a double-blind study in which previously untreated adults with HCV genotype 1 infection were randomly assigned to one of three groups. In all three groups, peginterferon alfa-2b and ribavirin were administered for 4 weeks (the lead-in period). Subsequently, group 1 (the control group) received placebo plus peginterferon-ribavirin for 44 weeks; group 2 received boceprevir plus peginterferon-ribavirin for 24 weeks, and those with a detectable HCV RNA level between weeks 8 and 24 received placebo plus peginterferon-ribavirin for an additional 20 weeks; and group 3 received boceprevir plus peginterferon-ribavirin for 44 weeks. Nonblack patients and black patients were enrolled and analyzed separately. RESULTS A total of 938 nonblack and 159 black patients were treated. In the nonblack cohort, a sustained virologic response was achieved in 125 of the 311 patients (40%) in group 1, in 211 of the 316 patients (67%) in group 2 (P<0.001), and in 213 of the 311 patients (68%) in group 3 (P<0.001). In the black cohort, a sustained virologic response was achieved in 12 of the 52 patients (23%) in group 1, in 22 of the 52 patients (42%) in group 2 (P = 0.04), and in 29 of the 55 patients (53%) in group 3 (P = 0.004). In group 2, a total of 44% of patients received peginterferon-ribavirin for 28 weeks. Anemia led to dose reductions in 13% of controls and 21% of boceprevir recipients, with discontinuations in 1% and 2%, respectively. CONCLUSIONS The addition of boceprevir to standard therapy with peginterferon-ribavirin, as compared with standard therapy alone, significantly increased the rates of sustained virologic response in previously untreated adults with chronic HCV genotype 1 infection. The rates were similar with 24 weeks and 44 weeks of boceprevir.	[Poordad, Fred] Cedars Sinai Med Ctr, Suite 1060W,8635 W 3rd St, Los Angeles, CA 90048 USA; [McCone, Jonathan, Jr.] Gastroenterol Hepatol Certified Endoscopy Ctr, Alexandria, VA USA; [Bacon, Bruce R.] St Louis Univ, Sch Med, St Louis, MO USA; [Bruno, Savino] Azienda Osped Fatebenefratelli & Oftalm, Milan, Italy; [Manns, Michael P.] Hannover Med Sch, D-3000 Hannover, Germany; [Sulkowski, Mark S.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Jacobson, Ira M.] Weill Cornell Med Coll, Ctr Study Hepatitis C, New York, NY USA; [Reddy, K. Rajender] Univ Penn, Philadelphia, PA 19104 USA; [Goodman, Zachary D.] Inova Fairfax Hosp, Falls Church, VA USA; [Goodman, Zachary D.] Betty & Guy Beatty Ctr Integrated Res, Falls Church, VA USA; [Boparai, Navdeep; DiNubile, Mark J.; Sniukiene, Vilma; Brass, Clifford A.; Albrecht, Janice K.] Merck, Whitehouse Stn, NJ USA; [Bronowicki, Jean-Pierre] Univ Nancy 1, Ctr Hosp Univ Nancy, INSERM, Unite 954, Vandoeuvre Les Nancy, France	Cedars Sinai Medical Center; Saint Louis University; Hannover Medical School; Johns Hopkins University; Cornell University; University of Pennsylvania; Inova Fairfax Hospital; Merck & Company; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine	Poordad, F (corresponding author), Cedars Sinai Med Ctr, Suite 1060W,8635 W 3rd St, Los Angeles, CA 90048 USA.	fred.poordad@cshs.org	DIAGO, MOISES/AAH-5364-2019; Pirisi, Mario/ABF-2102-2020; Galle, Peter R/T-5292-2018; Zignego, Anna Linda/AAL-8205-2021; Poynard, Thierry/C-1355-2010; Rubin, Rita/AAD-1259-2020; Zeuzem, Stefan/AAE-7435-2019; Hezode, Christophe/U-4659-2018; Panero, Jose Luis Calleja/A-5351-2010; Bowlus, Christopher/N-9276-2016; Mathurin, Philippe/A-9121-2018; Mangia, A/AAL-5357-2020; Vargas, Hugo E./K-1562-2019; Kowdley, Kris/AAF-5202-2019; CASTELLANO, GAETANO/AAG-6134-2021; Sulkowski, Michael/ABG-9532-2020; Craxi, Antonio/K-9529-2016	Galle, Peter R/0000-0001-8294-0992; Poynard, Thierry/0000-0002-3726-7230; Panero, Jose Luis Calleja/0000-0002-2265-6591; Bowlus, Christopher/0000-0002-3906-6811; Mathurin, Philippe/0000-0003-3447-2025; Mangia, A/0000-0002-2600-3555; Vargas, Hugo E./0000-0002-7802-688X; Craxi, Antonio/0000-0002-4480-9544; Fernandez Rodriguez, Conrado M/0000-0002-1915-2157; Albert, TRAN/0000-0003-0003-5361; Afdhal, Nezam/0000-0002-7342-6593; Van Vlierberghe, Hans/0000-0003-0647-9238; ANGELICO, Mario/0000-0003-2883-9206; Pirisi, Mario/0000-0001-9740-0155; Herrine, Steven/0000-0001-5763-1821; Bruno, Savino/0000-0002-3887-864X; esteban, rafael/0000-0001-5280-392X	Merck; Vertex; Abbott; Gilead; Achillion; Genentech; Tibotec; Schering-Plough; Three Rivers Pharmaceuticals; Valeant; Human Genome Sciences; Roche; Bristol-Myers Squibb; Wyeth; Romark Laboratories; Boehringer Ingelheim; Novartis; Idenix; GlaxoSmithKline; Pfizer; Pharmasset; Zymogenetics; Orasure; GlobeImmune; Roche-Genentech; Anadys; Sanofi-Aventis; Biolex; Salix; ViralEd; NATIONAL CANCER INSTITUTE [K24CA139570] Funding Source: NIH RePORTER	Merck(Merck & Company); Vertex(Vertex Pharmaceuticals); Abbott(Abbott Laboratories); Gilead(Gilead Sciences); Achillion; Genentech(Roche HoldingGenentech); Tibotec; Schering-Plough(Merck & CompanySchering Plough Corporation); Three Rivers Pharmaceuticals; Valeant; Human Genome Sciences(GlaxoSmithKline); Roche(Roche Holding); Bristol-Myers Squibb(Bristol-Myers Squibb); Wyeth(Wyeth); Romark Laboratories; Boehringer Ingelheim(Boehringer Ingelheim); Novartis(Novartis); Idenix; GlaxoSmithKline(GlaxoSmithKline); Pfizer(Pfizer); Pharmasset; Zymogenetics; Orasure; GlobeImmune; Roche-Genentech(Roche HoldingGenentech); Anadys; Sanofi-Aventis(Sanofi-Aventis); Biolex; Salix; ViralEd; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr. Poordad reports receiving consulting fees from Merck, Vertex, Abbott, Gilead, Achillion, Genentech, and Tibotec; grant support from Merck; and payment for development of educational presentations from Merck. Dr. McCone reports receiving lecture fees and speaker's fees from Schering-Plough (now part of Merck). Dr. Bacon reports receiving consulting fees from Gilead, Three Rivers Pharmaceuticals, Valeant, Vertex, and Human Genome Sciences; grant support from Roche, Gilead, Bristol-Myers Squibb, Three Rivers Pharmaceuticals, Valeant, Vertex, Human Genome Sciences, Wyeth, and Romark Laboratories; and lecture or speaker's fees from Three Rivers Pharmaceuticals, Gilead, and Schering-Plough (now part of Merck); as well as having served on data and safety monitoring boards for Novartis, Isis, Vertex, and Gilead. Dr. Manns reports receiving consulting fees from Schering-Plough (now part of Merck), Roche, Bristol-Myers Squibb, Gilead, Valeant, Boehringer Ingelheim, Novartis, Idenix, Tibotec, Vertex, GlaxoSmithKline, and Merck; grant support from Schering-Plough (now part of Merck), Roche, Gilead, Novartis, Boehringer Ingelheim, and Bristol-Myers Squibb; and payment for development of educational presentations from Schering-Plough (now part of Merck), Roche, Bristol-Myers Squibb, GlaxoSmithKline, and Gilead. Dr. Sulkowski reports receiving consulting fees from Vertex, Boehringer Ingelheim, Pfizer, Bristol-Myers Squibb, GlaxoSmithKline, Pharmasset, Abbott, Tibotec, Roche, and Gilead; fees for expert testimony from Abbott; and grant support from Vertex, Abbott, Boehringer Ingelheim, Tibotic, Gilead, Pharmasset, Zymogenetics, Bristol-Myers Squibb, Orasure, Achillion, and Roche. Dr. Jacobson reports receiving consulting fees from Bristol-Myers Squibb, Novartis, Gilead, Schering-Plough (now part of Merck), Pfizer, Vertex, GlobeImmune, Human Genome Sciences, Boehringer Ingelheim, Pharmasset, Zymogenetics, Tibotec, Abbott, Roche-Genentech, Anadys, Sanofi-Aventis, Achillion, GlaxoSmithKline, and Biolex; grant support from Schering-Plough (now part of Merck), Tibotec, Roche-Genentech, Pharmasset, Anadys, Boehringer Ingelheim, Novartis, Gilead, Vertex, GlobeImmune, Human Genome Sciences, Pfizer, Bristol-Myers Squibb, and Zymogenetics; lecture or speaker's fees from Schering-Plough (now part of Merck), Gilead, Bristol-Myers Squibb, and Roche-Genentech; and payment for development of educational presentations from Bristol-Myers Squibb, Gilead, and Vertex. Dr. Reddy reports receiving consulting fees from Roche, Merck, Salix, Vertex, Tibotec, and Human Genome Sciences; grant support from Roche, Vertex, Tibotec, Bristol-Myers Squibb, and Gilead; and payment for development of educational presentations from ViralEd. Dr. Goodman reports receiving consulting fees from Merck and Gilead Sciences; grant support from Schering-Plough (now part of Merck), GlaxoSmithKline, Bristol-Myers Squibb, Novartis, GlobeImmune, Gilead Sciences; and lecture or speaker's fees from Bristol-Myers Squibb. Ms. Boparai and Drs. DiNubile, Sniukiene, Brass, and Albrecht report being employees of Merck and owning stock or stock options in the company. Dr. Bronowicki reports receiving fees for board membership from Schering-Plough (now part of Merck), Roche, Gilead, Bristol-Myers Squibb, Janssen, and Bayer; consulting fees from Merck, Boehringer Ingelheim, and Novartis; lecture or speaker's fees from Schering-Plough (now part of Merck), Roche, Bayer and Bristol-Myers Squibb; and reimbursement for travel expenses from Roche.; r No other potential conflict of interest relevant to this articlewas reported.	Buti M, 2010, HEPATOLOGY, V52, P1201, DOI 10.1002/hep.23816; Chung RT, 2004, NEW ENGL J MED, V351, P451, DOI 10.1056/NEJMoa032653; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Jessner W, 2001, LANCET, V358, P1241, DOI 10.1016/S0140-6736(01)06356-5; Kieffer TL, 2007, HEPATOLOGY, V46, P631, DOI 10.1002/hep.21781; Kwo PY, 2010, LANCET, V376, P705, DOI 10.1016/S0140-6736(10)60934-8; Lavanchy D, 1999, J VIRAL HEPATITIS, V6, P35; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McHutchison JG, 2009, NEW ENGL J MED, V361, P1516; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Muir AJ, 2004, NEW ENGL J MED, V351, P1268; Rodriguez-Torres M, 2009, NEW ENGL J MED, V360, P257, DOI 10.1056/NEJMoa0805062; Rodriguez-Torres M, 2010, NEW ENGL J MED, V363, P2474; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1270, DOI 10.1053/j.gastro.2007.01.041; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Torriani FJ, 2004, NEW ENGL J MED, V351, P438, DOI 10.1056/NEJMoa040842; Venkatraman S, 2006, J MED CHEM, V49, P6074, DOI 10.1021/jm060325b; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506	20	1988	2090	0	140	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2011	364	13					1195	1206		10.1056/NEJMoa1010494	http://dx.doi.org/10.1056/NEJMoa1010494			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	742NO	21449783	Green Accepted, Green Published			2022-12-28	WOS:000288951300004
J	Sun, G; Dilcher, DL; Wang, HS; Chen, ZD				Sun, Ge; Dilcher, David L.; Wang, Hongshan; Chen, Zhiduan			A eudicot from the Early Cretaceous of China	NATURE			English	Article							JURASSIC ANGIOSPERM; YIXIAN FORMATION; FOSSIL EVIDENCE; AGE; FLOWER; NOV.	The current molecular systematics of angiosperms(1) recognizes the basal angiosperms and five major angiosperm lineages: the Chloranthaceae, the magnoliids, the monocots, Ceratophyllum and the eudicots, which consist of the basal eudicots and the core eudicots(2). The eudicots form the majority of the angiosperms in the world today. The flowering plants are of exceptional evolutionary interest because of their diversity of over 250,000 species and their abundance as the dominant vegetation in most terrestrial ecosystems, but little is known of their very early history. In this report we document an early presence of eudicots during the Early Cretaceous Period. Diagnostic characters of the eudicot fossil Leefructus gen. nov. include simple and deeply trilobate leaves clustered at the nodes in threes or fours, basal palinactinodromous primary venation, pinnate secondary venation, and a long axillary reproductive axis terminating in a flattened receptacle bearing five long, narrow pseudo-syncarpous carpels. These morphological characters suggest that its affinities are with the Ranunculaceae, a basal eudicot family. The fossil co-occurs with Archaefructus sinensis(3) and Hyrcantha decussata(4) whereas Archaefructus liaoningensis(5) comes from more ancient sediments. Multiple radiometric dates of the Lower Cretaceous Yixian Formation place the bed yielding this fossil at 122.6-125.8 million years old(6-8). The earliest fossil records of eudicots are 127 to 125 million years old, on the basis of pollen(9,10). Thus, Leefructus gen. nov. suggests that the basal eudicots were already present and diverse by the latest Barremian and earliest Aptian.	[Sun, Ge; Dilcher, David L.; Wang, Hongshan] Shenyang Normal Univ, Inst Paleontol, Shenyang 110034, Peoples R China; [Sun, Ge; Dilcher, David L.] Jilin Univ, Res Ctr Paleontol, Changchun 130026, Peoples R China; [Dilcher, David L.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Wang, Hongshan] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Chen, Zhiduan] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing 100093, Peoples R China	Shenyang Normal University; Jilin University; Indiana University System; Indiana University Bloomington; State University System of Florida; University of Florida; Chinese Academy of Sciences; Institute of Botany, CAS	Sun, G (corresponding author), Shenyang Normal Univ, Inst Paleontol, Shenyang 110034, Peoples R China.	sunge@synu.edu.cn; dilcher@indiana.edu			Key Lab of Evolution of Past Life and Environment in Northeast Asia, Ministry of Education, China; Project "111'' of China; NSFC [40842002]	Key Lab of Evolution of Past Life and Environment in Northeast Asia, Ministry of Education, China(Ministry of Education, China); Project "111'' of China(Ministry of Education, China - 111 Project); NSFC(National Natural Science Foundation of China (NSFC))	We acknowledge the support of the Key Lab of Evolution of Past Life and Environment in Northeast Asia, Ministry of Education, China, and Project "111'' of China, NSFC project number 40842002, and the President Special Fund of Shenyang Normal University to carry out this research project during 2008-2009. Many thanks to S. M. Li and L. X. Wang for their help in collecting the fossil specimen. We thank Y. Duan, C. T. Li, Y. S. Liu, D. M. Jarzen, T. Lott, S. Trammel and W. Wang for their assistance in analysis, computer work, photography and artwork. We also thank P. and D. Soltis, K. Nixon, M. Moore and J. Doyle for suggestions.	Anderson CL, 2005, AM J BOT, V92, P1737, DOI 10.3732/ajb.92.10.1737; [Anonymous], 1991, POLLEN SPORES PATTER; Barrett PM, 2000, TRENDS ECOL EVOL, V15, P99, DOI 10.1016/S0169-5347(99)01782-6; Bell CD, 2005, EVOLUTION, V59, P1245, DOI 10.1111/j.0014-3820.2005.tb01775.x; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Chang M.M., 2001, JEHOL BIOTA; Chang SC, 2009, PALAEOGEOGR PALAEOCL, V280, P94, DOI 10.1016/j.palaeo.2009.06.021; Crepet WL, 2004, AM J BOT, V91, P1666, DOI 10.3732/ajb.91.10.1666; Dilcher DL, 2007, P NATL ACAD SCI USA, V104, P9370, DOI 10.1073/pnas.0703497104; Doyle J., 1977, B CTR RECH EXPLOR PR, V1, P451; DOYLE JA, 1969, J ARNOLD ARBORETUM, V50, P1; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Hughes NF., 1994, ENIGMA ANGIOSPERM OR; Leng Q, 2003, PLANT SYST EVOL, V241, P77, DOI 10.1007/s00606-003-0028-8; [孟凡雪 MENG Fanxue], 2008, [地质通报, Geological Bulletin of China], V27, P364; Moore MJ, 2007, P NATL ACAD SCI USA, V104, P19363, DOI 10.1073/pnas.0708072104; Peng Y. D., 2003, GEOCHIMICA, V32, P427, DOI DOI 10.3321/J.ISSN:0379-1726.2003.05.003; Qiu YL, 1999, NATURE, V402, P404, DOI 10.1038/46536; Ren D, 1998, SCIENCE, V280, P85, DOI 10.1126/science.280.5360.85; Smith SA, 2010, P NATL ACAD SCI USA, V107, P5897, DOI 10.1073/pnas.1001225107; Sun G, 2002, SCIENCE, V296, P899, DOI 10.1126/science.1069439; Sun G, 1998, SCIENCE, V282, P1692, DOI 10.1126/science.282.5394.1692; Swisher CC, 2002, CHINESE SCI BULL, V47, P135; Swisher CC, 1999, NATURE, V400, P58, DOI 10.1038/21872; Taylor T.N., 2008, PALEOBOTANY BIOL EVO; Wang SS, 2001, ACTA PETROL SIN, V17, P663; Wang W, 2009, PERSPECT PLANT ECOL, V11, P81, DOI 10.1016/j.ppees.2009.01.001; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; [张宏 Zhang Hong], 2006, [地质论评, Geological Review], V52, P63; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420	30	92	105	3	83	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 31	2011	471	7340					625	628		10.1038/nature09811	http://dx.doi.org/10.1038/nature09811			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21455178				2022-12-28	WOS:000288951200040
J	Chaffer, CL; Weinberg, RA				Chaffer, Christine L.; Weinberg, Robert A.			A Perspective on Cancer Cell Metastasis	SCIENCE			English	Review							EPITHELIAL-MESENCHYMAL TRANSITION; BONE-MARROW MICROMETASTASIS; CIRCULATING TUMOR-CELLS; BREAST-CANCER; STEM-CELLS; LUNG METASTASIS; PANCREATIC-CANCER; DORMANCY; GROWTH; CHEMOTHERAPY	Metastasis causes most cancer deaths, yet this process remains one of the most enigmatic aspects of the disease. Building on new mechanistic insights emerging from recent research, we offer our perspective on the metastatic process and reflect on possible paths of future exploration. We suggest that metastasis can be portrayed as a two-phase process: The first phase involves the physical translocation of a cancer cell to a distant organ, whereas the second encompasses the ability of the cancer cell to develop into a metastatic lesion at that distant site. Although much remains to be learned about the second phase, we feel that an understanding of the first phase is now within sight, due in part to a better understanding of how cancer cell behavior can be modified by a cell-biological program called the epithelial-to-mesenchymal transition.	[Chaffer, Christine L.; Weinberg, Robert A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Weinberg, Robert A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Chaffer, Christine L.; Weinberg, Robert A.] Ludwig MIT Ctr Mol Oncol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Chaffer, CL (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	chaffer@wi.mit.edu; weinberg@wi.mit.edu			National Health and Medical Research Council of Australia; Advanced Medical Research Foundation; National Cancer Institute; MIT Ludwig Center for Molecular Oncology; Breast Cancer Research Fund	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Advanced Medical Research Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MIT Ludwig Center for Molecular Oncology; Breast Cancer Research Fund	C.L.C. is supported by the National Health and Medical Research Council of Australia and the Advanced Medical Research Foundation. R.A.W. is supported by the National Cancer Institute, MIT Ludwig Center for Molecular Oncology, and Breast Cancer Research Fund. R.A.W. is a founder and shareholder of Verastem, Inc., a biopharmaceutical company focused on discovering and developing drugs that target cancer stem cells.	Abdel-Ghany M, 2001, J BIOL CHEM, V276, P25438, DOI 10.1074/jbc.M100478200; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alix-Panabieres C, 2008, CLIN CANCER RES, V14, P5013, DOI 10.1158/1078-0432.CCR-07-5125; Bloom G, 2004, AM J PATHOL, V164, P9, DOI 10.1016/S0002-9440(10)63090-8; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Braun S, 2005, NEW ENGL J MED, V353, P793, DOI 10.1056/NEJMoa050434; Braun S, 2000, J CLIN ONCOL, V18, P80, DOI 10.1200/JCO.2000.18.1.80; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Buck E, 2007, MOL CANCER THER, V6, P532, DOI 10.1158/1535-7163.MCT-06-0462; Camerer E, 2004, BLOOD, V104, P397, DOI 10.1182/blood-2004-02-0434; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; FIDLER IJ, 1970, JNCI-J NATL CANCER I, V45, P773; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; FOULDS L, 1954, CANCER RES, V14, P327; Gal A, 2008, ONCOGENE, V27, P1218, DOI 10.1038/sj.onc.1210741; Goss PE, 2010, NAT REV CANCER, V10, P871, DOI 10.1038/nrc2933; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hess KR, 2006, CANCER, V106, P1624, DOI 10.1002/cncr.21778; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; HIRSHBERG A, 1993, J ORAL MAXIL SURG, V51, P1334, DOI 10.1016/S0278-2391(10)80138-7; Ishizawa K, 2010, CELL STEM CELL, V7, P279, DOI 10.1016/j.stem.2010.08.009; Ito S, 2001, INT J CANCER, V93, P212, DOI 10.1002/ijc.1318; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kang SY, 2009, P NATL ACAD SCI USA, V106, P12115, DOI 10.1073/pnas.0903120106; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P1033, DOI 10.1677/ERC-06-0001; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marcato P, 2011, STEM CELLS, V29, P32, DOI 10.1002/stem.563; Mego M, 2010, NAT REV CLIN ONCOL, V7, P693, DOI 10.1038/nrclinonc.2010.171; Meng SD, 2004, CLIN CANCER RES, V10, P8152, DOI 10.1158/1078-0432.CCR-04-1110; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Naumov GN, 2003, BREAST CANCER RES TR, V82, P199, DOI 10.1023/B:BREA.0000004377.12288.3c; Nieswandt B, 1999, CANCER RES, V59, P1295; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Pantel K, 2009, NAT REV CLIN ONCOL, V6, P339, DOI 10.1038/nrclinonc.2009.44; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Wang H, 2004, J CELL BIOL, V164, P935, DOI 10.1083/jcb.200309112; Weil RJ, 2005, AM J PATHOL, V167, P913, DOI 10.1016/S0002-9440(10)61180-7; Wong CW, 2002, AM J PATHOL, V161, P749, DOI 10.1016/S0002-9440(10)64233-2; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009	60	3185	3346	41	1325	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 25	2011	331	6024					1559	1564		10.1126/science.1203543	http://dx.doi.org/10.1126/science.1203543			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21436443				2022-12-28	WOS:000288754500044
J	Eisenstein, M				Eisenstein, Michael			VACCINES Know your enemy	NATURE			English	Editorial Material							CARCINOMA											Chang MH, 2009, JNCI-J NATL CANCER I, V101, P1348, DOI 10.1093/jnci/djp288; De Giovanni C, 2004, CANCER RES, V64, P4001, DOI 10.1158/0008-5472.CAN-03-2984; Gray A, 2009, VACCINE, V27, pG52, DOI 10.1016/j.vaccine.2009.09.106; Jaini R, 2010, NAT MED, V16, P799, DOI 10.1038/nm.2161; Malfertheiner P, 2008, GASTROENTEROLOGY, V135, P787, DOI 10.1053/j.gastro.2008.05.054	5	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					S8	S9		10.1038/471S8a	http://dx.doi.org/10.1038/471S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430720	hybrid			2022-12-28	WOS:000288702200010
J	Smyth, RL				Smyth, Rosalind L.			Lessons from normal heart and respiratory rates in children	LANCET			English	Editorial Material							RATE-VARIABILITY; SCORE; AGE		[Smyth, Rosalind L.] Univ Liverpool, Inst Translat Med, Liverpool L12 2AP, Merseyside, England; [Smyth, Rosalind L.] Alder Hey Childrens Hosp, Liverpool L12 2AP, Merseyside, England	University of Liverpool; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital	Smyth, RL (corresponding author), Univ Liverpool, Inst Translat Med, Liverpool L12 2AP, Merseyside, England.	r.l.smyth@liv.ac.uk						Agelink MW, 2001, CLIN AUTON RES, V11, P99, DOI 10.1007/BF02322053; Akre M, 2010, PEDIATRICS, V125, pE763, DOI 10.1542/peds.2009-0338; Egdell P, 2008, EMERG MED J, V25, P745, DOI 10.1136/emj.2007.054965; Fleming S, 2011, LANCET, V377, P1011, DOI 10.1016/S0140-6736(10)62226-X; National Collaborating Centre for Women's and Children's Health, 2007, FEV ILLN CHILDR ASS; *NHS I INN IMPR, 2009, RED PAED ADM; Stein PK, 1997, AM J CARDIOL, V80, P302, DOI 10.1016/S0002-9149(97)00350-0; Van den Bruel A, 2010, LANCET, V375, P834, DOI 10.1016/S0140-6736(09)62000-6; *WHO, 2010, TECHN BAS WHO REC MA; Wright CM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1140	10	6	6	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 19	2011	377	9770					974	975		10.1016/S0140-6736(11)60102-5	http://dx.doi.org/10.1016/S0140-6736(11)60102-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	740FA	21411135				2022-12-28	WOS:000288775800007
J	Seebacher, J; Gavin, AC				Seebacher, Jan; Gavin, Anne-Claude			SnapShot: Protein-Protein Interaction Networks	CELL			English	Editorial Material							ORGANIZATION; MAP		[Seebacher, Jan; Gavin, Anne-Claude] EMBL, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Seebacher, J (corresponding author), EMBL, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany.			Gavin, Anne-Claude/0000-0003-4917-2340				Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Orchard S, 2007, NAT BIOTECHNOL, V25, P894, DOI 10.1038/nbt1324; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Yamada T, 2009, NAT REV MOL CELL BIO, V10, P791, DOI 10.1038/nrm2787; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	8	47	49	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 18	2011	144	6					1000	U1		10.1016/j.cell.2011.02.025	http://dx.doi.org/10.1016/j.cell.2011.02.025			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	737BQ	21414489	Bronze, Green Published			2022-12-28	WOS:000288543500016
J	Soutourina, J; Wydau, S; Ambroise, Y; Boschiero, C; Werner, M				Soutourina, Julie; Wydau, Sandra; Ambroise, Yves; Boschiero, Claire; Werner, Michel			Direct Interaction of RNA Polymerase II and Mediator Required for Transcription in Vivo	SCIENCE			English	Article							REPEAT DOMAIN; ACTIVATION; PROTEIN; YEAST; COMPLEX; RESOLUTION; GENOME; HOLOENZYME; INITIATION; MECHANISM	Gene transcription is highly regulated. Altered transcription can lead to cancer or developmental diseases. Mediator, a multisubunit complex conserved among eukaryotes, is generally required for RNA polymerase II (Pol II) transcription. An interaction between the two complexes is known, but its molecular nature and physiological role are unclear. We identify a direct physical interaction between the Rpb3 Pol II subunit of Saccharomyces cerevisiae and the essential Mediator subunit, Med17. Furthermore, we demonstrate a functional element in the Mediator-Pol II interface that is important for genome-wide Pol II recruitment in vivo. Our findings suggest that a direct interaction between Mediator and Pol II is generally required for transcription of class II genes in eukaryotes.	[Soutourina, Julie; Wydau, Sandra; Boschiero, Claire; Werner, Michel] Commissariat Energie Atom & Energies Alternat CEA, IBiTec S, Serv Biol Integrat & Genet Mol, F-91191 Gif Sur Yvette, France; [Ambroise, Yves] CEA, IBiTec S, Serv Chim Bioorgan & Marquage, F-91191 Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Soutourina, J (corresponding author), Commissariat Energie Atom & Energies Alternat CEA, IBiTec S, Serv Biol Integrat & Genet Mol, F-91191 Gif Sur Yvette, France.	julie.soutourina@cea.fr; michel.werner@cea.fr	Soutourina, Julie/F-8305-2014; Werner, Michel/B-7316-2009	Soutourina, Julie/0000-0001-5218-2350; Werner, Michel/0000-0002-2965-5858; Ambroise, Yves/0000-0001-7174-9914; Wydau-Dematteis, Sandra/0000-0003-2023-3656	Agence Nationale de la Recherche [ANR-08-BLAN-0229]; Association pour la Recherche sur le Cancer [5118]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	We thank N. Woychik, P. Thuriaux, O. Gadal, and B. Guglielmi for strains or plasmids; S. Hahn and M. Ptashne for antibodies; the Service de Pharmacologie et d'Immuno Analyse (CEA/Saclay) for monoclonal antibodies; A. Sentenac, A. W. Rutherford, and P. Thuriaux for discussions and critical reading of the manuscript; P. Thuriaux for help with crystal-structures visualization; Y. Ghavi-Helm and M. Pinskaya for help with ChIP-chip data analyses; and B. Guglielmi for initial interest in Mediator-Pol II interaction. This work was supported by the Agence Nationale de la Recherche (ANR-08-BLAN-0229) and Association pour la Recherche sur le Cancer (subvention fixe 5118). J.S. and S. W. performed the experimental work and analyzed the results, Y. A. participated in photo-cross-linking experiments and C. B. in yeast-strain constructions, and J.S. and M. W. designed the research and wrote the manuscript. Raw ChIP-chip data are available at Array Express under accession number E-MEXP-3043 (www.ebi.ac.uk/arrayexpress).	Andrau JC, 2006, MOL CELL, V22, P179, DOI 10.1016/j.molcel.2006.03.023; Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Cai G, 2010, NAT STRUCT MOL BIOL, V17, P273, DOI 10.1038/nsmb.1757; Cai G, 2009, STRUCTURE, V17, P559, DOI 10.1016/j.str.2009.01.016; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Esnault C, 2008, MOL CELL, V31, P337, DOI 10.1016/j.molcel.2008.06.021; Guglielmi B, 2004, NUCLEIC ACIDS RES, V32, P5379, DOI 10.1093/nar/gkh878; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; KOLESKE AJ, 1994, NATURE, V368, P466, DOI 10.1038/368466a0; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Mehta S, 2009, FEBS LETT, V583, P3115, DOI 10.1016/j.febslet.2009.08.036; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; NONET ML, 1989, GENETICS, V123, P715; Suchanek M, 2005, NAT METHODS, V2, P261, DOI 10.1038/NMETH752; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Tan Q, 2000, GENE DEV, V14, P339; Tardiff DF, 2007, P NATL ACAD SCI USA, V104, P19948, DOI 10.1073/pnas.0710179104; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; Zhu XF, 2006, MOL CELL, V22, P169, DOI 10.1016/j.molcel.2006.03.032	24	105	108	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2011	331	6023					1451	1454		10.1126/science.1200188	http://dx.doi.org/10.1126/science.1200188			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21415355				2022-12-28	WOS:000288504000045
J	Sloan, RP				Sloan, Richard P.			The art of medicine Virtue and vice in health and illness: the idea that wouldn't die	LANCET			English	Editorial Material									Columbia Univ, Med Ctr, New York, NY 10032 USA	Columbia University	Sloan, RP (corresponding author), Columbia Univ, Med Ctr, New York, NY 10032 USA.	rps7@columbia.edu							0	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 12	2011	377	9769					896	897		10.1016/S0140-6736(11)60339-5	http://dx.doi.org/10.1016/S0140-6736(11)60339-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	738GR	21409785				2022-12-28	WOS:000288628800018
J	Yang, ZP; Fan, DM				Yang, Zhiping; Fan, Daiming			How to solve the crisis behind Bribegate for Chinese doctors	LANCET			English	Editorial Material									[Yang, Zhiping; Fan, Daiming] Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian 710032, Peoples R China	Air Force Military Medical University	Fan, DM (corresponding author), Fourth Mil Med Univ, Xijing Hosp Digest Dis, Xian 710032, Peoples R China.	fandaim@fmmu.edu.cn						[Anonymous], 2008, XINHUANET       0316; [Anonymous], 2010, ENGLISH XINHUAN 1118; [Anonymous], 2010, ENGLISH XINHUAN 1117; Bai J., 2010, PEOPLE DAILY    1117; Cang W, 2010, CHINA DAILY     1118; Li R., 2006, MED IND INFORM, V3, P41; Luo Z., 2006, XINHUANET       0810; Pan X., 2009, CHINA HOSP CEO, V5, P93; Qiu L, 2010, CHINA DAILY     1111; Wang C., 2004, COMMON PEOPLE, V4, P8; Wu M., 2009, J SOC SCI HUNAN MED, V11, P19; Yang T, 2008, LANCET, V371, P1576	12	16	16	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 21	2012	379	9812					E13	E15		10.1016/S0140-6736(11)60137-2	http://dx.doi.org/10.1016/S0140-6736(11)60137-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	879FW	21420729				2022-12-28	WOS:000299316100002
J	Winslow, MM; Dayton, TL; Verhaak, RGW; Kim-Kiselak, C; Snyder, EL; Feldser, DM; Hubbard, DD; DuPage, MJ; Whittaker, CA; Hoersch, S; Yoon, S; Crowley, D; Bronson, RT; Chiang, DY; Meyerson, M; Jacks, T				Winslow, Monte M.; Dayton, Talya L.; Verhaak, Roel G. W.; Kim-Kiselak, Caroline; Snyder, Eric L.; Feldser, David M.; Hubbard, Diana D.; DuPage, Michel J.; Whittaker, Charles A.; Hoersch, Sebastian; Yoon, Stephanie; Crowley, Denise; Bronson, Roderick T.; Chiang, Derek Y.; Meyerson, Matthew; Jacks, Tyler			Suppression of lung adenocarcinoma progression by Nkx2-1	NATURE			English	Article							EMBRYONIC STEM-CELLS; CLINICAL-SIGNIFICANCE; PROTEIN EXPRESSION; BREAST-CANCER; SELF-RENEWAL; HMGI-C; K-RAS; METASTASIS; P53; ONCOGENE	Despite the high prevalence and poor outcome of patients with metastatic lung cancer the mechanisms of tumour progression and metastasis remain largely uncharacterized. Here we modelled human lung adenocarcinoma, which frequently harbours activating point mutations in KRAS(1) and inactivation of the p53 pathway(2), using conditional alleles in mice(3-5). Lentiviral-mediated somatic activation of oncogenic Kras and deletion of p53 in the lung epithelial cells of Kras(LSL-G12D/+); p53(flox/flox) mice initiates lung adenocarcinoma development(4). Although tumours are initiated synchronously by defined genetic alterations, only a subset becomes malignant, indicating that disease progression requires additional alterations. Identification of the lentiviral integration sites allowed us to distinguish metastatic from non-metastatic tumours and determine the gene expression alterations that distinguish these tumour types. Cross-species analysis identified the NK2-related homeobox transcription factor Nkx2-1 (also called Ttf-1 or Titf1) as a candidate suppressor of malignant progression. In this mouse model, Nkx2-1 negativity is pathognomonic of high-grade poorly differentiated tumours. Gain-and loss-of-function experiments in cells derived from metastatic and non-metastatic tumours demonstrated that Nkx2-1 controls tumour differentiation and limits metastatic potential in vivo. Interrogation of Nkx2-1-regulated genes, analysis of tumours at defined developmental stages, and functional complementation experiments indicate that Nkx2-1 constrains tumours in part by repressing the embryonically restricted chromatin regulator Hmga(2). Whereas focal amplification of NKX2-1 in a fraction of human lung adenocarcinomas has focused attention on its oncogenic function(6-9), our data specifically link Nkx2-1 downregulation to loss of differentiation, enhanced tumour seeding ability and increased metastatic proclivity. Thus, the oncogenic and suppressive functions of Nkx2-1 in the same tumour type substantiate its role as a dual function lineage factor.	[Winslow, Monte M.; Dayton, Talya L.; Kim-Kiselak, Caroline; Snyder, Eric L.; Feldser, David M.; DuPage, Michel J.; Whittaker, Charles A.; Hoersch, Sebastian; Yoon, Stephanie; Crowley, Denise; Jacks, Tyler] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Winslow, Monte M.; Kim-Kiselak, Caroline; Jacks, Tyler] MIT, Ludwig Ctr Mol Oncol, Cambridge, MA 02139 USA; [Verhaak, Roel G. W.; Hubbard, Diana D.; Chiang, Derek Y.; Meyerson, Matthew] Harvard Univ, Dana Farber Canc Inst, Cambridge, MA 02115 USA; [Verhaak, Roel G. W.; Hubbard, Diana D.; Chiang, Derek Y.; Meyerson, Matthew] Broad Inst, Cambridge, MA 02142 USA; [Bronson, Roderick T.] Tufts Univ, Sch Vet, Dept Biomed Sci, North Grafton, MA 01536 USA; [Chiang, Derek Y.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02139 USA; [Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Tufts University; University of North Carolina; University of North Carolina Chapel Hill; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Jacks, T (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tjacks@mit.edu	Chiang, Derek/L-6452-2019; Verhaak, Roel/ABE-7058-2020; Meyerson, Matthew L/E-7123-2012	Chiang, Derek/0000-0002-1131-6065; Whittaker, Charles/0000-0002-2400-0094; Dayton, Talya/0000-0002-7994-7963; Meyerson, Matthew/0000-0002-9133-8108	Genentech; Dutch Cancer Society KWF; Alfred P. Sloan Foundation; National Institutes of Health [U01-CA84306, K99-CA151968]; Howard Hughes Medical Institute; Ludwig Center for Molecular Oncology at MIT; National Cancer Institute [P30-CA14051];  [T32-HL007627]; NATIONAL CANCER INSTITUTE [K08CA154784, R00CA151968, U01CA084306, P30CA014051, K99CA151968, R01CA109038] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007627] Funding Source: NIH RePORTER	Genentech(Roche HoldingGenentech); Dutch Cancer Society KWF(KWF Kankerbestrijding); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ludwig Center for Molecular Oncology at MIT; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank A. Dooley, N. Dimitrova, T. Oliver and M. Ebert for providing reagents; M. Luo (Biology/Koch Institute BioMicro Core) for array processing; M. Kumar for experimental assistance; T. Staton, D. McFadden, A. Shaw and the entire T.J. laboratory for comments. M.M.W. was a Merck Fellow of the Damon Runyon Cancer Research Foundation and was funded by a Genentech Postdoctoral Fellowship. R. G. W. V. is supported by a Fellowship from the Dutch Cancer Society KWF. E.L.S. is supported by a training grant (T32-HL007627). D.Y.C. is supported by an Alfred P. Sloan Foundation Research Fellowship. D.M.F. is a Leukemia and Lymphoma Postdoctoral Fellow. This work was supported by National Institutes of Health grants U01-CA84306 (to T.J.) and K99-CA151968 (to M.M.W.), the Howard Hughes Medical Institute, the Ludwig Center for Molecular Oncology at MIT, and in part by the Cancer Center Support (core) grant P30-CA14051 from the National Cancer Institute. T.J. is the David H. Koch Professor of Biology and a Daniel K. Ludwig Scholar.	Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barletta JA, 2009, J CELL MOL MED, V13, P1977, DOI 10.1111/j.1582-4934.2008.00594.x; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bengtsson H, 2009, BIOINFORMATICS, V25, P861, DOI 10.1093/bioinformatics/btp074; Berghmans T, 2006, ANN ONCOL, V17, P1673, DOI 10.1093/annonc/mdl287; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Di Cello F, 2008, MOL CANCER RES, V6, P743, DOI 10.1158/1541-7786.MCR-07-0095; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hristov AC, 2009, MODERN PATHOL, V22, P43, DOI 10.1038/modpathol.2008.140; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Krude H, 2002, J CLIN INVEST, V109, P475, DOI 10.1172/JC1200214341; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Kwei KA, 2008, ONCOGENE, V27, P3635, DOI 10.1038/sj.onc.1211012; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Li O, 2006, GENESIS, V44, P523, DOI 10.1002/dvg.20242; Liu HF, 2007, BIOINFORMATICS, V23, P2385, DOI 10.1093/bioinformatics/btm360; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Meyer B, 2007, MOL CARCINOGEN, V46, P503, DOI 10.1002/mc.20235; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Morimoto-Tomita M, 2005, CLIN EXP METASTAS, V22, P513, DOI 10.1007/s10585-005-3585-0; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Purdom E, 2008, BIOINFORMATICS, V24, P1707, DOI 10.1093/bioinformatics/btn284; *R DEV COR TEAM, 2005, R LANG ENV STAT COMP; RODENHUIS S, 1988, CANCER RES, V48, P5738; Rogalla P, 1997, MOL CARCINOGEN, V19, P153, DOI 10.1002/(SICI)1098-2744(199707)19:3<153::AID-MC2>3.0.CO;2-F; Rommel B, 1997, LEUKEMIA LYMPHOMA, V26, P603, DOI 10.3109/10428199709050896; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; Tanaka H, 2007, CANCER RES, V67, P6007, DOI 10.1158/0008-5472.CAN-06-4774; Trono D, 2000, GENE THER, V7, P20, DOI 10.1038/sj.gt.3301105; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	49	303	322	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 5	2011	473	7345					101	U120		10.1038/nature09881	http://dx.doi.org/10.1038/nature09881			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	759CQ	21471965	Green Accepted, Green Submitted			2022-12-28	WOS:000290218300039
J	Grove, TL; Benner, JS; Radle, MI; Ahlum, JH; Landgraf, BJ; Krebs, C; Booker, SJ				Grove, Tyler L.; Benner, Jack S.; Radle, Matthew I.; Ahlum, Jessica H.; Landgraf, Bradley J.; Krebs, Carsten; Booker, Squire J.			A Radically Different Mechanism for S-Adenosylmethionine-Dependent Methyltransferases	SCIENCE			English	Article							RIBOSOMAL-RNA METHYLTRANSFERASE; CONFERS ANTIBIOTIC-RESISTANCE; CATECHOL O-METHYLTRANSFERASE; BACTERIAL RIBOSOME; BIOTIN SYNTHASE; SAM; CFR; RESOLUTION; GENE; COLI	Methylation of small molecules and macromolecules is crucial in metabolism, cell signaling, and epigenetic programming and is most often achieved by S-adenosylmethionine (SAM)-dependent methyltransferases. Most employ an S(N)2 mechanism to methylate nucleophilic sites on their substrates, but recently, radical SAM enzymes have been identified that methylate carbon atoms that are not inherently nucleophilic via the intermediacy of a 5'-deoxyadenosyl 5'-radical. We have determined the mechanisms of two such reactions targeting the sp(2)-hybridized carbons at positions 2 and 8 of adenosine 2503 in 23S ribosomal RNA, catalyzed by RlmN and Cfr, respectively. In neither case is a methyl group transferred directly from SAM to the RNA; rather, both reactions proceed by a ping-pong mechanism involving intermediate methylation of a conserved cysteine residue.	[Grove, Tyler L.; Radle, Matthew I.; Ahlum, Jessica H.; Landgraf, Bradley J.; Krebs, Carsten; Booker, Squire J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Benner, Jack S.] New England Biolabs Inc, Div Chem Biol, Ipswich, MA 01938 USA; [Krebs, Carsten; Booker, Squire J.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; New England Biolabs; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Booker, SJ (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	squire@psu.edu	Squire, Jeremy A/A-9352-2012; Krebs, Carsten/D-4773-2009	Squire, Jeremy A/0000-0002-9863-468X; Krebs, Carsten/0000-0002-3302-7053	NIH [GM-63847]; American Chemical Society [46065-AC4]; Dreyfus Foundation; Beckman Foundation; New England Biolabs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063847, R01GM101957] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Chemical Society(American Chemical Society); Dreyfus Foundation; Beckman Foundation; New England Biolabs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Martin Bollinger Jr. for a critical reading of the manuscript and helpful discussions, L. Saleh for assistance, H. Noller and L. Lancaster for plasmid pKK3535, S. Tan for E. coli strain B834(DE3)pLysS, and P. Bevilacqua for a plasmid-encoding hexahistidine-tagged T7 RNA polymerase and his research group for sharing their expertise in RNA manipulation. This work was supported by NIH grant GM-63847 and American Chemical Society-Petroleum Research Fund grant 46065-AC4 (S. J. B.), the Dreyfus Foundation (Teacher Scholar Award to C. K.), the Beckman Foundation (Young Investigator Award to C. K.), and New England Biolabs (J.S.B).	Atta M, 2010, CURR OPIN STRUC BIOL, V20, P684, DOI 10.1016/j.sbi.2010.09.009; Ban N, 1998, CELL, V93, P1105, DOI 10.1016/S0092-8674(00)81455-5; Booker SJ, 2009, CURR OPIN CHEM BIOL, V13, P58, DOI 10.1016/j.cbpa.2009.02.036; Booth MPS, 2010, PROTEIN EXPRES PURIF, V74, P204, DOI 10.1016/j.pep.2010.07.010; Chow CS, 2007, ACS CHEM BIOL, V2, P610, DOI 10.1021/cb7001494; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P6378, DOI 10.1021/bi049528x; Frey P. A., 2007, ENZYMATIC REACTION M; Frey PA, 2001, ADV PROTEIN CHEM, V58, P1; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Giessing AMB, 2009, RNA, V15, P327, DOI 10.1261/rna.1371409; Grove TL, 2010, BIOCHEMISTRY-US, V49, P3783, DOI 10.1021/bi9022126; Guianvarc'h D, 1997, BIOCHEM BIOPH RES CO, V236, P402, DOI 10.1006/bbrc.1997.6952; Harms J, 2001, CELL, V107, P679, DOI 10.1016/S0092-8674(01)00546-3; HEGAZI MF, 1979, J AM CHEM SOC, V101, P4359, DOI 10.1021/ja00509a052; Kaczanowska M, 2007, MICROBIOL MOL BIOL R, V71, P477, DOI 10.1128/MMBR.00013-07; Kaminska KH, 2010, NUCLEIC ACIDS RES, V38, P1652, DOI 10.1093/nar/gkp1142; Kehrenberg C, 2005, MOL MICROBIOL, V57, P1064, DOI 10.1111/j.1365-2958.2005.04754.x; KOWALAK JA, 1995, J BIOL CHEM, V270, P17758, DOI 10.1074/jbc.270.30.17758; Kudo F, 2007, J ANTIBIOT, V60, P492, DOI 10.1038/ja.2007.63; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; Poehlsgaard J, 2005, NAT REV MICROBIOL, V3, P870, DOI 10.1038/nrmicro1265; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Schwarz S, 2000, ANTIMICROB AGENTS CH, V44, P2530, DOI 10.1128/AAC.44.9.2530-2533.2000; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Seto H, 1999, NAT PROD REP, V16, P589, DOI 10.1039/a809398i; Silverman R.B., 2002, ORGANIC CHEM ENZYME, V2nd; Smith LK, 2008, ANTIMICROB AGENTS CH, V52, P1703, DOI 10.1128/AAC.01583-07; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Steitz TA, 2010, ANGEW CHEM INT EDIT, V49, P4381, DOI 10.1002/anie.201000708; Taylor AM, 2008, BIOCHEMISTRY-US, V47, P9309, DOI 10.1021/bi801035b; Toh SM, 2007, MOL MICROBIOL, V64, P1506, DOI 10.1111/j.1365-2958.2007.05744.x; Toh SM, 2008, RNA, V14, P98, DOI 10.1261/rna.814408; van der Donk WA, 2006, J ORG CHEM, V71, P9561, DOI 10.1021/jo0614240; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P577, DOI 10.1128/AAC.39.3.577; WOODARD RW, 1980, J BIOL CHEM, V255, P9124; WU WM, 1995, BIOCHEMISTRY-US, V34, P10532, DOI 10.1021/bi00033a027; Yan F, 2010, J AM CHEM SOC, V132, P3953, DOI 10.1021/ja910850y	38	165	172	4	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2011	332	6029					604	607		10.1126/science.1200877	http://dx.doi.org/10.1126/science.1200877			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21415317				2022-12-28	WOS:000289991100053
J	Luz, D; Berry, DL; Piccioni, G; Drossart, P; Politi, R; Wilson, CF; Erard, S; Nuccilli, F				Luz, D.; Berry, D. L.; Piccioni, G.; Drossart, P.; Politi, R.; Wilson, C. F.; Erard, S.; Nuccilli, F.			Venus's Southern Polar Vortex Reveals Precessing Circulation	SCIENCE			English	Article							CLOUD; ROTATION; DYNAMICS; GALILEO; IMAGES; LAYER; WINDS	Initial images of Venus's south pole by the Venus Express mission have shown the presence of a bright, highly variable vortex, similar to that at the planet's north pole. Using high-resolution infrared measurements of polar winds from the Venus Express Visible and Infrared Thermal Imaging Spectrometer (VIRTIS) instrument, we show the vortex to have a constantly varying internal structure, with a center of rotation displaced from the geographic south pole by similar to 3 degrees of latitude and that drifts around the pole with a period of 5 to 10 Earth days. This is indicative of a nonsymmetric and varying precession of the polar atmospheric circulation with respect to the planetary axis.	[Luz, D.] Univ Lisbon, Ctr Astron & Astrofis, Observ Astron Lisboa, P-1349018 Lisbon, Portugal; [Berry, D. L.] Univ Evora, Dept Fis, P-7002554 Evora, Portugal; [Piccioni, G.; Politi, R.] Ist Astrofis Spaziale & Fis Cosm INAF IASF Rome, Ist Nazl Astrofis, I-00133 Rome, Italy; [Drossart, P.; Erard, S.] Univ Paris Diderot, Univ Paris 06, Observ Paris, Lab Etud Spatiales & Instrumentat Astrophys,CNRS, F-92195 Meudon, France; [Wilson, C. F.] Univ Oxford, Dept Phys, Oxford OX1 3PU, England; [Nuccilli, F.] INAF Ist Fis Spazio Interplanetario IFSI Rome, I-00133 Rome, Italy	Universidade de Lisboa; University of Evora; Istituto Nazionale Astrofisica (INAF); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; University of Oxford	Luz, D (corresponding author), Univ Lisbon, Ctr Astron & Astrofis, Observ Astron Lisboa, P-1349018 Lisbon, Portugal.	dluz@oal.ul.pt	Piccioni, Giuseppe/T-9272-2017; Drossart, Pierre/H-8670-2013; Luz, David/J-4588-2013; Wilson, Colin/AAI-3307-2020	Piccioni, Giuseppe/0000-0002-7893-6808; Luz, David/0000-0002-9473-8035; Wilson, Colin/0000-0001-5355-1533; Erard, Stephane/0000-0002-9099-8366; Berry, David L./0000-0001-9075-5746; Politi, Romolo/0000-0002-9793-9780	Fundacao para a Ciencia e a Tecnologia [PTDC/CTE-AST/110702/2009]; UK's Science and Technology Facilities Council; European Space Agency (ESA); Agenzia Spaziale Italiana; Centre National d'Etudes Spatiales; VIRTIS/VEX technical team	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); UK's Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); European Space Agency (ESA)(European Space AgencyEuropean Commission); Agenzia Spaziale Italiana(Agenzia Spaziale Italiana (ASI)); Centre National d'Etudes Spatiales(Centre National D'etudes Spatiales); VIRTIS/VEX technical team	D.L. and D.L.B. acknowledge support from Fundacao para a Ciencia e a Tecnologia project PTDC/CTE-AST/110702/2009, and C.F.W. from the UK's Science and Technology Facilities Council and from the European Space Agency (ESA). The authors thank ESA, Agenzia Spaziale Italiana, Centre National d'Etudes Spatiales, and the other national agencies for supporting the Venus Express mission and acknowledge support from the VIRTIS/VEX technical team. They are also grateful to three anonymous referees for constructive comments.	Dyudina UA, 2009, ICARUS, V202, P240, DOI 10.1016/j.icarus.2009.02.014; Gierasch P., 1997, VENUS; GIERASCH PJ, 1975, J ATMOS SCI, V32, P1038, DOI 10.1175/1520-0469(1975)032<1038:MCATMO>2.0.CO;2; HIDE R, 1969, J ATMOS SCI, V26, P841, DOI 10.1175/1520-0469(1969)026<0841:DOTAOT>2.0.CO;2; Ignatiev NI, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2008JE003320; Irwin PGJ, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003093; Limaye SS, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002814; Limaye SS, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036093; LIMAYE SS, 1981, J ATMOS SCI, V38, P1220, DOI 10.1175/1520-0469(1981)038<1220:CMOVGS>2.0.CO;2; Markiewicz WJ, 2007, NATURE, V450, P633, DOI 10.1038/nature06320; MAROV MY, 1978, ANNU REV ASTRON ASTR, V16, P141, DOI 10.1146/annurev.aa.16.090178.001041; Moissl R, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2008JE003117; Peralta J, 2007, ICARUS, V190, P469, DOI 10.1016/j.icarus.2007.03.028; Piccioni G, 2007, NATURE, V450, P637, DOI 10.1038/nature06209; ROSSOW WB, 1979, J ATMOS SCI, V36, P377, DOI 10.1175/1520-0469(1979)036<0377:LSMITV>2.0.CO;2; ROSSOW WB, 1990, J ATMOS SCI, V47, P2053, DOI 10.1175/1520-0469(1990)047<2053:CTWFVO>2.0.CO;2; Sanchez-Lavega A, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033817; SCHOFIELD JT, 1983, NATURE, V305, P116, DOI 10.1038/305116a0; SCHUBERT G, 1983, VENUS; SUOMI VE, 1978, SCIENCE, V201, P1009, DOI 10.1126/science.201.4360.1009; Taylor FW, 1980, J GEOPHYS RES-SPACE, V85, P7963, DOI 10.1029/JA085iA13p07963; TAYLOR FW, 1979, NATURE, V279, P613, DOI 10.1038/279613a0; TOIGO A, 1994, ICARUS, V109, P318, DOI 10.1006/icar.1994.1097	23	46	47	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 29	2011	332	6029					577	580		10.1126/science.1201629	http://dx.doi.org/10.1126/science.1201629			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	756DE	21474710	Green Published			2022-12-28	WOS:000289991100045
J	Bonow, RO; Maurer, G; Lee, KL; Holly, TA; Binkley, PF; Desvigne-Nickens, P; Drozdz, J; Farsky, PS; Feldman, AM; Doenst, T; Michler, RE; Berman, DS; Nicolau, JC; Pellikka, PA; Wrobel, K; Alotti, N; Asch, FM; Favaloro, LE; She, LL; Velazquez, EJ; Jones, RH; Panza, JA				Bonow, Robert O.; Maurer, Gerald; Lee, Kerry L.; Holly, Thomas A.; Binkley, Philip F.; Desvigne-Nickens, Patrice; Drozdz, Jaroslaw; Farsky, Pedro S.; Feldman, Arthur M.; Doenst, Torsten; Michler, Robert E.; Berman, Daniel S.; Nicolau, Jose C.; Pellikka, Patricia A.; Wrobel, Krzysztof; Alotti, Nasri; Asch, Federico M.; Favaloro, Liliana E.; She, Lilin; Velazquez, Eric J.; Jones, Robert H.; Panza, Julio A.		STICH Trial Investigators	Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-ARTERY-DISEASE; DOSE DOBUTAMINE ECHOCARDIOGRAPHY; POSITRON-EMISSION-TOMOGRAPHY; BETA-BLOCKER THERAPY; LONG-TERM SURVIVAL; PROGNOSTIC VALUE; HEART-FAILURE; HIBERNATING MYOCARDIUM; CONTRACTILE RESERVE; SURGICAL-TREATMENT	BACKGROUND The assessment of myocardial viability has been used to identify patients with coronary artery disease and left ventricular dysfunction in whom coronary-artery bypass grafting (CABG) will provide a survival benefit. However, the efficacy of this approach is uncertain. METHODS In a substudy of patients with coronary artery disease and left ventricular dysfunction who were enrolled in a randomized trial of medical therapy with or without CABG, we used single-photon-emission computed tomography (SPECT), dobutamine echocardiography, or both to assess myocardial viability on the basis of pre-specified thresholds. RESULTS Among the 1212 patients enrolled in the randomized trial, 601 underwent assessment of myocardial viability. Of these patients, we randomly assigned 298 to receive medical therapy plus CABG and 303 to receive medical therapy alone. A total of 178 of 487 patients with viable myocardium (37%) and 58 of 114 patients without viable myocardium (51%) died (hazard ratio for death among patients with viable myocardium, 0.64; 95% confidence interval [CI], 0.48 to 0.86; P = 0.003). However, after adjustment for other baseline variables, this association with mortality was not significant (P = 0.21). There was no significant interaction between viability status and treatment assignment with respect to mortality (P = 0.53). CONCLUSIONS The presence of viable myocardium was associated with a greater likelihood of survival in patients with coronary artery disease and left ventricular dysfunction, but this relationship was not significant after adjustment for other baseline variables. The assessment of myocardial viability did not identify patients with a differential survival benefit from CABG, as compared with medical therapy alone.	[Bonow, Robert O.] Northwestern Univ, Ctr Cardiovasc Innovat, Feinberg Sch Med, Chicago, IL 60611 USA; [Maurer, Gerald] Med Univ Vienna, Vienna, Austria; [Lee, Kerry L.; She, Lilin; Velazquez, Eric J.; Jones, Robert H.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Binkley, Philip F.] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA; [Desvigne-Nickens, Patrice] NHLBI, Bethesda, MD 20892 USA; [Drozdz, Jaroslaw] Med Univ Lodz, Lodz, Poland; [Wrobel, Krzysztof] John Paul 2 Hosp, Krakow, Poland; [Farsky, Pedro S.] Univ Sao Paulo, Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil; [Nicolau, Jose C.] Univ Sao Paulo, Hosp Clin, Fac Med, Inst Coracao, Sao Paulo, Brazil; [Feldman, Arthur M.] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA; [Doenst, Torsten] Univ Leipzig, Ctr Heart, Leipzig, Germany; [Michler, Robert E.] Albert Einstein Coll Med, Montefiore Med Ctr, New York, NY USA; [Berman, Daniel S.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Pellikka, Patricia A.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA; [Alotti, Nasri] Zala Cty Hosp, Zalaegerszeg, Hungary; [Asch, Federico M.; Panza, Julio A.] Washington Hosp Ctr, Washington, DC 20010 USA; [Favaloro, Liliana E.] Univ Hosp, Favaloro Fdn, Buenos Aires, DF, Argentina	Northwestern University; Feinberg School of Medicine; Medical University of Vienna; Duke University; University System of Ohio; Ohio State University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Medical University Lodz; Instituto Dante Pazzanese de Cardiologia; Universidade de Sao Paulo; Universidade de Sao Paulo; Jefferson University; Heart Center Leipzig GMBH; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Montefiore Medical Center; Yeshiva University; Cedars Sinai Medical Center; Mayo Clinic; MedStar Washington Hospital Center; University of Buenos Aires	Bonow, RO (corresponding author), Northwestern Univ, Ctr Cardiovasc Innovat, Feinberg Sch Med, 645 N Michigan Ave,Suite 1006, Chicago, IL 60611 USA.	r-bonow@northwestern.edu	Binkley, Philip/E-2759-2011; Senni, Michele/J-9380-2018; Siepe, Matthias/AAF-9846-2019; Drozdz, Jaroslaw/K-8951-2012; Nicolau, Jose C/E-1487-2012; menicanti, lorenzo/K-5649-2018; Pellikka, Patricia A/N-5387-2014; Crestanello, Juan/E-2930-2011; Asch, Federico/AAS-7653-2021	Senni, Michele/0000-0001-5502-7882; Siepe, Matthias/0000-0003-3305-9343; Nicolau, Jose C/0000-0002-9680-3689; menicanti, lorenzo/0000-0001-8530-6284; Pellikka, Patricia A/0000-0001-6800-3521; Asch, Federico/0000-0002-1744-5271; Maurer, Gerald/0000-0002-9043-7657; Golba, Krzysztof/0000-0001-5722-7976; Bochenek, Andrzej/0000-0002-3046-3001; Varga-Szemes, Akos/0000-0002-2781-7462; Drozdz, Jaroslaw/0000-0002-0732-2104	National Heart, Lung, and Blood Institute [U01-HL-069009, HL-069010, HL-069011, HL-069012, HL-069012-03, HL-069013, HL-069015, HL-070011, HL-072683]; Sorin; Astellas Healthcare; Bracco; Lantheus Medical Imaging; Mitralign; RegeneRx; Novartis; Gilead; Boehringer Ingelheim Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL069012, R01HL105853, U01HL069013, U01HL072683, U01HL069015, U01HL069011, U01HL070011, U01HL069009, R01HL070011, U01HL069010] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Sorin; Astellas Healthcare; Bracco; Lantheus Medical Imaging; Mitralign; RegeneRx; Novartis(Novartis); Gilead(Gilead Sciences); Boehringer Ingelheim Pharmaceuticals(Boehringer Ingelheim); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by cooperative agreements (U01-HL-069009, HL-069010, HL-069011, HL-069012, HL-069012-03, HL-069013, HL-069015, HL-070011, and HL-072683) with the National Heart, Lung, and Blood Institute.; Dr. Feldman reports having an equity interest in Cardiokine; Dr. Michler, receiving grant support from Sorin; Dr. Berman, receiving consulting fees from Astellas Healthcare, Bracco, and Lantheus Medical Imaging and grant support from Lantheus Medical Imaging and Astellas Healthcare and having an equity interest in Spectrum Dynamics; Dr. Asch, being an investigator in studies for which his institution received grant support from Sorin, Mitralign, and RegeneRx; and Dr. Velazquez, receiving consulting fees from Novartis, Gilead, and Boehringer Ingelheim Pharmaceuticals. No other potential conflict of interest relevant to this article was reported.	Afridi I, 1998, J AM COLL CARDIOL, V32, P921, DOI 10.1016/S0735-1097(98)00321-0; Allman KC, 2002, J AM COLL CARDIOL, V39, P1151, DOI 10.1016/S0735-1097(02)01726-6; Anselmi M, 1998, AM J CARDIOL, V81, p21G, DOI 10.1016/S0002-9149(98)00049-6; Beanlands RSB, 2007, J AM COLL CARDIOL, V50, P2002, DOI 10.1016/j.jacc.2007.09.006; Bello D, 2003, CIRCULATION, V108, P1945, DOI 10.1161/01.CIR.0000095029.57483.60; Bourque JM, 2003, AM HEART J, V146, P621, DOI 10.1016/S0002-8703(03)00428-9; Camici PG, 2008, CIRCULATION, V117, P103, DOI 10.1161/CIRCULATIONAHA.107.702993; Chaudhry FA, 1999, J AM COLL CARDIOL, V34, P730, DOI 10.1016/S0735-1097(99)00252-1; Cleland JGF, 2003, LANCET, V362, P14, DOI 10.1016/S0140-6736(03)13801-9; Cuocolo A, 1998, EUR J NUCL MED, V25, P60; DICARLI MF, 1994, AM J CARDIOL, V73, P527, DOI 10.1016/0002-9149(94)90327-1; DILSIZIAN V, 1993, CIRCULATION, V87, P1; Douglas PS, 2009, JACC-CARDIOVASC IMAG, V2, P897, DOI 10.1016/j.jcmg.2009.01.018; ELEFTERIADES JA, 1993, J AM COLL CARDIOL, V22, P1411, DOI 10.1016/0735-1097(93)90551-B; Felker GM, 2002, J AM COLL CARDIOL, V39, P210, DOI 10.1016/S0735-1097(01)01738-7; Gheorghiade M, 2006, CIRCULATION, V114, P1202, DOI 10.1161/CIRCULATIONAHA.106.623199; Gioia G, 1996, J NUCL CARDIOL, V3, P150, DOI 10.1016/S1071-3581(96)90007-0; GIOIA G, 1995, AM J CARDIOL, V75, P759, DOI 10.1016/S0002-9149(99)80406-8; Hage FG, 2010, J NUCL CARDIOL, V17, P378, DOI 10.1007/s12350-010-9199-1; He ZX, 2003, AM J CARDIOL, V92, P696, DOI 10.1016/S0002-9149(03)00827-0; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Jones RH, 2010, J AM COLL CARDIOL, V56, P490, DOI 10.1016/j.jacc.2009.11.102; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; Liao L, 2004, AM J CARDIOL, V93, P1275, DOI 10.1016/j.amjcard.2004.01.071; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Meluzin J, 2003, EUR J HEART FAIL, V5, P85, DOI 10.1016/S1388-9842(02)00089-2; Morse RW, 1999, CHEST, V115, P1621, DOI 10.1378/chest.115.6.1621; Pagley PR, 1997, CIRCULATION, V96, P793; Pasquet A, 1999, CIRCULATION, V100, P141, DOI 10.1161/01.CIR.100.2.141; Petrasinovic Z, 2003, NUCL MED COMMUN, V24, P175, DOI 10.1097/00006231-200302000-00010; Petretta M, 1997, J NUCL MED, V38, P195; Podio V, 2002, NUCL MED COMMUN, V23, P933, DOI 10.1097/00006231-200210000-00002; Sawada SG, 2010, AM J CARDIOL, V106, P187, DOI 10.1016/j.amjcard.2010.03.014; Schinkel AFL, 2007, CURR PROB CARDIOLOGY, V32, P375, DOI 10.1016/j.cpcardiol.2007.04.001; Sciagra R, 2000, J AM COLL CARDIOL, V36, P739, DOI 10.1016/S0735-1097(00)00797-X; Seghatol FF, 2004, AM J CARDIOL, V93, P854, DOI 10.1016/j.amjcard.2003.12.023; Senior R, 1999, J AM COLL CARDIOL, V33, P1848, DOI 10.1016/S0735-1097(99)00102-3; Senior R, 2002, J NUCL CARDIOL, V9, P454, DOI 10.1067/mnc.2002.123913; Shapira Itzhak, 2000, Journal of Medicine (Westbury), V31, P205; Sicari R, 2003, AM J CARDIOL, V92, P1263, DOI 10.1016/j.amjcard.2003.08.004; Sicari R, 2001, EUR HEART J, V22, P837, DOI 10.1053/euhj.2000.2322; Velazquez EJ, 2007, J THORAC CARDIOV SUR, V134, P1540, DOI 10.1016/j.jtcvs.2007.05.069; Velazquez EJ, 2011, NEW ENGL J MED, V364, P1607, DOI 10.1056/NEJMoa1100356; Wellnhofer E, 2004, CIRCULATION, V109, P2172, DOI 10.1161/01.CIR.0000128862.34201.74; Williams MJ, 1996, J AM COLL CARDIOL, V27, P132, DOI 10.1016/0735-1097(95)00393-2	45	530	556	1	43	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 28	2011	364	17					1617	1625		10.1056/NEJMoa1100358	http://dx.doi.org/10.1056/NEJMoa1100358			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755NW	21463153	Green Accepted			2022-12-28	WOS:000289940400008
J	Hemingway, C; Dahl, W; Haufler, C; Stuessy, C				Hemingway, Claire; Dahl, William; Haufler, Chris; Stuessy, Carol			Building Botanical Literacy	SCIENCE			English	Editorial Material									[Hemingway, Claire; Dahl, William] Bot Soc Amer, St Louis, MO 63166 USA; [Haufler, Chris] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Stuessy, Carol] Texas A&M Univ, Dept Teaching Learning & Culture, College Stn, TX 77843 USA	University of Kansas; Texas A&M University System; Texas A&M University College Station	Hemingway, C (corresponding author), Bot Soc Amer, St Louis, MO 63166 USA.	chemingway@botany.org						*AM I BIOL SCI AM, 4HSET AM I BIOL SCI; [Anonymous], 2006, AM LAB REP INV HIGH; Haufler CH, 2009, AM J BOT, V96, P1751, DOI 10.3732/ajb.0900241; HAVENS K, 2010, ASSESSING BOT CAPACI; Michaels S., 2008, READY SET SCI PUTTIN; National Research Council, 2009, NEW BIOL 21 CENT; President's Council of Advisors on Science and Technology, 2010, PREP INSP K 12 SCI T; Uno GE, 2009, AM J BOT, V96, P1753, DOI 10.3732/ajb.0900025; Wandersee JH, 1999, AM BIOL TEACH, V61, P82, DOI 10.2307/4450624	9	6	6	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2011	331	6024					1535	1536		10.1126/science.1196979	http://dx.doi.org/10.1126/science.1196979			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739XH	21436432				2022-12-28	WOS:000288754500035
J	Cassel, CK; Reuben, DB				Cassel, Christine K.; Reuben, David B.			Specialization, Subspecialization, and Subsubspecialization in Internal Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PRIMARY-CARE; CERTIFICATION		[Cassel, Christine K.; Reuben, David B.] Amer Board Internal Med, Philadelphia, PA 19106 USA; [Reuben, David B.] Univ Calif Los Angeles, David Geffen Sch Med, Div Geriatr, Los Angeles, CA 90095 USA	American Board of Internal Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cassel, CK (corresponding author), Amer Board Internal Med, Philadelphia, PA 19106 USA.							[Anonymous], 2006, FIN REP COMM REC NEW; [Anonymous], 2010, WHAT SHOULD OUTP INT; [Anonymous], 1936, NEW ENGL J MED, V215, P468; Baron RJ, 2008, JAMA-J AM MED ASSOC, V299, P1595, DOI 10.1001/jama.299.13.1595; Bodenheimer T, 1999, JAMA-J AM MED ASSOC, V281, P2045, DOI 10.1001/jama.281.21.2045; Brennan TA, 2004, JAMA-J AM MED ASSOC, V292, P1038, DOI 10.1001/jama.292.9.1038; Drazen JM, 2010, NEW ENGL J MED, V362, P946, DOI 10.1056/NEJMe1000174; FITZ R, 1950, NEW ENGL J MED, V242, P569, DOI 10.1056/NEJM195004132421501; Flexner Abraham, 1910, B CARNEGIE FDN ADV T, V4; Levinson W, 2010, NEW ENGL J MED, V362, P948, DOI 10.1056/NEJMclde0911205; Lipner RS, 2006, ANN INTERN MED, V144, P29, DOI 10.7326/0003-4819-144-1-200601030-00007; Obama B, 2010, MEMORANDUM HEADS EXE; PETERSDORF RG, 1978, NEW ENGL J MED, V299, P628, DOI 10.1056/NEJM197809212991204; REITEMEIER RJ, 1978, NEW ENGL J MED, V299, P1308, DOI 10.1056/NEJM197812072992313; Stevens R, 1998, AM MED PUBLIC INTERE, pxxvi	15	93	97	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2011	364	12					1169	1173		10.1056/NEJMsb1012647	http://dx.doi.org/10.1056/NEJMsb1012647			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	739FY	21428774				2022-12-28	WOS:000288701100014
J	Price, K				Price, Kim			The Art of Medicine The crusade against out-relief: a nudge from history	LANCET			English	Editorial Material									Univ Leicester, Sch Hist Studies, Leicester LE1 7RH, Leics, England	University of Leicester	Price, K (corresponding author), Univ Leicester, Sch Hist Studies, Leicester LE1 7RH, Leics, England.	kp178@leicester.ac.uk		Price, Kim/0000-0002-9934-9653	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		CROWTHER MA, 1984, J HIST MED ALL SCI, V39, P33, DOI 10.1093/jhmas/39.1.33; Digby A., 1994, MAKING MEDICAL LIVIN; HASTINGS G, 1871, BRIT MED J, V564, P460; *HORN CO, 1878, CH SICK PAUP THEIR M; Hurren E., 2007, PROTESTING PAUPERISM; LEONARD D, 2008, COMMUNICATION; RAMSDEN J, 1998, APPETITE POWER HIST; 1877, LANCET, V109, P889	8	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 19	2011	377	9770					988	989		10.1016/S0140-6736(11)60376-0	http://dx.doi.org/10.1016/S0140-6736(11)60376-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	740FA	21427805				2022-12-28	WOS:000288775800015
J	Chambers, JD; Neumann, PJ				Chambers, James D.; Neumann, Peter J.			Listening to Provenge - What a Costly Cancer Treatment Says about Future Medicare Policy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chambers, James D.; Neumann, Peter J.] Tufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Inst Clin Res & Hlth Policy Studies, Boston, MA USA; [Chambers, James D.] Brunel Univ, Hlth Econ Res Grp, Uxbridge UB8 3PH, Middx, England	Tufts Medical Center; Brunel University	Chambers, JD (corresponding author), Tufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Inst Clin Res & Hlth Policy Studies, Boston, MA USA.							[Anonymous], 2010, FED REG, V75, P57045; *CTR MED MED SERV, 2010, CAG00422N CTR MED ME; Food and Drug Administration, 2010, SUMM REV SUMM BAS RE; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294	4	48	49	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2011	364	18					1687	1689		10.1056/NEJMp1103057	http://dx.doi.org/10.1056/NEJMp1103057			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	759DC	21470004				2022-12-28	WOS:000290219800002
J	Di Mario, C; Viceconte, N				Di Mario, Carlo; Viceconte, Nicola			Radial angioplasty: worthy RIVAL, not undisputed winner	LANCET			English	Editorial Material							PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED-TRIALS; METAANALYSIS; OUTCOMES; IMPACT; ANGIOGRAPHY; ARTERY		[Di Mario, Carlo; Viceconte, Nicola] Royal Brompton Hosp, Cardiovasc Biomed Res Unit, London SW3 6NP, England	Royal Brompton Hospital	Di Mario, C (corresponding author), Royal Brompton Hosp, Cardiovasc Biomed Res Unit, London SW3 6NP, England.	C.DiMario@rbht.nhs.uk	viceconte, nicola/AAU-9899-2021; Di Mario, Carlo/K-5185-2018	Di Mario, Carlo/0000-0002-4461-2055; VICECONTE, Giuseppe nicola/0000-0002-4963-005X				Agostoni P, 2004, J AM COLL CARDIOL, V44, P349, DOI 10.1016/j.jacc.2004.04.034; Benamer Hakim, 2007, EuroIntervention, V3, P327, DOI 10.4244/EIJV3I3A60; Bertrand OF, 2010, JACC-CARDIOVASC INTE, V3, P1022, DOI 10.1016/j.jcin.2010.07.013; Di Mario Carlo, 2007, EuroIntervention, V3, P30; Di Mario Carlo, 2006, EuroIntervention, V2, P31; Hamon M, 2009, EUROINTERVENTION, V5, P115, DOI 10.4244/EIJV5I1A18; Hetherington SL, 2009, HEART, V95, pA8; Jolly SS, 2011, LANCET, V377, P1409, DOI 10.1016/S0140-6736(11)60404-2; Jolly SS, 2009, AM HEART J, V157, P132, DOI 10.1016/j.ahj.2008.08.023; KIEMENEIJ F, 1993, CATHETER CARDIO DIAG, V30, P173, DOI 10.1002/ccd.1810300220; Lo TS, 2008, EUR HEART J, V29, P2180, DOI 10.1093/eurheartj/ehn271; Manoukian SV, 2007, J AM COLL CARDIOL, V49, P1362, DOI 10.1016/j.jacc.2007.02.027; Mehta SR, 2010, LANCET, V376, P1233, DOI 10.1016/S0140-6736(10)61088-4; Pristipino C, 2010, EUROINTERVENTION, V6, P240, DOI 10.4244/; Rao SV, 2008, JACC-CARDIOVASC INTE, V1, P379, DOI 10.1016/j.jcin.2008.05.007; Vorobcsuk A, 2009, AM HEART J, V158, P814, DOI 10.1016/j.ahj.2009.08.022; Yan ZX, 2010, ANGIOLOGY, V61, P8, DOI 10.1177/0003319709348293	17	10	10	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 23	2011	377	9775					1381	1383		10.1016/S0140-6736(11)60469-8	http://dx.doi.org/10.1016/S0140-6736(11)60469-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755UF	21470672				2022-12-28	WOS:000289963000004
J	Senturk, A; Pfennig, S; Weiss, A; Burk, K; Acker-Palmer, A				Sentuerk, Aycan; Pfennig, Sylvia; Weiss, Alexander; Burk, Katja; Acker-Palmer, Amparo			Ephrin Bs are essential components of the Reelin pathway to regulate neuronal migration	NATURE			English	Article							TYROSINE KINASES; PHOSPHORYLATION; SPECIFICATION; DISABLED-1; MECHANISMS; EXPRESSION; MUTATIONS; CASPASE-3; PREPLATE; RECEPTOR	Coordinated migration of neurons in the developing and adult brain is essential for its proper function. The secreted glycoprotein Reelin (also known as RELN) guides migration of neurons by binding to two lipoprotein receptors, the very-low-density lipoprotein receptor (VLDLR) and apolipoprotein E receptor 2 (ApoER2, also known as LRP8)(1). Loss of Reelin function in humans results in the severe developmental disorder lissencephaly(2) and it has also been associated with other neurological disorders such as epilepsy, schizophrenia and Alzheimer's disease(3). The molecular mechanisms by which Reelin activates its receptors and controls cellular functions are largely unknown. Here we show that the neuronal guidance cues ephrin B proteins are essential for Reelin signalling during the development of laminated structures in the brain. We show that ephrin Bs genetically interact with Reelin. Notably, compound mouse mutants (Reln(+/-); Efnb3(-/-) or Reln(+/-); Efnb2(-/-)) and triple ephrin B1, B2, B3 knockouts show neuronal migration defects that recapitulate the ones observed in the neocortex, hippocampus and cerebellum of the reeler mouse. Mechanistically, we show that Reelin binds to the extracellular domain of ephrin Bs, which associate at the membrane with VLDLR and ApoER2 in neurons. Clustering of ephrin Bs leads to the recruitment and phosphorylation of Dab1 which is necessary for Reelin signalling. Conversely, loss of function of ephrin Bs severely impairs Reelin-induced Dab1 phosphorylation. Importantly, activation of ephrin Bs can rescue the reeler neuronal migration defects in the absence of Reelin protein. Together, our results identify ephrin Bs as essential components of the Reelin receptor/signalling pathway to control neuronal migration during the development of the nervous system.	[Sentuerk, Aycan; Pfennig, Sylvia; Weiss, Alexander; Burk, Katja; Acker-Palmer, Amparo] Goethe Univ Frankfurt, Frankfurt Inst Mol Life Sci FMLS, D-60438 Frankfurt, Germany; [Sentuerk, Aycan; Pfennig, Sylvia; Weiss, Alexander; Burk, Katja; Acker-Palmer, Amparo] Goethe Univ Frankfurt, Inst Cell Biol & Neurosci, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Acker-Palmer, A (corresponding author), Goethe Univ Frankfurt, Frankfurt Inst Mol Life Sci FMLS, Max von Laue Str 9, D-60438 Frankfurt, Germany.	Acker-Palmer@bio.uni-frankfurt.de		Burk, Katja/0000-0001-6083-4152	Max Planck Institute of Neurobiology in Martinsried (Germany); Deutsche Forschungsgemeinschaft [AC180/2-1, 2-2]; University Frankfurt [EXC115, EXC147]	Max Planck Institute of Neurobiology in Martinsried (Germany); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University Frankfurt	We would like to thank R. Klein for the ephrin B2<SUP>lox/lox</SUP> and ephrin B1<SUP>lox/lox</SUP> mice, N. Gale for the ephrin B3<SUP>-/-</SUP> mouse, J. Herz for the ApoER2<SUP>-/-</SUP> mouse, M. Goetz for 293-cells expressing Reelin or GFP, I. Segura for help with the ephrin B triple mutants, U. Bauer, O. Yildiz, C. Saygi, F. Kasikci, F. Voss and K. Happich for technical support, K. Hong and A. Griciuc for early contributions to this project, M. Frotscher for helpful discussions and I. Dikic and T. Acker for critically reading the manuscript. We acknowledge the Max Planck Institute of Neurobiology in Martinsried (Germany) for support and the use of equipment and animal facilities in the early stages of this project. This work was supported by grants from the Deutsche Forschungsgemeinschaft (AC180/2-1, 2-2 to A. A.-P.) and the Clusters of Excellence "Macromolecular Complexes (CEF)'' (EXC115) and ECCPS (EXC147) at the University Frankfurt.	Alifragis P, 2002, EXP NEUROL, V174, P259, DOI 10.1006/exnr.2002.7870; Angrand PO, 2006, MOL CELL PROTEOMICS, V5, P2211, DOI 10.1074/mcp.M600147-MCP200; Arnaud L, 2003, CURR BIOL, V13, P9, DOI 10.1016/S0960-9822(02)01397-0; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; Botella-Lopez A, 2006, P NATL ACAD SCI USA, V103, P5573, DOI 10.1073/pnas.0601279103; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252; Caviness V S Jr, 1982, Brain Res, V256, P293; CAVINESS VS, 1978, ANNU REV NEUROSCI, V1, P297, DOI 10.1146/annurev.ne.01.030178.001501; Compagni A, 2003, DEV CELL, V5, P217, DOI 10.1016/S1534-5807(03)00198-9; Costa E, 2002, Mol Interv, V2, P47, DOI 10.1124/mi.2.1.47; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; Essmann CL, 2008, NAT NEUROSCI, V11, P1035, DOI 10.1038/nn.2171; Forster E, 2002, P NATL ACAD SCI USA, V99, P13178, DOI 10.1073/pnas.202035899; Ghoumari AM, 2000, EUR J NEUROSCI, V12, P2935, DOI 10.1046/j.1460-9568.2000.00186.x; Grunwald IC, 2004, NAT NEUROSCI, V7, P33, DOI 10.1038/nn1164; Hack I, 2007, DEVELOPMENT, V134, P3883, DOI 10.1242/dev.005447; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901; Liebl DJ, 2003, J NEUROSCI RES, V71, P7, DOI 10.1002/jnr.10457; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Palmer A, 2002, MOL CELL, V9, P725, DOI 10.1016/S1097-2765(02)00488-4; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Sawamiphak S, 2010, NATURE, V465, P487, DOI 10.1038/nature08995; Segura I, 2007, NAT NEUROSCI, V10, P301, DOI 10.1038/nn1858; Sheppard AM, 1997, J COMP NEUROL, V378, P173, DOI 10.1002/(SICI)1096-9861(19970210)378:2<173::AID-CNE2>3.0.CO;2-0; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Walsh CA, 2000, CURR OPIN GENET DEV, V10, P270, DOI 10.1016/S0959-437X(00)00076-9; Zhang YM, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-13	34	112	118	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 21	2011	472	7343					356	U123		10.1038/nature09874	http://dx.doi.org/10.1038/nature09874			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752VW	21460838				2022-12-28	WOS:000289724600041
J	Montgomery, MH				Montgomery, M. H.			Shooting for the Stars	SCIENCE			English	Editorial Material									[Montgomery, M. H.] Univ Texas Austin, Dept Astron, McDonald Observ, Austin, TX 78712 USA; [Montgomery, M. H.] Univ Texas Austin, Texas Cosmol Ctr, Austin, TX 78712 USA; [Montgomery, M. H.] Mt Cuba Observ, Delaware Asteroseism Res Ctr, Greenville, DE 19716 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Montgomery, MH (corresponding author), Univ Texas Austin, Dept Astron, McDonald Observ, Austin, TX 78712 USA.	mikemon@astro.as.utexas.edu		Montgomery, Michael/0000-0002-6748-1748				Beck PG, 2011, SCIENCE, V332, P205, DOI 10.1126/science.1201939; Chaplin WJ, 2011, SCIENCE, V332, P213, DOI 10.1126/science.1201827; Derekas A, 2011, SCIENCE, V332, P216, DOI 10.1126/science.1201762; Gough DO, 1996, SCIENCE, V272, P1281, DOI 10.1126/science.272.5266.1281; SANDAGE A, 1968, ASTROPHYS J, V151, P531, DOI 10.1086/149454	5	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					180	181		10.1126/science.1203887	http://dx.doi.org/10.1126/science.1203887			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474741				2022-12-28	WOS:000289251100030
J	Yarus, M				Yarus, Michael			Climbing in 190 Dimensions	SCIENCE			English	Editorial Material							RNA; RIBOZYME		Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Yarus, M (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	michael.yarus@colorado.edu	Yarus, Michael/Q-9813-2019					EKLAND EH, 1995, SCIENCE, V269, P364, DOI 10.1126/science.7618102; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; Lincoln TA, 2009, SCIENCE, V323, P1229, DOI 10.1126/science.1167856; McCall MJ, 2000, MOL BIOTECHNOL, V14, P5, DOI 10.1385/MB:14:1:5; Shechner DM, 2009, SCIENCE, V326, P1271, DOI 10.1126/science.1174676; Turk RM, 2010, P NATL ACAD SCI USA, V107, P4585, DOI 10.1073/pnas.0912895107; Wang QS, 2011, RNA, V17, P469, DOI 10.1261/rna.2495011; Wochner A, 2011, SCIENCE, V332, P209, DOI 10.1126/science.1200752; Zaher HS, 2007, RNA, V13, P1017, DOI 10.1261/rna.548807	9	2	2	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2011	332	6026					181	182		10.1126/science.1205379	http://dx.doi.org/10.1126/science.1205379			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474742				2022-12-28	WOS:000289251100031
J	Eiraku, M; Takata, N; Ishibashi, H; Kawada, M; Sakakura, E; Okuda, S; Sekiguchi, K; Adachi, T; Sasai, Y				Eiraku, Mototsugu; Takata, Nozomu; Ishibashi, Hiroki; Kawada, Masako; Sakakura, Eriko; Okuda, Satoru; Sekiguchi, Kiyotoshi; Adachi, Taiji; Sasai, Yoshiki			Self-organizing optic-cup morphogenesis in three-dimensional culture	NATURE			English	Article							RETINAL-PIGMENT EPITHELIUM; EMBRYONIC STEM-CELLS; EYE DEVELOPMENT; APICAL CONSTRICTION; MOUSE EMBRYOS; NEURAL PLATE; SHAPE CHANGE; VESICLE; DIFFERENTIATION; RHO	Balanced organogenesis requires the orchestration of multiple cellular interactions to create the collective cell behaviours that progressively shape developing tissues. It is currently unclear how individual, localized parts are able to coordinate with each other to develop a whole organ shape. Here we report the dynamic, autonomous formation of the optic cup (retinal primordium) structure from a three-dimensional culture of mouse embryonic stem cell aggregates. Embryonic-stem-cell-derived retinal epithelium spontaneously formed hemispherical epithelial vesicles that became patterned along their proximal-distal axis. Whereas the proximal portion differentiated into mechanically rigid pigment epithelium, the flexible distal portion progressively folded inward to form a shape reminiscent of the embryonic optic cup, exhibited interkinetic nuclear migration and generated stratified neural retinal tissue, as seen in vivo. We demonstrate that optic-cup morphogenesis in this simple cell culture depends on an intrinsic self-organizing program involving stepwise and domain-specific regulation of local epithelial properties.	[Eiraku, Mototsugu; Takata, Nozomu; Kawada, Masako; Sakakura, Eriko; Sasai, Yoshiki] RIKEN Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan; [Eiraku, Mototsugu; Sakakura, Eriko; Sasai, Yoshiki] RIKEN Ctr Dev Biol, Dimens Tissue Anal Unit 4, Kobe, Hyogo 6500047, Japan; [Ishibashi, Hiroki; Okuda, Satoru; Adachi, Taiji] Kyoto Univ, Inst Frontier Med Sci, Dept Biomech, Kyoto 6068507, Japan; [Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, Lab Extracellular Matrix Biochem, Suita, Osaka 5650871, Japan; [Adachi, Taiji] RIKEN, VCAD Syst Res Program, Computat Cell Biomech Team, Wako, Saitama 3510198, Japan	RIKEN; RIKEN; Kyoto University; Osaka University; RIKEN	Eiraku, M (corresponding author), RIKEN Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan.	eiraku@cdb.riken.jp; yoshikisasai@cdb.riken.jp	Takata, Nozomu/AAI-9801-2020; Adachi, Taiji/P-8981-2016	Adachi, Taiji/0000-0001-5280-4156; Eiraku, Mototsugu/0000-0002-9433-9085; Takata, Nozomu/0000-0003-0171-6994	MEXT; Knowledge Cluster Initiative at Kobe; S-Innovation Project; Leading Project for Realization of Regenerative Medicine	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Knowledge Cluster Initiative at Kobe; S-Innovation Project; Leading Project for Realization of Regenerative Medicine	We are grateful to S. Nakanishi, S. Yonemura, R. Ladher, K. Muguruma, H. Inomata and M. Ohgushi for comments and to members of the Sasai laboratory for discussion. We also thank Olympus, particularly Y. Saito, M. Suzuki and Y. Imai, for their help and discussion regarding the design, assembly and optimized utility of the incubator-combined multi-photon and confocal optic systems, and T. Sugitate and N. Saito at JPK Instruments for technical advice on the AFM assay. This work was supported by grants-in-aid from MEXT (Y.S., M.E., T.A.), the Knowledge Cluster Initiative at Kobe and the S-Innovation Project (Y.S., K.S.), and the Leading Project for Realization of Regenerative Medicine (Y.S).	Adler R, 2007, DEV BIOL, V305, P1, DOI 10.1016/j.ydbio.2007.01.045; Agius E, 2004, DEV BIOL, V270, P308, DOI 10.1016/j.ydbio.2004.02.015; Allegra Mascaro AL, 2010, FRONT NEUROENERGETIC, P2; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Au E, 2008, CELL STEM CELL, V3, P472, DOI 10.1016/j.stem.2008.10.013; Bailey TJ, 2004, INT J DEV BIOL, V48, P761, DOI 10.1387/ijdb.041878tb; Cavodeassi F, 2005, NEURON, V47, P43, DOI 10.1016/j.neuron.2005.05.026; Cayouette M, 2006, TRENDS NEUROSCI, V29, P563, DOI 10.1016/j.tins.2006.08.003; Diep DB, 2004, DEV BRAIN RES, V153, P261, DOI 10.1016/j.devbrainres.2004.09.008; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Fuhrmann S, 2000, DEVELOPMENT, V127, P4599; Fuhrmann S, 2010, CURR TOP DEV BIOL, V93, P61, DOI [10.1016/B978-0-12-385044-7.00003-5, 10.1016/S0070-2153(10)93003-2]; Fuhrmann Sabine, 2008, Organogenesis, V4, P60; Fujimura N, 2009, DEV BIOL, V334, P31, DOI 10.1016/j.ydbio.2009.07.002; Fujiwara H, 2007, J BIOL CHEM, V282, P29701, DOI 10.1074/jbc.M611452200; Haigo SL, 2003, CURR BIOL, V13, P2125, DOI 10.1016/j.cub.2003.11.054; Hildebrand JD, 2005, J CELL SCI, V118, P5191, DOI 10.1242/jcs.02626; HILFER SR, 1980, ANAT REC, V197, P423; Honda H, 2004, J THEOR BIOL, V226, P439, DOI 10.1016/j.jtbi.2003.10.001; Hyer J, 2003, DEV BIOL, V259, P351, DOI 10.1016/S0012-1606(03)00205-7; Hyer J, 1998, DEVELOPMENT, V125, P869; Ikeda H, 2005, P NATL ACAD SCI USA, V102, P11331, DOI 10.1073/pnas.0500010102; Inoue Y, 2011, BIOMECH MODEL MECHAN, V10, P495, DOI 10.1007/s10237-010-0250-6; Kinoshita N, 2008, MOL BIOL CELL, V19, P2289, DOI 10.1091/mbc.E07-12-1286; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Lagutin O, 2001, DEV DYNAM, V221, P342, DOI 10.1002/dvdy.1148; Lewis WH, 1904, AM J ANAT, V3, P505, DOI 10.1002/aja.1000030405; Liu W, 2010, J CLIN INVEST, V120, P3568, DOI 10.1172/JCI43219; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Lopashov GV, 1963, DEV MECH VERTEBRATE; Martinez-Morales JR, 2004, BIOESSAYS, V26, P766, DOI 10.1002/bies.20064; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Mu XQ, 2004, SEMIN CELL DEV BIOL, V15, P115, DOI 10.1016/j.semcdb.2003.09.009; Nagai T, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.061903; Nakagawa S, 2003, DEV BIOL, V260, P414, DOI 10.1016/S0012-1606(03)00320-8; Nishimura T, 2008, DEVELOPMENT, V135, P1493, DOI 10.1242/dev.019646; Norden C, 2009, CELL, V138, P1195, DOI 10.1016/j.cell.2009.06.032; Picker A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000214; Pinzon-Duarte G, 2000, VISION RES, V40, P3455, DOI 10.1016/S0042-6989(00)00185-1; Martinez-Morales JR, 2009, CURR OPIN GENET DEV, V19, P511, DOI 10.1016/j.gde.2009.08.003; Rembold M, 2006, SCIENCE, V313, P1130, DOI 10.1126/science.1127144; Rico F, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021914; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; SCHOENWOLF GC, 1990, DEVELOPMENT, V109, P243; Seiler MJ, 2010, EUR J NEUROSCI, V31, P508, DOI 10.1111/j.1460-9568.2010.07085.x; Smith AN, 2009, DEVELOPMENT, V136, P2977, DOI 10.1242/dev.037341; Spemann H, 1901, VERH ANAT GESELLSCH, V15, P61; Stella SL, 2008, BRAIN RES, V1215, P20, DOI 10.1016/j.brainres.2008.03.038; Tang K, 2010, DEVELOPMENT, V137, P725, DOI 10.1242/dev.040568; Wataya T, 2008, P NATL ACAD SCI USA, V105, P11796, DOI 10.1073/pnas.0803078105; Westenskow P, 2009, DEVELOPMENT, V136, P2505, DOI 10.1242/dev.032136; Wilson SW, 2004, DEV CELL, V6, P167, DOI 10.1016/S1534-5807(04)00027-9; Yang XH, 2004, SEMIN CELL DEV BIOL, V15, P91, DOI 10.1016/j.semcdb.2003.09.004	53	1246	1313	7	275	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 7	2011	472	7341					51	U73		10.1038/nature09941	http://dx.doi.org/10.1038/nature09941			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21475194				2022-12-28	WOS:000289199400035
J	Lozano, AM				Lozano, Andres M.			Harnessing Plasticity to Reset Dysfunctional Neurons	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Toronto Western Res Inst, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Lozano, AM (corresponding author), Toronto Western Res Inst, Toronto, ON, Canada.		Lozano, Andres M/A-5058-2012	Lozano, Andres M./0000-0001-8257-3694				Davis KD, 1998, NATURE, V391, P385, DOI 10.1038/34905; Engineer ND, 2011, NATURE, V470, P101, DOI 10.1038/nature09656; Krings T, 2000, NEUROSCI LETT, V278, P189, DOI 10.1016/S0304-3940(99)00930-1; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Moller AR, 2009, NEUROL RES, V31, P1023, DOI 10.1179/174313209X383303	5	17	22	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 7	2011	364	14					1367	1368		10.1056/NEJMcibr1100496	http://dx.doi.org/10.1056/NEJMcibr1100496			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745WS	21470016				2022-12-28	WOS:000289202800015
J	Schutze, M; Boeing, H; Pischon, T; Rehm, J; Kehoe, T; Gmel, G; Olsen, A; Tjonneland, AM; Dahm, CC; Overvad, K; Clavel-Chapelon, F; Boutron-Ruault, MC; Trichopoulou, A; Benetou, V; Zylis, D; Kaaks, R; Rohrmann, S; Palli, D; Berrino, F; Tumino, R; Vineis, P; Rodriguez, L; Agudo, A; Sanchez, MJ; Dorronsoro, M; Chirlaque, MD; Barricarte, A; Peeters, PH; van Gils, CH; Khaw, KT; Wareham, N; Allen, NE; Key, TJ; Boffetta, P; Slimani, N; Jenab, M; Romaguera, D; Wark, PA; Riboli, E; Bergmann, MM				Schuetze, Madlen; Boeing, Heiner; Pischon, Tobias; Rehm, Juergen; Kehoe, Tara; Gmel, Gerrit; Olsen, Anja; Tjonneland, Anne M.; Dahm, Christina C.; Overvad, Kim; Clavel-Chapelon, Francoise; Boutron-Ruault, Marie-Christine; Trichopoulou, Antonia; Benetou, Vasiliki; Zylis, Dimosthenis; Kaaks, Rudolf; Rohrmann, Sabine; Palli, Domenico; Berrino, Franco; Tumino, Rosario; Vineis, Paolo; Rodriguez, Laudina; Agudo, Antonio; Sanchez, Maria-Jose; Dorronsoro, Miren; Chirlaque, Maria-Dolores; Barricarte, Aurelio; Peeters, Petra H.; van Gils, Carla H.; Khaw, Kay-Tee; Wareham, Nick; Allen, Naomi E.; Key, Timothy J.; Boffetta, Paolo; Slimani, Nadia; Jenab, Mazda; Romaguera, Dora; Wark, Petra A.; Riboli, Elio; Bergmann, Manuela M.			Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTERNATIONAL HEAD; POOLED ANALYSIS; GLOBAL BURDEN; EPIC PROJECT; NECK-CANCER; RISK; CONSUMPTION; MORTALITY; METAANALYSIS; TOBACCO	Objective To compute the burden of cancer attributable to current and former alcohol consumption in eight European countries based on direct relative risk estimates from a cohort study. Design Combination of prospective cohort study with representative population based data on alcohol exposure. Setting Eight countries (France, Italy, Spain, United Kingdom, the Netherlands, Greece, Germany, Denmark) participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Participants 109 118 men and 254 870 women, mainly aged 37-70. Main outcome measures Hazard rate ratios expressing the relative risk of cancer incidence for former and current alcohol consumption among EPIC participants. Hazard rate ratios combined with representative information on alcohol consumption to calculate alcohol attributable fractions of causally related cancers by country and sex. Partial alcohol attributable fractions for consumption higher than the recommended upper limit (two drinks a day for men with about 24 g alcohol, one for women with about 12 g alcohol) and the estimated total annual number of cases of alcohol attributable cancer. Results If we assume causality, among men and women, 10% (95% confidence interval 7 to 13%) and 3% (1 to 5%) of the incidence of total cancer was attributable to former and current alcohol consumption in the selected European countries. For selected cancers the figures were 44% (31 to 56%) and 25% (5 to 46%) for upper aerodigestive tract, 33% (11 to 54%) and 18% (-3 to 38%) for liver, 17% (10 to 25%) and 4% (-1 to 10%) for colorectal cancer for men and women, respectively, and 5.0% (2 to 8%) for female breast cancer. A substantial part of the alcohol attributable fraction in 2008 was associated with alcohol consumption higher than the recommended upper limit: 33 037 of 178 578 alcohol related cancer cases in men and 17 470 of 397 043 alcohol related cases in women. Conclusions In western Europe, an important proportion of cases of cancer can be attributable to alcohol consumption, especially consumption higher than the recommended upper limits. These data support current political efforts to reduce or to abstain from alcohol consumption to reduce the incidence of cancer.	[Schuetze, Madlen; Boeing, Heiner; Pischon, Tobias; Bergmann, Manuela M.] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, D-14558 Nuthetal, Germany; [Rehm, Juergen; Kehoe, Tara; Gmel, Gerrit] CAMH, Toronto, ON, Canada; [Rehm, Juergen] Tech Univ Dresden, Inst Clin Psychol & Psychotherapy, Dresden, Germany; [Olsen, Anja; Tjonneland, Anne M.] Danish Canc Soc, Inst Canc Epidemiol, Copenhagen, Denmark; [Dahm, Christina C.] Aarhus Univ Hosp, Dept Clin Epidemiol, Aalborg, Denmark; [Overvad, Kim] Aarhus Univ, Sch Publ Hlth, Dept Epidemiol, Aarhus, Denmark; [Clavel-Chapelon, Francoise; Boutron-Ruault, Marie-Christine] Inst Gustave Roussy, Ctr Res Epidemiol & Populat Hlth, U1018, F-94805 Villejuif, France; [Clavel-Chapelon, Francoise; Boutron-Ruault, Marie-Christine] Paris S Univ, UMRS 1018, F-94805 Villejuif, France; [Trichopoulou, Antonia; Benetou, Vasiliki; Zylis, Dimosthenis] Univ Athens, Sch Med, Dept Hyg Epidemiol & Med Stat, WHO Collaborating Ctr Food & Nutr Policies, GR-10679 Athens, Greece; [Kaaks, Rudolf; Rohrmann, Sabine] German Canc Res Ctr, Div Canc Epidemiol, D-6900 Heidelberg, Germany; [Palli, Domenico] Canc Res & Prevent Inst, Mol & Nutr Epidemiol Unit, Florence, Italy; [Berrino, Franco] Fdn IRCCS Ist Nazl Tumori, Dept Prevent & Predict Med, Epidemiol Unit, Milan, Italy; [Tumino, Rosario] Civile MP Arezzo Hosp, ASP Ragusa 7, Canc Registry, Ragusa, Italy; [Vineis, Paolo] Inst Sci Interchange Fdn, Turin, Italy; [Rodriguez, Laudina] Hlth & Hlth Care Serv Council, Publ Hlth & Participat Directorate, Asturias, Spain; [Tumino, Rosario] Civile MP Arezzo Hosp, ASP Ragusa 7, Histopathol Unit, Ragusa, Italy; [Agudo, Antonio] Catalan Inst Oncol IDIBELL, Canc Epidemiol Res Programme, Unit Nutr Environm & Canc, Barcelona, Spain; [Sanchez, Maria-Jose] Andalusian Sch Publ Hlth, Granada, Spain; [Sanchez, Maria-Jose; Dorronsoro, Miren; Chirlaque, Maria-Dolores; Barricarte, Aurelio] CIBERESP, San Sebastian, Spain; [Dorronsoro, Miren] Publ Hlth Dept Gipuzkoa, San Sebastian, Spain; [Chirlaque, Maria-Dolores] Murcia Reg Hlth Council, Dept Epidemiol, Murcia, Spain; [Peeters, Petra H.; van Gils, Carla H.] Univ Med Ctr, Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Khaw, Kay-Tee] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Wareham, Nick] MRC, Epidemiol Unit, Cambridge, England; [Allen, Naomi E.; Key, Timothy J.] Univ Oxford, Nuffield Dept Clin Med, Canc Epidemiol Unit, Oxford OX1 2JD, England; [Boffetta, Paolo; Slimani, Nadia; Jenab, Mazda] Int Agcy Res Canc, F-69372 Lyon, France; [Boffetta, Paolo] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Vineis, Paolo; Romaguera, Dora; Wark, Petra A.; Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London SW7 2AZ, England	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Technische Universitat Dresden; Danish Cancer Society; Aarhus University; Aarhus University; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Athens Medical School; National & Kapodistrian University of Athens; World Health Organization; Helmholtz Association; German Cancer Research Center (DKFZ); Fondazione IRCCS Istituto Nazionale Tumori Milan; Civile M.P. Arezzo Hospital; Civile M.P. Arezzo Hospital; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Escuela Andaluza de Salud Publica; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Murcia Regional Health Council; Utrecht University; Utrecht University Medical Center; University of Cambridge; University of Oxford; World Health Organization; International Agency for Research on Cancer (IARC); Icahn School of Medicine at Mount Sinai; Imperial College London	Schutze, M (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, D-14558 Nuthetal, Germany.	m.schuetze@dife.de	Dahm, Christina C/G-9787-2014; Pischon, Tobias/HGE-8577-2022; Berrino, Franco/AAC-2364-2020; Romaguera, Dora/AAB-2852-2020; TRICHOPOULOU, ANTONIA/ABF-8727-2021; Rohrmann, Sabine/D-2113-2012; Boffetta, Paolo/AAI-7767-2021; Sánchez, Maria-José/D-1087-2011; Rehm, Jürgen/K-2147-2012; Romaguera, Dora/ABE-7004-2020; Khaw, Kay-Tee/AAZ-3209-2021; Agudo, Antonio/J-1805-2016; Rem, Jürgen/H-1309-2011; Boutron-Ruault, Marie-Christine/H-3936-2014; Clavel-Chapelon, Francoise/G-6733-2014; Wark, Petra/C-1752-2016	Dahm, Christina C/0000-0003-0481-2893; Pischon, Tobias/0000-0003-1568-767X; Berrino, Franco/0000-0002-4858-1866; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Rohrmann, Sabine/0000-0002-2215-1200; Boffetta, Paolo/0000-0002-3811-2791; Sánchez, Maria-José/0000-0003-4817-0757; Rehm, Jürgen/0000-0001-5665-0385; Romaguera, Dora/0000-0002-5762-8558; Agudo, Antonio/0000-0001-9900-5677; Boutron-Ruault, Marie-Christine/0000-0002-5956-5693; Riboli, Elio/0000-0001-6795-6080; PALLI, Domenico/0000-0002-5558-2437; Jenab, Mazda/0000-0002-0573-1852; tumino, rosario/0000-0003-2666-414X; Overvad, Kim/0000-0001-6429-7921; Olsen, Anja/0000-0003-4788-503X; Tjonneland, Anne/0000-0003-4385-2097; Wark, Petra/0000-0003-1020-4640; Benetou, Vassiliki/0000-0002-0415-0386	Community's Sixth Framework Programme; European Commission; Deutsche Krebshilfe; German Cancer Research Center; German Federal Ministry of Education and Research; Danish Cancer Society; Spanish Ministry of Health [Network RCESP C03/09]; Spanish Regional Governments of Andalucia, Asturias, Basque Country, Murcia and Navarra; ISCIII, Red de Centros RETIC [C03/09]; Cancer Research UK; Medical Research Council, UK; Stroke Association, UK; British Heart Foundation; Department of Health, UK; Food Standards Agency, UK; Wellcome Trust, UK; Italian Association for Research on Cancer (AIRC); Compagnia di San Paolo; Progetto Integrato Oncologia-PIO, Regione Toscana; Dutch Ministry of Public Health, Welfare and Sports; National Cancer Registry of the Netherlands; Greek Ministry of Health and Social Solidarity; Hellenic Health Foundation; Stavros Niarchos Foundation; Medical Research Council [G0401527, G1000143, MC_U106179471, G0801056B] Funding Source: researchfish	Community's Sixth Framework Programme(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Krebshilfe(Deutsche Krebshilfe); German Cancer Research Center; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Danish Cancer Society(Danish Cancer Society); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Spanish Regional Governments of Andalucia, Asturias, Basque Country, Murcia and Navarra; ISCIII, Red de Centros RETIC(Instituto de Salud Carlos III); Cancer Research UK(Cancer Research UK); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stroke Association, UK; British Heart Foundation(British Heart Foundation); Department of Health, UK; Food Standards Agency, UK; Wellcome Trust, UK(Wellcome Trust); Italian Association for Research on Cancer (AIRC)(Fondazione AIRC per la ricerca sul cancro); Compagnia di San Paolo(Compagnia di San Paolo); Progetto Integrato Oncologia-PIO, Regione Toscana(Regione Toscana); Dutch Ministry of Public Health, Welfare and Sports; National Cancer Registry of the Netherlands; Greek Ministry of Health and Social Solidarity; Hellenic Health Foundation; Stavros Niarchos Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was performed (partly) within the coordinated action EPIC (SP23-CT-2005-006438), which has received research funding from the Community's Sixth Framework Programme, as well as by the "Europe Against Cancer" Programme of the European Commission (SANCO); Deutsche Krebshilfe; German Cancer Research Center; German Federal Ministry of Education and Research; Danish Cancer Society; Health Research Fund (FIS) of the Spanish Ministry of Health (grant No: Network RCESP C03/09); Spanish Regional Governments of Andalucia, Asturias, Basque Country, Murcia and Navarra; ISCIII, Red de Centros RETIC(RD06/0020) (grant No: C03/09); Cancer Research UK; Medical Research Council, UK; Stroke Association, UK; British Heart Foundation; Department of Health, UK; Food Standards Agency, UK; Wellcome Trust, UK; Italian Association for Research on Cancer (AIRC); Compagnia di San Paolo; Progetto Integrato Oncologia-PIO, Regione Toscana; Dutch Ministry of Public Health, Welfare and Sports; National Cancer Registry of the Netherlands; Greek Ministry of Health and Social Solidarity; Hellenic Health Foundation and Stavros Niarchos Foundation. The funders were independent of the research of the presented study.	Allen NE, 2009, JNCI-J NATL CANCER I, V101, P296, DOI 10.1093/jnci/djn514; ARICO S, 1994, EUR J EPIDEMIOL, V10, P251, DOI 10.1007/BF01719346; Baan R, 2007, LANCET ONCOL, V8, P292, DOI 10.1016/S1470-2045(07)70099-2; Bagnardi V, 2001, BRIT J CANCER, V85, P1700, DOI 10.1054/bjoc.2001.2140; Bagnardi V, 2001, ALCOHOL RES HEALTH, V25, P263; Boeing H, 1999, ANN NUTR METAB, V43, P205, DOI 10.1159/000012787; Boffetta P, 2009, ANN ONCOL, V20, P550, DOI 10.1093/annonc/mdn597; Boffetta P, 2006, INT J CANCER, V119, P884, DOI 10.1002/ijc.21903; Boffetta P, 2010, JNCI-J NATL CANCER I, V102, P529, DOI 10.1093/jnci/djq072; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; Corrao G, 1999, ADDICTION, V94, P1551, DOI 10.1046/j.1360-0443.1999.9410155111.x; Corrao G, 2002, EUR J PUBLIC HEALTH, V12, P214, DOI 10.1093/eurpub/12.3.214; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; Di Castelnuovo A, 2006, ARCH INTERN MED, V166, P2437, DOI 10.1001/archinte.166.22.2437; Di Castelnuovo A, 2010, INTERN EMERG MED, V5, P291, DOI 10.1007/s11739-010-0346-0; Ferlay J, 2004, GLOBOCAN 2002 CANC I; Ferlay J, 2010, GLOBOCAN 2008 CANC I; Ferrari P, 2007, INT J CANCER, V121, P2065, DOI 10.1002/ijc.22966; Flegal KM, 2006, AM J PUBLIC HEALTH, V96, P398, DOI 10.2105/AJPH.2005.079731; Flegal KM, 2004, CAN J PUBLIC HEALTH, V95, P235; Grant I., 2009, ALCOHOL ATTRIBUTABLE; GREENLAND S, 1988, AM J EPIDEMIOL, V128, P1185, DOI 10.1093/oxfordjournals.aje.a115073; Hardy RJ, 1998, STAT MED, V17, P841, DOI 10.1002/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D; Hashibe M, 2007, J NATL CANCER I, V99, P777, DOI 10.1093/jnci/djk179; Hashibe M, 2009, CANCER EPIDEM BIOMAR, V18, P541, DOI 10.1158/1055-9965.EPI-08-0347; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jones L., 2008, ALCOHOL ATTRIBUTABLE; Kaaks R, 1997, INT J EPIDEMIOL, V26, pS26, DOI 10.1093/ije/26.suppl_1.S26; Kehoe T., 2009, FITTING DIFFERENT DI; Klatsky AL, 2010, PHYSIOL BEHAV, V100, P76, DOI 10.1016/j.physbeh.2009.12.019; Kokkevi A, 2000, EUR ADDICT RES, V6, P42, DOI 10.1159/000019008; Mukamal KJ, 2010, J AM COLL CARDIOL, V55, P1328, DOI 10.1016/j.jacc.2009.10.056; Organisation World Health, 1993, EUR ALC ACT PLAN; Rehm J, 2007, INT J EPIDEMIOL, V36, P458, DOI 10.1093/ije/dyl294; Rehm J, 2007, INT J METH PSYCH RES, V16, P66, DOI 10.1002/mpr.204; Rehm J, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-3; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Rohrmann S, 2008, CANCER EPIDEM BIOMAR, V17, P1282, DOI 10.1158/1055-9965.EPI-07-2888; Rohrmann S, 2006, AM J EPIDEMIOL, V164, P1103, DOI 10.1093/aje/kwj326; Rohrmann S, 2009, CANCER CAUSE CONTROL, V20, P785, DOI 10.1007/s10552-008-9293-8; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Sieri S, 2002, IARC Sci Publ, V156, P173; Slimani N, 2000, EUR J CLIN NUTR, V54, P900, DOI 10.1038/sj.ejcn.1601107; Symons MJ, 2002, J CLIN EPIDEMIOL, V55, P893, DOI 10.1016/S0895-4356(02)00443-2; Taylor B, 2006, ADDICT BEHAV, V31, P1522, DOI 10.1016/j.addbeh.2005.11.008; Tjonneland A, 2007, CANCER CAUSE CONTROL, V18, P361, DOI 10.1007/s10552-006-0112-9; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; Weikert C, 2009, INT J CANCER, V125, P406, DOI 10.1002/ijc.24393; WHO IARC, 2007, IARC WORK GROUP REP, V3; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Health Organization, 2007, GLOB INF SYST ALC HL; World Health Organization, 2011, GLOB STAT REP COUNTR	55	169	179	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 7	2011	342								d1584	10.1136/bmj.d1584	http://dx.doi.org/10.1136/bmj.d1584			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	749JT	21474525	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-28	WOS:000289462400001
J	Calonge, N; Bibbins-Domingo, K; Cantu, AG; Curry, S; Dietrich, AJ; Flores, G; Grossman, D; Isham, G; LeFevre, ML; Leipzig, RM; Melnikow, JA; Melnyk, B; Nicholson, W; Reyes, C; Schwartz, JS; Wilt, T				Calonge, Ned; Bibbins-Domingo, Kristin; Cantu, Adelita Gonzales; Curry, Susan; Dietrich, Allen J.; Flores, Glenn; Grossman, David; Isham, George; LeFevre, Michael L.; Leipzig, Rosanne M.; Melnikow, Joy A.; Melnyk, Bernadette; Nicholson, Wanda; Reyes, Carolina; Schwartz, J. Sanford; Wilt, Timothy		US Preventive Serv Task Force	Screening for Testicular Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article								Description: Reaffirmation of the 2004 U. S. Preventive Services Task Force (USPSTF) recommendation statement on screening for testicular cancer. Methods: The USPSTF performed a targeted literature search for benefits and harms of screening for testicular cancer in asymptomatic males and found no new studies. Recommendation: The USPSTF does not recommend screening for testicular cancer in asymptomatic adolescent or adult males. (Grade D recommendation) Ann Intern Med. 2011;154:483-486.	[Calonge, Ned] Colorado Trust, Denver, CO USA; US Prevent Serv Task Force, Rockville, MD USA; [Bibbins-Domingo, Kristin] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Cantu, Adelita Gonzales] Univ Texas Hlth Sci Ctr San Antonio, San Francisco, CA USA; [Curry, Susan] Univ Iowa, Coll Publ Hlth, Iowa City, IA USA; [Dietrich, Allen J.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03756 USA; [Flores, Glenn] Univ Texas SW, Dallas, TX USA; [Grossman, David] Grp Hlth Cooperat Puget Sound, Seattle, WA USA; [Isham, George] HealthPartners, Minneapolis, MN USA; [LeFevre, Michael L.] Univ Missouri, Sch Med, Columbia, MO USA; [Leipzig, Rosanne M.] Mt Sinai Sch Med, New York, NY USA; [Melnikow, Joy A.] Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA; [Melnyk, Bernadette] Arizona State Univ, Coll Nursing & Healthcare Innovat, Phoenix, AZ USA; [Nicholson, Wanda] Johns Hopkins Sch Med, Baltimore, MD USA; [Nicholson, Wanda] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Reyes, Carolina] Univ So Calif, Los Angeles, CA USA; [Schwartz, J. Sanford] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Schwartz, J. Sanford] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; [Wilt, Timothy] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Wilt, Timothy] Minneapolis Vet Affairs Med Ctr, Minneapolis, MN USA	University of California System; University of California San Francisco; University of Texas System; University of Texas Health San Antonio; University of Iowa; Dartmouth College; University of Texas System; University of Texas Southwestern Medical Center Dallas; Group Health Cooperative; University of Missouri System; University of Missouri Columbia; Icahn School of Medicine at Mount Sinai; University of California System; University of California Davis; Arizona State University; Arizona State University-Downtown Phoenix; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Southern California; University of Pennsylvania; University of Pennsylvania; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Calonge, N (corresponding author), Colorado Trust, Denver, CO USA.		Melnyk, Bernadette J/E-9868-2013					American Academy of Family Physicians, 2010, SUMM REC CLIN PREV S; American Academy of Pediatrics Committee on Practice and Ambulatory Medicine, 2007, PEDIATRICS, V120, P1376, DOI DOI 10.1542/PEDS.2007-2901; American Cancer Society, 2010, AM CANC SOC GUID EAR; Lin K, 2010, ANN INTERN MED, V153, P396, DOI 10.7326/0003-4819-153-6-201009210-00007; *NAT CANC I, 2010, TEST CANC TREATM PDQ; U. S. Preventive Services Task Force, 2004, SCREEN TEST CANC REC; *US PREV SERV TASK, 1996, GUID CLIN PREV SERV, P153; *US PREV SERV TASK, 2004, SCREEN TEST CANC BRI	8	56	56	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 5	2011	154	7							483	10.7326/0003-4819-154-7-201104050-00006	http://dx.doi.org/10.7326/0003-4819-154-7-201104050-00006			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744EX	21464350				2022-12-28	WOS:000289078700005
J	Resnick, MD				Resnick, Michael D.			A better understanding of mortality in young people	LANCET			English	Editorial Material									Univ Minnesota, Sch Med, Dept Pediat, Div Adolescent Hlth & Med, Minneapolis, MN 55414 USA	University of Minnesota System; University of Minnesota Twin Cities	Resnick, MD (corresponding author), Univ Minnesota, Sch Med, Dept Pediat, Div Adolescent Hlth & Med, Minneapolis, MN 55414 USA.	resni001@umn.edu						Last JM, 2006, DICT PUBLIC HLTH; Lloyd Cynthia B., 2005, GROWING GLOBAL CHANG; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Resnick MD, 2007, LANCET, V369, P1058, DOI 10.1016/S0140-6736(07)60372-9; *UNICEF, STAT WORLDS CHILDR 2; Viner RM, 2011, LANCET, V377, P1162, DOI 10.1016/S0140-6736(11)60106-2	6	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 2	2011	377	9772					1128	1130		10.1016/S0140-6736(11)60412-1	http://dx.doi.org/10.1016/S0140-6736(11)60412-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	750IH	21450339				2022-12-28	WOS:000289539300005
J	Ikeda, F; Deribe, YL; Skanland, SS; Stieglitz, B; Grabbe, C; Franz-Wachtel, M; van Wijk, SJL; Goswami, P; Nagy, V; Terzic, J; Tokunaga, F; Androulidaki, A; Nakagawa, T; Pasparakis, M; Iwai, K; Sundberg, JP; Schaefer, L; Rittinger, K; Macek, B; Dikic, I				Ikeda, Fumiyo; Deribe, Yonathan Lissanu; Skanland, Sigrid S.; Stieglitz, Benjamin; Grabbe, Caroline; Franz-Wachtel, Mirita; van Wijk, Sjoerd J. L.; Goswami, Panchali; Nagy, Vanja; Terzic, Janos; Tokunaga, Fuminori; Androulidaki, Ariadne; Nakagawa, Tomoko; Pasparakis, Manolis; Iwai, Kazuhiro; Sundberg, John P.; Schaefer, Liliana; Rittinger, Katrin; Macek, Boris; Dikic, Ivan			SHARPIN forms a linear ubiquitin ligase complex regulating NF-kappa B activity and apoptosis	NATURE			English	Article							POLYUBIQUITIN CHAINS; IMMUNE-SYSTEM; PROTEINS; ACTIVATION; FRACTIONATION; DERMATITIS; PROTEOMICS; INDUCTION; NEMO	SHARPIN is a ubiquitin-binding and ubiquitin-like-domain-containing protein which, when mutated in mice, results in immune system disorders and multi-organ inflammation(1,2). Here we report that SHARPIN functions as a novel component of the linear ubiquitin chain assembly complex (LUBAC) and that the absence of SHARPIN causes dysregulation of NF-kappa B and apoptotic signalling pathways, explaining the severe phenotypes displayed by chronic proliferative dermatitis (cpdm) in SHARPIN-deficient mice. Upon binding to the LUBAC subunit HOIP (also known as RNF31), SHARPIN stimulates the formation of linear ubiquitin chains in vitro and in vivo. Coexpression of SHARPIN and HOIP promotes linear ubiquitination of NEMO (also known as IKBKG), an adaptor of the I kappa B kinases (IKKs) and subsequent activation of NF-kappa B signalling, whereas SHARPIN deficiency in mice causes an impaired activation of the IKK complex and NF-kappa B in B cells, macrophages and mouse embryonic fibroblasts (MEFs). This effect is further enhanced upon concurrent downregulation of HOIL-1L (also known as RBCK1), another HOIP-binding component of LUBAC. In addition, SHARPIN deficiency leads to rapid cell death upon tumour-necrosis factor alpha (TNF-alpha) stimulation via FADD- and caspase-8-dependent pathways. SHARPIN thus activates NF kappa B and inhibits apoptosis via distinct pathways in vivo.	[Ikeda, Fumiyo; Deribe, Yonathan Lissanu; Skanland, Sigrid S.; Grabbe, Caroline; van Wijk, Sjoerd J. L.; Goswami, Panchali; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Frankfurt Inst Mol Life Sci, D-60590 Frankfurt, Germany; [Ikeda, Fumiyo; Deribe, Yonathan Lissanu; Skanland, Sigrid S.; Grabbe, Caroline; van Wijk, Sjoerd J. L.; Goswami, Panchali; Dikic, Ivan] Goethe Univ Frankfurt, Sch Med, Inst Biochem 2, D-60590 Frankfurt, Germany; [Stieglitz, Benjamin; Rittinger, Katrin] Natl Inst Med Res, MRC, London NW7 1AA, England; [Grabbe, Caroline] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; [Franz-Wachtel, Mirita; Macek, Boris] Univ Tubingen, Interfac Inst Cell Biol, Proteome Ctr Tubingen, D-72076 Tubingen, Germany; [Nagy, Vanja] Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria; [Terzic, Janos; Dikic, Ivan] Univ Split, Sch Med, HR-21000 Split, Croatia; [Tokunaga, Fuminori; Nakagawa, Tomoko; Iwai, Kazuhiro] Osaka Univ, Grad Sch Med, Dept Biophys & Biochem, Suita, Osaka 5650871, Japan; [Androulidaki, Ariadne; Pasparakis, Manolis] Univ Cologne, Ctr Mol Med CMMC, Inst Genet, D-50674 Cologne, Germany; [Androulidaki, Ariadne; Pasparakis, Manolis] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Iwai, Kazuhiro] Osaka Univ, Grad Sch Frontier Biosci, Cell Biol & Metab Grp, Suita, Osaka 5650871, Japan; [Sundberg, John P.] Jackson Lab, Bar Harbor, ME 04609 USA; [Schaefer, Liliana] Klinikum Goethe Univ, Div Nephropharmakol, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; MRC National Institute for Medical Research; Umea University; Eberhard Karls University of Tubingen; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); University of Split; Osaka University; University of Cologne; University of Cologne; Osaka University; Jackson Laboratory; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Dikic, I (corresponding author), Goethe Univ Frankfurt, Sch Med, Frankfurt Inst Mol Life Sci, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	Ivan.Dikic@biochem2.de	Stieglitz, Benjamin/AAY-4140-2020; van Wijk, Sjoerd/AAL-6680-2021; Rittinger, Katrin/N-3344-2019; Rittinger, Katrin/D-2586-2014; Pasparakis, Manolis/H-9292-2017; Skånland, Sigrid S/AAW-4817-2021; Macek, Boris/N-1442-2015; Ikeda, Fumiyo/AAD-3770-2020; IWAI, KAZUHIRO/GSN-7385-2022; Pasparakis, Manolis/N-4350-2019; Dikic, Ivan/O-4650-2015	Stieglitz, Benjamin/0000-0003-3634-6997; van Wijk, Sjoerd/0000-0001-6532-7651; Rittinger, Katrin/0000-0002-7698-4435; Rittinger, Katrin/0000-0002-7698-4435; Pasparakis, Manolis/0000-0002-9870-0966; Macek, Boris/0000-0002-1206-2458; Ikeda, Fumiyo/0000-0003-0407-2768; Pasparakis, Manolis/0000-0002-9870-0966; Dikic, Ivan/0000-0001-8156-9511; Tokunaga, Fuminori/0000-0003-3626-9119; Iwai, Kazuhiro/0000-0001-5620-5951; Nagy, Vanja/0000-0002-9521-4794; Schaefer, Liliana/0000-0002-3318-3005; Skanland, Sigrid S./0000-0003-1630-356X; Terzic, Janos/0000-0003-3228-2076	Deutsche Forschungsgemeinschaft [DI 931/3-1]; Goethe University Frankfurt [EXC115]; Landesstiftung Baden-Wurttemberg; Medical Research Council UK; JSPS; EMBO; National Institutes of Health [AR049288]; Unity Through Knowledge Fund; International Human Frontier Science Program Organization; Medical Research Council [MC_U117565398] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049288] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [22117006] Funding Source: KAKEN; MRC [MC_U117565398] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Goethe University Frankfurt; Landesstiftung Baden-Wurttemberg; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); EMBO(European Molecular Biology Organization (EMBO)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Unity Through Knowledge Fund; International Human Frontier Science Program Organization(Human Frontier Science Program); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank E. Kim, K. Rajalingham and H.-J. Kreienkampfor reagents used in this study, I. Matic for initial MS analysis of HOIP/HOIL-1L samples, S. Wahl for sample preparation, and V. Dotsch and members of the Dikic lab for discussions and comments. This work was supported by grants from the Deutsche Forschungsgemeinschaft (DI 931/3-1), the Cluster of Excellence "Macromolecular Complexes'' of the Goethe University Frankfurt (EXC115) to I.D., Landesstiftung Baden-Wurttemberg to B.M., the Medical Research Council UK to K.R. and B.S., JSPS Postdoctoral Fellowships for Research Abroad to F.I., EMBO long-term fellowship to S.S.S. and The National Institutes of Health (AR049288 to J.P.S.). V.N. was supported by the Unity Through Knowledge Fund, 3B Grant. C.G. acknowledges support from The International Human Frontier Science Program Organization.	Borchert N, 2010, GENOME RES, V20, P837, DOI 10.1101/gr.103119.109; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dynek JN, 2010, EMBO J, V29, P4198, DOI 10.1038/emboj.2010.300; GIJBELS MJJ, 1995, ULTRASTRUCT PATHOL, V19, P107, DOI 10.3109/01913129509014610; Grabbe C, 2009, CHEM REV, V109, P1481, DOI 10.1021/cr800413p; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Ikeda F, 2010, CELL, V143, P677, DOI 10.1016/j.cell.2010.10.026; Ishihama Y, 2006, J PROTEOME RES, V5, P988, DOI 10.1021/pr050385q; Iwai K, 2009, EMBO REP, V10, P706, DOI 10.1038/embor.2009.144; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Lim S, 2001, MOL CELL NEUROSCI, V17, P385, DOI 10.1006/mcne.2000.0940; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Nielsen ML, 2008, NAT METHODS, V5, P459, DOI 10.1038/nmeth0608-459; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Seymour RE, 2007, GENES IMMUN, V8, P416, DOI 10.1038/sj.gene.6364403; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Wertz IE, 2008, CYTOKINE GROWTH F R, V19, P313, DOI 10.1016/j.cytogfr.2008.04.014; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714	27	536	553	2	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 31	2011	471	7340					637	U120		10.1038/nature09814	http://dx.doi.org/10.1038/nature09814			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21455181	Green Accepted			2022-12-28	WOS:000288951200043
J	Brody, H				Brody, Herb			CANCER PREVENTION	NATURE			English	Editorial Material																			0	12	12	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					S1	S1		10.1038/471S1a	http://dx.doi.org/10.1038/471S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430709	Bronze			2022-12-28	WOS:000288702200007
J	Thomson, MC; Connor, SJ; Zebiak, SE; Jancloes, M; Mihretie, A				Thomson, Madeleine C.; Connor, Stephen J.; Zebiak, Stephen E.; Jancloes, Michel; Mihretie, Abere			Africa needs climate data to fight disease	NATURE			English	Editorial Material									[Thomson, Madeleine C.; Connor, Stephen J.; Zebiak, Stephen E.] Columbia Univ, Int Res Inst Climate & Soc, Earth Inst, Palisades, NY 10964 USA; [Jancloes, Michel] Hlth & Climate Fdn, Washington, DC 20005 USA; [Mihretie, Abere] Antimalaria Assoc, Addis Ababa, Ethiopia	Columbia University	Thomson, MC (corresponding author), Columbia Univ, Int Res Inst Climate & Soc, Earth Inst, Palisades, NY 10964 USA.	mthomson@iri.columbia.edu						Alonso D, 2011, P ROY SOC B-BIOL SCI, V278, P1661, DOI 10.1098/rspb.2010.2020; Cibrelus L., 2010, 163 ITI; Connor SJ, 2010, PROCEDIA ENVIRON SCI, V1, P27, DOI 10.1016/j.proenv.2010.09.004; Dinku T, 2010, CLIM DEV, V2, P9, DOI 10.3763/cdev.2010.0029; Ghebreyesus TAZ., 2008, WMO B, V57, P256; Hay SI, 2002, TRENDS PARASITOL, V18, P530, DOI 10.1016/S1471-4922(02)02374-7; Omumbo JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-12; Parry M. L., 2007, CLIMATE CHANGE 2007; Reiter P, 2008, REV SCI TECH OIE, V27, P383, DOI 10.20506/rst.27.2.1804; Williams AP, 2011, CLIM DYNAM, V37, P2417, DOI 10.1007/s00382-010-0984-y	10	25	25	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					440	442		10.1038/471440a	http://dx.doi.org/10.1038/471440a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430752	Bronze, Green Submitted			2022-12-28	WOS:000288702200033
J	Vogelmeier, C; Hederer, B; Glaab, T; Schmidt, H; Rutten-van Molken, MPMH; Beeh, KM; Rabe, KF; Fabbri, LM				Vogelmeier, Claus; Hederer, Bettina; Glaab, Thomas; Schmidt, Hendrik; Rutten-van Molken, Maureen P. M. H.; Beeh, Kai M.; Rabe, Klaus F.; Fabbri, Leonardo M.		POET-COPD Investigators	Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; FLUTICASONE PROPIONATE; CARDIOVASCULAR SAFETY; EFFICACY; WITHDRAWAL; XINAFOATE; TORCH	BACKGROUND Treatment guidelines recommend the use of inhaled long-acting bronchodilators to alleviate symptoms and reduce the risk of exacerbations in patients with moderate-tovery- severe chronic obstructive pulmonary disease (COPD) but do not specify whether a long-acting anticholinergic drug or a beta(2)-agonist is the preferred agent. We investigated whether the anticholinergic drug tiotropium is superior to the beta(2)-agonist salmeterol in preventing exacerbations of COPD. METHODS In a 1-year, randomized, double-blind, double-dummy, parallel-group trial, we compared the effect of treatment with 18 mu g of tiotropium once daily with that of 50 mu g of salmeterol twice daily on the incidence of moderate or severe exacerbations in patients with moderate-to-very-severe COPD and a history of exacerbations in the preceding year. RESULTS A total of 7376 patients were randomly assigned to and treated with tiotropium (3707 patients) or salmeterol (3669 patients). Tiotropium, as compared with salmeterol, increased the time to the first exacerbation (187 days vs. 145 days), with a 17% reduction in risk (hazard ratio, 0.83; 95% confidence interval [CI], 0.77 to 0.90; P<0.001). Tiotropium also increased the time to the first severe exacerbation (hazard ratio, 0.72; 95% CI, 0.61 to 0.85; P<0.001), reduced the annual number of moderate or severe exacerbations (0.64 vs. 0.72; rate ratio, 0.89; 95% CI, 0.83 to 0.96; P = 0.002), and reduced the annual number of severe exacerbations (0.09 vs. 0.13; rate ratio, 0.73; 95% CI, 0.66 to 0.82; P<0.001). Overall, the incidence of serious adverse events and of adverse events leading to the discontinuation of treatment was similar in the two study groups. There were 64 deaths (1.7%) in the tiotropium group and 78 (2.1%) in the salmeterol group. CONCLUSIONS These results show that, in patients with moderate-to-very-severe COPD, tiotropium is more effective than salmeterol in preventing exacerbations.	[Fabbri, Leonardo M.] Univ Modena & Reggio Emilia, Sect Resp Dis, Dept Oncol Hematol & Pulm Dis, Policlin Modena, I-41124 Modena, Italy; [Vogelmeier, Claus] Univ Giessen, Marburg, Germany; [Vogelmeier, Claus] Univ Marburg, Marburg, Germany; [Hederer, Bettina; Glaab, Thomas; Schmidt, Hendrik] Boehringer Ingelheim GmbH & Co KG, Ingelheim, Germany; [Beeh, Kai M.] Insaf Resp Res Inst, Wiesbaden, Germany; [Rutten-van Molken, Maureen P. M. H.] Erasmus Univ, IMTA, Rotterdam, Netherlands; [Rabe, Klaus F.] Leiden Univ, Med Ctr, Leiden, Netherlands	Universita di Modena e Reggio Emilia; Justus Liebig University Giessen; Philipps University Marburg; Boehringer Ingelheim; Erasmus University Rotterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Fabbri, LM (corresponding author), Univ Modena & Reggio Emilia, Sect Resp Dis, Dept Oncol Hematol & Pulm Dis, Policlin Modena, Largo Pozzo 71, I-41124 Modena, Italy.	leonardo.fabbri@unimore.it	Molken, Maureen Rutten-van/X-8712-2019; Molken, Maureen PMH Rutten-van/G-8481-2014; Yarokhno, Natalya/R-4854-2017; Rabe, Klaus F./AAW-6296-2021; Barbé, Ferran/A-5988-2010; Khokhlov, Alexander L./E-2765-2017; Lubiński, Wojciech/S-8520-2016; Acican, Turan/W-1764-2017; Hug, Balthasar L./G-1568-2010; Reshetko, Olga/I-7011-2013; Panina, Svitlana/W-2900-2019; Arghir, Oana C/F-8515-2015; Blanc, François-Xavier/D-7425-2015; Korzh, Oleksii/E-4291-2016; Fabbri, Leonardo M/I-4055-2012; Mazurov, Vadim I/J-9643-2014; Zadionchenko, Vladimir/A-7445-2016; Bazylevych, Andriy/G-2834-2019; del campo, Felix/G-5716-2017; Arkhipov, Mikhail V/Q-2316-2015; KIYAN, ESEN/AAE-3380-2020; Beloglazov, Vladimir A/P-8419-2015	Molken, Maureen Rutten-van/0000-0001-8706-3159; Molken, Maureen PMH Rutten-van/0000-0001-8706-3159; Yarokhno, Natalya/0000-0003-2055-648X; Rabe, Klaus F./0000-0002-7020-1401; Barbé, Ferran/0000-0002-2340-8928; Khokhlov, Alexander L./0000-0002-0032-0341; Acican, Turan/0000-0002-2866-6686; Reshetko, Olga/0000-0003-3107-7636; Panina, Svitlana/0000-0003-1080-7185; Arghir, Oana C/0000-0001-9844-8521; Blanc, François-Xavier/0000-0001-7644-2188; Korzh, Oleksii/0000-0001-6838-4360; Fabbri, Leonardo M/0000-0001-8894-1689; Mazurov, Vadim I/0000-0002-0797-2051; Zadionchenko, Vladimir/0000-0003-2377-5266; Bazylevych, Andriy/0000-0001-5053-2548; del campo, Felix/0000-0002-4554-2167; Arkhipov, Mikhail V/0000-0002-7924-7668; Beloglazov, Vladimir A/0000-0001-9640-754X; Bozek, Andrzej/0000-0003-2263-2263; Domingos, Antonio/0000-0003-1417-5912; /0000-0002-8537-9165; Gorenkov, Roman/0000-0003-3483-7928; Vizir, Vadym/0000-0002-5486-2963; RUSSELL, RICHARD/0000-0002-3890-7201; Van de Werf, Frans/0000-0001-9479-7767	Boehringer Ingelheim; AstraZeneca; Biotherapeutics; GlaxoSmithKline; Janssen; Merck; Novartis; Nycomed; Talecris Biotherapeutics; Almirall; Novartis, Mundipharma; Cytos Biotechnology; Pfizer; Revotar Biopharmaceuticals; Roche; Chiesi Farmaceutici; Sigma-Tau Pharmaceuticals; Menarini; Schering-Plough; SigmaTau Pharmaceuticals; Union Chimique Belge	Boehringer Ingelheim(Boehringer Ingelheim); AstraZeneca(AstraZeneca); Biotherapeutics; GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); Novartis(Novartis); Nycomed; Talecris Biotherapeutics; Almirall(Almirall); Novartis, Mundipharma; Cytos Biotechnology; Pfizer(Pfizer); Revotar Biopharmaceuticals; Roche(Roche Holding); Chiesi Farmaceutici(Chiesi Pharmaceuticals Inc); Sigma-Tau Pharmaceuticals; Menarini(Menarini Group); Schering-Plough(Merck & CompanySchering Plough Corporation); SigmaTau Pharmaceuticals; Union Chimique Belge	Dr. Vogelmeier reports receiving consulting fees and travel support from Boehringer Ingelheim, payment for board membership from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Mundipharma, Novartis, and Nycomed, fees for expert testimony and grant support from Talecris Biotherapeutics, and lecture fees from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Janssen, Merck, Novartis, Nycomed, and Talecris Biotherapeutics; Dr. Hederer, being formerly employed by Boehringer Ingelheim; Drs. Glaab and Schmidt, being currently employed by Boehringer Ingelheim; Dr. Rutten- van Mlken, receiving grant support from Boehringer Ingelheim and having consulting fees, travel support, and fees for participation in review activities from Boehringer Ingelheim paid to her institution on her behalf; Dr. Beeh, having consulting fees or honoraria, grant support, and payments for development of educational materials from Boehringer Ingelheim and grant support from Almirall, Novartis, Mundipharma, Cytos Biotechnology, GlaxoSmithKline, Pfizer, and Revotar Biopharmaceuticals paid to his institution on his behalf; Dr. Rabe, receiving consulting fees and honoraria and payment for board membership from AstraZeneca, Boehringer Ingelheim, Chiesi Farmaceutici, GlaxoSmithKline, Merck, Novartis, Nycomed, and Pfizer and grant support from Altana, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Novartis, and Roche; and Dr. Fabbri, receiving travel support from Boehringer Ingelheim, consulting fees from AstraZeneca, Boehringer Ingelheim, Chiesi Farmaceutici, GlaxoSmithKline, Merck, Novartis, Nycomed, Pfizer, and Sigma-Tau Pharmaceuticals, and lecture fees from AstraZeneca, Boehringer Ingelheim, Chiesi Farmaceutici, GlaxoSmithKline, Merck, Novartis, Nycomed, and Pfizer and having grant support from AstraZeneca, Boehringer Ingelheim, Chiesi Farmaceutici, GlaxoSmithKline, Menarini, Merck, Nycomed, Pfizer, Schering-Plough (now Merck), SigmaTau Pharmaceuticals, and Union Chimique Belge paid to his institution on his behalf. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Bateman ED, 2009, PULM PHARMACOL THER, V22, P533, DOI 10.1016/j.pupt.2009.06.002; Beeh Kai-Michael, 2009, Int J Chron Obstruct Pulmon Dis, V4, P119; Briggs DD, 2005, PULM PHARMACOL THER, V18, P397, DOI 10.1016/j.pupt.2005.02.013; Brusasco V, 2003, THORAX, V58, P399, DOI 10.1136/thorax.58.5.399; Brusasco V, 2005, THORAX, V60, P105; Calverley P, 2003, LANCET, V361, P449, DOI 10.1016/S0140-6736(03)12459-2; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Calverley PMA, 2010, THORAX, V65, P719, DOI 10.1136/thx.2010.136077; Calverley PMA, 2003, CHEST, V124, P1350, DOI 10.1378/chest.124.4.1350; Casaburi R, 2002, EUR RESPIR J, V19, P217, DOI 10.1183/09031936.02.00269802; Celli B, 2010, CHEST, V137, P20, DOI 10.1378/chest.09-0011; Dahl R, 2010, THORAX, V65, P473, DOI 10.1136/thx.2009.125435; Donaldson GC, 2008, THORAX, V63, P753; Ferguson GT, 2003, CHEST, V123, P1817, DOI 10.1378/chest.123.6.1817; Global Initiative for Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Johnson M, 2001, CHEST, V120, P258, DOI 10.1378/chest.120.1.258; Keene ON, 2009, EUR RESPIR J, V34, P1018, DOI 10.1183/09031936.00122608; Kesten Steven, 2009, Int J Chron Obstruct Pulmon Dis, V4, P397; Mahler DA, 1999, CHEST, V115, P957, DOI 10.1378/chest.115.4.957; Mushlin AI, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp0912651; National Institute for Health and Clinical Excellence, 2010, CHRON OBSTR PULM DIS; Niewoehner DE, 2005, ANN INTERN MED, V143, P317, DOI 10.7326/0003-4819-143-5-200509060-00007; Niewoehner DE, 2010, NEW ENGL J MED, V362, P1407, DOI 10.1056/NEJMcp0912556; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rennard SI, 2001, AM J RESP CRIT CARE, V163, P1087, DOI 10.1164/ajrccm.163.5.9903053; Sawicki PT, 2009, NEW ENGL J MED, V361, DOI 10.1056/NEJMp0908797; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Wouters EFM, 2005, THORAX, V60, P480, DOI 10.1136/thx.2004.034280	32	473	495	1	78	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2011	364	12					1093	1103		10.1056/NEJMoa1008378	http://dx.doi.org/10.1056/NEJMoa1008378			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739FY	21428765	Green Published, Bronze			2022-12-28	WOS:000288701100004
J	Davis, PM; Jackson, DD				Davis, Paul M.; Jackson, David D.			Leon Knopoff (1925-2011)	SCIENCE			English	Biographical-Item									[Davis, Paul M.; Jackson, David D.] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Davis, PM (corresponding author), Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA.	pdavisucla@gmail.com	DAVIS, Paul/HCH-8889-2022					KNOPOFF L, PUBLICATION LIST, P16997	1	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2011	331	6023					1400	1400		10.1126/science.1204861	http://dx.doi.org/10.1126/science.1204861			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21415345				2022-12-28	WOS:000288504000030
J	Annas, GJ; Mariner, WK				Annas, George J.; Mariner, Wendy K.			Women and Children Last - The Predictable Effects of Proposed Federal Funding Cuts	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Annas, George J.; Mariner, Wendy K.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Mariner, Wendy/0000-0001-5176-5917; Annas, George/0000-0001-5836-7831				Annas GJ, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp1003944; Annas GJ, 2009, NEW ENGL J MED, V361, P2589, DOI 10.1056/NEJMp0911513; ANNAS GJ, 1995, NEW ENGL J MED, V333, P1647, DOI 10.1056/NEJM199512143332420; *COUNC WOM GIRLS, 2011, WOM AM IND SOC EC WE; Richards, 2009, NEXT STEPS AM FAMILY	5	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 28	2011	364	17					1590	1591		10.1056/NEJMp1102915	http://dx.doi.org/10.1056/NEJMp1102915			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755NW	21470003	Green Published			2022-12-28	WOS:000289940400003
J	Liu, YL; Chen, L				Liu, Yuanli; Chen, Lincoln			New medical data and leadership on tobacco control in China	LANCET			English	Editorial Material							ATTITUDES; KNOWLEDGE; SMOKING		[Liu, Yuanli; Chen, Lincoln] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Chen, Lincoln] China Med Board, Cambridge, MA USA	Harvard University; Harvard T.H. Chan School of Public Health	Liu, YL (corresponding author), Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA.	yuanliu@hsph.harvard.edu						[Anonymous], 2007, 2007 CHIN TOB CONTR; Bland B, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b993; Ceraso M, 2009, PREV CHRONIC DIS, V6; *CHIN MIN HLTH, 2010, PRESS C CHIN NURS SM; *CHIN MIN HLTH, 2009, DEC BANN SMOK ALL HL; *CHIN MIN HLTH, 2009, HLTH STAT DIG; *CHIN MIN HLTH CDC, 2010, GATS CHIN REP; Cui WY, 2010, B WORLD HEALTH ORGAN, V88, P251, DOI 10.2471/BLT.10.040410; Jha P, 2009, NAT REV CANCER, V9, P655, DOI 10.1038/nrc2703; Shi Y, 2010, ANESTHESIOLOGY, V112, P338, DOI 10.1097/ALN.0b013e3181c91ee7; Yan J, 2008, NICOTINE TOB RES, V10, P737, DOI 10.1080/14622200801901930; [杨功焕 Yang Gonghuan], 2005, [中华流行病学杂志, Chinese Journal of Epidemiology], V26, P77; Zhou JT, 2010, PREV CHRONIC DIS, V7	13	19	19	1	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2011	377	9773					1218	1220		10.1016/S0140-6736(10)61391-8	http://dx.doi.org/10.1016/S0140-6736(10)61391-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	751DI	21439632				2022-12-28	WOS:000289597300007
J	Grumbine, RE; Xu, JC				Grumbine, R. Edward; Xu, Jianchu			Mekong Hydropower Development	SCIENCE			English	Editorial Material							BASIN		[Grumbine, R. Edward] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming 650204, Peoples R China; [Xu, Jianchu] World Agroforestry Ctr, Kunming 650204, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Grumbine, RE (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming 650204, Peoples R China.	ed.grumbine@gmail.com	Xu, Jianchu/Y-2890-2019					Baran E, 2009, AQUAT ECOSYST HEALTH, V12, P227, DOI 10.1080/14634980903149902; CIA, 2017, GHAN WORLD FACTB 201; Cruz RV, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P469; Dore J, 2010, ENVIRON MANAGE, V46, P60, DOI 10.1007/s00267-010-9527-x; Evans A, 2010, GLOBALIZATION SCARCI; Foran T., 2009, CONTESTED WATERSCAPE, P55; Friend R., 2009, CONTESTED WATERSCAPE, P307; Hirsch P., 2006, NATL INTERESTS TRANS; International Center for Environmental Management, 2010, MRC STRAT ENV ASS SE; Jensen JG, 2001, WATER SCI TECHNOL, V43, P157, DOI 10.2166/wst.2001.0529; Kummu M, 2010, GEOMORPHOLOGY, V119, P181, DOI 10.1016/j.geomorph.2010.03.018; Lebel L, 2010, INT ENVIRON AGREEM-P, V10, P355, DOI 10.1007/s10784-010-9141-7; Population Reference Bureau, 2010, 2010 WORLD POP DAT S; Shankleman J., 2009, GOING GLOBAL CHINESE; WANG JJ, 2009, RIVER RES APPL, V25, P33; WIPATAYOTIN A, 2011, BANGKOK POST    0217	16	161	168	3	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					178	179		10.1126/science.1200990	http://dx.doi.org/10.1126/science.1200990			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	746MM	21474740				2022-12-28	WOS:000289251100029
J	Bohnert, ASB; Valenstein, M; Bair, MJ; Ganoczy, D; McCarthy, JF; Ilgen, MA; Blow, FC				Bohnert, Amy S. B.; Valenstein, Marcia; Bair, Matthew J.; Ganoczy, Dara; McCarthy, John F.; Ilgen, Mark A.; Blow, Frederic C.			Association Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BREAKTHROUGH PAIN; CANCER PAIN; CASE-COHORT; MORTALITY; TIME	Context The rate of prescription opioid-related overdose death increased substantially in the United States over the past decade. Patterns of opioid prescribing may be related to risk of overdose mortality. Objective To examine the association of maximum prescribed daily opioid dose and dosing schedule ("as needed," regularly scheduled, or both) with risk of opioid overdose death among patients with cancer, chronic pain, acute pain, and substance use disorders. Design Case-cohort study. Setting Veterans Health Administration (VHA), 2004 through 2008. Participants All unintentional prescription opioid overdose decedents (n=750) and a random sample of patients (n=154 684) among those individuals who used medical services in 2004 or 2005 and received opioid therapy for pain. Main Outcome Measure Associations of opioid regimens (dose and schedule) with death by unintentional prescription opioid overdose in subgroups defined by clinical diagnoses, adjusting for age group, sex, race, ethnicity, and comorbid conditions. Results The frequency of fatal overdose over the study period among individuals treated with opioids was estimated to be 0.04%. The risk of overdose death was directly related to the maximum prescribed daily dose of opioid medication. The adjusted hazard ratios (HRs) associated with a maximum prescribed dose of 100 mg/d or more, compared with the dose category 1 mg/d to less than 20 mg/d, were as follows: among those with substance use disorders, adjusted HR=4.54 (95% confidence interval [CI], 2.46-8.37; absolute risk difference approximation [ARDA]=0.14%); among those with chronic pain, adjusted HR=7.18 (95% CI, 4.85-10.65; ARDA=0.25%); among those with acute pain, adjusted HR=6.64 (95% CI, 3.31-13.31; ARDA=0.23%); and among those with cancer, adjusted HR=11.99 (95% CI, 4.42-32.56; ARDA=0.45%). Receiving both as-needed and regularly scheduled doses was not associated with overdose risk after adjustment. Conclusion Among patients receiving opioid prescriptions for pain, higher opioid doses were associated with increased risk of opioid overdose death. JAMA. 2011;305(13):1315-1321 www.jama.com	[Bohnert, Amy S. B.; Valenstein, Marcia; Ganoczy, Dara; McCarthy, John F.; Ilgen, Mark A.; Blow, Frederic C.] Univ Michigan, Sch Med, Dept Psychiat, Ann Arbor, MI 48109 USA; [Bohnert, Amy S. B.; Valenstein, Marcia; Ganoczy, Dara; McCarthy, John F.; Ilgen, Mark A.; Blow, Frederic C.] Ctr Excellence, Dept Vet Affairs Hlth Serv Res & Dev HSR&D, Ann Arbor, MI USA; [Bohnert, Amy S. B.; Valenstein, Marcia; Ganoczy, Dara; McCarthy, John F.; Ilgen, Mark A.; Blow, Frederic C.] Serious Mental Illness Treatment Resource & Evalu, Ann Arbor, MI USA; [Bair, Matthew J.] Ctr Excellence, Dept Vet Affairs HSR&D, Indianapolis, IN USA; [Bair, Matthew J.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN USA	University of Michigan System; University of Michigan; Indiana University System; Indiana University Bloomington	Bohnert, ASB (corresponding author), Univ Michigan, Sch Med, Dept Psychiat, 4250 Plymouth Rd,Box 5765, Ann Arbor, MI 48109 USA.	amybohne@med.umich.edu	Bohnert, Amy SB/C-7313-2015		Health Services Research and Development Service (HSRD) [CDA-09-204]; Department of Veterans Affairs Office of Mental Health Services, Patient Care Services	Health Services Research and Development Service (HSRD)(US Department of Veterans Affairs); Department of Veterans Affairs Office of Mental Health Services, Patient Care Services(US Department of Veterans Affairs)	This work was financially supported by the Department of Veterans Affairs Office of Mental Health Services, Patient Care Services, and a Health Services Research and Development Service (HSR&D) Career Development Award (CDA-09-204; A.S.B.B.).	[Anonymous], NAT DEATH IND; Centers for Disease Control and Prevention, WEB BAS INJ STAT QUE; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Cowper DC, 2002, ANN EPIDEMIOL, V12, P462, DOI 10.1016/S1047-2797(01)00285-X; Donaldson AE, 2006, INJURY PREV, V12, P338, DOI 10.1136/ip.2005.011171; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Gammaitoni AR, 2003, CLIN J PAIN, V19, P286, DOI 10.1097/00002508-200309000-00002; Hall AJ, 2008, JAMA-J AM MED ASSOC, V300, P2613, DOI 10.1001/jama.2008.802; Langholz B, 2007, COMPUT STAT DATA AN, V51, P3737, DOI 10.1016/j.csda.2006.12.028; Lash TL, 2009, J CLIN ONCOL, V27, pE55, DOI 10.1200/JCO.2009.24.1877; Lawlor PG, 1998, CANCER, V82, P1167, DOI 10.1002/(SICI)1097-0142(19980315)82:6<1167::AID-CNCR23>3.0.CO;2-3; Lo B, 2005, JAMA-J AM MED ASSOC, V294, P1810, DOI 10.1001/jama.294.14.1810; McCarthy JF, 2009, AM J EPIDEMIOL, V169, P1033, DOI 10.1093/aje/kwp010; McLellan AT, 2008, JAMA-J AM MED ASSOC, V300, P2672, DOI 10.1001/jama.2008.793; Okie S, 2010, NEW ENGL J MED, V363, P1981, DOI 10.1056/NEJMp1011512; Paulozzi LJ, 2006, PHARMACOEPIDEM DR S, V15, P618, DOI 10.1002/pds.1276; Portenoy RK, 1999, PAIN, V81, P129, DOI 10.1016/S0304-3959(99)00006-8; Portenoy RK, 2007, CURR MED RES OPIN, V23, P222, DOI 10.1185/030079906X162818; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; Prommer E, 2006, SUPPORT CARE CANCER, V14, P109, DOI 10.1007/s00520-005-0917-1; Schumann H, 2008, CLIN TOXICOL, V46, P501, DOI 10.1080/15563650701877374; Simpson DM, 2007, CLIN THER, V29, P588, DOI 10.1016/j.clinthera.2007.04.007; Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; The Management of Posttraumatic Stress Disorder Work Group, 2017, VA DOD CLIN PRACT GU; Valenstein M, 2004, AM J PSYCHIAT, V161, P654, DOI 10.1176/appi.ajp.161.4.654; Wysowski DK, 2007, DRUG SAFETY, V30, P533, DOI 10.2165/00002018-200730060-00007	27	1046	1055	2	73	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2011	305	13					1315	1321		10.1001/jama.2011.370	http://dx.doi.org/10.1001/jama.2011.370			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745JT	21467284				2022-12-28	WOS:000289162400020
J	Tierney, LM; Thabet, A; Nishino, H				Tierney, Lawrence M., Jr.; Thabet, Ashraf; Nishino, Ha			A Woman with Fever, Confusion, Liver Failure, Anemia, and Thrombocytopenia Hemophagocytic lymphohistiocytosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEPATITIS-C VIRUS; EXTRAHEPATIC MANIFESTATIONS; INFECTION; VETERANS; DISEASES; THERAPY		[Tierney, Lawrence M., Jr.] Univ Calif San Francisco, Dept Med, Vet Affairs Med Ctr, San Francisco, CA 94143 USA; [Thabet, Ashraf] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Nishino, Ha] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Thabet, Ashraf] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Nishino, Ha] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Tierney, LM (corresponding author), Univ Calif San Francisco, Dept Med, Vet Affairs Med Ctr, San Francisco, CA 94143 USA.							Bass NM, 2010, NEW ENGL J MED, V362, P1071, DOI 10.1056/NEJMoa0907893; Dufourcq-Lagelouse R, 1999, INT J MOL MED, V4, P127; El-Serag HB, 2002, HEPATOLOGY, V36, P1439, DOI 10.1053/jhep.2002.37191; FAVARA BE, 1992, SEMIN DIAGN PATHOL, V9, P63; Filipovich Alexandra H, 2009, Hematology Am Soc Hematol Educ Program, P127, DOI 10.1182/asheducation-2009.1.127; Fisman DN, 2000, EMERG INFECT DIS, V6, P601, DOI 10.3201/eid0606.000608; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Giordano TP, 2007, JAMA-J AM MED ASSOC, V297, P2010, DOI 10.1001/jama.297.18.2010; GUMBER SC, 1995, ANN INTERN MED, V123, P615, DOI 10.7326/0003-4819-123-8-199510150-00008; HENTER JI, 1991, SEMIN ONCOL, V18, P29; Janka Gritta, 2005, Hematology Am Soc Hematol Educ Program, P82; JOHNSON RJ, 1994, KIDNEY INT, V46, P1700, DOI 10.1038/ki.1994.471; Lay JD, 1997, J CLIN INVEST, V100, P1969, DOI 10.1172/JCI119728; MCCLAIN KL, 2011, UPTODATE; Poynard Thierry, 2004, Comp Hepatol, V3, P8, DOI 10.1186/1476-5926-3-8; Ramos-Casals M, 2009, J RHEUMATOL, V36, P1442, DOI 10.3899/jrheum.080874; Strader DB, 2004, HEPATOLOGY, V40, P269, DOI 10.1002/hep.20316; Warner JL, 2010, ACAD MED, V85, P556, DOI 10.1097/ACM.0b013e3181ccd59b; Zeuzem S, 2004, ANN INTERN MED, V140, P370, DOI 10.7326/0003-4819-140-5-200403020-00033; 1963, N ENGL J MED, V258, P378	20	14	14	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2011	364	13					1259	1270		10.1056/NEJMcpc1013924	http://dx.doi.org/10.1056/NEJMcpc1013924			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	742NO	21449790				2022-12-28	WOS:000288951300013
J	Frobisch, J				Froebisch, Joerg			On Dental Occlusion and Saber Teeth	SCIENCE			English	Editorial Material							EVOLUTION; HERBIVORE; THERAPSIDA; SYNAPSIDA; ORIGIN		Humboldt Univ, Museum Nat Kunde, Leibniz Inst Evolut & Biodiversitatsforsch, D-10115 Berlin, Germany	Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung	Frobisch, J (corresponding author), Humboldt Univ, Museum Nat Kunde, Leibniz Inst Evolut & Biodiversitatsforsch, Invalidenstr 43, D-10115 Berlin, Germany.	joerg.froebisch@mfn-berlin.de						Cisneros JC, 2011, SCIENCE, V331, P1603, DOI 10.1126/science.1200305; Cox C.B., 1972, P173; Frobisch J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003733; Frobisch J, 2008, J VERTEBR PALEONTOL, V28, P770, DOI 10.1671/0272-4634(2008)28[770:ANSOES]2.0.CO;2; Frobisch J, 2009, P ROY SOC B-BIOL SCI, V276, P3611, DOI 10.1098/rspb.2009.0911; Frobisch J, 2009, EARTH-SCI REV, V95, P119, DOI 10.1016/j.earscirev.2009.04.001; Hopson JA, 1995, J VERTEBR PALEONTOL, V15, P615, DOI 10.1080/02724634.1995.10011252; KEMP TS, 2005, ORIGIN EVOLUTION MAM; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; OLSON EC, 1966, ECOLOGY, V47, P291, DOI 10.2307/1933776; Peyer B, 1968, COMP ODONTOLOGY; Ray S, 2005, PALAEONTOLOGY, V48, P1169, DOI 10.1111/j.1475-4983.2005.00513.x; Reisz RR, 2006, J EXP ZOOL PART B, V306B, P261, DOI 10.1002/jez.b.21115; Rybczynski N, 2001, NATURE, V411, P684, DOI 10.1038/35079567; Sidor CA, 1998, PALEOBIOLOGY, V24, P254; Sullivan C, 2003, P ROY SOC B-BIOL SCI, V270, P173, DOI 10.1098/rspb.2002.2189	16	5	5	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 25	2011	331	6024					1525	1528		10.1126/science.1204206	http://dx.doi.org/10.1126/science.1204206			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21436427				2022-12-28	WOS:000288754500030
J	Zhang, K; Fischer, T; Porter, RL; Dhakshnamoorthy, J; Zofall, M; Zhou, M; Veenstra, T; Grewal, SIS				Zhang, Ke; Fischer, Tamas; Porter, Rebecca L.; Dhakshnamoorthy, Jothy; Zofall, Martin; Zhou, Ming; Veenstra, Timothy; Grewal, Shiv I. S.			Clr4/Suv39 and RNA Quality Control Factors Cooperate to Trigger RNAi and Suppress Antisense RNA	SCIENCE			English	Article							FISSION YEAST; CHROMOSOME SEGREGATION; LYSINE METHYLATION; MRNP FORMATION; HETEROCHROMATIN; COMPLEX; EXPORT; TRANSCRIPTION; PROTEINS; DEGRADATION	Pervasive transcription of eukaryotic genomes generates a plethora of noncoding RNAs. In fission yeast, the heterochromatin factor Clr4/Suv39 methyltransferase facilitates RNA interference (RNAi)-mediated processing of centromeric transcripts into small interfering RNAs (siRNAs). Clr4 also mediates degradation of antisense RNAs at euchromatic loci, but the underlying mechanism has remained elusive. We show that Clr4 and the RNAi effector RITS (RNA-induced transcriptional silencing) interact with Mlo3, a protein related to mRNA quality control and export factors. Loss of Clr4 impairs RITS interaction with Mlo3, which is required for centromeric siRNA production and antisense suppression. Mlo3 also interacts with the RNA surveillance factor TRAMP, which suppresses antisense RNAs targeted by Clr4 and RNAi. These findings link Clr4 to RNA quality control machinery and suggest a pathway for processing potentially deleterious RNAs through the coordinated actions of RNAi and other RNA processing activities.	[Zhang, Ke; Fischer, Tamas; Porter, Rebecca L.; Dhakshnamoorthy, Jothy; Zofall, Martin; Grewal, Shiv I. S.] NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Zhou, Ming; Veenstra, Timothy] NCI, Lab Prote & Analyt Anal, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Grewal, SIS (corresponding author), NCI, Biochem & Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov	Fischer, Tamas/A-7729-2016	Fischer, Tamas/0000-0002-7996-4042	National Institutes of Health, National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC011208, ZIABC010523] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. Dhar and R. Allshire for antibody to Mlo3 and strains, E. Chen for helpful contributions, and F. Reyes-Turcu, N. Komissarova, and M. Lichten for comments on manuscripts and discussions. Microarray data are available at the National Center for Biotechnology Information's Gene Expression Omnibus repository under accession numbers GSE26999 and GSE17271. This work is supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute.	Bayne EH, 2010, CELL, V140, P666, DOI 10.1016/j.cell.2010.01.038; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Djupedal I, 2009, EMBO J, V28, P3832, DOI 10.1038/emboj.2009.351; Fischer T, 2009, P NATL ACAD SCI USA, V106, P8998, DOI 10.1073/pnas.0813063106; Gerace EL, 2010, MOL CELL, V39, P360, DOI 10.1016/j.molcel.2010.07.017; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Hieronymus H, 2003, NAT GENET, V33, P155, DOI 10.1038/ng1080; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Javerzat JP, 1996, NUCLEIC ACIDS RES, V24, P4676, DOI 10.1093/nar/24.23.4676; Jensen TH, 2003, NAT STRUCT BIOL, V10, P10, DOI 10.1038/nsb0103-10; Kim VN, 2001, MOL CELLS, V12, P1; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Li XL, 2006, GENE DEV, V20, P1838, DOI 10.1101/gad.1438306; Libri D, 2002, MOL CELL BIOL, V22, P8254, DOI 10.1128/MCB.22.23.8254-8266.2002; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Rathert P, 2008, NAT CHEM BIOL, V4, P344, DOI 10.1038/nchembio.88; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Thakurta AG, 2005, EMBO J, V24, P2512, DOI 10.1038/sj.emboj.7600713; Zenklusen D, 2002, MOL CELL BIOL, V22, P8241, DOI 10.1128/MCB.22.23.8241-8253.2002; Zhang K, 2005, CELL, V122, P723, DOI 10.1016/j.cell.2005.06.021; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406; Zofall M, 2009, NATURE, V461, P419, DOI 10.1038/nature08321	27	58	59	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 25	2011	331	6024					1624	1627		10.1126/science.1198712	http://dx.doi.org/10.1126/science.1198712			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21436456	Green Accepted			2022-12-28	WOS:000288754500061
J	Jonietz, E				Jonietz, Erika			DESIGNING SMARTER CANCER PREVENTION TRIALS	NATURE			English	Editorial Material							PROSTATE-CANCER											Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660	2	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					S20	S21		10.1038/471S20a	http://dx.doi.org/10.1038/471S20a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430717	Bronze			2022-12-28	WOS:000288702200017
J	Graf, W; Mellgren, A; Matzel, KE; Hull, T; Johansson, C; Bernstein, M				Graf, Wilhelm; Mellgren, Anders; Matzel, Klaus E.; Hull, Tracy; Johansson, Claes; Bernstein, Mitch		NASHA Dx Study Grp	Efficacy of dextranomer in stabilised hyaluronic acid for treatment of faecal incontinence: a randomised, sham-controlled trial	LANCET			English	Article							INJECTABLE SILICONE BIOMATERIAL; QUALITY-OF-LIFE; INJECTION SCLEROTHERAPY; CLINICAL-TRIAL; ADULTS; HEMORRHOIDS; MANAGEMENT; IMPLANTS; CHILDREN; PTQ(TM)	Background Injection of a bulking agent in the anal canal is an increasingly used treatment for faecal incontinence, but efficacy has not been shown in a controlled trial. We aimed to assess the efficacy of injection of dextranomer in stabilised hyaluronic acid (NASHA Dx) for treatment of faecal incontinence. Methods In this randomised, double-blind, sham-controlled trial, patients aged 18-75 years from centres in USA and Europe were randomly assigned (2:1) to receive either transanal submucosal injections of NASHA Dx or sham injections. Randomisation was stratified by sex and region in blocks of six, and managed with a computer generated, real-time, web-based system. Patients and investigators were masked to assignment for 6 months when the effect on severity of faecal incontinence and quality of life was assessed with a 2-week diary and clinical assessments. The primary endpoint was response to treatment based on the number of incontinence episodes. A response to treatment was defined as a reduction in number of episodes by 50% or more. Patients in the active treatment group are still being followed up. This trial was registered with ClinicalTrials.gov, number NCT00605826. Findings 278 patients were screened for inclusion, of whom 206 were randomised assigned to receive NASHA Dx (n=136) or sham treatment (n=70). 71 patients who received NASHA Dx (52%) had a 50% or more reduction in the number of incontinence episode, compared with 22 patients who received sham treatment (31%; odds ratio 2.36, 95% CI 1.24-4.47, p=0.0089). We recorded 128 treatment-related adverse events, of which two were serious (1 rectal abscess and 1 prostatic abscess). Interpretation Anal injection of NASHA Dx is an effective treatment for faecal incontinence. A refinement of selection criteria for patients, optimum injected dose, ideal site of injection, and long-term results might further increase the acceptance of this minimally invasive treatment.	[Graf, Wilhelm] Uppsala Univ, Akad Sjukhuset, Dept Surg, S-75185 Uppsala, Sweden; [Mellgren, Anders] Univ Minnesota, Minneapolis, MN USA; [Matzel, Klaus E.] Univ Erlangen Nurnberg, Erlangen, Germany; [Hull, Tracy] Cleveland Clin Fdn, Cleveland, OH 44195 USA; [Johansson, Claes] Danderyds Sjukhus, Dept Surg, Stockholm, Sweden; [Bernstein, Mitch] St Lukes Roosevelt Hosp, New York, NY 10025 USA	Uppsala University; Uppsala University Hospital; University of Minnesota System; University of Minnesota Twin Cities; University of Erlangen Nuremberg; Cleveland Clinic Foundation; Danderyds Hospital; Mount Sinai St. Luke's; Mount Sinai West	Graf, W (corresponding author), Uppsala Univ, Akad Sjukhuset, Dept Surg, S-75185 Uppsala, Sweden.	wilhelm.graf@akademiska.se			Q-Med AB	Q-Med AB	WG, KEM, and AM have received travel grants and honoraria from Q-Med AB. TH has received travel grants from Q-Med AB. No other conflicts of interest have been declared.	Aigner F, 2009, DIS COLON RECTUM, V52, P293, DOI 10.1007/DCR.0b013e318197d755; Al-Ghnaniem R, 2001, ANN ROY COLL SURG, V83, P325; Alkan M, 2008, UROL INT, V81, P41, DOI 10.1159/000137639; Alkan M, 2007, PEDIATR SURG INT, V23, P183, DOI 10.1007/s00383-006-1818-1; Bond C, 2007, J CLIN GASTROENTEROL, V41, P45, DOI 10.1097/MCG.0b013e31802dcba5; Bordeianou L, 2008, COLORECTAL DIS, V10, P273, DOI 10.1111/j.1463-1318.2007.01288.x; Chan MKY, 2006, DIS COLON RECTUM, V49, P433, DOI 10.1007/s10350-005-0307-2; Danielson J, 2009, DIS COLON RECTUM, V52, P1101, DOI 10.1007/DCR.0b013e31819f5cbf; ENGEL AF, 1995, INT J COLORECTAL DIS, V10, P152, DOI 10.1007/BF00298538; Ganio E, 2008, TECH COLOPROCTOL, V12, P99, DOI 10.1007/s10151-008-0406-x; Kaman L, 1999, DIS COLON RECTUM, V42, P419, DOI 10.1007/BF02236363; Luo C, 2010, COLORECTAL DIS, V12, P296, DOI 10.1111/j.1463-1318.2009.01828.x; Madoff RD, 2004, LANCET, V364, P621, DOI 10.1016/S0140-6736(04)16856-6; Maeda Y, 2010, COCHRANE DB SYST REV, V12; MARCIO J, 1993, DIS COLON RECTUM, V36, P77; Molitierno Joseph A, 2008, J Pediatr Urol, V4, P221, DOI 10.1016/j.jpurol.2007.11.015; Naimy N, 2007, DIS COLON RECTUM, V50, P2040, DOI 10.1007/s10350-007-9075-5; Osterberg A, 2004, BRIT J SURG, V91, P1131, DOI 10.1002/bjs.4577; Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236; SHAFIK A, 1993, INT SURG, V78, P159; Siproudhis L, 2007, ALIMENT PHARM THER, V25, P1125, DOI 10.1111/j.1365-2036.2007.03293.x; Soerensen MM, 2009, COLORECTAL DIS, V11, P73, DOI 10.1111/j.1463-1318.2008.01544.x; Stenberg AM, 1997, J UROLOGY, V158, P1937, DOI 10.1016/S0022-5347(01)64185-5; Tan JJY, 2007, DIS COLON RECTUM, V50, P1950, DOI 10.1007/s10350-007-9009-2; Tjandra JJ, 2009, COLORECTAL DIS, V11, P382, DOI 10.1111/j.1463-1318.2008.01634.x; Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3; Whitehead WE, 2009, GASTROENTEROLOGY, V137, P512, DOI 10.1053/j.gastro.2009.04.054	27	155	158	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 19	2011	377	9770					997	1003		10.1016/S0140-6736(10)62297-0	http://dx.doi.org/10.1016/S0140-6736(10)62297-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	740FA	21420555				2022-12-28	WOS:000288775800028
J	Nichols, S				Nichols, Shaun			Experimental Philosophy and the Problem of Free Will	SCIENCE			English	Review							MORAL RESPONSIBILITY; DETERMINISM; PSYCHOLOGY	Many philosophical problems are rooted in everyday thought, and experimental philosophy uses social scientific techniques to study the psychological underpinnings of such problems. In the case of free will, research suggests that people in a diverse range of cultures reject determinism, but people give conflicting responses on whether determinism would undermine moral responsibility. When presented with abstract questions, people tend to maintain that determinism would undermine responsibility, but when presented with concrete cases of wrongdoing, people tend to say that determinism is consistent with moral responsibility. It remains unclear why people reject determinism and what drives people's conflicted attitudes about responsibility. Experimental philosophy aims to address these issues and thereby illuminate the philosophical problem of free will.	Univ Arizona, Dept Philosophy, Tucson, AZ 85721 USA	University of Arizona	Nichols, S (corresponding author), Univ Arizona, Dept Philosophy, Tucson, AZ 85721 USA.	sbn@email.arizona.edu						[Anonymous], 1957, SELFHOOD GODHOOD; Bargh JA, 1999, AM PSYCHOL, V54, P462, DOI 10.1037/0003-066x.54.7.462; Blakemore SJ, 2002, TRENDS COGN SCI, V6, P237, DOI 10.1016/S1364-6613(02)01907-1; De Brigard F, 2009, ETHICAL THEORY MORAL, V12, P511, DOI 10.1007/s10677-008-9143-5; DENNETT D. C., 1984, ELBOW ROOM; Goldberg JH, 1999, EUR J SOC PSYCHOL, V29, P781, DOI 10.1002/(SICI)1099-0992(199908/09)29:5/6<781::AID-EJSP960>3.3.CO;2-V; Holton R., 2006, PHILOS IMPRINT, V6, P1; Hume D., 2009, TREATISE HUMAN NATUR; Huxley Thomas, 1868, LESSONS ELEMENTARY P; Kane R, 1999, J PHILOS, V96, P217, DOI 10.2307/2564666; Knobe J., 2008, EXPT PHILOS; Kushnir T., 2009, P 31 ANN C COGN SCI, P87; Lerner JS, 1998, PERS SOC PSYCHOL B, V24, P563, DOI 10.1177/0146167298246001; Moore GE, 1912, ETHICS; Moore JW, 2009, CONSCIOUS COGN, V18, P1056, DOI 10.1016/j.concog.2009.05.004; NAHMIAS E, 2011, NEW WAVES PHILOS ACT, pCH9; Nahmias E, 2006, MIDWEST STUD PHILOS, V31, P214; Nahmias E, 2006, J COGN CULT, V6, P215, DOI 10.1163/156853706776931295; Nichols S, 2004, MIND LANG, V19, P473, DOI 10.1111/j.0268-1064.2004.00269.x; NICHOLS S, 2009, ARE WE FREE PSYCHOL, pCH2; Nichols S, 2007, NOUS, V41, P663, DOI 10.1111/j.1468-0068.2007.00666.x; Nietzsche Friedrich, 1886, GOOD EVIL; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Pereboom D., 2001, CAMBRIDGE STUDIES PH; Roskies AL, 2008, J PHILOS, V105, P371, DOI 10.5840/jphil2008105737; Sarkissian H, 2010, MIND LANG, V25, P346, DOI 10.1111/j.1468-0017.2010.01393.x; Schulz LE, 2006, CHILD DEV, V77, P427, DOI 10.1111/j.1467-8624.2006.00880.x; SINNOTTARMSTRON.W, 2008, EXPT PHILOS, pCH11; Spinoza Baruch, 1677, ETHICS; STRAWSON G, 1994, PHILOS STUD, V75, P5, DOI 10.1007/BF00989879; STRAWSON G., 1986, FREEDOM BELIEF; van Inwagen Peter, 1983, ESSAY FREE WILL; Wegner DM, 1999, AM PSYCHOL, V54, P480, DOI 10.1037/0003-066X.54.7.480	34	64	65	3	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2011	331	6023					1401	1403		10.1126/science.1192931	http://dx.doi.org/10.1126/science.1192931			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	736OM	21415346				2022-12-28	WOS:000288504000031
J	Sutton, AD; Burrell, AK; Dixon, DA; Garner, EB; Gordon, JC; Nakagawa, T; Ott, KC; Robinson, P; Vasiliu, M				Sutton, Andrew D.; Burrell, Anthony K.; Dixon, David A.; Garner, Edward B., III; Gordon, John C.; Nakagawa, Tessui; Ott, Kevin C.; Robinson, Pierce; Vasiliu, Monica			Regeneration of Ammonia Borane Spent Fuel by Direct Reaction with Hydrazine and Liquid Ammonia	SCIENCE			English	Article							CHEMICAL HYDROGEN STORAGE; CERAMIC CONVERSION REACTIONS; YIELD POLYMERIC PRECURSOR; BORON-NITROGEN BONDS; CATALYZED FORMATION; DEHYDROGENATION; COORDINATION; AMINOBORANES; BORAZINES; NITRIDE	Ammonia borane (H3N-BH3, AB) is a lightweight material containing a high density of hydrogen (H-2) that can be readily liberated for use in fuel cell-powered applications. However, in the absence of a straightforward, efficient method for regenerating AB from dehydrogenated polymeric spent fuel, its full potential as a viable H-2 storage material will not be realized. We demonstrate that the spent fuel type derived from the removal of greater than two equivalents of H-2 per molecule of AB (i.e., polyborazylene, PB) can be converted back to AB nearly quantitatively by 24-hour treatment with hydrazine (N2H4) in liquid ammonia (NH3) at 40 degrees C in a sealed pressure vessel.	[Sutton, Andrew D.; Gordon, John C.] Los Alamos Natl Lab, Div Chem, MS J582, Los Alamos, NM 87545 USA; [Burrell, Anthony K.; Nakagawa, Tessui] Los Alamos Natl Lab, Mat Phys & Applicat Div, MS J514, Los Alamos, NM 87545 USA; [Dixon, David A.; Garner, Edward B., III; Robinson, Pierce; Vasiliu, Monica] Univ Alabama, Dept Chem, Tuscaloosa, AL 35487 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Alabama System; University of Alabama Tuscaloosa	Sutton, AD (corresponding author), Los Alamos Natl Lab, Div Chem, MS J582, POB 1663, Los Alamos, NM 87545 USA.	adsutton@lanl.gov; jgordon@lanl.gov	Nakagawa, Tessui/C-3553-2014; Sutton, Andrew D/D-1047-2015	Nakagawa, Tessui/0000-0001-6340-756X; Sutton, Andrew D/0000-0001-7984-1715	U.S. Department of Energy, Office of Energy Efficiency and Renewable Energy	U.S. Department of Energy, Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE))	This work was funded by the U.S. Department of Energy, Office of Energy Efficiency and Renewable Energy. The authors and Los Alamos National Laboratory have filed a patent on the methods presented herein. We thank L. Sneddon for invaluable discussions.	Alcaraz G, 2010, ANGEW CHEM INT EDIT, V49, P7170, DOI 10.1002/anie.201000898; Baboul AG, 1999, J CHEM PHYS, V110, P7650, DOI 10.1063/1.478676; BAERENDS EJB, 2008, ADF 2008 01; Baitalow F, 2002, THERMOCHIM ACTA, V391, P159, DOI 10.1016/S0040-6031(02)00173-9; BAUMANN J, 2003, THESIS TU BERGAKADEM; Bluhm ME, 2006, J AM CHEM SOC, V128, P7748, DOI 10.1021/ja062085v; Burrell A. K., 2009, DOE HYDROGEN PROGRAM; Davis BL, 2009, ANGEW CHEM INT EDIT, V48, P6812, DOI 10.1002/anie.200900680; Denney MC, 2006, J AM CHEM SOC, V128, P12048, DOI 10.1021/ja062419g; FAZEN PJ, 1995, CHEM MATER, V7, P1942, DOI 10.1021/cm00058a028; FAZEN PJ, 1990, CHEM MATER, V2, P96, DOI 10.1021/cm00008a004; Frisch M.J., 2016, GAUSSIAN16 REV B01; GOUBEAU J, 1961, Z ANORG ALLG CHEM, V310, P123, DOI 10.1002/zaac.19613100303; Hamilton CW, 2009, CHEM SOC REV, V38, P279, DOI 10.1039/b800312m; Hausdorf S, 2008, INT J HYDROGEN ENERG, V33, P608, DOI 10.1016/j.ijhydene.2007.10.035; Hugle T, 2009, J AM CHEM SOC, V131, P7444, DOI 10.1021/ja9013437; Jaska CA, 2003, J AM CHEM SOC, V125, P9424, DOI 10.1021/ja030160l; Jaska CA, 2001, CHEM COMMUN, P962, DOI 10.1039/b102361f; Keaton RJ, 2007, J AM CHEM SOC, V129, P1844, DOI 10.1021/ja066860i; Klamt A., 1993, J CHEM SOC P2, V2, P799, DOI DOI 10.1039/P29930000799; Matus MH, 2007, J PHYS CHEM A, V111, P4411, DOI 10.1021/jp070931y; Miranda CR, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2730785; Orimo SI, 2007, CHEM REV, V107, P4111, DOI 10.1021/cr0501846; Pons V, 2008, CHEM COMMUN, P6597, DOI 10.1039/b809190k; Ramachandran PV, 2007, INORG CHEM, V46, P7810, DOI 10.1021/ic700772a; Schmidt E.W., 2001, HYDRAZINE ITS DERIVA, Vsecond; Smythe NC, 2010, EUR J INORG CHEM, P509, DOI 10.1002/ejic.200900932; Sneddon L. G., 2007, DEP ENERGY HYDROGEN; Sneddon L. G., 2006, DEP ENERGY HYDROGEN; Staubitz A, 2010, J AM CHEM SOC, V132, P13332, DOI 10.1021/ja104607y; Stephens FH, 2007, DALTON T, P2613, DOI 10.1039/b703053c; Stephens FH, 2007, ANGEW CHEM INT EDIT, V46, P746, DOI 10.1002/anie.200603285; Sutton AD, 2010, CHEM COMMUN, V46, P148, DOI 10.1039/b919383a; te Velde G, 2001, J COMPUT CHEM, V22, P931, DOI 10.1002/jcc.1056; Tomasi J, 2005, CHEM REV, V105, P2999, DOI 10.1021/cr9904009; Wang LF, 2008, ENERG ENVIRON SCI, V1, P268, DOI 10.1039/b807957a; Wolf G., 2005, 361 WE HER SEM HYDR	37	341	348	3	258	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2011	331	6023					1426	1429		10.1126/science.1199003	http://dx.doi.org/10.1126/science.1199003			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21415349				2022-12-28	WOS:000288504000038
J	Young, RA				Young, Richard A.			Control of the Embryonic Stem Cell State	CELL			English	Review							RNA-POLYMERASE-II; TRANSCRIPTIONAL REGULATORY CIRCUITRY; DE-LANGE-SYNDROME; PROTEIN-INTERACTION NETWORK; MAMMALIAN MEDIATOR COMPLEX; LEUKEMIA INHIBITORY FACTOR; POLYCOMB TARGET GENES; LONG NONCODING RNA; MOUSE ES CELLS; SELF-RENEWAL	Embryonic stem cells and induced pluripotent stem cells hold great promise for regenerative medicine. These cells can be propagated in culture in an undifferentiated state but can be induced to differentiate into specialized cell types. Moreover, these cells provide a powerful model system for studies of cellular identity and early mammalian development. Recent studies have provided insights into the transcriptional control of embryonic stem cell state, including the regulatory circuitry underlying pluripotency. These studies have, as a consequence, uncovered fundamental mechanisms that control mammalian gene expression, connect gene expression to chromosome structure, and contribute to human disease.	[Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Young, RA (corresponding author), Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	young@wi.mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG002668, R01 HG002668-08] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Ambrosetti DC, 2000, J BIOL CHEM, V275, P23387, DOI 10.1074/jbc.M000932200; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; BENSHUSHAN E, 1995, MOL CELL BIOL, V15, P1034; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Cammas F, 2004, GENE DEV, V18, P2147, DOI 10.1101/gad.302904; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen X, 2008, COLD SH Q B, V73, P203, DOI 10.1101/sqb.2008.73.026; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Cohen J, 1998, HUM REPROD, V13, P244; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; Deato MDE, 2008, MOL CELL, V32, P96, DOI 10.1016/j.molcel.2008.09.009; Deato MDE, 2007, GENE DEV, V21, P2137, DOI 10.1101/gad.1583407; Dejosez M, 2008, CELL, V133, P1162, DOI 10.1016/j.cell.2008.05.047; Dejosez M, 2010, GENE DEV, V24, P1479, DOI 10.1101/gad.1935210; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Ding N, 2008, MOL CELL, V31, P347, DOI 10.1016/j.molcel.2008.05.023; Dodge JE, 2004, MOL CELL BIOL, V24, P2478, DOI 10.1128/MCB.24.6.2478-2486.2004; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Fazzio TG, 2010, J CELL BIOL, V188, P491, DOI 10.1083/jcb.200908026; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Fuhrmann G, 2001, DEV CELL, V1, P377, DOI 10.1016/S1534-5807(01)00038-7; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Guenther MG, 2010, SCIENCE, V329, P150, DOI 10.1126/science.1193995; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; HAN M, 1988, CELL, V55, P1137, DOI 10.1016/0092-8674(88)90258-9; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; KAYNE PS, 1988, CELL, V55, P27, DOI 10.1016/0092-8674(88)90006-2; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; KNEZETIC JA, 1986, CELL, V45, P95, DOI 10.1016/0092-8674(86)90541-6; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; KORNBERG RD, 1974, SCIENCE, V184, P865, DOI 10.1126/science.184.4139.865; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lluis F, 2008, CELL STEM CELL, V3, P493, DOI 10.1016/j.stem.2008.08.017; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Muncke N, 2003, CIRCULATION, V108, P2843, DOI 10.1161/01.CIR.0000103684.77636.CD; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Niakan KK, 2006, MOL GENET METAB, V88, P261, DOI 10.1016/j.ymgme.2005.12.010; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Okita Keisuke, 2006, Curr Stem Cell Res Ther, V1, P103, DOI 10.2174/157488806775269061; OLINS AL, 1974, SCIENCE, V183, P330, DOI 10.1126/science.183.4122.330; Orkin SH, 2008, COLD SH Q B, V73, P195, DOI 10.1101/sqb.2008.72.001; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2008, COLD SH Q B, V73, P253, DOI 10.1101/sqb.2008.73.009; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Pera MF, 2010, NATURE, V465, P713, DOI 10.1038/nature09228; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Philiber RA, 2007, PHARMACOGENOMICS, V8, P909, DOI 10.2217/14622416.8.8.909; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Risheg H, 2007, NAT GENET, V39, P451, DOI 10.1038/ng1992; Roeder RG, 1998, COLD SPRING HARB SYM, V63, P201, DOI 10.1101/sqb.1998.63.201; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schnetz MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001023; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schwartz CE, 2007, J MED GENET, V44, P472, DOI 10.1136/jmg.2006.048637; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Smith SK, 1998, HUM REPROD, V13, P237, DOI 10.1093/humrep/13.suppl_3.237; SMITH TA, 1983, EXP CELL RES, V145, P458, DOI 10.1016/0014-4827(83)90025-3; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Strachan T, 2005, CURR OPIN GENET DEV, V15, P258, DOI 10.1016/j.gde.2005.04.005; Sun CH, 2009, MOL CELL BIOL, V29, P4574, DOI 10.1128/MCB.01863-08; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Tam WL, 2008, STEM CELLS, V26, P2019, DOI 10.1634/stemcells.2007-1115; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; van der Stoop P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002235; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Wood AJ, 2010, NAT REV GENET, V11, P391, DOI 10.1038/nrg2794; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yeap LS, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-12; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yuan P, 2009, GENE DEV, V23, P2507, DOI 10.1101/gad.1831909; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhang XF, 2008, J BIOL CHEM, V283, P35825, DOI 10.1074/jbc.M803481200; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhong XM, 2009, J BIOL CHEM, V284, P9168, DOI 10.1074/jbc.M805562200; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zhou W, 2008, MOL CELL, V29, P69, DOI 10.1016/j.molcel.2007.11.002	198	820	858	6	388	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 18	2011	144	6					940	954		10.1016/j.cell.2011.01.032	http://dx.doi.org/10.1016/j.cell.2011.01.032			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	737BQ	21414485	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000288543500012
J	Strunker, T; Goodwin, N; Brenker, C; Kashikar, ND; Weyand, I; Seifert, R; Kaupp, UB				Struenker, Timo; Goodwin, Normann; Brenker, Christoph; Kashikar, Nachiket D.; Weyand, Ingo; Seifert, Reinhard; Kaupp, U. Benjamin			The CatSper channel mediates progesterone-induced Ca2+ influx in human sperm	NATURE			English	Article							HUMAN SPERMATOZOA; CALCIUM INFLUX; CHEMOTAXIS; ACTIVATION; RECEPTORS; MECHANISM; CELLS	In the oviduct, cumulus cells that surround the oocyte release progesterone. In human sperm, progesterone stimulates a Ca2+ increase by a non-genomic mechanism(1-3). The Ca2+ signal has been proposed to control chemotaxis, hyperactivation and acrosomal exocytosis of sperm(4-8). However, the underlying signalling mechanism has remained mysterious. Here we show that progesterone activates the sperm-specific, pH-sensitive CatSper Ca2+ channel(9-11). We found that both progesterone and alkaline pH stimulate a rapid Ca2+ influx with almost no latency, incompatible with a signalling pathway involving metabotropic receptors and second messengers. The Ca2+ signals evoked by alkaline pH and progesterone are inhibited by the Ca-v channel blockers NNC 55-0396 and mibefradil. Patch-clamp recordings from sperm reveal an alkaline-activated current carried by mono-and divalent ions that exhibits all the hallmarks of sperm-specific CatSper Ca2+ channels(10,11). Progesterone substantially enhances the CatSper current. The alkaline- and progesterone-activated CatSper current is inhibited by both drugs. Our results resolve a long-standing controversy over the non-genomic progesterone signalling. In human sperm, either the CatSper channel itself or an associated protein serves as the non-genomic progesterone receptor. The identification of CatSper channel blockers will greatly facilitate the study of Ca2+ signalling in sperm and help to define further the physiological role of progesterone and CatSper.	[Struenker, Timo; Goodwin, Normann; Brenker, Christoph; Kashikar, Nachiket D.; Seifert, Reinhard; Kaupp, U. Benjamin] Ctr Adv European Studies & Res, Abt Mol Neurosensor, D-53175 Bonn, Germany; [Weyand, Ingo] Forschungszentrum Julich, Inst Complex Syst Cellular Biophys ICS 4, D-52425 Julich, Germany	Center of Advanced European Studies & Research (CAESAR); Helmholtz Association; Research Center Julich	Kaupp, UB (corresponding author), Ctr Adv European Studies & Res, Abt Mol Neurosensor, Ludwig Erhard Allee 2, D-53175 Bonn, Germany.	timo.struenker@caesar.de; u.b.kaupp@caesar.de	Strünker, Timo/AAE-4722-2020	Kashikar, Nachiket/0000-0002-4466-7486	German Research Foundation [SFB 645]; International Helmholtz Research School on Biophysics and Soft Matter	German Research Foundation(German Research Foundation (DFG)); International Helmholtz Research School on Biophysics and Soft Matter	This work was supported by the German Research Foundation (SFB 645) and the International Helmholtz Research School on Biophysics and Soft Matter. We thank S. Stark for technical assistance, H. Krause and B. Kayser for preparing the manuscript, and C. Bernsdorff for preparing the figures. The caged compounds were kindly provided by V. Hagen.	Baldi E, 2009, MOL CELL ENDOCRINOL, V308, P39, DOI 10.1016/j.mce.2009.02.006; Bedu-Addo K, 2008, INT J DEV BIOL, V52, P615, DOI 10.1387/ijdb.072535kb; BLACKMORE PF, 1990, J BIOL CHEM, V265, P1376; BLACKMORE PF, 1991, J BIOL CHEM, V266, P18655; Carlson AE, 2007, DEV BIOL, V312, P183, DOI 10.1016/j.ydbio.2007.09.017; Costello S, 2009, REPRODUCTION, V138, P425, DOI 10.1530/REP-09-0134; Eisenbach M, 2006, NAT REV MOL CELL BIO, V7, P276, DOI 10.1038/nrm1893; Gellersen B, 2009, HUM REPROD UPDATE, V15, P119, DOI 10.1093/humupd/dmn044; Harper CV, 2003, BIOCHEM J, V372, P407, DOI 10.1042/BJ20021560; Kamenetsky M, 2006, J MOL BIOL, V362, P623, DOI 10.1016/j.jmb.2006.07.045; Kaupp UB, 2008, ANNU REV PHYSIOL, V70, P93, DOI 10.1146/annurev.physiol.70.113006.100654; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Kaupp UB, 2003, NAT CELL BIOL, V5, P109, DOI 10.1038/ncb915; Kilic F, 2009, J AM CHEM SOC, V131, P4027, DOI 10.1021/ja808334f; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; Kirkman-Brown JC, 2000, DEV BIOL, V222, P326, DOI 10.1006/dbio.2000.9729; Lishko PV, 2010, CELL, V140, P327, DOI 10.1016/j.cell.2009.12.053; Oren-Benaroya R, 2008, HUM REPROD, V23, P2339, DOI 10.1093/humrep/den265; Parinaud J, 1996, J CLIN ENDOCR METAB, V81, P1357, DOI 10.1210/jc.81.4.1357; Publicover S, 2007, NAT CELL BIOL, V9, P235, DOI 10.1038/ncb0307-235; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schaefer M, 1998, P NATL ACAD SCI USA, V95, P3008, DOI 10.1073/pnas.95.6.3008; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Strunker T, 2006, NAT CELL BIOL, V8, P1149, DOI 10.1038/ncb1473; Suarez SS, 2008, HUM REPROD UPDATE, V14, P647, DOI 10.1093/humupd/dmn029; Sun F, 2003, DEV BIOL, V255, P423, DOI 10.1016/S0012-1606(02)00090-8; Teves ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008211; THOMAS P, 1989, BIOCHEM J, V264, P539, DOI 10.1042/bj2640539; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861	30	389	413	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2011	471	7338					382	+		10.1038/nature09769	http://dx.doi.org/10.1038/nature09769			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21412338				2022-12-28	WOS:000288444000046
J	Goemans, NM; Tulinius, M; van den Akker, JT; Burm, BE; Ekhart, PF; Heuvelmans, N; Holling, T; Janson, AA; Platenburg, GJ; Sipkens, JA; Sitsen, JMA; Aartsma-Rus, A; van Ommen, GJB; Buyse, G; Darin, N; Verschuuren, JJ; Campion, GV; de Kimpe, SJ; van Deutekom, JC				Goemans, Nathalie M.; Tulinius, Mar; van den Akker, Johanna T.; Burm, Brigitte E.; Ekhart, Peter F.; Heuvelmans, Niki; Holling, Tjadine; Janson, Anneke A.; Platenburg, Gerard J.; Sipkens, Jessica A.; Sitsen, J. M. Ad; Aartsma-Rus, Annemieke; van Ommen, Gert-Jan B.; Buyse, Gunnar; Darin, Niklas; Verschuuren, Jan J.; Campion, Giles V.; de Kimpe, Sjef J.; van Deutekom, Judith C.			Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							6-MINUTE WALK TEST; MUSCLE; GENE; MUTATIONS; DELETIONS; THERAPY	BACKGROUND Local intramuscular administration of the antisense oligonucleotide PRO051 in patients with Duchenne's muscular dystrophy with relevant mutations was previously reported to induce the skipping of exon 51 during pre-messenger RNA splicing of the dystrophin gene and to facilitate new dystrophin expression in muscle-fiber membranes. The present phase 1-2a study aimed to assess the safety, pharmacokinetics, and molecular and clinical effects of systemically administered PRO051. METHODS We administered weekly abdominal subcutaneous injections of PRO051 for 5 weeks in 12 patients, with each of four possible doses (0.5, 2.0, 4.0, and 6.0 mg per kilogram of body weight) given to 3 patients. Changes in RNA splicing and protein levels in the tibialis anterior muscle were assessed at two time points. All patients subsequently entered a 12-week open-label extension phase, during which they all received PRO051 at a dose of 6.0 mg per kilogram per week. Safety, pharmacokinetics, serum creatine kinase levels, and muscle strength and function were assessed. RESULTS The most common adverse events were irritation at the administration site and, during the extension phase, mild and variable proteinuria and increased urinary a 1 -microglobulin levels; there were no serious adverse events. The mean terminal half-life of PRO051 in the circulation was 29 days. PRO051 induced detectable, specific exon-51 skipping at doses of 2.0 mg or more per kilogram. New dystrophin expression was observed between approximately 60% and 100% of muscle fibers in 10 of the 12 patients, as measured on post-treatment biopsy, which increased in a dose-dependent manner to up to 15.6% of the expression in healthy muscle. After the 12-week extension phase, there was a mean (+/- SD) improvement of 35.2 +/- 28.7 m (from the baseline of 384 +/- 121 m) on the 6-minute walk test. CONCLUSIONS Systemically administered PRO051 showed dose-dependent molecular efficacy in patients with Duchenne's muscular dystrophy, with a modest improvement in the 6-minute walk test after 12 weeks of extended treatment.	[Goemans, Nathalie M.; Buyse, Gunnar] Katholieke Univ Leuven Hosp, Dept Pediat Neurol, Louvain, Belgium; [Tulinius, Mar; Darin, Niklas] Univ Gothenburg, Dept Pediat, Queen Silvia Childrens Hosp, Gothenburg, Sweden; [Aartsma-Rus, Annemieke; van Ommen, Gert-Jan B.] Leiden Univ, Med Ctr, Dept Human Genet, Ctr Human & Clin Genet, Leiden, Netherlands; [Verschuuren, Jan J.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [Sitsen, J. M. Ad] ClinPharMed, Ermelo, Netherlands; [van den Akker, Johanna T.; Burm, Brigitte E.; Ekhart, Peter F.; Heuvelmans, Niki; Holling, Tjadine; Janson, Anneke A.; Platenburg, Gerard J.; Sipkens, Jessica A.; Campion, Giles V.; de Kimpe, Sjef J.; van Deutekom, Judith C.] Prosensa Therapeut, Leiden, Netherlands	Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Queen Silvia Children's Hospital; University of Gothenburg; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; BioMarin Pharmaceutical Inc.; Prosensa	van Deutekom, JC (corresponding author), Prosensa, POB 281, NL-2300 AG Leiden, Netherlands.	j.vandeutekom@prosensa.nl	Darin, Niklas/AAL-6345-2020	Aartsma-Rus, Annemieke/0000-0003-1565-654X; Verschuuren, Jan/0000-0002-4572-1501	Prosensa Therapeutics, Leiden, the Netherlands	Prosensa Therapeutics, Leiden, the Netherlands(Netherlands Government)	Supported by Prosensa Therapeutics, Leiden, the Netherlands.	Aartsma-Rus A, 2002, NEUROMUSCULAR DISORD, V12, pS71, DOI 10.1016/S0960-8966(02)00086-X; Aartsma-Rus A, 2003, HUM MOL GENET, V12, P907, DOI 10.1093/hmg/ddg100; Aartsma-Rus A, 2006, MUSCLE NERVE, V34, P135, DOI 10.1002/mus.20586; Aartsma-Rus A, 2009, MOL THER, V17, P548, DOI 10.1038/mt.2008.205; Aartsma-Rus A, 2009, HUM MUTAT, V30, P293, DOI 10.1002/humu.20918; Braun S, 2000, GENE THER, V7, P1447, DOI 10.1038/sj.gt.3301261; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Emery AEH, 2003, DUCHENNE MUSCULAR DY; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; Escolar DM, 2001, MUSCLE NERVE, V24, P787, DOI 10.1002/mus.1070; Geary RS, 2009, EXPERT OPIN DRUG MET, V5, P381, DOI [10.1517/17425250902877680 , 10.1517/17425250902877680]; Heemskerk H, 2010, MOL THER, V18, P1210, DOI 10.1038/mt.2010.72; Helderman-van den Enden ATJM, 2010, NEUROMUSCULAR DISORD, V20, P251, DOI 10.1016/j.nmd.2010.01.013; HOFFMAN EP, 1988, NEW ENGL J MED, V318, P1363, DOI 10.1056/NEJM198805263182104; KOENIG M, 1989, AM J HUM GENET, V45, P498; Levin A.A., 2007, ANTISENSE DRUG TECHN, P183; Lu QL, 2000, J CELL BIOL, V148, P985, DOI 10.1083/jcb.148.5.985; Mayhew JE, 2007, MUSCLE NERVE, V35, P36, DOI 10.1002/mus.20654; McDonald CM, 2010, MUSCLE NERVE, V42, P966, DOI 10.1002/mus.21808; McDonald CM, 2010, MUSCLE NERVE, V41, P500, DOI 10.1002/mus.21544; Melis M A, 1998, Eur J Paediatr Neurol, V2, P255, DOI 10.1016/S1090-3798(98)80039-1; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; NGUYEN TM, 1992, BIOCHEM J, V288, P663, DOI 10.1042/bj2880663; NICHOLSON LVB, 1993, NEUROMUSCULAR DISORD, V3, P525, DOI 10.1016/0960-8966(93)90109-W; SHERRAT TG, 1993, AM J HUM GENET, V53, P1007; van Deutekom JC, 2007, NEW ENGL J MED, V357, P2677, DOI 10.1056/NEJMoa073108; van Ommen GJ, 2008, CURR OPIN MOL THER, V10, P140; Yu RZ, 2002, ANAL BIOCHEM, V304, P19, DOI 10.1006/abio.2002.5576	30	521	584	0	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 21	2011	364	16					1513	1522		10.1056/NEJMoa1011367	http://dx.doi.org/10.1056/NEJMoa1011367			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752VH	21428760				2022-12-28	WOS:000289722700008
J	Maizels, RM; Allen, JE				Maizels, Rick M.; Allen, Judith E.			Eosinophils Forestall Obesity	SCIENCE			English	Editorial Material							INSULIN-RESISTANCE; ADIPOSE-TISSUE; T-CELLS; INFLAMMATION; MACROPHAGE		[Maizels, Rick M.] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh EH9 3JT, Midlothian, Scotland; Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Maizels, RM (corresponding author), Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh EH9 3JT, Midlothian, Scotland.	r.maizels@ed.ac.uk	Allen, Judith E/C-9198-2011	Allen, Judith E/0000-0002-3829-066X				Eagle AR, 2010, J CLIN INVEST, V120, P3437, DOI 10.1172/JCI44721; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jenkins SJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/262609; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Ye J, 2009, INT J OBESITY, V33, P54, DOI 10.1038/ijo.2008.229	16	17	17	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					186	187		10.1126/science.1205313	http://dx.doi.org/10.1126/science.1205313			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474746				2022-12-28	WOS:000289251100035
J	Ozaki, M; Kato, J; Kawata, S				Ozaki, Miyu; Kato, Jun-ichi; Kawata, Satoshi			Surface-Plasmon Holography with White-Light Illumination	SCIENCE			English	Article							WAVE; RESONANCE	The recently emerging three-dimensional (3D) displays in the electronic shops imitate depth illusion by overlapping two parallax 2D images through either polarized glasses that viewers are required to wear or lenticular lenses fixed directly on the display. Holography, on the other hand, provides real 3D imaging, although usually limiting colors to monochrome. The so-called rainbow holograms-mounted, for example, on credit cards-are also produced from parallax images that change color with viewing angle. We report on a holographic technique based on surface plasmons that can reconstruct true 3D color images, where the colors are reconstructed by satisfying resonance conditions of surface plasmon polaritons for individual wavelengths. Such real 3D color images can be viewed from any angle, just like the original object.	[Ozaki, Miyu; Kato, Jun-ichi; Kawata, Satoshi] RIKEN, Wako, Saitama 3510198, Japan; [Ozaki, Miyu] Tokyo Denki Univ, Dept Robot & Mechatron, Chiyoda Ku, Tokyo 1018457, Japan; [Kawata, Satoshi] Osaka Univ, Dept Appl Phys, Suita, Osaka 5650871, Japan; [Kawata, Satoshi] Osaka Univ, Adv Photon Res Ctr, Suita, Osaka 5650871, Japan	RIKEN; Tokyo Denki University; Osaka University; Osaka University	Kawata, S (corresponding author), RIKEN, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kawata@skawata.com	Kato, Jun-ichi/G-8427-2011; Kawata, Satoshi/N-7228-2013					BENTON SA, 1969, J OPT SOC AM, V59, P1545; BRYNGDAHL O, 1969, J OPT SOC AM, V59, P1645, DOI 10.1364/JOSA.59.001645; Cowan J. J., 1972, OPT COMMUN, V5, P69; Denisyuk Y.N., 1962, DOKL PHYS, V7, P543; Fang N, 2005, SCIENCE, V308, P534, DOI 10.1126/science.1108759; Ferry VE, 2008, NANO LETT, V8, P4391, DOI 10.1021/nl8022548; Hayazawa N, 2000, OPT COMMUN, V183, P333, DOI 10.1016/S0030-4018(00)00894-4; Heber J, 2009, NATURE, V461, P720, DOI 10.1038/461720a; Kano H, 1996, OPT LETT, V21, P1848, DOI 10.1364/OL.21.001848; Kawata S., 2001, NEAR FIELD OPTICS SU; Kawata S, 2009, NAT PHOTONICS, V3, P388, DOI 10.1038/NPHOTON.2009.111; LIEDBERG B, 1983, SENSOR ACTUATOR, V4, P299, DOI 10.1016/0250-6874(83)85036-7; Loo C, 2005, NANO LETT, V5, P709, DOI 10.1021/nl050127s; Maruo S, 1997, APPL OPTICS, V36, P2343, DOI 10.1364/AO.36.002343; Okamoto T, 2004, APPL PHYS LETT, V85, P3968, DOI 10.1063/1.1814793; Ozaki Miyu, 2008, Journal of the Japan Society of Precision Engineering, V74, P1113, DOI 10.2493/jjspe.74.1113; Pendry JB, 2000, PHYS REV LETT, V85, P3966, DOI 10.1103/PhysRevLett.85.3966; Raether H., 1988, SURFACE PLASMONS SMO, DOI 10.1007/BFb0048319; Wang GP, 2001, APPL OPTICS, V40, P3649, DOI 10.1364/AO.40.003649; Zheludev NI, 2008, NAT PHOTONICS, V2, P351, DOI 10.1038/nphoton.2008.82	20	220	225	5	211	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					218	220		10.1126/science.1201045	http://dx.doi.org/10.1126/science.1201045			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474756				2022-12-28	WOS:000289251100046
J	Goldstein, BD; Osofsky, HJ; Lichtveld, MY				Goldstein, Bernard D.; Osofsky, Howard J.; Lichtveld, Maureen Y.			CURRENT CONCEPTS The Gulf Oil Spill	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ACUTE HEALTH-PROBLEMS; MENTAL-HEALTH; PRESTIGE OIL; HURRICANE-KATRINA; NEEDS-ASSESSMENT; CANTABRIA SPAIN; CLEANUP WORKERS; RISK ASSESSMENT; LUNG-FUNCTION; TANKER BRAER		[Goldstein, Bernard D.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15213 USA; [Osofsky, Howard J.] Louisiana State Univ, Hlth Sci Ctr, Dept Psychiat, New Orleans, LA USA; [Lichtveld, Maureen Y.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Environm Hlth Sci, New Orleans, LA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Tulane University	Goldstein, BD (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, 130 DeSoto St,A712, Pittsburgh, PA 15213 USA.	bdgold@pitt.edu						Aguilera F, 2010, J APPL TOXICOL, V30, P291, DOI 10.1002/jat.1521; Baars BJ, 2002, TOXICOL LETT, V128, P55, DOI 10.1016/S0378-4274(01)00533-1; Barbeau DN, 2010, ANNU REV PUBL HEALTH, V31, P165, DOI 10.1146/annurev.publhealth.012809.103643; Bernard TE, 1999, ANN OCCUP HYG, V43, P321, DOI 10.1093/annhyg/43.5.321; Boscarino Joseph A, 2008, Int J Emerg Ment Health, V10, P275; CAMPBELL D, 1994, BRIT MED J, V309, P773, DOI 10.1136/bmj.309.6957.773; Carrasco JM, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-1; Cleveland C., DEEPWATER HORIZON OI; Cole J, 1997, ENVIRON MOL MUTAGEN, V30, P97; CRUM JE, 1993, BRIT MED J, V307, P23, DOI 10.1136/bmj.307.6895.23; de la Hoz RE, 2008, J OCCUP ENVIRON MED, V50, P1329, DOI 10.1097/JOM.0b013e31818ff6fd; Delp L, 2009, ORGAN ENVIRON, V22, P479, DOI 10.1177/1086026609347193; Department of Health and Human Services Public Health Service, 2010, TOX PROF POL AR HYDR; Do MP, 2009, RES SOCIOL HEALTH CA, V27, P301, DOI 10.1108/S0275-4959(2009)0000027016; Dor F, 2003, RISK ANAL, V23, P1199, DOI 10.1111/j.0272-4332.2003.00394.x; Eggleston PA, 2007, CHEST, V132, p782S, DOI 10.1378/chest.07-1906; Environmental Protection Agency, EPA RESP BP SPILL GU; Farfel M, 2008, J URBAN HEALTH, V85, P880, DOI 10.1007/s11524-008-9317-4; Galea S, 2008, INT J METH PSYCH RES, V17, pS21, DOI 10.1002/mpr.267; Gallacher J, 2007, J EPIDEMIOL COMMUN H, V61, P506, DOI 10.1136/jech.2006.046987; Gill DA, 1998, SOC NATUR RESOUR, V11, P795, DOI 10.1080/08941929809381119; Ginzburg K, 2008, INT J METH PSYCH RES, V17, pS36, DOI 10.1002/mpr.268; Goldstein BD, 2009, ENV TOXICANTS HUMAN, P459; Gualtieri JF, 2003, J TOXICOL-CLIN TOXIC, V41, P57, DOI 10.1081/CLT-120018271; Institute of Medicine, 2010, REP BRIEF FUT NURS L, P1; Janjua NZ, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-84; Kessler RC, 2008, MOL PSYCHIATR, V13, P374, DOI 10.1038/sj.mp.4002119; Kessler RC, 2008, INT J METH PSYCH RES, V17, pS6, DOI 10.1002/mpr.269; Khurshid R., 2008, Eastern Mediterranean Health Journal, V14, P179; Kronenberg ME, 2010, CHILD DEV, V81, P1241, DOI 10.1111/j.1467-8624.2010.01465.x; Laffon B, 2006, FOOD CHEM TOXICOL, V44, P1714, DOI 10.1016/j.fct.2006.05.010; Lan Q, 2004, SCIENCE, V306, P1774, DOI 10.1126/science.1102443; Leikauf GD, 2002, ENVIRON HEALTH PERSP, V110, P505, DOI 10.1289/ehp.02110s4505; Lemiere S, 2005, MUTAT RES-GEN TOX EN, V581, P11, DOI 10.1016/j.mrgentox.2004.10.015; Lomax P, 1998, PROG BRAIN RES, V115, P193; Louisiana Department of Health and Hospitals Office of Public Health, 2010, OIL SPILL HLTH EFF S; Lyons RA, 1999, J EPIDEMIOL COMMUN H, V53, P306, DOI 10.1136/jech.53.5.306; Sabucedo JM, 2009, INT J CLIN HLTH PSYC, V9, P105; Masten AS, 2010, CHILD DEV, V81, P1029, DOI 10.1111/j.1467-8624.2010.01452.x; McCoy MA, 2010, ASSESSING EFFECTS GU, P1; Meo SA, 2008, MAR POLLUT BULL, V56, P88, DOI 10.1016/j.marpolbul.2007.09.039; Meo SA, 2009, INT J OCCUP MED ENV, V22, P35, DOI 10.2478/v10001-009-0007-6; Carrasco JM, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-245; Moline JM, 2008, MT SINAI J MED, V75, P67, DOI 10.1002/msj.20022; Morita A, 1999, ENVIRON RES, V81, P185, DOI 10.1006/enrs.1999.3979; National Institute for Occupational Safety and Health Education and Information Division, NIOSH VOL ROST DEEPW; National Institute for Occupational Safety and Health Education and Information Division, INT REP NAT I OCC SA, P1; National Institute of Environmental Health Sciences, GULF WORK STUD; Norris FH, 2009, J TRAUMA STRESS, V22, P91, DOI 10.1002/jts.20389; PALINKAS LA, 1993, AM J PSYCHIAT, V150, P1517; PALINKAS LA, 1992, J NERV MENT DIS, V180, P287, DOI 10.1097/00005053-199205000-00002; Palinkas Lawrence A, 2004, Prehosp Disaster Med, V19, P102; Perez-Cadahia B, 2008, MUTAT RES-GEN TOX EN, V653, P117, DOI 10.1016/j.mrgentox.2008.04.002; Perez-Cadahia B, 2008, CHEMOSPHERE, V71, P447, DOI 10.1016/j.chemosphere.2007.10.053; Pfefferbaum B, 2008, INT J METH PSYCH RES, V17, pS49, DOI 10.1002/mpr.271; Picou S., 2009, SYNTHESIS 3 DECADES, P279; Raphael B, 2008, INT J METH PSYCH RES, V17, pS42, DOI 10.1002/mpr.265; Reissman DB, 2008, MT SINAI J MED, V75, P135, DOI 10.1002/msj.20024; Sabucedo JM, 2010, DISASTERS, V34, P809, DOI 10.1111/j.1467-7717.2010.01170.x; Savitz DA, 2008, MT SINAI J MED, V75, P77, DOI 10.1002/msj.20023; Schvoerer C, 2000, ETUDE EPIDEMIOLOGIQU; Sim MS, 2010, MAR POLLUT BULL, V60, P51, DOI 10.1016/j.marpolbul.2009.09.003; Stellman JM, 2008, ENVIRON HEALTH PERSP, V116, P1248, DOI 10.1289/ehp.11164; Suarez B, 2005, ENVIRON RES, V99, P413, DOI 10.1016/j.envres.2004.12.012; United Health Foundation, AM HLTH RANK 2009 LO; Vu L, 2009, ORGAN ENVIRON, V22, P422, DOI 10.1177/1086026609347187; Wainipee W, 2010, WATER RES, V44, P5673, DOI 10.1016/j.watres.2010.05.056; Witters D, GULF COAST RESIDENTS; Xing CH, 2010, ENVIRON HEALTH PERSP, V118, P833, DOI 10.1289/ehp.0901531; Xu Y, 2005, PUBLIC HEALTH NURS, V22, P119, DOI 10.1111/j.0737-1209.2005.220205.x; Yun K, 2010, NEW ENGL J MED, V363, P1193, DOI 10.1056/NEJMp1008304; Zock JP, 2007, AM J RESP CRIT CARE, V176, P610, DOI 10.1164/rccm.200701-016OC; Zoek JP, 2009, EPIDEMIOLOGY, V20, pS242; Zoraster RM, 2010, PREHOSPITAL DISASTER, V25, P74, DOI 10.1017/S1049023X00007718	74	138	138	3	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 7	2011	364	14					1334	1348		10.1056/NEJMra1007197	http://dx.doi.org/10.1056/NEJMra1007197			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	745WS	21470011	Bronze			2022-12-28	WOS:000289202800009
J	Leichtman, AB; McCullough, KP; Wolfe, RA				Leichtman, Alan B.; McCullough, Keith P.; Wolfe, Robert A.			Improving the Allocation System for Deceased-Donor Kidneys	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SURVIVAL; LYFT		[Leichtman, Alan B.] Univ Michigan, Sch Med, Dept Med, Ann Arbor, MI 48104 USA; [McCullough, Keith P.; Wolfe, Robert A.] Arbor Res Collaborat Hlth, Ann Arbor, MI USA	University of Michigan System; University of Michigan; Arbor Research Collaborative for Health	Leichtman, AB (corresponding author), Univ Michigan, Sch Med, Dept Med, Ann Arbor, MI 48104 USA.		McCullough, Keith/AAD-1071-2021					*ORG PROC TRANSPL, KIDN ALL POL DEV; Port FK, 2002, TRANSPLANTATION, V74, P1281, DOI 10.1097/00007890-200211150-00014; Rao PS, 2009, TRANSPLANTATION, V88, P231, DOI 10.1097/TP.0b013e3181ac620b; Wolfe RA, 2008, AM J TRANSPLANT, V8, P997, DOI 10.1111/j.1600-6143.2008.02177.x; Wolfe RA, 2009, AM J TRANSPLANT, V9, P1523, DOI 10.1111/j.1600-6143.2009.02708.x	5	33	33	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 7	2011	364	14					1287	1289		10.1056/NEJMp1102728	http://dx.doi.org/10.1056/NEJMp1102728			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	745WS	21410390				2022-12-28	WOS:000289202800002
J	Liu, Y; Jiang, YA; Si, YX; Kim, JY; Chen, ZF; Rao, Y				Liu, Yan; Jiang, Yun'ai; Si, Yunxia; Kim, Ji-Young; Chen, Zhou-Feng; Rao, Yi			Molecular regulation of sexual preference revealed by genetic studies of 5-HT in the brains of male mice	NATURE			English	Article							PARA-CHLOROPHENYLALANINE; COPULATORY-BEHAVIOR; SEROTONIN; LACKING; INNATE; RATS	Although the question of to whom a male directs his mating attempts(1,2) is a critical one in social interactions, little is known about the molecular and cellular mechanisms controlling mammalian sexual preference. Here we report that the neurotransmitter 5-hydroxytryptamine (5-HT) is required for male sexual preference. Wild-type male mice preferred females over males, but males lacking central serotonergic neurons lost sexual preference although they were not generally defective in olfaction or in pheromone sensing. A role for 5-HT was demonstrated by the phenotype of mice lacking tryptophan hydroxylase 2 (Tph2), which is required for the first step of 5-HT synthesis in the brain. Thirty-five minutes after the injection of the intermediate 5-hydroxytryptophan (5-HTP), which circumvented Tph2 to restore 5-HT to the wildtype level, adult Tph2 knockout mice also preferred females over males. These results indicate that 5-HT and serotonergic neurons in the adult brain regulate mammalian sexual preference.	[Liu, Yan; Jiang, Yun'ai; Si, Yunxia; Rao, Yi] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Liu, Yan] Chinese Acad Med Sci, Grad Sch, Beijing 100730, Peoples R China; [Liu, Yan] Peking Union Med Coll, Beijing 100730, Peoples R China; [Jiang, Yun'ai] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Beijing 100864, Peoples R China; [Jiang, Yun'ai] Chinese Acad Sci, Grad Sch, Beijing 100864, Peoples R China; [Kim, Ji-Young; Chen, Zhou-Feng] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Kim, Ji-Young; Chen, Zhou-Feng] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Kim, Ji-Young; Chen, Zhou-Feng] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Rao, Yi] Peking Univ, Sch Life Sci, State Key Lab Membrane Biol, Beijing 100871, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Peking University	Rao, Y (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	yrao@pku.edu.cn		Rao, Yi/0000-0002-0405-5426	Ministry of Science and Technology [2010CB833901]; Beijing Municipal Commission on Science and Technology; NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056318] Funding Source: NIH RePORTER	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Beijing Municipal Commission on Science and Technology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to E. S. Deneris for ePet1-Cre mice; to R. Johnson for Lmx1b<SUP>fl</SUP> mice; to M. Luo for discussions; to Z. Yan and Y. Lu for the operant conditioning apparatus; to X. Wang and Y. Wan for help with HPLC; to J. Lang and J. Yin for mouse breeding and genotyping; to P. Ding, P. Wang, H. Lu and X. Wang for technical assistance; to L. Zhao, Z. Qiu and H. Jing for animal caring; and to the Ministry of Science and Technology (973 program 2010CB833901) and Beijing Municipal Commission on Science and Technology for grant support (to Y.R.), and the NIH for grant support (to Z.-F.C.).	Alenina N, 2009, P NATL ACAD SCI USA, V106, P10332, DOI 10.1073/pnas.0810793106; Blanchard DC, 2003, BEHAV NEUROSCI, V117, P360, DOI 10.1037/0735-7044.117.2.360; Burwash MD, 1998, J CHEM ECOL, V24, P49, DOI 10.1023/A:1022384728170; Dailly E, 2006, J NEUROSCI METH, V150, P111, DOI 10.1016/j.jneumeth.2005.06.008; ERWIN J, 1976, ARCH SEX BEHAV, V5, P9, DOI 10.1007/BF01542236; FERGUSON J, 1970, SCIENCE, V168, P499, DOI 10.1126/science.168.3930.499; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Ferkin MH, 2005, PHYSIOL BEHAV, V85, P489, DOI 10.1016/j.physbeh.2005.05.014; GAWIENOWSKI AM, 1971, PHYSIOL BEHAV, V7, P551, DOI 10.1016/0031-9384(71)90108-9; Guo ZS, 2007, CHEM SENSES, V32, P463, DOI 10.1093/chemse/bjm015; Gutknecht L, 2008, J NEURAL TRANSM, V115, P1127, DOI 10.1007/s00702-008-0096-6; Hull EM, 2007, HORM BEHAV, V52, P45, DOI 10.1016/j.yhbeh.2007.03.030; Hull EM, 2004, PHYSIOL BEHAV, V83, P291, DOI 10.1016/j.physbeh.2004.08.018; Kinnunen LH, 2004, BRAIN RES, V1024, P251, DOI 10.1016/j.brainres.2004.07.070; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; KOE BK, 1966, J PHARMACOL EXP THER, V154, P499; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; MALMNAS CO, 1971, NATURE, V232, P398, DOI 10.1038/232398a0; Moncho-Bogani J, 2002, PHYSIOL BEHAV, V77, P167, DOI 10.1016/S0031-9384(02)00842-9; Mustanski BS, 2005, HUM GENET, V116, P272, DOI 10.1007/s00439-004-1241-4; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; PRICE EO, 1991, J ANIM SCI, V69, P1019; SALIS PJ, 1971, NATURE, V232, P400, DOI 10.1038/232400a0; Savelieva KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003301; Sommer V, 2006, HOMOSEXUAL BEHAV ANI; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; TRIVERS RL, 1974, AM ZOOL, V14, P249; Wainberg ML, 2006, J CLIN PSYCHIAT, V67, P1968, DOI 10.4088/JCP.v67n1218; Yan ZQ, 2008, NEURON, V58, P613, DOI 10.1016/j.neuron.2008.03.012; Zhao ZQ, 2006, J NEUROSCI, V26, P12781, DOI 10.1523/JNEUROSCI.4143-06.2006	30	99	106	8	158	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 7	2011	472	7341					95	U125		10.1038/nature09822	http://dx.doi.org/10.1038/nature09822			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	745VV	21441904	Green Accepted			2022-12-28	WOS:000289199400044
J	Morris, MC; Tangney, CC				Morris, Martha Clare; Tangney, Christine C.			A Potential Design Flaw of Randomized Trials of Vitamin Supplements	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COGNITIVE FUNCTION; ALZHEIMER-DISEASE; CARDIOVASCULAR-DISEASE; ACID SUPPLEMENTATION; DIETARY-INTAKE; RISK; ANTIOXIDANT; WOMEN		[Morris, Martha Clare] Rush Univ, Med Ctr, Sect Nutr & Nutr Epidemiol, Dept Internal Med, Oak Pk, IL 60304 USA; [Tangney, Christine C.] Rush Univ, Med Ctr, Dept Clin Nutr, Oak Pk, IL 60304 USA	Rush University; Rush University	Morris, MC (corresponding author), Rush Univ, Med Ctr, Sect Nutr & Nutr Epidemiol, Dept Internal Med, Rush Oak Pk Profess Off Bldg,610 S Maple,Ste 4700, Oak Pk, IL 60304 USA.	martha_c_morris@rush.edu			NIA NIH HHS [R01 AG021972] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG021972] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Durga J, 2007, LANCET, V369, P208, DOI 10.1016/S0140-6736(07)60109-3; Engelhart MJ, 2002, JAMA-J AM MED ASSOC, V287, P3223, DOI 10.1001/jama.287.24.3223; Kang JH, 2009, CIRCULATION, V119, P2772, DOI 10.1161/CIRCULATIONAHA.108.816900; Kang JH, 2008, AM J CLIN NUTR, V88, P1602, DOI 10.3945/ajcn.2008.26404; Kang JH, 2006, ARCH INTERN MED, V166, P2462, DOI 10.1001/archinte.166.22.2462; Luchsinger JA, 2003, ARCH NEUROL-CHICAGO, V60, P203, DOI 10.1001/archneur.60.2.203; Morris MC, 2002, JAMA-J AM MED ASSOC, V287, P3230, DOI 10.1001/jama.287.24.3230; Petersen RC, 2005, NEW ENGL J MED, V352, P2379, DOI 10.1056/NEJMoa050151; Quinn JF, 2010, JAMA-J AM MED ASSOC, V304, P1903, DOI 10.1001/jama.2010.1510; van de Rest O, 2008, NEUROLOGY, V71, P430, DOI 10.1212/01.wnl.0000324268.45138.86	10	80	83	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 6	2011	305	13					1348	1349		10.1001/jama.2011.383	http://dx.doi.org/10.1001/jama.2011.383			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	745JT	21467288	Green Accepted			2022-12-28	WOS:000289162400025
J	Gilbertson, RJ				Gilbertson, Richard J.			Mapping Cancer Origins	CELL			English	Review							STEM-CELLS; BCR-ABL; PROGENITORS; LEUKEMIA; MEDULLOBLASTOMA; TRANSFORMATION; POPULATION; EPENDYMOMA	Cancer comprises a bewildering assortment of diseases that kill 7.5 million people each year. Poor understanding of cancer's diversity currently thwarts our goal of a cure for every patient, but recent integration of genomic and stem cell technologies promises a route through this impasse.	[Gilbertson, Richard J.] St Jude Childrens Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Gilbertson, Richard J.] St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Gilbertson, RJ (corresponding author), St Jude Childrens Hosp, Dept Dev Neurobiol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	richard.gilbertson@stjude.org	Gilbertson, Richard James/ABE-1346-2021	Gilbertson, Richard James/0000-0001-7539-9472	NATIONAL CANCER INSTITUTE [P01CA096832, R01CA129541] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA129541, R01 CA129541-05, P01 CA096832-07, P01 CA096832] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 2008, NATURE, V455, P1061; Barabe F, 2007, SCIENCE, V316, P600, DOI 10.1126/science.1139851; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Chen W, 2008, CANCER CELL, V13, P432, DOI 10.1016/j.ccr.2008.03.005; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Johnson RA, 2010, NATURE, V466, P632, DOI 10.1038/nature09173; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Ross ME, 2004, BLOOD, V104, P3679, DOI 10.1182/blood-2004-03-1154; Schemionek M, 2010, BLOOD, V115, P3185, DOI 10.1182/blood-2009-04-215376; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003	21	31	32	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 1	2011	145	1					25	29		10.1016/j.cell.2011.03.019	http://dx.doi.org/10.1016/j.cell.2011.03.019			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458665	Bronze, Green Accepted			2022-12-28	WOS:000289053900006
J	Gomez, P; Buckling, A				Gomez, Pedro; Buckling, Angus			Bacteria-Phage Antagonistic Coevolution in Soil	SCIENCE			English	Article							LOCAL ADAPTATION; POPULATION; EVOLUTION; DYNAMICS; COST	Bacteria and their viruses (phages) undergo rapid coevolution in test tubes, but the relevance to natural environments is unclear. By using a "mark-recapture" approach, we showed rapid coevolution of bacteria and phages in a soil community. Unlike coevolution in vitro, which is characterized by increases in infectivity and resistance through time (arms race dynamics), coevolution in soil resulted in hosts more resistant to their contemporary than past and future parasites (fluctuating selection dynamics). Fluctuating selection dynamics, which can potentially continue indefinitely, can be explained by fitness costs constraining the evolution of high levels of resistance in soil. These results suggest that rapid coevolution between bacteria and phage is likely to play a key role in structuring natural microbial communities.	[Gomez, Pedro; Buckling, Angus] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Gomez, Pedro] CSIC, CEBAS, Murcia 30100, Espinardo, Spain; [Buckling, Angus] Univ Exeter, Penryn TR10 9EZ, England	University of Oxford; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS); University of Exeter	Gomez, P (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	pedro.gomezlopez@zoo.ox.ac.uk	Gómez López, Pedro/H-2230-2012; López, Pedro Gómez/M-4712-2019	Gómez López, Pedro/0000-0003-2830-4105; López, Pedro Gómez/0000-0003-2830-4105; Buckling, Angus/0000-0003-1170-4604	Ministerio de Ciencia e Innovacion (MICINN, Spain)	Ministerio de Ciencia e Innovacion (MICINN, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	We thank T. Bell and A. Hall for comments on the manuscript. The work was supported by the European Research Council. P. G. was supported from Ministerio de Ciencia e Innovacion (MICINN, Spain) by National Mobility Program of Human Resources "Jose Castillejo." Partial 16S ribosomal RNA sequences have been assigned to the European Nucleotide Archive, European Molecular Biology Laboratory-European Bioinformatics Institute, under accession numbers FR746065 to FR746094.	Adams MH, 1959, BACTERIOPHAGES; Agrawal A, 2002, EVOL ECOL RES, V4, P79; Bohannan BJM, 2000, ECOL LETT, V3, P362, DOI 10.1046/j.1461-0248.2000.00161.x; Brockhurst MA, 2003, ECOL LETT, V6, P975, DOI 10.1046/j.1461-0248.2003.00531.x; Brockhurst MA, 2007, INFECT GENET EVOL, V7, P547, DOI 10.1016/j.meegid.2007.01.005; Buckling A, 2006, P ROY SOC B-BIOL SCI, V273, P45, DOI 10.1098/rspb.2005.3279; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; BULL JJ, 1994, EVOLUTION, V48, P1423, DOI 10.1111/j.1558-5646.1994.tb02185.x; Decaestecker E, 2007, NATURE, V450, P870, DOI 10.1038/nature06291; EBERT D, 1994, SCIENCE, V265, P1084, DOI 10.1126/science.265.5175.1084; Finkel SE, 2006, NAT REV MICROBIOL, V4, P113, DOI 10.1038/nrmicro1340; Gandon S, 2008, J EVOLUTION BIOL, V21, P1861, DOI 10.1111/j.1420-9101.2008.01598.x; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; Greischar MA, 2007, ECOL LETT, V10, P418, DOI 10.1111/j.1461-0248.2007.01028.x; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; Held NL, 2009, ENVIRON MICROBIOL, V11, P457, DOI 10.1111/j.1462-2920.2008.01784.x; Hoeksema JD, 2008, AM NAT, V171, P275, DOI 10.1086/527496; Lennon JT, 2007, ISME J, V1, P300, DOI 10.1038/ismej.2007.37; Levin BR, 2004, NAT REV MICROBIOL, V2, P166, DOI 10.1038/nrmicro822; Lively CM, 2000, NATURE, V405, P679, DOI 10.1038/35015069; Lopez-Pascua LDC, 2008, J EVOLUTION BIOL, V21, P853, DOI 10.1111/j.1420-9101.2008.01501.x; Pal C, 2007, NATURE, V450, P1079, DOI 10.1038/nature06350; PARKER MA, 1985, EVOLUTION, V39, P713, DOI 10.1111/j.1558-5646.1985.tb00414.x; Sasaki A, 2000, P ROY SOC B-BIOL SCI, V267, P2183, DOI 10.1098/rspb.2000.1267; Thompson J.N., 2005, INTERSPEC INTERACT; Thrall PH, 2002, EVOLUTION, V56, P1340; Vos M, 2009, SCIENCE, V325, P833, DOI 10.1126/science.1174173	27	291	295	7	214	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2011	332	6025					106	109		10.1126/science.1198767	http://dx.doi.org/10.1126/science.1198767			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21454789				2022-12-28	WOS:000289000000048
J	Midgley, PA				Midgley, Paul A.			Electronic Bonding Revealed by Electron Diffraction	SCIENCE			English	Editorial Material									Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England	University of Cambridge	Midgley, PA (corresponding author), Univ Cambridge, Dept Mat Sci & Met, Pembroke St, Cambridge CB2 3QZ, England.	pam33@cam.ac.uk		Midgley, Paul/0000-0002-6817-458X				HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0; Midgley PA, 1996, CONTEMP PHYS, V37, P441, DOI 10.1080/00107519608217535; Nakashima PNH, 2011, SCIENCE, V331, P1583, DOI 10.1126/science.1198543; Nakashima PNH, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.115135; Saunders M, 1999, ACTA CRYSTALLOGR A, V55, P471, DOI 10.1107/S0108767398012604; VINCENT R, 1994, ULTRAMICROSCOPY, V53, P271, DOI 10.1016/0304-3991(94)90039-6; VINCENT R, 1984, PHILOS MAG A, V50, P745; WATANABE D, 1968, ACTA CRYSTALL A-CRYS, VA 24, P580, DOI 10.1107/S0567739468001245; Zuo JM, 1999, NATURE, V401, P49, DOI 10.1038/43403	9	18	18	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 25	2011	331	6024					1528	1529		10.1126/science.1203614	http://dx.doi.org/10.1126/science.1203614			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21436428				2022-12-28	WOS:000288754500031
J	Pappu, S; Gunnell, Y; Akhilesh, K; Braucher, R; Taieb, M; Demory, F; Thouveny, N				Pappu, Shanti; Gunnell, Yanni; Akhilesh, Kumar; Braucher, Regis; Taieb, Maurice; Demory, Francois; Thouveny, Nicolas			Early Pleistocene Presence of Acheulian Hominins in South India	SCIENCE			English	Article							ATTIRAMPAKKAM; EXCAVATIONS; ARTIFACTS; BURIAL; SITE; AGE	South Asia is rich in Lower Paleolithic Acheulian sites. These have been attributed to the Middle Pleistocene on the basis of a small number of dates, with a few older but disputed age estimates. Here, we report new ages from the excavated site of Attirampakkam, where paleomagnetic measurements and direct Al-26/Be-10 burial dating of stone artifacts now position the earliest Acheulian levels as no younger than 1.07 million years ago (Ma), with a pooled average age of 1.51 +/- 0.07 Ma. These results reveal that, during the Early Pleistocene, India was already occupied by hominins fully conversant with an Acheulian technology including handaxes and cleavers among other artifacts. This implies that a spread of bifacial technologies across Asia occurred earlier than previously accepted.	[Pappu, Shanti; Akhilesh, Kumar] Sharma Ctr Heritage Educ, Madras 600004, Tamil Nadu, India; [Gunnell, Yanni] Univ Lyon 2, Dept Geog, CNRS UMR 5600, F-69676 Bron, France; [Braucher, Regis; Taieb, Maurice; Demory, Francois; Thouveny, Nicolas] CEREGE, F-13545 Aix En Provence 04, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National des Sciences Appliquees de Lyon - INSA Lyon; Universite Jean Monnet; Universite Jean Moulin Lyon 3; Universite Lyon 2; UDICE-French Research Universities; Aix-Marseille Universite	Pappu, S (corresponding author), Sharma Ctr Heritage Educ, 28 I Main Rd, Madras 600004, Tamil Nadu, India.	pappu.shanti@gmail.com	, Braucher/Q-5971-2017; DEMORY, FRANCOIS/AAC-6641-2019	, Braucher/0000-0002-4637-4302; Pappu, Shanti/0000-0003-4786-4968; THOUVENY, Nicolas/0000-0001-6601-856X; Demory, Francois/0000-0002-7526-9886	Homi Bhabha Fellowships Council; Leakey Foundation; Earthwatch Institute; Sharma Centre for Heritage Education; Indian Space Research Organisation, Regional Remote Sensing Centre, Bengaluru; Archaeological Survey of India, Delhi and Chennai Circle; Department of Archaeology, State Government of Tamil Nadu; Institut Universitaire de France; Institut National des Sciences de l'Univers/CNRS; French Ministry of Research; Institut de Recherche pour le Developpement; Commissariat a l'Energie Atomique	Homi Bhabha Fellowships Council; Leakey Foundation; Earthwatch Institute; Sharma Centre for Heritage Education; Indian Space Research Organisation, Regional Remote Sensing Centre, Bengaluru; Archaeological Survey of India, Delhi and Chennai Circle; Department of Archaeology, State Government of Tamil Nadu; Institut Universitaire de France; Institut National des Sciences de l'Univers/CNRS(Centre National de la Recherche Scientifique (CNRS)); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Institut de Recherche pour le Developpement; Commissariat a l'Energie Atomique(French Atomic Energy Commission)	Excavations at Attirampakkam were funded by the Homi Bhabha Fellowships Council, the Leakey Foundation, the Earthwatch Institute, and the Sharma Centre for Heritage Education. Ongoing studies are being funded by the Indian Space Research Organisation, Regional Remote Sensing Centre, Bengaluru, (Geosphere Biosphere Program). We thank Uday Raj, S. Ravindranath, C. B. S. Dutt, P. G. Diwakar, and R. Ramesh. We also thank the Archaeological Survey of India, Delhi and Chennai Circle, and the Department of Archaeology, State Government of Tamil Nadu, for licenses to excavate and support; the Institut Universitaire de France for field and analytical costs; M. Arnold and G. Aumaitre for assistance with <SUP>10</SUP>Be and <SUP>26</SUP>Al measurements; and the ASTER (Accelerateur pour les Sciences de la Terre, Environnement, Risques) national facility (CEREGE, Aix-en-Provence), which is supported by the Institut National des Sciences de l'Univers/CNRS, the French Ministry of Research, the Institut de Recherche pour le Developpement, and the Commissariat a l'Energie Atomique. All three reviewers contributed valuable comments.	Acharyya SK, 2003, CURR SCI INDIA, V84, P127; ASFAW B, 1992, NATURE, V360, P732, DOI 10.1038/360732a0; Bar-Yosef O, 1993, LITHIC ASSEMBLAGES U; CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; Chauhan PR, 2010, QUATERN INT, V223, P248, DOI 10.1016/j.quaint.2010.01.021; de la Torre I, 2008, J ANTHROPOL ARCHAEOL, V27, P244, DOI 10.1016/j.jaa.2007.12.001; DENNELL RW, 1988, CURR ANTHROPOL, V29, P495, DOI 10.1086/203666; DENNELL RW, 2004, BAR INT SERIES, V1265; Dennell RW, 2009, PALAEOLITHIC SETTLEM; Gaillard C, 2010, QUATERN INT, V223, P234, DOI 10.1016/j.quaint.2009.08.021; Gibbon RJ, 2009, J HUM EVOL, V56, P152, DOI 10.1016/j.jhevol.2008.09.006; Goren-Inbar N, 2000, SCIENCE, V289, P944, DOI 10.1126/science.289.5481.944; Granger DE, 2001, EARTH PLANET SC LETT, V188, P269, DOI 10.1016/S0012-821X(01)00309-0; Gunnell Y, 2006, CURR SCI INDIA, V91, P114; Hou YM, 2000, SCIENCE, V287, P1622, DOI 10.1126/science.287.5458.1622; Kailath AJ, 2000, RADIAT MEAS, V32, P371, DOI 10.1016/S1350-4487(99)00282-6; MISHRA S, 1995, CURR ANTHROPOL, V36, P847, DOI 10.1086/204442; MISHRA S, 1992, CURR ANTHROPOL, V33, P325, DOI 10.1086/204074; Paddayya K, 2002, CURR SCI INDIA, V83, P641; Pappu S, 2003, CURR ANTHROPOL, V44, P591, DOI 10.1086/377652; Pappu S., 2004, MAN ENV, VXXIX, P1; PAPPU S, 2001, BRIT ARCHAOLOGICAL R, V1003; Pappu S., 2006, AXE AGE ACHEULIAN TO, P155; Patnaik R, 2009, J HUM EVOL, V56, P114, DOI 10.1016/j.jhevol.2008.08.023; Petraglia MD, 2007, VERTEBR PALEOBIOL PA, P1, DOI 10.1007/1-4020-5562-5_1; RENDELL H, 1985, CURR ANTHROPOL, V26, P393, DOI 10.1086/203287; Sangode S.J., 2007, GONDWANA GEOLOGICAL, V10, P111; Shen GJ, 2009, NATURE, V458, P198, DOI 10.1038/nature07741; Westgate JA, 1998, QUATERNARY RES, V50, P107, DOI 10.1006/qres.1998.1974	29	127	131	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 25	2011	331	6024					1596	1599		10.1126/science.1200183	http://dx.doi.org/10.1126/science.1200183			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739XH	21436450				2022-12-28	WOS:000288754500053
J	O'Malley, AS				O'Malley, Ann S.			Tapping the Unmet Potential of Health Information Technology	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RECORDS; CARE		Ctr Studying Hlth Syst Change, Washington, DC 20024 USA		O'Malley, AS (corresponding author), Ctr Studying Hlth Syst Change, Washington, DC 20024 USA.							Bates DW, 2010, HEALTH AFFAIR, V29, P614, DOI 10.1377/hlthaff.2010.0007; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; CL G, 2009, HLTH Aff, V28, pW282, DOI DOI 10.1377/HLTHAFF.28.2.W282; O'Malley AS, 2010, J GEN INTERN MED, V25, P177, DOI 10.1007/s11606-009-1195-2; Stille CJ, 2005, ANN INTERN MED, V142, P700, DOI 10.7326/0003-4819-142-8-200504190-00038	5	44	45	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2011	364	12					1090	1091		10.1056/NEJMp1011227	http://dx.doi.org/10.1056/NEJMp1011227			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	739FY	21428764				2022-12-28	WOS:000288701100003
J	Sato, T; Katagiri, K; Gohbara, A; Inoue, K; Ogonuki, N; Ogura, A; Kubota, Y; Ogawa, T				Sato, Takuya; Katagiri, Kumiko; Gohbara, Ayako; Inoue, Kimiko; Ogonuki, Narumi; Ogura, Atsuo; Kubota, Yoshinobu; Ogawa, Takehiko			In vitro production of functional sperm in cultured neonatal mouse testes	NATURE			English	Article							RAT SPERMATOGENIC CELLS; TRANSMEIOTIC DIFFERENTIATION; ORGAN-CULTURE; GERM-CELLS; PROTEIN; NUCLEI; MARKER	Spermatogenesis is one of the most complex and longest processes of sequential cell proliferation and differentiation in the body, taking more than a month from spermatogonial stem cells, through meiosis, to sperm formation(1,2). The whole process, therefore, has never been reproduced in vitro in mammals(3-5), nor in any other species with a very few exceptions in some particular types of fish(6,7). Here we show that neonatal mouse testes which contain only gonocytes or primitive spermatogonia as germ cells can produce spermatids and sperm in vitro with serum-free culture media. Spermatogenesis was maintained over 2 months in tissue fragments positioned at the gas-liquid interphase. The obtained spermatids and sperm resulted in healthy and reproductively competent offspring through microinsemination. In addition, neonatal testis tissues were cryopreserved and, after thawing, showed complete spermatogenesis in vitro. Our organ culture method could be applicable through further refinements to a variety of mammalian species, which will serve as a platform for future clinical application as well as mechanistic understanding of spermatogenesis.	[Sato, Takuya; Katagiri, Kumiko; Gohbara, Ayako; Kubota, Yoshinobu; Ogawa, Takehiko] Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa 2360004, Japan; [Inoue, Kimiko; Ogonuki, Narumi; Ogura, Atsuo] RIKEN, Bioresource Ctr, Ibaraki 3050074, Japan; [Ogawa, Takehiko] Yokohama City Univ, Adv Med Res Ctr, Yokohama, Kanagawa 2360004, Japan	Yokohama City University; RIKEN; Yokohama City University	Ogawa, T (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa 2360004, Japan.	ogawa@med.yokohama-cu.ac.jp	Ogura, Atsuo/J-3916-2014; Jeong, Wonjun/AAM-5937-2020; Sato, Takuya/F-8251-2017; Sato, Takuya/X-9143-2019	Ogura, Atsuo/0000-0003-0447-1988; Sato, Takuya/0000-0002-6198-2234; Sato, Takuya/0000-0002-6198-2234	Ministry of Education, Culture, Sports, Science, and Technology, Japan [20116005, 21592080]; Yokohama Foundation for Advancement of Medical Science; Yokohama City University, Japan [S2116]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yokohama Foundation for Advancement of Medical Science; Yokohama City University, Japan	We thank S. Yoshida and G. Yoshizaki for comments and pre-submission review. We thank A. Tanaka and Y. W. Zheng for their technical help in flow cytometric analysis. T.O. is grateful to his mentor R. L. Brinster for his advice on devising the experimental strategies and for his encouragements. We would like to thank A. Steinberger and the late E. Steinberger whose work in the study of in vitro spermatogenesis became the ground work for our present study. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas, "Regulatory Mechanism of Gamete Stem Cells'' (#20116005); a Grant-in-Aid for Scientific Research (C) (#21592080) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; a grant from the Yokohama Foundation for Advancement of Medical Science; and a grant for Research and Development Project II (No.S2116) of Yokohama City University, Japan (to T.O.).	Champy C., 1920, Archives de Zoologie Experimentale Paris, V60; CLERMONT Y, 1972, PHYSIOL REV, V52, P198, DOI 10.1152/physrev.1972.52.1.198; Feng LX, 2002, SCIENCE, V297, P392, DOI 10.1126/science.1073162; GOETZ P, 1984, J CELL SCI, V65, P249; Gohbara A, 2010, BIOL REPROD, V83, P261, DOI 10.1095/biolreprod.110.083899; Goldsborough M.D, 1998, FOCUS, V20, P8; La Salle S, 2009, METHODS MOL BIOL, V558, P279, DOI 10.1007/978-1-60761-103-5_17; Martinovitch P. N., 1937, Nature London, V139, P413, DOI 10.1038/139413a0; MIURA T, 1991, P NATL ACAD SCI USA, V88, P5774, DOI 10.1073/pnas.88.13.5774; Nakanishi T, 1999, FEBS LETT, V449, P277, DOI 10.1016/S0014-5793(99)00433-0; Ogonuki N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011062; Ogura A, 1999, HUM REPROD, V14, P1294, DOI 10.1093/humrep/14.5.1294; Parks JE, 2003, THERIOGENOLOGY, V59, P73, DOI 10.1016/S0093-691X(02)01275-X; PRICE PJ, 1998, Patent No. 9830679; Price PJ, 1998, Patent No. [PCT/US98/00467, 9800467]; RASSOULZADEGAN M, 1993, CELL, V75, P997, DOI 10.1016/0092-8674(93)90543-Y; Russell LD, 1990, HISTOLOGICAL HISTOPA, P1; Sakai N, 2002, DEVELOPMENT, V129, P3359; SHARPE RM, 2006, SERTOLI CELL BIOL, P199; Staub C, 2000, EXP CELL RES, V260, P85, DOI 10.1006/excr.2000.4998; Staub C, 2001, J ANDROL, V22, P911; STEINBERGER A, 1964, EXP CELL RES, V36, P19, DOI 10.1016/0014-4827(64)90156-9; Steinberger A., 1967, J REPROD FERTIL S, V2, P117; Tanaka H, 1999, J BIOL CHEM, V274, P17049, DOI 10.1074/jbc.274.24.17049; TRES LL, 1983, P NATL ACAD SCI-BIOL, V80, P3377, DOI 10.1073/pnas.80.11.3377; TROWELL OA, 1959, EXP CELL RES, V16, P118, DOI 10.1016/0014-4827(59)90201-0; Ventela S, 2000, TISSUE CELL, V32, P501, DOI [10.1016/S0040-8166(00)80006-3, 10.1054/tice.2000.0140]; Wachs FP, 2003, LAB INVEST, V83, P949, DOI 10.1097/01.LAB.0000075556.74231.A5	28	457	486	2	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					504	+		10.1038/nature09850	http://dx.doi.org/10.1038/nature09850			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21430778				2022-12-28	WOS:000288702200060
J	Tigas, S; Tsatsoulis, A				Tigas, Stelios; Tsatsoulis, Agathocles			Case Report A 42 year old man with bilateral exophthalmos and weight loss	BRITISH MEDICAL JOURNAL			English	Editorial Material							THYROTROPIN-RECEPTOR ANTIBODIES; RADIOIODINE TREATMENT; GRAVES-DISEASE; ANTITHYROID DRUGS; CANCER-MORTALITY; THYROID-DISEASES; HYPERTHYROIDISM; OPHTHALMOPATHY; POPULATION; THERAPY					stigas@cc.uoi.gr	Tigas, Stelios/H-9478-2019	Tigas, Stelios/0000-0001-7325-8983				Bahn Rebecca S, 2009, Thyroid, V19, P673, DOI 10.1089/thy.2009.0169; BARTALENA L, 1989, NEW ENGL J MED, V321, P1349, DOI 10.1056/NEJM198911163212001; Bartalena L, 2008, THYROID, V18, P333, DOI 10.1089/thy.2007.0315; Bartalena L, 2009, NEW ENGL J MED, V360, P994, DOI 10.1056/NEJMcp0806317; Brent GA, 2008, NEW ENGL J MED, V358, P2594, DOI 10.1056/NEJMcp0801880; COOPER DS, 1984, NEW ENGL J MED, V311, P1353, DOI 10.1056/NEJM198411223112106; Costagliola S, 1999, J CLIN ENDOCR METAB, V84, P90, DOI 10.1210/jc.84.1.90; El Fassi D, 2006, THYROID, V16, P709; Flynn RWV, 2006, J CLIN ENDOCR METAB, V91, P2159, DOI 10.1210/jc.2005-1833; Franklyn JA, 1999, LANCET, V353, P2111, DOI 10.1016/S0140-6736(98)12295-X; Franklyn JA, 2005, JAMA-J AM MED ASSOC, V294, P71, DOI 10.1001/jama.294.1.71; Gupta MK, 2000, CLIN CHIM ACTA, V293, P1, DOI 10.1016/S0009-8981(99)00235-1; HALL P, 1993, ACTA ENDOCRINOL-COP, V128, P230, DOI 10.1530/acta.0.1280230; Metso S, 2008, CLIN ENDOCRINOL, V68, P450, DOI 10.1111/j.1365-2265.2007.03064.x; Metso S, 2007, J CLIN ENDOCR METAB, V92, P2190, DOI 10.1210/jc.2006-2321; Perros P, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b560; Ron E, 1998, JAMA-J AM MED ASSOC, V280, P347, DOI 10.1001/jama.280.4.347; Royal College of Physicians, 2007, REP WORK PART; SINGER PA, 1995, JAMA-J AM MED ASSOC, V273, P808, DOI 10.1001/jama.273.10.808; The Association of Clinical Biochemistry British Thyroid Association British Thyroid Foundation, 2006, UK GUID US THYR FUNC; Toft A, 2007, BMJ-BRIT MED J, V334, P483, DOI 10.1136/bmj.39140.373646.BE; Torring O, 1996, J CLIN ENDOCR METAB, V81, P2986, DOI 10.1210/jc.81.8.2986; Wartofsky L, 1991, Thyroid, V1, P129, DOI 10.1089/thy.1991.1.129; Weetman AP, 2007, CLIN ENDOCRINOL, V66, P757, DOI 10.1111/j.1365-2265.2007.02841.x; Weetman AP, 2000, NEW ENGL J MED, V343, P1236, DOI 10.1056/NEJM200010263431707; WERNER MC, 1989, AM J MED SCI, V297, P216, DOI 10.1097/00000441-198904000-00003; YANAGAWA T, 1995, J CLIN ENDOCR METAB, V80, P41, DOI 10.1210/jc.80.1.41	27	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 23	2011	342								d1105	10.1136/bmj.d1105	http://dx.doi.org/10.1136/bmj.d1105			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	742MJ	21436114				2022-12-28	WOS:000288948000001
J	Balazsi, G; van Oudenaarden, A; Collins, JJ				Balazsi, Gabor; van Oudenaarden, Alexander; Collins, James J.			Cellular Decision Making and Biological Noise: From Microbes to Mammals	CELL			English	Review							STOCHASTIC GENE-EXPRESSION; DIVISION-OF-LABOR; FLUCTUATING ENVIRONMENTS; EPIGENETIC INHERITANCE; SINGLE-CELL; TRANSCRIPTIONAL NOISE; BACTERIOPHAGE-LAMBDA; PHENOTYPIC DIVERSITY; BACILLUS-SUBTILIS; ESCHERICHIA-COLI	Cellular decision making is the process whereby cells assume different, functionally important and heritable fates without an associated genetic or environmental difference. Such stochastic cell fate decisions generate nongenetic cellular diversity, which may be critical for metazoan development as well as optimized microbial resource utilization and survival in a fluctuating, frequently stressful environment. Here, we review several examples of cellular decision making from viruses, bacteria, yeast, lower metazoans, and mammals, highlighting the role of regulatory network structure and molecular noise. We propose that cellular decision making is one of at least three key processes underlying development at various scales of biological organization.	[Collins, James J.] Boston Univ, Howard Hughes Med Inst, Dept Biomed Engn, Boston, MA 02215 USA; [Collins, James J.] Boston Univ, Ctr BioDynam, Boston, MA 02215 USA; [Balazsi, Gabor] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Unit 950, Houston, TX 77054 USA; [van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [van Oudenaarden, Alexander] MIT, Dept Biol, Cambridge, MA 02139 USA; [Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02215 USA	Boston University; Howard Hughes Medical Institute; Boston University; University of Texas System; UTMD Anderson Cancer Center; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University	Collins, JJ (corresponding author), Boston Univ, Howard Hughes Med Inst, Dept Biomed Engn, Boston, MA 02215 USA.	jcollins@bu.edu	van Oudenaarden, Alexander/AAA-1705-2019	Balazsi, Gabor/0000-0002-6865-5818	NIH [1DP2 OD006481-01, 1DP1OD003936, DP1 OD00344, RC2 HL102815, RL1 DE019021]; NSF [IOS 1021675]; NIH/NCI Physical Sciences Oncology Center at MIT [U54CA143874]; Ellison Medical Foundation; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [U54CA143874] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RL1DE019021] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003936, DP1OD003644, DP2OD006481] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NIH/NCI Physical Sciences Oncology Center at MIT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank D. Nevozhay, R.M. Adams, G.B. Mills, O.A. Igoshin, R. Azevedo, J.E. Strassmann, and two anonymous reviewers for their helpful comments on the manuscript. G.B. was supported by the NIH Director's New Innovator Award Program (grant 1DP2 OD006481-01) and by NSF grant IOS 1021675. A.v.O. was supported by the NIH/NCI Physical Sciences Oncology Center at MIT (U54CA143874) and the NIH Director's Pioneer Award Program (grant 1DP1OD003936). J.J.C. was supported by the NIH Director's Pioneer Award Program (grant DP1 OD00344), NIH grants RC2 HL102815 and RL1 DE019021, the Ellison Medical Foundation, and the Howard Hughes Medical Institute.	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Ambravaneswaran V, 2010, INTEGR BIOL-UK, V2, P639, DOI 10.1039/c0ib00011f; Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Arkin A, 1998, GENETICS, V149, P1633; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Ben-Jacob E, 1998, ANNU REV MICROBIOL, V52, P779, DOI 10.1146/annurev.micro.52.1.779; Biggar SR, 2001, EMBO J, V20, P3167, DOI 10.1093/emboj/20.12.3167; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Boettiger AN, 2009, SCIENCE, V325, P471, DOI 10.1126/science.1173976; Bonner JT, 2003, J BIOSCIENCES, V28, P523, DOI 10.1007/BF02705126; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Cooper TF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-11; Dawkins R, 2006, SELFISH GENE; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Doktycz MJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100165; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Gardner A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000752; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Glauche I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011238; Goldstein AM, 2008, PEDIATR RES, V64, P326, DOI 10.1203/PDR.0b013e31818535e8; Gregor T, 2007, CELL, V130, P153, DOI 10.1016/j.cell.2007.05.025; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Han YF, 2007, NAT REV MICROBIOL, V5, P95, DOI 10.1038/nrmicro1580; HANGGI P, 1984, PHYS REV A, V29, P371, DOI 10.1103/PhysRevA.29.371; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Holloway DM, 2006, DEV DYNAM, V235, P2949, DOI 10.1002/dvdy.20940; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kirk DL, 2005, BIOESSAYS, V27, P299, DOI 10.1002/bies.20197; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Koonin EV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-29; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Long T, 2009, PLOS BIOL, V7, P640, DOI 10.1371/journal.pbio.1000068; Lopez D, 2009, FEMS MICROBIOL REV, V33, P152, DOI 10.1111/j.1574-6976.2008.00148.x; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; Mehta P, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026005; Murphy KF, 2010, NUCLEIC ACIDS RES, V38, P2712, DOI 10.1093/nar/gkq091; Nevozhay D, 2009, P NATL ACAD SCI USA, V106, P5123, DOI 10.1073/pnas.0809901106; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Octavio LM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000673; Oppenheim AB, 2005, ANNU REV GENET, V39, P409, DOI 10.1146/annurev.genet.39.073003.113656; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Pal C, 1999, J THEOR BIOL, V200, P19, DOI 10.1006/jtbi.1999.0974; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; PTASHNE M, 1967, NATURE, V214, P232, DOI 10.1038/214232a0; Ptashne M, 2004, GENETIC SWITCH PHAGE; Queller DC, 2009, PHILOS T R SOC B, V364, P3143, DOI 10.1098/rstb.2009.0095; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Ray JCJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000676; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; SHEA MA, 1985, J MOL BIOL, V181, P211, DOI 10.1016/0022-2836(85)90086-5; Smukalla S, 2008, CELL, V135, P726, DOI 10.1016/j.cell.2008.09.037; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; St-Pierre F, 2008, P NATL ACAD SCI USA, V105, P20705, DOI 10.1073/pnas.0808831105; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Sureka K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001771; Szathmary E, 1995, MAJOR TRANSITIONS EV; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan C, 2009, NAT CHEM BIOL, V5, P842, DOI 10.1038/nchembio.218; Teng SW, 2010, BIOPHYS J, V98, P2024, DOI 10.1016/j.bpj.2010.01.031; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Tiwari A, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/3/036005; Tu KC, 2010, MOL CELL, V37, P567, DOI 10.1016/j.molcel.2010.01.022; Veening JW, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.18; Veening JW, 2008, P NATL ACAD SCI USA, V105, P4393, DOI 10.1073/pnas.0700463105; Waddington C H, 1957, STRATEGY GENES DISCU; Wahl LM, 2002, J THEOR BIOL, V219, P371, DOI 10.1006/jtbi.2002.3133; Walczak AM, 2005, P NATL ACAD SCI USA, V102, P18926, DOI 10.1073/pnas.0509547102; Wang J, 2008, P NATL ACAD SCI USA, V105, P12271, DOI 10.1073/pnas.0800579105; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Weinberger LS, 2008, NAT GENET, V40, P466, DOI 10.1038/ng.116; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Weitz JS, 2008, BIOPHYS J, V95, P2673, DOI 10.1529/biophysj.108.133694; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461; WIESENFELD K, 1995, NATURE, V373, P33, DOI 10.1038/373033a0; Wolf DM, 2005, J THEOR BIOL, V234, P227, DOI 10.1016/j.jtbi.2004.11.020; Wolk CP, 1996, ANNU REV GENET, V30, P59, DOI 10.1146/annurev.genet.30.1.59; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Zeng LY, 2010, CELL, V141, P682, DOI 10.1016/j.cell.2010.03.034	101	670	681	4	192	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 18	2011	144	6					910	925		10.1016/j.cell.2011.01.030	http://dx.doi.org/10.1016/j.cell.2011.01.030			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	737BQ	21414483	Green Accepted, Bronze			2022-12-28	WOS:000288543500010
J	[Anonymous]				[Anonymous]			A bold unifying leap	NATURE			English	Editorial Material																			0	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2011	471	7338					265	265		10.1038/471265a	http://dx.doi.org/10.1038/471265a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21412288	Bronze			2022-12-28	WOS:000288444000001
J	Redmond, AD; O'Dempsey, TJ; Taithe, B				Redmond, Anthony D.; O'Dempsey, Timothy J.; Taithe, Bertrand			Disasters and a register for foreign medical teams	LANCET			English	Editorial Material									[Redmond, Anthony D.; Taithe, Bertrand] Univ Manchester, Humanitarian & Conflict Response Inst, Manchester M13 9PL, Lancs, England; [O'Dempsey, Timothy J.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	University of Manchester; Liverpool School of Tropical Medicine; University of Liverpool	Redmond, AD (corresponding author), Univ Manchester, Humanitarian & Conflict Response Inst, Manchester M13 9PL, Lancs, England.	tony.redmond@manchester.ac.uk		Taithe, Bertrand/0000-0001-7842-6800				Abolghasemi H, 2006, PREHOSP DISASTER MED, V21, P141, DOI 10.1017/S1049023X00003599; Brennan RJ, 2006, NEW ENGL J MED, V354, P1769, DOI 10.1056/NEJMp068017; Department of Health, 2008, GLOB HLTH PARTN UK R; International Health Links Centre, 2011, PROM EFF HLTH PARTN; Krin CS, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c562; McQueen KAK, 2010, WORLD J SURG, V34, P397, DOI 10.1007/s00268-009-0181-5; [Pan American Health Organization WHO], 2010, EARTHQ HAIT PAHO WHO; Peranteau WH, 2010, J AM COLL SURGEONS, V211, P126, DOI 10.1016/j.jamcollsurg.2010.04.015; REDMOND AD, 1992, BRIT MED J, V304, P653, DOI 10.1136/bmj.304.6828.653; UK-MED, 2010, UK INT EM TRAUM REG	10	23	23	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2011	377	9771					1054	1055		10.1016/S0140-6736(11)60319-X	http://dx.doi.org/10.1016/S0140-6736(11)60319-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	743QY	21440794				2022-12-28	WOS:000289035000007
J	Than, M; Cullen, L; Reid, CM; Lim, SH; Aldous, S; Ardagh, MW; Peacock, WF; Parsonage, WA; Ho, HF; Ko, HF; Kasliwal, RR; Bansal, M; Soerianata, S; Hu, DY; Ding, RJ; Hua, Q; Seok-Min, K; Sritara, P; Sae-Lee, R; Chiu, TF; Tsai, KC; Chu, FY; Chen, WK; Chang, WH; Flaws, DF; George, PM; Richards, AM				Than, Martin; Cullen, Louise; Reid, Christopher M.; Lim, Swee Han; Aldous, Sally; Ardagh, Michael W.; Peacock, W. Frank; Parsonage, William A.; Ho, Hiu Fai; Ko, Hiu Fai; Kasliwal, Ravi R.; Bansal, Manish; Soerianata, Sunarya; Hu, Dayi; Ding, Rongjing; Hua, Qi; Seok-Min, Kang; Sritara, Piyamitr; Sae-Lee, Ratchanee; Chiu, Te-Fa; Tsai, Kuang-Chau; Chu, Fang-Yeh; Chen, Wei-Kung; Chang, Wen-Han; Flaws, Dylan F.; George, Peter M.; Richards, A. Mark			A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study	LANCET			English	Article							ACUTE CORONARY SYNDROME; INFARCTION RISK SCORE; STANDARDIZED REPORTING GUIDELINES; EMERGENCY-DEPARTMENT PATIENTS; CLINICAL DECISION-MAKING; MYOCARDIAL-INFARCTION; MODIFIED THROMBOLYSIS; STRATIFICATION; DEFINITIONS; POPULATION	Background Patients with chest pain contribute substantially to emergency department attendances, lengthy hospital stay, and inpatient admissions. A reliable, reproducible, and fast process to identify patients presenting with chest pain who have a low short-term risk of a major adverse cardiac event is needed to facilitate early discharge. We aimed to prospectively validate the safety of a predefined 2-h accelerated diagnostic protocol (ADP) to assess patients presenting to the emergency department with chest pain symptoms suggestive of acute coronary syndrome. Methods This observational study was undertaken in 14 emergency departments in nine countries in the Asia-Pacific region, in patients aged 18 years and older with at least 5 min of chest pain. The ADP included use of a structured pre-test probability scoring method (Thrombolysis in Myocardial Infarction [TIMI] score), electrocardiograph, and point-of-care biomarker panel of troponin, creatine kinase MB, and myoglobin. The primary endpoint was major adverse cardiac events within 30 days after initial presentation (including initial hospital attendance). This trial is registered with the Australia-New Zealand Clinical Trials Registry, number ACTRN12609000283279. Findings 3582 consecutive patients were recruited and completed 30-day follow-up. 421 (11.8%) patients had a major adverse cardiac event. The ADP classified 352 (9.8%) patients as low risk and potentially suitable for early discharge. A major adverse cardiac event occurred in three (0.9%) of these patients, giving the ADP a sensitivity of 99.3% (95% CI 97.9-99.8), a negative predictive value of 99.1% (97.3-99.8), and a specificity of 11.0% (10-0-12.2). Interpretation This novel ADP identifies patients at very low risk of a short-term major adverse cardiac event who might be suitable for early discharge. Such an approach could be used to decrease the overall observation periods and admissions for chest pain. The components needed for the implementation of this strategy are widely available. The ADP has the potential to affect health-service delivery worldwide.	[Than, Martin; Aldous, Sally; George, Peter M.] Christchurch Hosp, Christchurch, New Zealand; [Cullen, Louise; Parsonage, William A.] Royal Brisbane & Womens Hosp, Herston, Qld, Australia; [Reid, Christopher M.] Monash Univ, Melbourne, Vic 3004, Australia; [Lim, Swee Han] Singapore Gen Hosp, Singapore 0316, Singapore; [Ardagh, Michael W.; Richards, A. Mark] Univ Otago, Christchurch, New Zealand; [Peacock, W. Frank] Cleveland Clin Fdn, Cleveland, OH 44195 USA; [Ho, Hiu Fai; Ko, Hiu Fai] Queen Elizabeth Hosp, Hong Kong, Hong Kong, Peoples R China; [Kasliwal, Ravi R.; Bansal, Manish] Medanta Medicity, Gurgaon, India; [Soerianata, Sunarya] Natl Cardiovasc Ctr Harapan Kita, Jakarta, Indonesia; [Hu, Dayi; Ding, Rongjing] Peoples Hosp, Beijing, Peoples R China; [Hua, Qi] Xuanwu Hosp, Beijing, Peoples R China; [Seok-Min, Kang] Severence Hosp, Seoul, South Korea; [Sritara, Piyamitr; Sae-Lee, Ratchanee] Ramathibodi Hosp, Bangkok, Thailand; [Chiu, Te-Fa] Chang Gung Mem Hosp, Chilung, Taiwan; [Tsai, Kuang-Chau; Chu, Fang-Yeh] Far Eastern Mem Hosp, Taipei, Taiwan; [Chen, Wei-Kung] China Med Univ Hosp, Taichung, Taiwan; [Chang, Wen-Han] MacKay Mem Hosp, Taipei, Taiwan; [Cullen, Louise] Queensland Univ Technol, Brisbane, Qld 4001, Australia; [Flaws, Dylan F.] Univ Queensland, Brisbane, Qld, Australia	Christchurch Hospital New Zealand; Royal Brisbane & Women's Hospital; Monash University; Singapore General Hospital; University of Otago; Cleveland Clinic Foundation; Harapan Kita National Heart Center; Capital Medical University; Mahidol University; Chang Gung Memorial Hospital; Far Eastern Memorial Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; Mackay Memorial Hospital; Queensland University of Technology (QUT); University of Queensland	Than, M (corresponding author), Canterbury Dist Hlth Board, Dept Emergency Med, Private Bag 4710, Christchurch, New Zealand.	martinthan@xtra.co.nz	George, Peter M/A-1315-2013; Cullen, Louise/ABC-9266-2021; Bansal, Manish/O-7899-2015; Cullen, Louise A/D-2274-2013; Reid, Christopher M/AAP-8135-2021; Flaws, Dylan/AAX-1611-2020; Parsonage, William/O-9233-2018	George, Peter M/0000-0001-9100-3466; Cullen, Louise/0000-0001-6611-8229; Bansal, Manish/0000-0002-2125-8073; Cullen, Louise A/0000-0001-6611-8229; Flaws, Dylan/0000-0002-4094-5936; Parsonage, William/0000-0002-0223-5378; Kang, Seok-Min/0000-0001-9856-9227; Reid, Christopher/0000-0001-9173-3944; Chang, WenHan/0000-0002-2071-7258	Mere Medical; Queensland Emergency Medicine Research Foundation; National Health and Medical Research Council (Australia); Christchurch Cardio-Endocrine Research Group (New Zealand); Medquest Jaya Global (Indonesia); Science International (Hong Kong); Bio Laboratories Pte (Singapore); National Heart Foundation of New Zealand; Progressive Group (Taiwan); Science International Corporation; HRCNZ; Queensland Emergency research Foundation (QEMRF); National Health and Medical Research Council; Alere; Health Research Council New Zealand; National Heart Foundation New Zealand	Mere Medical; Queensland Emergency Medicine Research Foundation; National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Christchurch Cardio-Endocrine Research Group (New Zealand); Medquest Jaya Global (Indonesia); Science International (Hong Kong); Bio Laboratories Pte (Singapore); National Heart Foundation of New Zealand; Progressive Group (Taiwan); Science International Corporation; HRCNZ; Queensland Emergency research Foundation (QEMRF); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Alere; Health Research Council New Zealand(Health Research Council of New Zealand); National Heart Foundation New Zealand	Funding Alere Medical (all countries), Queensland Emergency Medicine Research Foundation and National Health and Medical Research Council (Australia), Christchurch Cardio-Endocrine Research Group (New Zealand), Medquest Jaya Global (Indonesia), Science International (Hong Kong), Bio Laboratories Pte (Singapore), National Heart Foundation of New Zealand, and Progressive Group (Taiwan).; MT, MB, SHL, RRK, and LC received grants and supplies by Alere Medical. MT, AMR, and LC received honoraria for previous speaking and lecturing from Alere Medical. MT, MB, AMR, SHL, RRK, LC, and W-KC received support for travel to meetings from Alere Medical. MT received provision of administrative support funds from Alere Medical. HFH and HFK received grants from Science International Corporation. HFH received support for travel from Science International Corporation. MWA received unrelated grants from HRCNZ. LC received grants from the Queensland Emergency research Foundation (QEMRF). SA received grants from the National Heart Foundation of New Zealand, and support for travel to meetings from the Christchurch Cardio-Endocrine Research Group. CMR received grants from the National Health and Medical Research Council. WAP has received grants from the QEMRF. He is a board member of Sanofi-Aventis, is a consultant for Hospira, and has been paid to give lectures for Sanofi-Aventis and Roche, all unrelated to this project. WFP has received consultancy payments from Alere for unrelated projects. SS received grants, support for travel to meetings, and fees for participation in review activities from Medquest Jaya Global. DH, RD, QH, KS-M, DFF, RS-L, SS, and PS received support from Alere to travel to meetings. T-FC, K-CT, F-YC, and W-HC received grants for nurses and support for travel from Progressive Group (Taiwan). PMG has received unrelated grants from the Health Research Council New Zealand, National Heart Foundation New Zealand, and National Health and Medical Research Council; and unrelated honoraria from Roche, AstraZenica, and Abbott Laboratories.	Valle HA, 2008, EUR J EMERG MED, V15, P140, DOI 10.1097/MEJ.0b013e3282efd47a; Amsterdam EA, 2010, CIRCULATION, V122, P1756, DOI 10.1161/CIR.0b013e3181ec61df; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Apple Fred S, 2007, Circulation, V115, pe352; Aroney CN, 2003, MED J AUSTRALIA, V178, P370, DOI 10.5694/j.1326-5377.2003.tb05252.x; Attia JR, 2004, MED J AUSTRALIA, V180, P449, DOI 10.5694/j.1326-5377.2004.tb06020.x; Bernstein SL, 2009, ACAD EMERG MED, V16, P1, DOI 10.1111/j.1553-2712.2008.00295.x; Body R, 2009, EMERG MED J, V26, P95, DOI 10.1136/emj.2008.058495; Body R, 2010, RESUSCITATION, V81, P281, DOI 10.1016/j.resuscitation.2009.11.014; Cahan A, 2003, QJM-INT J MED, V96, P763, DOI 10.1093/qjmed/hcg122; Campbell CF, 2009, AM J EMERG MED, V27, P37, DOI 10.1016/j.ajem.2008.01.028; Cannon CP, 2001, J AM COLL CARDIOL, V38, P2114, DOI 10.1016/S0735-1097(01)01702-8; Chase M, 2006, ANN EMERG MED, V48, P252, DOI 10.1016/j.annemergmed.2006.01.032; Cullen L, 2010, EMERG MED AUSTRALAS, V22, P35, DOI 10.1111/j.1742-6723.2010.01256.x; DOLAN JG, 1986, MED DECIS MAKING, V6, P216, DOI 10.1177/0272989X8600600406; Fesmire FM, 1998, AM HEART J, V136, P237, DOI 10.1053/hj.1998.v136.89571; Forest RS, 2004, ANN EMERG MED, V44, P206, DOI 10.1016/j.annemergmed.2004.02.031; Goodacre S, 2005, HEART, V91, P229, DOI 10.1136/hrt.2003.027599; Goodacre S, 2002, ACAD EMERG MED, V9, P203; Goodacre SW, 2011, HEART, V97, P190, DOI 10.1136/hrt.2010.203166; Han JH, 2007, ANN EMERG MED, V49, P145, DOI 10.1016/j.annemergmed.2006.09.027; Hess EP, 2008, BMC EMERG MED, V8, DOI 10.1186/1471-227X-8-3; Hess EP, 2010, ACAD EMERG MED, V17, P368, DOI 10.1111/j.1553-2712.2010.00696.x; Hollander JE, 2004, ACAD EMERG MED, V11, P1331, DOI 10.1197/j.aem.2004.08.033; Hollander JE, 1999, ACAD EMERG MED, V6, P979, DOI 10.1111/j.1553-2712.1999.tb01177.x; Iles S, 2003, QJM-INT J MED, V96, P211, DOI 10.1093/qjmed/hcg027; KASSIRER JP, 1989, AM J MED, V86, P433, DOI 10.1016/0002-9343(89)90342-2; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; Miller CD, 2005, ACAD EMERG MED, V12, P423, DOI 10.1197/j.aem.2004.11.016; Morris AC, 2006, HEART, V92, P1333, DOI 10.1136/hrt.2005.080226; Newby LK, 2001, CIRCULATION, V103, P1832; Phelps MA, 2004, ACAD EMERG MED, V11, P692, DOI 10.1197/j.aem.2003.08.022; Pollack CV, 2008, ANN EMERG MED, V52, P344, DOI 10.1016/j.annemergmed.2008.04.004; Pollack CV, 2006, ACAD EMERG MED, V13, P13, DOI 10.1197/j.aem.2005.06.031; Reichlin T, 2009, J AM COLL CARDIOL, V54, P60, DOI 10.1016/j.jacc.2009.01.076; Steurer J, 2010, EMERG MED J, V27, P896, DOI 10.1136/emj.2010.092619; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397	37	265	279	0	29	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2011	377	9771					1077	1084		10.1016/S0140-6736(11)60310-3	http://dx.doi.org/10.1016/S0140-6736(11)60310-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	743QY	21435709				2022-12-28	WOS:000289035000028
J	Jolly, SS; Yusuf, S; Cairns, J; Niemela, K; Xavier, D; Widimsky, P; Budaj, A; Niemela, M; Valentin, V; Lewis, BS; Avezum, A; Steg, PG; Rao, SV; Gao, P; Afzal, R; Joyner, CD; Chrolavicius, S; Mehta, SR				Jolly, Sanjit S.; Yusuf, Salim; Cairns, John; Niemela, Kari; Xavier, Denis; Widimsky, Petr; Budaj, Andrzej; Niemela, Matti; Valentin, Vicent; Lewis, Basil S.; Avezum, Alvaro; Steg, Philippe Gabriel; Rao, Sunil V.; Gao, Peggy; Afzal, Rizwan; Joyner, Campbell D.; Chrolavicius, Susan; Mehta, Shamir R.		RIVAL Trial Grp	Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial	LANCET			English	Article							ACUTE MYOCARDIAL-INFARCTION; CURRENT-OASIS 7; TRANSFEMORAL APPROACH; TRANSRADIAL APPROACH; CLINICAL-OUTCOMES; FACTORIAL TRIAL; ASPIRIN; IMPACT; ANGIOPLASTY; CLOPIDOGREL	Background Small trials have suggested that radial vascular complications and bleeding compared with superior to femoral access in patients with acute angiography with possible intervention. access for percutaneous coronary intervention (PCI) reduces femoral access. We aimed to assess whether radial access was coronary syndromes (ACS) who were undergoing coronary Methods The RadIal Vs femorAL access for coronary intervention (RIVAL) trial was a randomised, parallel group, multicentre trial. Patients with ACS were randomly assigned (1:1) by a 24 h computerised central automated voice response system to radial or femoral artery access. The primary outcome was a composite of death, myocardial infarction, stroke, or non-coronary artery bypass graft (non-CABG)-related major bleeding at 30 days. Key secondary outcomes were death, myocardial infarction, or stroke; and non-CABG-related major bleeding at 30 days. A masked central committee adjudicated the primary outcome, components of the primary outcome, and stent thrombosis. All other outcomes were as reported by the investigators. Patients and investigators were not masked to treatment allocation. Analyses were by intention to treat. This trial is registered with ClinicalTrials.gov, NCT01014273. Findings Between June 6, 2006, and Nov 3, 2010, 7021 patients were enrolled from 158 hospitals in 32 countries. 3507 patients were randomly assigned to radial access and 3514 to femoral access. The primary outcome occurred in 128 (3.7%) of 3507 patients in the radial access group compared with 139 (4.0%) of 3514 in the femoral access group (hazard ratio [HR] 0.92, 95% CI 0.72-1.17; p=0.50). Of the six prespecified subgroups, there was a significant interaction for the primary outcome with benefit for radial access in highest tertile volume radial centres (HR 0.49, 95% CI 0.28-0.87; p=0.015) and in patients with ST-segment elevation myocardial infarction (0.60, 0.38-0.94; p=0.026). The rate of death, myocardial infarction, or stroke at 30 days was 112 (3.2%) of 3507 patients in the radial group compared with 114 (3.2%) of 3514 in the femoral group (HR 0.98, 95% CI 0.76-1.28; p=0 90). The rate of non-CABG-related major bleeding at 30 days was 24 (0.7%) of 3507 patients in the radial group compared with 33 (0.9%) of 3514 patients in the femoral group (HR 0.73, 95% CI 0.43-1.23; p=0. 23). At 30 days, 42 of 3507 patients in the radial group had large haematoma compared with 106 of 3514 in the femoral group (HR 0.40, 95% CI 0-28-0.57; p<0.0001). Pseudoaneurysm needing closure occurred in seven of 3507 patients in the radial group compared with 23 of 3514 in the femoral group (HR 0.30, 95% CI 0.13-0.71; p=0. 006). Interpretation Radial and femoral approaches are both safe and effective for PCI. However, the lower rate of local vascular complications may be a reason to use the radial approach.	[Jolly, Sanjit S.; Yusuf, Salim; Gao, Peggy; Afzal, Rizwan; Chrolavicius, Susan; Mehta, Shamir R.] McMaster Univ, Hamilton, ON, Canada; [Jolly, Sanjit S.; Yusuf, Salim; Gao, Peggy; Afzal, Rizwan; Chrolavicius, Susan; Mehta, Shamir R.] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Cairns, John] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Niemela, Kari] Tampere Univ Hosp, Tampere, Finland; [Niemela, Kari] Tampere Heart Ctr, Tampere, Finland; [Xavier, Denis] St Johns Med Coll & Res Inst, Bangalore, Karnataka, India; [Widimsky, Petr] Charles Univ Prague, Hosp Kralovske Vinohrady, Prague, Czech Republic; [Budaj, Andrzej] Grochowski Hosp, Dept Cardiol, Postgrad Med Sch, Warsaw, Poland; [Niemela, Matti] Univ Oulu, Oulu Univ Hosp, Oulu, Finland; [Valentin, Vicent] Hosp Univ Dr Peset, Valencia, Spain; [Lewis, Basil S.] Lady Davis Carmel Med Ctr, Haifa, Israel; [Avezum, Alvaro] Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil; [Steg, Philippe Gabriel] Univ Paris 07, INSERM, Rech Clin Atherothrombose U698, Paris, France; [Steg, Philippe Gabriel] AP HP, Paris, France; [Rao, Sunil V.] Duke Univ, Duke Clin Res Inst, Durham, NC USA; [Joyner, Campbell D.] Sunnybrook Hlth Sci, Toronto, ON, Canada	McMaster University; McMaster University; Population Health Research Institute; University of British Columbia; Tampere University; Tampere University Hospital; St. John's National Academy of Health Sciences; St. John's Medical College; Charles University Prague; University Hospital Vinohrady; Centre of Postgraduate Medical Education - Poland; University of Oulu; Clalit Health Services; Carmel Medical Center; Instituto Dante Pazzanese de Cardiologia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Duke University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Jolly, SS (corresponding author), Hamilton Gen Hosp, Room C3-118,DBCVSRI Bldg,237 Barton St E, Hamilton, ON L8L 2X2, Canada.	sanjit.jollly@phri.ca	Avezum, Alvaro AA/K-6137-2016; STEG, Philippe Gabriel/Z-1567-2019; Avezum, Alvaro/AAP-7687-2020; Jolly, Sanjit/O-2534-2015; Fernandez-Ortiz, Antonio/B-2227-2017; Widimsky, Petr/P-8088-2016; Cairns, John/AAI-8744-2021; Linhart, Ales/O-2375-2017	Avezum, Alvaro AA/0000-0002-3073-6890; Fernandez-Ortiz, Antonio/0000-0002-3239-1910; Widimsky, Petr/0000-0001-5686-7752; Linhart, Ales/0000-0002-3372-7850; Budaj, Andrzej/0000-0002-6395-2098; Yusuf, Salim/0000-0003-4776-5601; STEG, Philippe Gabriel/0000-0001-6896-2941; TRILLO, RAMIRO/0000-0002-9377-8254; Lopez-Palop, Ramon/0000-0003-4385-7939; moreu, jose/0000-0003-4020-0325; Airaksinen, Juhani/0000-0002-0193-568X; Baumbach, Andreas/0000-0001-7707-2254; Lanas, Fernando/0000-0003-3595-9759; Nunez, Julio/0000-0003-1672-7119; Wlodarczak, Adrian/0000-0003-3104-7728	Sanofi-Aventis; Bristol-Myers Squibb; Medtronic; GlaxoSmithKline; AstraZeneca; Population Health Research Institute; Eli Lilly; Novartis; AstraZenca; Merck; Boehringer Ingelheim; Hamilton Health Sciences; Servier; Astellas; Bayer; Daiichi-Sankyo-Lilly; Otsuka; Roche; Medicines Company; Terumo Medical; Canadian Network for Trials Internationally (CANNeCTIN), an initiative of the Canadian Institutes of Health Research	Sanofi-Aventis(Sanofi-Aventis); Bristol-Myers Squibb(Bristol-Myers Squibb); Medtronic(Medtronic); GlaxoSmithKline(GlaxoSmithKline); AstraZeneca(AstraZeneca); Population Health Research Institute; Eli Lilly(Eli Lilly); Novartis(Novartis); AstraZenca; Merck(Merck & Company); Boehringer Ingelheim(Boehringer Ingelheim); Hamilton Health Sciences; Servier(Servier); Astellas(Astellas Pharmaceuticals); Bayer(Bayer AG); Daiichi-Sankyo-Lilly(Daiichi Sankyo Company LimitedEli Lilly); Otsuka(Otsuka Pharmaceutical); Roche(Roche Holding); Medicines Company; Terumo Medical; Canadian Network for Trials Internationally (CANNeCTIN), an initiative of the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	SSJ receives institutional research grants from Sanofi-Aventis, Bristol-Myers Squibb, and Medtronic, and consulting fees from Sanofi-Aventis, GlaxoSmithKline, and AstraZeneca. JC is a board member for Boerhinger Inglelheim. DX receives grants and travel or accommodation expenses from AstraZeneca, Boerhinger Ingelheim, Cadila Pharma, GlaxoSmithKline, Sanofi-Aventis, and Bristol-Myers Squibb. PW and VV have received payments for services from Population Health Research Institute. AB receives consultancy fees from Sanofi-Aventis, Eli Lilly, Novartis, AstraZenca, and Merck, and grants from Sanofi-Aventis, Boehringer Ingelheim, GlaxoSmithKline, Bristol-Myers Squibb, and AstraZenca. BSL receives grant support from Population Health Research Institute. AA receives consultancy fees from GlaxoSmithKline and Boerhinger Ingelheim. PGS and CDJ receive payments for services from Hamilton Health Sciences. PCS also receives institutional research grants from Servier; consulting fees or honoraria from Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi-Sankyo-Lilly, GlaxoSmithKline, Medtronic, Merck, Otsuka, Roche, Sanofi-Aventis, Servier, and The Medicines Company; and has stock options in Aterovax. SVR receives consultancy fees and travel and accommodation expenses from Terumo Medical. SRM receives institutional research grants from Sanofi-Aventis and Bristol-Myers Squibb, and consulting fees from Sanofi-Aventis, Eli Lilly, AstraZeneca, and Bristol-Myers Squibb. SY, KN, MN, SC, PG, and RA declare that they have no conflicts of interest.; The RIVAL trial was funded by Sanofi-Aventis, Population Health Research Institute, and the Canadian Network for Trials Internationally (CANNeCTIN), an initiative of the Canadian Institutes of Health Research. We thank A Sharma for his assistance with the meta-analysis.	Brueck M, 2009, JACC-CARDIOVASC INTE, V2, P1047, DOI 10.1016/j.jcin.2009.07.016; Budaj A, 2009, EUR HEART J, V30, P655, DOI 10.1093/eurheartj/ehn358; Chase AJ, 2008, HEART, V94, P1019, DOI 10.1136/hrt.2007.136390; Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812; Fox KAA, 2002, EUR HEART J, V23, P1177, DOI 10.1053/euhj.2001.3081; Hou L, 2010, SAUDI MED J, V31, P158; Jolly SS, 2011, AM HEART J, V161, P254, DOI 10.1016/j.ahj.2010.11.021; Jolly SS, 2009, AM HEART J, V157, P132, DOI 10.1016/j.ahj.2008.08.023; McGrath PD, 2000, JAMA-J AM MED ASSOC, V284, P3139, DOI 10.1001/jama.284.24.3139; Mehta SR, 2010, LANCET, V376, P1233, DOI 10.1016/S0140-6736(10)61088-4; Mehta SR, 2010, NEW ENGL J MED, V363, P930, DOI 10.1056/NEJMoa0909475; Mehta SR, 2008, AM HEART J, V156, P1080, DOI 10.1016/j.ahj.2008.07.026; Montalescot G, 2008, INT J CARDIOL, V129, P379, DOI 10.1016/j.ijcard.2007.07.127; Pose PN, 2010, EUR HEART J, V31, P1985, DOI 10.1093/eurheartj/ehq151; Rao SV, 2010, J AM COLL CARDIOL, V55, P2187, DOI 10.1016/j.jacc.2010.01.039; Rao SV, 2008, JACC-CARDIOVASC INTE, V1, P379, DOI 10.1016/j.jcin.2008.05.007; Rao SV, 2005, AM J CARDIOL, V96, P1200, DOI 10.1016/j.amjcard.2005.06.056; SCHAUFELE TG, 2009, CIRCULATION, V120, P2152; Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437; Yan ZX, 2008, CHINESE MED J-PEKING, V121, P782, DOI 10.1097/00029330-200805010-00004; Yusuf S, 2006, NEW ENGL J MED, V354, P1464; Ziakas A, 2003, AM J CARDIOL, V91, P598, DOI 10.1016/S0002-9149(02)03316-7	22	1366	1443	2	75	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 23	2011	377	9775					1409	1420		10.1016/S0140-6736(11)60404-2	http://dx.doi.org/10.1016/S0140-6736(11)60404-2			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	755UF	21470671				2022-12-28	WOS:000289963000030
J	Rosenbaum, S				Rosenbaum, Sara			Medicaid and Access to the Courts	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									George Washington Univ, Med Ctr, Dept Hlth Policy, Sch Publ Hlth & Hlth Serv, Washington, DC 20037 USA	George Washington University	Rosenbaum, S (corresponding author), George Washington Univ, Med Ctr, Dept Hlth Policy, Sch Publ Hlth & Hlth Serv, Washington, DC 20037 USA.							Stevens Robert, 1974, WELFARE MED AM CASE	1	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 21	2011	364	16					1489	1491		10.1056/NEJMp1100991	http://dx.doi.org/10.1056/NEJMp1100991			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	752VH	21449772				2022-12-28	WOS:000289722700003
J	Sosulski, DL; Bloom, ML; Cutforth, T; Axel, R; Datta, SR				Sosulski, Dara L.; Bloom, Maria Lissitsyna; Cutforth, Tyler; Axel, Richard; Datta, Sandeep Robert			Distinct representations of olfactory information in different cortical centres	NATURE			English	Article							TUFTED CELLS; BULB; PROJECTIONS; CORTEX; ODOR; ORGANIZATION; PATTERNS; SYSTEM; GENES; AXONS	Sensory information is transmitted to the brain where it must be processed to translate stimulus features into appropriate behavioural output. In the olfactory system, distributed neural activity in the nose is converted into a segregated map in the olfactory bulb(1-3). Here we investigate how this ordered representation is transformed in higher olfactory centres in mice. We have developed a tracing strategy to define the neural circuits that convey information from individual glomeruli in the olfactory bulb to the piriform cortex and the cortical amygdala. The spatial order in the bulb is discarded in the piriform cortex; axons from individual glomeruli project diffusely to the piriform without apparent spatial preference. In the cortical amygdala, we observe broad patches of projections that are spatially stereotyped for individual glomeruli. These projections to the amygdala are overlapping and afford the opportunity for spatially localized integration of information from multiple glomeruli. The identification of a distributive pattern of projections to the piriform and stereotyped projections to the amygdala provides an anatomical context for the generation of learned and innate behaviours.	[Sosulski, Dara L.; Bloom, Maria Lissitsyna; Cutforth, Tyler; Axel, Richard; Datta, Sandeep Robert] Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA; [Sosulski, Dara L.; Bloom, Maria Lissitsyna; Cutforth, Tyler; Axel, Richard; Datta, Sandeep Robert] Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute	Axel, R (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA.	ra27@columbia.edu		Datta, Sandeep/0000-0002-8068-3862; Axel, Richard/0000-0002-3141-4076	Burroughs Wellcome Fund; National Institutes of Health [DP2-OD-007109]; Howard Hughes Medical Institute; Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative; Helen Hay Whitney Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011558] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007109] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the R.A. and S.R.D. laboratories for comments and advice, B. Shykind for mice with GFP-labelled olfactory receptor neurons, S. X. Luo for image alignment advice, D. M. Bear for cross-correlation analysis advice, D. Padfield for Matlab code, R. Wilson for comments on the manuscript and P. Kisloff for manuscript preparation assistance. Financial support was provided by a Helen Hay Whitney Foundation Fellowship, a Career Award in the Medical Sciences grant from the Burroughs Wellcome Fund, and funding from the National Institutes of Health through the NIH Director's New Innovator Award Program (DP2-OD-007109) (S.R.D.), a Ruth L. Kirschstein National Research Service Award predoctoral fellowship from the National Institutes of Health (D.L.S.), and the Howard Hughes Medical Institute and a grant from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative (R.A.).	BLANCHARD DC, 1972, J COMP PHYSIOL PSYCH, V81, P281, DOI 10.1037/h0033521; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; BUONVISO N, 1991, EUR J NEUROSCI, V3, P493, DOI 10.1111/j.1460-9568.1991.tb00836.x; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; DEOLMOS J, 1978, J COMP NEUROL, V181, P213, DOI 10.1002/cne.901810202; Emmenlauer M, 2009, J MICROSC-OXFORD, V233, P42, DOI 10.1111/j.1365-2818.2008.03094.x; Ghosh S, 2011, NATURE, V472, P217, DOI 10.1038/nature09945; HABERLY LB, 1977, BRAIN RES, V129, P152, DOI 10.1016/0006-8993(77)90978-7; LUSKIN MB, 1982, J COMP NEUROL, V209, P249, DOI 10.1002/cne.902090304; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Niimura Y, 2005, GENE, V346, P23, DOI 10.1016/j.gene.2004.09.027; OJIMA H, 1984, J COMP NEUROL, V230, P77, DOI 10.1002/cne.902300107; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; PRICE JL, 1973, J COMP NEUROL, V150, P87, DOI 10.1002/cne.901500105; Rennaker RL, 2007, J NEUROSCI, V27, P1534, DOI 10.1523/JNEUROSCI.4072-06.2007; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; SCHNEIDER SP, 1983, J NEUROPHYSIOL, V50, P358, DOI 10.1152/jn.1983.50.2.358; SCOTT JW, 1980, J COMP NEUROL, V194, P519, DOI 10.1002/cne.901940304; SCOTT JW, 1981, J NEUROPHYSIOL, V46, P918, DOI 10.1152/jn.1981.46.5.918; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; SKEEN LC, 1977, J COMP NEUROL, V172, P1, DOI 10.1002/cne.901720102; SLOTNICK BM, 1985, BEHAV NEUROSCI, V99, P956, DOI 10.1037/0735-7044.99.5.956; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306	31	302	309	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 14	2011	472	7342					213	216		10.1038/nature09868	http://dx.doi.org/10.1038/nature09868			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	749LR	21451525	Green Accepted			2022-12-28	WOS:000289469100041
J	Andrews, JR; Basu, S				Andrews, Jason R.; Basu, Sanjay			Transmission dynamics and control of cholera in Haiti: an epidemic model	LANCET			English	Article							ENDEMIC CHOLERA; BANGLADESH; OUTBREAK; EXPERTS; SCALE	Background Official projections of the cholera epidemic in Haiti have not incorporated existing disease trends or patterns of transmission, and proposed interventions have been debated without comparative estimates of their effect. We used a mathematical model of the epidemic to provide projections of future morbidity and mortality, and to Produce comparative estimates of the effects of proposed interventions. Methods We designed mathematical models of cholera transmission based on existing models and fitted them to incidence data reported in Haiti for each province from Oct 31, 2010, to Jan 24, 2011. We then simulated future epidemic trajectories from March 1 to Nov 30, 2011, to estimate the effect of clean water, vaccination, and enhanced antibiotic distribution programmes. Findings We project 779 000 cases of cholera in Haiti (95% CI 599 000-914 000) and 11 100 deaths (7300-17 400) between March 1 and Nov 30, 2011. We expect that a 1% per week reduction in consumption of contaminated water would avert 105 000 cases (88 000-116 000) and 1500 deaths (1100-2300). We predict that the vaccination of 10% of the population, from March 1, will avert 63 000 cases (48 000-78 000) and 900 deaths (600-1500). The proposed extension of the use of antibiotics to all patients with severe dehydration and half of patients with moderate dehydration is expected to avert 9000 cases (8000-10 000) and 1300 deaths (900-2000). Interpretation A decline in cholera prevalence in early 2011 is part of the natural course of the epidemic, and should not be interpreted as indicative of successful intervention. Substantially more cases of cholera are expected than official estimates used for resource allocation. Combined, clean water provision, vaccination, and expanded access to antibiotics might avert thousands of deaths.	[Andrews, Jason R.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Andrews, Jason R.] Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, Boston, MA 02114 USA; [Basu, Sanjay] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Basu, Sanjay] San Francisco Gen Hosp, Div Gen Internal Med, San Francisco, CA 94110 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center	Andrews, JR (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Infect Dis, Cox 5, Boston, MA 02114 USA.	jandrews6@partners.org		Andrews, Jason/0000-0002-5967-251X	National Institutes of Health (NIGMS) [U54 GM088558]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JRA is supported by the National Institutes of Health (NIGMS grant number U54 GM088558). This report is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. We thank Marc Lipsitch for his helpful comments.	Alam A, 2005, INFECT IMMUN, V73, P6674, DOI 10.1128/IAI.73.10.6674-6679.2005; Anh Dang Duc, 2011, PLoS Negl Trop Dis, V5, pe1006, DOI 10.1371/journal.pntd.0001006; CLAYTON E, 2011, HAITI PROGR REPORT 2; Codeco CT, 2001, BMC INFECT DIS, V1, DOI 10.1186/1471-2334-1-1; Cyranoski D, 2011, NATURE, V469, P273, DOI 10.1038/469273a; Dowell SF, 2011, NEW ENGL J MED, V364, P300, DOI 10.1056/NEJMp1100118; FOX B, 2011, CHOLERA TAKES BREATH; Hartley DM, 2006, PLOS MED, V3, P63, DOI 10.1371/journal.pmed.0030007; International Federation of Red Cross and Red Crescent Societies, 2011, HAIT DOM REP CHOL OU; Ivers LC, 2010, LANCET, V376, P2048, DOI 10.1016/S0140-6736(10)62243-X; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; King AA, 2008, NATURE, V454, P877, DOI 10.1038/nature07084; Lawoyin TO, 1999, EUR J EPIDEMIOL, V15, P367, DOI 10.1023/A:1007547117763; Longini IM, 2002, J INFECT DIS, V186, P246, DOI 10.1086/341206; Longini IM, 2007, PLOS MED, V4, P1776, DOI 10.1371/journal.pmed.0040336; Luby SP, 2008, AM J TROP MED HYG, V78, P382, DOI 10.4269/ajtmh.2008.78.382; Merrell DS, 2002, NATURE, V417, P642, DOI 10.1038/nature00778; Neilan RLM, 2010, B MATH BIOL, V72, P2004, DOI 10.1007/s11538-010-9521-8; Nelson EJ, 2011, NEW ENGL J MED, V364, P5, DOI 10.1056/NEJMp1013771; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; Pascual M, 2002, MICROBES INFECT, V4, P237, DOI 10.1016/S1286-4579(01)01533-7; RAHAMAN MM, 1976, ANTIMICROB AGENTS CH, V10, P610, DOI 10.1128/AAC.10.4.610; Reyburn R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000952; Ryan ET, 2000, AM J TROP MED HYG, V63, P12, DOI 10.4269/ajtmh.2000.63.12; Siddique AK, 2010, EPIDEMIOL INFECT, V138, P347, DOI 10.1017/S0950268809990550; Sullivan CA, 2003, NAT RESOUR FORUM, V27, P189, DOI 10.1111/1477-8947.00054; Sur D, 2009, LANCET, V374, P1694, DOI 10.1016/S0140-6736(09)61297-6; Thiem VD, 2006, VACCINE, V24, P4297, DOI 10.1016/j.vaccine.2006.03.008; United Nations Office for the Coordination of Humanitarian Affairs, 2010, CHOL INT RESP STRAT; Walton DA, 2011, NEW ENGL J MED, V364, P3, DOI 10.1056/NEJMp1012997; WHO/UNICEF-Joint Monitoring Program, 2010, PROGR SAN DRINK WAT; World Health Organization, 2010, WKLY EPIDEMIOL REC, V85, P117; World Health Organization, 2010, 107 WHO; Zarocostas J, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d23	34	131	137	3	49	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 9	2011	377	9773					1248	1255		10.1016/S0140-6736(11)60273-0	http://dx.doi.org/10.1016/S0140-6736(11)60273-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	751DI	21414658	Green Accepted			2022-12-28	WOS:000289597300031
J	Bhabha, G; Lee, J; Ekiert, DC; Gam, J; Wilson, IA; Dyson, HJ; Benkovic, SJ; Wright, PE				Bhabha, Gira; Lee, Jeeyeon; Ekiert, Damian C.; Gam, Jongsik; Wilson, Ian A.; Dyson, H. Jane; Benkovic, Stephen J.; Wright, Peter E.			A Dynamic Knockout Reveals That Conformational Fluctuations Influence the Chemical Step of Enzyme Catalysis	SCIENCE			English	Article							COLI DIHYDROFOLATE-REDUCTASE; ESCHERICHIA-COLI; LOOP; MOTIONS; COMPLEXES; MECHANISM	Conformational dynamics play a key role in enzyme catalysis. Although protein motions have clear implications for ligand flux, a role for dynamics in the chemical step of enzyme catalysis has not been clearly established. We generated a mutant of Escherichia coli dihydrofolate reductase that abrogates millisecond-time-scale fluctuations in the enzyme active site without perturbing its structural and electrostatic preorganization. This dynamic knockout severely impairs hydride transfer. Thus, we have found a link between conformational fluctuations on the millisecond time scale and the chemical step of an enzymatic reaction, with broad implications for our understanding of enzyme mechanisms and for design of novel protein catalysts.	[Bhabha, Gira; Ekiert, Damian C.; Wilson, Ian A.; Dyson, H. Jane; Wright, Peter E.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Bhabha, Gira; Ekiert, Damian C.; Wilson, Ian A.; Dyson, H. Jane; Wright, Peter E.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Lee, Jeeyeon; Gam, Jongsik; Benkovic, Stephen J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Scripps Research Institute; Scripps Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Wright, PE (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wright@scripps.edu	Dyson, Jane/D-4160-2011	Dyson, Jane/0000-0001-6855-3398; Wright, Peter/0000-0002-1368-0223; Ekiert, Damian/0000-0002-2570-0404	National Institutes of Health (NIH) [GM75995, GM080209]; Skaggs Institute of Chemical Biology; NIH National Institute of General Medical Sciences (NIGMS) [U54 GM094586]; Achievement Rewards for College Scientists Foundation; National Cancer Institute [Y1-CO-1020]; NIGMS [Y1-GM-1104]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075995, U54GM094586, T32GM080209] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute of Chemical Biology; NIH National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)General Electric); Achievement Rewards for College Scientists Foundation(General Electric); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge L. Tuttle for invaluable discussions, S. Bae for NMR data on the S148A mutant, H. Tien and D. Marciano of the Robotics Core at the Joint Center for Structural Genomics (JCSG) for automated crystal screening, and X. Dai for technical assistance with crystallographic data collection. This work was supported by the National Institutes of Health (NIH) grant GM75995 and the Skaggs Institute of Chemical Biology. The JCSG is supported by NIH National Institute of General Medical Sciences (NIGMS) (U54 GM094586). D. C. E. is supported by a predoctoral fellowship from the Achievement Rewards for College Scientists Foundation and grant GM080209 from the NIH Molecular Evolution Training Program. The GM/CA CAT 23-ID-D has been funded in whole or in part with federal funds from National Cancer Institute (Y1-CO-1020) and NIGMS (Y1-GM-1104). Use of the Advanced Photon Source (APS) was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract DE-AC02-06CH11357. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIGMS or NIH. Coordinates and structure factors of N23PP/S148A ecDHFR and 1RX2-re-refined are deposited in PDB (code 3QL0 and 3QL3). G. B. and P. E. W. designed the research. G. B. performed NMR experiments. G. B. and D. C. E. performed crystallography experiments and structure refinement. I. A. W. supervised structure refinement. J.L. and J.G. performed kinetic experiments and analysis. G. B., P. E. W., and S.J.B. analyzed and interpreted the data. G. B., P. E. W., and J.L. wrote the manuscript. I. A. W., H.J.D., and S.J.B. edited the manuscript.	Agarwal PK, 2002, P NATL ACAD SCI USA, V99, P2794, DOI 10.1073/pnas.052005999; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Cameron CE, 1997, BIOCHEMISTRY-US, V36, P15792, DOI 10.1021/bi9716231; DAVIES JF, 1990, BIOCHEMISTRY-US, V29, P9467, DOI 10.1021/bi00492a021; Doucet N, 2009, BIOCHEMISTRY-US, V48, P7160, DOI 10.1021/bi900830g; FIERKE CA, 1987, BIOCHEMISTRY-US, V26, P4085, DOI 10.1021/bi00387a052; Garcia-Viloca M, 2003, BIOCHEMISTRY-US, V42, P13558, DOI 10.1021/bi034824f; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Kamerlin SCL, 2010, PROTEINS, V78, P1339, DOI 10.1002/prot.22654; Khavrutskii IV, 2007, PROTEIN SCI, V16, P1087, DOI 10.1110/ps.062724307; Liang ZX, 2004, P NATL ACAD SCI USA, V101, P9556, DOI 10.1073/pnas.0403337101; McElheny D, 2005, P NATL ACAD SCI USA, V102, P5032, DOI 10.1073/pnas.0500699102; Miller GP, 2001, BIOCHEMISTRY-US, V40, P867, DOI 10.1021/bi001608n; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Nagel ZD, 2009, NAT CHEM BIOL, V5, P543, DOI 10.1038/nchembio.204; Osborne MJ, 2003, PROTEIN SCI, V12, P2230, DOI 10.1110/ps.03219603; Osborne MJ, 2001, BIOCHEMISTRY-US, V40, P9846, DOI 10.1021/bi010621k; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Pisliakov AV, 2009, P NATL ACAD SCI USA, V106, P17359, DOI 10.1073/pnas.0909150106; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P586, DOI 10.1021/bi962337c; Schnell JR, 2004, ANNU REV BIOPH BIOM, V33, P119, DOI 10.1146/annurev.biophys.33.110502.133613; Venkitakrishnan RP, 2004, BIOCHEMISTRY-US, V43, P16046, DOI 10.1021/bi048119y; Watt ED, 2007, P NATL ACAD SCI USA, V104, P11981, DOI 10.1073/pnas.0702551104; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821	26	345	345	2	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 8	2011	332	6026					234	238		10.1126/science.1198542	http://dx.doi.org/10.1126/science.1198542			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474759	Green Accepted			2022-12-28	WOS:000289251100051
J	Colson, JW; Woll, AR; Mukherjee, A; Levendorf, MP; Spitler, EL; Shields, VB; Spencer, MG; Park, J; Dichtel, WR				Colson, John W.; Woll, Arthur R.; Mukherjee, Arnab; Levendorf, Mark P.; Spitler, Eric L.; Shields, Virgil B.; Spencer, Michael G.; Park, Jiwoong; Dichtel, William R.			Oriented 2D Covalent Organic Framework Thin Films on Single-Layer Graphene	SCIENCE			English	Article							LARGE-AREA; CRYSTALLINE	Covalent organic frameworks (COFs), in which molecular building blocks form robust microporous networks, are usually synthesized as insoluble and unprocessable powders. We have grown two-dimensional (2D) COF films on single-layer graphene (SLG) under operationally simple solvothermal conditions. The layered films stack normal to the SLG surface and show improved crystallinity compared with COF powders. We used SLG surfaces supported on copper, silicon carbide, and transparent fused silica (SiO2) substrates, enabling optical spectroscopy of COFs in transmission mode. Three chemically distinct COF films grown on SLG exhibit similar vertical alignment and long-range order, and two of these are of interest for organic electronic devices for which thin-film formation is a prerequisite for characterizing their optoelectronic properties.	[Colson, John W.; Mukherjee, Arnab; Levendorf, Mark P.; Spitler, Eric L.; Park, Jiwoong; Dichtel, William R.] Cornell Univ, Dept Chem & Chem Biol, Baker Lab, Ithaca, NY 14853 USA; [Shields, Virgil B.; Spencer, Michael G.] Cornell Univ, Dept Elect Engn, Ithaca, NY 14853 USA; [Woll, Arthur R.] Cornell Univ, Cornell High Energy Synchrotron Source, Ithaca, NY 14853 USA; [Park, Jiwoong] Cornell Univ, Kavli Inst Nanoscale Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University; Cornell University	Dichtel, WR (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Baker Lab, Ithaca, NY 14853 USA.	wdichtel@cornell.edu	Dichtel, William R/A-5503-2009; Park, Jiwoong/C-2327-2013; Spencer, Michael/AAV-5283-2020	Dichtel, William R/0000-0002-3635-6119; Spencer, Michael/0000-0003-0914-9218; Woll, Arthur/0000-0001-8925-2199	Cornell University; NSF [CHE-0847926, CHE-0936988]; NIH/National Institute of General Medical Sciences under NSF [DMR-0936384]; NSF Materials Research Science and Engineering Centers [DMR-0520404]	Cornell University; NSF(National Science Foundation (NSF)); NIH/National Institute of General Medical Sciences under NSF(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF Materials Research Science and Engineering Centers(National Science Foundation (NSF))	This research was supported by startup funds provided by Cornell University and the NSF-funded CCI-I Center for Molecular Interfacing (CHE-0847926). This work is based on research conducted at the Cornell High Energy Synchrotron Source (CHESS), which is supported by the NSF and the NIH/National Institute of General Medical Sciences under NSF award DMR-0936384. We also made use of the Cornell Center for Materials Research facilities with support from the NSF Materials Research Science and Engineering Centers program (DMR-0520404). J.W.C. thanks the NSF for the award of a Graduate Research Fellowship; E. L. S. thanks the NSF for the award of the American Competitiveness in Chemistry postdoctoral fellowship (CHE-0936988); and M. G. S. (FA9550-07-1-0332) and J.P. (FA9550-09-1-0691) thank the Air Force Office of Scientific Research. We thank D. Smilgies for helpful discussions and K. Cox for technical illustration assistance. A provisional patent application based on this work has been filed by Cornell University (USA 61/382,093).	Bae S, 2010, NAT NANOTECHNOL, V5, P574, DOI [10.1038/nnano.2010.132, 10.1038/NNANO.2010.132]; Baker JL, 2010, LANGMUIR, V26, P9146, DOI 10.1021/la904840q; Berger C, 2006, SCIENCE, V312, P1191, DOI 10.1126/science.1125925; Cote AP, 2007, J AM CHEM SOC, V129, P12914, DOI 10.1021/ja0751781; Cote AP, 2005, SCIENCE, V310, P1166, DOI 10.1126/science.1120411; Ding XS, 2011, ANGEW CHEM INT EDIT, V50, P1289, DOI 10.1002/anie.201005919; El-Kaderi HM, 2007, SCIENCE, V316, P268, DOI 10.1126/science.1139915; Emtsev KV, 2009, NAT MATER, V8, P203, DOI [10.1038/NMAT2382, 10.1038/nmat2382]; Gourdon A, 2008, ANGEW CHEM INT EDIT, V47, P6950, DOI 10.1002/anie.200802229; Grill L, 2007, NAT NANOTECHNOL, V2, P687, DOI 10.1038/nnano.2007.346; Kim KS, 2009, NATURE, V457, P706, DOI 10.1038/nature07719; Kumar A, 2010, ACS NANO, V4, P11, DOI 10.1021/nn901903b; Levendorf MP, 2009, NANO LETT, V9, P4479, DOI 10.1021/nl902790r; Li XS, 2009, NANO LETT, V9, P4359, DOI 10.1021/nl902623y; Li XS, 2009, SCIENCE, V324, P1312, DOI 10.1126/science.1171245; Lukose B, 2011, CHEM-EUR J, V17, P2388, DOI 10.1002/chem.201001290; Mayer AC, 2007, MATER TODAY, V10, P28, DOI 10.1016/S1369-7021(07)70276-6; Perepichka DF, 2009, SCIENCE, V323, P216, DOI 10.1126/science.1165429; Reina A, 2009, NANO LETT, V9, P30, DOI 10.1021/nl801827v; Smilgies DM, 2007, J APPL CRYSTALLOGR, V40, P716, DOI 10.1107/S0021889807023382; Smilgies DM, 2009, J APPL CRYSTALLOGR, V42, P1030, DOI [10.1107/S0021889809040126, 10.1107/S00218898090401]; Spitler EL, 2010, NAT CHEM, V2, P672, DOI [10.1038/NCHEM.695, 10.1038/nchem.695]; Tilford RW, 2006, CHEM MATER, V18, P5296, DOI 10.1021/cm061177g; Veld MI, 2008, CHEM COMMUN, P1536, DOI 10.1039/b718865j; Wan S, 2008, ANGEW CHEM INT EDIT, V47, P8826, DOI 10.1002/anie.200803826; Wan S, 2009, ANGEW CHEM INT EDIT, V48, P5439, DOI 10.1002/anie.200900881; Zwaneveld NAA, 2008, J AM CHEM SOC, V130, P6678, DOI 10.1021/ja800906f	27	829	851	79	1929	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 8	2011	332	6026					228	231		10.1126/science.1202747	http://dx.doi.org/10.1126/science.1202747			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746MM	21474758				2022-12-28	WOS:000289251100049
J	Macilwain, C				Macilwain, Colin			Concerns over nuclear energy are legitimate	NATURE			English	Editorial Material												cfmworldview@gmail.com							0	3	3	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 31	2011	471	7340					549	549		10.1038/471549a	http://dx.doi.org/10.1038/471549a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	742NN	21455133	Bronze			2022-12-28	WOS:000288951200005
J	Teagle, D; Ildefonse, B				Teagle, Damon; Ildefonse, Benoit			Journey to the mantle of the Earth	NATURE			English	Editorial Material									[Teagle, Damon] Univ Southampton, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; [Ildefonse, Benoit] Univ Montpellier 2, CNRS, F-34095 Montpellier 5, France	NERC National Oceanography Centre; University of Southampton; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Teagle, D (corresponding author), Univ Southampton, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England.	damon.teagle@soton.ac.uk; benoit.ildefonse@um2.fr	ildefonse, benoit/A-6205-2009	ildefonse, benoit/0000-0001-7635-9288				Ildefonse B, 2010, SCI DRILL, V10, P56, DOI 10.5194/sd-10-56-2010; Teagle D. A. H., 2010, IODP EXP 335 SCI PRO, DOI [10.2204/iodp.sp.335.2010, DOI 10.2204/I0DP.SP.335.2010]; Teagle D. A. H., 2006, PROC INTEGR OCEAN DR, V312, P1; Wilson DS, 2006, SCIENCE, V312, P1016, DOI 10.1126/science.1126090; Workshop Report Writing Group, SCI DRILL IN PRESS, P53	5	6	6	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					437	439		10.1038/471437a	http://dx.doi.org/10.1038/471437a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430751				2022-12-28	WOS:000288702200032
J	Rahimi, K; Martin, J; Emberson, J; McGale, P; Majoni, W; Merhi, A; Asselbergs, FW; Krane, V; Macfarlane, PW				Rahimi, Kazem; Martin, James; Emberson, Jonathan; McGale, Paul; Majoni, William; Merhi, Amal; Asselbergs, Folkert W.; Krane, Vera; Macfarlane, Peter W.		PROSPER Executive	Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONGESTIVE-HEART-FAILURE; LIPID-LOWERING TREATMENT; PRIMARY PREVENTION; MYOCARDIAL-INFARCTION; CORONARY ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE; ATORVASTATIN THERAPY; DIABETES-MELLITUS; DOSE ATORVASTATIN; EVENTS	Objective To examine whether statins can reduce the risk of atrial fibrillation. Design Meta-analysis of published and unpublished results from larger scale statin trials, with comparison of the findings against the published results from smaller scale or shorter duration studies. Data sources Medline, Embase, and Cochrane's CENTRAL up to October 2010. Unpublished data from longer term trials were obtained through contact with investigators. Study selection Randomised controlled trials comparing statin with no statin or comparing high dose versus standard dose statin; all longer term trials had at least 100 participants and at least six months' follow-up. Results In published data from 13 short term trials (4414 randomised patients, 659 events), statin treatment seemed to reduce the odds of an episode of atrial fibrillation by 39% (odds ratio 0.61, 95% confidence interval 0.51 to 0.74; P<0.001), but there was significant heterogeneity (P<0.001) between the trials. In contrast, among 22 longer term and mostly larger trials of statin versus control (105 791 randomised patients, 2535 events), statin treatment was not associated with a significant reduction in atrial fibrillation (0.95, 0.88 to 1.03; P=0.24) (P<0.001 for test of difference between the two sets of trials). Seven longer term trials of more intensive versus standard statin regimens (28 964 randomised patients and 1419 events) also showed no evidence of a reduction in the risk of atrial fibrillation (1.00, 0.90 to 1.12; P=0.99). Conclusions The suggested beneficial effect of statins on atrial fibrillation from published shorter term studies is not supported by a comprehensive review of published and unpublished evidence from larger scale trials.	[Rahimi, Kazem] Univ Oxford, George Ctr Healthcare Innovat, Oxford, England; [Martin, James] John Radcliffe Hosp, Dept Cardiol, Oxford OX3 9DU, England; [Emberson, Jonathan; McGale, Paul; Merhi, Amal] Univ Oxford, Epidemiol Studies Unit, Oxford, England; [Emberson, Jonathan; McGale, Paul; Merhi, Amal] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Majoni, William] Royal Darwin Hosp, Dept Nephrol, Darwin, NT, Australia; [Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Dept Cardiol, Div Heart & Lungs, Utrecht, Netherlands; [Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Asselbergs, Folkert W.] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands; [Krane, Vera] Univ Wurzburg, Dept Internal Med, Div Nephrol, Wurzburg, Germany; [Macfarlane, Peter W.; PROSPER Executive] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	University of Oxford; University of Oxford; University of Oxford; University of Oxford; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Wurzburg; University of Glasgow	Rahimi, K (corresponding author), Univ Oxford, George Ctr Healthcare Innovat, Oxford, England.	kazem.rahimi@cardiov.ox.ac.uk	Rahimi, Kazem/AAA-4250-2022; Asselbergs, Folkert W./ABD-6752-2021; Rahimi, Kazem/Q-1279-2015	Asselbergs, Folkert W./0000-0002-1692-8669; Rahimi, Kazem/0000-0002-4807-4610; Emberson, Jonathan/0000-0001-7792-9422	James Martin School; BHF Centre of Research Excellence, Oxford [RE/08/004]; Netherlands Organisation for Health Research and Development [90700342]	James Martin School; BHF Centre of Research Excellence, Oxford; Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. KR is supported by a senior fellowship from the James Martin School; JE acknowledges support from the BHF Centre of Research Excellence, Oxford (RE/08/004); and FWA is supported by a clinical fellowship from the Netherlands Organisation for Health Research and Development (ZonMw grant 90700342);	Adam O, 2008, CIRCULATION, V118, P1285, DOI 10.1161/CIRCULATIONAHA.107.760892; Alberte C, 2003, J CARDIOVASC ELECTR, V14, pS87, DOI 10.1046/j.1540-8167.14.s9.23.x; Almroth H, 2009, EUR HEART J, V30, P827, DOI 10.1093/eurheartj/ehp006; [Anonymous], 2000, Ital Heart J, V1, P810; Anter E, 2009, CIRCULATION, V119, P2516, DOI 10.1161/CIRCULATIONAHA.108.821306; Asselbergs FW, 2004, CIRCULATION, V110, P2809, DOI 10.1161/01.CIR.0000146378.65439.7A; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Baigent C, 2010, OXFORD TXB MED, P42; Benjamin EJ, 2009, CIRCULATION, V119, P606, DOI 10.1161/CIRCULATIONAHA.108.825380; Briguori C, 2009, J AM COLL CARDIOL, V54, P2157, DOI 10.1016/j.jacc.2009.07.005; Chello M, 2006, CRIT CARE MED, V34, P660, DOI 10.1097/01.CCM.0000201407.89977.EA; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Colivicchi F, 2010, CURR MED RES OPIN, V26, P1277, DOI 10.1185/03007991003751496; Collins R, 2002, LANCET, V360, P1618, DOI 10.1016/S0140-6736(02)11650-3; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Collins R, 2001, LANCET, V357, P373, DOI 10.1016/S0140-6736(00)03651-5; Corradi D, 2008, NAT CLIN PRACT CARD, V5, P782, DOI 10.1038/ncpcardio1370; Crouse JR, 2007, JAMA-J AM MED ASSOC, V297, P1344, DOI 10.1001/jama.297.12.1344; Dernellis J, 2005, AM HEART J, V150, DOI 10.1016/j.ahj.2005.06.032; DICKERSIN K, 1987, CONTROL CLIN TRIALS, V8, P343, DOI 10.1016/0197-2456(87)90155-3; Disertori M, 2009, NEW ENGL J MED, V360, P1606, DOI 10.1056/NEJMoa0805710; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Fauchier L, 2008, J AM COLL CARDIOL, V51, P828, DOI 10.1016/j.jacc.2007.09.063; Feldman HH, 2010, NEUROLOGY, V74, P956, DOI 10.1212/WNL.0b013e3181d6476a; Fuster V, 2006, EUROPACE, V8, P651, DOI 10.1093/europace/eul097; Garcia-Fernandez A, 2006, AM J CARDIOL, V98, P1299, DOI 10.1016/j.amjcard.2006.07.019; Haywood LJ, 2009, J AM COLL CARDIOL, V54, P2023, DOI 10.1016/j.jacc.2009.08.020; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Issac TT, 2007, J AM COLL CARDIOL, V50, P2021, DOI 10.1016/j.jacc.2007.06.054; Ji Q, 2009, CIRC J, V73, P2244, DOI 10.1253/circj.CJ-09-0352; Knopp RH, 2006, DIABETES CARE, V29, P1478, DOI 10.2337/dc05-2415; Korantzopoulos P, 2007, PACE, V30, P1391, DOI 10.1111/j.1540-8159.2007.00877.x; Koren MJ, 2004, J AM COLL CARDIOL, V44, P1772, DOI 10.1016/j.jacc.2004.07.053; Kudaiberdieva Gulmira, 2007, Acute Card Care, V9, P69, DOI 10.1080/17482940600990285; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Liu T, 2008, INT J CARDIOL, V126, P160, DOI 10.1016/j.ijcard.2007.07.137; Macfarlane PW, 2007, J ELECTROCARDIOL, V40, P101, DOI 10.1016/j.jelectrocard.2006.05.003; Macfarlane PW, 2011, EUROPACE, V13, P634, DOI 10.1093/europace/eur016; Maggioni AP, 2009, EUR HEART J, V30, P2327, DOI 10.1093/eurheartj/ehp357; Majeed A, 2001, HEART, V86, P284, DOI 10.1136/heart.86.3.284; Makuuchi H, 2005, CIRC J, V69, P636, DOI 10.1253/circj.69.636; Mannacio VA, 2008, J THORAC CARDIOV SUR, V136, P1541, DOI 10.1016/j.jtcvs.2008.06.038; McLean DS, 2008, AM HEART J, V155, P298, DOI 10.1016/j.ahj.2007.10.024; Nakamura H, 2006, LANCET, V368, P1155, DOI 10.1016/S0140-6736(06)69472-5; Nissen SE, 2005, AM J CARDIOL, V96, p61F, DOI 10.1016/j.amjcard.2005.07.013; Ozaydin M, 2006, AM J CARDIOL, V97, P1490, DOI 10.1016/j.amjcard.2005.11.082; Patti G, 2006, CIRCULATION, V114, P1455, DOI 10.1161/CIRCULATIONAHA.106.621763; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; *R DEV COR TEAM, 2005, R LANG ENV STAT COMP; Rahimi K, 2009, HEART, V95, P1937, DOI 10.1136/hrt.2009.173302; Rahimi K, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5707; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Schmermund A, 2006, CIRCULATION, V113, P427, DOI 10.1161/CIRCULATIONAHA.105.568147; Schreiber BD, 2003, AM J MED SCI, V325, P179, DOI 10.1097/00000441-200304000-00004; Schwartz GG, 2004, CIRCULATION, V110, P740; Serruys PWJC, 2002, JAMA-J AM MED ASSOC, V287, P3215, DOI 10.1001/jama.287.24.3215; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Sola S, 2006, J AM COLL CARDIOL, V47, P332, DOI 10.1016/j.jacc.2005.06.088; Song YB, 2008, AM HEART J, V156, P373, DOI 10.1016/j.ahj.2008.04.020; Stewart S, 2004, HEART, V90, P286, DOI 10.1136/hrt.2002.008748; Tamayo E, 2008, MED CLIN-BARCELONA, V130, P773, DOI 10.1157/13121102; Thrall G, 2006, AM J MED, V119, DOI 10.1016/jamjmed.2005.10.057; Tsai CT, 2008, AM HEART J, V156, P65, DOI 10.1016/j.ahj.2008.01.028; Tveit A, 2004, AM J CARDIOL, V93, P780, DOI 10.1016/j.amjcard.2003.12.009; Vrtovec B, 2008, J CARD FAIL, V14, P140, DOI 10.1016/j.cardfail.2007.10.013; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Xia W, 2009, PACE, V32, P1562, DOI 10.1111/j.1540-8159.2009.02554.x; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7	71	92	97	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2011	342								d1250	10.1136/bmj.d1250	http://dx.doi.org/10.1136/bmj.d1250			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	739FK	21411487	hybrid, Green Accepted			2022-12-28	WOS:000288699200001
J	Arora, N; Chertow, GM				Arora, Neiha; Chertow, Glenn M.			Update in Nephrology: Evidence Published in 2010	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Chertow, Glenn M.] Stanford Univ, Sch Med, Div Nephrol, Palo Alto, CA 94034 USA	Stanford University	Chertow, GM (corresponding author), Stanford Univ, Sch Med, Div Nephrol, 780 Welch Rd,Suite 106, Palo Alto, CA 94034 USA.	gchertow@stanford.edu		Chertow, Glenn/0000-0002-7599-0534					0	2	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 21	2011	154	12					824	829		10.7326/0003-4819-154-12-201106210-00342	http://dx.doi.org/10.7326/0003-4819-154-12-201106210-00342			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	779SA	21464341				2022-12-28	WOS:000291800500018
J	Armstrong, J				Armstrong, Joanne			Unintended Consequences - The Cost of Preventing Preterm Births after FDA Approval of a Branded Version of 17OHP	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Aetna, Womens Hlth Div, Sugar Land, TX USA		Armstrong, J (corresponding author), Aetna, Womens Hlth Div, Sugar Land, TX USA.							Behrman R.E, 2006, PRETERM BIRTH CAUSES; *FOOD DRUG ADM, 2002, FOOD DRUG ADM COMPL; Petrini JR, 2005, OBSTET GYNECOL, V105, P267, DOI 10.1097/01.AOG.0000150560.24297.4f; PJ MEIS, 2003, NEW ENGL J MED, V348, P2379; 2011, MAKENA WHOLESALE ACQ	5	8	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 5	2011	364	18					1689	1691		10.1056/NEJMp1102796	http://dx.doi.org/10.1056/NEJMp1102796			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	759DC	21410391				2022-12-28	WOS:000290219800003
J	Humphrey, C; Hickman, S; Gulliford, MC				Humphrey, Charlotte; Hickman, Shaista; Gulliford, Martin C.			Place of medical qualification and outcomes of UK General Medical Council "fitness to practise" process: cohort study	BRITISH MEDICAL JOURNAL			English	Article							ETHNICITY; CONSULTANTS; DOCTORS; SCHOOLS; RACE	Objectives To evaluate whether country of medical qualification is associated with "higher impact" decisions at different stages of the UK General Medical Council's (GMC's) "fitness to practise" process after allowing for other characteristics of doctors and inquiries. Design Retrospective cohort study. Setting Medical practice in the United Kingdom. Participants 7526 inquiries to the GMC concerning 6954 doctors. Main outcome measures Proportion of inquiries referred for further investigation at initial triage by the GMC, proportion of inquiries investigated that were subsequently referred for adjudication, and proportion of inquiries resulting in doctors being erased or suspended from the medical register; relative odds of higher impact decisions, by country of qualification, adjusted for doctors' sex, years since primary medical qualification, medical specialty, source and type of inquiry, and nature of allegations. Results Of 7526 inquiries, 4702 concerned doctors who qualified in the UK, 624 concerned doctors who qualified elsewhere in the European Union (EU), and 2190 concerned doctors who qualified outside the EU. At the initial triage, 30% (n=1398) of inquiries concerning doctors who qualified in the UK had a high impact decision, compared with 43% (267) for doctors who qualified elsewhere in the EU and 46% (998) for those who qualified outside the EU. The adjusted relative odds of an inquiry being referred for further investigation were 1.67 (95% confidence interval 1.28 to 2.17) for doctors who qualified elsewhere in the EU and 1.61 (1.38 to 1.88) for those who qualified outside the EU, compared with doctors who qualified in the UK. At the investigation stage, 5% (228) of inquiries received concerning UK qualified doctors were referred for adjudication, compared with 10% for EU (63) or non- EU (221) qualified doctors. The adjusted relative odds of referral for adjudication were 2.14 (1.46 to 3.16) for doctors who qualified elsewhere in the EU and 1.68 (1.31 to 2.16) for those who qualified outside the EU. At the adjudication stage, 1% (69) of inquiries received concerning UK qualified doctors led to erasure or suspension, compared with 4% (24) for doctors who qualified elsewhere in the EU and 3%(71) for non- EU qualified doctors. The adjusted relative odds of erasure or suspension were 2.16 (1.22 to 3.80) for doctors who qualified elsewhere in the EU and 1.48 (1.00 to 2.19) for those who qualified outside the EU. Conclusions Inquiries to the GMC concerning doctors qualified outside the UK are more likely to be associated with higher impact decisions at each stage of the fitness to practice process. These associations were not explained by measured inquiry related and doctor related characteristics, but residual confounding cannot be excluded.	[Humphrey, Charlotte; Hickman, Shaista] Kings Coll London, Florence Nightingale Sch Nursing & Midwifery, London SE1 8WA, England; [Gulliford, Martin C.] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London SE1 3QD, England	University of London; King's College London; University of London; King's College London	Humphrey, C (corresponding author), Kings Coll London, Florence Nightingale Sch Nursing & Midwifery, London SE1 8WA, England.	charlotte.humphrey@kcl.ac.uk	Gulliford, Martin C/I-8606-2018	Gulliford, Martin C/0000-0003-1898-9075	Economic and Social Research Council through the ESRC Public Services [RES-153-25-0101]; Economic and Social Research Council [ES/F039670/1] Funding Source: researchfish; ESRC [ES/F039670/1] Funding Source: UKRI	Economic and Social Research Council through the ESRC Public Services(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The study was funded by the Economic and Social Research Council (RES-153-25-0101) through the ESRC Public Services Programme Third Call. The ESRC was not involved in data collection, analysis, or interpretation or in writing this manuscript.	Allan HT., 2004, DIVERSITY EQUALITY H, V1, P117; Allen I., 2000, HANDLING COMPLAINTS; [Anonymous], 2009, NCAS CAS 1 8 YEARS; *BMA CENTR CONS SP, 2005, TACKL RAC MED CAR RO; Chen PGC, 2010, J GEN INTERN MED, V25, P947, DOI 10.1007/s11606-010-1401-2; Cooke L, 2003, RACISM MED PROFESSIO; Department of Health, 2007, STAT PUBL HLTH ANN R; Esmail A, 2003, BRIT MED J, V326, P687, DOI 10.1136/bmj.326.7391.687; ESMAIL A, 1994, BRIT MED J, V208, P1374; Esmail A, 2006, BR J HLTH CARE MANAG, V12, P303; *GEN MED COUNC, 2009, ETHN FTP FACT SHEET; *GEN MED COUNC, 2010, GOOD MED PRACT; *GEN MED COUNC, 2009, PRIM MED QUAL FTP FA; Kyriakides C, 2003, ETHNIC HEALTH, V8, P283, DOI 10.1080/13557850310001631731; Lambert TW, 2004, BMJ-BRIT MED J, V328, P1347, DOI 10.1136/bmj.38062.639190.44; Louis WR, 2010, MED EDUC, V44, P1241, DOI 10.1111/j.1365-2923.2010.03769.x; Mahajan J, 2007, ARCH DIS CHILD, V92, P219, DOI 10.1136/adc.2006.098939; McManus IC, 1998, BRIT MED J, V317, P1111; MOYNIHAN R, 2010, BRIT MED J, V341, pE6780; *NHS INF CTR, 2010, NHS STAFF 1999 2009; Nunez-Smith M, 2007, ANN INTERN MED, V146, P45, DOI 10.7326/0003-4819-146-1-200701020-00008; Roberts C, 2000, BRIT MED J, V320, P370, DOI 10.1136/bmj.320.7231.370; Roberts JH, 2008, MED EDUC, V42, P45, DOI 10.1111/j.1365-2923.2007.02902.x; Secretary of State for Health, 2007, TRUST ASS SAF REG HL; Woolf K, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1220	25	30	30	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 5	2011	342								d1817	10.1136/bmj.d1817	http://dx.doi.org/10.1136/bmj.d1817			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	749JL	21467101	hybrid, Green Published			2022-12-28	WOS:000289461200001
J	Root, CM; Ko, KI; Jafari, A; Wang, JW				Root, Cory M.; Ko, Kang I.; Jafari, Amir; Wang, Jing W.			Presynaptic Facilitation by Neuropeptide Signaling Mediates Odor-Driven Food Search	CELL			English	Article							ANTENNAL LOBE; PHOSPHOINOSITIDE 3-KINASE; GENE-EXPRESSION; SOCIAL-BEHAVIOR; GAIN-CONTROL; Y-LIKE; CIRCUIT; NEURONS; INHIBITION; RECEPTOR	Internal physiological states influence behavioral decisions. We have investigated the underlying cellular and molecular mechanisms at the first olfactory synapse for starvation modulation of food-search behavior in Drosophila. We found that a local signal by short neuropeptide F (sNPF) and a global metabolic cue by insulin are integrated at specific odorant receptor neurons (ORNs) to modulate olfactory sensitivity. Results from two-photon calcium imaging show that starvation increases presynaptic activity via intraglomerular sNPF signaling. Expression of sNPF and its receptor (sNPFR1) in Or42b neurons is necessary for starvation-induced food-search behavior. Presynaptic facilitation in Or42b neurons is sufficient to mimic starvation-like behavior in fed flies. Furthermore, starvation elevates the transcription level of sNPFR1 but not that of sNPF, and insulin signaling suppresses sNPFR1 expression. Thus, starvation increases expression of sNPFR1 to change the odor map, resulting in more robust food-search behavior.	[Root, Cory M.; Ko, Kang I.; Jafari, Amir; Wang, Jing W.] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Wang, JW (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	jw800@ucsd.edu	Wang, Jing W/C-3885-2008	Wang, Jing W/0000-0001-6291-5802	National Institute of Deafness and other Communication Disorders [R01DC009597, R21DC010458, 1F31DC009511]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092640] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC009511, R01DC009597, R21DC010458] Funding Source: NIH RePORTER	National Institute of Deafness and other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We would like to thank R. Axel, M. Gallio, A. Gelperin, S. Kim, and M. Ramaswami for comments on the manuscript. We thank D. Green for assistance with the fly tracking software, E. Troemel for assistance with quantitative RT-PCR, and Jun Hee Lee for helpful discussion of insulin signaling. This work was supported by research grants from the National Institute of Deafness and other Communication Disorders to J.W.W. (R01DC009597, R21DC010458) and fellowship to C. M. R. (1F31DC009511). C. M. R. and J.W.W. designed experiments, analyzed data, and wrote the manuscript. C. M. R, K. I. K., and A.J. carried out experiments.	ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Barsh GS, 2002, NAT REV GENET, V3, P589, DOI [10.1038/nrn902, 10.1038/nrg862]; Berthoud HR, 2002, NEUROSCI BIOBEHAV R, V26, P393, DOI 10.1016/S0149-7634(02)00014-3; Brown MR, 1999, PEPTIDES, V20, P1035, DOI 10.1016/S0196-9781(99)00097-2; Carlsson MA, 2010, J COMP NEUROL, V518, P3359, DOI 10.1002/cne.22405; Chalasani SH, 2010, NAT NEUROSCI, V13, P615, DOI 10.1038/nn.2526; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; Dacks AM, 2009, J NEUROGENET, V23, P366, DOI 10.3109/01677060903085722; Dethier V. G., 1976, HUNGRY FLY PHYSL STU; Distler PG, 1997, J COMP NEUROL, V383, P529, DOI 10.1002/(SICI)1096-9861(19970714)383:4&lt;529::AID-CNE9&gt;3.0.CO;2-4; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Feng GP, 2003, EUR J NEUROSCI, V18, P227, DOI 10.1046/j.1460-9568.2003.02719.x; GELPERIN A, 1971, ANNU REV ENTOMOL, V16, P365, DOI 10.1146/annurev.en.16.010171.002053; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Hansel DE, 2001, NATURE, V410, P940, DOI 10.1038/35073601; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Ignell R, 2009, P NATL ACAD SCI USA, V106, P13070, DOI 10.1073/pnas.0813004106; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Kyriaki G, 2003, CELL MOL NEUROBIOL, V23, P1, DOI 10.1023/A:1022598900246; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Lee KS, 2008, NAT CELL BIOL, V10, P468, DOI 10.1038/ncb1710; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Mathieu M, 2002, DEV BRAIN RES, V139, P255, DOI 10.1016/S0165-3806(02)00577-1; Mayer CM, 2009, MOL CELL ENDOCRINOL, V307, P99, DOI 10.1016/j.mce.2009.02.031; Mousley A, 2006, J NEUROSCI, V26, P7707, DOI 10.1523/JNEUROSCI.1977-06.2006; Murakami M, 2005, NEURON, V46, P285, DOI 10.1016/j.neuron.2005.02.025; Nassel DR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-90; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Root CM, 2007, P NATL ACAD SCI USA, V104, P11826, DOI 10.1073/pnas.0704523104; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; SCHWARTZ MW, 1992, ENDOCRINOLOGY, V130, P3608, DOI 10.1210/en.130.6.3608; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Weinkove D, 1999, CURR BIOL, V9, P1019, DOI 10.1016/S0960-9822(99)80450-3; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; Wu Q, 2005, NAT NEUROSCI, V8, P1350, DOI 10.1038/nn1540; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9	51	314	317	2	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 1	2011	145	1					133	144		10.1016/j.cell.2011.02.008	http://dx.doi.org/10.1016/j.cell.2011.02.008			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	743XW	21458672	Green Accepted, Bronze			2022-12-28	WOS:000289053900015
J	Villareal, DT; Chode, S; Parimi, N; Sinacore, DR; Hilton, T; Armamento-Villareal, R; Napoli, N; Qualls, C; Shah, K				Villareal, Dennis T.; Chode, Suresh; Parimi, Nehu; Sinacore, David R.; Hilton, Tiffany; Armamento-Villareal, Reina; Napoli, Nicola; Qualls, Clifford; Shah, Krupa			Weight Loss, Exercise, or Both and Physical Function in Obese Older Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NURSING-HOME ADMISSION; CALORIC RESTRICTION; KNEE OSTEOARTHRITIS; CONTROLLED-TRIAL; US ADULTS; FRAILTY; WOMEN; PERFORMANCE; HEALTH; ASSOCIATION	BACKGROUND Obesity exacerbates the age-related decline in physical function and causes frailty in older adults; however, the appropriate treatment for obese older adults is controversial. METHODS In this 1-year, randomized, controlled trial, we evaluated the independent and combined effects of weight loss and exercise in 107 adults who were 65 years of age or older and obese. Participants were randomly assigned to a control group, a weight-management (diet) group, an exercise group, or a weight-management-plus-exercise (diet-exercise) group. The primary outcome was the change in score on the modified Physical Performance Test. Secondary outcomes included other measures of frailty, body composition, bone mineral density, specific physical functions, and quality of life. RESULTS A total of 93 participants (87%) completed the study. In the intention-to-treat analysis, the score on the Physical Performance Test, in which higher scores indicate better physical status, increased more in the diet-exercise group than in the diet group or the exercise group (increases from baseline of 21% vs. 12% and 15%, respectively); the scores in all three of those groups increased more than the scores in the control group (in which the score increased by 1%) (P<0.001 for the between-group differences). Moreover, the peak oxygen consumption improved more in the diet-exercise group than in the diet group or the exercise group (increases of 17% vs. 10% and 8%, respectively; P<0.001); the score on the Functional Status Questionnaire, in which higher scores indicate better physical function, increased more in the diet-exercise group than in the diet group (increase of 10% vs. 4%, P<0.001). Body weight decreased by 10% in the diet group and by 9% in the diet-exercise group, but did not decrease in the exercise group or the control group (P<0.001). Lean body mass and bone mineral density at the hip decreased less in the diet-exercise group than in the diet group (reductions of 3% and 1%, respectively, in the diet-exercise group vs. reductions of 5% and 3%, respectively, in the diet group; P<0.05 for both comparisons). Strength, balance, and gait improved consistently in the diet-exercise group (P<0.05 for all comparisons). Adverse events included a small number of exercise-associated musculoskeletal injuries. CONCLUSIONS These findings suggest that a combination of weight loss and exercise provides greater improvement in physical function than either intervention alone.	[Villareal, Dennis T.; Chode, Suresh; Parimi, Nehu; Sinacore, David R.; Shah, Krupa] Washington Univ, Sch Med, Div Geriatr & Nutr Sci, St Louis, MO USA; [Sinacore, David R.; Hilton, Tiffany] Washington Univ, Sch Med, Program Phys Therapy, St Louis, MO USA; [Armamento-Villareal, Reina; Napoli, Nicola] Washington Univ, Sch Med, Div Bone & Mineral Dis, St Louis, MO USA; [Villareal, Dennis T.] New Mexico VA Hlth Care Syst, Sect Geriatr, Albuquerque, NM 87108 USA; [Armamento-Villareal, Reina] New Mexico VA Hlth Care Syst, Endocrinol Sect, Albuquerque, NM 87108 USA; [Villareal, Dennis T.] Univ New Mexico, Sch Med, Div Geriatr, Albuquerque, NM 87131 USA; [Armamento-Villareal, Reina] Univ New Mexico, Sch Med, Div Endocrinol, Albuquerque, NM 87131 USA; [Qualls, Clifford] Univ New Mexico, Sch Med, Dept Math & Stat, Albuquerque, NM 87131 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of New Mexico; University of New Mexico; University of New Mexico	Villareal, DT (corresponding author), New Mexico VA Hlth Care Syst, Sect Geriatr, Geriatr 111K,1501 San Pedro Dr, Albuquerque, NM 87108 USA.	dennis.villareal@va.gov	Biguzzi, Felipe A/E-4724-2015; PT, David R. Sinacore/AAS-3377-2020; Villareal, Reina/AAH-6028-2019; Napoli, Nicola/K-8242-2016	PT, David R. Sinacore/0000-0002-7242-3585; Hilton, Tiffany/0000-0001-5869-201X; Napoli, Nicola/0000-0002-3091-8205	National Institutes of Health [RO1-AG025501, P30-DK56341, UL1-RR024992, DK20579]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD007434]; Foundation for Physical Therapy; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007434] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, P60DK020579, P30DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Foundation for Physical Therapy; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants (RO1-AG025501 and P30-DK56341 [Clinical Nutrition Research Unit], UL1-RR024992 [a Clinical and Translational Science Award], and DK20579 [Diabetes Research and Training Center]) from the National Institutes of Health. Dr. Hilton was supported by a postdoctoral fellowship (HD007434) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and a New Investigator Fellowship Initiative grant from the Foundation for Physical Therapy.	Ahmed N, 2007, AM J MED, V120, P748, DOI 10.1016/j.amjmed.2006.10.018; Alley DE, 2008, J GERONTOL A-BIOL, V63, P1257, DOI 10.1093/gerona/63.11.1257; Apovian CM, 1996, J AM GERIATR SOC, V44, P1487, DOI 10.1111/j.1532-5415.1996.tb04082.x; Arterburn DE, 2004, J AM GERIATR SOC, V52, P1907, DOI 10.1111/j.1532-5415.2004.52517.x; Bales CW, 2008, J AM MED DIR ASSOC, V9, P302, DOI 10.1016/j.jamda.2008.01.006; Binder EF, 2002, J AM GERIATR SOC, V50, P1921, DOI 10.1046/j.1532-5415.2002.50601.x; Binder EF, 1999, J GERONTOL A-BIOL, V54, pM353, DOI 10.1093/gerona/54.7.M353; Blaum CS, 2005, J AM GERIATR SOC, V53, P927, DOI 10.1111/j.1532-5415.2005.53300.x; Bouchard DR, 2009, MENOPAUSE, V16, P66, DOI 10.1097/gme.0b013e31817dacf7; Brown M, 2000, ARCH PHYS MED REHAB, V81, P960, DOI 10.1053/apmr.2000.4425; Brown M, 2000, J GERONTOL A-BIOL, V55, pM350, DOI 10.1093/gerona/55.6.M350; Elia M, 2001, OBES RES, V9, p244S, DOI 10.1038/oby.2001.126; Elkins JS, 2006, OBESITY, V14, P1472, DOI 10.1038/oby.2006.167; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hamerman D, 1999, ANN INTERN MED, V130, P945, DOI 10.7326/0003-4819-130-11-199906010-00022; Host H., 1996, PHYS THER, V76; Jensen GL, 2010, CURR OPIN CLIN NUTR, V13, P46, DOI 10.1097/MCO.0b013e32833309cf; JETTE AM, 1987, PHYS THER, V67, P1854, DOI 10.1093/ptj/67.12.1854; Kalantar-Zadeh K, 2001, J AM SOC NEPHROL, V12, P2797, DOI 10.1681/ASN.V12122797; Klein S, 2002, GASTROENTEROLOGY, V123, P882, DOI 10.1053/gast.2002.35514; Lapane KL, 2005, J AM GERIATR SOC, V53, P1386, DOI 10.1111/j.1532-5415.2005.53420.x; Li FZ, 2005, J AM GERIATR SOC, V53, P737, DOI 10.1111/j.1532-5415.2005.53228_10.x; LYONS RA, 1994, AGE AGEING, V23, P182, DOI 10.1093/ageing/23.3.182; MA V, 2006, Am J Clin Nutr, V84, P1257; Messier SP, 2004, ARTHRITIS RHEUM-US, V50, P1501, DOI 10.1002/art.20256; Miller GD, 2006, OBESITY, V14, P1219, DOI 10.1038/oby.2006.139; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Rejeski WJ, 2010, OBES REV, V11, P671, DOI 10.1111/j.1467-789X.2009.00679.x; REUBEN DB, 1992, J GERONTOL, V47, pM106, DOI 10.1093/geronj/47.4.M106; Roubenoff R, 2004, OBES RES, V12, P887, DOI 10.1038/oby.2004.107; Shah K, 2008, J AM GERIATR SOC, V56, pS183; Shea MK, 2010, J GERONTOL A-BIOL, V65, P519, DOI 10.1093/gerona/glp217; Villareal DT, 2006, ARCH INTERN MED, V166, P2502, DOI 10.1001/archinte.166.22.2502; Villareal DT, 2006, ARCH INTERN MED, V166, P860, DOI 10.1001/archinte.166.8.860; Villareal DT, 2004, OBES RES, V12, P913, DOI 10.1038/oby.2004.111; Villareal DT, 2005, AM J CLIN NUTR, V82, P923, DOI 10.1093/ajcn/82.5.923; VILLAREAL DT, 2007, ARCH INTERN MED, V167, P452; Weiss EP, 2007, J APPL PHYSIOL, V102, P634, DOI 10.1152/japplphysiol.00853.2006; Witham MD, 2010, AGE AGEING, V39, P176, DOI 10.1093/ageing/afp251; Zizza CA, 2002, OBES RES, V10, P816, DOI 10.1038/oby.2002.110	41	641	675	3	128	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 31	2011	364	13					1218	1229		10.1056/NEJMoa1008234	http://dx.doi.org/10.1056/NEJMoa1008234			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	742NO	21449785	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000288951300006
J	Ceol, CJ; Houvras, Y; Jane-Valbuena, J; Bilodeau, S; Orlando, DA; Battisti, V; Fritsch, L; Lin, WM; Hollmann, TJ; Ferre, F; Bourque, C; Burke, CJ; Turner, L; Uong, A; Johnson, LA; Beroukhim, R; Mermel, CH; Loda, M; Ait-Si-Ali, S; Garraway, LA; Young, RA; Zon, LI				Ceol, Craig J.; Houvras, Yariv; Jane-Valbuena, Judit; Bilodeau, Steve; Orlando, David A.; Battisti, Valentine; Fritsch, Lauriane; Lin, William M.; Hollmann, Travis J.; Ferre, Fabrizio; Bourque, Caitlin; Burke, Christopher J.; Turner, Laura; Uong, Audrey; Johnson, Laura A.; Beroukhim, Rameen; Mermel, Craig H.; Loda, Massimo; Ait-Si-Ali, Slimane; Garraway, Levi A.; Young, Richard A.; Zon, Leonard I.			The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset	NATURE			English	Article							MALIGNANT-MELANOMA; BRAF MUTATIONS; HUMAN CANCER; GENES; NEVI; SENESCENCE; EXPRESSION; REPRESSION; LYSINE-9; CELLS	The most common mutation in human melanoma, BRAF(V600E), activates the serine/threonine kinase BRAF and causes excessive activity in the mitogen-activated protein kinase pathway(1,2). BRAF(V600E) mutations are also present in benign melanocytic naevi(3), highlighting the importance of additional genetic alterations in the genesis of malignant tumours. Such changes include recurrent copy number variations that result in the amplification of oncogenes(4,5). For certain amplifications, the large number of genes in the interval has precluded an understanding of the cooperating oncogenic events. Here we have used a zebrafish melanoma model to test genes in a recurrently amplified region of chromosome 1 for the ability to cooperate with BRAF(V600E) and accelerate melanoma. SETDB1, an enzyme that methylates histone H3 on lysine 9 (H3K9), was found to accelerate melanoma formation significantly in zebrafish. Chromatin immunoprecipitation coupled with massively parallel DNA sequencing and gene expression analyses uncovered genes, including HOX genes, that are transcriptionally dysregulated in response to increased levels of SETDB1. Our studies establish SETDB1 as an oncogene in melanoma and underscore the role of chromatin factors in regulating tumorigenesis.	[Ceol, Craig J.; Houvras, Yariv; Bourque, Caitlin; Burke, Christopher J.; Turner, Laura; Uong, Audrey; Zon, Leonard I.] Harvard Univ, Stem Cell Program & Hematol Oncol, Childrens Hosp Boston,Med Sch, Howard Hughes Med Inst,Harvard Stem Cell Inst, Boston, MA 02115 USA; [Houvras, Yariv] Harvard Univ, Massachusetts Gen Hosp, Ctr Canc, Sch Med, Boston, MA 02114 USA; [Jane-Valbuena, Judit; Lin, William M.; Johnson, Laura A.; Beroukhim, Rameen; Mermel, Craig H.; Garraway, Levi A.] Harvard Univ, Dept Med Oncol, Dana Farber Canc Inst, Sch Med, Boston, MA 02115 USA; [Jane-Valbuena, Judit; Lin, William M.; Johnson, Laura A.; Beroukhim, Rameen; Mermel, Craig H.; Garraway, Levi A.] Harvard Univ, Ctr Canc Genome Discovery, Dana Farber Canc Inst, Sch Med, Boston, MA 02115 USA; [Jane-Valbuena, Judit; Lin, William M.; Johnson, Laura A.; Beroukhim, Rameen; Mermel, Craig H.; Garraway, Levi A.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA; [Bilodeau, Steve; Orlando, David A.; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Battisti, Valentine; Fritsch, Lauriane; Ait-Si-Ali, Slimane] Univ Paris Diderot, Epigenet & Destin Cellulaire UMR7216, CNRS, F-75013 Paris, France; [Hollmann, Travis J.; Loda, Massimo] Harvard Univ, Ctr Mol Oncol Pathol, Brigham & Womens Hosp, Dana Farber Canc Inst,Med Sch, Boston, MA 02115 USA; [Ferre, Fabrizio] Univ Roma La Sapienza, A Rossi Fanelli Biochem Sci Dept, I-00185 Rome, Italy	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Sapienza University Rome	Zon, LI (corresponding author), Harvard Univ, Stem Cell Program & Hematol Oncol, Childrens Hosp Boston,Med Sch, Howard Hughes Med Inst,Harvard Stem Cell Inst, Boston, MA 02115 USA.	zon@enders.tch.harvard.edu	Young, Richard A/F-6495-2012; Mermel, Craig/AAZ-7322-2020	Young, Richard A/0000-0001-8855-8647; Mermel, Craig/0000-0002-0816-3395; Bilodeau, Steve/0000-0002-9799-3832; FERRE', FABRIZIO/0000-0003-2768-5305; Houvras, Yariv/0000-0003-0751-3215; Burke, Christopher/0000-0001-7609-1146	Damon Runyon Cancer Research Foundation [DRG-1855-05]; Charles A. King Trust Foundation; American Society of Clinical Oncology; Canadian Institutes of Health Research; National Institutes of Health [K99AR056899-02, K08DK075432-04, CA146455, HG002668, CA103846, DK055381]; NATIONAL CANCER INSTITUTE [R01CA103846, R01CA146445] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R00AR056899, K99AR056899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK055381, R01DK053298, R01DK055381, K08DK075432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; Charles A. King Trust Foundation; American Society of Clinical Oncology; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Harrington, R. White and Y. Zhou for discussions; C. Lawrence, I. Adatto and L.-K. Zhang for expert fish care; G. Frampton for bioinformatics assistance; and K. Kwan, C.-B. Chien, and J. Boehm for reagents. This work was supported by grants from the Damon Runyon Cancer Research Foundation (C.J.C., DRG-1855-05), the Charles A. King Trust Foundation (C.J.C.), a Young Investigator Award from the American Society of Clinical Oncology (Y.H.), the Canadian Institutes of Health Research (S.B.) and the National Institutes of Health (C.J.C., K99AR056899-02; Y.H., K08DK075432-04; R.A.Y., CA146455, HG002668; and L.I.Z., CA103846 and DK055381).	Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Fritsch L, 2010, MOL CELL, V37, P46, DOI 10.1016/j.molcel.2009.12.017; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nisolle M, 1999, HUM REPROD, V14, P2844, DOI 10.1093/humrep/14.11.2844; Patton EE, 2005, CURR BIOL, V15, P249, DOI 10.1016/j.cub.2005.01.031; Perner S, 2008, NEOPLASIA, V10, P298, DOI 10.1593/NEO.07878; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Santoriello C, 2009, DIS MODEL MECH, V2, P56, DOI 10.1242/dmm.001016; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007	23	383	392	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 24	2011	471	7339					513	+		10.1038/nature09806	http://dx.doi.org/10.1038/nature09806			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739GJ	21430779	Green Accepted, Green Submitted			2022-12-28	WOS:000288702200062
J	O'Callaghan, T				O'Callaghan, Tiffany			The prevention agenda INTRODUCTION	NATURE			English	Editorial Material																		Boyle P, 2008, WORLD CANC REPORT 20; Niederdeppe J, 2010, J COMMUN, V60, P230, DOI 10.1111/j.1460-2466.2009.01474.x	2	22	23	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 24	2011	471	7339					S2	S4		10.1038/471S2a	http://dx.doi.org/10.1038/471S2a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	739GJ	21430716	Bronze			2022-12-28	WOS:000288702200008
J	Chopra, V; Davis, M				Chopra, Vineet; Davis, Matthew			In Search of Equipoise	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED CONTROLLED-TRIALS; PRIMARY OUTCOMES		[Chopra, Vineet; Davis, Matthew] Univ Michigan, Div Gen Internal Med, Ann Arbor, MI 48109 USA; [Davis, Matthew] Univ Michigan, Div Gen Pediat, Ann Arbor, MI 48109 USA; [Davis, Matthew] Univ Michigan, Gerald R Ford Sch Publ Policy, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chopra, V (corresponding author), 3119 Taubman Hlth Ctr,1500 E Med Ctr Dr,SPC 5376, Ann Arbor, MI 48109 USA.	vineetc@umich.edu		Chopra, Vineet/0000-0001-8670-9376				Boutron I, 2010, JAMA-J AM MED ASSOC, V303, P2058, DOI 10.1001/jama.2010.651; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Deer B, 2011, BRIT MED J, V342, DOI 10.1136/bmj.c5347; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; LaFollette MC, 2000, P SOC EXP BIOL MED, V224, P211, DOI 10.1046/j.1525-1373.2000.22423.x; Martinson BC, 2006, J EMPIR RES HUM RES, V1, P51, DOI 10.1525/jer.2006.1.1.51; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Titus S, 2010, NATURE, V466, P436, DOI 10.1038/466436a	10	6	6	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	2011	305	12					1234	1235		10.1001/jama.2011.363	http://dx.doi.org/10.1001/jama.2011.363			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	738PA	21427376				2022-12-28	WOS:000288652100019
J	Peter, IS; Davidson, EH				Peter, Isabelle S.; Davidson, Eric H.			Evolution of Gene Regulatory Networks Controlling Body Plan Development	CELL			English	Review							HOX GENES; BITHORAX COMPLEX; TRANSCRIPTIONAL REGULATION; MORPHOLOGICAL EVOLUTION; ADAPTIVE EVOLUTION; EYE DEGENERATION; PELVIC REDUCTION; MOBILE ELEMENTS; DROSOPHILA; EXPRESSION	Evolutionary change in animal morphology results from alteration of the functional organization of the gene regulatory networks (GRNs) that control development of the body plan. A major mechanism of evolutionary change in GRN structure is alteration of cis-regulatory modules that determine regulatory gene expression. Here we consider the causes and consequences of GRN evolution. Although some GRN subcircuits are of great antiquity, other aspects are highly flexible and thus in any given genome more recent. This mosaic view of the evolution of GRN structure explains major aspects of evolutionary process, such as hierarchical phylogeny and discontinuities of paleontological change.	[Peter, Isabelle S.; Davidson, Eric H.] CALTECH, Dept Biol 156 29, Pasadena, CA 91125 USA	California Institute of Technology	Peter, IS (corresponding author), CALTECH, Dept Biol 156 29, Pasadena, CA 91125 USA.	ipeter@caltech.edu; davidson@caltech.edu		Peter, Isabelle/0000-0003-3685-3147	NIH [HD-037105]; NSF [IOS-0641398]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD037105] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We gratefully acknowledge support for this work from NIH Grant HD-037105 and from NSF Grant IOS-0641398.	Aboobaker A, 2010, ADV EXP MED BIOL, V689, P101; Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Abzhanov A, 2006, NATURE, V442, P563, DOI 10.1038/nature04843; Averof M, 1997, NATURE, V388, P682, DOI 10.1038/41786; Balhoff JP, 2005, P NATL ACAD SCI USA, V102, P8591, DOI 10.1073/pnas.0409638102; Baumer N, 2002, DEVELOPMENT, V129, P4535; Baylies MK, 1998, CELL, V93, P921, DOI 10.1016/S0092-8674(00)81198-8; BENDER W, 1983, SCIENCE, V221, P23, DOI 10.1126/science.221.4605.23; Bolouri H, 2010, DEV BIOL, V340, P170, DOI 10.1016/j.ydbio.2009.06.007; BRITTEN RJ, 1971, Q REV BIOL, V46, P111, DOI 10.1086/406830; Britten RJ, 1997, GENE, V205, P177, DOI 10.1016/S0378-1119(97)00399-5; Cameron RA, 2009, DEV BIOL, V336, P122, DOI 10.1016/j.ydbio.2009.09.018; Carapuco M, 2005, GENE DEV, V19, P2116, DOI 10.1101/gad.338705; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Choe CP, 2009, DEV BIOL, V325, P482, DOI 10.1016/j.ydbio.2008.10.037; Choe CP, 2006, P NATL ACAD SCI USA, V103, P6560, DOI 10.1073/pnas.0510440103; Cobb J, 2005, DEVELOPMENT, V132, P3055, DOI 10.1242/dev.01885; Cole NJ, 2003, CURR BIOL, V13, pR951, DOI 10.1016/S0960-9822(03)00881-9; Corbo JC, 2010, GENOME RES, V20, P1512, DOI 10.1101/gr.109405.110; Cretekos CJ, 2008, GENE DEV, V22, P141, DOI 10.1101/gad.1620408; Davidson EH, 2009, COLD SH Q B, V74, P65, DOI 10.1101/sqb.2009.74.042; Davidson E. H., 2001, DEV EVOLUTION; DAVIDSON EH, 1990, DEVELOPMENT, V108, P365; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Davidson EH, 2006, REG GEN GEN REG; Davidson EH, 2010, J EXP ZOOL PART B, V314B, P182, DOI 10.1002/jez.b.21329; Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040; Dermitzakis ET, 2003, MOL BIOL EVOL, V20, P703, DOI 10.1093/molbev/msg077; Di-Poi N, 2010, NATURE, V464, P99, DOI 10.1038/nature08789; Dubois L, 2007, DEVELOPMENT, V134, P4347, DOI 10.1242/dev.008409; Elgar G, 2008, TRENDS GENET, V24, P344, DOI 10.1016/j.tig.2008.04.005; Erwin DH, 2009, NAT REV GENET, V10, P141, DOI 10.1038/nrg2499; Fraser GJ, 2009, PLOS BIOL, V7, P233, DOI 10.1371/journal.pbio.1000031; Friedrich M, 2006, ARTHROPOD STRUCT DEV, V35, P357, DOI 10.1016/j.asd.2006.08.010; Galant R, 2002, DEVELOPMENT, V129, P3115; Gao F, 2008, P NATL ACAD SCI USA, V105, P6091, DOI 10.1073/pnas.0801201105; GARZA D, 1991, GENETICS, V128, P303; Gogvadze E, 2009, CELL MOL LIFE SCI, V66, P3727, DOI 10.1007/s00018-009-0107-2; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Gonzalez F, 2007, DEV BIOL, V306, P847, DOI 10.1016/j.ydbio.2007.03.020; Gross JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000326; Guo P, 2009, NATURE, V459, P796, DOI 10.1038/nature08068; Hare EE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000106; Hayakawa E, 2004, DEV GENES EVOL, V214, P486, DOI 10.1007/s00427-004-0430-4; Hennig AK, 2008, BRAIN RES, V1192, P114, DOI 10.1016/j.brainres.2007.06.036; Herault Y, 1999, DEV BIOL, V208, P157, DOI 10.1006/dbio.1998.9179; Herault Y, 1998, DEVELOPMENT, V125, P1669; Herpin A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000844; Herrin BR, 2010, J IMMUNOL, V185, P1367, DOI 10.4049/jimmunol.0903128; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Hinman VF, 2007, P NATL ACAD SCI USA, V104, P19404, DOI 10.1073/pnas.0709994104; Ho MCW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000709; Hoffmann JA, 2003, NATURE, V426, P33, DOI 10.1038/nature02021; Hong JW, 2008, P NATL ACAD SCI USA, V105, P20072, DOI 10.1073/pnas.0806476105; Hueber SD, 2008, BIOESSAYS, V30, P965, DOI 10.1002/bies.20823; Ikuta T, 2010, DEVELOPMENT, V137, P1505, DOI 10.1242/dev.046938; Jaynes JB, 2004, DEV BIOL, V269, P609, DOI 10.1016/j.ydbio.2004.03.001; Jeffery WR, 2009, ANNU REV GENET, V43, P25, DOI 10.1146/annurev-genet-102108-134216; Jeffery WR, 2005, J HERED, V96, P185, DOI 10.1093/jhered/esi028; Jimenez-Delgado Senda, 2009, Briefings in Functional Genomics & Proteomics, V8, P266, DOI 10.1093/bfgp/elp029; Johnson R, 2009, MOL BIOL EVOL, V26, P1491, DOI 10.1093/molbev/msp058; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kmita M, 2000, GENE DEV, V14, P198; Koshiba-Takeuchi K, 2009, NATURE, V461, P95, DOI 10.1038/nature08324; Kotkamp K, 2010, DEVELOPMENT, V137, P1853, DOI 10.1242/dev.047043; Kumar JP, 2009, BBA-GENE REGUL MECH, V1789, P306, DOI 10.1016/j.bbagrm.2008.10.001; LaBeau EM, 2009, MECH DEVELOP, V126, P478, DOI 10.1016/j.mod.2009.01.001; Lemons D, 2010, DEV BIOL, V344, P358, DOI 10.1016/j.ydbio.2010.04.022; Liberman LM, 2009, DEV BIOL, V327, P578, DOI 10.1016/j.ydbio.2008.12.020; Liubicich DM, 2009, P NATL ACAD SCI USA, V106, P13892, DOI 10.1073/pnas.0903105106; Lo PCH, 2002, DEV BIOL, V251, P307, DOI 10.1006/dbio.2002.0839; Logan M, 1999, SCIENCE, V283, P1736, DOI 10.1126/science.283.5408.1736; Lowe CJ, 2003, CELL, V113, P853, DOI 10.1016/S0092-8674(03)00469-0; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; Maeda RK, 2009, CURR TOP DEV BIOL, V88, P1, DOI 10.1016/S0070-2153(09)88001-0; Marques-Souza H, 2008, DEVELOPMENT, V135, P881, DOI 10.1242/dev.018317; Martinez P, 1999, P NATL ACAD SCI USA, V96, P1469, DOI 10.1073/pnas.96.4.1469; McCauley BS, 2010, DEV BIOL, V340, P200, DOI 10.1016/j.ydbio.2009.11.020; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Messier-Solek C, 2010, SEMIN IMMUNOL, V22, P39, DOI 10.1016/j.smim.2009.11.007; Miller CT, 2007, CELL, V131, P1179, DOI 10.1016/j.cell.2007.10.055; Minoux M, 2009, DEVELOPMENT, V136, P637, DOI 10.1242/dev.028621; Mishra M, 2010, DEVELOPMENT, V137, P2895, DOI 10.1242/dev.051722; Oda-Ishii I, 2005, DEVELOPMENT, V132, P1663, DOI 10.1242/dev.01707; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Ohshima K, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r74; Oliveri P, 2008, P NATL ACAD SCI USA, V105, P5955, DOI 10.1073/pnas.0711220105; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Parker HG, 2009, SCIENCE, V325, P995, DOI 10.1126/science.1173275; Pavlopoulos A, 2009, P NATL ACAD SCI USA, V106, P13897, DOI 10.1073/pnas.0902804106; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Pearson JC, 2009, P NATL ACAD SCI USA, V106, P2224, DOI 10.1073/pnas.0810219106; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Peter IS, 2009, FEBS LETT, V583, P3948, DOI 10.1016/j.febslet.2009.11.060; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P17692, DOI 10.1073/pnas.0707045104; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Ranade SS, 2008, DEV BIOL, V315, P521, DOI 10.1016/j.ydbio.2007.12.017; Rastegar S, 2008, DEV BIOL, V318, P366, DOI 10.1016/j.ydbio.2008.03.034; Rebeiz M, 2009, SCIENCE, V326, P1663, DOI 10.1126/science.1178357; Rokas A, 2006, PLOS BIOL, V4, P1899, DOI 10.1371/journal.pbio.0040352; RUVKUN G, 1991, DEVELOPMENT, P47; Seibert J, 2010, DEV BIOL, V346, P332, DOI 10.1016/j.ydbio.2010.07.024; Seipel K, 2005, DEV BIOL, V282, P14, DOI 10.1016/j.ydbio.2005.03.032; Shapiro MD, 2006, P NATL ACAD SCI USA, V103, P13753, DOI 10.1073/pnas.0604706103; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; SIMON J, 1990, EMBO J, V9, P3945, DOI 10.1002/j.1460-2075.1990.tb07615.x; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Spitz F, 2001, GENE DEV, V15, P2209, DOI 10.1101/gad.205701; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; Swiers G, 2010, DEV BIOL, V343, P138, DOI 10.1016/j.ydbio.2010.04.002; Szeto DP, 1999, GENE DEV, V13, P484, DOI 10.1101/gad.13.4.484; Tarchini B, 2006, DEV CELL, V10, P93, DOI 10.1016/j.devcel.2005.11.014; Tessmar-Raible K, 2007, CELL, V129, P1389, DOI 10.1016/j.cell.2007.04.041; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; Tumpel S, 2009, CURR TOP DEV BIOL, V88, P103, DOI 10.1016/S0070-2153(09)88004-6; Tumpel S, 2007, DEV BIOL, V302, P646, DOI 10.1016/j.ydbio.2006.10.029; Vavouri T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r15; Vinagre T, 2010, DEV CELL, V18, P655, DOI 10.1016/j.devcel.2010.02.011; Walters J, 2008, DEV BIOL, V315, P567, DOI 10.1016/j.ydbio.2008.01.007; Wang JL, 2009, MOL BIOL EVOL, V26, P487, DOI 10.1093/molbev/msn278; Weatherbee SD, 1998, GENE DEV, V12, P1474, DOI 10.1101/gad.12.10.1474; Wellik DM, 2009, CURR TOP DEV BIOL, V88, P257, DOI 10.1016/S0070-2153(09)88009-5; Wellik DM, 2003, SCIENCE, V301, P363, DOI 10.1126/science.1085672; Woltering JM, 2010, DEV CELL, V18, P526, DOI 10.1016/j.devcel.2010.04.002; Woltering JM, 2009, DEV BIOL, V332, P82, DOI 10.1016/j.ydbio.2009.04.031; Yamamoto Y, 2004, NATURE, V431, P844, DOI 10.1038/nature02864; Yang XY, 2009, DEV BIOL, V333, P202, DOI 10.1016/j.ydbio.2009.02.040; Zakany J, 2004, SCIENCE, V304, P1669, DOI 10.1126/science.1096049	129	251	262	2	84	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 18	2011	144	6					970	985		10.1016/j.cell.2011.02.017	http://dx.doi.org/10.1016/j.cell.2011.02.017			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	737BQ	21414487	Green Accepted, Bronze			2022-12-28	WOS:000288543500014
J	Catlow, R; Fisher, A				Catlow, Richard; Fisher, Andrew			Marshall Stoneham (1940-2011) OBITUARY	NATURE			English	Biographical-Item									[Catlow, Richard] UCL, London WC1H 0AJ, England; [Fisher, Andrew] UCL, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Catlow, R (corresponding author), UCL, London WC1H 0AJ, England.	c.r.a.catlow@ucl.ac.uk		Catlow, Charles/0000-0002-1341-1541				STONEHAM M, PUBLICATION LIST	1	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 17	2011	471	7338					306	306		10.1038/471306a	http://dx.doi.org/10.1038/471306a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21412325	Bronze			2022-12-28	WOS:000288444000025
J	Sexton, PF; Norris, RD; Wilson, PA; Palike, H; Westerhold, T; Rohl, U; Bolton, CT; Gibbs, S				Sexton, Philip F.; Norris, Richard D.; Wilson, Paul A.; Paelike, Heiko; Westerhold, Thomas; Roehl, Ursula; Bolton, Clara T.; Gibbs, Samantha			Eocene global warming events driven by ventilation of oceanic dissolved organic carbon	NATURE			English	Article							LATE PALEOCENE; ATMOSPHERIC CO2; HYDRATE; CYCLE; TIME	'Hyperthermals' are intervals of rapid, pronounced global warming known from six episodes within the Palaeocene and Eocene epochs (similar to 65-34 million years (Myr) ago)(1-13). The most extreme hyperthermal was the 170 thousand year (kyr) interval(2) of 5-7 degrees C global warming(3) during the Palaeocene-Eocene Thermal Maximum (PETM, 56 Myr ago). The PETM is widely attributed to massive release of greenhouse gases from buried sedimentary carbon reservoirs(1,3,6,11,14-17), and other, comparatively modest, hyperthermals have also been linked to the release of sedimentary carbon(3,6,11,16,17). Here we show, using new 2.4-Myr-long Eocene deep ocean records, that the comparatively modest hyperthermals are much more numerous than previously documented, paced by the eccentricity of Earth's orbit and have shorter durations (40 kyr) and more rapid recovery phases than the PETM. These findings point to the operation of fundamentally different forcing and feedback mechanisms than for the PETM, involving redistribution of carbon among Earth's readily exchangeable surface reservoirs rather than carbon exhumation from, and subsequent burial back into, the sedimentary reservoir. Specifically, we interpret our records to indicate repeated, large-scale releases of dissolved organic carbon (at least 1,600 giga-tonnes) from the ocean by ventilation (strengthened oxidation) of the ocean interior. The rapid recovery of the carbon cycle following each Eocene hyperthermal strongly suggests that carbon was re-sequestered by the ocean, rather than the much slower process of silicate rock weathering proposed for the PETM1,3. Our findings suggest that these pronounced climate warming events were driven not by repeated releases of carbon from buried sedimentary sources(3,6,11,16,17), but, rather, by patterns of surficial carbon redistribution familiar from younger intervals of Earth history.	[Sexton, Philip F.; Norris, Richard D.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Sexton, Philip F.; Wilson, Paul A.; Paelike, Heiko; Bolton, Clara T.; Gibbs, Samantha] Univ Southampton, Natl Oceanog Ctr Southampton, Southampton SO14 3ZH, Hants, England; [Westerhold, Thomas; Roehl, Ursula] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany	University of California System; University of California San Diego; Scripps Institution of Oceanography; NERC National Oceanography Centre; University of Southampton; University of Bremen	Sexton, PF (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	P.F.Sexton@open.ac.uk	Röhl, Ursula/G-5986-2011; Westerhold, Thomas/D-4581-2011; Bolton, Clara/A-2423-2012; Palike, Heiko/A-6560-2008	Röhl, Ursula/0000-0001-9469-7053; Westerhold, Thomas/0000-0001-8151-4684; Palike, Heiko/0000-0003-3386-0923; Bolton, Clara/0000-0002-3078-1253; Wilson, Paul/0000-0001-6425-8906	US NSF and; European Commission; Leverhulme Trust; Natural Environment Research Council UK; Philip Leverhulme Prize; DFG-Leibniz Center for Surface Process and Climate Studies at the University of Potsdam; DFG; NERC [NE/G009376/1] Funding Source: UKRI; STFC [PP/D002176/1] Funding Source: UKRI; Natural Environment Research Council [NE/G009376/1] Funding Source: researchfish; Science and Technology Facilities Council [PP/D002176/1] Funding Source: researchfish	US NSF and; European Commission(European CommissionEuropean Commission Joint Research Centre); Leverhulme Trust(Leverhulme Trust); Natural Environment Research Council UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Philip Leverhulme Prize; DFG-Leibniz Center for Surface Process and Climate Studies at the University of Potsdam; DFG(German Research Foundation (DFG)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank M. Bolshaw for laboratory assistance and the shipboard party and crew of Ocean Drilling Program (ODP) Leg 207 for a successful drilling expedition. We thank H. Brinkhuis, G. Dickens, G. Foster, M. Huber, S. Kirtland, D. Kroon, L. Kump, E. Rohling and J. Zachos for discussions. This research used samples and data provided by the ODP. ODP (now IODP) is sponsored by the US NSF and participating countries under the management of JOI, Inc. We thank W. Hale and A. Wulbers (IODP) for assistance with sediment core sampling. Financial support for this research was provided by a European Commission Marie Curie Outgoing International Fellowship (P. F. S.), a Leverhulme Trust Fellowship (P. F. S.), a Natural Environment Research Council UK ODP grant (P. A. W. and P. F. S.), a Philip Leverhulme Prize (H. P.), the DFG-Leibniz Center for Surface Process and Climate Studies at the University of Potsdam, and the DFG (U. R. and T. W.).	Archer D, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002625; Bemis BE, 1998, PALEOCEANOGRAPHY, V13, P150, DOI 10.1029/98PA00070; Berggren W. A., 1995, GEOCHRONOLOGY TIME S, P129, DOI DOI 10.2110/PEC.95.04.0129; Bralower T. J., 2002, P OCEAN DRILLING PRO, V198, P1, DOI DOI 10.2973/ODP.PROC.IR.198.2002; Browning JV, 1996, GEOLOGY, V24, P639, DOI 10.1130/0091-7613(1996)024<0639:GIOLTM>2.3.CO;2; Buffett B, 2004, EARTH PLANET SC LETT, V227, P185, DOI 10.1016/j.epsl.2004.09.005; Cramer BS, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000909; Curry W. B., 1993, EOS T AGU S, V74, P368; Dickens GR, 2003, EARTH PLANET SC LETT, V213, P169, DOI 10.1016/S0012-821X(03)00325-X; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Dickens GR, 2000, B SOC GEOL FR, V171, P37; Ducklow HW, 2007, MAR CHEM, V105, P140, DOI 10.1016/j.marchem.2007.01.015; Edgar KM, 2007, NATURE, V448, P908, DOI 10.1038/nature06053; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Hansell DA, 1998, NATURE, V395, P263, DOI 10.1038/26200; Hodell DA, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000367; Katz ME, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000798; Klaas C, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001765; Kurtz AC, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000908; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Lourens LJ, 2005, NATURE, V435, P1083, DOI 10.1038/nature03814; Machlus M, 2004, GEOLOGY, V32, P137, DOI 10.1130/G20091.1; Marchitto TM, 2007, SCIENCE, V316, P1456, DOI 10.1126/science.1138679; Nicolo MJ, 2007, GEOLOGY, V35, P699, DOI 10.1130/G23648A.1; Panchuk K, 2008, GEOLOGY, V36, P315, DOI 10.1130/G24474A.1; PETRIZZO MR, 2005, P OC DRILL PROGR SCI, V0198; Quillevere F, 2008, EARTH PLANET SC LETT, V265, P600, DOI 10.1016/j.epsl.2007.10.040; Rohl U, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001784; Schmittner A, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002953; Sexton PF, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001253; Shipboard Scientific Party, 2004, Proceedings of the Ocean Drilling Program Initial Reports, V208, P1; Shipboard Scientific Party, 2004, P OCEAN DRILL PROGRA, P1, DOI [10.2973/odp.proc.ir.207.105.2004, DOI 10.2973/ODP.PROC.IR.207.105.2004]; Sigman D. M., 2007, AGU GEOPHYS MONOGRAP, V173, P335; Skinner LC, 2010, SCIENCE, V328, P1147, DOI 10.1126/science.1183627; Stap L, 2010, GEOLOGY, V38, P607, DOI 10.1130/G30777.1; Suganuma Y., 2006, P ODP SCI RES, V207; Thomas Ellen, 2000, P132; Tjalsma R. C., 1983, MICROPALEONTOL SPEC, V4; Toggweiler JR, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001154; VANMORKHOVEN FPC, 1986, B CENT RECH EXPLOR P, V11; Westerhold T, 2009, CLIM PAST, V5, P309, DOI 10.5194/cp-5-309-2009; Westerhold T, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001322; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004	45	200	209	6	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2011	471	7338					349	+		10.1038/nature09826	http://dx.doi.org/10.1038/nature09826			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21412336	Green Submitted			2022-12-28	WOS:000288444000039
J	Hennekens, CH; DeMets, D				Hennekens, Charles H.; DeMets, David			Statistical Association and Causation Contributions of Different Types of Evidence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Hennekens, Charles H.] Florida Atlantic Univ, Nova SE Univ, Charles E Schmidt Coll Med, Boca Raton, FL 33432 USA; [Hennekens, Charles H.] Univ Miami, Miller Sch Med, Boca Raton, FL USA; [DeMets, David] Univ Wisconsin, Sch Med, Dept Biostat & Informat, Madison, WI USA	Nova Southeastern University; State University System of Florida; Florida Atlantic University; University of Wisconsin System; University of Wisconsin Madison	Hennekens, CH (corresponding author), Florida Atlantic Univ, Nova SE Univ, Charles E Schmidt Coll Med, 2800 S Ocean Blvd,PHA, Boca Raton, FL 33432 USA.	chenneke@fau.edu						DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; Friedman L. M., 1998, FUNDAMENTALS CLIN TR; Hennekens C.H., 1987, EPIDEMIOLOGY MED; Hennekens CH, 2009, JAMA-J AM MED ASSOC, V302, P2361, DOI 10.1001/jama.2009.1756; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503	5	66	69	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 16	2011	305	11					1134	1135		10.1001/jama.2011.322	http://dx.doi.org/10.1001/jama.2011.322			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734ZF	21406653				2022-12-28	WOS:000288381900028
